PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Gauthier, S; LeBlanc, J; Seresova, A; Laberge-Poirier, A; Correa, JA; Alturki, AY; Marcoux, J; Maleki, M; Feyz, M; de Guise, E				Gauthier, Sandra; LeBlanc, Joanne; Seresova, Alena; Laberge-Poirier, Andreanne; Correa, Jose A.; Alturki, Abdulrahman Y.; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra; de Guise, Elaine			Acute prediction of outcome and cognitive-communication impairments following traumatic brain injury: The influence of age, education and site of lesion	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Traumatic brain injury; Communication; Language; Acute care; Outcome	BOSTON NAMING TEST; VERBAL FLUENCY; POSTTRAUMATIC AMNESIA; NORMATIVE DATA; HEAD-INJURY; DISCOURSE; ADULTS; COMPREHENSION; PERFORMANCE; ABILITIES	Background. Communication impairment following a traumatic brain injury (TBI) has been well documented, yet information regarding communication skills in the acute period following the injury is limited in the literature. Also, little is known about the influence of TBI severity (mild, moderate or severe) on cognitive-communication impairments and how these impairments are related to short-term functional outcome. The goal of this study was to assess the performance of adults with mild, moderate and severe TBI on different language tests and to determine how this performance is related to functional capacity. We also aimed to explore which variables among age, sex, education, TBI severity and site of cerebral damage would predict initial language impairments. Methods: Several language tests were administered to a sample of 145 adult patients with TBI of a range of severities admitted to an acute care service and to 113 healthy participants from the community. Results: TBI patients of a range of severities performed poorly on all language tests in comparison to the healthy controls. In addition, patients with mild TBI performed better than the moderate and severe groups, except on the reading test and on the semantic naming test. In addition, their performance on verbal fluency, conversational discourse and procedural discourse tasks predicted acute functional outcome. Finally, age, education and TBI severity and site of lesion predicted some language performance. A left temporal lesion was associated with poorer performance in conversational discourse and auditory comprehension tasks, a left frontal lesion with a decrease in the verbal fluency results and a right parietal lesion with decreased auditory comprehension and reasoning skills. Conclusion Health care professionals working in the acute care setting should be aware of the possible presence of cognitive-communication impairments in patients with TBI, even for those with mild TBI. These deficits can lead to functional communication problems and assistance may be required for tasks frequently encountered in acute care requiring intact comprehension and expression.	[Gauthier, Sandra; de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gauthier, Sandra; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [LeBlanc, Joanne; Seresova, Alena; Laberge-Poirier, Andreanne; Feyz, Mitra] McGill Univ, Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ, Canada; [Correa, Jose A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Alturki, Abdulrahman Y.; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Alturki, Abdulrahman Y.; de Guise, Elaine] Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia; [de Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support as well as Marie-Michelle Boudreau Duhaime, Lucie C. Frenette, Camelie Archontakis, Laurence Malo-Veronneau, Dorothee Guilbault and Benedicte Santoire for their help in the recruitment and assessment of the control participants.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Avramovic P, 2017, BRAIN INJURY, V31, P502, DOI 10.1080/02699052.2017.1280854; Baker H. J., 1965, DETROIT TEST LEARNIN; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Benton A., 1976, MULTILINGUAL APHASIA; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Chapman JC, 1923, J EDUC RES, V8, P389; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Connor LT, 2004, J GERONTOL B-PSYCHOL, V59, pP203, DOI 10.1093/geronb/59.5.P203; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Federmeier KD, 2005, PSYCHOPHYSIOLOGY, V42, P133, DOI 10.1111/j.1469-8986.2005.00274.x; Federmeier KD, 2003, PSYCHOL AGING, V18, P858, DOI 10.1037/0882-7974.18.4.858; Feyereisen P, 1997, J SPEECH LANG HEAR R, V40, P1328, DOI 10.1044/jslhr.4006.1328; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Goodglass H, 1983, ASSESSMENT APHASIA R; Guinaud F., 2014, J READAPTATION MED P, V34, P155, DOI [10.1016/j.jrm.2014.07.001, DOI 10.1016/J.JRM.2014.07.001]; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Holliday R, 2005, BRAIN LANG, V95, P74, DOI 10.1016/j.bandl.2005.07.041; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Isaki E, 2000, BRAIN INJURY, V14, P441; Joanette Y, 2004, PROTOCOLE MONTREAL E; Kaplan E., 2001, BOSTON NAMING TEST; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Keuleers E, 2015, Q J EXP PSYCHOL, V68, P1665, DOI 10.1080/17470218.2015.1022560; Le K., 2011, ASHA LEADER, V16, P1821, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18]; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathuranath PS, 2003, J CLIN EXP NEUROPSYC, V25, P1057, DOI 10.1076/jcen.25.8.1057.16736; Mortensen L, 2006, LANG COGNITIVE PROC, V21, P238, DOI 10.1080/01690960444000278; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; NEILS J, 1995, J SPEECH HEAR RES, V38, P1143, DOI 10.1044/jshr.3805.1143; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Ratcliff G, 1998, BRAIN LANG, V61, P115, DOI 10.1006/brln.1997.1858; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; ROSS TP, 1995, CLIN NEUROPSYCHOL, V9, P321, DOI 10.1080/13854049508400496; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Silagi ML, 2014, CODAS, V26, P407, DOI 10.1590/2317-1782/20142013058; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Sohlberg MM, 2014, AM J SPEECH-LANG PAT, V23, P160, DOI 10.1044/2013_AJSLP-12-0005; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; Zec RF, 2005, J INT NEUROPSYCH SOC, V11, P716, DOI 10.1017/S1355617705050897	82	24	24	2	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAY-JUN	2018	73						77	90		10.1016/j.jcomdis.2018.04.003			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GI4WI	WOS:000434371500007	29709658				2022-02-06	
J	Xu, XP; Zhi, TL; Chao, HL; Jiang, K; Liu, YL; Bao, ZY; Fan, L; Wang, D; Li, Z; Liu, N; Ji, J				Xu, Xiupeng; Zhi, Tongle; Chao, Honglu; Jiang, Kuan; Liu, Yinlong; Bao, Zhongyuan; Fan, Liang; Wang, Dong; Li, Zheng; Liu, Ning; Ji, Jing			ERK1/2/mTOR/Stat3 pathway-mediated autophagy brain injury-induced acute lung injury	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Traumatic brain injury; Acute lung injury; Autophagy; Apoptosis; Inflammation; Oxidative stress	SIGNALING PATHWAY; INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; ORGAN DYSFUNCTION; ACTIVATION; CELLS; APOPTOSIS; RECEPTOR; DAMAGE; MICE	Acute lung injury (ALI) is one of several complications in patients with traumatic brain injury (TBI). Autophagy is a primary homeostatic process that promotes cell survival under stress. Accumulating evidence implicates autophagy in the pathogenesis of ALI under various conditions. However, the role of autophagy in TBI-induced ALI remains unknown. The aim of this study was to adjust autophagy with pharmacological agents to determine its functional significance in TBI-induced ALI. Rats were preconditioned with autophagy promoter rapamycin or inhibitor 3-methyladenine before they were challenged with TBI. Extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor U0126, mechanistic target of rapamycin (mTOR) inhibitor rapamycin, and signal transducer and activator of transcription 3 (Stat3) inhibitor S31-201 were used to test the role of ERK1/2/mTOR/Stat3 signaling pathway in regulating autophagy. Autophagy is activated in lung tissues after TBI. Enhancement of autophagy suppressed apoptosis, inflammation and oxidative stress in lung tissues, which were activated after TBI, whereas inhibition of autophagy aggravated these critical pathological changes. Autophagy also improved TBI-induced impairment in pulmonary barrier function, oxygenation function and static compliance. Furthermore, TBI-induced autophagy was mediated by ERK1/2/mTOR/Stat3 pathway, which may serve to reduce ALI and improve pulmonary barrier function, oxygenation function and static compliance. These findings are important for the prevention and treatment of TBI-induced ALI.	[Xu, Xiupeng; Zhi, Tongle; Chao, Honglu; Bao, Zhongyuan; Fan, Liang; Wang, Dong; Li, Zheng; Liu, Ning; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou Rd 300, Nanjing, Jiangsu, Peoples R China; [Jiang, Kuan] Yixing Peoples Hosp, Dept Neurosurg, Yixing, Jiangsu, Peoples R China; [Liu, Yinlong] Suzhou Municipal Hosp, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China		Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou Rd 300, Nanjing, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300998, 81471269]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131022, BK20160047]; Jiangsu Province's Key Discipline of Medicine [XK201117]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Specially Appointed Professor Foundation of Jiangsu Province [ky216r201307]	This work was supported by the National Natural Science Foundation of China (81300998 and 81471269), National Natural Science Foundation of Jiangsu Province (BK20131022 and BK20160047), Jiangsu Province's Key Discipline of Medicine (XK201117), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Specially Appointed Professor Foundation of Jiangsu Province (ky216r201307).	Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Antonioli M, 2017, TRENDS BIOCHEM SCI, V42, P28, DOI 10.1016/j.tibs.2016.09.008; Bethea JR, 1998, J NEUROSCI, V18, P3251; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Chen GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729831; Chi W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0360-2; Davison DL, 2012, CHEST, V141, P793, DOI 10.1378/chest.11-0789; Diao MY, 2016, INFLAMMATION, V39, P2029, DOI 10.1007/s10753-016-0440-1; Frank MG, 2016, BRAIN BEHAV IMMUN, V55, P215, DOI 10.1016/j.bbi.2015.10.009; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Granato M, 2017, J NUTR BIOCHEM, V41, P124, DOI 10.1016/j.jnutbio.2016.12.011; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Hu Y, 2016, AUTOPHAGY, V12, P2286, DOI 10.1080/15548627.2016.1230584; Hu Y, 2014, MICROBES INFECT, V16, P727, DOI 10.1016/j.micinf.2014.07.005; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Kagan VE, 2016, CELL DEATH DIFFER, V23, P1140, DOI 10.1038/cdd.2015.160; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kemp CD, 2008, AM SURGEON, V74, P866; Li DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep37751; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Maddahi A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-85; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Mizumura K, 2012, CHEST, V142, P1289, DOI 10.1378/chest.12-0809; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sun L., 2017, AUTOPHAGY; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Wen ZM, 2014, J IMMUNOL, V193, P4623, DOI 10.4049/jimmunol.1400899; Xiao YZ, 2016, DIABETES, V65, P393, DOI 10.2337/db15-1024; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Yang SQ, 2016, INT IMMUNOPHARMACOL, V40, P219, DOI 10.1016/j.intimp.2016.08.041; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang D, 2015, J HEART LUNG TRANSPL, V34, P746, DOI 10.1016/j.healun.2014.12.008; Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225; Zhao HL, 2017, AM J PHYSIOL-LUNG C, V312, pL155, DOI 10.1152/ajplung.00449.2016; Zou MJ, 2015, MOL CARCINOGEN, V54, P1363, DOI 10.1002/mc.22212; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	52	24	29	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAY	2018	1864	5	A				1663	1674		10.1016/j.bbadis.2018.02.011			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	GE0DB	WOS:000430883100012	29466698	Bronze			2022-02-06	
J	Boutin, ME; Kramer, LL; Livi, LL; Brown, T; Moore, C; Hoffman-Kim, D				Boutin, Molly E.; Kramer, Liana L.; Livi, Liane L.; Brown, Tyler; Moore, Christopher; Hoffman-Kim, Diane			A three-dimensional neural spheroid model for capillary-like network formation	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain; Cortex; Vasculogenesis; in vitro; Spheroid; Neurovascular unit; Capillary-like network; Cellular self-assembly; Endothelial cells	BLOOD-BRAIN-BARRIER; MICROVASCULAR ENDOTHELIAL-CELLS; DEVELOPING RAT-BRAIN; IN-VITRO MODEL; LUMEN FORMATION; ANGIOGENESIS; EXPRESSION; TISSUE; ADHESION; CULTURE	Background: In vitro three-dimensional neural spheroid models have an in vivo-like cell density, and have the potential to reduce animal usage and increase experimental throughput. The aim of this study was to establish a spheroid model to study the formation of capillary-like networks in a three-dimensional environment that incorporates both neuronal and glial cell types, and does not require exogenous vasculogenic growth factors. New method: We created self-assembled, scaffold-free cellular spheroids using primary-derived postnatal rodent cortex as a cell source. The interactions between relevant neural cell types, basement membrane proteins, and endothelial cells were characterized by immunohistochemistry. Transmission electron microscopy was used to determine if endothelial network structures had lumens. Results: Endothelial cells within cortical spheroids assembled into capillary-like networks with lumens. Networks were surrounded by basement membrane proteins, including laminin, fibronectin and collagen IV, as well as key neurovascular cell types. Comparison with existing method(s): Existing in vitro models of the cortical neurovascular environment study monolayers of endothelial cells, either on transwell inserts or coating cellular spheroids. These models are not well suited to study vasculogenesis, a process hallmarked by endothelial cell cord formation and subsequent lumenization. Conclusions: The neural spheroid is a new model to study the formation of endothelial cell capillary-like structures in vitro within a high cell density three-dimensional environment that contains both neuronal and glial populations. This model can be applied to investigate vascular assembly in healthy or disease states, such as stroke, traumatic brain injury, or neurodegenerative disorders. (C) 2017 Elsevier B.V. All rights reserved.	[Boutin, Molly E.; Livi, Liane L.; Hoffman-Kim, Diane] Brown Univ, Ctr Biomed Engn, 175 Meeting St, Providence, RI 02912 USA; [Boutin, Molly E.; Kramer, Liana L.; Livi, Liane L.; Hoffman-Kim, Diane] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, 175 Meeting St, Providence, RI 02912 USA; [Brown, Tyler; Moore, Christopher] Brown Univ, Dept Neurosci, 175 Meeting St, Providence, RI 02912 USA; [Brown, Tyler; Moore, Christopher; Hoffman-Kim, Diane] Brown Univ, Brown Inst Brain Sci, 175 Meeting St, Providence, RI 02912 USA; [Boutin, Molly E.] NCATS, NIH, 9800 Med Ctr Dr, Rockville, MD 20850 USA; [Kramer, Liana L.] Brown Univ, Box G-B3, Providence, RI 02912 USA; [Livi, Liane L.] Brown Univ, Box GB3, Providence, RI 02912 USA; [Brown, Tyler] 10 Cornelius Way, Cambridge, MA 02141 USA; [Moore, Christopher] Brown Univ, Box GL-N, Providence, RI 02912 USA		Hoffman-Kim, D (corresponding author), Brown Univ, Box G B3, Providence, RI 02912 USA.	mollyboutin@gmail.com; Liana_Kramer@brown.edu; Liane_Livi@brown.edu; tylerclarkbrown@gmail.com; Christopher_Moore@brown.edu; Diane_Hoffman-Kim@brown.edu			National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); Brown University Seed Grant; Brown Institute for Brain Science Normal Prince Neurosciences Institute New Frontiers Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HL110791]; National Institutes of Health NRSA Postdoctoral Award [F32NS078895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL110791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS078895] Funding Source: NIH RePORTER	The authors would like to thank Shai Shabbah for assistance with multiphoton imaging, Paula Weston for excellent technical assistance with TEM, Ken Miller and Justin Fallon for helpful consultations regarding TEM, and Timothy Bertram, Jason Machan, and Jeffrey Morgan for helpful scientific discussions. Financial support was provided to Molly Boutin from the National Science Foundation Graduate Research Fellowship, and to Diane Hoffman-Kim from the Brown University Seed Grant, Brown Institute for Brain Science Normal Prince Neurosciences Institute New Frontiers Program, and National Institutes of Health 5R01HL110791. Financial support was provided to Tyler Brown from the National Institutes of Health NRSA Postdoctoral Award (F32NS078895), and to Tyler Brown and Christopher Moore from the Association of Migraine Disorders. Support for this research was provided in part by a generous gift from Donna McGraw Weiss '89 and Jason Weiss. Funding sources had no involvement in the preparation of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Boutin ME, 2015, TISSUE ENG PART C-ME, V21, P292, DOI [10.1089/ten.tec.2014.0296, 10.1089/ten.TEC.2014.0296]; BREIER G, 1992, DEVELOPMENT, V114, P521; Calabria AR, 2008, J CEREBR BLOOD F MET, V28, P135, DOI 10.1038/sj.jcbfm.9600518; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Cho HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15222; Crabtree B, 2007, IN VITRO CELL DEV-AN, V43, P87, DOI 10.1007/s11626-007-9012-x; Cucullo L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-18; Dingle YTL, 2015, TISSUE ENG PART C-ME, V21, P1274, DOI [10.1089/ten.tec.2015.0135, 10.1089/ten.TEC.2015.0135]; Eckermann CW, 2011, CELL BIOL INT, V35, P1097, DOI 10.1042/CBI20100718; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Eichmann Anne, 2013, Cold Spring Harb Perspect Med, V3, pa006551, DOI 10.1101/cshperspect.a006551; ERIKSDOTTERNILSSON M, 1986, J NEUROSCI METH, V17, P275, DOI 10.1016/0165-0270(86)90128-7; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Hagan N, 2015, SEMIN CELL DEV BIOL, V38, P7, DOI 10.1016/j.semcdb.2014.12.006; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hutter-Schmid B., 2015, FRONT CELL DEV BIOL, V3; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kunz-Schughart LA, 2006, AM J PHYSIOL-CELL PH, V290, pC1385, DOI 10.1152/ajpcell.00248.2005; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Mokry J, 1999, Gen Physiol Biophys, V18 Suppl 1, P25; Mokry Jaroslav, 2008, Acta Medica (Hradec Kralove), V51, P173; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.TEC.2012.0430, 10.1089/ten.tec.2012.0430]; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; ROBERTSON PL, 1985, DEV BRAIN RES, V23, P219, DOI 10.1016/0165-3806(85)90044-6; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Urich E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01500; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	56	24	24	3	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 1	2018	299						55	63		10.1016/j.jneumeth.2017.01.014			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GG9IN	WOS:000433014300007	28143748				2022-02-06	
J	Chen, XL; Gestring, ML; Rosengart, MR; Billiar, TR; Peitzman, AB; Sperry, JL; Brown, JB				Chen, Xilin; Gestring, Mark L.; Rosengart, Matthew R.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.; Brown, Joshua B.			Speed is not everything: Identifying patients who may benefit from helicopter transport despite faster ground transport	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	76th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 13-16, 2017	Baltimore, MD	Amer Assoc Surg Trauma		Helicopter; air medical; emergency medical services; prehospital; triage	TRAUMATIC BRAIN-INJURY; EMERGENCY MEDICAL-SERVICES; RAPID-SEQUENCE INTUBATION; PREHOSPITAL TRIAGE SCORE; BLOOD-CELL TRANSFUSION; ENDOTRACHEAL INTUBATION; REDUCED MORTALITY; SCENE; SURVIVAL; IMPACT	BACKGROUND: Helicopter emergency medical services (HEMS) have demonstrated survival benefits over ground emergency medical services (GEMS) for trauma patient transport. While HEMS speed is often-cited, factors such as provider experience and level of care may also play a role. Our objective was to identify patient groups that may benefit from HEMS even when prehospital time for helicopter utilization is longer than GEMS transport. METHODS: Adult patients transported by HEMS or GEMS from the scene of injury in the Pennsylvania State Trauma Registry were included. Propensity score matching was used to match HEMS and GEMS patients for likelihood of HEMS, keeping only pairs in which the HEMS patient had longer total prehospital time than the matched GEMS patient. Mixed-effects logistic regression evaluated the effect of transport mode on survival while controlling for demographics, admission physiology, transfusions, and procedures. Interaction testing between transport mode and existing trauma triage criteria was conducted and models stratified across significant interactions to determine which criteria identify patients with a significant survival benefit when transported by HEMS even when slower than GEMS. RESULTS: From 153,729 eligible patients, 8,307 pairs were matched. Helicopter emergency medical services total prehospital time was a median of 13 minutes (interquartile range, 6-22) longer than GEMS. Patients with abnormal respiratory rate (odds ratio [OR], 2.39; 95% confidence interval [CI], 1.26-4.55; p = 0.01), Glasgow Coma Scale score of 8 or less (OR, 1.61; 95% CI, 1.16-2.22; p < 0.01), and hemo/pneumothorax (OR, 2.25; 95% CI, 1.06-4.78; p = 0.03) had a significant survival advantage when transported by HEMS even with longer prehospital time than GEMS. Conversely, there was no association between transport mode and survival in patients without these factors (p > 0.05). CONCLUSION: Patients with abnormal respiratory rate, Glasgow Coma Scale score of 8 or less, and hemo/pneumothorax benefit from HEMS transport even when GEMS transport was faster. This may indicate that these patients benefit primarily from HEMS care, such as advanced airway and chest trauma management, rather than simply faster transport to a trauma center. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Chen, Xilin; Rosengart, Matthew R.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.; Brown, Joshua B.] Univ Pittsburgh, Dept Surg, Med Ctr, Div Trauma & Gen Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Gestring, Mark L.] Univ Rochester, Med Ctr, Dept Surg, Div Acute Care Surg, Rochester, NY 14642 USA		Brown, JB (corresponding author), Univ Pittsburgh, Dept Surg, Med Ctr, Div Trauma & Gen Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	brownjb@upmc.edu					Abe T, 2014, CRIT CARE, V18, DOI 10.1186/cc13981; Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Bekelis K, 2014, ANN SURG; Blumen IJ, 2006, PRINCIPLES DIRECTION, P519; Brathwaite CEM, 1998, J TRAUMA, V45, P140, DOI 10.1097/00005373-199807000-00029; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P270, DOI 10.1097/TA.0000000000001326; Brown JB, 2016, ANN SURG, V264, P378, DOI 10.1097/SLA.0000000000001496; Brown JB, 2016, J TRAUMA ACUTE CARE, V81, P93, DOI 10.1097/TA.0000000000000999; Brown JB, 2016, SURGERY, V159, P947, DOI 10.1016/j.surg.2015.09.015; Brown JB, 2015, J AM COLL SURGEONS, V220, P797, DOI 10.1016/j.jamcollsurg.2015.01.006; Brown JB, 2015, ANN SURG, V261, P997, DOI 10.1097/SLA.0000000000000674; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P319, DOI 10.1097/TA.0b013e3182572bee; Brown JB, 2011, J TRAUMA, V70, P310, DOI 10.1097/TA.0b013e3182032b4f; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P573, DOI DOI 10.1097/TA.0B013E31824BADDF; Butler DP, 2010, EMERG MED J, V27, P692, DOI 10.1136/emj.2009.087486; Chou D, 2016, J TRAUMA ACUTE CARE, V80, P278, DOI 10.1097/TA.0000000000000901; Cudnik MT, 2008, PREHOSP EMERG CARE, V12, P459, DOI 10.1080/10903120802290745; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Delgado MK, 2013, ANN EMERG MED, V62, P351, DOI 10.1016/j.annemergmed.2013.02.025; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Galvagno SM, 2013, CRIT CARE, V17, DOI 10.1186/cc12779; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Hosmer DW, 2000, APPL LOGISTRIC REGRE; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Mitra R, 2012, STAT METHODS MED RES; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Ringburg A, 2009, PREHOSP EMERG CARE, V13, P28, DOI 10.1080/10903120802472012; Rubin D.B., 1987, MULTIPLE IMPUTATION; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Shatney CH, 2002, J TRAUMA, V53, P817, DOI 10.1097/00005373-200211000-00002; Shaw JJ, 2015, ANN SURG; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sonne A, 2017, DAN MED J, V64; StataCorp, 2013, STAT MULT MIX EFF RE; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Thomas SH, 2014, PREHOSP EMERG CARE, V18, P35, DOI 10.3109/10903127.2013.844872; Tsuchiya A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0335-z; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Yang D., UNIFIED APPROACH MEA	50	24	24	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2018	84	4					549	557		10.1097/TA.0000000000001769			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GE4IT	WOS:000431179700001	29251708				2022-02-06	
J	Bonow, RH; Barber, J; Temkin, NR; Videtta, W; Rondina, C; Petroni, G; Lujan, S; Alanis, V; La Fuente, G; Lavadenz, A; Merida, R; Jibaja, M; Gonzales, L; Falcao, A; Romero, R; Dikmen, S; Pridgeon, J; Chesnut, RM				Bonow, Robert H.; Barber, Jason; Temkin, Nancy R.; Videtta, Walter; Rondina, Carlos; Petroni, Gustavo; Lujan, Silvia; Alanis, Victor; La Fuente, Gustavo; Lavadenz, Arturo; Merida, Roberto; Jibaja, Manuel; Gonzales, Luis; Falcao, Antonio; Romero, Ricardo; Dikmen, Sureyya; Pridgeon, James; Chesnut, Randall M.		Global Neurotrauma Res Grp	The Outcome of Severe Traumatic Brain Injury in Latin America	WORLD NEUROSURGERY			English	Article						Global health; Social determinants of health; Traumatic brain injury	HEAD-INJURY; PROGNOSTIC VALUE; DIRECT TRANSPORT; LOW-INCOME; MORTALITY; HYPOTENSION; PRESSURE; CENTERS; SYSTEM; IMPACT	BACKGROUND: Traumatic brain injury (TBI) disproportionately affects lower-and middle-income countries (LMIC). The factors influencing outcomes in LMIC have not been examined as rigorously as in higher-income countries. METHODS: This study was conducted to examine clinical and demographic factors influencing TBI outcomes in Latin American LMIC. Data were prospectively collected during a randomized trial of intracranial pressure monitoring in severe TBI and a companion observational study. Participants were aged >= 13 years and admitted to study hospitals with Glasgow Coma Scale score <= 8. The primary outcome was Glasgow Outcome Scale, Extended (GOS-E) score at 6 months. Predictors were analyzed using a multivariable proportional odds model created by forward stepwise selection. RESULTS: A total of 550 patients were identified. Six-month outcomes were available for 88%, of whom 37% had died and 44% had achieved a GOS-E score of 5-8. In multivariable proportional odds modeling, higher Glasgow Coma Scale motor score (odds ratio [OR], 1.41 per point; 95% confidence interval [CI], 1.23-1.61) and epidural hematoma (OR, 1.83; 95% CI, 1.17-2.86) were significant predictors of higher GOS-E score, whereas advanced age (OR, 0.65 per 10 years; 95% CI, 0.57-0.73) and cisternal effacement (P < 0.001) were associated with lower GOS-E score. Study site (P < 0.001) and race (P = 0.004) significantly predicted outcome, outweighing clinical variables such as hypotension and pupillary examination. CONCLUSIONS: Mortality from severe TBI is high in Latin American LMIC, although the rate of favorable recovery is similar to that of high-income countries. Demographic factors such as race and study site played an outsized role in predicting outcome; further research is required to understand these associations.	[Bonow, Robert H.; Barber, Jason; Temkin, Nancy R.; Pridgeon, James; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Videtta, Walter] Hosp Posadas, Buenos Aires, DF, Argentina; [Rondina, Carlos] Fdn ALAS, Buenos Aires, DF, Argentina; [Petroni, Gustavo; Lujan, Silvia] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Alanis, Victor] Univ Hosp San Juan Dios, Santa Cruz, Bolivia; [La Fuente, Gustavo] Hosp Japones, Santa Cruz, Bolivia; [Lavadenz, Arturo] Hosp Viedma, Cochabamba, Bolivia; [Merida, Roberto] San Juan Dios Hosp, Tarija, Bolivia; [Jibaja, Manuel] Espejo Hosp, Quito, Ecuador; [Gonzales, Luis] Vernaza Hosp, Guayaquil, Ecuador; [Falcao, Antonio] Univ Estadual Campinas, Campinas, SP, Brazil; [Romero, Ricardo] Fdn Clin Campbell, Barranquilla, Colombia; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Bonow, RH (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	rbonow@uw.edu		Chesnut, Randall/0000-0001-6377-3666; Falcao, Antonio/0000-0002-1630-7889; ROMERO FIGUEROA, RICARDO LUIS/0000-0002-3124-8717	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058302] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS080648, R01 NS058302] Funding Source: Medline		Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Canadian Association for Community Living, 1997, INT PERS DIS PROD WO; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dudzik P, 2000, DISABILITY POLICIES, P1; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Leipziger DM, 2001, FINANCE DEV, V38; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2005, ACT NEUR S, V95, P281; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; MULLINS RJ, 1996, J TRAUMA, V40, P545; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Pan American Health Organization, 2013, ROAD SAF FACTS REG A; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perry G, 2004, INEQUALITY LATIN AM; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	41	24	26	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E82	E90		10.1016/j.wneu.2017.11.171			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700012	29229352	Green Accepted			2022-02-06	
J	Choi, GS; Kwak, SG; Do Lee, H; Chang, MC				Choi, Gyu-sik; Kwak, Sang Gyu; Do Lee, Han; Chang, Min Cheol			EFFECT OF HIGH-FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON CHRONIC CENTRAL PAIN AFTER MILD TRAUMATIC BRAIN INJURY: A PILOT STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						central pain; traumatic brain injury; repetitive transcranial magnetic stimulation; high-frequency; spinothalamocortical tract; diffusion tensor tractography	MOTOR CORTEX STIMULATION; DIFFUSE AXONAL INJURY; SPINOTHALAMIC TRACT; CONTROLLED TRIAL; POSTSTROKE PAIN; MECHANISMS; RELIEF; EXCITABILITY; MODULATION; SYMPTOMS	Objective: Central pain can occur following traumatic brain injury, leading to poor functional recovery, limitation of activities of daily living, and decreased quality of life. The aim of this study was to determine whether high-frequency (10 Hz) repetitive transcranial magnetic stimulation, applied over the primary motor cortex of the affected hemisphere, can be used to manage chronic central pain after mitd traumatic brain injury. Design: Prospective randomized feasibility study. Methods; Twelve patients with mild traumatic brain injury anil chronic central pain were randomly assigned to transcranial magnetic stimulation (high-frequency stimulation, 10 sessions) or sham groups. Diffuse tensor tractography revealed partially injured spinothalamocortical tracts in all recruited patients. A numerical rating scale (NRS) was used to evaluate pain intensity during pre-treatment and immediately after the 5(th) transcranial magnetic stimulation session (post1), 10(th) transcranial magnetic stimulation session (post2), and 1 (post3), 2 (post4), and 4 weeks (post 5) after finishing treatment. Physical and mental health status were evaluated using the Short Form 36 Health Survey (SF-36), including physical and mental component scores (PCS, MCS). Results: The NRS score of the repetitive transcranial magnetic stimulation group was significantly lower than the sham group score at all clinical evaluation time-points during and after transcranial magnetic stimulation sessions. The transcranial magnetic stimulation group's SF-36 PCS score was significantly higher at post2, post3, post4, and post5 compared with the sham group. Conclusion; High-frequency transcranial magnetic stimulation may be used to manage chronic central pain and improve quality of life in patients with mild traumatic brain injury. However, this is a pilot study and further research is needed.	[Choi, Gyu-sik] Cheokbareun Rehabil Clin, Pohang Si, Gyeongsangbuk D, South Korea; [Kwak, Sang Gyu] Catholic Univ Daegu, Coll Med, Dept Med Stat, Daegu, South Korea; [Do Lee, Han; Chang, Min Cheol] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea		Chang, MC (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	wheel633@gmail.com	Kwak, Sanggyu/AAG-4341-2021				Almeida TF, 2004, BRAIN RES, V1000, P40, DOI 10.1016/j.brainres.2003.10.073; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; de Oliveira RAA, 2014, J PAIN, V15, P1271, DOI 10.1016/j.jpain.2014.09.009; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Brissebrat B., 2016, ANN PHYS REHABIL MED, V59, pe145; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Gu SY, 2017, BRAIN STIMUL, V10, P270, DOI 10.1016/j.brs.2016.10.010; Hasan M, 2014, NEUROMODULATION, V17, P731, DOI 10.1111/ner.12198; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Hosomi K, 2013, PAIN, V154, P1352, DOI 10.1016/j.pain.2013.04.017; Ivanhoe CB, 2004, J HEAD TRAUMA REHAB, V19, P29, DOI 10.1097/00001199-200401000-00004; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jang SH, 2016, BRAIN INJURY, V30, P933, DOI 10.3109/02699052.2016.1146966; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kobayashi M, 2015, NEUROMODULATION, V18, P249, DOI 10.1111/ner.12301; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lee SJ, 2012, AM J PHYS MED REHAB, V91, P1077, DOI 10.1097/PHM.0b013e3182745a04; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Matsumura Y, 2013, NEUROMODULATION, V16, P349, DOI 10.1111/ner.12019; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ohn SH, 2012, NEUROREHAB NEURAL RE, V26, P344, DOI 10.1177/1545968311423110; Pagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Saitoh Y, 2004, J NEUROSURG, V100, P935, DOI 10.3171/jns.2004.100.5.0935; Saitoh Y, 2013, IEEE ENG MED BIO, P6163, DOI 10.1109/EMBC.2013.6610960; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TEASDALE G, 1974, LANCET, V2, P81; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Ware J.E., 2001, SCORE VERSION 2 SF 3, V3; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Ziemann U, 1998, J NEUROSCI, V18, P1115	49	24	25	2	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2018	50	3					246	252		10.2340/16501977-2321			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GF3NY	WOS:000431864100003	29392332	Green Submitted, gold			2022-02-06	
J	Kortagere, S; Mortensen, OV; Xia, JS; Lester, W; Fang, YH; Srikanth, Y; Salvino, JM; Fontana, ACK				Kortagere, Sandhya; Mortensen, Ole V.; Xia, Jingsheng; Lester, William; Fang, Yuhong; Srikanth, Yellamelli; Salvino, Joseph M.; Fontana, Andreia C. K.			Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2	ACS CHEMICAL NEUROSCIENCE			English	Article						EAAT2; EAAT2 activators; glutamate transporter; glutamate uptake; hybrid structure based method; positive allosteric modulation; transport enhancement	TRAUMATIC BRAIN-INJURY; AMINO-ACID TRANSPORTERS; SPINAL-CORD; RAT MODEL; DRUG DISCOVERY; UP-REGULATION; EXPRESSION; CEFTRIAXONE; GLT-1; EXCITOTOXICITY	[Graphics] Dysfunction of excitatory amino acid transporters (EAATs) has been implicated in the pathogenesis of various neurological disorders, such as stroke, brain trauma, epilepsy, and neurodegenerative diseases, among others. EAAT2 is the main subtype responsible for glutamate clearance in the brain, having a key role in regulating transmission and preventing excitotoxicity. Therefore, compounds that increase the expression or activity of EAAT2 have therapeutic potential for neuroprotection. Previous studies identified molecular determinants for EAAT2 transport stimulation in a structural domain that lies at the interface of the rigid trimerization domain and the central substrate binding transport domain. In this work, a hybrid structure based approach was applied, based on this molecular domain, to create a high-resolution pharmacophore. Subsequently, virtual screening of a library of small molecules was performed, identifying 10 hit molecules that interact at the proposed domain. Among these, three compounds were determined to be activators, four were inhibitors, and three had no effect on EAAT2-mediated transport in vitro. Further characterization of the two best ranking EAAT2 activators for efficacy, potency, and selectivity for glutamate over monoamine transporters subtypes and NMDA receptors and for efficacy in cultured astrocytes is demonstrated. Mutagenesis studies suggest that the EAAT2 activators interact with residues forming the interface between the trimerization and transport domains. These compounds enhance the glutamate translocation rate, with no effect on substrate interaction, suggesting an allosteric mechanism. The identification of these novel positive allosteric modulators of EAAT2 offers an innovative approach for the development of therapies based on glutamate transport enhancement.	[Kortagere, Sandhya] Drexel Univ, Coll Med, Ctr Mol Parasitol, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA; [Kortagere, Sandhya] Drexel Univ, Coll Med, Centers Virol & Translat Neurosci, Inst Mol Med, Philadelphia, PA 19129 USA; [Mortensen, Ole V.; Xia, Jingsheng; Srikanth, Yellamelli; Salvino, Joseph M.; Fontana, Andreia C. K.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Lester, William; Fang, Yuhong] NIH, NCATS, Div Preclin Innovat DPI, Analyt Chem, Rockville, MD 20850 USA		Fontana, ACK (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA.	acm83@drexel.edu	Mortensen, Andreia/AAR-2177-2020	Mortensen, Andreia/0000-0002-4791-8746; Yellamelli, Valli Venkata Srikanth/0000-0002-5414-0119; Mortensen, Ole Valente/0000-0002-3487-8239	Drexel University College of Medicine; Drexel Coulter grant; Faculty development funds from the Department of Microbiology and Immunology	This work was supported by startup funds to O.V.M. and A.C.K.F. (Drexel University College of Medicine) and Drexel Coulter grant and Faculty development funds from the Department of Microbiology and Immunology to S.K.	Akyuz N, 2015, NATURE, V518, P68, DOI 10.1038/nature14158; Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; AMATO A, 1994, J PHYSIOL-LONDON, V479, P371, DOI 10.1113/jphysiol.1994.sp020302; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bienayme H, 1998, TETRAHEDRON LETT, V39, P2735, DOI 10.1016/S0040-4039(98)00283-4; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bunch L, 2009, EXPERT OPIN THER TAR, V13, P719, DOI 10.1517/14728220902926127; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Canul-Tec JC, 2017, NATURE, V544, P446, DOI 10.1038/nature22064; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; Chekmarev DS, 2008, CHEM RES TOXICOL, V21, P1304, DOI 10.1021/tx800063r; Chi-Castaneda D, 2017, ADV NEUROBIOL, V16, P199, DOI 10.1007/978-3-319-55769-4_10; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; COUTINHONETTO J, 1981, EPILEPSIA, V22, P289, DOI 10.1111/j.1528-1157.1981.tb04112.x; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dunlop J, 2003, J NEUROSCI, V23, P1688; Dunlop J, 2006, CURR OPIN PHARMACOL, V6, P103, DOI 10.1016/j.coph.2005.09.004; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fontana ACK, 2003, BRIT J PHARMACOL, V139, P1297, DOI 10.1038/sj.bjp.0705352; Fontana ACK, 2015, J NEUROCHEM, V134, P982, DOI 10.1111/jnc.13200; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; Hammad AM, 2017, BEHAV BRAIN RES, V332, P288, DOI 10.1016/j.bbr.2017.06.017; HARDY J, 1987, NEUROSCI LETT, V73, P77, DOI 10.1016/0304-3940(87)90034-6; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hota SK, 2008, NEUROBIOL LEARN MEM, V89, P522, DOI 10.1016/j.nlm.2008.01.003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jabs R, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01488.x; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kim R, 2018, NEUROPHARMACOLOGY, V128, P1, DOI 10.1016/j.neuropharm.2017.09.019; Kong QM, 2014, J CLIN INVEST, V124, P1255, DOI 10.1172/JCI66163; Kortagere S, 2008, PHARM RES-DORDR, V25, P1836, DOI 10.1007/s11095-008-9584-5; Kortagere S, 2006, J COMPUT AID MOL DES, V20, P789, DOI 10.1007/s10822-006-9077-8; Kortagere S, 2009, PHARM RES-DORDR, V26, P1001, DOI 10.1007/s11095-008-9809-7; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Li Y, 2011, NEUROPHARMACOLOGY, V60, P1168, DOI 10.1016/j.neuropharm.2010.10.016; Lin CLG, 2012, FUTURE MED CHEM, V4, P1689, DOI [10.4155/fmc.12.122, 10.4155/FMC.12.122]; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; LOUZADAJUNIOR P, 1992, J NEUROCHEM, V59, P358, DOI 10.1111/j.1471-4159.1992.tb08912.x; Maas AIR, 2000, CNS DRUGS, V13, P139, DOI 10.2165/00023210-200013020-00007; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Massieu L, 1998, Neurobiology (Bp), V6, P99; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Mortensen OV, 2015, J NEUROCHEM, V133, P199, DOI 10.1111/jnc.13047; Munir M, 2000, NEUROCHEM INT, V37, P147, DOI 10.1016/S0197-0186(00)00018-8; Nederkoorn PJ, 2011, INT J STROKE, V6, P159, DOI 10.1111/j.1747-4949.2010.00555.x; Nicolai J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.10; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; [潘向东 PAN Xingdong], 2011, [浙江大学学报. 医学版, Journal of Zhejiang University. Medical Sciences], V40, P522; Peng S, 2011, MOL BIOL REP, V38, P453, DOI 10.1007/s11033-010-0128-9; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rasmussen B, 2011, DRUG ALCOHOL DEPEN, V118, P484, DOI 10.1016/j.drugalcdep.2011.03.022; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rives ML, 2017, BIOCHEM PHARMACOL, V135, P1, DOI 10.1016/j.bcp.2017.02.010; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Scofield MD, 2014, NEUROSCIENTIST, V20, P610, DOI 10.1177/1073858413520347; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimizu S, 2011, JOVE-J VIS EXP, DOI 10.3791/3257; SISK DR, 1985, GRAEF ARCH CLIN EXP, V223, P250, DOI 10.1007/BF02153655; Suchak SK, 2003, J NEUROCHEM, V84, P522, DOI 10.1046/j.1471-4159.2003.01553.x; Swanson RA, 1997, J NEUROSCI, V17, P932; Takahashi K, 2015, CELL MOL LIFE SCI, V72, P3489, DOI 10.1007/s00018-015-1937-8; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thone-Reineke C, 2008, J HYPERTENS, V26, P2426, DOI 10.1097/HJH.0b013e328313e403; Timple JMV, 2013, J NAT PROD, V76, P1889, DOI 10.1021/np400452n; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Verma R, 2010, EUR J PHARMACOL, V638, P65, DOI 10.1016/j.ejphar.2010.04.021; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; Xia JS, 2014, J PHYSIOL-LONDON, V592, P3443, DOI 10.1113/jphysiol.2014.275065; Xing XC, 2011, BIOORG MED CHEM LETT, V21, P5774, DOI 10.1016/j.bmcl.2011.08.009; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yatomi Y, 2013, NEUROSCIENCE, V244, P113, DOI 10.1016/j.neuroscience.2013.04.018; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	110	24	24	1	11	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	MAR	2018	9	3					522	534		10.1021/acschemneuro.7b00308			25	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	GA5EX	WOS:000428356500017	29140675				2022-02-06	
J	Xiong, LL; Hu, Y; Zhang, P; Zhang, Z; Li, LH; Gao, GD; Zhou, XF; Wang, TH				Xiong, Liu-Lin; Hu, Yue; Zhang, Piao; Zhang, Zhuo; Li, Li-Hong; Gao, Guo-Dong; Zhou, Xin-Fu; Wang, Ting-Hua			Neural Stem Cell Transplantation Promotes Functional Recovery from Traumatic Brain Injury via Brain Derived Neurotrophic Factor-Mediated Neuroplasticity	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Neural stem cell transplantation; Synaptophysin; Brain-derived neurotrophic factor; RNA knockdown	SPINAL-CORD-INJURY; ADULT RATS; DOPAMINERGIC-NEURONS; TEMPORAL-CHANGES; BDNF; DIFFERENTIATION; HIPPOCAMPUS; EXPRESSION; DISEASES; MICE	Traumatic brain injury (TBI) induces cognitive impairments, motor and behavioral deficits. Previous evidences have suggested that neural stem cell (NSC) transplantation could facilitate functional recovery from brain insults, but their underlying mechanisms remains to be elucidated. Here, we established TBI model by an electromagnetic-controlled cortical impact device in the rats. Then, 5 mu l NSCs (5.0 x 10(5)/mu l), derived from green fluorescent protein (GFP) transgenic mouse, was transplanted into the traumatic brain regions of rats at 24 h after injury. After differentiation of the NSCs was determined using immunohistochemistry, neurological severity scores (NSS) and rotarod test were conducted to detect the neurological behavior. Western blot and RT-PCR as well as ELASA were used to evaluate the expression of synaptophysin and brain-derived neurotrophic factor (BDNF). In order to elucidate the role of BDNF on the neural recovery after NSC transplantation, BDNF knockdown in NSC was performed and transplanted into the rats with TBI, and potential mechanism for BDNF knockdown in the NSC was analyzed using microassay analysis. Meanwhile, BDNF antibody blockade was conducted to further confirm the effect of BDNF on neural activity. As a result, an increasing neurological function improvement was seen in NSC transplanted rats, which was associated with the upregulation of synaptophysin and BDNF expression. Moreover, transplantation of BDNF knockdown NSCs and BDNF antibody block reduced not only the level of synaptophysin but also exacerbated neurological function deficits. Microassay analysis showed that 14 genes such as Wnt and Gsk3-beta were downregulated after BDNF knockdown. The present data therefore showed that BDNF-mediated neuroplasticity underlie the mechanism of NSC transplantation for the treatment of TBI in adult rats.	[Xiong, Liu-Lin; Hu, Yue; Wang, Ting-Hua] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China; [Xiong, Liu-Lin; Hu, Yue; Wang, Ting-Hua] Sichuan Univ, Dept Anesthesiol, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Piao; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Kunming 650500, Yunnan, Peoples R China; [Zhang, Piao; Wang, Ting-Hua] Kunming Med Univ, Anim Zool Dept, Kunming 650500, Yunnan, Peoples R China; [Zhang, Zhuo; Li, Li-Hong; Gao, Guo-Dong] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, GPO Box 2100, Adelaide, SA 5001, Australia		Wang, TH (corresponding author), Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China.; Wang, TH (corresponding author), Sichuan Univ, Dept Anesthesiol, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China.; Wang, TH (corresponding author), Kunming Med Univ, Inst Neurosci, Kunming 650500, Yunnan, Peoples R China.; Wang, TH (corresponding author), Kunming Med Univ, Anim Zool Dept, Kunming 650500, Yunnan, Peoples R China.	tinghua_neuron@263.net	Zhou, Xiaofang/C-6169-2013; Zhou, Xin-Fu/F-4119-2013	Zhou, Xiaofang/0000-0001-6343-1455; Zhou, Xin-Fu/0000-0002-8687-0175	National Key Technology Research and Development Program of the Ministry of Science and Technology of China (CN) [2014BAI01B10]; Program of Innovative Research Team in Science and Technology in University of Yunnan (IRTSTYN); program Innovative Research Team in Science and Technology in Yunnan Province	This research was supported by a grant from the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (CN) (No. 2014BAI01B10) and supported by the Program of Innovative Research Team in Science and Technology in University of Yunnan (IRTSTYN), together with program Innovative Research Team in Science and Technology in Yunnan Province.	Ba YC, 2010, NEUROCHEM RES, V35, P273, DOI 10.1007/s11064-009-0052-3; Beliaeva Ia S, 2013, Ross Fiziol Zh Im I M Sechenova, V99, P976; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Chaturvedi RK, 2008, EXP NEUROL, V210, P608, DOI 10.1016/j.expneurol.2007.12.016; Chen J, 2007, NEUROSCI RES, V59, P399, DOI 10.1016/j.neures.2007.08.006; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cheng XA, 2011, NEUROSCI LETT, V493, P18, DOI 10.1016/j.neulet.2011.02.006; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Conti L, 2006, BRAIN PATHOL, V16, P143, DOI 10.1111/j.1750-3639.2006.00009.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fu KY, 2011, ARTIF ORGANS, V35, P363, DOI 10.1111/j.1525-1594.2010.01105.x; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kim SU, 2007, BRAIN DEV-JPN, V29, P193, DOI 10.1016/j.braindev.2006.07.012; Leveque X, 2011, CURR OPIN ORGAN TRAN, V16, P190, DOI 10.1097/MOT.0b013e32834494b5; Li XL, 2007, NEUROPEPTIDES, V41, P135, DOI 10.1016/j.npep.2007.02.001; Li Y, 2011, CELL MOL NEUROBIOL, V31, P407, DOI 10.1007/s10571-010-9633-6; Maller JJ, 2014, MED HYPOTHESES, V83, P838, DOI 10.1016/j.mehy.2014.11.003; Martinez SA, 2001, CURR GENE THER, V1, P279; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pincus DW, 1998, NEUROSURGERY, V42, P858, DOI 10.1097/00006123-199804000-00103; Qin DX, 2006, NEUROSCI LETT, V410, P222, DOI 10.1016/j.neulet.2006.10.006; Ramage R, 1999, J PEPT SCI, V5, P195, DOI 10.1002/(SICI)1099-1387(199904)5:4<195::AID-PSC203>3.0.CO;2-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rong R, 2011, GROWTH FACTORS, V29, P263, DOI 10.3109/08977194.2011.606786; Shin MS, 2016, INT NEUROUROL J, V20, pS49, DOI 10.5213/inj.1632616.308; Solomon D, 2011, CYTOKINE, V54, P20, DOI 10.1016/j.cyto.2010.12.013; Sun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083523; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Wang L, 2011, J NEUROSCI METH, V194, P274, DOI 10.1016/j.jneumeth.2010.10.025; Wang TTH, 2006, NEUROREPORT, V17, P1433, DOI 10.1097/01.wnr.0000227980.06013.31; Wei P, 2007, NEUROSCI LETT, V419, P49, DOI 10.1016/j.neulet.2007.03.046; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Xu CJ, 2011, NEUROPATH APPL NEURO, V37, P135, DOI 10.1111/j.1365-2990.2010.01117.x; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Yang HJ, 2009, GROWTH FACTORS, V27, P237, DOI 10.1080/08977190903024298; Yang JW, 2015, NEUROPEPTIDES, V54, P35, DOI 10.1016/j.npep.2015.08.005; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181; Zhang C, 2017, REDOX BIOL, V11, P1, DOI 10.1016/j.redox.2016.10.019; Zhang HT, 2008, J CHEM NEUROANAT, V36, P138, DOI 10.1016/j.jchemneu.2008.07.004; Zhang HT, 2007, J HISTOCHEM CYTOCHEM, V55, P1, DOI 10.1369/jhc.6A6952.2006; Zhang ZB, 2011, BRAIN INJURY, V25, P227, DOI 10.3109/02699052.2010.542430; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217	47	24	26	3	29	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2018	55	3					2696	2711		10.1007/s12035-017-0551-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY5TG	WOS:000426897800070	28421542				2022-02-06	
J	Wettervik, TS; Lenell, S; Nyholm, L; Howells, T; Lewen, A; Enblad, P				Wettervik, Teodor Svedung; Lenell, Samuel; Nyholm, Lena; Howells, Tim; Lewen, Anders; Enblad, Per			Decompressive craniectomy in traumatic brain injury: usage and clinical outcome in a single centre	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Neurointensive care; Standardised treatment protocol; Decompressive craniectomy; Thiopental	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL HYPERTENSION; HEAD-INJURY; MANAGEMENT; SECONDARY; SCALE	Background Two randomised controlled trials (RCTs) of decompressive craniectomy (DC) in traumatic brain injury (TBI) have shown poor outcome, but there are considerations of how these protocols relate to real practice. The aims of this study were to evaluate usage and outcome of DC and thiopental in a single centre. Method The study included all TBI patients treated at the neurointensive care unit, Akademiska sjukhuset, Uppsala, Sweden, between 2008 and 2014. Of 609 patients aged 16 years or older, 35 treated with DC and 23 treated with thiopental only were studied in particular. Background variables, intracranial pressure (ICP) measures and global outcome were analysed. Results Of 35 DC patients, 9 were treated stepwise with thiopental before DC, 9 were treated stepwise with no thiopental before DC and 17 were treated primarily with DC. Six patients received thiopental after DC. For 23 patients, no DC was needed after thiopental. Eighty-eight percent of our DC patients would have qualified for the DECRA study and 38% for the Rescue-ICP trial. Favourable outcome was 44% in patients treated with thiopental before DC, 56% in patients treated with DC without prior thiopental, 29% in patients treated primarily with DC and 52% in patients treated with thiopental with no DC. Conclusions The place for DC in TBI management must be evaluated better, and we believe it is important that future RCTs should have clearer and less permissive ICP criteria regarding when thiopental should be followed by DC and DC followed by thiopental.	[Wettervik, Teodor Svedung; Lenell, Samuel; Nyholm, Lena; Howells, Tim; Lewen, Anders; Enblad, Per] Uppsala Univ, Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se	Lewen, Anders/A-5156-2013; Wettervik, Teodor Mikael Svedung/S-5356-2017	Lewen, Anders/0000-0003-4925-1348; Lenell, Samuel/0000-0001-8914-5086			Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson P, LANCET; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kocher T., 1901, THERAPIE HIRNDRUCKES; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	21	24	26	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2018	160	2					229	237		10.1007/s00701-017-3418-3			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FS7ER	WOS:000419961200003	29234973	Green Published, hybrid			2022-02-06	
J	Nukolova, NV; Aleksashkin, AD; Abakumova, TO; Morozova, AY; Gubskiy, IL; Kirzhanova, EA; Abakumov, MA; Chekhonin, VP; Klyachko, NL; Kabanov, AV				Nukolova, N. V.; Aleksashkin, A. D.; Abakumova, T. O.; Morozova, A. Y.; Gubskiy, I. L.; Kirzhanova, E. A.; Abakumov, M. A.; Chekhonin, V. P.; Klyachko, N. L.; Kabanov, A. V.			Multilayer polyion complex nanoformulations of superoxide dismutase 1 for acute spinal cord injury	JOURNAL OF CONTROLLED RELEASE			English	Article						Antioxidant enzymes; Superoxide dismutase (SOD1); Spinal cord injury (SCI); BBB score; Inflammation; Nanoparticles; Double layered polyelectrolyte complex	LINKED ANTIOXIDANT NANOZYMES; OXIDATIVE STRESS; ISCHEMIC BRAIN; DELIVERY; INFLAMMATION; THERAPY; RATS; SOD; DNA	As one of the most devastating forms of trauma, spinal cord injury (SCI) remains a challenging clinical problem. The secondary processes associated with the primary injury, such as overproduction of reactive oxygen species (ROS) and inflammation, lead to concomitant compression of the injured spinal cord and neuronal death. Delivery of copper-zinc superoxide dismutase (SOD1), an efficient ROS scavenger, to the site of injury can mitigate SCI-induced oxidative stress and tissue damage. Towards this goal catalytically active nanoformulations of SOD1 ("nanozymes") are developed as a modality for treatment of SCI. Along with the cross-linked polyion complex of SOD1 with polycation poly(ethylene glycol) (PEG)-polylysine (single-coat (SC) nanozyme), we introduce for the first time the chemically cross-linked multilayer polyion complex in which SOD1 is first incorporated into a polyion complex with polycation, then coated by anionic block copolymer, PEG-polyglutamic acid (double-coat (DC) nanozyme). We developed DC nanozymes with high enzymatic activity and ability to retain and protect SOD1 under physiological conditions. Pharmacokinetic study revealed that DC nanozymes significantly prolonged circulation of active SOD1 in the blood stream compared to free SOD1 or SC nanozymes (half-life was 60 vs 6 min). Single intravenous injection of DC nanozymes (5 kU of SOD1/kg) improved the recovery of locomotor functions in rats with moderate SCI, along with reduction of swelling, concomitant compression of the spinal cord and formation of post-traumatic cysts. Thus, based on the testing in a rodent model the SOD1 DC nanozymes are promising modality for scavenging ROS, decreasing inflammation and edema, and improving recovery after SCI.	[Nukolova, N. V.; Abakumova, T. O.; Morozova, A. Y.; Chekhonin, V. P.] V Serbsky Natl Med Res Ctr Psychiat & Narcol, Dept Fundamental & Appl Neurobiol, Kropotkinskiy 23, Moscow 119034, Russia; [Aleksashkin, A. D.; Kirzhanova, E. A.; Klyachko, N. L.; Kabanov, A. V.] Moscow MV Lomonosov State Univ, Fac Chem, Lab Chem Design Bionanomat, Leninskie Gory 1, Moscow 119991, Russia; [Nukolova, N. V.; Gubskiy, I. L.; Abakumov, M. A.; Chekhonin, V. P.] NI Pirogov Russian Natl Res Med Univ, Dept Med Nanobiotechnol, Ostrovityanova St 1, Moscow 117997, Russia; [Klyachko, N. L.; Kabanov, A. V.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Ctr Nanotechnol Drug Delivery, Div Pharmacoengn & Mol Pharmaceut, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Abakumov, M. A.] Natl Univ Sci & Technol MISiS, Lab Biomed Nanomat, Leninskiy Prospekt 4, Moscow 119049, Russia; [Nukolova, N. V.] MIT, Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA		Kabanov, AV (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	kabanov@email.unc.edu	Chekhonin, Vladimir VP/T-4511-2018; Abakumova, Tatiana/H-2431-2013; Kabanov, Alexander V/N-3356-2013; Abakumov, Maxim A/O-5728-2017; Kabanov, Alexander/AAY-5751-2020; Aleksashkin, Anton/AAR-2723-2021; Morozova, Anna/T-1361-2019; Gubskiy, Ilya/V-4376-2017	Kabanov, Alexander V/0000-0002-3665-946X; Abakumov, Maxim A/0000-0003-2622-9201; Kabanov, Alexander/0000-0002-3665-946X; Abakumova, Tatiana/0000-0002-9139-3326; Aleksashkin, Anton/0000-0001-8724-0629; Gubskiy, Ilya/0000-0003-1726-6801; Chekhonin, Vladimir P./0000-0003-4386-7897	Russian Ministry of Science and EducationMinistry of Education and Science, Russian Federation [11G34.31.0004]	This work was supported by grant 11G34.31.0004 from Russian Ministry of Science and Education (to A.V.K.). We thank our colleagues at the V. Serbsky Medical Research Center of Psychiatry and Narcology N. P. Grinenko and P. A. Melnikov for their help with cytotoxicity and confocal imaging, and K. P. Ionova, A. Kuzkina and T. Mustafina for their help with SCI modeling. We also gratefully acknowledge N. G. Balabushevich and M. A. Pechenkin (M. V. Lomonosov Moscow State University) for establishing of SOD1 activity assay in plasma. MRI and confocal microscopy were carried out using equipment located in the Center for Collective Usage "Medical nanobiotechologies" (N. I. Pirogov Russian National Research Medical University).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Efremenko EN, 2017, J CONTROL RELEASE, V247, P175, DOI 10.1016/j.jconrel.2016.12.037; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jiang YH, 2015, J CONTROL RELEASE, V213, P36, DOI 10.1016/j.jconrel.2015.06.021; KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002; Kataoka K, 1996, MACROMOLECULES, V29, P8556, DOI 10.1021/ma961217+; Klyachko NL, 2012, NANOMED-NANOTECHNOL, V8, P119, DOI 10.1016/j.nano.2011.05.010; Krishna V., 2013, JOVE-J VIS EXP, V78, P1; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; McCord JM, 2008, DOSE-RESPONSE, V6, P223, DOI 10.2203/dose-response.08-012.McCord; Nakauchi K, 1996, J NEUROTRAUM, V13, P573, DOI 10.1089/neu.1996.13.573; OMAR BA, 1990, FREE RADICAL BIO MED, V9, P465, DOI 10.1016/0891-5849(90)90123-Z; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Rosenbaugh EG, 2010, BIOMATERIALS, V31, P5218, DOI 10.1016/j.biomaterials.2010.03.026; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Takenaga M, 2006, J CONTROL RELEASE, V110, P283, DOI 10.1016/j.jconrel.2005.10.022; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P587, DOI 10.1016/S0169-409X(02)00029-7; Wolfert MA, 1996, HUM GENE THER, V7, P2123, DOI 10.1089/hum.1996.7.17-2123; World Health Organization, 2013, SPIN CORD INJ; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y; Yusubalieva GM, 2010, B EXP BIOL MED+, V149, P125, DOI 10.1007/s10517-010-0890-7	33	24	25	6	64	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	JAN 28	2018	270						226	236		10.1016/j.jconrel.2017.11.044			11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	FV5VI	WOS:000424650100018	29196042				2022-02-06	
J	Ishii, N; Tsubouchi, H; Miura, A; Yanagi, S; Ueno, H; Shiomi, K; Nakazato, M				Ishii, Nobuyuki; Tsubouchi, Hironobu; Miura, Ayako; Yanagi, Shigehisa; Ueno, Hiroaki; Shiomi, Kazutaka; Nakazato, Masamitsu			Ghrelin alleviates paclitaxel-induced peripheral neuropathy by reducing oxidative stress and enhancing mitochondrial anti-oxidant functions in mice	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Ghrelin; Growth hormone secretagogue receptor; Paclitaxel; Chemotherapy-induced peripheral neuropathy; Peripheral neuropathic pain; PC12	TRAUMATIC BRAIN-INJURY; CONTRIBUTES; APOPTOSIS; PREVENTS; HORMONE; DISEASE; DRUG; STIMULATION; MECHANISMS; INDUCTION	Paclitaxel is an effective chemotherapeutic agent, but has some treatment-limiting adverse effects that markedly decrease patients' quality of life. Peripheral neuropathy is one of these, and no treatment for it has been established yet. Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, is secreted from the stomach and has widespread effects on multiple systems. We investigated the pharmacological potential of ghrelin in preventing paclitaxel-induced peripheral neuropathy using wild-type mice, ghrelin-null mice, and growth hormone secretagogue receptor-null mice. In wild-type mice, ghrelin administration alleviated mechanical and thermal hypersensitivity, and partially prevented neuronal loss of small unmyelinated intraepidermal nerve fibers but not large myelinated nerve fibers. Moreover, ghrelin administration decreased plasma oxidative and nitrosative stress and increased the expression of uncoupling protein 2 (UCP2) and superoxide dismutase 2 (SOD2) in the dorsal root ganglia, which are mitochondrial antioxidant proteins, and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha), a regulator of mitochondrial number. Both ghrelin-null mice and growth hormone secretagogue receptor-null mice developed more severe nerve injuries than wild-type mice. Our results suggest that ghrelin administration exerts a protective effect against paclitaxel-induced neuropathy by reducing oxidative stress and enhancing mitochondrial anti-oxidant functions, and that endogenous ghrelin has a neuroprotective effect that is mediated by ghrelin/growth hormone secretagogue receptor signaling. Ghrelin could be a promising therapeutic agent for the management of this intractable disease.	[Ishii, Nobuyuki; Tsubouchi, Hironobu; Miura, Ayako; Yanagi, Shigehisa; Ueno, Hiroaki; Shiomi, Kazutaka; Nakazato, Masamitsu] Univ Miyazaki, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki, Japan		Tsubouchi, H (corresponding author), Univ Miyazaki, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	hironobu_tsubouchi@med.miyazaki-u.ac.jp	ISHII, Nobuyuki/AAI-6966-2020	ISHII, Nobuyuki/0000-0003-1302-4151			Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bobylev I, 2015, NEUROBIOL DIS, V82, P321, DOI 10.1016/j.nbd.2015.07.006; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Carozzi VA, 2015, NEUROSCI LETT, V596, P90, DOI 10.1016/j.neulet.2014.10.014; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dobutovic B, 2014, ARCH MED SCI, V10, P806, DOI 10.5114/aoms.2014.44872; Duggett NA, 2016, NEUROSCIENCE, V333, P13, DOI 10.1016/j.neuroscience.2016.06.050; Erriquez J, 2009, CELL CALCIUM, V46, P197, DOI 10.1016/j.ceca.2009.07.003; Fujimura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094373; Garcia JM, 2008, ENDOCRINOLOGY, V149, P455, DOI 10.1210/en.2007-0828; Giuliani D, 2014, NEUROBIOL AGING, V35, P537, DOI 10.1016/j.neurobiolaging.2013.08.030; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Ko MH, 2002, NEUROBIOL DIS, V11, P155, DOI 10.1006/nbdi.2002.0537; Ko MH, 2014, NEUROPEPTIDES, V48, P109, DOI 10.1016/j.npep.2014.02.001; Kojima M, 2006, NAT CLIN PRACT ENDOC, V2, P80, DOI 10.1038/ncpendmet0080; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konaka K, 2017, J PHARM HEALTH CARE, V3, DOI 10.1186/s40780-017-0090-y; Kyoraku I, 2009, BIOCHEM BIOPH RES CO, V389, P405, DOI 10.1016/j.bbrc.2009.08.171; Li Y, 2013, ENDOCRINE, V43, P376, DOI 10.1007/s12020-012-9761-5; Liu XY, 2013, INFLAMMATION, V36, P1286, DOI 10.1007/s10753-013-9667-2; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Masocha W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21582; Masocha W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06719; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Qin Y, 2014, LIVER INT, V34, P567, DOI 10.1111/liv.12286; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Sato T, 2008, REGUL PEPTIDES, V145, P7, DOI 10.1016/j.regpep.2007.09.010; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Tofthagen Cindy, 2010, Clin J Oncol Nurs, V14, pE22, DOI 10.1188/10.CJON.E22-E28; Tsuchimochi W, 2013, EUR J PHARMACOL, V702, P187, DOI 10.1016/j.ejphar.2013.01.035; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu ZW, 2008, TOXICOLOGY, V247, P133, DOI 10.1016/j.tox.2008.02.018; Zeng M, 2015, INFLAMMATION, V38, P683, DOI 10.1007/s10753-014-9977-z; Zhang HJ, 2013, J PAIN, V14, P1031, DOI 10.1016/j.jpain.2013.03.012; Zhang HM, 2016, J PAIN, V17, P775, DOI 10.1016/j.jpain.2016.02.011	42	24	25	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JAN 15	2018	819						35	42		10.1016/j.ejphar.2017.11.024			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FS2SQ	WOS:000419629200005	29154935				2022-02-06	
J	Chong, CD; Berisha, V; Chiang, CC; Ross, K; Schwedt, TJ				Chong, Catherine D.; Berisha, Visar; Chiang, Chia-Chun; Ross, Katherine; Schwedt, Todd J.			Less Cortical Thickness in Patients With Persistent Post-Traumatic Headache Compared With Healthy Controls: An MRI Study	HEADACHE			English	Article						cortical thickness; concussion; magnetic resonance imaging; migraine; post-traumatic headache; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TRAIT ANXIETY; SEGMENTATION; INVENTORY; ACCURATE; REGIONS; STATE	ObjectiveTo investigate differences in cortical thickness in patients with persistent post-traumatic headache (PPTH) relative to healthy controls and to interrogate whether cortical morphology relates to headache burden (headache frequency, years with post-traumatic headache, PTH) in patients with PPTH. BackgroundPTHs are one of the most common symptoms following concussion. In some patients, PTHs continue for longer than three months and are classified as PPTH. This study has two main goals: (1) To delineate the neuropathology of PPTH, by interrogating differences in cortical thickness in patients with PPTH relative to healthy controls. (2) To interrogate potential associations between brain morphology and headache burden in patients with PPTH by examining whether cortical thickness relates to frequency of headaches or years lived with PTH. MethodsAdults with PPTH diagnosed according to ICHD 3 beta diagnostic criteria and healthy controls underwent brain MRI on a 3 Tesla scanner. Vertex-by-vertex whole brain estimates of cortical thickness were automatically calculated using FreeSurfer v5.3. Differences in cortical thickness in patients with PPTH relative to healthy controls were determined using a general linear model design. Associations were explored between regional clusters where patients with PPTH showed cortical thickness differences compared with healthy controls with headache frequency and years lived with PPTH. ResultsThis study included 33 patients with PPTH and 33 healthy control subjects (healthy controls: median age=33.0, IQR=15.5; patients with PPTH: median age=36.0, IQR=20.5; P=.56). Patients with PPTH had less cortical thickness relative to healthy controls in the left and right superior frontal, caudal middle frontal, and precentral cortex as well as less cortical thickness in the right supramarginal, right superior and inferior parietal, and right precuneus region (P<.05, Monte Carlo corrected for multiple comparisons). There were no regions where patients with PPTH had more cortical thickness relative to healthy controls. A correlation analysis of regions that showed less cortical thickness in patients with PPTH demonstrated a negative correlation between left and right superior frontal thickness with headache frequency (P<.05). There was no association between regional cortical thickness and years lived with PPTH. ConclusionCompared with healthy controls, patients with PPTH had less cortical thickness in bilateral frontal regions and right hemisphere parietal regions. For patients with PPTH, more frequent headaches were related to less thickness in the left and right superior frontal regions, potentially indicating that brain morphology changes in the superior frontal regions in patients with PPTH are modified by headache frequency.	[Chong, Catherine D.; Chiang, Chia-Chun; Schwedt, Todd J.] Mayo Clin, Dept Neurol, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ USA; [Berisha, Visar] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Audiol & Speech Pathol Serv, Phoenix, AZ USA		Chong, CD (corresponding author), Mayo Clin, Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	chong.catherine@mayo.edu		Chiang, Chia-Chun/0000-0001-7802-7172; Berisha, Visar/0000-0001-8804-8874	U.S. Department of DefenseUnited States Department of Defense [W81XWH-15-1-0286]; NIH Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23NS070891]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS070891] Funding Source: NIH RePORTER	U.S. Department of Defense, Grant/Award Number: W81XWH-15-1-0286; NIH Clinical Center, Grant/Award Number: K23NS070891.	Addolorato G, 1999, J PSYCHOSOM RES, V46, P283, DOI 10.1016/S0022-3999(98)00109-3; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Centers for Disease Control and Prevention (CDC), 2003, C MILD TRAUM BRAIN I; Chong CD, 2017, NEUROIMAGE-CLIN, V13, P223, DOI 10.1016/j.nicl.2016.10.023; Chong CD, 2017, CEPHALALGIA, V37, P828, DOI 10.1177/0333102416652091; Chong CD, 2014, CEPHALALGIA, V34, P1115, DOI 10.1177/0333102414531157; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Ghodadra A, 2016, AM J NEURORADIOL, V37, P274, DOI 10.3174/ajnr.A4505; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lucas S., 2015, BRAIN NEUROTRAUMA; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Riederer F, 2017, HEADACHE, V57, P255, DOI 10.1111/head.12993; Schwedt TJ, 2015, HEADACHE, V55, P762, DOI 10.1111/head.12584; Schwedt TJ, 2014, CEPHALALGIA, V34, P947, DOI 10.1177/0333102414526069; Schwedt TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099791; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492	42	24	24	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JAN	2018	58	1					53	61		10.1111/head.13223			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR4WP	WOS:000419067600005	29139130	Green Accepted, Bronze			2022-02-06	
S	Dwyer, B; Katz, DI		Hainline, B; Stern, RA		Dwyer, Brigid; Katz, Douglas I.			Postconcussion syndrome	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; SPORT-RELATED CONCUSSION; POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; EMOTIONAL RISK-FACTORS; HEAD-INJURY; HIGH-SCHOOL; MISERABLE MINORITY; PROLONGED RECOVERY	Postconcussion syndrome (PCS) is a heterogeneous condition comprised of a set of signs and symptoms in somatic, cognitive, and emotional domains. PCS is a controversial concept because of differing consensus criteria, variability in presentation, and lack of specificity to concussion. Whereas symptoms of concussion resolve in most individuals over days to weeks, a minority of individuals experience symptoms persisting months to years. The clinical consequences of concussion may be best conceptualized as two multidimensional disorders: (1) a constellation of acute symptoms termed early-phase posttraumatic disorder (commonly headache, dizziness, imbalance, fatigue, sleep disruption, impaired cognition, photo- and phonophobia); and (2) late-phase posttraumatic disorder, consisting of somatic, emotional, and cognitive symptoms. This phase is highly influenced by various psychosocial factors and is much less specific to the brain injury itself. Risk factors for development of a late-phase disorder include a high early symptom burden (e.g., headache, fatigue), a history of multiple concussions, psychiatric conditions (anxiety, depression), longer duration of unconsciousness or amnesia, and younger age. Successful treatment requires thoughtful differential diagnosis, including consideration of comorbid and premorbid conditions and other possible contributing factors. Treatment should include a hierarchic, sequential approach to management of treatable symptoms that impact functioning, such as depression, anxiety, insomnia, headache, musculoskeletal pain, and vertigo. A guided prescription of aerobic exercise is beneficial for early- and late-phase disorders after concussion.	[Dwyer, Brigid; Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, 72 E Concord St C3, Boston, MA 02118 USA		Katz, DI (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St C3, Boston, MA 02118 USA.	dkatz@bu.edu	Dwyer, Brigid/AAI-6199-2020	Dwyer, Brigid/0000-0002-6446-8054			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arendt-Nielsen L, 2000, Prog Brain Res, V129, P343; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V1, P9; Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Charmaz K., 2002, OCCUP THER J RES, V22, P31; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Davis J D, 2007, Minerva Endocrinol, V32, P49; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Fenech AM, 2013, LIFELONG THERAPEUTIC; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Ganti L, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0091-4; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guilmette T, 2013, ROLE CLIN JUDGMENT S; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Heinmiller L, 2016, CURR OPIN OPHTHALMOL, V27, P407, DOI 10.1097/ICU.0000000000000296; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horn LJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P932; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Iverson GL, 2013, BRAIN INJURY MED PRI; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jacob S, 2008, CEPHALALGIA, V28, P991, DOI 10.1111/j.1468-2982.2008.01622.x; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; King ML, 1997, BRAIN INJURY, V11, P445; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Lovell M, 2000, IMPACT IMMEDIATE POS; Lucas S, 2017, NEUROL CLIN, V35, P501, DOI 10.1016/j.ncl.2017.03.012; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Paniak C, 2000, BRAIN INJURY, V14, P219; Pardini D., 2004, BR J SPORTS MED, V38, P661; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Putzki N, 2005, CEPHALALGIA, V25, P395, DOI 10.1111/j.1468-2982.2004.00860.x; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shepard N, 2013, BRAIN INJURY MED; Siavoshi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010003; Siedlik JA, 2016, J SPORT MED PHYS FIT, V56, P1086; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Sufrinko A, 2017, J ATHL TRAINING, V52, P676, DOI 10.4085/1062-6050-52.4.01; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Swartz R, 2005, AM FAM PHYSICIAN, V71, P1115; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	132	24	24	1	3	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						163	178		10.1016/B978-0-444-63954-7.00017-3			16	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100019	30482344				2022-02-06	
J	Ghalaenovi, H; Fattahi, A; Koohpayehzadeh, J; Khodadost, M; Fatahi, N; Taheri, M; Azimi, A; Rohani, S; Rahatlou, H				Ghalaenovi, Hossein; Fattahi, Arash; Koohpayehzadeh, Jalil; Khodadost, Mahmoud; Fatahi, Neda; Taheri, Morteza; Azimi, Alireza; Rohani, Sadra; Rahatlou, Hessam			The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial	BRAIN INJURY			English	Article						Traumatic brain injury; amantadine; outcome assessment; double-blind method	COGNITION; IRRITABILITY; RECEPTORS; GLUTAMATE; CHILDREN; EFFICACY; STATE	Introduction: Amantadine, as a dopamine receptor agonist, may stimulate and help the recovery of the nervous system after traumatic brain injury (TBI).Methods: We performed this study as a double-blind, randomized, controlled clinical trial with target population including all patients with TBI who scored nine or lower on the Glasgow Coma Scale (GCS), admitted to our hospital between January 2013 and April 2014. The protocol included administration of the drug (placebo or amantadine) for 6 weeks and patient evaluation using the GCS and FOUR score on the first, third and seventh days after the drug was started. After 6 months from starting study drug, the patients were evaluated on the Mini-Mental State Examination, Glasgow Outcome Study, Disability Rating Scale and Karnofsky Performance Scale.Results: We included 40 patients in the study. The mean age of the patients was 36.7718.21. As an only important finding, the amantadine group registered an important rise between the first and the seventh day of study drug (GCS7-GCS1) with p-value=0.044.Conclusion: Based on our findings during the first week and the 6months (since starting drug) follow-ups, prescribing amantadine did not lead to reportable effects on the patients' level of consciousness, memory, disability, cognition, mortality and performance.	[Ghalaenovi, Hossein; Fattahi, Arash] Iran Univ Med Sci, Dept Neurosurg, Neurosurg, Tehran, Iran; [Koohpayehzadeh, Jalil] Iran Univ Med Sci, Community Med, Tehran, Iran; [Khodadost, Mahmoud] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Epidemiol, Tehran, Iran; [Fatahi, Neda] Ronash Med Genet Ctr, Genet, Tehran, Iran; [Taheri, Morteza; Azimi, Alireza; Rohani, Sadra; Rahatlou, Hessam] Iran Univ Med Sci, Dept Neurosurg, Neurosurg, Tehran, Iran		Fattahi, A (corresponding author), Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran.	arashmedicine@yahoo.com	Fattahi, Arash/M-3492-2017; Khodadost, Mahmoud/AAC-1293-2022; Taheri, Morteza/AAF-8208-2019	Fattahi, Arash/0000-0002-1874-6527; Khodadost, Mahmoud/0000-0003-4241-4300; Taheri, Morteza/0000-0001-5308-8040; Rahatlou, Hessam/0000-0003-1476-8005			Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; [Anonymous], 2001, SYMM AM PROD INF; Bales James W, 2010, Open Drug Discov J, V2, P119; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock Ross, 1993, Journal of Emergency Medicine, V11, P23; Chandler M C, 1988, Brain Inj, V2, P309; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Muzi F, 2005, TRANSPL P, V37, P1705, DOI 10.1016/j.transproceed.2005.03.077; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schneider WN, 1999, BRAIN INJURY, V13, P863; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Takahashi H, 2012, J CEREBR BLOOD F MET, V32, P1248, DOI 10.1038/jcbfm.2011.194	27	24	24	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1050	1055		10.1080/02699052.2018.1476733			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400012	29790790				2022-02-06	
J	Jochems, D; van Wessem, KJP; Houwert, RM; Brouwers, HB; Dankbaar, JW; van Es, MA; Geurts, M; Slooter, AJC; Leenen, LPH				Jochems, D.; van Wessem, K. J. P.; Houwert, R. M.; Brouwers, H. B.; Dankbaar, J. W.; van Es, M. A.; Geurts, M.; Slooter, A. J. C.; Leenen, L. P. H.			Outcome in Patients with Isolated Moderate to Severe Traumatic Brain Injury	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							WITHDRAWAL; CARE; RECOMMENDATIONS; DECISIONS; COMMON; IMPACT	Introduction. Traumatic brain injury (TBI) remains a major cause of death. Withdrawal of life-sustaining treatment (WLST) can be initiated if there is little anticipated chance of recovery to an acceptable quality of life. The aim of this study was firstly to investigate WLST rates in patients with moderate to severe isolated TBI and secondly to assess outcome data in the survivor group. Material and Methods. A retrospective cohort study was performed. Patients aged >= 18 years with moderate or severe isolated TBI admitted to the ICU of a single academic hospital between 2011 and 2015 were included. Exclusion criteria were isolated spinal cord injury and referrals to and from other hospitals. Gathered data included demographics, mortality, cause of death, WLST, and Glasgow Outcome Scale (GOS) score after three months. Good functional outcome was defined as GOS > 3. Results. Of 367 patients, 179 patients were included after applying inclusion and exclusion criteria. 55 died during admission (33%), of whom 45 (82%) after WLST. Patients undergoing WLST were older, had worse neurological performance at presentation, and had more radiological abnormalities than patients without WLST. The decision to withdraw life-sustaining treatment was made on the day of admission in 40% of patients. In 33% of these patients, this decision was made while the patient was in the Emergency Department. 71% of survivors had a good functional outcome after three months. No patient left hospital with an unresponsive wakefulness syndrome (UWS) or suffered from UWS after three months. One patient died within three months of discharge. Conclusion. In-hospital mortality in isolated brain injured patients was 33%. The vast majority died after a decision to withdraw life-sustaining treatment. None of the patients were discharged with an unresponsive wakefulness syndrome.	[Jochems, D.; van Wessem, K. J. P.; Houwert, R. M.; Leenen, L. P. H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Trauma, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [Brouwers, H. B.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurosurg, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [Dankbaar, J. W.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [van Es, M. A.; Geurts, M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurol, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [Slooter, A. J. C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands		Jochems, D (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Trauma, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands.	d.jochems-3@umcutrecht.nl	Houwert, Roderick/K-7887-2019; Geurts, Marjolein/AAP-4148-2020; van+Es, Michael/AAC-5772-2021	Houwert, Roderick/0000-0003-3497-659X; van Es, Michael/0000-0002-7709-5883			Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Fraccaro P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004973; Geocadin RG, 2012, CRIT CARE MED, V40, P979, DOI 10.1097/CCM.0b013e3182410146; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Gunning AC, 2015, WORLD J SURG, V39, P2677, DOI 10.1007/s00268-015-3162-x; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sise MJ, 2012, J TRAUMA ACUTE CARE, V72, P1186, DOI 10.1097/TA.0b013e31824d0e57; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010	23	24	24	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2018	2018								3769418	10.1155/2018/3769418			7	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GW3FL	WOS:000446779100001	30345113	Green Published, Green Submitted, gold			2022-02-06	
J	Leary, JB; Kim, GY; Bradley, CL; Hussain, UZ; Sacco, M; Bernad, M; Collins, J; Dsurney, J; Chan, L				Leary, Jacob B.; Kim, Grace Y.; Bradley, Catherine L.; Hussain, Uzma Z.; Sacco, Maryanne; Bernad, Martha; Collins, John; Dsurney, John; Chan, Leighton			The Association of Cognitive Reserve in Chronic-Phase Functional and Neuropsychological Outcomes Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive reserve; intelligence; neuropsychological tests; premorbid function; TBI severity; traumatic brain injury	MILD ALZHEIMERS-DISEASE; HEAD-INJURY; OLDER-ADULTS; IMPAIRMENT; EDUCATION; STYLE; RISK; RECOVERY; DEMENTIA; MODERATE	Objective: Examine the association of cognitive reserve (CR) factors (estimated premorbid intelligence quotient [IQ], years of education, and occupational attainment) and traumatic brain injury (TBI) severity with functional and neuropsychological outcomes 1 to 5 years following TBI. Participants: Patients with mild (N = 58), moderate (N = 25), or severe (N = 17) TBI. Main Measures: Cognitive reserve factors (estimated premorbid IQ, years of education, and occupational attainment); neuropsychological test battery; Glasgow Outcome Scale-Extended; Short Form-36 Health Survey. Analyses: Spearman-Brown correlations, linear regression models, and analyses of covariance were used to analyze the relation between CR factors and outcome measures. Results: Analyses revealed significant relations between estimated premorbid IQ and neuropsychological outcomes (P < .004): California Verbal Learning Test, Wechsler Adult Intelligence Scale-Fourth Edition working memory, Booklet Category Test, Trail Making Test B, and Grooved Pegboard Test. There was also a significant correlation between estimated premorbid IQ and Wechsler Adult Intelligence Scale-Fourth Edition processing speed. Years of education had significant relations with California Verbal Learning Test and Wechsler Adult Intelligence Scale-Fourth Edition working memory and processing speed scores. There were significant differences between TBI severity groups and performance on the TrailMaking Test A, Grooved Pegboard Test, and Finger Tapping Test. Conclusions: Cognitive reserve factors may be associated with outcomes following TBI. Additional alternatives to TBI severity are needed to help guide rehabilitative planning postinjury.	[Leary, Jacob B.; Kim, Grace Y.; Bradley, Catherine L.; Hussain, Uzma Z.; Sacco, Maryanne; Bernad, Martha; Chan, Leighton] NIH, Dept Rehabil Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Collins, John] George Mason Univ, Dept Rehabil Sci, Coll Hlth & Human Serv, Fairfax, VA 22030 USA; [Dsurney, John; Chan, Leighton] NIH, Ctr Neurosci & Regenerat Med, Bldg 10, Bethesda, MD 20892 USA		Dsurney, J (corresponding author), NIH, Dept Rehabil Med, 10 Ctr Dr,Room 1-1469 MSC1604, Bethesda, MD 20892 USA.	john.dsurney@nih.gov		Collins, John/0000-0002-3863-0329	Department of Defense (Center for Neuroscience and Regenerative Medicine)United States Department of Defense; National Institutes of Health Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CLINICAL CENTER [ZIACL060079, ZIACL060065] Funding Source: NIH RePORTER	This work was supported by the Department of Defense (Center for Neuroscience and Regenerative Medicine) and the National Institutes of Health Intramural Research Program.	Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bosch B, 2010, CORTEX, V46, P451, DOI 10.1016/j.cortex.2009.05.006; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Duda B, 2014, J CLIN EXP NEUROPSYC, V36, P368, DOI 10.1080/13803395.2014.892916; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hindle JV, 2016, INT J GERIATR PSYCH, V31, P13, DOI 10.1002/gps.4284; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Lopez KC, 2016, J NEUROTRAUM, V33, P1; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Sandry J, 2015, J NEUROL, V12, P2562; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sumowski JF, 2016, EUR J NEUROL, V23, P39, DOI 10.1111/ene.12662; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Verghese J, 2009, J GERIATR PSYCH NEUR, V22, P110, DOI 10.1177/0891988709332938; Wechsler D, 1944, MEASUREMENT ADULT IN, P3	27	24	24	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E28	E35		10.1097/HTR.0000000000000329			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300004	28731870	Green Accepted			2022-02-06	
S	Sheehy, EJ; Cunniffe, GM; O'Brien, FJ		Barbosa, MA; Martins, MCL		Sheehy, E. J.; Cunniffe, G. M.; O'Brien, F. J.			Collagen-based biomaterials for tissue regeneration and repair	PEPTIDES AND PROTEINS AS BIOMATERIALS FOR TISSUE REGENERATION AND REPAIR	Woodhead Publishing Series in Biomaterials		English	Article; Book Chapter							BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; TRAUMATIC BRAIN-INJURY; ENGINEERING APPLICATIONS; CROSS-LINKING; GAG SCAFFOLDS; IN-VIVO; GLYCOSAMINOGLYCAN SCAFFOLDS; EXTRACELLULAR-MATRIX		[Sheehy, E. J.; O'Brien, F. J.] Royal Coll Surgeons Ireland, Dublin, Ireland; [Sheehy, E. J.; Cunniffe, G. M.; O'Brien, F. J.] Trinity Coll Dublin, Dublin, Ireland		Sheehy, EJ (corresponding author), Royal Coll Surgeons Ireland, Dublin, Ireland.; Sheehy, EJ (corresponding author), Trinity Coll Dublin, Dublin, Ireland.		Teixeira, Catia AS/B-5680-2011; O'Brien, Fergal/F-9485-2011	Teixeira, Catia AS/0000-0001-9506-3781; O'Brien, Fergal/0000-0003-2030-8005; Sheehy`, Eamon/0000-0002-2902-4562			Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010; Agren M S, 2001, J Wound Care, V10, P301; Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320; Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035; Arbelaez Maria Clara, 2009, Oman J Ophthalmol, V2, P33, DOI 10.4103/0974-620X.48420; Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Baek J, 2016, TISSUE ENG PT A, V22, P436, DOI [10.1089/ten.tea.2015.0284, 10.1089/ten.TEA.2015.0284]; Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Bishop S M, 2003, J Wound Care, V12, P125; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473; Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395; Bronzino J.D., 2015, BIOMEDICAL ENG HDB, V4th; Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.tea.2012.0721, 10.1089/ten.TEA.2012.0721]; Bulleid NJ, 2000, BIOCHEM SOC T, V28, P350, DOI 10.1042/0300-5127:0280350; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483; Castano IM, 2015, J CONTROL RELEASE, V200, P42, DOI 10.1016/j.jconrel.2014.12.034; Catrina S, 2013, EUR J PHARM BIOPHARM, V85, P139, DOI 10.1016/j.ejpb.2013.03.030; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004; Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436; Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012; Chwalek K, 2015, JOVE-J VIS EXP, DOI 10.3791/52970; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cunniffe GM, 2011, JOM-US, V63, P66, DOI 10.1007/s11837-011-0061-y; Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397; Di Bella C, 2015, FRONT SURG, P2; Dickhut A, 2010, TISSUE ENG PT A, V16, P453, DOI [10.1089/ten.tea.2009.0168, 10.1089/ten.TEA.2009.0168]; Diederichs S, 2012, TISSUE ENG PT A, V18, P1140, DOI [10.1089/ten.tea.2011.0426, 10.1089/ten.TEA.2011.0426]; Donaghue V M, 1998, Adv Wound Care, V11, P114; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147; Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459; Ferrario C, 2017, MAR ENVIRON RES, V128, P46, DOI 10.1016/j.marenvres.2016.03.007; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Fitzgerald KA, 2015, BIOMATERIALS, V66, P53, DOI 10.1016/j.biomaterials.2015.07.019; Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4; Gannon AR, 2012, OSTEOARTHR CARTILAGE, V20, P1417, DOI 10.1016/j.joca.2012.08.005; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gleeson JP, 2010, EUR CELLS MATER, V20, P218; Gonzalez-Henriquez CM, 2017, MATERIALS, V10, DOI 10.3390/ma10030232; Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145; Grier WK, 2017, J MECH BEHAV BIOMED, V65, P295, DOI 10.1016/j.jmbbm.2016.08.034; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.TEA.2010.0590, 10.1089/ten.tea.2010.0590]; Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955; Herland A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150360; Huang C, 2012, PROG NAT SCI-MATER, V22, P108, DOI 10.1016/j.pnsc.2012.03.005; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Jacobi M, 2011, BMC SPORTS SCI MED R, V3, DOI 10.1186/1758-2555-3-10; Joanne P, 2016, BIOMATERIALS, V80, P157, DOI 10.1016/j.biomaterials.2015.11.035; Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518; Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003; Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9; Lee HJ, 2015, ADV HEALTHC MATER, V4, P1359, DOI 10.1002/adhm.201500193; Levingstone TJ, 2016, ACTA BIOMATER, V32, P149, DOI 10.1016/j.actbio.2015.12.034; Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0; Mackie EJ, 2003, INT J BIOCHEM CELL B, V35, P1301, DOI 10.1016/S1357-2725(03)00107-9; Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021; Marsano A, 2016, STEM CELL TRANSL MED, V5, P1730, DOI 10.5966/sctm.2015-0321; Matsiko A, 2015, ADV HEALTHC MATER, V4, P1175, DOI 10.1002/adhm.201500053; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/0883911503018002003; Meena C, 1999, P INDIAN AS-CHEM SCI, V111, P319; Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nannan D, 2016, BIOMED MATER, V11; Nisi Giuseppe, 2005, Chir Ital, V57, P465; Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004; O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6; O'Leary C, 2016, BIOMATERIALS, V85, P111, DOI 10.1016/j.biomaterials.2016.01.065; O'Leary C, 2015, TISSUE ENG PART B-RE, V21, P323, DOI [10.1089/ten.teb.2014.0525, 10.1089/ten.TEB.2014.0525]; Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887; Pacak CA, 2011, TISSUE ENG PART C-ME, V17, P879, DOI [10.1089/ten.tec.2010.0720, 10.1089/ten.TEC.2010.0720]; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024; Pawelec KM, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4871083; Pereira H, 2014, OSTEOARTHR CARTILAGE, V22, P1271, DOI 10.1016/j.joca.2014.07.001; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030; Prabu P, 2008, MACROMOL RES, V16, P303, DOI 10.1007/BF03218521; Quinlan E, 2017, J TISSUE ENG REGEN M, V11, P1097, DOI 10.1002/term.2013; Quinlan E, 2015, J CONTROL RELEASE, V207, P112, DOI 10.1016/j.jconrel.2015.03.028; Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021; Raftery RM, 2016, ACTA BIOMATER, V43, P160, DOI 10.1016/j.actbio.2016.07.009; Raftery RM, 2016, ADV MATER, V28, P5447, DOI 10.1002/adma.201505088; Ramburrun P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/132350; Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004; Rose JB, 2014, MATERIALS, V7, P3106, DOI 10.3390/ma7043106; Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X; Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076; Ryan AJ, 2015, BIOMATERIALS, V73, P296, DOI 10.1016/j.biomaterials.2015.09.003; Shah SR, 2013, CHINESE SCI BULL, V58, P4342, DOI 10.1007/s11434-013-5780-8; Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283; Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017; Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Sun LP, 2015, CHEMBIOCHEM, V16, P1415, DOI 10.1002/cbic.201500205; Tan A, 2016, BIOMATER SCI-UK, V4, P1503, DOI 10.1039/c6bm00340k; Tani A, 2012, ANN OTO RHINOL LARYN, V121, P261, DOI 10.1177/000348941212100412; Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060; Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007; Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207; Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006; Tsaryk R, 2015, ACTA BIOMATER, V20, P10, DOI 10.1016/j.actbio.2015.03.041; Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035; Vavken J, 2016, EUR SPINE J, V25, P3979, DOI 10.1007/s00586-015-3870-9; Veiga AS, 2013, BIOPOLYMERS, V100, P637, DOI 10.1002/bip.22412; Veves A, 2002, ARCH SURG-CHICAGO, V137, P822, DOI 10.1001/archsurg.137.7.822; Vivian H.M.M., 2016, BIOFABRICATION, V8; Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599; Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06; WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815; WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108; Woo EJ, 2012, SPINE J, V12, P894, DOI 10.1016/j.spinee.2012.09.052; Wu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24474; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933; Yeo M, 2016, BIOMACROMOLECULES, V17, P1365, DOI 10.1021/acs.biomac.5b01764; Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052; Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009	141	24	24	0	3	WOODHEAD PUBL LTD	CAMBRIDGE	ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND	2049-9485		978-0-08-100852-2; 978-0-08-100803-4	WOODH PUBL SER BIOM			2018							127	150		10.1016/B978-0-08-100803-4.00005-X			24	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Materials Science, Biomaterials	Book Citation Index – Science (BKCI-S)	Cell Biology; Biotechnology & Applied Microbiology; Materials Science	BJ0IY	WOS:000416869700006					2022-02-06	
J	Starkey, NJ; Jones, K; Case, R; Theadom, A; Barker-Collo, S; Feigin, V				Starkey, Nicola J.; Jones, Kelly; Case, Rosalind; Theadom, Alice; Barker-Collo, Suzanne; Feigin, Valery			Post-concussive symptoms after a mild traumatic brain injury during childhood and adolescence	BRAIN INJURY			English	Article						Adolescence; behaviour; child; concussion; longitudinal; mild TBI; symptoms	HEAD-INJURY; POSTCONCUSSION SYNDROME; CHILDREN; POPULATION; OUTCOMES; QUESTIONNAIRE; RELIABILITY; PREDICTORS; ADULTS; SCALE	Objective: Mild traumatic brain injury (mTBI) is common injury during childhood and adolescence but the long-term outcomes are poorly understood. This study examined post-concussive symptoms and behavioural outcomes in children and adolescents up to 24months post-mTBI.Method: Parents of children aged 8-15years with mTBI completed the BASC-2 and Rivermead Post-Concussion Symptoms Questionnaire at baseline, 1-, 6-, 12- and 24months post-injury. An age-matched traumatic brain injury-free cohort was recruited and assessed at 12- and 24months.Results: PCSs decreased significantly over the first 12months post-injury. At 12- and 24months post-injury, the mTBI group reported more PCSs and behavioural symptoms compared to controls. Parents of children with mTBI were more likely to report 4 problematic PCS symptoms (28% at both time points) compared to controls (7.7% and 1.7% at 12 and 24months, respectively). The mTBI group was 4.63 times more likely to have four or more ongoing PCS symptoms at 12months post-injury compared to controls. Headache was the most common acute post-injury symptom (55%), while the most commonly reported persistent symptoms were irritability, frustration, forgetfulness and fatigue.Conclusions: PCSs are common 2years post-mTBI in childhood or adolescence. Given this, additional intervention and support is needed for families post-injury.	[Starkey, Nicola J.] Univ Waikato, Sch Psychol, Private Bag 3105, Hamilton 3204, New Zealand; [Jones, Kelly; Theadom, Alice; Feigin, Valery] AUT Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Case, Rosalind] Cairn Miller Inst, Sch Psychol Counselling & Psychotherapy, Melbourne, Vic, Australia; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand		Starkey, NJ (corresponding author), Univ Waikato, Sch Psychol, Private Bag 3105, Hamilton 3204, New Zealand.	nstarkey@waikato.ac.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Case, Rosalind/0000-0003-3182-9930; Feigin, Valery L./0000-0002-6372-1740	Heath Research Council of New Zealand [09/063A, 11/192]; Lottery Health Grants Board of New Zealand	The study was funded by the Heath Research Council of New Zealand: [Grant Number 09/063A, 11/192] and the Lottery Health Grants Board of New Zealand.	Albicini M, 2015, J CLIN EXP NEUROPSYC, V37, P776, DOI 10.1080/13803395.2015.1053843; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Bergman DA, 1999, PEDIATRICS, V104, P1407; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McKinlay A, 2018, J CLIN EXP NEUROPSYC, V40, P285, DOI 10.1080/13803395.2017.1342771; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Olsson K, 2014, BRAIN IMPAIR, V15, P177, DOI 10.1017/BrImp.2014.22; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	24	24	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					617	626		10.1080/02699052.2018.1439533			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200013	29446658				2022-02-06	
J	Wiesner, D; Tar, L; Linkus, B; Chandrasekar, A; Heuvel, FO; Dupuis, L; Tsao, W; Wong, PC; Ludolph, A; Roselli, F				Wiesner, Diana; Tar, Lilla; Linkus, Birgit; Chandrasekar, Akila; Heuvel, Florian Olde; Dupuis, Luc; Tsao, William; Wong, Philip C.; Ludolph, Albert; Roselli, Francesco			Reversible induction of TDP-43 granules in cortical neurons after traumatic injury	EXPERIMENTAL NEUROLOGY			English	Article						TDP-43; Cortical injury; ALS	AMYOTROPHIC-LATERAL-SCLEROSIS; FRAGILE-X-SYNDROME; HEAD-INJURY; BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; PATHOLOGICAL TDP-43; ALZHEIMERS-DISEASE; MOTOR CORTEX; MUTANT SOD1; ALS	Traumatic brain injury (TBI) has been proposed as a risk factor for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). To determine whether TBI might trigger or exacerbate ALS-relevant pathology, we delivered a mild stab-wound injury to the motor cortex of three different ALS mouse models expressing mutations in SOD1, TDP-43 or FUS and scrutinized the effects on the formation of phospho-TDP-43 (pTDP-43) cytoplasmic granules. Stab-injury induced the formation of cytoplasmic TDP-43 granules in wt animals, peaking at 3 dpi; a much larger response was seen in mutant TDP-43 mice, whose response peaked at 7 dpi. The pTDP-43 granules did not colocalize with the stress markers TIAR-1 and FUS but colocalized with FMRP (35%) and with p62 (65%), suggesting their involvement in transport granules and their clearance by autophagy. A similar, albeit smaller effect, was seen in mutant FUS mice. In the SOD1(G93A) mouse model, neither increase in pTDP-43 granules nor in SOD1 aggregates were detected. In all cases, pTDP-43 granules were cleared and the number of pTDP-43-positive neurons returned to baseline by 40 dpi. Neither injury-related neuronal loss nor motor performance or survival was significantly different in transgenic mice receiving injury vs sham mice. Thus, trauma can trigger ALS-related TDP-43 pathology, the extent of which is modulated by ALS-related mutations. However, the pathological findings prove reversible and do not affect disease progression and neuronal vulnerability.	[Wiesner, Diana; Tar, Lilla; Linkus, Birgit; Chandrasekar, Akila; Heuvel, Florian Olde; Ludolph, Albert; Roselli, Francesco] Univ Ulm, Sch Med, Dept Neurol, Ulm, Germany; [Dupuis, Luc] INSERM, U1118, Mecanismes Cent & Periphet Neurodegeneresce, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Fac Med, Strasbourg, France; [Tsao, William; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tsao, William; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Cellular & Mol Med Program, Baltimore, MD USA; [Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Roselli, Francesco] Univ Ulm, Sch Med, Dept Anat & Cell Biol, Ulm, Germany		Roselli, F (corresponding author), Univ Ulm, Sch Med, Dept Neurol, Ctr Biomed Res, Helmholzstr 8-2, D-89081 Ulm De, Germany.	francesco.roselli@uni-ulm.de	roselli, francesco/O-8847-2019; Dupuis, Luc/A-6981-2012	roselli, francesco/0000-0001-9935-6899; Dupuis, Luc/0000-0002-0902-5824	DFG in the "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma" Collaborative Research Center [SFB1149-B05, SFB1149]; ERANET-NEURON "External insults to the CNS" program as part of the MICRONET consortium; Baustein Program of the Ulm University Medical Faculty [LSBN108]	F.R. is member of the Ulm Trauma Research Center and it is supported by DFG (SFB1149-B05) in the "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma" Collaborative Research Center (SFB1149), by the ERANET-NEURON "External insults to the CNS" program as part of the MICRONET consortium and by the Baustein Program of the Ulm University Medical Faculty (LSBN108).	AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4; Al-Chalabi A, 2015, EPIDEMIOLOGY, V26, P821, DOI 10.1097/EDE.0000000000000381; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Braak H., 2016, ACTA NEUROPATHOL, V18; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brenner D., 2016, BRAIN, V5; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Caller TA, 2015, NEURODEGENER DIS, V15, P202, DOI 10.1159/000374117; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Ciura S, 2016, AUTOPHAGY, V12, P1406, DOI 10.1080/15548627.2016.1189070; Correia AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140248; Couratier P, 2016, REV NEUROL-FRANCE, V172, P37, DOI 10.1016/j.neurol.2015.11.002; Coyne AN, 2015, HUM MOL GENET, V24, P6886, DOI 10.1093/hmg/ddv389; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gal J, 2016, ACTA NEUROPATHOL, V132, P563, DOI 10.1007/s00401-016-1601-x; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hubers A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.08.005; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Lee S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6791; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Majumder P, 2016, ACTA NEUROPATHOL, V132, P721, DOI 10.1007/s00401-016-1603-8; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Riva N., 2016, J NEUROL, V30; Rosenbohm A, 2014, J NEUROL, V261, P283, DOI 10.1007/s00415-013-7185-7; Scekic-Zahirovic J, 2016, EMBO J, V35, P1077, DOI 10.15252/embj.201592559; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Shan XY, 2009, NEUROSCI LETT, V458, P70, DOI 10.1016/j.neulet.2009.04.031; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Soo KY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.30; Steinberg KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09124; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Valavanis A, 2014, J NEUROL, V261, P732, DOI 10.1007/s00415-014-7260-8; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Ying Z, 2016, AUTOPHAGY, V12, P707, DOI 10.1080/15548627.2016.1151596	60	24	24	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.		2018	299		A				15	25		10.1016/j.expneurol.2017.09.011			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR7PD	WOS:000419261500002	28941811				2022-02-06	
J	Zhu, YH; Wang, HD; Fang, J; Dai, W; Zhou, J; Wang, XL; Zhou, ML				Zhu, Yihao; Wang, Handong; Fang, Jiang; Dai, Wei; Zhou, Jiang; Wang, Xiaoliang; Zhou, Mengliang			SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							OXIDATIVE STRESS; COGNITIVE DEFICITS; APOPTOSIS; MODEL; COACTIVATORS; INFLAMMATION; PGC-1-ALPHA; BIOGENESIS; ISCHEMIA; PATHWAY	SS-31, a novel mitochondria-targeted peptide, has been proven to provide neuroprotection in a variety of neurological diseases. Its role as a mitochondrial reactive oxygen species (ROS) scavenger and the underlying pathophysiological mechanisms in traumatic brain injury (TBI) are still not well understood. The aim of the designed study was to investigate the potential neuroprotective effects of SS-31 and fulfill our understanding of the process of the mitochondrial change in the modified Marmarou weight-drop model of TBI. Mice were randomly divided into sham, TBI, TBI + vehicle, and TBI + SS-31 groups in this study. Peptide SS-31 (5 mg/kg) or vehicle was intraperitoneally administrated 30 min after TBI with brain samples harvested 24 h later for further analysis. SS-31 treatment significantly reversed mitochondrial dysfunction and ameliorated secondary brain injury caused by TBI. SS-31 can directly decrease the ROS content, restore the activity of superoxide dismutase (SOD), and decrease the level of malondialdehyde (MDA) and the release of cytochrome c, thus attenuating neurological deficits, brain water content, DNA damage, and neural apoptosis. Moreover, SS-31 restored the expression of SIRT1 and upregulated the nuclear translocation of PGC-1 alpha, which were proved by Western blot and immunohistochemistry. Taken together, these data demonstrate that SS-31 improves the mitochondrial function and provides neuroprotection in mice after TBI potentially through enhanced mitochondrial rebiogenesis. The present study gives us an implication for further clinical research.	[Zhu, Yihao; Wang, Handong; Wang, Xiaoliang; Zhou, Mengliang] Nanjing Univ, Jinling Hosp, Med Sch, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Fang, Jiang] Southeast Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Dai, Wei; Zhou, Jiang] Nanjing Med Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Med Sch, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371357]; National Natural Science Foundation for Distinguished Young Scholars of ChinaNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81401026]	This study was supported by grants from the National Natural Science Foundation of China (no. 81371357) and the National Natural Science Foundation for Distinguished Young Scholars of China (no. 81401026).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chance B, 1973, Adv Exp Med Biol, V37A, P277; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen-Roetling J, 2016, J NEUROCHEM, V139, P586, DOI 10.1111/jnc.13720; CHO DH, 1993, CANCER LETT, V74, P141, DOI 10.1016/0304-3835(93)90235-2; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kim EH, 2015, CNS NEUROSCI THER, V21, P385, DOI 10.1111/cns.12326; Kress GJ, 2002, J NEUROSCI, V22, P5848; Li X, 2018, J CELL MOL MED, V22, P883, DOI 10.1111/jcmm.13313; Negrette-Guzman M, 2013, FREE RADICAL BIO MED, V65, P1078, DOI 10.1016/j.freeradbiomed.2013.08.182; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Petri S, 2006, J NEUROCHEM, V98, P1141, DOI 10.1111/j.1471-4159.2006.04018.x; Procaccio V, 2014, REV NEUROL-FRANCE, V170, P390, DOI 10.1016/j.neurol.2014.03.005; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Szeto HH, 2008, ANTIOXID REDOX SIGN, V10, P601, DOI 10.1089/ars.2007.1892; Tsai CJ, 2015, STRUCTURE, V23, P139, DOI 10.1016/j.str.2014.10.016; Voigt C, 2012, NEUROPATH APPL NEURO, V38, P354, DOI 10.1111/j.1365-2990.2011.01211.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu J, 2015, MOL NEUROBIOL, V52, P783, DOI 10.1007/s12035-014-8918-z; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhao HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11779-9; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017; Zhu L. L., 2018, CELLULAR PHYSL BIOCH, V44, P388; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	40	24	25	1	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2018	2018								4783602	10.1155/2018/4783602			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GT0UJ	WOS:000444163800001	30224944	gold, Green Submitted, Green Published			2022-02-06	
J	Ownsworth, T; Fleming, J; Tate, R; Beadle, E; Griffin, J; Kendall, M; Schmidt, J; Lane-Brown, A; Chevignard, M; Shum, DHK				Ownsworth, Tamara; Fleming, Jennifer; Tate, Robyn; Beadle, Elizabeth; Griffin, Janelle; Kendall, Melissa; Schmidt, Julia; Lane-Brown, Amanda; Chevignard, Mathilde; Shum, David H. K.			Do People With Severe Traumatic Brain Injury Benefit From Making Errors? A Randomized Controlled Trial of Error-Based and Errorless Learning	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						rehabilitation; executive function; neuropsychology; brain injuries	IMPAIRED SELF-AWARENESS; ASSESSING SUPPORT NEEDS; INCOG RECOMMENDATIONS; METACOGNITIVE SKILLS; EXECUTIVE FUNCTION; MANAGEMENT; SCALE; REHABILITATION; INTERVENTION; INDIVIDUALS	Background. Errorless learning (ELL) and error-based learning (EBL) are commonly used approaches to rehabilitation for people with traumatic brain injury (TBI). However, it is unknown whether making errors is beneficial in the learning process to promote skills generalization after severe TBI. Objective. To compare the efficacy of ELL and EBL for improving skills generalization, self-awareness, behavioral competency, and psychosocial functioning after severe TBI. Method. A total of 54 adults (79% male; mean age = 38.0 years, SD = 13.4) with severe TBI were randomly allocated to ELL or EBL and received 8 x 1.5-hour therapy sessions that involved meal preparation and other goal-directed activities. The primary outcome was total errors on the Cooking Task (near-transfer). Secondary outcome measures included the Zoo Map Test (far-transfer), Awareness Questionnaire, Patient Competency Rating Scale, Sydney Psychosocial Reintegration Scale, and Care and Needs Scale. Results. Controlling for baseline performance and years of education, participants in the EBL group made significantly fewer errors at postintervention (mean = 36.25; 95% CI = 32.5-40.0) than ELL participants (mean = 42.57; 95% CI = 38.8-46.3). EBL participants also demonstrated greater self-awareness and behavioral competency at postintervention than ELL participants (P < .05). There were no significant differences on other secondary outcomes (P > .05), or at the 6-month follow-up assessment. Conclusion. EBL was found to be more effective than ELL for enhancing skills generalization on a task related to training and improving self-awareness and behavioral competency.	[Ownsworth, Tamara; Beadle, Elizabeth; Shum, David H. K.] Griffith Univ, Mt Gravatt, Qld, Australia; [Fleming, Jennifer] Univ Queensland, St Lucia, Qld, Australia; [Tate, Robyn] Univ Sydney, Sydney, NSW, Australia; [Griffin, Janelle] Princess Alexandra Hosp, Woolloongabba, Australia; [Kendall, Melissa] Acquired Brain Injury Outreach Serv, Brisbane, Qld, Australia; [Kendall, Melissa] Griffith Univ, Div Rehabil, Metro South Hlth, Brisbane, Qld, Australia; [Schmidt, Julia] Univ British Columbia, Vancouver, BC, Canada; [Schmidt, Julia] La Trobe Univ, Melbourne, Vic, Australia; [Lane-Brown, Amanda] Liverpool Hosp, Sydney, NSW, Australia; [Chevignard, Mathilde] Hop St Maurice, St Maurice, France; [Chevignard, Mathilde] Sorbonne Univ, Paris, France; [Chevignard, Mathilde] GRC UPMC 18 Handicap Cognitif & Readaptat HanCRe, Paris, France; [Shum, David H. K.] Chinese Acad Sci, Beijing, Peoples R China		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David H. K./0000-0002-4810-9262; Schmidt, Julia/0000-0003-2004-4871	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1043677]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This trial was funded by a National Health and Medical Research Council Project Grant (APP1043677). This funding body was otherwise not involved in the study.	Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Chiaravalloti ND, 2016, NEUROREHAB NEURAL RE, V30, P539, DOI 10.1177/1545968315604395; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dunlosky J, 2013, PSYCHOL SCI PUBL INT, V14, P4, DOI 10.1177/1529100612453266; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandez J, 2017, METACOGN LEARN, V12, P131, DOI 10.1007/s11409-016-9163-9; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Lee GY, 2013, CLIN INTERV AGING, V8, P623, DOI 10.2147/CIA.S45726; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Poncet F, 2015, NEUROPSYCHOL REHABIL, V25, P298, DOI 10.1080/09602011.2014.971819; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schulz KF, 2011, INT J SURG, V9, P672, DOI [10.7326/0003-4819-152-11-201006010-00232, 10.1016/j.ijsu.2011.09.004]; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; The Center for Outcome Measurement in Brain Injury, INTR AW QUEST AQ; Toglia J.P., 2011, COGNITION OCCUPATION, P116; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069	38	24	24	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	DEC	2017	31	12					1072	1082		10.1177/1545968317740635			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ5BW	WOS:000418374500008	29139337	Bronze, Green Published			2022-02-06	
J	Yilmaz, T; Roks, G; de Koning, M; Scheenen, M; van der Horn, H; Plas, G; Hageman, G; Schoonman, G; Spikman, J; van der Naalt, J				Yilmaz, Tansel; Roks, Gerwin; de Koning, Myrthe; Scheenen, Myrthe; van der Horn, Harm; Plas, Gerben; Hageman, Gerard; Schoonman, Guus; Spikman, Jacoba; van der Naalt, Joukje			Risk factors and outcomes associated with post-traumatic headache after mild traumatic brain injury	EMERGENCY MEDICINE JOURNAL			English	Article							SYMPTOMS FOLLOWING MILD; FOLLOW-UP; PREDICTION; COMPLAINTS; ANXIETY	Objectives To determine the prevalence and potential risk factors of acute and chronic post-traumatic headache (PTH) in patients with mild to moderate traumatic brain injury (TBI) in a prospective longitudinal observational multicentre study. Acute PTH (aPTH) is defined by new or worsening of pre-existing headache occurring within 7 days after trauma, whereas chronic PTH (cPTH) is defined as persisting aPTH >3 months after trauma. An additional goal was to study the impact of aPTH and cPTH in terms of return to work (RTW), anxiety and depression. Methods This was a prospective observational study conducted between January 2013 and February 2014 in three trauma centres in the Netherlands. Patients aged 16 years and older with a GCS score of 9-15 on admission to the ED, with loss of consciousness and/ or amnesia were prospectively enrolled. Follow-up questionnaires were completed at 2 weeks and 3 months after injury with the Head Injury Symptom Checklist, the Hospital Anxiety and Depression Scale and RTW scale. Results In total, 628 patients were enrolled in the study, 469 completed the 2-week questionnaire (75%) at 2 weeks and 409 (65%) at 3 months. At 2 weeks, 238 (51%) had developed aPTH and at 3 months 95 (23%) had developed cPTH. Female gender, younger age, headache immediately at the ED and CT scan abnormalities increased the risk for aPTH. Risk factors for cPTH were female gender and headache at the ED. Patients with cPTH were less likely to have returned to work than those without cPTH (35% vs 14%, P=0.001). Patients with aPTH and cPTH more often report anxiety (20% and 28%, P=0.001) and depression (19% and 28%, P=0.001) after trauma in comparison with the group without PTH (10% anxiety and 8% depression). Conclusions PTH is an important health problem with a significant impact on long-term outcome of TBI patients. Several risk factors were identified, which can aid in early identification of subjects at risk for PTH.	[Yilmaz, Tansel; Roks, Gerwin; Schoonman, Guus] St Elizabeth Hosp, Dept Neurol, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands; [de Koning, Myrthe; Scheenen, Myrthe; van der Horn, Harm; Spikman, Jacoba; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Plas, Gerben; Hageman, Gerard] MST, Dept Neurol, Enschede, Netherlands		Yilmaz, T (corresponding author), St Elizabeth Hosp, Dept Neurol, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands.	t.yilmaz@elisabeth.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763			Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Erickson Jay C, 2010, Continuum (Minneap Minn), V16, P55, DOI 10.1212/01.CON.0000391453.37923.83; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; GANTI L, 2014, INT J EMERG MED, V7; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMurtray AM, 2013, INT J PSYCHIAT MED, V45, P227, DOI 10.2190/PM.45.3.b; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	22	24	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	DEC	2017	34	12					800	805		10.1136/emermed-2015-205429			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FN8UO	WOS:000416301200007	28689194				2022-02-06	
J	Kingery, KM; Narad, ME; Taylor, HG; Yeates, KO; Stancin, T; Wade, SL				Kingery, Kathleen M.; Narad, Megan E.; Taylor, H. Gerry; Yeates, Keith Owen; Stancin, Terry; Wade, Shari L.			Do Children Who Sustain Traumatic Brain Injury in Early Childhood Need and Receive Academic Services 7 Years After Injury?	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						pediatric TBI; academic service; service utilization	TERM BEHAVIOR PROBLEMS; LONG-TERM; YOUNG-CHILDREN; EXECUTIVE FUNCTION; OUTCOMES; ADOLESCENTS; ADHD; ACHIEVEMENT; PREDICTORS; RECOVERY	Objective: To examine the prevalence of academic need, academic service utilization, and unmet need as well as factors associated with academic service utilization 6.8 years after traumatic brain injury (TBI) in early childhood. Methods: Fifty-eight (16 severe, 14 moderate, 28 complicated mild) children with TBI and 72 children with orthopedic injury (OI) completed the long-term follow-up 6.8 years after injury in early childhood (ages 3-7 years). Injury group differences in rates of need for academic services, academic service utilization, and unmet need as well as factors associated with service utilization and unmet need were examined. Results: Students with moderate and severe TBI had significantly greater rates of need than those with OI. A greater proportion of the severe TBI sample was receiving academic services at long-term follow-up than the OI and complicated mild groups however, among those with an identified need, injury group did not affect academic service utilization. Below average IQ/achievement scores was the only area of need predictive of academic service utilization. Rates of unmet need were high and similar across injury groups (46.2%-63.6%). Conclusion: The need for academic services among patients who sustained a TBI during early childhood remains high 6.8 years post injury. Findings underscore the importance of continued monitoring of behaviors and academic performance in students with a history of early childhood TBI. This may be especially true among children with less severe injuries who are at risk for being underserved.	[Kingery, Kathleen M.; Narad, Megan E.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 3015, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Stancin, Terry] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 3015, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729 K02 HD44099]; United States Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [8 UL1 TR000077-04, K12 HD001097-16]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011, R01HD042729, K12HD001097] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02HD044099] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	This project was supported by the National Institute of Child Health and Human Development (R01 HD42729 K02 HD44099), United States Public Health Service National Institutes of Health (M01 RR 08084), State of Ohio Emergency Medical Services trauma research grants, National Center for Research Resources and the National Center for Advancing Translational Sciences, and National Institutes of Health (8 UL1 TR000077-04 and K12 HD001097-16).	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bussing R, 2003, SOC PSYCH PSYCH EPID, V38, P563, DOI 10.1007/s00127-003-0674-8; Bussing R, 2003, J BEHAV HEALTH SER R, V30, P176, DOI 10.1007/BF02289806; Bussing R, 2001, HARVARD REV PSYCHIAT, V9, P223, DOI 10.1080/10673220127905; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Glang A, 2008, NEUROREHABILITATION, V23, P477; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jensen PS, 2011, PEDIATRICS, V128, P970, DOI 10.1542/peds.2009-0367; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott MN, 2012, J DEV BEHAV PEDIATR, V33, P202, DOI 10.1097/DBP.0b013e3182475287; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wechsler D., 1999, WESCHLER ABBREVIATED; Wolraich ML, 2004, J DEV BEHAV PEDIATR, V25, P41, DOI 10.1097/00004703-200402000-00007; Woodcock R. W., 2001, TECHNICAL MANUAL WOO; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_	56	24	24	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	NOV-DEC	2017	38	9					728	735		10.1097/DBP.0000000000000489			8	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	FS5AX	WOS:000419806500007	28953005	Green Accepted			2022-02-06	
J	Renno, WM; Benov, L; Khan, KM				Renno, Waleed M.; Benov, Ludmil; Khan, Khalid M.			Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury	JOURNAL OF NEUROSURGERY-SPINE			English	Article						EGCG; oxidative stress; neuroregeneration; neuroprotection; stereological analysis; rat	GREEN TEA POLYPHENOL; EPIGALLOCATECHIN-GALLATE EGCG; TRAUMATIC BRAIN-INJURY; NON-SERRATED CLAMP; SPINAL-CORD; PERIPHERAL-NERVES; NEUROPATHIC PAIN; NEURODEGENERATIVE DISEASES; NRF2-MEDIATED ANTIOXIDANT; QUANTITATIVE ASSESSMENT	OBJECTIVE This study examined the capacity of the major polyphenolic green tea extract (-)-epigallocatechin-3-gallate (EGCG) to suppress oxidative stress and stimulate the recovery and prompt the regeneration of sciatic nerve after crush injury. METHODS Adult male Wistar rats were randomly assigned to one of 4 groups: 1) Naive, 2) Sham (sham injury, surgical control group), 3) Crush (sciatic nerve crush injury treated with saline), and 4) Crush+EGCG (sciatic nerve crush injury treated with intraperitoneally administered EGCG, 50 mg/kg). All animals were tested for motor and sensory neurobehavioral parameters throughout the study. Sciatic nerve and spinal cord tissues were harvested and processed for morphometric and stereological analysis. For the biochemical assays, the time points were Day 1, Day 7, Day 14, and Day 28 after nerve injury. RESULTS After sciatic nerve crush injury, the EGCG-treated animals (Crush+EGCG group) showed significantly better recovery of foot position and toe spread and 50% greater improvement in motor recovery than the saline-treated animals (Crush group). The Crush+EGCG group displayed an early hopping response at the beginning of the 3rd week postinjury. Animals in the Crush+EGCG group also showed a significant reduction in mechanical allodynia and hyperalgesia latencies and significant improvement in recovery from nociception deficits in both heat withdrawal and tail flick withdrawal latencies compared with the Crush group. In both the Crush+EGCG and Crush groups, quantitative evaluation revealed significant morphological evidence of neuroregeneration according to the following parameters: mean ncross-sectional area of axons,myelin thickness in the sciatic nerve (from Week 4 to Week 8), increase of myelin basic protein concentration and gene expression in both the injured sciatic nerve and spinal cord, and fiber diameter to axon diameter ratio and myelin thickness to axon diameter ratio at Week 2 after sciatic nerve injury. However, the axon area remained much smaller in both the Crush+EGCG and Crush groups compared with the Sham and Naive groups. The number of axons per unit area was significantly decreased in the Crush+ EGCG and Crush groups compared with controls. Sciatic nerve injury produced generalized oxidative stress manifested as a significant increase of isoprostanes in the urine and decrease of the total antioxidant capacity (TAC) of the blood from Day 7 until Day 14. EGCG-treated rats showed significantly less increase of isoprostanes than saline-treated animals and also showed full recovery of TAC levels by Day 14 after nerve injury. In spinal cord tissue analysis, EGCG-treated animals showed induced glutathione reductase and suppressed induction of heme oxygenase 1 gene expression compared with nontreated animals. CONCLUSIONS EGCG treatment suppressed the crush-induced production of isoprostanes and stimulated the recovery of the TAC and was associated with remarkable alleviation of motor and sensory impairment and significant histomorphological evidence of neuronal regeneration following sciatic nerve crush injury in rats. The findings of this study suggest that EGCG can be used as an adjunctive therapeutic remedy for nerve injury. However, further investigations are needed to establish the antioxidative mechanism involved in the regenerative process after nerve injury. Only upregulation of glutathione reductase supports the idea that EGCG is acting indirectly via induction of enzymes or transcription factors.	[Renno, Waleed M.; Khan, Khalid M.] Kuwait Univ, Fac Med, Dept Anat, POB 24923, Safat 13110, Kuwait; [Benov, Ludmil] Kuwait Univ, Fac Med, Dept Biochem, Safat, Kuwait		Renno, WM (corresponding author), Kuwait Univ, Fac Med, Dept Anat, POB 24923, Safat 13110, Kuwait.	wrenno@hsc.edu.kw	Benov, Ludmil/AAD-3714-2020	Benov, Ludmil/0000-0002-0205-0146; Renno, Waleed/0000-0001-9024-9712	Animal Resource Center, Health Science Center, Kuwait University; Kuwait University Research Administration [MA01/11]; Research Sector OMICSRU grant [SRUL02/13]	We would like to thank Mr. Jijin Kumar, Mrs. Preethi George, Mrs. Sinu Joe, Mrs. Soumya Jose, and Mrs. Shabeeba Pattillath for their excellent technical assistance. Also, we acknowledge the support of the Animal Resource Center, Health Science Center, Kuwait University. This work was funded by Kuwait University Research Administration (grant No. MA01/11) and Research Sector OMICSRU grant SRUL02/13.	Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368; An SS, 2014, KOREAN J ANESTHESIOL, V67, P123, DOI 10.4097/kjae.2014.67.2.123; Aslan H, 2006, OBES SURG, V16, P1526, DOI 10.1381/096089206778869942; Baluchnejadmojarad T, 2012, IRAN J PHARM RES, V11, P1243; Belanger E, 2011, BIOMED OPT EXPRESS, V2, P2698, DOI 10.1364/BOE.2.002698; Cai J, 2014, J NUTR BIOCHEM, V25, P716, DOI 10.1016/j.jnutbio.2014.02.012; Canan S, 2008, NEUROPATH APPL NEURO, V34, P638, DOI 10.1111/j.1365-2990.2008.00938.x; Canan S, 2008, INT J DEV NEUROSCI, V26, P733, DOI 10.1016/j.ijdevneu.2008.07.005; Chen WQ, 2010, EXP BIOL MED, V235, P577, DOI 10.1258/ebm.2010.009329; Chen WQ, 2009, BEHAV BRAIN RES, V202, P71, DOI 10.1016/j.bbr.2009.03.017; Choi JI, 2012, NEUROSCI LETT, V510, P53, DOI 10.1016/j.neulet.2011.12.070; Choi YB, 2004, BRAIN RES, V1019, P47, DOI 10.1016/j.brainres.2004.05.079; De Vry J, 2004, EUR J PHARMACOL, V491, P137, DOI 10.1016/j.ejphar.2004.03.051; Francisco Jairo Silva, 2004, Braz. oral res., V18, P100, DOI 10.1590/S1806-83242004000200002; FRIEDE RL, 1985, J NEUROL NEUROSUR PS, V48, P749, DOI 10.1136/jnnp.48.8.749; Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011; Geuna S, 2005, MICROSC RES TECHNIQ, V66, P270, DOI 10.1002/jemt.20167; Geuna S, 2001, ANAT EMBRYOL, V204, P1, DOI 10.1007/s004290100188; Gundersen RY, 2005, ACTA ANAESTH SCAND, V49, P1108, DOI 10.1111/j.1399-6576.2005.00786.x; Hadlock TA, 1999, J PERIPHER NERV SYST, V4, P258; Haque AM, 2008, J NUTR BIOCHEM, V19, P619, DOI 10.1016/j.jnutbio.2007.08.008; He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hirata K, 2000, EUR J NEUROSCI, V12, P4147, DOI 10.1046/j.1460-9568.2000.00307.x; Huang GS, 2010, RHEUMATOL INT, V30, P1197, DOI 10.1007/s00296-009-1128-8; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; JACOBS JM, 1985, BRAIN, V108, P897, DOI 10.1093/brain/108.4.897; Jiang J, 2012, INT J MOL MED, V29, P946, DOI 10.3892/ijmm.2012.924; Kaplan S, 2005, J NEUROSCI METH, V145, P277, DOI 10.1016/j.jneumeth.2005.02.012; Keilhoff G, 2007, DEV NEUROBIOL, V67, P1382, DOI 10.1002/dneu.20384; Kuang X, 2012, EUR J PHARMACOL, V676, P51, DOI 10.1016/j.ejphar.2011.11.037; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Lee JS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-124; Lee SY, 2003, BRAIN RES BULL, V61, P399, DOI 10.1016/S0361-9230(03)00139-4; Leong Daniel J, 2014, Arthritis Res Ther, V16, P508, DOI 10.1186/s13075-014-0508-y; Liu MY, 2014, MOL NEUROBIOL, V49, P1350, DOI 10.1007/s12035-013-8608-2; Luis AL, 2007, J NEUROSCI METH, V163, P92, DOI 10.1016/j.jneumeth.2007.02.017; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Mendonca AC, 2003, J NEUROSCI METH, V129, P183, DOI 10.1016/S0165-0270(03)00207-3; Moore AM, 2012, J NEUROSCI METH, V204, P19, DOI 10.1016/j.jneumeth.2011.10.011; Mozaffar T, 2009, J ORTHOP RES, V27, P114, DOI 10.1002/jor.20704; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; Ownby SL, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-8; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Peng PH, 2010, EXP EYE RES, V90, P528, DOI 10.1016/j.exer.2010.01.007; Raposo D, 2015, BRAIN RES BULL, V110, P68, DOI 10.1016/j.brainresbull.2014.12.004; Renno WM, 2006, NUTR NEUROSCI, V9, P41, DOI 10.1080/10284150600576705; Renno WM, 2016, NEUROPHARMACOLOGY, V102, P1, DOI 10.1016/j.neuropharm.2015.10.029; Renno WM, 2015, J NEUROTRAUM, V32, P170, DOI 10.1089/neu.2014.3491; Renno WM, 2014, NEUROPHARMACOLOGY, V77, P100, DOI 10.1016/j.neuropharm.2013.09.013; Renno WM, 2013, NEUROCHEM INT, V62, P221, DOI 10.1016/j.neuint.2012.12.018; Renno WM, 2012, N-S ARCH PHARMACOL, V385, P807, DOI 10.1007/s00210-012-0758-7; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Ronchi G, 2014, J PERIPHER NERV SYST, V19, P224, DOI 10.1111/jns.12090; Savastano LE, 2014, J NEUROSCI METH, V227, P166, DOI 10.1016/j.jneumeth.2014.01.020; Senggunprai L, 2014, PHYTOTHER RES, V28, P841, DOI 10.1002/ptr.5061; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; Shirai N, 2004, ANN NUTR METAB, V48, P51, DOI 10.1159/000075305; Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005; THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026; Tiwari V, 2011, EUR J PAIN, V15, P286, DOI 10.1016/j.ejpain.2010.07.005; TURGUT M, 2010, J BRACHIAL PLEX PERI, V5; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Unal B, 2005, BRAIN RES, V1048, P228, DOI 10.1016/j.brainres.2005.05.001; Unno K, 2004, EXP GERONTOL, V39, P1027, DOI 10.1016/j.exger.2004.03.033; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Varejao ASP, 2004, J NEUROTRAUM, V21, P1652, DOI 10.1089/neu.2004.21.1652; Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833; Wang T, 2014, INT J MOL MED, V33, P994, DOI 10.3892/ijmm.2014.1635; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4; Xie J, 2010, NEUROSCI LETT, V479, P26, DOI 10.1016/j.neulet.2010.05.020; Yoo KY, 2010, PHYTOTHER RES, V24, P1065, DOI 10.1002/ptr.3083	75	24	24	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	NOV	2017	27	5					593	613		10.3171/2016.10.SPINE16218			21	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL6LV	WOS:000414357100016	28777065	Bronze			2022-02-06	
J	Vedantam, A; Robertson, CS; Gopinath, SP				Vedantam, Aditya; Robertson, Claudia S.; Gopinath, Shankar P.			Morbidity and mortality associated with hypernatremia in patients with severe traumatic brain injury	NEUROSURGICAL FOCUS			English	Article						severe traumatic brain injury; hypernatremia; neurocritical care; mannitol; mortality	ANEURYSMAL SUBARACHNOID HEMORRHAGE; INTENSIVE-CARE-UNIT; RENAL BLOOD-FLOW; CRITICALLY-ILL; ACQUIRED HYPERNATREMIA; HYPERTONIC SALINE; RISK; THERAPY	OBJECTIVE Hypernatremia is independently associated with increased mortality in critically ill patients. Few studies have evaluated the impact of hypernatremia on early mortality in patients with severe traumatic brain injury (TBI) treated in a neurocritical care unit. METHODS A retrospective review of patients with severe TBI (admission Glasgow Coma Scale score <= 8) treated in a single neurocritical care unit between 1986 and 2012 was performed. Patients with at least 3 serum sodium values were selected for the study. Patients with diabetes insipidus and those with hypernatremia on admission were excluded. The highest serum sodium level during the hospital stay was recorded, and hypernatremia was classified as none (<= 150 mEq/L), mild (151-155 mEq/L), moderate (156-160 mEq/L), and severe (> 160 mEq/L). Multivariate Cox regression analysis was performed to determine independent predictors of early mortality. RESULTS A total of 588 patients with severe TBI were studied. The median number of serum sodium measurements for patients in this study was 17 (range 3-190). No hypernatremia was seen in 371 patients (63.1%), mild hypernatremia in 77 patients (13.1%), moderate hypernatremia in 50 patients (8.5%), and severe hypernatremia in 90 patients (15.3%). Hypernatremia was detected within the 1st week of admission in 79.3% of patients (n = 172), with the majority of patients (46%) being diagnosed within 72 hours after admission. Acute kidney injury, defined as a rise in creatinine of = 0.3 mg/dl, was observed in 162 patients (27.6%) and was significantly associated with the degree of hypernatremia (p < 0.001). At discharge, 148 patients (25.2%) had died. Hypernatremia was a significant independent predictor of mortality (hazard ratios for mild: 3.4, moderate: 4.4, and severe: 8.4; p < 0.001). Survival analysis showed significantly lower survival rates for patients with greater degrees of hypernatremia (log-rank test, p < 0.001). CONCLUSIONS Hypernatremia after admission in patients with severe TBI was independently associated with greater risk of early mortality. In addition to severe hypernatremia, mild and moderate hypernatremia were significantly associated with increased early mortality in patients with severe TBI.	[Vedantam, Aditya; Robertson, Claudia S.; Gopinath, Shankar P.] Baylor Coll Med, Dept Neurosurg, 7200 Cambridge,Ste 9A,MS BCM650, Houston, TX 77030 USA		Gopinath, SP (corresponding author), Baylor Coll Med, Dept Neurosurg, 7200 Cambridge,Ste 9A,MS BCM650, Houston, TX 77030 USA.	shankarg@bcm.edu					Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Ayus JC, 1996, J PHYSIOL-LONDON, V492, P243, DOI 10.1113/jphysiol.1996.sp021305; Beseoglu K, 2014, CLIN NEUROL NEUROSUR, V123, P164, DOI 10.1016/j.clineuro.2014.05.022; Darmon M, 2010, NEPHROL DIAL TRANSPL, V25, P2510, DOI 10.1093/ndt/gfq067; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; KAHN A, 1979, INTENS CARE MED, V5, P27, DOI 10.1007/BF01738999; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2013, J CRIT CARE, V28, P214, DOI 10.1016/j.jcrc.2012.11.017; Lindner G, 2010, INTENS CARE MED, V36, P1718, DOI 10.1007/s00134-010-1968-4; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551; O'Donoghue SD, 2009, ANAESTHESIA, V64, P514, DOI 10.1111/j.1365-2044.2008.05857.x; Qureshi AI, 2002, NEUROSURGERY, V50, P749, DOI 10.1097/00006123-200204000-00012; Shehata M, 2010, CRIT CARE S1, V14, pP355; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820	21	24	24	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E2	10.3171/2017.7.FOCUS17418			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800004	29088954	gold			2022-02-06	
J	Frassanito, P; Tamburrini, G; Massimi, L; Peraio, S; Caldarelli, M; Di Rocco, C				Frassanito, Paolo; Tamburrini, Gianpiero; Massimi, Luca; Peraio, Simone; Caldarelli, Massimo; Di Rocco, Concezio			Problems of reconstructive cranioplasty after traumatic brain injury in children	CHILDS NERVOUS SYSTEM			English	Article						Reconstructive cranioplasty; Brain injury; Autologous bone; Decompressive craniectomy; Alloplastic material; Biomaterial; Hydroxyapatite	SINGLE-CENTER EXPERIENCE; AUTOLOGOUS BONE FLAP; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; CRANIAL REPAIR; EARLY OUTCOMES; RISK-FACTORS; SURGERY; COMPLICATIONS; ADOLESCENTS	Cranial repair after traumatic brain injury in children is still burdened by unsolved problems and controversial issues, mainly due to the high rate of resorption of autologous bone as well as the absence of valid alternative material to replace the autologous bone. Indeed, inert biomaterials are associated to satisfactory results in the short period but bear the continuous risk of complications related to the lack of osteointegration capacity. Biomimetic materials claiming osteoconductive properties that could balance their mechanical limits seem to allow good cranial bone reconstruction. However, these results should be confirmed in the long term and in larger series. Further complicating factors that may affect cranial reconstruction after head injury should be identified in the possible associated alterations of CSF dynamics and in difficulties to manage the traumatic skin lesion and the surgical wound, which also might impact on the cranioplasty outcome. All the abovementioned considerations should be taken into account when dealing with the cranial reconstruction after decompressive craniectomy in children.	[Frassanito, Paolo; Tamburrini, Gianpiero; Massimi, Luca; Peraio, Simone; Caldarelli, Massimo] Catholic Univ, Fdn Policlin Univ A Gemelli, Pediat Neurosurg, Sch Med, Largo A Gemelli 8, I-00168 Rome, Italy; [Di Rocco, Concezio] Int Neurosci Inst, Dept Neurosurg, Hannover, Germany		Frassanito, P (corresponding author), Catholic Univ, Fdn Policlin Univ A Gemelli, Pediat Neurosurg, Sch Med, Largo A Gemelli 8, I-00168 Rome, Italy.	paolo.frassanito@gmail.com	FRASSANITO, Paolo/K-4099-2018	FRASSANITO, Paolo/0000-0003-0071-3126			Beuriat PA, 2015, J NEUROSURG SCI, V59, P405; Biskup NI, 2010, J CRANIOFAC SURG, V21, P358, DOI 10.1097/SCS.0b013e3181cf606b; Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Breisch E, 2010, FORENSIC SCI MED PAT, V6, P249, DOI 10.1007/s12024-009-9136-2; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cordaro ER, 2011, J CRANIOFAC SURG, V22, P598, DOI 10.1097/SCS.0b013e3182077dca; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Duke BJ, 1996, PEDIATR NEUROSURG, V25, P31, DOI 10.1159/000121093; Feroze AH, 2015, J NEUROSURG, V123, P1098, DOI 10.3171/2014.11.JNS14622; Fiaschi P, 2016, J NEUROSURG-PEDIATR, V17, P705, DOI 10.3171/2015.10.PEDS15489; Fong KD, 2003, PLAST RECONSTR SURG, V112, P1312, DOI 10.1097/01.PRS.0000079860.14734.D6; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Goodrich JT, 2012, CHILD NERV SYST, V28, P1577, DOI 10.1007/s00381-012-1776-y; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Halani SH, 2017, NEUROSURGERY; HASEGAWA M, 1992, NEUROSURGERY, V31, P580, DOI 10.1227/00006123-199209000-00024; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Lemee JM, 2013, NEUROCHIRURGIE, V59, P60, DOI 10.1016/j.neuchi.2012.10.138; Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Messina G, 2011, ACTA NEUROCHIR, V153, P1717, DOI 10.1007/s00701-011-1014-5; Morice A, 2017, J NEUROSURG-PEDIATR, V19, P51, DOI 10.3171/2016.8.PEDS1653; Ozerdem OR, 2002, ANN PLAS SURG, V49, P127; Payne KFB, 2014, BRIT J ORAL MAX SURG, V52, P7, DOI 10.1016/j.bjoms.2013.03.005; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Piitulainen JM, 2015, ACTA NEUROCHIR, V157, P681, DOI 10.1007/s00701-015-2363-2; Prasad GL, 2015, BRAIN INJURY, V29, P1717, DOI 10.3109/02699052.2015.1075146; Quah BL, 2016, WORLD NEUROSURG, V94, P13, DOI 10.1016/j.wneu.2016.06.081; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2015, WORLD NEUROSURG, V83, P133, DOI 10.1016/j.wneu.2014.08.031; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Shido H, 2013, J CRANIOFAC SURG, V24, P946, DOI 10.1097/SCS.0b013e3182868876; Stefini R, 2015, J APPL BIOMATER FUNC, V13, pE136, DOI 10.5301/jabfm.5000211; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Thesleff T, 2011, NEUROSURGERY, V68, P1535, DOI 10.1227/NEU.0b013e31820ee24e; Tubbs RS, 2011, CHILD NERV SYST, V27, P497, DOI 10.1007/s00381-010-1327-3; Villa MM, 2014, J BIOMED MAT RES B; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Williams L, 2016, J CRANIO MAXILL SURG, V44, P789, DOI 10.1016/j.jcms.2016.03.010; Williams P.L., 1980, GRAYS ANATOMY; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4	54	24	25	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1759	1768		10.1007/s00381-017-3541-8			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900020	29149388				2022-02-06	
J	Izzy, S; Mazwi, NL; Martinez, S; Spencer, CA; Klein, JP; Parikh, G; Glenn, MB; Greenberg, SM; Greer, DM; Wu, O; Edlow, BL				Izzy, Saef; Mazwi, Nicole L.; Martinez, Sergi; Spencer, Camille A.; Klein, Joshua P.; Parikh, Gunjan; Glenn, Mel B.; Greenberg, Steven M.; Greer, David M.; Wu, Ona; Edlow, Brian L.			Revisiting Grade 3 Diffuse Axonal Injury: Not All Brainstem Microbleeds are Prognostically Equal	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Traumatic axonal injury; Diffuse axonal injury; Gradient-recalled echo MRI; Traumatic microbleed; Brainstem	DISABILITY RATING-SCALE; TRAUMATIC HEAD-INJURY; VASCULAR INJURY; WHITE-MATTER; LESIONS; COMA; MRI; CLASSIFICATION; IMMEDIATE; IMPACT	Recovery of functional independence is possible in patients with brainstem traumatic axonal injury (TAI), also referred to as "grade 3 diffuse axonal injury," but acute prognostic biomarkers are lacking. We hypothesized that the extent of dorsal brainstem TAI measured by burden of traumatic microbleeds (TMBs) correlates with 1-year functional outcome more strongly than does ventral brainstem, corpus callosal, or global brain TMB burden. Further, we hypothesized that TMBs within brainstem nuclei of the ascending arousal network (AAN) correlate with 1-year outcome. Using a prospective outcome database of patients treated for moderate-to-severe traumatic brain injury at an inpatient rehabilitation hospital, we retrospectively identified 39 patients who underwent acute gradient-recalled echo (GRE) magnetic resonance imaging (MRI). TMBs were counted on the acute GRE scans globally and in the dorsal brainstem, ventral brainstem, and corpus callosum. TMBs were also mapped onto an atlas of AAN nuclei. The primary outcome was the disability rating scale (DRS) score at 1 year post-injury. Associations between regional TMBs, AAN TMB volume, and 1-year DRS score were assessed by calculating Spearman rank correlation coefficients. Mean +/- SD number of TMBs was: dorsal brainstem = 0.7 +/- 1.4, ventral brainstem = 0.2 +/- 0.6, corpus callosum = 1.8 +/- 2.8, and global = 14.4 +/- 12.5. The mean +/- SD TMB volume within AAN nuclei was 6.1 +/- 18.7 mm(3). Increased dorsal brainstem TMBs and larger AAN TMB volume correlated with worse 1-year outcomes (R = 0.37, p = 0.02, and R = 0.36, p = 0.02, respectively). Global, callosal, and ventral brainstem TMBs did not correlate with outcomes. These findings suggest that dorsal brainstem TAI, especially involving AAN nuclei, may have greater prognostic utility than the total number of lesions in the brain or brainstem.	[Izzy, Saef; Martinez, Sergi; Spencer, Camille A.; Greenberg, Steven M.; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Izzy, Saef; Klein, Joshua P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Klein, Joshua P.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Mazwi, Nicole L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Mazwi, Nicole L.; Glenn, Mel B.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA; [Parikh, Gunjan] Univ Maryland, Sch Med, Dept Neurol, Program Trauma, Baltimore, MD 21201 USA; [Wu, Ona; Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Greer, David M.] Yale New Haven Med Ctr, Yale Sch Med, Dept Neurol, 20 York St, New Haven, CT 06504 USA; [Wu, Ona] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA		Izzy, S (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.; Izzy, S (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	Sizzy@bwh.harvard.edu	Parikh, Gunjan/AAS-1375-2020; Demchuk, Andrew M/E-1103-2012	Parikh, Gunjan/0000-0002-8447-1349; Demchuk, Andrew M/0000-0002-4930-7789; Wu, Ona/0000-0002-5509-9461; Greer, David/0000-0002-2026-8333	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25NS065743, K23NS094538]; American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, US Department Health and Human Services [H133A120085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743, K23NS094538] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (R25NS065743, K23NS094538), the American Academy of Neurology/American Brain Foundation, the James S. McDonnell Foundation, and the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, US Department Health and Human Services to Spaulding Rehabilitation Hospital (H133A120085). However, the contents of this manuscript do not necessarily represent the policy of the Department of Health and Human Services and endorsement by the Federal Government should not be assumed.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aguas J, 2005, NEUROCIRUGIA, V16, P14; CROMPTON MR, 1966, LANCET, V2, P938; Edlow BL, 2016, NEUROCRIT CARE, V24, P342, DOI 10.1007/s12028-015-0216-8; Edlow BL, 2016, BRAIN CONNECT, V6, P187, DOI 10.1089/brain.2015.0378; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Martinez-Ramirez S, 2015, ALZHEIMERS DEMENT, V11, P1480, DOI 10.1016/j.jalz.2015.04.009; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parikh G, 2013, NEUROLOGY, V80, pE205; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4	47	24	25	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					199	207		10.1007/s12028-017-0399-2			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900007	28477152	Green Accepted			2022-02-06	
J	Cao, JQ; El Gaamouch, F; Meabon, JS; Meeker, KD; Zhu, L; Zhong, MB; Bendik, J; Elder, G; Jing, P; Xia, JH; Luo, WJ; Cook, DG; Cai, DM				Cao, Jiqing; El Gaamouch, Farida; Meabon, James S.; Meeker, Kole D.; Zhu, Li; Zhong, Margaret B.; Bendik, John; Elder, Gregory; Jing, Ping; Xia, Jiahong; Luo, Wenjie; Cook, David G.; Cai, Dongming			ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; MOUSE MODEL; HEAD-INJURY; LIPOPROTEIN PARTICLES; BETA-PROTEIN; APOE; HIPPOCAMPAL; REDUCTION	The apolipoprotein E4 (ApoE4) genotype combines with traumatic brain injury (TBI) to increase the risk of developing Alzheimer's Disease (AD). However, the underlying mechanism(s) is not well-understood. We found that after exposure to repetitive blast-induced TBI, phosphoinositol biphosphate (PIP2) levels in hippocampal regions of young ApoE3 mice were elevated and associated with reduction in expression of a PIP2 degrading enzyme, synaptojanin 1 (synj1). In contrast, hippocampal PIP2 levels in ApoE4 mice did not increase after blast TBI. Following blast TBI, phospho-Tau (pTau) levels were unchanged in ApoE3 mice, whereas in ApoE4 mice, levels of pTau were significantly increased. To determine the causal relationship between changes in pTau and PIP2/synj1 levels after TBI, we tested if down-regulation of synj1 prevented blast-induced Tau hyper-phosphorylation. Knockdown of synj1 decreased pTau levels in vitro, and abolished blast-induced elevation of pTau in vivo. Blast TBI increased glycogen synthase kinase (GSK)-3 beta activities in ApoE4 mice, and synj1 knockdown inhibited GSK3 beta phosphorylation of Tau. Together, these data suggest that ApoE proteins regulate brain phospholipid homeostasis in response to TBI and that the ApoE4 isoform is dysfunctional in this process. Downregulation of synj1 rescues blast-induced phospholipid dysregulation and prevents development of Tau hyper-phosphorylation in ApoE4 carriers.	[Cao, Jiqing; El Gaamouch, Farida; Zhu, Li; Elder, Gregory; Cai, Dongming] James J Peters VA Med Ctr, Neurol Serv, Bronx, NY 10468 USA; [Cao, Jiqing; Jing, Ping; Xia, Jiahong; Cai, Dongming] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Wuhan 430021, Hubei, Peoples R China; [Cao, Jiqing; El Gaamouch, Farida; Zhu, Li; Zhong, Margaret B.; Bendik, John; Cai, Dongming] Icahn Sch Med Mt Sinai, Dept Neurol, Alzheimer Dis Res Ctr, New York, NY 10029 USA; [Meabon, James S.; Meeker, Kole D.] Mental Illness Res & Educ Clin Ctr, Vet Affairs Med Ctr VAPSHCS, Seattle, WA 98108 USA; [Meabon, James S.; Meeker, Kole D.] Univ Washington, Sch Med, Dept Psychiat, Seattle, WA 98195 USA; [Luo, Wenjie] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY 10065 USA; [Cook, David G.] Geriatr Res Educ & Clin Ctr, Vet Affairs Med Ctr VAPSHCS, Seattle, WA 98108 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med & Pharmacol, Seattle, WA 98195 USA		Cai, DM (corresponding author), James J Peters VA Med Ctr, Neurol Serv, Bronx, NY 10468 USA.; Cai, DM (corresponding author), Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Wuhan 430021, Hubei, Peoples R China.; Cai, DM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, Alzheimer Dis Res Ctr, New York, NY 10029 USA.; Cook, DG (corresponding author), Geriatr Res Educ & Clin Ctr, Vet Affairs Med Ctr VAPSHCS, Seattle, WA 98108 USA.; Cook, DG (corresponding author), Univ Washington, Sch Med, Dept Med & Pharmacol, Seattle, WA 98195 USA.	dgcook@u.washington.edu; dongming.cai@mssm.edu	Luo, Wenjie/ABF-8451-2020		Alzheimer AssociationAlzheimer's AssociationBrightFocus Foundation [NIRP14-304720]; Department of Veteran Affairs RRD Service SPiRE [1I21RX001558-01A1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01AG048923-01, 1RF1AG054014]; Department of Veterans Affairs Office of Research and Development Medical Research Service (RDIS)US Department of Veterans Affairs [0005]; University of Washington Friends of Alzheimer's Research; University of Washington Royalty Research FundUniversity of Washington; Northwest Network Mental Illness Research, Education and Clinical Center; James J. Peters VA Medical CenterUS Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054014, R01AG048923] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I21RX001558, I01RX002290, I01BX003380] Funding Source: NIH RePORTER	We thank Dr. Pietro De Camilli (Yale School of Medicine) for providing synj1 haploinsufficiency mice. Antibody p369 was generously provided by Dr. Paul Greengard. This work was supported by funding from Alzheimer Association (NIRP14-304720), Department of Veteran Affairs RR&D Service SPiRE (1I21RX001558-01A1), NIH R01 (1R01AG048923-01), NIH RF1 (1RF1AG054014) (DC); and by the Department of Veterans Affairs Office of Research and Development Medical Research Service (RDIS# 0005), the University of Washington Friends of Alzheimer's Research, University of Washington Royalty Research Fund (DGC); and the Northwest Network Mental Illness Research, Education and Clinical Center (JSM). Confocal microscopy studies were supported by James J. Peters VA Medical Center Research Core Facility. We thank Dr. William Netzer and Dr. Christopher Cardozo for critical reading of the manuscript.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Anand KS, 2012, ANN INDIAN ACAD NEUR, V15, P239, DOI 10.4103/0972-2327.104323; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drelon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12751; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Ezra Y, 2003, NEUROSCIENCE, V121, P315, DOI 10.1016/S0306-4522(03)00436-6; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fu Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0099-y; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lin LY, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0107-2; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; MAYEUX R, 1995, AM J PUBLIC HEALTH, V85, P1280, DOI 10.2105/AJPH.85.9.1280; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Pal R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04528-5; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Spolcova A, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-111; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013; Washington P. M., 2015, EXPT NEUROLOGY; Zhu L, 2015, P NATL ACAD SCI USA, V112, P11965, DOI 10.1073/pnas.1510011112; Zhu L, 2013, J BIOL CHEM, V288, P32050, DOI 10.1074/jbc.M113.504365	67	24	25	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 12	2017	7								11372	10.1038/s41598-017-11654-7			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4ZR	WOS:000410297900086	28900205	Green Published, gold			2022-02-06	
J	Castranio, EL; Mounier, A; Wolfe, CM; Nam, KN; Fitz, NF; Letronne, F; Schug, J; Koldamova, R; Lefterov, I				Castranio, Emilie L.; Mounier, Anais; Wolfe, Cody M.; Nam, Kyong Nyon; Fitz, Nicholas F.; Letronne, Florent; Schug, Jonathan; Koldamova, Radosveta; Lefterov, Iliya			Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Apolipoprotein E; Traumatic brain injury; Trem2; Tyrobp; Myelination; Immune response; Fyn; Innate immune response	CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; APOLIPOPROTEIN E4; NEUROINFLAMMATORY RESPONSES; MYELOID CELLS; DEFICIENCY; PATHOLOGY; MILD; ALPHA-1-ANTICHYMOTRYPSIN; REPLACEMENT	Traumatic brain injury (TBI) is strongly linked to an increased risk of developing dementia, including chronic traumatic encephalopathy and possibly Alzheimer's disease (AD). APOE epsilon 4 allele of human Apolipoprotein E (APOE) gene is the major genetic risk factor for late onset AD and has been associated with chronic traumatic encephalopathy and unfavorable outcome following TBI. To determine if there is an APOE isoform-specific response to TBI we performed controlled cortical impact on 3-month-old mice expressing human APOE3 or APOE4 isoforms. Following injury, we used several behavior paradigms to test for anxiety and learning and found that APOE3 and APOE4 targeted replacement mice demonstrate cognitive impairments following moderate TBI. Transcriptional profiling 14 days following injury revealed a significant effect of TBI, which was similar in both genotypes. Significantly upregulated by injury in both genotypes were mRNA expression and protein level of ABCA1 transporter and APOJ, but not APOE. To identify gene-networks correlated to injury and APOE isoform, we performed Weighted Gene Co-expression Network Analysis. We determined that the network mostly correlated to TBI in animals expressing both isoforms is immune response with major hub genes including Trem2, Tyrobp, Clec7a and Cd68. We also found a significant increase of TREM2, IBA-1 and GFAP protein levels in the brains of injured mice. We identified a network representing myelination that correlated significantly with APOE isoform in both injury groups. This network was significantly enriched in oligodendrocyte signature genes, such as Mbp and Plp1. Our results demonstrate unique and distinct gene networks at this acute time point for injury and APOE isoform, as well as a network driven by APOE isoform across TBI groups. (C) 2017 Elsevier Inc. All rights reserved.	[Castranio, Emilie L.; Mounier, Anais; Wolfe, Cody M.; Nam, Kyong Nyon; Fitz, Nicholas F.; Letronne, Florent; Koldamova, Radosveta; Lefterov, Iliya] Univ Pittsburgh, Dept Environm & Occupat Hlth, 100 Technol Dr,BRIDG Bldg, Pittsburgh, PA 15219 USA; [Schug, Jonathan] Univ Penn, Dept Genet, Funct Genom Core, Philadelphia, PA 19104 USA		Koldamova, R; Lefterov, I (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, 100 Technol Dr,BRIDG Bldg, Pittsburgh, PA 15219 USA.	radak@pitt.edu; iliyal@pitt.edu	Lefterov, Iliya/B-4767-2008	Lefterov, Iliya/0000-0002-0249-0280; Nam, Kyongnyon/0000-0002-5140-6014; Fitz, Nicholas/0000-0001-6938-6536; Letronne, Florent/0000-0002-5330-0395	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG037481, R01AG037919, K01AG044490, R01ES024233]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-1-0384]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES024233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037919, R01AG037481, K01AG044490] Funding Source: NIH RePORTER	Supported by National Institutes of Health (R01AG037481, R01AG037919, K01AG044490, R01ES024233) and U.S. Department of Defense (W81XWH-13-1-0384). We would like to thank Dr. H. I. Kamboh for technical assistance.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Alderson NL, 2006, J LIPID RES, V47, P2772, DOI 10.1194/jlr.M600362-JLR200; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Bennett RE, 2013, J NEUROPATH EXP NEUR, V72, P396, DOI 10.1097/NEN.0b013e31828e24ab; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Cartagena CM, 2008, J NEUROTRAUM, V25, P1087, DOI 10.1089/neu.2007.0444; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fitz NF, 2015, BRAIN, V138, P3699, DOI 10.1093/brain/awv293; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Ghroubi S, 2016, ANN PHYS REHABIL MED, V59, P87, DOI 10.1016/j.rehab.2016.01.005; Guan FL, 2012, MOL BIOL REP, V39, P6661, DOI 10.1007/s11033-012-1472-8; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Haile Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0376-7; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hooli BV, 2015, NATURE, V520, pE7, DOI 10.1038/nature14040; Hsu I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.423; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan Barry D, 2014, Continuum (Minneap Minn), V20, P1588, DOI 10.1212/01.CON.0000458972.94013.e1; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Lau DHW, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0317-4; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Mannix RC, 2016, J CEREB BLOOD FLOW M, V31, P351; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Nam KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24048; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Osisami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033341; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Perez-Garcia G., 2016, BEHAV BRAIN RES; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Richter F, 2014, NEUROBIOL DIS, V69, P263, DOI 10.1016/j.nbd.2014.05.012; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Saber M., 2016, J NEUROTRAUMA; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Saher G, 2015, BBA-MOL CELL BIOL L, V1851, P1083, DOI 10.1016/j.bbalip.2015.02.010; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; Schiza N, 2015, HUM MOL GENET, V24, P2049, DOI 10.1093/hmg/ddu725; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai PC, 2016, ANN CLIN TRANSL NEUR, V3, P854, DOI 10.1002/acn3.347; Venables WN, 2002, MODERN APPL STAT S S, V4th; Wang C, 2015, J ALZHEIMERS DIS, V46, P491, DOI 10.3233/JAD-150110; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	76	24	24	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2017	105						1	14		10.1016/j.nbd.2017.05.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC3JG	WOS:000406734300001	28502803	Green Accepted			2022-02-06	
J	Hammond, FM; Malec, JF; Zafonte, RD; Sherer, M; Bogner, J; Dikmen, S; Whitney, MP; Bell, KR; Perkins, SM; Moser, EA				Hammond, Flora M.; Malec, James F.; Zafonte, Ross D.; Sherer, Mark; Bogner, Jennifer; Dikmen, Sureyya; Whitney, Marybeth P.; Bell, Kathleen R.; Perkins, Susan M.; Moser, Elizabeth A.			Potential Impact of Amantadine on Aggression in Chronic Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; amantadine; anger; brain injuries	NEUROPSYCHIATRIC INVENTORY; PHARMACOLOGICAL MANAGEMENT; BEHAVIOR; INTERVENTION; IRRITABILITY; THERAPY; COMMON; SCALE; STATE	Objective: To assess the effects of amantadine on anger and aggression among individuals with a chronic traumatic brain injury (TBI). Methods: A cohort of 118 persons with chronic TBI (>6 months postinjury) and moderate-severe aggression selected from a larger cohort of 168 participants enrolled in a parallel-group, randomized, double-blind, placebo-controlled trial of amantadine 100 mg twice daily (n = 82) versus placebo (n = 86) for treatment of irritability were studied. Anger and aggression were measured at treatment days 0, 28, and 60 using observerrated and participant-rated State-Trait Anger Expression Inventory-2 (STAXI-2) and Neuropsychiatric Inventory-Agitation/Aggression domain (NPI-A) Most Problematic and Distress scores. Results: Participant-rated day 60 NPI-A Most Problematic (adjusted P = .0118) and NPI-A Distress (adjusted P = .0118) were statistically significant between the 2 groups, but STAXI-2 differences were not significant after adjustment for multiple comparisons. Substantial improvements were noted in both amantadine and placebo groups (70% vs 56% improving at least 3 points on day 60 Observer NPI-A; P = .11). Conclusion: Amantadine 100 mg twice daily in this population with chronic TBI appears to be beneficial in decreasing aggression from the perspective of the individual with TBI. No beneficial impact on anger was found. Trial Registration: clinicaltrials.gov Identifier: NCT00779324; http://www.clinicaltrials.gov/ct2/show/NCT00779324?term=irritability&rank=6.	[Hammond, Flora M.; Malec, James F.; Perkins, Susan M.; Moser, Elizabeth A.] Indiana Univ Sch Med, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Hammond, Flora M.; Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Zafonte, Ross D.] Harvard Med Sch, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Dikmen, Sureyya; Bell, Kathleen R.] Univ Washington, Seattle, WA 98195 USA; [Whitney, Marybeth P.] Carolinas Hlth Care Syst, Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, 4141 Shore Dr, Indianapolis, IN 46254 USA.	hammond@rhin.com		Bell, Kathleen/0000-0002-0928-2046	US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability, Independent Living, and Rehabilitation Research [H133A080035]	The research reported in this article was supported by US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability, Independent Living, and Rehabilitation Research grant H133A080035. This support included the funds to purchase amantadine. The study sponsor had no role in the design and conduct of this study; the collection, management, analysis, and interpretation of the data; or the preparation review, or approval of the manuscript.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Berry DA, 1996, J NATL CANCER I, V88, P1606, DOI 10.1093/jnci/88.22.1606; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; HOLM S, 1979, SCAND J STAT, V6, P65; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Rybin D, 2015, STAT MED, V34, P2281, DOI 10.1002/sim.6494; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Spahn JM, 2010, J AM DIET ASSOC, V110, P879, DOI 10.1016/j.jada.2010.03.021; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	24	24	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					308	318		10.1097/HTR.0000000000000342			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800011	28891908	Green Submitted			2022-02-06	
J	Neumann, D; Malec, JF; Hammond, FM				Neumann, Dawn; Malec, James F.; Hammond, Flora M.			Reductions in Alexithymia and Emotion Dysregulation After Training Emotional Self-Awareness Following Traumatic Brain Injury: A Phase I Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affect; aggression; alexithymia; anxiety; brain injury; emotion; emotion regulation	SCALE; VALIDATION; VALIDITY; PREVALENCE; SEVERITY; PROGRAM; SYSTEM; SAMPLE; ADULTS	Objectives: To examine the acceptability and initial efficacy of an emotional self-awareness treatment at reducing alexithymia and emotion dysregulation in participants with traumatic brain injury (TBI). Setting: An outpatient rehabilitation hospital. Participants: Seventeen adults with moderate to severe TBI and alexithymia. Time postinjury ranged 1 to 33 years. Design: Within subject design, with 3 assessment times: baseline, posttest, and 2-month follow-up. Intervention: Eight lessons incorporated psychoeducational information and skill-building exercises teaching emotional vocabulary, labeling, and differentiating self-emotions; interoceptive awareness; and distinguishing emotions from thoughts, actions, and sensations. Measures: Toronto Alexithymia Scale-20 (TAS-20); Levels of Emotional Awareness Scale (LEAS); Trait Anxiety Inventory (TAI); Patient Health Questionnaire-9 (PHQ-9); State-Trait Anger Expression Inventory (STAXI); Difficulty With Emotion Regulation Scale (DERS); and Positive and Negative Affect Scale (PANAS). Results: Thirteen participants completed the treatment. Repeated-measures analysis of variance revealed changes on the TAS-20 (P = .003), LEAS (P < .001), TAI (P = .014), STAXI (P = .015), DERS (P = .020), and positive affect (P < .005). Paired t tests indicated significant baseline to posttest improvements on these measures. Gains were maintained at follow-up for the TAS, LEAS, and positive affect. Treatment satisfaction was high. Conclusion: This is the first study published on treating alexithymia post-TBI. Positive changes were identified for emotional self-awareness and emotion regulation; some changes were maintained several months posttreatment. Findings justify advancing to the next investigational phase for this novel intervention.	[Neumann, Dawn; Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			NIH NICHD/NCMRR STTR Phase I grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R41HD077967-01A1]; Indiana University; NIH STTR Phase I grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R41HD077967] Funding Source: NIH RePORTER	This work is supported by NIH NICHD/NCMRR STTR Phase I grant 1R41HD077967-01A1 and the Indiana University Funding Opportunities for Research Commercialization and Economic Success.; Dr Neumann is the owner of a small business funded by an NIH STTR Phase I grant. She was financially compensated for efforts pertaining to this research and has a commercial interest in the training program described in the article. Drs Malec and Hammond, and Mr Langston received funds through Indiana University's subcontract with the business for their work on this project.	Ashman TA, 2006, MT SINAI J MED, V73, P999; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barchard KA, 2010, BEHAV RES METHODS, V42, P586, DOI 10.3758/BRM.42.2.586; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cohen J., 2013, STAT POWER ANAL BEHA; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Etzler SL, 2014, PSYCHOL REST ASSESSM, V56, P178; Fakra E, 2008, SCHIZOPHR RES, V100, P191, DOI 10.1016/j.schres.2007.11.040; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Foland-Ross LC, 2010, J NEUROSCI, V30, P16673, DOI 10.1523/JNEUROSCI.4578-09.2010; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kokkonen P, 2001, COMPR PSYCHIAT, V42, P471, DOI 10.1053/comp.2001.27892; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; Levant RF., 2009, J MENS STUD, V17, P75, DOI [10.3149/jms.1701.75, DOI 10.3149/JMS.1701.75]; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Neumann D, J HEAD TRAU IN PRESS; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Prince L, 2012, 9 C NEUR REH SPEC IN; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Spielberger C.D., 1999, MANUAL STATE TRAIT A; SPIELBERGER CD, 1995, ASSESSMENT EMOTIONAL; Spielberger CD., 1970, STATE TRAIT ANXIETY; Torrado M, 2013, ACTA MEDICA PORT, V26, P145; Tsaousides T, 2014, NEUROPSYCHOL REHABIL, V24, P784, DOI 10.1080/09602011.2014.907186; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whyte J, 2009, ARCH PHYS MED REHAB, V90, pS3, DOI 10.1016/j.apmr.2009.07.008; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	47	24	25	2	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					286	295		10.1097/HTR.0000000000000277			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800009	28060205	Green Accepted			2022-02-06	
J	Snook, ML; Henry, LC; Sanfilippo, JS; Zeleznik, AJ; Kontos, AP				Snook, Meredith L.; Henry, Luke C.; Sanfilippo, Joseph S.; Zeleznik, Anthony J.; Kontos, Anthony P.			Association of Concussion With Abnormal Menstrual Patterns in Adolescent and Young Women	JAMA PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; FEMALE ATHLETE TRIAD; BONE-MINERAL DENSITY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; INTERNATIONAL-CONFERENCE; REPRODUCTIVE FUNCTION; CONSENSUS STATEMENT	IMPORTANCE Brain injurymay interrupt menstrual patterns by altering hypothalamic-pituitary-ovarian axis function. Investigators have yet to evaluate the association of concussion with menstrual patterns in young women. OBJECTIVE To compare abnormal menstrual patterns in adolescent and young women after a sport-related concussion with those after sport-related orthopedic injuries to areas other than the head (nonhead). DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study of adolescent and young women with a sport-related concussion (n = 68) or a nonhead sport-related orthopedic injury (n = 61) followed up participants for 120 days after injury. Patients aged 12 to 21 years who presented within 30 days after a sport-related injury to a concussion or sports medicine clinic at a single academic center were eligible. Menstrual patterns were assessed using a weekly text message link to an online survey inquiring about bleeding episodes each week. The first patient was enrolled on October 14, 2014, and follow-up was completed on January 24, 2016. Inclusion criteria required participants to be at least 2 years postmenarche, to report regular menses in the previous year, and to report no use of hormonal contraception. EXPOSURES Sport-related concussion or nonhead sport-related orthopedic injury. MAIN OUTCOMES AND MEASURES Abnormal menstrual patternswere defined by an intermenstrual interval of less than 21 days (short) or more than 35 days (long) or a bleeding duration of less than 3 days or more than 7 days. RESULTS A total of 1784 survey responses were completed of the 1888 text messages received by patients, yielding 487 menstrual patterns in 128 patients (mean [SD] age, 16.2 [2.0] years). Of the 68 patients who had a concussion, 16 (23.5%) experienced 2 or more abnormal menstrual patterns during the study period compared with 3 of 60 patients (5%) who had an orthopedic injury. Despite similar gynecologic age, body mass index, and type of sports participation between groups, the risk of 2 or more abnormal menstrual bleeding patterns after injury was significantly higher among patients with concussion than among those with an orthopedic injury (odds ratio, 5.85; 95% CI, 1.61-21.22). CONCLUSIONS AND RELEVANCE Adolescent and young women may have increased risk of multiple abnormal menstrual patterns after concussion. Because abnormal menstrual patterns can have important health implications, monitoring menstrual patterns after concussion may be warranted in this population. Additional research is needed to elucidate the relationship between long-term consequences of concussion and the function of the hypothalamic-pituitary-ovarian axis.	[Snook, Meredith L.; Sanfilippo, Joseph S.; Zeleznik, Anthony J.] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Henry, Luke C.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; [Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Sports Med Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Sports Med Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; Magee-Women's Research Institute [CTRA-8064]	This research was supported in part by grant 1K01DC012332-01A1 from the National Institute on Deafness and Other Communication Disorders (Dr Kontos and University of Pittsburgh) and grant CTRA-8064 from the Magee-Women's Research Institute (Dr Snook).	Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS219, DOI 10.1016/j.fertnstert.2008.08.038; [Anonymous], 2016, PEDIATRICS, V137, P53; Austin Tricia M, 2009, Int J Adolesc Med Health, V21, P555; Barrack MT, 2014, AM J SPORT MED, V42, P949, DOI 10.1177/0363546513520295; Beals KA, 2002, INT J SPORT NUTR EXE, V12, P281, DOI 10.1123/ijsnem.12.3.281; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BERGA SL, 1995, ENDOCRINOLOGIST, V5, P416, DOI 10.1097/00019616-199511000-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention Injury Center, HEADS YOUTH SPORTS; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; CYTOWIC RE, 1986, NEW ENGL J MED, V314, P715; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; De Souza MJ, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093218; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; FLUG D, 1984, ANN HUM BIOL, V11, P495, DOI 10.1080/03014468400007411; Fourman LT, 2015, J CLIN ENDOCR METAB, V100, P812, DOI 10.1210/jc.2014-3344; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GROSSMAN WF, 1994, J REPROD MED, V39, P738; Henry YM, 2004, OSTEOPOROSIS INT, V15, P263, DOI 10.1007/s00198-003-1542-9; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Legro RS, 2000, J CLIN ENDOCR METAB, V85, P1021, DOI 10.1210/jc.85.3.1021; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Menstruation in girls and adolescents: using the menstrual cycle as a vital sign, 2015, OBSTET GYNECOL, V126, pe143; Nichols JF, 2007, INT J SPORT NUTR EXE, V17, P364, DOI 10.1123/ijsnem.17.4.364; Nichols JF, 2007, BONE, V41, P371, DOI 10.1016/j.bone.2007.05.003; Nichols JF, 2006, ARCH PEDIAT ADOL MED, V160, P137, DOI 10.1001/archpedi.160.2.137; Popat VB, 2009, J CLIN ENDOCR METAB, V94, P2277, DOI 10.1210/jc.2008-1878; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Thein-Nissenbaum JM, 2012, J ATHL TRAINING, V47, P74; Williams NI, 2007, AM J PHYSIOL-ENDOC M, V293, pE270, DOI 10.1152/ajpendo.00108.2007; Williams NI, 2015, AM J PHYSIOL-ENDOC M, V308, pE29, DOI 10.1152/ajpendo.00386.2013; World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls, 1986, J ADOLESC HLTH CARE, V7, P229; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	49	24	25	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	SEP	2017	171	9					879	886		10.1001/jamapediatrics.2017.1140			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FG3XL	WOS:000410140700015	28672284	Green Published			2022-02-06	
J	McDonough, A; Lee, RV; Noor, S; Lee, C; Le, T; Iorga, M; Phillips, JLH; Murphy, S; Moller, T; Weinstein, JR				McDonough, Ashley; Lee, Richard V.; Noor, Shahani; Lee, Chungeun; Le, Thu; Iorga, Michael; Phillips, Jessica L. H.; Murphy, Sean; Moller, Thomas; Weinstein, Jonathan R.			Ischemia/Reperfusion Induces Interferon-Stimulated Gene Expression in Microglia	JOURNAL OF NEUROSCIENCE			English	Article						hypoxia; interferons; ischemia; microglia; reperfusion	TOLL-LIKE RECEPTOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; ALPHA RECEPTOR; INFLAMMATORY RESPONSES; ARTERY OCCLUSION; NEURONAL INJURY; DOWN-REGULATION; I INTERFERONS	Innate immune signaling is important in the pathophysiology of ischemia/reperfusion (stroke)-induced injury and recovery. Several lines of evidence support a central role for microglia in these processes. Recent work has identified Toll-like receptors (TLRs) and type I interferon (IFN) signaling in both ischemia/reperfusion-induced brain injury and ischemic preconditioning-mediated neuroprotection. To determine the effects of "ischemia/reperfusion-like" conditions on microglia, we performed genomic analyses on wild-type (WT) and TLR4(-/-) cultured microglia after sequential exposure to hypoxia/hypoglycemia and normoxia/normoglycemia (H/H-N/N). We observed increased expression of type 1 IFN-stimulated genes (ISGs) as the predominant transcriptomal feature of H/H-N/N-exposed WT, but not TLR4(-/-), microglia. Microarray analysis on ex vivo sorted microglia from ipsilateral male mouse cortex after a transient in vivo ischemic pulse also demonstrated robust expression of ISGs. Type 1 IFNs, including the IFN-alpha s and IFN-beta, activate the interferon-alpha/beta receptor (IFNAR) complex. We confirmed both in vitro H/H-N/N-and in vivo ischemia/reperfusion-induced microglial ISG responses by quantitative real-time PCR and demonstrated that both were dependent on IFNAR1. We characterized the effects of hypoxia/hypoglycemia on phosphorylation of signal transducer and activator of transcription 1 (STAT1), release of type 1 IFNs, and surface expression of IFNAR1 in microglia. We demonstrated that IFN-beta induces dose-dependent secretion of ISG chemokines in cultured microglia and robust ISG expression in microglia both in vitro and in vivo. Finally, we demonstrated that the microglial ISG chemokine responses to TLR4 agonists were dependent on TLR4 and IFNAR1. Together, these data suggest novel ischemia/reperfusion-induced pathways for both TLR4-dependent and -independent, IFNAR1-dependent, type 1 IFN signaling in microglia.	[McDonough, Ashley; Lee, Richard V.; Noor, Shahani; Lee, Chungeun; Le, Thu; Iorga, Michael; Phillips, Jessica L. H.; Moller, Thomas; Weinstein, Jonathan R.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Murphy, Sean; Weinstein, Jonathan R.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Weinstein, JR (corresponding author), Univ Washington, Dept Neurol, Box 356465,1959 NE Pacific St, Seattle, WA 98195 USA.	jweinste@u.washington.edu	Moller, Thomas/W-8974-2019	Weinstein, Jonathan/0000-0001-6080-9758; McDonough, Ashley/0000-0003-3864-9449; /0000-0003-3386-8212	National Institute of Neurological Disorders and Stroke-National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065008, NS076620, NS100245]; UW Center on Human Development and Disability; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS065008, R01NS076620, F32NS100245] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke-National Institutes of Health (Grants NS065008 and NS076620 to J.R.W. and Grant NS100245 to A.M.). We thank Anna Conti, Jamie Colman, Diana Chao, and Rona Lee for assistance with the middle cerebral artery occlusion surgery; Theo Bammler, Richard P. Beyer, and Michael Coon at the University of Washington (UW) Functional Genomics and Proteomics Core for excellent technical assistance with processing our microarrays and bioinformatics analysis; and the UW Center on Human Development and Disability for their support of our genomics work.	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Bhattacharya S, 2011, J BIOL CHEM, V286, P22069, DOI 10.1074/jbc.M111.238766; Brendecke SM, 2012, J LEUKOCYTE BIOL, V92, P479, DOI 10.1189/jlb.0112043; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cadena-Herrera Daniela, 2015, Biotechnol Rep (Amst), V7, P9, DOI 10.1016/j.btre.2015.04.004; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chmiest D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13476; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Crotti A., 2016, J NEUROINFLAMM, V44, P505; Esen N, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-10; Fitts DA, 2010, BEHAV RES METHODS, V42, P3, DOI 10.3758/BRM.42.1.3; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Gesuete R, 2014, J NEUROPATH EXP NEUR, V73, P378, DOI 10.1097/NEN.0000000000000068; Gesuete R, 2012, J NEUROCHEM, V123, P75, DOI 10.1111/j.1471-4159.2012.07946.x; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hamner MA, 2015, J NEUROSCI, V35, P15599, DOI 10.1523/JNEUROSCI.2544-15.2015; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holm TH, 2012, GLIA, V60, P630, DOI 10.1002/glia.22296; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Inacio AR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0427-0; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janeway CA, 2005, IMMUNOBIOLOGY IMMUNE, Vsixth; Janova H, 2016, GLIA, V64, P635, DOI 10.1002/glia.22955; Kapil P, 2012, GLIA, V60, P1555, DOI 10.1002/glia.22375; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Kuo P-C, 2016, J AM HEART ASS, V5; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lin RT, 1999, MOL CELL BIOL, V19, P959; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2008, CURR OPIN PHARMACOL, V8, P8, DOI 10.1016/j.coph.2007.09.009; McDonough A, 2016, NEUROTHERAPEUTICS, V13, P748, DOI 10.1007/s13311-016-0465-z; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Mohr J, 2010, STROKE PATHOPHYSIOLO; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268	64	24	24	0	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	AUG 23	2017	37	34					8292	8308		10.1523/JNEUROSCI.0725-17.2017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE5JE	WOS:000408247000022	28747383	Green Published, Bronze			2022-02-06	
J	Churchill, NW; Hutchison, MG; Di Battista, AP; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Di Battista, Alex P.; Graham, Simon J.; Schweizer, Tom A.			Strutural, Functional, and Metabolic Brain Markers Differentiate Collision versus Contact and Non-Contact Athletes	FRONTIERS IN NEUROLOGY			English	Article						concussion; subconcussive; contact sports; diffusion tensor imaging; magnetic resonance spectroscopy; functional magnetic resonance imaging	COLLEGIATE FOOTBALL PLAYERS; CHRONIC TRAUMATIC ENCEPHALOPATHY; MAGNETIC-RESONANCE-SPECTROSCOPY; SUBCONCUSSIVE HEAD TRAUMA; SPORTS-RELATED CONCUSSION; PARTIAL LEAST-SQUARES; DEFAULT-MODE NETWORK; HIGH-SCHOOL FOOTBALL; RECURRENT CONCUSSION; TEMPORAL WINDOW	There is growing concern about how participation in contact sports affects the brain. Retrospective evidence suggests that contact sports are associated with long-term negative health outcomes. However, much of the research to date has focused on former athletes with significant health problems. Less is known about the health of current athletes in contact and collision sports who have not reported significant medical issues. In this cross-sectional study, advanced magnetic resonance imaging (MRI) was used to evaluate multiple aspects of brain physiology in three groups of athletes participating in non-contact sports (N = 20), contact sports (N = 22), and collision sports (N = 23). Diffusion tensor imaging was used to assess white matter microstructure based on measures of fractional anisotropy (FA) and mean diffusivity (MD); resting-state functional MRI was used to evaluate global functional connectivity; single-voxel spectroscopy was used to compare ratios of neural metabolites, including N-acetyl aspartate (NAA), creatine (Cr), choline, and myo-inositol. Multivariate analysis revealed structural, functional, and metabolic measures that reliably differentiated between sport groups. The collision group had significantly elevated FA and reduced MD in white matter, compared to both contact and non-contact groups. In contrast, the collision group showed significant reductions in functional connectivity and the NAA/Cr metabolite ratio, relative to only the non-contact group, while the contact group overlapped with both non-contact and collision groups. For brain regions associated with contact sport participation, athletes with a history of concussion also showed greater alterations in FA and functional connectivity, indicating a potential cumulative effect of both contact exposure and concussion history on brain physiology. These findings indicate persistent differences in brain physiology for athletes participating in contact and collision sports, which should be considered in future studies of concussion and subconcussive impacts.	[Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Di Battista, Alex P.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.	nchurchill.research@gmail.com		Di Battista, Alex/0000-0002-3325-6833	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN294001-367456]; Defence Research and Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada, Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant number RN294001-367456], the Defence Research and Development Canada (DRDC), and the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967] and pilot funding from Siemens Canada, Ltd.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Weir DR., 2009, NATL FOOTBALL LEAGUE; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	58	24	25	1	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 22	2017	8								390	10.3389/fneur.2017.00390			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE6MD	WOS:000408322700001	28878729	Green Published, gold			2022-02-06	
J	Corrigan, F; Arulsamy, A; Collins-Praino, LE; Holmes, JL; Vink, R				Corrigan, Frances; Arulsamy, Alina; Collins-Praino, Lyndsey E.; Holmes, Joshua L.; Vink, Robert			Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Concussion; Chronic traumatic encephalopathy; TLR4; Tau; Neurodegeneration	PROFESSIONAL FOOTBALL PLAYERS; SPINAL-CORD-INJURY; KAPPA-B ACTIVITY; ENDOTOXIN TOLERANCE; ALZHEIMERS-DISEASE; MEDIATED NEURODEGENERATION; MICROGLIAL POLARIZATION; BEHAVIORAL IMPAIRMENTS; INFLAMMATORY RESPONSE; RECURRENT CONCUSSION	A history of repeated concussion has been linked to the later development of neurodegeneration, which is associated with the accumulation of hyperphosphorylated tau and the development of behavioral deficits. However, the role that exogenous factors, such as immune activation, may play in the development of neurodegeneration following repeated mild traumatic brain injury (rmTBI) has not yet been explored. To investigate, male Sprague-Dawley rats were administered three mTBIs 5 days apart using the diffuse impact-acceleration model to generate similar to 100 G. Sham animals underwent surgery only. At 1 or 5 days following the last injury rats were given the TLR4 agonist, lipopolysaccharide (LPS, 0.1 mg/kg), or saline. TLR4 activation had differential effects following rmTBI depending on the timing of activation. When given at 1 day post-injury, LPS acutely activated microglia, but decreased production of pro inflammatory cytoldnes like IL-6. This was associated with a reduction in neuronal injury, both acutely, with a restoration of levels of myelin basic protein (MBP), and chronically, preventing a loss of both MBP and PSD-95. Furthermore, these animals did not develop behavioral deficits with no changes in locomotion, anxiety, depressive-like behavior or cognition at 3 months post-injury. Conversely, when LPS was given at 5 days post-injury, it was associated acutely with an increase in pro-inflammatory cytokine production, with an exacerbation of neuronal damage and increased levels of aggregated and phosphorylated tau. At 3 months post-injury, there was a slight exacerbation of functional deficits, particularly in cognition and depressive-like behavior. This highlights the complexity of the immune response following rmTBI and the need to understand how a history of rmTBI interacts with environmental factors to influence the potential to develop later neurodegeneration. Crown Copyright (C) 2017 Published by Elsevier Inc. All rights reserved.	[Corrigan, Frances; Arulsamy, Alina; Collins-Praino, Lyndsey E.; Holmes, Joshua L.] Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia		Corrigan, F (corresponding author), Univ Adelaide, Sch Med, Translat Neuropathol Lab, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	frances.corrigan@adelaide.edu.au	Arulsamy, Alina/AAU-9166-2021; Vink, Robert/J-7351-2012; Collins-Praino, Lyndsey/AAB-3318-2019	Arulsamy, Alina/0000-0003-0993-5622; Vink, Robert/0000-0002-4885-0667; Collins-Praino, Lyndsey/0000-0002-4380-7600; Corrigan, Frances/0000-0001-6150-8893	Neurosurgical Research Foundation	This work was supported by a grant from the Neurosurgical Research Foundation.	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bastide M, 2003, J CEREBR BLOOD F MET, V23, P399, DOI 10.1097/01.WCB.0000050064.57184.F2; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bingham D, 2013, J NEUROIMMUNOL, V256, P28, DOI 10.1016/j.jneuroim.2012.12.009; Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Broad A, 2007, IMMUNOLOGY, V120, P103, DOI 10.1111/j.1365-2567.2006.02485.x; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Caldeira C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00152; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chongwatpol P, 2015, J INFLAMM RES, V8, P117, DOI 10.2147/JIR.S82261; Chu CH, 2016, BRAIN BEHAV IMMUN, V55, P260, DOI 10.1016/j.bbi.2016.04.015; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Couch Y, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0572-0; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cruz MT, 2001, NITRIC OXIDE-BIOL CH, V5, P53, DOI 10.1006/niox.2000.0320; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Li YK, 2003, J NEUROSCI, V23, P1605; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez C, 1999, ANN SURG, V229, P843, DOI 10.1097/00000658-199906000-00011; Mendoza J, 2013, J PROTEOME RES, V12, P2654, DOI 10.1021/pr400008f; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Rawji KS, 2016, BRAIN, V139, P653, DOI 10.1093/brain/awv395; Reis J, 2011, CELL BIOCHEM BIOPHYS, V60, P77, DOI 10.1007/s12013-011-9182-8; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Seeger JM, 1999, ANN SURG, V229, P849; Selkirk GA, 2008, AM J PHYSIOL-REG I, V295, pR611, DOI 10.1152/ajpregu.00917.2007; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00138; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tarassishin L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-187; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vartanian KB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-140; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	97	24	26	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2017	64						124	139		10.1016/j.bbi.2017.04.006			16	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EZ1XR	WOS:000404504600014	28412141				2022-02-06	
J	Chiluwal, A; Narayan, RK; Chaung, W; Mehan, N; Wang, P; Bouton, CE; Golanov, EV; Li, CY				Chiluwal, Amrit; Narayan, Raj K.; Chaung, Wayne; Mehan, Neal; Wang, Ping; Bouton, Chad E.; Golanov, Eugene V.; Li, Chunyan			Neuroprotective Effects of Trigeminal Nerve Stimulation in Severe Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							CEREBRAL-BLOOD-FLOW; ROSTRAL VENTROLATERAL MEDULLA; ELECTRICAL-STIMULATION; DIVING RESPONSE; HEMORRHAGIC-SHOCK; PATHO-PHYSIOLOGY; CARDIAC REFLEX; NASAL-MUCOSA; RAT; VAGUS	Following traumatic brain injury (TBI), ischemia and hypoxia play a major role in further worsening of the damage, a process referred to as 'secondary injury'. Protecting neurons from causative factors of secondary injury has been the guiding principle of modern TBI management. Stimulation of trigeminal nerve induces pressor response and improves cerebral blood flow (CBF) by activating the rostral ventrolateral medulla. Moreover, it causes cerebrovasodilation through the trigemino-cerebrovascular system and trigemino-parasympathetic reflex. These effects are capable of increasing cerebral perfusion, making trigeminal nerve stimulation (TNS) a promising strategy for TBI management. Here, we investigated the use of electrical TNS for improving CBF and brain oxygen tension (PbrO(2)), with the goal of decreasing secondary injury. Severe TBI was produced using controlled cortical impact (CCI) in a rat model, and TNS treatment was delivered for the first hour after CCI. In comparison to TBI group, TBI animals with TNS treatment demonstrated significantly increased systemic blood pressure, CBF and PbrO(2) at the hyperacute phase of TBI. Furthermore, rats in TNS-treatment group showed significantly reduced brain edema, blood-brain barrier disruption, lesion volume, and brain cortical levels of TNF-alpha and IL-6. These data provide strong early evidence that TNS could be an effective neuroprotective strategy.	[Chiluwal, Amrit; Narayan, Raj K.; Mehan, Neal; Li, Chunyan] Feinstein Inst Med Res, Northwell Neuromonitoring Lab, Manhasset, NY 11030 USA; [Chiluwal, Amrit; Narayan, Raj K.; Mehan, Neal; Li, Chunyan] Hofstra Northwell Sch Med, Dept Neurosurg, Hempstead, NY 11549 USA; [Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY USA; [Golanov, Eugene V.] Houston Methodist Res Inst, Dept Neurosurg, Houston, TX USA; [Narayan, Raj K.; Bouton, Chad E.; Li, Chunyan] Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY 11030 USA		Li, CY (corresponding author), Feinstein Inst Med Res, Northwell Neuromonitoring Lab, Manhasset, NY 11030 USA.; Li, CY (corresponding author), Hofstra Northwell Sch Med, Dept Neurosurg, Hempstead, NY 11549 USA.; Li, CY (corresponding author), Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY 11030 USA.	cli11@northwell.edu	Golanov, Eugene/B-6462-2011	Golanov, Eugene/0000-0003-0220-822X; Wang, Ping/0000-0002-1557-0394	Department of Neurosurgery at Northwell Health; U.S. Department of Defense CDMRP PH/TBI Research Program [PT090526P4 (W81XWH-10-1-0978)]	This work was supported in part by the Department of Neurosurgery at Northwell Health and U.S. Department of Defense CDMRP PH/TBI Research Program under project No. PT090526P4 (W81XWH-10-1-0978).	Atalay B, 2002, J NEUROSURG, V97, P1179, DOI 10.3171/jns.2002.97.5.1179; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; BRANSTON NM, 1995, BRIT J NEUROSURG, V9, P319, DOI 10.1080/02688699550041331; Brown CM, 2003, BRAIN RES BULL, V61, P81, DOI 10.1016/S0361-9230(03)00065-0; Carney N., 2017, NEUROSURGERY, V159, P771; Cook IA, 2016, NEUROMODULATION, V19, P299, DOI 10.1111/ner.12399; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davies CA, 1998, EXP NEUROL, V154, P199, DOI 10.1006/exnr.1998.6891; DeGiorgio CM, 2013, NEUROLOGY, V80, P786, DOI 10.1212/WNL.0b013e318285c11a; Dutschmann M, 1998, NEUROREPORT, V9, P1053; Englot DJ, 2016, NEUROSURGERY, V79, P345, DOI 10.1227/NEU.0000000000001165; GINSBERG MD, 1994, ANN NEUROL, V36, P553, DOI 10.1002/ana.410360402; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goadsby PJ, 1997, BRAIN RES, V751, P247, DOI 10.1016/S0006-8993(96)01344-3; Golanov EV, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00157; GOLANOV EV, 1994, J CEREBR BLOOD F MET, V14, P492, DOI 10.1038/jcbfm.1994.61; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Gulturk S, 2009, INT J NEUROSCI, V119, P1292, DOI 10.1080/00207450802335610; Gurelik M, 2004, NEUROSCI LETT, V365, P210, DOI 10.1016/j.neulet.2004.04.079; Guyenet PG, 1996, PROG BRAIN RES, V107, P127; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Ishii H, 2014, J COMP PHYSIOL B, V184, P385, DOI 10.1007/s00360-014-0807-2; Ito G, 2013, EUR J PAIN, V17, P185, DOI 10.1002/j.1532-2149.2012.00174.x; Jiang M, 2017, MED GAS RES, V7, P48, DOI 10.4103/2045-9912.202910; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Lapi D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnuls.2016.00470; Lazaridis C, 2016, NEUROSURG CLIN N AM, V27, P509, DOI 10.1016/j.nec.2016.05.010; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Li CY, 2017, J CEREBR BLOOD F MET, V37, P1634, DOI 10.1177/0271678X16667131; Li CY, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0034-6; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma F, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-44; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magis D., 2016, CEPHALALGIA; Mandel M, 2012, FUNCT NEUROL, V27, P207; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Martindale V., 2015, MEDSCAPE; McCulloch P. F., 1998, NEUROSCIENCE, V24, P374; McCulloch PF, 1999, J PHYSIOL-LONDON, V516, P471, DOI 10.1111/j.1469-7793.1999.0471v.x; McCulloch PF, 1999, BRAIN RES, V830, P24, DOI 10.1016/S0006-8993(99)01374-8; McIntosh TK, 1996, LAB INVEST, V74, P315; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; MESSLINGER K, 1995, CAN J PHYSIOL PHARM, V73, P1020; Meuwly C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000484; MOSKOWITZ MA, 1979, LANCET, V2, P883; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Panneton WM, 2013, PHYSIOLOGY, V28, P284, DOI 10.1152/physiol.00020.2013; Panneton WM, 2000, BRAIN RES, V874, P48, DOI 10.1016/S0006-8993(00)02549-X; Pearn ML, 2016, CELL MOL NEUROBIOL; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; ROGERS RC, 1980, BRAIN RES BULL, V5, P365, DOI 10.1016/S0361-9230(80)80006-2; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Shaparin N, 2015, PAIN RES MANAG, V20, P63, DOI 10.1155/2015/482652; Shiflett, 2015, J NEUROLOGY STROKE, V2, P1; SHIOKAWA Y, 1992, BRIT J NEUROSURG, V6, P445, DOI 10.3109/02688699208995034; Shiozawa P, 2014, EPILEPSY BEHAV, V39, P6, DOI 10.1016/j.yebeh.2014.07.021; SUZUKI N, 1990, J CEREBR BLOOD F MET, V10, P399, DOI 10.1038/jcbfm.1990.70; SUZUKI N, 1990, ACTA PHYSIOL SCAND, V138, P307, DOI 10.1111/j.1748-1716.1990.tb08851.x; Svendgaard NA, 1996, NEUROL RES, V18, P394; Toader E, 2011, MINERVA ANESTESIOL, V77, P142; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Underwood M. D., 2016, J CEREB BLOOD FLOW M; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Wang QQ, 2016, J MOL NEUROSCI, V59, P78, DOI 10.1007/s12031-016-0736-5; Weber B, 2003, J CEREBR BLOOD F MET, V23, P1455, DOI 10.1097/01.WCB.0000095799.98378.7D; WOLMAN M, 1981, ACTA NEUROPATHOL, V54, P55, DOI 10.1007/BF00691332; Yamakawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056728; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang YJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0550-6; Yilmaz Adem, 2011, Surg Neurol Int, V2, P77, DOI 10.4103/2152-7806.82084; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZHANG QJ, 1993, NEUROSURGERY, V32, P993, DOI 10.1227/00006123-199306000-00019; Zhou L, 2014, NEURAL REGEN RES, V9, P1585, DOI 10.4103/1673-5374.141783	81	24	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 28	2017	7								6792	10.1038/s41598-017-07219-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1PP	WOS:000406610000043	28754973	gold, Green Published			2022-02-06	
J	Gasenzer, ER; Kanat, A; Neugebauer, E				Gasenzer, Elena Romana; Kanat, Ayhan; Neugebauer, Edmund			Neurosurgery and Music; Effect of Wolfgang Amadeus Mozart	WORLD NEUROSURGERY			English	Article						Chronic epidural hematoma; History of neurosurgery; Musician; Skull fracture; Traumatic brain injury	SUBARACHNOID HEMORRHAGE; MECHANICAL VENTILATION; GEORGE GERSHWIN; BRAIN-TUMOR; DID MOZART; DEATH; ILLNESS; RAVEL,MAURICE; DEGENERATION; CREATIVITY	BACKGROUND: The nervous system works like a great orchestra. Specifically, the music of Mozart with its "Mozart effect" is appropriate to use in neurosurgery. We investigated the relationship between Mozart's music and neurosurgery. MATERIAL AND METHODS: We used digital catalogs like "PubMed" and the libraries of universities. Key words were "Wolfgang Amadeus Mozart" and "neurosurgery and music." RESULTS: In the first half of the 20th century, performing neurosurgery on some musicians, such as Maurice Ravel, Josef Hassid, and George Gershwin, resulted in a fatal outcome. The cause of this is probably that neurosurgery had not been developed yet in the first half of the 20th century. In the past 3 decades, the neurosurgical operations of musicians show that musicians have rich associations among auditory, somatic, and sensorial systems. CONCLUSION: It is clear that we have much to learn from studies about music and brain function that derive from our surgical experiences with patients. The neuronal plasticity of musicians' brains may be different from that of nonmusicians' brains. Musicians with enhanced motor skills have greater capacity for plasticity because of enriched interhemispheric connections. Listening to music and the effect of Mozart in neurosurgical practice, intensive care, or rehabilitation were documented in many studies. As authors, we mean something different: Its effectiveness should be studied. We concluded that in current neurosurgical practice, Mozart has an effect. More research and clinical studies are needed.	[Gasenzer, Elena Romana] Univ Witten Herdecke, Dept Med, Cologne, Germany; [Kanat, Ayhan] Recep Tayyip Erdogan Univ, Dept Neurosurg, Rize, Turkey; [Neugebauer, Edmund] Witten Herdecke Univ, Brandenburg Theodor Fontane Hlth Serv Res, Campus Neuruppin, North Rhine Westphalia, Germany		Gasenzer, ER (corresponding author), Univ Witten Herdecke, Dept Med, Cologne, Germany.	elena.gasenzer@uni-wh.de	INECIKLI, MEHMET FATIH/AAK-5124-2020; Kanat, Ayhan/N-2296-2015	INECIKLI, MEHMET FATIH/0000-0002-9796-8223; Gasenzer, Elena Romana/0000-0002-1221-2735; Kanat, Ayhan/0000-0002-8189-2877			Altenmuller EO, 2001, ANN NY ACAD SCI, V930, P273, DOI 10.1111/j.1749-6632.2001.tb05738.x; Amaducci L, 2002, EUR J NEUROL, V9, P75, DOI 10.1046/j.1468-1331.2002.00351.x; Apuzzo MLJ, 2001, NEUROSURGERY, V48, P1, DOI 10.1097/00006123-200101000-00001; Ashoori A, 2007, J NEUROL NEUROSUR PS, V78, P1171, DOI 10.1136/jnnp.2007.114520; Baeck E, 2001, Verh K Acad Geneeskd Belg, V63, P543; Baeck E, 2002, EUR J NEUROL, V9, P321, DOI 10.1046/j.1468-1331.2002.t01-5-00389.x; Baeck E, 1996, CLIN NEUROL NEUROSUR, V98, P57, DOI 10.1016/0303-8467(95)00086-0; Bagatti D, 2016, WORLD NEUROSURG, V85, P298, DOI [10.1016/j.WNEU.2015.07.054, 10.1016/j.wneu.2015.07.054]; Bangerter A, 2004, BRIT J SOC PSYCHOL, V43, P605, DOI 10.1348/0144666042565353; Bankl H, 1992, RELIQUIEN MOZARTS TO; Bentivoglio M, 2003, ANN NY ACAD SCI, V999, P234, DOI 10.1196/annals.1284.034; Bhattacharyya KB, 2015, ANN INDIAN ACAD NEUR, V18, P157, DOI 10.4103/0972-2327.145288; Breitenfeld T, 2007, UROLOGE, V46, P172, DOI 10.1007/s00120-006-1260-y; Cabej NR, 2012, ELSEV INSIGHT, P307, DOI 10.1016/B978-0-12-415831-3.00009-4; Chang WTW, 2013, NEUROSURG CLIN N AM, V24, P407, DOI 10.1016/j.nec.2013.02.004; Coorevits E, 2016, MUSIC PERCEPT, V33, P523, DOI 10.1525/MP.2016.33.5.523; Coppola G, 2015, EPILEPSY BEHAV, V50, P18, DOI 10.1016/j.yebeh.2015.05.038; Dastugue J., 2000, ILLUSTRIERTE GESCH M, P19; DAVIES PJ, 1991, J ROY SOC MED, V84, P737, DOI 10.1177/014107689108401215; DAVIES PJ, 1983, J ROY SOC MED, V76, P776, DOI 10.1177/014107688307600914; de Divitiis E, 2010, WORLD NEUROSURG, V73, P454, DOI 10.1016/j.wneu.2010.03.003; Demarin V, 2016, PSYCHIAT DANUB, V28, P343; Deutsch O, 1963, MOZART DOCUMENT HIS; DRAKE ME, 1993, NEUROLOGY, V43, P2400, DOI 10.1212/WNL.43.11.2400; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Duffau H, 2014, WORLD NEUROSURG, V81, P508, DOI 10.1016/j.wneu.2013.10.006; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; Epilepsy Maguire M., 2017, PRACT NEUROL, V17, P86; Eramo Stefano, 2011, J Hist Dent, V59, P129; Foo Francine, 2016, Front Hum Neurosci, V10, P154, DOI 10.3389/fnhum.2016.00154; Freeman W David, 2015, Continuum (Minneap Minn), V21, P1299, DOI 10.1212/CON.0000000000000235; Galarza M, 2014, WORLD NEUROSURG, V81, DOI 10.1016/j.wneu.2013.09.042; Gasenzer E, 2015, ACTA NEUROCHIR WIEN, V157, P1389; Gasenzer E, 2016, J NEUROL SURG A; Gasenzer E, 2016, WORLD NEUROSURG, pS1878; Gasenzer E, 2014, ACTA NEUROCHIR, V156, P1251, DOI 10.1007/s00701-014-2045-5; Geck M., 2009, FELIX MENDELSSOHN BA; Groen RJM, 2015, ACTA NEUROCHIR, V157, P1389, DOI 10.1007/s00701-015-2430-8; Grout J, 1996, HIST W MUSIC, P508; GUILLERY EN, 1992, J AM SOC NEPHROL, V2, P1671; Hatzinger M, 2013, ACTA MED-HIST ADRIAT, V11, P149; Hegde S, 2016, NEUROCASE, V22, P512, DOI 10.1080/13554794.2016.1198815; HENSON RA, 1988, BRIT MED J, V296, P1585, DOI 10.1136/bmj.296.6636.1585; Hetland L, 2000, J AESTHET EDUC, V34, P105, DOI 10.2307/3333640; Hildesheimer W., 1990, MOZART; Ist es Breitinger F., 1941, IDENTIFIZIERUNG MOZA, V1990, P36; Ivkic G, 2011, COLLEGIUM ANTROPOL, V35, P169; Jadavji-Mithani R, 2015, CAN J NEUROL SCI, V42, P7, DOI 10.1017/cjn.2014.127; Jahncke L, 2015, MUSIK UND MED, P49; JENKINS JS, 1991, J ROY COLL PHYS LOND, V25, P351; Jenkins JS, 2001, J ROY SOC MED, V94, P170, DOI 10.1177/014107680109400404; Jordan I., 2015, MOL MED MICROBIOLOGY, P517; Jourdain R., 2001, WOHLTEMPERIERTE GEHI; Kaas JH, 2015, INT ENCY SOCIAL BEHA, P619; Kanat A, 2010, CLIN NEUROL NEUROSUR, V112, P839, DOI 10.1016/j.clineuro.2010.07.012; Kanat A, 2010, ACTA NEUROCHIR, V152, P737, DOI 10.1007/s00701-009-0507-y; Kanat A, 2009, NEUROL NEUROCHIR POL, V43, P286; KARHAUSEN L, 1987, BRIT MED J, V294, P511, DOI 10.1136/bmj.294.6570.511-b; Karhausen L., 1991, J ROY SOC MED, V84, P743; Karpati F, 2016, BRAIN RES, V8993, P30804; Kasdan M L, 1987, J Ky Med Assoc, V85, P649; Kloppel R., 2003, PSYCHOMOTORIK INSTRU, P24; Kobets Andrew Joshua, 2011, Yale Journal of Biology and Medicine, V84, P161; Laws ER, 2010, WORLD NEUROSURG, V73, P458, DOI 10.1016/j.wneu.2010.03.004; Lebensschule Menuhin Y., 1987, LEBENSSCHULE; Lee CH, 2017, BIOL RES NURS, V19, P137, DOI 10.1177/1099800416669601; Lin LC, 2015, TRANSL PEDIATR, V4, P323, DOI 10.3978/j.issn.2224-4336.2015.09.02; Lin LC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-17; LJUNGGREN B, 1982, NEUROSURGERY, V10, P733, DOI 10.1227/00006123-198206010-00009; Marini F, 2009, COMPREHENSIVE CHEMOMETRICS: CHEMICAL AND BIOCHEMICAL DATA ANALYSIS, VOLS 1-4, pB477; Massimi L, 2006, CHILD NERV SYST, V22, P451, DOI 10.1007/s00381-006-0098-3; Millichap J., 2015, PEDIATR NEUROL, V29, P9; Mofredj A, 2016, J CRIT CARE, V35, P195, DOI 10.1016/j.jcrc.2016.05.021; Montinaro A, 2010, WORLD NEUROSURG, V73, P442, DOI 10.1016/j.wneu.2010.02.060; Mozart Jenkins J., 1995, J ROY SOC MED, V88, P408; Neumayr A., 1990, WOLFGANG AMADEUS MOZ, P49; Newman J, 1995, PERCEPT MOTOR SKILL, V81, P1379, DOI 10.2466/pms.1995.81.3f.1379; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Omigie D, 2014, NEUROPSYCHOL REV, V24, P445, DOI 10.1007/s11065-014-9274-5; Ozdemir B, 2017, WORLD NEUROSURG, V99, P409, DOI 10.1016/j.wneu.2016.11.133; Pauwels EKJ, 2014, MED PRIN PRACT, V23, P403, DOI 10.1159/000364873; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Peretz I, 2001, BRAIN, V124, P928, DOI 10.1093/brain/124.5.928; Pietschnig J, 2010, INTELLIGENCE, V38, P314, DOI 10.1016/j.intell.2010.03.001; Popp AJ, 2010, WORLD NEUROSURG, V73, P456, DOI 10.1016/j.wneu.2010.03.030; Potters JW, 2015, CURR OPIN ANESTHESIO, V28, P511, DOI 10.1097/ACO.0000000000000231; Psychosurgery Feinstein A., 1997, HIST PSYCHIATR, V8, P55; PUECH B, 1989, J FORENSIC SCI, V34, P487; PUECH B, 1989, INJURY, V20, P327, DOI 10.1016/0020-1383(89)90004-1; Rauschecker JP, 2001, ANN NY ACAD SCI, V930, P330, DOI 10.1111/j.1749-6632.2001.tb05742.x; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Riva M, 2016, WORLD NEUROSURG, V93, DOI 10.1016/j.wneu.2016.06.130; Sarkamo T., 2011, THESIS; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sarkamo T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00103; Schadeltrepanationen Dastugue J., 2000, ILLUSTRIERTE GESCH M, P35; Schirmer-Mikalsen K, 2016, NEUROCRIT CARE, V24, P332, DOI 10.1007/s12028-015-0208-8; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schlaug G, 2015, PROG BRAIN RES, V217, P37, DOI 10.1016/bs.pbr.2014.11.020; Schmithorst VJ, 2003, NEUROSCI LETT, V348, P65, DOI 10.1016/S0304-3940(03)00714-6; Silverstein A, 1999, SEMIN NEUROL, V19, P3; SIMKIN B, 1992, BRIT MED J, V305, P1563, DOI 10.1136/bmj.305.6868.1563; Supnet C, 2016, CRIT CARE NURSE, V36, pE1, DOI 10.4037/ccn2016413; Tracy Mary Fran, 2015, Music Med, V7, P54; Triarhou LC, 2016, J CHEM NEUROANAT, V77, P143, DOI 10.1016/j.jchemneu.2016.06.002; Unwiderstehlich Sacks O., 2013, EINARMIGE PIANIST MU, P376; Verrusio W, 2015, CONSCIOUS COGN, V35, P150, DOI 10.1016/j.concog.2015.05.005; Vlcek E, 2006, Acta Chir Plast, V48, P133; Wernhard E., 1997, CLARA HASKIL APROPOS; WHEATER M, 1990, J ROY SOC MED, V83, P586, DOI 10.1177/014107689008300917; Wolfensberger R., 1962, CLARA HASKIL BEITRAG; Xing YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep18744; Yolas C, 2016, WORLD NEUROSURG, V90, P484, DOI 10.1016/j.wneu.2016.03.049; Yolas C, 2016, WORLD NEUROSURG, V89, P208, DOI 10.1016/j.wneu.2016.01.082; Zegers RHC, 2009, ANN INTERN MED, V151, P274, DOI 10.7326/0003-4819-151-4-200908180-00010	116	24	25	3	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2017	102						313	319		10.1016/j.wneu.2017.02.081			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FA5HA	WOS:000405472500042	28242489				2022-02-06	
J	Wang, ZG; Luo, Y; Chen, LA; Liang, W				Wang, Zhigang; Luo, Yong; Chen, Lvan; Liang, Wu			Safety of neural stem cell transplantation in patients with severe traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						cell transplantation; traumatic brain injury; stem cell	AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; PRACTICAL SCALE; RATS; DIFFERENTIATE; EPIDEMIOLOGY; SCAFFOLDS; NEURONS	Neural stem cell (NSC) therapy is a promising treatment for traumatic brain injury (TBI). In addition, mesenchymal stem cells (MSCs) have been investigated for the treatment of TBI due to their functions in neural regeneration and their neurotrophic effect. In the present study, the safety, feasibility and biological effects of autologous MSC-derived NSC-like cell transplantation were investigated in 10 patients with severe TBI. All patients received intravenous or intrathecal injections of human NSC-like cells and were evaluated with physical and neurological examinations, routine laboratory tests and neuroradiological findings. The results indicated that the majority of patients experienced improved neurological function in different degrees during the follow-up period. No mortality or serious adverse events were observed in any patient subsequent to transplantation. Higher serum levels of nerve growth factor and brain-derived neurotrophic factor were detected following the transplantation, as compared with the levels prior to treatment. Overall, the present results suggest that transplantation of autologous NSC-like cells is feasible and appears to be safe for the treatment of non-acute severe TBI.	[Wang, Zhigang; Luo, Yong; Chen, Lvan; Liang, Wu] First Peoples Hosp Jingmen, Dept Neurosurg, 67 Xiangshan Rd, Jingmen 448000, Hubei, Peoples R China		Liang, W (corresponding author), First Peoples Hosp Jingmen, Dept Neurosurg, 67 Xiangshan Rd, Jingmen 448000, Hubei, Peoples R China.	360234044@qq.com			Science and Technology Bureau of Jingmen [2012YD34]	The present study was supported by the Science and Technology Bureau of Jingmen (grant no. 2012YD34).	Anbari F, 2014, NEURAL REGEN RES, V9, P919, DOI 10.4103/1673-5374.133133; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen GJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-21; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Fujiwara Y, 2004, NEUROSCI LETT, V366, P287, DOI 10.1016/j.neulet.2004.05.080; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; JENNETT B, 1975, LANCET, V1, P480; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Liu Y, 2014, MOL MED REP, V9, P333, DOI 10.3892/mmr.2013.1803; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Ma K, 2011, NEUROL RES, V33, P1083, DOI 10.1179/1743132811Y.0000000053; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Stabenfeldt SE, 2011, CURR STEM CELL RES T, V6, P208; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Ver Hage, 2011, NURSE COM NURSING SP, V24, P44; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5	38	24	25	0	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2017	13	6					3613	3618		10.3892/etm.2017.4423			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EU5NW	WOS:000401080000149	28588689	gold, Green Published			2022-02-06	
J	Hsieh, TH; Kang, JW; Lai, JH; Huang, YZ; Rotenberg, A; Chen, KY; Wang, JY; Chan, SY; Chen, SC; Chiang, YH; Peng, CW				Hsieh, Tsung-Hsun; Kang, Jing-Wei; Lai, Jing-Huei; Huang, Ying-Zu; Rotenberg, Alexander; Chen, Kai-Yun; Wang, Jia-Yi; Chan, Shu-Yen; Chen, Shih-Ching; Chiang, Yung-Hsiao; Peng, Chih-Wei			Relationship of mechanical impact magnitude to neurologic dysfunction severity in a rat traumatic brain injury model	PLOS ONE			English	Article							AXONAL INJURY; BEHAVIORAL DEFICITS; ACCELERATION MODEL; FLUID PERCUSSION; ANIMAL-MODELS; GFAP; PATHOPHYSIOLOGY; MODERATE; MOUSE; SERUM	Objective Traumatic brain injury (TBI) is a major brain injury type commonly caused by traffic accidents, falls, violence, or sports injuries. To obtain mechanistic insights about TBI, experimental animal models such as weight-drop-induced TBI in rats have been developed to mimic closed-head injury in humans. However, the relationship between the mechanical impact level and neurological severity following weight-drop-induced TBI remains uncertain. In this study, we comprehensively investigated the relationship between physical impact and graded severity at various weight-drop heights. Approach The acceleration, impact force, and displacement during the impact were accurately measured using an accelerometer, a pressure sensor, and a high-speed camera, respectively. In addition, the longitudinal changes in neurological deficits and balance function were investigated at 1, 4, and 7 days post TBI lesion. The inflammatory expression markers tested by Western blot analysis, including glial fibrillary acidic protein, beta-amyloid precursor protein, and bone marrow tyrosine kinase gene in chromosome X, in the frontal cortex, hippocampus, and corpus callosum were investigated at 1 and 7 days post-lesion. Results Gradations in impact pressure produced progressive degrees of injury severity in the neurological score and balance function. Western blot analysis demonstrated that all inflammatory expression markers were increased at 1 and 7 days post-impact injury when compared to the sham control rats. The severity of neurologic dysfunction and induction in inflammatory markers strongly correlated with the graded mechanical impact levels. Conclusions We conclude that the weight-drop-induced TBI model can produce graded brain injury and induction of neurobehavioral deficits and may have translational relevance to developing therapeutic strategies for TBI.	[Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Linkou, Taiwan; [Hsieh, Tsung-Hsun; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Kang, Jing-Wei; Lai, Jing-Huei; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Kang, Jing-Wei; Chan, Shu-Yen] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Huang, Ying-Zu] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Huang, Ying-Zu] Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Rotenberg, Alexander] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chen, Shih-Ching; Peng, Chih-Wei] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Shih-Ching; Peng, Chih-Wei] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan		Peng, CW (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan.	cwpeng@tmu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941; Wang, Jia-Yi/0000-0002-9106-3351; Huang, Ying-Zu/0000-0002-8666-4013	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST103-2321-B-038-013, MOST103-2221E-038-007-MY3, MOST 103-2320-B182-033-MY2, MOST 105-2314-B-182-016]; Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPD1F0501]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088583] Funding Source: NIH RePORTER	This study was supported by grants from the Ministry of Science and Technology of Taiwan (MOST103-2321-B-038-013 and MOST103-2221E-038-007-MY3 to C.W. Peng, MOST 103-2320-B182-033-MY2, MOST 105-2314-B-182-016 to T.H. Hsieh) and Chang Gung Memorial Hospital (CMRPD1F0501) to T.H.Hsieh.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Faul M, 2010, CENTERS FOR DISEASE; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Viano DC, 2012, ANN BIOMED ENG, V40, P213, DOI 10.1007/s10439-011-0386-2; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wu JCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039226; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yu Y.W., 2016, J NEUROTRAUMA	31	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178186	10.1371/journal.pone.0178186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	WOS:000402063000025	28552947	gold, Green Published			2022-02-06	
J	Salo, RA; Miettinen, T; Laitinen, T; Grohn, O; Sierra, A				Salo, Raimo A.; Miettinen, Tuukka; Laitinen, Teemu; Grohn, Olli; Sierra, Alejandra			Diffusion tensor MRI shows progressive changes in the hippocampus and dentate gyrus after status epilepticus in rat - histological validation with Fourier-based analysis	NEUROIMAGE			English	Article							TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; WATER DIFFUSION; SPONTANEOUS SEIZURES; PILOCARPINE MODEL; AXONAL INJURY; TREATED RATS; MOUSE MODEL; EX-VIVO; SCLEROSIS	Imaging markers for monitoring disease progression, recovery, and treatment efficacy are a major unmet need for many neurological diseases, including epilepsy. Recent evidence suggests that diffusion tensor imaging (DTI) provides high microstructural contrast even outside major white matter tracts. We hypothesized that in vivo DTI could detect progressive microstructural changes in the dentate gyrus and the hippocampal CA3bc in the rat brain after status epilepticus (SE). To test this hypothesis, we induced SE with systemic kainic acid or pilocarpine in adult male Wistar rats and subsequently scanned them using in vivo DTI at five time-points: prior to SE, and 10, 20, 34, and 79 days post SE. In order to tie the DTI findings to changes in the tissue microstructure, myelin-and glial fibrillary acidic protein (GFAP)-stained sections from the same animals underwent Fourier analysis. We compared the Fourier analysis parameters, anisotropy index and angle of myelinated axons or astrocyte processes, to corresponding DTI parameters, fractional anisotropy (FA) and the orientation angle of the principal eigenvector. We found progressive detectable changes in DTI parameters in both the dentate gyrus (FA, axial diffusivity [D-ll], linear anisotropy [CL] and spherical anisotropy [CS], p < 0.001, linear mixed-effects model [LMEM]) and the CA3bc (FA, (ll), CS, and angle, p < 0.001, LMEM; CL and planar anisotropy [CP], p < 0.01, LMEM) post SE. The Fourier analysis revealed that both myelinated axons and astrocyte processes played a role in the water diffusion anisotropy changes detected by DTI in individual portions of the dentate gyrus (suprapyramidal blade, mid-portion, and infrapyramidal blade). In the whole dentate gyrus, myelinated axons markedly contributed to the water diffusion changes. In CA3bc as well as in CA3b and CA3c, both myelinated axons and astrocyte processes contributed to water diffusion anisotropy and orientation. Our study revealed that DTI is a promising method for noninvasive detection of microstructural alterations in the hippocampus proper. These alterations may be potential imaging markers for epileptogenesis.	[Salo, Raimo A.; Miettinen, Tuukka; Laitinen, Teemu; Grohn, Olli; Sierra, Alejandra] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland		Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	alejandra.sierralopez@uef.fi		Sierra Lopez, Alejandra/0000-0001-5399-2056; Salo, Raimo/0000-0003-3610-236X	Academy of FinlandAcademy of FinlandEuropean Commission [275453]	This work was funded by the Academy of Finland (#275453). We thank Maarit Pulkkinen for providing technical assistance, M.Sc. Juhana Sorvari for his help during the scans, and M.Sc. Heikki Yli-Ollila for helping with the Fourier analysis implementation.	Aggarwal M, 2015, NEUROIMAGE, V105, P198, DOI 10.1016/j.neuroimage.2014.10.053; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Borges K, 2006, EXP NEUROL, V201, P416, DOI 10.1016/j.expneurol.2006.04.031; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Elkommos S, 2016, SEIZURE-EUR J EPILEP, V35, P65, DOI 10.1016/j.seizure.2016.01.007; Engel Jr J., 2006, EPILEPSY RES S1, V70; Gong G, 2008, EPILEPSIA, V49, P1941, DOI 10.1111/j.1528-1167.2008.01666.x; Howe KL, 2010, AM J NEURORADIOL, V31, P1682, DOI 10.3174/ajnr.A2154; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Khan AR, 2015, NEUROIMAGE, V111, P192, DOI 10.1016/j.neuroimage.2015.01.061; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kuo LW, 2008, NEUROIMAGE, V41, P789, DOI 10.1016/j.neuroimage.2008.03.013; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liu M, 2013, NEUROIMAGE, V74, P128, DOI 10.1016/j.neuroimage.2013.01.069; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Modo M, 2016, HUM BRAIN MAPP, V37, P780, DOI 10.1002/hbm.23066; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; Parekh MB, 2010, EXP NEUROL, V224, P258, DOI 10.1016/j.expneurol.2010.03.031; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Sayin U, 2015, NEUROSCIENCE, V288, P120, DOI 10.1016/j.neuroscience.2014.12.017; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Shepherd TM, 2006, NEUROIMAGE, V32, P1499, DOI 10.1016/j.neuroimage.2006.04.210; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Sierra A, 2011, BRAIN STRUCT FUNCT, V216, P123, DOI 10.1007/s00429-010-0299-0; Suleymanova EM, 2016, NEUROSCIENCE, V315, P79, DOI 10.1016/j.neuroscience.2015.11.061; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Sutula T, 1998, J COMP NEUROL, V390, P578, DOI 10.1002/(SICI)1096-9861(19980126)390:4<578::AID-CNE9>3.0.CO;2-Y; Tejada J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003601; van Vliet EA, 2016, EPILEPSIA, V57, P59, DOI 10.1111/epi.13246; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Winston GP, 2013, EPILEPSIA, V54, P1143, DOI 10.1111/epi.12193; Zhang JY, 2002, NEUROIMAGE, V15, P892, DOI 10.1006/nimg.2001.1012	49	24	27	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2017	152						221	236		10.1016/j.neuroimage.2017.03.003			16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EW5ZH	WOS:000402584500019	28267625				2022-02-06	
J	Fishman, M; Taranto, E; Perlman, M; Quinlan, K; Benjamin, HJ; Ross, LF				Fishman, Michael; Taranto, Eleanor; Perlman, Meryl; Quinlan, Kyran; Benjamin, Holly J.; Ross, Lainie Friedman			Attitudes and Counseling Practices of Pediatricians Regarding Youth Sports Participation and Concussion Risks	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; DOCTOR; CHILD; IF; EPIDEMIOLOGY; MANAGEMENT; KNOWLEDGE; FOOTBALL	Objective To examine attitudes and practices of pediatricians toward sports-related head trauma and youth participation in tackle football and ice hockey. Study design A respondent-anonymous electronic survey was distributed 3 times to members of the American Academy of Pediatrics Section of Bioethics, Council on Injury, Violence, and Poison Prevention, and Council on Sports Medicine and Fitness. Results Of 791 eligible pediatricians, 227 (29%) responded. Most respondents (189/223;85%) treat sportsrelated concussions, among whom 83% (137/165) reported access to an established return-to-play protocol within their practice. Virtually all (160/166;96%) reported increased parental awareness/concern regarding concussions and 85% (139/163) reported increased visits for head trauma. Overall, 77% (140/183) would not allow their son to play tackle football and 35% (64/181) and 34% (63/184) would not allow their son or daughter, respectively, to participate in ice hockey. Most respondents endorsed limiting or eliminating tackling (143/176; 81%) and checking (144/179; 80%) from practice. Respondents were evenly divided in their support for counseling against youth participation in full-contact sports, with 48% in favor (87/180). Conclusions Most respondents would not allow their own child to play tackle football and endorsed limiting or eliminating tackling in practice. The American Academy of Pediatrics should consider recommending restrictions on tackling in football to support the current concussion concerns of its members.	[Fishman, Michael; Taranto, Eleanor] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Perlman, Meryl; Ross, Lainie Friedman] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Quinlan, Kyran] Rush Univ, Dept Pediat, Med Ctr, Chicago, IL 60612 USA; [Benjamin, Holly J.; Ross, Lainie Friedman] Univ Chicago, Dept Pediat, 5841 S Maryland Ave,MC 6082, Chicago, IL 60637 USA; [Benjamin, Holly J.] Univ Chicago, Dept Orthoped Surg & Rehabil Med, Chicago, IL 60637 USA		Ross, LF (corresponding author), Univ Chicago, Dept Pediat, 5841 S Maryland Ave,MC 6082, Chicago, IL 60637 USA.	Lross@uchicago.edu		Ross, Lainie/0000-0002-7395-3000	University of Chicago Pritzker School of Medicine Summer Research Project; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK062719-29]	Supported by the University of Chicago Pritzker School of Medicine Summer Research Project (to M.F. and E.T.). Also supported by National Institute of Diabetes and Digestive and Kidney Diseases (T35DK062719-29 [to E.T].). The authors declare no conflicts of interest.	Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Arbogast KB, 2016, JAMA PEDIAT, V170, P1; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P785; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Halstead M, 2003, PEDIATRICS, V126, P597; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jinguji TM, 2011, PHYS MED REH CLIN N, V22, P565, DOI 10.1016/j.pmr.2011.08.001; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kon AA, 2006, PEDIATRICS, V118, P393, DOI 10.1542/peds.2005-2655; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Metzl JD, 2006, PEDIATRICS, V117, P1813, DOI 10.1542/peds.2006-0480; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2000, PEDIATRICS, V107, P1205; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Ross LF, 2003, J CLIN ETHIC, V14, P59; Schneider DK, 2016, BRIT J SPORT MED, P1; Truog R, 2003, J CLIN ETHIC, V14, P63; Truog RD, 1999, PEDIATRICS, V103, P153, DOI 10.1542/peds.103.1.153; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	31	24	24	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2017	184						19	25		10.1016/j.jpeds.2017.01.048			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EU5WH	WOS:000401104300006	28238481				2022-02-06	
J	Higgins, KL; Denney, RL; Maerlender, A				Higgins, Kathryn L.; Denney, Robert L.; Maerlender, Arthur			Sandbagging on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) in a high school athlete population	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychological testing; High school athletes; Baseline; Concussion; Concussion assessment	NEUROCOGNITIVE TEST-PERFORMANCE; TEST-RETEST	The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a computerized neuropsychological test battery commonly used to assess cognitive functioning after a concussion. It is recommended that application of ImPACT utilizes a baseline administration so athletes have an individualized baseline with which to compare post-injury results should they sustain a concussion. It has been suggested that athletes may provide suboptimal effort, called "sandbagging," in order to return to their baseline cognitive scores, and thus to play, more quickly. This research examines ImPACT baseline scores when high school athletes were asked to attempt to " sandbag," and compares those scores with scores obtained when they were asked to give their "best effort." Fifty-four high school student athlete volunteers participated in the study. In contrast to previous research that just looked at the cut-score invalidity indicators built into ImPACT, this research developed a regression equation to predict sandbagging. A logistic regression equation developed with four variables that demonstrated the largest effect size between "best effort" and "sandbagged" baselines showed a 99.7% classification accuracy for the " best effort" and "sandbag" groups.	[Higgins, Kathryn L.; Maerlender, Arthur] Univ Nebraska, Ctr Brain Biol & Behav, C76,East Stadium,POB 880156, Lincoln, NE 68588 USA; [Denney, Robert L.] Neuropsychol Associates Southwest Missouri, Springfield, MO USA		Higgins, KL (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, C76,East Stadium,POB 880156, Lincoln, NE 68588 USA.	khiggins@unl.edu			Forest Institute of Professional Psychology	This work was supported by a Research Grant from Forest Institute of Professional Psychology.	Agresti A., 2007, INTRO CATEGORICAL DA, V2nd; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barth JT, 1989, MILD HEAD INJURY, P257; Boone K. B., 2007, ASSESSMENT FEIGNED C; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Faure C, 2010, J PHYS EDUC RECREAT, V81, P19, DOI 10.1080/07303084.2010.10598410; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; ImPACT Applications Inc., 2011, TECHN MAN ONL IMPACT; Maerlender AC, 2016, J CLIN EXP NEUROPSYC, V38, P869, DOI 10.1080/13803395.2016.1168781; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Pallant, 2005, SPSS SURVIVAL MANUAL; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	21	24	24	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					259	266		10.1093/arclin/acw108			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700001	28431031	Green Published			2022-02-06	
J	Menyhart, A; Zolei-Szenasi, D; Puskas, T; Makra, P; Orsolya, MT; Szepes, BE; Toth, R; Ivankovits-Kiss, O; Obrenovitch, TP; Bari, F; Farkas, E				Menyhart, Akos; Zolei-Szenasi, Daniel; Puskas, Tamas; Makra, Peter; Orsolya, M. Toth; Szepes, Borbala E.; Toth, Reka; Ivankovits-Kiss, Orsolya; Obrenovitch, Tihomir P.; Bari, Ferenc; Farkas, Eszter			Spreading depolarization remarkably exacerbates ischemia-induced tissue acidosis in the young and aged rat brain	SCIENTIFIC REPORTS			English	Article							CEREBRAL-BLOOD-FLOW; INTRACELLULAR PH; ENERGY-METABOLISM; DEPRESSION; LACTATE; GLUCOSE; ASTROCYTES; MECHANISMS; NEURONS; CORTEX	Spreading depolarizations (SDs) occur spontaneously in the cerebral cortex of subarachnoid hemorrhage, stroke or traumatic brain injury patients. Accumulating evidence prove that SDs exacerbate focal ischemic injury by converting zones of the viable but non-functional ischemic penumbra to the core region beyond rescue. Yet the SD-related mechanisms to mediate neurodegeneration remain poorly understood. Here we show in the cerebral cortex of isoflurane-anesthetized, young and old laboratory rats, that SDs propagating under ischemic penumbra-like conditions decrease intra and- extracellular tissue pH transiently to levels, which have been recognized to cause tissue damage. Further, tissue pH after the passage of each spontaneous SD event remains acidic for over 10 minutes. Finally, the recovery from SD-related tissue acidosis is hampered further by age. We propose that accumulating acid load is an effective mechanism for SD to cause delayed cell death in the ischemic nervous tissue, particularly in the aged brain.	[Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary; Univ Szeged, Fac Sci & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary		Farkas, E (corresponding author), Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary.	farkas.eszter.1@med.u-szeged.hu	Puskas, Tomas/AAB-3542-2020	Farkas, Eszter/0000-0002-8478-9664; Menyhart, Akos/0000-0002-1355-3208	Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K111923]; Hungarian Brain Research Program [KTIA_13_NAP-A-I/13]; Bolyai Janos Research Scholarship of the Hungarian Academy of SciencesHungarian Academy of Sciences [BO/00327/14/5]; New National Excellence Program of the Ministry of Human Capacities of Hungary [UNKP-16-2-I]; Economic Development and Innovation Operational Programme in Hungary - European Union; European Regional Development FundEuropean Commission [GINOP-2.3.2-15-2016-00006]	This work was supported by grants from the Hungarian Scientific Research Fund (Grant No. K111923); the Hungarian Brain Research Program (No. KTIA_13_NAP-A-I/13); the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences (No. BO/00327/14/5, to EF); the New National Excellence Program of the Ministry of Human Capacities of Hungary (No. UNKP-16-2-I. to OMT); and the Economic Development and Innovation Operational Programme in Hungary co-financed by the European Union and the European Regional Development Fund (No. GINOP-2.3.2-15-2016-00006).	ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Ay H, 2005, STROKE, V36, P2632, DOI 10.1161/01.STR.0000189991.23918.01; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.0.CO;2-8; Chen G, 1998, NEUROSCIENCE, V84, P645, DOI 10.1016/S0306-4522(97)00441-7; Chen G, 2005, J NEUROPHYSIOL, V94, P1287, DOI 10.1152/jn.00224.2005; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; CHESLER M, 1987, AM J PHYSIOL, V253, pR666, DOI 10.1152/ajpregu.1987.253.4.R666; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Clark D, 2014, NEUROBIOL AGING, V35, P2803, DOI 10.1016/j.neurobiolaging.2014.06.013; Domoki F, 2012, MICROVASC RES, V83, P311, DOI 10.1016/j.mvr.2012.01.003; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Farkas E, 2014, J GERONTOL A-BIOL, V69, P1363, DOI 10.1093/gerona/glu066; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hertelendy P, 2017, J CEREBR BLOOD F MET, V37, P1763, DOI 10.1177/0271678X16643735; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; KATSURA K, 1992, EUR J NEUROSCI, V4, P166, DOI 10.1111/j.1460-9568.1992.tb00863.x; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; KRIVANEK J, 1961, J NEUROCHEM, V6, P183, DOI 10.1111/j.1471-4159.1961.tb13463.x; LAMANNA JC, 1984, ANAL BIOCHEM, V142, P117, DOI 10.1016/0003-2697(84)90525-6; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; MEYER FB, 1986, J CEREBR BLOOD F MET, V6, P71, DOI 10.1038/jcbfm.1986.9; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; Nedergaard M, 1996, ADV NEUROL, V71, P75; NOWICKI JP, 1988, J CEREBR BLOOD F MET, V8, P462, DOI 10.1038/jcbfm.1988.87; Obrenovitch TP, 2009, NEUROIMAGE, V45, P68, DOI 10.1016/j.neuroimage.2008.11.025; OBRENOVITCH TP, 1988, J CEREBR BLOOD F MET, V8, P866, DOI 10.1038/jcbfm.1988.144; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; PEEK KE, 1989, METAB BRAIN DIS, V4, P261, DOI 10.1007/BF00999772; ROSENTHAL M, 1973, J NEUROPHYSIOL, V36, P739, DOI 10.1152/jn.1973.36.4.739; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; Selman WR, 2004, BRAIN RES, V999, P167, DOI 10.1016/j.brainres.2003.11.016; Shen PP, 2016, NEURAL REGEN RES, V11, P1857, DOI 10.4103/1673-5374.194759; Siesjo BK, 1996, ACT NEUR S, V66, P8; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sun XL, 2011, NEUROIMAGE, V57, P873, DOI 10.1016/j.neuroimage.2011.05.040; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; TOMBAUGH GC, 1994, J NEUROSCI, V14, P5635; Varga DP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31402; VOIPIO J, 1993, PFLUG ARCH EUR J PHY, V423, P193, DOI 10.1007/BF00374394; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	56	24	24	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 25	2017	7								1154	10.1038/s41598-017-01284-4			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET2LP	WOS:000400104700003	28442781	gold, Green Accepted, Green Published			2022-02-06	
J	Krasny-Pacini, A; Chevignard, M; Lancien, S; Escolano, S; Laurent-Vannier, A; De Agostini, M; Meyer, P				Krasny-Pacini, Agata; Chevignard, Mathilde; Lancien, Sabine; Escolano, Sylvie; Laurent-Vannier, Anne; De Agostini, Maria; Meyer, Philippe			Executive function after severe childhood traumatic brain injury - Age-at-injury vulnerability periods: The TGE prospective longitudinal study	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Traumatic brain injury; Executive functions; Child; Cohort; Longitudinal prospective study; Outcome; Vulnerability periods; Follow-up	PERFORMANCE-BASED MEASURES; BEHAVIOR RATING INVENTORY; YOUNG-CHILDREN; ECOLOGICAL ASSESSMENT; COGNITIVE PREDICTORS; OUTCOMES; PLASTICITY; TBI; RECOVERY; DEFICITS	Background: Executive function (EF) impairment is a major predictor of overall outcome after traumatic brain injury (TBI). TBI severity is a factor of poor outcome, but most studies include a majority of children with mild and moderate TBI. The aims of this study were to estimate EF impairment after severe childhood TBI and to explore factors predicting EF outcome. The secondary aim was to compare recovery trajectories by age-at-injury groups. Methods: This was a prospective longitudinal study of children with severe TBI who were tested for EFs by performance-based tests and questionnaires at 3, 12 and 24 months. Results: Children with TBI (n = 65) showed significant impairment in working memory, inhibition, attention and global EF, with little or no recovery at 24 months. For flexibility and performance-based EF score, children were impaired at 3 months only and showed normal scores by 12 months. No impairment was found in planning. At 3 and 24 months, Glasgow Coma Scale score and parental education predicted global EF. Coma length was not a significant predictor of outcome. Age at injury predicted progress in EF, but the relationship was not linear; children 10-12 years old at injury showed better outcome than older and younger children. Conclusions: EFs are impaired after severe TBI in childhood. The relationship between age at injury and outcome is not linear. Relying on only performance-based EF tests can underestimate EF impairment. (C) 2016 Elsevier Masson SAS. All rights reserved.	[Krasny-Pacini, Agata] Univ Rehabil Inst Clemenceau Strasbourg, Outreach Dept Patients Acquired Brain Injury, Strasbourg, France; [Krasny-Pacini, Agata] Strasbourg Univ Hosp, Hautepierre Hosp, Pediat Orthoped Dept, Strasbourg, France; [Krasny-Pacini, Agata; Chevignard, Mathilde] UPMC Univ Paris 06, LIB, Sorbonne Univ, CNRS,INSERM, Paris, France; [Chevignard, Mathilde; Laurent-Vannier, Anne] Hop St Maurice, Rehabil Dept Children Acquired Brain Injury, F-7013 St Maurice, France; [Krasny-Pacini, Agata; Chevignard, Mathilde] UPMC Paris 6, Grp Rech Clin Handicap Cognitif & Readaptat, Paris, France; [Lancien, Sabine] AP HP, Dept Rech Clin & Dev DRCC, Paris, France; [Escolano, Sylvie] INSERM, UMR 1181, Equipe Biostat & Pharmacoepidemiol, Biostat Biomath Pharmacoepidemiol & Malad Infect, Villejuif, France; [Laurent-Vannier, Anne] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [De Agostini, Maria] INSERM, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, UMR1153, Dev Origins Hlth & Dis ORCHAD Team, F-94807 Villejuif, France; [Meyer, Philippe] Univ Descartes Paris5, Hop Univ Necker, Anesthesiol Dept, Pediat Neuro Crit Care Unit, F-75015 Paris, France		Krasny-Pacini, A (corresponding author), Inst Univ Readaptat Clemenceau, Serv EMOI TC Illkirch, 10 Ave Achille Baumann,BP 80096, F-67402 Illkirch Graffenstaden, France.	agatakrasny@yahoo.com	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; escolano, sylvie/0000-0003-0864-4321	Departement de la recherche clinique et du developpement, AP-HP (Paris) [PHRC 2003, AOM 03018]	This study was funded by the Departement de la recherche clinique et du developpement, AP-HP (Paris, No. PHRC 2003; AOM 03018). We thank Drs. Dominique Brugel and Hanna Toure for help in data collection and Laurence Watier for help with data management.	Achenbach T., 2001, VOL ADAPTATION FRANC; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beck DM, 2011, J COGN DEV, V12, P169, DOI 10.1080/15248372.2011.563485; Burgess PW., 2005, EFFECTIVENESS REHABI; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Cowan N, 2011, DEVELOPMENTAL SCI, V14, P1066, DOI 10.1111/j.1467-7687.2011.01060.x; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Korkman M, 2003, TEST NEPSY BILAN NEU; Krasny-Pacini A, 2015, DEV NEUROREHABIL, P1; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Longaud-Vales A, 2015, NEUROPSYCHOL REHABIL, P1; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Rabbitt P., 1997, METHODOLOGY FRONTAL; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Roy A, 2012, BEHAV RATING INVENTO; Schmitt AJ, 2004, ARCH CLIN NEUROPSYCH, V19, P1077, DOI 10.1016/j.acn.2004.02.002; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stinnett TA, 2002, J PSYCHOEDUC ASSESS, V20, P66, DOI 10.1177/073428290202000105; Thurman D. J., 2014, J CHILD NEUROL; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	68	24	24	0	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	APR	2017	60	2					74	82		10.1016/j.rehab.2016.06.001			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FO5VL	WOS:000416929400003	27566925	Bronze			2022-02-06	
J	Robel, S				Robel, Stefanie			Astroglial Scarring and Seizures: A Cell Biological Perspective on Epilepsy	NEUROSCIENTIST			English	Article						epilepsy; seizures; astroglial scar; astrogliosis; astrocytes; reactive astrocytes; astrocyte physiology; hyperexcitability	BLOOD-BRAIN-BARRIER; TEMPORAL-LOBE EPILEPSY; NEURONAL CHLORIDE CONCENTRATION; IMPERMEANT ANIONS ESTABLISH; CHONDROITIN SULFATE PROTEOGLYCANS; POSTNATAL SUBVENTRICULAR ZONE; AMYOTROPHIC-LATERAL-SCLEROSIS; GLUTAMATE TRANSPORTER GLT-1; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY	Epilepsy is among the most prevalent chronic neurological diseases and affects an estimated 2.2 million people in the United States alone. About one third of patients are resistant to currently available antiepileptic drugs, which are exclusively targeting neuronal function. Yet, reactive astrocytes have emerged as potential contributors to neuronal hyperexcitability and seizures. Astrocytes react to any kind of CNS insult with a range of cellular adjustments to form a scar and protect uninjured brain regions. This process changes astrocyte physiology and can affect neuronal network function in various ways. Traumatic brain injury and stroke, both conditions that trigger astroglial scar formation, are leading causes of acquired epilepsies and surgical removal of this glial scar in patients with drug-resistant epilepsy can alleviate the seizures. This review will summarize the currently available evidence suggesting that epilepsy is not a disease of neurons alone, but that astrocytes, glial cells in the brain, can be major contributors to the disease, especially when they adopt a reactive state in response to central nervous system insult.	[Robel, Stefanie] Virginia Tech Caril Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA; [Robel, Stefanie] Virginia Tech Sch Neurosci, Blacksburg, VA USA		Robel, S (corresponding author), Virginia Tech Caril Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	srobel@vtc.vt.edu	Robel, Stefanie/AAA-7166-2019	Robel, Stefanie/0000-0001-6716-3670	Epilepsy Foundation; American Brain Tumor Association	The author(s) disclosed receipt of the following financial support for the research, authorship, and publication of this article: SR was funded by the Epilepsy Foundation and the American Brain Tumor Association.	Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asher RA, 2000, J NEUROSCI, V20, P2427; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Bedner P, 2013, NEUROCHEM INT, V63, P682, DOI 10.1016/j.neuint.2013.01.011; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bellesi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0176-7; Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; Binder DK, 2013, NEUROCHEM INT, V63, P635, DOI 10.1016/j.neuint.2013.09.004; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bordey A, 2000, GLIA, V30, P27, DOI 10.1002/(SICI)1098-1136(200003)30:1<27::AID-GLIA4>3.0.CO;2-#; Bordey A, 1997, J NEUROPHYSIOL, V78, P461, DOI 10.1152/jn.1997.78.1.461; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Bringmann A, 1999, INVEST OPHTH VIS SCI, V40, P3316; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Buckingham SC, 2013, NEUROCHEM INT, V63, P696, DOI 10.1016/j.neuint.2013.01.027; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Cao ZY, 2013, J BIOL CHEM, V288, P13831, DOI 10.1074/jbc.M112.441055; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Crunelli V, 2015, NEUROSCIENTIST, V21, P62, DOI 10.1177/1073858414523320; Cudkowicz ME, 2014, LANCET NEUROL, V13, P1083, DOI 10.1016/S1474-4422(14)70222-4; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Delekate A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6422; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dibaj P, 2007, J NEUROCHEM, V103, P2620, DOI 10.1111/j.1471-4159.2007.04979.x; Dityatev A, 2008, NEURON GLIA BIOL, V4, P235, DOI 10.1017/S1740925X09000118; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; England MJ, 2012, EPILEPSY SPECTRUM PR; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Frigerio F, 2012, EPILEPSIA, V53, P1887, DOI 10.1111/j.1528-1167.2012.03666.x; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Goodwin F, 1997, Eur J Paediatr Neurol, V1, P115, DOI 10.1016/S1090-3798(97)80042-6; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gorter JA, 2015, EPILEPSY BEHAV, V49, P13, DOI 10.1016/j.yebeh.2015.04.047; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Heuser K, 2012, J NEUROPATH EXP NEUR, V71, P814, DOI 10.1097/NEN.0b013e318267b5af; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Hoogland TM, 2010, CEREBELLUM, V9, P264, DOI 10.1007/s12311-009-0139-z; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jahan N, 2015, EXP NEUROL, V263, P372, DOI 10.1016/j.expneurol.2014.10.023; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kim KJ, 2015, J NEUROSCI, V35, P8245, DOI 10.1523/JNEUROSCI.4486-14.2015; Kim Y, 2011, BRAIN RES, V1389, P194, DOI 10.1016/j.brainres.2011.03.037; Kimbrough IF, 2015, BRAIN, V138, P3716, DOI 10.1093/brain/awv327; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lacar B, 2012, J NEUROSCI, V32, P16435, DOI 10.1523/JNEUROSCI.1457-12.2012; Lee DJ, 2012, EXP NEUROL, V235, P246, DOI 10.1016/j.expneurol.2012.02.002; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; Loscher W, 2012, NAT REV NEUROL, V8, P661, DOI 10.1038/nrneurol.2012.222; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Luhmann HJ, 2014, SCIENCE, V345, DOI [10.1126/science.1252978, 10.1126/science.1255337]; Ma HT, 2013, CEREB CORTEX, V23, P885, DOI 10.1093/cercor/bhs079; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Minkel HR, 2015, GLIA, V63, P2285, DOI 10.1002/glia.22893; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Na I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073476; Newman EA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0195; Nicholson KJ, 2014, J NEUROSCI RES, V92, P116, DOI 10.1002/jnr.23295; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Nwaobi SE, 2014, GLIA, V62, P411, DOI 10.1002/glia.22613; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Olsen ML, 2015, J NEUROSCI, V35, P13827, DOI 10.1523/JNEUROSCI.2603-15.2015; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Otahal J, 2014, INT REV NEUROBIOL, V114, P209, DOI 10.1016/B978-0-12-418693-4.00009-1; Pappas AC, 2015, J NEUROSCI, V35, P13375, DOI 10.1523/JNEUROSCI.1551-15.2015; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Rosenegger DG, 2015, J NEUROSCI, V35, P13463, DOI 10.1523/JNEUROSCI.1780-15.2015; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Roycik MD, 2013, CURR MOL MED, V13, P1299, DOI 10.2174/15665240113139990067; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schroder W, 2000, EPILEPSIA, V41, pS181, DOI 10.1111/j.1528-1157.2000.tb01578.x; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2014, COLD SPRING HARB PER, V7; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Soni N, 2014, PHARMACOL BIOCHEM BE, V127, P70, DOI 10.1016/j.pbb.2014.10.001; Swann John W, 2008, Epilepsy Curr, V8, P168, DOI 10.1111/j.1535-7511.2008.00282.x; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Watanabe T, 1999, BRAIN RES, V845, P92, DOI 10.1016/S0006-8993(99)01945-9; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Weng HR, 2014, EXP NEUROL, V252, P18, DOI 10.1016/j.expneurol.2013.11.018; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang J, 2011, J ALZHEIMERS DIS, V27, P711, DOI 10.3233/JAD-2011-110725; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang XL, 2011, AM J PHYSIOL-CELL PH, V301, pC729, DOI 10.1152/ajpcell.00334.2010; Zhao MR, 2007, EPILEPSIA, V48, P2059, DOI 10.1111/j.1528-1167.2007.01229.x; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	154	24	26	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	APR	2017	23	2					152	168		10.1177/1073858416645498			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ4LN	WOS:000398048800009	27118807				2022-02-06	
J	Adamczak, J; Aswendt, M; Kreutzer, C; Rotheneichner, P; Riou, A; Selt, M; Beyrau, A; Uhlenkuken, U; Diedenhofen, M; Nelles, M; Aigner, L; Couillard-Despres, S; Hoehn, M				Adamczak, Joanna; Aswendt, Markus; Kreutzer, Christina; Rotheneichner, Peter; Riou, Adrien; Selt, Marion; Beyrau, Andreas; Uhlenkueken, Ulla; Diedenhofen, Michael; Nelles, Melanie; Aigner, Ludwig; Couillard-Despres, Sebastien; Hoehn, Mathias			Neurogenesis upregulation on the healthy hemisphere after stroke enhances compensation for age-dependent decrease of basal neurogenesis	NEUROBIOLOGY OF DISEASE			English	Article						Stroke; Neurogenesis; Age dependence of neurogenesis after stroke; Bioluminescence imaging; Magnetic resonance imaging; Doublecortin	FOCAL CEREBRAL-ISCHEMIA; ENDOGENOUS NEURAL STEM; TRAUMATIC BRAIN-INJURY; SUBVENTRICULAR ZONE; PROGENITOR CELLS; ADULT; PROLIFERATION; EXPRESSION; NEURONS; DOUBLECORTIN	Stroke is a leading cause of death and disability worldwide with no treatment for the chronic phase available. Interestingly, an endogenous repair program comprising inflammation and neurogenesis is known to modulate stroke outcome. Several studies have shown that neurogenesis decreases with age but the therapeutic importance of endogenous neurogenesis for recovery from cerebral diseases has been indicated as its ablation leads to stroke aggravation and worsened outcome. A detailed characterization of the neurogenic response after stroke related to ageing would help to develop novel and targeted therapies. In an innovative approach, we used the DCX-Luc mouse, a transgenic model expressing luciferase in doublecortin-positive neuroblasts, to monitor the neurogenic response following middle cerebral artery occlusion over three weeks in three age groups (2, 6, 12 months) by optical imaging while the stroke lesion was monitored by quantitative MRI. The individual longitudinal and noninvasive time profiles provided exclusive insight into age-dependent decrease in basal neurogenesis and neurogenic upregulation in response to stroke which are not accessible by conventional BrdU-based measures of cell proliferation. For cortico-striatal strokes the maximal upregulation occurred at 4 days post stroke followed by a continuous decrease to basal levels by three weeks post stroke. Older animals effectively compensated for reduced basal neurogenesis by an enhanced sensitivity to the cerebral lesion, resulting in upregulated neurogenesis levels approaching those measured in young mice. In middle aged and older mice, but not in the youngest ones, additional upregulation of neurogenesis was observed in the contralateral healthy hemisphere. This further substantiates the increased propensity of older brains to respond to lesion situation. Our results clearly support the therapeutic relevance of endogenous neurogenesis for stroke recovery and particularly in older brains. (C) 2016 Elsevier Inc. All rights reserved.	[Adamczak, Joanna; Aswendt, Markus; Riou, Adrien; Selt, Marion; Beyrau, Andreas; Uhlenkueken, Ulla; Diedenhofen, Michael; Nelles, Melanie; Hoehn, Mathias] Max Planck Inst Metab Res, In Vivo NMR Lab, Gleuelerstr 50, D-50931 Cologne, Germany; [Kreutzer, Christina; Rotheneichner, Peter; Couillard-Despres, Sebastien] Paracelsus Med Univ Salzburg, Inst Expt Neuroregenerat, Spinal Cord Injury & Tissue Regenerat Ctr, Strubergasse 21, A-5020 Salzburg, Austria; [Aigner, Ludwig] Paracelsus Med Univ Salzburg, Inst Mol Regenerat Med, Spinal Cord Injury & Tissue Regenerat Ctr, Strubergasse 21, A-5020 Salzburg, Austria; [Hoehn, Mathias] Leiden Univ, Med Ctr, Dept Radiol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Hoehn, Mathias] Percuros BV, Drienerlolaan 5 Zuidhorst, NL-7522 NB Enschede, Netherlands; [Kreutzer, Christina; Rotheneichner, Peter; Aigner, Ludwig; Couillard-Despres, Sebastien] Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria		Hoehn, M (corresponding author), Max Planck Inst Metab Res, In Vivo NMR Lab, Gleuelerstr 50, D-50931 Cologne, Germany.	mathias@sf.mpg.de	Aswendt, Markus/L-2743-2019	Aswendt, Markus/0000-0003-1423-0934; Aigner, Ludwig/0000-0002-1653-8046; Couillard-Despres, Sebastien/0000-0002-8486-6412; Hummer, Joanna/0000-0002-0329-2892	European UnionEuropean Commission [HEALTH-F2-2012-279017, PIAPP-GA-2013-612360, HEALTH-F2-2011-278850, HEALTH-F2-2011-279288]; German Research Foundation DFGGerman Research Foundation (DFG) [AS-464/1-1]	This work was financially supported by grants from the European Union Seventh Framework Programme TargetBraln (HEALTH-F2-2012-279017) and BrainPath (PIAPP-GA-2013-612360) and by a grant from the German Research Foundation DFG (AS-464/1-1). In addition, this work received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2011-278850 (INMiND) and no HEALTH-F2-2011-279288 (IDEA).	Adamczak JM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00274; Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; Bahmani P, 2011, J CEREBR BLOOD F MET, V31, P1311, DOI 10.1038/jcbfm.2010.233; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Butti E, 2012, BRAIN, V135, P3320, DOI 10.1093/brain/aws194; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Erlandsson A, 2011, EXP NEUROL, V230, P48, DOI 10.1016/j.expneurol.2010.05.018; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Hamilton LK, 2013, EUR J NEUROSCI, V37, P1978, DOI 10.1111/ejn.12207; Hammelrath L, 2016, NEUROIMAGE, V125, P144, DOI 10.1016/j.neuroimage.2015.10.009; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Mengler L, 2014, NEUROIMAGE, V84, P35, DOI 10.1016/j.neuroimage.2013.08.034; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pereira L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00057; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Sato K, 2001, BRAIN RES, V922, P135, DOI 10.1016/S0006-8993(01)03137-7; Shook BA, 2012, J NEUROSCI, V32, P6947, DOI 10.1523/JNEUROSCI.5987-11.2012; Sun F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046326; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Tang YH, 2014, J CEREBR BLOOD F MET, V34, P1138, DOI 10.1038/jcbfm.2014.61; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Tropepe V, 1997, J NEUROSCI, V17, P7850; Vandeputte C, 2014, NEUROBIOL DIS, V69, P144, DOI 10.1016/j.nbd.2014.05.014; Villeda SA, 2013, AUTOIMMUN REV, V12, P674, DOI 10.1016/j.autrev.2012.10.014; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0040084]; Yager JY, 2006, BEHAV BRAIN RES, V173, P171, DOI 10.1016/j.bbr.2006.06.019	41	24	25	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	MAR	2017	99						47	57		10.1016/j.nbd.2016.12.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9EP	WOS:000394922800005	28007584	Green Accepted			2022-02-06	
J	Merz, ZC; Van Patten, R; Lace, J				Merz, Zachary C.; Van Patten, Ryan; Lace, John			Current Public Knowledge Pertaining to Traumatic Brain Injury: Influence of Demographic Factors, Social Trends, and Sport Concussion Experience on the Understanding of Traumatic Brain Injury Sequelae	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Sport concussion; Post-concussive syndrome	PROFESSIONAL FOOTBALL PLAYERS; HEAD-INJURY; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; HEALTH-PROFESSIONALS; LEAGUE PLAYER; ENCEPHALOPATHY; MISCONCEPTIONS; RISK; EPIDEMIOLOGY	Objective: The current study aimed to assess current broad traumatic brain injury (TBI)-related knowledge in the general public, as well as understanding regarding specific TBI-related conditions including post-concussive syndrome (PCS) and chronic traumatic encephalopathy (CTE). Methods: Data were collected from 307 domestic and 73 international individuals via online researcher-developed survey instrumentation utilizing the Amazon Mechanical Turk marketplace, a recently developed website that allows for a streamlined process of survey-based participant recruitment and data collection. Participants completed background demographics questions, a 31-item true/false questionnaire pertaining to TBI-related knowledge, and an inquiry related to willingness to allow (future) child(ren) to participate in several popular U.S. sports. Results: The overall accuracy rate of our U. S. sample was 61%. No accuracy differences were present for gender or geographic region (p's > .05). Participants who self-reported a prior concussion diagnosis, who reported receiving formal concussion training, and who endorsed participation in collegiate, semi-professional, or professional athletic competition, all exhibited lower accuracy rates than the respective comparison groups (p's < .001). Finally, individual item analysis revealed the presence of significant misconceptions pertaining to PCS and CTE. Conclusions: Misconceptions regarding TBI remain highly prevalent within the general public and may be explained, to some extent, by inefficiencies in current TBI-education practices. Moreover, misconceptions regarding PCS and CTE are also prevalent and likely reflect inconsistencies in the scientific literature, coupled with misleading media reports. To combat these trends, greater emphasis must be placed on construct definition within the field and streamlined, efficient communication with the general public.	[Merz, Zachary C.; Van Patten, Ryan; Lace, John] St Louis Univ, Dept Psychol, 3700 Lindell Blvd Suite 1200, St Louis, MO 63108 USA		Merz, ZC (corresponding author), St Louis Univ, Dept Psychol, 3700 Lindell Blvd Suite 1200, St Louis, MO 63108 USA.	merzz@slu.edu	Lace, John/AAF-7063-2020; Van+Patten, Ryan/AAZ-6757-2021	Merz, Zachary/0000-0001-7268-6265; Lace, John/0000-0003-3628-0334			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bradford LS, 2015, REHABIL PSYCHOL, V60, P344, DOI 10.1037/rep0000057; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Difallah DE, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P238, DOI 10.1145/2736277.2741685; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul M, 2010, TRAUMATIC BRAIN INJU; Field A., 2017, DISCOVERING STAT USI, V5th; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak M. D., 2012, NEUROPSYCHOLOGICAL A, P10; Linden MA, 2010, BRAIN INJURY, V24, P642, DOI 10.3109/02699051003601689; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Minton E., 2013, AMA WINT ED C P, V24; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280	64	24	24	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2017	32	2					155	167		10.1093/arclin/acw092			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EQ4EG	WOS:000398026400003	27765734	Bronze			2022-02-06	
J	Narad, ME; Treble-Barna, A; Peugh, J; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Narad, Megan E.; Treble-Barna, Amery; Peugh, James; Yeates, Keith O.; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			Recovery Trajectories of Executive Functioning After Pediatric TBI: A Latent Class Growth Modeling Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						executive functioning; latent class growth modeling; pediatric traumatic brain injury	TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; COGNITIVE PREDICTORS; EARLY-CHILDHOOD; SHORT-TERM; OUTCOMES; BEHAVIOR; ACHIEVEMENT; RELIABILITY; VALIDITY	Objective: To identify latent trajectories of executive functioning (EF) recovery overtime after childhood traumatic brain injury (TBI) and examine the predictive value of known risk factors within and across recovery trajectories using latent class growth modeling (LCGM). Method: A total of 206 children between the ages of 3 and 7 years with a moderate to severe TBI or orthopedic injury (OI) were included. LCGM was applied to identify longitudinal trajectories of postinjury EF as assessed by the Behavior Rating Inventory of Executive Functioning General Executive Composite (GEC). Separate models were estimated for the TBI and OI groups. Results: Two TBI trajectories-normal limits (70.8%) and clinically elevated (29.2%)-and 3 OI trajectories-normal limits (20.9%), subclinical (49.0%), and clinically elevated (30.17%)-were identified. Baseline GEC was the only predictor of class membership for all models. Both TBI trajectories demonstrated an increase in GEC over time, whereas only 1 of the 3 OI classes demonstrated this pattern. Family variables were associated with GEC across trajectories. Conclusion: The lack of association of injury characteristics with trajectory class membership highlights the heterogeneity in recovery after pediatric TBI. Associations of EF trajectories with family factors underscore the importance of involving the family in interventions for children with traumatic injuries.	[Narad, Megan E.; Treble-Barna, Amery; Peugh, James; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Dept Psychol, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Megan.narad@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human Development and Trauma Research grants from the State of Ohio Emergency Medical Services [R01 HD42729]; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011, R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	This publication was supported by grant R01 HD42729 from the National Institute of Child Health and Human Development and Trauma Research grants from the State of Ohio Emergency Medical Services. Additional support was provided through Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Nagin D.S., 2005, GROUP BASED MODELING; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Querido JG, 2002, J CLIN CHILD ADOLESC, V31, P272, DOI 10.1207/S15374424JCCP3102_12; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	39	24	24	3	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					98	106		10.1097/HTR.0000000000000247			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700010	27455434	Green Accepted			2022-02-06	
J	Byrne, JP; Geerts, W; Mason, SA; Gomez, D; Hoeft, C; Murphy, R; Neal, M; Nathens, AB				Byrne, James P.; Geerts, William; Mason, Stephanie A.; Gomez, David; Hoeft, Christopher; Murphy, Ryan; Neal, Melanie; Nathens, Avery B.			Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: A propensity-matched analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	75th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 14-17, 2016	Waikoloa, HI	Amer Assoc Surg Trauma		Low-molecular-weight heparin; pulmonary embolism; trauma; Trauma Quality Improvement Program; unfractionated heparin	VENOUS THROMBOEMBOLISM PROPHYLAXIS; RISK-ASSESSMENT; COHORT; IMPROVEMENT; ENOXAPARIN; MANAGEMENT; THROMBOSIS; PROGRAM; DISEASE; EVENTS	BACKGROUND: Pulmonary embolism (PE) is a leading cause of delayed mortality in patients with severe injury. While low-molecular-weight heparin (LMWH) is often favored over unfractionated heparin (UH) for thromboprophylaxis, evidence is lacking to demonstrate an effect on the occurrence of PE. This study compared the effectiveness of LMWH versus UH to prevent PE in patients following major trauma. METHODS: Data for adults with severe injury who received thromboprophylaxis with LMWH or UH were derived from the American College of Surgeons Trauma Quality Improvement Program (2012-2015). Patients who died or were discharged within 5 days were excluded. Rates of PE were compared between propensity-matched LMWH and UH groups. Subgroup analyses included patients with blunt multisystem injury, penetrating truncal injury, shock, severe traumatic brain injury, and isolated orthopedic injury. A center-level analysis was performed to determine if practices with respect to choice of prophylaxis type influence hospital PE rates. RESULTS: We identified 153,474 patients at 217 trauma centers who received thromboprophylaxis with LMWH or UH. Low-molecular-weight heparin was given in 74% of patients. Pulmonary embolism occurred in 1.8%. Propensity score matching yielded a well-balanced cohort of 75,920 patients. After matching, LMWH was associated with a significantly lower rate of PE compared with UH (1.4% vs. 2.4%; odds ratio, 0.56; 95% confidence interval, 0.50-0.63). This finding was consistent across injury subgroups. Trauma centers in the highest quartile of LMWH utilization (median LMWH use, 95%) reported significantly fewer PE compared with centers in the lowest quartile (median LMWH use, 39%; 1.2% vs. 2.0%; odds ratio, 0.59; 95% confidence interval, 0.48-0.74). CONCLUSIONS: Thromboprophylaxis with LMWH (vs. UH) was associated with significantly lower risk of PE. Trauma centers favoring LMWH-based prophylaxis strategies reported lower rates of PE. Low-molecular-weight heparin should be the anticoagulant agent of choice for prevention of PE in patients with major trauma. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.) LEVEL OF EVIDENCE: Therapeutic study, level III.	[Byrne, James P.; Geerts, William; Mason, Stephanie A.; Nathens, Avery B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Byrne, James P.; Mason, Stephanie A.; Nathens, Avery B.] Univ Toronto, Clin Epidemiol Program, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Byrne, James P.; Mason, Stephanie A.; Gomez, David; Nathens, Avery B.] Univ Toronto, Div Gen Surg, Toronto, ON, Canada; [Geerts, William; Nathens, Avery B.] Univ Toronto, Dept Surg, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Hoeft, Christopher; Murphy, Ryan; Neal, Melanie; Nathens, Avery B.] Amer Coll Surgeons, Trauma Qual Improvement Program, Chicago, IL USA		Byrne, JP (corresponding author), Sunnybrook Hlth Sci Ctr, Room D-574,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jpbyrne@gmail.com		Gomez, David/0000-0002-0926-2547; Byrne, James/0000-0002-3760-8509	De Souza Chair in Trauma Research	This work was supported by funds from the De Souza Chair in Trauma Research (A.B.N.).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; American College of Surgeons Committee on Trauma, 2015, NAT TRAUM DAT STAND; Amin AN, 2009, THROMB HAEMOSTASIS, V102, P321, DOI 10.1160/TH09-03-0147; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bandle J, 2014, J TRAUMA ACUTE CARE, V76, P213, DOI 10.1097/TA.0b013e3182aa2fa9; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Cook D, 2014, J CRIT CARE, V29; CORRIGAN TP, 1974, BRIT J SURG, V61, P320; Dossett LA, 2011, J TRAUMA, V70, P1066, DOI 10.1097/TA.0b013e31821282d5; Fowler RA, 2014, JAMA-J AM MED ASSOC, V312, P2135, DOI 10.1001/jama.2014.15101; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hegsted D, 2013, AM J SURG, V205, P517, DOI 10.1016/j.amjsurg.2013.01.022; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Machado-Aranda DA, 2015, J AM COLL SURGEONS, V221, P661, DOI 10.1016/j.jamcollsurg.2015.05.006; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; McGowan KE, 2016, BLOOD, V127, P1954, DOI 10.1182/blood-2015-07-660001; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Olson EJ, 2015, J TRAUMA ACUTE CARE, V79, P961, DOI 10.1097/TA.0000000000000750; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Rogers SO, 2007, J TRAUMA, V62, P562; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2010, AM J OPHTHALMOL, V149, P7, DOI 10.1016/j.ajo.2009.08.024; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Thirugnanam S, 2012, CRIT CARE, V16, DOI 10.1186/cc11241; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V76, P1270, DOI 10.1097/TA.0000000000000233; Velmahos GC, 2009, ARCH SURG-CHICAGO, V144, P928, DOI 10.1001/archsurg.2009.97; Yuan Y, 2011, J STAT SOFTW, V45, P1	40	24	24	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					252	260		10.1097/TA.0000000000001321			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600005	27906870				2022-02-06	
J	DiCesare, CA; Kiefer, AW; Nalepka, P; Myer, GD				DiCesare, Christopher A.; Kiefer, Adam W.; Nalepka, Patrick; Myer, Gregory D.			Quantification and analysis of saccadic and smooth pursuit eye movements and fixations to detect oculomotor deficits	BEHAVIOR RESEARCH METHODS			English	Article						Concussion; Oculomotor; Eye tracking; Saccade; Fixation; Smooth pursuit	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; MILD; CONCUSSION; TARGET; RECOVERY; SYSTEM	Assessment of deficits in oculomotor functionmay be useful to detect visuomotor impairments due to a closed head injury. Systematic analysis schemes are needed to reliably quantify oculomotor deficits associated with oculomotor impairment via brain trauma. We propose a systematic, automated analysis scheme using various eye-tracking tasks to assess oculomotor function in a cohort of adolescents with acute concussion symptoms and aged-matched healthy controls. From these data we have evidence that thesemethods reliably detect oculomotor deficits in the concussed group, including reduced spatial accuracy and diminished tracking performance during visually guided prosaccade and self-paced saccade tasks. The accuracy and tracking deficits are consistent with prior studies on oculomotor function, while introducing novel discriminatory measures relative to fixation assessments -methodologically, a less complicated measure of performance - and thus represent a reliable and simple scheme of detection and analysis of oculomotor deficits associated with brain injury.	[DiCesare, Christopher A.; Kiefer, Adam W.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA; [Kiefer, Adam W.; Nalepka, Patrick] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Kiefer, Adam W.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Boston, MA USA		DiCesare, CA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	christopher.dicesare@cchmc.org	DiCesare, Christopher/ABH-9573-2020; Kiefer, Adam/F-1756-2018; DiCesare, Christopher/AAA-3327-2021; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Nalepka, Patrick/0000-0003-1719-8044	state of Ohio Emergency Medical Services grant; Q30 Sports Sciences, LLC	This work was funded in part by a state of Ohio Emergency Medical Services grant and also by Q30 Sports Sciences, LLC.	Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; BECKER W, 1985, EXP BRAIN RES, V57, P562; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; KAPOULA Z, 1985, VISION RES, V25, P1155, DOI 10.1016/0042-6989(85)90105-1; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Olsen A, 2012, TOBII I VT FIXATION; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	22	24	24	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	FEB	2017	49	1					258	266		10.3758/s13428-015-0693-x			9	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	EP2FJ	WOS:000397198300018	26705117	Bronze			2022-02-06	
J	Khodaee, M; Currie, DW; Asif, IM; Comstock, RD				Khodaee, Morteza; Currie, Dustin W.; Asif, Irfan M.; Comstock, R. Dawn			Nine-year study of US high school soccer injuries: data from a national sports injury surveillance programme	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CONSENSUS STATEMENT; FOOTBALL; EPIDEMIOLOGY; PLAYERS; CONCUSSIONS; CHILDREN	Background Research on high school soccer injury epidemiology is sparse. Aim To describe high school soccer injury rates, trends and patterns by type of athlete exposure (AE), position and sex. Methods This descriptive epidemiological study used data from a large national high school sports injury surveillance programme to describe rates and patterns of soccer-related injuries including concussion sustained from 2005/2006 to 2013/2014. Injury rates are calculated per 1000 AEs. Results Overall, 6154 soccer injuries occurred during 2 985 991 AEs; injury rate= 2.06 per 1000 AEs. Injury rates were higher during competition (4.42) than practice (1.05; rate ratio (RR)= 4.19; 95% CI 3.98 to 4.41), and in girls (2.33) than boys (1.83; RR= 1.27, 95% CI 1.21 to 1.34). Boys' non-concussion injury rates decreased significantly (p= 0.001) during the study period while reported concussion rates increased significantly (p= 0.002). Girls' non-concussion rates were relatively stable and reported concussion rates increased significantly (p= 0.004). Player-player contact was the injury mechanism that led to the most competition injuries (injury proportion ratio (IPR)= 2.87; 95% CI 2.57 to 3.21), while non-contact injuries were the most common mechanisms among practice injuries (IPR= 2.10; 95% CI 1.86 to 2.38). Recovery from concussion was > 7 days in a third of the cases. Injury patterns were similar between sexes with respect to position played and location on the field at the time of injury. Conclusions High school soccer injury rates vary by sex and type of exposure, while injury patterns are more similar across sexes. Reported concussion rates increased significantly over the study period in male and female athletes.	[Khodaee, Morteza] Univ Colorado, Dept Family Med, Sch Med, Denver, CO USA; [Currie, Dustin W.; Comstock, R. Dawn] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Anschutz Med Campus, Aurora, CO USA; [Asif, Irfan M.] Univ South Carolina, Dept Family Med, Greenville Hlth Syst, Greenville Sch Med, Greenville, SC USA; [Comstock, R. Dawn] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA		Khodaee, M (corresponding author), Univ Colorado, Dept Family Med, AFW Clin, Sch Med, 3055 Roslyn St, Denver, CO 80238 USA.	morteza.khodaee@ucdenver.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]	The content of this report was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01.	Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI 10.1197/j.aem.2005.12.015; Agel J, 2007, J ATHL TRAINING, V42, P270; Brito J, 2012, J ATHL TRAINING, V47, P191; Clausen MB, 2014, AM J SPORT MED, V42, P2487, DOI 10.1177/0363546514541224; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Elias SR, 2001, MED SCI SPORT EXER, V33, P359, DOI 10.1097/00005768-200103000-00004; Faude O, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2009.01087.x; Faude O, 2013, SPORTS MED, V43, P819, DOI 10.1007/s40279-013-0061-x; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Giannotti M, 2011, PEDIATR EMERG CARE, V27, P81, DOI 10.1097/PEC.0b013e3182094340; Giza Eric, 2005, Med Sport Sci, V49, P140, DOI 10.1159/000085395; Hunt M, 1990, Br J Sports Med, V24, P265; Injuries in youth soccer: a subject review, 2000, PEDIATRICS 1, V105, P659; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Khodaee M, 2011, RES SPORTS MED, V19, P129, DOI 10.1080/15438627.2011.556907; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; Kucera KL, 2005, BRIT J SPORT MED, V39, P462, DOI 10.1136/bjsm.2004.013672; Le Gall F, 2008, AM J SPORT MED, V36, P276, DOI 10.1177/0363546507307866; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchi AG, 1999, ARCH DIS CHILD, V81, P324, DOI 10.1136/adc.81.4.324; Mountjoy M, 2016, BRIT J SPORT MED, V50, P590, DOI 10.1136/bjsports-2015-095686; Myer GD, 2013, AM J SPORT MED, V41, P203, DOI 10.1177/0363546512460637; Orchard JW, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012732; Pluim BM, 2009, BRIT J SPORT MED, V43, P893, DOI 10.1136/bjsm.2009.064915; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schneider AS, 2013, SPORTVERLETZ SPORTSC, V27, P34, DOI 10.1055/s-0032-1330764; Sugimoto Dai, 2015, Curr Phys Med Rehabil Rep, V3, P43; Tourny C, 2014, J SPORT MED PHYS FIT, V54, P526; Walden M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094573; Walters BS, 2014, J EMERG MED, V46, P650, DOI 10.1016/j.jemermed.2013.11.081; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	38	24	24	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2017	51	3					185	193		10.1136/bjsports-2015-095946			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EL2NF	WOS:000394455800012	28031189	Bronze			2022-02-06	
J	Mollayeva, T; Cassidy, JD; Shapiro, CM; Mollayeva, S; Colantonio, A				Mollayeva, Tatyana; Cassidy, J. David; Shapiro, Colin M.; Mollayeva, Shirin; Colantonio, Angela			Concussion/mild traumatic brain injury-related chronic pain in males and females: A diagnostic modelling study	MEDICINE			English	Article						chronic pain; cultural/social model; environmental/behavioral model; perceived states; physical/medical model; physiological and brain injury-related model; psychological model; sex differences	POSTTRAUMATIC-STRESS-DISORDER; LINEAR-REGRESSION; MENTAL-HEALTH; UNITED-STATES; SLEEP; POPULATION; SYMPTOMS; PREVALENCE; SEX; PATHOPHYSIOLOGY	Pain is an unpleasant, complex, and perceived experience that places a significant burden on patients and clinicians. Its severity may be mediated by emotion, attitude, and environmental influences, and pain may be expressed differently in males and females. Traumatic brain injury (TBI) is frequently associated with chronic pain. This diagnostic modeling study examined sex differences in the construct of chronic pain in patients with delayed recovery from concussion/mild traumatic brain injury (mTBI). Data were collected from standardized questionnaires, neuroimaging records, and comprehensive clinical assessments. Bivariate associations were calculated using the Spearman correlation coefficient or analysis of variance. We established sex-specific stepwise multivariate linear regression models of factors associated with pain. Of the 94 participants diagnosed with mTBI (the mean age was 45.20 +/- 9.94 years; 61.2% were males; the median time since injury was 197 days [interquartile range 139-416]), head/neck, and bodily pain were reported by 93% and 64%, respectively. No sex differences were identified in pain frequencies or severity. Pain was significantly associated with certain socio-demographic, injuryrelated, behavioral, and clinical variables. In the multivariable regression analysis, several determinants explained 60% of the pain variance in males and 46% in females. Pain is common in patients with delayed recovery from mTBI and is significantly associated with potentially modifiable clinical and nonclinical variables. Examining the multidimensional construct of pain in concussion/mTBI through a sex lens garners new directions for future longitudinal research on the pain mechanisms involved in postconcussion syndrome.	[Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Fac Med, Rehabil Sci Inst, Mississauga, ON, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Mississauga, ON, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Mississauga, ON, Canada; [Cassidy, J. David] Univ Hlth Network, Div Hlth Care & Outcomes Res, Mississauga, ON, Canada; [Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Mississauga, ON, Canada; [Shapiro, Colin M.] Univ Hlth Network, Toronto Western Hosp, Mississauga, ON, Canada; [Shapiro, Colin M.] Univ Toronto, Youthdale Child & Adolescent Sleep Clin, Mississauga, ON, Canada; [Mollayeva, Shirin] Univ Toronto, Dept Biol, Mississauga, ON, Canada		Mollayeva, T (corresponding author), Univ Toronto, Fac Med, Rehabil Sci Inst, 550 Univ Ave,Rm 11207, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765	Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); postdoctoral fellowship from the Acquired Brain Injury Laboratory of the Rehabilitation Sciences Institute at the University of Toronto; Toronto Rehabilitation Institute-University Health Network research fellowship; Canadian Institutes for Health Research Grant-Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	TM was supported by the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research and the 2015/2016 postdoctoral fellowship from the Acquired Brain Injury Laboratory of the Rehabilitation Sciences Institute at the University of Toronto and the Toronto Rehabilitation Institute-University Health Network research fellowship. AC was supported by the Canadian Institutes for Health Research Grant-Institute for Gender and Health (#CGW-126580).	Al-Harthy M, 2016, J ORAL REHABIL, V43, P81, DOI 10.1111/joor.12346; Alhalabi Mohammad Salem, 2015, Avicenna J Med, V5, P110, DOI 10.4103/2231-0770.165123; *AM PSYCH ASS, 2000, AM PSYCH ASS DIAGN S; Andrews NE, 2015, PAIN, V156, P1991, DOI 10.1097/j.pain.0000000000000259; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Bastuji H, 2012, HUM BRAIN MAPP, V33, P2638, DOI 10.1002/hbm.21390; Behan M, 2008, RESP PHYSIOL NEUROBI, V164, P213, DOI 10.1016/j.resp.2008.06.006; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Borsook D, 2014, NEUROBIOL DIS, V68, P200, DOI 10.1016/j.nbd.2014.03.008; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Campos-Fumero A, 2016, OCCUP ENVIRON MED, V73, P394, DOI 10.1136/oemed-2015-103327; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Casson RJ, 2014, CLIN EXP OPHTHALMOL, V42, P590, DOI 10.1111/ceo.12358; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Dallenbach KM, 1939, AM J PSYCHOL, V52, P331, DOI 10.2307/1416740; Daoust R, 2008, PAIN, V138, P565, DOI 10.1016/j.pain.2008.02.007; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Duan-Porter W, 2015, VA EVIDENCE BASED SY; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; ELKIND AH, 1989, OTOLARYNG CLIN N AM, V22, P1251; EPSTEIN LH, 1992, J CONSULT CLIN PSYCH, V60, P493, DOI 10.1037/0022-006X.60.4.493; Ertas M, 2012, J HEADACHE PAIN, V13, P147, DOI 10.1007/s10194-011-0414-5; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Foo H, 2003, SLEEP MED REV, V7, P145, DOI 10.1053/smrv.2002.0224; Gorczyca R, 2013, ANN AGR ENV MED, P23; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; Guindon J, 2009, HDB NEUROSCIENCE BEH, P635; Hassed C, 2013, AUST FAM PHYSICIAN, V42, P112; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Huskisson EC, 1983, PAIN MEASUREMENT ASS, P33; Jensen M. P., 1992, HDB PAIN ASSESSMENT, P135; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kilpatrick LA, 2015, BIOL PSYCHOL, V112, P107, DOI 10.1016/j.biopsycho.2015.09.010; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lavie P, 1800, J Clin Hypertens (Greenwich), V3, P296, DOI 10.1111/j.1524-6175.2001.00491.x; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lindell Odd, 2010, Clin Epidemiol, V2, P261, DOI 10.2147/CLEP.S14761; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Mandel H, 2014, DEMOGRAPHY, V51, P1597, DOI 10.1007/s13524-014-0320-y; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Marshall O, 2015, HUM BRAIN MAPP, V36, P3912, DOI 10.1002/hbm.22886; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Mazumdar M, 2003, STAT MED, V22, P559, DOI 10.1002/sim.1333; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Melzack R, 1991, CHALLENGE PAIN; Mihai Verona, 2010, Pneumologia, V59, P64; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Moshourab RA, 2015, BRAIN NEUROTRAUMA MO; MUSE M, 1985, PAIN, V23, P295, DOI 10.1016/0304-3959(85)90108-3; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Nicholl BI, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0343-5; Nicholson K, 2002, PAIN MANAGEMENT PRAC, P465; Palmer KT, 2008, PAIN, V136, P30, DOI 10.1016/j.pain.2007.06.011; PRICE DD, 1986, PAIN, V24, P197, DOI 10.1016/0304-3959(86)90042-4; Roder CH, 2007, PSYCHOTHER PSYCHOSOM, V76, P115, DOI 10.1159/000097970; Sarver J, 2000, J GEN INTERN MED, V15, P256, DOI 10.1046/j.1525-1497.2000.015004256.x; Stedman Thomas Lathrop, 2000, STEDMANS MED DICT; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Valipour A, 2007, SLEEP, V30, P312, DOI 10.1093/sleep/30.3.312; Wahner-Roedler DL, 2007, GENDER MED, V4, P329, DOI 10.1016/S1550-8579(07)80062-3; Wasner G, 2010, CURR PAIN HEADACHE R, V14, P489, DOI 10.1007/s11916-010-0140-8; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002	72	24	24	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2017	96	7							e5917	10.1097/MD.0000000000005917			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL2EL	WOS:000394432800012	28207508	Green Published, gold			2022-02-06	
J	Sheridan, DC; Newgard, CD; Selden, NR; Jafri, MA; Hansen, ML				Sheridan, David C.; Newgard, Craig D.; Selden, Nathan R.; Jafri, Mubeen A.; Hansen, Matthew L.			QuickBrain MRI for the detection of acute pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						trauma; imaging; child	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CHILDREN; HEMORRHAGE; CANCER; CT	OBJECTIVE The current gold-standard imaging modality for pediatric traumatic brain injury (TB1) is CT, but it confers risks associated with ionizing radiation. QuickBrain MRI (qbMRI) is a rapid brain MRI protocol that has been studied in the setting of hydrocephalus, but its ability to detect traumatic injuries is unknown. METHODS The authors performed a retrospective cohort study of pediatric patients with TBI who were undergoing evaluation at a single Level I trauma center between February 2010 and December 2013. Patients who underwent CT imaging of the head and qbMRI during their acute hospitalization were included. Images were reviewed independently by 2 neuroradiology fellows blinded to patient identifiers. Image review consisted of identifying traumatic mass lesions and their intracranial compartment and the presence or absence of midline shift. CT imaging was used as the reference against which qbMRI was measured. RESULTS A total of 54 patients met the inclusion criteria; the median patient age was 3.24 years, 65% were male, and 74% were noted to have a Glasgow Coma Scale score of 14 or greater. The sensitivity and specificity of qbMRI to detect any lesion were 85% (95% Cl 73%-93%) and 100% (95% Cl 61%-100%), respectively; the sensitivity increased to 100% (95% CI 89%-100%) for clinically important TB's as previously defined. The mean interval between CT and qbMRI was 27.5 hours, and approximately half of the images were obtained within 12 hours. CONCLUSIONS In this retrospective pilot study, qbMRI demonstrated reasonable sensitivity and specificity for detecting a lesion or injury seen with neuroimaging (radiographic TBI) and clinically important acute pediatric TBI.	[Sheridan, David C.; Newgard, Craig D.; Hansen, Matthew L.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, Portland, OR 97201 USA; [Selden, Nathan R.] Oregon Hlth & Sci Univ, Div Pediat Neurosurg, Dept Neurol Surg, Portland, OR 97201 USA; [Jafri, Mubeen A.] Oregon Hlth & Sci Univ, Div Pediat Surg, Dept Surg, Portland, OR 97201 USA		Sheridan, DC (corresponding author), Oregon Hlth & Sci Univ, Dept Emergency Med, 707 SW Gaines Rd,Mail Code CDRC W, Portland, OR 97239 USA.	sheridda@ohsu.edu					Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Choi SJ, 2014, PEDIATR EMERG CARE, V30, P479, DOI 10.1097/PEC.0000000000000165; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Copenhaver BR, 2009, NEUROLOGY, V72, P1576, DOI 10.1212/WNL.0b013e3181a411df; Di Leva A, 2015, J NEUROSURG, V123, P1463, DOI 10.3171/2015.1.JNS142349; Donnelly LF, 2001, AM J ROENTGENOL, V176, P303, DOI 10.2214/ajr.176.2.1760303; Hahn B, 2013, PEDIATR EMERG CARE, V29, P822, DOI 10.1097/PEC.0b013e3182983d5d; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Iskandar BJ, 2004, J NEUROSURG, V101, P147, DOI 10.3171/ped.2004.101.2.0147; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee Bruce, 2005, NeuroRx, V2, P372; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Romanova AL, 2014, J STROKE CEREBROVASC, V23, P2036, DOI 10.1016/j.jstrokecerebrovasdis.2014.03.005; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Thompson EM, 2014, J NEUROSURG-PEDIATR, V13, P636, DOI 10.3171/2014.2.PEDS13567; Yue EL, 2015, J NEUROSURG-PEDIATR, V15, P420, DOI 10.3171/2014.9.PEDS14207	21	24	24	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2017	19	2					259	264		10.3171/2016.7.PEDS16204			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EJ3CM	WOS:000393089000016	27885947	Bronze			2022-02-06	
J	Mannix, R; Berkner, J; Mei, ZR; Alcon, S; Hashim, J; Robinson, S; Jantzie, L; Meehan, WP; Qiu, JH				Mannix, Rebekah; Berkner, Justin; Mei, Zhengrong; Alcon, Sasha; Hashim, Jumana; Robinson, Shenandoah; Jantzie, Lauren; Meehan, William P., III; Qiu, Jianhua			Adolescent Mice Demonstrate a Distinct Pattern of Injury after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						age; pediatric brain injury; TBI	CONTROLLED CORTICAL IMPACT; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; ALZHEIMERS-DISEASE; ADULT MICE; ENCEPHALOPATHY; RECEPTOR; NR2B; AGE; EPIDEMIOLOGY	Recently, there has been increasing interest in outcomes after repetitive mild traumatic brain injury (rmTBI) (e.g., sports concussions). Although most of the scientific attention has focused on elite athlete populations, the sequelae of rmTBI in children and young adults have not been well studied. Prior TBI studies have suggested that developmental differences in response to injury, including differences in excitotoxicity and inflammation, could result in differences in functional and histopathological outcomes after injury. The purpose of this study is to compare outcomes in adolescent (5-week-old) versus adult (4-month-old) mice in a clinically relevant model of rmTBI. We hypothesized that functional and histopathological outcomes after rmTBI would differ in developing adolescent brains compared with mature adult brains. Male adolescent and adult (C57Bl/6) mice were subjected to a weight drop model of rmTBI (n = 10-16/group). Loss of consciousness (LOC) after each injury was measured. Functional outcomes were assessed including tests of balance (rotorod), spatial memory (Morris water maze), and impulsivity (elevated plus maze). After behavioral testing, brains were assessed for histopathological outcomes including microglial immunolabeling and N-methyl-d-aspartate (NMDA) receptor subunit expression. Injured adolescent mice had longer LOC than injured adult mice compared with their respective sham controls. Compared with sham mice, adolescent and adult mice subjected to rmTBI had impaired balance, increased impulsivity, and worse spatial memory that persisted up to 3 months after injury, and the effect of injury was worse in adolescent than in adult mice in terms of spatial memory. Three months after injury, adolescent and adult mice demonstrated increased ionized calcium binding adaptor 1 (IbA1) immunolabeling compared with sham controls. Compared with sham controls, NMDA receptor subtype 2B (NR2B) expression in the hippocampus was reduced by similar to 20% in both adolescent and adult injured mice. The data suggest that injured adolescent mice may show a distinct pattern of functional deficits after injury that warrants further mechanistic studies.	[Mannix, Rebekah; Berkner, Justin; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Qiu, Jianhua] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Robinson, Shenandoah] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Mannix, Rebekah; Robinson, Shenandoah; Meehan, William P., III; Qiu, Jianhua] Harvard Med Sch, Boston, MA USA; [Mei, Zhengrong] Guangzhou Med Univ, Affiliated Hosp 3, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Jantzie, Lauren] Univ New Mexico, Off Pediat Res, Dept Pediat & Neurosci, Albuquerque, NM 87131 USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		Guangzhou Medical College Research Grant [1201421151]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	Boston Children's Hospital Intellectual and Developmental Disabilities Research Center, Rebekah Mannix is supported by T32 HD40128-11A1, and Zhongrong Mei is supported by a Guangzhou Medical College Research Grant (1201421151).	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bi H, 2002, J NEUROL SCI, V200, P11, DOI 10.1016/S0022-510X(02)00087-4; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brewer GJ, 1998, NEUROBIOL AGING, V19, P561, DOI 10.1016/S0197-4580(98)00091-8; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Ferreira JS, 2015, J NEUROSCI, V35, P8462, DOI 10.1523/JNEUROSCI.3567-14.2015; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Jantzie LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-131; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller T, 2009, LEARN MEMORY, V16, P395, DOI 10.1101/lm.1398709; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Zhang Xueqing, 2013, Proceedings of the CSEE, V33, P33	31	24	24	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					495	504		10.1089/neu.2016.4457			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800025	27368354	Green Published			2022-02-06	
J	Ravindra, VM; Bollo, RJ; Sivakumar, W; Akbari, H; Naftel, RP; Limbrick, DD; Jea, A; Gannon, S; Shannon, C; Birkas, Y; Yang, GL; Prather, CT; Kestle, JR; Riva-Cambrin, J				Ravindra, Vijay M.; Bollo, Robert J.; Sivakumar, Walavan; Akbari, Hassan; Naftel, Robert P.; Limbrick, David D., Jr.; Jea, Andrew; Gannon, Stephen; Shannon, Chevis; Birkas, Yekaterina; Yang, George L.; Prather, Colin T.; Kestle, John R.; Riva-Cambrin, Jay			Predicting Blunt Cerebrovascular Injury in Pediatric Trauma: Validation of the "Utah Score''	JOURNAL OF NEUROTRAUMA			English	Article						blunt cerebrovascular injury; computed tomography angiography; pediatrics; traumatic brain injury; Utah Score	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; VERTEBRAL ARTERY INJURIES; RADIATION-EXPOSURE; BRAIN-INJURY; RETROSPECTIVE COHORT; CERVICAL-SPINE; SCREENING-TEST; RISK-FACTORS; CHILDREN; DIAGNOSIS	Risk factors for blunt cerebrovascular injury (BCVI) may differ between children and adults, suggesting that children at low risk for BCVI after trauma receive unnecessary computed tomography angiography (CTA) and high-dose radiation. We previously developed a score for predicting pediatric BCVI based on retrospective cohort analysis. Our objective is to externally validate this prediction score with a retrospective multi-institutional cohort. We included patients who underwent CTA for traumatic cranial injury at four pediatric Level I trauma centers. Each patient in the validation cohort was scored using the "Utah Score'' and classified as high or low risk. Before analysis, we defined a misclassification rate <25% as validating the Utah Score. Six hundred forty-five patients (mean age 8.6 -5.4 years; 63.4% males) underwent screening for BCVI via CTA. The validation cohort was 411 patients from three sites compared with the training cohort of 234 patients. Twenty-two BCVIs (5.4%) were identified in the validation cohort. The Utah Score was significantly associated with BCVIs in the validation cohort (odds ratio 8.1 [3.3, 19.8], p < 0.001) and discriminated well in the validation cohort (area under the curve 72%). When the Utah Score was applied to the validation cohort, the sensitivity was 59%, specificity was 85%, positive predictive value was 18%, and negative predictive value was 97%. The Utah Score misclassified 16.6% of patients in the validation cohort. The Utah Score for predicting BCVI in pediatric trauma patients was validated with a low misclassification rate using a large, independent, multicenter cohort. Its implementation in the clinical setting may reduce the use of CTA in low-risk patients.	[Ravindra, Vijay M.; Bollo, Robert J.; Sivakumar, Walavan; Birkas, Yekaterina; Kestle, John R.; Riva-Cambrin, Jay] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA; [Ravindra, Vijay M.; Bollo, Robert J.; Sivakumar, Walavan; Birkas, Yekaterina; Kestle, John R.; Riva-Cambrin, Jay] Primary Childrens Med Ctr, Div Pediat Neurosurg, Salt Lake City, UT USA; [Akbari, Hassan; Limbrick, David D., Jr.] Washington Univ, Dept Neurosurg, St Louis, MO USA; [Akbari, Hassan; Limbrick, David D., Jr.] St Louis Childrens Hosp, Div Pediat Neurosurg, St Louis, MO 63178 USA; [Naftel, Robert P.; Gannon, Stephen; Shannon, Chevis; Yang, George L.; Prather, Colin T.] Vanderbilt Univ, Dept Neurosurg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Naftel, Robert P.; Gannon, Stephen; Shannon, Chevis; Yang, George L.; Prather, Colin T.] Monroe Carell Jr Childrens Hosp, Div Pediat Neurosurg, Nashville, TN USA; [Jea, Andrew] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Jea, Andrew] Texas Childrens Hosp, Div Pediat Neurosurg, Houston, TX 77030 USA		Riva-Cambrin, J (corresponding author), Alberta Childrens Prov Gen Hosp, Div Pediat Neurosurg, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	neuropub@hsc.utah.edu			Primary Children's Hospital Foundation Grant; Center for Clinical and Translational Sciences (NCATS/NIH) [8UL1TR000105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025764] Funding Source: NIH RePORTER	Funding for this project was received through the Primary Children's Hospital Foundation Grant awarded to Vijay M. Ravindra in the amount of $14,750. REDcap use and management was funded by Center for Clinical and Translational Sciences grant support (8UL1TR000105 (formerly UL1RR025764) NCATS/NIH).	Azarakhsh N, 2013, J TRAUMA ACUTE CARE, V75, P1006, DOI 10.1097/TA.0b013e31829d3526; Berne JD, 2004, J TRAUMA, V57, P11, DOI 10.1097/01.TA.0000135499.70048.C7; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 1999, J TRAUMA, V47, P438, DOI 10.1097/00005373-199908000-00051; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Bok APL, 1996, J TRAUMA, V40, P968, DOI 10.1097/00005373-199606000-00017; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Brunetti MA, 2011, J TRAUMA, V70, pE24, DOI 10.1097/TA.0b013e3181e80d8d; Burke D C, 1974, Paraplegia, V11, P268; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; Burroughs AK, 2006, LANCET, V367, P225, DOI 10.1016/S0140-6736(06)68033-1; Carrillo EH, 1999, J TRAUMA, V46, P1120, DOI 10.1097/00005373-199906000-00030; Cothren C. Clay, 2005, Clinics, V60, P489, DOI 10.1590/S1807-59322005000600011; DULA DJ, 1979, JACEP-J AM COLL EMER, V8, P504, DOI 10.1016/S0361-1124(79)80295-6; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Fassett DR, 2008, J SPINAL DISORD TECH, V21, P252, DOI 10.1097/BSD.0b013e3180cab162; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HUBBARD DD, 1974, CLIN ORTHOP RELAT R, P56; Jones TS, 2012, AM J SURG, V204, P7, DOI 10.1016/j.amjsurg.2011.07.015; KALFAS I, 1988, NEUROSURGERY, V23, P295, DOI 10.1227/00006123-198809000-00002; Kaye D, 2011, J TRAUMA, V70, P1051, DOI 10.1097/TA.0b013e318211857d; Kopelman TR, 2011, J TRAUMA, V71, P559, DOI 10.1097/TA.0b013e318226eadd; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Lew SM, 1999, PEDIATR NEUROSURG, V30, P239, DOI 10.1159/000028804; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MELZAK J, 1969, LANCET, V2, P45; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rang M., 1974, CHILDRENS FRACTURES, V1; Ravindra VM, 2015, J NEUROSURG-PEDIATR, V15, P599, DOI 10.3171/2014.11.PEDS14397; Riva-Cambrin J, 2009, J NEUROSURG-PEDIATR, V3, P378, DOI 10.3171/2009.1.PEDS08298; Roberts DJ, 2013, ANN SURG, V257, P621, DOI 10.1097/SLA.0b013e318288c514; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Takei Y, 2016, PEDIATR RADIOL, V46, P280, DOI 10.1007/s00247-015-3474-x; Wang AC, 2012, J TRAUMA ACUTE CARE, V72, P1599, DOI 10.1097/TA.0b013e318246ead4	41	24	24	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					391	399		10.1089/neu.2016.4415			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800015	27297774	Green Published, Green Submitted			2022-02-06	
J	Strain, JF; Didehbani, N; Spence, J; Conover, H; Bartz, EK; Mansinghani, S; Jeroudi, MK; Rao, NK; Fields, LM; Kraut, MA; Cullum, CM; Hart, J; Womack, KB				Strain, Jeremy F.; Didehbani, Nyaz; Spence, Jeffrey; Conover, Heather; Bartz, Elizabeth K.; Mansinghani, Sethesh; Jeroudi, Myrtle K.; Rao, Neena K.; Fields, Lindy M.; Kraut, Michael A.; Cullum, C. Munro; Hart, John, Jr.; Womack, Kyle B.			White Matter Changes and Confrontation Naming in Retired Aging National Football League Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; DTI; naming; National Football League; TBSS; white matter	TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; RECURRENT CONCUSSION; COMPREHENSION; DEPRESSION; INTEGRITY; DEFICITS; PLAYERS; FMRI	Using diffusion tensor imaging (DTI), we assessed the relationship of white matter integrity and performance on the Boston Naming Test (BNT) in a group of retired professional football players and a control group. We examined correlations between fractional anisotropy (FA) and mean diffusivity (MD) with BNT T-scores in an unbiased voxelwise analysis processed with tract-based spatial statistics (TBSS). We also analyzed the DTI data by grouping voxels together as white matter tracts and testing each tract's association with BNT T-scores. Significant voxelwise correlations between FA and BNT performance were only seen in the retired football players (p < 0.02). Two tracts had mean FA values that significantly correlated with BNT performance: forceps minor and forceps major. White matter integrity is important for distributed cognitive processes, and disruption correlates with diminished performance in athletes exposed to concussive and subconcussive brain injuries, but not in controls without such exposure.	[Strain, Jeremy F.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Didehbani, Nyaz; Spence, Jeffrey; Conover, Heather; Bartz, Elizabeth K.; Mansinghani, Sethesh; Rao, Neena K.; Fields, Lindy M.; Kraut, Michael A.; Hart, John, Jr.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX USA; [Didehbani, Nyaz; Jeroudi, Myrtle K.; Cullum, C. Munro; Hart, John, Jr.; Womack, Kyle B.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Didehbani, Nyaz; Jeroudi, Myrtle K.; Cullum, C. Munro; Hart, John, Jr.; Womack, Kyle B.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Kraut, Michael A.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA		Womack, KB (corresponding author), UT Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kyle.Womack@UTSouthwestern.edu	Cullum, C. Munro/AAC-2496-2019; Womack, Kyle/O-5422-2018	Cullum, C. Munro/0000-0001-9706-5465; Womack, Kyle/0000-0002-6060-9075; Didehbani, Nyaz/0000-0001-6121-5759	BrainHealth Institute for Athletes at the Center for BrainHealth, a research center at the University of Texas at Dallas; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5K23AG030006]	This work was made possible by support from the BrainHealth Institute for Athletes at the Center for BrainHealth, a research center at the University of Texas at Dallas. We also express our sincerest gratitude to the retired NFL athletes who participated in our study. No author involved in this project has a financial conflict of interest regarding this study or the reported data. This project was partially funded by National Institute on Aging grant 5K23AG030006.	Alosco Michael L., 2016, ALZHEIMERS DEMENTIA; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Binder DK, 2009, J NEUROSURG, V111, P1283, DOI 10.3171/2009.3.JNS081366; Binder JR, 2011, NEUROIMAGE, V54, P1465, DOI 10.1016/j.neuroimage.2010.09.048; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Crosson B, 1999, CEREB CORTEX, V9, P307, DOI 10.1093/cercor/9.4.307; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 1998, P NATL ACAD SCI USA, V95, P6498, DOI 10.1073/pnas.95.11.6498; Hart J, 2000, NEUROPSY NEUROPSY BE, V13, P1; HART J, 1990, ANN NEUROL, V27, P226, DOI 10.1002/ana.410270303; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heaton R. K., 2004, REVISED COMPREHENSIV; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jou RJ, 2011, AM J NEURORADIOL, V32, P1607, DOI 10.3174/ajnr.A2558; Kaplan E, 1983, BOSTON NAMING TEST; Kelly JP, 1997, NEUROLOGY, V48, P581; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kraut M, 1997, NEUROLOGY, V48, P1416, DOI 10.1212/WNL.48.5.1416; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Moritz-Gasser S, 2013, NEUROPSYCHOLOGIA, V51, P1814, DOI 10.1016/j.neuropsychologia.2013.06.007; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Obler LK, 2010, BRAIN LANG, V113, P113, DOI [10.1016/j.bandl.2010.03.001, 10.1016/j.band1.2010.03.001]; Papagno C, 2011, CURR NEUROL NEUROSCI, V11, P553, DOI 10.1007/s11910-011-0219-6; Peltier J, 2012, J NEUROL, V259, P1860, DOI 10.1007/s00415-012-6421-x; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Ralph MAL, 2010, P NATL ACAD SCI USA, V107, P2717, DOI 10.1073/pnas.0907307107; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542	52	24	24	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					372	+		10.1089/neu.2016.4446			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800012	27297660	Green Published, Green Submitted			2022-02-06	
J	Elliott, S; Tomita, D; Endre, Z				Elliott, Steve; Tomita, Dianne; Endre, Zoltan			Erythropoiesis stimulating agents and reno-protection: a meta-analysis	BMC NEPHROLOGY			English	Article						AKI (acute kidney injury); Anemia; Clinical trial; EPO; Erythropoietin; ESA; Meta-analysis; Progression of CKD; Reno-protection; Tissue protection; Transplant	RECOMBINANT-HUMAN-ERYTHROPOIETIN; ACUTE KIDNEY INJURY; HIGH-DOSE ERYTHROPOIETIN; ELEVATION MYOCARDIAL-INFARCTION; TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE CONTROL; LEFT-VENTRICULAR MASS; DOUBLE-BLIND; CARDIAC-SURGERY; RANDOMIZED-TRIAL	Background: Erythropoiesis stimulating agents (ESAs) were proposed to enhance survival of renal tissues through direct effects via activation of EPO receptors on renal cells resulting in reduced cell apoptosis, or indirect effects via increased oxygen delivery due to increased numbers of Hb containing red blood cells. Thus through several mechanisms there may be benefit of ESA administration on kidney disease progression and kidney function in renal patients. However conflicting ESA reno-protection outcomes have been reported in both pre-clinical animal studies and human clinical trials. To better understand the potential beneficial effects of ESAs on renal-patients, meta-analyses of clinical trials is needed. Methods: Literature searches and manual searches of references lists from published studies were performed. Controlled trials that included ESA treatment on renal patients with relevant renal endpoints were selected. Results: Thirty two ESA controlled trials in 3 categories of intervention were identified. These included 7 trials with patients who had a high likelihood of AKI, 7 trials with kidney transplant patients and 18 anemia correction trials with chronic kidney disease (predialysis) patients. There was a trend toward improvement in renal outcomes in the ESA treated arm of AKI and transplant trials, but none reached statistical significance. In 12 of the anemia correction trials, meta-analyses showed no difference in renal outcomes with the anemia correction but both arms received some ESA treatment making it difficult to assess effects of ESA treatment alone. However, in 6 trials the low Hb arm received no ESAs and meta-analysis also showed no difference in renal outcomes, consistent with no benefit of ESA/Hb increase. Conclusions: Most ESA trials were small with modest event rates. While trends tended to favor the ESA treatment arm, these meta-analyses showed no reduction of incidence of AKI, no reduction in DGF or improvement in 1-year graft survival after renal transplantation and no significant delay in progression of CKD. These results do not support significant clinical reno-protection by ESAs.	[Elliott, Steve; Tomita, Dianne] Amgen Inc, One Amgen Ctr,Newbury Pk, Thousand Oaks, CA 91320 USA; [Endre, Zoltan] Univ New South Wales, Prince Wales Hosp, Dept Nephrol, Sydney, NSW 2031, Australia; [Endre, Zoltan] Univ New South Wales, Sch Clin, Sydney, NSW 2031, Australia		Elliott, S (corresponding author), Amgen Inc, One Amgen Ctr,Newbury Pk, Thousand Oaks, CA 91320 USA.	elliottsge@gmail.com					ABRAHAM PA, 1990, AM J NEPHROL, V10, P128, DOI 10.1159/000168067; Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Aher SM, 2014, COCHRANE DB SYST REV, V4; Akizawa T, 2011, THER APHER DIAL, V15, P431, DOI 10.1111/j.1744-9987.2011.00931.x; Aydin Z, 2012, AM J TRANSPLANT, V12, P1793, DOI 10.1111/j.1600-6143.2012.04019.x; Bahlmann FH, 2009, CURR OPIN NEPHROL HY, V18, P15, DOI 10.1097/MNH.0b013e32831a9dde; Chhabra D, 2008, CLIN J AM SOC NEPHRO, V3, P1168, DOI 10.2215/CJN.04641007; Choukroun G, 2012, J AM SOC NEPHROL, V23, P360, DOI 10.1681/ASN.2011060546; Cianciaruso B, 2008, J NEPHROL, V21, P861; CLYNE N, 1992, NEPHRON, V60, P390, DOI 10.1159/000186797; CODY J, 2005, COCHRANE DB SYST REV, V20; Coupes Beatrice, 2015, BMC Res Notes, V8, P21, DOI 10.1186/s13104-014-0964-0; Covic A, 2014, AM J NEPHROL, V40, P13; Dardashti A, 2014, ANESTHESIOLOGY, V121, P582, DOI 10.1097/ALN.0000000000000321; de Seigneux S, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-132; Desai A, 2010, EUR J HEART FAIL, V12, P936, DOI 10.1093/eurjhf/hfq094; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2012, BIOL-TARGETS THER, V6, P163, DOI 10.2147/BTT.S32281; Elliott S, 2012, NEPHROL DIAL TRANSPL, V27, P2733, DOI 10.1093/ndt/gfr698; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Hafer C, 2012, KIDNEY INT, V81, P314, DOI 10.1038/ki.2011.349; Imai E, 2016, NEPHROL DIAL TRANSPL, V31, P447, DOI 10.1093/ndt/gfv272; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kamar N, 2008, TRANSPLANTATION, V85, P1120, DOI 10.1097/TP.0b013e31816a8a1f; Kamar N, 2010, TRANSPL INT, V23, P277, DOI 10.1111/j.1432-2277.2009.00982.x; Kim JH, 2013, CRIT CARE, V17, DOI 10.1186/cc13081; KLEINMAN KS, 1989, AM J KIDNEY DIS, V14, P486, DOI 10.1016/S0272-6386(89)80149-0; Kosiborod M, 2003, AM J MED, V114, P112, DOI 10.1016/S0002-9343(02)01498-5; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kuriyama S, 1997, NEPHRON, V77, P176, DOI 10.1159/000190270; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Li J, 2012, EUR J CLIN PHARMACOL, V68, P469, DOI 10.1007/s00228-011-1160-y; Lietz Katarzyna, 2003, Ann Transplant, V8, P17; LIM VS, 1989, ANN INTERN MED, V110, P108, DOI 10.7326/0003-4819-110-2-108; LIM VS, 1990, KIDNEY INT, V37, P131, DOI 10.1038/ki.1990.18; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Linde T, 2001, TRANSPLANTATION, V71, P79, DOI 10.1097/00007890-200101150-00013; Lucas MF, 1996, NEPHRON, V73, P54; Macdougall IC, 2007, NEPHROL DIAL TRANSPL, V22, P784, DOI 10.1093/ndt/gfl483; Martinez F, 2010, AM J TRANSPLANT, V10, P1695, DOI 10.1111/j.1600-6143.2010.03142.x; Moore E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-3; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Oh SW, 2012, J KOREAN MED SCI, V27, P506, DOI 10.3346/jkms.2012.27.5.506; Olweny EO, 2012, WORLD J UROL, V30, P519, DOI 10.1007/s00345-011-0760-6; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Park J, 2005, AM J KIDNEY DIS, V46, P791, DOI 10.1053/j.ajkd.2005.07.034; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; REVICKI DA, 1995, AM J KIDNEY DIS, V25, P548, DOI 10.1016/0272-6386(95)90122-1; Ritz E, 2007, AM J KIDNEY DIS, V49, P194, DOI 10.1053/j.ajkd.2006.11.032; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Rossert J, 2006, AM J KIDNEY DIS, V47, P738, DOI 10.1053/j.ajkd.2006.02.170; ROTH D, 1994, AM J KIDNEY DIS, V24, P777, DOI 10.1016/S0272-6386(12)80671-8; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Sico JJ, 2013, J STROKE CEREBROVASC, V22, P271, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.003; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Solling C, 2012, BASIC CLIN PHARMACOL, V110, P113, DOI 10.1111/j.1742-7843.2011.00820.x; Song YR, 2009, AM J NEPHROL, V30, P253, DOI 10.1159/000223229; Sureshkumar KK, 2012, CLIN J AM SOC NEPHRO, V7, P1498, DOI 10.2215/CJN.01360212; Suzuki M, 2012, INT HEART J, V2012, P53; Tasanarong A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-136; Tie HT, 2015, EUR J CARDIO-THORAC, V48, P32, DOI 10.1093/ejcts/ezu378; Togel FE, 2016, J AM SOC NEPHROL, V27, P3394, DOI 10.1681/ASN.2015091059; Uzu T, 2012, J AM SOC HYPERTENS, V6, P124, DOI 10.1016/j.jash.2011.11.001; Van Biesen W, 2005, TRANSPLANTATION, V79, P367, DOI 10.1097/01.TP.0000150370.51700.99; VanLoo A, 1996, NEPHROL DIAL TRANSPL, V11, P1815; Vasquez EM, 1996, TRANSPLANTATION, V62, P1026, DOI 10.1097/00007890-199610150-00024; Villar E, 2011, J DIABETES COMPLICAT, V25, P237, DOI 10.1016/j.jdiacomp.2011.03.003; Wen YT, 2013, AM J CARDIOVASC DRUG, V13, P435, DOI 10.1007/s40256-013-0042-3; Yoo YC, 2011, ANESTHESIOLOGY, V115, P929, DOI 10.1097/ALN.0b013e318232004b	75	24	24	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2369			BMC NEPHROL	BMC Nephrol.	JAN 11	2017	18								14	10.1186/s12882-017-0438-4			16	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	EH4UJ	WOS:000391765800002	28077085	Green Published, gold			2022-02-06	
J	Abdul-Muneer, PM; Conte, AA; Haldar, D; Long, M; Patel, RK; Santhakumar, V; Overall, CM; Pfister, BJ				Abdul-Muneer, P. M.; Conte, Adriano Andrea; Haldar, Debanjan; Long, Mathew; Patel, Rachel K.; Santhakumar, Vijayalakshmi; Overall, Christopher M.; Pfister, Bryan J.			Traumatic brain injury induced matrix metalloproteinase2 cleaves CXCL12 alpha (stromal cell derived factor 1 alpha) and causes neurodegeneration	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Stromal cell derived factor; CXCL12; MMP2; Oxidative stress; Apoptosis; Neurodegeneration	HIV-ASSOCIATED NEURODEGENERATION; FLUID PERCUSSION INJURY; INDUCED AXONAL INJURY; FACTOR-I; BARRIER DISRUPTION; OXIDATIVE STRESS; HEAD-INJURY; MATRIX-METALLOPROTEINASE-9; ACTIVATION; PERMEABILITY	Traumatic brain injury (TBI), even at mild levels, can activate matrix metalloproteinases (MMPs) and the induction of neuroinflammation that can result in blood brain barrier breakdown and neurodegeneration. MMP2 has a significant role in neuroinflammation and neurodegeneration by modulating the chemokine CXCL12 alpha (stromal cell derived factor SDF-1 alpha) signaling pathway and the induction of apoptosis. SDF-1 alpha is responsible for cell proliferation and differentiation throughout the nervous system and is also implicated in various neurodegenerative illnesses. We hypothesized that TBI leads to MMP2 activation and cleavage of the N-terminal 4 amino acid residues of CXCL12 alpha with generation of the highly neurotoxic fragment SDF-1(5-67). Using an in vitro stretch-injury model of rat neuronal cultures and the in vivo fluid percussion injury (FPI) model in rats, we found that oxidative stress has a significant role in the activation of MMP2. This is initiated by the induction of free radical generating enzyme NADPH oxidase 1 (NOX1). Induction of NOXI correlated well with the signatures of oxidative stress marker, 4HNE in the injured neuronal cultures and cerebral cortex of rats. Further, using MMP2 siRNA and pharmacological MMP2 inhibitor, ARP100, we established the neurodegenerative role of MMP2 in cleaving SDF-1 alpha to a neurotoxic fragment SDF-1(5-67). By immunofluorescence, western blotting and TUNEL experiments, we show the cleaved form of SDF leads to apoptotic cell death in neurons. This work identifies a new potential therapeutic target to reduce the complications of brain damage in TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Abdul-Muneer, P. M.; Haldar, Debanjan; Patel, Rachel K.] JFK Med Ctr, Lab CNS Injury & Repair, Neurosci Inst, 65 James St, Edison, NJ 08820 USA; [Abdul-Muneer, P. M.; Conte, Adriano Andrea; Haldar, Debanjan; Long, Mathew; Patel, Rachel K.; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, 2199 Westbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, 2199 Westbrook Mall, Vancouver, BC V6T 1Z3, Canada		Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Lab CNS Injury & Repair, Neurosci Inst, 65 James St, Edison, NJ 08820 USA.; Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	pmamuneer@gmail.com; pfister@njit.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Abdul-Muneer, P. M/0000-0001-8231-4385; Haldar, Debanjan/0000-0002-5061-0953	New Jersey Commission on Brain Injury Research [CBIR11PJT003]; Neuroscience Institute at JFK Medical Center	This work was funded by New Jersey Commission on Brain Injury Research #CBIR11PJT003 to Bryan J. Pfister and in part by the Neuroscience Institute at JFK Medical Center, Edison NJ to P. M. Abdul-Muneer.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abdul-Muneer P.M., 2016, MOL NEUROBIOL; [Anonymous], 2015, MOL NEUROBIOL; Barlaka E, 2015, PHARMACOL RES, V95-96, P102, DOI 10.1016/j.phrs.2015.03.008; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Egashira Y, 2015, STROKE, V46, P2909, DOI 10.1161/STROKEAHA.115.010351; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002; Ketsawatsomkron P, 2016, HYPERTENSION, V67, P214, DOI 10.1161/HYPERTENSIONAHA.115.06391; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121739; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Qiu JH, 2002, J NEUROSCI, V22, P3504; Ransohoff RM, 2003, NAT NEUROSCI, V6, P1009, DOI 10.1038/nn1003-1009; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Trentini A, 2015, MULT SCLER J, V21, P1121, DOI 10.1177/1352458514560925; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhang S., 2016, NEUROCHEM INT; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583	58	24	25	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2017	59						190	199		10.1016/j.bbi.2016.09.002			10	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EF8YU	WOS:000390618700018	27614125				2022-02-06	
J	Banks, WA; Kovac, A; Majerova, P; Bullock, KM; Shi, M; Zhang, J				Banks, William A.; Kovac, Andrej; Majerova, Petra; Bullock, Kristin M.; Shi, Min; Zhang, Jing			Tau Proteins Cross the Blood-Brain Barrier	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; blood-brain barrier; tau protein; tauopathy	PAIRED HELICAL FILAMENT; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; ALPHA-SYNUCLEIN; DISORDERED PROTEINS; CEREBROSPINAL-FLUID; EFFLUX TRANSPORT; CLEARANCE; PATHOLOGY; PEPTIDE	Tauopathies are a hallmark of many neurodegenerative diseases, including Alzheimer's disease and traumatic brain injuries. It has been demonstrated that amyloid-beta peptides, alpha-synuclein, and prion proteins cross the blood-brain barrier (BBB), contributing to their abilities to induce disease. Very little is known about whether tau proteins can cross the BBB. Here we systematically characterized several key forms of tau proteins to cross the BBB, including Tau-441 (2N4R), Tau-410 (2N3R), truncated tau 151-391 (0N4R), and truncated tau 121-227. All of these tau proteins crossed the BBB readily and bidirectonally; however, only Tau-410 had a saturable component to its influx. The tau proteins also entered the blood after their injection into the brain, with Tau 121-227 having the slowest exit from brain. The tau proteins varied in regards to their enzymatic stability in brain and blood and in their peripheral pharmacokinetics. These results show that blood-borne tau proteins could contribute to brain tauopathies. The result also suggest that the CNS can contribute to blood levels of tau, raising the possibility that, as suggested for other misfolded proteins, blood levels of tau proteins could be used as a biomarker of CNS disease.	[Banks, William A.; Bullock, Kristin M.] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA USA; [Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Kovac, Andrej; Majerova, Petra] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia; [Kovac, Andrej] Univ Vet Med & Pharm, Dept Pharmacol & Toxicol, Kosice, Slovakia; [Majerova, Petra] AXON Neurosci SE, Bratislava, Slovakia; [Shi, Min; Zhang, Jing] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Zhang, Jing] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing, Peoples R China; [Zhang, Jing] Peking Univ, Hosp 3, Beijing, Peoples R China		Banks, WA (corresponding author), VAPSHCS, 1660S ColumbianWay, Seattle, WA 98108 USA.	wabanks1@uw.edu	Shi, Min/G-6165-2012; Banks, William A/K-1330-2017	Shi, Min/0000-0002-6901-2558; Banks, William A/0000-0002-0496-3619; Zhang, Jing/0000-0002-9224-6299	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG046619]; Alzheimer's Association grantAlzheimer's Association [2015-NIRG-342009]; Veterans AffairsUS Department of Veterans Affairs; APVV-14-0547	Supported by APVV-14-0547, Veterans Affairs, Alzheimer's Association grant 2015-NIRG-342009, and NIH R01 AG046619.	Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; BANKS WA, 1988, J PHARMACOL EXP THER, V244, P579; BANKS WA, 1992, PROG BRAIN RES, V91, P139; Banks WA, 2005, EFFLUX TRANSPORTERS AND THE BLOOD-BRAIN BARRIER, P21; Barthelemy NR, 2016, J PROTEOME RES, V15, P667, DOI 10.1021/acs.jproteome.5b01001; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Csokova N, 2004, PROTEIN EXPRES PURIF, V35, P366, DOI 10.1016/j.pep.2004.01.012; DAVSON H, 1996, PHYSL CSF BLOOD BRAI, P573; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Greig NH, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P251; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jadhav S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00024; Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; Krajciova G, 2008, ANAL BIOCHEM, V383, P343, DOI 10.1016/j.ab.2008.09.022; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Maness LM, 1996, PEPTIDES, V17, P247, DOI 10.1016/0196-9781(95)02135-3; MANESS LM, 1994, LIFE SCI, V55, P1643, DOI 10.1016/0024-3205(94)00331-9; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Michalicova A, 2016, CURR ALZHEIMER RES; Morales R, 2015, VIRUS RES, V207, P106, DOI 10.1016/j.virusres.2014.12.031; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pan WH, 2001, J NEUROIMMUNOL, V115, P64, DOI 10.1016/S0165-5728(01)00256-9; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Sagare AP, 2013, J ALZHEIMERS DIS, V33, pS87, DOI 10.3233/JAD-2012-129037; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Shi M, 2016, ALZHEIMERS DEMENT, V12, P1125, DOI 10.1016/j.jalz.2016.04.003; Shi M, 2014, ACTA NEUROPATHOL, V128, P639, DOI 10.1007/s00401-014-1314-y; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sui YT, 2014, PEPTIDES, V62, P197, DOI 10.1016/j.peptides.2014.09.018; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vasudevaraju P, 2012, J PHARM BIOALLIED SC, V4, P112, DOI 10.4103/0975-7406.94811; Vogelgesang S, 2002, PHARMACOGENETICS, V12, P535, DOI 10.1097/00008571-200210000-00005; Vogelgesang S, 2011, CURR PHARM DESIGN, V17, P2778, DOI 10.2174/138161211797440168; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yu CH, 2008, CELL PHYSIOL BIOCHEM, V22, P745, DOI 10.1159/000185558; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	48	24	24	2	32	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	55	1					411	419		10.3233/JAD-160542			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB8WI	WOS:000387671600032	27662303				2022-02-06	
J	Churchill, N; Hutchison, MG; Leung, G; Graham, S; Schweizer, TA				Churchill, Nathan; Hutchison, Michael G.; Leung, General; Graham, Simon; Schweizer, Tom A.			Changes in functional connectivity of the brain associated with a history of sport concussion: A preliminary investigation	BRAIN INJURY			English	Article						Concussion; functional MRI; neuroimaging; MRI scan	DEFAULT-MODE NETWORK; PROFESSIONAL FOOTBALL PLAYERS; RESTING-STATE FMRI; RECURRENT CONCUSSION; NCAA CONCUSSION; INDIVIDUALS; PERFORMANCE; RECOVERY; ABILITY; MRI	Objective: There is evidence of long-term clinical consequences associated with a history of sport concussion. However, there remains limited information about the underlyingchanges in brain function. The goal of this study was to identify brain regions where abnormal resting-state function is associated with chronic concussion, for athletes without persistent symptoms. Methods: Functional Magnetic Resonance Imaging (fMRI) was performed on a group of athletes with prior concussion (n = 22) and a group without documented injury (n = 21). Multivariate predictive modelling was used to localize reliable changes in brain connectivity that are associated with a history of concussion and with clinical factors, including number of prior concussions and recovery time from last injury. Results: No significant differences were found between athletes with and without a history of concussion, but functional connectivity was significantly associated with clinical history. The number of prior concussions was associated with most extensive connectivity changes, particularly for elements of the visual attention network and cerebellum. Conclusion: The findings of this preliminary study indicate that functional brain abnormalities associated with chronic concussion may be significantly dependent on clinical history. In addition, elements of the visual and cerebellar systems may be most sensitive to the long-term effects of sport concussion.	[Churchill, Nathan; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan; Hutchison, Michael G.; Leung, General; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Leung, General] Univ Toronto, Med Imaging, Toronto, ON, Canada; [Graham, Simon] Univ Toronto, Med Biophys, Toronto, ON, Canada; [Graham, Simon] Sunnybrook Med Ctr, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada		Churchill, N (corresponding author), 209 Victoria St, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com			Defence Research & Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR); Siemens Canada Ltd.	This research received funding from the Defence Research & Development Canada (DRDC) and the Canadian Institutes of Military and Veterans Health (CIMVHR). This study was approved by the Canadian Forces Surgeon General's Health Research Program. This research was also conducted with partial support from Siemens Canada Ltd. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Behm DG, 2005, J STRENGTH COND RES, V19, P326; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Consonni V, 2010, J CHEMOMETR, V24, P194, DOI 10.1002/cem.1290; Efron B., 1994, INTRO BOOTSTRAP; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham D., 2002, TRAUMA GREENFIELDS N; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	31	24	24	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					39	48		10.1080/02699052.2016.1221135			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600006	27901587				2022-02-06	
J	Fuller, CW; Fuller, GW; Kemp, SPT; Raftery, M				Fuller, Colin W.; Fuller, Gordon W.; Kemp, Simon P. T.; Raftery, Martin			Evaluation of World Rugby's concussion management process: results from Rugby World Cup 2015	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CONSENSUS STATEMENT; OPERATIONAL DEFINITION; POSITION STATEMENT; BRAIN-INJURY; SPORT; PATHOPHYSIOLOGY; ZURICH	Objective To evaluate World Rugby's concussion management process during Rugby World Cup (RWC) 2015. Design A prospective, whole population study. Population 639 international rugby players representing 20 countries. Method The concussion management process consisted of 3 time-based, multifaceted stages: an initial on-pitch and/or pitch-side assessment of the injury, a follow-up assessment within 3 hours and an assessment at 36-48 hours. The initial on-pitch assessment targeted obvious signs of concussion, which, if identified, lead to a 'permanent removal from play' decision and a diagnosis of concussion. If the on-pitch diagnosis was unclear, a 10-min off-pitch assessment was undertaken for signs and symptoms of concussion leading to a 'suspected concussion with permanent removal from play' or a 'no indication of concussion with return to play' decision. Evaluations at 3 and 36-48 hours postmatch lead to diagnoses of 'confirmed concussion' or 'no concussion'. Medical staff's decision-making was supported during each stage by real-time video review of events. Players diagnosed with confirmed concussion followed a 5-stage graduated-return-to-play protocol before being allowed to return to training and/or competition. Results Players were evaluated for concussion on 49 occasions, of which 24 resulted in diagnoses of concussion. Fourteen players showing on-pitch signs of concussion were permanently removed from play: 4 of the 5 players removed from play following off-pitch medical room evaluation were later diagnosed with a confirmed concussion. Five players not exhibiting in-match signs or symptoms of concussion were later diagnosed with concussion. The overall incidence of concussion during RWC 2015 was 12.5 concussions/1000 player-match-hours. Conclusions This study supports the implementation of a multimodal, multitime-based concussion evaluation process to ensure that immediate and late developing concussions are captured.	[Fuller, Colin W.] Colin Fuller Consultancy Ltd, Loughborough, England; [Fuller, Gordon W.] Univ Sheffield, Sch Hlth & Related Res, Emergency Med Res Sheffield Grp, Sheffield, S Yorkshire, England; [Kemp, Simon P. T.] Rugby Football Union, London, England; [Raftery, Martin] World Rugby, Dublin, Ireland		Fuller, CW (corresponding author), Colin Fuller Consultancy Ltd, Loughborough, England.	ColinFullerConsultancy@gmail.com	Ball, James E/G-1734-2011	Ball, James E/0000-0001-8342-1916; Fuller, Gordon Ward/0000-0001-8532-3500; Kemp, Simon/0000-0002-3250-2713	World Rugby; England Rugby; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2015-04-005] Funding Source: researchfish	The study was funded by World Rugby and supported by England Rugby 2015.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Helmy A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5748; Herring SA, 2011, MED SCI SPORTS EXERC, V43, P2412; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Patricios JS, 2014, BRIT J SPORT MED, V48, P76, DOI 10.1136/bjsports-2013-093031; Quarrie KL, 2014, BRIT J SPORT MED, V48, P1589, DOI 10.1136/bjsports-2014-094112; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; Rugby Football Union, 2016, ENGL PROF RUGB INJ S; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Sterne, 2003, ESSENTIAL MED STAT	23	24	24	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2017	51	1					64	+		10.1136/bjsports-2016-096461			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EH0EK	WOS:000391435400014	27587799	Green Accepted			2022-02-06	
J	Mishra, SK; Kumar, BSH; Khushu, S; Singh, AK; Gangenahalli, G				Mishra, Sushanta Kumar; Kumar, B. S. Hemanth; Khushu, Subash; Singh, Ajay K.; Gangenahalli, Gurudutta			Early monitoring and quantitative evaluation of macrophage infiltration after experimental traumatic brain injury: A magnetic resonance imaging and flow cytometric analysis	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Flow cytometry; Macrophages; Magnetic resonance imaging; Microglia; Neuroinflammation; Traumatic brain injury; USPIO	SUPERPARAMAGNETIC IRON-OXIDE; INFLAMMATORY MECHANISMS; MONOCYTE INFILTRATION; BARRIER PERMEABILITY; CONTRAST AGENT; MOUSE-BRAIN; MRI; ISCHEMIA; CELL; NEUROINFLAMMATION	The inflammatory response following traumatic brain injury (TBI) is regulated by phagocytic cells. These cells comprising resident microglia and infiltrating macrophages play a pivotal role in the interface between early detrimental and delayed beneficial effects of inflammation. The aim of the present study was to monitor the early effect of monocyte/phagocytic accumulation and further to explore its kinetics in TBI mice. Localized macrophage population was monitored using ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle enhanced in vivo serial magnetic resonance imaging (MRI). Flow cytometry based gating study was performed to discriminate between resident microglia (Ly6G(-) CD11b+ CD45(low)) and infiltrating macrophages (Ly6G(-) CD11b+ CD45(high)) at the injury site. The T-2* relaxation analysis revealed that maximum macrophage infiltration occurs between 66 and 72 h post injury (42-48 h post administration of USPIO) at the site of inflammation. This imaging data was well supported by iron oxide specific Prussian blue staining and macrophage specific F4/80 immunohistochemistry (IHC) analysis. Quantitative real-time PCR analysis found significant expression of monocyte chemoattractant protein-1 (MCP-1) at 72 h post injury. Also, we found that flow cytometric analysis demonstrated a 7-fold increase in infiltrating macrophages around 72 h post injuries as compared to control. The MR imaging in combination with flow cytometric analysis enabled the dynamic measurement of macrophage infiltration at the injury site. This study may help in setting an optimal time window to intervene and prevent damage due to inflammation and to increase the therapeutic efficacy. (C) 2016 Elsevier Inc All rights reserved.	[Mishra, Sushanta Kumar; Kumar, B. S. Hemanth; Khushu, Subash] DRDO, INMAS, NMR Res Ctr, Delhi 54, India; [Singh, Ajay K.] DRDO, INMAS, Div Radiat Biosci, Delhi 54, India; [Mishra, Sushanta Kumar; Gangenahalli, Gurudutta] DRDO, INMAS, Div Stem Cell & Gene Therapy Res, Delhi 54, India		Khushu, S (corresponding author), DRDO, INMAS, NMR Res Ctr, Delhi 54, India.; Gangenahalli, G (corresponding author), DRDO, INMAS, Div Stem Cell & Gene Therapy Res, Delhi 54, India.	skhushu@yahoo.com; gugdutta@rediffmail.com	Singh, Ajay/AAF-4414-2020; Mishra, Sushanta Kumar/N-5958-2019	Mishra, Sushanta/0000-0002-3403-6891	Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 4.1]; Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR)	The project (INM-311, 4.1) was supported by the Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of India. The authors also thank Sunil Koundal (SRF, INMAS) for help in MRI data analysis. We also acknowledge Dr. Anurag Agrawal and Mr. Bijaya Ranjan Pattanaik (SRF, IGIB) for providing flow cytometry facility and data interpretation. The fellowship support from the Indian Council of Medical Research (ICMR) is gratefully acknowledged by Mr. Sushanta Kumar Mishra.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dousset V, 2006, AM J NEURORADIOL, V27, P1000; Easo SL, 2013, CARBOHYD POLYM, V92, P726, DOI 10.1016/j.carbpol.2012.09.098; Engberink RDO, 2008, J CEREBR BLOOD F MET, V28, P841, DOI 10.1038/sj.jcbfm.9600580; Farr TD, 2011, NMR BIOMED, V24, P35, DOI 10.1002/nbm.1553; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Gensel J.C., 2015, BRAIN RES, V14; Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Lobel U, 2009, NEURORADIOLOGY, V51, P253, DOI 10.1007/s00234-008-0488-1; Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1996, LAB INVEST, V74, P315; Mishra S.K., 2016, STEM CELL TRANSL MED, V5, P1; Mishra SK, 2016, CONTRAST MEDIA MOL I, V11, P350, DOI 10.1002/cmmi.1698; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Price CJS, 2003, J NEUROL NEUROSUR PS, V74, P1476, DOI 10.1136/jnnp.74.11.1476; Rausch M, 2002, NMR BIOMED, V15, P278, DOI 10.1002/nbm.770; Saleh A, 2004, BRAIN, V127, P1670, DOI 10.1093/brain/awh191; Saleh A, 2007, STROKE, V38, P2733, DOI 10.1161/STROKEAHA.107.481788; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Soares HD, 1995, J NEUROSCI, V15, P8223; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wiart M, 2007, STROKE, V38, P131, DOI 10.1161/01.STR.0000252159.05702.00; Xu FH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/40/405102; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	47	24	24	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	JAN	2017	78						25	34		10.1016/j.mcn.2016.11.008			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI0LW	WOS:000392167000003	27864037				2022-02-06	
J	Stanley, IH; Joiner, TE; Bryan, CJ				Stanley, Ian H.; Joiner, Thomas E.; Bryan, Craig J.			Mild traumatic brain injury and suicide risk among a clinical sample of deployed military personnel: Evidence for a serial mediation model of anger and depression	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						TBI; Suicide; Suicidality; Anger; Depression	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; BEHAVIORS QUESTIONNAIRE; VETERANS; TBI; POPULATION; PREVALENCE; MANAGEMENT; SYMPTOMS; IDEATION; HEALTH	Research has demonstrated a robust link between traumatic brain injuries (TBIs) and suicide risk. Yet, few studies have investigated factors that account for this link. Utilizing a clinical sample of deployed military personnel, this study aimed to examine a serial meditation model of anger and depression in the association of mild TBI and suicide risk. A total of 149 military service members referred for evaluation/treatment of a suspected head injury at a military hospital participated in the present study (92.6% male; M-age = 27.9y). Self-report measures included the Suicidal Behaviors Questionnaire Revised (SBQ-R), Automated Neuropsychological Assessment Metrics (ANAM) anger and depression subscales, and Behavioral Health Measure-20 depression subscale. A current mild TBI diagnosis was confirmed by a licensed clinical psychologist/physician. Overall, 84.6% (126/149) of participants met diagnostic criteria for a current mild TB]. Bootstrapped serial mediation analyses indicated that the association of mild TBI and suicide risk is serially mediated by anger and depression symptoms (bias-corrected 95% confidence interval [CI] for the indirect effect = 0.044, 0.576). An alternate serial mediation model in which depression symptoms precede anger was not statistically significant (bias-corrected 95% Cl for the indirect effect = -0.405, 0.050). Among a clinical sample of military personnel, increased anger and depression statistically mediated the association of mild TBI and suicide risk, and anger appears to precede depression in this pathway. Findings suggest that therapeutically targeting anger may serve to thwart the trajectory to suicide risk among military personnel who experience a mild TBI. Future research should investigate this conjecture within a prospective design to establish temporality. (C) 2016 Elsevier Ltd. All rights reserved.	[Stanley, Ian H.; Joiner, Thomas E.] Florida State Univ, Dept Psychol, 1107 West Call St, Tallahassee, FL 32306 USA; [Bryan, Craig J.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Bryan, Craig J.] Natl Ctr Vet Studies, Salt Lake City, UT USA		Stanley, IH (corresponding author), Florida State Univ, Dept Psychol, 1107 West Call St, Tallahassee, FL 32306 USA.	stanley@psy.fsu.edu		Bryan, Craig/0000-0002-9714-0733	Military Suicide Research Consortium; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0181]	This research was supported in part by the Military Suicide Research Consortium, an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. (W81XWH-10-2-0181). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Military Suicide Research Consortium or the Department of Defense.	Aboulafia-Brakha T., 2015, J HEAD TRAUMA REHABI, V1; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Batterham PJ, 2015, PSYCHOL ASSESSMENT, V27, P501, DOI 10.1037/pas0000053; Blount T. H., 2010, ASS BEHAV COGNITIVE; Bossarte R.M., 2013, SUICIDE DATA REPORT; Brenner LA, 2015, ARCH PHYS MED REHAB, V96, P1411, DOI 10.1016/j.apmr.2015.04.010; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Centers for Disease Control and Prevention, 2016, LEAD CAUS DEATH REP; Chu C, 2015, J CLIN PSYCHOL, V71, P1186, DOI 10.1002/jclp.22210; COTTON CR, 1995, DEATH STUD, V19, P391, DOI 10.1080/07481189508252740; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Defense Suicide Prevention Office, 2014, FISC YEAR 2013 ANN R; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; FAVA M, 1993, AM J PSYCHIAT, V150, P1158; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Gutierrez PM, 2008, ARCH SUICIDE RES, V12, P336, DOI 10.1080/13811110802324961; Hawkins KA, 2013, J NERV MENT DIS, V201, P959, DOI 10.1097/NMD.0000000000000041; Hayes, 2018, INTRO MEDIATION MODE; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Johnson DR, 2008, ARCH CLIN NEUROPSYCH, V23, P73, DOI 10.1016/j.acn.2007.10.001; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2016, PSYCHIATRY, V79, P107, DOI 10.1080/00332747.2016.1142800; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Klonsky ED, 2016, ANNU REV CLIN PSYCHO, V12, P307, DOI 10.1146/annurev-clinpsy-021815-093204; Koh KB, 2002, J CLIN PSYCHIAT, V63, P486, DOI 10.4088/JCP.v63n0604; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Luutonen S, 2007, NORD J PSYCHIAT, V61, P246, DOI 10.1080/08039480701414890; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MINKOFF K, 1973, AM J PSYCHIAT, V130, P455; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Pernin C.G., 2011, WAR PREVENTING SUICI; Potegal M, 2010, INTERNATIONAL HANDBOOK OF ANGER, P3, DOI 10.1007/978-0-387-89676-2_1; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ribeiro JD, 2011, J PERS ASSESS, V93, P597, DOI 10.1080/00223891.2011.608758; Rudd M.D., 2006, ASSESSMENT MANAGEMEN; Skopp Nancy A, 2012, MSMR, V19, P7; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Stefan A., 2016, ANN PHYS REHABIL MED; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Health and Human Services Office of the Surgeon General, 2012, NAT STRAT SUIC PREV; VANORDEN KA, 2010, Patent No. 117575; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721	59	24	24	0	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JAN	2017	84						161	168		10.1016/j.jpsychires.2016.10.004			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EG0OW	WOS:000390733100020	27743528	Bronze			2022-02-06	
J	Stazyk, K; DeMatteo, C; Moll, S; Missiuna, C				Stazyk, Kathy; DeMatteo, Carol; Moll, Sandra; Missiuna, Cheryl			Depression in youth recovering from concussion: Correlates and predictors	BRAIN INJURY			English	Article						Child; concussion; mild traumatic brain injury; post-concussion syndrome; depression and anxiety; children's depression inventory-2	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; MAJOR DEPRESSION; CHILDREN; ADOLESCENTS; SYMPTOMS; PREVALENCE; SCHOOL; RECOMMENDATIONS	Objectives: Although depression can be a serious consequence of concussion, little is known about the factors that predict depression and concussion recovery outcomes in children. The purpose of this study was to explore the risk and possible predictors of developing significant depressive symptoms in children recovering from concussion.Methods: A prospective cohort study was conducted in a paediatric tertiary care clinic. Depression data were collected from 92 children using the Children's Depression Inventory-2 (CDI-2) screening tool. Correlations, t-tests and logistic regression were used to examine the associations between depression scores and demographic as well as injury-related factors.Results: Depressive symptoms were found in 22% of the children (T score on CDI-2 >65). Children with evidence of depressive symptomatology had significantly higher mean post-concussive symptom inventory (PCSI) scores in recovery (p = 0.004) than children who were not depressed. Variables of i) Sex; ii) hospital admission; iii) number of head injuries; iv) post-concussion symptom score and v) experience of prolonged symptoms were predictive of clinically significant CDI T scores, explaining 36% of the variation in the binary logistic model.Conclusion: Depression is commonly reported in this subset of children. High post-concussive symptom scores and hospital admission were strong predictors of depression. Screening for depression should be standard practice in concussion management in children and youth.	[Stazyk, Kathy; DeMatteo, Carol; Moll, Sandra; Missiuna, Cheryl] McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 403, Hamilton, ON L8S 1C7, Canada; [Stazyk, Kathy; DeMatteo, Carol; Missiuna, Cheryl] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada		Stazyk, K (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 403, Hamilton, ON L8S 1C7, Canada.	stazyk@mcmaster.ca	Moll, Sandra/AAF-5742-2020	Moll, Sandra/0000-0002-1937-0103			Ahmoi C, 1999, DEPRESSIVE DISORDERS, P69; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Allgaier AK, 2012, J PSYCHOSOM RES, V73, P369, DOI 10.1016/j.jpsychores.2012.08.016; [Anonymous], 2006, IMM POSTCONCUSSION A; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Avenevoli S., 2008, HDB DEPRESSION CHILD; Avenevoli S, 2015, J AM ACAD CHILD PSY, V54, P37, DOI 10.1016/j.jaac.2014.10.010; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carr A, 2008, DEV NEUROREHABIL, V11, P3, DOI 10.1080/17518420701536095; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Duffy A, 2012, CONCUSSIONS RUIN QUA; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Garber J, 2010, VULNERABILITY PSYCHO, P189; Garland E., 2002, B C MED J, V44, P469; Gioia G, 2006, ACUTE CONCUSSION EVA; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hankin BL, 2015, J ABNORM PSYCHOL, V124, P803, DOI 10.1037/abn0000089; Hankin BL, 2006, EPILEPSY BEHAV, V8, P102, DOI 10.1016/j.yebeh.2005.10.012; IBM, 2013, IBM SPSS STAT WINDOW; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Klein DN, 2009, J AM ACAD CHILD PSY, V48, P703, DOI 10.1097/CHI.0b013e3181a56606; Kovacs M., 2011, CHILDRENS DEPRESSION; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCrory P, SCAT3 INTERNET; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; National Institute of Mental Health, 2014, MAJ DEPR SD INT; Ontario Children's Mental Health, 2001, EV BAS PRACT DEPR CH; Parsons JT, 2013, BRIT J SPORT MED, V47, pe1; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Public Health Agency of Canada, 2011, CHIEF PUBL HLTH OFF; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	64	24	24	3	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					631	638		10.1080/02699052.2017.1283533			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900008	28326857				2022-02-06	
J	Wu, FZ; Chen, ZF; Tang, CH; Zhang, JJ; Cheng, L; Zuo, HX; Zhang, HY; Chen, DQ; Xiang, LP; Xiao, J; Li, XK; Xu, XL; Wei, XJ				Wu, Fenzan; Chen, Zaifeng; Tang, Chonghui; Zhang, Jinjing; Cheng, Li; Zuo, Hongxia; Zhang, Hongyu; Chen, Daqing; Xiang, Liping; Xiao, Jian; Li, Xiaokun; Xu, Xinlong; Wei, Xiaojie			Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Traumatic brain injury; blood-brain barrier; acid fibroblast growth factor; junction protein; RhoA	MICROVASCULAR ENDOTHELIAL-CELLS; CEREBRAL-ISCHEMIA; PERMEABILITY; PROTECTS; EDEMA; DISRUPTION; MECHANISMS; CLAUDIN-5; OCCLUDIN; DELIVERY	The blood-brain barrier (BBB) plays important roles in the recovery of traumatic brain injury (TBI) which is a major factor contributing to cerebral edema. Acid fibroblast growth factor (aFGF) contributes to maintain vascular integrity and restores nerve function. However, whether aFGF protects BBB following TBI remains unknown. The purpose of this study was to determine whether exogenous aFGF preserves BBB integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA after TBI. BBB permeability was assessed using evans blue dye and fluorescein isothiocyanate dextran fluorescence. Neurofunctional tests, such as the garcia test, were conducted in a blinded fashion, and protein expression was evaluated via western blotting and immunofluorescence staining. Our results showed that aFGF improved neurofunctional deficits, preserved BBB integrity, and up-regulated tight junction proteins and adherens junction proteins 24 h after experimental TBI. However, the PI3K/Akt inhibitor LY294002 reversed the protective effects of aFGF on neurofunctional deficits and junction protein expression and significantly suppressed p-Akt and GTP-Rac1 activity. Furthermore, aFGF administration significantly decreased GTP-RhoA expression in the treated group compared with the vehicle group, while PI3K/Akt inhibition increased GTP-RhoA expression. Similar results were observed in vitro, as aFGF exerted protective effects on endothelial cell integrity by up-regulating junction proteins and PI3K-Akt-Rac1 pathway and down-regulating RhoA expression under oxygen-glucose deprivation/reoxygenation (OGD) conditions. These data suggest that exogenous aFGF reduces RhoA activity in part by activating the PI3K-Akt-Rac1 signaling pathway, thus improving neurofunctional deficits and preserving BBB integrity after TBI.	[Wu, Fenzan; Chen, Zaifeng; Tang, Chonghui; Zhang, Jinjing; Cheng, Li; Zuo, Hongxia; Xu, Xinlong; Wei, Xiaojie] Wenzhou Med Univ, Cixi Peoples Hosp, Dept Neurosurg, Ningbo 315300, Zhejiang, Peoples R China; [Zhang, Hongyu; Xiao, Jian; Li, Xiaokun] Wenzhou Med Univ, Sch Pharm, Mol Pharmacol Res Ctr, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Chen, Daqing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou 325035, Zhejiang, Peoples R China; [Xiang, Liping] Cangnan Peoples Hosp, Dept Nursing, Wenzhou 325800, Zhejiang, Peoples R China		Xu, XL; Wei, XJ (corresponding author), Wenzhou Med Univ, Cixi Peoples Hosp, Dept Neurosurg, Ningbo 315300, Zhejiang, Peoples R China.	cry9020@126.com; weixj5100@126.com			Nature Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY14H09-0013, LQ16H090007, LY14H150010]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501953]; Nature Science Foundation of Ningbo City [2015A610192, 2015A610213]	This work was supported by the Nature Science Foundation of Zhejiang Province (LY14H09-0013, LQ16H090007, LY14H150010), the National Natural Science Foundation of China (81501953) and Nature Science Foundation of Ningbo City (2015A610192, 2015A610213).	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Camire RB, 2014, J PHARMACOL EXP THER, V351, P654, DOI 10.1124/jpet.114.218339; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Cuevas P, 1998, SURG NEUROL, V49, P77, DOI 10.1016/S0090-3019(97)00193-6; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; Dejana E, 2013, J CELL SCI, V126, P2545, DOI 10.1242/jcs.124529; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gunduz D, 2010, ARTERIOSCL THROM VAS, V30, P1237, DOI 10.1161/ATVBAHA.110.203901; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Hemmings B. A., 2015, COLD SPRING HARB PER, V7; Herbert C, 2014, PHARM PAT ANAL, V3, P585, DOI [10.4155/PPA.14.45, 10.4155/ppa.14.45]; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israeli D, 2011, INT J BIOL SCI, V7, P1; Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005; Li Z, 2016, J MOL NEUROSCI, V59, P193, DOI 10.1007/s12031-015-0668-5; Liu N, 2015, INT J CLIN EXP PATHO, V8, P4204; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Murillo CA, 2004, SURGERY, V136, P143, DOI 10.1016/j.surg.2004.04.006; Reyes R, 2009, J NEUROSURG, V110, P1218, DOI 10.3171/2008.8.JNS08382; Shimizu F, 2011, J CELL PHYSIOL, V226, P255, DOI 10.1002/jcp.22337; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Suzuki Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00002; Thurman D. J., 2016, J CHILD NEUROL, V31, P20, DOI DOI 10.1177/0883073814544363; Tran KA, 2016, CIRCULATION, V133, P177, DOI 10.1161/CIRCULATIONAHA.115.015982; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Wu S, 2010, MOL CELL BIOCHEM, V343, P223, DOI 10.1007/s11010-010-0517-3; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858; Zheng BB, 2016, J CELL MOL MED, V20, P1062, DOI 10.1111/jcmm.12761	41	24	27	0	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2017	9	3					910	+					18	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	ER7XK	WOS:000399028800007	28386321				2022-02-06	
J	Haring, RS; Sheffield, ID; Canner, JK; Schneider, EB				Haring, R. Sterling; Sheffield, Isaac D.; Canner, Joseph K.; Schneider, Eric B.			Epidemiology of Sports-Related Eye Injuries in the United States	JAMA OPHTHALMOLOGY			English	Article							US EMERGENCY-DEPARTMENTS; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; VISUAL IMPAIRMENT; PROTECTIVE EYEWEAR; VISION; RISK; SEVERITY; CASUALTY; TRENDS	IMPORTANCE Ocular trauma can lead to lifelong sequelae, and sports-related ocular injuries have been shown to disproportionately affect the young. Studies quantifying and characterizing the incidence and type of injuries seen with sports-related ocular trauma may be useful for resource utilization, training, and prevention efforts. OBJECTIVE To examine the emergency department (ED) burden of sports-related ocular trauma in the United States. DESIGN, SETTING, AND PARTICIPANTS This retrospective, cross-sectional study examined the Nationwide Emergency Department Sample, containing data from approximately 30 million ED visits annually at more than 900 hospitals nationwide, from January 1, 2010, to December 31, 2013, to determine factors associated with sports-related ocular trauma. MAIN OUTCOMES AND MEASURES Annual incidence of sports-related ocular trauma, broken down by age, sex, mechanism of injury, and related activity, as well as factors associated with short-term impaired vision. RESULTS During the study period, 120 847 individuals (mean age, 22.3 years [95% CI, 21.9-22.7]; 96 872 males, 23 963 females, and 12 with missing data) presented with sports-related ocular trauma, which was the primary diagnosis in 85 961 patients. Injuries occurred most commonly among males (69 849 [81.3%]; 95% CI, 80.6%-81.9%) and occurred most frequently as a result of playing basketball (22.6%; 95% CI, 21.7%-23.6%), playing baseball or softball (14.3%; 95% CI, 13.7%-14.9%), and shooting an air gun (11.8%; 95% CI, 10.8%-12.8%). Odds of presentation to the ED with impaired vision were greatest for paintball and air gun injuries relative to football-related injuries (odds ratio, 4.75; 95% CI, 2.21-10.19 and 3.71; 95% CI, 2.34-5.88, respectively; P < .001). CONCLUSIONS AND RELEVANCE In our study, approximately 30 000 individuals presented annually to EDs in the United States with sports-related eye injuries; in more than 70% of these cases, eye injuries were the primary diagnosis. Activities involving projectiles pose the greatest risk for visual impairment in the short term, although long-term outcomes were unavailable.	[Haring, R. Sterling] Univ Lugano, Ctr Healthcare Qual & Patient Safety, Via G Buffi 13, CH-6900 Lugano, Switzerland; [Haring, R. Sterling; Sheffield, Isaac D.; Schneider, Eric B.] Harvard Med Sch, Ctr Surg & Publ Hlth, Boston, MA USA; [Haring, R. Sterling; Schneider, Eric B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Haring, R. Sterling; Canner, Joseph K.; Schneider, Eric B.] Johns Hopkins Sch Med, Johns Hopkins Surg Ctr Outcomes Res, Baltimore, MD USA; [Sheffield, Isaac D.] Univ Iowa, Carver Coll Med, Iowa City, IA USA		Haring, RS (corresponding author), Univ Lugano, Ctr Healthcare Qual & Patient Safety, Via G Buffi 13, CH-6900 Lugano, Switzerland.	sterling.haring@jhmi.edu					[Anonymous], 2007, AV ANN RAT EY REL EM; Black AA, 2016, OPTOMETRY VISION SCI, V93, P560, DOI 10.1097/OPX.0000000000000831; Bro T, SCAND J MED SCI SPOR; Channa R, 2016, JAMA OPHTHALMOL, V134, P312, DOI 10.1001/jamaophthalmol.2015.5778; Chen Allison J, 2014, R I Med J (2013), V97, P44; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Court H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0181-7; Crews JE, 2006, J VISUAL IMPAIR BLIN, V100, P824; Esquivel AO, 2015, SPORTS HEALTH, V7, P366, DOI 10.1177/1941738115579854; Faul M, 2010, TRAUMATIC BRAIN INJU; FONG LP, 1994, MED J AUSTRALIA, V160, P743, DOI 10.5694/j.1326-5377.1994.tb125941.x; Frick KD, 2012, INDIAN J OPHTHALMOL, V60, P406, DOI 10.4103/0301-4738.100535; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Goldstein MH, 2011, EYE CONTACT LENS, V37, P160, DOI 10.1097/ICL.0b013e31821790db; Green D, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/4691276; Haring RS, 2016, INJURY, V47, P104, DOI 10.1016/j.injury.2015.07.020; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Hayes A, 2016, VALUE HEALTH, V19, P36, DOI 10.1016/j.jval.2015.10.010; Horowitz A, 2003, GENERATIONS, V27, P32; Hoskin AK, 2016, ACTA OPHTHALMOL, V94, pE407, DOI 10.1111/aos.12911; Ivers RQ, 2000, AM J EPIDEMIOL, V152, P633, DOI 10.1093/aje/152.7.633; JONES NP, 1989, SPORTS MED, V7, P163, DOI 10.2165/00007256-198907030-00003; JONES NP, 1988, EYE, V2, P484, DOI 10.1038/eye.1988.97; Karpman S, 2016, CLIN J SPORT MED, V26, P332, DOI 10.1097/JSM.0000000000000235; Kim T, 2011, GRAEF ARCH CLIN EXP, V249, P1743, DOI 10.1007/s00417-010-1556-x; Kriz PK, 2015, PEDIATRICS, V136, P521, DOI 10.1542/peds.2015-0216; Kriz PK, 2012, PEDIATRICS, V130, P1069, DOI 10.1542/peds.2012-1492; Kuhn F, 2006, OPHTHAL EPIDEMIOL, V13, P209, DOI 10.1080/09286580600665886; Lee DJ, 2002, ARCH OPHTHALMOL-CHIC, V120, P1544, DOI 10.1001/archopht.120.11.1544; Legood R, 2002, INJ PREV, V8, P155, DOI 10.1136/ip.8.2.155; Leivo T, 2007, SCAND J MED SCI SPOR, V17, P556, DOI 10.1111/j.1600-0838.2006.00607.x; Leivo T, 2015, ACTA OPHTHALMOL, V93, P224, DOI 10.1111/aos.12633; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; MACEWEN CJ, 1987, BRIT J OPHTHALMOL, V71, P701, DOI 10.1136/bjo.71.9.701; Micieli JA, 2014, CAN J OPHTHALMOL, V49, P243, DOI 10.1016/j.jcjo.2014.03.008; Ong HS, 2012, CONTACT LENS ANTERIO, V35, P285, DOI 10.1016/j.clae.2012.07.007; Pardhan S, 1995, EYE, V9, P50; Park HY, 2015, ASIA-PAC J PUBLIC HE, V27, P631, DOI 10.1177/1010539515588944; Park SJ, 2014, EYE, V28, P312, DOI 10.1038/eye.2013.283; Pineles SL, 2015, JAMA OPHTHALMOL, V133, P60, DOI 10.1001/jamaophthalmol.2014.3941; Pollard KA, 2012, CLIN PEDIATR, V51, P374, DOI 10.1177/0009922811427583; Popchak A, 2015, AM J PHYS MED REHAB, V94, P395, DOI 10.1097/PHM.0000000000000184; Press VG, 2015, J HOSP MED, V10, P311, DOI 10.1002/jhm.2342; Radic B, 2014, ACTA CLIN CROAT, V53, P430; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Wilson P, 2014, J R Nav Med Serv, V100, P56; Yuksel H, 2014, ARQ BRAS OFTALMOL, V77, P95, DOI 10.5935/0004-2749.20140024	49	24	25	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	DEC 1	2016	134	12					1382	1390		10.1001/jamaophthalmol.2016.4253			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	EF8SR	WOS:000390600300014	27812702				2022-02-06	
J	Harvey, L; Mitchell, R; Brodaty, H; Draper, B; Close, J				Harvey, Lara; Mitchell, Rebecca; Brodaty, Henry; Draper, Brian; Close, Jacqueline			Differing trends in fall-related fracture and non-fracture injuries in older people with and without dementia	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Falls; Injury; Dementia; Hospitalisation	HIP FRACTURE; RISK-FACTORS; ALZHEIMERS-DISEASE; POPULATION; RATES; CARE; MORTALITY; FINLAND; HOME	Objectives: To explore the impact of dementia on the trends in fall-related fracture and non-fracture injuries for older people. Methods: Individuals aged >= 65 years who were admitted to a NSW hospital for at least an over-night stay for a fall-related injury from 2003 to 2012 were identified. Age-standardised hospitalisation rates, length of stay, access to in-hospital rehabilitation, 30-day and 1-year mortality were examined. Annual percentage change (PAC) over time was calculated using negative binomial regression. Results: Of the 228,628 fall-related injury hospitalisations, 20.6% were for people with dementia. People with dementia were more likely to be admitted with a hip fracture, and less likely to be admitted with a fracture of the forearm/wrist, and received less in-hospital rehabilitation than people without dementia. Fall-related hip-fracture rates for people with dementia decreased by 4.2% (95% CI -5.6 to -2.7, p < 0.001) per annum; there was no change over time for people without dementia (PAC-0.2%; 95% CI -0.8 to 0.5, p = 0.643). Rates for other fractures decreased by 1.2% (95% CI -1.9 to -0.5, p < 0.001) per annum in people with dementia, while rates increased by 2.2% (95% CI 1.9-2.5, p < 0.001) for people without dementia. By contrast, non-fracture injuries including traumatic brain injury increased significantly for both people with and without dementia. Conclusion: Rates of fall-related fracture and non-fracture hospitalisations for people with dementia remain higher than for those without dementia. However, fall-related fracture hospitalisation rates have decreased for people with dementia, while there has not been a corresponding decrease in people without dementia. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Harvey, Lara; Mitchell, Rebecca; Close, Jacqueline] UNSW, Neurosci Res Australia, Falls Balance & Injury Res Ctr, Barker St, Randwick, NSW 2031, Australia; [Mitchell, Rebecca] Macquarie Univ, Australian Inst Hlth Innovat, Level 6,75 Talavera Rd, N Ryde, NSW 2109, Australia; [Brodaty, Henry; Draper, Brian] UNSW, Sch Psychiat, Dementia Collaborat Res Ctr Assessment & Better C, Level 3,AGSM Bldg, Sydney, NSW 2052, Australia; [Brodaty, Henry; Draper, Brian] UNSW Med, UNSW, Sch Psychiat, Ctr Hlth Brain Ageing,Euroa Ctr, Randwick, NSW 2031, Australia; [Close, Jacqueline] UNSW Med, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Harvey, Lara] UNSW, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia		Harvey, L (corresponding author), Neurosci Res Australia, Barker St, Sydney, NSW 2031, Australia.	l.harvey@neura.edu.au; r.mitchell@mq.edu.au; h.brodaty@unsw.edu.au; b.draper@unsw.edu.au; j.close@neura.edu.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761	Dementia Collaborative Research Centre-Assessment and Better Care, UNSW, Australia	This study was funded by the Dementia Collaborative Research Centre-Assessment and Better Care, UNSW, Australia. The authors would like to thank the NSW Ministry of Health and the NSW Registry of Birth Deaths and Marriages for the provision of the hospitalisation and death data extracts, and the Centre for Health Record Linkage (CHeReL) for the provision of the unique patient identifiers used to link the datasets.	Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Alzheimer's Association, 2015, ALZHEIMERS DEMENTIA, V11; Australian Health Performance Authority, 2013, HOSP PERF LENGTH S S; Australian Insitutute of Health and Welfare, 2015, INJ RES STAT SER, V95; Australian Insitutute of Health and Welfare, 2010, PROBL OST HIP FRACT; Australian Institute of Health and Welfare, 2012, 70 AGE AUSTR I HLTH; Australian Institute of Health and Welfare, 2012, BULLETIN, V110; Baker NL, 2011, AGE AGEING, V40, P49, DOI 10.1093/ageing/afq146; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Berry J., 2006, GUIDE STAT METHODS I; Centers for Disease Control and Prevention, 2015, COSTS FALLS OLD AD; Centre for Health Record Linkage, 2012, MAST LINK KEY QUAL A; Chau PH, 2013, AGE AGEING, V42, P229, DOI 10.1093/ageing/afs177; Cirera E, 2014, INJURY, V45, P2076, DOI 10.1016/j.injury.2014.09.016; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Deloitte Access Economics, 2011, DEM AUSTR; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Hartholt KA, 2011, J TRAUMA, V71, P255, DOI 10.1097/TA.0b013e31821c36e7; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey L, 2015, INJURY; Harvey L, 2013, TRENDS FALL RELATED; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hindmarsh D. M., 2012, AUSTRALASIAN J AGEIN, P1; Jaglal SB, 2005, J BONE MINER RES, V20, P898, DOI 10.1359/JBMR.041231; Jensen J, 2002, SCAND J PUBLIC HEALT, V30, P54, DOI 10.1177/14034948020300011201; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; King B, 2006, AUSTRALAS J AGEING, V25, P20, DOI 10.1111/j.1741-6612.2006.00135.x; Knopp-Sihota JA, 2014, GERIATR GERONTOL INT, V14, P121, DOI 10.1111/ggi.12069; Korhonen N, 2013, OSTEOPOROSIS INT, V24, P1599, DOI 10.1007/s00198-012-2190-8; Langa KM, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0118-1; Lenze EJ, 2004, INT J GERIATR PSYCH, V19, P472, DOI 10.1002/gps.1116; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Lip GYH, 2011, EUROPACE, V13, P723, DOI 10.1093/europace/eur126; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; NSW Ministry of Health, 2010, NEW S WAL FALLS PREV; Nurmi I, 1996, SCAND J CARING SCI, V10, P212; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Requena G, 2014, CALCIFIED TISSUE INT, V94, P580, DOI 10.1007/s00223-014-9850-y; Sachdev P. S., 2014, IS INCIDENCE DEMENTI; Scandol JP, 2013, INJURY, V44, P776, DOI 10.1016/j.injury.2012.11.023; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VANDIJK PTM, 1993, GERONTOLOGIST, V33, P200, DOI 10.1093/geront/33.2.200; Yiannopoulou KG, 2012, HIP INT, V22, P209, DOI 10.5301/HIP.2012.9229; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	46	24	24	1	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	NOV-DEC	2016	67						61	67		10.1016/j.archger.2016.06.014			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DU5RO	WOS:000382269200010	27434743				2022-02-06	
J	Hoflich, KM; Beyer, C; Clarner, T; Schmitz, C; Nyamoya, S; Kipp, M; Hochstrasser, T				Hoeflich, Katharina Marie; Beyer, Cordian; Clarner, Tim; Schmitz, Christoph; Nyamoya, Stella; Kipp, Markus; Hochstrasser, Tanja			Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach	BRAIN RESEARCH			English	Article						Axonal damage; APP; Experimental autoimmune encephalomyelitis; Cuprizone; Lysolecithin	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CUPRIZONE-INDUCED DEMYELINATION; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; KINESIN LIGHT-CHAIN; CORPUS-CALLOSUM; C57BL/6 MICE; IN-VIVO; FOCAL DEMYELINATION; GLATIRAMER ACETATE	Axonal damage has been identified as a significant contributor to permanent clinical disability in multiple sclerosis. In the context of demyelinating disorders, this destructive event can be the result of inflammation, demyelination and/or the activation of innate defense cells such as microglia or monocytes. The relative contribution of each of these variables to acute axonal injury is, however, unknown. In the present study, we compared the extent of acute axonal damage in three different murine demyelination models using anti-amyloid precursor protein (APP) immunohistochemistry. T cell dependent (MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE)) as well as T cell independent demyelination models (cuprizone- and lysolecithin-induced demyelination) were used. APP(+) spheroids were present in all three experimental demyelination models. The number of APP+ spheroids was highest within LPC-induced lesions. Equal amounts were found in the spinal cord of MOG(35-55)-EAE animals and the corpus callosum of cuprizone-intoxicated animals. Moreover, we detected increased immunoreactivity of the pre-synaptic protein vesicular glutamate transporter 1 (VGIuT1) in demyelinated foci. VG1uT1-staining revealed long stretched, ovoid-like axonal structures which co-localized with APP. In summary, we showed that acute axonal damage is evident under various experimental demyelination paradigms. Furthermore, disturbed axonal transport mechanisms, which are responsible for intraaxonal APP accumulation, do not only disturb APP, but also the transport of other synaptic proteins. These results indicate that, despite differences in their characteristics, all three models may serve as valid and suitable systems for investigating responsible mechanisms of axonal damage and potential protective strategies. (C) 2016 Elsevier B.V. All rights reserved.	[Hoeflich, Katharina Marie; Beyer, Cordian; Clarner, Tim; Nyamoya, Stella] Rhein Westfal TH Aachen, Fac Med, Inst Neuroanat, D-52074 Aachen, Germany; [Schmitz, Christoph; Nyamoya, Stella; Kipp, Markus; Hochstrasser, Tanja] Univ Munich, Dept Neuroanat, D-80336 Munich, Germany		Hochstrasser, T (corresponding author), Univ Munich, Dept Neuroanat, D-80336 Munich, Germany.	tanja.hochstrasser@med.uni-muenchen.de			Doktor Robert Pfleger - Stiftung	We would like to thank H. Helten, P. Ibold and A. Baltruschat for their excellent technical assistance and N. Angstman for English language and grammatical technical support. The present work was supported by the Doktor Robert Pfleger - Stiftung.	Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; ALVORD EC, 1985, NEUROCHEM PATHOL, V3, P195, DOI 10.1007/BF02834271; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brumovsky PR, 2013, J UROLOGY, V189, P2342, DOI 10.1016/j.juro.2012.11.046; Charcot JM., 1868, GAZETTE HOPITAUX, V41, P554; Choi J, 2008, ENDOCRINOLOGY, V149, P6146, DOI 10.1210/en.2008-0432; Clarner T, 2015, J IMMUNOL, V194, P3400, DOI 10.4049/jimmunol.1401459; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Correale J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00180; DOUSSET V, 1995, AM J NEURORADIOL, V16, P225; Franklin KBJ., 2001, PAXINOS FRANKLINS MO; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; Gilgun-Sherki Y, 2003, NEUROSCI RES, V47, P201, DOI 10.1016/S0168-0102(03)00217-7; Goldberg J, 2015, J MOL NEUROSCI; Grosse-Veldmann R., 2015, MOL NEUROBIOL; Haider L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/725370; Hares K, 2016, NEUROPATHOL APPL NEU; Heese K, 1998, J NEUROCHEM, V70, P699; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Herder V, 2011, NEUROPATH APPL NEURO, V37, P676, DOI 10.1111/j.1365-2990.2011.01168.x; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Imai M, 2008, J NEUROSURG-SPINE, V8, P58, DOI 10.3171/SPI-08/01/058; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Kipp M, 2011, BRAIN BEHAV IMMUN, V25, P1554, DOI 10.1016/j.bbi.2011.05.003; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Lassmann H, 1998, MULT SCLER J, V4, P93, DOI 10.1177/135245859800400301; Lindner M, 2009, NEUROSCI LETT, V453, P120, DOI 10.1016/j.neulet.2009.02.004; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ormel L, 2012, GLIA, V60, P229, DOI 10.1002/glia.21258; Paolillo A, 1999, NEUROLOGY, V53, P751, DOI 10.1212/WNL.53.4.751; Pfeifenbring S, 2015, ANN NEUROL, V77, P655, DOI 10.1002/ana.24364; Pierce ET., 1971, ATLAS MOUSE BRAIN SP; Pierce JES, 1996, J NEUROSCI, V16, P1083; Scalfari A, 2013, JAMA NEUROL, V70, P214, DOI 10.1001/jamaneurol.2013.599; Scheld M, 2016, J NEUROSCI, V36, P1410, DOI 10.1523/JNEUROSCI.2456-15.2016; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Schmidt T, 2013, J MOL NEUROSCI, V49, P80, DOI 10.1007/s12031-012-9896-0; Serbinek D, 2010, CARDIOVASC PSYCHIAT, V2010; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shriver LP, 2006, AM J PATHOL, V169, P999, DOI 10.2353/ajpath.2006.050791; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Slowik A, 2015, BRIT J PHARMACOL, V172, P80, DOI 10.1111/bph.12938; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Sun J., 2016, ONCOTARGET; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; van Noort JM, 2011, CNS NEUROL DISORD-DR, V10, P68; WAXMAN SG, 1979, J NEUROL SCI, V44, P45, DOI 10.1016/0022-510X(79)90221-1; Wessig C, 2007, EXP NEUROL, V204, P14, DOI 10.1016/j.expneurol.2006.09.022; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	62	24	24	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 1	2016	1650						125	133		10.1016/j.brainres.2016.08.048			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ9IF	WOS:000386187800014	27592741				2022-02-06	
J	Vynorius, KC; Paquin, AM; Seichepine, DR				Vynorius, Kyle C.; Paquin, Alyssa M.; Seichepine, Daniel R.			Lifetime Multiple Mild Traumatic Brain Injures Are Associated with Cognitive and Mood Symptoms in Young Healthy College Students	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; neuropsychology; executive function; cognition	FOOTBALL; IMPAIRMENT	Background/objectives: Repetitive mild traumatic brain injury (mTBI, also known as concussion) has been associated with a range of long-term mood and cognitive deficits, including executive dysfunction. Previous research in athletes suggests that cognitive and mood problems are associated with a history of repetitive mTBI. However, to date, no studies have examined the impact of a lifetime accumulation of repetitive mTBIs on cognition, particularly executive functioning, and mood in a sample of young adults who were not athletes. Therefore, the present study looked at potential effects of repetitive mTBIs on self-reported cognitive complaints, executive functioning, and mood in young adults. Methods: Eighty-four total students responded, and 26 of those were excluded from analyses due to reporting only 1 mTBI. The final sample consisted of 58 healthy young adults (mean age = 22.84, STD = 4.88) who completed the Cognitive Complaint Index (CCI), the Behavior Rating Inventory of Executive Function, adult version (BRIEF-A), and the Beck Depression Inventory, second edition (BDI-II). Twenty-nine participants denied having an mTBI history, and 29 reported 2 or more lifetime mTBIs (range 2-7). Results: Young otherwise healthy adults with a lifetime history of repetitive mTBI compared to those that reported no history of mTBI reported more change in cognitive functioning over the past 5 years, worse executive functioning, and more symptoms of depression. As the number of lifetime mTBIs increased, scores on the CCI, BRIEF-A, and BDI-II also increased, indicating worse functioning. Conclusion: These findings suggest that a lifetime accumulation of two or more mTBIs as compared to a history of no reported mTBIs may result in worse cognitive functioning and symptoms of depression in young adults.	[Vynorius, Kyle C.; Paquin, Alyssa M.; Seichepine, Daniel R.] Univ New Hampshire Manchester, Neuropsychol Lab, Manchester, NH USA		Seichepine, DR (corresponding author), Univ New Hampshire Manchester, Neuropsychol Lab, Manchester, NH USA.	daniel.seichepine@unh.edu			UNH, Manchester's Manchester Undergraduate Project Support Grant	Portions of this study were supported by UNH, Manchester's Manchester Undergraduate Project Support Grant.	[Anonymous], 2015, C TRAUM BRAIN INJ US; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Center for Disease Control and Prevention, 2003, CTR DIS CONTR FACT S, P1; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roth RM, 2005, BRIEF A BEHAV RATING; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Ware JB, 2016, RADIOLOGY, V280, P212, DOI 10.1148/radiol.2016151013	24	24	24	0	24	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 31	2016	7								188	10.3389/fneur.2016.00188			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EA3UH	WOS:000386530300001	27843436	gold, Green Published			2022-02-06	
J	Sherman, SA; Phillips, JK; Costa, JT; Cho, FS; Oungoulian, SR; Finan, JD				Sherman, Sydney A.; Phillips, Jack K.; Costa, J. Tighe; Cho, Frances S.; Oungoulian, Sevan R.; Finan, John D.			Stretch Injury of Human Induced Pluripotent Stem Cell Derived Neurons in a 96 Well Format	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; HIPPOCAMPAL SLICE CULTURES; MECHANICAL STRETCH; AXONAL INJURY; STRAIN-RATE; MEMBRANE-PERMEABILITY; CALCIUM INFLUX; NEURAL TRAUMA; ION CHANNELS	Traumatic brain injury (TBI) is a major cause of mortality and morbidity with limited therapeutic options. Traumatic axonal injury (TAI) is an important component of TBI pathology. It is difficult to reproduce TAI in animal models of closed head injury, but in vitro stretch injury models reproduce clinical TAI pathology. Existing in vitro models employ primary rodent neurons or human cancer cell line cells in low throughput formats. This in vitro neuronal stretch injury model employs human induced pluripotent stem cell-derived neurons (hiPSCNs) in a 96 well format. Silicone membranes were attached to 96 well plate tops to create stretchable, culture substrates. A custom-built device was designed and validated to apply repeatable, biofidelic strains and strain rates to these plates. A high content approach was used to measure injury in a hypothesis-free manner. These measurements are shown to provide a sensitive, dose-dependent, multi-modal description of the response to mechanical insult. hiPSCNs transition from healthy to injured phenotype at approximately 35% Lagrangian strain. Continued development of this model may create novel opportunities for drug discovery and exploration of the role of human genotype in TAI pathology.	[Sherman, Sydney A.; Phillips, Jack K.; Finan, John D.] NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA; [Costa, J. Tighe; Cho, Frances S.] Columbia Univ, Dept Biomed Engn, New York, NY USA		Finan, JD (corresponding author), NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA.	jfinan@northshore.org		Phillips, Jack/0000-0002-5362-8833; Finan, John/0000-0003-4626-9702			Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alhebshi AH, 2014, NEUROSCI LETT, V570, P126, DOI 10.1016/j.neulet.2013.09.049; Amin H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00121; Becker N, 2013, J PHARMACOL TOX MET, V68, P82, DOI 10.1016/j.vascn.2013.03.009; Berry BJ, 2015, BIOTECHNOL PROGR, V31, P1613, DOI 10.1002/btpr.2160; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Faul M, 2010, TRAUMATIC BRAIN INJU; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Haythornthwaite A, 2012, J BIOMOL SCREEN, V17, P1264, DOI 10.1177/1087057112457821; Holbourn A.H.S, 1943, LANCET, V243, P483; HUNG CT, 1994, J BIOMECH, V27, P227, DOI 10.1016/0021-9290(94)90212-7; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Lai W.M., 1993, INTRO CONTINUUM MECH, V134; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Markos SM, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000224; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; Meneghello G, 2015, NEUROSCIENCE, V301, P204, DOI 10.1016/j.neuroscience.2015.05.071; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Morrison G, 2016, STEM CELL RES, V16, P140, DOI 10.1016/j.scr.2015.12.025; Odawara A, 2014, BIOCHEM BIOPH RES CO, V443, P1176, DOI 10.1016/j.bbrc.2013.12.142; Padmanabhan K, 2010, J NEUROSCI METH, V193, P380, DOI 10.1016/j.jneumeth.2010.08.031; Peterson C, 2015, CHILD MALTREATMENT, V20, P162, DOI 10.1177/1077559515583549; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Ryan KR, 2016, NEUROTOXICOLOGY, V53, P271, DOI 10.1016/j.neuro.2016.02.003; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sirenko O, 2014, ASSAY DRUG DEV TECHN, V12, P536, DOI 10.1089/adt.2014.592; Smith DH, 1999, J NEUROSCI, V19, P4263; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sunkara V, 2011, LAB CHIP, V11, P962, DOI [10.1039/c0lc00272k, 10.1039/c01c00272k]; Tukker A. M., 2016, ALTEX, DOI 10.14573/altex.1510091; Ursekar CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090665; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Wheeler HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118020; WILLIAMS JL, 1992, J BIOMECH ENG-T ASME, V114, P377, DOI 10.1115/1.2891398; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	60	24	24	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 27	2016	6								34097	10.1038/srep34097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX0VY	WOS:000384085500001	27671211	Green Published, gold			2022-02-06	
J	Abdel-Aziz, AK; Mantawy, EM; Said, RS; Helwa, R				Abdel-Aziz, Aural Kamal; Mantawy, Eman M.; Said, Riham Soliman; Helwa, Reham			The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries	EXPERIMENTAL NEUROLOGY			English	Article						Sunitinib; Cognition; VEGF; Apoptosis; Autophagy	NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; PHASE-II TRIAL; HIPPOCAMPAL NEUROGENESIS; NEURODEGENERATIVE DISORDERS; ENDOMETRIAL CARCINOMA; MOLECULAR-MECHANISMS; NEURONAL APOPTOSIS	Chemobrain refers to a cluster of cognitive deficits which affects almost 4-75% of chemotherapy-treated cancer patients. Sunitinib, an FDA-approved multityrosine kinase inhibitor, is currently used in treating different types of tumors. Despite being regarded as targeted therapy which blunts sustained angiogenesis in cancer milieu through inhibiting vascular endothelial growth factor receptor 2 (VEGFR2) signaling, the latter has a cardinal role in cognition. Recent clinical reports warned that sunitinib adversely affected memory processing in cancer patients. Nevertheless, the underlying mechanisms have not been investigated yet. Hence, we explored the impact of a clinically relevant dose of sunitinib on memory processing in vivo and questioned the implication of VEGFR2 signaling, autophagy and apoptosis. Strikingly, sunitinib preferentially impaired spatial cognition as evidenced in Morris water maze, T-maze and passive avoidance task. Consistently, sunitinib degenerated cortical and hippocampal neurons as assessed by histopathological examination and toluidine blue staining. Ultra structural examination also depicted chromatin condensation, mitochondrial damage and accumulated autophagosomes. Digging deeper, central VEGF/VEGFR2/mTOR signaling was robustly suppressed. Besides, sunitinib boosted cortical and hippocampal p53 and executioner caspase-3 and decreased nuclear factor kappa B and Bcl-2 levels promoting apoptotic cell death. It also profoundly impeded neuronal autophagic flux as shown by decreased beclin-1 and AtgS and increased p62/SQTSM1 levels. To our knowledge, this is the first study to provide molecular insights into sunitinib-induced chemofog where impeded VEGFR2 signaling and autophagic and hyperactivated apoptotic machineries act in neurodegenerative concert. Importantly, our findings shed light on potential therapeutic strategies to be exploited in the management of sunitinib-induced chemobrain. (C) 2016 Elsevier Inc. All rights reserved.	[Abdel-Aziz, Aural Kamal; Mantawy, Eman M.] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, African Union Org St, Cairo 11566, Egypt; [Said, Riham Soliman] Atom Energy Author, Natl Ctr Radiat Res & Technol, Cairo, Egypt; [Helwa, Reham] Ain Shams Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Abdel-Aziz, Aural Kamal] European Inst Oncol, Dept Expt Oncol, Milan, Italy		Abdel-Aziz, AK (corresponding author), Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, African Union Org St, Cairo 11566, Egypt.	AmalAbdel-Aziz@pharma.asu.edu.eg	Said, Riham/AAR-1943-2021; Abdel-Aziz, Amal Kamal/AAB-9050-2019; Abdel-Aziz, Amal Kamal/AAA-1360-2021; Helwa, Reham/N-9198-2016	Abdel-Aziz, Amal Kamal/0000-0003-1709-1183; Helwa, Reham/0000-0003-1009-0786			Abdel-Aziz AK, 2014, CHEM-BIOL INTERACT, V217, P28, DOI 10.1016/j.cbi.2014.04.007; Abouantoun TJ, 2011, J NEURO-ONCOL, V101, P215, DOI 10.1007/s11060-010-0259-9; Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Aita Y, 2012, AM J PHYSIOL-ENDOC M, V303, pE1006, DOI 10.1152/ajpendo.00156.2012; Aparicio-Gallego G, 2011, MOL CANCER THER, V10, P2215, DOI 10.1158/1535-7163.MCT-10-1124; Bachelot T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-166; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Baumann KH, 2012, ANN ONCOL, V23, P2265, DOI 10.1093/annonc/mds003; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Bordun KA, 2015, AM J PHYSIOL-HEART C, V309, pH692, DOI 10.1152/ajpheart.00172.2015; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Calero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095628; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Castonguay V, 2014, GYNECOL ONCOL, V134, P274, DOI 10.1016/j.ygyno.2014.05.016; Cavaletti Guido, 2015, Am Soc Clin Oncol Educ Book, pe553, DOI 10.14694/EdBook_AM.2015.35.e553; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Correa DD, 2008, CANCER J, V14, P396, DOI 10.1097/PPO.0b013e31818d8769; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Huang H, 2015, FASEB J, V29, P227, DOI 10.1096/fj.14-250985; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jackson GE, 2008, MED HYPOTHESES, V70, P572, DOI 10.1016/j.mehy.2007.06.019; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; Kitamura Y, 2015, BEHAV BRAIN RES, V292, P184, DOI 10.1016/j.bbr.2015.06.007; Klug M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00149; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lopergolo A, 2014, J CLIN ENDOCR METAB, V99, P498, DOI 10.1210/jc.2013-2574; Martini M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00202; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Michel HE, 2013, NEUROSCI LETT, V544, P110, DOI 10.1016/j.neulet.2013.03.055; Mulder SF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-219; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ortuzar N, 2013, BEHAV BRAIN RES, V246, P36, DOI 10.1016/j.bbr.2013.02.036; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Plaschke K, 2008, EXP NEUROL, V214, P285, DOI 10.1016/j.expneurol.2008.08.014; Santoni M, 2013, BRIT J CANCER, V109, P1040, DOI 10.1038/bjc.2013.420; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sorolla A, 2012, MOL ONCOL, V6, P530, DOI 10.1016/j.molonc.2012.06.006; Speed B, 2012, DRUG METAB DISPOS, V40, P539, DOI 10.1124/dmd.111.042853; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; van der Veldt AAM, 2007, ANN ONCOL, V18, P1747, DOI 10.1093/annonc/mdm455; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Wrasidlo W, 2014, BRIT J PHARMACOL, V171, P5757, DOI 10.1111/bph.12875; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102110; Yang FY, 2014, BEHAV BRAIN RES, V264, P82, DOI 10.1016/j.bbr.2014.02.005; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	61	24	24	1	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2016	283		A				129	141		10.1016/j.expneurol.2016.06.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW0EU	WOS:000383314500012	27288242				2022-02-06	
J	Myrga, JM; Failla, MD; Ricker, JH; Dixon, CE; Conley, YP; Arenth, PM; Wagner, AK				Myrga, John M.; Failla, Michelle D.; Ricker, Joseph H.; Dixon, C. Edward; Conley, Yvette P.; Arenth, Patricia M.; Wagner, Amy K.			A Dopamine Pathway Gene Risk Score for Cognitive Recovery Following Traumatic Brain Injury: Methodological Considerations, Preliminary Findings, and Interactions With Sex	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; dopamine; genetics; Rehabilomics; traumatic brain injury	CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET POLYMORPHISM; PREFRONTAL CORTEX; MOLECULAR HETEROSIS; TRANSPORTER EXPRESSION; GENDER-DIFFERENCES; HEALTHY-ADULTS; WORKING-MEMORY; FEMALE RATS; RECEPTOR	Objectives: With evidence of sexual dimorphism involving the dopamine (DA)-pathway, and the importance of DA pathways in traumatic brain injury (TBI) recovery, we hypothesized that sex x DA-gene interactions may influence cognition post-TBI. Participants: Adult survivors of severe TBI (n = 193) consecutively recruited from a level 1 trauma center. Design: Risk allele assignments were made for multiple DA pathway genes using a sex-specific stratified approach. Genetic risk alleles, and their impacts on cognition, were assessed at 6 and 12 months postinjury using unweighted, semiweighted, and weighted gene risk score (GRS) approaches. Main Measures: A cognitive composite score generated from 8 standardized neuropsychological tests targeting multiple cognitive domains. Results: A significant sex x gene interaction was observed at 6 and 12 months for ANKK1 rs1800497 (6M: P =.002, 12M: P =.001) and COMT rs4680 (6M: P =.048; 12M: P =.004); DRD2 rs6279 (P =.001) and VMAT rs363226 (P =.043) genotypes were independently associated with cognition at 6 months, with trends for a sex x gene interaction at 12 months. All GRS methods were significant predictors of cognitive performance in multivariable models. Weighted GRS multivariate models captured the greatest variance in cognition: R-2 = 0.344 (6 months); R-2 = 0.441 (12 months), significantly increasing the variance captured from the base prediction models. Conclusions: A sex-specific DA-pathway GRS may be a valuable tool when predicting cognitive recovery post-TBI. Future work should validate these findings and explore how DA-pathway genetics may guide therapeutic intervention.	[Myrga, John M.; Failla, Michelle D.; Dixon, C. Edward; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Failla, Michelle D.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Ctr Neurosci, Pittsburgh, PA USA; [Ricker, Joseph H.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Hlth Care Syst, Educ & Clin Ctr, Geriatr Res, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Dixon, C. Edward; Conley, Yvette P.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Ricker, Joseph/0000-0003-3415-991X; Conley, Yvette/0000-0002-1784-6067	NIDILRRUnited States Department of Health & Human Services [H133A120087]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162, R01 NR013342]; DODUnited States Department of Defense [W81XWH-071-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342] Funding Source: NIH RePORTER	This research was supported by the following: NIDILRR: H133A120087; NIH: R01 HD048162; DOD: W81XWH-071-0701; NIH: R01 NR013342.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Altar CA, 2015, PHARMACOGENOMICS J, V15, P443, DOI 10.1038/tpj.2014.85; Amstadter AB, 2012, J PSYCHIATR RES, V46, P940, DOI 10.1016/j.jpsychires.2012.04.010; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Backman L, 2000, AM J PSYCHIAT, V157, P635; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BECKER JB, 1990, NEUROSCI LETT, V118, P169, DOI 10.1016/0304-3940(90)90618-J; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brighina L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.020; Centers for Disease Control and Prevention, TBI US REP TRAUM BRA; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chen CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1593, DOI 10.1038/npp.2011.39; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Comings DE, 1999, MOL PSYCHIATR, V4, P213, DOI 10.1038/sj.mp.4000500; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis D.C., 2001, D KEFS EXAMINERS MAN; Dluzen DE, 2008, NEUROSCIENCE, V154, P1488, DOI 10.1016/j.neuroscience.2008.04.051; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Failla MD, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000118, DOI 10.1097/HTR.0000000000000118.]; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; GORDON JH, 1980, BRAIN RES BULL, V5, P679, DOI 10.1016/0361-9230(80)90205-1; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Gurvich C, 2015, BEHAV BRAIN RES, V281, P96, DOI 10.1016/j.bbr.2014.11.045; Haghgoo SM, 2015, EUR J PHARMACOL, V754, P88, DOI 10.1016/j.ejphar.2015.02.029; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P620, DOI 10.1038/sj.npp.1300070; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Harun R, 2015, J NEUROTRAUM, V32, pA97; HRUSKA RE, 1982, PHARMACOL BIOCHEM BE, V16, P285, DOI 10.1016/0091-3057(82)90162-9; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Janssens ACJW, 2011, EUR J HUM GENET, V19, P833, DOI 10.1038/ejhg.2011.25; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kazantseva A, 2011, PROG NEURO-PSYCHOPH, V35, P1033, DOI 10.1016/j.pnpbp.2011.02.013; Kerkhof HJM, 2014, ANN RHEUM DIS, V73, P2116, DOI 10.1136/annrheumdis-2013-203620; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kritzer MF, 2008, J NEUROSCI, V28, P9525, DOI 10.1523/JNEUROSCI.2637-08.2008; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Lee HS, 2003, AM J MED GENET B, V118B, P55, DOI 10.1002/ajmg.b.10036; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lohoff FW, 2010, METHODS MOL BIOL, V637, P165, DOI 10.1007/978-1-60761-700-6_9; Madan A, 2015, PHARMACOGENOMICS, V16, P433, DOI [10.2217/PGS.15.9, 10.2217/pgs.15.9]; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Munro CA, 2006, BIOL PSYCHIAT, V59, P966, DOI 10.1016/j.biopsych.2006.01.008; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Seamans JK, 2010, RECEPT SER, P373, DOI 10.1007/978-1-60327-333-6_14; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Simons CJP, 2013, SCHIZOPHRENIA BULL, V39, P848, DOI 10.1093/schbul/sbs067; Soeiro-de-Souza MG, 2013, MOL MED REP, V8, P837, DOI 10.3892/mmr.2013.1564; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2013, NEUROIMAGE, V68, P49, DOI 10.1016/j.neuroimage.2012.11.059; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; van der Net JB, 2009, AM J CARDIOL, V103, P375, DOI 10.1016/j.amjcard.2008.09.093; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; White TP, 2014, NEUROPSYCHOPHARMACOL, V39, P2560, DOI 10.1038/npp.2014.107; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Wolfson D., 1985, HELSTEAD REITAN NEUR; XIAO L, 1994, NEUROSCI LETT, V180, P155, DOI 10.1016/0304-3940(94)90510-X; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Yaffe K, 2002, BIOL PSYCHIAT, V51, P677, DOI 10.1016/S0006-3223(01)01289-6; Yaffe K, 2009, NEUROBIOL AGING, V30, P607, DOI 10.1016/j.neurobiolaging.2007.08.003; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zai CC, 2013, J PSYCHIATR RES, V47, P1760, DOI 10.1016/j.jpsychires.2013.07.025; Zawarynski P, 1998, FEBS LETT, V441, P383, DOI 10.1016/S0014-5793(98)01588-9	102	24	24	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					E15	E29		10.1097/HTR.0000000000000199			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600003	26580694				2022-02-06	
J	Stache, S; Howell, D; Meehan, WP				Stache, Stephen; Howell, David; Meehan, William P., III			Concussion Management Practice Patterns Among Sports Medicine Physicians	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport-related concussion; management; medications; neuropsychological testing; return to play	STATES HIGH-SCHOOL; UNITED-STATES; PEDIATRIC-PATIENTS	Objective:The primary purpose of this study was to examine concussion management practice patterns among sports medicine physicians in the United States.Design:Cross-sectional study using a web-based survey.Participants:Members of the American Medical Society for Sports Medicine (AMSSM).Main Outcome Measures:We distributed a questionnaire to physician members of the AMSSM assessing the current practices for evaluating and managing concussions sustained during sports. Specifically, we asked respondents about their use of management guidelines, medications, balance assessments, neuropsychological tests, and return-to-play strategies.Results:Of the 3591 members emailed, 425 (11.8%) respondents responded. Ninety-seven percent of respondents reported basing current management of sport-related concussion on a published set of criteria, with a majority (91.9%) following the guidelines provided by the Fourth International Conference on Concussion in Sport. Seventy-six percent of respondents reported using medication beyond 48 hours postinjury. Acetaminophen was reported as the most commonly administered medication, although tricyclic antidepressants and amantadine were also commonly administered. Vitamins, minerals, and dietary supplements were also reported as commonly administered. Most respondents reported using a form of neuropsychological testing (87.1%). A majority of respondents (88.6%) reported allowing athletes to return to competition after concussion only once the athlete becomes symptom free and completes a return-to-play protocol.Conclusions:Most sports medicine physicians seem to use recently developed guidelines for concussion management, regularly use medications and neuropsychological testing in management strategies, and follow established return-to-play guidelines.Clinical Relevance:Sports medicine physicians seem to have clinical expertise in the management of sport-related concussion.	[Stache, Stephen] Rothman Inst Orthopaed, Philadelphia, PA USA; [Stache, Stephen] Thomas Jefferson Univ, Dept Family & Community Med, Philadelphia, PA 19107 USA; [Howell, David; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthoped, Boston, MA USA; [Howell, David; Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Howell, David; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Emergency Med, Dept Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA; Harvard Med Sch, Dept Orthoped, Boston, MA USA		Stache, S (corresponding author), 825 Old Lancaster Ave,Ste 200, Bryn Mawr, PA 19096 USA.	Stephen.stache@rothmaninstitute.com		Howell, David/0000-0002-2955-0191	National Football League Players Association	W.P.M. receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and royalties from Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. The reamining authors report no conflicts of interest.	[Anonymous], 2014, TRAUM BRAIN INJ LEG; [Anonymous], 2014, POP WARNER CONCUSSIO; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2002, BRIT J SPORT MED, V36, P3, DOI 10.1136/bjsm.36.1.3; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	22	24	24	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2016	26	5					381	385		10.1097/JSM.0000000000000270			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DW8LH	WOS:000383906800008	26584436				2022-02-06	
J	Wang, SN; Xu, TY; Wang, X; Guan, YF; Zhang, SL; Wang, P; Miao, CY				Wang, Shu-Na; Xu, Tian-Ying; Wang, Xia; Guan, Yun-Feng; Zhang, Sai-Long; Wang, Pei; Miao, Chao-Yu			Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Aminopropyl carbazole chemical; Ischemic stroke; Neuroprotection; Nicotinamide adenine dinucleotide; Nicotinamide phosphoribosyltransferase; P7C3-A20	TARGETING NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL NEUROGENESIS; MOUSE MODEL; RATS; DISCOVERY; ACTIVATION; AUTOPHAGY; VISFATIN	AimNAMPT is a novel therapeutic target of ischemic stroke. The aim of this study was to investigate the effect of a potential NAMPT activator, P7C3-A20, an aminopropyl carbazole derivative, on ischemic stroke. MethodsIn vitro study, neuron protection effect of P7C3-A20 was investigated by co-incubation with primary neurons subjected to oxygen-glucose deprivation (OGD) or oxygen-glucose deprivation/reperfusion (OGD/R) injury. In vivo experiment, P7C3-A20 was administrated in middle cerebral artery occlusion (MCAO) rats and infarct volume was examined. Lastly, the brain tissue nicotinamide adenine dinucleotide (NAD) levels were detected in P7C3-A20 treated normal or MCAO mice. ResultsCell viability, morphology, and Tuj-1 staining confirmed the neuroprotective effect of P7C3-A20 in OGD or OGD/R model. P7C3-A20 administration significantly reduced cerebral infarction in MCAO rats. Moreover, brain NAD levels were elevated both in normal and MCAO mice after P7C3-A20 treatment. ConclusionsP7C3-A20 has neuroprotective effect in cerebral ischemia. The study contributes to the development of NAMPT activators against ischemic stroke and expands the horizon of the neuroprotective effect of aminopropyl carbazole chemicals.	[Wang, Shu-Na; Xu, Tian-Ying; Wang, Xia; Guan, Yun-Feng; Zhang, Sai-Long; Wang, Pei; Miao, Chao-Yu] Second Mil Med Univ, Dept Pharmacol, 325 Guo He Rd, Shanghai 200433, Peoples R China; [Miao, Chao-Yu] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China		Miao, CY (corresponding author), Second Mil Med Univ, Dept Pharmacol, 325 Guo He Rd, Shanghai 200433, Peoples R China.	cymiao@smmu.edu.cn	WANG, PEI/AAH-3926-2019	WANG, PEI/0000-0002-1650-3353; Miao, Chao-Yu/0000-0002-8176-3434	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81130061, 81373414, 81422049]; National Science and Technology Major Project [2009ZX09303-002]; National 863 Plan Young Scientist Program of ChinaNational High Technology Research and Development Program of China [2015AA020943]	This work was supported by grants from the National Natural Science Foundation of China (81130061 and 81373414 to C.-Y.M.), the National Science and Technology Major Project (2009ZX09303-002 to C.-Y.M), the National Natural Science Foundation of China (81422049 to P.W.), and the National 863 Plan Young Scientist Program of China (2015AA020943 to P.W.). We thank Ming-Jun Zheng for technical assistance.	Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Chen J, 2015, CNS NEUROSCI THER, V21, P301, DOI 10.1111/cns.12392; Chen WF, 2015, CNS NEUROSCI THER, V21, P698, DOI 10.1111/cns.12429; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Dirnagl U, 2014, STROKE, V45, P1510, DOI 10.1161/STROKEAHA.113.004075; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Guo XB, 2015, ACTA PHARMACOL SIN, V36, P1266, DOI 10.1038/aps.2015.25; Guo ZL, 2015, ACTA PHARMACOL SIN, V36, P748, DOI 10.1038/aps.2014.167; Jiang BM, 2013, CARDIOVASC RES, V99, P92, DOI 10.1093/cvr/cvt085; Kemp SWP, 2015, NEUROSCIENCE, V284, P202, DOI 10.1016/j.neuroscience.2014.10.005; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Latchney SE, 2015, NEUROSCI LETT, V591, P86, DOI 10.1016/j.neulet.2015.02.008; Li Y, 2015, CNS NEUROSCI THER, V21, P905, DOI 10.1111/cns.12469; Lin Y, 2016, CNS NEUROSCI THER, V22, P477, DOI 10.1111/cns.12519; Liu ZJ, 2016, CNS NEUROSCI THER, V22, P43, DOI 10.1111/cns.12448; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Naidoo J, 2014, J MED CHEM, V57, P3746, DOI 10.1021/jm401919s; Pacher P, 2002, J PHARMACOL EXP THER, V300, P862, DOI 10.1124/jpet.300.3.862; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Sampath D, 2015, PHARMACOL THERAPEUT, V151, P16, DOI 10.1016/j.pharmthera.2015.02.004; Shen L, 2016, ACTA PHARMACOL SIN, V37, P312, DOI 10.1038/aps.2015.106; Su Y, 2015, CNS NEUROSCI THER, V21, P870, DOI 10.1111/cns.12419; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang P, 2015, CNS NEUROSCI THER, V21, P475, DOI 10.1111/cns.12388; Wang P, 2014, CARDIOVASC RES, V104, P477, DOI 10.1093/cvr/cvu220; Wang P, 2014, AUTOPHAGY, V10, P1535, DOI 10.4161/auto.29203; Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2012, J CARDIOVASC PHARM, V59, P1, DOI 10.1097/FJC.0b013e31820eb8f6; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Wang P, 2015, MAT SCI SEMICON PROC, V36, P36, DOI 10.1016/j.mssp.2015.03.022; Wang SN, 2016, CNS NEUROSCI THER, V22, P431, DOI 10.1111/cns.12539; Wang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep12657; Xie H, 2014, ACTA PHARMACOL SIN, V35, P1504, DOI 10.1038/aps.2014.78; Xu TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10043; Xu TY, 2015, ACTA PHARMACOL SIN, V36, P429, DOI 10.1038/aps.2015.5; Yang D, 2015, CNS NEUROSCI THER, V21, P367, DOI 10.1111/cns.12365; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Zhang RY, 2011, ANAL BIOCHEM, V412, P18, DOI 10.1016/j.ab.2010.12.035; Zhang XH, 2011, CNS NEUROSCI THER, V17, P590, DOI 10.1111/j.1755-5949.2011.00271.x; Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216; Zhao Y, 2014, CNS NEUROSCI THER, V20, P539, DOI 10.1111/cns.12273	47	24	25	0	18	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	SEP	2016	22	9					782	788		10.1111/cns.12576			7	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DS8ER	WOS:000381016600006	27333812	Green Published, Bronze			2022-02-06	
J	Dong, TT; Zhi, L; Bhayana, B; Wu, MX				Dong, Tingting; Zhi, Liang; Bhayana, Brijesh; Wu, Mei X.			Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						TBI; T lymphocytes; Cortisol; Inflammation; cAMP	SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; SPHINGOSINE 1-PHOSPHATE; T-CELLS; TREATMENT STRATEGIES; CONTROLLED-TRIAL; PROGESTERONE; METHYLPREDNISOLONE; NEUROGENESIS; RECEPTORS	Background: Acute traumatic brain injury (TBI) represents one of major causes of mortality and disability in the USA. Neuroinflammation has been regarded both beneficial and detrimental, probably in a time-dependent fashion. Methods: To address a role for neuroinflammation in brain injury, C57BL/6 mice were subjected to a closed head mild TBI (mTBI) by a standard controlled cortical impact, along with or without treatment of sphingosine 1-phosphate (S1P) or rolipram, after which the brain tissue of the impact site was evaluated for cell morphology via histology, inflammation by qRT-PCR and T cell staining, and cell death with Caspase-3 and TUNEL staining. Circulating lymphocytes were quantified by flow cytometry, and plasma hydrocortisone was analyzed by LC-MS/MS. To investigate the mechanism whereby cortisol lowered the number of peripheral T cells, T cell egress was tracked in lymph nodes by intravital confocal microscopy after hydrocortisone administration. Results: We detected a decreased number of circulating lymphocytes, in particular, T cells soon after mTBI, which was inversely correlated with a transient and robust increase of plasma cortisol. The transient lymphocytopenia might be caused by cortisol in part via a blockade of lymphocyte egress as demonstrated by the ability of cortisol to inhibit T cell egress from the secondary lymphoid tissues. Moreover, exogenous hydrocortisone severely suppressed periphery lymphocytes in uninjured mice, whereas administering an egress-promoting agent SIP normalized circulating T cells in mTBI mice and increased T cells in the injured brain. Likewise, rolipram, a cAMP phosphodiesterase inhibitor, was also able to elevate cAMP levels in T cells in the presence of hydrocortisone in vitro and abrogate the action of cortisol in mTBI mice. The investigation demonstrated that the number of circulating T cells in the early phase of TBI was positively correlated with T cell infiltration and inflammatory responses as well as cell death at the cerebral cortex and hippocampus beneath the impact site. Conclusions: Decreases in intracellular cAMP might be part of the mechanism behind cortisol-mediated blockade of T cell egress. The study argues strongly for a protective role of cortisol-induced immune suppression in the early stage of TBI.	[Dong, Tingting; Zhi, Liang; Bhayana, Brijesh; Wu, Mei X.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, 50 Blossom St, Boston, MA 02114 USA		Wu, MX (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, 50 Blossom St, Boston, MA 02114 USA.	mwu5@mgh.harvard.edu			Department of Defense/Air Force Office of Scientific Research Militory Photomedicine Program; Department of DefenseUnited States Department of Defense; CDMRP/BAA; Wellman Center for Photomedicine;  [FA9550-11-1-0415];  [FA9550-13-1-0068];  [W81XWH-13-2-0067]	This work is supported by FA9550-11-1-0415 and FA9550-13-1-0068, Department of Defense/Air Force Office of Scientific Research Militory Photomedicine Program, W81XWH-13-2-0067, Department of Defense, CDMRP/BAA, and the fund of Wellman Center for Photomedicine to MXW.	BOLTON PM, 1979, AUST J EXP BIOL MED, V57, P479, DOI 10.1038/icb.1979.49; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; COX JH, 1982, CELL IMMUNOL, V66, P407, DOI 10.1016/0008-8749(82)90190-3; De KIoet ER, 2004, ANN NY ACAD SCI, V1018, P1; Dong TT, 2015, J CEREBR BLOOD F MET, V35, P1435, DOI 10.1038/jcbfm.2015.87; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sensken SC, 2011, J IMMUNOL, V186, P3432, DOI 10.4049/jimmunol.1002169; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Soares HD, 1995, J NEUROSCI, V15, P8223; Thompson BD, 2007, J BIOL CHEM, V282, P9547, DOI 10.1074/jbc.M610931200; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95; Zhi L, 2011, J IMMUNOL, V187, P2244, DOI 10.4049/jimmunol.1100670; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	50	24	24	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	AUG 25	2016	13								197	10.1186/s12974-016-0663-y			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DV3QI	WOS:000382837500002	27561600	Green Published, gold			2022-02-06	
J	You, WD; Feng, JF; Tang, QL; Cao, J; Wang, L; Lei, J; Mao, Q; Gao, GY; Jiang, JY				You, Wendong; Feng, Junfeng; Tang, Qilin; Cao, Jun; Wang, Lei; Lei, Jin; Mao, Qing; Gao, Guoyi; Jiang, Jiyao			Intraventricular intracranial pressure monitoring improves the outcome of older adults with severe traumatic brain injury: an observational, prospective study	BMC ANESTHESIOLOGY			English	Article						Intraventricular intracranial pressure monitoring; Severe traumatic brain injury; Older adults	SEVERE HEAD-INJURY; INCREASED MORTALITY; INTENSIVE-CARE; MANAGEMENT; TRIAL; MULTICENTER; HYPOXIA; AGE	Background: Intracranial pressure (ICP) monitoring is widely used in the management of patients with severe traumatic brain injury (TBI). However, there is limited evidence about the efficacy of ICP monitoring in older subjects (aged >= 65 years). This study evaluated the effect of intraventricular ICP monitoring on the outcome of older adults suffering from a severe TBI. Methods: This prospective, observational study included 166 older TBI patients (aged >= 65 years) with Glasgow Coma scale (GCS) scores lower than 9 at admission. The study cohort was divided into two groups, intraventricular ICP monitoring and non-ICP monitoring. The primary outcome was in-hospital mortality. The secondary outcomes included the Glasgow Outcome Scale (GOS) score 6 months after injury, the ICU and total hospital lengths of stay, and mechanical ventilation days. Results: There were 80 patients in the intraventricular ICP monitoring group and 86 patients in non-ICP monitoring group. There was no statistical difference between groups in demographics and severity of head injury. Patients treated with intraventricular ICP monitoring had lower in-hospital mortality (33.8 % vs 51.2 %, P < 0.05), a higher 6-month GOS score (3.0 +/- 1.4 vs 2.5 +/- 1.2 P < 0.05), and a lower dosage (514 +/- 246 g vs 840 +/- 323 g, P < 0.0001) and shorter duration (7.2 +/- 3.6 days vs 8.4 +/- 4.3 days, P < 0.01) of mannitol use. However, the ICU length of stay (14.3 +/- 6.4 days vs 11.6 +/- 5.8 days, P < 0.01) and mechanical ventilation days (6.7 +/- 3.5 days vs 5.6 +/- 2.4 days, P < 0.05) were longer in the ICP monitoring group. The total length of hospital stay did not differ between the two groups (28.5 +/- 12.1 days vs 26.1 +/- 13.5 days, P = 0.23). Conclusions: Intraventricular ICP monitoring may have beneficial effects on the decreased in-hospital mortality and improved 6-month outcome of older patients with severe TBI. However, given that this was an observational study conducted in a single institution, further well-designed randomized control trials are needed to evaluate the effect of intraventricular ICP monitoring on the outcome of older severe TBI patients.	[You, Wendong; Feng, Junfeng; Tang, Qilin; Cao, Jun; Wang, Lei; Lei, Jin; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China; [You, Wendong; Feng, Junfeng; Tang, Qilin; Cao, Jun; Wang, Lei; Lei, Jin; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai 200127, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China.; Gao, GY (corresponding author), Shanghai Inst Head Trauma, Shanghai 200127, Peoples R China.	gao3@sina.com					Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Lane PL, 2000, CAN J SURG, V43, P442; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Melhem S, 2014, CRIT CARE, V18, DOI 10.1186/cc13713; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Sarrafzadeh AS, 2014, WORLD NEUROSURG, V82, pE393, DOI 10.1016/j.wneu.2013.07.012; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	34	24	26	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	JUL 11	2016	16								35	10.1186/s12871-016-0199-9			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DR3UX	WOS:000379829200003	27401211	gold, Green Published			2022-02-06	
J	Howell, DR; Osternig, LR; Christie, AD; Chou, LS				Howell, David R.; Osternig, Louis R.; Christie, Anita D.; Chou, Li-Shan			Return to Physical Activity Timing and Dual-Task Gait Stability Are Associated 2 Months Following Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cerebral concussion; locomotion; mild traumatic brain injury; physical activity; postural balance; recovery; rehabilitation	SPORTS-RELATED CONCUSSION; BALANCE CONTROL; HIGH-SCHOOL; ADOLESCENTS; STATEMENT; PLAY; PERFORMANCE; MANAGEMENT; ATTENTION; PARADIGM	Objective: The effect of physical activity resumption on functional recovery following concussion is poorly understood. We sought to examine the relationship between physical activity resumption timing and gait stability 2 months following concussion. Setting: Motion analysis laboratory. Participants: Twenty-nine individuals who sustained a concussion and were subsequently allowed to return to preinjury levels of physical activity within 2 months postinjury. Design: Prospective cohort study. Main Measures: The return-to-activity day (RTA-day) was identified as the first day postinjury that each participant was medically cleared to resume regular physical activity. Whole-body center-of-mass (COM) motion during single-task and dual-task walking was assessed 2 months postinjury. Correlation coefficients were calculated between the RTA-day and single/dual-task gait stability as well as symptom severity measurements 2 months postinjury. Results: Dual-task medial-lateral COM displacement (r = -0.52, P = .004) and peak medial-lateral COM velocity (r = -0.37, P = .048) were significantly correlated with RTA-day. Dual-task peak forward velocity and single-task gait stability measures were not significantly correlated with RTA-day. Conclusions: The time of RTA-day clearance, within a 2 months postinjury period, is significantly correlated with dual-task medial-lateral gait stability measured at the end of that period, suggesting that frontal plane gait stability recovery is sensitive to the timing of RTA-day.	[Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.] Childrens Hosp Boston, Dept Orthoped, Div Sports Med, Boston, MA USA; [Osternig, Louis R.; Christie, Anita D.; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, 122 Esslinger Hall,1240 Univ Oregon, Eugene, OR 97403 USA		Chou, LS (corresponding author), Univ Oregon, Dept Human Physiol, 122 Esslinger Hall,1240 Univ Oregon, Eugene, OR 97403 USA.	chou@uoregon.edu		Howell, David/0000-0002-2955-0191	Translational Research Award from the University of Oregon; Peace Health Oregon Region, the Department of Defense-TATRC Award [W81XWH-11-1-0717]; Eugene; Clarissa Evonuk Memorial Graduate Fellowship in Environmental, Cardiovascular, or Stress Physiology	This work was supported in part by the Translational Research Award from the University of Oregon and Peace Health Oregon Region, the Department of Defense-TATRC Award (W81XWH-11-1-0717), and the Eugene and Clarissa Evonuk Memorial Graduate Fellowship in Environmental, Cardiovascular, or Stress Physiology.	Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Feddermann-Demont N, 2014, J SPORT SCI, V32, P1217, DOI 10.1080/02640414.2014.918273; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hahn ME, 2004, J BIOMECH, V37, P837, DOI 10.1016/j.jbiomech.2003.11.010; Hahn ME, 2003, CLIN BIOMECH, V18, P737, DOI 10.1016/S0268-0033(03)00139-6; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Mayers L, 2012, CURR SPORT MED REP, V11, P277, DOI 10.1249/JSR.0b013e318272bbba; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Weinberg S. L., 2002, DATA ANAL BEHAV SCI, P136; Winter D, 2009, BIOMECHANICS MOTOR C, Vfourth, P86	36	24	24	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					262	268		10.1097/HTR.0000000000000176			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000011	26291630				2022-02-06	
J	Miyashita, TL; Diakogeorgiou, E; VanderVegt, C				Miyashita, Theresa L.; Diakogeorgiou, Eleni; VanderVegt, Christina			Gender Differences in Concussion Reporting Among High School Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; reporting; sex; high school	SPORTS-RELATED CONCUSSION; NEUROCOGNITIVE PERFORMANCE; FOOTBALL PLAYERS; KNOWLEDGE; EDUCATION; RECOVERY; SYMPTOMS; AGE	Background: An athlete's lack of concussion knowledge could lead to significant underreporting and injury mismanagement. To provide more effective management strategies of concussions in adolescent athletes, further examination of reporting behaviors is of critical importance. Hypothesis: The hypotheses for this study were as follows: (1) Girls are more likely to report concussion, (2) girls are more likely to report future concussions after an educational intervention, and (3) a difference in rationale for not reporting concussion will be found between sexes. Study Design: Cross-sectional, cohort design. Level of Evidence: Level 3. Methods: Survey answers were collected on 454 high school athletes (212 girls, 242 boys; mean age, 15.7 +/- 1.15 years). Individual team meetings lasting approximately 30 minutes were held to collect data and provide an educational lecture. Participants were randomly provided an iClicker to submit a response to questions asked. Results: Girls were more likely to report a concussion (chi(2) = 8.32, df = 3, N = 454, P = 0.040) and more likely to report future concussions after educational intervention (chi(2) = 8.54, df = 2, N = 454, P = 0.014). There were no differences between sexes regarding rationale for not reporting a concussion (chi(2) = 6.42, df = 4, N = 454, P = 0.170). Conclusion: There is concern these athletes still fail to understand the severity and potential sequelae of concussion injury. Both sexes cited that concussion is not a serious enough injury to warrant reporting to a medical professional. Clinical Relevance: High school athletes recover more slowly from concussions compared with college athletes; therefore, educating this population and promoting the importance of being knowledgeable regarding concussion recognition may increase reporting prevalence.	[Miyashita, Theresa L.; Diakogeorgiou, Eleni] Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA; [VanderVegt, Christina] Ben Hogan Sports Med, Arlington, TX USA		Miyashita, TL (corresponding author), Sacred Heart Univ, 5151 Pk Ave, Fairfield, CT 06825 USA.	miyashitat@sacredheart.edu					Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cripps AE, 2015, INT J ATHL THER TRAI, V20, P46, DOI 10.1123/ijatt.2014-0051; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	17	24	23	2	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2016	8	4					359	363		10.1177/1941738116651856			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8CT	WOS:000391284000009	27233957	Green Published			2022-02-06	
J	Wang, JY; Huang, YN; Chiu, CC; Tweedie, D; Luo, WM; Pick, CG; Chou, SY; Luo, Y; Hoffer, BJ; Greig, NH; Wang, JY				Wang, Jin-Ya; Huang, Ya-Ni; Chiu, Chong-Chi; Tweedie, David; Luo, Weiming; Pick, Chaim G.; Chou, Szu-Yi; Luo, Yu; Hoffer, Barry J.; Greig, Nigel H.; Wang, Jia-Yi			Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat	JOURNAL OF NEUROINFLAMMATION			English	Article						Pomalidomide; Thalidomide; Traumatic brain injury; Controlled cortical impact; Tumor necrosis factor-alpha; Interleukin-1 beta; Interleukin-6; Glutamate excitotoxicity; Neuronal apoptosis; Neuroinflammation	TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; CLOSED-HEAD INJURY; CONTROLLED CORTICAL IMPACT; ALPHA SYNTHESIS INHIBITOR; TNF-ALPHA; IN-VITRO; INFLAMMATORY CYTOKINES; FUNCTIONAL OUTCOMES; COGNITIVE DEFICITS	Background: Traumatic brain injury (TBI) is a global health concern that typically causes emotional disturbances and cognitive dysfunction. Secondary pathologies following TBI may be associated with chronic neurodegenerative disorders and an enhanced likelihood of developing dementia-like disease in later life. There are currently no approved drugs for mitigating the acute or chronic effects of TBI. Methods: The effects of the drug pomalidomide (Pom), an FDA-approved immunomodulatory agent, were evaluated in a rat model of moderate to severe TBI induced by controlled cortical impact. Post-TBI intravenous administration of Pom (0.5 mg/kg at 5 or 7 h and 0.1 mg/kg at 5 h) was evaluated on functional and histological measures that included motor function, fine more coordination, somatosensory function, lesion volume, cortical neurodegeneration, neuronal apoptosis, and the induction of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6). Results: Pom 0.5 mg/kg administration at 5 h, but not at 7 h post-TBI, significantly mitigated the TBI-induced injury volume and functional impairments, neurodegeneration, neuronal apoptosis, and cytokine mRNA and protein induction. To evaluate underlying mechanisms, the actions of Pom on neuronal survival, microglial activation, and the induction of TNF-alpha were assessed in mixed cortical cultures following a glutamate challenge. Pom dose-dependently ameliorated glutamate-mediated cytotoxic effects on cell viability and reduced microglial cell activation, significantly attenuating the induction of TNF-alpha. Conclusions: Post-injury treatment with a single Pom dose within 5 h significantly reduced functional impairments in a well-characterized animal model of TBI. Pom decreased the injury lesion volume, augmented neuronal survival, and provided anti-inflammatory properties. These findings strongly support the further evaluation and optimization of Pom for potential use in clinical TBI.	[Tweedie, David; Luo, Weiming; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Wang, Jin-Ya; Huang, Ya-Ni; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Hsing St, Taipei 110, Taiwan; [Huang, Ya-Ni] Hsin Sheng Jr Coll Med Care & Management, Dept Nursing, Taoyuan, Taiwan; [Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Tainan, Taiwan; [Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Liouying, Taiwan; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Chou, Szu-Yi] Taipei Med Univ, Coll Med Sci & Technol, Grad Program Neuroregenerat, Taipei, Taiwan; [Luo, Yu; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Dept Physiol, 250 Wu Hsing St, Taipei 110, Taiwan		Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.; Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Hsing St, Taipei 110, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Dept Physiol, 250 Wu Hsing St, Taipei 110, Taiwan.	greign@mail.NIH.gov; jywang2010@tmu.edu.tw		Chou, Szu-Yi/0000-0002-4387-749X; Wang, Jia-Yi/0000-0002-9106-3351; Luo, Yu/0000-0002-7939-5505	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST104-2923-B-038-001-MY3]; Ari and Regine Aprijaskis Fund at Tel-Aviv University, Tel-Aviv, Israel; National Institute of Neurological Disorders and Stroke, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS094152]; Intramural Research Program of the National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 000311-16]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [Z01AG000311] Funding Source: NIH RePORTER	This study was supported in part by (i) a grant from the Ministry of Science and Technology, Taiwan (MOST104-2923-B-038-001-MY3); (ii) the Ari and Regine Aprijaskis Fund at Tel-Aviv University, Tel-Aviv, Israel; (iii) the National Institute of Neurological Disorders and Stroke, NIH (grant RO1NS094152); and (iv) the Intramural Research Program of the National Institute on Aging, NIH (AG 000311-16). These funding organizations had no role in the design of the study or the collection, analysis, and interpretation of data and in writing the manuscript.	Aizawa M, 2011, NEUROSCI RES, V69, P343, DOI 10.1016/j.neures.2010.12.019; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chanan-Khan AA, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.38; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Davies FE, 2001, BLOOD, V98, P210, DOI 10.1182/blood.V98.1.210; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EGER K, 1990, ARZNEIMITTEL-FORSCH, V40-2, P1073; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng Y., 2016, CELL MOL NEUROBIOL; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hanaizi Z, 2015, ONCOLOGIST, V20, P329, DOI 10.1634/theoncologist.2014-0073; Hernandez-Ilizaliturri FJ, 2005, CLIN CANCER RES, V11, P5984, DOI 10.1158/1078-0432.CCR-05-0577; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; KLING J, 2000, MODERN DRUG DISCOVER, V3, P35; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lee KM, 2015, BIOCHEM BIOPH RES CO, V458, P34, DOI 10.1016/j.bbrc.2015.01.054; Li ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071754; Liu WM, 2009, BRIT J CANCER, V101, P803, DOI 10.1038/sj.bjc.6605206; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Mahony C, 2013, P NATL ACAD SCI USA, V110, P12703, DOI 10.1073/pnas.1307684110; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Millrine D, 2016, INT IMMUNOL; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Niwayama S, 1996, J MED CHEM, V39, P3044, DOI 10.1021/jm960284r; Ocio EM, 2015, LEUKEMIA, V29, P705, DOI 10.1038/leu.2014.238; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Sampaio EP, 2002, BIOMED PHARMACOTHER, V56, P13, DOI 10.1016/S0753-3322(01)00147-0; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/S1074-7613(04)00234-1; Shalapour S, 2006, CLIN CANCER RES, V12, P5526, DOI 10.1158/1078-0432.CCR-06-0719; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; SMITH RL, 1995, J NEUROSCI, V15, P4057; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teo SK, 2002, MICROBES INFECT, V4, P1193, DOI 10.1016/S1286-4579(02)01645-3; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2005, GUID IND EST MAX SAF; Vargesson N, 2015, BIRTH DEFECTS RES C, V105, P140, DOI 10.1002/bdrc.21096; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Weingartner S, 2012, ANN RHEUM DIS, V71, P1895, DOI 10.1136/annrheumdis-2012-201784; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	89	24	25	1	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUN 28	2016	13								168	10.1186/s12974-016-0631-6			17	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DQ0BZ	WOS:000378864100002	27353053	gold, Green Published			2022-02-06	
J	Fuller, CW; Taylor, AE; Raftery, M				Fuller, Colin W.; Taylor, Aileen E.; Raftery, Martin			Should player fatigue be the focus of injury prevention strategies for international rugby sevens tournaments?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							WORLD-CUP; MUSCLE FATIGUE; MATCH ANALYSIS; PROPRIOCEPTION; PERFORMANCE; PATTERNS; SERIES; SENSE	Objective To assess the incidence, severity and nature of injuries, to determine risk factors for injury and to identify potential injury prevention strategies in men's international Rugby-7s tournaments. Design A prospective cohort study. Participants Players from core teams competing in matches at 6 Sevens World Series from 2008/2009 to 2014/2015. Results The incidence of injury across all Series was 108.3 injuries/1000 player-match-hours (backs: 121.0; forwards: 91.5) with a mean severity of 44.2 days (backs: 46.1; forwards: 40.9) and a median severity of 28 days (backs: 29; forwards: 26). The proportion of injuries sustained in the second half was significantly higher (60%; p<0.001) than the first half of matches and the proportion increased from match to match and day to day in a tournament. The knee (17.4%), ankle (15.9%) and posterior thigh (13.2%) were the most common injury locations for backs and the knee (18.5%), head/face (17.3%) and shoulder/clavicle (13.0%) for forwards. The four most common injuries across all players were knee ligament (13.0%), ankle ligament (12.8%), concussion (10.4%) and posterior thigh muscle strains (9.8%). Conclusions The incidence of injury in Rugby-7s suggests that teams require squads of around 20 players for a Sevens World Series. The higher incidence of injury in the second half of matches is probably the result of player fatigue; therefore, injury prevention strategies for teams and the Governing Body should address this issue. The results presented support the World Rugby trial allowing 'rolling substitutes' during Sevens World Series matches, as this approach may help to mitigate the effects of player fatigue during the second half of matches.	[Fuller, Colin W.; Taylor, Aileen E.; Raftery, Martin] World Rugby, World Rugby House,8-10 Pembroke St Lower, Dublin 2, Ireland		Fuller, CW (corresponding author), World Rugby, World Rugby House,8-10 Pembroke St Lower, Dublin 2, Ireland.	ColinFullerConsultancy@gmail.com			World Rugby, Dublin, Ireland	The study was funded by World Rugby, Dublin, Ireland.	Aughey RJ, 2010, INT J SPORT PHYSIOL, V5, P394, DOI 10.1123/ijspp.5.3.394; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Bruckner P, 2007, CLIN SPORTS MED, P8; Cortes N, 2014, GAIT POSTURE, V39, P888, DOI 10.1016/j.gaitpost.2013.11.020; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P458, DOI 10.1136/bjsports-2014-094369; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2010, CLIN J SPORT MED, V20, P179, DOI 10.1097/JSM.0b013e3181df1eea; Furlan N, 2015, INT J SPORT PHYSIOL, V10, P802, DOI 10.1123/ijspp.2014-0315; Granatelli G, 2014, J STRENGTH COND RES, V28, P728, DOI 10.1519/JSC.0b013e31829d23c3; Herrington L, 2008, PHYS THER SPORT, V9, P67, DOI 10.1016/j.ptsp.2008.01.001; Hiemstra LA, 2001, J ORTHOP SPORT PHYS, V31, P598, DOI 10.2519/jospt.2001.31.10.598; Higham DG, 2016, J STRENGTH COND RES, V30, P1287, DOI [10.1519/JSC.0b013e3182a9536f, 10.1097/JSC.0000000000000212]; Higham DG, 2013, INT J SPORT PHYSIOL, V8, P19, DOI 10.1123/ijspp.8.1.19; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Kibler WB, 2007, CLIN SPORTS MED, P243; Lee HM, 2003, CLIN BIOMECH, V18, P843, DOI 10.1016/S0268-0033(03)00151-7; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; Myers JB, 2000, J ATHL TRAINING, V35, P351; Orchard J., 1995, SPORT HLTH, V11, P39; Pedersen J, 1999, MED SCI SPORT EXER, V31, P1047, DOI 10.1097/00005768-199907000-00019; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Ross A, 2015, J SPORT SCI, V33, P1035, DOI 10.1080/02640414.2014.979858; Ross A, 2014, SPORTS MED, V44, P357, DOI 10.1007/s40279-013-0123-0; Sterne, 2003, ESSENTIAL MED STAT; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Weinhandl JT, 2014, CLIN BIOMECH, V29, P752, DOI 10.1016/j.clinbiomech.2014.05.013; Wojtys EM, 1996, AM J SPORT MED, V24, P615, DOI 10.1177/036354659602400509; World Rugby, GAM AN SEV WORLD SER; World Rugby, WHAT IS RUGB	32	24	24	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2016	50	11					682	U72		10.1136/bjsports-2016-096043			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DN0NX	WOS:000376761700014	27190230				2022-02-06	
J	Rigon, A; Duff, MC; McAuley, E; Kramer, AF; Voss, MW				Rigon, Arianna; Duff, Melissa C.; McAuley, Edward; Kramer, Arthur F.; Voss, Michelle W.			Is Traumatic Brain Injury Associated with Reduced Inter-Hemispheric Functional Connectivity? A Study of Large-Scale Resting State Networks following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						externally oriented networks; inter-hemispheric functional connectivity; internally oriented networks; resting state fMRI; traumatic brain injury	DEFAULT MODE NETWORK; COMPLEX FIGURE TEST; MILD HEAD-INJURY; EXECUTIVE CONTROL; FMRI; MRI; DEFICITS; DISEASE; CORTEX; MEMORY	Traumatic brain injury (TBI) often has long-term debilitating sequelae in cognitive and behavioral domains. Understanding how TBI impacts functional integrity of brain networks that underlie these domains is key to guiding future approaches to TBI rehabilitation. In the current study, we investigated the differences in inter-hemispheric functional connectivity (FC) of resting state networks (RSNs) between chronic mild-to-severe TBI patients and normal comparisons (NC), focusing on two externally oriented networks (i.e., the fronto-parietal network [FPN] and the executive control network [ECN]), one internally oriented network (i.e., the default mode network [DMN]), and one somato-motor network (SMN). Seed voxel correlation analysis revealed that TBI patients displayed significantly less FC between lateralized seeds and both homologous and non-homologous regions in the opposite hemisphere for externally oriented networks but not for DMN or SMN; conversely, TBI patients showed increased FC within regions of the DMN, especially precuneus and parahippocampal gyrus. Region of interest correlation analyses confirmed the presence of significantly higher inter-hemispheric FC in NC for the FPN (p<0.01), and ECN (p<0.05), but not for the DMN (p>0.05) or SMN (p>0.05). Further analysis revealed that performance on a neuropsychological test measuring organizational skills and visuo-spatial abilities administered to the TBI group, the Rey-Osterrieth Complex Figure Test, positively correlated with FC between the right FPN and homologous regions. Our findings suggest that distinct RSNs display specific patterns of aberrant FC following TBI; this represents a step forward in the search for biomarkers useful for early diagnosis and treatment of TBI-related cognitive impairment.	[Rigon, Arianna; Duff, Melissa C.; Voss, Michelle W.] Univ Iowa, Neurosci Grad Program, WJSHC 250 Hawkins Dr, Iowa City, IA 52242 USA; Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Duff, Melissa C.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA; [McAuley, Edward; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA		Rigon, A (corresponding author), Univ Iowa, Neurosci Grad Program, WJSHC 250 Hawkins Dr, Iowa City, IA 52242 USA.	arianna-rigon@uiowa.edu	Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	University of Iowa; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 AG025667, RO1 HD069381]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG025667] Funding Source: NIH RePORTER	This work was supported in part by start-up funds provided by the University of Iowa to MD and MV, and grant funding from NIH R37 AG025667 and NIH RO1 HD069381 supported image acquisition for the normal control participants. The authors would like to thank Joel Bruss for his advice during visual inspection of the anatomical images, Jocelyn Cole for the hand-tracing of the brain masks and Ruth Henson for logistic support in scheduling TBI participants.	Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], 1996, BIOSTATISTICAL ANAL; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Centers for disease control and prevention, 2014, INJ PREV CONTR TRAUM; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Krmpotich TD, 2013, DRUG ALCOHOL DEPEN, V129, P1, DOI 10.1016/j.drugalcdep.2013.01.021; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lezack M. D., 2004, NEUROPYCHOLOGICAL AS; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; TEASDALE G, 1974, LANCET, V2, P81; Tranel D., 1996, IOWA BENTON SCH NEUR; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	71	24	24	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					977	989		10.1089/neu.2014.3847			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600001	25719433	Green Published			2022-02-06	
J	Richards, RI; Robertson, SA; O'Keefe, LV; Fornarino, D; Scott, A; Lardelli, M; Baune, BT				Richards, Robert I.; Robertson, Sarah A.; O'Keefe, Louise V.; Fornarino, Dani; Scott, Andrew; Lardelli, Michael; Baune, Bernhard T.			The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease	FRONTIERS IN NEUROSCIENCE			English	Article						dementia; innate autoimmunity; inflammation; neurodegeneration; Alzheimer's; Parkinson's; Huntington's	AMYOTROPHIC-LATERAL-SCLEROSIS; UNFOLDED PROTEIN RESPONSE; TOLL-LIKE RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; AMYLOID CASCADE HYPOTHESIS; AICARDI-GOUTIERES SYNDROME; MOTOR-NEURON DEGENERATION; TERM COGNITIVE IMPAIRMENT; ONSET ALZHEIMERS-DISEASE; TRAUMATIC BRAIN-INJURY	Neurodegenerative diseases comprise an array of progressive neurological disorders all characterized by the selective death of neurons in the central nervous system. Although, rare (familial) and common (sporadic) forms can occur for the same disease, it is unclear whether this reflects several distinct pathogenic pathways or the convergence of different causes into a common form of nerve cell death. Remarkably, neurodegenerative diseases are increasingly found to be accompanied by activation of the innate immune surveillance system normally associated with pathogen recognition and response. Innate surveillance is the cell's quality control system for the purpose of detecting such danger signals and responding in an appropriate manner. Innate surveillance is an "intelligent system," in that the manner of response is relevant to the magnitude and duration of the threat. If possible, the threat is dealt with within the cell in which it is detected, by degrading the danger signal(s) and restoring homeostasis. If this is not successful then an inflammatory response is instigated that is aimed at restricting the spread of the threat by elevating degradative pathways, sensitizing neighboring cells, and recruiting specialized cell types to the site. If the danger signal persists, then the ultimate response can include not only the programmed cell death of the original cell, but the contents of this dead cell can also bring about the death of adjacent sensitized cells. These responses are clearly aimed at destroying the ability of the detected pathogen to propagate and spread. Innate surveillance comprises intracellular, extracellular, non-cell autonomous and systemic processes. Recent studies have revealed how multiple steps in these processes involve proteins that, through their mutation, have been linked to many familial forms of neurodegenerative disease. This suggests that individuals harboring these mutations may have an amplified response to innate-mediated damage in neural tissues, and renders innate surveillance mediated cell death a plausible common pathogenic pathway responsible for neurodegenerative diseases, in both familial and sporadic forms. Here we have assembled evidence in favor of the hypothesis that neurodegenerative disease is the cumulative result of chronic activation of the innate surveillance pathway, triggered by endogenous or environmental danger or damage associated molecular patterns in a progressively expanding cascade of inflammation, tissue damage and cell death.	[Richards, Robert I.; O'Keefe, Louise V.; Fornarino, Dani; Scott, Andrew; Lardelli, Michael] Univ Adelaide, Dept Genet & Evolut, Ctr Mol Pathol, Sch Biol Sci, Adelaide, SA, Australia; [Robertson, Sarah A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Baune, Bernhard T.] Univ Adelaide, Discipline Psychiat, Sch Med, Adelaide, SA, Australia		Richards, RI (corresponding author), Univ Adelaide, Dept Genet & Evolut, Ctr Mol Pathol, Sch Biol Sci, Adelaide, SA, Australia.	robert.richards@adelaide.edu.au	Richards, Robert/ABE-6423-2020; Robertson, Sarah A/C-8182-2009; O'Keefe, Louise V/B-9856-2008	Robertson, Sarah A/0000-0002-9967-0084; Lardelli, Michael/0000-0002-4289-444X	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1069348]; National Ataxia Foundation (USA)	This research is funded in part by Project Grant (APP1069348) from the National Health and Medical Research Council of Australia and a grant from the National Ataxia Foundation (USA).	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Aikawa T, 2015, HUM MOL GENET, V24, P4780, DOI 10.1093/hmg/ddv202; Andries O, 2013, J CONTROL RELEASE, V167, P157, DOI 10.1016/j.jconrel.2013.01.033; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Asakura T, 2015, GENES CELLS, V20, P153, DOI 10.1111/gtc.12206; Azuma Y, 2014, HUM MOL GENET, V23, P3467, DOI 10.1093/hmg/ddu055; Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Batra R., 2016, BIORVIX, V4, P74, DOI [10.1101/038448, DOI 10.1101/038448]; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Bentmann E, 2013, FEBS J, V280, P4348, DOI 10.1111/febs.12287; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blin J, 2015, CYTOKINE, V74, P175, DOI 10.1016/j.cyto.2015.03.005; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Catala-Lopez F, 2014, PSYCHOTHER PSYCHOSOM, V83, P89, DOI 10.1159/000356498; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Celardo I, 2014, BRIT J PHARMACOL, V171, P1943, DOI 10.1111/bph.12433; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Crow YJ, 2014, NEUROPEDIATRICS, V45, P386, DOI 10.1055/s-0034-1389161; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Dunys J, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-35; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661; Fang L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00016; Feng Y, 2015, NAT REV CANCER, V15, P556, DOI 10.1038/nrc3979; Fonseca ACRG, 2013, BBA-MOL BASIS DIS, V1832, P2191, DOI 10.1016/j.bbadis.2013.08.007; Francisco NM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0345-1; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gelderblom M, 2015, AGEING RES REV, V24, P77, DOI 10.1016/j.arr.2015.07.004; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goldwurm S, 2007, NEUROLOGY, V68, P1141, DOI 10.1212/01.wnl.0000254483.19854.ef; Gottschalk W. K., 2015, J PARKINSONS DIS ALZ, V1, DOI 10.13188/2376-922X; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Guillot-Sestier MV, 2015, TRENDS NEUROSCI, V38, P674, DOI 10.1016/j.tins.2015.08.008; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; HAMILTON JA, 1980, ENVIRON HEALTH PERSP, V34, P69, DOI 10.1289/ehp.803469; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hausler M, 2003, HUM PATHOL, V34, P253, DOI 10.1053/hupa.2003.35; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Hofer MJ, 2013, CYTOKINE GROWTH F R, V24, P257, DOI 10.1016/j.cytogfr.2013.03.006; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hu SQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005367; Cornejo VH, 2013, SEMIN IMMUNOPATHOL, V35, P277, DOI 10.1007/s00281-013-0373-9; IQBAL K, 1977, J NEUROCHEM, V29, P417, DOI 10.1111/j.1471-4159.1977.tb10689.x; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Juranek JK, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00485, 10.3289/fncel.2015.00435]; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kauppinen TM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-152; Khoo JJ, 2011, J INTERF CYTOK RES, V31, P13, DOI 10.1089/jir.2010.0095; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lattante S, 2015, TRENDS GENET, V31, P263, DOI 10.1016/j.tig.2015.03.005; Lawlor KT, 2011, HUM MOL GENET, V20, P3757, DOI 10.1093/hmg/ddr292; Lee JY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0310-z; Lee JH, 2010, EXP MOL MED, V42, P386, DOI 10.3858/emm.2010.42.5.040; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0211-2; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Lui PCW, 2009, HUM PATHOL, V40, P1611, DOI 10.1016/j.humpath.2009.04.016; MacKay CR, 2014, CURR OPIN IMMUNOL, V26, P49, DOI 10.1016/j.coi.2013.10.015; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mann DMA, 2015, NEUROBIOL AGING, V36, P1224, DOI 10.1016/j.neurobiolaging.2014.10.011; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; McGlasson S, 2015, NAT REV NEUROL, V11, P515, DOI 10.1038/nrneurol.2015.143; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Meyer SN, 2014, SCIENCE, V346, P1199, DOI 10.1126/science.1258236; Michels M, 2015, BRAIN BEHAV IMMUN, V43, P54, DOI 10.1016/j.bbi.2014.07.002; Miller JRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141793; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2; Muller-Schiffmann A, 2016, BRAIN, V139, P509, DOI 10.1093/brain/awv355; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Musicco M, 2013, NEUROLOGY, V81, P322, DOI 10.1212/WNL.0b013e31829c5ec1; Nakano S, 2010, RHEUMATOLOGY, V49, P876, DOI 10.1093/rheumatology/keq001; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Norris KL, 2015, J BIOL CHEM, V290, P13862, DOI 10.1074/jbc.M114.634063; Nystrom S, 2013, EMBO J, V32, P86, DOI 10.1038/emboj.2012.328; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pellegrino MW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0129-1; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Radian AD, 2015, MOL IMMUNOL, V67, P294, DOI 10.1016/j.molimm.2015.06.013; Radian AD, 2013, MICROBES INFECT, V15, P630, DOI 10.1016/j.micinf.2013.04.001; Ray R, 2016, NEUROSCI BIOBEHAV R, V62, P48, DOI 10.1016/j.neubiorev.2015.12.006; Rhodes JD, 2012, HUM MOL GENET, V21, P852, DOI 10.1093/hmg/ddr515; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rodriguez-Vieitez E, 2016, BRAIN, V139, P922, DOI 10.1093/brain/awv404; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Ryan SM, 2016, NEUROSCI BIOBEHAV R, V61, P121, DOI 10.1016/j.neubiorev.2015.12.004; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; Samaraweera SE, 2013, HUM MOL GENET, V22, P2811, DOI 10.1093/hmg/ddt130; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Schapansky J, 2015, NEUROSCIENCE, V302, P74, DOI 10.1016/j.neuroscience.2014.09.049; Schapansky J, 2014, HUM MOL GENET, V23, P4201, DOI 10.1093/hmg/ddu138; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sharshar T, 2014, LANCET NEUROL, V13, P534, DOI 10.1016/S1474-4422(14)70064-X; Shichita T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00319; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; STEIN D, 1992, CELL, V68, P429, DOI 10.1016/0092-8674(92)90181-B; Talbot K, 2006, HUM MOL GENET, V15, pR182, DOI 10.1093/hmg/ddl202; Tan MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.348; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Tekkok I H, 2000, Brain Tumor Pathol, V17, P97, DOI 10.1007/BF02484280; Thaiss CA, 2016, TRENDS IMMUNOL, V37, P84, DOI 10.1016/j.it.2015.12.003; Thundyil J, 2015, AGEING RES REV, V24, P17, DOI 10.1016/j.arr.2014.11.003; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valdes-Ferrer SI, 2013, J INTERN MED, V274, P381, DOI 10.1111/joim.12104; van Eyk CL, 2011, HUM MOL GENET, V20, P2783, DOI 10.1093/hmg/ddr177; Vanha-aho LM, 2016, IMMUNOL LETT, V170, P42, DOI 10.1016/j.imlet.2015.12.005; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; West RJH, 2015, J CELL BIOL, V208, P931, DOI 10.1083/jcb.201404066; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1; Wu W, 2012, CRIT REV ONCOL HEMAT, V82, P249, DOI 10.1016/j.critrevonc.2011.08.004; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056; Yoneyama M, 2016, J BIOCHEM, V159, P279, DOI 10.1093/jb/mvv122; Yu AK, 2015, HUM MOL GENET, V24, P2848, DOI 10.1093/hmg/ddv045; Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340; Yuan FH, 2015, J BIOL CHEM, V290, P13344, DOI 10.1074/jbc.M115.653915; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	202	24	24	0	29	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 10	2016	10								193	10.3389/fnins.2016.00193			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DL3QO	WOS:000375548500002	27242399	Green Published, gold			2022-02-06	
J	Chagdes, JR; Rietdyk, S; Haddad, JM; Zelaznik, HN; Cinelli, ME; Denomme, LT; Powers, KC; Raman, A				Chagdes, James R.; Rietdyk, Shirley; Haddad, Jeffrey M.; Zelaznik, Howard N.; Cinelli, Michael E.; Denomme, Luke T.; Powers, Kaley C.; Raman, Arvind			Limit cycle oscillations in standing human posture	JOURNAL OF BIOMECHANICS			English	Article						Balance; Model; Time-delay; Bifurcations; Limit cycle; Neuromuscular disease	DIFFERENTIAL-DELAY EQUATIONS; OF-PRESSURE TRAJECTORIES; MULTIPLE-SCLEROSIS; SENSORIMOTOR INTEGRATION; DYNAMICAL STRUCTURE; VISUAL-STIMULATION; SWAY; STABILITY; BALANCE; SYSTEM	Limit cycle oscillations (LCOs) are a hallmark of dynamic instability in time-delayed and nonlinear systems such as climate change models, biological oscillators, and robotics. Here we study the links between the human neuromuscular system and LCOs in standing posture. First, we demonstrate through a simple mathematical model that the observation of LCOs in posture is indicative of excessive neuromuscular time-delay. To test this hypothesis we study LCOs in the postural sway of individuals with multiple sclerosis and concussed athletes representing two different populations with chronically and acutely increased neuromuscular time-delays. Using a wavelet analysis method we demonstrate that 67% of individuals with multiple sclerosis and 44% of individuals with concussion exhibit intermittent LCOs; 8% of MS-controls, 0% of older adults, and 0% of concussion-controls displayed LCOs. Thus, LCOs are not only key to understanding postural instability but also may have important applications for the detection of neuromuscular deficiencies. (C) 2016 Published by Elsevier Ltd.	[Chagdes, James R.] Miami Univ, Dept Mech & Mfg Engn, 650 East High St, Oxford, OH 45056 USA; [Rietdyk, Shirley; Haddad, Jeffrey M.; Zelaznik, Howard N.] Purdue Univ, Dept Hlth & Kinesiol, 800 West Stadium Ave, W Lafayette, IN 47907 USA; [Cinelli, Michael E.; Denomme, Luke T.; Powers, Kaley C.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, 75 Univ Ave West, Waterloo, ON N2L 3C5, Canada; [Raman, Arvind] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA		Raman, A (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	raman@purdue.edu	Cinelli, Michael/ABE-7625-2020; Chagdes, James/R-9241-2019	Cinelli, Michael/0000-0002-5802-2590; Chagdes, James/0000-0001-5307-7608	National Science FoundationNational Science Foundation (NSF) [CMMI-1300632]	The authors are grateful to the National Science Foundation for partial financial support for this project provided through the Grant CMMI-1300632.	Addison PS., 2002, ILLUSTRATED WAVELET; ALBRECHT F, 1973, SCIENCE, V181, P1073, DOI 10.1126/science.181.4104.1073; [Anonymous], 2009, BR J SPORTS MED S1, V43, pi85; Asai H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007371; Barauskas R, 2007, J SOUND VIB, V308, P612, DOI 10.1016/j.jsv.2007.03.051; Batzel JJ, 2000, J MATH BIOL, V41, P45, DOI 10.1007/s002850000044; Benedetti MG, 1999, MULT SCLER J, V5, P363, DOI 10.1191/135245899678846393; Cameron MH, 2008, SOMATOSENS MOT RES, V25, P113, DOI 10.1080/08990220802131127; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; DEGREGORIO S, 1992, J NONLINEAR SCI, V2, P293, DOI 10.1007/BF01208927; Denomme L., 2014, EXP BRAIN RES, P1; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Dowell EH., 1975, AEROELASTICITY PLATE; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Eckner JT, 2012, MED SCI SPORT EXER, V44, P411; Engelborghs K, 2001, TW330 KU LEUVEN DEP; EPSTEIN IR, 1991, J CHEM PHYS, V95, P244, DOI 10.1063/1.461481; EPSTEIN IR, 1992, INT REV PHYS CHEM, V11, P135, DOI 10.1080/01442359209353268; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Fukuoka Y, 2001, IEEE T NEUR SYS REH, V9, P145, DOI 10.1109/7333.928574; Gawthrop P., 2014, BIOL CYBERN, P1; Haddad JM, 2008, EXP BRAIN RES, V190, P431, DOI 10.1007/s00221-008-1483-9; Haddad JM, 2013, EXERC SPORT SCI REV, V41, P123, DOI 10.1097/JES.0b013e3182877cc8; Haddad JM, 2011, J MOTOR BEHAV, V43, P345, DOI 10.1080/00222895.2011.596169; HOLMES PJ, 1977, J SOUND VIB, V53, P471, DOI 10.1016/0022-460X(77)90521-1; Insperger T, 2000, CISM COURSES LECT, V422, P197; Insperger T., 2011, SEMIDISCRETIZATION T SEMIDISCRETIZATION T; Jankovic J, 2006, NEUROLOGY, V66, P1286; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Kowalczyk P, 2012, J R SOC INTERFACE, V9, P234, DOI 10.1098/rsif.2011.0212; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Ladislao L, 2007, MED BIOL ENG COMPUT, V45, P679, DOI 10.1007/s11517-007-0213-y; Liang ZQ, 2014, GAIT POSTURE, V39, P397, DOI 10.1016/j.gaitpost.2013.08.007; MacDonald N., 1978, TIME LAGS IN BIOLOGI; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Masani K, 2006, GAIT POSTURE, V23, P164, DOI 10.1016/j.gaitpost.2005.01.006; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Maurer C, 2004, EXP BRAIN RES, V157, P369, DOI 10.1007/s00221-004-1852-y; Maurer C, 2003, BRAIN, V126, P1146, DOI 10.1093/brain/awg100; MAY RM, 1972, SCIENCE, V177, P900, DOI 10.1126/science.177.4052.900; Milton J, 1995, J DYN DIFFER EQU, V7, P213, DOI DOI 10.1007/BF02218819; Orosz G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046205; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2000, BIOL CYBERN, V82, P335, DOI 10.1007/s004220050587; Peterka RJ, 2003, IEEE ENG MED BIOL, V22, P63, DOI 10.1109/MEMB.2003.1195698; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Porter B, 1967, STABILITY CRITERIA L; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; Rhea CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017696; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; STEPAN G, 1986, NONLINEAR ANAL-THEOR, V10, P913, DOI 10.1016/0362-546X(86)90078-7; Stepan G, 2009, PHILOS T R SOC A, V367, P1195, DOI 10.1098/rsta.2008.0278; Suarez H, 2001, ACTA OTO-LARYNGOL, V121, P220; Suarez H, 2000, ACTA OTO-LARYNGOL, V120, P168; Suzuki T, 2002, CNS DRUGS, V16, P165, DOI 10.2165/00023210-200216030-00003; Ting LH, 2009, CHAOS, V19, DOI 10.1063/1.3142245; Tobias S., 1965, MACHINE TOOL VIBRATI; Verdaasdonk BW, 2004, BIOL CYBERN, V91, P48, DOI 10.1007/s00422-004-0494-2; Vette AH, 2010, IEEE T NEUR SYS REH, V18, P86, DOI 10.1109/TNSRE.2009.2037891; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Winter D.A., 1995, ABC ANATOMY BIOMECHA; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; WINTERS JM, 1985, IEEE T BIO-MED ENG, V32, P826, DOI 10.1109/TBME.1985.325498; Yamada N, 1995, HUM MOVEMENT SCI, V14, P711, DOI 10.1016/0167-9457(95)00032-1; Yao W, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021902	72	24	24	0	18	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 3	2016	49	7					1170	1179		10.1016/j.jbiomech.2016.03.005			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DM0RB	WOS:000376052400026	27018157	Bronze			2022-02-06	
J	Cherian, I; Bernardo, A; Grasso, G				Cherian, Iype; Bernardo, Antonio; Grasso, Giovanni			Cisternostomy for Traumatic Brain Injury: Pathophysiologic Mechanisms and Surgical Technical Notes	WORLD NEUROSURGERY			English	Article						Cisternostomy; Decompressive hemicraniectomy; Traumatic brain injury	ISCHEMIA; EDEMA; DECRA; MODEL; TIME	OBJECTIVE: Traumatic brain injury (TBI) is one of the major challenges in health care, representing the third most frequent cause of death. Current optimal management is based on a progressive, target-driven approach combining both medical and surgical treatment strategies. Here we describe cisternostomy, an emerging surgical treatment for the treatment of TBI. METHODS: Cisternostomy is a novel technique that incorporates knowledge of skull base and microvascular surgery. By opening the brain cisterns to atmospheric pressure, the technique could decrease the intracranial pressure due to a backshift of the cerebrospinal fluid (CSF) from the swollen brain to the cisterns through the Virchow-Robin spaces. RESULTS: An increasing number of evidence has demonstrated a paravascular pathway that facilitates CSF flow from the subarachnoid space through the brain parenchyma. This network of paravascular channels, termed as the "glymphatic" pathway, reduces considerably its activity after TBI, thus participating in the development of brain edema formation. Cisternostomy, by opening the brain cisterns to atmospheric pressure, could decrease the intracerebral pressure due to a backshift of CSF through the Virchow-Robin spaces. CONCLUSIONS: In the current common practice, the surgical measures for TBI include external ventricular drainage insertion and decompressive craniectomy. There is evidence that both of these measures reduce intracranial pressure but the effect on the outcome, particularly in the long term, is equivocal. A new line of evidence supports cisternostomy as an emerging surgical treatment for TBI.	[Cherian, Iype] Coll Med Sci, Dept Neurosurg, Bharatpur, Nepal; [Bernardo, Antonio] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Grasso, Giovanni] Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, Neurosurg Sect, Palermo, Italy		Grasso, G (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, Neurosurg Sect, Palermo, Italy.	giovanni.grasso@unipa.it	bernardo, Antonio/AAB-9474-2020; grasso, giovanni/K-3774-2018	bernardo, Antonio/0000-0002-2751-2626; grasso, giovanni/0000-0001-5362-0092			Baethmann A, 1998, Curr Opin Anaesthesiol, V11, P193, DOI 10.1097/00001503-199804000-00013; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Chi JH, 2011, NEUROSURGERY, V68, pN19, DOI [10.1227/01.neu.0000398210.58112.7e, 10.1227/01.neu.0000393594.53816.33]; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Fukuda H, 2014, J NEUROL SURG PART B, V75, P125, DOI 10.1055/s-0033-1359302; Grasso G, 2015, WORLD NEUROSURG, V84, P1491, DOI 10.1016/j.wneu.2015.05.056; Grasso G, 2015, WORLD NEUROSURG, V84, P594, DOI 10.1016/j.wneu.2015.01.043; Iaccarino C, 2013, WORLD NEUROSURG, V79, P78, DOI 10.1016/j.wneu.2012.10.061; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McIntosh TK, 1996, LAB INVEST, V74, P315; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Zhang XA, 2014, J NEUROSURG, V121, P390, DOI 10.3171/2014.3.JNS132206	21	24	27	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2016	89						51	57		10.1016/j.wneu.2016.01.072			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6GM	WOS:000376448700009	26851743				2022-02-06	
J	Greenhill, DA; Navo, P; Zhao, HQ; Torg, J; Comstock, RD; Boden, BP				Greenhill, Dustin A.; Navo, Paul; Zhao, Huaqing; Torg, Joseph; Comstock, R. Dawn; Boden, Barry P.			Inadequate Helmet Fit Increases Concussion Severity in American High School Football Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; football helmets; athletic trainer	SYMPTOM SEVERITY; RISK-FACTORS; INJURY; PREDICTORS; EQUIPMENT; RATES	Background: There is limited information on the relationship between football helmet fit and concussion severity. Hypothesis: Poor helmet fit may predispose football players to a more severe concussion. Study Design: Descriptive epidemiology study. Level of Evidence: Level 3. Methods: Data from concussion injury reports were obtained from the National High School Sports-Related Injury Surveillance System over a 9-year period. Symptoms, duration, and helmet parameters (fit, interior padding) were analyzed for all first-time concussions. Results: Data from 4580 concussions were analyzed. Patients who suffered concussions with a helmet that did not fit properly (3.22%), as determined by an athletic trainer, had higher rates of drowsiness (RR, 1.46; P = 0.005), hyperexcitability (RR, 2.38; P = 0.047), and sensitivity to noise (RR, 1.88; P < 0.001); had more symptoms (5.34 vs 4.54, P = 0.004); and had longer symptom duration (P = 0.04). Athletes with helmets lined with an air bladder had greater rates of sensitivity to light (RR, 1.13; P = 0.02), sensitivity to noise (RR, 1.25; P = 0.009), and longer symptom duration (P = 0.004) compared with foam or gel liners. Conclusion: An improperly fitted football helmet is a risk factor for a concussion with more symptoms and of longer duration. Concussions of longer duration are also more common in players with an air bladder-lined helmet. Current high school football rules should mandate supervision and maintenance of helmet fit throughout the season, prior to impact.	[Greenhill, Dustin A.; Torg, Joseph] Temple Univ Hosp & Med Sch, Dept Orthopaed Surg & Sports Med, 3401 North Broad St,Zone B 6th Floor, Philadelphia, PA 19140 USA; [Navo, Paul; Zhao, Huaqing] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Boden, Barry P.] Orthopaed Ctr, Rockville, MD USA		Greenhill, DA (corresponding author), Temple Univ Hosp & Med Sch, Dept Orthopaed Surg & Sports Med, 3401 North Broad St,Zone B 6th Floor, Philadelphia, PA 19140 USA.	dustin.greenhill2@tuhs.temple.edu					Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colgate B, 2015, NATL FEDERATION STAT; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Gadd C, 1961, NATL RES COUNCIL PUB, P141; GIECK J, 1980, AM J SPORT MED, V8, P192, DOI 10.1177/036354658000800309; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4	24	24	24	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2016	8	3					238	243		10.1177/1941738116639027			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8CM	WOS:000391283300005	27005467	Green Published			2022-02-06	
J	Kerr, ZY; Dalton, SL; Roos, KG; Djoko, A; Phelps, J; Dompier, TP				Kerr, Zachary Y.; Dalton, Sara L.; Roos, Karen G.; Djoko, Aristarque; Phelps, Jennifer; Dompier, Thomas P.			Comparison of Indiana High School Football Injury Rates by Inclusion of the USA Football "Heads Up Football" Player Safety Coach	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; pediatrics; prevention	SPORTS-RELATED INJURIES; UNITED-STATES; EPIDEMIOLOGY; CONCUSSION	Background: In Indiana, high school football coaches are required to complete a coaching education course with material related to concussion awareness, equipment fitting, heat emergency preparedness, and proper technique. Some high schools have also opted to implement a player safety coach (PSC). The PSC, an integral component of USA Football's Heads Up Football (HUF) program, is a coach whose primary responsibility is to ensure that other coaches are implementing proper tackling and blocking techniques alongside other components of the HUF program. Purpose: To compare injury rates in Indiana high school football teams by their usage of a PSC or online coaching education only. Study Design: Cohort study; Level of evidence, 2. Methods: Athletic trainers (ATs) evaluated and tracked injuries at each practice and game during the 2015 high school football season. Players were drawn from 6 teams in Indiana. The PSC group, which used the PSC component, was comprised of 204 players from 3 teams. The education only group (EDU), which utilized coaching education only, was composed of 186 players from 3 teams. Injury rates and injury rate ratios (IRRs) were reported with 95% confidence intervals (CIs). Results: During 25,938 athlete-exposures (AEs), a total of 149 injuries were reported, of which 54 (36.2%) and 95 (63.8%) originated from the PSC and EDU groups, respectively. The practice injury rate was lower in the PSC group than the EDU group (2.99 vs 4.83/1000 AEs; IRR, 0.62; 95% CI, 0.40-0.95). The game injury rate was also lower in the PSC group than the EDU group (11.37 vs 26.37/1000 AEs; IRR, 0.43; 95% CI, 0.25-0.74). When restricted to concussions only, the rate was lower in the PSC group (0.09 vs 0.73/1000 AEs; IRR, 0.12; 95% CI, 0.01-0.94), although only 1 concussion was reported in the PSC group. No differences were found in game concussion rates (0.60 vs 4.39/1000 AEs; IRR, 0.14; 95% CI, 0.02-1.11). Conclusion: Findings support the PSC as an effective method of injury mitigation in high school football. Future research should seek to replicate this study using larger samples from additional states.	[Kerr, Zachary Y.; Dalton, Sara L.; Roos, Karen G.; Djoko, Aristarque; Phelps, Jennifer; Dompier, Thomas P.] Sports Injury Res & Prevent Inc, Datalys Ctr, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA; [Phelps, Jennifer] USA Football, Indianapolis, IN USA		Kerr, ZY (corresponding author), Sports Injury Res & Prevent Inc, Datalys Ctr, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	zkerr@datalyscenter.org		Kerr, Zachary/0000-0003-1423-1259	NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002880, U01CE002885] Funding Source: NIH RePORTER		[Anonymous], 2014, 2014 15 HIGH SCH ATH; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, CONVENIENCE SAMPLE S; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Institute of Medicine, SPORTS RELATED CONCU; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; National Federation of High Schools, IND FOOTB SEA 222, V222; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Thackston L., INDIANA 1 STATE CONC; USA Football, HEADS UP FOOTB; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	21	24	24	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAY	2016	4	5								10.1177/2325967116648441			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DQ2MT	WOS:000379037100010	27275000	Green Published, gold			2022-02-06	
J	Sufrinko, A; Johnson, EW; Henry, LC				Sufrinko, Alicia; Johnson, Eric W.; Henry, Luke C.			The Influence of Sleep Duration and Sleep-Related Symptoms on Baseline Neurocognitive Performance Among Male and Female High School Athletes	NEUROPSYCHOLOGY			English	Article						sleep; neurocognition; sex; concussion	SPORTS-RELATED CONCUSSION; GENDER-DIFFERENCES; ADOLESCENTS; PATTERNS; METAANALYSIS; DIFFERENCE; IMPACT; NEED; SEX	Typically, the effects of sleep duration on cognition are examined in isolation. Objective: This study examined the effects of restricted sleep and related symptoms on neurocognitive performance. Method: Baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and postconcussion symptom scale (PCSS) were administered to athletes (N = 7,150) ages 14-17 (M = 15.26, SD = 1.09) prior to sport participation. Three groups of athletes were derived from total sleep duration: sleep restriction (<= 5 hours), typical sleep (5.5-8.5 hours), and optimal sleep (>= 9 hours). A MANCOVA (age and sex as covariates) was conducted to examine differences across ImPACT/PCSS. Follow-up MANOVA compared ImPACT/PCSS performance among symptomatic (e.g., trouble falling asleep, sleeping less than usual) adolescents from the sleep restriction group (n = 78) with asymptomatic optimal sleepers (n = 99). Results: A dose-response effect of sleep duration on ImPACT performance and PCSS was replicated (Wilk's lambda = .98, F-2,F-7145 = 17.25, p < .001, eta(2) = .01). The symptomatic sleep restricted adolescents (n = 78) had poorer neurocognitive performance: verbal memory, F = 11.60, p = .001, visual memory, F = 6.57, p = .01, visual motor speed, F = 6.19, p = .01, and reaction time (RT), F = 5.21, p = .02, compared to demographically matched controls (n = 99). Girls in the sleep problem group performed worse on RT (p = .024). Conclusion: Examining the combination of sleep-related symptoms and reduced sleep duration effectively identified adolescents at risk for poor neurocognitive performance than sleep duration alone.	[Sufrinko, Alicia; Johnson, Eric W.; Henry, Luke C.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Sports Med Concuss Program, Pittsburgh, PA 15203 USA; [Johnson, Eric W.; Henry, Luke C.] Univ Pittsburgh, Sch Med, 3200 South Water St, Pittsburgh, PA 15203 USA		Henry, LC (corresponding author), Univ Pittsburgh, Sch Med, 3200 South Water St, Pittsburgh, PA 15203 USA.	lch32@pitt.edu		Henry, Luke/0000-0003-4557-0309			Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443; Arnett P., 2014, CONCUSSION ATHLETICS, P35; Beijamini F, 2008, BRAZ J MED BIOL RES, V41, P734, DOI 10.1590/S0100-879X2008000800016; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; CARSKADON MA, 1980, SLEEP, V2, P453; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P81, DOI 10.1017/S1355617713001288; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Jenni OG, 2007, SLEEP MED CLIN, V2, P321, DOI 10.1016/j.jsmc.2007.05.001; Klein JD, 2002, J ADOLESCENT HEALTH, V30, P190, DOI 10.1016/S1054-139X(01)00342-1; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Laberge L, 2001, J SLEEP RES, V10, P59, DOI 10.1046/j.1365-2869.2001.00242.x; Lee KA, 1999, J ADOLESCENT HEALTH, V24, P16, DOI 10.1016/S1054-139X(98)00074-3; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McClure D. J., 2013, ORTHOPAEDIC J SPO S1, V1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mercer PW, 1998, J ADOLESCENT HEALTH, V23, P259, DOI 10.1016/S1054-139X(98)00037-8; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; MORRISON DN, 1992, J AM ACAD CHILD PSY, V31, P94, DOI 10.1097/00004583-199201000-00014; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; National Sleep Foundation, 2006, SLEEP AM POLL; Noland H, 2009, J SCHOOL HEALTH, V79, P224, DOI 10.1111/j.1746-1561.2009.00402.x; Pennebaker JW, 2000, SCIENCE OF SELF-REPORT, P299; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roberts RE, 2002, J PSYCHOSOM RES, V53, P561, DOI 10.1016/S0022-3999(02)00446-4; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Tonetti L, 2008, CHRONOBIOL INT, V25, P745, DOI 10.1080/07420520802394191; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	37	24	24	2	29	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2016	30	4					484	491		10.1037/neu0000250			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DK2XM	WOS:000374777700009	26569029				2022-02-06	
J	Hasanin, A; Kamal, A; Amin, S; Zakaria, D; El Sayed, R; Mahmoud, K; Mukhtar, A				Hasanin, Ahmed; Kamal, Amr; Amin, Shereen; Zakaria, Dina; El Sayed, Riham; Mahmoud, Kareem; Mukhtar, Ahmed			Incidence and outcome of cardiac injury in patients with severe head trauma	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Severe head injury; Cardiac injury; Echocardiography; Tsroponin	SYMPATHETIC NERVOUS ACTIVITY; LEFT-VENTRICULAR DYSFUNCTION; TROPONIN-I; SUBARACHNOID HEMORRHAGE; MYOCARDIAL DYSFUNCTION; WALL-MOTION; ABNORMALITIES; PREDICTORS; INFARCTION; STROKE	Background: Although cardiac injury has been reported in patients with various neurological conditions, few data report cardiac injury in patients with traumatic brain injury (TBI). The aim of this work is to report the incidence of cardiac injury in patients with TBI and its impact on patient outcome. Methods: A prospective observational study was conducted on a cohort of 50 patients with severe TBI. Only patients with isolated severe TBI defined as Glascow coma scale (GCS) < 8 were included in the study. Acute physiology and chronic health evaluation (APACHE) II score, GCS, hemodynamic data, serum Troponin I, electrocardiogram (ECG), and echocardiographic examination, and patients' outcome were recorded. A neurogenic cardiac injury score (NCIS) was calculated for all patients (rising troponin = 1, abnormal echocardiography = 1, hypotension = 1). Univariate and multivariate analyses for risk factors for mortality were done for all risk factors. Results and discussion: Fifty patients were included; age was 31 +/- 12, APACHE II was 21 +/- 5, and male patients were 45 (90 %). Troponin I was elevated in 27 (54 %) patients, abnormal echocardiography and hypotension were documented in 14 (28 %) and 16 (32 %) patients, respectively. The in-hospital mortality was 36 %. Risk factors for mortality by univariate analysis were age, GCS, APACHE II score, serum troponin level, NCIS, and hypotension. However, in multivariate analysis, the only two independent risk factors for mortality were APACHE II score (OR = 1.25, 95 % confidence interval: 1.02-1.54, P = 0.03) and NCIS score (OR = 8.38, 95 % confidence interval: 1.44-48.74, P = 0.018). Conclusions: Cardiac injury is common in patients with TBI and is associated with increased mortality. The association of high NCIS and poor outcome in these patients warrants a further larger study.	[Hasanin, Ahmed; Kamal, Amr; Amin, Shereen; Zakaria, Dina; Mukhtar, Ahmed] Cairo Univ, Dept Anesthesia & Crit Care Med, Fac Med, Cairo, Egypt; [El Sayed, Riham] Cairo Univ, Dept Clin & Chem Pathol, Fac Med, Cairo, Egypt; [Mahmoud, Kareem] Cairo Univ, Dept Cardiol, Fac Med, Cairo, Egypt		Hasanin, A (corresponding author), Cairo Univ, Dept Anesthesia & Crit Care Med, Fac Med, Cairo, Egypt.	ahmedmohamedhasanin@gmail.com	Hasanin, Ahmed/H-3378-2018; Mahmoud, Kareem/AAP-5921-2021; Mukhtar, Ahmed/C-7916-2015	El Sayed, Riham/0000-0002-8634-5872; hasanin, ahmed/0000-0001-9947-5863; Mukhtar, Ahmed/0000-0002-0504-274X; Mahmoud, Kareem/0000-0002-2398-0000			Bahloul M, 2006, AM J CRIT CARE, V15, P462; Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; Bergenzaun L, 2011, CRIT CARE, V15, DOI 10.1186/cc10368; Bulsara KR, 2003, J NEUROSURG, V98, P524, DOI 10.3171/jns.2003.98.3.0524; Cheung Raymond T.F., 2004, Curr Treat Options Cardiovasc Med, V6, P199, DOI 10.1007/s11936-996-0014-x; Chew MS, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/139537; Coghlan LA, 2009, STROKE, V40, P412, DOI 10.1161/STROKEAHA.108.528778; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Gelow J, 2009, AM J MED, V122, P583, DOI 10.1016/j.amjmed.2008.12.016; Horowitz MB, 1998, ACTA NEUROCHIR, V140, P87, DOI 10.1007/s007010050063; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; KOEPP M, 1995, ARCH NEUROL-CHICAGO, V52, P152, DOI 10.1001/archneur.1995.00540260056016; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; Okabe T, 2013, NEUROCRIT CARE, V18, P271, DOI 10.1007/s12028-012-9804-z; Parekh N, 2000, J AM COLL CARDIOL, V36, P1328, DOI 10.1016/S0735-1097(00)00857-3; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Riera Maria, 2010, J Trauma, V68, pE13, DOI 10.1097/TA.0b013e3181469d5b; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Song HS, 2008, J CLIN NEUROL, V4, P75, DOI 10.3988/jcn.2008.4.2.75; Stollberger C, 2009, EUR J NEUROL, V16, pe116, DOI 10.1111/j.1468-1331.2009.02619.x; Sugimoto K, 2008, INT HEART J, V49, P75, DOI 10.1536/ihj.49.75; Temes RE, 2010, NEUROCRIT CARE, V13, P359, DOI 10.1007/s12028-010-9447-x; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Zaroff JG, 2012, NEUROCRIT CARE, V17, P374, DOI 10.1007/s12028-011-9592-x	28	24	24	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 27	2016	24								58	10.1186/s13049-016-0246-z			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DM1AI	WOS:000376077000003	27121183	Green Published, gold			2022-02-06	
J	Abogresha, NM; Greish, SM; Abdelaziz, EZ; Khalil, WF				Abogresha, Noha M.; Greish, Sahar Mansour; Abdelaziz, Eman Z.; Khalil, Waleed F.			Remote effect of kidney ischemia-reperfusion injury on pancreas: role of oxidative stress and mitochondrial apoptosis	ARCHIVES OF MEDICAL SCIENCE			English	Article						kidney ischemia-reperfusion; pancreatic apoptosis; oxidative stress	ISCHEMIA/REPERFUSION; EXPRESSION; THYMUS; BLOOD; RATIO	Introduction: Recent studies have demonstrated remote effects of renal ischemia/reperfusion (IR) injury on some organs such as brain, liver, and lungs. Oxidative stress is reported to be the cornerstone in such ischemic conditions. Associated apoptosis is also reported in remote lung, liver and myocardial injury after acute kidney injury. So, we postulated that renal IR may affect the pancreas by its remote effect. Oxidative stress and mitochondria) mediated apoptosis may play a crucial role in this injury. We investigated the effects of kidney IR on pancreatic exocrine and endocrine functions, antioxidant enzyme activity, and apoptosis. Material and methods: The protective effect of vitamin C was also investigated. The animals were submitted to non-traumatic bilateral renal IR, sham operation or treatment with vitamin C after IR. Rats were sacrificed on the 1st, 3rd, and 7th days of the experiment to evaluate the parameters of oxidative stress (catalase, lipid peroxidase, reduced glutathione and superoxide dismutase), pancreatic endocrine and exocrine function (amylase, insulin and fasting blood glucose), renal functions (serum creatinine and blood urea nitrogen), cellular injury and apoptotic markers (Bcl-2, Bax and caspase-3). Results: Kidney I/R significantly increased the renal and pancreatic functions at 1, 3 and 7 days, while fasting insulin was significantly increased at day 3 after ischemia. Moreover, I/R significantly increased the studied oxidative stress markers and decreased the antioxidant capacity in pancreatic tissues. In addition, renal I/R induced numerous histopatological lesions in pancreatic tissues and increased the apoptosis-related genes. Treating the rats with vitamin C (100 mg/kg) significantly restored the renal and pancreatic functions, improved the pancreatic antioxidant capacity and protected the pancreatic tissues from apoptotic necrosis. Conclusions: The results suggested that bilateral renal ischemia for 45 min caused significant impairment of pancreatic function and structure as indicators of acute pancreatitis. While IR enhances oxidative stress and apoptosis, vitamin C appears to play a cytoprotective role.	[Abogresha, Noha M.; Greish, Sahar Mansour] Suez Canal Univ, Fac Med, Dept Physiol, Ismaileya 41522, Egypt; [Abdelaziz, Eman Z.] Suez Canal Univ, Fac Med, Dept Pharmacol, Ismaileya, Egypt; [Khalil, Waleed F.] Suez Canal Univ, Fac Vet Med, Dept Pharmacol, Ismaileya, Egypt		Greish, SM (corresponding author), Suez Canal Univ, Fac Med, Dept Physiol, Ismaileya 41522, Egypt.	saharmg@yahoo.com	khalil, Waleed/AAJ-7724-2020; Abdelaziz, Eman Z/ABG-6634-2020	khalil, Waleed/0000-0003-2198-6406; Abdelaziz, Eman Z/0000-0002-6120-5048; Abogresha, Noha/0000-0001-7548-6349; Greish, Sahar/0000-0002-6729-9006			Abdollahzad H, 2009, INT J VITAM NUTR RES, V79, P281, DOI 10.1024/0300-9831.79.56.281; AEBI H, 1984, METHOD ENZYMOL, V105, P121; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bulent G, ISCHEMIA REPERFUSION; Chambial S, 2013, INDIAN J CLIN BIOCHE, V28, P314, DOI 10.1007/s12291-013-0375-3; Chang BJ, 2002, ARCH BIOCHEM BIOPHYS, V405, P55, DOI 10.1016/S0003-9861(02)00342-9; Chappel J.B., 1969, SUBCELLULAR COMPONEN, V2nd ed.; Chen CC, 2004, ACTA PHARMACOL SIN, V25, P1334; Doustar Y, 2012, J ANIM VET ADV, V11, P108; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Fujimoto K, 1997, J SURG RES, V71, P127, DOI 10.1006/jsre.1997.5151; Hengartner M O, 2000, Symp Soc Exp Biol, V52, P1; Hussein AM, 2014, PHYSIOL RES, V63, P47, DOI 10.33549/physiolres.932497; Kockar C, 2012, NOBEL MED, V8, P49; Laura E, 2012, INTERN J NEPHROL, V2012; Munoz-Casares FC, 2006, J PINEAL RES, V40, P195, DOI 10.1111/j.1600-079X.2005.00291.x; Obermaier R, 2001, CLIN EXP MED, V1, P51, DOI 10.1007/PL00012237; Philchenkov A, 2004, EXP ONCOL, V26, P82; Rodrigo R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-192; Russell D.W., 2001, MOL CLONING LAB MANU; Salakou S, 2001, EUR J CARDIO-THORAC, V20, P712, DOI 10.1016/S1010-7940(01)00776-X; Salakou S, 2007, IN VIVO, V21, P123; Scopa CD, 2001, APPL IMMUNOHISTO M M, V9, P329, DOI 10.1097/00022744-200112000-00007; TAMURA K, 1993, HEPATO-GASTROENTEROL, V40, P452; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Warzecha Z, 2004, J PHYSIOL PHARMACOL, V55, P791; WOOLLIAMS JA, 1983, RES VET SCI, V34, P253, DOI 10.1016/S0034-5288(18)32219-7; Yildirim A, 2009, INT J MORPHOL, V27, P519, DOI 10.4067/S0717-95022009000200036	28	24	31	0	5	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.	APR	2016	12	2					252	262		10.5114/aoms.2015.48130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ9BY	WOS:000374510200003	27186168	Green Submitted, gold, Green Published			2022-02-06	
J	Chakrabarti, M; Das, A; Samantaray, S; Smith, JA; Banik, NL; Haque, A; Ray, SK				Chakrabarti, Mrinmay; Das, Arabinda; Samantaray, Supriti; Smith, Joshua A.; Banik, Naren L.; Haque, Azizul; Ray, Swapan K.			Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury	REVIEWS IN THE NEUROSCIENCES			English	Article						estrogen; inflammation; neuroprotection; spinal cord injury; traumatic brain injury	ACTIVATED PROTEIN-KINASE; PRIMARY CORTICAL-NEURONS; VEIN ENDOTHELIAL-CELLS; RECEPTOR-BETA; MALE RATS; REPLACEMENT THERAPY; VSC4.1 MOTONEURONS; GROWTH-FACTOR; IN-VITRO; NEURODEGENERATIVE DISEASES	Estrogen (EST) is a steroid hormone that exhibits several important physiological roles in the human body. During the last few decades, EST has been well recognized as an important neuroprotective agent in a variety of neurological disorders in the central nervous system (CNS), such as spinal cord injury (SCI), traumatic brain injury (TBI), Alzheimer's disease, and multiple sclerosis. The exact molecular mechanisms of EST-mediated neuro-protection in the CNS remain unclear due to heterogeneity of cell populations that express EST receptors (ERs) in the CNS as well as in the innate and adaptive immune system. Recent investigations suggest that EST protects the CNS from injury by suppressing pro-inflammatory pathways, oxidative stress, and cell death, while promoting neurogenesis, angiogenesis, and neurotrophic support. In this review, we have described the currently known molecular mechanisms of EST-mediated neuroprotection and neuroregeneration in SCI and TBI. At the same time, we have emphasized on the recent in vitro and in vivo findings from our and other laboratories, implying potential clinical benefits of EST in the treatment of SCI and TBI.	[Chakrabarti, Mrinmay; Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd, Columbia, SC 29209 USA; [Das, Arabinda; Samantaray, Supriti; Smith, Joshua A.; Banik, Naren L.] Med Univ S Carolina, Dept Neurol & Neurosurg, Charleston, SC 29425 USA; [Haque, Azizul] Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA		Ray, SK (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019	Smith, Joshua/0000-0003-2172-9207	South Carolina Spinal Cord Injury Research Fund (SC SCIRF, Columbia, SC, USA); University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA)	This work was supported in part by grants from South Carolina Spinal Cord Injury Research Fund (SC SCIRF, Columbia, SC, USA) and University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA).	Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Azevedo RB, 2001, BRAZ J MED BIOL RES, V34, P683, DOI 10.1590/S0100-879X2001000500018; Baker KA, 2005, J NEUROTRAUM, V22, P415, DOI 10.1089/neu.2005.22.415; Ball LJ, 2009, MOL CELL ENDOCRINOL, V299, P204, DOI 10.1016/j.mce.2008.10.050; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Behl C, 2000, Novartis Found Symp, V230, P221, DOI 10.1002/0470870818.ch16; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brinton LA, 2008, CANCER EPIDEM BIOMAR, V17, P3150, DOI 10.1158/1055-9965.EPI-08-0435; Caliceti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071440; Chakrabarti M, 2014, NEUROSCIENCE, V256, P322, DOI 10.1016/j.neuroscience.2013.10.027; Chakrabarti M, 2014, BRAIN RES BULL, V109, P22, DOI 10.1016/j.brainresbull.2014.09.004; Chakrabarti S, 2008, IUBMB LIFE, V60, P376, DOI 10.1002/iub.48; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Chen SH, 2006, ENDOCRINOLOGY, V147, P5303, DOI 10.1210/en.2006-0495; Conti Alfredo, 2010, Cancers (Basel), V2, P693, DOI 10.3390/cancers2020693; Cuzzocrea S, 2008, SHOCK, V29, P362, DOI 10.1097/shk.0b013e31814545dc; Das A, 2005, J NEUROSCI RES, V81, P551, DOI 10.1002/jnr.20581; Das A, 2011, J ENDOCRINOL, V208, P171, DOI 10.1677/JOE-10-0338; Deroo BJ, 2010, MOL ENDOCRINOL, V24, P1703, DOI 10.1210/me.2009-0288; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; Doperalski NJ, 2008, RESP PHYSIOL NEUROBI, V162, P160, DOI 10.1016/j.resp.2008.06.005; Doshi Sejal B, 2013, J Midlife Health, V4, P140, DOI 10.4103/0976-7800.118990; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Endoh H, 1997, BIOCHEM BIOPH RES CO, V235, P99, DOI 10.1006/bbrc.1997.6746; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gatson JW, 2011, ENDOCRINOLOGY, V152, P207, DOI 10.1210/en.2010-0724; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Gottipati S, 2008, MOL VIS, V14, P898; Greb RR, 1997, HUM REPROD, V12, P1280; Green PS, 1997, J STEROID BIOCHEM, V63, P229, DOI 10.1016/S0960-0760(97)00124-6; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hawk T, 1998, BRAIN RES, V796, P296, DOI 10.1016/S0006-8993(98)00327-8; Henderson VW, 1997, NEUROLOGY, V48, pS27, DOI 10.1212/WNL.48.5_Suppl_7.27S; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kachadroka S, 2010, J NEUROTRAUM, V27, P611, DOI 10.1089/neu.2009.1069; Keller JN, 1997, J NEUROSCI RES, V50, P522, DOI 10.1002/(SICI)1097-4547(19971115)50:4<522::AID-JNR3>3.0.CO;2-G; Khalil R. A., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P29; KimSchulze S, 1996, CIRCULATION, V94, P1402, DOI 10.1161/01.CIR.94.6.1402; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lahm T, 2008, CRIT CARE MED, V36, P2174, DOI 10.1097/CCM.0b013e31817d1a92; Lapanantasin S, 2006, SYNAPSE, V60, P406, DOI 10.1002/syn.20308; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Liu W, 1998, NUCLEIC ACIDS RES, V26, P3616, DOI 10.1093/nar/26.15.3616; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martinkovich S, 2014, CLIN INTERV AGING, V9, P1437, DOI 10.2147/CIA.S66690; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Moosmann B, 1999, P NATL ACAD SCI USA, V96, P8867, DOI 10.1073/pnas.96.16.8867; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Murakoshi Masanori, 1999, Journal of Toxicological Sciences, V24, P415; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Nilsen J, 2002, BRAIN RES, V930, P216, DOI 10.1016/S0006-8993(02)02254-0; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Ray SK, 2006, NEUROSCIENCE, V139, P577, DOI 10.1016/j.neuroscience.2005.12.057; Ritz MF, 2008, BRAIN RES, V1203, P177, DOI 10.1016/j.brainres.2008.01.091; Rong W, 2012, INT J NEUROSCI, V122, P381, DOI 10.3109/00207454.2012.668726; Saatman K.E., 2010, J NEUROTRAUM, V25, P719; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Samantaray S, 2011, NEUROCHEM RES, V36, P1809, DOI 10.1007/s11064-011-0498-y; Samantaray S, 2010, ANN NY ACAD SCI, V1199, P90, DOI 10.1111/j.1749-6632.2009.05357.x; Schmidt R, 1996, J AM GERIATR SOC, V44, P1307, DOI 10.1111/j.1532-5415.1996.tb01400.x; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Seo KH, 2004, EUR J IMMUNOL, V34, P2129, DOI 10.1002/eji.200424957; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Smiley DA, 2009, CURR MED CHEM, V16, P1863, DOI 10.2174/092986709788186093; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2004, NEUROCHEM RES, V29, P2007, DOI 10.1007/s11064-004-6874-0; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Sribnick EA, 2007, NEUROCHEM RES, V32, P2210, DOI 10.1007/s11064-007-9433-7; Sribnick EA, 2010, J NEUROSCI RES, V88, P1738, DOI 10.1002/jnr.22337; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Tucker L. B., 2015, J NEUROTRAU IN PRESS; Unnikrishnan AG, 2000, NATL MED J INDIA, V13, P145; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Venkov CD, 1996, CIRCULATION, V94, P727, DOI 10.1161/01.CIR.94.4.727; Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336; Wang TD, 2007, J FORMOS MED ASSOC, V106, P919, DOI 10.1016/S0929-6646(08)60062-5; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yan J, 2012, J CELL MOL MED, V16, P2968, DOI 10.1111/j.1582-4934.2012.01624.x; Yanhong Li, 2007, Neural Regeneration Research, V2, P471; Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3	112	24	27	0	18	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	APR	2016	27	3					271	281		10.1515/revneuro-2015-0032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK6QY	WOS:000375051300003	26461840				2022-02-06	
J	Karelina, K; Sarac, B; Freeman, LM; Gaier, KR; Weil, ZM				Karelina, Kate; Sarac, Benjamin; Freeman, Lindsey M.; Gaier, Kristopher R.; Weil, Zachary M.			Traumatic brain injury and obesity induce persistent central insulin resistance	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						anxiety; central metabolism; high-fat diet; insulin receptor; mouse; neuroinflammation	ENDOTHELIAL GROWTH-FACTOR; DIET-INDUCED OBESITY; ALZHEIMERS-DISEASE; GLUCOSE-HOMEOSTASIS; AKT PHOSPHORYLATION; OXIDATIVE STRESS; DIABETES-MELLITUS; CEREBRAL-ISCHEMIA; VASCULAR DEMENTIA; MATERNAL OBESITY	Traumatic brain injury (TBI)-induced impairments in cerebral energy metabolism impede tissue repair and contribute to delayed functional recovery. Moreover, the transient alteration in brain glucose utilization corresponds to a period of increased vulnerability to the negative effects of a subsequent TBI. In order to better understand the factors contributing to TBI-induced central metabolic dysfunction, we examined the effect of single and repeated TBIs on brain insulin signalling. Here we show that TBI induced acute brain insulin resistance, which resolved within 7days following a single injury but persisted until 28days following repeated injuries. Obesity, which causes brain insulin resistance and neuroinflammation, exacerbated the consequences of TBI. Obese mice that underwent a TBI exhibited a prolonged reduction of Akt (also known as protein kinase B) signalling, exacerbated neuroinflammation (microglial activation), learning and memory deficits, and anxiety-like behaviours. Taken together, the transient changes in brain insulin sensitivity following TBI suggest a reduced capacity of the injured brain to respond to the neuroprotective and anti-inflammatory actions of insulin and Akt signalling, and thus may be a contributing factor for the damaging neuroinflammation and long-lasting deficits that occur following TBI.	[Karelina, Kate] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Dept Neurosci, Wexner Med Ctr, Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA; Ohio State Univ, Wexner Med Ctr, Grp Behav Neuroendocrinol, Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA		Karelina, K (corresponding author), Ohio State Univ, Ctr Brain & Spinal Cord Repair, Dept Neurosci, Wexner Med Ctr, Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Ekaterina.karelina@osumc.edu	Weil, Zachary M/B-5003-2008; Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768	OSU Neurological Institute Pilot Award;  [NS045758]	We are grateful to undergraduate research assistants Joseph Abraham, Katie Centner, Samuel Nicholson, Maya Prabhu, and Vanessa Wenger for their tireless assistance with these experiments. This work was supported by an OSU Neurological Institute Pilot Award and additional support for behavioural research was provided by NS045758.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Aguliar-Valles A, 2014, MOL PSYCHIATR, V19, P599, DOI 10.1038/mp.2013.137; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andre C, 2014, BRAIN BEHAV IMMUN, V41, P10, DOI 10.1016/j.bbi.2014.03.012; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Bateman JM, 2006, CELL MOL LIFE SCI, V63, P1701, DOI 10.1007/s00018-006-6036-4; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Bosco D, 2012, J NEUROL SCI, V315, P39, DOI 10.1016/j.jns.2011.12.008; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Cardoso S, 2009, J ALZHEIMERS DIS, V18, P483, DOI 10.3233/JAD-2009-1155; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Castanon N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00229; Dandona P, 2002, DIABETOLOGIA, V45, P924, DOI 10.1007/s00125-001-0766-5; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Duarte AI, 2008, BBA-MOL CELL RES, V1783, P994, DOI 10.1016/j.bbamcr.2008.02.016; Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Franke K, 2005, BRAIN RES, V1031, P276, DOI 10.1016/j.brainres.2004.11.006; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Ghasemi R, 2013, MOL NEUROBIOL, V47, P145, DOI 10.1007/s12035-012-8339-9; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hopkins DFC, 1997, DIABETIC MED, V14, P1044, DOI 10.1002/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jin KL, 2000, NEUROSCIENCE, V100, P713, DOI 10.1016/S0306-4522(00)00331-6; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Lima MHM, 2002, ENDOCRINE, V18, P1, DOI 10.1385/ENDO:18:1:01; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raygada M, 1998, J NUTR, V128, P2505; RAZAY G, 1994, AGE AGEING, V23, P396, DOI 10.1093/ageing/23.5.396; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salkovic-Petrisic M., 2007, CENTRAL INSULIN RESI; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Sharma B, 2011, PHARMACOL BIOCHEM BE, V100, P320, DOI 10.1016/j.pbb.2011.08.020; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamagishi S, 1999, MICROVASC RES, V57, P329, DOI 10.1006/mvre.1999.2145; Yu XR, 2006, ACTA BIOCH BIOPH SIN, V38, P241, DOI 10.1111/j.1745-7270.2006.00152.x; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144	77	24	25	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2016	43	8					1034	1043		10.1111/ejn.13194			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK1BA	WOS:000374645700005	26833850				2022-02-06	
J	Mountney, A; Bramlett, HM; Dixon, CE; Mondello, S; Dietrich, WD; Wang, KKW; Caudle, K; Empey, PE; Poloyac, SM; Hayes, RL; Povlishock, JT; Tortella, FC; Kochanek, PM; Shear, DA				Mountney, Andrea; Bramlett, Helen M.; Dixon, C. Edward; Mondello, Stefania; Dietrich, W. Dalton; Wang, Kevin K. W.; Caudle, Krista; Empey, Philip E.; Poloyac, Samuel M.; Hayes, Ronald L.; Povlishock, John T.; Tortella, Frank C.; Kochanek, Patrick M.; Shear, Deborah A.			Simvastatin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy	JOURNAL OF NEUROTRAUMA			English	Article						penetrating ballistic-like brain injury; therapy; micropig; biomarker; controlled cortical impact; neuroprotection; statin; fluid percussion; rat	ANEURYSMAL SUBARACHNOID HEMORRHAGE; COA REDUCTASE INHIBITOR; COMBINATION THERAPY; COGNITIVE DEFICITS; NEURONAL SURVIVAL; GENE-EXPRESSION; STATINS; ATORVASTATIN; MODEL; RAT	Simvastatin, the fourth drug selected for testing by Operation Brain Trauma Therapy (OBTT), is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor used clinically to reduce serum cholesterol. In addition, simvastatin has demonstrated potent antineuroinflammatory and brain edema reducing effects and has shown promise in promoting functional recovery in pre-clinical models of traumatic brain injury (TBI). The purpose of this study was to assess the potential neuroprotective effects of oral administration of simvastatin on neurobehavioral, biomarker, and histopathological outcome measures compared across three pre-clinical TBI animal models. Adult male Sprague-Dawley rats were exposed to either moderate fluid percussion injury (FPI), controlled cortical impact injury (CCI), or penetrating ballistic-like brain injury (PBBI). Simvastatin (1 or 5 mg/kg) was delivered via oral gavage at 3 h post-injury and continued once daily out to 14 days post-injury. Results indicated an intermediate beneficial effect of simvastatin on motor performance on the gridwalk (FPI), balance beam (CCI), and rotarod tasks (PBBI). No significant therapeutic benefit was detected, however, on cognitive outcome across the OBTT TBI models. In fact, Morris water maze (MWM) performance was actually worsened by treatment in the FPI model and scored full negative points for low dose in the MWM latency and swim distance to locate the hidden platform. A detrimental effect on cortical tissue loss was also seen in the FPI model, and there were no benefits on histology across the other models. Simvastatin also produced negative effects on circulating glial fibrillary acidic protein biomarker outcomes that were evident in the FPI and PBBI models. Overall, the current findings do not support the beneficial effects of simvastatin administration over 2 weeks post-TBI using the oral route of administration and, as such, it will not be further pursued by OBTT.	[Mountney, Andrea; Caudle, Krista; Tortella, Frank C.; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Neurorestorat, Silver Spring, MD USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Vet Affairs Med Ctr, Bruce W Carter Dept, Miami, FL 33125 USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Brain Trauma Res Ctr, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Empey, Philip E.; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15260 USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Ctr Neuroprote & Biomarkers Res, Ctr Innovat Res, Alachua, FL USA; [Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Mondello, Stefania/A-1813-2012; Empey, Philip/L-9604-2019	Mondello, Stefania/0000-0002-8587-3614; Empey, Philip/0000-0001-7474-2339; Wang, Kevin/0000-0002-9343-6473			Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Bulsara Ketan R, 2006, Neurosurg Focus, V21, pE11; Chauhan NB, 2011, RESTOR NEUROL NEUROS, V29, P23, DOI 10.3233/RNN-2011-0573; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Cimino A, 2005, NEUROTOXICOLOGY, V26, P929, DOI 10.1016/j.neuro.2005.03.009; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Jung KH, 2004, STROKE, V35, P1744, DOI 10.1161/01.STR.0000131270.45822.85; Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; Kobayashi M, 2006, INT J PHARMACEUT, V317, P19, DOI 10.1016/j.ijpharm.2006.02.043; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Lee G, 2001, PHARMACOL REV, V53, P569; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; McGirt MJ, 2006, J NEUROSURG, V105, P671, DOI 10.3171/jns.2006.105.5.671; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Nagasawa K, 2002, J PHARM SCI, V91, P2605, DOI 10.1002/jps.10246; Ogasawara A, 2009, DRUG METAB DISPOS, V37, P122, DOI 10.1124/dmd.108.022574; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Seyfried D, 2004, J NEUROSURG, V101, P104, DOI 10.3171/jns.2004.101.1.0104; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Xie HZ, 2014, CORONARY ARTERY DIS, V25, P565, DOI 10.1097/MCA.0000000000000148	50	24	24	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 15	2016	33	6					567	580		10.1089/neu.2015.4130			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DG6HN	WOS:000372184800006	26541177	Green Published			2022-02-06	
J	Baimukanova, G; Miyazawa, B; Potter, DR; Muench, MO; Bruhn, R; Gibb, SL; Spinella, PC; Cap, AP; Cohen, MJ; Pati, S				Baimukanova, Gyulnar; Miyazawa, Byron; Potter, Daniel R.; Muench, Marcus O.; Bruhn, Roberta; Gibb, Stuart L.; Spinella, Philip C.; Cap, Andrew P.; Cohen, Mitchell J.; Pati, Shibani			Platelets regulate vascular endothelial stability: assessing the storage lesion and donor variability of apheresis platelets	TRANSFUSION			English	Article							TRAUMATIC BRAIN-INJURY; FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; HEMORRHAGIC-SHOCK; MOLECULAR-BASIS; RESUSCITATION; MAINTENANCE; SURVIVAL; PERMEABILITY; CONTAINERS	BACKGROUNDIn current blood banking practices, platelets (PLTs) are stored in plasma at 22 degrees C, with gentle agitation for up to 5 days. To date, the effects of storage and donor variability on PLT regulation of vascular integrity are not known. STUDY DESIGN AND METHODSIn this study, we examined the donor variability of leukoreduced fresh (Day 1) or stored (Day 5) PLTs on vascular endothelial barrier function in vitro and in vivo. In vitro, PLT effects on endothelial cell (EC) monolayer permeability were assessed by analyzing transendothelial electrical resistances (TEER). PLT aggregation, a measure of hemostatic potential, was analyzed by impedance aggregometry. In vivo, PLTs were investigated in a vascular endothelial growth factor A (VEGF-A)-induced vascular permeability model in NSG mice, and PLT circulation was measured by flow cytometry. RESULTSTreatment of endothelial monolayers with fresh Day 1 PLTs resulted in an increase in EC barrier resistance and decreased permeability in a dose-dependent manner. Subsequent treatment of EC monolayers with Day 5 PLTs demonstrated diminished vasculoprotective effects. Donor variability was noted in all measures of PLT function. Day 1 PLT donors were more variable in their effects on TEER than Day 5 PLTs. In mice, while all PLTs regardless of storage time demonstrated significant protection against VEGF-A-induced vascular leakage, Day 5 PLTs exhibited reduced protection when compared to Day 1 PLTs. Day 1 PLTs demonstrated significant donor variability against VEGF-A-challenged vascular leakage in vivo. Systemic circulating levels of Day 1 PLTs were higher than those of Day 5 PLTs CONCLUSIONSIn vitro and in vivo, Day 1 PLTs are protective in measures of vascular endothelial permeability. Donor variability is most prominent in Day 1 PLTs. A decrease in the protective effects is found with storage of the PLT units between Day 1 and Day 5 at 22 degrees C, thereby suggesting that Day 5 PLTs are diminished in their ability to attenuate vascular endothelial permeability.	[Baimukanova, Gyulnar; Potter, Daniel R.; Muench, Marcus O.; Bruhn, Roberta; Gibb, Stuart L.; Pati, Shibani] Blood Syst Res Inst, 270 Mason Ave, San Francisco, CA 94118 USA; [Miyazawa, Byron; Cohen, Mitchell J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Pati, Shibani] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Spinella, Philip C.] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Cap, Andrew P.] US Army, Inst Surg Res USAISR, Jbsa Ft Sam Houston, TX USA		Pati, S (corresponding author), Blood Syst Res Inst, 270 Mason Ave, San Francisco, CA 94118 USA.	spati@bloodsystems.org	Muench, Marcus O./C-5025-2009	Muench, Marcus O./0000-0001-8946-6605; Bruhn, Roberta/0000-0002-5898-8168	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 DK088760]; Blood Systems Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK088760] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health, P01 DK088760 (to MM), and funding from Blood Systems Research Institute.	Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brkovic A, 2007, J CELL BIOCHEM, V100, P727, DOI 10.1002/jcb.21124; CHERNOFF A, 1992, TRANSFUSION, V32, P386, DOI 10.1046/j.1537-2995.1992.32492263456.x; Devine DV, 2010, CLIN LAB MED, V30, P475, DOI 10.1016/j.cll.2010.02.002; GIAEVER I, 1986, IEEE T BIO-MED ENG, V33, P242, DOI 10.1109/TBME.1986.325896; Glenister KM, 2008, TRANSFUSION, V48, P99, DOI 10.1111/j.1537-2995.2007.01487.x; Grozovsky R, 2010, CURR OPIN HEMATOL, V17, P585, DOI 10.1097/MOH.0b013e32833e7561; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; HOLME S, 1987, VOX SANG, V53, P214, DOI 10.1111/j.1423-0410.1987.tb05069.x; HOLME S, 1992, J LAB CLIN MED, V119, P144; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Inaba K, 2011, J TRAUMA, V71, P1766, DOI 10.1097/TA.0b013e31823bdbf9; Jenkins DH, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000140; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Krailadsiri P, 2001, TRANSFUSION, V41, P243, DOI 10.1046/j.1537-2995.2001.41020243.x; MURPHY S, 1975, BLOOD, V46, P209; MURPHY S, 1971, J CLIN INVEST, V50, P370, DOI 10.1172/JCI106504; MURPHY S, 1970, BLOOD-J HEMATOL, V35, P549, DOI 10.1182/blood.V35.4.549.549; MURPHY S, 1971, VOX SANG, V20, P427, DOI 10.1111/j.1423-0410.1971.tb01814.x; MURPHY S, 1976, TRANSFUSION, V16, P2; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Newman PJ, 2007, J THROMB HAEMOST, V5, P305, DOI 10.1111/j.1538-7836.2007.02466.x; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Rinder HM, 2003, TRANSFUSION, V43, P2, DOI 10.1046/j.1537-2995.2003.00261.x; Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002; Stroncek DF, 2007, LANCET, V370, P427, DOI 10.1016/S0140-6736(07)61198-2	36	24	26	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	MAR	2016	56			1	SI		S65	S75		10.1111/trf.13532			11	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	DI2YJ	WOS:000373364800009	27001364	Green Accepted			2022-02-06	
J	Crowe, L; Collie, A; Hearps, S; Dooley, J; Clausen, H; Maddocks, D; McCrory, P; Davis, G; Anderson, V				Crowe, Louise; Collie, Alex; Hearps, Stephen; Dooley, Julian; Clausen, Helen; Maddocks, David; McCrory, Paul; Davis, Gavin; Anderson, Vicki			Cognitive and physical symptoms of concussive injury in children: a detailed longitudinal recovery study	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; HIGH-SCHOOL; EPIDEMIOLOGY; PREDICTORS; APPROPRIATE; GUIDELINES; OUTCOMES; PLAY	Background Recovery from concussion sustained in childhood and adolescence is poorly understood. We explored patterns of recovery for neurocognition and postconcussive symptoms following concussion in children and adolescents. Methods Using a prospective, longitudinal design, we collected baseline data on 728 children and adolescents aged 10-17 years. 10 participants sustained a concussive injury (n=10) in the 12 months following baseline testing and they were reviewed at day 5, 10 and 30 postconcussion. Assessments included the CogSport for Kids computerised test battery to evaluate neurocognitive function and self-report, and parent measures of postconcussive symptoms. At day 30, parents also completed measures rating their child's quality of life and executive functions. Results Children and adolescents displayed a gradual reduction in postconcussive symptoms over the 30 days following injury. At day 5, 87% of participants were reporting physical and cognitive symptoms, with a generalised reduction in all symptoms by day 10 (40% of participants). On the computerised measure, reaction time was slower after concussion, but returned to baseline levels by day 30. At day 30, 10% of participants demonstrated ongoing postconcussive symptoms. Number of previous concussions was related to speed of symptom resolution. Conclusions At 5 days postconcussion, the majority of children and adolescents experienced debilitating postconcussive symptoms. However, by 30 days postinjury, 90% demonstrated recovery to normal for both neurocognition and postconcussive symptoms.	[Crowe, Louise; Dooley, Julian; Anderson, Vicki] Murdoch Childrens Res Inst, Child Neuropsychol, Melbourne, Vic, Australia; [Collie, Alex] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Hearps, Stephen] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Clausen, Helen] Melbourne Neuropsychol Serv, Melbourne, Vic, Australia; [Maddocks, David] Perry Maddocks Trellope, Melbourne, Vic, Australia; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Davis, Gavin] Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, 4 West,50 Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	McCrory, Paul/Q-8688-2019; Meijer, Anna/K-5118-2016; Hearps, Stephen/L-6853-2016	Collie, Alex/0000-0003-2617-9339; Crowe, Louise/0000-0003-4619-9708; Hearps, Stephen/0000-0003-2984-1172; McCrory, Paul/0000-0003-4850-0568	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [334337]; Victorian Government Operational Infrastructure grant; NHMRCNational Health and Medical Research Council of Australia	This study was funded by the Australian National Health and Medical Research Council (#334337) and was supported by a Victorian Government Operational Infrastructure grant to the Murdoch Childrens Research Institute. VA is funded by an NHMRC Senior Practitioner. Fellowship of LC is funded by a NHMRC Early Career Fellowship.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broshek DK, 2014, J CHILD NEUROL; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA IP, 2000, BEHAV RATING INVENTO; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Langlois JA, 2006, TBI US EMERGENCY DEP; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Urbina S, 1997, PSYCHOL TESTING; WATERS E, 1999, AUSTR AUTHORISED ADA; Williams J, 2014, APP NEUROPSYCHOL CHI, P1; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	35	24	24	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2016	50	5					311	U69		10.1136/bjsports-2015-094663			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DF4KT	WOS:000371317800015	26429808				2022-02-06	
J	Ismail, S; McIntosh, M; Kalynych, C; Joseph, M; Wylie, T; Butterfield, R; Smotherman, C; Kraemer, DF; Osian, SR				Ismail, Shareen; McIntosh, Mark; Kalynych, Colleen; Joseph, Madeline; Wylie, Todd; Butterfield, Ryan; Smotherman, Carmen; Kraemer, Dale F.; Osian, Sarah R.			IMPACT OF VIDEO DISCHARGE INSTRUCTIONS FOR PEDIATRIC FEVER AND CLOSED HEAD INJURY FROM THE EMERGENCY DEPARTMENT	JOURNAL OF EMERGENCY MEDICINE			English	Article						caregiver knowledge; discharge instructions; emergency medicine; emergency room; pediatrics	PATIENT LITERACY; COMMUNICATION; COMPREHENSION; UNDERSTAND	Background: Lack of understanding of diagnosis and disease process remains a major complaint of caregivers who bring their children to the pediatric emergency department (PED). Misunderstanding of diagnosis and discharge instructions can lead to unnecessary return visits and health disparities. Objective: We attempted to determine if video discharge instructions when added to standard of care written and verbal instruction improved caregivers' comprehension of their child's diagnosis, disease process, and discharge instructions. Methods: Caregivers who presented to the PED with a child's chief complaint of fever or closed head injury (CHI) were included and randomized into a control or intervention group. Each group received standard discharge instructions, and the intervention group additionally viewed a video. Participants completed a post-test on knowledge and were followed 2 weeks post-visit to determine follow-up care. Results: Sixty-three caregivers participated in the study. Eleven participants had less than a high school (HS) education and 52 had more than a HS education. Thirty-one children presented with fever and 32 with CHI. The intervention group had significantly higher percentage of correct answers on postintervention tests (median [Mdn] = 88.89) than the control (Mdn = 75.73; p < 0.0001). Participants in the intervention group with less than a HS education (Mdn = 89.47) and more than HS education (Mdn = 88.89) had similar test scores (p = 0.13), whereas those in the control group with less than a HS education (Mdn = 66.67) had significantly lower test scores than those with more than a HS education (Mdn = 77.78; p = 0.03). Conclusion: For caregivers with children who presented to the PED with fever and CHI, video discharge instructions improved caregiver comprehension of the child's diagnosis and disease process when added to verbal and written instructions. (C) 2016 Elsevier Inc.	[Ismail, Shareen; McIntosh, Mark; Kalynych, Colleen; Joseph, Madeline; Wylie, Todd] Univ Florida, Coll Med, Dept Emergency Med, 655 W 8th St, Jacksonville, FL 32209 USA; [Butterfield, Ryan; Smotherman, Carmen; Kraemer, Dale F.; Osian, Sarah R.] Univ Florida, Coll Med, Ctr Hlth Equ & Qual Res, Jacksonville, FL USA		Kalynych, C (corresponding author), Univ Florida, Coll Med, Dept Emergency Med, 655 W 8th St, Jacksonville, FL 32209 USA.						Adams JG, 2010, J CLIN OUTCOMES MANA, V17, P449; ALPERN ER, 2006, TXB PEDIAT EMERGENCY, P295; Beagley L, 2011, J PERIANESTH NURS, V26, P331, DOI 10.1016/j.jopan.2011.06.002; Bloch SA, 2013, PEDIATR EMERG CARE, V29, P699, DOI 10.1097/PEC.0b013e3182955480; Clarke Collin, 2005, CJEM, V7, P5; DAVIS TC, 1994, PEDIATRICS, V93, P460; Eisenberg EM, 2005, COMMUN MONOGR, V72, P390, DOI 10.1080/03637750500322602; Engel KG, 2012, ACAD EMERG MED, V19, pE1035, DOI 10.1111/j.1553-2712.2012.01425.x; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Herndon JB, 2011, ANN EMERG MED, V57, P334, DOI 10.1016/j.annemergmed.2010.08.035; McLauglin HG, 1969, J READING, V12, P639; POWERS RD, 1988, ANN EMERG MED, V17, P124, DOI 10.1016/S0196-0644(88)80295-6; Samuels-Kalow ME, 2012, ANN EMERG MED, V60, P152, DOI 10.1016/j.annemergmed.2011.10.023; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Vashi A, 2011, ANN EMERG MED, V57, P315, DOI 10.1016/j.annemergmed.2010.08.024; Waisman Y, 2003, ISRAEL MED ASSOC J, V5, P567; Williams DM, 1996, AM J EMERG MED, V14, P19, DOI 10.1016/S0735-6757(96)90006-6	18	24	25	2	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2016	50	3					E177	E183		10.1016/j.jemermed.2015.10.006			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI2BV	WOS:000373301600019	26806318				2022-02-06	
J	Moore, M; Jimenez, N; Rowhani-Rahbar, A; Willis, M; Baron, K; Giordano, J; Crawley, D; Rivara, FP; Jaffe, KM; Ebel, BE				Moore, Megan; Jimenez, Nathalia; Rowhani-Rahbar, Ali; Willis, Margaret; Baron, Kate; Giordano, Jessica; Crawley, Deborah; Rivara, Frederick P.; Jaffe, Kenneth M.; Ebel, Beth E.			Availability of Outpatient Rehabilitation Services for Children After Traumatic Brain Injury Differences by Language and Insurance Status	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Disability; Health Care Accessibility; Rehabilitation; Health Care Disparities; Hispanic Children; Brain Injuries	HEALTH-CARE; ETHNIC DISPARITIES; PROFICIENCY; IMPACT; BARRIERS; OUTCOMES; SPANISH; TBI	Objective The objective of this study was to explore associations between English proficiency, insurance status, outpatient rehabilitation service availability, and travel time for children with traumatic brain injury. Design The authors used an ecologic cross-sectional design. Data were analyzed from a cohort of 82 children with moderate to severe traumatic brain injury and rehabilitation providers in Washington State. Main measures included availability and travel time to services. Results Less than 20% of providers accepted children with Medicaid and provided language interpretation. Mental health services were most limited. Adjusted for median household income, multilingual service availability was lowest in counties with greater language diversity; for every 10% increase in persons older than 5 yrs speaking a language other than English at home, there was a 34% decrease in availability of multilingual services (prevalence ratio, 0.66; 95% confidence interval, 0.48-0.90). Adjusted for education and Medicaid status, children from Spanish-speaking families had significantly longer travel times to services (mean, 16 additional minutes to mental health; 9 to other therapies). Conclusions Children in households with limited English proficiency and Medicaid faced significant barriers in availability and proximity of outpatient rehabilitation services. Innovative service strategies are needed to equitably improve availability of rehabilitation for children with traumatic brain injury. Similar studies in other regions will inform one's understanding of the scope of these disparities.	[Moore, Megan; Jimenez, Nathalia; Rowhani-Rahbar, Ali; Baron, Kate; Rivara, Frederick P.; Jaffe, Kenneth M.; Ebel, Beth E.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Moore, Megan] Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA; [Jimenez, Nathalia] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Rivara, Frederick P.; Jaffe, Kenneth M.; Ebel, Beth E.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali; Ebel, Beth E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Willis, Margaret] Boston Coll, Dept Sociol, Chestnut Hill, MA 02167 USA; [Giordano, Jessica; Crawley, Deborah] Brain Injury Alliance Washington, Seattle, WA USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA.			Jimenez, Nathalia/0000-0002-6785-8330; Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD078453-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002317, KL2TR000421] Funding Source: NIH RePORTER	Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421 [MM]) and the National Institute of Child Health and Human Development (1K23HD078453-01 [NJ]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 1999, JAMA, V282, P974; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; DeCamp LR, 2013, PEDIATRICS, V132, pE396, DOI 10.1542/peds.2012-2909; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; [DHHS U.S. Department of Health and Human Services], 2001, NAT STAND CULT LING; Diamond LC, 2010, MED CARE, V48, P1080, DOI 10.1097/MLR.0b013e3181f380bc; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Flores GF, 2005, PUBLIC HEALTH REP, V120, P418, DOI 10.1177/003335490512000409; Gregory PC, 2006, AM J PHYS MED REHAB, V85, P705, DOI 10.1097/01.phm.0000233181.34999.3d; Jimenez Nathalia, 2014, Hosp Pediatr, V4, P23, DOI 10.1542/hpeds.2013-0031; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Lion KC, 2013, ACAD MED, V88, P1478, DOI 10.1097/ACM.0b013e3182a2e30d; Lion KC, 2012, PEDIATRICS, V130, pE80, DOI 10.1542/peds.2011-2794; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Marr A., 2004, CENTRAL NERVOUS SYST; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Schwei RJ, 2015, INT J NURS STUD; Seedall RB, 2014, J MARITAL FAM THER, V40, P139, DOI 10.1111/jmft.12015; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Timmins CL, 2002, J MIDWIFERY WOM HEAL, V47, P80, DOI 10.1016/S1526-9523(02)00218-0; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Zuckerman S, 2011, HLTH AFF MILLWOOD, V30, P1997, DOI DOI 10.1377/hlthaff.2011.0604	37	24	25	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2016	95	3					204	213		10.1097/PHM.0000000000000362			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DE9LI	WOS:000370958600005	26259055	Green Accepted			2022-02-06	
J	Bosco, FM; Gabbatore, I; Gastaldo, L; Sacco, K				Bosco, Francesca M.; Gabbatore, Ilaria; Gastaldo, Luigi; Sacco, Katiuscia			Communicative-Pragmatic Treatment in Schizophrenia: A Pilot Study	FRONTIERS IN PSYCHOLOGY			English	Article						rehabilitation; schizophrenia; pragmatic; communication; training	TRAUMATIC BRAIN-INJURY; FACIAL AFFECT RECOGNITION; TRAINING-PROGRAM; MIND; IMPAIRMENTS; LANGUAGE; DEFICITS; REHABILITATION; REMEDIATION; PERSPECTIVE	This paper aims to verify the efficacy of Cognitive Pragmatic Treatment (CPT), a new remediation training for the improvement of the communicative-pragmatic abilities, in patients with schizophrenia. The CPT program is made up of 20 group sessions, focused on a number of communication modalities, i.e., linguistic, extralinguistic and paralinguistic, theory of mind (ToM) and other cognitive functions able to play a role on the communicative performance, such as awareness and planning. A group of 17 patients with schizophrenia took part in the training program. They were evaluated before and after training, through the equivalent forms of the Assessment Battery for Communication (ABaCo), a tool for testing, both in comprehension and in production, a wide range of pragmatic phenomena such as direct and indirect speech acts, irony and deceit, and a series of neuropsychological and ToM tests. The results showed a significant improvement in patients' performance on both production and comprehension tasks following the program, and in all the communication modalities evaluated through the ABaCo, i.e., linguistic, extralinguistic, paralinguistic, and social appropriateness. This improvement persisted after 3 months from the end of the training program, as shown by the follow-up tests. These preliminary findings provide evidence of the efficacy of the CPT program in improving communicative-pragmatic abilities in schizophrenic individuals.	[Bosco, Francesca M.; Sacco, Katiuscia] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Bosco, Francesca M.] Neurosci Inst Turin, Turin, Italy; [Gabbatore, Ilaria] Oulu Univ, Child Language Res Ctr, Res Unit Logoped, Fac Humanities, Oulu, Finland; [Gastaldo, Luigi] AslTo2 Dept Mental Hlth, Turin, Italy; [Sacco, Katiuscia] Brain Imaging Grp, Turin, Italy		Gabbatore, I (corresponding author), Oulu Univ, Child Language Res Ctr, Res Unit Logoped, Fac Humanities, Oulu, Finland.	ilaria.gabbatore@oulu.fi	bosco, francesca marina/B-6746-2013; Gabbatore, Ilaria/AAC-1925-2019	bosco, francesca marina/0000-0001-6101-8587; Gabbatore, Ilaria/0000-0002-9724-8066	University of Turin	The project was founded by the University of Turin ex-60% project, "La riabilitazione delle abilita comunicativo pragmatiche in soggetti con trauma cranico".	Abu-Akel A, 2000, PSYCHOL MED, V30, P735, DOI 10.1017/S0033291799002123; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; AIRENTI G, 1993, COGNITIVE SCI, V17, P197, DOI 10.1207/s15516709cog1702_2; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; Austin J. L., 1962, PHILOS ANAL; Bara Bruno, 2010, COGNITIVE PRAGMATICS; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bazin N, 2005, SCHIZOPHR RES, V77, P75, DOI 10.1016/j.schres.2005.01.020; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bosco FM, 2004, J PRAGMATICS, V36, P467, DOI 10.1016/S0378-2166(03)00055-9; Bosco FM, 2008, J PRAGMATICS, V40, P583, DOI 10.1016/j.pragma.2007.05.004; Bosco FM, 2006, J PRAGMATICS, V38, P1398, DOI 10.1016/j.pragma.2005.06.011; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Bosco FM, 2009, CONSCIOUS COGN, V18, P306, DOI 10.1016/j.concog.2008.06.006; Brookshire R. H., 1997, DISCOURSE COMPREHENS; Brune M, 2011, CURR PSYCHIATRY REV, V7, P239, DOI 10.2174/157340011797183210; Clark H.H., 1992, ARENAS LANGUAGE USE; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Corcoran Rhiannon, 2003, Cogn Neuropsychiatry, V8, P223, DOI 10.1080/13546800244000319; Cummings L., 2014, PRAGMATIC DISORDERS; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Ekman P., 1976, PICTURES FACIAL AFFE; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith C.D., 1992, COGN NEUROPSYCHOL; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Frommann N, 2003, PSYCHIAT RES, V117, P281, DOI 10.1016/S0165-1781(03)00039-8; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Grice P., 1989, STUDIES WAY WORDS; Happe F, 2002, MIND LANG, V17, P24, DOI 10.1111/1468-0017.00187; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Huber W., 1983, AACHENER APHASIE TES; Kanade T., 2000, Proceedings Fourth IEEE International Conference on Automatic Face and Gesture Recognition (Cat. No. PR00580), P46, DOI 10.1109/AFGR.2000.840611; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kayser N, 2006, NEUROPSYCHOL REHABIL, V16, P83, DOI 10.1080/09602010443000236; Kertesz A., 1982, W APHASIA BATTERY; Kurtz MM, 2008, J CONSULT CLIN PSYCH, V76, P491, DOI 10.1037/0022-006X.76.3.491; Kurtz MM, 2012, SCHIZOPHRENIA BULL, V38, P1092, DOI 10.1093/schbul/sbr036; Langdon R, 2002, MIND LANG, V17, P68, DOI 10.1111/1468-0017.00189; Linscott RJ, 2005, SCHIZOPHR RES, V75, P225, DOI 10.1016/j.schres.2004.10.007; Marder SR, 2006, J CLIN PSYCHIAT, V67, P31; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Matsumoto D., 1988, JAPANESE CAUCASIAN F; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; Moritz S., 2005, METACOGNITIVE SKILL; Moritz S, 2010, CURR OPIN PSYCHIATR, V23, P561, DOI 10.1097/YCO.0b013e32833d16a8; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Penn DL, 2007, PSYCHIAT SERV, V58, P449; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raven, 1938, PROGR MATRICES PERCE; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roncone R, 2004, NEUROPSYCHOL REHABIL, V14, P421, DOI 10.1080/09602010343000291; Sacco K, 2008, J COGN SCI, V9, P111; Salvatore G, 2008, B MENNINGER CLIN, V72, P191, DOI 10.1521/bumc.2008.72.3.191; Searle, 1979, EXPRESSION MEANING S; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Spinnler H., 1987, ITALIAN J NEUROLOGIC, V6, P20; Sponheim SR, 2003, SCHIZOPHR RES, V65, P117, DOI 10.1016/S0920-9964(02)00525-X; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; Tirassa M, 2006, CONSCIOUS COGN, V15, P197, DOI 10.1016/j.concog.2005.06.005; Tirassa M, 2006, COGN SYST RES, V7, P128, DOI 10.1016/j.cogsys.2006.01.002; Tirassa M, 2008, EMERG COMMUN-STUD NE, V10, P81; Wolwer W, 2005, SCHIZOPHR RES, V80, P295, DOI 10.1016/j.schres.2005.07.018	75	24	25	0	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	FEB 23	2016	7								166	10.3389/fpsyg.2016.00166			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	DE4JZ	WOS:000370596300001	26941667	Green Published, gold			2022-02-06	
J	Alfano, CA; Lau, S; Balderas, J; Bunnell, BE; Beidel, DC				Alfano, Candice A.; Lau, Simon; Balderas, Jessica; Bunnell, Brian E.; Beidel, Deborah C.			The impact of military deployment on children: Placing developmental risk in context	CLINICAL PSYCHOLOGY REVIEW			English	Article						Children; Military families; Deployment; Mental health; Parents; Intervention	MENTAL-HEALTH-SERVICES; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC STRESS SYMPTOMS; FAMILY COMMUNICATION; PARENTAL DEPLOYMENT; YOUNG-CHILDREN; SUBSTANCE USE; IRAQ; MALTREATMENT; ADOLESCENTS	During recent conflicts in the Middle East, U.S. military families have endured multiple separations, relocations, and alterations in family structure/routines, combined with other significant stressors. This review examines what is known about children's mental health and functioning in relation to parental military deployment during conflicts spanning the last 14 years. Findings are organized and considered by age group (i.e., toddlers and preschoolers, school age children, and adolescents) in an effort to highlight unique challenges and strengths present at different stages of development. Across all age groups, numerous studies document an increase in the number of military-connected children receiving mental health services in relation to parental deployment, though specific types of problems and long-term outcomes are not well understood. Evidence for a concerning increase in rates of child maltreatment related to parental deployment has also emerged. However, findings are largely based on aggregate data and the specific perpetrator is often unclear. Overall, we emphasize several critical next steps for research in this area including investigations characterized by greater methodological rigor, consideration of broader parental and contextual influences on child mental health, objective indicators of stress and coping, and longitudinal designs to examine persistence of child emotional/behavioral problems. A focus on adaptive/resilient outcomes is equally essential for understanding long-term outcomes and developing effective intervention programs. (C) 2015 Elsevier Ltd. All rights reserved.	[Alfano, Candice A.; Lau, Simon; Balderas, Jessica] Univ Houston, Dept Psychol, 4811 Calhoun Rd, Houston, TX 77204 USA; [Bunnell, Brian E.] Med Univ S Carolina, Dept Nursing, Charleston, SC 29425 USA; [Beidel, Deborah C.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA		Alfano, CA (corresponding author), Univ Houston, Dept Psychol, 4811 Calhoun Rd, Houston, TX 77204 USA.	caalfano@uh.edu	Alfano, Candice/ABD-4455-2021; Bunnell, Brian/AAA-7202-2019	Bunnell, Brian/0000-0002-4964-0688			Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Acion L, 2013, ADDICTION, V108, P1418, DOI 10.1111/add.12161; Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT, DOI 10.1037/t28248-000; Allen ES, 2010, J FAM PSYCHOL, V24, P280, DOI 10.1037/a0019405; Amato PR, 2001, J FAM PSYCHOL, V15, P355, DOI 10.1037/0893-3200.15.3.355; Aranda MC, 2011, MIL MED, V176, P402, DOI 10.7205/MILMED-D-10-00202; Aronson KR, 2013, J CHILD FAM STUD, V22, P516, DOI 10.1007/s10826-012-9605-1; Averdijk M, 2012, CHILD PSYCHIAT HUM D, V43, P184, DOI 10.1007/s10578-011-0259-9; Barker LH, 2009, MIL MED, V174, P1033, DOI 10.7205/MILMED-D-04-1108; Barnes VA, 2007, MIL MED, V172, P40, DOI 10.7205/MILMED.172.1.40; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Blow AJ, 2013, J FAM PSYCHOL, V27, P303, DOI 10.1037/a0031881; Britt P, 2006, MILITARY LIFE PSYCHO, V3, P12; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Burton T, 2009, J AM ACAD NURSE PRAC, V21, P332, DOI 10.1111/j.1745-7599.2009.00411.x; Card NA, 2011, J FAM PSYCHOL, V25, P508, DOI 10.1037/a0024395; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Castaneda LW., 2008, DEPLOYMENT EXPERIENC; Cederbaum JA, 2014, J ADOLESCENT HEALTH, V54, P672, DOI 10.1016/j.jadohealth.2013.09.006; Chandra A., 2011, VIEWS HOMEFRONT EXPE; CHANDRA A, 2008, UNDERSTANDING IMPACT; Chandra A, 2010, J ADOLESCENT HEALTH, V46, P218, DOI 10.1016/j.jadohealth.2009.10.009; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Chartrand MM, 2008, ARCH PEDIAT ADOL MED, V162, P1009, DOI 10.1001/archpedi.162.11.1009; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Creech SK, 2014, PROF PSYCHOL-RES PR, V45, P452, DOI 10.1037/a0035055; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; Department of Defense, 2010, REP IMP DEPL MEMB AR; Department of Defense Education Activity, 2013, MIL K 12 PARTN DODEA; Deputy Assistant Secretary of Defense, 2015, 2014 DEM PROF MIL CO; DeVore ER, 2005, CURR OPIN PEDIATR, V17, P460, DOI 10.1097/01.mop.0000170514.27649.c9; Drummet AR, 2003, FAM RELAT, V52, P279, DOI 10.1111/j.1741-3729.2003.00279.x; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Engel RC, 2010, ECON EDUC REV, V29, P73, DOI 10.1016/j.econedurev.2008.12.003; Evans BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061724; FERGUSSON DM, 1994, J CHILD PSYCHOL PSYC, V35, P1123, DOI 10.1111/j.1469-7610.1994.tb01813.x; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.2307/1129837; Gavazzi SM, 2008, J YOUTH ADOLESCENCE, V37, P1071, DOI 10.1007/s10964-008-9306-7; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gilreath TD, 2013, AM J PREV MED, V44, P150, DOI 10.1016/j.amepre.2012.09.059; Goff BSN, 2007, J FAM PSYCHOL, V21, P344, DOI 10.1037/0893-3200.21.3.344; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Gorman GH, 2010, PEDIATRICS, V126, P1058, DOI 10.1542/peds.2009-2856; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Hisle-Gorman E, 2014, MIL MED, V179, P573, DOI 10.7205/MILMED-D-13-00334; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Houston JB, 2013, J LOSS TRAUMA, V18, P103, DOI 10.1080/15325024.2012.684576; Huebner A. J., 2005, ADJUSTMENT ADOLESCEN; JELLINEK MS, 1988, J PEDIATR-US, V112, P201, DOI 10.1016/S0022-3476(88)80056-8; Juszczak L, 1999, Adolesc Med, V10, P1; Kelley ML, 1994, MIL PSYCHOL, V6, P163, DOI DOI 10.1207/S15327876MP0603_2; Kier C., 1997, J DIVORCE REMARRIAGE, V26, P185; Knobloch LK, 2014, J FAM COMMUN, V14, P291, DOI 10.1080/15267431.2014.945701; Knobloch LK, 2015, YOUTH SOC, V47, P319, DOI 10.1177/0044118X12462040; Lamberg L, 2008, JAMA-J AM MED ASSOC, V300, P644, DOI 10.1001/jama.300.6.644; Larson MJ, 2012, MED CARE, V50, P821, DOI 10.1097/MLR.0b013e31825516d8; Laser JA, 2011, CLIN SOC WORK J, V39, P28, DOI 10.1007/s10615-010-0310-5; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Louie AD, 2014, PROF PSYCHOL-RES PR, V45, P496, DOI 10.1037/a0036603; Lyle DS, 2006, J LABOR ECON, V24, P319, DOI 10.1086/499975; MacDermid S. M., 2008, UNDERSTANDING PROMOT; Magnuson K, 2009, J MARRIAGE FAM, V71, P575, DOI 10.1111/j.1741-3737.2009.00620.x; Mansfield AJ, 2011, ARCH PEDIAT ADOL MED, V165, P999, DOI 10.1001/archpediatrics.2011.123; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; McCarroll JE, 2008, CHILD ABUSE REV, V17, P108, DOI 10.1002/car.986; McCarthy RJ, 2015, PSYCHOL VIOLENCE, V5, P26, DOI 10.1037/a0035433; Military One Source, 2012, MIL DEPL GUID PREP Y; Millegan J, 2013, GEN HOSP PSYCHIAT, V35, P556, DOI 10.1016/j.genhosppsych.2013.04.015; Mmari K, 2009, YOUTH SOC, V40, P455, DOI 10.1177/0044118X08327873; Morris AS, 2009, J APPL DEV PSYCHOL, V30, P695, DOI 10.1016/j.appdev.2009.01.002; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Orthner D. K., 2005, ADJUSTMENT ARMY CHIL; Padden DL, 2011, MIL MED, V176, P26; Park N, 2011, AM PSYCHOL, V66, P65, DOI 10.1037/a0021249; Pfefferbaum B, 2011, J LOSS TRAUMA, V16, P291, DOI 10.1080/15325024.2010.519293; Pittman JF, 2004, FAM RELAT, V53, P249, DOI 10.1111/j.0197-6664.2004.0001.x; Rabenhorst MM, 2015, CHILD MALTREATMENT, V20, P61, DOI 10.1177/1077559514560625; Rai AA, 2003, J ADOLESCENT HEALTH, V33, P108, DOI 10.1016/S1054-139X(03)00179-4; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Reed SC, 2011, AM J PUBLIC HEALTH, V101, P1676, DOI 10.2105/AJPH.2011.300165; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Richardson A., 2011, EFFECTS SOLDIERS DEP; ROTTER JC, 1999, FAMILY J, V7, P379, DOI DOI 10.1177/1066480799074009; RUTTER M, 1972, J PSYCHOSOM RES, V16, P241, DOI 10.1016/0022-3999(72)90005-0; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Segal DR, 2004, POPUL BULL, V59, P3; SteelFisher GK, 2008, MIL MED, V173, P221, DOI 10.7205/MILMED.173.3.221; Sullivan R, 2011, CLIN PERINATOL, V38, P643, DOI 10.1016/j.clp.2011.08.011; Swedean SK, 2013, MIL MED, V178, P274, DOI 10.7205/MILMED-D-12-00171; Tan M., 2009, ARMY TIMES; Thompson D. E., 2015, YOUTH SOC; Thomsen CJ, 2014, PSYCHOL VIOLENCE, V4, P143, DOI 10.1037/a0031766; U. S. Medicine, 2009, DEP DEF REACH OUT CH; Waliski A, 2012, J HUM BEHAV SOC ENVI, V22, P653, DOI 10.1080/10911359.2012.655621; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Walsh TB, 2014, HEALTH SOC WORK, V39, P35, DOI 10.1093/hsw/hlu005; White House, 2011, STRENGTH OUR MIL FAM; Willerton E, 2011, J FAM PSYCHOL, V25, P521, DOI 10.1037/a0024511; Wilson SR, 2014, J FAM COMMUN, V14, P32, DOI 10.1080/15267431.2013.857325; Wilson SR, 2011, J APPL COMMUN RES, V39, P223, DOI 10.1080/00909882.2011.585399; Yosick T, 2012, REV POSTDEPLOYMENT R	114	24	24	0	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0272-7358	1873-7811		CLIN PSYCHOL REV	Clin. Psychol. Rev.	FEB	2016	43						17	29		10.1016/j.cpr.2015.11.003			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DC6UT	WOS:000369355800002	26655960				2022-02-06	
J	Gulsen, I; Ak, H; Colcimen, N; Alp, HH; Akyol, ME; Demir, I; Atalay, T; Balahroglu, R; Ragbetli, MC				Gulsen, Ismail; Ak, Hakan; Colcimen, Nese; Alp, Hamit H.; Akyol, Mehmet E.; Demir, Ismail; Atalay, Tugay; Balahroglu, Ragip; Ragbetli, Murat C.			Neuroprotective Effects of Thymoquinone on the Hippocampus in a Rat Model of Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Malondialdehyde; Neuron density; Thymoquinone; Traumatic brain injury; Stereology	ISCHEMIA-REPERFUSION; COENZYME Q(10); NIGELLA-SATIVA; DNA; DAMAGE; NEURONS; GINSENG; DYSFUNCTION; MELATONIN; EDEMA	BACKGROUND: Traumatic brain injury is a leading cause of morbidity and mortality worldwide. We evaluated the neuroprotective effects of thymoquinone (TQ) in a rat model of traumatic brain injury by using biochemical and histopathologic methods for the first time. MATERIALS AND METHODS: Twenty-four rats were divided into sham (n = 8), trauma (n = 8), and TQ-treated (n = 8) groups. A moderate degree of head trauma was induced with the use of Feeney's falling weight technique, and TQ (5 mg/kg/day) was administered to the TQ-treated group for 7 days. All animals were killed after cardiac perfusion. Brain tissues were extracted immediately after perfusion without damaging the tissues. Biochemical procedures were performed with the serum, and a histopathologic evaluation was performed on the brain tissues. Biochemical experiments included malondialdehyde (MDA), reduced and oxidized coenzyme Q10 analysis, DNA isolation and hydroylazation, and glutathione peroxidase, and superoxide dismutase analyses. RESULTS: Neuron density in contralateral hippocampal regions (CA1, CA2-3, and CA4) 7 days after the trauma decreased significantly in the trauma and TQ-treated groups, compared with that in the control group. Neuron densities in contralateral hippocampal regions (CA1, CA2-3, and CA4) were greater in the TQ-treated group than in the trauma group. TQ did not increase superoxide dismutase or glutathione peroxidase antioxidant levels. However, TQ decreased the MDA levels. CONCLUSIONS: These results indicate that TQ has a healing effect on neural cells after head injury and this effect is mediated by decreasing MDA levels in the nuclei and mitochondrial membrane of neurons.	[Gulsen, Ismail; Akyol, Mehmet E.] Yuzuncu Yil Univ, Dept Neurosurg, Van, Turkey; [Ak, Hakan; Atalay, Tugay] Bozok Univ, Sch Med, Dept Neurosurg, Yozgat, Turkey; [Colcimen, Nese; Ragbetli, Murat C.] Yuzuncu Yil Univ, Sch Med, Dept Histol & Embryol, Yozgat, Turkey; [Alp, Hamit H.; Balahroglu, Ragip] Yuzuncu Yil Univ, Sch Med, Dept Biochem, Yozgat, Turkey; [Demir, Ismail] Pamukkale Univ, Sch Med, Dept Neurosurg, Denizli, Turkey		Ak, H (corresponding author), Bozok Univ, Sch Med, Dept Neurosurg, Yozgat, Turkey.	nrsdrhakanak@yahoo.com	ALP, Hamit Hakan/U-2671-2018; Ragbetli, Murat Cetin/ABG-5631-2021; Atalay, Tugay/AAY-2265-2020; Ragbetli, Murat/Q-5060-2017	Ragbetli, Murat Cetin/0000-0002-8189-264X; Atalay, Tugay/0000-0003-0243-9132; Ragbetli, Murat/0000-0002-8189-264X; alp, hamit hakan/0000-0002-9202-4944			AARABI B, 1979, J NEUROSURG, V51, P779, DOI 10.3171/jns.1979.51.6.0779; ADELI K, 1990, CLIN CHEM, V36, P261; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Majed AA, 2006, EUR J PHARMACOL, V543, P40, DOI 10.1016/j.ejphar.2006.05.046; Ammar ESM, 2011, INT IMMUNOPHARMACOL, V11, P2232, DOI 10.1016/j.intimp.2011.10.013; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Awad AS, 2011, J PHARM PHARMACOL, V63, P1037, DOI 10.1111/j.2042-7158.2011.01303.x; Badary OA, 2003, DRUG CHEM TOXICOL, V26, P87, DOI 10.1081/DCT-120020404; BEAL MF, 1994, ANN NEUROL, V36, P882, DOI 10.1002/ana.410360613; Bonnefont-Rousselot D, 2000, DIABETES METAB, V26, P163; DEJONG AMP, 1994, EUR J BIOCHEM, V222, P975; Demir I, 2013, ACTA NEUROCHIR, V155, P913, DOI 10.1007/s00701-013-1672-6; EDLUND C, 1994, J NEUROCHEM, V63, P634; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FAVIT A, 1992, J CEREBR BLOOD F MET, V12, P638, DOI 10.1038/jcbfm.1992.88; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fouda AMM, 2008, BASIC CLIN PHARMACOL, V103, P109, DOI 10.1111/j.1742-7843.2008.00260.x; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gutteridge J.M.C, 2007, FREE RADICALS BIOL M; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kanter M, 2006, HUM EXP TOXICOL, V25, P127, DOI 10.1191/0960327106ht608oa; Kaur H, 1996, BIOCHEM J, V318, P21, DOI 10.1042/bj3180021; Khoschsorur GA, 2000, CHROMATOGRAPHIA, V52, P181, DOI 10.1007/BF02490453; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Koc PK, 1999, RES EXP MED, V199, P21, DOI 10.1007/s004330050129; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Landi L, 1997, FREE RADICAL BIO MED, V22, P329, DOI 10.1016/S0891-5849(96)00294-8; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Littarru GP, 2004, METHOD ENZYMOL, V378, P170; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mehri S, 2014, IRAN J BASIC MED SCI, V17, P1007; Naval MV, 2007, J ETHNOPHARMACOL, V112, P262, DOI 10.1016/j.jep.2007.03.010; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Padhye Subhash, 2008, Cancer Ther, V6, P495; Rausch WD, 2006, ACTA NEUROBIOL EXP, V66, P369; Reed MG, 1998, UNBIASED STEREOLOGY, P39; Silver J, 2005, TXB TRAUMATIC BRAIN, P27; SUN Y, 1988, CLIN CHEM, V34, P497; Takizawa Y, 2009, PEDIATR RES, V65, P636, DOI 10.1203/PDR.0b013e3181a16a9f; Tarng DG, 2000, AM J KIDNEY DIS, V36, P934, DOI 10.1053/ajkd.2000.19086; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Ustun N, 2014, ULUS TRAVMA ACIL CER, V20, P328, DOI 10.5505/tjtes.2014.05021; Wang XY, 2001, BIOL NEONATE, V79, P172; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Yao XF, 2005, MUTAT RES-GEN TOX EN, V587, P38, DOI 10.1016/j.mrgentox.2005.07.010; Yildiz F, 2010, RENAL FAILURE, V32, P126, DOI 10.3109/08860220903367577	53	24	25	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86						243	249		10.1016/j.wneu.2015.09.052			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300057	26428323				2022-02-06	
J	Kirkwood, MW; Peterson, RL; Connery, AK; Baker, DA; Forster, J				Kirkwood, Michael W.; Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Forster, Jeri			A Pilot Study Investigating Neuropsychological Consultation as an Intervention for Persistent Postconcussive Symptoms in a Pediatric Sample	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; POST-CONCUSSIVE SYMPTOMS; MILD HEAD-INJURY; PSYCHOLOGICAL-ASSESSMENT; NEUROCOGNITIVE OUTCOMES; SUBOPTIMAL EFFORT; CHILDREN; PREDICTORS; RECOVERY; ADOLESCENTS	Objective To examine the efficacy of a one-time neuropsychological consultation as an intervention for youth with persistent postconcussive symptoms following mild traumatic brain injury. Study design Using a prospective interrupted time series design, we enrolled 80 patients aged 8-17 years referred consecutively for clinical neuropsychological consultation. Patients needed to have sustained injury between 2 and 12 months prior to enrollment. Parent and child postconcussive symptom ratings were used as the primary outcome measures and were collected at 6 time points, 3 before the neuropsychological consultation and 3 after. Repeated measure ANOVA was used to estimate the magnitude of change in symptom ratings before and after the neuropsychological intervention. Results The decrease in symptoms for the week prior to consultation was nonsignificant by both child (P = .63) and parent (P = .19) report. In contrast, for both reporters, the decrease in symptoms at 1 week and 3 months postconsultation was significant (P < .0001). The difference in reported change was also significant when comparing the week before the intervention to the 3 months after (child: P < .0001; parent: P = .0009). Conclusions Postconcussive symptoms decreased significantly following the neuropsychological consultation. The primary limitation of the study is that it lacked randomization and a control group. The results warrant further research into the benefits of neuropsychological consultation after mild traumatic brain injury and provide justification for clinical providers to consider referring to neuropsychologists in the face of persistent postconcussive symptoms.	[Kirkwood, Michael W.; Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Forster, Jeri] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.; Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Forster, Jeri] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Forster, Jeri] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA		Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, 13123 E 16th Ave, Aurora, CO 80045 USA.	Michael.Kirkwood@childrenscolorado.org			Children's Hospital Colorado Research Institute	Supported by the Children's Hospital Colorado Research Institute. M.K. receives royalties from, Mild Traumatic Brain Injury in Children and Adolescents: From Basic Science to Clinical Management, which is cited in the article. The other authors declare no conflicts of interest.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; BIJUR PE, 1990, PEDIATRICS, V86, P337; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gaynor ST, 2003, J CONSULT CLIN PSYCH, V71, P386, DOI 10.1037/0022-006X.71.2.386; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Peterson RL, 2015, J NEUROPSYCH CLIN N, V27, P280, DOI 10.1176/appi.neuropsych.14120373; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates K. O., 2012, MILD TRAUMATIC BRAIN, P124; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	51	24	24	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2016	169						244	+		10.1016/j.jpeds.2015.10.014			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DB6AK	WOS:000368595300046	26541427				2022-02-06	
J	Pang, EW; Dunkley, BT; Doesburg, SM; da Costa, L; Taylor, MJ				Pang, Elizabeth W.; Dunkley, Benjamin T.; Doesburg, Sam M.; da Costa, Leodante; Taylor, Margot J.			Reduced brain connectivity and mental flexibility in mild traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; MEG; CONCUSSION; NETWORKS; MAGNETOENCEPHALOGRAPHY; NEUROSCIENCE; ACTIVATIONS; SEQUELAE; MRI	ObjectiveA mild traumatic brain injury (mTBI), or concussion, has known neuropsychological sequelae, and neuroimaging shows disturbed brain connectivity during the resting state. We hypothesized that task-based functional connectivity measures, using magnetoencephalography (MEG), would better link the neurobiological underpinnings of cognitive deficits to specific brain damage. MethodsWe used a mental flexibility task in the MEG and compared brain connectivity between adults with and without mTBI. ResultsAffected individuals showed significant reductions in connectivity. When challenged with a more difficult task, these individuals were not able to boost their connectivity, and as such, showed deterioration in performance. InterpretationWe discuss these findings in the context of limitations in cognitive reserve as a consequence of a mTBI.	[Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5J 1X8, Canada; [Pang, Elizabeth W.; Taylor, Margot J.] Sick Kids Res Inst, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Pang, Elizabeth W.; Dunkley, Benjamin T.; da Costa, Leodante; Taylor, Margot J.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Dunkley, Benjamin T.] Hosp Sick Children, Diagnost Imaging, Toronto, ON M5J 1X8, Canada; [Doesburg, Sam M.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [da Costa, Leodante] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada		Pang, EW (corresponding author), Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5J 1X8, Canada.	elizabeth.pang@sickkids.ca	da Costa, Leodante/F-7474-2010	da Costa, Leodante/0000-0002-3222-4944; Dunkley, Ben/0000-0001-6173-1171			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Hamalainen Matti S., 1992, Brain Topography, V5, P95, DOI 10.1007/BF01129036; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henaff MA, 2010, CLIN NEUROPHYSIOL, V121, P508, DOI 10.1016/j.clinph.2009.11.082; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Lalancette M, 2011, PHYS MED BIOL, V56, P5621, DOI 10.1088/0031-9155/56/17/010; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nagahama Y, 2001, CEREB CORTEX, V11, P85, DOI 10.1093/cercor/11.1.85; Nagahama Y, 1999, NEUROIMAGE, V10, P193, DOI 10.1006/nimg.1999.0451; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Perianez JA, 2004, NEUROIMAGE, V21, P687, DOI 10.1016/j.neuroimage.2003.10.008; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang LH, 2001, COGNITIVE BRAIN RES, V12, P19, DOI 10.1016/S0926-6410(01)00022-2; Wechsler D., 2011, WECHSLER ABBREVIATED; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wilmsmeier A, 2010, J PSYCHIATR NEUROSCI, V35, P321, DOI 10.1503/jpn.090181; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	56	24	24	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	FEB	2016	3	2					124	131		10.1002/acn3.280			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD9SA	WOS:000370264700006	26900581	Green Published, gold			2022-02-06	
J	Yu, P; Zhang, ZF; Li, SJ; Wen, XL; Quan, W; Tian, QL; Chen, JL; Zhang, JN; Jiang, RC				Yu, Peng; Zhang, Zhifei; Li, Shengjie; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Chen, Jieli; Zhang, Jianning; Jiang, Rongcai			Progesterone modulates endothelial progenitor cell (EPC) viability through the CXCL12/CXCR4/PI3K/Akt signalling pathway	CELL PROLIFERATION			English	Article							TRAUMATIC BRAIN-INJURY; ENDOMETRIAL STROMAL CELLS; MEMBRANE COMPONENT 1; NEUROTROPHIC FACTOR; EPITHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; CANCER CELLS; TUMOR-GROWTH; IN-VITRO	ObjectivesProgesterone treatment can effectively increase levels of circulating endothelial progenitor cells (EPCs) and improve neurological functional outcome in a traumatic brain injury (TBI) rat model. However, the mechanisms of progesterone's effects on EPC viability remain elusive. The CXCL12/CXCR4 (CXC chemokine ligand 12/CXC chemokine receptor 4) signalling pathway regulates cell proliferation; we hypothesize that it mediates progesterone-induced EPC viability. Materials and methodsEPCs were isolated from bone marrow-derived mononuclear cells (BM-MNCs) and treated with progesterone (5, 10 and 100 nm). MTS assay was used to investigate EPC viability. Protein expression was examined by Western blotting, ELISA assay and flow cytometry. Cell membrane and cytoplasm proteins were extracted with membrane and cytoplasm protein extraction kits. CXCR4 antagonist (AMD3100) and phosphatidylinositol 3-kinases (PI3K) antagonist (LY294002) were used to characterize underlying mechanisms. ResultsProgesterone-induced EPC viability was time- and dose-dependent. Administration of progesterone facilitated EPC viability and increased expression of CXCL12 and phosphorylated Akt (also known as protein kinase B, pAkt) activity (P < 0.05). Progesterone did not regulate CXCR4 protein expression in cultured EPC membranes or cytoplasm. However, progesterone-induced EPC viability was significantly attenuated by AMD3100 or LY294002. Inhibition of the signalling pathway with AMD3100 and LY294002 subsequently reduced progesterone-induced CXCL12/CXCR4/PI3K/pAkt signalling activity. ConclusionsThe CXCL12/CXCR4/PI3K/pAkt signalling pathway increased progesterone-induced EPC viability.	[Yu, Peng; Zhang, Zhifei; Li, Shengjie; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Yu, Peng; Zhang, Zhifei; Li, Shengjie; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Yu, Peng; Zhang, Zhifei; Li, Shengjie; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Zhang, Jianning; Jiang, Rongcai] Minist Educ & Tianjin City, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin 300052, Peoples R China; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Zhang, JN; Jiang, RC (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China.	jiang116216@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271359]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]; Tianjin Research Program of Application Foundation and Advanced Technology [11JCZDJC18100]	This work was financially supported by the National Natural Science Foundation of China (grant 81271359), The Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430) and Tianjin Research Program of Application Foundation and Advanced Technology (grant 11JCZDJC18100).	Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Atluri P, 2006, ANN THORAC SURG, V81, P1728, DOI 10.1016/j.athoracsur.2005.12.015; Basso FG, 2015, ARCH ORAL BIOL, V60, P1117, DOI 10.1016/j.archoralbio.2015.04.010; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brandl A, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-12; Briasoulis A, 2011, CARDIOVASC THER, V29, P125, DOI 10.1111/j.1755-5922.2009.00131.x; Carr AN, 2006, CARDIOVASC RES, V69, P925, DOI 10.1016/j.cardiores.2005.12.005; Colombo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066734; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Frontczak-Baniewicz M, 2003, ACTA NEUROBIOL EXP, V63, P65; Gatti M, 2013, TOXICOLOGY, V314, P209, DOI 10.1016/j.tox.2013.10.003; Gong XM, 2006, CELL BIOL INT, V30, P466, DOI 10.1016/j.cellbi.2006.01.007; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Jiang JX, 2015, ONCOTARGET, V6, P6359, DOI 10.18632/oncotarget.3438; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kang H, 2005, INT J ONCOL, V26, P1429; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Khan MZ, 2003, J NEUROVIROL, V9, P300, DOI 10.1080/13550280390201010; Kucia M, 2004, J MOL HISTOL, V35, P233; Li B, 2014, J INTERFERON CYTOKIN, V35, P23; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu B, 2009, J NEUROENDOCRINOL, V21, P993, DOI 10.1111/j.1365-2826.2009.01920.x; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Mayol JM, 2002, WORLD J SURG, V26, P652, DOI 10.1007/s00268-001-0284-0; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI [10.1586/ehm.10.16, 10.1586/EHM.10.16]; Okada H, 2011, FERTIL STERIL, V96, P786, DOI 10.1016/j.fertnstert.2011.06.048; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103036; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Scioli MG, 2014, INT J MOL SCI, V15, P6517, DOI 10.3390/ijms15046517; Shiah YJ, 2015, STEM CELL REP, V4, P313, DOI 10.1016/j.stemcr.2015.01.011; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Spratte J, 2015, FERTIL STERIL, V103, P1363, DOI 10.1016/j.fertnstert.2015.02.023; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Suh KS, 2005, CURR PHARM DESIGN, V11, P2753, DOI 10.2174/1381612054546806; Swiatek-De Lange M, 2007, GLIA, V55, P1061, DOI 10.1002/glia.20523; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; Wang H, 2014, ENVIRON SCI ENG, P11, DOI 10.1007/978-3-319-00867-7_2; Wang L, 2015, ACTA BIOCH BIOPH SIN, V47, P663, DOI 10.1093/abbs/gmv064; Wei L, 2014, J RECEPT SIG TRANSD, V35, P329; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Xu QH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/546353; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Zhao LR, 2014, INT J MOL MED, V34, P1025, DOI 10.3892/ijmm.2014.1852; Zheng SH, 2012, J CELL MOL MED, V16, P296, DOI 10.1111/j.1582-4934.2011.01305.x; Zhou ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100372	63	24	29	0	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7722	1365-2184		CELL PROLIFERAT	Cell Prolif.	FEB	2016	49	1					48	57		10.1111/cpr.12231			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DD8DP	WOS:000370155400005	26818151	Green Published, Bronze			2022-02-06	
J	Ting, WKC; Schweizer, TA; Topolovec-Vranic, J; Cusimano, MD				Ting, Windsor Kwan-Chun; Schweizer, Tom A.; Topolovec-Vranic, Jane; Cusimano, Michael D.			Antisaccadic Eye Movements Are Correlated with Corpus Callosum White Matter Mean Diffusivity, Stroop Performance, and Symptom Burden in Mild Traumatic Brain Injury and Concussion	FRONTIERS IN NEUROLOGY			English	Article						antisaccade; concussion; mild traumatic brain injury; diffusion tensor imaging; executive function; corpus callosum; symptom burden	CLOSED-HEAD INJURY; DEFICITS; REFLEXIVE; SACCADES; MEMORY; INHIBITION; INTEGRITY; CHILDREN; RECOVERY	Antisaccades are thought to involve higher level inputs from neural centers involved in rapid eye movement inhibition and control. Previous work has demonstrated that performance on the antisaccade task can help in the assessment of injury in acute and/or chronic mild traumatic brain injury (mTBI). In this exploratory study, we performed cross-sectional and longitudinal comparisons of rapid eye movement, followed by correlations of antisaccade performance with assessments of symptom burden, diffusion tensor imaging, and a neuropsychological test of response inhibition. Significant deficits in antisaccade median latency, F(2, 31) = 3.65, p = 0.04 and prosaccade error mean duration, F(2, 31) = 3.63, p = 0.04 were found between patient groups and controls: the former was correlated with loss of white matter integrity in the splenium of the corpus callosum in acute mTBI, rho = 0.90, p = 0.0005. Furthermore, increased antisaccade median latency was also correlated with poor performance on an executive functioning task, r(2) = 0.439, p = 0.03, and greater symptom burden, r(2) = 0.480, p = 0.02 in the acute mTBI patients. Our preliminary research suggests that the antisaccade task could be useful as a neurological marker for mTBI and concussion, but more work is required.	[Ting, Windsor Kwan-Chun; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Ting, Windsor Kwan-Chun; Schweizer, Tom A.; Topolovec-Vranic, Jane; Cusimano, Michael D.] St Michaels Hosp, Neurosci Res Program, Toronto, ON M5B 1W8, Canada; [Schweizer, Tom A.; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013; Ting, Windsor Kwan-Chun/I-4013-2014	Topolovec-Vranic, Jane/0000-0001-7695-4212; Ting, Windsor Kwan-Chun/0000-0003-4293-9617	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 123371]; Institute of Medical Science Open Fellowship Award at the University of Toronto	We would like to thank the Canadian Institutes of Health Research MOP 123371 for study funding. WT was financially supported by the Institute of Medical Science Open Fellowship Award at the University of Toronto.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; GUITTON D, 1985, EXP BRAIN RES, V58, P455; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Killian G., 1985, STROOP COLOR WORD TE; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mendoza J, 2010, CLIN NEUROANATOMY NE; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; NeuroDebian-Team, 2014, FSL JHU DTI WHIT ATL; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Paolozza A, 2014, NEUROIMAGE-CLIN, V5, P53, DOI 10.1016/j.nicl.2014.05.019; Phillipou A, 2014, DEV MED CHILD NEUROL, V56, P337, DOI 10.1111/dmcn.12345; Pierrot-Deseilligny C, 2005, ANN NY ACAD SCI, V1039, P239, DOI 10.1196/annals.1325.023; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Ting WKC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00137; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Wong AMF., 2008, EYE MOVEMENT DISORDE; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	40	24	24	0	21	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 18	2016	6								271	10.3389/fneur.2015.00271			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DA9JT	WOS:000368125600002	26834693	Green Published, gold			2022-02-06	
J	Fu, TS; Jing, RW; Fu, WW; Cusimano, MD				Fu, Terence S.; Jing, Ruwei; Fu, Wayne W.; Cusimano, Michael D.			Epidemiological Trends of Traumatic Brain Injury Identified in the Emergency Department in a Publicly-Insured Population, 2002-2010	PLOS ONE			English	Article							UNITED-STATES; VISITS; CONCUSSIONS; ADMISSION	Objectives To examine epidemiological trends of Traumatic Brain Injury (TBI) treated in the Emergency Department (ED), identify demographic groups at risk of TBI, and determine the factors associated with hospitalization following an ED visit for TBI. Methods A province-wide database was used to identify all ED visits for TBI in Ontario, Canada between April 2002 and March 2010. Trends were analyzed using linear regression, and predictors of hospital admission were evaluated using logistic regression. Results There were 986,194 ED visits for TBI over the eight-year study period, resulting in 49,290 hospitalizations and 1,072 deaths. The age- and sex-adjusted rate of TBI decreased by 3%, from 1,013.9 per 100,000 (95% CI 1,008.3-1,010.6) to 979.1 per 100,000 (95% CI 973.7-984.4; p = 0.11). We found trends towards increasing age, comorbidity level, length of stay, and ambulatory transport use. Children and young adults (ages 5-24) sustained peak rates of motor vehicle crash (MVC) and bicyclist-related TBI, but also experienced the greatest decline in these rates (p = 0.003 and p = 0.005). In contrast, peak rates of fall-related TBI occurred among the youngest (ages 0-4) and oldest (ages 85+) segments of the population, but rates remained stable over time (p = 0.52 and 0.54). The 5-24 age group also sustained the highest rates of sports-related TBI but rates remained stable (p = 0.80). On multivariate analysis, the odds of hospital admission decreased by 1% for each year over the study period (OR = 0.991, 95% CI = 0.987-0.995). Increasing age and comorbidity, male sex, and ambulatory transport were significant predictors of hospital admission. Conclusions ED visits for TBI are involving older populations with increasingly complex comorbidities. While TBI rates are either stable or declining among vulnerable groups such as young drivers, youth athletes, and the elderly, these populations remain key targets for focused injury prevention and surveillance. Clinicians in the ED setting should be cognizant of factors associated with hospitalization following TBI.	[Fu, Terence S.; Jing, Ruwei; Fu, Wayne W.; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Fu, Terence S.; Jing, Ruwei; Fu, Wayne W.; Cusimano, Michael D.] Univ Toronto, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019		Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (#TIR-103946), and the Ontario Neurotrauma Foundation.	Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Canadian Institute of Health Information (CIHI), 2008, DAT QUAL STUD EM DEP, VII; Canadian Institute of Health Information (CIHI), 2006, HEAD INJ CAN DEC CHA; Centers for Disease Control and Prevention, 2014, DAT STAT WISQARS COS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CIHI, 2007, BURD NEUR DIS DIS IN; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fingerhut L, 2002, EXTERNAL CAUSES INJU; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2015, CAN J NEURO IN PRESS; Gillespie LD, 2012, COCHRANE DB SYST REV; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Klein KS, 2005, INJURY PREV, V11, P288, DOI 10.1136/ip.2004.007013; Macpherson A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub2; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayhew D.R., 2005, BEST PRACTICES GRADU; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Ponsky TA, 2005, J TRAUMA, V59, P1292, DOI 10.1097/01.ta.0000197439.19171.25; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Russell KF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003300.pub3; Schull MJ, 2012, ACAD EMERG MED, V19, P828, DOI 10.1111/j.1553-2712.2012.01396.x; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Simniceanu A, 2014, TRAFFIC INJ PREV, V15, P734, DOI 10.1080/15389588.2013.867483; Solomon R, 2014, CAN PUBLIC POL, V40, P15, DOI 10.3138/cpp.2012-102; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	33	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2016	11	1							e0145469	10.1371/journal.pone.0145469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA8CX	WOS:000368033100017	26760779	Green Published, gold			2022-02-06	
J	Shu, LF; Wang, CL; Wang, JB; Zhang, YM; Zhang, X; Yang, YY; Zhuo, JW; Liu, JC				Shu, Longfei; Wang, Chunlin; Wang, Jinbiao; Zhang, Yongming; Zhang, Xing; Yang, Yanyan; Zhuo, Jianwei; Liu, Jiachuan			The neuroprotection of hypoxic preconditioning on rat brain against traumatic brain injury by up-regulated transcription factor Nrf2 and HO-1 expression	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Hypoxic preconditioning; Nuclear factor erythroid 2-related factor 2p; Heme oxygenase-1	POSTTRAUMATIC-STRESS-DISORDER; CONTROLLED CORTICAL IMPACT; ANTIOXIDANT THERAPIES; CEREBRAL-ISCHEMIA; PATHWAY; AFGHANISTAN; MICE	Hypoxic preconditioning (HPC) increases the inherent tolerance of brain tissue suffering from severe hypoxia or ischemia insult by stimulating the protective ability of the brain. However, little is known concerning the effect of HPC on traumatic brain injury (TBI). We designed this study to investigate the effect of HPC on TBI and explore its underlying mechanisms. We found that HPC significantly alleviates neurological dysfunction, lessens brain edema, reduces cell apoptosis, increases neuronal survival, up regulates the expressions of Nrf2 and HO-1, and decreases the inducer of protein carbonyls, 4-hydroxy2-nonenal, and 8-hydroxy-2-deoxyguanosine in the brain tissue of rats 24 h after brain injury. However, no influence was observed in normal rats after only 3 d of hypoxic training. Results further indicated that HPC protects the brain against traumatic damage. This protective effect may be achieved by up-regulating Nrf2 and HO-1 expression and alleviating oxidative stress damage. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Shu, Longfei; Wang, Chunlin; Wang, Jinbiao; Zhang, Yongming; Zhang, Xing; Yang, Yanyan; Zhuo, Jianwei; Liu, Jiachuan] Anhui Med Univ, PLA, Hosp 105, Dept Neurosurg,Clin Coll, Hefei 230031, Anhui, Peoples R China		Liu, JC (corresponding author), PLA, Hosp 105, Dept Neurosurg, Changjiang Rd 424, Beijing, Peoples R China.	ljc571017@sina.com			Military "Twelfth Five" Medical Scientific Research of China [CWS11J262]; Nanjing Military Medical Technology Innovation Pre-program of China [09Z009]	This work was supported by the following grants: Military "Twelfth Five" Medical Scientific Research of China (CWS11J262) and Nanjing Military Medical Technology Innovation Pre-program of China (09Z009).	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Das RR, 2005, NEW ENGL J MED, V353, P633; Deshane J, 2005, ACTA BIOCHIM POL, V52, P273; Dubinina EE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1069, DOI 10.1134/S0006297910090014; Galle AA, 2013, BRAIN RES, V1498, P1, DOI 10.1016/j.brainres.2012.12.026; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Huang XS, 2014, MOL CELL BIOCHEM, V385, P33, DOI 10.1007/s11010-013-1812-6; Jones NM, 2008, PEDIATR RES, V63, P620, DOI 10.1203/PDR.0b013e31816d9117; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Rybnikova E, 2012, NEUROSCI LETT, V513, P100, DOI 10.1016/j.neulet.2012.02.019; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Wacker BK, 2012, J NEUROCHEM, V123, P954, DOI 10.1111/jnc.12047; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Zhan LX, 2013, MOL NEUROBIOL, V48, P109, DOI 10.1007/s12035-013-8436-4; Zhang N, 2011, NEUROCHEM INT, V58, P684, DOI 10.1016/j.neuint.2011.02.007; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	28	24	26	1	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 12	2016	611						74	80		10.1016/j.neulet.2015.11.012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC1BO	WOS:000368952000013	26590328				2022-02-06	
J	Alway, Y; McKay, A; Gould, KR; Johnston, L; Ponsford, J				Alway, Yvette; McKay, Adam; Gould, Kate Rachel; Johnston, Lisa; Ponsford, Jennie			FACTORS ASSOCIATED WITH POSTTRAUMATIC STRESS DISORDER FOLLOWING MODERATE TO SEVERE TRAUMATIC BRAIN INJURY: A PROSPECTIVE STUDY	DEPRESSION AND ANXIETY			English	Article						traumatic brain injury; anxiety disorder; posttraumatic stress disorder; trauma; quality of life; rehabilitation	STRUCTURED CLINICAL INTERVIEW; HEAD-INJURY; PSYCHIATRIC-DISORDERS; SELF-REPORT; PTSD; SYMPTOMS; AMNESIA; DEPRESSION; TELEPHONE; ANXIETY	Background This study prospectively examined the relationship between preinjury, injury-related, and postinjury factors and posttraumatic stress disorder (PTSD) following moderate to severe traumatic brain injury (TBI). Method Two hundred and three participants were recruited during inpatient admission following moderate to severe TBI. Participants completed an initial assessment soon after injury and were reassessed at 3, 6, and 12 months, 2, 3, 4, and 5 years postinjury. The Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders-fourth edition was used to diagnose pre- and postinjury PTSD and other psychiatric disorders. The Glasgow Outcome Scale-Extended (GOSE) and the Quality of Life Inventory (QOLI) were used to evaluate functional and psychosocial outcome from 6 months postinjury.ResultsThe frequency of PTSD ranged between 0.5 and 9.4% during the 5-year period, increasing throughout the first 12 months and declining thereafter. After controlling for other predictors, shorter posttraumatic amnesia duration (odds ratio = 0.96, 95% CI = 0.92-1.00), other concurrent psychiatric disorder (odds ratio = 14.22, 95% CI = 2.68-75.38), and lower GOSE (odds ratio = 0.38, 95% CI = 0.20-0.72) and QOLI scores (odds ratio = 0.97, 95% CI = 0.95-0.97) were associated with greater odds of having injury-related PTSD.DiscussionThe results of this study indicate that while shorter posttraumatic amnesia duration is associated with PTSD, greater TBI severity does not prevent PTSD from evolving. Patients with PTSD experienced high rates of psychiatric comorbidity and poorer functional and quality of life outcomes after TBI.ConclusionThere is a need to direct clinical attention to early identification and treatment of PTSD following TBI to improve outcomes.	[Alway, Yvette; McKay, Adam; Gould, Kate Rachel; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Alway, Yvette; McKay, Adam; Gould, Kate Rachel; Johnston, Lisa; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Gould, Kate Rachel; Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Alway, Y (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	yvette.alway@monash.edu	Gould, Kate Rachel/AAA-5511-2020; McKay, Adam JD/M-6003-2017	Gould, Kate Rachel/0000-0002-3564-7408; McKay, Adam JD/0000-0002-0479-7681			[Anonymous], 2008, REPORT ARMY SURG GEN; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Barker-Collo S, 2013, BRAIN IMPAIR, V14, P425, DOI 10.1017/BrImp.2013.27; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273; Chung H, 2008, PSYCHOL MED, V38, P563, DOI 10.1017/S0033291707002589; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Crippa JAS, 2008, PERSPECT PSYCHIATR C, V44, P241, DOI 10.1111/j.1744-6163.2008.00183.x; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gill IJ, 2014, BRAIN INJURY, V28, P1, DOI 10.3109/02699052.2013.851416; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hajebi A, 2012, COMPR PSYCHIAT, V53, P579, DOI 10.1016/j.comppsych.2011.06.001; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hidalgo RB, 2000, J CLIN PSYCHIAT, V61, P5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Reid LM, 2011, J NEUROPSYCH CLIN N, V23, P454, DOI 10.1176/jnp.23.4.jnp454; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; SIMON GE, 1993, J PSYCHIAT RES, V27, P247, DOI 10.1016/0022-3956(93)90035-Z; STIRATELLI R, 1984, BIOMETRICS, V40, P961, DOI 10.2307/2531147; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	48	24	24	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety	JAN	2016	33	1					19	26		10.1002/da.22396			8	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DA3TX	WOS:000367722900002	26219232				2022-02-06	
S	Glushakov, AV; Glushakova, OY; Dore, S; Carney, PR; Hayes, RL		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Glushakov, Alexander V.; Glushakova, Olena Y.; Dore, Sylvain; Carney, Paul R.; Hayes, Ronald L.			Animal Models of Posttraumatic Seizures and Epilepsy	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Posttraumatic epilepsy; Posttraumatic seizures; Epileptogenesis; Animal model; Rodents; CCI; TBI; Fluid percussion injury; Behavioral seizures; Electroencephalography (EEG)	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; ACID-INDUCED SEIZURE; ANTAGONIST IMPROVES OUTCOMES; EP1 RECEPTOR INHIBITION; TEMPORAL-LOBE EPILEPSY; PROSTAGLANDIN E-2; KAINIC ACID; RAT HIPPOCAMPUS	Posttraumatic epilepsy (PTE) is one of the most common and devastating complications of traumatic brain injury (TBI). Currently, the etiopathology and mechanisms of PTE are poorly understood and as a result, there is no effective treatment or means to prevent it. Antiepileptic drugs remain common preventive strategies in the management of TBI to control acute posttraumatic seizures and to prevent the development of PTE, although their efficacy in the latter case is disputed. Different strategies of PTE prophylaxis have been showing promise in preclinical models, but their translation to the clinic still remains elusive due in part to the variability of these models and the fact they do not recapitulate all complex pathologies associated with human TBI. TBI is a multifaceted disorder reflected in several potentially epileptogenic alterations in the brain, including mechanical neuronal and vascular damage, parenchymal and subarachnoid hemorrhage, subsequent toxicity caused by iron-rich hemoglobin breakdown products, and energy disruption resulting in secondary injuries, including excitotoxicity, gliosis, and neuroinflammation, often coexisting to a different degree. Several in vivo models have been developed to reproduce the acute TBI cascade of events, to reflect its anatomical pathologies, and to replicate neurological deficits. Although acute and chronic recurrent posttraumatic seizures are well-recognized phenomena in these models, there is only a limited number of studies focused on PTE. The most used mechanical TBI models with documented electroencephalographic and behavioral seizures with remote epileptogenesis include fluid percussion, controlled cortical impact, and weight-drop. This chapter describes the most popular models of PTE-induced TBI models, focusing on the controlled cortical impact and the fluid percussion injury models, the methods of behavioral and electroencephalogram seizure assessments, and other approaches to detect epileptogenic properties, and discusses their potential application for translational research.	[Glushakov, Alexander V.] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA; [Glushakov, Alexander V.; Dore, Sylvain] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Glushakova, Olena Y.; Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA; [Dore, Sylvain; Carney, Paul R.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Dore, Sylvain; Carney, Paul R.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA; [Carney, Paul R.] Univ Florida, Dept Pediat, Coll Med, Gainesville, FL USA; [Carney, Paul R.] Univ Florida, Coll Med, Dept Biomed Engn, Gainesville, FL USA		Glushakov, AV (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA.; Glushakov, AV (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.		Glushakova, Olena/AAY-1130-2021; Glushakov, Alexander V/B-5452-2008; Dore, Sylvain/AAG-1470-2020	Glushakova, Olena/0000-0002-2109-3651; Glushakov, Alexander V/0000-0003-2872-8960; Dore, Sylvain/0000-0003-3771-5109	NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R01 AT007429] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS046400] Funding Source: Medline; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT007429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046400] Funding Source: NIH RePORTER		Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Baik EJ, 1999, BRAIN RES, V843, P118, DOI 10.1016/S0006-8993(99)01797-7; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; BERCHTOLDKANZ E, 1981, PROSTAGLANDINS, V22, P65, DOI 10.1016/0090-6980(81)90054-X; BERGER AR, 1988, NEUROLOGY, V38, P1363, DOI 10.1212/WNL.38.9.1363; Berges S, 2000, EUR NEUROL, V43, P3, DOI 10.1159/000008120; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; CABRAL RJ, 1976, J NEUROL NEUROSUR PS, V39, P1052, DOI 10.1136/jnnp.39.11.1052; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Cao W, 2009, BRIT J PHARMACOL, V158, P2005, DOI 10.1111/j.1476-5381.2009.00498.x; Cao WG, 2011, AMINO ACIDS, V40, P1151, DOI 10.1007/s00726-010-0739-4; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Chung JI, 2013, EXP NEUROL, V249, P95, DOI 10.1016/j.expneurol.2013.08.014; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ferro JM, 2004, DRUG AGING, V21, P639, DOI 10.2165/00002512-200421100-00003; Fischborn SV, 2010, EPILEPSY RES, V91, P57, DOI 10.1016/j.eplepsyres.2010.06.012; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; FOLCO GC, 1977, PROSTAG OTH LIPID M, V13, P893, DOI 10.1016/0090-6980(77)90218-0; FORSTERMANN U, 1983, ARCH INT PHARMACOD T, V263, P180; FORSTERMANN U, 1983, PSYCHOPHARMACOLOGY, V80, P365, DOI 10.1007/BF00432122; FORSTERMANN U, 1984, PROSTAGLANDINS, V27, P913, DOI 10.1016/S0090-6980(84)80010-6; FORSTERMANN U, 1982, BRAIN RES, V240, P303, DOI 10.1016/0006-8993(82)90225-6; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Glushakov AV, 2013, J NEUROTRAUM, V30, pA163; Glushakov AV, 2015, J TRAUMA CARE, V1, P1007; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GRANDMAISON F, 1991, ELECTROEN CLIN NEURO, V79, P264, DOI 10.1016/0013-4694(91)90121-J; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hartl R, 1997, ACT NEUR S, V70, P240; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huang YH, 2015, SEIZURE-EUR J EPILEP, V25, P150, DOI 10.1016/j.seizure.2014.10.008; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kawaguchi K, 2005, BRAIN RES, V1050, P130, DOI 10.1016/j.brainres.2005.05.038; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kazemi H, 2012, INJURY, V43, P2132, DOI 10.1016/j.injury.2012.06.007; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P277, DOI 10.1007/978-3-7091-0693-8_46; Kim HJ, 2008, BRAIN RES, V1193, P153, DOI 10.1016/j.brainres.2007.12.017; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kinirons P, 2006, SEIZURE-EUR J EPILEP, V15, P387, DOI 10.1016/j.seizure.2006.05.001; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kramer G, 2001, EPILEPSIA, V42, P55, DOI 10.1046/j.1528-1157.2001.042suppl.3055.x; Kucukkaya B, 1998, BRAIN RES, V788, P133, DOI 10.1016/S0006-8993(97)01544-8; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Li BC, 2014, NEUROL RES, V36, P974, DOI 10.1179/1743132813Y.0000000314; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lopez PHH, 2011, J NEUROCHEM, V116, P900, DOI 10.1111/j.1471-4159.2010.07069.x; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martynyuk Anatoly E, 2006, Recent Pat CNS Drug Discov, V1, P261, DOI 10.2174/157488906778773706; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Menon B, 2009, EPILEPSY RES, V87, P1, DOI 10.1016/j.eplepsyres.2009.08.007; Menzler K, 2011, EPILEPSIA, V52, P707, DOI 10.1111/j.1528-1167.2011.02984.x; Michelucci R, 2006, NEUROLOGY, V67, pS14, DOI 10.1212/WNL.67.12_suppl_4.S14; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Moezi L, 2011, EPILEPSY BEHAV, V22, P200, DOI 10.1016/j.yebeh.2011.07.002; NAFFAHMAZZACORATTI MG, 1995, NEUROCHEM INT, V27, P461, DOI 10.1016/0197-0186(95)00053-B; Nandan M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036001; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Okada K, 2001, BRAIN RES, V894, P332, DOI 10.1016/S0006-8993(01)02019-4; Oliveira MS, 2008, NEUROSCIENCE, V152, P1110, DOI 10.1016/j.neuroscience.2008.01.005; Pagni CA, 2005, ACT NEUR S, V93, P27; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; Pitkanen A, 2014, EPILEPSY RES, V108, P653, DOI 10.1016/j.eplepsyres.2014.02.001; Privitera Michael D., 1994, Emergency Medicine Clinics of North America, V12, P1089; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sanchez JC, 2006, IEEE T NEUR SYS REH, V14, P217, DOI 10.1109/TNSRE.2006.875581; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scher AI, 2011, J NEUROTRAUM, V28, P1739, DOI 10.1089/neu.2011.1982; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1207, DOI 10.1038/jcbfm.2013.69; Silverman IE, 2002, ARCH NEUROL-CHICAGO, V59, P195, DOI 10.1001/archneur.59.2.195; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; STEINHAUER HB, 1979, N-S ARCH PHARMACOL, V310, P53, DOI 10.1007/BF00499874; STEINHAUER HB, 1981, EUR J PHARMACOL, V69, P199, DOI 10.1016/0014-2999(81)90414-3; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takemiya T, 2006, NEUROSCI RES, V56, P103, DOI 10.1016/j.neures.2006.06.003; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomimoto H, 2000, ACTA NEUROPATHOL, V99, P26, DOI 10.1007/PL00007402; Tomimoto H, 2002, ACTA NEUROPATHOL, V104, P601, DOI 10.1007/s00401-002-0590-0; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Toscano CD, 2008, NEUROTOXICOLOGY, V29, P1114, DOI 10.1016/j.neuro.2008.08.008; Toth Z, 1997, J NEUROSCI, V17, P8106; Toti P., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P245; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Velioglu SK, 1999, CEPHALALGIA, V19, P797, DOI 10.1046/j.1468-2982.1999.1909797.x; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; WILLMORE LJ, 1983, BRAIN RES, V277, P393, DOI 10.1016/0006-8993(83)90954-X; WILLMORE LJ, 1991, INT J DEV NEUROSCI, V9, P175, DOI 10.1016/0736-5748(91)90009-B; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007; Zweckberger K, 2010, NEUROSCI LETT, V470, P150, DOI 10.1016/j.neulet.2009.12.075	202	24	26	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						481	519		10.1007/978-1-4939-3816-2_27	10.1007/978-1-4939-3816-2		39	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500029	27604735	Green Accepted			2022-02-06	
J	Rhine, T; Babcock, L; Zhang, NH; Leach, J; Wade, SL				Rhine, Tara; Babcock, Lynn; Zhang, Nanhua; Leach, James; Wade, Shari L.			Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?	BRAIN INJURY			English	Article						Paediatric; concussion; biomarkers; diagnosis	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; INTRACRANIAL LESIONS; NEUROSURGICAL INTERVENTION; COMPUTED-TOMOGRAPHY; CONCUSSION; SCALE	Objectives: To compare serum biomarker levels between children with mild traumatic brain injury (mTBI) and orthopaedic injury (OI), acutely following injury. Secondarily, to explore the association between biomarker levels and symptom burden over 1 month post-injury.Methods: This was a prospective cohort study of children aged 11-16 years who presented to the emergency department within 6 hours of sustaining mTBI or isolated extremity OI. Serum was drawn at the time of study enrollment and levels of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) and glial fibrillary acid protein (GFAP) were analysed. Symptom burden was assessed by the Post-Concussion Symptom Scale (PCSS) acutely following injury and at three subsequent time points over 1 month.Results: Twenty-five children with mTBI and 20 children with OI were enrolled. The average age for the overall cohort was 13 ( 1.6) years and the majority were male and injured playing sports. GFAP levels and PCSS scores were significantly higher acutely following mTBI vs OI (p < 0.01). There was not a significant group difference in UCH-L1 levels. Neither GFAP nor UCH-L1 were predictive of PCSS scores over the 1month post-injury.Conclusions: GFAP may be a promising diagnostic tool for children with mTBI. Additional approaches are needed to predict symptom severity and persistence.	[Rhine, Tara; Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Dept Pediat, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Dept Pediat, Cincinnati, OH 45229 USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Med Imaging, Dept Pediat, Cincinnati, OH 45229 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA		Rhine, T (corresponding author), Univ Cincinnati, Div Pediat Emergency Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org		Babcock, Lynn/0000-0002-2658-6893; Zhang, Nanhua/0000-0001-5796-3404	National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000078 (KL2 RR026315)]; Cincinnati Children's Hospital Medical Center Division of Emergency Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000078] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR026315] Funding Source: NIH RePORTER	This study was funded in part by (1) National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2 TR000078 (KL2 RR026315) (Babcock); and (2) Cincinnati Children's Hospital Medical Center Division of Emergency Medicine. The additional authors have no funding sources or conflicts to disclose for this work.	Achenbach T, 1983, MANUAL CHILD BEHAV C; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bergstrand M, 2009, AAPS J, V11, P371, DOI 10.1208/s12248-009-9112-5; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Faul M, 2010, TRAUMATIC BRAIN INJU; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Kaiser D, 2015, BRAIN IMAGING BEHAV, V9, P32, DOI 10.1007/s11682-014-9327-7; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Obuchowski NA, 2000, AM J ROENTGENOL, V175, P603, DOI 10.2214/ajr.175.3.1750603; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	28	24	24	2	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1231	1238		10.1080/02699052.2016.1178396			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300010	27416022	Green Accepted			2022-02-06	
J	Gibb, SL; Zhao, YH; Potter, D; Hylin, MJ; Bruhn, R; Baimukanova, G; Zhao, J; Xue, HS; Abdel-Mohsen, M; Pillai, SK; Moore, AN; Johnson, EM; Cox, CS; Dash, PK; Pati, S				Gibb, Stuart L.; Zhao, Yuhai; Potter, Daniel; Hylin, Michael J.; Bruhn, Roberta; Baimukanova, Gyulnar; Zhao, Jing; Xue, Hasen; Abdel-Mohsen, Mohamed; Pillai, Satish K.; Moore, Anthony N.; Johnson, Evan M.; Cox, Charles S., Jr.; Dash, Pramod K.; Pati, Shibani			TIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain Injury	STEM CELLS			English	Article						Tissue inhibitor of matrix metalloproteinase-3; Mesenchymal stem cell; Neural stem cell; Traumatic brain injury; Hippocampus	HIPPOCAMPAL NEUROGENESIS; RAPAMYCIN; INHIBITION; MOTOR; DEFICITS; KINASE; TARGET; SURVEILLANCE; EXPRESSION; SURVIVAL	Mesenchymal stem cells (MSCs) have been shown to have potent therapeutic effects in a number of disorders including traumatic brain injury (TBI). However, the molecular mechanism(s) underlying these protective effects are largely unknown. Herein we demonstrate that tissue inhibitor of matrix metalloproteinase-3 (TIMP3), a soluble protein released by MSCs, is neuroprotective and enhances neuronal survival and neurite outgrowth in vitro. In vivo in a murine model of TBI, intravenous recombinant TIMP3 enhances dendritic outgrowth and abrogates loss of hippocampal neural stem cells and mature neurons. Mechanistically we demonstrate in vitro and in vivo that TIMP3-mediated neuroprotection is critically dependent on activation of the Akt-mTORC1 pathway. In support of the neuroprotective effect of TIMP3, we find that intravenous delivery of recombinant TIMP3 attenuates deficits in hippocampal-dependent neurocognition. Taken together, our data strongly suggest that TIMP3 has direct neuroprotective effects that can mitigate the deleterious effects associated with TBI, an area with few if any therapeutic options.	[Gibb, Stuart L.; Potter, Daniel; Bruhn, Roberta; Baimukanova, Gyulnar; Abdel-Mohsen, Mohamed; Pillai, Satish K.; Pati, Shibani] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Gibb, Stuart L.; Potter, Daniel; Bruhn, Roberta; Baimukanova, Gyulnar; Abdel-Mohsen, Mohamed; Pillai, Satish K.; Pati, Shibani] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Zhao, Yuhai; Hylin, Michael J.; Zhao, Jing; Moore, Anthony N.; Johnson, Evan M.; Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol, Houston, TX 77030 USA; [Xue, Hasen; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Xue, Hasen; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA		Pati, S (corresponding author), Blood Syst Res Inst, 270 Mason Ave, San Francisco, CA 94118 USA.	spati@bloodsystems.org	Hylin, Michael/U-2878-2019	Bruhn, Roberta/0000-0002-5898-8168	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K18HL102256-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K18HL102256] Funding Source: NIH RePORTER	This work was made possible in part by Mission Connect; the Texas Institute for Rehabilitation and Research; the Bentsen Foundation, Houston, Texas; and National Heart, Lung, and Blood Institute K18 award (K18HL102256-01).	Ahn YJ, 2014, FOOD CHEM TOXICOL, V64, P210, DOI 10.1016/j.fct.2013.11.033; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Bohbot VD, 2000, ANN NY ACAD SCI, V911, P355; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; BREW K, 2010, MOL CELL RES, V1803, P55, DOI DOI 10.1016/J.BBAMCR.2010.01.003; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; CHEN S, 2006, J CEREB BLOOD FLOW M, V27, P939; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eckhouse SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007244; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Guo D, 2013, PLOS ONE, V8, P1; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kallio JP, 2011, INT J CANCER, V128, P991, DOI 10.1002/ijc.25404; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Lin H, 2012, CANCER GENE THER, V19, P845, DOI 10.1038/cgt.2012.70; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Malkesman O, 2013, FRONT NEUROSCI, P1; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Mersmann J, 2012, RESUSCITATION, V83, P1404, DOI 10.1016/j.resuscitation.2012.04.001; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okada K, 2011, NEUROSCI LETT, V495, P201, DOI 10.1016/j.neulet.2011.03.065; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Raman L, 2013, NEUROSCI LETT, V541, P9, DOI 10.1016/j.neulet.2013.01.045; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Zhang W-N, 2013, BRIT J NEUROSURG, P1; Zhang Y, 2008, GYNECOL ONCOL, V108, P234, DOI 10.1016/j.ygyno.2007.09.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou SL, 2015, NEUROSCI LETT, V586, P43, DOI 10.1016/j.neulet.2014.12.006	64	24	24	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	DEC	2015	33	12			SI		3530	3544		10.1002/stem.2189			15	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	CW5PR	WOS:000365049000018	26299440	Bronze			2022-02-06	
J	Liu, XX; Niethammer, M; Kwitt, R; Singh, N; McCormick, M; Aylward, S				Liu, Xiaoxiao; Niethammer, Marc; Kwitt, Roland; Singh, Nikhil; McCormick, Matt; Aylward, Stephen			Low-Rank Atlas Image Analyses in the Presence of Pathologies	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Low-rank and sparse decomposition; sparse images; unbiased atlas; atlas-based segmentation	BRAIN; REGISTRATION	We present a common framework, for registering images to an atlas and for forming an unbiased atlas, that tolerates the presence of pathologies such as tumors and traumatic brain injury lesions. This common framework is particularly useful when a sufficient number of protocol-matched scans from healthy subjects cannot be easily acquired for atlas formation and when the pathologies in a patient cause large appearance changes. Our framework combines a low-rank-plus-sparse image decomposition technique with an iterative, diffeomorphic, group-wise image registration method. At each iteration of image registration, the decomposition technique estimates a "healthy" version of each image as its low-rank component and estimates the pathologies in each image as its sparse component. The healthy version of each image is used for the next iteration of image registration. The low-rank and sparse estimates are refined as the image registrations iteratively improve. For unbiased atlas formation, at each iteration, the average of the low-rank images from the patients is used as the atlas image for the next iteration, until convergence. Since each iteration's atlas is comprised of low-rank components, it provides a population-consistent, pathology-free appearance. Evaluations of the proposed methodology are presented using synthetic data as well as simulated and clinical tumor MRI images from the brain tumor segmentation (BRATS) challenge from MICCAI 2012.	[Liu, Xiaoxiao] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Niethammer, Marc; Singh, Nikhil] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Kwitt, Roland] Salzburg Univ, Dept Comp Sci, A-5020 Salzburg, Austria; [McCormick, Matt] Kitware Inc, Clifton Pk, NY 12065 USA; [Aylward, Stephen] Kitware Inc, Carrboro, NC 27510 USA		Liu, XX (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	liuxiaoxiao@gmail.com	singh, Nikhil/AAX-5380-2020	McCormick, Matthew/0000-0001-9475-3756	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44CA143234, R41EB015775, R43EB016621, R41NS081792, R43CA165621]; NSFNational Science Foundation (NSF) [EECS-1148870, EECS-0925875]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R43CA165621, R43CA143234, R44CA143234, R44CA165621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R41EB015775, R43EB016621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS081792, R41NS081792] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health under grants R44CA143234, R41EB015775, R43EB016621, R41NS081792, R43CA165621, and by NSF under grants EECS-1148870 and EECS-0925875.	Atkinson D, 1997, IEEE T MED IMAGING, V16, P903, DOI 10.1109/42.650886; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Chitphakdithai N, 2010, LECT NOTES COMPUT SC, V6361, P367; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Lin Z., 2010, ARXIV10095055; Liu XX, 2014, LECT NOTES COMPUT SC, V8675, P97, DOI 10.1007/978-3-319-10443-0_13; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Niethammer M, 2011, LECT NOTES COMPUT SC, V6892, P639, DOI 10.1007/978-3-642-23629-7_78; Peng YG, 2012, IEEE T PATTERN ANAL, V34, P2233, DOI 10.1109/TPAMI.2011.282; Prastawa M, 2009, MED IMAGE ANAL, V13, P297, DOI 10.1016/j.media.2008.11.002; Ramus L, 2010, LECT NOTES COMPUT SC, V6363, P155; Rohlfing T, 2010, HUM BRAIN MAPP, V31, P798, DOI 10.1002/hbm.20906; Wang B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1152, DOI 10.1109/ISBI.2012.6235764	15	24	25	2	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	DEC	2015	34	12					2583	2591		10.1109/TMI.2015.2448556			9	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	CY0OD	WOS:000366104500014	26111390	Green Accepted, Green Published, Green Submitted			2022-02-06	
J	Chin, LMK; Chan, L; Woolstenhulme, JG; Christensen, EJ; Shenouda, CN; Keyser, RE				Chin, Lisa M. K.; Chan, Leighton; Woolstenhulme, Joshua G.; Christensen, Eric J.; Shenouda, Christian N.; Keyser, Randall E.			Improved Cardiorespiratory Fitness With Aerobic Exercise Training in Individuals With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						endurance training; exercise tolerance; fatigue; physical activity; (V)over dotO(2)	FATIGUE SEVERITY SCALE; PHYSICAL-ACTIVITY; ANAEROBIC THRESHOLD; MULTIPLE-SCLEROSIS; SLEEP DISTURBANCE; CAPACITY; ADULTS; EPIDEMIOLOGY; INTENSITY; HEALTH	Objective: To examine cardiorespiratory fitness in individuals with traumatic brain injury (TBI), before and following participation in a supervised 12-week aerobic exercise training program. Methods: Ten subjects with nonpenetrating TBI (TBI severity: mild, 50%; moderate, 40%; severe, 10%; time since injury [mean +/- SD]: 6.6 +/- 6.8 years) performed exercise training on a treadmill 3 times a week for 30 minutes at vigorous intensity (70%-80% of heart rate reserve). All subjects completed a cardiopulmonary exercise test, with pulmonary gas exchange measured and a questionnaire related to fatigue (Fatigue Severity Scale) at baseline and following exercise training. Results: After training, increases (P <.01) in peak oxygen consumption ((V)over dotO(2); + 3.1 +/- 2.4 mL/min/kg), time to volitional fatigue (+ 1.4 +/- 0.8 minutes), and peak work rate (+ 59 +/- 43 W) were observed. At the anaerobic threshold, (V)over dotO(2) (+ 3.6 +/- 2.1 mL/kg/min), treadmill time (+ 1.8 +/- 1.1 minutes), and work rate (+ 37 +/- 39 W) were higher (P <.01) following exercise training. Subjects also reported significantly lower (P <.05) Fatigue Severity Scale composite scores (-0.9 +/- 1.3) following exercise training. Conclusion: These findings suggest that individuals with TBI may benefit from participation in vigorous aerobic exercise training with improved cardiorespiratory fitness and diminished fatigue.	[Chin, Lisa M. K.; Woolstenhulme, Joshua G.; Keyser, Randall E.] George Mason Univ, Dept Rehabil Sci, 4400 Univ Dr, Fairfax, VA 22030 USA; [Chin, Lisa M. K.; Chan, Leighton; Woolstenhulme, Joshua G.; Christensen, Eric J.; Keyser, Randall E.] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA; [Chan, Leighton; Shenouda, Christian N.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA		Chin, LMK (corresponding author), George Mason Univ, Dept Rehabil Sci, 4400 Univ Dr, Fairfax, VA 22030 USA.	lchin2@gmu.edu	Chin, Lisa MK/O-4706-2014	Chin, Lisa MK/0000-0002-0178-739X	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G192HI-H]; National Institutes of Health Clinical Center (Rehabilitation Medicine Department Intramural Funds)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This study was supported by the Center for Neuroscience and Regenerative Medicine (G192HI-H) and the National Institutes of Health Clinical Center (Rehabilitation Medicine Department Intramural Funds). The authors thank Bart Drinkard and Anne Quinn for their assistance with the exercise training sessions and data collection. They also thank Beth Kvochak for initial recruitment efforts.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Amonette WE, 2013, J HEAD TRAUMA REHAB, V28, pE13, DOI 10.1097/HTR.0b013e31826463a1; Baquet G, 2003, SPORTS MED, V33, P1127, DOI 10.2165/00007256-200333150-00004; Bartlo P, 2007, J CARDIOPULM REHABIL, V27, P368, DOI 10.1097/01.HCR.0000300263.07764.4a; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; BLUMENTHAL JA, 1989, J GERONTOL, V44, pM147, DOI 10.1093/geronj/44.5.M147; Borg E, 2006, SCAND J MED SCI SPOR, V16, P57, DOI 10.1111/j.1600-0838.2005.00448.x; Borg E., 2001, P 17 ANN M INT SOC P, P298; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; CHEN MK, 1986, PREV MED, V15, P74, DOI 10.1016/0091-7435(86)90037-X; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DAVIS JA, 1985, MED SCI SPORT EXER, V17, P6; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Faul M, 2010, TRAUMATIC BRAIN INJU; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2011, BRAIN INJURY, V25, P698, DOI 10.3109/02699052.2011.579934; Hootman JM, 2002, MED SCI SPORT EXER, V34, P838, DOI 10.1097/00005768-200205000-00017; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kennedy-Armbruster C, 2013, MIL MED, V178, P1358, DOI 10.7205/MILMED-D-13-00186; Krupp, 2003, FATIGUE; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lange G, 2005, ISS CLIN COGN NEUROP, P301; Latimer-Cheung AE, 2013, ARCH PHYS MED REHAB, V94, P1800, DOI 10.1016/j.apmr.2013.04.020; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Linke SE, 2011, ANN BEHAV MED, V42, P197, DOI 10.1007/s12160-011-9279-8; Londeree BR, 1997, MED SCI SPORT EXER, V29, P837, DOI 10.1097/00005768-199706000-00016; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MCINNIS KJ, 1992, AM J CARDIOL, V69, P84, DOI 10.1016/0002-9149(92)90680-W; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Milani RV, 2006, MAYO CLIN PROC, V81, P1603, DOI 10.4065/81.12.1603; Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Mulligan HF, 2012, ADAPT PHYS ACT Q, V29, P243, DOI 10.1123/apaq.29.3.243; Murphy MH, 2009, SPORTS MED, V39, P29, DOI 10.2165/00007256-200939010-00003; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Neuberger G, 2003, ARTHRIT CARE RES, V49, pS175, DOI DOI 10.1002/ART.11405; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; REYBROUCK T, 1986, INT J SPORTS MED, V7, P26, DOI 10.1055/s-2008-1025730; Sue, 2005, PRINCIPLES EXERCISE; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; Thompson W, 2009, ACSMS GUIDELINES EXE; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention & President's Council on Physical Fitness, 1996, PHYS ACT HLTH REP SU; VAGO P, 1987, INT J SPORTS MED, V8, P190, DOI 10.1055/s-2008-1025654; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; WASSERMAN K, 1984, AM REV RESPIR DIS, V129, pS35, DOI 10.1164/arrd.1984.129.2P2.S35; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Wolman RL, 1994, CLIN REHABIL, V8, P253; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	67	24	27	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					382	390		10.1097/HTR.0000000000000062			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300010	24901330	Green Accepted			2022-02-06	
J	Deepika, A; Prabhuraj, AR; Saikia, A; Shukla, D				Deepika, Akhil; Prabhuraj, A. R.; Saikia, Amrit; Shukla, Dhaval			Comparison of predictability of Marshall and Rotterdam CT scan scoring system in determining early mortality after traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Marshall CT scan classification; Rotterdam CT scan score; Traumatic brain injury	CLASSIFICATION	Marshall computed tomographic (CT) classification is widely used as a predictor of outcome. However, this grading system lacks the following variables, which are found to be useful predictors: subarachnoid/intraventricular hemorrhage, extradural hematoma, and extent of basal cistern compression. A new classification called the Rotterdam grading system, incorporating the above variables, was proposed later. In the original paper, this system was found to have superior discrimination as compared to Marshall grading, however, Rotterdam grading has not been validated widely. We aimed to compare the discriminatory power of both grading systems. This is a prospective study of patients with moderate and severe TBI (Glasgow coma scale (GCS) 3-12) who presented to our casualty. All the patients were followed up for 2 weeks to determine early mortality. The discriminatory power of each grading system was determined using area under the receiver operating characteristic curve (AUC). A total of 134 patients, mean age 38.3 (+/- 15.7) years, were recruited for study. The overall mortality was 11.2 %. The mean GCS of these patients was 9.6 (+/- 2.3). There was good correlation between Marshall and Rotterdam grading, r = 0.68 (significant at 0.01 level). The Marshall CT classification had reasonable discrimination (AUC - 0.707), and Rotterdam grading had good discrimination (AUC - 0.681). Both Marshal and Rotterdam grading systems are good in predicting early mortality after moderate and severe TBI. As the Rotterdam system also includes additional variables like subarachnoid hemorrhage, it may be preferable, particularly in patients with diffuse injury.	[Deepika, Akhil; Prabhuraj, A. R.; Saikia, Amrit; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 560029, Karnataka, India		Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 560029, Karnataka, India.	neurodhaval@rediffmail.com					Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Morris GF, 1997, ACTA NEUROCHIR S, V71, P382; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shukla D, 2007, CLIN NEUROPATHOL, V26, P197; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013	15	24	25	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2015	157	11					2033	2038		10.1007/s00701-015-2575-5			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CT7CL	WOS:000362970800034	26374440				2022-02-06	
J	Littleton, AC; Schmidt, JD; Register-Mihalik, JK; Gioia, GA; Waicus, KM; Mihalik, JP; Guskiewicz, KM				Littleton, Ashley C.; Schmidt, Julianne D.; Register-Mihalik, Johna K.; Gioia, Gerard A.; Waicus, Kelly M.; Mihalik, Jason P.; Guskiewicz, Kevin M.			Effects of Attention Deficit Hyperactivity Disorder and Stimulant Medication on Concussion Symptom Reporting and Computerized Neurocognitive Test Performance	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ADHD; Concussion vital signs; Psychometrics; Reliability; Neuropsychology; Traumatic brain injury	TEST-RETEST RELIABILITY; SPORT-RELATED CONCUSSION; CNS VITAL SIGNS; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; PREADOLESCENT CHILDREN; RESPONSE VARIABILITY; COGNITIVE CONTROL; PHYSICAL-ACTIVITY; COLLEGE-STUDENTS	Effects of attention deficit hyperactivity disorder (ADHD) and stimulant medications on concussion measures are unclear. The objectives of this study were to (i) examine consistency of performance in an unmedicated ADHD group and a control group on concussion measures, (ii) assess performance differences between the two groups, and (iii) assess the effect of stimulant medication on performance in the ADHD group. College-aged participants (22 ADHD and 22 matched controls) were administered a symptom checklist and a computerized neurocognitive test (CNS Vital Signs, CNSVS) 3 times (1 week apart): Sessions 1 and 2 were unmedicated for all participants; Session 3 was medicated for the ADHD group. The reliability of the measures (intraclass correlation coefficients, ICC2,1) was consistent for both groups. When unmedicated, the ADHD group performed worse than controls on psychomotor speed [F(1,40) = 15.19, p < 0.001], and worse than when medicated on reaction time [F(1,39) = 6.34, p = 0.02]. The ADHD group performed better and comparable with controls when medicated. Clinicians should take medication status into account when interpreting scores.	[Littleton, Ashley C.] Univ N Carolina, Human Movement Sci & Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Register-Mihalik, Johna K.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Waicus, Kelly M.] Univ N Carolina, Campus Hlth Serv, Chapel Hill, NC 27599 USA		Littleton, AC (corresponding author), 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	alittlet@live.unc.edu	Meijer, Anna/K-5118-2016				Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Agay N, 2010, PSYCHOPHARMACOLOGY, V210, P511, DOI 10.1007/s00213-010-1853-4; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Brams M, 2010, CURR MED RES OPIN, V26, P1809, DOI 10.1185/03007995.2010.488553; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brown Thomas E, 2008, Curr Psychiatry Rep, V10, P407, DOI 10.1007/s11920-008-0065-7; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Chang Z, 2014, J CHILD PSYCHOL PSYC, V55, P878, DOI 10.1111/jcpp.12164; CHELUNE GJ, 1991, NEUROLOGY, V41, P399, DOI 10.1212/WNL.41.3.399; Choi JW, 2015, MED SCI SPORT EXER, V47, P33, DOI 10.1249/MSS.0000000000000373; Cohen J, 1977, STAT POWER ANAL BEHA; Connor DF, 2005, CONTEMPORARY CLIN NE, P487; Cornforth C, 2010, CURR PHARM DESIGN, V16, P2424, DOI 10.2174/138161210791959827; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fisher BC, 2014, PSYCHOL REP, V114, P404, DOI 10.2466/15.10.PR0.114k23w0; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gropper RJ, 2009, J ATTEN DISORD, V12, P574, DOI 10.1177/1087054708320390; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hautmann C, 2017, J ATTEN DISORD, V21, P120, DOI 10.1177/1087054713502233; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Hinton-Bayre A, 2000, J INT NEUROPSYCH SOC, V6, P362, DOI 10.1017/S1355617700633118; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Huang YS, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-194; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2014, APPL NEUROPSYCH-ADUL, V21, P36, DOI 10.1080/09084282.2012.721149; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Kinsbourne M, 2001, ANN NY ACAD SCI, V931, P287; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leckie RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00985; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Mikami AY, 2009, J CLIN PSYCHOL MED S, V16, P233, DOI 10.1007/s10880-009-9165-8; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; NICE, 2008, ATTENTION DEFICIT HY; Nielsen NP, 2011, INT J PSYCHIAT CLIN, V15, P219, DOI 10.3109/13651501.2011.582538; Nikolas MA, 2013, NEUROPSYCHOLOGY, V27, P107, DOI 10.1037/a0030685; Pasini A, 2013, EUR J PAEDIATR NEURO, V17, P407, DOI 10.1016/j.ejpn.2013.02.002; Patel AV, 2007, J ATHL TRAINING, V42, P66; Pietrzak RH, 2006, NEUROSCI BIOBEHAV R, V30, P1225, DOI 10.1016/j.neubiorev.2006.10.002; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Pontifex MB, 2013, J PEDIATR-US, V162, P543, DOI 10.1016/j.jpeds.2012.08.036; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Riordan HJ, 1999, ARCH CLIN NEUROPSYCH, V14, P217, DOI 10.1016/S0887-6177(98)00015-8; Robinson AM, 2014, BEHAV NEUROSCI, V128, P703, DOI 10.1037/bne0000015; Rowe DL, 2005, CLIN NEUROPHYSIOL, V116, P324, DOI 10.1016/j.clinph.2004.08.001; Ruiz JR, 2010, J PEDIATR-US, V157, P917, DOI 10.1016/j.jpeds.2010.06.026; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schwartz K, 2008, PSYCHOL MED, V38, P1607, DOI 10.1017/S003329170700267X; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Wolf LE, 2001, ANN NY ACAD SCI, V931, P385; Wu CT, 2011, NEUROPSYCHOLOGY, V25, P333, DOI 10.1037/a0022167; Ziereis S, 2015, RES DEV DISABIL, V38, P181, DOI 10.1016/j.ridd.2014.12.005; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	67	24	24	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2015	30	7					683	693		10.1093/arclin/acv043			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CY4GQ	WOS:000366367000009	26310392	Bronze			2022-02-06	
J	Sun, LH; Perakyla, J; Polvivaara, M; Ohman, J; Peltola, J; Lehtimaki, K; Huhtala, H; Hartikainen, KM				Sun, Lihua; Perakyla, Jani; Polvivaara, Markus; Ohman, Juha; Peltola, Jukka; Lehtimaki, Kai; Huhtala, Heini; Hartikainen, Kaisa M.			Human anterior thalamic nuclei are involved in emotion-attention interaction	NEUROPSYCHOLOGIA			English	Article						Deep brain stimulation; Anterior thalamic nuclei; EEG; Emotion; Attention; Epilepsy	TRAUMATIC BRAIN-INJURY; CINGULATE CORTEX; ORBITOFRONTAL CORTEX; INTEGRATIVE THEORY; PREFRONTAL CORTEX; NEURAL MECHANISMS; COGNITIVE CONTROL; STIMULI COMPETE; EPILEPSY; FEAR	Patients treated with deep brain stimulation (DBS) provide an opportunity to study affective processes in humans with "lesion on demand" at key nodes in the limbic circuitries, such as at the anterior thalamic nuclei (ANT). ANT has been suggested to play a role in emotional control with its connection to the orbitofrontal cortex and the anterior cingulate cortex. However, direct evidence for its role in emotional function in human subjects is lacking. Reported side effects of ANT-DBS in the treatment of refractory epilepsy include depression related symptoms. In line with these mood-related clinical side effects, we have previously reported that stimulating the anterior thalamus increased emotional interference in a visual attention task as indicated by prolonged reaction times due to threat-related emotional distractors. We used event-related potentials to investigate potential attentional mechanism behind this behavioural observation. We hypothesized that ANT-DBS leads to greater attention capture by threat-related distractors. We tested this hypothesis using centro-parietal N2-P3 peak-to-peak amplitude as a measure of allocated attentional resources. Six epileptic patients treated with deep brain stimulation at ANT participated in the study. Electroencephalography was recorded while the patients performed a computer based Executive-Reaction Time test with threat-related emotional distractors. During the task, either ANT or a thalamic control location was stimulated, or the stimulation was turned off. Stimulation of ANT was associated with increased centro-parietal N2-P3 amplitude and increased reaction time in the context of threat-related emotional distractors. We conclude that high frequency electric stimulation of ANT leads to greater attentional capture by emotional stimuli. This is the first study to provide direct evidence from human subjects with on-line electric manipulation of ANT for its role in emotion-attention interaction. (C) 2015 The Authors. Published by Elsevier Ltd.	[Sun, Lihua; Perakyla, Jani; Polvivaara, Markus; Hartikainen, Kaisa M.] Tampere Univ Hosp, Behav Neurol Res Unit, FI-33520 Tampere, Finland; [Ohman, Juha; Peltola, Jukka; Lehtimaki, Kai; Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33520 Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland		Hartikainen, KM (corresponding author), Tampere Univ Hosp, Behav Neurol Res Unit, Finn Medi 6-7,POB 2000, FI-33520 Tampere, Finland.	kaisa.hartikainen@uta.fi		Ohman, Juha/0000-0002-6592-1367; Hartikainen, Kaisa/0000-0001-7278-9635; Sun, Lihua/0000-0002-9931-9497	Academy of FinlandAcademy of FinlandEuropean Commission; Competitive Research Fund of Pirkanmaa Hospital District	This research was supported by the Academy of Finland and the Competitive Research Fund of Pirkanmaa Hospital District.	Arend I, 2015, NEUROPSYCHOLOGY, V29, P191, DOI 10.1037/neu0000139; Barcelo F, 2009, FRONT NEUROSCI-SWITZ, V3, P6, DOI 10.3389/neuro.01.010.2009; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Bockova M., 2014, BRAIN TOPOGR; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Child ND, 2013, NEUROLOGY, V81, P1869, DOI 10.1212/01.wnl.0000436078.95856.56; Daffner KR, 1998, NEUROREPORT, V9, P787, DOI 10.1097/00001756-199803300-00004; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Lanna MED, 2012, J NEUROL SCI, V322, P176, DOI 10.1016/j.jns.2012.08.004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Jaeger A, 2012, COGN AFFECT BEHAV NE, V12, P748, DOI 10.3758/s13415-012-0110-1; Kayser J, 1997, PSYCHOPHYSIOLOGY, V34, P414, DOI 10.1111/j.1469-8986.1997.tb02385.x; LeDoux JE, 2012, PROG BRAIN RES, V195, P431, DOI 10.1016/B978-0-444-53860-4.00021-0; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338, DOI 10.1097/00006842-194911000-00003; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Maki-Marttunen V, 2014, NEUROREPORT, V25, P1038, DOI 10.1097/WNR.0000000000000223; Maratos EJ, 2000, NEUROPSYCHOLOGIA, V38, P1452, DOI 10.1016/S0028-3932(00)00061-0; Marchand A, 2014, BRAIN STRUCT FUNCT, V219, P1575, DOI 10.1007/s00429-013-0586-7; Matthews G, 2000, BEHAV MODIF, V24, P69, DOI 10.1177/0145445500241004; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Moddel G, 2012, NERVENARZT, V83, P1001, DOI 10.1007/s00115-012-3572-z; Montgomery EW, 2010, DEEP BRAIN STIMULATI; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Okon-Singer H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00058; Papez J. W., 1937, J NEUROPSYCHIATRY CL, V79, P217; Patel Salil H, 2005, Int J Med Sci, V2, P147; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pessoa L, 2012, EMOTION, V12, P192, DOI 10.1037/a0024109; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Sen F., 2005, NEUROANATOMY, V4, P10; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Spinks R, 2002, NEUROIMAGE, V17, P631, DOI 10.1006/nimg.2002.1185; Takebayashi S, 2007, EPILEPSIA, V48, P348, DOI 10.1111/j.1528-1167.2006.00948.x; van Groen T, 1999, BRAIN RES REV, V30, P1, DOI 10.1016/S0165-0173(99)00006-5; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Wharen W, 1998, ATLAS STEREOTAXY HUM; Xiao D., 2002, Thalamus & Related Systems, V2, P21, DOI 10.1016/S1472-9288(02)00031-6	53	24	24	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	NOV	2015	78						88	94		10.1016/j.neuropsychologia.2015.10.001			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CW5RH	WOS:000365053800010	26440152	Green Published, hybrid			2022-02-06	
J	Bartels, RHMA; Meijer, FJA; van der Hoeven, H; Edwards, M; Prokop, M				Bartels, Ronald H. M. A.; Meijer, Frederick J. A.; van der Hoeven, Hans; Edwards, Michael; Prokop, Mathias			Midline shift in relation to thickness of traumatic acute subdural hematoma predicts mortality	BMC NEUROLOGY			English	Article						Acute subdural hematoma; Survival; Prediction; CT	BRAIN-INJURY; PROGNOSTIC MODELS; VALIDATION; ADMISSION; CRITERIA; MODERATE; IMPACT	Background: Traumatic acute subdural hematoma has a high mortality despite intensive treatment. Despite the existence of several prediction models, it is very hard to predict an outcome. We investigated whether a specific combination of initial head CT-scan findings is a factor in predicting outcome, especially non-survival. Methods: We retrospectively studied admission head CT scans of all adult patients referred for a traumatic acute subdural hematoma between April 2009 and April 2013. Chart review was performed for every included patient. Midline shift and thickness of the hematoma were measured by two independent observers. The difference between midline shift and thickness of the hematoma was calculated. These differences were correlated with outcome. IRB has approved the study. Results: A total of 59 patients were included, of whom 29 died. We found a strong correlation between a midline shift exceeding the thickness of the hematoma by 3 mm or more, and subsequent mortality. For each evaluation, specificity was 1.0 ( 95 % CI: 0.85-1 for all evaluations), positive predictive value 1.0 ( 95 % CI between 0.31-1 and 0.56-1), while sensitivity ranged from 0.1 to 0.23 ( 95 % CI between 0.08-0.39 and 0.17-0.43), and negative predictive value varied from 0.52 to 0.56 ( 95 % CI between 0.38-0.65 and 0.41-0.69). Conclusions: In case of a traumatic acute subdural hematoma, a difference between the midline shift and the thickness of the hematoma >= 3 mm at the initial CT predicted mortality in all cases. This is the first time that such a strong correlation was reported. Especially for the future development of prediction models, the relation between midline shift and thickness of the hematoma could be included as a separate factor.	[Bartels, Ronald H. M. A.] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 ED Nijmegen, Netherlands; [Meijer, Frederick J. A.; Prokop, Mathias] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [van der Hoeven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands; [Edwards, Michael] Radboud Univ Nijmegen, Med Ctr, Dept Trauma & Emergency Surg, NL-6525 ED Nijmegen, Netherlands		Bartels, RHMA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 ED Nijmegen, Netherlands.	ronald.bartels@radboudumc.nl	Prokop, W.M./H-8081-2014; Edwards, M.J.R./H-8026-2014; Bartels, Ronald HMA/L-4184-2015; Meijer, Frederick/L-4516-2015	Bartels, Ronald HMA/0000-0002-8638-4660; Meijer, Frederick/0000-0001-5921-639X; Prokop, Mathias/0000-0001-8157-8055			Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; D'Amato L, 2007, J Neurosurg Sci, V51, P107; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011; Zumkeller M, 1996, NEUROSURGERY, V39(, P712	11	24	26	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	OCT 24	2015	15								220	10.1186/s12883-015-0479-x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU1WA	WOS:000363311500002	26496765	Green Published, gold			2022-02-06	
J	Thiagarajan, P; Ciuffreda, KJ				Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Pupillary responses to light in chronic non-blast-induced mTBI	BRAIN INJURY			English	Article						Mild traumatic brain injury; parasympathetic system; pupillary dynamics; pupillary light reaction; sympathetic system	TRAUMATIC BRAIN-INJURY; PATHOPHYSIOLOGY	Purpose: To evaluate objectively and quantitatively human pupillary responses to a light stimulus under photopic conditions in individuals with non-blast-induced, chronic, mild traumatic brain injury (mTBI).Methods: Seventeen individuals with chronic, non-blast-induced mTBI and 15 visually-normal (VN) controls were tested (aged 21-45 years). Pupillary responsivity to a brief step-input light stimulus was assessed objectively in each eye for 5 seconds using the Neuroptics PLR-200 monocular, hand-held pupillometer with its pre-set and automated eight parameter analysis.Results: Five of the eight parameters assessed were significantly reduced (p0.05) in the mTBI group as compared to the VN control group: maximum (or peak) constriction velocity, average constriction velocity, average dilation velocity, maximum diameter and amplitude of constriction. The remaining three parameters were similar in each group (p>0.05): constriction latency, 75% dilation recovery time and minimum diameter.Conclusions: The slowed dilation dynamics and reduced maximum pupillary diameter in mTBI suggest deficiency primarily of the sympathetic control system. The reduced peak velocities and related amplitudes suggest subtle parasympathetic involvement.	[Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			SUNY College of Optometry's Schnurmacher Institute for Vision Research	This project was funded by the SUNY College of Optometry's Schnurmacher Institute for Vision Research. The authors report non conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Adoni Andea, 2007, J Trauma Nurs, V14, P191; Birch D., 2003, ADLERS PHYSL EYE, P586; Bitsios R, 1996, AGE AGEING, V25, P432; Bradley JC, 2010, J CATARACT REFR SURG, V36, P277, DOI 10.1016/j.jcrs.2009.09.025; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P7343, DOI 10.1167/iovs.12-10881; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Ciuffreda K. J, 2006, BORISHS CLIN REFRACT, V2nd, P77, DOI DOI 10.1016/B978-0-7506-7524-6.50009-0; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Department ofVeterans Affairs/DepartmentofDefense (VA/ DoD), 2009, CLIN PRACT GUID MAN; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Kardon R, 1995, Curr Opin Ophthalmol, V6, P20, DOI 10.1097/00055735-199512000-00004; KARDON R, 2003, ADLERS PHYSL EYE, P713; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Loewenfeld IE, 1999, PUPIL ANATOMY PHYSL; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; Stark L., 1968, NEUROLOGICAL CONTROL, P160; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zinn KM, 1972, THE PUPIL	27	24	25	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1420	1425		10.3109/02699052.2015.1045029			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200004	26182230				2022-02-06	
J	Sekhon, MS; Griesdale, DE; Czosnyka, M; Donnelly, J; Liu, X; Aries, MJ; Robba, C; Lavinio, A; Menon, DK; Smielewski, P; Gupta, AK				Sekhon, Mypinder S.; Griesdale, Donald E.; Czosnyka, Marek; Donnelly, Joseph; Liu, Xia; Aries, Marcel J.; Robba, Chiara; Lavinio, Andrea; Menon, David K.; Smielewski, Peter; Gupta, Arun K.			The Effect of Red Blood Cell Transfusion on Cerebral Autoregulation in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Vascular reactivity; Cerebral blood flow; Autoregulation; Traumatic brain injury; Pressure reactivity index	PERFUSION-PRESSURE; CEREBROVASCULAR AUTOREGULATION; CRITICALLY-ILL; ANEMIA; OXYGENATION; MORTALITY; ASSOCIATION; METABOLISM; TRIAL; AGE	Red blood cell (RBC) transfusion is associated with inconsistent changes in brain tissue oxygenation (PbO2). Previous studies have failed to consider alterations in cerebral autoregulation. Our objective was to investigate the effect of RBC transfusion on cerebral autoregulation, as measured by pressure reactivity index (PRx). Retrospective analysis of 28 severe traumatic brain injury (TBI) patients from a prospective registry between 2007 and 2014. We recorded hemoglobin (Hb) concentration, intracranial pressure, PbO2, cerebral perfusion pressure, PRx, and cerebral lactate/pyruvate ratio for 6 h before and after RBC transfusion. We also recorded body temperature, PaO2, PCO2, pH, and fraction of inspired oxygen. Subgroups of normoxia (PbO2 > 20 mmHg) and hypoxia (PbO2 < 20 mmHg) prior to transfusion were defined a priori. The median age was 36 years [interquartile range (IQR) 27-49], 32 % were female. The median admission Glasgow Coma score was 5 (IQR 4-9) and injury severity score was 16 (IQR 9-21). Overall, mean Hb concentration [80 g/L (SD 7) to 89 g/L (SD 8), p < 0.001] and PbO2 increased [23.5 mmHg (SD 8) to 25.0 mmHg (SD 9), p = 0.033] following transfusion. PRx increased post-transfusion [0.028 (SD 0.29) to 0.11 (SD 0.24), p = 0.034], indicating worsening cerebrovascular pressure reactivity. In patients with mean PbO2 > 20 mmHg pre-transfusion (n = 20), the PRx increased significantly [-0.052 (SD 0.24) to 0.079 (SD 0.22), p = 0.007] but did not change in patients with PbO2 < 20 mmHg: PRx [0.22 (SD 0.34) to 0.18 (SD 0.30), p = 0.36]. RBC transfusion in severe TBI patients results in worsening PRx, indicating impaired cerebral autoregulation.	[Sekhon, Mypinder S.; Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada; [Czosnyka, Marek; Donnelly, Joseph; Liu, Xia; Aries, Marcel J.; Robba, Chiara; Lavinio, Andrea; Menon, David K.; Smielewski, Peter; Gupta, Arun K.] Univ Cambridge, Cambridge Univ Hosp Trust, Addenbrookes Hosp, Neurocrit Care Unit, Cambridge CB2 0QQ, England; [Sekhon, Mypinder S.] Vancouver Gen Hosp, Crit Care Med, Vancouver, BC V5Z 1M9, Canada		Sekhon, MS (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, West 12th Ave, Vancouver, BC V5Z 1M9, Canada.	mypindersekhon@gmail.com	Lavinio, Andrea/M-1778-2016; Robba, Chiara/AAS-7421-2020; Donnelly, Joseph/E-9235-2018; Griesdale, Donald/AAT-7762-2021; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Griesdale, Donald/0000-0001-5985-8624; Donnelly, Joseph/0000-0002-6502-8069; czosnyka, marek/0000-0003-2446-8006; Smielewski, Peter/0000-0001-5096-3938	Cambridge Enterprise Ltd, UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	Mypinder S. Sekhon, Donald E. Griesdale, Joseph Donnelly, Xia Liu, Marcel J. Aries, Chiara Robba, Andrea Lavinio, David K. Menon, Peter Smielewski, Arun K. Gupta have no conflict of interest. Marek Czosnyka and Peter Smielewski are co-founders of the ICM+ software (www.neurosurg.cam.ac.uk/icmplus) and receives licensing fees (Cambridge Enterprise Ltd, UK).	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bisschops LLA, 2014, CRIT CARE MED, V42, P632, DOI 10.1097/CCM.0000000000000027; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Neuman R, 2015, TRANSFUSION, V55, P782, DOI 10.1111/trf.12919; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Sriram K, 2012, AM J PHYSIOL-HEART C, V303, pH1096, DOI 10.1152/ajpheart.00438.2012; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Weinberg JA, 2011, TRANSFUSION, V51, P867, DOI 10.1111/j.1537-2995.2011.03098.x; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	33	24	26	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2015	23	2					210	216		10.1007/s12028-015-0141-x			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CQ6FU	WOS:000360700700010	25894454				2022-02-06	
J	Villapol, S; Kryndushkin, D; Balarezo, MG; Campbell, AM; Saavedra, JM; Shewmaker, FP; Symes, AJ				Villapol, Sonia; Kryndushkin, Dmitry; Balarezo, Maria G.; Campbell, Ashley M.; Saavedra, Juan M.; Shewmaker, Frank P.; Symes, Aviva J.			Hepatic Expression of Serum Amyloid A1 Is Induced by Traumatic Brain Injury and Modulated by Telmisartan	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ACUTE-PHASE RESPONSE; NF-KAPPA-B; PROTEIN-COUPLED RECEPTOR; RENIN-ANGIOTENSIN SYSTEM; GENE-EXPRESSION; LIVER-INJURY; TRANSCRIPTIONAL REGULATION; HUMAN NEUTROPHILS; OXIDATIVE STRESS; GAMMA ACTIVATION	Traumatic brain injury affects the whole body in addition to the direct impact on the brain. The systemic response to trauma is associated with the hepatic acute-phase response. To further characterize this response, we performed controlled cortical impact injury on male mice and determined the expression of serum amyloid A1 (SAA1), an apolipoprotein, induced at the early stages of the acute-phase response in liver and plasma. After cortical impact injury, induction of SAA1 was detectable in plasma at 6 hours post-injury and in liver at 1 day post-injury, followed by gradual diminution over time. In the liver, cortical impact injury increased neutrophil and macrophage infiltration, apoptosis, and expression of mRNA encoding the chemokines CXCL1 and CXCL10. An increase in angiotensin II AT1 receptor mRNA at 3 days post-injury was also observed. Administration of the AT1 receptor antagonist telmisartan 1 hour post-injury significantly decreased Liver SAA1 levels and CXCL10 mRNA expression, but did not affect CXCL1 expression or the number of apoptotic cells or infiltrating leukocytes. To our knowledge, this is the first study to demonstrate that SAA1 is induced in the liver after traumatic brain injury and that telmisartan prevents this response. Elucidating the molecular pathogenesis of the Liver after brain injury will assist in understanding the efficacy of therapeutic approaches to brain injury.	[Villapol, Sonia; Balarezo, Maria G.; Campbell, Ashley M.; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Villapol, Sonia; Kryndushkin, Dmitry; Balarezo, Maria G.; Campbell, Ashley M.; Shewmaker, Frank P.; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Villapol, Sonia] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Saavedra, Juan M.] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20057 USA		Villapol, S (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Res Bldg,Room WG20,3970 Reservoir Rd NW, Washington, DC 20057 USA.	sonia.villapol@georgetown.edu; aviva.symes@usuhs.edu	Saavedra, Juan/AAO-7149-2020; Symes, Aviva J/S-7471-2016; Villapol, Sonia/D-1949-2014	Saavedra, Juan/0000-0002-7238-9647; Symes, Aviva J/0000-0003-2557-9939; Villapol, Sonia/0000-0002-6174-4113	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Institute of Mental Health/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 002762-16]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [Z01MH002762] Funding Source: NIH RePORTER	Supported by Center for Neuroscience and Regenerative Medicine grants (A.J.S.), a postdoctoral fellowship (S.V.) and the Intramural Research Program at the National Institute of Mental Health/NIH (MH 002762-16; J.M.S.).	Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Bundzikova J, 2011, Endocr Regul, V45, P163; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Chiba T, 2011, ARTERIOSCL THROM VAS, V31, P1326, DOI 10.1161/ATVBAHA.111.226159; Christenson K, 2008, J LEUKOCYTE BIOL, V83, P139, DOI 10.1189/jlb.0507276; Cowling RT, 2002, J BIOL CHEM, V277, P5719, DOI 10.1074/jbc.M107515200; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Eikelenboom P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt118; El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; Enjoji M, 2008, INT J MOL MED, V22, P521, DOI 10.3892/ijmm_00000051; Fouad AA, 2012, TOXICOLOGY, V300, P149, DOI 10.1016/j.tox.2012.06.015; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Gorevic PD, 2013, P NATL ACAD SCI USA, V110, P16291, DOI 10.1073/pnas.1315112110; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Huet O, 2014, CLIN SCI, V126, P31, DOI 10.1042/CS20120668; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Jung KH, 2007, J PHARMACOL EXP THER, V322, P1051, DOI 10.1124/jpet.107.120097; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kryndushkin D, 2013, PRION, V7, P464, DOI 10.4161/pri.27503; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Li HZ, 2013, ATHEROSCLEROSIS, V227, P72, DOI 10.1016/j.atherosclerosis.2012.12.007; LIAO F, 1994, ARTERIOSCLER THROMB, V14, P1475, DOI 10.1161/01.ATV.14.9.1475; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; Lubel JS, 2008, J GASTROEN HEPATOL, V23, P1327, DOI 10.1111/j.1440-1746.2008.05461.x; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; MOZES G, 1989, J TRAUMA, V29, P71, DOI 10.1097/00005373-198901000-00014; National Research Council, 2011, COMM UPD GUID CAR US; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; Obici L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13580; Okamoto H, 2008, J RHEUMATOL, V35, P752; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rodriguez-Perez AI, 2015, GLIA, V63, P466, DOI 10.1002/glia.22765; RON D, 1990, MOL CELL ENDOCRINOL, V74, pC97, DOI 10.1016/0303-7207(90)90221-S; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SELINGER MJ, 1980, NATURE, V285, P498, DOI 10.1038/285498a0; SHIMIZU H, 1994, GENE, V149, P305; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Steckelings UM, 2009, FUND CLIN PHARMACOL, V23, P693, DOI 10.1111/j.1472-8206.2009.00780.x; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Villapol S, 2015, BRAIN IN PRESS, DOI [10.1093/brain/awv172, DOI 10.1093/BRAIN/AWV172]; Villapol S, 2015, AM J HYPERTENS, V28, P289, DOI 10.1093/ajh/hpu197; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Villapol S, 2009, AM J PATHOL, V175, P2111, DOI 10.2353/ajpath.2009.090257; Wang J, 2014, NEUROPHARMACOLOGY, V79, P249, DOI 10.1016/j.neuropharm.2013.11.022; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; XU LL, 1995, J IMMUNOL, V155, P1184; Yokote H, 2013, J NEUROIMMUNOL, V259, P92, DOI 10.1016/j.jneuroim.2013.03.004; Yoneda M, 2001, J GASTROENTEROL, V36, P361, DOI 10.1007/s005350170079; Yu Y, 2014, J ALZHEIMERS DIS, V38, P133, DOI 10.3233/JAD-130818; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	77	24	25	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	OCT	2015	185	10					2641	2652		10.1016/j.ajpath.2015.06.016			12	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	CT3HR	WOS:000362698300006	26435412	Bronze, Green Published			2022-02-06	
J	Seidman, DH; Burlingame, J; Yousif, LR; Donahue, XP; Krier, J; Rayes, LJ; Young, R; Lilla, M; Mazurek, R; Hittle, K; McCloskey, C; Misra, S; Shaw, MK				Seidman, Daniel H.; Burlingame, Jennifer; Yousif, Lina R.; Donahue, Xinh P.; Krier, Joshua; Rayes, Lydia J.; Young, Rachel; Lilla, Muareen; Mazurek, Rochelle; Hittle, Kristie; McCloskey, Charles; Misra, Saroj; Shaw, Michael K.			Evaluation of the King-Devick test as a concussion screening tool in high school football players	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Diffuse axonal injury; Neuropsychological tests; Post-concussion syndrome; Visual motor coordination; Football	CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORT; VULNERABILITY; STATEMENT; POSITION	Objective: Concussion is the most common type of traumatic brain injury, and results from impact or impulsive forces to the head, neck or face. Due to the variability and subtlety of symptoms, concussions may go unrecognized or be ignored, especially with the pressure placed on athletes to return to competition. The King-Devick (KID) test, an oculomotor test originally designed for reading evaluation, was recently validated as a concussion screening tool in collegiate athletes. A prospective study was performed using high school football players in an attempt to study the KD as a concussion screening tool in this younger population. Methods: 343 athletes from four local high school football teams were recruited to participate. These athletes were given baseline KD tests prior to competition. Individual demographic information was collected on the subjects. Standard team protocol was employed to determine if a concussion had occurred during competition. Immediately after diagnosis, the MD test was re-administered to the concussed athlete for comparison to baseline. Post-season testing was also performed in non-concussed individuals. Results: Of the 343 athletes, nine were diagnosed with concussions. In all concussed players, cumulative read times for the KD test were significantly increased (p < 0.001). Post-season testing of non-concussed athletes revealed minimal change in read times relative to baseline. Univariate analysis revealed that history of concussion was the only demographic factor predictive of concussion in this cohort. Conclusion: The MD test is an accurate and easily administered sideline screening tool for concussion in adolescent football players. (C) 2015 Elsevier B.V. All rights reserved.	[Seidman, Daniel H.; Burlingame, Jennifer; Yousif, Lina R.; Donahue, Xinh P.; Krier, Joshua; Rayes, Lydia J.; Young, Rachel; McCloskey, Charles; Misra, Saroj] St John Providence Hlth Syst, St John Macomb Oakland Hosp, Dept Family Med, Detroit, MI USA; [Lilla, Muareen; Mazurek, Rochelle; Hittle, Kristie] St John Providence Hlth Syst, St John Macomb Oakland Hosp, Dept Phys Rehabil, Detroit, MI USA; [Shaw, Michael K.] St John Providence Hlth Syst, St John Macomb Oakland Hosp, Dept Med Educ & Res, Detroit, MI USA		Shaw, MK (corresponding author), St John Macomb Oakland Hosp, 12001 E Twelve Mile Rd, Warren, MI 48093 USA.	michael.shaw@stjohn.org			Medical Executive Committee at St. John Macomb-Oakland Hospital	The authors would like to thank the following individuals for their contributions: Allison Blumenthal BS, Scott Mueller BS, Collin Blattner BS, Logan McCool BS, Jacqueline Dufour BS, and Mary Predko BS. We would like to acknowledge the Medical Executive Committee at St. John Macomb-Oakland Hospital for their financial support of these research efforts. We would also like to acknowledge all of the high school football coaches and administrators who allowed us access to the athletes throughout the football season. Finally, we would like to acknowledge the athletes and their parents for their participation in this study.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, J NEURO-OPHTHALMOL, P1; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luoto T.M., 2003, IMMEDIATE POSTCONCUS; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	26	24	24	0	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2015	356	1-2					97	101		10.1016/j.jns.2015.06.021			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ9QU	WOS:000360950800017	26094155				2022-02-06	
J	Ditty, BJ; Omar, NB; Foreman, PM; Patel, DM; Pritchard, PR; Okor, MO				Ditty, Benjamin J.; Omar, Nidal B.; Foreman, Paul M.; Patel, Daxa M.; Pritchard, Patrick R.; Okor, Mamerhi O.			The nonsurgical nature of patients with subarachnoid or intraparenchymal hemorrhage associated with mild traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						mild traumatic brain injury; subarachnoid hemorrhage; intraparenchymal hemorrhage; contusion; vascular disorders	NEUROSURGICAL CONSULTATION; INTRACRANIAL INJURY; HEAD-INJURY; MANAGEMENT; DETERIORATION	OBJECT Mild traumatic brain injury (mTBI), as defined by Glasgow Coma Scale (GCS) score of 13 or higher, is a common problem in the United States and worldwide, estimated to affect more than 1 million patients yearly. When associated with intracranial hemorrhage, it is a common reason for neurosurgical consultation and transfer to tertiary care centers. The authors set out to investigate the clinical implications of subarachnoid hemorrhage (SAH) and/or intraparenchymal hemorrhage (IPH) associated with mTBI in hopes of standardization of mTBI clinical care and optimization of resource allocation. METHODS The authors performed a retrospective review of 500 consecutively treated patients with mTBI and SAH and/or IPH admitted to a Level I trauma center in Alabama between May 2003 and May 2013. They performed a review of medical records to confirm the diagnosis, determine neurological condition at admission, and assess for episodes of neurological decline or brain injury related complications including altered mental status, seizures, and hyponatremia. RESULTS Of the 500 patients for whom data were reviewed, 304(60.8%) were male and 196 (39.2%) were female. Average age was 46.3 years. Overall, 63 patients (12.6%) had isolated IPH, 411 (82.2%) had isolated SAH, and 26 (5.2%) had radiographic evidence of both IPH and SAH. One hundred forty-five patients (29%) were transferred an average distance of 64.5 miles. The authors identified no patients who experienced neurological worsening during their hospital course. Two patients experienced hyponatremia that required treatment with sodium supplementation. CONCLUSIONS Patients with the constellation of SAH and/or IPH and mTBI do not require neurosurgical consultation, and these findings should not be used as the sole criteria to justify transfer to tertiary referral centers.	[Ditty, Benjamin J.; Foreman, Paul M.; Patel, Daxa M.; Pritchard, Patrick R.; Okor, Mamerhi O.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Omar, Nidal B.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA		Okor, MO (corresponding author), Dept Neurosurg, 510 20th St S,FOT 1034, Birmingham, AL 35294 USA.	mookor@uabmc.edu					AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; van Essen TA, 2010, CLIN NEUROL NEUROSUR, V112, P775, DOI 10.1016/j.clineuro.2010.06.012; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e	15	24	24	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2015	123	3					649	653		10.3171/2014.10.JNS132713			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CP6VZ	WOS:000360027600019	25526270	Bronze			2022-02-06	
J	Joseph, B; Pandit, V; Haider, AA; Kulvatunyou, N; Zangbar, B; Tang, A; Aziz, H; Vercruysse, G; O'Keeffe, T; Freise, RS; Rhee, P				Joseph, Bellal; Pandit, Viraj; Haider, Ansab A.; Kulvatunyou, Narong; Zangbar, Bardiya; Tang, Andrew; Aziz, Hassan; Vercruysse, Gary; O'Keeffe, Terence; Freise, Randall S.; Rhee, Peter			Improving Hospital Quality and Costs in Nonoperative Traumatic Brain Injury The Role of Acute Care Surgeons	JAMA SURGERY			English	Article							HEAD COMPUTED-TOMOGRAPHY; CT; MANAGEMENT; UTILITY; MILD	IMPORTANCE The role of acute care surgeons is evolving; however, no guidelines exist for the selective treatment of patients with traumatic brain injury (TBI) exclusively by acute care surgeons. We implemented the Brain Injury Guidelines (BIG) for managing TBI at our institution on March 1, 2012. OBJECTIVE To compare the outcomes in patients with TBI before and after implementation of the BIG protocol. DESIGN, SETTING, AND PARTICIPANTS We conducted a 2-year analysis of our prospectively maintained database of all patients with TBI (findings of skull fracture and/or intracranial hemorrhage on an initial computed tomographic scan of the head) who presented to our level I trauma center. The pre-BIG group included patients with TBI from March 1, 2011, through February 29, 2012, and the post-BIG group included patients from July 1, 2012, through June 30, 2013. MAIN OUTCOMES AND MEASURES The primary outcome measureswere patients with repeated computed tomography of the head and neurosurgical consultations. Secondary outcome measures were findings of progression of intracranial hemorrhage on repeated computed tomographic scans, neurosurgical intervention, hospital admission, intensive care unit admission, hospital and intensive care unit length of stay, 30-day readmission rate, and hospital costs per patient. RESULTS A total of 796 patients (415 in the pre-BIG group and 381 in the post-BIG group) were included. Therewas a significant reduction (19.0%) in the rate of neurosurgical consultation (post-BIG group, 273 patients [71.7%]; pre-BIG group, 376 [90.6%]; P < .001), repeated computed tomography of the head (post-BIG group, 255 patients [66.9%]; pre-BIG group, 381 patients [91.8%]; P < .001), hospital (post-BIG group, 330 [86.6%]; pre-BIG group, 398 [95.9%]; P < .001) and intensive care unit admission (post-BIG group, 202 [53.0%]; pre-BIG group, 257 [61.9%]; P = .01), hospital length of stay (post-BIG group, 5.4 [4.5] days; pre-BIG group, 6.1 [4.8] days; P = .03), and hospital costs per patient ($4772 per patient; P = .03) with implementation of BIG. Therewas no difference in the in-hospital mortality rate (post-BIG group, 62 patients [16.3%]; pre-BIG group, 69 patients [16.6%]; P = .89), progression of intracranial hemorrhage on repeated scans (post-BIG group, 41 patients [10.8%]; pre-BIG group, 59 patients [14.2%]; P = .14), neurosurgical intervention (post-BIG group, 61 patients [16.0%]; pre-BIG group, 59 patients [14.2%]; P = .48), and 30-day readmission rate (post-BIG group, 31 patients [8.1%]; pre-BIG group, 37 patients [8.9%]; P = .69) after implementation of BIG. CONCLUSIONS AND RELEVANCE Implementation of BIG is safe and cost-effective. BIG defines the management of TBI without the need for neurosurgical consultation and unnecessary imaging. Establishing a national, multi-institutional study implementing the BIG protocol is warranted.	[Joseph, Bellal; Pandit, Viraj; Haider, Ansab A.; Kulvatunyou, Narong; Zangbar, Bardiya; Tang, Andrew; Aziz, Hassan; Vercruysse, Gary; O'Keeffe, Terence; Freise, Randall S.; Rhee, Peter] Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, Tucson, AZ 85727 USA		Joseph, B (corresponding author), Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Aziz, Hassan/ABA-5681-2021	Aziz, Hassan/0000-0003-0406-1946			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barker DE, 2006, AM SURGEON, V72, P1166; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Campbell D, DO ALL PATIENTS MILD; Faul M, 2010, TRAUMATIC BRAIN INJU; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	23	24	24	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	SEP	2015	150	9					866	872		10.1001/jamasurg.2015.1134			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DA1VR	WOS:000367584100010	26107247	Bronze			2022-02-06	
J	Pozzi, M; Conti, V; Locatelli, F; Galbiati, S; Radice, S; Citerio, G; Clementi, E; Strazzer, S				Pozzi, Marco; Conti, Valentino; Locatelli, Federica; Galbiati, Sara; Radice, Sonia; Citerio, Giuseppe; Clementi, Emilio; Strazzer, Sandra			Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Clinical Factors and Acute Pharmacological Management	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dysautonomia; drug therapy; paroxysmal sympathetic hyperactivity; rehabilitation; pediatric	TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; DYSAUTONOMIA; SPECTRUM	Objective: Paroxysmal sympathetic hyperactivity (PSH) is widely described as occurring during intensive care, but in a number of patients it may last longer into the rehabilitation phase. Furthermore, drug therapy has been based on isolated observations. In this study, our aims are to describe a group of 26 pediatric rehabilitation patients with PSH and to quantify the effect of several drugs used to suppress PSH episodes. Setting: Neurorehabilitation unit of IRCCS Eugenio Medea, Bosisio Parini (LC), Italy. Participants: A total of 407 pediatric patients with postacute acquired brain injury, 26 of which had PSH. Design: Retrospective cohort study. Main Measures: Descriptive demographic and clinical data. Odds ratios quantification of the efficacy of drug therapies administered acutely to suppress PSH episodes. Results: PSH was associated with a longer duration of coma and a greater incidence of death. When administered acutely to suppress PSH episodes, the best drugs were clonazepam, hydroxyzine, and delorazepam, while analgesic drugs showed little efficacy. Conclusions: PSH, whether causative or not, is associated with a worse long-term course in rehabilitation. Clinical management of PSH may be helped by a number of acutely administered drug therapies.	[Pozzi, Marco; Locatelli, Federica; Galbiati, Sara; Clementi, Emilio; Strazzer, Sandra] Sci Inst IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy; [Conti, Valentino] Reg Ctr Pharmacovigilance Lombardy, Milan, Italy; [Radice, Sonia] Univ Milan, Luigi Sacco Univ Hosp, Dept Biomed & Clin Sci L Sacco, Clin Pharmacol Unit, Milan, Italy; [Citerio, Giuseppe] AO San Gerardo, Neuroreanimat, Monza, Italy; [Clementi, Emilio] Univ Milan, Luigi Sacco Univ Hosp, Dept Biomed & Clin Sci L Sacco, Unit Clin Pharmacol,CNR Inst Neurosci, Milan, Italy		Strazzer, S (corresponding author), IRCCS Eugenio Medea, Inst Sci, UO Gravi Cerebrolesioni Acquisite NR3, I-23842 Bosisio Parini, Lecco, Italy.	sandra.strazzer@bp.lnf.it	FEDERICA, LOCATELLI/AAA-5601-2020; Strazzer, Sandra/AAH-5712-2019; Galbiati, Sara/AAA-7115-2020; Pozzi, Marco/Z-2684-2019; Citerio, Giuseppe/B-1839-2015; Pozzi, Marco/J-7915-2016	FEDERICA, LOCATELLI/0000-0002-8243-5483; Strazzer, Sandra/0000-0001-8414-6565; Galbiati, Sara/0000-0001-6810-359X; Pozzi, Marco/0000-0002-3800-5697; Citerio, Giuseppe/0000-0002-5374-3161; Pozzi, Marco/0000-0002-3800-5697	Agenzia Italiana del Farmaco (AIFA); Regione Lombardia (MEAP Project, Monitoraggio degli Eventi Avversi in Pediatria)Regione Lombardia; Italian Ministry of Health (Ricerca Corrente)Ministry of Health, Italy	The financial support by Agenzia Italiana del Farmaco (AIFA) and Regione Lombardia (MEAP Project, Monitoraggio degli Eventi Avversi in Pediatria, to E.C.) and by the Italian Ministry of Health (Ricerca Corrente 2014, to E.C. and S.S.) is gratefully acknowledged. The funding public institutions had no role in any part of the work.	Altamura AC, 2013, EXPERT OPIN DRUG MET, V9, P423, DOI 10.1517/17425255.2013.759209; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Dolce G, 2008, J NEUROTRAUM, DOI [10.1089/neu.2008.0536, DOI 10.1089/NEU.2008.0536, 10.1089/neu.2008.0536.]; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Koike H, 2013, J NEUROL NEUROSUR PS, V84, P98, DOI 10.1136/jnnp-2012-302833; Kwasnica C, 2008, ARCH PHYS MED REHAB, V89, pS15, DOI 10.1016/j.apmr.2007.12.006; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; Norcliffe-Kaufmann L, 2012, AUTON NEUROSCI-BASIC, V172, P26, DOI 10.1016/j.autneu.2012.10.012; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Wenning GK, 2013, LANCET NEUROL, V12, P264, DOI 10.1016/S1474-4422(12)70327-7	29	24	24	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					357	363		10.1097/HTR.0000000000000084			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400013	25310291				2022-02-06	
J	Shelhamer, MC; Rowan, MP; Cancio, LC; Aden, JK; Rhie, RY; Merrill, GA; Wolf, SE; Renz, EM; Chung, KK				Shelhamer, Mehdi C.; Rowan, Matthew P.; Cancio, Leopoldo C.; Aden, James K.; Rhie, Ryan Y.; Merrill, Gerald A.; Wolf, Steven E.; Renz, Evan M.; Chung, Kevin K.			Recent trends in hospitalization and in-hospital mortality associated with traumatic brain injury in Canada: A nationwide, population-based study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article							ACUTE RESPIRATORY-DISTRESS; FREQUENCY PERCUSSIVE VENTILATION; INHALATION INJURY; PREDICTIVE-VALUE; TIDAL VOLUMES; PATIENT; TIME; BIOMARKERS; PNEUMONIA; IMPROVES		[Shelhamer, Mehdi C.] Univ Cincinnati, Med Ctr, US Air Force, Ctr Sustainment Trauma & Readiness Skills, Cincinnati, OH 45267 USA; [Rowan, Matthew P.; Cancio, Leopoldo C.; Aden, James K.; Rhie, Ryan Y.; Merrill, Gerald A.; Renz, Evan M.; Chung, Kevin K.] US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX USA; [Cancio, Leopoldo C.; Chung, Kevin K.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Wolf, Steven E.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Renz, Evan M.; Chung, Kevin K.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Rowan, MP (corresponding author), 3698 Chambers Pass, San Antonio, TX 78234 USA.	matthew.p.rowan.vol@mail.mil		Cannon, Jeremy/0000-0002-2969-9316; Rasmussen, Todd/0000-0003-1120-4116; Wolf, Steven/0000-0003-2972-3440	Percussionaire, Inc.	This research was supported in part by an appointment (M.P.R.) to the Postgraduate Research Participation Program and an appointment (L.C.C.) to the Knowledge Preservation Program at the US Army Institute of Surgical Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and USAMRMC. L.C.C. received funding for travel expenses from Percussionaire, Inc., to speak at the Bird Institute, Sandpoint, Idaho, in 2013. The authors have no other conflicts of interest to declare.	Allan PF, 2010, J BURN CARE RES, V31, P510, DOI 10.1097/BCR.0b013e3181e4d605; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Belenkiy SM, 2014, J TRAUMA ACUTE CARE, V76, P821, DOI 10.1097/TA.0b013e3182aa2d21; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cancio LC, 2009, CLIN PLAST SURG, V36, P555, DOI 10.1016/j.cps.2009.05.013; Chung KK, 2010, CRIT CARE MED, V38, P1970, DOI 10.1097/CCM.0b013e3181eb9d0b; Csontos C, 2010, BURNS, V36, P483, DOI 10.1016/j.burns.2009.10.009; Davis Kimberly A, 2006, J Intensive Care Med, V21, P211, DOI 10.1177/0885066606288837; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Dries DJ, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-31; DROST AC, 1993, J TRAUMA, V35, P335, DOI 10.1097/00005373-199309000-00001; Eastman A, 2006, AM J SURG, V192, P191, DOI 10.1016/j.amjsurg.2006.01.021; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; Finnerty CC, 2013, CRIT CARE MED, V41, P1421, DOI 10.1097/CCM.0b013e31827c072e; Finnerty CC, 2012, CTS-CLIN TRANSL SCI, V5, P243, DOI 10.1111/j.1752-8062.2012.00412.x; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Gauglitz GG, 2008, CRIT CARE, V12, DOI 10.1186/cc6932; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Guo R, 2014, CLIN CHEST MED, V35, P729, DOI 10.1016/j.ccm.2014.08.010; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Kacmarek RM, 2010, CRIT CARE MED, V38, P2069, DOI 10.1097/CCM.0b013e3181f178cb; Kraft R, 2015, SHOCK, V43, P222, DOI 10.1097/SHK.0000000000000294; Luh Shi-Ping, 2007, Journal of Zhejiang University-Science B, V8, P60, DOI 10.1631/jzus.2007.B0060; Morris AC, 2010, THORAX, V65, P201, DOI 10.1136/thx.2009.122291; Peck MD, 2009, J BURN CARE RES, V30, P172, DOI 10.1097/BCR.0b013e3181923c32; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Ramirez P, 2009, CRIT CARE MED, V37, P1691, DOI 10.1097/CCM.0b013e31819fec5f; SHIRANI KZ, 1987, ANN SURG, V205, P82, DOI 10.1097/00000658-198701000-00015; Terpstra ML, 2014, CRIT CARE MED, V42, P691, DOI 10.1097/01.ccm.0000435669.60811.24; Tousoulis D, 2012, CURR MED CHEM, V19, P2534, DOI 10.2174/092986712800492968; Tousoulis D, 2015, CURR MED CHEM; Wang Y, 2010, BURNS, V36, P57, DOI 10.1016/j.burns.2009.04.014; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	36	24	25	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2015	79	3					431	436		10.1097/TA.0000000000000786			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CQ4JV	WOS:000360571900018	26307877				2022-02-06	
J	Bogner, J; Barrett, RS; Hammond, FM; Horn, SD; Corrigan, JD; Rosenthal, J; Beaulieu, CL; Waszkiewicz, M; Shea, T; Reddin, CJ; Cullen, N; Giuffrida, CG; Young, J; Garmoe, W				Bogner, Jennifer; Barrett, Ryan S.; Hammond, Flora M.; Horn, Susan D.; Corrigan, John D.; Rosenthal, Joseph; Beaulieu, Cynthia L.; Waszkiewicz, Margaret; Shea, Timothy; Reddin, Christopher J.; Cullen, Nora; Giuffrida, Clare G.; Young, James; Garmoe, William			Predictors of Agitated Behavior During Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Confusion; Rehabilitation	FUNCTIONAL INDEPENDENCE MEASURE; GOOD ANTISEIZURE PROPHYLAXIS; DECREASE SEIZURE RATES; OF-THE-LITERATURE; RECOVERY; SCALE; METHYLPHENIDATE; RELIABILITY; MANAGEMENT; CONFUSION	Objective: To identify predictors of the severity of agitated behavior during inpatient traumatic brain injury (TBI) rehabilitation. Design: Prospective, longitudinal observational study. Setting: Inpatient rehabilitation centers. Participants: Consecutive patients enrolled between 2008 and 2011, admitted for inpatient rehabilitation after index TBI, who exhibited agitation during their stay (n=555, N=2130). Interventions: Not applicable. Main Outcome Measure: Daytime Agitated Behavior Scale scores. Results: Infection and lower FIM cognitive scores predicted more severe agitation. The medication classes associated with more severe agitation included sodium channel antagonist anticonvulsants, second-generation antipsychotics, and gamma-aminobutyric acid-A anxiolytics/hypnotics. Medication classes associated with less severe agitation included antiasthmatics, statins, and norepinephrine-dopamine-5 hydroxytryptamine (serotonin) agonist stimulants. Conclusions: Further support is provided for the importance of careful serial monitoring of both agitation and cognition to provide early indicators of Possible beneficial or adverse effects of pharmacologic interventions used for any purpose and for giving careful consideration to the effects of any intervention on underlying cognition when attempting to control agitation. Cognitive functioning was found to predict agitation, medications that have been found in previous studies to enhance cognition were associated with less agitation, and medications that can potentially suppress cognition were associated with more agitation. There could be factors other than the interventions that account for these relations. In addition, the study provides support for treatment of underlying disorders as a possible first step in management of agitation. Although the results of this study cannot be used to draw causal inferences, the associations that were found can be used to generate hypotheses about the most viable interventions that should be tested in future controlled trials. (C) 2015 by the American Congress of Rehabilitation Medicine	[Bogner, Jennifer; Corrigan, John D.; Rosenthal, Joseph; Shea, Timothy] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Barrett, Ryan S.; Horn, Susan D.] Int Sever Informat Syst, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Hammond, Flora M.] Indiana Univ Sch Med, Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Waszkiewicz, Margaret; Giuffrida, Clare G.; Young, James] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Reddin, Christopher J.] Naval Med Ctr, San Diego, CA USA; [Cullen, Nora] Toronto Rehabil Inst, Toronto, ON, Canada; [Garmoe, William] MedStar Natl Rehabil Hosp, Washington, DC USA		Bogner, J (corresponding author), 480 Med Ctr Dr, Columbus, OH 43210 USA.	Jennifer.Bogner@osumc.edu		Cullen, Nora/0000-0001-6359-9418	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01); National Institute on Disability and Rehabilitation Research (grant no. H133A080023); and Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; DIKMEN S, 1984, EPILEPSIA, V25, P741, DOI 10.1111/j.1528-1157.1984.tb03485.x; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Inaba K, 2014, J TRAUMA ACUTE CARE, V76, P60; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Levy M, 2005, NEUROREHABILITATION, V20, P279; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Tang V, 2007, J HEAD TRAUMA REHAB, V22, P409, DOI 10.1097/01.HTR.0000300236.21114.bc; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632	37	24	24	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S274	S281		10.1016/j.apmr.2015.04.020			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100009	26212403				2022-02-06	
J	Lu, KT; Huang, TC; Wang, JY; You, YS; Chou, JL; Chan, MWY; Wo, PYY; Amstislavskaya, TG; Tikhonova, MA; Yang, YL				Lu, Kwok-Tung; Huang, Tai-Chun; Wang, Jia-Yi; You, Ya-Shen; Chou, Jian-Liang; Chan, Michael W. Y.; Wo, Peter Y. Y.; Amstislavskaya, Tamara G.; Tikhonova, Maria A.; Yang, Yi-Ling			NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1 alpha expression	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						TBI; Neurogenesis; NKCC1; CREB; Hippocampus	K-CL COTRANSPORTER; GROWTH-FACTOR EXPRESSION; NEWLY GENERATED NEURONS; CAMP RESPONSE; NA+-K+-2CL(-) COTRANSPORTER; SUBVENTRICULAR ZONE; CELL-PROLIFERATION; NEWBORN NEURONS; PROTEIN-KINASE; DENTATE GYRUS	Traumatic brain injury (TBI) is one of the most prevalent causes of worldwide mortality and morbidity. We previously had evidenced that TBI induced Na-K-2Cl co-transporter (NKCC1) upregulation in hippocampus. Here, we aim to investigate the role of NKCC1 in TBI-induced neurogenesis and the detailed mechanisms. The TBI-associated alternations in the expression of NKCC1, HIF-1 alpha, VEGF, MAPK cascade, and CREB phosphorylation were analyzed by Western blot. TBI-induced neurogenesis was determined by immuno-fluorescence labeling. Chromatin immunoprecipitation was used to elucidate whether HIF-1 alpha would activate VEGF gene after TBI. We found that the level of hippocampal NKCC1 and VEGF began to rise 8 h after TBI, and both of them reached maxima at day 7. Along with the upregulation of NKCC1 and VEGF, MAPK cascade was activated and hippocampal neurogenesis was promoted. Administration of CREB antisense oligonucleotide significantly attenuated the expression of HIF-1 alpha, while HIF-1 alpha antisense oligonucleotide exhibited little effect on the expression of CREB. However, HIF-1 alpha antisense oligonucleotide administration did effectively suppress the expression of VEGF. Our results of the chromosome immunoprecipitation also indicated that HIF-1 alpha could directly act on the VEGF promoter and presumably would elevate the VEGF expression after TBI. All these results have illustrated the correlation between NKCC1 upregulation and TBI-associated neurogenesis. The pathway involves the activation of Raf/MEK/ERK cascade, CREB phosphorylation, and HIF-1 alpha upregulation, and finally leads to the stimulation of VEGF expression and the induction of neurogenesis.	[Lu, Kwok-Tung; Huang, Tai-Chun] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Dept Physiol, Taipei, Taiwan; [You, Ya-Shen; Wo, Peter Y. Y.; Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chou, Jian-Liang; Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Amstislavskaya, Tamara G.; Tikhonova, Maria A.] State Res Inst Physiol & Fundamental Med SB RAMS, Lab Biol Psychiat, Novosibirsk, Russia		Yang, YL (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw	Amstislavskaya, Tamara G/K-4149-2018; Chan, Michael/F-9615-2018; Tikhonova, Maria A/K-3455-2018	Chan, Michael/0000-0003-1431-322X; Tikhonova, Maria A/0000-0002-4265-8981; Chan, Michael/0000-0003-0314-2437; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [NSC 97-2320-B-415-006-MY3]; State Research Institute of Physiology and Fundamental Medicine SB RAMS [053]	Supported by grants from the Ministry of Science and Technology of Taiwan (NSC 97-2320-B-415-006-MY3) and partially by the project No. 053 of the State Research Institute of Physiology and Fundamental Medicine SB RAMS.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Alvarez-Leefmans FJ, 2001, NEUROSCIENCE, V104, P569, DOI 10.1016/S0306-4522(01)00091-4; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Braveman Melissa W., 2004, V277, P261; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Gur TL, 2007, J NEUROSCI, V27, P7860, DOI 10.1523/JNEUROSCI.2051-07.2007; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Miljan EA, 2009, CURR OPIN MOL THER, V11, P394; MINCHENKO A, 1994, LAB INVEST, V71, P374; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747, DOI 10.1152/ajpcell.1995.268.3.C747; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Panet R, 2006, J CELL PHYSIOL, V206, P578, DOI 10.1002/jcp.20506; Panet R, 2002, J CELL PHYSIOL, V190, P227, DOI 10.1002/JCP.10055; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; PAYNE JA, 1995, CURR OPIN CELL BIOL, V7, P493, DOI 10.1016/0955-0674(95)80005-0; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316	50	24	25	0	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	AUG	2015	467	8					1651	1661		10.1007/s00424-014-1588-x			11	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	CM9WD	WOS:000358059300003	25201604				2022-02-06	
J	Madden, LK; DeVon, HA				Madden, Lori Kennedy; DeVon, Holli A.			A Systematic Review of the Effects of Body Temperature on Outcome After Adult Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						body temperature; body temperature changes; brain injuries; craniocerebral trauma; emergency treatment; fever; hypothermia; normothermia; outcome	MILD HYPOTHERMIA THERAPY; SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; INTENSIVE-CARE; SECONDARY INSULTS; CARDIAC-ARREST; PHASE-II; HYPERTHERMIA; MANAGEMENT	Objective: This systematic review describes effects of body temperature alterations defined as fever, controlled normothermia, and spontaneous or induced hypothermia on outcome after traumatic brain injury (TBI) in adults. Data Sources: A search was conducted using PubMed, Cochrane Library database, Cumulative Index to Nursing and Allied Health Literature, EMBASE, and ISI Web of Science in July 2013 with no back date restriction except for induced hypothermia (2009). Study Selection: Of 1366 titles identified, 712 were reviewed. Sixteen articles met inclusion criteria: randomized controlled trials in hypothermia since 2009 (last Cochrane review) or cohort studies of temperature in TBI, measure core and/or brain temperature, neurologic outcome reporting, primarily adult patients, and English language publications. Exclusion criteria were as follows: most patients with non-TBI diagnosis, primarily pediatric patients, case reports, or laboratory/animal studies. Data Synthesis: Most studies found that fever avoidance resulted in positive outcomes including decreased length of stay in the intensive care unit; mortality; and incidence of hypertension, elevated intracranial pressure, and tachycardia. Hypothermia on admission correlated with poor outcomes. Controlled normothermia improved surrogate outcomes. Prophylactic induced hypothermia is not supported by the available evidence from randomized controlled trial. Conclusion: Setting a goal of normothermia, avoiding fever, and aggressively treating fever may be most important after TBI. Further research is needed to characterize the magnitude and duration of temperature alteration after TBI, determine if temperature alteration influences or predicts neurologic outcome, determine if rate of temperature change influences or predicts neurologic outcome, and compare controlled normothermia versus standard practice or hypothermia.	[Madden, Lori Kennedy] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; [DeVon, Holli A.] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL USA		Madden, LK (corresponding author), Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA.	lkmadden@ucdavis.edu	Madden, Lori K/K-3749-2012	Madden, Lori K/0000-0001-9179-4202; DeVon, Holli/0000-0002-4526-9631	National Institute of Nursing Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR013813]; Gordon and Betty Moore FoundationGordon and Betty Moore Foundation; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR013813, R01NR012012] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Nursing Research of the National Institutes of Health (F31NR013813) and the Gordon and Betty Moore Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bratton S.L., 2007, J NEUROTRAUMA S1, V24; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; BURCH JM, 1992, ANN SURG, V215, P476, DOI 10.1097/00000658-199205000-00010; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Childs Charmaine, 2010, Front Neurol, V1, P146, DOI 10.3389/fneur.2010.00146; Clifton G L, 1995, New Horiz, V3, P474; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Faul M. D., 2010, NATL CTR INJURY PREV, V2, P1; Fox JL, 2010, CAN J EMERG MED, V12, P355; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Inamasu J, 2006, J CLIN NEUROSCI, V13, P733, DOI 10.1016/j.jocn.2005.03.018; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Rittenberger JC, 2013, NEW ENGL J MED, V369, P2262, DOI 10.1056/NEJMe1312700; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Wong F W, 2000, Crit Care Nurse, V20, P18; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014	53	24	25	0	31	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2015	47	4					190	203		10.1097/JNN.0000000000000142			14	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	CM8KC	WOS:000357948100002	25951311	Green Accepted			2022-02-06	
J	Wang, YC; Cui, Y; Cui, JZ; Sun, LQ; Cui, CM; Zhang, HA; Zhu, HX; Li, R; Tian, YX; Gao, JL				Wang, Yong-Chao; Cui, Ying; Cui, Jian-Zhong; Sun, Li-Qian; Cui, Chang-Meng; Zhang, Hong-Ao; Zhu, Hui-Xing; Li, Ran; Tian, Yan-Xia; Gao, Jun-Ling			Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						brilliant blue G; P2X7; neuroprotection; traumatic brain injury; rats	PROTEIN-KINASE-C; SPINAL-CORD-INJURY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; CLOSED-HEAD INJURY; P2X(7) RECEPTORS; INFLAMMATORY RESPONSE; IMPROVES RECOVERY; EXTRACELLULAR ATP; MICROGLIAL CELLS	The P2X7 inhibitor, brilliant blue G (BBG), has been reported as a neuroprotective drug against a variety of disorders, including neuropathic pain and brain ischemia. Currently, no studies have examined the potential for BBG to provide neuroprotection in animal models of TBI. The aim of the present study was to investigate the neuroprotective effect of BBG on TBI and to determine the underlying mechanisms. The rats were subjected to a diffuse cortical impact injury caused by a modified weight-drop device, and then divided randomly into three groups: the sham-operated, BBG treatment and vehicle groups. In the BBG treatment group, 50 mg/kg brilliant blue G (BBG; 100% pure), a highly specific and clinically useful P2X7 antagonist, was administered via the tail vein 15 min prior to or up to 8 h following TBI. The co-localization of NeuN and protein kinase C gamma (PKC gamma) was followed with immunofluorescent staining. The expression of P2X7, PKC. and inflammatory cytokines was identified by western blot analysis. Wet-dry weight method was used to evaluate brain edema, and motor function outcome was examined using the neurological severity score. The present study demonstrated that the administration of BBG attenuated TBI-induced cerebral edema and the associated motor deficits. Following trauma, BBG treatment significantly reduced the levels of PKC. and interleukin-1 beta in the cortex. The results provide in vivo evidence that BBG exerted neuroprotective effects by attenuating brain edema and improving neurological functions via reducing PKC. and interleukin-1 beta levels following TBI.	[Wang, Yong-Chao; Zhang, Hong-Ao; Zhu, Hui-Xing; Li, Ran; Tian, Yan-Xia; Gao, Jun-Ling] Hebei United Univ, Dept Basic Med Sci, Tangshan 063000, Hebei, Peoples R China; [Cui, Ying; Cui, Jian-Zhong; Sun, Li-Qian] Tangshan Workers Hosp, Dept Surg, Tangshan 063000, Hebei, Peoples R China; [Cui, Jian-Zhong; Cui, Chang-Meng] Hebei Med Univ, Dept Surg, Shijiazhuang 050017, Hebei, Peoples R China		Gao, JL (corresponding author), Hebei United Univ, Dept Basic Med Sci, Tangshan 063000, Hebei, Peoples R China.	junlinggao666@163.com			Natural Science Foundation of Hebei, Hebei, China [H2012401071, H2014105079]	This study was supported by grants from the Natural Science Foundation of Hebei, Hebei, China (grant nos. H2012401071 and NO. H2014105079).	Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; HUANG FL, 1988, J NEUROSCI, V8, P4734; Iwashita A, 2007, J PHARMACOL EXP THER, V320, P1087, DOI 10.1124/jpet.106.115758; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; KARPIAK SE, 1990, CRIT REV NEUROBIOL, V5, P221; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsumoto S, 2008, NEUROCHEM RES, V33, P2302, DOI 10.1007/s11064-008-9727-4; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ohno S, 1997, PROTEIN KINASE C, P178; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SAITO N, 1988, J NEUROSCI, V8, P369; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; TANAKA C, 1992, NEUROCHEM INT, V21, P499, DOI 10.1016/0197-0186(92)90081-2; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	47	24	24	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	AUG	2015	12	2					2149	2154		10.3892/mmr.2015.3607			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CN8GR	WOS:000358678600075	25873133	Bronze			2022-02-06	
J	Zhao, W; Ruan, SJ; Ji, SB				Zhao, Wei; Ruan, Shijie; Ji, Songbai			Brain pressure responses in translational head impact: a dimensional analysis and a further computational study	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Finite element model; Linear acceleration; Rotational acceleration; Dartmouth Head Injury Model	FINITE-ELEMENT MODELS; INTRACRANIAL-PRESSURE; INJURY; ACCELERATION; BIOMECHANICS; PREDICTORS; MOTION; SKULL	Brain pressure responses resulting from translational head impact are typically related to focal injuries at the coup and contrecoup sites. Despite significant efforts characterizing brain pressure responses using experimental and modeling approaches, a thorough investigation of the key controlling parameters appears lacking. In this study, we identified three parameters specific and important for brain pressure responses induced by isolated linear acceleration via a dimensional analysis: itself (magnitude and directionality), brain size and shape. These findings were verified using our recently developed Dartmouth Head Injury Model (DHIM). Applying to the rigid skull, we found that the temporal profile of the given directly determined that of pressure. Brain pressure was also found to be linearly proportional to brain size and dependent on impact direction. In addition, we investigated perturbations to brain pressure responses as a result of non-rigid skull deformation. Finally, DHIM pressure responses were quantitatively validated against two representative cadaveric head impacts (categorized as "good" to "excellent" in performance). These results suggest that both the magnitude and directionality of as well as brain size and shape should be considered when interpreting brain pressure responses. Further, a model validated against pressure responses alone is not sufficient to ensure its fidelity in strain-related responses. These findings provide important insights into brain pressure responses in translational head impact and the resulting risk of pressure-induced injury. In addition, they establish the feasibility of creating a pre-computed atlas for real-time tissue-level pressure responses without a direct simulation in the future.	[Zhao, Wei; Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Ruan, Shijie] Tianjin Univ Sci & Technol, Tianjin 300222, Peoples R China; [Ji, Songbai] Dartmouth Coll, Geisel Sch Med, Dept Surg, Hanover, NH 03755 USA; [Ji, Songbai] Dartmouth Coll, Geisel Sch Med, Dept Orthopaed Surg, Hanover, NH 03755 USA		Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, 14 Engn Dr, Hanover, NH 03755 USA.	Songbai.Ji@Dartmouth.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS078607]; Dartmouth Hitchcock Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R21NS078607] Funding Source: NIH RePORTER	This work was sponsored, in part, by the NIH Grant R21 NS078607 and the Dartmouth Hitchcock Foundation.	Abaqus, 2012, ABAQUS, V6, P12; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; de Lange Ronald, 2005, Stapp Car Crash J, V49, P457; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ji S, 2014, ANN BIOMED IN PRESS; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kang HS, 1997, P 41 STAPP CAR CRASH; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Morse JD, 2014, ANN BIOMED ENG, V42, P2501, DOI 10.1007/s10439-014-1091-8; Nahum A, 1977, 770922 SAE; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Newman J A, 2000, Stapp Car Crash J, V44, P215; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruan J, 2001, Stapp Car Crash J, V45, P395; Ruan J, 2006, INT J VEH SAF, V1, P281, DOI [10. 1504/IJVS. 2006. 011230, DOI 10.1504/IJVS.2006.011230]; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; Sonin AA., 2001, PHYS BASIS DIMENSION; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; THOMAS LM, 1966, J NEUROL NEUROSUR PS, V29, P404, DOI 10.1136/jnnp.29.5.404; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Ward C., 1980, 801304 SAE, DOI [10.4271/801304, DOI 10.4271/801304]; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2014, J BIOMECH, V47, P1749, DOI 10.1016/j.jbiomech.2014.03.010; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	53	24	26	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	AUG	2015	14	4					753	766		10.1007/s10237-014-0634-0			14	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CL9ZZ	WOS:000357339300006	25412925	Green Accepted			2022-02-06	
J	Rovegno, M; Soto, PA; Saez, PJ; Naus, CC; Saez, JC; von Bernhardi, R				Rovegno, Maximiliano; Soto, Paola A.; Saez, Pablo J.; Naus, Christian C.; Saez, Juan C.; von Bernhardi, Rommy			Connexin43 Hemichannels Mediate Secondary Cellular Damage Spread from the Trauma Zone to Distal Zones in Astrocyte Monolayers	GLIA			English	Article						traumatic brain injury; connexins; P2 receptors; astroglia; apoptosis	GAP-JUNCTION HEMICHANNELS; STRETCH-INDUCED INJURY; CENTRAL-NERVOUS-SYSTEM; BRAIN-INJURY; CULTURED ASTROCYTES; PANNEXIN 1; CORTICAL ASTROCYTES; ATP RELEASE; NEURONS; CHANNELS	The mechanism of secondary damage spread after brain trauma remains unsolved. In this work, we redirected the attention to astrocytic communication pathways. Using an in vitro trauma model that consists of a scratch injury applied to an astrocyte monolayer, we found a significant and transient induction of connexin43 (Cx43) hemichannel activity in regions distal from the injury, which was maximal approximate to 1 h after scratch. Two connexin hemichannel blockers, La3+ and the peptide Gap26, abolished the increased activity, which was also absent in Cx43 KO astrocytes. In addition, the scratch-induced increase of hemichannel activity was prevented by inhibition of P2 purinergic receptors. Changes in hemichannel activity took place with a particular spatial distribution, with cells located at approximate to 17 mm away from the scratch presenting the highest activity (dye uptake). In contrast, the functional state of gap junction channels (dye coupling) was not significantly affected. Cx43 hemichannel activity was also enhanced by the acute extracellular application of 60 mM K+. The increase in hemichannel activity was associated with an increment in apoptotic cells at 24 h after scratch that was totally prevented by Gap26 peptide. These findings suggest that Cx43 hemichannels could be a new approach to prevent or reduce the secondary cell damage of brain trauma. GLIA 2015;63:1185-1199	[Rovegno, Maximiliano; von Bernhardi, Rommy] Pontificia Univ Catolica Chile, Fac Med, Dept Neurol, Lab Neurociencias, Santiago, Chile; [Rovegno, Maximiliano] Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile; [Soto, Paola A.; Saez, Pablo J.; Saez, Juan C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile; [Naus, Christian C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Inst Milenio, Valparaiso, Chile		Rovegno, M (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Marcoleta 367, Santiago, Chile.	maxrovegno@uc.cl	Saez, Pablo J./AAB-4458-2019	Saez, Pablo J./0000-0003-0521-9426; von Bernhardi, Rommy/0000-0002-9022-7676	Direccion de Investigacion de la Facultad de Medicina-PUC [PMD-09/09]; CONICYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [AT-24100202]; FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1131025]; AnilloComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS [ACT-71]; FONDEF [D07I1086]; Instituto Milenio, Centro Interdisciplinario de Neurociencia de Valparaiso [P09-022-F]; Heart & Stroke Foundation of BC Yukon	Grant sponsor: Direccion de Investigacion de la Facultad de Medicina-PUC; Grant number: PMD-09/09; Grant sponsor: CONICYT; Grant number: AT-24100202; Grant sponsor: FONDECYT; Grant number: 1131025; Grant sponsor: Anillo; Grant number: ACT-71; Grant sponsor: FONDEF; Grant number: D07I1086; Grant sponsor: Instituto Milenio, Centro Interdisciplinario de Neurociencia de Valparaiso; Grant number: P09-022-F; Grant sponsor: Heart & Stroke Foundation of BC & Yukon.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Allen NJ, 2004, PFLUG ARCH EUR J PHY, V449, P132, DOI 10.1007/s00424-004-1318-x; Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bennett MVL, 2012, BRAIN RES, V1487, P3, DOI 10.1016/j.brainres.2012.08.042; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Corvalan LA, 2007, J CELL PHYSIOL, V211, P649, DOI 10.1002/jcp.20971; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Dobrenis K, 2005, J NEUROSCI RES, V82, P306, DOI 10.1002/jnr.20650; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fischer W, 2007, CURR MED CHEM, V14, P2429, DOI 10.2174/092986707782023695; Fischer W, 2009, NEUROSCIENCE, V160, P767, DOI 10.1016/j.neuroscience.2009.02.026; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jackson DG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04576; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Morita M, 2007, GLIA, V55, P508, DOI 10.1002/glia.20471; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; O'Carroll SJ, 2008, CELL COMMUN ADHES, V15, P27, DOI 10.1080/15419060802014164; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Rao VLR, 2001, NEUROCHEM RES, V26, P497; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; Saez PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071361; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Theis M, 2012, BRAIN RES, V1487, P88, DOI 10.1016/j.brainres.2012.06.045; Theodoric N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047311; Udawatte C, 2005, APOPTOSIS, V10, P1019, DOI 10.1007/s10495-005-0776-8; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614	73	24	24	0	21	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2015	63	7					1185	1199		10.1002/glia.22808			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG6IC	WOS:000353402100006	25731866				2022-02-06	
J	Xu, L; Yang, Y; Gao, LX; Zhao, JH; Cai, YL; Huang, J; Jing, S; Bao, XH; Wang, Y; Gao, JW; Xu, HW; Fan, XT				Xu, Le; Yang, Yang; Gao, Lixiong; Zhao, Jinghui; Cai, Yulong; Huang, Jing; Jing, Sheng; Bao, Xiaohang; Wang, Ying; Gao, Junwei; Xu, Haiwei; Fan, Xiaotang			Protective effects of resveratrol on the inhibition of hippocampal neurogenesis induced by ethanol during early postnatal life	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Ethanol; Neurogenesis; Hippocampal development; Neural precursor cell; Resveratrol	RADIAL GLIAL-CELLS; NEURAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; ALCOHOL EXPOSURE; NEURONAL DIFFERENTIATION; STRUCTURAL PLASTICITY; CYCLE PROGRESSION; DENDRITIC SPINES; CEREBRAL-CORTEX; DENTATE GYRUS	Ethanol (EtOH) exposure during early postnatal life triggers obvious neurotoxic effects on the developing hippocampus and results in long-term effects on hippocampal neurogenesis. Resveratrol (RSV) has been demonstrated to exert potential neuroprotective effects by promoting hippocampal neurogenesis. However, the effects of RSV on the EtOH-mediated impairment of hippocampal neurogenesis remain undetermined. Thus, mice were pretreated with RSV and were later exposed to EtOH to evaluate its protective effects on EtOH-mediated toxicity during hippocampal development. The results indicated that a brief exposure of EtOH on postnatal day 7 resulted in a significant impairment in hippocampal neurogenesis and a depletion of hippocampal neural precursor cells (NPCs). This effect was attenuated by pretreatment with RSV. Furthermore, EtOH exposure resulted in a reduction in spine density on the granular neurons of the dentate gyrus (DG), and the spines exhibited a less mature morphological phenotype characterized by a higher proportion of stubby spines and a lower proportion of mushroom spines. However, RSV treatment effectively reversed these responses. We further confirmed that RSV treatment reversed the EtOH-induced down-regulation of hippocampal pERK and Hesl protein levels, which may be related to the proliferation and maintenance of NPCs. Furthermore, EtOH exposure in the C17.2 NPCs also diminished cell proliferation and activated apoptosis, which could be reversed by pretreatment of RSV. Overall, our results suggest that RSV pretreatment protects against EtOH-induced defects in neurogenesis in postnatal mice and may thus play a critical role in preventing EtOH-mediated toxicity in the developing hippocampus. (C) 2015 Elsevier B.V. All rights reserved.	[Xu, Le; Zhao, Jinghui; Cai, Yulong; Wang, Ying; Gao, Junwei; Fan, Xiaotang] Third Mil Med Univ, Sch Psychol, Dept Dev Neuropsychol, Chongqing 400038, Peoples R China; [Xu, Le] Third Mil Med Univ, Battal Cadet Brigade 5, Chongqing 400038, Peoples R China; [Yang, Yang] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China; [Gao, Lixiong; Xu, Haiwei] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing 400038, Peoples R China; [Huang, Jing; Jing, Sheng; Bao, Xiaohang] Third Mil Med Univ, Xinqiao Hosp, Dept Anesthesiol, Chongqing 400037, Peoples R China		Xu, HW (corresponding author), Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing 400038, Peoples R China.	haiweixu2001@163.com; fanxiaotang2005@163.com	Yang, Yang/AAC-6532-2022	Yang, Yang/0000-0001-6472-5578	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371197, 31271051]; Natural Science Foundation Project of CQ CSTCNatural Science Foundation Project of CQ CSTC [2013jjB10028]	This study was supported by the National Natural Science Foundation of China (no. 81371197 and no. 31271051) and the Natural Science Foundation Project of CQ CSTC (no. 2013jjB10028).	Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Basavarajappa BS, 2008, J NEUROCHEM, V107, P1001, DOI 10.1111/j.1471-4159.2008.05685.x; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brunne B, 2010, GLIA, V58, P1553, DOI 10.1002/glia.21029; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Chen X, 2014, CELL PHYSIOL BIOCHEM, V34, P1109, DOI 10.1159/000366325; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; Coleman LG, 2012, ALCOHOL, V46, P603, DOI 10.1016/j.alcohol.2012.01.003; Cullen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054924; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Hamilton GF, 2011, BRAIN RES, V1412, P88, DOI 10.1016/j.brainres.2011.07.027; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Harada N, 2011, J NUTR BIOCHEM, V22, P1150, DOI 10.1016/j.jnutbio.2010.09.016; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang J., 2015, MOL NEUROBIOL; Ieraci A, 2007, NEUROBIOL DIS, V26, P597, DOI 10.1016/j.nbd.2007.02.011; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Komatsu S, 2001, ACTA NEUROPATHOL, V101, P22; Livy DJ, 2003, NEUROTOXICOL TERATOL, V25, P447, DOI 10.1016/S0892-0362(03)00030-8; Madhyastha S, 2013, INT J DEV NEUROSCI, V31, P580, DOI 10.1016/j.ijdevneu.2013.06.010; Menard C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00281; Mo ZC, 2012, ALCOHOL CLIN EXP RES, V36, P1374, DOI 10.1111/j.1530-0277.2012.01736.x; Mooney SM, 2004, CEREB CORTEX, V14, P1071, DOI 10.1093/cercor/bhh066; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Moriya J, 2011, BIOL PHARM BULL, V34, P354, DOI 10.1248/bpb.34.354; Nelson BR, 2013, J NEUROSCI, V33, P9122, DOI 10.1523/JNEUROSCI.0791-13.2013; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Park HR, 2012, J BIOL CHEM, V287, P42588, DOI 10.1074/jbc.M112.406413; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Pasinetti GM, 2015, BBA-MOL BASIS DIS, V1852, P1202, DOI 10.1016/j.bbadis.2014.10.006; Patterson M, 2011, BRIT J PHARMACOL, V163, P1626, DOI 10.1111/j.1476-5381.2011.01328.x; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Romero AM, 2013, NEUROTOX RES, V24, P532, DOI 10.1007/s12640-013-9409-0; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; Samudio-Ruiz SL, 2009, J NEUROCHEM, V109, P1311, DOI 10.1111/j.1471-4159.2009.06049.x; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Singh AK, 2009, ALCOHOL ALCOHOLISM, V44, P185, DOI 10.1093/alcalc/agn109; Singh N, 2013, ACS CHEM NEUROSCI, V4, P1151, DOI 10.1021/cn400094w; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Sovak Milos, 2001, J Med Food, V4, P93, DOI 10.1089/109662001300341752; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Spanos M, 2012, BEHAV BRAIN RES, V230, P158, DOI 10.1016/j.bbr.2012.02.010; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Subbanna S, 2013, J NEUROSCI, V33, P6350, DOI 10.1523/JNEUROSCI.3786-12.2013; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Ungerer M, 2013, ALCOHOL RES-CURR REV, V35, P37; Valles S, 1996, J NEUROCHEM, V67, P2425; Wang SJ, 2014, J MEMBRANE BIOL, V247, P493, DOI 10.1007/s00232-014-9659-7; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Wood CE, 2007, EXP PHYSIOL, V92, P821, DOI 10.1113/expphysiol.2007.038448; Xu L, 2015, MOL NEUROBIOL, V51, P131, DOI 10.1007/s12035-014-8692-y; Yang Y, 2014, MOL NEUROBIOL, V49, P176, DOI 10.1007/s12035-013-8510-y; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077	70	24	26	0	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JUL	2015	1852	7					1298	1310		10.1016/j.bbadis.2015.03.009			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CJ7YB	WOS:000355715200009	25817400	Bronze			2022-02-06	
J	Awwad, HO; Gonzalez, LP; Tompkins, P; Lerner, M; Brackett, DJ; Awasthi, V; Standifer, KM				Awwad, Hibah O.; Gonzalez, Larry P.; Tompkins, Paul; Lerner, Megan; Brackett, Daniel J.; Awasthi, Vibhudutta; Standifer, Kelly M.			Blast overpressure waves induce transient anxiety and regional changes in cerebral glucose metabolism and delayed hyperarousal in rats	FRONTIERS IN NEUROLOGY			English	Article						blast injury; traumatic brain injury; anxiety; fluorodeoxyglucose; positron emission tomography imaging; glucose metabolism; acoustic startle response	TRAUMATIC BRAIN-INJURY; CORTICAL CONTUSION; AXONAL INJURY; PLUS-MAZE; EXPOSURE; PRESSURE; MODEL; MECHANISMS; REACTIVITY; INFLAMMATION	Physiological alterations, anxiety, and cognitive disorders are strongly associated with blast-induced traumatic brain injury (blast TBI), and are common symptoms in service personnel exposed to blasts. Since 2006, 25,000-30,000 new TBI cases are diagnosed annually in U.S. Service members; increasing evidence confirms that primary blast exposure causes diffuse axonal injury and is often accompanied by altered behavioral outcomes. Behavioral and acute metabolic effects resulting from blast to the head in the absence of thoracic contributions from the periphery were examined, following a single blast wave directed to the head of male Sprague-Dawley rats protected by a lead shield over the torso. An 80 psi head blast produced cognitive deficits that were detected in working memory. Blast TBI rats displayed increased anxiety as determined by elevated plus maze at day 9 post-blast compared to sham rats; blast TBI rats spent significantly more time than the sham controls in the closed arms (p < 0.05; n = 8-11). Interestingly, anxiety symptoms were absent at days 22 and 48 post-blast. Instead, blast TBI rats displayed increased rearing behavior at day 48 post-blast compared to sham rats. Blast TBI rats also exhibited suppressed acoustic startle responses, but similar pre-pulse inhibition at day 15 post-blast compared to sham rats. Acute physiological alterations in cerebral glucose metabolism were determined by positron emission tomography 1 and 9 days post-blast using F-18-fluorodeoxyglucose (F-18-FDG). Global glucose uptake in blast TBI rat brains increased at day 1 post-blast (p < 0.05; n = 4-6) and returned to sham levels by day 9. Our results indicate a transient increase in cerebral metabolism following a blast injury. Markers for reactive astrogliosis and neuronal damage were noted by immunoblotting motor cortex tissue from day 10 post-blast in blast TBI rats compared to sham controls (p < 0.05; n = 5-6).	[Awwad, Hibah O.; Awasthi, Vibhudutta; Standifer, Kelly M.] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73117 USA; [Awwad, Hibah O.; Gonzalez, Larry P.; Standifer, Kelly M.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Oklahoma Ctr Neurosci, Oklahoma City, OK 73117 USA; [Gonzalez, Larry P.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Psychiat & Behav Sci, Oklahoma City, OK 73117 USA; [Tompkins, Paul] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Neurosurg, Oklahoma City, OK 73117 USA; [Lerner, Megan; Brackett, Daniel J.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Surg, Oklahoma City, OK 73117 USA; [Lerner, Megan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA; [Standifer, Kelly M.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, Oklahoma City, OK 73117 USA		Awwad, HO (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 1110 N Stonewall Ave,Suite 315, Oklahoma City, OK 73117 USA.	hawwad@ouhsc.edu	Gonzalez, Larry P/A-4362-2008		Department of the Army [W81XWH-09-1-0443]	The authors would like to acknowledge: Cindy Simpson-Durand for her excellent technical assistance, Patrick Dib and Robert Stover for help with PET image layouts, Dr. Charles Vorhees for helpful discussions regarding MWM paradigms, and Dr. Ethan Stolzenberg for his expertise on histopathology. Special acknowledgments to Dr. Namas Chandra and Aaron Alai from the University of Nebraska-Lincoln for their input and discussions related to blast loading mechanics and parameters. This work was supported by the Department of the Army W81XWH-09-1-0443 to KMS.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; [Anonymous], 2009, BRAIN NAVIGATOR RELE; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Awasthi V, 2010, NUCL MED COMMUN, V31, P152, DOI 10.1097/MNM.0b013e3283339f92; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Borta A, 2005, PHYSIOL BEHAV, V84, P387, DOI 10.1016/j.physbeh.2005.01.009; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CARNEVALE UAG, 1990, BEHAV BRAIN RES, V39, P187, DOI 10.1016/0166-4328(90)90104-M; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; DeLellis Stephen M, 2009, J Spec Oper Med, V9, P36; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Glenn Thomas C, 2012, Acta Neurochir Suppl, V114, P11, DOI 10.1007/978-3-7091-0956-4_3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Hattori N, 2004, J NUCL MED, V45, P775; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Irwin R J, 1998, J Okla State Med Assoc, V91, P387; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schrauwen JTC, 2012, J STRUCT BIOL, V180, P335, DOI 10.1016/j.jsb.2012.06.007; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Uys JDK, 2006, ANN NY ACAD SCI, V1071, P542, DOI 10.1196/annals.1364.060; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Warden DL, 2005, NEW ENGL J MED, V353, P633; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	95	24	25	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 17	2015	6								132	10.3389/fneur.2015.00132			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU9FG	WOS:000363848900001	26136722	Green Published, gold			2022-02-06	
J	Garcia-Ovejero, D; Arevalo-Martin, A; Paniagua-Torija, B; Florensa-Vila, J; Ferrer, I; Grassner, L; Molina-Holgado, E				Garcia-Ovejero, Daniel; Arevalo-Martin, Angel; Paniagua-Torija, Beatriz; Florensa-Vila, Jose; Ferrer, Isidro; Grassner, Lukas; Molina-Holgado, Eduardo			The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features	BRAIN			English	Article						neural stem cells; spinal cord injury; ependymoma; regeneration; central canal	NEURAL STEM-CELLS; GENE-EXPRESSION; GLIAL-CELLS; SYRINGOMYELIA; BRAIN; PROLIFERATION; MODEL; DIFFERENTIATION; CLASSIFICATION; IDENTIFICATION	Several laboratories have described the existence of undifferentiated precursor cells that may act like stem cells in the ependyma of the rodent spinal cord. However, there are reports showing that this region is occluded and disassembled in humans after the second decade of life, although this has been largely ignored or interpreted as a post-mortem artefact. To gain insight into the patency, actual structure, and molecular properties of the adult human spinal cord ependymal region, we followed three approaches: (i) with MRI, we estimated the central canal patency in 59 control subjects, 99 patients with traumatic spinal cord injury, and 26 patients with non-traumatic spinal cord injuries. We observed that the central canal is absent from the vast majority of individuals beyond the age of 18 years, gender-independently, throughout the entire length of the spinal cord, both in healthy controls and after injury; (ii) with histology and immunohistochemistry, we describe morphological properties of the non-lesioned ependymal region, which showed the presence of perivascular pseudorosettes, a common feature of ependymoma; and (iii) with laser capture microdissection, followed by TaqMan (R) low density arrays, we studied the gene expression profile of the ependymal region and found that it is mainly enriched in genes compatible with a low grade or quiescent ependymoma (53 genes); this region is enriched only in 14 genes related to neurogenic niches. In summary, we demonstrate here that the central canal is mainly absent in the adult human spinal cord and is replaced by a structure morphologically and molecularly different from that described for rodents and other primates. The presented data suggest that the ependymal region is more likely to be reminiscent of a low-grade ependymoma. Therefore, a direct translation to adult human patients of an eventual therapeutic potential of this region based on animal models should be approached with caution.	[Garcia-Ovejero, Daniel; Arevalo-Martin, Angel; Paniagua-Torija, Beatriz; Molina-Holgado, Eduardo] Hosp Nacl Paraplej SESCAM, Lab Neuroinflammat, Toledo, Spain; [Florensa-Vila, Jose] Hosp Nacl Paraplej SESCAM, Radiol Unit, Toledo, Spain; [Ferrer, Isidro] IDIBELL Hosp Univ Bellvitge, Inst Neuropatol, Serv Anat Patol, Lhospitalet De Llobregat, Spain; [Grassner, Lukas] Trauma Ctr Murnau, Ctr Spinal Cord Injuries, Murnau, Germany; [Grassner, Lukas] Paracelsus Med Univ, Inst Mol Regenerat Med, SCI TReCS Spinal Cord Injury & Tissue Regenerat C, Salzburg, Austria		Garcia-Ovejero, D (corresponding author), Hosp Nacl Paraplej, Lab Neuroinflammat, Finca La Peraleda S-N, Toledo 45071, Spain.	dgarciao@sescam.jccm.es	Garcia-Ovejero, Daniel/H-9090-2019; Arevalo-Martin, Angel/A-5376-2011; Florensa-Vila, Jose/AAA-5194-2019; Molina-Holgado, Eduardo/C-2714-2008	Garcia-Ovejero, Daniel/0000-0002-7479-5104; Molina-Holgado, Eduardo/0000-0001-6693-1682; Arevalo-Martin, Angel/0000-0002-0549-6098	Wings For Life Foundation; Instituto de Salud Carlos III (Ministry of Economy and Competitiveness of Spain); Fundacion Mutua-Madrilena (Madrid, Spain)	This work was funded by Wings For Life Foundation. Laboratory of Neuroinflammation has been supported by Instituto de Salud Carlos III (Ministry of Economy and Competitiveness of Spain) and Fundacion Mutua-Madrilena (Madrid, Spain).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Alelu-Paz R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003378; Alfaro-Cervello C, 2014, J COMP NEUROL, V522, P1800, DOI 10.1002/cne.23501; Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Andreiuolo F, 2010, NEURO-ONCOLOGY, V12, P1126, DOI 10.1093/neuonc/noq074; Auguste KI, 2006, NEUROSURG CLIN N AM, V17, P51, DOI 10.1016/j.nec.2005.10.004; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Clarke J.L., 1859, PHILOS T R SOC LOND, V149, P437; Cornil L, 1933, REV NEUROL-FRANCE, V59, P749; Dromard C, 2008, J NEUROSCI RES, V86, P1916, DOI 10.1002/jnr.21646; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellison D., 2004, NEUROPATHOLOGY REFER, V2nd ed.; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; Fu H, 2003, J COMP NEUROL, V456, P237, DOI 10.1002/cne.10481; Garcia-Ovejero D, 2013, J COMP NEUROL, V521, P233, DOI 10.1002/cne.23184; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hu ZZ, 2008, CLIN CHEM, V54, P824, DOI 10.1373/clinchem.2007.096164; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; KASANTIKUL V, 1979, J NEUROSURG, V51, P85, DOI 10.3171/jns.1979.51.1.0085; Kelly TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004213; Klekamp J, 2002, J NEUROSURG, V97, P317, DOI 10.3171/spi.2002.97.3.0317; Ko HY, 2012, SPINAL CORD, V50, P695, DOI 10.1038/sc.2012.35; Koelliker A., 1893, HDB GEWEBELEHRE MENS; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2007, WHO CLASSIFICATION T, V4th; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Mamaeva D, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-99; Mamber C, 2013, PROG NEUROBIOL, V111, P1, DOI 10.1016/j.pneurobio.2013.07.003; McDonough A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/387513; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Milde T, 2012, BRAIN PATHOL, V22, P848, DOI 10.1111/j.1750-3639.2012.00600.x; MILHORAT TH, 1994, J NEUROSURG, V81, P103, DOI 10.3171/jns.1994.81.1.0103; MILHORAT TH, 1994, J NEUROSURG, V80, P716, DOI 10.3171/jns.1994.80.4.0716; MILHORAT TH, 1995, J NEUROSURG, V82, P802, DOI 10.3171/jns.1995.82.5.0802; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; NETSKY MG, 1953, AMA ARCH NEUROL PSY, V70, P741, DOI 10.1001/archneurpsyc.1953.02320360056006; Obermair FJ, 2010, STEM CELL RES, V5, P131, DOI 10.1016/j.scr.2010.05.001; Palm T, 2009, CANCER-AM CANCER SOC, V115, P3955, DOI 10.1002/cncr.24476; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Petit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024538; Peyre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012932; Pfenninger CV, 2011, GLIA, V59, P68, DOI 10.1002/glia.21077; Puget S, 2009, J CLIN ONCOL, V27, P1884, DOI 10.1200/JCO.2007.15.4195; R DEVELOPMENT CORE TEAM, 2014, R LANG ENV STAT COMP; Radojicic M, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-30; Ramon y Cajal S., 1899, TEXTURA SISTEMA NERV; Retzius G, 1893, BIOL UNTERSUCH, V5, P2; Ritter AM, 1998, J NEURO-ONCOL, V40, P51, DOI 10.1023/A:1006082622699; ROSSIER AB, 1985, BRAIN, V108, P439, DOI 10.1093/brain/108.2.439; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Sakakibara A, 2007, PATHOL INT, V57, P358, DOI 10.1111/j.1440-1827.2007.02108.x; Scheithauer BW, 2008, BRAIN PATHOL, V18, P307, DOI 10.1111/j.1750-3639.2008.00179.x; Schiffer D, 1997, BRAIN TUMOURS BIOL P; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tysseling VM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-16; von Lenhossek M., 1895, FEINERE BAU NERVENSS; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wani K, 2012, ACTA NEUROPATHOL, V123, P727, DOI 10.1007/s00401-012-0941-4; Weigert K., 1895, BEITRAGE KENNTNIS NO; Weiss S, 1996, J NEUROSCI, V16, P7599; Wippold FJ, 2006, AM J NEURORADIOL, V27, P488; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Yasui K, 1999, ACTA NEUROPATHOL, V97, P253, DOI 10.1007/s004010050982	79	24	24	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUN 1	2015	138		6				1583	1597		10.1093/brain/awv089			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM9BD	WOS:000357999300023	25882650	Bronze, Green Published			2022-02-06	
J	Pistoia, F; Sacco, S; Franceschini, M; Sara, M; Pistarini, C; Cazzulani, B; Simonelli, I; Pasqualetti, P; Carolei, A				Pistoia, Francesca; Sacco, Simona; Franceschini, Marco; Sara, Marco; Pistarini, Caterina; Cazzulani, Benedetta; Simonelli, Ilaria; Pasqualetti, Patrizio; Carolei, Antonio			Comorbidities: A Key Issue in Patients with Disorders of Consciousness	JOURNAL OF NEUROTRAUMA			English	Article						vegetative state; comorbidities; minimally conscious state; outcome; brain injury	TRAUMATIC BRAIN-INJURY; PERSISTENT VEGETATIVE STATE; PAROXYSMAL SYMPATHETIC HYPERACTIVITY; REVISED CRS-R; MEDICAL COMPLICATIONS; ITALIAN VERSION; RECOVERY; OUTCOMES; SCALE; REHABILITATION	The aim of this study was to identify the impact of comorbidities on outcomes of patients with vegetative state (VS) or minimally conscious state (MCS). All patients in VS or MCS consecutively admitted to two postacute care units within a 1-year period were evaluated at baseline and at 6 months through the Coma Recovery Scale-Revised Version and the Disability Rating Scale (DRS). Comorbidities were also recorded for each patient along the same period. Six-month outcomes included death, full recovery of consciousness, and functional improvement. One hundred and thirty-nine patients (88 male and 51 female; median age, 59 years) were included. Ninety-seven patients were in VS (70%) and 42 in MCS (30%). At 6 months, 33 patients were dead (24%), 39 had a full recovery of consciousness (28%), and 67 remained in VS or MCS (48%). According to DRS scores, 40% of patients (n=55) showed a functional improvement in the level of disability. One hundred and thirty patients (94%) showed at least one comorbidity. Severity of comorbidities (hazard ratio [HR]=2.8; 95% confidence interval [CI], 1.71-4.68; p<0.001) and the presence of ischemic or organic heart diseases (HR=2.6; 95% CI, 1.21-5.43; p=0.014) were the strongest predictors of death, together with increasing age (HR=1.0; 95% CI, 1.0-1.06; p=0.033). Respiratory diseases and arrhythmias without organic heart diseases were negative predictors of full recovery of consciousness (odds ratio [OR]=0.3; 95% CI, 0.12-0.7; p=0.006; OR=0.2; 95% CI, 0.07-0.43; p<0.001) and functional improvement (OR=0.4; 95% CI, 0.15-0.85, p=0.020; OR=0.2; 95% CI, 0.08-0.45; p<0.001). Our data show that comorbidities are common in these patients and some of them influence recovery of consciousness and outcomes.	[Pistoia, Francesca; Sacco, Simona; Carolei, Antonio] Univ Aquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Franceschini, Marco] IRCCS San Raffaele Pisana, Dept Neurorehabil, Rome, Italy; [Sara, Marco] Hosp San Raffaele, Postcoma & Rehabil Care Unit, Cassino, Italy; [Pistarini, Caterina; Cazzulani, Benedetta] IRCCS Maugeri Fdn, Postcoma & Rehabil Care Unit, Pavia, Italy; [Simonelli, Ilaria; Pasqualetti, Patrizio] Fatebenefratelli Fdn Hlth Res & Educ, Med Stat & Informat Technol, AFaR Div, Rome, Italy; [Simonelli, Ilaria; Pasqualetti, Patrizio] IRCCS San Raffaele Pisana, Unit Clin & Mol Epidemiol, Rome, Italy		Pistoia, F (corresponding author), Univ Aquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	francesca.pistoia@univaq.it	Sara, Marco/AAB-3651-2019; Sacco, Simona/I-5253-2012; Simonelli, Ilaria/K-5968-2016; Cazzulani, Benedetta/AAC-1818-2020; Pistarini, CATERINA/K-5234-2018; Pistoia, Francesca/AAC-1027-2019; Pasqualetti, Patrizio/D-4496-2013	Sacco, Simona/0000-0003-0651-1939; Simonelli, Ilaria/0000-0002-6172-1317; Cazzulani, Benedetta/0000-0002-1219-9163; Pistarini, CATERINA/0000-0001-8925-0484; Pasqualetti, Patrizio/0000-0001-5560-1979; PISTOIA, Francesca/0000-0003-0790-4240; Franceschini, Marco/0000-0002-2131-1583			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; Dolce G, 2008, J NEUROTRAUM, DOI [10.1089/neu.2008.0536, DOI 10.1089/NEU.2008.0536, 10.1089/neu.2008.0536.]; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenfield S., 1987, CLIN RES A, V35, P346; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Luce JM, 2013, CHEST, V144, P1381, DOI 10.1378/chest.13-0395; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pistoia F, 2012, J NEUROTRAUM, V29, P2328, DOI 10.1089/neu.2009.1257; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sara M, 2008, BRAIN INJURY, V22, P33, DOI 10.1080/02699050701810670; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Sara M, 2010, J NEUROTRAUM, V27, P771, DOI [10.1089/neu.2008.0804, 10.1089/neu.2008-0804]; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Schiff Nicholas D, 2010, Cleve Clin J Med, V77 Suppl 3, pS27, DOI 10.3949/ccjm.77.s3.05; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; StataCorp, 2007, STAT STAT SOFTW REL; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	32	24	25	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					682	688		10.1089/neu.2014.3659			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200003	25333386				2022-02-06	
J	Geng, CK; Cao, HH; Ying, X; Zhang, HT; Yu, HL				Geng, Cheng-Kui; Cao, Hong-Hua; Ying, Xiong; Zhang, Hong-Tian; Yu, Hua-Lin			The effects of hyperbaric oxygen on macrophage polarization after rat spinal cord injury	BRAIN RESEARCH			English	Article						Spinal cord injury; Hyperbaric oxygen therapy; Secondary damage; Macrophage polarization; Inflammation	TRAUMATIC BRAIN-INJURY; ALTERNATIVE ACTIVATION; FUNCTIONAL RECOVERY; INTERFERON-GAMMA; THERAPY; MICROGLIA; NEUROPROTECTION; INFLAMMATION; ANTAGONIST; EXPRESSION	The immunoreactive responses are a two-edged sword after spinal cord injury (SCI). Macrophages are the predominant inflammatory cells responsible for this response. However, the mechanism underlying the effects of HBOT on the immunomodulation following SCI is unclear now. The present study was performed to examine the effects of hyperbaric oxygen therapy (HBOT) on macrophage polarization after the rat compressive injury of the spinal cord. HBOT was associated with significant increases in IL-4 and IL-13 levels, and reductions in TNF-alpha and IFN-gamma levels. This was associated simultaneously with the levels of alternatively activated macrophages (M2 phenotype: arginase-1- or CD206-positive), and decreased levels of classically activated macrophages (M1 phenotype: iNOS- or CD16/32-positive). These changes were associated with functional recovery in the HBOT-transplanted group, which correlated with preserved axons and increased myelin sparing. Our results suggested that HBOT after SCI modified the inflammatory environment by shifting the macrophage phenotype from M1 to M2, which may further promote the axonal extension and functional recovery. (C) 2015 Elsevier B.V. All rights reserved.	[Geng, Cheng-Kui; Ying, Xiong] Kunming Med Univ, Affiliated Hosp 1, Yanan Hosp Kunming, Dept Orthoped, Kunming 650032, Peoples R China; [Geng, Cheng-Kui; Zhang, Hong-Tian; Yu, Hua-Lin] Kunming Med Univ, Affiliated Hosp 1, Dept Minimally Invas Neurosurg, Kunming 650032, Peoples R China; [Cao, Hong-Hua] Tumor Hosp Yunnan Prov, Dept Hematol, Kunming 650118, Peoples R China; [Cao, Hong-Hua] Kunming Med Univ, Affiliated Hosp 3, Kunming 650118, Peoples R China; [Zhang, Hong-Tian] Gen Hosp Beijing PLA, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China		Zhang, HT (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Minimally Invas Neurosurg, 295 Xichang Rd, Kunming 650032, Peoples R China.	xiaohaijun_neu@126.com; zhanghongtian007@126.com			Natural Scientific Research funds of China [81371345]; Beijing Nova programBeijing Municipal Science & Technology Commission [XX2013059]	This work was supported by the Natural Scientific Research funds of China (No. 81371345) for Dr. Hong-Tian Zhang and Beijing Nova program (XX2013059) for Dr. Hong-Tian Zhang.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Asamoto S, 2000, SPINAL CORD, V38, P538, DOI 10.1038/sj.sc.3101023; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dayan K, 2012, LIFE SCI, V90, P360, DOI 10.1016/j.lfs.2011.12.005; DEMEDIUK P, 1985, PROG BRAIN RES, V63, P211; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; Genovese T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-58; Gertsch-Lapcevic Y, 1991, SCI Nurs, V8, P97; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Huang H, 2013, INT J CLIN EXP PATHO, V6, P1337; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Huang LX, 2003, J NEUROSURG, V99, P198, DOI 10.3171/spi.2003.99.2.0198; Kahraman S, 2007, NEUROCHEM RES, V32, P1547, DOI 10.1007/s11064-007-9354-5; Kigerl K. A., 2009, J NEUROSCI, V29, P13435; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; KNIGHTON DR, 1981, SURGERY, V90, P262; Li J, 2011, SPINAL CORD, V49, P777, DOI 10.1038/sc.2011.8; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; RAWE SE, 1981, NEUROSURGERY, V9, P40, DOI 10.1227/00006123-198107000-00007; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Shin WH, 2004, GLIA, V46, P142, DOI 10.1002/glia.10357; Suzuki Y, 2005, INT J PARASITOL, V35, P83, DOI 10.1016/j.ijpara.2004.10.020; Tai PA, 2010, J NEUROTRAUM, V27, P1121, DOI 10.1089/neu.2009.1162; Tompach PC, 1997, INT J ORAL MAX SURG, V26, P82, DOI 10.1016/S0901-5027(05)80632-0; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Tuna M, 2001, J NEUROSURG, V95, P64, DOI 10.3171/spi.2001.95.1.0064; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; Yang J., 2013, LIFE SCI; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Yeo J D, 1984, Cent Nerv Syst Trauma, V1, P161; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667; Zhang YK, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-67	46	24	31	0	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 5	2015	1606						68	76		10.1016/j.brainres.2015.01.029			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CH0XR	WOS:000353746200007	25724144				2022-02-06	
J	Bragin, DE; Statom, GL; Hagberg, S; Nemoto, EM				Bragin, Denis E.; Statom, Gloria L.; Hagberg, Sean; Nemoto, Edwin M.			Increases in microvascular perfusion and tissue oxygenation via pulsed electromagnetic fields in the healthy rat brain	JOURNAL OF NEUROSURGERY			English	Article						pulsed electromagnetic field; cerebrovascular flow; brain metabolism; two-photon laser scanning microscopy; NADH; vasodilation	FLUID SHEAR-STRESS; CEREBROCORTICAL CAPILLARY-FLOW; HIGH INTRACRANIAL-PRESSURE; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; DOUBLE-BLIND; POSTOPERATIVE PAIN; 1ST MESSENGER; SKIN; ISCHEMIA	OBJECT High-frequency pulsed electromagnetic field stimulation is an emerging noninvasive therapy being used clinically to facilitate bone and cutaneous wound healing. Although the mechanisms of action of pulsed electromagnetic fields (PEMF) are unknown, some studies suggest that its effects are mediated by increased nitric oxide (NO), a well-known vasodilator. The authors hypothesized that in the brain, PEMF increase NO, which induces vasodilation, enhances microvascular perfusion and tissue oxygenation, and may be a useful adjunct therapy in stroke and traumatic brain injury. To test this hypothesis, they studied the effect of PEMF on a healthy rat brain with and without NO synthase (NOS) inhibition. METHODS In vivo two-photon laser scanning microscopy (2PLSM) was used on the parietal cortex of rat brains to measure microvascular tone and red blood cell (RBC) flow velocity in microvessels with diameters ranging from 3 to 50 mu m, which includes capillaries, arterioles, and venules. Tissue oxygenation (reduced nicotinamide adenine dinucleotide [NADH] fluorescence) was also measured before and for 3 hours after PEMF treatment using the FDA-cleared Sof Pulse device (Ivivi Health Sciences, LLC). To test NO involvement, the NOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) was intravenously injected (10 mg/kg). In a time control group, PEMF were not used. Doppler flux (0.8-mm probe diameter), brain and rectal temperatures, arterial blood pressure, blood gases, hematocrit, and electrolytes were monitored. RESULTS Pulsed electromagnetic field stimulation significantly dilated cerebral arterioles from a baseline average diameter of 26.4 +/- 0.84 mu m to 29.1 +/- 0.91 mu m (11 rats, p < 0.01). Increased blood volume flow through dilated arterioles enhanced capillary flow with an average increase in RBC flow velocity by 5.5% +/- 1.3% (p < 0.01). Enhanced microvascular flow increased tissue oxygenation as reflected by a decrease in NADH autofluorescence to 94.7% +/- 1.6% of baseline (p < 0.05). Nitric oxide synthase inhibition by L-NAME prevented PEMF-induced changes in arteriolar diameter, microvascular perfusion, and tissue oxygenation (7 rats). No changes in measured parameters were observed throughout the study in the untreated time controls (5 rats). CONCLUSIONS This is the first demonstration of the acute effects of PEMF on cerebral cortical microvascular perfusion and metabolism. Thirty minutes of PEMF treatment induced cerebral arteriolar dilation leading to an increase in microvascular blood flow and tissue oxygenation that persisted for at least 3 hours. The effects of PEMF were mediated by NO, as we have shown in NOS inhibition experiments. These results suggest that PEMF may be an effective treatment for patients after traumatic or ischemic brain injury. Studies on the effect of PEMF on the injured brain are in progress.	[Bragin, Denis E.; Statom, Gloria L.; Nemoto, Edwin M.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Bragin, Denis E.] Univ New Mexico, Biomed Res & Integrat Neuroimaging Ctr, Albuquerque, NM 87131 USA; [Hagberg, Sean] Ivivi Hlth Sci, San Francisco, CA USA		Bragin, DE (corresponding author), 1 Univ New Mexico, Dept Neurosurg, MSC10 5615, Albuquerque, NM 87131 USA.	dbragin@salud.unm.edu	Bragin, Denis/E-5494-2016	Bragin, Denis/0000-0003-4894-0061	Ivivi Health Sciences, LLC; American Heart AssociationAmerican Heart Association [12BGIA11730011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103400] Funding Source: NIH RePORTER	This research was supported by Ivivi Health Sciences, LLC, and American Heart Association grant 12BGIA11730011.	Aaron RK, 2004, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000118699.26862.41; Akai M, 2002, BIOELECTROMAGNETICS, V23, P132, DOI 10.1002/bem.106; Akdag MZ, 2007, ELECTROMAGN BIOL MED, V26, P99, DOI 10.1080/15368370701357866; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; Baptista AF, 2009, J PERIPHER NERV SYST, V14, P285, DOI 10.1111/j.1529-8027.2009.00240.x; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Diniz P, 2002, NITRIC OXIDE-BIOL CH, V7, P18, DOI 10.1016/S1089-8603(02)00004-6; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Gilcreast Darlene M., 1998, Wound Repair and Regeneration, V6, P434, DOI 10.1046/j.1524-475X.1998.60505.x; GOSSLING HR, 1992, ORTHOPEDICS, V15, P711; Goudarzi I, 2010, BIOELECTROMAGNETICS, V31, P318, DOI 10.1002/bem.20567; GRANT G, 1994, BIOELECTROMAGNETICS, V15, P205, DOI 10.1002/bem.2250150305; Gupta A, 2009, NEUROL INDIA, V57, P622, DOI 10.4103/0028-3886.57820; Haarala C, 2003, NEUROREPORT, V14, P2019, DOI 10.1097/00001756-200311140-00003; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; Heden P, 2008, AESTHET PLAST SURG, V32, P660, DOI 10.1007/s00266-008-9169-z; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Hudetz AG, 1996, MICROVASC RES, V51, P131, DOI 10.1006/mvre.1996.0015; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202, DOI 10.1152/ajpheart.1995.268.6.H2202; ITO H, 1983, CLIN ORTHOP RELAT R, P283; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Kim SS, 2002, EXP MOL MED, V34, P53, DOI 10.1038/emm.2002.8; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; MAYROVITZ HN, 1992, WOUNDS, V4, P197; MAYROVITZ HN, 1995, WOUNDS, V7, P90; Mckay JC, 2007, BIOELECTROMAGNETICS, V28, P81, DOI 10.1002/bem.20284; McKay JC, 2010, BIOELECTROMAGNETICS, V31, P64, DOI 10.1002/bem.20533; Midura RJ, 2005, J ORTHOP RES, V23, P1035, DOI 10.1016/j.orthres.2005.03.015; MIURA M, 1991, J PHYSIOL-LONDON, V435, P257, DOI 10.1113/jphysiol.1991.sp018509; MIURA M, 1993, J PHYSIOL-LONDON, V461, P513, DOI 10.1113/jphysiol.1993.sp019526; MOTTI EDF, 1986, J NEUROSURG, V65, P834, DOI 10.3171/jns.1986.65.6.0834; Nelson FR, 2013, RHEUMATOL INT, V33, P2169, DOI 10.1007/s00296-012-2366-8; Noda, 2000, Pathophysiology, V7, P127, DOI 10.1016/S0928-4680(00)00039-0; Pan YH, 2013, BIOELECTROMAGNETICS, V34, P180, DOI 10.1002/bem.21755; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Pena-Philippides JC, 2014, TRANSL STROKE RES, V5, P491, DOI 10.1007/s12975-014-0334-1; PENNINGTON GM, 1993, MIL MED, V158, P101, DOI 10.1093/milmed/158.2.101; Pilla A., 2006, HDB BIOL EFFECTS ELE, P351; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Pilla AA, 2013, ELECTROMAGN BIOL MED, V32, P123, DOI 10.3109/15368378.2013.776335; Pilla AA, 2012, BIOCHEM BIOPH RES CO, V426, P330, DOI 10.1016/j.bbrc.2012.08.078; Rasouli J, 2012, NEUROSCI LETT, V519, P4, DOI 10.1016/j.neulet.2012.03.089; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rohde C, 2010, PLAST RECONSTR SURG, V125, P1620, DOI 10.1097/PRS.0b013e3181c9f6d3; Sandyk R, 1994, Int J Neurosci, V76, P185; Sandyk R, 1996, INT J NEUROSCI, V87, P209, DOI 10.3109/00207459609070839; Schuhfried O, 2005, INT J SPORTS MED, V26, P886, DOI 10.1055/s-2005-837451; Seylaz J, 1999, J CEREBR BLOOD F MET, V19, P863, DOI 10.1097/00004647-199908000-00005; Sisken B F, 1990, Restor Neurol Neurosci, V1, P303, DOI 10.3233/RNN-1990-13419; Smith TL, 2004, J ORTHOPAED RES, V22, P80, DOI 10.1016/S0736-0266(03)00157-8; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tepper OM, 2004, FASEB J, V18, P1231, DOI 10.1096/fj.03-0847fje; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; UENO S, 1986, MED BIOL ENG COMPUT, V24, P57, DOI 10.1007/BF02441606; World Cameron J, 2006, Curr Atheroscler Rep, V8, P240, DOI 10.1007/s11883-006-0079-8; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yuan YA, 2010, CARDIOLOGY, V117, P57, DOI 10.1159/000321459	59	24	25	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2015	122	5					1239	1247		10.3171/2014.8.JNS132083			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CG5XP	WOS:000353369500038	25343187	Bronze, Green Accepted			2022-02-06	
J	Reid, MW; Velez, CS				Reid, Matthew W.; Velez, Carmen S.			Discriminating military and civilian traumatic brain injuries	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Military; Blast exposure; Polytrauma; Comorbidity	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; OEF/OIF SERVICE MEMBERS; CHRONIC PAIN; BLAST EXPOSURES; WAR VETERAN; PREVALENCE; IRAQ; AFGHANISTAN; HEALTH	Traumatic brain injury (TBI) occurs at higher rates among service members than civilians. Explosions from improvised explosive devices and mines are the leading cause of TBI in the military. As such, TBI is frequently accompanied by other injuries, which makes its diagnosis and treatment difficult. In addition to postconcussion symptoms, those who sustain a TBI commonly report chronic pain and posttraumatic stress symptoms. This combination of symptoms is so typical they have been referred to as the "polytrauma clinical triad" among injured service members. We explore whether these symptoms discriminate civilian occurrences of TBI from those of service members, as well as the possibility that repeated blast exposure contributes to the development of chronic traumatic encephalopathy (CTE). This article is part of a Special Issue entitled 'Traumatic Brain Injury'. (C) 2015 Elsevier Inc. All rights reserved.	[Reid, Matthew W.] Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Reid, Matthew W.; Velez, Carmen S.] San Antonio Mil Med Ctr, San Antonio, TX USA		Reid, MW (corresponding author), Def & Vet Brain Injury Ctr, Washington, DC 20307 USA.	matthew.w.reid2.ctr@mail.mil					Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adler NE, 2010, ANN NY ACAD SCI, V1186, P1, DOI 10.1111/j.1749-6632.2009.05385.x; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Alfano DP, 2006, BRAIN COGNITION, V60, P194; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Casscells S., 2007, HLTH AFFAIRS MEMORAN; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; DVBIC, 2014, DOD WORLDW TBI NUMB; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Gill IJ, 2014, BRAIN INJURY, V28, P1, DOI 10.3109/02699052.2013.851416; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald C.L, 2015, BRAIN; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nicholson K, 2004, J HEAD TRAUMA REHAB, V19, P2, DOI 10.1097/00001199-200401000-00002; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; PITMAN RK, 1989, AM J PSYCHIAT, V146, P667; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Turk DC, 2010, HDB PAIN ASSESSMENT; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Winterstein CE, 1937, LANCET, V230, P719; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	70	24	24	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2015	66		B		SI		123	128		10.1016/j.mcn.2015.03.014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK7FT	WOS:000356398900008	25827093				2022-02-06	
J	Lim, YW; Meyer, NP; Shah, AS; Budde, MD; Stemper, BD; Olsen, CM				Lim, Yi Wei; Meyer, Nathan P.; Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.			Voluntary Alcohol Intake following Blast Exposure in a Rat Model of Mild Traumatic Brain Injury	PLOS ONE			English	Article							SUBSTANCE-ABUSE; ETHANOL-CONSUMPTION; PREFRONTAL CORTEX; ANIMAL-MODELS; DRINKING; OVERPRESSURE; PREFERENCE; RESISTANT; ADDICTION; BEHAVIOR	Alcoholism is a frequent comorbidity following mild traumatic brain injury (mTBI), even in patients without a previous history of alcohol dependence. Despite this correlational relationship, the extent to which the neurological effects of mTBI contribute to the development of alcoholism is unknown. In this study, we used a rodent blast exposure model to investigate the relationship between mTBI and voluntary alcohol drinking in alcohol naive rats. We have previously demonstrated in Sprague Dawley rats that blast exposure leads to microstructural abnormalities in the medial prefrontal cortex (mPFC) and other brain regions that progress from four to thirty days. The mPFC is a brain region implicated in alcoholism and drug addiction, although the impact of mTBI on drug reward and addiction using controlled models remains largely unexplored. Alcohol naive Sprague Dawley rats were subjected to a blast model of mTBI (or sham conditions) and then tested in several common measures of voluntary alcohol intake. In a seven-week intermittent two-bottle choice alcohol drinking test, sham and blast exposed rats had comparable levels of alcohol intake. In a short access test session at the conclusion of the two-bottle test, blast rats fell into a bimodal distribution, and among high intake rats, blast treated animals had significantly elevated intake compared to shams. We found no effect of blast when rats were tested for an alcohol deprivation effect or compulsive drinking in a quinine adulteration test. Throughout the experiment, alcohol drinking was modest in both groups, consistent with other studies using Sprague Dawley rats. In conclusion, blast exposure had a minimal impact on overall alcohol intake in Sprague Dawley rats, although intake was increased in a subpopulation of blast animals in a short access session following intermittent access exposure.	[Lim, Yi Wei; Meyer, Nathan P.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Lim, Yi Wei; Meyer, Nathan P.; Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA		Olsen, CM (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA.	colsen@mcw.edu	Olsen, Christopher/G-9595-2013; Stemper, Brian/AAX-7611-2020	Olsen, Christopher/0000-0003-2700-0310; 	Neuroscience Research Center at the Medical College of Wisconsin; Research and Education Initiative Fund , a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; United States (U.S.) Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX000380]; Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA039276] Funding Source: NIH RePORTER	This work was supported by the Neuroscience Research Center at the Medical College of Wisconsin (CMO), the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin (CMO), Merit Review Award I01 RX000380 from the United States (U.S.) Department of Veterans Affairs (MDB), Veterans Health Administration, Rehabilitation Research and Development Service Program, and Veterans Affairs Medical Research (BDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; AMIT Z, 1970, PSYCHOPHARMACOLOGIA, V17, P367, DOI 10.1007/BF00403808; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Beck A, 2012, ARCH GEN PSYCHIAT, V69, P842, DOI 10.1001/archgenpsychiatry.2011.2026; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Bito-Onon JJ, 2011, ADDICT BIOL, V16, P440, DOI 10.1111/j.1369-1600.2010.00309.x; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Control NcfIPa, 2003, REP C MILD TRAUM BRA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Edwards S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.70; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fein G, 2002, ALCOHOL CLIN EXP RES, V26, P558, DOI 10.1097/00000374-200204000-00017; Fetzner MG, 2011, DEPRESS ANXIETY, V28, P632, DOI 10.1002/da.20852; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; KHANNA JM, 1990, ALCOHOL, V7, P429, DOI 10.1016/0741-8329(90)90027-A; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Li J, 2011, BRAIN RES BULL, V86, P428, DOI 10.1016/j.brainresbull.2011.08.013; LINSEMAN MA, 1987, PSYCHOPHARMACOLOGY, V92, P254; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lowing JL, 2014, J NEUROTRAUMA; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Samson HH, 2003, INT REV NEUROBIOL, V54, P109; Seif T, 2013, NAT NEUROSCI, V16, P1094, DOI 10.1038/nn.3445; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; SINCLAIR JD, 1968, Q J STUD ALCOHOL, V29, P863; Stemper B.D., 2014, ANN BIOMED ENG; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teng SX, 2014, BRAIN BEHAV IMMUN; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vengeliene V, 2014, ALCOHOL, V48, P313, DOI 10.1016/j.alcohol.2014.03.002; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	66	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2015	10	4							e0125130	10.1371/journal.pone.0125130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG6AH	WOS:000353376800130	25910266	Green Submitted, Green Published, gold			2022-02-06	
J	Cristofori, I; Zhong, WT; Chau, A; Solomon, J; Krueger, F; Grafman, J				Cristofori, Irene; Zhong, Wanting; Chau, Aileen; Solomon, Jeffrey; Krueger, Frank; Grafman, Jordan			White and gray matter contributions to executive function recovery after traumatic brain injury	NEUROLOGY			English	Article							POST-ACUTE REHABILITATION; PENETRATING HEAD-INJURY; NEUROTROPHIC FACTOR; COGNITIVE RESERVE; APHASIA; ADULTS; TRACTOGRAPHY; PREDICTORS; ASYMMETRY; ATTENTION	Objective: We investigated the association between regional white and gray matter volume loss and performance on executive functions (EFs) in patients with penetrating traumatic brain injury (pTBI). Methods: We studied 164 pTBI patients and 43 healthy controls from the Vietnam Head Injury Study. We acquired CT scans for pTBI patients and divided them according to lesion localization (left and right prefrontal cortex [PFC]). We administered EF tests (Verbal Fluency, Trail Making, Twenty Questions) and used voxel-based lesion symptom mapping (VLSM) and group-based correlational and multiple regression analyses to examine the relative influence of gray and white matter lesions on EF recovery. Results: The VLSM analysis revealed that white and gray white matter lesions were associated with impaired EFs. In the left PFC lesion group, damage to the PFC gray matter, anterior corona radiata, and superior longitudinal fasciculus (SLF) were most correlated with functional recovery. Verbal Fluency, which involves a broad fronto-temporo-parietal network, was best predicted by SLF lesion volume. Trail Making and Twenty Questions, which is associated with more focal left frontal damage, was better predicted by PFC lesions. Conclusions: Our results indicated that whitematter volume loss can be a superior predictor of recovery and a crucial factor driving clinical outcome in functions involving a broad network such as Verbal Fluency. White matter damage may place additional burden on recovery by deteriorating signal transmission between cortical areas within a functional network.	[Cristofori, Irene; Zhong, Wanting; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL USA; [Cristofori, Irene; Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL 60208 USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Cristofori, I (corresponding author), Rehabil Inst Chicago, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL USA.	irene.cristofori@northwestern.edu		Cristofori, Irene/0000-0003-2339-1457; Zhong, Wanting/0000-0002-6025-1739	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	The authors thank the Vietnam veterans for their participation in the study; A. Salazar, V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants; and the National Naval Medical Center and the National Institute of Neurological Disorders and Stroke for providing their facilities and supporting the research.	Almairac F., 2014, BRAIN STRUCT FUNCT; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Benson D.F., 1986, FRONTAL LOBES; Benton AL, 1991, FRONTAL LOBE FUNCTIO; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; CDC, 2006, INJ FACT BOOK; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Delis DC., 2001, DELIS KAPLAN EXECUTI; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LUDLOW CL, 1986, BRAIN, V109, P55, DOI 10.1093/brain/109.1.55; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Petrides M., 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont V, 2006, PROG BRAIN RES, V157, P199, DOI 10.1016/S0079-6123(06)57013-X; Rudrauf D, 2008, CORTEX, V44, P1084, DOI 10.1016/j.cortex.2008.05.005; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477; Ziegler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069290	40	24	24	2	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 7	2015	84	14					1394	1401		10.1212/WNL.0000000000001446			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CF4BP	WOS:000352493700006	25746558	Green Published			2022-02-06	
J	Berger, RP; Parks, S; Fromkin, J; Rubin, P; Pecora, PJ				Berger, Rachel P.; Parks, Sharyn; Fromkin, Janet; Rubin, Pamela; Pecora, Peter J.			Assessing the accuracy of the International Classification of Diseases codes to identify abusive head trauma: a feasibility study	INJURY PREVENTION			English	Article							OPERATIONAL CASE-DEFINITION; HOSPITAL INPATIENT DATA; SHAKEN BABY SYNDROME; BRAIN-INJURY; CHILDREN; SURVEILLANCE; USA	Objective To assess the accuracy of an International Classification of Diseases (ICD) code-based operational case definition for abusive head trauma (AHT). Methods Subjects were children <5 years of age evaluated for AHT by a hospital-based Child Protection Team (CPT) at a tertiary care paediatric hospital with a completely electronic medical record (EMR) system. Subjects were designated as non-AHT traumatic brain injury (TBI) or AHT based on whether the CPT determined that the injuries were due to AHT. The sensitivity and specificity of the ICD-based definition were calculated. Results There were 223 children evaluated for AHT: 117 AHT and 106 non-AHT TBI. The sensitivity and specificity of the ICD-based operational case definition were 92% (95% CI 85.8 to 96.2) and 96% (95% CI 92.3 to 99.7), respectively. All errors in sensitivity and three of the four specificity errors were due to coder error; one specificity error was a physician error. Conclusions In a paediatric tertiary care hospital with an EMR system, the accuracy of an ICD-based case definition for AHT was high. Additional studies are needed to assess the accuracy of this definition in all types of hospitals in which children with AHT are cared for.	[Berger, Rachel P.; Fromkin, Janet; Rubin, Pamela] Childrens Hosp Pittsburgh UPMC, Dept Pediat, Pittsburgh, PA 15224 USA; [Parks, Sharyn] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Pecora, Peter J.] Univ Washington, Sch Social Work, Casey Family Programs, Seattle, WA 98195 USA		Berger, RP (corresponding author), Childrens Hosp Pittsburgh UPMC, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	Rachel.berger@chp.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD055986]; Matty Eappen Foundation; Casey Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER	This project was funded, in part, by NIH R01HD055986 (RB), the Matty Eappen Foundation (RB) and the Casey Family Foundation. Neither NIH nor Matty Eappen Foundation had any role in (1) the study design; (2) the collection, analysis and interpretation of the data; (3) the writing of the report and (4) the decision to submit the article for publication. Casey Family Foundation assisted with study design, interpretation of the data, writing of the report and gave approval for submission.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; [Anonymous], 2012, KIDS INPATIENT DATAB; Bennett S, 2011, CHILD ABUSE NEGLECT, V35, P930, DOI 10.1016/j.chiabu.2011.05.018; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; McKenzie K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-8; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Ryan MAK, 2008, AM J PREV MED, V34, pS143, DOI 10.1016/j.amepre.2007.12.020; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Stavrou E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-331; U. S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2011, CHILD MALTR 2011; Wirtz SJ, 2008, AM J PREV MED, V34, pS134, DOI 10.1016/j.amepre.2007.11.004	24	24	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2015	21	E1					E133	E137		10.1136/injuryprev-2013-040924			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CE2ZS	WOS:000351693200024	24167034	Green Accepted			2022-02-06	
J	Terre, R; Mearin, F				Terre, R.; Mearin, F.			A randomized controlled study of neuromuscular electrical stimulation in oropharyngeal dysphagia secondary to acquired brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						aspiration; dysphagia; neuromuscular electrical stimulation; rehabilitation; stroke; traumatic brain injury; videofluoroscopy	TRACHEAL ASPIRATION; INTERRATER RELIABILITY; PHARYNGEAL DYSPHAGIA; STROKE PATIENTS; RESOLUTION; DISORDERS; THERAPY; SCALE	Background and purposeTo evaluate the effectiveness of neuromuscular electrical stimulation (NMES) treatment in patients with oropharyngeal dysphagia secondary to acquired brain injury. MethodsTwenty patients with neurological oropharyngeal dysphagia (14 stroke and six severe traumatic brain injury) were enrolled in a prospective randomized study, with patients and assessors blinded (to group allocation): 10 patients underwent NMES and conventional swallowing therapy and 10 patients underwent sham electrical stimulation (SES) and conventional swallowing therapy. Both groups completed 20 sessions. At baseline, at the end of treatment (1month) and at 3-month follow-up, clinical, videofluoroscopic and esophageal manometric analyses were done. Feeding swallowing capacity was evaluated using the functional oral intake scale (FOIS). ResultsMean FOIS score before treatment was 1.9 for the NMES group and 2.1 for the SES group. After treatment, the NMES group increased by 2.6 points (4.5 points) compared with only 1 point (3.1 points) for the SES group (P=0.005). At 3months of follow-up, mean scores were 5.3 and 4.6 respectively; thus, both groups improved similarly. At that time point (3months), tracheal aspiration persisted in six patients in each group. However, a significant improvement in relation to the bolus viscosity at which aspiration appeared was found in the NMES group versus the SES group (P=0.015). Also, a significant increase (P=0.04) in pharyngeal amplitude contraction was observed at the end of treatment (1month) in the NMES group compared with the SES group. ConclusionNeuromuscular electrical stimulation significantly accelerated swallowing function improvement in patients with oropharyngeal dysphagia secondary to acquired brain injury.	[Terre, R.; Mearin, F.] Neurorehabil Hosp, Inst Guttmann, Funct Digest Rehabil Unit, Barcelona, Spain; [Terre, R.; Mearin, F.] Inst Univ Neurorehabil, Inst Guttmann, Bellaterra, Cerdanyola Del, Spain; [Terre, R.; Mearin, F.] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Terre, R.; Mearin, F.] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain		Terre, R (corresponding author), Inst Guttmann, Unit Funct Digest Rehabil, Cami Can Ruti S-N, Barcelona 08916, Spain.	rterre@guttmann.com			FUNDACION MAPFRE	We thank Ms Raquel Lopez for statistical analysis and the Speech Therapy Department (Ms Montse Martinell, Beatriz Gonzalez and Judith Ejarque) for its assistance in the technical performance of NMES. We are also indebted to Ms Christine O'Hara who helped to prepare the manuscript. This research was supported by a grant of the FUNDACION MAPFRE.	Blumenfeld L, 2006, OTOLARYNG HEAD NECK, V135, P754, DOI 10.1016/j.otohns.2006.04.016; Bulow M, 2008, DYSPHAGIA, V23, P302, DOI 10.1007/s00455-007-9145-9; Clark H, 2009, AM J SPEECH-LANG PAT, V18, P361, DOI 10.1044/1058-0360(2009/08-0088); Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Crary MA, 2007, DYSPHAGIA, V22, P165, DOI 10.1007/s00455-006-9068-x; Doeltgen SH, 2012, ARCH PHYS MED REHAB, V93, P207, DOI 10.1016/j.apmr.2011.08.030; Fraser C, 2002, NEURON, V34, P831, DOI 10.1016/S0896-6273(02)00705-5; Ghosh SK, 2006, AM J PHYSIOL-GASTR L, V291, pG525, DOI 10.1152/ajpgi.00081.2006; Grupo Espanol para el Estudio de la Motilidad Digestiva (GEEMD), 1997, TECNICAS ESTUDIO ACT, P11; Hagen CMD, 1999, REHABILITATION HEAD, P70; Hamdy S, 2010, PERSPECTIVES SWALLOW, V19, P3, DOI DOI 10.1161/01.STR.0000190056.76543.EB; Hara Yukihiro, 2010, Brain and Nerve (Tokyo), V62, P113; Kimberley TJ, 2004, EXP BRAIN RES, V154, P450, DOI 10.1007/s00221-003-1695-y; Korfage JAM, 2001, ARCH ORAL BIOL, V46, P821, DOI 10.1016/S0003-9969(01)00042-5; Kushner DS, 2013, AM J PHYS MED REHAB, V92, P486, DOI 10.1097/PHM.0b013e31828762ec; Laufer Y, 2011, NEUROREHAB NEURAL RE, V25, P799, DOI 10.1177/1545968310397205; Leelamanit V, 2002, LARYNGOSCOPE, V112, P2204, DOI 10.1097/00005537-200212000-00015; Leonard R, 2008, DYSPHAGIA ASSESSMENT, P295; Logemann J., 1993, MANUAL VIDEOFLUOROGR, P115; Logemann JA, 1998, EVALUATION TREATMENT, P307; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Pena-Casanova J., 1991, PROGRAMA INTEGRADO E; Permsirivanich Wutichai, 2009, Journal of the Medical Association of Thailand, V92, P259; Power M, 2004, AM J PHYSIOL-GASTR L, V286, pG45, DOI 10.1152/ajpgi.00114.2003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rofes L, 2013, NEUROGASTROENT MOTIL, V25, P888, DOI 10.1111/nmo.12211; Scott A, 1998, DYSPHAGIA, V13, P223, DOI 10.1007/PL00009576; Singh S, 2006, POSTGRAD MED J, V82, P383, DOI 10.1136/pgmj.2005.043281; Smith GV, 2003, EXP BRAIN RES, V150, P33, DOI 10.1007/s00221-003-1405-9; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P233, DOI 10.1016/S0016-5085(99)70573-1; Stevens-Lapsley JE, 2012, PHYS THER, V92, P210, DOI 10.2522/ptj.20110124; Stoeckli SJ, 2003, DYSPHAGIA, V18, P53, DOI 10.1007/s00455-002-0085-0; Terre R, 2012, NEUROGASTROENT MOTIL, V24, P414, DOI 10.1111/j.1365-2982.2011.01869.x; Terre R, 2009, NEUROGASTROENT MOTIL, V21, P361, DOI 10.1111/j.1365-2982.2008.01208.x; Terre R, 2013, MED CLIN-BARCELONA, V140, P157, DOI 10.1016/j.medcli.2012.09.037; Terre R, 2009, AM J GASTROENTEROL, V104, P923, DOI 10.1038/ajg.2008.160; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Uniform Data System for Medical Rehabilitation, 1990, GUID US UN DAT SET M	39	24	25	0	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	APR	2015	22	4					687	E44		10.1111/ene.12631			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD9DX	WOS:000351398900014	25573027				2022-02-06	
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Argueso, M; Ramos, L; Sole-Violan, J; Caceres, JJ; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Argueso, Monica; Ramos, Luis; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum Levels of Caspase-Cleaved Cytokeratin-18 in Patients with Severe Traumatic Brain Injury Are Associated with Mortality: A Pilot Study	PLOS ONE			English	Article							CELL APOPTOSIS; BCL-2 FAMILY; DEATH; BIOMARKERS; EXPRESSION; FRAGMENTS; THERAPY; LIVER	Objective There have been found apoptotic changes in brain tissue samples from animals and humans after a traumatic brain injury (TBI). The protein cytokeratin 18 (CK-18), present in epithelial cells, is cleaved by the action of caspases during apoptosis, and the resulting fragments are released into the blood as caspase-cleaved CK (CCCK)-18. Circulating levels of CCCK-18, as biomarker of apoptosis, have been determined in patients with different processes; however, it has not been explored in TBI patients. Thus, the objective of this study was to determine whether there is an association between serum CCCK-18 levels and mortality and whether such levels could be used as a biomarker to predict outcomes in TBI patients. Methods A prospective, observational, multicenter study carried out in six Spanish Intensive Care Units. We included patients with severe TBI defined as Glasgow Coma Scale (GCS) lower than 9; and were excluded those patients with Injury Severity Score (ISS) in non-cranial aspects higher than 9. We measured serum CCCK-18 levels at admission. The end-point of the study was 30-day mortality. Results Surviving patients (n = 73) showed lower serum CCCK-18 levels (P = 0.003) than non-survivors (n = 27). On ROC analysis, the area under the curve (AUC) for serum CCCK-18 levels as predictor of 30-day mortality was 0.69 (95% CI = 0.59-0.78; P = 0.006). We found in survival analysis that patients with serum CCCK-18 higher than 201 u/L had higher 30-day mortality than patients with lower levels (Hazard ratio = 3.9; 95% CI = 1.81-8.34; P< 0.001). Regression analyses showed that serum CCCK-18 levels higher than 201 u/L were associated with 30-day mortality (OR = 8.476; 95% CI = 2.087-34.434; P = 0.003) after controlling for age and GCS. Conclusions The novel finding of our study was that serum CCCK-18 levels are associated with 30-day mortality and could be used as a prognostic biomarker in patients with severe TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Deparment, Tenerife, Spain; [Argueso, Monica] Univ Valencia, Hosp Clin, Intens Care Unit, Valencia, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, CIBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Tenerife, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain.	lorentemartin@msn.com		Borreguero Leon, Juan Maria/0000-0001-7414-5278; Argueso, Monica/0000-0001-5917-1056	Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain)	This study was supported by fundings from Fundacion Canaria de Investigacion Sanitaria (FUNCANIS) (La Laguna, Tenerife, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chen R, 2013, EXP THER MED, V6, P1463, DOI 10.3892/etm.2013.1342; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luft T, 2007, BLOOD, V110, P4535, DOI 10.1182/blood-2006-10-049817; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Moore DJ, 2012, CLIN DRUG INVEST, V32, P179, DOI 10.2165/11598610-000000000-00000; Parfieniuk-Kowerda A, 2014, LIVER INT, V34, P544, DOI 10.1111/liv.12297; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Sgier C, 2010, J VIRAL HEPATITIS, V17, P845, DOI 10.1111/j.1365-2893.2009.01251.x; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Sumer S, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10106; TEASDALE G, 1974, LANCET, V2, P81; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764	31	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2015	10	3							e0121739	10.1371/journal.pone.0121739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AD	WOS:000352134700124	25822281	Green Published, Green Submitted, gold			2022-02-06	
J	Carr, W; Yarnell, AM; Ong, R; Walilko, T; Kamimori, GH; da Silva, U; McCarron, RM; LoPresti, ML				Carr, Walter; Yarnell, Angela M.; Ong, Ricardo; Walilko, Timothy; Kamimori, Gary H.; da Silva, Uade; McCarron, Richard M.; LoPresti, Matthew L.			Ubiquitin carboxy-terminal hydrolase-L1 as a serum neurotrauma biomarker for exposure to occupational low-level blast	FRONTIERS IN NEUROLOGY			English	Article						biomarker; blast; military; neurotrauma; breacher	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; CONCUSSION; MILD; SYMPTOMS; RECOVERY; L1	Repeated exposure to low-level blast is a characteristic of a few select occupations and there is concern that such occupational exposures present risk for traumatic brain injury. These occupations include specialized military and law enforcement units that employ controlled detonation of explosive charges for the purpose of tactical entry into secured structures. The concern for negative effects from blast exposure is based on rates of operator self-reported headache, sleep disturbance, working memory impairment, and other concussion-like symptoms. A challenge in research on this topic has been the need for improved assessment tools to empirically evaluate the risk associated with repeated exposure to blast overpressure levels commonly considered to be too low in magnitude to cause acute injury. Evaluation of serum-based neurotrauma biomarkers provides an objective measure that is logistically feasible for use in field training environments. Among candidate biomarkers, ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) has some empirical support and was evaluated in this study. We used daily blood draws to examine acute change in UCH-L1 among 108 healthy military personnel who were exposed to repeated low-level blast across a 2-week period. These research volunteers also wore pressure sensors to record blast exposures, wrist actigraphs to monitor sleep patterns, and completed daily behavioral assessments of symptomology, postural stability, and neurocognitive function. UCH-L1 levels were elevated as a function of participating in the 2-week training with explosives, but the correlation of UCH-L1 elevation and blast magnitude was weak and inconsistent. Also, UCH-L1 elevations did not correlate with deficits in behavioral measures. These results provide some support for including UCH-L1 as a measure of central nervous system effects from exposure to low-level blast. However, the weak relation observed suggests that additional indicators of blast effect are needed.	[Carr, Walter; Yarnell, Angela M.; Kamimori, Gary H.; LoPresti, Matthew L.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Ong, Ricardo] US Army Special Forces Command, Ft Bragg, NC USA; [Walilko, Timothy] Appl Res Associates Inc, Littleton, CO USA; [da Silva, Uade; McCarron, Richard M.] Walter Reed Army Inst Res, NeuroTrauma Dept, Silver Spring, MD 20910 USA		Carr, W (corresponding author), Walter Reed Army Inst Res, Dept Behav Biol, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	walter.s.carr.mil@mail.mil		Olaghere da Silva, Uade/0000-0003-1755-4985	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Navy Bureau of Medicine; US Army Special Operations Command; US Army Engineer School	This work was supported by the US Army Medical Research and Materiel Command and the US Navy Bureau of Medicine. We thank the members of the study team who helped collect and process the data: SGT Ashlie Strickland-Mangano, SGT Benjamin Joiner, SPC George Adams, SSG Kelly McWhirter, SGT Shawn McLoughlin, SSG Dominic Prankienas, SGT Robert Catalano, SGT Reginald Acklin, HM3 Eric Cho, Luke Aurich, Dan Welsh, Brandon Peterson, Zach Gates, Stephanie Eonta, Carmen Contreras-Sesvold, and David Miles. We also thank the leadership from the US Army Special Operations Command and US Army Engineer School for their support and the Soldiers of the units studied for their service to our nation and their participation in the study.	Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; El-Maraghi S, 2013, EGYPT J CRIT CARE ME, V1, P25, DOI 10.1016/j.ejccm.2012.12.002; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goemaere J, 2012, J COMP NEUROL, V520, P258, DOI 10.1002/cne.22689; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Ichikawa T, 2010, BIOCHEM BIOPH RES CO, V391, P852, DOI 10.1016/j.bbrc.2009.11.151; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS3, DOI 10.1016/j.acn.2006.10.001; Kelley A., 2010, 201016 US ARM AER RE; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tator CH, 2002, INJURY PREV, V8, pIV33, DOI 10.1136/ip.8.suppl_4.iv33; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	39	24	24	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 16	2015	6								49	10.3389/fneur.2015.00049			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8CX	WOS:000363769900002	25852633	Green Published, gold			2022-02-06	
J	Perrin, PB; Niemeier, JP; Mougeot, JL; Vannoy, CH; Hirsch, MA; Watts, JA; Rossman, W; Grafton, LM; Guerrier, TD; Pershad, R; Kingsbury, CA; Bartel, SW; Whitney, MP				Perrin, Paul B.; Niemeier, Janet P.; Mougeot, Jean-Luc; Vannoy, Charles H.; Hirsch, Mark A.; Watts, John A.; Rossman, Whitney; Grafton, Lori M.; Guerrier, Tami D.; Pershad, Rashmi; Kingsbury, Carla A.; Bartel, Sheri W.; Whitney, Marybeth P.			Measures of Injury Severity and Prediction of Acute Traumatic Brain Injury Outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; inpatient; outcomes; traumatic brain injury	GLASGOW COMA SCALE; POSTTRAUMATIC AMNESIA DURATION; MILD HEAD-INJURY; FUNCTIONAL OUTCOMES; PRACTICAL SCALE; REHABILITATION; MODERATE; CLASSIFICATION; CONSCIOUSNESS; MULTICENTER	Objective: To examine the comparative efficacy of 3 common measures of traumatic brain injury (TBI) severity for predicting inpatient outcomes upon hospital discharge. Setting: Acute brain injury rehabilitation unit at level 1 trauma center. Participants: 100 patients with TBI. Design: Retrospective analysis of injury severity, demographic, and outcome data. Main Measures: Glasgow Coma Scale (GCS) at admission, time to follow commands (TTC), duration of posttraumatic amnesia (PTA), and Functional Independence Measure at hospital discharge. Results: A hierarchal multiple regression revealed that duration of PTA was a significant and powerful unique predictor of Functional Independence Measure scores at discharge (beta = -0.46, P = .001), while TTC (beta = 0.26, P = .056) and GCS (beta = 0.16, P = .143) were not. These effects were present even after controlling for age, gender, educational level, racial/ethnic minority status, cause of injury, history of substance abuse, and neurosurgical intervention. Conclusion: Although clinicians often use GCS scores and TTC when assessing acute TBI severity and during treatment formulation, this study provides evidence that duration of PTA may be a more meaningful predictor of patients' functional levels at discharge.	[Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Niemeier, Janet P.; Hirsch, Mark A.; Guerrier, Tami D.; Pershad, Rashmi; Kingsbury, Carla A.; Bartel, Sheri W.; Whitney, Marybeth P.] Carolinas Rehabil, Charlotte, NC USA; [Mougeot, Jean-Luc; Vannoy, Charles H.; Rossman, Whitney] Cannon Res Ctr, Charlotte, NC USA; [Watts, John A.] Dept Emergency Med, Charlotte, NC USA; [Grafton, Lori M.] Carolinas Rehabil, Brain Injury Unit, Charlotte, NC USA; [Whitney, Marybeth P.] Carolinas Healthcare Syst, Charlotte, NC 28203 USA		Niemeier, JP (corresponding author), Carolinas Healthcare Syst, Carolinas Rehabil, 1100 Blythe Ave, Charlotte, NC 28203 USA.	Janet.niemeier@carolinashealthcare.org	Hirsch, Mark A./D-2798-2016; Perrin, Paul/L-5373-2015	Hirsch, Mark A./0000-0002-8997-7971; Perrin, Paul/0000-0003-2070-215X; Vannoy, Charles/0000-0003-3617-8081	National Center for Medical Rehabilitation Research (NCMRR); Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD052922-01A2]; NIH CTSA AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR00058]; National Center for Medical Rehabilitation Research (NCMRR) [1RO1HD052922-01A2]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD052922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000058] Funding Source: NIH RePORTER	This research was supported by the National Center for Medical Rehabilitation Research (NCMRR), The Eunice Kennedy Shriver National Institute of Child Health and Human Development, 1R01HD052922-01A2 and, in part, by NIH CTSA Award UL1 TR00058; Dr Niemeier is currently receiving a grant 1RO1HD052922-01A2 from National Center for Medical Rehabilitation Research (NCMRR), The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD).	BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLOMERT DM, 1974, CAN PSYCHIAT ASSOC J, V19, P185, DOI 10.1177/070674377401900215; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Faul M, 2010, TRAUMATIC BRAIN INJU; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Jennett B, 1975, Ciba Found Symp, P309; Jennett B, 1972, Scand J Rehabil Med, V4, P16; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; Kevric J, 2011, EMERG MED J, V28, P486, DOI 10.1136/emj.2009.085845; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; PONSFORD J, J NEUROTRAUM, DOI DOI 10.1089/NEU.2012.2843; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; SICHEZ JP, 1983, NEUROCHIRURGIE, V29, P21; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JM, 1984, J NEUROSURG, V61, P581, DOI 10.3171/jns.1984.61.3.0581	43	24	25	1	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					136	142		10.1097/HTR.0000000000000026			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300016	24590151				2022-02-06	
J	Richardson, C; McKay, A; Ponsford, JL				Richardson, Cally; McKay, Adam; Ponsford, Jennie L.			Factors Influencing Self-Awareness Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						close other; depression; injury severity; self-awareness; traumatic brain injury	IMPAIRED AWARENESS; EXECUTIVE FUNCTION; POSTTRAUMATIC AMNESIA; PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; EMOTIONAL STATUS; HEAD-INJURY; REHABILITATION; DEFICITS	Objective: To examine self-awareness and injury-related, emotional and demographic factors across acute/subacute (3-12 months), medium-term (24-60 months), and long-term (120-240 months) time periods after traumatic brain injury (TBI), because unawareness of injury-related changes can affect engagement in rehabilitation and functional outcomes. Participants: A total of 168 individuals with mild to severe TBI and 105 of their close others. Main Outcomes Measures: Awareness Questionnaire (AQ) and Hospital Anxiety and Depression Scale. Design: Cross-sectional study. Results: There were no significant differences in awareness as a function of time postinjury, except for the AQ motor/sensory domain wherein individuals with TBI at longer time periods displayed increased awareness of deficits than those at earlier time periods. Greater patient-other AQ discrepancy scores (interpreted as lower patient awareness) were associated with longer posttraumatic amnesia duration in the individual with TBI and also with increased self-reported depressive symptoms in the close others. Conversely, smaller AQ discrepancy scores (interpreted as better awareness) were associated with increased self-reported depressive symptoms by the individuals with TBI. Conclusion: This study highlights the limitations of using discrepancy scores to measure awareness, as ratings of injury-related changes are influenced by the mood of the individual with TBI and the close other, as well as by injury severity.	[Richardson, Cally; McKay, Adam; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Richardson, Cally; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKay, Adam] Epworth Rehabil, Melbourne, Vic, Australia		Richardson, C (corresponding author), Monash Univ, Sch Psychol & Psychiat, Wellington Rd, Melbourne, Vic 3800, Australia.	cally.richardson@monash.edu	McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681			Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Jones SJ., 2008, BRIT J OCCUP THER, V71, P44, DOI DOI 10.1177/030802260807100202; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Newman AC, 2000, BRAIN INJURY, V14, P333; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snaith R., 1994, HOSP ANXIETY DEPRESS; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wallace CA, 2000, BRAIN INJURY, V14, P549; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007	65	24	25	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E43	E54		10.1097/HTR.0000000000000048			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300005	24721809				2022-02-06	
J	Trahanas, DM; Cuda, CM; Perlman, H; Schwulst, SJ				Trahanas, Diane M.; Cuda, Carla M.; Perlman, Harris; Schwulst, Steven J.			DIFFERENTIAL ACTIVATION OF INFILTRATING MONOCYTE-DERIVED CELLS AFTER MILD AND SEVERE TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Flow cytometry; mouse brain; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; MYELOID CELLS; SPINAL-CORD; STEM-CELLS; IN-VIVO; MICROGLIA; MACROPHAGES; CNS; FATE; PLAY	Microglia are the resident innate immune cells of the brain. Although embryologically and functionally distinct, they are morphologically similar to peripheral monocyte-derived cells, resulting in a poor ability to discriminate between the two cell types. The purpose of this study was to develop a rapid and reliable method to simultaneously characterize, quantify, and discriminate between whole populations of myeloid cells from the brain in a murine model of traumatic brain injury. Male C57BL/6 mice underwent traumatic brain injury (n = 16) or sham injury (n = 14). Brains were harvested at 24 h after injury. Multiparameter flow cytometry and sequential gating analysis were performed, allowing for discrimination between microglia and infiltrating leukocytes as well as for the characterization and quantification of individual subtypes within the infiltrating population. The proportion of infiltrating leukocytes within the brain increased with the severity of injury, and the predominant cell types within the infiltrating population were monocyte derived (P = 0.01). In addition, the severity of injury altered the overall makeup of the infiltrating monocyte-derived cells. In conclusion, we describe a flow cytometry-based technique for gross discrimination between infiltrating leukocytes and microglia as well as the ability to simultaneously characterize and quantify individual myeloid subtypes and their maturation states within these populations.	[Trahanas, Diane M.; Schwulst, Steven J.] Northwestern Univ, Dept Surg, Div Trauma & Crit Care, Chicago, IL 60611 USA; [Cuda, Carla M.; Perlman, Harris] Northwestern Univ, Dept Med, Div Rheumatol, Chicago, IL 60611 USA		Schwulst, SJ (corresponding author), Northwestern Univ, Dept Surg, Div Trauma & Crit Care, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA.	sschwuls@nmh.org		Cuda, Carla/0000-0002-2022-8171	Shock Society Research Fellowship; American Association for the Surgery of Trauma Research and Education Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AR050250, AR054796, AI092490, HL108795]; Solovy/Arthritis Research Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL108795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21AI092490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K01AR064313, R01AR050250, R01AR054796] Funding Source: NIH RePORTER	This study was supported by the Shock Society Research Fellowship for Early Career Investigators and a grant from the American Association for the Surgery of Trauma Research and Education Foundation (to S.J.S.) and by National Institutes of Health grants (AR050250, AR054796, AI092490, and HL108795) and funds provided by Solovy/Arthritis Research Society Professor (to H.P.).	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FORD AL, 1995, J IMMUNOL, V154, P4309; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Jung S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00089; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009	28	24	25	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAR	2015	43	3					255	260		10.1097/SHK.0000000000000291			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CB1UE	WOS:000349412700009	26091024	Green Accepted			2022-02-06	
J	Tsai, MC; Chang, CP; Peng, SW; Jhuang, KS; Fang, YH; Lin, MT; Tsao, TCY				Tsai, Ming-Che; Chang, Ching-Ping; Peng, Syue-Wei; Jhuang, Kai-Sheng; Fang, Yi-Hsien; Lin, Mao-Tsun; Tsao, Thomas Chang-Yao			Therapeutic Efficacy of Neuro AiD (TM) (MLC 601), a Traditional Chinese Medicine, in Experimental Traumatic Brain Injury	JOURNAL OF NEUROIMMUNE PHARMACOLOGY			English	Article						Astragalosides; Traumatic brain injury; Microglia; Tumor necrosis factor-alpha	MOTOR-ACTIVITY; ADULT-RAT; STROKE; MICROGLIA; EXPRESSION; SYNAPTOGENESIS; ANGIOGENESIS; ETANERCEPT; INHIBITION; ACTIVATION	Traumatic brain injury (TBI) causes increased release of several mediators from injured and dead cells and elicits microglial activation. Activated microglia change their morphology, migrate to injury sites, and release tumor necrosis factor-alpha (TNF-alpha) and others. In this study we used a controlled fluid percussion injury model of TBI in the rat to determine whether early (4 h post-injury) or late (4 days post-injury) treatment with MLC 601, a Traditional Chinese Medicine, would affect microglial activation and improve recovery. MLC 601 was chosen for this study because its herbal component MLC 901 was beneficial in treating TBI in rats. Herein, rats with induced TBI were treated with MLC 601 (0.2-0.8 mg/kg) 1 h (early treatment) or 4 day post-injury (late treatment) and then injected once daily for consecutive 2 days. Acute neurological and motor deficits were assessed in all rats the day before and 4 days after early MLC 601 treatment. An immunofluorescence microscopy method was used to count the numbers of the cells colocalized with neuron- and apoptosis-specific markers, and the cells colocalized with microglia- and TNF-alpha-specific markers, in the contused brain regions 4 days post-injury. An immunohistochemistry method was used to evaluate both the number and the morphological transformation of microglia in the injured areas. It was found that early treatment with MLC 601 had better effects in reducing TBI-induced cerebral contusion than did the late therapy with MLC 601. Cerebral contusion caused by TBI was associated with neurological motor deficits, brain apoptosis, and activated microglia (e.g., microgliosis, amoeboid microglia, and microglial overexpression of TNF-alpha), which all were significantly attenuated by MLC 601 therapy. Our data suggest that MLC 601 is a promising agent for treatment of TBI in rats.	[Tsai, Ming-Che] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tsai, Ming-Che] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Tsai, Ming-Che] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung 40201, Taiwan; [Chang, Ching-Ping; Peng, Syue-Wei; Jhuang, Kai-Sheng; Fang, Yi-Hsien; Lin, Mao-Tsun] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Peng, Syue-Wei] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Jhuang, Kai-Sheng] Natl Chung Cheng Univ, Inst Biomed Sci, Inst Mol Biol, Dept Life Sci, Chiayi, Taiwan; [Chang, Ching-Ping; Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Tsao, Thomas Chang-Yao] Chung Shan Med Univ Hosp, Div Thorac Med, Taichung 40201, Taiwan; [Tsao, Thomas Chang-Yao] Chung Shan Med Univ, Taichung, Taiwan		Lin, MT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	891201@mail.chimei.org.tw; tcyt@csmu.edu.tw		Chang, Ching-Ping/0000-0003-0890-9414	Taiwan National Science and Technology Department [NSC 101-2314-B-218-001-MY3]	This work was supported by research grant NSC 101-2314-B-218-001-MY3 from the Taiwan National Science and Technology Department.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Batchelor PE, 1999, J NEUROSCI, V19, P1708; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen CLH, 2013, STROKE, V44, P3580, DOI 10.1161/STROKEAHA.113.003226; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Ding YC, 2002, J NEUROSURG, V96, P310, DOI 10.3171/jns.2002.96.2.0310; Ding YC, 2002, BEHAV BRAIN RES, V132, P29, DOI 10.1016/S0166-4328(01)00405-3; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gan R, 2008, CEREBROVASC DIS, V25, P450, DOI 10.1159/000126919; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Kleim JA, 1996, J NEUROSCI, V16, P4529; Klintsova AY, 1998, BRAIN RES, V800, P48, DOI 10.1016/S0006-8993(98)00495-8; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maati HMO, 2012, NEUROPHARMACOLOGY, V63, P692, DOI 10.1016/j.neuropharm.2012.05.035; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Navarro JC, 2014, 23 EUR STROK C NIC; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Rimaniol AC, 1995, NEUROREPORT, V7, P133, DOI 10.1097/00001756-199512290-00032; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scherbel U., 1997, J NEUROTRAUM, V14, P781; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Wang Y, 1997, J NEUROSCI, V17, P4341; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398	46	24	24	0	10	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1557-1890	1557-1904		J NEUROIMMUNE PHARM	J. Neuroimmune Pharm.	MAR	2015	10	1					45	54		10.1007/s11481-014-9570-0			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CC4PK	WOS:000350335100005	25331680				2022-02-06	
J	Wintermark, M; Coombs, L; Druzgal, TJ; Field, AS; Filippi, CG; Hicks, R; Horton, R; Lui, YW; Law, M; Mukherjee, P; Norbash, A; Riedy, G; Sanelli, PC; Stone, JR; Sze, G; Tilkin, M; Whitlow, CT; Wilde, EA; York, G; Provenzale, JM				Wintermark, M.; Coombs, L.; Druzgal, T. J.; Field, A. S.; Filippi, C. G.; Hicks, R.; Horton, R.; Lui, Y. W.; Law, M.; Mukherjee, P.; Norbash, A.; Riedy, G.; Sanelli, P. C.; Stone, J. R.; Sze, G.; Tilkin, M.; Whitlow, C. T.; Wilde, E. A.; York, G.; Provenzale, J. M.		Amer Coll Radiology	Traumatic Brain Injury Imaging Research Roadmap	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							COMMON DATA ELEMENTS; WHITE-MATTER ABNORMALITIES; MILD HEAD TRAUMA; FUNCTIONAL CONNECTIVITY; COGNITIVE DEFICITS; OUTCOME MEASURES; RECOMMENDATIONS; MEG; MODERATE; SPECT	The past decade has seen impressive advances in the types of neuroimaging information that can be acquired in patients with traumatic brain injury. However, despite this increase in information, understanding of the contribution of this information to prognostic accuracy and treatment pathways for patients is limited. Available techniques often allow us to infer the presence of microscopic changes indicative of alterations in physiology and function in brain tissue. However, because histologic confirmation is typically lacking, conclusions reached by using these techniques remain solely inferential in almost all cases. Hence, a need exists for validation of these techniques by using data from large population samples that are obtained in a uniform manner, analyzed according to well-accepted procedures, and correlated with closely monitored clinical outcomes. At present, many of these approaches remain confined to population-based research rather than diagnosis at an individual level, particularly with regard to traumatic brain injury that is mild or moderate in degree. A need and a priority exist for patient-centered tools that will allow advanced neuroimaging tools to be brought into clinical settings. One barrier to developing these tools is a lack of an age-, sex-, and comorbidities-stratified, sequence-specific, reference imaging data base that could provide a clear understanding of normal variations across populations. Such a data base would provide researchers and clinicians with the information necessary to develop computational tools for the patient-based interpretation of advanced neuroimaging studies in the clinical setting. The recent "Joint ASNR-ACR HII-ASFNR TBI Workshop: Bringing Advanced Neuroimaging for Traumatic Brain Injury into the Clinic" on May 23, 2014, in Montreal, Quebec, Canada, brought together neuroradiologists, neurologists, psychiatrists, neuropsychologists, neuroimaging scientists, members of the National Institute of Neurologic Disorders and Stroke, industry representatives, and other traumatic brain injury stakeholders to attempt to reach consensus on issues related to and develop consensus recommendations in terms of creating both a well-characterized normative data base of comprehensive imaging and ancillary data to serve as a reference for tools that will allow interpretation of advanced neuroimaging tests at an individual level of a patient with traumatic brain injury. The workshop involved discussions concerning the following: 1) designation of the policies and infrastructure needed for a normative data base, 2) principles for characterizing normal control subjects, and 3) standardizing research neuroimaging protocols for traumatic brain injury. The present article summarizes these recommendations and examines practical steps to achieve them.	[Wintermark, M.] Stanford Univ, Dept Radiol, Neuroradiol Div, Stanford, CA 94305 USA; [Coombs, L.; Horton, R.; Tilkin, M.] Amer Coll Radiol, Reston, VA USA; [Druzgal, T. J.; Stone, J. R.] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [Stone, J. R.] Univ Virginia, Dept Med Imaging & Neurol Surg, Charlottesville, VA USA; [Field, A. S.] Univ Wisconsin, Dept Radiol, Neuroradiol Sect, Madison, WI 53706 USA; [Filippi, C. G.] Columbia Univ, Dept Radiol, New York, NY USA; [Filippi, C. G.; Sanelli, P. C.] North Shore Long Isl Jewish Hlth Syst, Dept Radiol, Manhasset, NY USA; [Hicks, R.] One Mind, Seattle, WA USA; [Lui, Y. W.] NYU, Dept Radiol, Neuroradiol Div, Sch Med, New York, NY 10016 USA; [Law, M.] Univ So Calif, Dept Radiol, Neuroradiol Sect, Los Angeles, CA USA; [Mukherjee, P.] Univ Calif San Francisco, Dept Radiol, Neuroradiol Sect, San Francisco, CA 94143 USA; [Norbash, A.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Riedy, G.] Natl Intrepid Ctr Excellence, Washington, DC USA; [Sze, G.] Yale Univ, Dept Radiol, Neuroradiol Sect, New Haven, CT USA; [Whitlow, C. T.] Wake Forest Sch Med, Dept Radiol, Neuroradiol & Translat Sci Inst, Winston Salem, NC USA; [Wilde, E. A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, E. A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, E. A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [York, G.] San Antonio Mil Med Ctr, San Antonio, TX USA; [Provenzale, J. M.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA		Wintermark, M (corresponding author), Stanford Univ, Dept Radiol, Neuroradiol Div, 300 Pasteur Dr,Room SO47, Stanford, CA 94305 USA.	Max.Wintermark@gmail.com	Rettmann, Dan/G-5265-2015; Filippi, Christopher/AAA-5493-2021	Druzgal, Jason/0000-0001-7240-9487; Mukherjee, Pratik/0000-0001-7473-7409; Andrews, Trevor/0000-0003-0331-1798; Wintermark, Max/0000-0002-6726-3951	American Society of Neuroradiology; Head Injury Institute of the American College of Radiology; American Society of Functional Neuroradiology; GE HealthcareGeneral ElectricGE Healthcare; Philips Healthcare	We wish to acknowledge the generous support of the American Society of Neuroradiology, the Head Injury Institute of the American College of Radiology, the American Society of Functional Neuroradiology, GE Healthcare and Philips Healthcare, whose contributions made possible the "Joint ASNR-ACR HII-ASFNR TBI Workshop: Bringing Advanced Neuroimaging for TBI into the Clinic," held on Friday May 23, 2014, in Montreal, Quebec, Canada, as a parallel session during the 52nd Annual Meeting of the ASNR and The Foundation of the ASNR Symposium 2014,	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Batoulis H, 2014, CLIN EXP IMMUNOL, V175, P41, DOI 10.1111/cei.12209; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chokshi FH, 2011, AM J ROENTGENOL, V196, pW309, DOI 10.2214/AJR.10.4548; Das S, 2012, FRONT NEUROINFORM, V5, DOI 10.3389/fninf.2011.00037; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	51	24	24	0	19	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2015	36	3					E12	E23		10.3174/ajnr.A4254			12	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CD3PL	WOS:000350990900001	25655872	Green Published, hybrid			2022-02-06	
J	DeMatteo, C; Stazyk, K; Singh, SK; Giglia, L; Hollenberg, R; Malcolmson, CH; Mahoney, W; Harper, JA; Missiuna, C; Law, M; McCauley, D				DeMatteo, Carol; Stazyk, Kathy; Singh, Sheila K.; Giglia, Lucy; Hollenberg, Robert; Malcolmson, Charles H.; Mahoney, William; Harper, Jessica A.; Missiuna, Cheryl; Law, Mary; McCauley, Dayle			Development of a Conservative Protocol to Return Children and Youth to Activity Following Concussive Injury	CLINICAL PEDIATRICS			English	Article						child; mild traumatic brain injury; concussion; return to play; return to activity; postconcussion syndrome; recovery	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TO-PLAY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; RECURRENT CONCUSSION; CONSENSUS STATEMENT; PATHOPHYSIOLOGY; ADOLESCENTS	Background. Consensus-based guidelines exist for adult athletes returning to play after concussion, but there are no protocols developed specifically for children. The goal of this knowledge translation research was to develop evidence-based materials to inform physicians about pediatric concussion. Methods. A pediatric concussion protocol was developed based on the National Institute for Health and Care Excellence procedures. Results. This return to activity protocol was developed to guide management when children/youth sustain a concussion. The protocol incorporated 3 main themes: (a) a protocol must include return to all activity, including sport and school; (b) existing consensus-based adult protocols are not appropriate for children; and (c) a more conservative protocol is needed. After pilot testing, the developed protocol is being used across Ontario. Conclusion. Implementation of these new pediatric recommendations is an important addition to prevention of subsequent concussions during vulnerable recovery periods, with potential to facilitate recovery by preventing prolonged symptomatology, and secondary sequelae.	[DeMatteo, Carol; Stazyk, Kathy; Singh, Sheila K.; Giglia, Lucy; Hollenberg, Robert; Malcolmson, Charles H.; Mahoney, William; Harper, Jessica A.; Missiuna, Cheryl; Law, Mary] McMaster Univ, Hamilton, ON L8S 1C7, Canada; [Singh, Sheila K.; Giglia, Lucy; Hollenberg, Robert; Malcolmson, Charles H.; McCauley, Dayle] McMaster Childrens Hosp, Hamilton, ON, Canada		DeMatteo, C (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 403, Hamilton, ON L8S 1C7, Canada.	dematteo@mcmaster.ca	Singh, Sheila K/W-2799-2018	Singh, Sheila K/0000-0003-1272-5300	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [115228]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Canadian Institute of Health Research (Grant No. 115228).	[Anonymous], 2010, THINKFIRST SPORT SMA; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Berlin AA, 2006, PSYCHOSOM MED, V68, pA; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; *CDCP, WHAT IS TRAUM BRAIN; Centre for Evidence Based Medicine, FIND THE EV; Colorado Medical Society School and Sports Medicine Committee, 1990, COLO MED, V87, P4; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kelly JP, 1997, NEUROLOGY, V48, P581; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Laker SR, 2011, PHYS MED REH CLIN N, V22, P619, DOI 10.1016/j.pmr.2011.08.004; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Morin D, 2011, AM AC PED NAT C OCT; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Institute for Health and Care Excellence (NICE), WHO WE AR; Ontario Neurotrauma Foundation, GUID CONC MTBI PERS; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	70	24	24	0	27	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	FEB	2015	54	2					152	163		10.1177/0009922814558256			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AZ4NA	WOS:000348197200008	25422524				2022-02-06	
J	Kiers, H; van Dieen, JH; Brumagne, S; Vanhees, L				Kiers, Henri; van Dieen, Jaap H.; Brumagne, Simon; Vanhees, Luc			Postural sway and integration of proprioceptive signals in subjects with LBP	HUMAN MOVEMENT SCIENCE			English	Article						Low back pain; Postural control; Proprioception; Center of pressure; Nonlinear methods	LOW-BACK-PAIN; OF-PRESSURE TRAJECTORIES; TEST-RETEST RELIABILITY; MUSCLE VIBRATION; CEREBRAL CONCUSSION; TENDON VIBRATION; MOVEMENT; BALANCE; VARIABILITY; REGULARITY	Patients with non-specific low back pain (LBP) may use postural control strategies that differ from healthy subjects. To study these possible differences, we measured the amount and structure of postural sway, and the response to muscle vibration in a working cohort of 215 subjects. Subjects were standing on a force plate in bipedal stance. In the first trial the eyes were open, no perturbation applied. In the following 6 trials, vision was occluded and subjects stood under various conditions of vibration/no vibration of the lumbar spine or m. Triceps Surae (TSM) on firm surface and on foam surface. We performed a factor analysis to reduce the large amount of variables that are available to quantify all effects. Subjects with LBP showed the same amount of sway as subjects without LBP, but the structure of their sway pattern was less regular with higher frequency content. Subjects with LBP also showed a smaller response to TSM vibration, and a slower balance recovery after cessation of vibration when standing on a solid surface. There was a weak but significant association between smaller responses to TSM vibration and an irregular, high frequency sway pattern, independent from LBP. A model for control of postural sway is proposed. This model suggests that subjects with LBP use more co-contraction and less cognitive control, to maintain a standing balance when compared to subjects without LBP. In addition, a reduced weighting of proprioceptive signals in subjects with LBP is suggested as an explanation for the findings in this study. (C) 2014 Published by Elsevier B.V.	[Kiers, Henri; Vanhees, Luc] Univ Appl Sci Utrecht, Res Grp Lifestyle & Hlth, Utrecht, Netherlands; [van Dieen, Jaap H.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands; [Brumagne, Simon; Vanhees, Luc] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium		Kiers, H (corresponding author), Bolognalaan 101, NL-3584 CJ Utrecht, Netherlands.	henri.kiers@hu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Brumagne, Simon/0000-0002-0251-9338			Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 1999, J ORTHOP SPORT PHYS, V29, P345, DOI 10.2519/jospt.1999.29.6.345; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Claeys K, 2011, EUR J APPL PHYSIOL, V111, P115, DOI 10.1007/s00421-010-1637-x; Cordo PJ, 2005, EXP BRAIN RES, V167, P324, DOI 10.1007/s00221-005-0034-x; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Gautier G, 2008, J MOTOR BEHAV, V40, P400, DOI 10.3200/JMBR.40.5.400-408; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; Johanson E, 2011, EUR SPINE J, V20, P2152, DOI 10.1007/s00586-011-1825-3; Kiers H, 2014, GAIT POSTURE, V40, P166, DOI 10.1016/j.gaitpost.2014.03.184; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Mazaheri M, 2013, GAIT POSTURE, V37, P12, DOI 10.1016/j.gaitpost.2012.06.013; Mazaheri M, 2010, GAIT POSTURE, V31, P116, DOI 10.1016/j.gaitpost.2009.09.009; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Nafati G, 2011, RES Q EXERCISE SPORT, V82, P634, DOI 10.1080/02701367.2011.10599800; Negahban H, 2014, KNEE SURG SPORT TR A, V22, P1491, DOI 10.1007/s00167-013-2501-4; Nijs J, 2012, CLIN J PAIN, V28, P175, DOI 10.1097/AJP.0b013e318225daf3; O'Sullivan PB, 2003, SPINE, V28, P1074, DOI 10.1097/00007632-200305150-00022; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Riley MA, 2003, BRAIN RES BULL, V62, P191, DOI 10.1016/j.brainresbull.2003.09.012; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Ruhe A, 2013, J BACK MUSCULOSKELET, V26, P401, DOI 10.3233/BMR-130399; Ruhe A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-39; Ruhe A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-162; Ruhe A, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-13; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Sipko T., 2012, EUROPEAN J PAIN; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; van Drunen P, 2013, J BIOMECH, V46, P1440, DOI 10.1016/j.jbiomech.2013.03.007; Vuillerme N, 2001, NEUROSCI LETT, V311, P73, DOI 10.1016/S0304-3940(01)02147-4; Willigenburg NW, 2013, HUM MOVEMENT SCI, V32, P228, DOI 10.1016/j.humov.2012.12.007; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yilmaz B, 2010, TURK J RHEUMATOL, V25, P68, DOI 10.5152/tjr.2010.04; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	51	24	24	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	FEB	2015	39						109	120		10.1016/j.humov.2014.05.011			12	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	CA2NY	WOS:000348746100010	25436915	Green Published			2022-02-06	
J	Bivona, U; Formisano, R; De Laurentiis, S; Accetta, N; Di Cosimo, MR; Massicci, R; Ciurli, P; Azicnuda, E; Silvestro, D; Sabatini, U; Caravasso, CF; Carlesimo, GA; Caltagirone, C; Costa, A				Bivona, Umberto; Formisano, Rita; De Laurentiis, Sara; Accetta, Natascia; Di Cosimo, Maria Rita; Massicci, Roberta; Ciurli, Paola; Azicnuda, Eva; Silvestro, Daniela; Sabatini, Umberto; Caravasso, Chiara Falletta; Carlesimo, Giovanni Augusto; Caltagirone, Carlo; Costa, Alberto			Theory of mind impairment after severe traumatic brain injury and its relationship with caregivers' quality of life	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; theory of mind; self-awareness; quality of life; psychological support; neuropsychotherapeutic approach	COMPETENCE RATING-SCALE; SELF-AWARENESS; SOCIAL COGNITION; REHABILITATION; QOLIBRI; REPRESENTATION; PERSPECTIVE; VALIDATION; DEFICITS; BELIEFS	Purpose: Theory of mind (ToM) deficits are common consequences of severe Traumatic Brain Injury (sTBI), but little is known about their impact on patients' and their caregivers' quality of life. This study aimed (i) to examine the presence of ToM difficulties in individuals with sTBI and adequate levels of self-awareness (SA); (ii) to investigate their relationship with perceived Health Related Quality of Life (HRQoL) in patients and their caregivers. Methods: Twenty individuals with sTBI and adequate levels of SA, and 20 healthy controls (HCs) were recruited. ToM was examined by the Faux-pas Recognition paradigm. The QOLIBRI questionnaire was administered to patients and their caregivers to assess their HRQoL. Cognitive functioning and psychopathology were evaluated. Results: Individuals with sTBI were less accurate than HCs on the Faux-pas Recognition paradigm. Patients' satisfaction of HRQoL was related to their performance on the Wisconsin Card Sorting Test. Caregivers' satisfaction was significantly predicted by patients' score on the Faux-pas paradigm. Conclusions: ToM is impaired in individuals with sTBI and adequate levels of SA. Moreover, their ToM performance predicted HRQoL in the caregivers. From a clinical perspective, these results provide understanding of the potential impact of ToM impairment in subjects with sTBI and their social system.	[Bivona, Umberto; Formisano, Rita; De Laurentiis, Sara; Accetta, Natascia; Di Cosimo, Maria Rita; Massicci, Roberta; Ciurli, Paola; Azicnuda, Eva; Silvestro, Daniela; Sabatini, Umberto; Caravasso, Chiara Falletta; Carlesimo, Giovanni Augusto; Caltagirone, Carlo; Costa, Alberto] Fdn Santa Lucia, Rome, Italy; [Carlesimo, Giovanni Augusto; Caltagirone, Carlo] Univ Roma Tor Vergata, Rome, Italy		Bivona, U (corresponding author), IRCCS, Fdn Santa Lucia, Via Ardeatina 306, I-00100 Rome, Italy.	u.bivona@hsantalucia.it	Costa, Alberto/AAA-7038-2019; Massicci, Roberta/J-5596-2018; Sabatini, Umberto/K-4659-2016; Azicnuda, Eva/K-9010-2016	Massicci, Roberta/0000-0003-2154-6822; Sabatini, Umberto/0000-0001-5321-8626; COSTA, Alberto/0000-0002-4784-5524; Falletta Caravasso, Chiara/0000-0003-3389-2853			Bagby R.M., 1997, DISORDERS AFFECT REG, P26, DOI DOI 10.1017/CBO9780511526831.005; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S. J., 2000, UNDERSTANDING OTHER; Basso A, 1987, Funct Neurol, V2, P189; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; BROTHERS L, 1992, J COGNITIVE NEUROSCI, V4, P107, DOI 10.1162/jocn.1992.4.2.107; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Costa A, 2008, BEHAV NEUROL, V19, P71, DOI 10.1155/2008/694632; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Hagen C., 2005, LEVELS COGNITIVE FUN; Hamilton H., J NEUROL NEUROSURG P, V23, P56; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton RK, 2000, FORMA COMPLETA REVIS, P1; Hoofien D, 2006, ISR J PSYCHIATR REL, V43, P296; JENNETT B, 1975, LANCET, V1, P480; Keenan J.P., 2003, FACE MIRROR SEARCH O; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Maat A, 2012, SCHIZOPHR RES, V137, P212, DOI 10.1016/j.schres.2012.02.017; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Orsini A., 2003, B PSICOL APPL, V239, P73; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; TEASDALE G, 1974, LANCET, V2, P81; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	60	24	25	0	22	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	3					335	345		10.3233/RNN-140484			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CK9CU	WOS:000356538900008	25720542				2022-02-06	
J	Bodanapally, UK; Saksobhavivat, N; Shanmuganathan, K; Aarabi, B; Roy, AK				Bodanapally, Uttam K.; Saksobhavivat, Nitima; Shanmuganathan, Kathirkamanathan; Aarabi, Bizhan; Roy, Ashis K.			Arterial injuries after penetrating brain injury in civilians: risk factors on admission head computed tomography	JOURNAL OF NEUROSURGERY			English	Article						intracranial arterial injuries; penetrating traumatic brain injury; traumatic intracranial pseudoaneurysms; trauma	TRAUMATIC ANEURYSMS; SUBARACHNOID HEMORRHAGE; DIAGNOSIS; ANGIOGRAPHY; MANAGEMENT; WOUNDS	OBJECT The object of this study was to determine the specific CT findings of the injury profile in penetrating brain injury (PBI) that are risk factors related to intracranial arterial injuries. METHODS The authors retrospectively evaluated admission head CTs and accompanying digital subtraction angiography (DSA) studies from patients with penetrating trauma to the head in the period between January 2005 and December 2012. Two authors reviewed the CT images to determine the presence or absence of 30 injury profile variables and quantified selected variables. The CT characteristics in patients with and without arterial injuries were compared using univariate analysis, multivariate analysis, and receiver operating characteristic (ROC) curve analysis to determine the respective risk factors, independent predictors, and optimal threshold values for the continuous variables. RESULTS Fifty:five patients were eligible for study inclusion. The risk factors for an intracranial arterial injury on univariate analysis were an entry wound over the frontobasal-temporal regions, a bihemispheric wound trajectory, a wound trajectory in proximity to the circle of Willis (COW), a subarachnoid hemorrhage (SAH), a higher SAH score, an intraventricular hemorrhage (IVH), and a higher IVH score. A trajectory in proximity to the COW was the best predictor of injury (OR 6.8 and p = 0.005 for all penetrating brain injuries [PBIs]; OR 13.3 and p = 0.001 for gunshot wounds [GSWs]). Significant quantitative variables were higher SAH and IVH scores. An SAH score of 3 (area under the ROC curve [AUC] for all PBIs 0.72; AUC for GSWs 0.71) and an IVH score of 3 (AUC for all PBIs 0.65; AUC for GSWs 0.65) could be used as threshold values to suggest an arterial injury. CONCLUSIONS The risk factors identified may help radiologists suggest the possibility of arterial injury and prioritize neurointerventional consultation and potential DSA studies.	[Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Roy, Ashis K.] Univ Maryland, Med Ctr, Dept Radiol, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Aarabi, Bizhan] Univ Maryland, Med Ctr, Dept Neurosurg, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Saksobhavivat, Nitima] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Radiol, Bangkok 10700, Thailand		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu					AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Aarabi B, 2001, J TRAUMA S, V51, pS26; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Sliker CW, 2008, AM J ROENTGENOL, V190, P790, DOI 10.2214/AJR.07.2378; Steenburg SD, 2010, RADIOGRAPHICS, V30, P869, DOI 10.1148/rg.304105022	13	24	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2015	122	1					219	226		10.3171/2014.9.JNS14679			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX5DQ	WOS:000346947600031	25361486	Bronze			2022-02-06	
J	DeMatteo, C; McCauley, D; Stazyk, K; Harper, J; Adamich, J; Randall, S; Missiuna, C				DeMatteo, Carol; McCauley, Dayle; Stazyk, Kathy; Harper, Jessica; Adamich, John; Randall, Sarah; Missiuna, Cheryl			Post-concussion return to play and return to school guidelines for children and youth: a scoping methodology	DISABILITY AND REHABILITATION			English	Article						Concussion; children; guidelines; participation; school	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TO-PLAY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY; SYMPTOMS; PATHOPHYSIOLOGY; RECOMMENDATIONS; ABNORMALITIES	Purpose: The objective of this study was to identify and describe management strategies to ensure safe return to activity (RTA) and return to school (RTS) of children with mild traumatic brain injury (MTBI) and determine whether they are evidence-based. Methods: A scoping methodology was conducted using research published between 1990 and 2013, gray literature and clinical expertise. Once the data had been charted, an expert panel of physicians and clinicians was consulted to inform and validate study findings. An analytical and thematic framework was used to examine the study findings. Results: A total of 400 potentially relevant published articles, 100 websites and 24 iPad Applications were found. Ten articles and three web-based resources met inclusion criteria and were included in the final review. Nine articles recommended a more conservative approach to RTA, as well as identified a step-wise or severity-oriented approach. General recommendations were also found regarding safe RTS. One study recommended a stepwise RTS protocol for children. Conclusions: This scoping methodology determined that the most comprehensive guidelines for management are focused on adults. Evidence concerning prolonged recovery patterns in children and the impact of concussion on the developing brain suggests that pediatric-specific guidelines are needed for RTA and RTS after MTBI/concussion.	[DeMatteo, Carol; McCauley, Dayle; Stazyk, Kathy; Missiuna, Cheryl] McMaster Univ, Sch Rehabil Sci, Hamilton, ON L8S 1C7, Canada; [DeMatteo, Carol; McCauley, Dayle; Stazyk, Kathy; Harper, Jessica; Adamich, John; Randall, Sarah; Missiuna, Cheryl] Ctr Childhood Disabil Res, CanChild, Hamilton, ON, Canada		DeMatteo, C (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 433, Hamilton, ON L8S 1C7, Canada.	dematteo@mcmaster.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [115228]	This scoping methodology was funded as part of a knowledge translation study funded through the Canadian Institutes of Health Research (funding reference number: 115228).	Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; [Anonymous], 1991, COL MED SOC REP SPOR; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Faul M, 2010, CTR DIS CONTROL PREV; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman D, 2011, MONTREAL CHILDRENS H; Grey Literature Network Service, 1999, 4 INT C GREY LIT OCT; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kelly JP, 1997, NEUROLOGY, V48, P581; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kissick J, 2005, NEW CONCUSSION MANAG; Laker SR, 2011, PHYS MED REH CLIN N, V22, P619, DOI 10.1016/j.pmr.2011.08.004; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mays N., 2001, SYNTHESISING RES EVI, P188; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Morin D, 2011, AM AC PED NAT C EXH; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	63	24	25	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	12					1107	1112		10.3109/09638288.2014.952452			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CG2SK	WOS:000353125000012	25144831				2022-02-06	
J	Dorman, JC; Valentine, VD; Munce, TA; Tjarks, BJ; Thompson, PA; Bergeron, MF				Dorman, Jason C.; Valentine, Verle D.; Munce, Thayne A.; Tjarks, B. Joel; Thompson, Paul A.; Bergeron, Michael F.			Tracking postural stability of young concussion patients using dual-task interference	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Balance; Brain injury; Clinical assessment; Cognitive function; Injury management	MILD HEAD-INJURY; BALANCE PERFORMANCE; FOOTBALL PLAYERS; SEX-DIFFERENCES; COGNITIVE TASK; BRAIN; STATEMENT; RECOVERY; SYMPTOMS; DEFICITS	Objectives: This study examined the diagnostic benefit of using dual-task interference balance testing in young concussion patients and the longitudinal changes in postural stability that occur relative to other standard clinical assessments of concussion injury. Design: Longitudinal, case-control. Methods: Eighteen patients (16.6 (1.6)y) diagnosed with a concussion provided 22 separate ratings to characterize the severity of their current concussion-related symptoms and were evaluated for postural stability at each of four clinical visits. Twenty-six injury-free adolescents (17 (2.8) y) performed balance testing on two occasions, separated by 1 week. Results: There was a progressive decrease in self-reported symptoms from visit 1 to visit 4 (P<0.0001-0.001). A similar improvement occurred in postural stability, indicated by 95% ellipse area and velocity. However, the differences in ellipse area and velocity were significant only between visit 1 and the rest of the visits as a whole (P<0.0001-0.05). There was a significant difference between concussion patients and healthy, injury-free participants in ellipse area and velocity during visit 1. A group difference was also observed in ellipse area on visit 2, but only during the two balance tests that involved a concomitant secondary cognitive task. Conclusions: Improvements in postural stability coincide with reductions in reported symptoms, though apparent recovery of these selected measures of postural stability seemingly occurs sooner. Because of the distinguishing time course of recovery indicated by dual-task interference balance testing, this type of balance testing assessment may be particularly valuable in evaluating integrated functional impairment and recovery in young concussion patients. (C) 2013 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Dorman, Jason C.; Munce, Thayne A.; Bergeron, Michael F.] Sanford USD Med Ctr, Natl Inst Athlet Hlth & Performance, Sioux Falls, SD 57117 USA; [Valentine, Verle D.] Sanford USD Med Ctr, Sanford Orthoped & Sports Med, Sioux Falls, SD USA; [Valentine, Verle D.; Munce, Thayne A.; Tjarks, B. Joel; Thompson, Paul A.; Bergeron, Michael F.] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA; [Thompson, Paul A.] Sanford Res, Methodol & Data Anal Ctr, Sioux Falls, SD USA		Dorman, JC (corresponding author), Sanford USD Med Ctr, Natl Inst Athlet Hlth & Performance, Sioux Falls, SD 57117 USA.	jason.dorman@sanfordhealth.org	Meijer, Anna/K-5118-2016	Thompson, Paul/0000-0002-8612-165X			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brauer SG, 2004, HUM MOVEMENT SCI, V23, P489, DOI 10.1016/j.humov.2004.08.020; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Giza CC, 2013, NEUROLOGY, P1; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Holmes JD, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/696492; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Morris M, 2000, GAIT POSTURE, V12, P205, DOI 10.1016/S0966-6362(00)00076-X; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wu T., 2009, US NEUROL, V5, P30, DOI [10.17925/USN.2009.05.01.30, DOI 10.17925/USN.2009.05.01.30]	26	24	24	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JAN	2015	18	1					2	7		10.1016/j.jsams.2013.11.010			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AY7UK	WOS:000347764000002	24380848				2022-02-06	
J	Kim, C; Searson, PC				Kim, Chloe; Searson, Peter C.			Magnetic bead-quantum dot assay for detection of a biomarker for traumatic brain injury	NANOSCALE			English	Article							IMMUNOMAGNETIC SEPARATION; SANDWICH ASSAY; NANOPARTICLES; CANCER; S-100B	Current diagnostic methods for traumatic brain injury (TBI), which accounts for 15% of all emergency room visits, are limited to neuroimaging modalities. The challenges of accurate diagnosis and monitoring of TBI have created the need for a simple and sensitive blood test to detect brain-specific biomarkers. Here we report on an assay for detection of S100B, a putative biomarker for TBI, using antibody-conjugated magnetic beads for capture of the protein, and antibody-conjugated quantum dots for optical detection. From Western Blot, we show efficient antigen capture and concentration by the magnetic beads. Using magnetic bead capture and quantum dot detection in serum samples, we show a wide detection range and detection limit below the clinical cut-off level.	[Kim, Chloe; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Kim, Chloe; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA		Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 North Charles St, Baltimore, MD 21218 USA.	searson@jhu.edu		Searson, Peter/0000-0002-5417-0828			Astrand R., 2012, TRAUMATIC BRAIN INJU, P176, DOI [10.1039/9781849734745-00176, DOI 10.1039/9781849734745-00176]; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bettermann K., 2012, TRAUMATIC BRAIN INJU, P1, DOI [10.1039/9781849734745-00001, DOI 10.1039/9781849734745-00001]; Bruno JG, 2009, J FLUORESC, V19, P427, DOI 10.1007/s10895-008-0429-8; Dambinova S. A., 2012, TRAUMATIC BRAIN INJU, P200, DOI [10.1039/9781849734745-00200, DOI 10.1039/9781849734745-00200]; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Franzreb M, 2006, APPL MICROBIOL BIOT, V70, P505, DOI 10.1007/s00253-006-0344-3; Galloway JF, 2012, NANOMED-NANOTECHNOL, V8, P1190, DOI 10.1016/j.nano.2011.12.002; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; HAUSER H, 1981, BIOCHIM BIOPHYS ACTA, V650, P21, DOI 10.1016/0304-4157(81)90007-1; Huang KW, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-413; Jin T, 2010, MOL BIOSYST, V6, P2325, DOI 10.1039/c0mb00056f; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kim C, 2014, BIOCONJUGATE CHEM, V25, P1893, DOI 10.1021/bc5003778; Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; KONDO A, 1994, APPL MICROBIOL BIOT, V41, P99; Lee KH, 2012, NANOMED-NANOTECHNOL, V8, P1043, DOI 10.1016/j.nano.2012.01.005; Li N, 2013, ANAL CHEM, V85, P9699, DOI 10.1021/ac402082s; Lisi F, 2012, ADV HEALTHC MATER, V1, P631, DOI 10.1002/adhm.201200072; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Park H, 2013, INT J NANOMED, V8, P4543, DOI 10.2147/IJN.S51893; Park H, 2013, NANOSCALE, V5, P8609, DOI 10.1039/c3nr02357e; Park H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/28/285103; Pei XM, 2013, ANAL CHIM ACTA, V758, P1, DOI 10.1016/j.aca.2012.10.060; Petryayeva E, 2013, APPL SPECTROSC, V67, P215, DOI 10.1366/12-06948; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Su XL, 2004, ANAL CHEM, V76, P4806, DOI 10.1021/ac049442+; Tennico YH, 2010, ANAL CHEM, V82, P5591, DOI 10.1021/ac101269u; Vacklin HP, 2005, BBA-BIOMEMBRANES, V1668, P17, DOI 10.1016/j.bbamem.2004.11.001; WRIGHT DJ, 1994, EPIDEMIOL INFECT, V113, P31, DOI 10.1017/S0950268800051438; Yu LSL, 2001, J IMMUNOL METHODS, V256, P11, DOI 10.1016/S0022-1759(01)00372-6; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463; Yu X, 2013, BIOSENS BIOELECTRON, V41, P129, DOI 10.1016/j.bios.2012.08.007; Zhu XS, 2010, ANALYST, V135, P381, DOI 10.1039/b918623a; Zrazhevskiy P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2635	42	24	25	1	49	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	42					17820	17826		10.1039/c5nr05608j			7	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CU6OB	WOS:000363650700029	26457768				2022-02-06	
J	Lam, KC; Valier, ARS; McLeod, TCV				Lam, Kenneth C.; Valier, Alison R. Snyder; McLeod, Tamara C. Valovich			Injury and Treatment Characteristics of Sport-Specific Injuries Sustained in Interscholastic Athletics: A Report From the Athletic Training Practice-Based Research Network	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						medical coverage; practice characteristics; adolescent athletes	STATES HIGH-SCHOOL; US HIGH-SCHOOL; SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; SOCCER INJURIES; FOOTBALL INJURIES; KNEE INJURIES; CONCUSSIONS	Background: The inclusion of clinical practice factors, beyond epidemiologic data, may help guide medical coverage and care decisions. Hypothesis: Trends in injury and treatment characteristics of sport-specific injuries sustained by secondary school athletes will differ based on sport. Study Design: Retrospective analysis of electronic patient records. Methods: Participants consisted of 3302 boys and 2293 girls who were diagnosed with a sport-related injury or condition during the study years. Injury (sport, body part, diagnosis via ICD-9 codes) and treatment (type, amount, and duration of care) characteristics were grouped by sport and reported using summary statistics. Results: Most injuries and treatments occurred in football, girls' soccer, basketball, volleyball, and track and field. Sprain or strain of the ankle, knee, and thigh/hip/groin and concussion were the most commonly documented injuries across sports. The injury pattern for boys' wrestling differed from other sports and included sprain or strain of the elbow and neck and general medical skin conditions. The most frequently reported service was athletic training evaluation/reevaluation treatment, followed by hot/cold pack, therapeutic exercise, manual therapy techniques, electrical stimulation, and strapping of lower extremity joints. Most sports required 4 to 5 services per injury. With the exception of boys' soccer and girls' softball, duration of care ranged from 10 to 14 days. Girls' soccer and girls' and boys' track and field reported the longest durations of care. Conclusion: Injury and treatment characteristics are generally comparable across sports, suggesting that secondary school athletic trainers may diagnose and treat similar injuries regardless of sport.	[Lam, Kenneth C.; Valier, Alison R. Snyder; McLeod, Tamara C. Valovich] AT Still Univ, Dept Interdisciplinary Hlth Sci, Athlet Training Program, Mesa, AZ USA		Lam, KC (corresponding author), AT Still Univ, Dept Interdisciplinary Hlth Sci, Clin Res, 5850 East Still Circle, Mesa, AZ 85206 USA.	klam@atsu.edu	Lam, Kenny/ABB-9733-2020; Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Lam, Kenneth/0000-0002-2185-0990			Agel J, 2007, J ATHL TRAINING, V42, P303; Agel J, 2007, J ATHL TRAINING, V42, P295; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P202; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; American Orthopaedic Society for Sports Medicine, PRINC SEL TEAM MED C; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Borowski L, 2008, AM J SPORTS MED, V36, P2328; Comstock R, 2012, NATL HIGH SCH SPORTS; Courson R, INTERASSOCIATION CON; Dick R, 1988, J ATHL TRAIN; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P221; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Krajnik S, 2010, PEDIATRICS, V125, P497, DOI 10.1542/peds.2009-0961; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; McLeod TCV, 2012, J ATHL TRAINING, V47, P557, DOI 10.4085/1062-6050-47.5.05; National Federation of State High School Associations, 2012 2013 HIGH SCH A; National Institutes of Health, RES REP DAT HIPAA PR; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Rindal DB, 2010, J DENT, V38, P1027, DOI 10.1016/j.jdent.2010.09.003; Roos KG, 2014, SPORTS MED, V44, P405, DOI 10.1007/s40279-013-0124-z; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	32	24	24	2	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2015	7	1					67	74		10.1177/1941738114555842			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	V20GY	WOS:000214876300008	25553215	Green Published			2022-02-06	
J	Mohn, TC; Koob, AO				Mohn, Tal C.; Koob, Andrew O.			Adult Astrogenesis and the Etiology of Cortical Neurodegeneration	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						astrocyte; gliogenesis; neurogenesis; gliosis; Alzheimer's disease; dementia with Lewy bodies	NEURAL STEM-CELLS; ASTROGLIAL INTERLAMINAR PROCESSES; ASTROCYTE-MEDIATED CONTROL; AMYLOID PRECURSOR PROTEIN; MULTIPLE SYSTEM ATROPHY; TRANSGENIC MOUSE MODEL; TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX	As more evidence points to a clear role for astrocytes in synaptic processing, synaptogenesis and cognition, continuing research on astrocytic function could lead to strategies for neurodegenerative disease prevention. Reactive astrogliosis results in astrocyte proliferation early in injury and disease states and is considered neuroprotective, indicating a role for astrocytes in disease etiology. This review describes the different types of human cortical astrocytes and the current evidence regarding adult cortical astrogenesis in injury and degenerative disease. A role for disrupted astrogenesis as a cause of cortical degeneration, with a focus on the tauopathies and synucleinopathies, will also be considered.	[Mohn, Tal C.; Koob, Andrew O.] Univ Wisconsin, Biol Dept, River Falls, WI 54022 USA		Koob, AO (corresponding author), Univ Wisconsin, Biol Dept, River Falls, WI 54022 USA.	andrew.koob@uwrf.edu		Koob, Andrew/0000-0003-3381-6770			Alonso G, GLIA; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALTMAN J, 1964, NATURE, V204, P1161, DOI 10.1038/2041161a0; Anderson CM, 2003, TRENDS NEUROSCI, V26, P340, DOI 10.1016/S0166-2236(03)00141-3; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Boda E, 2010, ARCH ITAL BIOL, V148, P119; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Broe M, 2004, BRAIN, V127, P2214, DOI 10.1093/brain/awh250; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Capilla-Gonzalez V, 2014, GLIA, V62, P790, DOI 10.1002/glia.22642; Casal C, 2004, NEUROSCI RES, V48, P315, DOI 10.1016/j.neures.2003.11.006; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chow SK, 2010, ASN NEURO, V2, DOI 10.1042/AN20090035; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Colombo JA, 2004, BRAIN RES, V1006, P126, DOI 10.1016/j.brainres.2004.02.003; Colombo JA, 1997, INT J DEV NEUROSCI, V15, P823, DOI 10.1016/S0736-5748(97)00043-9; COLOMBO JA, 1995, J NEUROSCI RES, V40, P551, DOI 10.1002/jnr.490400414; Colombo JA, 1997, J NEUROSCI RES, V48, P352, DOI 10.1002/(SICI)1097-4547(19970515)48:4<352::AID-JNR7>3.0.CO;2-A; Colombo JA, 1998, ANAT EMBRYOL, V197, P369, DOI 10.1007/s004290050147; Cotrina ML, 2002, J NEUROSCI RES, V67, P1; Crouch EE, 2015, J NEUROSCI, V35, P4528, DOI 10.1523/JNEUROSCI.1188-14.2015; Dabir DV, 2006, J NEUROSCI, V26, P644, DOI 10.1523/JNEUROSCI.3861-05.2006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Fabricius K, 2013, NEUROBIOL AGING, V34, P91, DOI 10.1016/j.neurobiolaging.2012.06.009; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; HANSEN LA, 1987, NEUROBIOL AGING, V8, P1, DOI 10.1016/0197-4580(87)90051-0; Haydon PG, 2001, NAT REV NEUROSCI; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jellinger KA, 1997, J NEURAL TRANSM-SUPP, P57; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; KIMELBERG HK, 1995, NEUROCHEM INT, V26, P27, DOI 10.1016/0197-0186(94)00118-E; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Koob AO, 2008, INT J DEV NEUROSCI, V26, P641, DOI 10.1016/j.ijdevneu.2008.04.001; Koob AO, 2014, BRAIN RES, V1591, P102, DOI 10.1016/j.brainres.2014.10.013; Koob AO, 2010, NEUROSCI LETT, V469, P11, DOI 10.1016/j.neulet.2009.11.034; KRAIG RP, 1991, J NEUROSCI, V11, P2187; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kronenberg G, 2007, BRAIN STRUCT FUNCT, V212, P19, DOI 10.1007/s00429-007-0141-5; Kulijewicz-Nawrot M, 2012, J ANAT, V221, P252, DOI 10.1111/j.1469-7580.2012.01536.x; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee IS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.125; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Lim DA, 2014, TRENDS NEUROSCI, V37, P563, DOI 10.1016/j.tins.2014.08.006; Lim D, 2014, REV PHYSIOL BIOCH P, V167, P45, DOI 10.1007/112_2014_19; Luccarini I, 2012, NEUROSCI LETT, V506, P94, DOI 10.1016/j.neulet.2011.10.056; LUSE SA, 1956, J BIOPHYS BIOCHEM CY, V2, P531, DOI 10.1083/jcb.2.5.531; Magnus T, 2007, J NEUROSCI RES, V85, P2126, DOI 10.1002/jnr.21368; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mathur R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118463; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23; Mukaetova-Ladinska EB, 2008, DEMENT GERIATR COGN, V26, P32, DOI 10.1159/000141039; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; O'Flanagan CH, 2014, BBA-REV CANCER, V1846, P590, DOI 10.1016/j.bbcan.2014.10.006; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Olsson B, 2013, MOVEMENT DISORD, V28, P1882, DOI 10.1002/mds.25589; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Peinado MA, 1997, ANAT REC, V247, P420; Peinado MA, 1998, MICROSC RES TECHNIQ, V43, P34, DOI 10.1002/(SICI)1097-0029(19981001)43:1<34::AID-JEMT6>3.3.CO;2-7; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Peng L, 2014, CURR NEUROPHARMACOL, V12, P303, DOI 10.2174/1570159X12999140829152550; PETERS A, 1994, CEREB CORTEX, V4, P621, DOI 10.1093/cercor/4.6.621; PETERS A, 1991, ANAT REC, V229, P384, DOI 10.1002/ar.1092290311; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Radford R, 2015, MOL CELL NEUROSCI, V65, P68, DOI 10.1016/j.mcn.2015.02.015; Raina AK, 2004, ACTA NEUROBIOL EXP, V64, P107; Rapanelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014713; Reyes RC, 2012, ASN NEURO, V4, P33, DOI 10.1042/AN20110059; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Rodriguez JJ, 2014, NEUROBIOL AGING, V35, P15, DOI 10.1016/j.neurobiolaging.2013.07.002; Rodriguez-Arellano JJ, 2015, NEUROSCIENCE; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sampedro-Piquero P, 2014, NEUROBIOL LEARN MEM, V114, P16, DOI 10.1016/j.nlm.2014.04.002; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SCHECHTER R, 1981, J NEUROPATH EXP NEUR, V40, P95, DOI 10.1097/00005072-198103000-00002; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shibuya K, 2011, BRAIN RES, V1404, P50, DOI 10.1016/j.brainres.2011.06.014; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2015, GLIA; Sohn JH, 2015, J NEUROSCI, V35, P3756, DOI 10.1523/JNEUROSCI.3454-14.2015; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Surgucheva I, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0132-8; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tamura Y, 2012, J CEREBR BLOOD F MET, V32, P1879, DOI 10.1038/jcbfm.2012.98; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Toledano A., 2004, Current Alzheimer Research, V1, P189, DOI 10.2174/1567205043332117; Tong JC, 2015, NEUROBIOL DIS, V82, P243, DOI 10.1016/j.nbd.2015.06.010; Trazzi S, 2013, J BIOL CHEM, V288, P20817, DOI 10.1074/jbc.M113.451088; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; Urbach A, 2015, J CEREBR BLOOD F MET, V35, P576, DOI 10.1038/jcbfm.2014.232; van den Berge SA, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/420957; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Verkhratsky A., 2013, GLIAL PHYSL PATHOPHY; Verkhratsky A, 2014, NEUROSCIENTIST, V21, P562; Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Xue JH, 2009, STROKE, V40, pE606, DOI 10.1161/STROKEAHA.109.560334; Yang L, 2013, J TRANSL MED, V1, P11; Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025; Yurov YB, 2011, THESCIENTIFICWORLDJO, V11, P2602, DOI 10.1100/2011/625690; Zhang Y., 2015, J NANOMATER, V2015, P1, DOI [DOI 10.1038/CR.2015.77, DOI 10.1080/10298436.2015.1019502]; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	184	24	27	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.		2015	9			2			25	34	UNSP JEn.S25520	10.4137/JEn.S25520			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V30XG	WOS:000215594700003	26568684	gold, Green Published			2022-02-06	
J	Normoyle, KP; Kim, M; Farahvar, A; Llano, D; Jackson, K; Wang, H				Normoyle, Kieran P.; Kim, Miri; Farahvar, Arash; Llano, Daniel; Jackson, Kevin; Wang, Huan			THE EMERGING NEUROPROTECTIVE ROLE OF MITOCHONDRIAL UNCOUPLING PROTEIN-2 IN TRAUMATIC BRAIN INJURY	TRANSLATIONAL NEUROSCIENCE			English	Article						Neuronal injury; Mitochondria; Traumatic brain injury; Ischemia; Neuronal cell death	PREVENTS NEURONAL DEATH; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; TEMPERATURE MANAGEMENT; MILD HYPOTHERMIA; CARDIAC-ARREST; RAT-BRAIN; OXYGEN; UCP2; DISRUPTION	Traumatic brain injury (TBI) is a multifaceted disease with intrinsically complex heterogeneity and remains a significant clinical challenge to manage. TBI model systems have demonstrated many mechanisms that contribute to brain parenchymal cell death, including glutamate and calcium toxicity, oxidative stress, inflammation, and mitochondrial dysfunction. Mitochondria are critically regulated by uncoupling proteins (UCP), which allow protons to leak back into the matrix and thus reduce the mitochondrial membrane potential by dissipating the proton motive force. This uncoupling of oxidative phosphorylation from adenosine triphosphate (ATP) synthesis is potentially critical for protection against cellular injury as a result of TBI and stroke. A greater understanding of the underlying mechanism or mechanisms by which uncoupling protein-2 (UCP2) functions to maintain or optimize mitochondrial function, and the conditions which precipitate the failure of these mechanisms, would inform future research and treatment strategies. We posit that UCP2-mediated function underlies the physiological response to neuronal stress associated with traumatic and ischemic injury and that clinical development of UCP2-targeted treatment would significantly impact these patient populations. With a focus on clinical relevance in TBI, we synthesize current knowledge concerning UCP2 and its potential neuroprotective role and apply this body of knowledge to current and potential treatment modalities.	[Normoyle, Kieran P.; Llano, Daniel] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Normoyle, Kieran P.; Kim, Miri] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Normoyle, Kieran P.] Massachusetts Gen Hosp, Dept Child Neurol, Boston, MA 02114 USA; [Kim, Miri] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Farahvar, Arash] Carle Fdn Hosp, Dept Neurosurg, Urbana, IL USA; [Llano, Daniel; Wang, Huan] Carle Fdn Hosp, Dept Neurol, Urbana, IL 61801 USA; [Llano, Daniel; Jackson, Kevin] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Jackson, Kevin; Wang, Huan] Univ Illinois, Beckman Inst, TNL, Urbana, IL 61801 USA		Wang, H (corresponding author), Carle Fdn Hosp, Dept Neurol, Urbana, IL 61801 USA.	huanwang@illinois.edu	Llano, Daniel/X-8184-2019	Llano, Daniel/0000-0003-0933-1837; , Miri/0000-0002-5227-9803; Jackson, kevin/0000-0001-9917-3312			Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Ciccarelli O, 2010, NEUROLOGY, V74, P721, DOI 10.1212/WNL.0b013e3181d26968; Crouser E, 2013, AM J RESP CRIT CARE, V187, P460, DOI 10.1164/rccm.201301-0107ED; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Diano S, 2000, ENDOCRINOLOGY, V141, P4226, DOI 10.1210/en.141.11.4226; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fuxe K, 2005, J NEURAL TRANSM, V112, P65, DOI 10.1007/s00702-004-0158-3; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Graw JA, 2013, ALCOHOL CLIN EXP RES, V37, P1650, DOI 10.1111/acer.12144; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Henry BA, 2011, ENDOCRINOLOGY, V152, P2609, DOI 10.1210/en.2011-0143; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kinnally K. W., 2006, CURR PROTOC TOXICOL, V2, P12; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Kleinridders A, 2013, J CLIN INVEST, V123, P4667, DOI 10.1172/JCI67615; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Li N, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/740849; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859; Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Niethammer P, 2008, CURR BIOL, V18, P586, DOI 10.1016/j.cub.2008.03.038; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Olsen RKJ, 2013, MOL GENET METAB, V110, pS31, DOI 10.1016/j.ymgme.2013.10.007; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Richard D, 1998, J COMP NEUROL, V397, P549; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Rittenberger JC, 2013, NEW ENGL J MED, V369, P2262, DOI 10.1056/NEJMe1312700; Robinson AD, 2011, AM J MED SCI, V342, P129, DOI 10.1097/MAJ.0b013e3182231ee3; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Steer JH, 2013, INHAL TOXICOL, V25, P544, DOI 10.3109/08958378.2013.810679; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Van Vleet TM, 2015, NEUROCASE, V21, P489, DOI 10.1080/13554794.2014.928329; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yamada S, 2003, J NEUROCHEM, V87, P461, DOI 10.1046/j.1471-4159.2003.02005.x; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014	107	24	27	0	1	SCIENDO	WARSAW	DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2015	6	1					179	186		10.1515/tnsci-2015-0019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ6GJ	WOS:000360702200012	28123803	Green Published, gold			2022-02-06	
J	Salinsky, M; Storzbach, D; Goy, E; Evrard, C				Salinsky, Martin; Storzbach, Daniel; Goy, Elizabeth; Evrard, Collette			Traumatic Brain Injury and Psychogenic Seizures in Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epilepsy; psychogenic seizures; PTSD; TBI; Veterans	POSTTRAUMATIC-STRESS-DISORDER; NONEPILEPTIC SEIZURES; EPILEPSY; HEALTH; COMORBIDITY; SYMPTOMS; SEQUELAE	Objective: To evaluate a proposed seizure etiology of traumatic brain injury (TBI) as a risk factor for psychogenic nonepileptic seizures (PNESs), the effect of reported TBI severity on the diagnosis of PNES versus epileptic seizures (ESs), and the potential moderating role of posttraumatic stress disorder (PTSD). Participants, Setting: Veterans with a diagnosis of PNES or ES during epilepsy monitoring at a Veterans Affairs Medical Center. Design: Retrospective review of seizure type, proposed seizure etiology, TBI severity, and PTSD. Main Outcomes: Both PNES and ES groups were compared for TBI history and severity, and prior diagnosis of PTSD. Results: Traumatic brain injury was the proposed seizure etiology for 57% of 67 PNES patients versus 35% of 54 ES patients (P < .05). It was mild in 87% of PNES patients and 37% of ES patients (P < .001). Posttraumatic stress disorder increased the likelihood of diagnosing PNES versus ES in Veterans with mild TBI as the proposed seizure etiology. Conclusions: Veterans with PNES commonly cite a TBI as the cause for seizures. Mild TBI was strongly associated with PNES versus ES. Posttraumatic stress disorder may moderate the development of PNES in Veterans with a history of mild TBI. Clinicians caring for Veterans with seizures may use these results in selecting patients for early diagnostic evaluation.	[Salinsky, Martin; Storzbach, Daniel; Goy, Elizabeth; Evrard, Collette] Portland VA Med Ctr, Portland, OR USA; [Salinsky, Martin] Oregon Hlth & Sci Univ, Portland, OR 97201 USA		Salinsky, M (corresponding author), Portland VAMC Epilepsy Ctr, 3710 SWUS Vet Hosp Rd P3ECOE, Portland, OR 97239 USA.	Salinsky@ohsu.edu					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Annegers JF, 1996, TREATMENT EPILEPSY P, P166; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson K, 2009, ASSESSMENT TREATMENT, P1; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Goldstein LH, 2010, NEUROLOGY, V74, P1986, DOI 10.1212/WNL.0b013e3181e39658; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Krawetz P, 2001, J NERV MENT DIS, V189, P38, DOI 10.1097/00005053-200101000-00007; LaFrance WC, 2010, NEUROLOGY, V75, P1166, DOI 10.1212/WNL.0b013e3181f4d5a9; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; LaFrance WC, 2006, NEUROLOGY, V66, P1620, DOI 10.1212/01.wnl.0000224953.94807.be; Lippa SM, 2012, J INT NEUROPSYCH SOC, V16, P856; Litz B. T., 2009, PTSD RES Q, V20, P1; Martin R, 2003, NEUROLOGY, V61, P1791, DOI 10.1212/01.WNL.0000098890.13946.F5; Martin RC, 1998, SEIZURE-EUR J EPILEP, V7, P385, DOI 10.1016/S1059-1311(05)80007-X; Nelson N. W., 2012, J INT NEUROPSYCH SOC, V18, P1, DOI DOI 10.1017/S1355617711001548; PIERELLI F, 1989, EPILEPSIA, V30, P513, DOI 10.1111/j.1528-1157.1989.tb05465.x; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; R Development Core Team,, 2012, R LANG ENV STAT COMP; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Rosenberg HJ, 2000, EPILEPSIA, V41, P447, DOI 10.1111/j.1528-1157.2000.tb00187.x; Salinsky M, 2012, EPILEPSY BEHAV, V25, P345, DOI 10.1016/j.yebeh.2012.07.013; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sigurdardottir KR, 1998, EPILEPSIA, V39, P749, DOI 10.1111/j.1528-1157.1998.tb01161.x; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tingley D, 2012, MEDIATION R PACKAGE; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	38	24	26	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					E65	E70		10.1097/HTR.0000000000000057			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400008	24901325				2022-02-06	
J	Snell, DL; Surgenor, LJ; Hay-Smith, EJC; Williman, J; Siegert, RJ				Snell, Deborah L.; Surgenor, Lois J.; Hay-Smith, E. Jean C.; Williman, Jonathan; Siegert, Richard J.			The contribution of psychological factors to recovery after mild traumatic brain injury: Is cluster analysis a useful approach?	BRAIN INJURY			English	Article						Cluster analysis; illness beliefs; mild traumatic brain injury; MTBI; post-concussion symptoms	POST-CONCUSSION SYMPTOMS; LOW-BACK-PAIN; ILLNESS PERCEPTIONS; HEAD-INJURY; POSTCONCUSSION SYNDROME; MYOCARDIAL-INFARCTION; RISK-FACTORS; BASE RATES; QUESTIONNAIRE; BELIEFS	Objectives: Outcomes after mild traumatic brain injury (MTBI) vary, with slow or incomplete recovery for a significant minority. This study examines whether groups of cases with shared psychological factors but with different injury outcomes could be identified using cluster analysis. Method: This is a prospective observational study following 147 adults presenting to a hospital-based emergency department or concussion services in Christchurch, New Zealand. This study examined associations between baseline demographic, clinical, psychological variables (distress, injury beliefs and symptom burden) and outcome 6 months later. A two-step approach to cluster analysis was applied (Ward's method to identify clusters, K-means to refine results). Results: Three meaningful clusters emerged (high-adapters, medium-adapters, low-adapters). Baseline cluster-group membership was significantly associated with outcomes over time. High-adapters appeared recovered by 6-weeks and medium-adapters revealed improvements by 6-months. The low-adapters continued to endorse many symptoms, negative recovery expectations and distress, being significantly at risk for poor outcome more than 6-months after injury (OR (good outcome) = 0.12; CI = 0.03-0.53; p<0.01). Conclusions: Cluster analysis supported the notion that groups could be identified early post-injury based on psychological factors, with group membership associated with differing outcomes over time. Implications for clinical care providers regarding therapy targets and cases that may benefit from different intensities of intervention are discussed.	[Snell, Deborah L.] Burwood Hosp, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.] Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch 8140, New Zealand; [Surgenor, Lois J.] Univ Otago, Dept Psychol Med, Christchurch 8140, New Zealand; [Hay-Smith, E. Jean C.] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Williman, Jonathan] Univ Otago, Sch Med, Wellington, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Studies, Auckland, New Zealand		Snell, DL (corresponding author), Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, POB 4345, Christchurch 8140, New Zealand.	debbie.snell@burwood.org.nz	Williman, Jonathan/E-8206-2016; Siegert, Richard J./K-2030-2019	Williman, Jonathan/0000-0001-5080-4435; Siegert, Richard/0000-0002-3074-0929	Neurological Foundation of New Zealand [0728-SPG]	The authors report no conflicts of interest. This research has been support by a Small Project Grant from the Neurological Foundation of New Zealand (Grant no: 0728-SPG).	Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll L, 2004, J REHABILITATION M S, V43, P113; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Goulding L, 2010, J ADV NURS, V66, P946, DOI 10.1111/j.1365-2648.2010.05306.x; Hobro N, 2004, PAIN, V108, P276, DOI 10.1016/j.pain.2003.12.027; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Jonsbu E, 2013, BEHAV COGN PSYCHOTH, V41, P398, DOI 10.1017/S1352465813000179; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V41, P611; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; MossMorris R, 1996, BRIT J HEALTH PSYCH, V1, P15, DOI 10.1111/j.2044-8287.1996.tb00488.x; Munro BH, 2005, STAT METHODS HLTH CA, V5th; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; NZGG, 2006, TRAUM BRAIN INJ DIAG; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; PETRIE K, 1995, J PSYCHOSOM RES, V39, P31, DOI 10.1016/0022-3999(94)00071-C; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Siemonsma PC, 2013, PHYS THER REHABIL J, V93, P435, DOI 10.2522/ptj.20110150; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell D, 2006, NEW ZEAL MED J, V119, P66; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stuifbergen AK, 2006, WOMEN HEALTH ISS, V16, P353, DOI 10.1016/j.whi.2006.05.003; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; TEASDALE G, 1974, LANCET, V2, P81; Van Ittersum MW, 2009, PATIENT EDUC COUNS, V74, P53, DOI 10.1016/j.pec.2008.07.041; Weinman J, 2010, COMMUNICATION; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Yan J, 2014, INT J NURS STUD, V51, P844, DOI 10.1016/j.ijnurstu.2013.10.011	60	24	24	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					291	299		10.3109/02699052.2014.976594			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000002	25409487				2022-02-06	
J	Solomon, GS; Zuckerman, SL				Solomon, Gary S.; Zuckerman, Scott L.			Chronic traumatic encephalopathy in professional sports: Retrospective and prospective views	BRAIN INJURY			English	Article						Chronic traumatic encephalopathy; concussion; sports; traumatic brain injury	ALZHEIMERS-DISEASE; FOOTBALL; CONCUSSION; RISK; TAU; PLAYERS; INJURY	Primary objective: The purposes of this paper are to review: (1) the history of chronic traumatic encephalopathy (CTE) in sports, (2) the similarities and differences between historic and current definitions of CTE, (3) recent epidemiology and cohort studies of CTE and (4) controversies regarding the current CTE positions. Research design: Not applicable. Methods and procedures: Selective review of published articles relevant to CTE. Main outcome and results: The current definitions of CTE have evolved from its original definition and now rely heavily on the post-mortem detection of hyperphosphorylated tau for diagnosis. As of 2013, there is a blended cohort of 110 professional athletes diagnosed with CTE. It is being assumed that concussions and/or sub-concussive impacts in contact sports are the sole cause of CTE. Conclusions: There are multiple causes of abnormal tau protein deposition in the human brain and the pathogenesis of CTE may not be related solely to concussion and/or sub-concussive injury. In all likelihood, the causes of CTE are a multivariate, as opposed to a univariate, phenomenon.	[Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Orthoped Surg & Rehabil, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA		Solomon, GS (corresponding author), Neurosurg Clin, 1500 21st Ave South,Suite 1506, Nashville, TN 37232 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019		Nashville Predators; Tennessee Titans	Solomon receives royalties from book sales. He receives consulting fees for clinical services from the Nashville Predators and the Tennessee Titans. He is a member of the ImPACT Professional Advisory Board and receives free use of the ImPACT test when beta testing, as well as expense reimbursement for attendance at Board meetings. Dr Zuckerman has no competing interests to disclose.	Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Braak H, 2012, ALZHEIMERS DEMENT, V8, P227, DOI 10.1016/j.jalz.2012.01.011; Casson I, 2010, NEUROLOGY TODAY, V10, P6, DOI DOI 10.1097/01.NT.0000380917.17552.b7; Casson I, 2006, NEUROSURGERY, V58, pE1152; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Forman M, 2006, ANN NEUROL, V59, P592; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Josephs KA, 2008, ANN NEUROL, V64, P4, DOI 10.1002/ana.21426; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lesort M, 1999, J NEURAL TRANSM, V106, P1217, DOI 10.1007/s007020050235; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee A, 2012, BRAIN A J NEUROL, V1, P1; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Omalu B, 2006, NEUROSURGERY, V58, pE1152; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Weir D. R., 2009, STUDY RETIRED NFL PL	40	24	24	1	28	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	2					164	170		10.3109/02699052.2014.965205			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AZ4OI	WOS:000348201500005	25314314				2022-02-06	
J	Towns, SJ; Silva, MA; Belanger, HG				Towns, Stephanie J.; Silva, Marc A.; Belanger, Heather G.			Subjective sleep quality and postconcussion symptoms following mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; mood; postconcussive syndrome; psychological distress	DISTURBANCE; INDEX; INVENTORY-18; RELIABILITY; PREVALENCE; COMPLAINTS; INSOMNIA; VALIDITY	Primary objective: The goal of this investigation is to examine the prevalence of poor subjective sleep in patients with a history of mild traumatic brain injury (mTBI) and examine the relationship between subjective sleep quality and postconcussive symptoms (PCS), above and beyond the typical demographic and psychological distress variables. Research design: Individuals with a history of mTBI completed online questionnaires. Regression analysis was utilized to determine if subjective sleep quality would predict PCS severity, above and beyond demographic variables and psychological distress. Methods and procedures: Individuals with a history of mTBI (n = 158) completed surveys online. Sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI) and PCS with the Neurobehavioral Symptom Inventory (NSI). Demographic information was collected and psychological distress was measured using the Brief Symptom Inventory-18 (BSI-18). Main outcomes and results: In this sample, 92% of patients with mTBI reported poor sleep. Sleep quality significantly accounted for the variance in PCS, above and beyond demographics, time since injury and psychological distress (p < 0.001), although only a small amount of the variance in PCS was explained. Conclusions: Results indicate that poor subjective sleep quality is a significant problem in those with mTBI. While sleep is associated with PCS severity, psychological distress is a more potent predictor.	[Towns, Stephanie J.; Silva, Marc A.; Belanger, Heather G.] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Tampa, FL 33612 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Belanger, Heather G.] James A Haley Vet Hosp, Hlth Serv Res & Dev, Rehabil Res & Dev RR&D Ctr Excellence Maximizing, Tampa, FL 33612 USA		Towns, SJ (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat HB7750, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	stephanie.j.towns@dartmouth.edu	Silva, Marc A./J-1874-2019; Towns, Stephanie/AAS-5118-2021; Towns, Stephanie/AAF-2035-2020	Silva, Marc A./0000-0002-3879-6054; 	Department of DefenseUnited States Department of Defense [W81XWH-10-1-0719]; Department of Veterans Affairs, Veterans Health Administration (VHA)US Department of Veterans Affairs; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The research reported here was supported in part by the Department of Defense (W81XWH-10-1-0719), Department of Veterans Affairs, Veterans Health Administration (VHA) and the Defense and Veterans Brain Injury Center (DVBIC). Further support was provided by the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Army, Department of Defense, Department of Veterans Affairs or US Government.	American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Belanger HG, 2015, MIL MED, V180, P186; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; CDC, RAT TBI REL EM DEP V; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Derogatis LR, 2000, BSI 18 ADM SCOR PROC; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; World Health Organization, 1992, ICD 10 CLASSIFICATIO	27	24	24	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1337	1341		10.3109/02699052.2015.1045030			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100008	26288022				2022-02-06	
J	Gomez, PA; de-la-Cruz, J; Lora, D; Jimenez-Roldan, L; Rodriguez-Boto, G; Sarabia, R; Sahuquillo, J; Lastra, R; Morera, J; Lazo, E; Dominguez, J; Ibanez, J; Brell, M; de-la-Lama, A; Lobato, RD; Lagares, A				Gomez, Pedro A.; de-la-Cruz, Javier; Lora, David; Jimenez-Roldan, Luis; Rodriguez-Boto, Gregorio; Sarabia, Rosario; Sahuquillo, Juan; Lastra, Roberto; Morera, Jesus; Lazo, Eglis; Dominguez, Jaime; Ibanez, Javier; Brell, Marta; de-la-Lama, Adolfo; Lobato, Ramiro D.; Lagares, Alfonso			Validation of a prognostic score for early mortality in severe head injury cases	JOURNAL OF NEUROSURGERY			English	Article						severe traumatic brain injury; prognosis; early death; external validation	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; CLINICAL-TRIALS; OUTCOME PREDICTION; MODELS; DISABILITY; DEATHS; DESIGN; AGE	Object. Traumatic brain injury (TBI) represents a large health and economic burden. Because of the inability of previous randomized controlled trials (RCTs) on TBI to demonstrate the expected benefit of reducing unfavorable outcomes, the IMPACT (International Mission on Prognosis and Analysis of Clinical Trials in TBI) and CRASH (Corticosteroid Randomisation After Significant Head Injury) studies provided new methods for performing prognostic studies of TBI. This study aimed to develop and externally validate a prognostic model for early death (within 48 hours). The secondary aim was to identify patients who were more likely to succumb to an early death to limit their inclusion in RCTs and to improve the efficiency of RCTs. Methods. The derivation cohort was recruited at 1 center, Hospital 12 de Octubre, Madrid (1990-2003,925 patients). The validation cohort was recruited in 2004-2006 from 7 study centers (374 patients). The eligible patients had suffered closed severe TBIs. The study outcome was early death (within 48 hours post-TBI). The predictors were selected using logistic regression modeling with bootstrapping techniques, and a penalized reduction was used. A risk score was developed based on the regression coefficients of the variables included in the final model. Results. In the validation set, the final model showed a predictive ability of 50% (Nagelkerke R-2), with an area under the receiver operating characteristic curve of 89% and an acceptable calibration (goodness-of-fit test, p = 0.32). The final model included 7 variables, and it was used to develop a risk score with a range from 0 to 20 points. Age provided 0,1,2, or 3 points depending on the age group; motor score provided 0 points, 2 (untestable), or 3 (no response); pupillary reactivity, 0,2(1 pupil reacted), or 6 (no pupil reacted); shock, 0 (no) or 2 (yes); subarachnoid hemorrhage, 0 or 1 (severe deposit); cisternal status, 0 or 3 (compressed/absent); and epidural hematoma, 0 (yes) or 2 (no). Based on the risk of early death estimated with the model, 4 risk of early death groups were established: low risk, sum score 0-3 (< 1% predicted mortality); moderate risk, sum score 4-8 (predicted mortality between 1% and 10%); high risk, sum score 9-12 (probability of early death between 10% and 50%); and very high risk, sum score 13-20 (early mortality probability > 50%). This score could be used for selecting patients for clinical studies. For example, if patients with very high risk scores were excluded from our study sample, the patients included (eligibility score < 13) would represent 80% of the original sample and only 23% of the patients who died early. Conclusions. The combination of Glasgow Coma Scale score, CT scanning results, and secondary insult data into a prognostic score improved the prediction of early death and the classification of TBI patients.	[Gomez, Pedro A.; Jimenez-Roldan, Luis; Lobato, Ramiro D.; Lagares, Alfonso] Univ Complutense, Fac Med, Univ Hosp Octubre 12, Dept Neurosurg, Madrid 20841, Spain; [de-la-Cruz, Javier; Lora, David] Univ Complutense, Fac Med, Univ Hosp Octubre 12, Clin Res Unit,CIBERESP IMAS12, Madrid 20841, Spain; [Rodriguez-Boto, Gregorio] Clin Univ Hosp, Dept Neurosurg, Madrid, Spain; [Sarabia, Rosario] Clin Univ Hosp Rio Ortega, Dept Neurosurg, Valladolid, Spain; [Sahuquillo, Juan; Lastra, Roberto] Clin Univ Hosp Val dHebron, Dept Neurosurg, Barcelona, Spain; [Morera, Jesus] Clin Univ Hosp Dr Negrin, Dept Neurosurg, Las Palmas Gran Canaria, Spain; [Lazo, Eglis; Dominguez, Jaime] Clin Univ Hosp Virgen de la Candelaria, Dept Neurosurg, Tenerife, Spain; [Ibanez, Javier; Brell, Marta] Clin Univ Hosp Son Dureta, Dept Neurosurg, Palma De Mallorca, Spain; [de-la-Lama, Adolfo] Hosp Xeral Vigo, Clin Univ Hosp, Dept Neurosurg, Vigo, Spain		Gomez, PA (corresponding author), Univ Complutense, Fac Med, Univ Hosp Octubre 12, Dept Neurosurg, Carretera Andalucia S-N, Madrid 20841, Spain.	pagolopez@gmail.com	Jimenez-Roldan, Luis/K-2298-2017; Lagares, Alfonso/B-2969-2011; Rodriguez-Boto, Gregorio/AAR-9035-2021; Sahuquillo, Juan/B-3577-2008; Gomez, Pedro/N-5051-2019	Jimenez-Roldan, Luis/0000-0002-9864-0385; Lagares, Alfonso/0000-0003-3996-0554; Rodriguez-Boto, Gregorio/0000-0001-6361-5713; Sahuquillo, Juan/0000-0003-0713-5875; Gomez, Pedro/0000-0002-4185-5238; Ibanez, Javier/0000-0003-3735-8332	Fondo de Investigacion Sanitaria (FIS)Instituto de Salud Carlos III [PI-030318]; Fundacion Mutua Madrilena (FMM) [2010-007]	Funding was provided by the following: Fondo de Investigacion Sanitaria (FIS) PI-030318 (2004-2006) and Fundacion Mutua Madrilena (FMM) No. 2010-007. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE Jr, 2017, REGRESSION MODELING; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Moons KGM, 2004, J CLIN EPIDEMIOL, V57, P1262, DOI 10.1016/j.jclinepi.2004.01.020; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nissen JJ, 1999, J NEUROL NEUROSUR PS, V67, P796, DOI 10.1136/jnnp.67.6.796; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	43	24	25	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1314	1322		10.3171/2014.7.JNS131874			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700003	25237737				2022-02-06	
J	Perrin, PB; Krch, D; Sutter, M; Snipes, DJ; Arango-Lasprilla, JC; Kolakowsky-Hayner, SA; Wright, J; Lequerica, A				Perrin, Paul. B.; Krch, Denise; Sutter, Megan; Snipes, Daniel. J.; Carlos Arango-Lasprilla, Juan; Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Lequerica, Anthony			Racial/Ethnic Disparities in Mental Health Over the First 2 Years After Traumatic Brain Injury: A Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Mental health; Minority health; Rehabilitation	QUALITY-OF-LIFE; MAJOR DEPRESSIVE DISORDER; PERCEIVED DISCRIMINATION; ETHNIC DISPARITIES; UNITED-STATES; RACIAL DISPARITIES; SATISFACTION; RACE/ETHNICITY; OUTCOMES; ADULTS	Objective: To determine whether racial/ethnic disparities occur in depression, anxiety, and satisfaction with life at 1 and 2 years postdischarge. Design: A prospective, longitudinal, multicenter study of individuals with traumatic brain injury (TBI) participating in the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems project. Medical, demographic, and outcome data were obtained from the Model Systems database at baseline, as well as 1 and 2 years postdischarge. Setting: A total of 16 TBI Model Systems hospitals in the United States. Participants: Individuals with moderate or severe TBI (N=1662) aged 16 years or older consecutively discharged between January 2008 and June 2011 from acute care and comprehensive inpatient rehabilitation at a Model Systems hospital. Intervention: Not applicable. Main Outcome Measures: The Patient Health Questionnaire-9, Generalized Anxiety Disorder 7-item scale, and Satisfaction with Life Scale assessed depression, anxiety, and satisfaction with life at 1 and 2-year follow-ups. Results: After controlling for all possible covariates, hierarchal linear models found that black individuals had elevated depression across the 2 time points relative to white individuals Asian/Pacific Islanders' depression increased over time in comparison to the decreasing depression in those of Hispanic origin, which was a greater decrease than in white individuals. Black individuals had lower life satisfaction than did white and Hispanic individuals, but only marginally greater anxiety over time than did white individuals and similar levels of anxiety as did Asian/Pacific Islanders and Hispanic individuals. Conclusions: Mental health trajectories of individuals with TBI differed as a function of race/ethnicity across the first 2 years postdischarge, providing the first longitudinal evidence of racial/ethnic disparities in mental health after TBI during this time period. Further research will be required to understand the complex factors underlying these differences. (C) 2014 by the American Congress of Rehabilitation Medicine	[Perrin, Paul. B.; Sutter, Megan; Snipes, Daniel. J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Krch, Denise; Lequerica, Anthony] Kessler Fdn, W Orange, NJ USA; [Krch, Denise; Lequerica, Anthony] Rutgers, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Kolakowsky-Hayner, Stephanie A.; Wright, Jerry] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA		Perrin, PB (corresponding author), Virginia Commonwealth Univ, Dept Psychol, 808 W Franklin St,Rm 201,POB 842018, Richmond, VA 23284 USA.	pperrin@vcu.edu	Kolakowsky-Hayner, Stephanie A./I-9858-2019; Sutter, Megan/L-9770-2019; Perrin, Paul/L-5373-2015	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Sutter, Megan/0000-0001-9816-9549; Perrin, Paul/0000-0003-2070-215X			ALSTON RJ, 1994, J COUNS DEV, V72, P378, DOI 10.1002/j.1556-6676.1994.tb00953.x; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Ayalon L, 2001, AGING MENT HEALTH, V15, P587; Barger SD, 2009, QUAL LIFE RES, V18, P179, DOI 10.1007/s11136-008-9426-2; Blendon RJ, 2007, HEALTH AFFAIR, V26, P1437, DOI 10.1377/hlthaff.26.5.1437; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borowsky SJ, 2000, J GEN INTERN MED, V15, P381, DOI 10.1046/j.1525-1497.2000.12088.x; Borrell LN, 2008, J IMMIGR MINOR HEALT, V10, P229, DOI 10.1007/s10903-007-9074-6; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Chowdhury PR, 2008, ETHNIC DIS, V18, P483; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Finch BK, 2000, J HEALTH SOC BEHAV, V41, P295, DOI 10.2307/2676322; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gee GC, 2007, AM J PUBLIC HEALTH, V97, P1275, DOI 10.2105/AJPH.2006.091827; Hankerson SH, 2011, J NATL MED ASSOC, V103, P576, DOI 10.1016/S0027-9684(15)30383-7; Hines P. M., 1982, ETHNICITY FAMILY THE, P84; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JONES C, 1979, AM J NURS, V79, P1551; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Keppel Kenneth, 2008, Healthy People Stat Notes, P1; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Kim HS, 2008, AM PSYCHOL, V63, P518, DOI 10.1037/0003-066X; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Landale N. S., 2006, NATL RES COUNCIL US; MCADOO H, 1983, STRESS FAMILY, V1, P178; Myaskovsky L, 2011, ARCH PHYS MED REHAB, V92, P441, DOI 10.1016/j.apmr.2010.10.007; Noh S, 2003, AM J PUBLIC HEALTH, V93, P232, DOI 10.2105/AJPH.93.2.232; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pamuk E., 1998, SOCIOECONOMIC STATUS; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pieterse AL, 2012, J COUNS PSYCHOL, V59, P1, DOI 10.1037/a0026208; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Satcher D, 2001, MENT HLTH CULT RAC E; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shim RS, 2012, ETHNIC DIS, V22, P15; Skaer TL, 2000, CLIN THER, V22, P1575, DOI 10.1016/S0149-2918(00)83055-6; Smedley B, 2002, COMMITTEE UNDERSTAND; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P530, DOI 10.1016/j.neubiorev.2006.11.010; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stockdale SE, 2008, MED CARE, V46, P668, DOI 10.1097/MLR.0b013e3181789496; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Williams David R., 2001, Ethnicity and Disease, V11, P800; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams DR, 2000, ETHNIC HEALTH, V5, P243, DOI 10.1080/713667453; Wyatt SB, 2003, AM J MED SCI, V325, P315, DOI 10.1097/00000441-200306000-00003	60	24	24	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2014	95	12					2288	2295		10.1016/j.apmr.2014.07.409			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AW0AY	WOS:000345954000008	25128715				2022-02-06	
J	Papoutsis, J; Stargatt, R; Catroppa, C				Papoutsis, Jennifer; Stargatt, Robyn; Catroppa, Cathy			Long-Term Executive Functioning Outcomes for Complicated and Uncomplicated Mild Traumatic Brain Injury Sustained in Early Childhood	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							BEHAVIOR RATING INVENTORY; PEDIATRIC HEAD-INJURY; YOUNG-CHILDREN; FOLLOW-UP; TBI	This study investigated long-term executive functioning following early mild traumatic brain injury (TBI), differentiating between complicated (n = 34) and uncomplicated injuries (n = 18). Children post mild TBI were compared to 33 controls at least 7-years post-injury. The complicated mild TBI group performed significantly worse on divided attention compared to both groups, with younger age at injury and neurological symptoms predictors of outcome. No significant group differences existed on speed of information processing, selective attention, working memory, or goal setting. These findings indicate that specific aspects of executive function are compromised by early complicated mild TBI and argue for a stratified definition of mild TBI.	[Papoutsis, Jennifer; Stargatt, Robyn; Catroppa, Cathy] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Papoutsis, Jennifer; Stargatt, Robyn] La Trobe Univ, Dept Psychol, Bundoora, Vic 3083, Australia		Papoutsis, J (corresponding author), Murdoch Childrens Res Inst, Flemmington Rd, Parkville, Vic 3052, Australia.	jennifer.papoutsis@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; De Luca CR, 2010, STUD NEUROPSYCHOL NE, P23; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Kolb B., 1995, BRAIN PLASTICITY BEH; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	25	24	24	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	NOV 17	2014	39	8					638	645		10.1080/87565641.2014.979926			8	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AU6AS	WOS:000345685100004	25470225				2022-02-06	
J	McMillan, TM; Weir, CJ; Wainman-Lefley, J				McMillan, T. M.; Weir, C. J.; Wainman-Lefley, J.			Mortality and morbidity 15 years after hospital admission with mild head injury: a prospective case-controlled population study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; LIFE-STYLE INTERVENTIONS; YOUNG-PEOPLE; EPIDEMIOLOGY; DYSFUNCTION; DISABILITY; DEMENTIA; SINGLE; ADULTS; WORSE	Objective To investigate mortality rate in a population of adults admitted to hospital with mild head injury (MHI) 15 years later. Design A prospective case control, record linkage study. Participants 2428 adults with MHI and an equal number of community controls (CC) were case-matched for age, gender and social deprivation. A further control group admitted with a non-head injury was in addition matched for duration of hospital admission. Controls with a history of head injury prior to study entry were excluded. Main outcome measures Death or survival 15 years poststudy entry. Results Mortality per 1000 per year after MHI (24.49; 95% CI 23.21 to 25.79) was higher than in CC (13.34; 95% CI 12.29 to 14.44; p<0.0001) or 'other injury' controls (OIC) (19.63; 95% CI 18.43 to 20.87; p<0.0001). Age at injury was important: younger adults (15-54 years) with MHI had a 4.2-fold greater risk of death than CC; in adults aged over 54, the risk was 1.4 times higher. Gender and social deprivation showed a similar association with death in the MHI and control groups. Repeated head injury was a risk factor for death in the MHI group. The frequency of hospital admission with systemic disease preinjury and postinjury was higher in both injury groups than in CC and higher in MHI than OIC. Prospective data in the MHI group suggest an association between preinjury lifestyle and mortality. Causes of death after MHI were similar to those of the control groups. Conclusions Adults hospitalised with MHI had greater risk of death in the following 15 years than matched controls. The extent to which lifestyle and potential chronic changes in neuropathology explain these findings is unclear. Lifestyle factors do contribute to risk of death after MHI and this finding has implications for lifestyle management interventions.	[McMillan, T. M.; Wainman-Lefley, J.] Univ Glasgow, Inst Hlth & Wellbeing, MVLS, Glasgow G12 0XH, Lanark, Scotland; [Weir, C. J.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Weir, C. J.] Edinburgh Hlth Serv Res Unit, Edinburgh, Midlothian, Scotland		McMillan, TM (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk		Weir, Christopher/0000-0002-6494-4903	Chief Scientist Office for Scotland [CZH/4/674]; NHS Lothian via the Edinburgh Health Services Research Unit; Chief Scientist Office [CZH/4/674] Funding Source: researchfish	The study was funded by the Chief Scientist Office for Scotland; grant number CZH/4/674. CJW was supported in this work by NHS Lothian via the Edinburgh Health Services Research Unit.	[Anonymous], 2009, SCOTT INT GUID NETW; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Chacon F, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-22; Cole JA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/232351; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Lawrence M, 2012, INT J STROKE, V7, P243, DOI 10.1111/j.1747-4949.2012.00771.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCartney G, 2012, PUBLIC HEALTH, V126, P459, DOI 10.1016/j.puhe.2012.03.007; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; ROWORTH MA, 1988, COMMUNITY MED, V10, P327; Scottish Exec, 2006, SCOTT IND MULT DEPR; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taulbut M, 2013, PUBLIC HEALTH, V127, P153, DOI 10.1016/j.puhe.2012.11.007; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	33	24	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2014	85	11					1214	1220		10.1136/jnnp-2013-307279			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	AS2ER	WOS:000344093100009	24623794				2022-02-06	
J	Ornstein, TJ; Sagar, S; Schachar, RJ; Ewing-Cobbs, L; Chapman, SB; Dennis, M; Saunders, AE; Yang, TT; Levin, HS; Max, JE				Ornstein, Tisha J.; Sagar, Sanya; Schachar, Russell J.; Ewing-Cobbs, Linda; Chapman, Sandra B.; Dennis, Maureen; Saunders, Ann E.; Yang, Tony T.; Levin, Harvey S.; Max, Jeffrey E.			Neuropsychological Performance of Youth with Secondary Attention-Deficit/Hyperactivity Disorder 6-and 12-Months after Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Children; Adolescents; S-ADHD; P-ADHD; Neurocognitive function	DEFICIT HYPERACTIVITY DISORDER; EXECUTIVE FUNCTION EF; CLOSED-HEAD INJURY; PSYCHIATRIC-DISORDERS; SUSTAINED ATTENTION; RESPONSE-INHIBITION; DIVIDED ATTENTION; WORKING-MEMORY; K-SADS; CHILDREN	The present study compared executive dysfunction among children with attention-deficit/hyperactivity disorder (ADHD) after traumatic brain injury (TBI), also called secondary ADHD (S-ADHD), pre-injury ADHD and children with TBI only (i.e., no ADHD). Youth aged 6-16 years admitted for TBI to five trauma centers were enrolled (n = 177) and evaluated with a semi-structured psychiatric interview scheduled on three occasions (within 2 weeks of TBI, i.e., baseline assessment for pre-injury status; 6-months and 12-months post-TBI). This permitted the determination of 6- and 12-month post-injury classifications of membership in three mutually exclusive groups (S-ADHD; pre-injury ADHD; TBI-only). Several executive control measures were administered. Unremitted S-ADHD was present in 17/141 (12%) children at the 6-month assessment, and in 14/125 (11%) children at 12-months post-injury. The study found that children with S-ADHD exhibited deficient working memory, attention, and psychomotor speed as compared to children with pre-injury ADHD. Furthermore, the children with S-ADHD and the children with TBI-only were impaired compared to the children with pre-injury ADHD with regard to planning. No group differences related to response inhibition emerged. Age, but not injury severity, gender, or adaptive functioning was related to executive function outcome. Neuropsychological sequelae distinguish among children who develop S-ADHD following TBI and those with TBI only. Moreover, there appears to be a different pattern of executive control performance in those who develop S-ADHD than in children with pre-injury ADHD suggesting that differences exist in the underlying neural mechanisms that define each disorder, underscoring the need to identify targeted treatment interventions.	[Ornstein, Tisha J.; Sagar, Sanya] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Schachar, Russell J.] Hosp Sick Children, Res Inst, Dept Psychiat Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Schachar, Russell J.] Hosp Sick Children, Res Inst, Brain & Behav Program, Toronto, ON M5G 1X8, Canada; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Dennis, Maureen] Hosp Sick Children, Res Inst, Brain & Behav Program, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Saunders, Ann E.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat, Houston, TX 77030 USA; [Yang, Tony T.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON, Canada		Max, JE (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu		Schachar, Russell/0000-0002-2015-4395; Sagar, Sanya/0000-0001-7381-0803	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800, R01MH085734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by the National Institute of Mental Health (J. M., K-08 MH01800); and the National Institute of Neurological Disorders and Stroke (H. L., NS-21889). The authors thank Xioaqi Li, M. S. for database management. Russell Schachar is the Toronto Dominion Bank Financial Group Chair in Child and Adolescent Psychiatry. He has participated in an advisory or consultative capacity with Lilly Corporation, Purdue Pharma, and Highland Therapeutics. His institution has intellectual property rights on the stop signal task and several genes involved in ADHD. Dr. Max provides expert testimony in cases of traumatic brain injury on an ad hoc basis for plaintiffs and defendants on a more or less equal ratio. This activity constitutes approximately 5% of his professional activities. The other authors have no disclosures.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2011, DEV NEUROPSYCHOL, V36, P137, DOI 10.1080/87565641.2010.549877; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gopin C. B., 2011, J INFANT CHILD ADOLE, V10, P13, DOI DOI 10.1080/15289168.2011.575700; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Hinshaw SP, 2007, NEUROPSYCHOLOGY, V21, P263, DOI 10.1037/0894-4105.21.2.263; Hiscock Kinsbourne, 1987, J EXP PSYCHOL, V18, P643; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Klorman R, 1999, J AM ACAD CHILD PSY, V38, P1148, DOI 10.1097/00004583-199909000-00020; Konrad KN, 2000, BRAIN INJURY, V14, P859; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Logan Gordon D., 1994, P189; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Robin DA, 1999, APHASIOLOGY, V13, P701, DOI 10.1080/026870399401812; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; TEASDALE G, 1974, LANCET, V2, P81; Thorell LB, 2007, J CHILD PSYCHOL PSYC, V48, P1061, DOI 10.1111/j.1469-7610.2007.01777.x; Travis F, 1998, BIOL PSYCHOL, V48, P37, DOI 10.1016/S0301-0511(98)00005-2; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; WELSH MC, 1991, COGNITIVE DEV, V6, P59, DOI 10.1016/0885-2014(91)90006-Y; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	63	24	24	0	22	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2014	20	10					971	981		10.1017/S1355617714000903			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AW3FN	WOS:000346171700003	25489810	Green Accepted			2022-02-06	
J	Surgucheva, I; He, S; Rich, MC; Sharma, R; Ninkina, NN; Stahel, PF; Surguchov, A				Surgucheva, Irina; He, Shuangteng; Rich, Megan C.; Sharma, Ram; Ninkina, Natalia N.; Stahel, Philip F.; Surguchov, Andrei			Role of synucleins in traumatic brain injury - An experimental in vitro and in vivo study in mice	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Traumatic brain injury; In vitro scratch injury model; Protein aggregation; Synucleins; Cofilin-actin rods	GLIAL CYTOPLASMIC INCLUSIONS; ALPHA-SYNUCLEIN; GAMMA-SYNUCLEIN; AXONAL-TRANSPORT; HEAD-INJURY; PARKINSON-DISEASE; CELL-DEATH; PROTEINS; SYSTEM; OVEREXPRESSION	Synucleins are small prone to aggregate proteins associated with several neurodegenerative diseases (NDDs), however their role in traumatic brain injury (TBI) is an emerging area of investigation. Using in vitro scratch injury model and in vivo mouse weight-drop model we have found that the injury causes alterations in the expression and localization of synucleins near the damaged area. Before injury, alpha-synuclein is diffused in the cytoplasm of neurons and gamma-synuclein is both in the cytoplasm and nucleus of oligodendrocytes. After the scratch injury of the mixed neuronal and glial culture, alpha-synuclein forms punctate structures in the cytoplasm of neurons and gamma-synuclein is almost completely localized to the nucleus of the oligodendrocytes. Furthermore, the amount of post-translationally modified Met(38)-oxidized gamma-synuclein is increased 3.8 fold 24 h after the scratch. alpha- and gamma-synuclein containing cells increased in the initially cell free scratch zone up to 24 h after the scratch. Intracellular expression and localization of synucleins are also changed in a mouse model of focal closed head injury, using a standardized weight drop device. gamma-Synuclein goes from diffuse to punctate staining in a piriform cortex near the amygdala, which may reflect the first steps in the formation of deposits/inclusions. Surprisingly, oxidized gamma-synuclein co-localizes with cofilin-actin rods in the thalamus, which are absent in all other regions of the brain. These structures reach their peak amounts 7 days after injury. The changes in gamma-synuclein localization are accompanied by injury-induced alterations in the morphology of both astrocytes and neurons. Published by Elsevier Inc.	[Surgucheva, Irina; Surguchov, Andrei] VA Med Ctr, Retinal Biol Res Lab, Kansas City, MO 64128 USA; [Surgucheva, Irina; Surguchov, Andrei] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [He, Shuangteng] Kansas City Dept Vet Affairs Med Ctr, Stroke Res Lab, Kansas City, MO 64128 USA; [Rich, Megan C.; Stahel, Philip F.] Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Orthopaed, Denver, CO 80204 USA; [Rich, Megan C.; Stahel, Philip F.] Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Neurosurg, Denver, CO 80204 USA; [Sharma, Ram] VA Med Ctr, Res Serv, Kansas City, MO 64128 USA; [Ninkina, Natalia N.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales		Surguchov, A (corresponding author), VA Med Ctr, Retinal Biol Res Lab, 4801 East Linwood, Kansas City, MO 64128 USA.	asurguchov@kumc.edu	Ninkina, Natalia N/A-1732-2011	Sharma, Ram/0000-0002-7485-1356	VA Merit review grantUS Department of Veterans Affairs [1I01BX000361]; Glaucoma Foundation [QB42308]	This work was supported by VA Merit review grant 1I01BX000361 and the Glaucoma Foundation grant QB42308. We thank Dr. James R Bamburg from the Department of Biochemistry and Molecular Biology, Colorado State University for a generous gift of cofilin antibodies and many helpful suggestions.	Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Bachurin SO, 2012, NEUROTOX RES, V22, P33, DOI 10.1007/s12640-011-9299-y; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Benedict JW, 2007, J NEUROSCI RES, V85, P2882, DOI 10.1002/jnr.21416; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Beyer K, 2013, MOL NEUROBIOL, V47, P509, DOI 10.1007/s12035-012-8330-5; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Busch DJ, 2012, J COMP NEUROL, V520, P1751, DOI 10.1002/cne.23011; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chiba Y, 2012, NEUROPATH APPL NEURO, V38, P559, DOI 10.1111/j.1365-2990.2011.01229.x; Ding HP, 2013, J MOL NEUROSCI, V51, P1000, DOI 10.1007/s12031-013-0086-5; Ducas VC, 2012, J MOL BIOL, V423, P528, DOI 10.1016/j.jmb.2012.08.008; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guo YJ, 2012, CELL SIGNAL, V24, P1109, DOI 10.1016/j.cellsig.2012.01.007; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Roy S, 2008, J NEUROSCI, V28, P5248, DOI 10.1523/JNEUROSCI.0309-08.2008; Rub U, 2002, J NEUROL S3, V249, DOI DOI 10.1007/S00415-002-1301-4; Sakurai M, 2009, J CEREBR BLOOD F MET, V29, P752, DOI 10.1038/jcbfm.2008.167; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun CY, 2013, MOL CELLS, V36, P47, DOI 10.1007/s10059-013-0014-0; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva IG, 2003, ARCH BIOCHEM BIOPHYS, V410, P167, DOI 10.1016/S0003-9861(02)00664-1; Surgucheva I, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0132-8; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Surgucheva I, 2008, J BIOL CHEM, V283, P36377, DOI 10.1074/jbc.M806660200; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	76	24	25	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	NOV	2014	63						114	123		10.1016/j.mcn.2014.10.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW4BT	WOS:000346227200012	25447944				2022-02-06	
J	Lafrenaye, AD; Krahe, TE; Povlishock, JT				Lafrenaye, Audrey D.; Krahe, Thomas E.; Povlishock, John T.			Moderately elevated intracranial pressure after diffuse traumatic brain injury is associated with exacerbated neuronal pathology and behavioral morbidity in the rat	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						behavioral morbidity; histopathology; intracranial pressure; membrane poration; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; CONTROLLED CORTICAL IMPACT; HIPPOCAMPAL-NEURONS; MEMBRANE PORATION; HEMORRHAGIC-SHOCK; LATE-ONSET; CELLS; MICE; CONTUSION	Traumatic brain injury (TBI)-induced elevated intracranial pressure (ICP) is correlated with ensuing morbidity/mortality in humans. This relationship is assumed to rely mostly on the recognition that extremely elevated ICP either indicates hematoma/contusions capable of precipitating herniation or alters cerebral perfusion pressure (CPP), which precipitates global ischemia. However, whether subischemic levels of elevated ICP without hematoma/contusion contribute to increased morbidity/mortality remains unknown. To address this knowledge gap, we utilized a model of moderate diffuse TBI in rats followed by either intraventricular ICP monitoring or manual ICP elevation to 20 mm Hg, in which CPP was above ischemic levels. The effects of ICP elevation after TBI on acute and chronic histopathology, as well as on behavioral morbidity, were evaluated. ICP elevation after TBI resulted in increased acute neuronal membrane perturbation and was also associated with reduced neuronal density at 4 weeks after injury. Somatosensory hypersensitivity was exacerbated by ICP elevation and was correlated to the observed neuronal loss. In conclusion, this study indicates that morbidity and increased neuronal damage/death associated with elevated ICP can occur without concurrent global ischemia. Therefore, understanding the pathologies associated with subischemic levels of elevated ICP could lead to the development of better therapeutic strategies for the treatment and management of TBI patients.	[Lafrenaye, Audrey D.; Krahe, Thomas E.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Lafrenaye, AD (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	forrestad@mymail.vcu.edu	Krahe, Thomas E/H-1695-2013	Krahe, Thomas E/0000-0002-4686-9284	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045824, 5P30NS047463]; NIH-NINDS centerUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045824, P30NS047463] Funding Source: NIH RePORTER	This work was supported by NIH grants NS045824 and 5P30NS047463. This work was supported by NIH grant NS045824. Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS center core grant, 5P30NS047463.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Chesnut RM, 2008, J TRAUMA, V65, P500, DOI 10.1097/TA.0b013e31818020b3; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; De Bonis P, 2013, NEW ENGL J MED, V368, P1749, DOI 10.1056/NEJMc1301076; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Folgering JHA, 2008, PROG BIOPHYS MOL BIO, V97, P180, DOI 10.1016/j.pbiomolbio.2008.02.006; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Yacoub A, 2006, MOL PHARMACOL, V70, P589, DOI 10.1124/mol.106.025007; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	49	24	24	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2014	34	10					1628	1636		10.1038/jcbfm.2014.122			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AQ1IV	WOS:000342536000007	25027309	Green Published, Bronze			2022-02-06	
J	Lui, YW; Xue, YY; Kenul, D; Ge, YL; Grossman, RI; Wang, Y				Lui, Yvonne W.; Xue, Yuanyi; Kenul, Damon; Ge, Yulin; Grossman, Robert I.; Wang, Yao			Classification algorithms using multiple MRI features in mild traumatic brain injury	NEUROLOGY			English	Article							MAGNETIC-FIELD CORRELATION; DIFFUSION TENSOR; UNIFIED DEFINITION; MUTUAL INFORMATION; INTEGRITY; PERFUSION; SEARCH; VOLUME; TBI; DTI	Objective: The purpose of this study was to develop an algorithm incorporating MRI metrics to classify patients with mild traumatic brain injury (mTBI) and controls. Methods: This was an institutional review board-approved, Health Insurance Portability and Accountability Act-compliant prospective study. We recruited patients with mTBI and healthy controls through the emergency department and general population. We acquired data on a 3.0T Siemens Trio magnet including conventional brain imaging, resting-state fMRI, diffusion-weighted imaging, and magnetic field correlation (MFC), and performed multifeature analysis using the following MRI metrics: mean kurtosis (MK) of thalamus, MFC of thalamus and frontal white matter, thalamocortical resting-state networks, and 5 regional gray matter and white matter volumes including the anterior cingulum and left frontal and temporal poles. Feature selection was performed using minimal-redundancy maximal-relevance. We used classifiers including support vector machine, naive Bayesian, Bayesian network, radial basis network, and multilayer perceptron to test maximal accuracy. Results: We studied 24 patients with mTBI and 26 controls. Best single-feature classification uses thalamic MK yielding 74% accuracy. Multifeature analysis yields 80% accuracy using the full feature set, and up to 86% accuracy using minimal-redundancy maximal-relevance feature selection (MK thalamus, right anterior cingulate volume, thalamic thickness, thalamocortical resting-state network, thalamic microscopic MFC, and sex). Conclusion: Multifeature analysis using diffusion-weighted imaging, MFC, fMRI, and volumetrics may aid in the classification of patients with mTBI compared with controls based on optimal feature selection and classification methods. Classification of evidence: This study provides Class III evidence that classification algorithms using multiple MRI features accurately identifies patients with mTBI as defined by American Congress of Rehabilitation Medicine criteria compared with healthy controls.	[Lui, Yvonne W.; Kenul, Damon; Ge, Yulin; Grossman, Robert I.] NYU, Dept Radiol, Sch Med, New York, NY 10016 USA; [Xue, Yuanyi; Wang, Yao] NYU, Polytech Sch Engn, Dept Elect Engn, Brooklyn, NY USA		Lui, YW (corresponding author), NYU, Dept Radiol, Sch Med, 560 1St Ave, New York, NY 10016 USA.	Yvonne.lui@nyumc.org	Ge, Yulin/D-9060-2019; Ge, Yulin/L-7052-2019	Ge, Yulin/0000-0002-2320-6031; Wang, Yao/0000-0003-3199-3802	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR000038, 2 RO1 NS039135-11]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090349, R01NS039135] Funding Source: NIH RePORTER	Supported in part by NIH grants UL1 TR000038 and 2 RO1 NS039135-11.	Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Bianchi A, 2013, IEEE T MED IMAGING; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Faul M, TRAUMATIC BRAIN INJU; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2014, J NEUROTRAUM, V29, P2318; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; HECKERMAN D, 1996, TUTORIAL LEARNING BA; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jensen JH, 2006, MAGN RESON MED, V55, P1350, DOI 10.1002/mrm.20907; Jensen JH, 2009, MAGN RESON MED, V61, P481, DOI 10.1002/mrm.21823; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Luther N, 2012, NEUROSURGERY, V71, pE558, DOI 10.1227/01.neu.0000417733.09300.04; Manning C. D., 2008, INTRO INFORM RETRIEV; Marr A., 2004, CENTRAL NERVOUS SYST; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Ruff RM, 1999, BRAIN INJURY, V13, P943; Rumelhart D.E., 1986, Language., V22, P98, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Scholkopf B., 1999, ADV KERNEL METHODS S; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	36	24	24	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 30	2014	83	14					1235	1240		10.1212/WNL.0000000000000834			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AT3UN	WOS:000344860700008	25171930	Green Published			2022-02-06	
J	Hu, BY; Liu, XJ; Qiang, R; Jiang, ZL; Xu, LH; Wang, GH; Li, X; Peng, B				Hu, Bao-Ying; Liu, Xian-Jin; Qiang, Ren; Jiang, Zheng-Lin; Xu, Li-Hua; Wang, Guo-Hua; Li, Xia; Peng, Bin			Treatment with ginseng total saponins improves the neurorestoration of rat after traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Ginseng total saponins; Neuroprotection; Neural stem/progenitor cell; Neurorestoration; Rat; Traumatic brain injury	NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; DENTATE GYRUS; HIPPOCAMPAL-NEURONS; AXON REGENERATION; MOTOR-PERFORMANCE; PANAX-NOTOGINSENG; RG1	Ethnopharmacological relevance: Ginseng, the root of Panax ginseng CA. Meyer, is a traditional medicinal herb that has been widely used in Asia for the treatment of many diseases through its effects of reinforcing vitality, strengthening the bodily resistance to pathogenic factors, engendering body liquids and allaying thirst, relieving uneasiness of the body and mind and benefiting intelligence, reducing body weight and prolonging life. Ginsenosides are the most important biologically active substances in ginseng. Many reports have suggested that ginsenosides could exert prominent neuroprotective and neurotrophic effects, promote neural stem/progenitor cell (NSC) proliferation and promote neurite outgrowth and neuronal network formation. The present study aimed to investigate whether treatment with ginsenosides could facilitate NSC proliferation in the hippocampal formation after traumatic brain injury (TBI) and contribute to the recovery of neurological functions including learning and memory. Materials and methods: The modified Feeney's method was used to induce a TBI in rats. Ginseng total saponins (GTS) were treated intraperitoneally twice a day for 1 week after the TBI. The neurological functions, morphology of the hippocampus, expression of nerve growth-related factors and number of NSCs in the hippocampal formation ipsilateral to the trauma were determined. Results: We determined 1) GTS (5-80 mg/kg) treatment after a TBI improved the recovery of neurological functions, including learning and memory, and reduced cell loss in the hippocampal area. The effects of GTS at 20,40,60, and 80 mg/kg were better than the effects of GTS at 5 and 10 mg/kg. 2) GTS treatment (20 mg/kg) after a TBI increased the expression of NGF, GDNF and NCAM, inhibited the expression of Nogo-A, Nogo-B, TN-C, and increased the number of BrdU/nestin positive NSCs in the hippocampal formation. Conclusions: GTS treatment in rats after a TBI alleviated the secondary brain injury and ameliorated the neurological functions with an effective dose limit of 5-80 mg/kg. GTS regulated the expression of nerve growth-related factors and improved the proliferation of neural stem/progenitor cells, which might facilitate neural regeneration and tissue repair, and might contribute to the recovery of neurological functions, including learning and memory. These effects of GTS might provide a foundation for the use of ginseng as a medicinal herb to enhance intelligence, reduce the aging process and prolong life in the traditional medicine. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hu, Bao-Ying; Jiang, Zheng-Lin; Xu, Li-Hua; Wang, Guo-Hua; Li, Xia; Peng, Bin] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xian-Jin; Qiang, Ren] Third Peoples Hosp Nantong, Dept Infect Dis, Nantong 226001, Jiangsu, Peoples R China		Qiang, R (corresponding author), Third Peoples Hosp Nantong, Dept Infect Dis, 99 Cent Qingnian Rd, Nantong 226001, Jiangsu, Peoples R China.	ntqiangren@gmail.com; jiangzl@ntu.edu.cn			Administration of Science and Technology of Nantong [BK2012086]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071614, 81372131, 81000497]	This study was supported by a grant from the Administration of Science and Technology of Nantong (Project no. BK2012086) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Zheng-Lin Jiang is supported by the National Natural Science Foundation of China (Grant nos. 81071614, 81372131 and 81000497).	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Chen CF, 2008, ACTA PHARMACOL SIN, V29, P1103, DOI 10.1111/j.1745-7254.2008.00868.x; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DEGRABA TJ, 1994, J CEREBR BLOOD F MET, V14, P262, DOI 10.1038/jcbfm.1994.33; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Gong L, 2011, PHARM BIOL, V49, P501, DOI 10.3109/13880209.2010.521514; Hannila SS, 1999, J NEUROBIOL, V39, P51, DOI 10.1002/(SICI)1097-4695(199904)39:1<51::AID-NEU5>3.3.CO;2-K; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; JIANG S, 2003, J APOPLEXY NERVOUS D, V20, P415; JIANG ZL, 2001, CHIN J APPL PHYSL, V17, P105; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Leker RR, 2009, EXPERT OPIN BIOL TH, V9, P1117, DOI 10.1517/14712590903130558; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liang W, 2010, BRAIN RES, V1357, P19, DOI 10.1016/j.brainres.2010.07.091; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lim JH, 1997, NEUROSCI RES, V28, P191, DOI 10.1016/S0168-0102(97)00041-2; Liu JW, 2007, J NAT PROD, V70, P1329, DOI 10.1021/np070135j; Liu L, 2011, BRAIN RES, V1382, P147, DOI 10.1016/j.brainres.2011.01.051; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; Ng TB, 2006, J PHARM PHARMACOL, V58, P1007, DOI 10.1211/jpp.58.8.0001; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Rudakewich M, 2001, PLANTA MED, V67, P533, DOI 10.1055/s-2001-16488; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shen LH, 2004, NEUROL RES, V26, P422, DOI 10.1179/016164104225016047; Shen LH, 2003, NEUROSCI LETT, V344, P1, DOI 10.1016/S0304-3940(03)00318-5; Shi Q, 2005, LIFE SCI, V76, P983, DOI 10.1016/j.lfs.2004.07.026; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang ZJ, 2006, CHEM-BIOL INTERACT, V159, P58, DOI 10.1016/j.cbi.2005.09.003; WINSTON SR, 1979, J IOWA MED SOC, V69, P393; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP; Zhao HF, 2011, NEUROSCIENCE, V183, P189, DOI 10.1016/j.neuroscience.2011.03.048; Zhao HF, 2009, BRAIN RES, V1256, P111, DOI 10.1016/j.brainres.2008.12.031; Zheng GQ, 2011, J ETHNOPHARMACOL, V133, P724, DOI 10.1016/j.jep.2010.01.064; 姜正林, 2000, 中华航海医学杂志, V7, P28	63	24	25	3	45	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	SEP 11	2014	155	2					1243	1255		10.1016/j.jep.2014.07.009			13	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	AP2JE	WOS:000341897700030	25046825				2022-02-06	
J	Dick, AS				Dick, Anthony Steven			The development of cognitive flexibility beyond the preschool period: An investigation using a modified Flexible Item Selection Task	JOURNAL OF EXPERIMENTAL CHILD PSYCHOLOGY			English	Article						Executive function; Cognitive flexibility; Dimensional Change Card Sort; Wisconsin Card Sort; Flexible Item Selection Task; Working memory	CARD SORTING TEST; LATENT VARIABLE ANALYSIS; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; WORKING-MEMORY; YOUNG-CHILDREN; RELATIONAL COMPLEXITY; LIFE-SPAN; AGE; INHIBITION	We explored the development of cognitive flexibility in typically developing 6-, 8-, and 10-year-olds and adults by modifying a common cognitive flexibility task, the Flexible Item Selection Task (FIST). Although performance on the standard FIST reached ceiling by 8 years, FIST performance on other variations continued to improve until 10 years of age. Within a detailed task analysis, we also explored working memory storage and processing components of executive function and how these contribute to the development of cognitive flexibility. The findings reinforce the notion that cognitive flexibility is a multifaceted construct but that the development of working memory contributes in part to age-related change in this ability. (C) 2014 Elsevier Inc. All rights reserved.	Florida Int Univ, Dept Psychol, Miami, FL 33199 USA		Dick, AS (corresponding author), Florida Int Univ, Dept Psychol, Miami, FL 33199 USA.	adick@fiu.edu					Andrews G, 2003, CHILD DEV, V74, P1476, DOI 10.1111/1467-8624.00618; Ashendorf L, 2008, CLIN NEUROPSYCHOL, V22, P262, DOI 10.1080/13854040701218436; Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Barcelo F, 1999, NEUROREPORT, V10, P1299, DOI 10.1097/00001756-199904260-00027; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Blackwell KA, 2009, J EXP CHILD PSYCHOL, V103, P241, DOI 10.1016/j.jecp.2009.01.002; Blair C, 2004, DEV PSYCHOBIOL, V45, P113, DOI 10.1002/dev.20022; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bond T, 2001, APPL RASCH MODEL FUN; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; CARVAJAL HH, 1992, PSYCHOL SCHOOLS, V29, P22, DOI 10.1002/1520-6807(199201)29:1<22::AID-PITS2310290105>3.0.CO;2-P; Cepeda NJ, 2007, PSYCHON B REV, V14, P1058, DOI 10.3758/BF03193091; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; CHELUNE GJ, 1987, DEV NEUROPSYCHOL, V3, P81, DOI 10.1080/87565648709540365; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Chevalier N, 2008, DEVELOPMENTAL SCI, V11, P339, DOI 10.1111/j.1467-7687.2008.00679.x; Chevalier N, 2012, DEV NEUROPSYCHOL, V37, P99, DOI 10.1080/87565641.2011.632458; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cowan N, 2010, DEVELOPMENTAL SCI, V13, P120, DOI 10.1111/j.1467-7687.2009.00864.x; Cragg L, 2012, Q J EXP PSYCHOL, V65, P209, DOI 10.1080/17470210903204618; Cragg L, 2009, DEV PSYCHOL, V45, P1465, DOI 10.1037/a0015360; Crone EA, 2006, DEVELOPMENTAL SCI, V9, P278, DOI 10.1111/j.1467-7687.2006.00490.x; Crone EA, 2004, DEVELOPMENTAL SCI, V7, P443, DOI 10.1111/j.1467-7687.2004.00365.x; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Dawson TL, 2002, INT J BEHAV DEV, V26, P154, DOI 10.1080/01650250042000645; Deak GO, 2003, ADV CHILD DEV BEHAV, V31, P271; Diamond A, 2005, PSYCHOL SCI, V16, P291, DOI 10.1111/j.0956-7976.2005.01530.x; DIAMOND A, 1994, DEV PSYCHOL, V30, P192, DOI 10.1037/0012-1649.30.2.192; Dick A.S., 2010, SELF SOCIAL REGULATI, P7; Dick AS, 2012, J COGN DEV, V13, P82, DOI 10.1080/15248372.2011.573516; DUNN LM, 1981, MANUAL PEABODY PICTU; Ellefson MR, 2006, COGNITIVE DEV, V21, P108, DOI 10.1016/j.cogdev.2006.01.002; Espy KA, 2005, DEV NEUROPSYCHOL, V28, P669, DOI 10.1207/s15326942dn2802_6; Fristoe NM, 1997, NEUROPSYCHOLOGY, V11, P428, DOI 10.1037/0894-4105.11.3.428; Frye D, 1995, COGNITIVE DEV, V10, P483, DOI 10.1016/0885-2014(95)90024-1; Gamboz N, 2009, AGING NEUROPSYCHOL C, V16, P260, DOI 10.1080/13825580802573045; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2000, J EDUC PSYCHOL, V92, P377, DOI 10.1037//0022-0663.92.2.377; Gordon ACL, 1998, J EXP CHILD PSYCHOL, V68, P70, DOI 10.1006/jecp.1997.2423; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Halford GS, 1998, BEHAV BRAIN SCI, V21, P803, DOI 10.1017/S0140525X98001769; Heaton R.K., 2000, WCST 64 COMPUTER VER; HODAPP AF, 1993, PSYCHOL REP, V73, P1152, DOI 10.2466/pr0.1993.73.3f.1152; Hughes C., 2002, CHILD ADOLESCENT MEN, V7, P131, DOI DOI 10.1111/1475-3588.00024; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Jacques S, 2001, DEV NEUROPSYCHOL, V20, P573, DOI 10.1207/S15326942DN2003_2; Kelly M. A., 1986, J CLIN EXPT NEUROPSY, V7, P604; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P449, DOI 10.1111/1467-7687.00300; Kloo D, 2005, DEVELOPMENTAL SCI, V8, P44, DOI 10.1111/j.1467-7687.2005.00392.x; Kongs S. K., 2000, WCST 64 WISCONSIN CA; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Maes JHR, 2004, BRAIN COGNITION, V54, P201, DOI 10.1016/j.bandc.2004.01.003; Marcovitch S, 2010, CHILD DEV, V81, P1687, DOI 10.1111/j.1467-8624.2010.01503.x; Marcovitch S, 2009, DEVELOPMENTAL SCI, V12, P1, DOI 10.1111/j.1467-7687.2008.00754.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A., 1999, MODELS WORKING MEMOR; Morton JB, 2002, DEV PSYCHOBIOL, V40, P255, DOI 10.1002/dev.10033; Muller U, 2006, CHILD DEV, V77, P395, DOI 10.1111/j.1467-8624.2006.00878.x; Munakata Y, 2001, TRENDS COGN SCI, V5, P309, DOI 10.1016/S1364-6613(00)01682-X; Munakata Y, 2003, DEVELOPMENTAL SCI, V6, P471, DOI 10.1111/1467-7687.00302; Munakata Y, 1998, DEVELOPMENTAL SCI, V1, P161, DOI 10.1111/1467-7687.00021; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; PANIAK C, 1996, CANADIAN J REHABILIT, V9, P233; Parkin A. J., 1995, NEUROPSYCHOLOGY, V9, P304, DOI DOI 10.1037/0894-4105.9.3.304; Ramscar M, 2013, CHILD DEV, V84, P1308, DOI 10.1111/cdev.12044; ROSSELLI M, 1993, CLIN NEUROPSYCHOL, V7, P145, DOI 10.1080/13854049308401516; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Willoughby MT, 2013, PSYCHOL ASSESSMENT, V25, P664, DOI 10.1037/a0031747; Willoughby MT, 2010, PSYCHOL ASSESSMENT, V22, P306, DOI 10.1037/a0018708; Wright B, 1982, RATING SCALE ANAL RA; Wright BD, 1979, BEST TEST DESIGN HDB; Yerys BE, 2012, J AUTISM DEV DISORD, V42, P2013, DOI 10.1007/s10803-012-1443-x; Zelazo P. D., 2003, MONOGRAPHS SOC RES C, V68; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005; [No title captured]	81	24	31	1	41	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0965	1096-0457		J EXP CHILD PSYCHOL	J. Exp. Child Psychol.	SEP	2014	125						13	34		10.1016/j.jecp.2014.01.021			22	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	AJ7GA	WOS:000337864000002	24814204				2022-02-06	
J	Hendricks, S; Karpul, D; Lambert, M				Hendricks, Sharief; Karpul, David; Lambert, Mike			Momentum and Kinetic Energy before the Tackle in Rugby Union	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Tackle; rugby union; contact sports; momentum; kinetic energy	PROFESSIONAL FOOTBALL; MATCH PLAY; INJURY; RECONSTRUCTION; IMPACTS; MOTION; ACCELERATION; EPIDEMIOLOGY; CONCUSSION; STRATEGIES	Understanding the physical demands of a tackle in match situations is important for safe and effective training, developing equipment and research. Physical components such as momentum and kinetic energy, and it relationship to tackle outcome is not known. The aim of this study was to compare momenta between ball-carrier and tackler, level of play (elite, university and junior) and position (forwards vs. backs), and describe the relationship between ball-carrier and tackler mass, velocity and momentum and the tackle outcome. Also, report on the ball-carrier and tackler kinetic energy before contact and the estimated magnitude of impact (energy distributed between ballcarrier and tackler upon contact). Velocity over 0.5 seconds before contact was determined using a 2-dimensional scaled version of the field generated from a computer alogorithm. Body masses of players were obtained from their player profiles. Momentum and kinetic energy were subsequently calculated for 60 tackle events. Ball-carriers were heavier than the tacklers (ball-carrier 100 +/- 14 kg vs. tackler 93 +/- 11 kg, d = 0.52, p = 0.0041, n = 60). Ball-carriers as forwards had a significantly higher momentum than backs (forwards 563 +/- 226 Kg center dot m center dot s(-1) n = 31 vs. backs 438 +/- 135 Kg center dot m center dot s(-1), d = 0.63, p = 0.0012, n = 29). Tacklers dominated 57% of tackles and ball-carriers dominated 43% of tackles. Despite the ball-carrier having a mass advantage before contact more frequently than the tackler, momentum advantage and tackle dominance between the ball-carrier and tackler was proportionally similar. These findings may reflect a characteristic of the modern game of rugby where efficiently heavier players (particularly forwards) are tactically predetermined to carry the ball in contact.	[Hendricks, Sharief] Univ Cape Town, MRC UCT Res Unit Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; Sports Sci Inst South Africa, Cape Town, South Africa		Hendricks, S (corresponding author), Univ Cape Town, MRC UCT Res Unit Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	sharief.hendricks01@gmail.com; mike.lambert@uct.ac.za	Hendricks, Sharief/U-3278-2019	Hendricks, Sharief/0000-0002-3416-6266; Karpul, David/0000-0002-5197-4038; Lambert, Michael/0000-0001-8979-1504	National Research Foundation/German Academic Exchange ServiceDeutscher Akademischer Austausch Dienst (DAAD); Medical Research Council of South AfricaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Frank Foreman Scholarship; Glickman/Elliot Scholarship; University of Cape Town Equity Scholarship; Doctoral Research Scholarship; Exercise Science and Sports Medicine Scholarship	The authors of this paper would like to thank the National Research Foundation/German Academic Exchange Service, Medical Research Council of South Africa, Frank Foreman Scholarship, Glickman/Elliot Scholarship, University of Cape Town Equity Scholarship, Doctoral Research Scholarship, and the Exercise Science and Sports Medicine Scholarship for support during the study.	Alcock A, 2009, SPORT BIOMECH, V8, P129, DOI 10.1080/14763140902829342; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Batterham AM, 2006, INTJ SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; BLAZEVICH A., 2007, SPORTS BIOMECHANICS; Brewin MA, 2003, J APPL BIOMECH, V19, P79, DOI 10.1123/jab.19.1.79; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burkett B., 2010, SPORT MECH COACHES; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Eaton C, 2006, PHYS THER SPORT, V7, P30, DOI 10.1016/j.ptsp.2005.07.001; Edgecomb SJ, 2006, J SCI MED SPORT, V9, P25, DOI 10.1016/j.jsams.2006.01.003; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Garraway WM, 1999, BRIT J SPORT MED, V33, P37, DOI 10.1136/bjsm.33.1.37; Headey J, 2007, AM J SPORT MED, V35, P1537, DOI 10.1177/0363546507300691; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Kwon YH, 2006, SPORT BIOMECH, V5, P95, DOI 10.1080/14763141.2006.9628227; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McLellan CP, 2012, J STRENGTH COND RES, V26, P1431, DOI 10.1519/JSC.0b013e318231a627; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Olds T, 2001, J SPORT SCI, V19, P253, DOI 10.1080/026404101750158312; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Sedeaud A, 2012, BRIT J SPORT MED, V46, P580, DOI 10.1136/bjsports-2011-090506; Sundaram A, 2011, J SCI MED SPORT, V14, P111, DOI 10.1016/j.jsams.2010.08.005; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Wheeler K, 2009, INT J SPORTS SCI COA, V4, P535, DOI 10.1260/174795409790291420; Wheeler KW, 2010, EUR J SPORT SCI, V10, P237, DOI 10.1080/17461391.2010.482595	35	24	24	1	20	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	SEP	2014	13	3					557	563					7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AN7BL	WOS:000340753400014	25177182				2022-02-06	
J	Kumar, NS; Chin, M; O'Neill, C; Jakoi, AM; Tabb, L; Wolf, M				Kumar, Neil S.; Chin, Matthew; O'Neill, Craig; Jakoi, Andre M.; Tabb, Loni; Wolf, Michael			On-Field Performance of National Football League Players After Return From Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; football; National Football League; return to play	SPORT-RELATED CONCUSSION; PROFESSIONAL FOOTBALL; BASKETBALL ASSOCIATION; INJURIES; OUTCOMES; MICROFRACTURE; STATEMENT; RECOVERY; NFL	Background: There are few data examining the short-term effects of concussions on player performance upon return to play. This study examined changes in on-field performance and the influence of epidemiologic factors on performance and return to play. Hypothesis: On-field performance is different in players who return within 7 days after concussion compared with players who miss at least 1 game. Study Design: Case-control study; Level of evidence, 3. Methods: Players in the National Football League who were active during the 2008 to 2012 seasons were considered for inclusion. Weekly injury reports identified concussed players. All players played in at least 4 games before and after the game of injury (sentinel game) within the year of injury (sentinel year). Players who had missed games secondary to another injury or had sustained a second concussion within the sentinel year were excluded. The players' league profiles were used to determine age, position, body mass index, career experience, and games missed. ProFootballFocus performance scores determined player ratings. Statistical analysis used 2-sided t tests and both univariate and multivariate logistic regression models. Results: There were a total of 131 concussions in the 124 players who qualified for this study; 55% of these players missed no games. Defensive secondary, wide receiver, and offensive line were the most commonly affected positions. Players who missed at least 1 game were younger and less experienced. Preinjury ProFootballFocus performance scores were similar to postinjury performance in players without games missed (0.16 vs 0.33; P = .129) and players who missed at least 1 game (-0.06 vs 0.10; P = .219). Age, body mass index, experience, and previous concussion did not correlate with changes in postinjury scores (P > .05). Older, more experienced players and players with late-season concussions were more likely to return to play without missing games (P < .05). The odds of returning within 7 days increased by 18% for each career year and by 40% for each game before the sentinel game within the sentinel year; these same odds decreased by 85% after introduction of newer treatment guidelines in 2009. Conclusion: No difference in player performance after concussion was found whether the player did or did not miss games before return. Return without missing games may be associated with experience and timing of injury within a season and less likely after newer guidelines.	[Kumar, Neil S.; Chin, Matthew; O'Neill, Craig; Jakoi, Andre M.; Tabb, Loni; Wolf, Michael] Drexel Univ, Coll Med, Philadelphia, PA 19102 USA		Kumar, NS (corresponding author), Drexel Univ, Coll Med, Dept Orthopaed Surg, 245 N 15th St, Philadelphia, PA 19102 USA.	neilskumar1@gmail.com	Jakoi, Andre/K-8338-2019	Kumar, Neil/0000-0003-0634-2442			Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Casson IR, 2011, SPORTS HEALTH, V3, P130, DOI 10.1177/1941738110397876; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cerynik DL, 2009, KNEE SURG SPORT TR A, V17, P1135, DOI 10.1007/s00167-009-0765-5; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris JD, 2013, SPORTS HEALTH, V5, P562, DOI 10.1177/1941738113495788; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Klossner D, 2013, 2013 14 NCAA SPORTS; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lazarus Arthur, 2011, Physician Exec, V37, P6; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Namdari S, 2011, PHYSICIAN SPORTSMED, V39, P36, DOI 10.3810/psm.2011.02.1860; Namdari S, 2009, AM J SPORT MED, V37, P943, DOI 10.1177/0363546508330150; National Football League Head Neck and Spine Committee, 2014, NFL HEAD NECK SPIN C; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2013, COMPUT METHODS BIOME; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	34	24	24	0	31	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2014	42	9					2050	2055		10.1177/0363546514539449			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	AP9GQ	WOS:000342387400002	25008256				2022-02-06	
J	Kirschen, MP; Tsou, A; Nelson, SB; Russell, JA; Larriviere, D				Kirschen, Matthew P.; Tsou, Amy; Nelson, Sarah Bird; Russell, James A.; Larriviere, Daniel		Ethics Law Humanities Comm	Legal and ethical implications in the evaluation and management of sports-related concussion	NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; POSITION STATEMENT; BRAIN-INJURY; RISK; CARE; EPIDEMIOLOGY; CHILDREN	Objective: To examine the ethical and legal issues physicians face when evaluating and managing athletes with sports-related concussions, and to offer guidance to physicians as they navigate these situations. Results: This position paper reviews and compares the components of sports-related concussion laws, including education, removal from play, and clearance for return to play. It highlights the challenges privacy laws present relevant to providing care to concussed athletes and suggests ways to help physicians overcome these obstacles. The report also explores the ethical considerations physicians should bear in mind as they evaluate and manage concussed athletes, addressing them through a framework that includes considerations of professionalism, informed decision-making, patient autonomy, beneficence, nonmaleficence, conflicts of interest, and distributive justice. Conclusions: Physicians caring for concussed athletes have an ethical obligation to ensure that their primary responsibility is to safeguard the current and future physical and mental health of their patients. Physicians have a duty to provide athletes and their parents with information about concussion risk factors, symptoms, and the risks for postconcussion neurologic impairments. Physicians should facilitate informed and shared decision-making among athletes, parents, and medical teams while protecting athletes from potential harm. Additionally, including concussion evaluation and management training in neurology residency programs, as well as developing a national concussion registry, will benefit patients by the development of policies and clinical guidelines that optimize prevention and treatment of concussive head injury.	[Kirschen, Matthew P.] Univ Penn, Perelman Sch Med, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Kirschen, Matthew P.] Univ Penn, Perelman Sch Med, Dept Anesthesia & Crit Care Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Tsou, Amy] Emergency Care Res Inst, Plymouth, PA USA; [Tsou, Amy] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Nelson, Sarah Bird] Amer Acad Neurol, Minneapolis, MN USA; [Russell, James A.] Tufts Univ, Sch Med, Lahey Clin, Dept Neurol, Boston, MA 02111 USA; [Larriviere, Daniel] Ochsner Med Ctr, Ochner Neurosci Inst, New Orleans, LA USA		Kirschen, MP (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA.	kirschenm@chop.edu	Larriviere, Daniel G/N-7786-2013	Tsou, Amy/0000-0002-5544-3090			American Academy of Neurology, 2012, SPORTS NEUR SURV FIN; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V6th; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Dahodwala N, 2009, ANN NEUROL, V66, P142, DOI 10.1002/ana.21774; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Institute of Medicine, 2013, SPORTS REL CONC YOUT; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Judd T, 2009, ARCH CLIN NEUROPSYCH, V24, P127, DOI 10.1093/arclin/acp016; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kimball MM, 2014, J STROKE CEREBROVASC, V23, P17, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.004; KOHRMAN A, 1995, PEDIATRICS, V95, P314; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pennington B., 2008, NEW YORK TIMES; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Talavage TM, 2013, J NEUROTRAUM, V30, P1; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Watanabe T, 2010, PM&R, V2, P671, DOI 10.1016/j.pmrj.2010.06.002; WEITHORN LA, 1982, CHILD DEV, V53, P1589, DOI 10.1111/j.1467-8624.1982.tb03482.x	38	24	24	1	39	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 22	2014	83	4					352	358		10.1212/WNL.0000000000000613			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AM9YH	WOS:000340236500017	25008394	Bronze			2022-02-06	
J	Neselius, S; Brisby, H; Marcusson, J; Zetterberg, H; Blennow, K; Karlsson, T				Neselius, Sanna; Brisby, Helena; Marcusson, Jan; Zetterberg, Henrik; Blennow, Kaj; Karlsson, Thomas			Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DIFFUSE AXONAL INJURY; WORD-ASSOCIATION TEST; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; WORKING-MEMORY; FOOTBALL PLAYERS; HIGH-SCHOOL; INDIVIDUAL-DIFFERENCES	Background: Mild traumatic brain injury (TBI) or concussion is common in many sports. Today, neuropsychological evaluation is recommended in the monitoring of a concussion and in return-to-play considerations. To investigate the sensitivity of neuropsychological assessment, we tested amateur boxers post bout and compared with controls. Further the relationship between neuropsychological test results and brain injury biomarkers in the cerebrospinal fluid (CSF) were investigated. Method: Thirty amateur boxers on high elite level with a minimum of 45 bouts and 25 non-boxing matched controls were included. Memory tests (Rey Osterrieth Complex Figure, Listening Span, Digit Span, Controlled Word Association Test, and computerized testing of episodic memory), tests of processing speed and executive functions (Trail Making, Reaction Time, and Finger Tapping) were performed and related to previously published CSF biomarker results for the axonal injury marker neurofilament light (NFL). Results: The neurological assessment showed no significant differences between boxers and controls, although elevated CSF NFL, as a sign of axonal injury, was detected in about 80% of the boxers 1-6 days post bout. The investigation of the relationship between neuropsychological evaluation and CSF NFL concentrations revealed that boxers with persisting NFL concentration elevation after at least 14 days resting time post bout, had a significantly poorer performance on Trail Making A (p = 0.041) and Simple Reaction Time (p = 0.042) compared to other boxers. Conclusion: This is the first study showing traumatic axonal brain injury can be present without measureable cognitive impairment. The repetitive, subconcussive head trauma in amateur boxing causes axonal injury that can be detected with analysis of CSF NFL, but is not sufficient to produce impairment in memory tests, tests of processing speed, or executive functions. The association of prolonged CSF NFL increase in boxers with impairment of processing speed is an interesting observation, which needs to be verified in larger studies.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Marcusson, Jan] Linkoping Univ Hosp, Geriatr Sect, S-58185 Linkoping, Sweden; [Marcusson, Jan] Linkoping Univ, Inst Clin & Expt Med, Linkoping, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Linkoping, Sweden		Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden.	sanna.neselius@vgregion.se			ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; ALF Grants, County Council of Ostergotland	This work was supported by ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; and ALF Grants, County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Benton AL, 1994, MULTILINGUAL APHASIA; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; CORNELL DG, 1997, ARCH CLIN NEUROPSYCH, V12, P47; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Hannay HJ, 1986, EXPT TECHNIQUES HUMA; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jordan BD, 1996, AM J SPORT MED, V24, P704, DOI 10.1177/036354659602400526; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KASTE M, 1982, LANCET, V2, P1186; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lezak MD, 1984, SCANDINAVIAN J WO S1, V10, P25; Loring DW, 1990, NEUROLOGY, V74, P685; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Malek-Ahmadi M, 2011, DEMENT GERIATR COGN, V32, P235, DOI 10.1159/000334525; Malm J, 1998, NEUROLOGY, V51, P433, DOI 10.1212/WNL.51.2.433; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mayers LB, 2011, J CLIN EXP NEUROPSYC, V33, P532, DOI 10.1080/13803395.2010.535506; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; REITAN RM, 1994, J CLIN PSYCHOL, V50, P47, DOI 10.1002/1097-4679(199401)50:1<47::AID-JCLP2270500106>3.0.CO;2-X; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosen VM, 2002, NEUROPSYCHOLOGIA, V40, P2226, DOI 10.1016/S0028-3932(02)00132-X; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Thomas JR, 1999, RES Q EXERCISE SPORT, V70, P11, DOI 10.1080/02701367.1999.10607726; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tulving E., 1985, CAN PSYCHOL, V1, P1; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wechsler, 1997, WECHSLER ADULT INTEL; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	65	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99870	10.1371/journal.pone.0099870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	WOS:000338508200048	24941067	Green Submitted, Green Published, gold			2022-02-06	
J	Wilson, M; Staniforth, A; Till, R; das Nair, R; Vesey, P				Wilson, Michelle; Staniforth, Andrew; Till, Richard; das Nair, Roshan; Vesey, Patrick			The psychosocial outcomes of anoxic brain injury following cardiac arrest	RESUSCITATION			English	Article						Anoxic brain injury; Cardiac arrest; Psychological outcome	QUALITY-OF-LIFE; EVENT SCALE; PSYCHOMETRIC PROPERTIES; HOSPITAL ANXIETY; EVERYDAY MEMORY; INTENSIVE-CARE; DEPRESSION; IMPACT; RESUSCITATION; SURVIVORS	Aim of the study: This exploratory study aimed to investigate the psychosocial outcomes for cardiac arrest survivors and explore if there is a greater impact on psychosocial outcome for individuals experiencing anoxic brain injury as a result of the cardiac arrest. Methods: Self-report measures were used to compare the quality of life, social functioning and symptoms of anxiety, depression and post-traumatic stress of individuals with and without anoxic brain injury. Secondary measures of subjective memory and executive difficulties were also used. Fifty-six participants (27 with anoxia, 29 without anoxia) took part in the study between six months and four years after experiencing cardiac arrest. Results: A MANOVA identified a significant difference between the two groups, with the anoxia group reporting more psychosocial difficulties. They reported more social functioning difficulties and more anxiety, depression and post-traumatic stress symptoms. There was, however, no significant difference in self-reported quality of life between the two groups. Conclusion: As the first known study to compare psychosocial outcomes for cardiac arrest survivors experiencing anoxic brain injury with those without anoxia, the current results suggest that cardiac arrest survivors with subsequent acquired brain injury experience more psychosocial difficulties. This could be due to a combination of neuropsychological, social and psychological factors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Wilson, Michelle] Lincoln Univ, Trent Doctorate Clin Psychol, Hull Community Stroke Team, Highlands Hlth Ctr, Kingston Upon Hull HU7 5DD, N Humberside, England; [Staniforth, Andrew] Nottingham Univ Hosp NHS Trust, Linby Cardiol, City Hosp Campus, Nottingham NG5 1PB, England; [Till, Richard] Basildon & Thurrock NHS Trust, Essex Cardiothorac Ctr, Basildon Univ Hosp, Basildon SS16 5NL, Essex, England; [das Nair, Roshan] Univ Nottingham, Inst Work Hlth & Org, Nottingham NG8 1BB, England; [Vesey, Patrick] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham NG7 2UH, England		Wilson, M (corresponding author), Lincoln Univ, Trent Doctorate Clin Psychol, Hull Community Stroke Team, Highlands Hlth Ctr, Lothian Way, Kingston Upon Hull HU7 5DD, N Humberside, England.	micmichelle.wilson5@nhs.net		das Nair, Roshan/0000-0001-8143-7893			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Baumert J, 2004, J AFFECT DISORDERS, V82, P29, DOI 10.1016/j.jad.2003.09.006; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Cronberg T, 2009, RESUSCITATION, V80, P1119, DOI 10.1016/j.resuscitation.2009.06.021; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hirsch KG, 2009, CONTINUUM LIFELONG L, V15, P100; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jennett B., 2005, NEPAL J NEUROSCI, V2, P24; Ladwig KH, 1999, AM J PSYCHIAT, V156, P912, DOI 10.1176/ajp.156.6.912; Lundgren-Nilsson A, 2005, RESUSCITATION, V66, P285, DOI 10.1016/j.resuscitation.2005.04.001; Meyer NJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4980; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Moulaert VRMP, 2010, J REHABIL MED, V42, P553, DOI 10.2340/16501977-0547; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Rattray JE, 2008, J ADV NURS, V64, P2, DOI 10.1111/j.1365-2648.2008.04767.x; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Saner H, 2002, RESUSCITATION, V53, P7, DOI 10.1016/S0300-9572(02)00002-3; Schefold JC, 2009, RESUSCITATION, V80, P658, DOI 10.1016/j.resuscitation.2009.03.006; Snaith R., 1994, HOSP ANXIETY DEPRESS; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Sunnerhagen KS, 1996, RESUSCITATION, V31, P135, DOI 10.1016/0300-9572(95)00903-5; Tyrer P, 2005, INT J SOC PSYCHIATR, V51, P265, DOI 10.1177/0020764005057391; Wachelder EM, 2009, RESUSCITATION, V80, P517, DOI 10.1016/j.resuscitation.2009.01.020; Weiss D.S., 2007, CROSS CULTURAL ASSES, P219, DOI 10.1007/978-0-387-70990-1_10; Weiss Daniel S., 1997, P399; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	39	24	25	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	JUN	2014	85	6					795	800		10.1016/j.resuscitation.2014.02.008			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine	AJ0GY	WOS:000337329600030	24560827	Green Submitted, Green Accepted			2022-02-06	
J	Wilson, SM; Yeon, SK; Yang, XF; Park, KD; Khanna, R				Wilson, Sarah M.; Yeon, Seul Ki; Yang, Xiao-Fang; Park, Ki Duk; Khanna, Rajesh			Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3 beta and CDK5 following traumatic brain injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						CRMP2; GSK3 beta; CDK5; phosphorylation; mossy fiber sprouting; TIMM staining; epileptogenesis; (S)-Lacosamide	TEMPORAL-LOBE EPILEPSY; GLYCOGEN-SYNTHASE KINASE-3; NATIONAL GENERAL-PRACTICE; ANTICONVULSANT LACOSAMIDE; EPILEPTIFORM ACTIVITY; HIPPOCAMPAL-NEURONS; THERAPEUTIC TARGET; SIGNALING PATHWAY; RHO-KINASE; ACTIVATION	Aberrant ion channel function has been heralded as a main underlying mechanism driving epilepsy and its symptoms. However, it has become increasingly clear that treatment strategies targeting voltage-gated sodium or calcium channels merely mask the symptoms of epilepsy without providing disease-modifying benefits. Ion channel function is likely only one important cog in a highly complex machine. Gross morphological changes, such as reactive sprouting and outgrowth, may also play a role in epileptogenesis. Mechanisms responsible for these changes are not well-understood. Here we investigate the potential involvement of the neurite outgrowth-promoting molecule collapsin response mediator protein 2 (CRMP2). CRMP2 activity, in this respect, is regulated by phosphorylation state, where phosphorylation by a variety of kinases, including glycogen synthase kinase 3 (GSK3 beta) renders it inactive. Phosphorylation (inactivation) of CRMP2 was decreased at two distinct phases following traumatic brain injury (TBI). While reduced CRMP2 phosphorylation during the early phase was attributed to the inactivation of GSK3 beta, the sustained decrease in CRMP2 phosphorylation in the late phase appeared to be independent of GSK3 beta activity. Instead, the reduction in GSK3 beta-phosphorylated CRMP2 was attributed to a loss of priming by cyclin-dependent kinase 5 (CDK5), which allows for subsequent phosphorylation by GSK3 beta. Based on the observation that the proportion of active CRMP2 is increased for up to 4 weeks following TBI, it was hypothesized that it may drive neurite outgrowth, and therefore, circuit reorganization during this time. Therefore, a novel small-molecule tool was used to target CRMP2 in an attempt to determine its importance in mossy fiber sprouting following TBI. In this report, we demonstrate novel differential regulation of CRMP2 phosphorylation by GSK3 beta and CDK5 following TB I.	[Wilson, Sarah M.; Khanna, Rajesh] Indiana Univ, Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN USA; [Yeon, Seul Ki; Park, Ki Duk] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Yang, Xiao-Fang; Khanna, Rajesh] Univ Arizona, Dept Pharmacol, Coll Med, Tucson, AZ 85724 USA		Khanna, R (corresponding author), Univ Arizona, Dept Pharmacol, Coll Med, Rm 650,POB 245050,1501 North Campbell Dr, Tucson, AZ 85724 USA.	rkhanna@email.arizona.edu		Khanna, Rajesh/0000-0002-9066-2969	National Scientist Development from the American Heart AssociationAmerican Heart Association [5DG5280023]; Showalter foundation; Stark Fellowship and a Larry Kays Medical Neuroscience award	We thank Dr. Weina Ju for help with some of the immunoblots, and members of the Stark Neurosciences Research Institute for helpful comments and discussions. We express many thanks to Dr. Fletcher White and Matthew Ripsch for their generous guidance in experimental design, as well as, the use of their equipment. This work was supported, in part, by a grant a National Scientist Development from the American Heart Association (5DG5280023 to Rajesh Khanna) and a grant from the Showalter foundation (to Rajesh Khanna). Sarah M. Wilson was partially funded by a Stark Fellowship and a Larry Kays Medical Neuroscience award.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; Andurkar SV, 1999, BIOORGAN MED CHEM, V7, P2381, DOI 10.1016/S0968-0896(99)00186-8; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Blaabjerg M, 2007, PROG BRAIN RES, V163, P85, DOI 10.1016/S0079-6123(07)63005-2; Brittain JM, 2012, FEBS LETT, V586, P3813, DOI 10.1016/j.febslet.2012.09.022; Brittain JM, 2012, CHANNELS, V6, P52, DOI 10.4161/chan.18919; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; de Lanerolle NC, 2003, EPILEPSIA, V44, P677, DOI 10.1046/j.1528-1157.2003.32701.x; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; Dustrude ET, 2013, J BIOL CHEM, V288, P24316, DOI 10.1074/jbc.M113.474924; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; England MJ, 2012, EPILEPSY BEHAV, V25, P266, DOI 10.1016/j.yebeh.2012.06.016; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Ju WN, 2013, CHANNELS, V7, P153, DOI 10.4161/chan.24224; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kobau Rosemarie, 2012, Morbidity and Mortality Weekly Report, V61, P909; Koyama R, 2004, CURR NEUROVASC RES, V1, P3, DOI 10.2174/1567202043480242; LARNER AJ, 1995, SEIZURE, V4, P249, DOI 10.1016/S1059-1311(95)80001-8; Lee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038789; Lees G, 2006, NEUROPHARMACOLOGY, V50, P98, DOI 10.1016/j.neuropharm.2005.08.016; LeTiran A, 2001, BIOORGAN MED CHEM, V9, P2693, DOI 10.1016/S0968-0896(01)00204-8; Licko T, 2013, EPILEPSIA, V54, P1176, DOI 10.1111/epi.12196; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANFORD M, 1992, ARCH NEUROL-CHICAGO, V49, P801, DOI 10.1001/archneur.1992.00530320025008; MANFORD M, 1992, NEUROLOGY, V42, P1911; O'Dell CM, 2012, J NEUROSCI RES, V90, P913, DOI 10.1002/jnr.22829; Oliva M, 2012, EPILEPSIA, V53, P1849, DOI 10.1111/j.1528-1167.2012.03631.x; Panayiotopoulos C., 2005, EPILEPSIES SEIZURES; Park KD, 2009, J MED CHEM, V52, P6897, DOI 10.1021/jm9012054; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2014, EPILEPSY RES, V108, P653, DOI 10.1016/j.eplepsyres.2014.02.001; Sasaki C, 2001, NEUROL RES, V23, P588, DOI 10.1179/016164101101199054; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Siwek M, 2012, ADV EXP MED BIOL, V740, P1219, DOI 10.1007/978-94-007-2888-2_55; Sutula TP, 2004, EPILEPSY RES, V60, P161, DOI 10.1016/j.eplepsyres.2004.07.001; TIMM F, 1958, Dtsch Z Gesamte Gerichtl Med, V46, P706, DOI 10.1007/BF00665092; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uchida Y, 2009, J BIOL CHEM, V284, P27393, DOI 10.1074/jbc.M109.000240; Wang YY, 2011, TRANSL NEUROSCI, V2, P13, DOI 10.2478/s13380-011-0002-9; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wilson SM, 2012, J BIOL CHEM, V287, P35065, DOI 10.1074/jbc.M112.378695; Xiong T, 2012, NEUROSCIENCE, V216, P123, DOI 10.1016/j.neuroscience.2012.04.052; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; ZIMMER J, 1973, BRAIN RES, V64, P313, DOI 10.1016/0006-8993(73)90186-8	76	24	25	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAY 28	2014	8								135	10.3389/fncel.2014.00135			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1XM	WOS:000336648500001	24904280	gold, Green Published			2022-02-06	
J	Lannin, N; Carr, B; Allaous, J; Mackenzie, B; Falcon, A; Tate, R				Lannin, Natasha; Carr, Belinda; Allaous, Jeanine; Mackenzie, Bronwyn; Falcon, Alex; Tate, Robyn			A randomized controlled trial of the effectiveness of handheld computers for improving everyday memory functioning in patients with memory impairments after acquired brain injury	CLINICAL REHABILITATION			English	Article						handheld; executive function; Memory; rehabilitation; computers	ELECTRONIC MEMORY; REHABILITATION; AID; TECHNOLOGY; MODERATE; ADULTS	Objective: To determine the effectiveness of personal digital assistant devices on achievement of memory and organization goals in patients with poor memory after acquired brain injury. Design: Assessor blinded randomized controlled trial. Setting: Specialist brain injury rehabilitation hospital (inpatients and outpatients). Participants: Adults with acquired brain impairments (85% traumatic brain injury; aged >= 17 years) who were assessed as having functional memory impairment on the Rivermead Behavioural Memory Test (General Memory Index). Interventions: Training and support to use a personal digital assistant for eight weeks to compensate for memory failures by an occupational therapist. The control intervention was standard rehabilitation, including use of non-electronic memory aids. Main outcome measures: Goal Attainment Scale which assessed achievement of participants' daily memory functioning goals and caregiver perception of memory functioning; and General Frequency of Forgetting subscale of the Memory Functioning Questionnaire administered at baseline (pre-randomization) and post intervention (eight weeks later). Results: Forty-two participants with memory impairment were recruited. Use of a personal digital assistant led to greater achievement of functional memory goals (mean difference 1.6 (95% confidence interval (CI) 1.0 to 2.2), P = 0.0001) and improvement on the General Frequency of Forgetting subscale (mean difference 12.5 (95% CI 2.0 to 22.9), P = 0.021). Conclusions: Occupational therapy training in the use of a handheld computer improved patients' daily memory function more than standard rehabilitation.	[Lannin, Natasha] La Trobe Univ, Occupat Therapy Dept, Prahran, Vic 3181, Australia; [Lannin, Natasha] Alfred Hlth, Occupat Therapy Dept, Prahran, Vic, Australia; [Lannin, Natasha; Tate, Robyn] Univ Sydney, Fac Med, Northern Clin Sch, Rehabil Studies Unit, Ryde, NSW, Australia; [Carr, Belinda; Allaous, Jeanine; Falcon, Alex; Tate, Robyn] Royal Rehabil Ctr Sydney, Ryde, NSW, Australia; [Mackenzie, Bronwyn] All About Rehab, Camden, NSW, Australia		Lannin, N (corresponding author), La Trobe Univ, Alfred Ctr, Alfred Clin Sch, 99 Commercial Rd, Prahran, Vic 3181, Australia.	n.lannin@latrobe.edu.au	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345	Royal Rehabilitation Centre Sydney Foundation	This work was supported by a grant from the Royal Rehabilitation Centre Sydney Foundation.	Benton A., 1978, MULTILINGUAL APHASIA; Boman IL, 2010, DISABIL REHABIL-ASSI, V5, P339, DOI 10.3109/17483100903131777; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Cicerone K, 2005, ARCH PHYS MED REHAB, P86; de Frias CM, 2005, PSYCHOL ASSESSMENT, V17, P168, DOI 10.1037/1040-3590.17.2.168; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Delis DC., 2001, DELIS KAPLAN EXECUTI; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; GILEWSKI MJ, 1990, PSYCHOL AGING, V5, P482, DOI 10.1037/0882-7974.5.4.482; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Hutchinson J, 1997, TOP LANG DISORD, V18, P45, DOI 10.1097/00011363-199711000-00006; Inglis EA, 2004, NEUROPSYCHOL REHABIL, V14, P77, DOI 10.1080/09602010343000129; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Maher CG, 2003, PHYS THER REHABIL J, V83, P713, DOI 10.1093/ptj/83.8.713; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Tate RL, 2010, COMPENDIUM TESTS SCA; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; WechslerD, 2001, WECHSLER TEST ADULT; Wilson B, 1986, RIVERMEAD BEHAV MEMO; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; ZWEBER B, 1990, Occupational Therapy in Health Care, V7, P45, DOI 10.1080/J003v07n01_05	38	24	25	1	16	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAY	2014	28	5					470	481		10.1177/0269215513512216			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AE5HF	WOS:000334017700007	24452701				2022-02-06	
J	Kavalci, C; Aksel, G; Salt, O; Yilmaz, MS; Demir, A; Kavalci, G; Ozel, BA; Altinbilek, E; Durdu, T; Yel, C; Durukan, P; Isik, B				Kavalci, Cemil; Aksel, Gokhan; Salt, Omer; Yilmaz, M. Serkan; Demir, Ali; Kavalci, Gulsum; Ozel, Betul Akbuga; Altinbilek, Ertugrul; Durdu, Tamer; Yel, Cihat; Durukan, Polat; Isik, Bahattin			Comparison of the Canadian CT head rule and the new orleans criteria in patients with minor head injury	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Emergency; Head injury; CT rules	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; UNITED-STATES; PERFORMANCE; MANAGEMENT	Aim: The aim of the study was to compare the New Orleans Criteria and the New Orleans Criteria according to their diagnostic performance in patients with mild head injury. Methods: The study was designed and conducted prospectively after obtaining ethics committee approval. Data was collected prospectively for patients presenting to the ED with Minor Head Injury. After clinical assessment, a standard CT scan of the head was performed in patients having at least one of the risk factors stated in one of the two clinical decision rules. Patients with positive traumatic head injury according to BT results defined as Group 1 and those who had no intracranial injury defined as Group 2. Statistical analysis was performed with SPSS 11.00 for Windows. ROC analyze was performed to determine the effectiveness of detecting intracranial injury with both decision rules. p < 0.05 was considered statistically significant. Results: 175 patients enrolled the study. Male to female ratio was 1.5. The mean age of the patients was 45 +/- 21,3 in group 1 and 49 +/- 20,6 in group 2. The most common mechanism of trauma was falling. The sensitivity and specificity of CCHR were respectively 76.4% and 41.7%, whereas sensitivity and specificity of NOC were 88.2% and 6.9%. Conclusion: The CCHR has higher specificity, PPV and NPV for important clinical outcomes than does the NOC.	[Kavalci, Cemil; Aksel, Gokhan; Ozel, Betul Akbuga] Baskent Univ, Fac Med, Emergency Dept, TR-06490 Ankara, Turkey; [Salt, Omer] State Hosp, Emergency Dept, Yozgat, Turkey; [Yilmaz, M. Serkan; Durdu, Tamer; Yel, Cihat] Ankara Numune Training & Res Hosp, Emergency Dept, Ankara, Turkey; [Demir, Ali] Yenimahalle State Hosp, Emergency Dept, Ankara, Turkey; [Kavalci, Gulsum] Yenimahalle State Hosp, Dept Anesthesia, Ankara, Turkey; [Altinbilek, Ertugrul] Sisli Hamidiye Etfal Training & Res Hosp, Emergency Dept, Istanbul, Turkey; [Durukan, Polat] Erciyes Univ, Fac Med, Emergency Dept, Kayseri, Turkey; [Isik, Bahattin] Kecioren Training & Res Hosp, Emergency Dept, Ankara, Turkey		Kavalci, C (corresponding author), Baskent Univ, Fac Med, Emergency Dept, TR-06490 Ankara, Turkey.	cemkavalci@yahoo.com	altinbilek, ertugrul/AAB-1368-2019	Aksel, Gokhan/0000-0002-5580-3201; ALTINBILEK, ERTUGRUL/0000-0003-4201-8850			Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Hung RH, 2011, TINTINALLIS EMERGENC, P888; Klement W, 2012, ARTIF INTELL MED, V54, P163, DOI 10.1016/j.artmed.2011.11.005; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	16	24	26	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	APR 17	2014	9								31	10.1186/1749-7922-9-31			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	AF6DV	WOS:000334805500001	24742359	gold, Green Published			2022-02-06	
J	Agrawal, R; Tyagi, E; Vergnes, L; Reue, K; Gomez-Pinilla, F				Agrawal, Rahul; Tyagi, Ethika; Vergnes, Laurent; Reue, Karen; Gomez-Pinilla, Fernando			Coupling energy homeostasis with a mechanism to support plasticity in brain trauma	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Anxiety; Brain Trauma; Metabolism; Mitochondria; Omega-3; Plasticity	NEUROPEPTIDE-Y; MITOCHONDRIAL DYSFUNCTION; FATTY-ACIDS; DEPRESSION; INJURY; SUPPLEMENTATION; PGC-1-ALPHA; CREB; DHA; OMEGA-3-FATTY-ACIDS	Metabolic dysfunction occurring after traumatic brain injury (TBI) is an important risk factor for the development of psychiatric illness. In the present study, we utilized an omega-3 diet during early life as a metabolic preconditioning to alter the course of TBI during adulthood. TBI animals under omega-3 deficiency were more prone to alterations in energy homeostasis (adenosine monophosphate-activated protein kinase; AMPK phosphorylation and cytochrome C oxidase II; COII levels) and mitochondrial biogenesis (peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PGC-1 alpha and mitochondrial transcription factor A; TFAM). A similar response was found for brain-derived neurotrophic factor (BDNF) and its signaling through tropomyosin receptor kinase B (TrkB). The results from in vitro studies showed that 7,8-dihydroxyflavone (7,8-DHF), a TrkB receptor agonist, upregulates the levels of biogenesis activator PGC-1 alpha, and CREB phosphorylation in neuroblastoma cells suggesting that BDNF-TrkB signaling is pivotal for engaging signals related to synaptic plasticity and energy metabolism. The treatment with 7,8-DHF elevated the mitochondrial respiratory capacity, which emphasizes the role of BDNF-TrkB signaling as mitochondrial bioenergetics stimulator. Omega-3 deficiency worsened the effects of TBI on anxiety-like behavior and potentiated a reduction of anxiolytic neuropeptide Y1 receptor (NPY1R). These results highlight the action of metabolic preconditioning for building long-term neuronal resilience against TBI incurred during adulthood. Overall, the results emphasize the interactive action of metabolic and plasticity signals for supporting neurological health. (C) 2013 Published by Elsevier B.V.	[Agrawal, Rahul; Tyagi, Ethika; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; vergnes, laurent/0000-0002-8804-589X	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS056413]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR026744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health Grants NS050465 and NS056413. We are thankful to Ms. Rusvelda Cruz for her help in animal feeding.	Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Assies J, 2011, JAMA-J AM MED ASSOC, V305, P360, DOI 10.1001/jama.2011.18; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Gupta VK, 2013, J MOL NEUROSCI, V49, P96, DOI 10.1007/s12031-012-9899-x; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Kiecolt-Glaser JK, 2007, PSYCHOSOM MED, V69, P217, DOI 10.1097/PSY.0b013e3180313a45; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lands B, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-46; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Nguyen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040191; Painsipp E, 2010, J PSYCHOPHARMACOL, V24, P1541, DOI 10.1177/0269881109104851; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pandey SC, 2003, TRENDS PHARMACOL SCI, V24, P456, DOI 10.1016/S0165-6147(03)00226-8; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Reusens B, 2011, WORLD J DIABETES, V2, P149, DOI 10.4239/wjd.v2.i9.149; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115; Schwetz TA, 2013, AM J PHYSIOL-ENDOC M, V304, pE211, DOI 10.1152/ajpendo.00374.2012; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamanaka M, 2007, DIABETES OBES METAB, V9, P59, DOI 10.1111/j.1463-1326.2006.00572.x; Zhang L, 2012, DIABETES OBES METAB, V14, P727, DOI 10.1111/j.1463-1326.2012.01592.x	43	24	24	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	APR	2014	1842	4					535	546		10.1016/j.bbadis.2013.12.004			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AD8JC	WOS:000333511300001	24345766	Bronze			2022-02-06	
J	Kwon, HG; Jang, SH				Kwon, Hyeok Gyu; Jang, Sung Ho			Delayed gait disturbance due to injury of the corticoreticular pathway in a patient with mild traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; corticoreticulospinal tract; corticoreticular pathway; corticospinal tract; diffusion tensor imaging; head trauma	DIFFUSE AXONAL INJURY; TENSOR TRACTOGRAPHY; PROXIMAL WEAKNESS; HEAD TRAUMA; ABNORMALITIES; RECOVERY; HUMANS; FORNIX; COMA	Background: Many studies have demonstrated neural injury in patients with mild traumatic brain injury, using diffusion tensor imaging (DTI). However, knowledge regarding injury of the corticoreticular pathway (CRP) is limited. This study reports on a patient with mild TBI who showed delayed gait disturbance due to injury of the CRP following head trauma, which was demonstrated by DTI. Methods: A 14-year-old female patient suffered from an in-car accident: her head was hit with the backseat during hyperextension after flexion movement when her sedan was struck by another sedan from behind. She showed mild quadriparesis after onset. At 29 days after onset, she noted gait disturbance and aggravated quadriparesis with more severe weakness of the proximal joints. Results: No abnormality was observed on brain MRI and electromyography study performed at 10 weeks after onset. Both CRPs were discontinued at the midbrain level on 10-week DTI. Conclusion: It appears that the proximal weakness of this patient was attributed to injury of both CRPs following head trauma. It is assumed that the mild weakness at the onset of head trauma was caused by the primary traumatic axonal injury and the aggravated weakness that started from 29 days might be ascribed to the secondary traumatic axonal injury.	[Kwon, Hyeok Gyu; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Do KH, 2013, NEUROSCI LETT, V546, P21, DOI 10.1016/j.neulet.2013.04.040; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jackson CFE, 1970, STROKE, V1, P278, DOI 10.1161/01.STR.1.4.278; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Jang SH, 2010, NEURAL REGEN RES, V5, P1829, DOI 10.3969/j.issn.1673-5374.2010.23.011; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Medical Research Council (Great Britain), 1976, AIDS EX PER NERV SYS, P62; Mendoza JE, 2007, CLIN NEUROANATOMY NE, P704; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; TEASDALE G, 1974, LANCET, V2, P81; Van Zijl, 2004, MRI ATLAS HUMAN WHIT; Williams JM, 1991, MAS MEMORY ASSESSMEN, P127; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2013, NEUROREHABILITATION, V32, P665, DOI 10.3233/NRE-130889; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	34	24	24	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					511	514		10.3109/02699052.2014.887228			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900016	24564187				2022-02-06	
J	Liu, F; Liao, F; Li, W; Han, YF; Liao, DG				Liu, Feng; Liao, Fan; Li, Wei; Han, Yongfeng; Liao, Daguang			Progesterone alters Nogo-A, GFAP and GAP-43 expression in a rat model of traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						Nogo-A; GFAP; GAP-43; progesterone; traumatic brain injury	INHIBITS NEURITE OUTGROWTH; CERVICAL-SPINAL CORD; AXON REGENERATION; CONTUSION INJURY; MESSENGER-RNA; FEMALE RATS; CNS INJURY; RECOVERY; NEURONS; GROWTH	Previous studies have demonstrated that progesterone has neuroprotective effects in the central nervous system (CNS) following traumatic brain injury (TBI). Numerous cellular mechanisms have been reported to be important in the neuroprotective effects of progesterone, including the reduction of edema, inflammation and apoptosis, and the inhibition of oxidative stress. However, the effect of progesterone on neuronal protection following TBI remains unclear. The present study aimed to investigate the effects of progesterone on the expression of Nogo-A, an inhibitor of axonal growth, glial fibrillary acidic protein (GFAP), a main component of the glial scar and growth-associated protein-43 (GAP-43), a signaling molecule in neuronal growth in TBI rats. The TBI model was produced by the weight drop method. In total, 75 rats were assigned to three groups: the sham group, TBI group with vehicle treatment and TBI group with progesterone treatment. The protein expression of Nogo-A, GFAP and GAP-43 in the cortex and the hippocampus was examined by immunocytochemistry. TBI rats significantly increased the expression of Nogo-A, GFAP, and GAP-43 at 1, 3, 7 and 14 days post-injury. Progesterone significantly decreased the expression of Nogo-A and GFAP, and upregulated the GAP-43 protein. Our findings suggested that progesterone promotes neuroprotection following TBI by inhibiting the expression of Nogo-A and GFAP, and increasing GAP-43 expression.	[Liu, Feng; Liao, Fan; Liao, Daguang] Cent S Univ, Xiangya Hosp 3, Dept Neurosurg, Changsha 410013, Hunan, Peoples R China; [Li, Wei] First Hosp Changsha, Dept Neurosurg, Changsha 410013, Hunan, Peoples R China; [Han, Yongfeng] First Hosp Shijiazhuang City, Shijiazhuang 050000, Hebei, Peoples R China		Liao, DG (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Neurosurg, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	daguangliao@hotmail.com					Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Brenneman MM, 2008, BEHAV BRAIN RES, V187, P262, DOI 10.1016/j.bbr.2007.09.018; CLAYTON GH, 1994, J COMP NEUROL, V347, P470, DOI 10.1002/cne.903470312; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Deniselle MCG, 2001, CELL MOL NEUROBIOL, V21, P237, DOI 10.1023/A:1010943104315; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Donovan SL, 2008, SOMATOSENS MOT RES, V25, P33, DOI 10.1080/08990220701830696; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Garay L, 2009, BRAIN RES, V1283, P177, DOI 10.1016/j.brainres.2009.04.057; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Hughes-Davis EJ, 2005, NEUROSCIENCE, V135, P1231, DOI 10.1016/j.neuroscience.2005.07.017; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Labombarda F, 2010, NEUROIMMUNOMODULAT, V17, P146, DOI 10.1159/000258709; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Nguyen L, 2009, MOL CELL NEUROSCI, V41, P62, DOI 10.1016/j.mcn.2009.01.011; Oertle T, 2003, J NEUROSCI, V23, P5393; Pajovic SB, 1999, GEN PHYSIOL BIOPHYS, V18, P35; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Santoro B, 2004, NEUROBIOL DIS, V17, P349, DOI 10.1016/j.nbd.2004.07.003; SchmidtKastner R, 1997, CELL TISSUE RES, V288, P225, DOI 10.1007/s004410050808; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Udvadia AJ, 2001, DEVELOPMENT, V128, P1175; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wang Hua, 2006, Zhonghua Er Ke Za Zhi, V44, P792; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Nan-Xiang, 2007, Neurosci Bull, V23, P41, DOI 10.1007/s12264-007-0006-1; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	46	24	24	0	15	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2014	9	4					1225	1231		10.3892/mmr.2014.1967			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AE9RD	WOS:000334345300020	24567055	Bronze			2022-02-06	
J	Sima, XT; Xu, JG; Li, JM; Zhong, WY; You, C				Sima, Xiutian; Xu, Jianguo; Li, Jinmei; Zhong, Weiying; You, Chao			Expression of beta-amyloid precursor protein in refractory epilepsy	MOLECULAR MEDICINE REPORTS			English	Article						refractory epilepsy; beta-amyloid precursor protein	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; INDUCED SEIZURES; HIPPOCAMPUS; TRAFFICKING; PATHOLOGY; NEURONS; CORTEX	beta-amyloid precursor protein (beta-APP), also known as A beta peptide, has a key role in the pathogenesis of Alzheimer's disease, and is also likely to be involved in the development of refractory epilepsy. The mechanism behind the association between beta-APP and refractory epilepsy remains to be elucidated. The aim of the present study was to examine the levels of APP mRNA and beta-APP protein in patients with refractory epilepsy. Tissue samples were obtained from patients with chronic pharmacoresistant epilepsy who underwent surgery. Levels of APP mRNA and beta-APP protein in epileptic temporal lobe and hippocampal tissue were assessed using quantitative polymerase chain reaction, immunohistochemistry and immunofluorescence. The expression levels of protein significantly increased in the temporal cortex and the hippocampus of the patients with epilepsy. beta-APP may thus contribute to the pathogenesis of refractory epilepsy.	[Sima, Xiutian; Xu, Jianguo; Zhong, Weiying; You, Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Li, Jinmei] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610041, Sichuan, Peoples R China		You, C (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China.	youchao1977@163.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [30872646, 30973082]	This study was supported by the National Natural Science Foundation (nos 30872646 and 30973082).	Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Ghribi O, 2006, EXP NEUROL, V200, P460, DOI 10.1016/j.expneurol.2006.03.019; Gordon-Krajcer W, 2001, FOLIA NEUROPATHOL, V39, P163; KALARIA RN, 1993, ANN NY ACAD SCI, V695, P190, DOI 10.1111/j.1749-6632.1993.tb23050.x; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; LARNER AJ, 1995, SEIZURE, V4, P249, DOI 10.1016/S1059-1311(95)80001-8; Lozsadi DA, 2006, DEMENT GERIATR COGN, V22, P121, DOI 10.1159/000093664; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Pavia J, 1998, FUNDAM CLIN PHARM, V12, P473, DOI 10.1111/j.1472-8206.1998.tb00975.x; Peel AL, 2004, NEUROMOL MED, V5, P205, DOI 10.1385/NMM:5:3:205; Perez RG, 1997, J NEUROSCI, V17, P9407; POLLARD H, 1994, NEUROSCIENCE, V61, P773, DOI 10.1016/0306-4522(94)90401-4; Radhakrishnan VV, 1999, NEUROL INDIA, V47, P196; SHENG JG, 1994, J NEUROCHEM, V63, P1872; Shoham S, 1997, EXP NEUROL, V147, P361, DOI 10.1006/exnr.1997.6622; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; WILLOUGHBY DA, 1992, EXP NEUROL, V118, P332, DOI 10.1016/0014-4886(92)90191-R; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; Zhu Jin-long, 2005, Fa Yi Xue Za Zhi, V21, P165	24	24	24	1	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2014	9	4					1242	1248		10.3892/mmr.2014.1977			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AE9RD	WOS:000334345300023	24566726	Bronze			2022-02-06	
J	Zanata, ID; Santos, RS; Hirata, GC				Zanata, Isabel de Lima; Santos, Rosane Sampaio; Hirata, Gisela Carmona			Tracheal Decannulation Protocol in Patients Affected by Traumatic Brain Injury	INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY			English	Article						craniocerebral trauma; tracheostomy; weaning	TRACHEOSTOMY; ASPIRATION; DYSPHAGIA	Introduction The frequency of tracheostomy in patients with traumatic brain injury (TBI) contrasts with the lack of objective criteria for its management. The study arose from the need for a protocol in the decision to remove the tracheal tube. Objective To evaluate the applicability of a protocol for tracheal decannulation. Methods A prospective study with 20 patients, ranging between 21 and 85 years of age (average 33.55), 4 of whom were women (20%) and 16 were men (80%). All patients had been diagnosed by a neurologist as having TBI, and the anatomical region of the lesion was known. Patients were evaluated following criteria for tracheal decannulation through a clinical evaluation protocol developed by the authors. Results Decannulation was performed in 12 (60%) patients. Fourteen (70%) had a score greater than 8 on the Glasgow Coma Scale and only 2 (14%) of these were not able to undergo decannulation. Twelve (60%) patients maintained the breathing pattern with occlusion of the tube and were successfully decannulated. Of the 20 patients evaluated, 11 (55%) showed no signs suggestive of tracheal aspiration, and of these, 9 (82%) began training on occlusion of the cannula. The protocol was relevant to establish the beginning of the decannulation process. The clinical assessment should focus on the patient's condition to achieve early tracheal decannulation. Conclusion This study allowed, with the protocol, to establish six criteria for tracheal decannulation: level of consciousness, respiration, tracheal secretion, phonation, swallowing, and coughing.	[Zanata, Isabel de Lima] Hosp Idoso Zilda Arns, Dept Fonoaudiol, Curitiba, PR, Brazil; [Santos, Rosane Sampaio] Univ Tuiuti Parana, Dept Programa Mestrado & Doutorado Disturbios Com, Curitiba, PR, Brazil; [Hirata, Gisela Carmona] Univ Tuiuti Parana, Dept Disfagia, Curitiba, PR, Brazil		Zanata, ID (corresponding author), Rua Desembargador Antonio Paula,3194 Boqueirao, BR-81750450 Curitiba, Parana, Brazil.	isabelzanata@hotmail.com	Santos, Rosane S Sampaio/A-1597-2017	Santos, Rosane S Sampaio/0000-0001-6400-5706			Abdulmassih EMS, 2009, INT ARCH OTORHINOLAR, V13, P55; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Mendes TDB, 2008, EINSTEIN-SAO PAULO, V6, P1; Chadda K, 2002, INTENS CARE MED, V28, P1761, DOI 10.1007/s00134-002-1545-6; Christopher Kent L, 2005, Respir Care, V50, P538; Corbin-Lewis K, 2009, ANATOMIA CLIN FISIOL; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P412, DOI 10.1016/j.ejcts.2007.05.018; De Sa GM, 2003, TOPICOS DEGLUTICAO D, P365; Donzelli J, 2003, ANN OTO RHINOL LARYN, V112, P469, DOI 10.1177/000348940311200515; Enright SJ, 2006, PHYS THER, V86, P345, DOI 10.1093/ptj/86.3.345; Fischler L, 2000, INTENS CARE MED, V26, P1428, DOI 10.1007/s001340000634; Forte APFV, 2005, TRATADO FONOAUDIOLOG, P405; Frank U, 2007, DYSPHAGIA, V22, P20, DOI 10.1007/s00455-006-9036-5; Furia CLB, 2003, CONHECIMENTOS ESSENC, P31; Furkim Ana Maria, 2008, Rev. CEFAC, V10, P503; Gomes GF, 2001, THESIS; Hammond CAS, 2006, CHEST, V129, p154S, DOI 10.1378/chest.129.1_suppl.154S; Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851; MACEDO EDG, 2000, MANUAL CUIDADOS PACI; Mackiewicz-Nartowicz H, 2008, ADV PALL MED, V7, P69; O'Connor HH, 2010, RESP CARE, V55, P1076; OLIVEIRA IB, 2004, TRATADO FONOAUDIOLOG, P11; Rosado CV, 2005, REV CEFAC, V7, P34; Ryu JS, 2004, AM J PHYS MED REHAB, V83, P753, DOI 10.1097/01.PHM.0000140798.97706.A5; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc6802	26	24	32	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1809-9777	1809-4864		INT ARCH OTORHINOLAR	Int. Arch. Otorhinolaryngol.	APR	2014	18	2					108	114		10.1055/s-0033-1363467			7	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	VG0CD	WOS:000444292200003	25992074	gold, Green Submitted, Green Published			2022-02-06	
J	Cunningham, TL; Cartagena, CM; Lu, XCM; Konopko, M; Dave, JR; Tortella, FC; Shear, DA				Cunningham, Tracy L.; Cartagena, Casandra M.; Lu, Xi-Chun M.; Konopko, Melissa; Dave, Jitendra R.; Tortella, Frank C.; Shear, Deborah A.			Correlations between Blood-Brain Barrier Disruption and Neuroinflammation in an Experimental Model of Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier dysfunction; inflammation; penetrating brain injury; PBBI; traumatic brain injury	FLUID PERCUSSION INJURY; CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY RESPONSE; FUNCTIONAL NEUROANATOMY; INSULA ACTIVATION; PREFRONTAL CORTEX; AFFECTED FORELIMB; INNATE SENSE; RAT MODEL; ANXIETY	Blood-brain barrier (BBB) disruption is a pathological hallmark of severe traumatic brain injury (TBI) and is associated with neuroinflammatory events contributing to brain edema and cell death. The goal of this study was to elucidate the profile of BBB disruption after penetrating ballistic-like brain injury (PBBI) in conjunction with changes in neuroinflammatory markers. Brain uptake of biotin-dextran amine (BDA; 3kDa) and horseradish peroxidase (HRP; 44kDa) was evaluated in rats at 4h, 24h, 48h, 72h, and 7 days post-PBBI and compared with the histopathologic and molecular profiles for inflammatory markers. BDA and HRP both displayed a uniphasic profile of extravasation, greatest at 24h post-injury and which remained evident out to 48h for HRP and 7 days for BDA. This profile was most closely associated with markers for adhesion (mRNA for intercellular adhesion molecule-1) and infiltration of peripheral granulocytes (mRNA for matrix metalloproteinase-9 [MMP-9] and myeloperoxidase staining). Improvement of BBB dysfunction coincided with increased expression of markers implicated in tissue remodeling and repair. The results of this study reveal a uniphasic and gradient opening of the BBB after PBBI and suggest MMP-9 and resident inflammatory cell activation as candidates for future neurotherapeutic intervention after PBBI.	[Cunningham, Tracy L.; Cartagena, Casandra M.; Lu, Xi-Chun M.; Konopko, Melissa; Dave, Jitendra R.; Tortella, Frank C.; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD 20910 USA		Cunningham, TL (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Tracy.L.Cunningham2.ctr@us.army.mil		Konopko, Melissa/0000-0001-9515-398X			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Colangelo AM, 2012, BIOTECHNOL ADV, V30, P261, DOI 10.1016/j.biotechadv.2011.06.016; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Connor TJ, 1998, NEUROSCIENCE, V84, P923, DOI 10.1016/S0306-4522(97)00533-2; Cragnolini AB, 2006, PEPTIDES, V27, P1451, DOI 10.1016/j.peptides.2005.10.020; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Deb S, 1999, AM J PSYCHIAT, V156, P374; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Ellis A. L., 2008, 38 ANN M SOC NEUR WA; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Faul M, 2010, TRAUMATIC BRAIN INJU; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; GEHRMANN J, 1993, J NEUROIMMUNOL, V48, P189, DOI 10.1016/0165-5728(93)90191-Z; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gibson LCD, 2006, EUR J PHARMACOL, V538, P39, DOI 10.1016/j.ejphar.2006.02.053; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAEBER MB, 1988, J NEUROCYTOL, V17, P209, DOI 10.1007/BF01674208; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Konuk N, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/65704; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; McCann MJ, 1996, NEUROSCIENCE, V72, P273, DOI 10.1016/0306-4522(95)00526-9; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; MORRISSEY TK, 1989, BEHAV BRAIN RES, V35, P195, DOI 10.1016/S0166-4328(89)80141-X; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; NITZ AJ, 1986, EXP NEUROL, V94, P264, DOI 10.1016/0014-4886(86)90101-9; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; PELLIS SM, 1991, BEHAV BRAIN RES, V46, P151, DOI 10.1016/S0166-4328(05)80108-1; PELLIS SM, 1991, BEHAV BRAIN RES, V45, P185, DOI 10.1016/S0166-4328(05)80084-1; Pugin J, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-27; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rohleder N, 2004, BIOL PSYCHIAT, V55, P745, DOI 10.1016/j.biopsych.2003.11.018; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Rudy JW, 2001, COGN AFFECT BEHAV NE, V1, P66, DOI 10.3758/CABN.1.1.66; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHALLERT T, 1979, EXP NEUROL, V64, P33, DOI 10.1016/0014-4886(79)90003-7; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sokolova E S, 2007, Neurosci Behav Physiol, V37, P499, DOI 10.1007/s11055-007-0042-3; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tucker P, 2004, BIOL PSYCHIAT, V56, P121, DOI 10.1016/j.biopsych.2004.03.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Wang FZ, 2011, ANESTHESIOLOGY, V114, P643, DOI 10.1097/ALN.0b013e31820a4bf3; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zubareva O E, 2009, Neurosci Behav Physiol, V39, P21, DOI 10.1007/s11055-008-9090-6	109	24	24	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					505	514		10.1089/neu.2013.2965			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600249	24138024	Green Published			2022-02-06	
J	Guise, BJ; Thompson, MD; Greve, KW; Bianchini, KJ; West, L				Guise, Brian J.; Thompson, Matthew D.; Greve, Kevin W.; Bianchini, Kevin J.; West, Laura			Assessment of performance validity in the Stroop Color and Word Test in mild traumatic brain injury patients: A criterion-groups validation design	JOURNAL OF NEUROPSYCHOLOGY			English	Article							MALINGERED NEUROCOGNITIVE DYSFUNCTION; CARD SORTING TEST; INCOMPLETE EFFORT; MMPI-2; SCALE; NAN	The current study assessed performance validity on the Stroop Color and Word Test (Stroop) in mild traumatic brain injury (TBI) using criterion-groups validation. The sample consisted of 77 patients with a reported history of mild TBI. Data from 42 moderate-severe TBI and 75 non-head-injured patients with other clinical diagnoses were also examined. TBI patients were categorized on the basis of Slick, Sherman, and Iverson (1999) criteria for malingered neurocognitive dysfunction (MND). Classification accuracy is reported for three indicators (Word, Color, and Color-Word residual raw scores) from the Stroop across a range of injury severities. With false-positive rates set at approximately 5%, sensitivity was as high as 29%. The clinical implications of these findings are discussed.	[Guise, Brian J.; Greve, Kevin W.; Bianchini, Kevin J.; West, Laura] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Thompson, Matthew D.; Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA 70002 USA; [Thompson, Matthew D.] Grayson & Associates, Birmingham, AL USA		Greve, KW (corresponding author), Jefferson Neurobehav Grp, 2901 N 1-10 Serv Rd East, Metairie, LA 70002 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BATCHELOR J, 1995, CLIN NEUROPSYCHOL, V9, P180, DOI 10.1080/13854049508401600; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, PORTLAND DIGIT RECOG; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; British Psychological Society Professional Practice Board, 2009, ASS EFF CLIN TEST CO; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Golden CJ., 2002, STROOP COLOR WORD TE; Gouvier WD, 1998, CRIT ISS NE, P55; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Lemeshow S, 2000, APPL LOGISTIC REGRES; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers J, 2000, TELEPHONY, V239, P7; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; Nigg JT, 2002, J AM ACAD CHILD PSY, V41, P59, DOI 10.1097/00004583-200201000-00012; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1	45	24	24	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2014	8	1					20	33		10.1111/jnp.12002			14	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AA9YD	WOS:000331448100002	23253228				2022-02-06	
J	Mtaweh, H; Smith, R; Kochanek, PM; Wisniewski, SR; Fabio, A; Vavilala, MS; Adelson, PD; Toney, NA; Bell, MJ				Mtaweh, Haifa; Smith, Rebecca; Kochanek, Patrick M.; Wisniewski, Stephen R.; Fabio, Anthony; Vavilala, Monica S.; Adelson, P. David; Toney, Nicole A.; Bell, Michael J.			Energy Expenditure in Children After Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						energy expenditure; metabolism; nutritional support; pediatric neurocritical care; traumatic brain injury	SEVERE HEAD-INJURY; INTENSIVE-CARE-UNIT; NEUROMUSCULAR BLOCKADE; INDIRECT CALORIMETRY; NUTRITION; TEMPERATURE; HYPOTHERMIA; METABOLISM; SEDATION; SUPPORT	Objective: To evaluate energy expenditure in a cohort of children with severe traumatic brain injury. Design: A prospective observational study. Setting: A pediatric neurotrauma center within a tertiary care institution. Patients: Mechanically ventilated children admitted with severe traumatic brain injury (Glasgow Coma Scale < 9) with a weight more than 10 kg were eligible for study. A subset of children was co-enrolled in a phase 3 study of early therapeutic hypothermia. All children were treated with a comprehensive neurotrauma protocol that included sedation, neuromuscular blockade, temperature control, antiseizure prophylaxis, and a tiered-based system for treating intracranial hypertension. Interventions: Within the first week after injury, indirect calorimetry measurements were performed daily when the patient's condition permitted. Measurements and Main Results: Data from 13 children were analyzed (with a total of 32 assessments). Measured energy expenditure obtained from indirect calorimetry was compared with predicted resting energy expenditure calculated from Harris-Benedict equation. Overall, measured energy expenditure/predicted resting energy expenditure averaged 70.2% 3.8%. Seven measurements obtained while children were hypothermic did not differ from normothermic values (75% +/- 4.5% vs 68.9% +/- 4.7%, respectively, p = 0.273). Furthermore, children with favorable neurologic outcome at 6 months did not differ from children with unfavorable outcome (76.4% +/- 6% vs 64.7% +/- 4.7% for the unfavorable outcome, p = 0.13). Conclusions: Contrary to previous work from several decades ago that suggested severe pediatric traumatic brain injury is associated with a hypermetabolic response (measured energy expenditure/predicted resting energy expenditure > 110%), our data suggest that contemporary neurocritical care practices may blunt such a response. Understanding the metabolic requirements of children with severe traumatic brain injury is the first step in development of rational nutritional support goals that might lead to improvements in outcome.	[Mtaweh, Haifa; Smith, Rebecca; Kochanek, Patrick M.; Toney, Nicole A.; Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Mtaweh, Haifa; Smith, Rebecca; Kochanek, Patrick M.; Toney, Nicole A.; Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wisniewski, Stephen R.; Fabio, Anthony] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Smith, Rebecca L/N-5911-2014; Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; Fabio, Anthony/0000-0002-6808-4939; Wisniewski, Stephen/0000-0002-3877-9860	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS070003]; US ArmyUnited States Department of Defense; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); Laerdal Foundation; AHAAmerican Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS070003] Funding Source: NIH RePORTER	Dr. Bell received support for article research from the National Institutes of Health. His institution received grant support from NIH. Dr. Smith received support for travel from the University of Pittsburgh Medical Center and Safar Center for Resuscitation Research, is employed as PICU fellow and attending at the University of Pittsburgh Medical Center, and received support for article research from NIH. Her institution received grant support from NIH (T32 Grant). Dr. Kochanek disclosed United States provisional patents (Method of Inducing EPR Following Cardiopulmonary Arrest 6/22/05, CMU Invention Disclosure 2012-081: Validation of a Multiplex Biomarker Panel for Detection of Abusive Head Trauma in Well-Appearing Children 1/10/2012, and United States Invention Disclosure: Small Molecule Inhibitors of RNA Binding MOTIF (RBM) Proteins for the Treatment of Acute Cellular Injury). He received support for article research from NIH. His institution received grant support from NIH (NS070003), US Army, DARPA, Laerdal Foundation, and AHA (Dr. Kochanek has numerous grants under consideration from these entities, including grants for trainees). Dr. Wisniewski's institution received grant support from NIH. Dr. Adelson receives royalties from Thieme Publishing and consulted for Tramatec. His institution received grant support from NIH, Integra Life Sciences, and Codman. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; BENOTTI PN, 1989, CRIT CARE MED, V17, P181, DOI 10.1097/00003246-198902000-00017; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Briassoulis G, 2005, INTENS CARE MED, V31, P851, DOI 10.1007/s00134-005-2631-3; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CARLSON GL, 1994, AM J PHYSIOL, V266, pE845, DOI 10.1152/ajpendo.1994.266.6.E845; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Coss-Bu JA, 1998, AM J CLIN NUTR, V67, P74, DOI 10.1093/ajcn/67.1.74; COVELLI HD, 1981, ANN INTERN MED, V95, P579, DOI 10.7326/0003-4819-95-5-579; DEMPSEY DT, 1985, SURG GYNECOL OBSTET, V160, P128; Exo J, 2009, Ped Health, V3, P533, DOI 10.2217/phe.09.54; Faul MD, 2010, TRAMAUTIC BRAIN INJU; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; FRASER IM, 1986, CLIN CHEST MED, V7, P131; HADFIELD JM, 1992, INJURY, V23, P177, DOI 10.1016/S0020-1383(05)80040-3; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Havalad Suresh, 2006, Nutr Clin Pract, V21, P175, DOI 10.1177/0115426506021002175; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P74, DOI 10.1177/014860710302700174; HEYMSFIELD SB, 1987, AM J CLIN NUTR, V45, P526, DOI 10.1093/ajcn/45.3.526; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Malakouti A, 2012, PEDIATR CRIT CARE ME, V13, pE18, DOI 10.1097/PCC.0b013e31820aba1f; MATTHEWS DSF, 1995, PEDIATR RES, V37, P409, DOI 10.1203/00006450-199504000-00005; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; Naumann RB, 2010, TRAFFIC INJ PREV, V11, P353, DOI 10.1080/15389588.2010.486429; Osuka A, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.05.012; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Suman OE, 2006, BURNS, V32, P335, DOI 10.1016/j.burns.2005.10.023; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	44	24	26	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2014	15	3					242	249		10.1097/PCC.0000000000000041			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AG3PL	WOS:000335331700011	24394999	Green Accepted			2022-02-06	
J	Ponsford, JL; Sinclair, KL				Ponsford, Jennie L.; Sinclair, Kelly L.			Sleep and Fatigue Following Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Fatigue; Sleep disturbance; Depression; Attention; Treatment	1ST 2 YEARS; EXCESSIVE DAYTIME SLEEPINESS; WAKE DISTURBANCES; OBJECTIVE MEASURES; MENTAL FATIGUE; QUALITY INDEX; HEAD INJURY; INSOMNIA; DISORDERS; MELATONIN	This article reviews literature relating to sleep disturbance and fatigue after traumatic brain injury. It discusses the nature and prevalence of sleep disturbances associated with traumatic brain injury and the measures used to assess them. Potential causes are discussed, including damage to sleep-wake regulating centers, disruption of circadian timing of sleep, and secondary causes, such as pain, depression, and anxiety. The nature and assessment of fatigue are discussed, followed by a review of evidence regarding causes. Evidence is reviewed of the consequences of sleep disturbance and fatigue. Potential treatments of nonpharmacologic and pharmacologic natures are reviewed.	[Ponsford, Jennie L.; Sinclair, Kelly L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Ponsford, Jennie L.; Sinclair, Kelly L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Bldg 17,Clayton Campus, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu					Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; GARFINKEL D, 1995, LANCET, V346, P541, DOI 10.1016/S0140-6736(95)91382-3; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Olver J, J NEUROTRAUMA; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Schonberger M, J HEAD TRAUMA REHABI; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Sinclair K, BEHAV SLEEP MED; Sinclair K, NEUROREHABIL NEURAL; Steele DL, 2005, CHRONOBIOL INT, V22, P89, DOI 10.1081/CBI-200042428; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Willmott C, J HEAD TRAU IN PRESS; Zhdanova IV, 2001, J CLIN ENDOCR METAB, V86, P4727, DOI 10.1210/jc.86.10.4727; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	76	24	25	0	25	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					77	+		10.1016/j.psc.2013.10.001			14	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	AD8UM	WOS:000333541200006	24529424				2022-02-06	
J	Rao, AT; Degnan, AJ; Levy, LM				Rao, A. T.; Degnan, A. J.; Levy, L. M.			Genetics of Alzheimer Disease	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article								Alzheimer disease prevails as a major cause of disability in the elderly population and ranks as the most common form of dementia that affects 1 of 8 individuals older than 65 years of age. Most AD cases are late in onset and are probably influenced by both genetic and environmental factors. Apart from age, the risk factors include family history; brain injury, both traumatic and vascular; and metabolic diseases, such as diabetes, hypercholesterolemia, and obesity. Based on twin studies, inheritance plays a role in approximately 80% of cases (familial and sporadic).	[Rao, A. T.; Levy, L. M.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Degnan, A. J.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA		Levy, LM (corresponding author), George Washington Univ, Med Ctr, 901 23rd St NW, Washington, DC 20037 USA.	llevy@mfa.gwu.edu		Degnan, Andrew/0000-0002-7373-0990			Alagiakrishnan K, 2012, POSTGRAD MED J, V88, P522, DOI 10.1136/postgradmedj-2011-130363; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bird TD, 2008, GENET MED, V10, P231, DOI 10.1097/GIM.0b013e31816b64dc; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Williamson J, 2009, NEUROLOGIST, V15, P80, DOI 10.1097/NRL.0b013e318187e76b	6	24	25	0	5	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2014	35	3					457	458		10.3174/ajnr.A3545			2	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AD9IU	WOS:000333579400011	23538412	hybrid, Green Published			2022-02-06	
J	Rau, TF; Kothiwal, AS; Rova, AR; Brooks, DM; Rhoderick, JF; Poulsen, AJ; Hutchinson, J; Poulsen, DJ				Rau, Thomas F.; Kothiwal, Aakriti S.; Rova, Annela R.; Brooks, Diane M.; Rhoderick, Joseph F.; Poulsen, Austin J.; Hutchinson, Jim; Poulsen, David J.			Administration of low dose methamphetamine 12 h after a severe traumatic brain injury prevents neurological dysfunction and cognitive impairment in rats	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Neuroprotection; Methamphetamine	PROTEIN 88 MYD88; CORTICOTROPIN-RELEASING HORMONE; MOTOR CORTEX INJURY; EXPRESSION; MODEL; AMPHETAMINE; HIPPOCAMPUS; RECOVERY; NEUROPROTECTION; PHARMACOLOGY	We recently published data that showed low dose of methamphetamine is neuroprotective when delivered 3 h after a severe traumatic brain injury (TBI). In the current study, we further characterized the neuroprotective potential of methamphetamine by determining the lowest effective dose, maximum therapeutic window, pharmacokinetic profile and gene expression changes associated with treatment. Graded doses of methamphetamine were administered to rats beginning 8 h after severe TBI. We assessed neuroprotection based on neurological severity scores, foot fault assessments, cognitive performance in the Morris water maze, and histopathology. We defined 0250 mg/kg/h as the lowest effective dose and treatment at 12 has the therapeutic window following severe TBI. We examined gene expression changes following TBI and methamphetamine treatment to further define the potential molecular mechanisms of neuroprotection and determined that methamphetamine significantly reduced the expression of key pro-inflammatory signals. Pharmacokinetic analysis revealed that a 24-hour intravenous infusion of methamphetamine at a dose of 0.500 mg/kg/h produced a plasma C-max value of 25.9 ng/ml and a total exposure of 544 ng/ml over a 32 hour time frame. This represents almost half the 24-hour total exposure predicted for a daily oral dose of 25 mg in a 70 kg adult human. Thus, we have demonstrated that methamphetamine is neuroprotective when delivered up to 12 h after injury at doses that are compatible with current FDA approved levels. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.	[Rau, Thomas F.; Kothiwal, Aakriti S.; Rova, Annela R.; Brooks, Diane M.; Rhoderick, Joseph F.; Poulsen, Austin J.; Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Hutchinson, Jim] Montana Dept Justice, Forens Sci Div, Missoula, MT 59808 USA		Poulsen, DJ (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, 32 Campus Dr, Missoula, MT 59812 USA.	david.poulsen@umontana.edu					Administration F.a.D, 2007, DES PROD INF; [Anonymous], 1996, MERCK INDEX ENCY CHE; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Charron C, 2008, BEHAV BRAIN RES, V188, P125, DOI 10.1016/j.bbr.2007.10.027; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Coffeen U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-75; Cravey B., 1982, INTRO FORENSIC TOXIC, P90; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1981, P W PHARMACOL SOC, V24, P15; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Gorchetchnikov A, 2007, NEURAL NETWORKS, V20, P182, DOI 10.1016/j.neunet.2006.11.007; Grossberg S, 1996, J COGNITIVE NEUROSCI, V8, P257, DOI 10.1162/jocn.1996.8.3.257; Grossberg S, 2006, PSYCHOL REV, V113, P483, DOI 10.1037/0033-295X.113.3.483; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Koutmani Y, 2013, MOL PSYCHIATR, V18, P300, DOI 10.1038/mp.2012.198; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li W, 2013, J SURG RES, V180, P133, DOI 10.1016/j.jss.2012.10.928; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Mendelson J, 2006, CLIN PHARMACOL THER, V80, P403, DOI 10.1016/j.clpt.2006.06.013; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Prevention C.f.D.C.a, 2006, TRAUMATIC BRAIN INJU; Rau T.K., 2012, J TRAUMA ACUTE CARE, V73; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; SOZZANI S, 1994, J IMMUNOL, V152, P3615; SOZZANI S, 1994, BIOCHEM BIOPH RES CO, V199, P761, DOI 10.1006/bbrc.1994.1294; Stevens SL, 2003, J CEREBR BLOOD F MET, V23, P1151, DOI 10.1097/01.WCB.0000086957.72078.D4; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vaarmann A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.194; Wittenberg GM, 2002, HIPPOCAMPUS, V12, P637, DOI 10.1002/hipo.10102; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771	63	24	25	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2014	253						31	40		10.1016/j.expneurol.2013.12.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8QS	WOS:000332055700004	24333768	hybrid			2022-02-06	
J	Rosario, ER; Kaplan, SE; Khonsari, S; Patterson, D				Rosario, Emily R.; Kaplan, Stephanie E.; Khonsari, Sepehr; Patterson, David			Predicting and Assessing Fall Risk in an Acute Inpatient Rehabilitation Facility	REHABILITATION NURSING			English	Article						Rehabilitation; fall risk; stroke; brain injury; inpatient rehabilitation facility	FUNCTIONAL INDEPENDENCE MEASURE; OLDER-ADULTS; HOSPITALIZED-PATIENTS; ASSESSMENT TOOLS; STROKE PATIENTS; COMMUNITY; FEAR; SETTINGS; INJURIES; VALIDATION	PurposeUnintentional falls account for 70% of all hospital accidents. The objective of this study was to identify risk factors for falls and develop an assessment tool specific for an inpatient rehabilitation facility setting. Design/MethodDiagnosis and Functional Independence Measure (FIM) scores were collected for 174 patients to assess predictors for fall risk. Independent t-tests, chi-square, and logistic regression analysis were conducted to examine differences between fallers and nonfallers. FindingsWe identified several risk factors for falls including 4 FIM items: toileting, bed transfer, tub/shower transfer, and stairs; and three diagnoses: right stroke, traumatic brain injury, and amputation. From these findings, we completed initial development of a risk assessment tool. ConclusionsEvaluation of the tool suggests good specificity with 20%-30% of the patient population identified as high risk and good sensitivity by correctly predicting nearly 90% of patient falls. Clinical RelevanceContinued evaluation of this assessment tool is needed to identify effectiveness in predicting patients who are at high risk for falling.	[Rosario, Emily R.; Kaplan, Stephanie E.; Khonsari, Sepehr; Patterson, David] Casa Colina Hosp Rehabilitat Med, Pomona, CA 91769 USA		Rosario, ER (corresponding author), Casa Colina Hosp Rehabilitat Med, Res Inst, 255 E Bonita Ave, Pomona, CA 91769 USA.	erosario@casacolina.org			Casa Colina Centers for Rehabilitation Foundation	The authors thank the Casa Colina Centers for Rehabilitation Foundation for supporting this research.	Adkin AL, 2002, EXP BRAIN RES, V143, P160, DOI 10.1007/s00221-001-0974-8; BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Englander F, 1996, J FORENSIC SCI, V41, P733; Fischer ID, 2005, INFECT CONT HOSP EP, V26, P822, DOI 10.1086/502500; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gilewski MJ, 2007, REHABIL NURS, V32, P234, DOI 10.1002/j.2048-7940.2007.tb00180.x; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; Kim EAN, 2007, J ADV NURS, V60, P427, DOI 10.1111/j.1365-2648.2007.04419.x; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Kressig RW, 2001, J AM GERIATR SOC, V49, P1456, DOI 10.1046/j.1532-5415.2001.4911237.x; Kwan F, 2012, REHABIL NURS, V37, P30, DOI 10.1002/RNJ.00004; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Legters K, 2002, PHYS THER, V82, P264, DOI 10.1093/ptj/82.3.264; MAYO NE, 1989, AM J PHYS MED REHAB, V68, P139, DOI 10.1097/00002060-198906000-00008; McKee KJ, 2002, DISABIL REHABIL, V24, P327, DOI 10.1080/09638280110093686; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; MORGAN VR, 1985, AM J PUBLIC HEALTH, V75, P775, DOI 10.2105/AJPH.75.7.775; Morrison G, 2011, DISABIL REHABIL, V33, P900, DOI 10.3109/09638288.2010.514019; MORSE JM, 1996, PREVENTING PATIENT F; Nakai Akihito, 2006, Journal of Nippon Medical School, V73, P265, DOI 10.1272/jnms.73.265; Nyberg L, 1996, STROKE, V27, P1821, DOI 10.1161/01.STR.27.10.1821; OCZKOWSKI WJ, 1993, ARCH PHYS MED REHAB, V74, P1291, DOI 10.1016/0003-9993(93)90081-K; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Oliver David, 2007, Br J Community Nurs, V12, P500; Rabadi MH, 2008, REHABIL NURS, V33, P104, DOI 10.1002/j.2048-7940.2008.tb00213.x; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Saverino A, 2006, Eura Medicophys, V42, P179; Schwendimann R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-69; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Sebastia E, 2006, J REHABIL MED, V38, P204, DOI 10.1080/16501970500540939; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vassallo M, 2003, AGE AGEING, V32, P338, DOI 10.1093/ageing/32.3.338; Vieira ER, 2011, CLIN REHABIL, V25, P788, DOI 10.1177/0269215511400639; VLAHOV D, 1990, ARCH PHYS MED REHAB, V71, P8	39	24	24	1	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	MAR	2014	39	2					86	93		10.1002/rnj.114			8	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	AC3DH	WOS:000332394700005	23813799				2022-02-06	
J	Hu, YC; Sun, Q; Li, W; Zhang, DD; Ma, B; Li, S; Li, WD; Zhou, ML; Hang, CH				Hu, Yang-Chun; Sun, Qing; Li, Wei; Zhang, Ding-Ding; Ma, Biao; Li, Song; Li, Wei-De; Zhou, Meng-Liang; Hang, Chun-Hua			Biphasic activation of nuclear factor kappa B and expression of p65 and c-Rel after traumatic brain injury in rats	INFLAMMATION RESEARCH			English	Article						Inflammatory response; Traumatic brain injury; Nuclear factor kappa B (NF-kappa B); Biphasic activation	CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; OXIDATIVE STRESS; NEURON SURVIVAL; DNA-BINDING; ROLES; ALPHA; OPPORTUNITIES; INDUCTION; PROTEINS	Nuclear factor kappa B (NF-kappa B) functions as a key regulator in the central nervous system and regulates the inflammatory pathway. There are two peaks of cerebral NF-kappa B activation after neonatal hypoxia-ischemia and subarachnoid hemorrhage. Our previous studies found that NF-kappa B activity was up-regulated at an early stage and remained elevated at day 7 after traumatic brain injury (TBI). However, data are lacking regarding an overview of NF-kappa B activity and expression of NF-kappa B subunits after TBI. Hence, the current study was designed to detect the time course of NF-kappa B activation and expression of NF-kappa B p65 and c-Rel subunits around the contused cortex following TBI. Adult Sprague-Dawley rats were randomly divided into sham and TBI groups at different time points. A TBI model was induced, and then the NF-kappa B DNA-binding activity in the surrounding areas of injured brain was detected by electrophoretic mobility shift assay. Western blotting was used to measure the protein levels of p65 and c-Rel in the nucleus. The concentrations of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) were detected by enzyme-linked immunosorbent assay. Moreover, the distribution of c-Rel and p65 was examined by immunohistochemical studies. There were double peaks of cerebral cortical NF-kappa B activity, at 3 and 10 days post-injury. Additionally, protein levels of p65 were found to be elevated and peaked at 3 days after TBI, while levels of c-Rel were elevated significantly during the later phase of injury. Furthermore, TNF-alpha and IL-1 beta concentrations also showed a biphasic increase. Biphasic activation of NF-kappa B could be induced after experimental TBI in rats. NF-kappa B p65 and c-Rel subunits were elevated at different post-TBI time periods, leading to a hypothesis that different NF-kappa B subunits might be involved in different pathophysiological processes after TBI.	[Hu, Yang-Chun; Sun, Qing; Li, Wei; Zhang, Ding-Ding; Ma, Biao; Zhou, Meng-Liang; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Li, Song; Li, Wei-De] Southern Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021	Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170, 81371294]; Nature Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]; Military Medical Scientific and Technological Innovation Project [10Z024]	We gratefully acknowledge the generous assistance from Dr. Gen-Bao Feng. This study was supported by the National Natural Science Foundation, China (NO. 81171170, 81371294), Nature Science Foundation of Jiangsu Province, China (BK2010459) and Military Medical Scientific and Technological Innovation Project (10Z024).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; ERNST MK, 1995, MOL CELL BIOL, V15, P872; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lescot T, 2007, PRESSE MED, V36, P1117, DOI 10.1016/j.lpm.2007.01.017; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; PRASAD AV, 1994, NEUROSCI LETT, V170, P145, DOI 10.1016/0304-3940(94)90260-7; PRASAD AV, 1994, RADIAT RES, V138, P367, DOI 10.2307/3578685; Qin ZH, 1998, MOL PHARMACOL, V53, P33, DOI 10.1124/mol.53.1.33; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; You WC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/786242; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901	33	24	27	0	9	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	FEB	2014	63	2					109	115		10.1007/s00011-013-0677-1			7	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	293JU	WOS:000329968000003	24146067				2022-02-06	
J	Post, A; Hoshizaki, TB; Gilchrist, MD; Brien, S; Cusimano, MD; Marshall, S				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael D.; Marshall, Shawn			The influence of dynamic response and brain deformation metrics on the occurrence of subdural hematoma in different regions of the brain Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; subdural hematoma; falling injuries; injury reconstruction	HUMAN HEAD; INJURY; FALLS; RECONSTRUCTION; ACCELERATION; BIOMECHANICS; TISSUE; MODEL	Object. The purpose of this study was to examine how the dynamic response and brain deformation of the head and brain-representing a series of injury reconstructions of which subdural hematoma (SDH) was the Outcome influence the location of the lesion in the lobes of the brain. Methods. Sixteen cases of falls in which SDH was the outcome were reconstructed using a monorail drop rig and Hybrid III headform. The location of the SDH in 1 of the 4 lobes of the brain (frontal, parietal, temporal, and occipital) was confirmed by CT/MR scan examined by a neurosurgeon. Results. The results indicated that there were minimal differences between locations of the SDH for linear acceleration. The peak resultant rotational acceleration and x-axis component were larger for the parietal lobe than for other lobes. There were also some differences between the parietal lobe and the other lobes in the z-axis component. Maximum principal strain, von Mises stress, shear strain, and product of strain and strain rate all had differences in magnitude depending on the lobe in which SDH was present. The parietal lobe consistently had the largest-magnitude response, followed by the frontal lobe and the occipital lobe. Conclusions. The results indicated that there are differences in magnitude for rotational acceleration and brain deformation metrics that may identify the location of SDH in the brain.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Cusimano, Michael D.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Marshall, Shawn] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Dept Med, Ottawa, ON, Canada		Post, A (corresponding author), Univ Ottawa, 200 Lees Ave,Rm A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019; Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Cusimano, Michael/0000-0002-9989-0650; Post, Andrew/0000-0002-5960-5552	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Funding for this work was received from the Canadian Institutes of Health Research (to T.B.H.). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Auer C, 2001, INT SOC BIOM 18 C JU; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Chan M., 1980, P 24 STAPP CAR CRASH, P347; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly MC, 2009, INT J CRASHWORTHINES, V14, P503, DOI 10.1080/13588260902826554; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1979, STAPP CAR CRASH C, P563; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hodgson VR, 1983, P 27 STAPP CAR CRASH, P225; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Miller R.T., 1998, STAPP CAR CRASH J, P155; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Prange MT, 2002, P 44 STAPP CAR CRASH, P205; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	33	24	24	2	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2014	120	2					453	461		10.3171/2013.10.JNS131101			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	301UA	WOS:000330556400029	24313604				2022-02-06	
J	Weeks, D; Sullivan, S; Kilbaugh, T; Smith, C; Margulies, SS				Weeks, Dianne; Sullivan, Sarah; Kilbaugh, Todd; Smith, Colin; Margulies, Susan S.			Influences of Developmental Age on the Resolution of Diffuse Traumatic Intracranial Hemorrhage and Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; hemorrhage; pediatric traumatic brain injury; swine; time course	ROTATIONAL HEAD-INJURY; BRAIN-INJURY; CEREBRAL CONCUSSION; COGNITIVE FUNCTION; CORPUS-CALLOSUM; CORTICAL IMPACT; ANIMAL-MODELS; VULNERABILITY; CHILDREN; PIGLET	This study investigated the age-dependent injury response of diffuse traumatic axonal injury (TAI) and regional subdural and subarachnoid intracranial hemorrhage (ICH) in two pediatric age groups using a porcine head injury model. Fifty-five 5-day-old and 40 four-week-old pigletswhich developmentally correspond to infants and toddlers, respectivelyunderwent either a sham injury or a single rapid non-impact rotational injury in the sagittal plane and were grouped by post-TBI survival time (sham, 3-8h, one day, 3-4 days, and 5-6 days). Both age groups exhibited similar initial levels of ICH and a significant reduction of ICH over time (p<0.0001). However, ICH took longer to resolve in the five-day-old age group. At 5-6 days post-injury, ICH in the cerebrum had returned to sham levels in the four-week-old piglets, while the five-day-olds still had significantly elevated cerebral ICH (p=0.012). Both ages also exhibited similar resolution of axonal injury with a peak in TAI at one day post-injury (p<0.03) and significantly elevated levels even at 5-6 days after the injury (p<0.008), which suggests a window of vulnerability to a second insult at one day post-injury that may extend for a prolonged period of time. However, five-day-old piglets had significantly more TAI than four-week-olds overall (p=0.016), which presents some evidence for an increased vulnerability to brain injury in this age group. These results provide insight into an optimal window for clinical intervention, the period of increased susceptibility to a second injury, and an age dependency in brain injury tolerance within the pediatric population.	[Weeks, Dianne; Sullivan, Sarah; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Kilbaugh, Todd] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Kilbaugh, Todd/0000-0002-4959-3092; Smith, Colin/0000-0002-4507-5132	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS039679, U01 NS069545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, R01NS039679] Funding Source: NIH RePORTER	The authors gratefully acknowledge the technical assistance of Michelle Skettini, Melissa Byro, Jill Ralston, Shreya Reddy, and Sharon Martinez. Studies were supported by NIH R01 NS039679 and NIH U01 NS069545.	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bruce D A, 1990, Curr Probl Pediatr, V20, P61; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Dobbing J, 1968, Prog Brain Res, V29, P417; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, TRAUMATIC BRAIN INJU; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; Ibrahim N.G., J NEUROTRAUMA, V27, P1021; Ibrahim NG, 2012, INT J DEV NEUROSCI, V30, P201, DOI 10.1016/j.ijdevneu.2011.10.007; Kilbaugh T.J., J NEUROTRAUMA, V28, P763; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Snyder R.C., 1977, UMHSRI77 CONS PROD S; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046	41	24	26	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2014	31	2					206	214		10.1089/neu.2013.3113			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	291ZE	WOS:000329870600007	23984914	Green Published			2022-02-06	
J	Chen, Y; Garcia, GE; Huang, W; Constantini, S				Chen, Yun; Garcia, Gregory E.; Huang, Wei; Constantini, Shlomi			The involvement of secondary neuronal damage in the development of neuropsychiatric disorders following bra insults	FRONTIERS IN NEUROLOGY			English	Article						neuropsychiatric disorders; secondary neuronal damage; brain insults; traumatic brain injury; neurodegenerative diseases; clinical manifestations; histomotphology; pathophysiology		Neuropsychiatric disorders are one of the leading causes of disability worldwide and affect the health of billions of people. Previous publications have demonstrated that neuropsychiatric disorders can cause histomorphological damage in particular regions of the brain. By using a clinical symptom-comparing approach, 55 neuropsychiatric signs or symptoms related usually to 14 types of acute and chronic brain insults were identified and categorized in the present study. Forty percent of the 55 neuropsychiatric signs and symptoms have been found to be commonly shared by the 14 brain insults. A meta-analysis supports existence of the same neuropsychiatric signs or symptoms in all brain insults. The results suggest that neuronal damage might be occurring in the same or similar regions or structures of the brain. Neuronal cell death, neural loss, and axonal degeneration in some parts of the brain (the limbic system, basal ganglia system, brainstem, cerebellum, and cerebral cortex) might be the histomorphological basis that is responsible for the neuropsychiatric symptom clusters. These morphological alterations may be the result of secondary neuronal damage (a cascade of progressive neural injury and neuronal cell death that is triggered by the initial insult). Secondary neuronal damage causes neuronal cell death and neural injury in not only the initial injured site but also remote brain regions. It may be a major contributor to subsequent neuropsychiatric disorders following brain insults.	[Chen, Yun] BrightstarTech Inc, 23102 Meadow Mist Rd, Clarksburg, MD 20871 USA; [Garcia, Gregory E.] US Army Med Res Inst Chem Def, Aberdeen, MD USA; [Huang, Wei] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Constantini, Shlomi] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel		Chen, Y (corresponding author), BrightstarTech Inc, 23102 Meadow Mist Rd, Clarksburg, MD 20871 USA.	yun.chen@brightstartechinc.com					Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Agrawal SK, 1996, J NEUROSCI, V16, P545; Ahn WK, 2009, COGNITIVE SCI, V33, P147, DOI 10.1111/j.1551-6709.2009.01008.x; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; [Anonymous], 2000, Bull World Health Organ, V78, P413; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Bellows J G, 1979, Compr Ther, V5, P3; BERENT S, 1988, ANN NEUROL, V23, P541, DOI 10.1002/ana.410230603; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361; Bolla KI, 2000, NEUROLOGY, V54, P2285, DOI 10.1212/WNL.54.12.2285; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; BOTHE HW, 1984, ACTA NEUROPATHOL, V64, P37, DOI 10.1007/BF00695604; BOWEN DM, 1989, P NATL ACAD SCI USA, V86, P9504, DOI 10.1073/pnas.86.23.9504; Bruce M, 2011, CHILD CARE HLTH DEV, V37, P244, DOI 10.1111/j.1365-2214.2010.01164.x; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Busser J, 1998, J NEUROSCI, V18, P2801; Buttner A, 2005, DRUG ALCOHOL DEPEN, V79, P63, DOI 10.1016/j.drugalcdep.2004.12.010; Chen J, 2003, J BIOL CHEM, V278, P28089, DOI 10.1074/jbc.M303094200; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Chen Y, 2012, NEUROTOXICOLOGY, V33, P391, DOI 10.1016/j.neuro.2012.03.011; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chio A, 2011, J NEUROL NEUROSUR PS, V82, P740, DOI 10.1136/jnnp.2010.235952; CLEMENT JG, 1993, NEUROTOXICOLOGY, V14, P485; CONSTANTINI S, 1993, NEUROSURGERY, V33, P204, DOI 10.1097/00006123-199308000-00004; Conti AC, 1998, J NEUROSCI, V18, P5663; Cullen J, 1996, Nurs N Z, V2, P20; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; de Oliveira Sheila Knupp Feitosa, 2010, Curr Infect Dis Rep, V12, P103, DOI 10.1007/s11908-010-0082-7; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; ECKERT WG, 1991, AM J FOREN MED PATH, V12, P119, DOI 10.1097/00000433-199106000-00007; Farrugia D, 2009, J MENT HLTH COUNS, V31, P189, DOI 10.17744/mehc.31.3.f2l6hk4834p82483; Fattore L, 2009, NEUROPSYCHOPHARMACOL, V34, P1091, DOI 10.1038/npp.2008.43; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Fix, 2008, BOARD REV SERIES, P274; FRACKOWIAK RSJ, 1991, CIBA F SYMP, V163, P235; Frank MG, 2012, J NEUROIMMUNOL, V252, P33, DOI 10.1016/j.jneuroim.2012.07.010; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Garcia-Campayo J, 2009, CURR OPIN PSYCHIATR, V22, P224, DOI 10.1097/YCO.0b013e3283252d43; Gil-Bea FJ, 2005, NEUROSCI LETT, V375, P37, DOI 10.1016/j.neulet.2004.10.062; Gold Carl A, 2008, Expert Rev Neurother, V8, P1879, DOI 10.1586/14737175.8.12.1879; Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7; Grossberg S, 2013, NEURAL NETWORKS, V37, P1, DOI [10.1016/j.neunet.2011.10.011, 10.1016/j.neunet.2012.09.017]; HILL DL, 1981, PHYSIOL BEHAV, V26, P269, DOI 10.1016/0031-9384(81)90022-6; Holleran L, 2014, NEUROPSYCHOPHARMACOL, V39, P944, DOI 10.1038/npp.2013.294; Hyman S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P605; Ishizawa Y, 2000, J PHARMACOL EXP THER, V293, P845; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jarquin-Valdivia AA, 2004, ARCH NEUROL-CHICAGO, V61, P1800, DOI 10.1001/archneur.61.11.1800; Jellinger KA, 2009, NEUROPSYCHIATRIE, V23, P115; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JORDAN WP, 1983, BEHAV NEUROSCI, V97, P710, DOI 10.1037/0735-7044.97.5.710; Katzer A, 2012, J ABNORM PSYCHOL, V121, P530, DOI 10.1037/a0026536; Kawana N, 2001, Mil Med, V166, P23; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KHAN T, 1993, EUR J CELL BIOL, V62, P406; Kinderman P, 2005, HARVARD REV PSYCHIAT, V13, P206, DOI 10.1080/10673220500243349; KING DJ, 1994, ACTA PSYCHIAT SCAND, V89, P53, DOI 10.1111/j.1600-0447.1994.tb05833.x; Kreipe Richard E, 2006, Adolesc Med Clin, V17, P1; Kronish IM, 2012, STROKE, V43, P2192, DOI 10.1161/STROKEAHA.112.655209; Lim HK, 2013, INT PSYCHOGERIATR, V25, P1929, DOI 10.1017/S104161021300149X; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; Malenka R.C., 2009, MOL NEUROPHARMACOLOG; Martino D, 2009, J PSYCHOSOM RES, V67, P547, DOI 10.1016/j.jpsychores.2009.07.004; Matthews PR, 2012, J AFFECT DISORDERS, V137, P125, DOI 10.1016/j.jad.2011.10.043; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Montoya A, 2006, J PSYCHIATR NEUROSCI, V31, P21; Moretti Germana, 2008, Clin Pract Epidemiol Ment Health, V4, P13, DOI 10.1186/1745-0179-4-13; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P13345, DOI 10.1073/pnas.93.23.13345; Nagatsu T, 2007, J NEURAL TRANSM-SUPP, P113; NAIL RL, 1976, DRUG ALCOHOL DEPEN, V1, P429, DOI 10.1016/0376-8716(76)90007-7; Neumann MA, 2005, ANESTH ANALG, V100, P1003, DOI 10.1213/01.ANE.0000146516.35921.1A; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Ostman M, 2002, BRIT J PSYCHIAT, V181, P494, DOI 10.1192/bjp.181.6.494; Oyama O, 2007, AM FAM PHYSICIAN, V76, P1333; Parent A, 1995, CARPENTERS HUMAN NEU, P186; Passarotti AM, 2011, PSYCHOPHARMACOLOGY, V216, P485, DOI 10.1007/s00213-011-2243-2; Paulsen JS, 2013, J NEUROL NEUROSUR PS, V84, P1233, DOI 10.1136/jnnp-2013-305114; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Pier MPBI, 2004, J AFFECT DISORDERS, V81, P73, DOI 10.1016/j.jad.2003.08.002; Planeta CS, 2013, BRAZ J MED BIOL RES, V46, P909, DOI 10.1590/1414-431X20133379; Pucak Michele L, 2007, Dialogues Clin Neurosci, V9, P125; PULLIAM L, 1994, ADV NEUROIMMUNOL, V4, P195, DOI 10.1016/S0960-5428(06)80257-3; REINVANG I, 1991, ACTA NEUROL SCAND, V83, P289, DOI 10.1111/j.1600-0404.1991.tb04703.x; RICHARDS M, 1993, ANN NEUROL, V33, P267, DOI 10.1002/ana.410330307; Roth J, 2012, J NEUROSURG-PEDIATR, V10, P168, DOI 10.3171/2012.6.PEDS11451; Rothwell JC, 2011, J INTEGR NEUROSCI, V10, P303, DOI 10.1142/S0219635211002798; Rutter M, 2005, BRIT J PSYCHIAT, V186, P4, DOI 10.1192/bjp.186.1.4; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Satterthwaite TD, 2010, AM J PSYCHIAT, V167, P418, DOI 10.1176/appi.ajp.2009.09060808; SCHAUMBURG HH, 1987, NEUROLOGY, V37, P276, DOI 10.1212/WNL.37.2.276; Schmidt CW, 2007, ENVIRON HEALTH PERSP, V115, pA404, DOI 10.1289/ehp.115-a404; Schulden JD, 2012, PSYCHIAT CLIN N AM, V35, P411, DOI 10.1016/j.psc.2012.03.007; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Sharma R, 2010, ALCOHOL CLIN EXP RES, V34, P813, DOI 10.1111/j.1530-0277.2010.01153.x; Sherer R, 2002, PSYCHIAT TIMES, VXIX, P1; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; SLEDZIK PS, 1994, AM J PHYS ANTHROPOL, V94, P269, DOI 10.1002/ajpa.1330940210; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Snyder Howard, 1993, Journal of Emergency Medicine, V11, P253, DOI 10.1016/0736-4679(93)90042-6; Stein DJ, 2008, CNS SPECTRUMS, V13, P379, DOI 10.1017/S1092852900016540; STERN Y, 1993, ARCH NEUROL-CHICAGO, V50, P1040, DOI 10.1001/archneur.1993.00540100035011; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Substance Abuse and Mental Health Services Administration, 2012, NSDUH SER H, V12-4713; SUMITOMO I, 1967, TOHOKU J EXP MED, V91, P13, DOI 10.1620/tjem.91.13; SZYMUSIAK R, 1986, EXP NEUROL, V94, P598, DOI 10.1016/0014-4886(86)90240-2; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Takei Y, 2013, J PSYCHIATR RES, V47, P1581, DOI 10.1016/j.jpsychires.2013.07.029; Tang Dean G, 1996, Pathol Oncol Res, V2, P117; Tilson HA, 1998, TOXICOL LETT, V103, P631, DOI 10.1016/S0378-4274(98)00271-9; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Ward RJ, 2009, ALCOHOL ALCOHOLISM, V44, P128, DOI 10.1093/alcalc/agn100; WIDLOCHER DJ, 1983, PSYCHIAT CLIN N AM, V6, P27; Willard SL, 2013, BIOL PSYCHIAT, V74, P890, DOI 10.1016/j.biopsych.2013.03.013; Wilson JMB, 2003, NEUROMOL MED, V3, P105, DOI 10.1385/NMM:3:2:105; Wolf U, 2009, J NEUROPSYCH CLIN N, V21, P245, DOI 10.1176/appi.neuropsych.21.3.245; World Health Organization (WHO), 2001, WORLD HLTH REPORT 20; Yoshihara Yujiro, 2008, Ann Gen Psychiatry, V7, P25, DOI 10.1186/1744-859X-7-25; YOUNG AB, 1993, RES P ARNMD, V71, P175; Young AB, 1997, REV NEUROL-FRANCE, V153, P496; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	139	24	24	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								22	10.3389/fneur.2014.00022			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300022	24653712	Green Published, gold			2022-02-06	
J	Dunkerson, J; Moritz, KE; Young, J; Pionk, T; Fink, K; Rossignol, J; Dunbar, G; Smith, JS				Dunkerson, Jacob; Moritz, Kasey E.; Young, Jennica; Pionk, Tim; Fink, Kyle; Rossignol, Julien; Dunbar, Gary; Smith, Jeffrey S.			Combining enriched environment and induced pluripotent stem cell therapy results in improved cognitive and motor function following traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article							SENSORIMOTOR FUNCTION; CORTICAL CONTUSION; RECOVERY; RATS; NEURONS; STROKE; TRANSPLANTATION; INTEGRATE; PROGRESS; TBI	Purpose: Despite advances towards potential clinically viable therapies there has been only limited success in improving functional recovery following traumatic brain injury (TBI). In rats, exposure to an enriched environment (EE) improves learning and fosters motor skill development. Induced pluripotent stem cells (iPSC) have been shown to survive transplantation and influence the recovery process. The current study evaluated EE and iPSC as a polytherapy for remediating cognitive deficits following medial frontal cortex (mFC) controlled cortical impact (CCI) injury. Methods: Sixty adult male rats received a midline mFC CCI or sham injury and were randomly placed in either EE or standard environment (SE). Seven days post-injury rats received bilateral transplantation of iPSCs or media. Behavioral measures were conducted throughout the remainder of the study. Following behavioral analysis, brains were extracted and prepared for histological analysis. Results: Open-field data revealed that combined therapy resulted in typical Sham/EE activity rearing patterns by the conclusion of the study. On the Vermicelli Handling task, rats with EE/iPSC polytherapy performed better than media-treated rats. Furthermore, rats treated with polytherapy performed equivalently to Sham/EE rats on the Morris water maze. Proficiency on the Rotarod was consistently better in EE when compared to SE counterparts. Confocal microscopy confirmed that iPSCs survived and migrated away from the transplantation site. Conclusions: Overall, EE or iPSC therapy improved cognition and motor performance, however, full cognitive restoration was seen only with the EE/iPSC treatment. These data suggest that EE/iPSC therapy should be explored as a potential, clinically relevant, treatment for TBI.	[Dunkerson, Jacob; Moritz, Kasey E.; Young, Jennica; Pionk, Tim; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA; [Fink, Kyle; Rossignol, Julien; Dunbar, Gary] Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu	Rossignol, Julien/I-1013-2019	Rossignol, Julien/0000-0002-8662-0547; Smith, Jeffrey/0000-0001-5499-4475	Field Neuroscience Institute	This study was generously funded through a contract with the Field Neuroscience Institute to Jeffrey Smith. The authors would like to thank Madeleine Searles and Evan Nudi for their countless contributions for technical support throughout the duration of the study.	Allred RP, 2008, FUTUR NEUROL, V3, P189, DOI 10.2217/14796708.3.2.189; Barrash J, 2011, J CLIN EXP NEUROPSYC, V33, P833, DOI 10.1080/13803395.2011.561300; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dobrossy MD, 2006, EUR J NEUROSCI, V24, P3223, DOI 10.1111/j.1460-9568.2006.05182.x; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Fink KD, 2014, CELL TRANSPLANT, V23, P1407, DOI 10.3727/096368913X670958; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; NEISTADT ME, 1994, AM J OCCUP THER, V48, P421, DOI 10.5014/ajot.48.5.421; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Rezanejad H, 2012, CELL REPROGRAM, V14, P459, DOI 10.1089/cell.2012.0039; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tennant Kelly A, 2010, J Vis Exp, DOI 10.3791/2076; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	37	24	24	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2014	32	5					675	687		10.3233/RNN-140408			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR2NP	WOS:000343424900009	25079980				2022-02-06	
J	Kang, XG; Li, L; Wei, D; Xu, XX; Zhao, R; Jing, YY; Su, YY; Xiong, LZ; Zhao, G; Jiang, W				Kang, Xiao-gang; Li, Li; Wei, Dong; Xu, Xiao-xia; Zhao, Rui; Jing, Yun-yun; Su, Ying-ying; Xiong, Li-ze; Zhao, Gang; Jiang, Wen			Development of a simple score to predict outcome for unresponsive wakefulness syndrome	CRITICAL CARE			English	Article							NEURON-SPECIFIC ENOLASE; PERSISTENT VEGETATIVE STATE; MINIMALLY CONSCIOUS STATES; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; SLEEP SPINDLES; COMA; DISORDERS; RECOVERY; EEG	Introduction: Accurate assessment of prognosis for patients with unresponsive wakefulness syndrome (UWS; formerly vegetative state) may help clinicians and families guide the type and intensity of therapy; however, there is no suitable and accurate means to predict the outcome so far. We aimed to develop a simple bedside scoring system to predict the likelihood of awareness recovery in patients with UWS. Methods: We prospectively enrolled 56 patients (age range 10 to 73 years) with UWS 3 to 12 weeks post-onset. We collected demographic data and performed neurological, serological and neurophysiological tests at study entry. Each patient received a one year follow-up, during which awareness recovery was assessed by experienced physicians on the basis of clinical criteria. Univariate and multivariable analyses were employed to assess the relationships between predictors and awareness recovery. Results: A total of 56 participants were included in the study; of these, 24 patients recovered awareness, 3 with moderate disabilities, 8 with severe disabilities, 12 were in a minimally conscious state, and 1 died after recovery. During the study, 23 patients remained in UWS and 9 died in UWS. Motor response, type of brain injury, electroencephalogram reactivity, sleep spindles and N20 were shown to be independent predictors for awareness recovery. Based on their coefficients in the model, we assigned these predictors with 1 point each and created a 5-point score for prediction of awareness recovery. The resulting score showed good predictive accuracy in the derivation cohort. The area under the receiver operating characteristic curve for the score was 0.918 with 87.50% sensitivity. Conclusion: This simple bedside prognostic score can be used to predict the probability of awareness recovery in UWS, thus provide families and clinicians with useful outcome information.	[Kang, Xiao-gang; Li, Li; Wei, Dong; Xu, Xiao-xia; Zhao, Rui; Jing, Yun-yun; Zhao, Gang; Jiang, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Su, Ying-ying] Capital Med Univ, Xuanwu Hosp, Div Neurocrit Care, Beijing 100053, Peoples R China; [Xiong, Li-ze] Fourth Mil Med Univ, Xijing Hosp, Dept Anaesthesia, Xian 710032, Peoples R China		Jiang, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China.	jiangwen@fmmu.edu.cn			Xijing Hospital Research Foundation [XKZT09Z07]; Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China [IRT1053]	This work is supported by the Xijing Hospital Research Foundation (grant number XKZT09Z07, to W Jiang) and the Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China (IRT1053).	Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Beuthien-Baumann B, 2005, NEUROPSYCHOL REHABIL, V15, P276, DOI 10.1080/09602010443000290; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Courjon J, 1971, Rev Electroencephalogr Neurophysiol Clin, V1, P133, DOI 10.1016/S0370-4475(71)80054-0; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Daubin C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-48; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Heiss WD, 2012, EUR J NEUROL, V19, P207, DOI 10.1111/j.1468-1331.2011.03489.x; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kaplan PW, 2006, SEMIN NEUROL, V26, P403, DOI 10.1055/s-2006-948321; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee YC, 2010, NEUROLOGY, V74, P572, DOI 10.1212/WNL.0b013e3181cff761; Leithner C, 2010, NEUROLOGY, V74, P965, DOI 10.1212/WNL.0b013e3181d5a631; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Machado C, 2010, NEUROLOGY, V75, P751, DOI 10.1212/WNL.0b013e3181ec67bb; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rabinstein AA, 2012, LANCET NEUROL, V11, P414, DOI 10.1016/S1474-4422(12)70060-1; Racine E, 2010, CAN J NEUROL SCI, V37, P758, DOI 10.1017/S0317167100051416; Rech TH, 2006, CRIT CARE, V10, DOI 10.1186/cc5046; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Thenayan EAL, 2010, J CRIT CARE, V25, P300, DOI 10.1016/j.jcrc.2009.06.049; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	45	24	26	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2014	18	1							R37	10.1186/cc13745			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2YP	WOS:000338991900074	24571596	Green Published, gold			2022-02-06	
J	Neipert, L; Pastorek, NJ; Troyanskaya, M; Scheibel, RS; Petersen, NJ; Levin, HS				Neipert, Leslie; Pastorek, Nicholas J.; Troyanskaya, Maya; Scheibel, Randall S.; Petersen, Nancy J.; Levin, Harvey S.			Effect of clinical characteristics on cognitive performance in service members and veterans with histories of blast-related mild traumatic brain injury	BRAIN INJURY			English	Article						Blast; cognitive function; concussion; mild traumatic brain injury; post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSIVE SYMPTOMS; EXECUTIVE FUNCTION; CHRONIC PAIN; MEMORY; SLEEP; AFGHANISTAN; ATTENTION; DEFICITS; IRAQ	Objective: To examine the relationship between clinical characteristics and cognitive performance in service members and veterans with histories of blast-related mild traumatic brain injury (mTBI). Design: This study consisted of 40 Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) service members and veterans; 20 participants reported blast exposure and alteration of mental status consistent with mTBI and 20 participants denied blast exposure and had no history of traumatic brain injury (TBI), but could have experienced extra-cranial injuries. Measures of simple reaction time, processing speed, visual attention, working memory and mathematical processing were used to assess long-term effects of mTBI. Measures of post-traumatic stress symptom severity, pain intensity, sleep difficulty and subjective appraisal of cognition at time of testing were also obtained. Multivariate analyses were conducted with clinical characteristics and mTBI history as predictors of cognitive performance. Results: There was no evidence of an effect of mTBI history on cognitive performance in this sample. However, post-traumatic stress symptom severity was significantly related to two measures of cognitive performance. Conclusions: This study demonstrated the importance of considering the effects of current clinical symptoms (e. g. post-traumatic stress) as possibly having greater influence on current cognitive functioning than the effects of a remote history of mTBI.	[Neipert, Leslie; Pastorek, Nicholas J.; Troyanskaya, Maya; Scheibel, Randall S.; Petersen, Nancy J.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Neipert, Leslie] Univ Houston, Dept Psychol, Houston, TX USA; [Pastorek, Nicholas J.; Troyanskaya, Maya; Scheibel, Randall S.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Petersen, Nancy J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA		Pastorek, NJ (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd RCL 117, Houston, TX 77030 USA.	nicholas.pastorek@va.gov		Pastorek, Nicholas/0000-0002-9290-380X	Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs; Department of Veterans AffairsUS Department of Veterans Affairs [RRDS B6812C]; Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks Center for Rehabilitation Research; Veterans AffairsUS Department of Veterans Affairs [I01RX000326] Funding Source: NIH RePORTER	This research was supported by the Department of Veterans Affairs, Veterans Health Administration and was funded by: RRDS B6812C (PI- Levin HS) Department of Veterans Affairs; Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks Center for Rehabilitation Research. This research was also supported in part with resources at the VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413), at the Michael E. DeBakey VA Medical Center, Houston, TX. The authors report no conflicts of interest. The opinions and assumptions described by the authors herein are those of the authors alone and should not be interpreted as being reflective of the official position or policy of the Department of Veterans Affairs or the US government.	[Anonymous], 2007, AUT NEUR ASS METR VE; Bandura A., 1997, SELF EFFICACY EXERCI; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Blackwood HD, 1996, ARCH CLIN NEUROPSYCH, V11, P93; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P1; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Field A., 2017, DISCOVERING STAT USI, V5th; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V81, P403, DOI 10.2466/pms.1995.81.2.403; Heyer EJ, 2000, J CLIN EXP NEUROPSYC, V22, P633; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jorge RE, 1999, NEUROLOGY, V53, P543, DOI 10.1212/WNL.53.3.543; King PR, 2012, J REHABILITATION RES, V49, P79; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCrea M., 2008, MILD TRAUMATIC BRAIN; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Stahle L, 2011, WILD ENVIRON MED, V22, P202, DOI 10.1016/j.wem.2011.02.018; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tanielian T, 2008, INVISIBLE SOUNDS WAR; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Weathers F., 1993, P ANN C INT SOC TRAU	43	24	24	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1667	1674		10.3109/02699052.2014.947623			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600005	25180439				2022-02-06	
J	Reistetter, TA; Karmarkar, AM; Graham, JE; Eschbach, K; Kuo, YF; Granger, CV; Freeman, J; Ottenbacher, KJ				Reistetter, Timothy A.; Karmarkar, Amol M.; Graham, James E.; Eschbach, Karl; Kuo, Yong-Fang; Granger, Carl V.; Freeman, Jean; Ottenbacher, Kenneth J.			Regional Variation in Stroke Rehabilitation Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Health services; Quality of health care; Rehabilitation	SKILLED NURSING FACILITIES; TRAUMATIC BRAIN-INJURY; LENGTH-OF-STAY; INPATIENT REHABILITATION; GEOGRAPHIC-VARIATION; THERAPY ACTIVITIES; CARE; QUALITY; REPLACEMENT; REIMBURSEMENT	Objective: To examine and describe regional variation in outcomes for persons with stroke receiving inpatient medical rehabilitation. Design: Retrospective cohort design. Setting: Inpatient rehabilitation units and facilities contributing to the Uniform Data System for Medical Rehabilitation from the United States. Participants: Patients (N=143,036) with stroke discharged from inpatient rehabilitation during 2006 and 2007. Interventions: Not applicable. Main Outcome Measures: Community discharge, length of stay (LOS), and discharge functional status ratings (motor, cognitive) across 10 geographic service regions defined by the Centers for Medicare and Medicaid Services (CMS). Results: Approximately 71% of the sample was discharged to the community. After adjusting for covariates, the percentage discharged to the community varied from 79.1% in the Southwest (CMS region 9) to 59.4% in the Northeast (CMS region 2). Adjusted LOS varied by 2.1 days, with CMS region 1 having the longest LOS at 18.3 days and CMS regions 5 and 9 having the shortest at 16.2 days. Conclusions: Rehabilitation outcomes for persons with stroke varied across CMS regions. Substantial variation in discharge destination and LOS remained after adjusting for demographic and clinical characteristics. Archives of Physical Medicine and Rehabilitation 2014;95:29-38 (c) 2014 by the American Congress of Rehabilitation Medicine	[Reistetter, Timothy A.] Univ Texas Med Branch, Dept Occupat Therapy, Galveston, TX 77555 USA; [Karmarkar, Amol M.; Graham, James E.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Eschbach, Karl; Kuo, Yong-Fang; Freeman, Jean] Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, Galveston, TX 77555 USA; [Eschbach, Karl; Kuo, Yong-Fang; Freeman, Jean] Univ Texas Med Branch, Dept Internal Med, Div Geriatr, Galveston, TX 77555 USA; [Granger, Carl V.] Uniform Data Syst Med Rehabil, Buffalo, NY USA		Reistetter, TA (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	tareiste@utmb.edu	Karmarkar, Amol/E-6030-2011	Karmarkar, Amol/0000-0001-8355-1585; Ottenbacher, Kenneth/0000-0001-5990-3982	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01-HD068513, R24 H12065702, R01-HD069443]; Institute for Translational Sciences at University of Texas Medical Branch; National Institutes of Health Clinical and Translational Science AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ULITR000071]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R24HS022134-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R24HS022134] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069443, R24HD065702, K01HD068513] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024832] Funding Source: NIH RePORTER	Supported by the National Institute of Child Health and Human Development, National Institutes of Health (grant nos. K01-HD068513, R24 H12065702); the Institute for Translational Sciences at University of Texas Medical Branch with support in part by a National Institutes of Health Clinical and Translational Science Award (grant no. ULITR000071); the Agency for Healthcare Research and Quality (grant no. 1R24HS022134-01); and the National Institutes of Health (grant no. R01-HD069443). The funding organizations had no role in the design and conduct of the study or the collection, management, analysis, interpretation, and preparation of the manuscript.	Anderson J G, 1973, Med Care, V11, P104, DOI 10.1097/00005650-197303000-00003; Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; Atalay A, 2009, INT J REHABIL RES, V32, P48, DOI 10.1097/MRR.0b013e32830d3689; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Berkowitz SA, 2009, RISK MANAG HEALTHC P, V2, P91, DOI 10.2147/RMHP.S6583; Bhandari VK, 2005, ARCH PHYS MED REHAB, V86, P2081, DOI 10.1016/j.apmr.2005.05.008; Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Buntin MB, 2007, ARCH PHYS MED REHAB, V88, P1488, DOI 10.1016/j.apmr.2007.07.023; Buntin MB, 2010, MED CARE, V48, P776, DOI 10.1097/MLR.0b013e3181e359df; Carod-Artal FJ, 2005, BRAIN INJURY, V19, P667, DOI 10.1080/02699050400013626; Carter GM, 2005, PRELIMINARY ANAL REF; Cooper RA, 2009, HEALTH AFFAIR, V28, pW103, DOI 10.1377/hlthaff.28.1.w103; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1284, DOI 10.1016/j.apmr.2009.02.009; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1306, DOI 10.1016/j.apmr.2009.04.003; Denti L, 2008, EUR J PHYS REHAB MED, V44, P3; Department of Health and Human Services, 2005, FED REGISTER, V70, P47880; Deutsch A, 2006, STROKE, V37, P1477, DOI 10.1161/01.STR.0000221172.99375.5a; Domanski M, 2004, CONTROL CLIN TRIALS, V25, P553, DOI 10.1016/j.cct.2004.08.005; Donabedian A, 2005, MILBANK Q, V83, P691, DOI 10.1111/j.1468-0009.2005.00397.x; Dowla N, 2010, TOP STROKE REHABIL, V17, P230, DOI 10.1310/tsr1704-230; Fisher E, 2010, TRENDS REGIONAL VIBR; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FitzGerald JD, 2009, HEALTH SERV RES, V44, P1232, DOI 10.1111/j.1475-6773.2009.00983.x; Foley N, 2012, DISABIL REHABIL, V34, P2132, DOI 10.3109/09638288.2012.676145; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Freburger JK, 2011, ARCH PHYS MED REHAB, V92, P1220, DOI 10.1016/j.apmr.2011.03.019; Freburger JK, 2011, ARTHRIT CARE RES, V63, P1020, DOI 10.1002/acr.20477; Gage B, 2008, EXAMINING RELATIONSH; Graham JE, 2009, ARCH PHYS MED REHAB, V90, P1110, DOI 10.1016/j.apmr.2009.01.014; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; Hoenig H, 2010, TOP STROKE REHABIL, V17, P239, DOI 10.1310/tsr1704-239; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ilet PA, 2010, ARCH PHYS MED REHAB, V91, P788, DOI 10.1016/j.apmr.2009.11.028; Kane RL, 2002, HEALTH SERV RES, V37, P667, DOI 10.1111/1475-6773.00043; Kane RL, 2013, MODELS CAUSAL THINKI, P25; Krupski TL, 2005, J CLIN ONCOL, V23, P7881, DOI 10.1200/JCO.2005.08.755; Latham NK, 2006, AM J OCCUP THER, V60, P369, DOI 10.5014/ajot.60.4.369; Lemeshow S, 2000, APPL LOGISTIC REGRES; Medicare Payment Advisory Commission, 2011, REP C MED PAYM POL; MedPAC, 2012, REP C MED PAYM POL; Mutai H, 2012, GERIATR GERONTOL INT, V12, P215, DOI 10.1111/j.1447-0594.2011.00747.x; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ottenbacher KJ, 2001, ARCH PHYS MED REHAB, V82, P1367, DOI 10.1053/apmr.2001.26088; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Reistetter TA, 2011, DIABETES CARE, V34, P1375, DOI 10.2337/dc10-2220; Reistetter TA, 2010, ARCH PHYS MED REHAB, V91, P345, DOI 10.1016/j.apmr.2009.11.010; Rosenthal T, 2012, ANNU REV MED, V63, P493, DOI 10.1146/annurev-med-050710-134438; Sporer SM, 2006, J AM ACAD ORTHOP SUR, V14, P246, DOI 10.5435/00124635-200604000-00006; Strasser DC, 2010, TOP STROKE REHABIL, V17, P225, DOI 10.1310/tsr1704-225; Tian WQ, 2009, ARCH PHYS MED REHAB, V90, P1260, DOI 10.1016/j.apmr.2008.10.035; Turhan N, 2009, NEUROREHABILITATION, V24, P321, DOI 10.3233/NRE-2009-0485; UB Foundation Activities, INP REH FAC PAT ASS; US Department of Education, 2007, FED REG, V72, P44284; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; Wennberg DE, 2003, HLTH AFF MILWO S JUL; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Wennberg John E, 2004, Spec Law Dig Health Care Law, P9; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980	61	24	24	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2014	95	1					29	38		10.1016/j.apmr.2013.07.018			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	289KI	WOS:000329681000004	23921200	Green Accepted			2022-02-06	
J	Reljic, T; Mahony, H; Djulbegovic, B; Etchason, J; Paxton, H; Flores, M; Kumar, A				Reljic, Tea; Mahony, Helen; Djulbegovic, Benjamin; Etchason, Jeff; Paxton, Hannah; Flores, Michelle; Kumar, Ambuj			Value of Repeat Head Computed Tomography after Traumatic Brain Injury: Systematic Review and Meta-Analysis	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography; meta-analysis; systematic review; traumatic brain injury	CLINICAL-EFFICACY; FOLLOW-UP; INFLUENCE MANAGEMENT; CT-SCAN; UTILITY; HEMORRHAGE; CHILDREN; MODERATE; PROGRESSION; DIAGNOSIS	Diagnosis and management of traumatic brain injury (TBI) is crucial to improve patient outcomes. While initial head computed tomography (CT) scan is the optimum tool for quick and accurate detection of intracranial hemorrhage, the guidelines on use of repeat CT differ among institutions. Three systematic reviews have been conducted on a similar topic; none have performed a comprehensive meta-analysis of all studies. Search of Medline, the Cochrane Library database, and Clinicaltrials.gov, and a hand search of conference abstracts and references for all completed studies reporting data on change in management following repeat CT was conducted. Two authors reviewed all studies and extracted data using a standardized form. A proportional meta-analysis was conducted using the random-effects model for outcomes related to any change in management following repeat CT. Any change in management included intracranial intervention, change in intracranial pressure monitoring, and/or administration of drug therapy. Search results yielded 6982 references. In all, 41 studies enrolling 10,501 patients were included. Change in management following repeat CT was reported in 13 prospective and 28 retrospective studies and yielded a pooled proportion of 11.4% (95% confidence interval [CI] 5.9-18.4) and 9.6% (95% CI 6.5-13.2), respectively. In a subgroup analysis of mild TBI patients (Glasgow Coma Scale score 13 to 15), five prospective and nine retrospective studies reported on change in management following repeat CT with the pooled proportion across prospective studies at 2.3% (95% CI 0.3-6.3) and across retrospective studies at 3.9% (95% CI 2.3-5.7), respectively. The evidence suggests that repeat CT in patients with TBI results in a change in management for only a minority of patients. Better designed studies are needed to address the issue of the value of repeat CT in the management of TBI.	[Reljic, Tea; Mahony, Helen; Djulbegovic, Benjamin; Kumar, Ambuj] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Etchason, Jeff] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin; Kumar, Ambuj] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol Malignancies, Tampa, FL USA; [Etchason, Jeff; Paxton, Hannah; Flores, Michelle] Lehigh Valley Hlth Network, Allentown, PA USA		Kumar, A (corresponding author), Univ S Florida, Ctr Evidence Based Med, 3515 East Fletcher Ave,MDT 1202, Tampa, FL 33612 USA.	akumar1@health.usf.edu	Kumar, Ambuj/I-4940-2012; Reljic, Tea/I-7578-2013	Reljic, Tea/0000-0003-2029-6753; Mahony, Helen/0000-0002-6874-6824	Dorothy Rider Pool Health Care Trust	This study was funded by the Dorothy Rider Pool Health Care Trust. No competing financial interests exist.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Almenawer S, 2012, NEUROSURGERY; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Dekkers OM, 2012, ANN INTERN MED, V156, P37, DOI 10.7326/0003-4819-156-1-201201030-00006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dharap SB, 2005, INJURY, V36, P412, DOI 10.1016/j.injury.2004.06.020; DURHAM RM, 1992, AM J SURG, V164, P477, DOI 10.1016/S0002-9610(05)81184-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faul M, 2010, TRAUMATIC BRAIN INJU; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; FRENCH BN, 1977, SURG NEUROL, V7, P171; Giannetti AV, 2005, SURG NEUROL, V64, pS22, DOI 10.1016/j.surneu.2004.11.008; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Haynes RB, 2004, BMJ-BRIT MED J, V328, P1040, DOI 10.1136/bmj.38068.557998.EE; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Huynh T, 2006, AM SURGEON, V72, P1162; IBM, 2012, SPSS STAT; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACPHERSON P, 1990, CLIN RADIOL, V42, P85, DOI 10.1016/S0009-9260(05)82072-0; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Roka Y B, 2008, Nepal Med Coll J, V10, P225; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schnellinger MG, 2010, CLIN PEDIATR, V49, P569, DOI 10.1177/0009922809352375; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schuster R, 2005, AM SURGEON, V71, P701; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sifri ZC, 2011, J TRAUMA, V71, P1605, DOI 10.1097/TA.0b013e31822b3728; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STATA, 2009, STAT STAT SOFTW REL, V13 edn; StatsDirectLtd, 2011, STATSDIRECT STAT SOF; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Stuart A., 1994, KENDALLS ADV THEORY, P173; Stubbs B., 2017, BMJ, V7, P1, DOI [10.1038/s41467-019-10003-8, 10.1038/s41598-017-07579-w, DOI 10.1136/BMJ.B2535]; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Turedi S, 2008, J EMERG MED, V34, P253, DOI 10.1016/j.jemermed.2007.05.055; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Zahari M., 1996, Singapore Medical Journal, V37, P285	62	24	24	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					78	98		10.1089/neu.2013.2873			21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500008	23914924				2022-02-06	
J	Thiagarajan, P; Ciuffreda, KJ				Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Effect of oculomotor rehabilitation on accommodative responsivity in mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; accommodative dysfunction; accommodative training; acquired brain injury; mild traumatic brain injury; neuroplasticity; oculomotor learning; oculomotor rehabilitation; traumatic brain injury; vision rehabilitation	CONVERGENCE INSUFFICIENCY; OBJECTIVE ASSESSMENT; NEURAL PLASTICITY; VERGENCE; DYNAMICS; SPASM; MODEL; VALIDITY; PROTOCOL; BEHAVIOR	Accommodative dysfunction is a common oculomotor sequelae of mild traumatic brain injury (mTBI). This study evaluated a range of dynamic (objective) and static (subjective) measures of accommodation in 12 nonstrabismic individuals with mTBI and near vision-related symptoms before and after oculomotor training (OMT) and placebo (P) training (6 wk, two sessions per week, 3 h of training each). Following OMT, the dynamics of accommodation improved markedly. Clinically, there was a significant increase in the maximum accommodative amplitude both monocularly and binocularly. In addition, the near vision symptoms reduced along with improved visual attention. None of the measures were found to change significantly following P training. These results provide evidence for a significant positive effect of the accommodatively based OMT on accommodative responsivity. Such improvement is suggestive of oculomotor learning, demonstrating considerable residual brain-visual system plasticity in the adult compromised brain.	[Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Thiagarajan, P (corresponding author), Retina Fdn Southwest, 9600 N Cent Expy,Ste 200, Dallas, TX 75231 USA.	pthiagarajan@retinafoundation.org			U.S. Department of Defense (DoD)United States Department of Defense [W81XWH-10-1-1041, W81XWH-12-1-0240]; College of Optometrists in Vision Development; SUNY graduate program	This material was based on work supported by the U.S. Department of Defense (DoD) (grant W81XWH-10-1-1041 and W81XWH-12-1-0240), College of Optometrists in Vision Development, and SUNY graduate program.	ALQURAINY IA, 1995, BRIT J ORAL MAX SURG, V33, P71, DOI 10.1016/0266-4356(95)90203-1; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BALSAM M H, 1959, Am J Optom Arch Am Acad Optom, V36, P567; Benjamin WT.., 2006, BORISHS CLIN REFRACT; BOHLMANN BJ, 1987, J CLIN NEURO-OPHTHAL, V7, P129; Chan RVP, 2002, J NEURO-OPHTHALMOL, V22, P15, DOI 10.1097/00041327-200203000-00005; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; CIUFFREDA K. J., 1992, J BEHAV OPTOM, V3, P3; Ciuffreda K. J, 2006, BORISHS CLIN REFRACT, V2nd, P77, DOI DOI 10.1016/B978-0-7506-7524-6.50009-0; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2012, PRESBYOPIA: ORIGIN, EFFECTS, AND TREATMENT, P103; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; CIUFFREDA KJ, 1984, DOC OPHTHALMOL, V56, P303, DOI 10.1007/BF00155676; CIUFFREDA KJ, 1988, AM J OPTOM PHYS OPT, V65, P365; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Filoteo JV, 1997, ARCH CLIN NEUROPSYCH, V12, P621; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115, DOI 10.1152/jn.1995.73.5.2115; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; GILMARTIN B, 1986, OPHTHAL PHYSL OPT, V6, P23, DOI 10.1016/0275-5408(86)90115-8; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Harrison RJ., 1987, BINO VIS, V2, P93; HEATH G G, 1956, Am J Optom Arch Am Acad Optom, V33, P569; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hung GK, 1996, OPHTHAL PHYSL OPT, V16, P31, DOI 10.1016/0275-5408(95)00110-7; HUNG GK, 1980, IEEE T BIO-MED ENG, V27, P439, DOI 10.1109/TBME.1980.326752; HUNG GK, 1983, IEEE T BIO-MED ENG, V30, P665, DOI 10.1109/TBME.1983.325069; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Khan A. A., 2005, DIGITAL SIGNAL PROCE; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; KRAN BS, 1988, AM J OPTOM PHYS OPT, V65, P703; Leslie S, 2001, VISUAL VESTIBULAR CO; LIU JS, 1979, AM J OPTOM PHYS OPT, V56, P285; Monteiro MLR, 2003, BRIT J OPHTHALMOL, V87, P243, DOI 10.1136/bjo.87.2.243; ODONNELL JP, 1994, J CLIN PSYCHOL, V50, P596, DOI 10.1002/1097-4679(199407)50:4<596::AID-JCLP2270500416>3.0.CO;2-S; Ohtsuka K, 2002, AM J OPHTHALMOL, V133, P425, DOI 10.1016/S0002-9394(01)01356-3; Ohtsuka K, 1997, BRIT J OPHTHALMOL, V81, P476, DOI 10.1136/bjo.81.6.476; ROSENFIELD M, 1991, INVEST OPHTH VIS SCI, V32, P2985; ROSENFIELD M, 1994, OPHTHAL PHYSL OPT, V14, P265, DOI 10.1111/j.1475-1313.1994.tb00007.x; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2001, VISUAL VESTIBULAR CO; SCHNIDER CM, 1984, INVEST OPHTH VIS SCI, V25, P414; Schor CM, 2006, VISION RES, V46, P242, DOI 10.1016/j.visres.2005.09.030; Schor CM, 2005, VISION RES, V45, P1237, DOI 10.1016/j.visres.2004.11.011; Snell RS., 1998, CLIN ANATOMY EYE; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiagarajan P., 2012, THESIS STATE U NEW Y; Trenerry MR, 1990, VISUAL SERACH ATTENT; Warraich Z, 2010, PM&R, V2, pS208, DOI 10.1016/j.pmrj.2010.10.016; Wick B., 2008, CLIN MANAGEMENT BINO; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495; Zellers J A, 1984, J Am Optom Assoc, V55, P31; Zost MG, 2001, DIAGNOSIS MANAGEMENT, P75	62	24	24	0	17	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	2					175	191		10.1682/JRRD.2013.01.0027			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AI3ZM	WOS:000336804700004	24933717	Bronze			2022-02-06	
J	Tsaousides, T; D'Antonio, E; Varbanova, V; Spielman, L				Tsaousides, Theodore; D'Antonio, Emily; Varbanova, Vladimira; Spielman, Lisa			Delivering group treatment via videoconference to individuals with traumatic brain injury: A feasibility study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Telerehabilitation; Emotion regulation; Group treatment; Cognitive-behavioural therapy; Videoconferencing	SCHEDULED TELEPHONE INTERVENTION; COGNITIVE-BEHAVIOR THERAPY; EXECUTIVE DYSFUNCTION; EMOTION REGULATION; REHABILITATION; PROGRAM; EFFICACY; TELEREHABILITATION; SATISFACTION; ADOLESCENTS	The objective was to assess the feasibility of delivering a group treatment to improve emotional regulation via videoconferencing to individuals with traumatic brain injury (TBI). A pre-post feasibility study was undertaken. Seven individuals with TBI were recruited at a brain injury research centre in an urban medical centre. The main measures were therapist assessment of session-by-session progress and feasibility, Difficulties in Emotion Regulation Scale (DERS), Brain Injury Rehabilitation Trust Regulation of Emotions Questionnaire (BREQ), Satisfaction with Therapy and Therapist Scale (STTS), and exit interview. Attendance across sessions and participants was over 90%. Adequate skill acquisition and ease of use of the technology were demonstrated. Self-reported satisfaction with treatment was high. Participants noted several benefits in terms of the treatment delivery modality. There was no change is self-reported emotional dysregulation. This is the first study to report the use of videoconferencing for the delivery of group treatment to individuals with TBI. The exceptional compliance and self-reported satisfaction suggest that this treatment delivery option could be a viable alternative for increasing access to healthcare in this population. The findings of the study supported the development of a large clinical trial to assess treatment effectiveness.	[Tsaousides, Theodore; D'Antonio, Emily; Varbanova, Vladimira; Spielman, Lisa] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Tsaousides, T (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	theodore.tsaousides@mountsinai.org			National Institute on Disability and Rehabilitation Research [H133P100016, H133A070033]	This research was funded by National Institute on Disability and Rehabilitation Research (grants H133P100016 and H133A070033) carried out at the Brain Injury Research Center, Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai.	Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brennan David M, 2011, Telemed J E Health, V17, P662, DOI 10.1089/tmj.2011.0036; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; Forducey PG, 2003, NEUROREHABILITATION, V18, P103; Gibbon M., 1997, USERS GUIDE STRUCTUR; GLADSTEIN GA, 1974, COUNS PSYCHOL, V4, P34, DOI 10.1177/001100007400400307; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Greene CJ, 2010, J CONSULT CLIN PSYCH, V78, P746, DOI 10.1037/a0020158; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; HEPPNER PP, 1982, J COUNS PSYCHOL, V29, P66, DOI 10.1037/0022-0167.29.1.66; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kazantzis N, 2004, J CLIN PSYCHOL, V60, P627, DOI 10.1002/jclp.10239; King VL, 2009, J SUBST ABUSE TREAT, V36, P331, DOI 10.1016/j.jsat.2008.06.011; Leszcz M., 1995, THEORY PRACTICE GROU; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Oei TPS, 1999, AUST NZ J PSYCHIAT, V33, P748, DOI 10.1080/j.1440-1614.1999.00628.x; Radley DC, 2012, NEW ENGL J MED, V367, P3, DOI 10.1056/NEJMp1204516; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Soong W, 2005, INT J REHABIL RES, V28, P341, DOI 10.1097/00004356-200512000-00006; Staples AM, 2012, J ANXIETY DISORD, V26, P385, DOI 10.1016/j.janxdis.2012.01.005; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Tsaousides T, 2011, 2011 INT NEUR SOC MI; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wechsler D., 2011, WECHSLER ABBREVIATED; Williams AD, 2012, BRIT J CLIN PSYCHOL, V51, P223, DOI 10.1111/j.2044-8260.2011.02022.x; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363	51	24	25	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2014	24	5					784	803		10.1080/09602011.2014.907186			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AN1UE	WOS:000340368400007	24810148				2022-02-06	
J	Graves, JM; Whitehill, JM; Stream, JO; Vavilala, MS; Rivara, FP				Graves, Janessa M.; Whitehill, Jennifer M.; Stream, Joshua O.; Vavilala, Monica S.; Rivara, Frederick P.			Emergency department reported head injuries from skiing and snowboarding among children and adolescents, 1996-2010	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; HELMET USE; RISK-FACTORS; SKIERS; CONCUSSION; OUTCOMES; PARKS; NECK	Objectives To evaluate the incidence of snow-sports-related head injuries among children and adolescents reported to emergency departments (EDs), and to examine the trend from 1996 to 2010 in ED visits for snow-sports-related traumatic brain injury (TBI) among children and adolescents. Methods A retrospective, population-based cohort study was conducted using data from the National Electronic Injury Surveillance System for patients (aged 17years) treated in EDs in the USA from 1996 to 2010, for TBIs associated with snow sports (defined as skiing or snowboarding). National estimates of snow sports participation were obtained from the National Ski Area Association and utilised to calculate incidence rates. Analyses were conducted separately for children (aged 4-12years) and adolescents (aged 13-17 years). Results An estimated number of 78538 (95% CI 66350 to 90727) snow sports-related head injuries among children and adolescents were treated in EDs during the 14-year study period. Among these, 77.2% were TBIs (intracranial injury, concussion or fracture). The annual average incidence rate of TBI was 2.24 per 10000 resort visits for children compared with 3.13 per 10000 visits for adolescents. The incidence of TBI increased from 1996 to 2010 among adolescents (p<0.003). Conclusions Given the increasing incidence of TBI among adolescents and the increased recognition of the importance of concussions, greater awareness efforts may be needed to ensure safety, especially helmet use, as youth engage in snow sports.	[Graves, Janessa M.; Whitehill, Jennifer M.; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Graves, Janessa M.; Whitehill, Jennifer M.; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98104 USA; [Stream, Joshua O.] Univ Utah, Sch Med, Dept Anesthesiol, Salt Lake City, UT USA; [Vavilala, Monica S.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98104 USA		Graves, JM (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.	janessa@uw.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634	Wilderness Medical Society Research-in-Training Award; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822-01A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	This research is supported in part by the Wilderness Medical Society Research-in-Training Award (Graves). JMG and JMW receive fellowship support from National Institute of Child Health and Human Development (T32 HD057822-01A2).	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Burtscher M, 2008, CLIN J SPORT MED, V18, P355, DOI 10.1097/MJT.0b013e31815fd0fe; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Cusimano MD, 2010, JAMA-J AM MED ASSOC, V303, P661, DOI 10.1001/jama.2010.147; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goulet C, 2007, CAN J PUBLIC HEALTH, V98, P402, DOI 10.1007/BF03405428; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Hagel BE, 2003, CAN J PUBLIC HEALTH, V94, P458, DOI 10.1007/BF03405085; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harlos S, 1999, Inj Prev, V5, P183; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; Klein KS, 2005, INJURY PREV, V11, P288, DOI 10.1136/ip.2004.007013; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Levy AS, 2007, HEALTH PROMOT PRACT, V8, P257, DOI 10.1177/1524839906292178; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; National Ski Area Association (NSAA), STUD SHOWS MOST SKIE; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Stata Statistics/Data Analysis Software, 2011, STAT STAT DAT AN SOF; State of New Jersey, 2011, HELM REQ DOWNH SKIER, P1; State of Washington, 1928, YOUTH SPORTS CONC HE; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	39	24	25	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2013	19	6					399	404		10.1136/injuryprev-2012-040727			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	255OG	WOS:000327249100006	23513009	Green Accepted			2022-02-06	
J	Imam, AM; Jin, G; Sillesen, M; Duggan, M; Jepsen, CH; Hwabejire, JO; Lu, J; Liu, BL; DeMoya, MA; Velmahos, GC; Alam, HB				Imam, Ayesha M.; Jin, Guang; Sillesen, Martin; Duggan, Michael; Jepsen, Cecilie H.; Hwabejire, John O.; Lu, Jennifer; Liu, Baoling; DeMoya, Marc A.; Velmahos, George C.; Alam, Hasan B.			Early treatment with lyophilized plasma protects the brain in a large animal model of combined traumatic brain injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	43rd Annual Meeting of the Western-Trauma-Association	MAR 03-08, 2013	Snowmass, CO	Western Trauma Assoc		Traumatic brain injury; hemorrhage; edema; swine; shock	SEVERE HEAD-INJURY; FOCAL CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; FLUID RESUSCITATION; BLOOD; MORTALITY; AGE; HEMODILUTION; COAGULOPATHY; COAGULATION	BACKGROUND: Combination of traumatic brain injury (TBI) and hemorrhagic shock (HS) can result in significant morbidity and mortality. We have previously shown that early administration of fresh frozen plasma (FFP) in a large animal model of TBI and HS reduces the size of the brain lesion as well as the associated edema. However, FFP is a perishable product that is not well suited for use in the austere prehospital settings. In this study, we tested whether a shelf-stable, low-volume, lyophilized plasma (LSP) product was as effective as FFP. METHODS: Yorkshire swine (42-50 kg) were instrumented to measure hemodynamic parameters, intracranial pressure, and brain tissue oxygenation. A prototype, computerized, cortical impact device was used to create TBI through a 20-mm craniotomy: 15-mm cylindrical tip impactor at 4 m/s velocity, 100-millisecond dwell time, and 12-mm penetration depth. Volume-controlled hemorrhage was induced (40-45% total blood volume) concurrent with the TBI. After 2 hours of shock, animals were treated with (1) normal saline (NS, n = 5), (2) FFP (n = 5), and (3) LSP (n = 5). The volume of FFP and LSP matched the shed blood volume, whereas NS was 3 times the volume. Six hours after resuscitation, brains were sectioned and stained with TTC (2, 3, 5-Triphenyltetrazolium chloride), and lesion size (mm(3)) and swelling (percent change in volume compared with the contralateral, uninjured side) were measured. RESULTS: This protocol resulted in a highly reproducible brain injury, with clinically relevant changes in blood pressure, cardiac output, tissue hypoperfusion, intracranial pressure, and brain tissue oxygenation. Compared with NS, treatment with LSP significantly (p < 0.05) decreased brain lesion size and swelling (51% and 54%, respectively). CONCLUSION: In a clinically realistic combined TBI + HS model, early administration of plasma products decreases brain lesion size and edema. LSP is as effective as FFP, while offering many logistic advantages. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Imam, Ayesha M.; Jin, Guang; Sillesen, Martin; Duggan, Michael; Jepsen, Cecilie H.; Hwabejire, John O.; Lu, Jennifer; DeMoya, Marc A.; Velmahos, George C.; Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Jin, Guang; Liu, Baoling; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475			Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aucar John A, 2009, Am J Surg, V198, P900, DOI 10.1016/j.amjsurg.2009.05.034; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Jin G, 2010, TRANSL STROKE RES, V1, P65, DOI 10.1007/s12975-009-0009-5; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Johnson VV, 2007, CURR OPIN HEMATOL, V14, P694, DOI 10.1097/MOH.0b013e3282ef477f; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Offner PJ, 2004, CRIT CARE, V8, pS24, DOI 10.1186/cc2405; OHTAKI M, 1993, SURG NEUROL, V40, P196, DOI 10.1016/0090-3019(93)90068-C; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shuja F, 2008, J TRAUMA, V65, P975, DOI 10.1097/TA.0b013e3181801cd9; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Takano K, 1997, STROKE, V28, P1255, DOI 10.1161/01.STR.28.6.1255; TU YK, 1988, J NEUROSURG, V69, P72, DOI 10.3171/jns.1988.69.1.0072; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wald SL, 1993, J TRAUMA, V34, P381; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	40	24	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2013	75	6					976	983		10.1097/TA.0b013e31829e2186			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	300IR	WOS:000330458100010	24256669				2022-02-06	
J	Kurtz, P; Claassen, J; Schmidt, JM; Helbok, R; Hanafy, KA; Presciutti, M; Lantigua, H; Connolly, ES; Lee, KW; Badjatia, N; Mayer, SA				Kurtz, Pedro; Claassen, Jan; Schmidt, J. Michael; Helbok, Raimund; Hanafy, Khalid A.; Presciutti, Mary; Lantigua, Hector; Connolly, E. Sander; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.			Reduced Brain/Serum Glucose Ratios Predict Cerebral Metabolic Distress and Mortality After Severe Brain Injury	NEUROCRITICAL CARE			English	Article						Brain injury; Coma; Cerebral microdialysis; Glucose; Metabolism; Glucose transport	INTENSIVE INSULIN THERAPY; LACTATE/PYRUVATE RATIO; COMBINED MICRODIALYSIS; COMATOSE PATIENTS; GLYCEMIC CONTROL; BLOOD-GLUCOSE; HYPERGLYCEMIA; IMPACT; PRESSURE; HYPERGLYCOLYSIS	The brain is dependent on glucose to meet its energy demands. We sought to evaluate the potential importance of impaired glucose transport by assessing the relationship between brain/serum glucose ratios, cerebral metabolic distress, and mortality after severe brain injury. We studied 46 consecutive comatose patients with subarachnoid or intracerebral hemorrhage, traumatic brain injury, or cardiac arrest who underwent cerebral microdialysis and intracranial pressure monitoring. Continuous insulin infusion was used to maintain target serum glucose levels of 80-120 mg/dL (4.4-6.7 mmol/L). General linear models of logistic function utilizing generalized estimating equations were used to relate predictors of cerebral metabolic distress (defined as a lactate/pyruvate ratio [LPR] a parts per thousand yen 40) and mortality. A total of 5,187 neuromonitoring hours over 300 days were analyzed. Mean serum glucose was 133 mg/dL (7.4 mmol/L). The median brain/serum glucose ratio, calculated hourly, was substantially lower (0.12) than the expected normal ratio of 0.40 (brain 2.0 and serum 5.0 mmol/L). In addition to low cerebral perfusion pressure (P = 0.05) and baseline Glasgow Coma Scale score (P < 0.0001), brain/serum glucose ratios below the median of 0.12 were independently associated with an increased risk of metabolic distress (adjusted OR = 1.4 [1.2-1.7], P < 0.001). Low brain/serum glucose ratios were also independently associated with in-hospital mortality (adjusted OR = 6.7 [1.2-38.9], P < 0.03) in addition to Glasgow Coma Scale scores (P = 0.029). Reduced brain/serum glucose ratios, consistent with impaired glucose transport across the blood brain barrier, are associated with cerebral metabolic distress and increased mortality after severe brain injury.	[Kurtz, Pedro; Claassen, Jan; Schmidt, J. Michael; Helbok, Raimund; Hanafy, Khalid A.; Presciutti, Mary; Lantigua, Hector; Connolly, E. Sander; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.] Columbia Univ Coll Phys & Surg, Milstein Hosp Ctr 8, Dept Neurol, Neurol Intens Care Unit, New York, NY 10032 USA		Mayer, SA (corresponding author), Columbia Univ Coll Phys & Surg, Milstein Hosp Ctr 8, Dept Neurol, Neurol Intens Care Unit, 177 Ft Washington Ave, New York, NY 10032 USA.	sam14@columbia.edu	Helbok, Raimund/AAA-8361-2021; Claassen, Jan/AAA-5451-2020; Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034; Schmidt, J. Michael/0000-0001-8141-2944	Charles A. Dana Foundation; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR024156]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024156] Funding Source: NIH RePORTER	This work was supported in part by a grant from the Charles A. Dana Foundation. The project described was also supported by Grant UL1 RR024156 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research, and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The authors were solely responsible for the study design, data collection, analysis and interpretation of the data, writing the manuscript, and in the decision to submit for publication.	Badjatia N, 2005, CRIT CARE MED, V33, P1603, DOI 10.1097/01.CCM.0000168054.60538.2B; Badjatia N, 2009, CRIT CARE MED, V37, P1893, DOI 10.1097/CCM.0b013e31819fffd3; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Nordmark J, 2009, ACTA ANAESTH SCAND, V53, P289, DOI 10.1111/j.1399-6576.2008.01885.x; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pan W, 2001, BIOMETRICS, V57, P529, DOI 10.1111/j.0006-341X.2001.00529.x; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Qaseem A, 2011, ANN INTERN MED, V154, P260, DOI 10.7326/0003-4819-154-4-201102150-00007; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Schmidt JM, 2010, STROKE, V42, P1531; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037	47	24	25	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2013	19	3					311	319		10.1007/s12028-013-9919-x			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	257OB	WOS:000327393200009	24081837				2022-02-06	
J	McCormick, CL; Yoash-Gantz, RE; McDonald, SD; Campbell, TC; Tupler, LA				McCormick, Cortney L.; Yoash-Gantz, Ruth E.; McDonald, Scott D.; Campbell, Thomas C.; Tupler, Larry A.			Performance on the Green Word Memory Test Following Operation Enduring Freedom/Operation Iraqi Freedom-Era Military Service: Test Failure is Related to Evaluation Context	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity tests; Effort; Neuropsychology; Military veterans; Traumatic brain injury; Posttraumatic stress disorder; Major depressive disorder; Service connection	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MENTAL-HEALTH PROBLEMS; POSTCONCUSSIVE SYMPTOMS; COMPLAINTS INVENTORY; DEPRESSIVE SYMPTOMS; PREFRONTAL CORTEX	This study investigates prior reports of high neuropsychological symptom validity test (SVT) failure rates in post-deployed Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) active and veteran military personnel, using a large, multi-site sample (N 214) drawn from three levels of the Department of Defense/Department of Veterans Affairs (VA) Polytrauma System of Care. The sample failure rate and its relationship to research versus dual research/clinical context of evaluation were examined, in addition to secondary variables explored in prior studies. Results yielded an overall failure rate of 25, lower than prior reports describing OEF/OIF active-duty and veteran military personnel. Findings also supported the hypothesis that SVT failure rates would differ by context (dual research). Participants with traumatic brain injury (TBI) failed more frequently than those without TBI in the dual context but not in the research context. Secondary analyses revealed that failure rates increased in the presence of depression, posttraumatic stress disorder, and male sex but were unrelated to active versus veteran military status, service connection (SC) or percentage of SC, age, education, or ethnicity. Further research is required to elucidate the underpinnings of these findings in light of the limited literature and variability between OEF/OIF-related SVT studies, as well as the substantial diagnostic and treatment implications for VA.	[McCormick, Cortney L.; Yoash-Gantz, Ruth E.; McDonald, Scott D.; Campbell, Thomas C.; Tupler, Larry A.] Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [McCormick, Cortney L.; Yoash-Gantz, Ruth E.] Hefner Vet Affairs Med Ctr, Salisbury, NC USA; [Yoash-Gantz, Ruth E.] Wake Forest Univ, Dept Psychiat & Behav Sci, Winston Salem, NC 27109 USA; [McDonald, Scott D.; Campbell, Thomas C.] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [McDonald, Scott D.; Campbell, Thomas C.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Tupler, Larry A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Tupler, Larry A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA		McCormick, CL (corresponding author), James A Haley VAMC, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cortney.mccormick@va.gov			Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) for the Study of Post-Deployment Mental Health; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Department of Veterans Affairs Rehabilitation Research and Development Career Development Award-2US Department of Veterans Affairs [1IK2RX000703-01]	Preparation of this manuscript was supported in part by the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) for the Study of Post-Deployment Mental Health, the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, and a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award-2 (1IK2RX000703-01 to S.D.M.).	Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Ansari TL, 2011, BIOL PSYCHOL, V86, P337, DOI 10.1016/j.biopsycho.2010.12.013; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boyko EJ, 2000, AM J EPIDEMIOL, V151, P307, DOI 10.1093/oxfordjournals.aje.a010207; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brinkmann K, 2009, INT J PSYCHOPHYSIOL, V74, P250, DOI 10.1016/j.ijpsycho.2009.09.009; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Burriss L, 2008, DEPRESS ANXIETY, V25, P149, DOI 10.1002/da.20291; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Cote Murray J, 2007, Health Care Manag Sci, V10, P253, DOI 10.1007/s10729-007-9018-7; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Everaert J, 2012, CLIN PSYCHOL REV, V32, P413, DOI 10.1016/j.cpr.2012.04.003; First MB, 1995, STRUCTURED CLIN INTE; Foland-Ross LC, 2013, PSYCHOL SCI, V24, P334, DOI 10.1177/0956797612457380; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Frueh BC, 2007, AM J PUBLIC HEALTH, V97, P2143, DOI 10.2105/AJPH.2007.115436; Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2007, ASSESSMENT FEIGNED C; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P477, DOI 10.1001/jama.2011.1092; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hess TM, 2012, J GERONTOL B-PSYCHOL, V67, P447, DOI 10.1093/geronb/gbr129; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoerger M, 2012, COGNITION EMOTION, V26, P1098, DOI 10.1080/02699931.2011.631985; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kahneman D., 1973, ATTENTION EFFORT; Karatekin C, 2010, SCHIZOPHRENIA BULL, V36, P1167, DOI 10.1093/schbul/sbp035; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kessels RPC, 2007, CLIN NEUROL NEUROSUR, V109, P323, DOI 10.1016/j.clineuro.2006.12.009; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mackin RS, 2012, INT J GERIATR PSYCH, V27, P637, DOI 10.1002/gps.2763; Manning JR, 2012, J NEUROSCI, V32, P8871, DOI 10.1523/JNEUROSCI.5321-11.2012; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCormick C. L., 2011, 5 ANN VHA MENT HLTH; McCormick C. L., 2009, MCCORMICK TBI UNPUB; McHugh PR, 2007, J ANXIETY DISORD, V21, P211, DOI 10.1016/j.janxdis.2006.09.003; Mernoff Stephen T, 2010, Med Health R I, V93, P16; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nelson N. W., 2012, J INT NEUROPSYCH SOC, V18, P1, DOI DOI 10.1017/S1355617711001548; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P2261, DOI 10.1016/j.neuropsychologia.2008.10.024; Riviere LA, 2011, BRIT J PSYCHIAT, V198, P136, DOI 10.1192/bjp.bp.110.084863; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Rosen GM, 2007, J ANXIETY DISORD, V21, P201, DOI 10.1016/j.janxdis.2006.09.011; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Telling AL, 2010, BRAIN COGNITION, V73, P203, DOI 10.1016/j.bandc.2010.05.004; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Tylee Andre, 2005, Prim Care Companion J Clin Psychiatry, V7, P167; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004	118	24	24	0	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2013	28	8					808	823		10.1093/arclin/act050			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	262FC	WOS:000327718700008	23877970	hybrid, Green Submitted			2022-02-06	
J	Quatman-Yates, CC; Lee, A; Hugentobler, JA; Kurowski, BG; Myer, GD; Riley, MA				Quatman-Yates, Catherine C.; Lee, Aaron; Hugentobler, Jason A.; Kurowski, Brad G.; Myer, Gregory D.; Riley, Michael A.			TEST-RETEST CONSISTENCY OF A POSTURAL SWAY ASSESSMENT PROTOCOL FOR ADOLESCENT ATHLETES MEASURED WITH A FORCE PLATE	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						concussion; force plate; reliability; postural control		Purpose/Background: Postural control assessments can provide a powerful means of detecting concussion-related neurophysiological abnormalities and are considered an important part of the concussion management processes. Studies with college athletes indicate that postural sway analyzed using complexity metrics may provide a sensitive and novel way to detect post-concussion postural control impairments. The purpose of this study was to determine if a postural sway assessment protocol (PSAP) measured using a force plate system can serve as a reliable assessment tool for adolescent athletes. Methods: The short-term and long-term test-retest reliability of the PSAP was examined in a group of adolescent female athletes under eyes open and eyes closed conditions. Detrended fluctuation analysis was used to evaluate the complexity of the times series data (i.e., degree of self-similarity across time scales). Conventional measures of standard deviation and total path length (distance traveled by the center-of-pressure) were also assessed. Results: The complexity and conventional measures generally demonstrated good reliability coefficients for short-term and long-term test-retest reliability with both eyes open and eyes closed conditions. Intra-class Correlation Coefficient (ICC) values ranged from .38-.90 The highest ICC values corresponded with the short-term reliability for the eyes open condition, while the lower ICC values corresponded with the long-term reliability for the eyes closed condition. Conclusions: The results of this study indicate that the PSAP demonstrated good short-term and long-term test-retest reliability. In addition, no evidence of learning effects was elicited through this study. Future studies should further explore the validity and feasibility of the use of this protocol for different age groups, different types of athletes, and longitudinal evaluations of post-concussion impairments. Clinical Relevance: This study provides preliminary support for the utility of a postural sway assessment protocol measured using a force plate for use with adolescent athletes.	[Quatman-Yates, Catherine C.; Lee, Aaron; Hugentobler, Jason A.] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine C.; Hugentobler, Jason A.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Sports Med Biodynam Ctr, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine C.; Myer, Gregory D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Phys Med & Rehabil, Cincinnati, OH USA; [Riley, Michael A.] Univ Cincinnati, Ctr Cognit Act & Percept, Dept Psychol, Cincinnati, OH 45221 USA		Quatman-Yates, CC (corresponding author), 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	Catherine.Quatman@cchmc.org	Quatman-Yates, Catherine/AAK-4507-2021; Quatman-Yates, Catherine/U-9580-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001097] Funding Source: Medline		Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Kuznetsov NA, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00062; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; OSullivan S., 2007, PHYS REHABILITATION, VFifth; PATERNO MV, 2010, AM J SPORTS MED, DOI DOI 10.4085/1062-6050-47.3.08; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; QUATMANYATES CC, 2013, AM PHYS THER ASS COM; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Sheehan DP, 2011, MEAS PHYS EDUC EXERC, V15, P234, DOI 10.1080/1091367X.2011.568368; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280	30	24	24	0	0	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	DEC	2013	8	6					741	748					8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA1DZ	WOS:000409649200001	24377060				2022-02-06	
J	Roitman, P; Gilad, M; Ankri, YLE; Shalev, AY				Roitman, Pablo; Gilad, Moran; Ankri, Yahel L. E.; Shalev, Arieh Y.			Head Injury and Loss of Consciousness Raise the Likelihood of Developing and Maintaining PTSD Symptoms	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ROAD TRAFFIC ACCIDENTS; POSTCONCUSSIVE SYMPTOMS; AMNESIA; HEALTH; SCALE; IRAQ; CARE; FEAR	Mild traumatic brain injury has been associated with higher prevalence of posttraumatic stress disorder (PTSD). The extent to which head injury or loss of consciousness predicts PTSD is unknown. To evaluate the contribution of head injury and loss of consciousness to the occurrence of PTSD, we made a longitudinal evaluation of 1,260 road accident survivors admitted to the emergency department with head injury (n = 287), head injury and loss of consciousness (n = 115), or neither (n = 858). A telephone-administered posttraumatic symptoms scale inferred PTSD and quantified PTSD symptoms at 10 days and 8 months after admission. The study groups had similar heart rate, blood pressure, and pain levels in the emergency department. Survivors with loss of consciousness and head injury had higher prevalence of PTSD and higher levels of PTSD symptoms, suggesting that patients with head injury and loss of consciousness reported in the emergency department are at higher risk for PTSD.	[Roitman, Pablo; Gilad, Moran; Ankri, Yahel L. E.; Shalev, Arieh Y.] Hadassah Univ Hosp, Dept Psychiat, IL-91120 Jerusalem, Israel; [Shalev, Arieh Y.] NYU, Dept Psychiat, Langone Med Ctr, Steven & Alexandra Cohen Vet Ctr Study Posttrauma, New York, NY 10016 USA		Roitman, P (corresponding author), Hadassah Univ Hosp, Dept Psychiat, Ein Kerem Campus, IL-91120 Jerusalem, Israel.	pablo@hadassah.org.il		Shalev, Arieh/0000-0001-9425-050X	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R34 MH071652] Funding Source: Medline		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 2004, CRASH PSYCHOL ASSESS; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2003, J NERV MENT DIS, V191, P191, DOI 10.1097/00005053-200303000-00009; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Capruso D. X., 2000, HEAD INJURY, P525; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Freedman SA, 2002, J TRAUMA STRESS, V15, P407, DOI 10.1023/A:1020189425935; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guy W., 1976, CLIN GLOBAL IMPRESSI; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jennings PA, 2009, EMERG MED J, V26, P552, DOI 10.1136/emj.2008.062539; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MAYOU R, 1995, J PSYCHOSOM RES, V39, P789, DOI 10.1016/0022-3999(95)00031-D; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schiller D, 2010, TRENDS COGN SCI, V14, P268, DOI 10.1016/j.tics.2010.04.002; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz I, 2008, BRAIN INJURY, V22, P255, DOI 10.1080/02699050801941763; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shalev AY, 2011, PSYCHIAT SERV, V62, P765, DOI 10.1176/ps.62.7.pss6207_0765; Shin LM, 2009, J TRAUMA STRESS, V22, P409, DOI 10.1002/jts.20442; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	55	24	25	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	DEC	2013	26	6					727	734		10.1002/jts.21862			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	273WL	WOS:000328566900011	24265212				2022-02-06	
J	Wang, HQ; Xin, T; Sun, XB; Wang, SZ; Guo, H; Holton-Burke, C; Pang, Q				Wang, Huaqing; Xin, Tao; Sun, Xiubin; Wang, Shuzhen; Guo, Hua; Holton-Burke, Conor; Pang, Qi			Post-traumatic seizures-A prospective, multicenter, large case study after head injury in China	EPILEPSY RESEARCH			English	Article						Post-traumatic seizures; Prospective; Multicenter; Risk factors	BRAIN-INJURY; RISK-FACTORS; EPILEPSY; EPIDEMIOLOGY; MODEL	Background: Post-traumatic seizures (PTS) is a well-known sequela of traumatic brain injury (TBI). The risk factors for PTS are still controversial. Studies on PTS in China are rare and no large prospective, multicenter-based studies are available. Methods: Data were collected from 15 hospitals prospectively using standardized structured questionnaires in Shandong, a province in China with a follow-up of 2 years. Results: A total of 3093 traumatic brain injury patients were validated and entered in this analysis. After 6 months of follow-up, 181 (59.9%) patients were identified as having PTS. The number were 236 (78.1%) and 302 after 1 year and 2 years' follow-up, respectively. The cumulative 24-month-rate of PTS is 9.8%. Among these 302 patients, 242 were male (80.1%) and 60 female (19.9%). A marked peak was seen in the young people group aged 15-24 (27.8%). Three factors were identified as significant in the multivariate model of PTS: Frontal-temporal lobar contusion, Linear fracture and Severity of TBI measured by initial Glasgow Coma Scale (GCS). Conclusion: This prospective cohort study shows the epidemiologic features and risk factors of PTS in China. Frontal-temporal lobar contusion, linear fracture and severity of TBI measured by initial Glasgow Coma Scale (GCS) are risk factors for PTS. It is essential to establish a standard surveillance system for PTS. (C) 2013 Elsevier B.V. All rights reserved.	[Wang, Huaqing; Xin, Tao; Guo, Hua; Pang, Qi] Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan 250021, Shandong, Peoples R China; [Sun, Xiubin] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250012, Shandong, Peoples R China; [Wang, Shuzhen] Shandong Univ, Qianfoshan Hosp, Dept Paediat, Jinan 250014, Shandong, Peoples R China; [Holton-Burke, Conor] Whitman Coll, Dept Biochem Biophys & Mol Biol, Walla Walla, WA 99362 USA		Pang, Q (corresponding author), Shandong Univ, Prov Hosp, Dept Neurosurg, 324 Jin Wu Wei Qi Rd, Jinan 250021, Shandong, Peoples R China.	pangqisdu@yahoo.com		wang, huaqing/0000-0001-9144-9644; Pang, Qi/0000-0001-8333-5647	Chinese national critical neuro-psychiatrical illness early warning system: risk factors and model development; Chinese Government [2008BAR52B03]	This study was supported by a grant called "Chinese national critical neuro-psychiatrical illness early warning system: risk factors and model development" which was funded by the Chinese Government (Grant no. 2008BAR52B03). The authors thank the doctors and patients in 15 hospitals of Shandong province in China. The authors also thank Dr. Anna Da Fonseca for editorial support.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dakin K A, 1993, Seizure, V2, P21, DOI 10.1016/S1059-1311(05)80098-6; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Jiang Taipeng, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P392; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Schutze M, 1999, ZBL NEUROCHIR, V60, P163; Sharma V, 2007, SEIZURE-EUR J EPILEP, V16, P680, DOI 10.1016/j.seizure.2007.05.012; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	19	24	29	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	DEC	2013	107	3					272	278		10.1016/j.eplepsyres.2013.10.006			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	295DP	WOS:000330097100009	24239245				2022-02-06	
J	Clerc, P; Young, CA; Bordt, EA; Grigore, AM; Fiskum, G; Polster, BM				Clerc, Pascaline; Young, Christina A.; Bordt, Evan A.; Grigore, Alina M.; Fiskum, Gary; Polster, Brian M.			Magnesium Sulfate Protects Against the Bioenergetic Consequences of Chronic Glutamate Receptor Stimulation	PLOS ONE			English	Article							SPARE RESPIRATORY CAPACITY; TRAUMATIC BRAIN-INJURY; NEURONAL CULTURES; OXIDATIVE STRESS; EXCITOTOXICITY; CALCIUM; DEATH; ACTIVATION; APOPTOSIS; MITOCHONDRIA	Extracellular glutamate is elevated following brain ischemia or trauma and contributes to neuronal injury. We tested the hypothesis that magnesium sulfate (MgSO4, 3 mM) protects against metabolic failure caused by excitotoxic glutamate exposure. Rat cortical neuron preparations treated in medium already containing a physiological concentration of Mg2+ (1 mM) could be segregated based on their response to glutamate (100 mu M). Type I preparations responded with a decrease or small transient increase in oxygen consumption rate (OCR). Type II neurons responded with >50% stimulation in OCR, indicating a robust response to increased energy demand without immediate toxicity. Pre-treatment with MgSO4 improved the initial bioenergetic response to glutamate and ameliorated subsequent loss of spare respiratory capacity, measured following addition of the uncoupler FCCP, in Type I but not Type II neurons. Spare respiratory capacity in Type I neurons was also improved by incubation with MgSO4 or NMDA receptor antagonist MK801 in the absence of glutamate treatment. This finding indicates that the major difference between Type I and Type II preparations is the amount of endogenous glutamate receptor activity. Incubation of Type II neurons with 5 mM glutamate prior to excitotoxic (100 mM) glutamate exposure recapitulated a Type I phenotype. MgSO4 protected against an excitotoxic glutamate-induced drop in neuronal ATP both with and without prior 5 mu M glutamate exposure. Results indicate that MgSO4 protects against chronic moderate glutamate receptor stimulation and preserves cellular ATP following treatment with excitotoxic glutamate.	[Polster, Brian M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA		Polster, BM (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS064978, P01HD016596]; National Institute of Child Health and Human Development/United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064978] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke/the National Institutes of Health (www.nih.gov, grant number R01NS064978) and by the National Institute of Child Health and Human Development/the National Institutes of Health (www.nih.gov, grant number P01HD016596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; Castilho RF, 1998, J NEUROSCI, V18, P10277; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Deshpande LS, 2008, EUR J PHARMACOL, V583, P73, DOI 10.1016/j.ejphar.2008.01.025; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Gleichmann M, 2009, J NEUROCHEM, V109, P644, DOI 10.1111/j.1471-4159.2009.05997.x; Greene MF, 2003, NEW ENGL J MED, V348, P275, DOI 10.1056/NEJMp020166; Hallak M, 1998, MAGNESIUM RES, V11, P117; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Kovac S, 2012, J CELL SCI, V125, P1796, DOI 10.1242/jcs.099176; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Panov A, 1996, BIOCHEMISTRY-US, V35, P427, DOI 10.1021/bi952101t; Rodriguez-Zavala JS, 1998, J BIOL CHEM, V273, P7850, DOI 10.1074/jbc.273.14.7850; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; van den Bergh WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu Minhui, 2002, Chin J Traumatol, V5, P361; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022	31	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79982	10.1371/journal.pone.0079982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	WOS:000327254700168	24236167	Green Submitted, Green Published, gold			2022-02-06	
J	Casey-Trott, TM; Millman, ST; Turner, PV; Nykamp, SG; Widowski, TM				Casey-Trott, T. M.; Millman, S. T.; Turner, P. V.; Nykamp, S. G.; Widowski, T. M.			Effectiveness of a nonpenetrating captive bolt for euthanasia of piglets less than 3 d of age	JOURNAL OF ANIMAL SCIENCE			English	Article						animal welfare; captive bolt; euthanasia; insensibility; neonate; piglet	DETERMINING BRAIN-DEATH; CERVICAL DISLOCATION; BLUNT TRAUMA; LAYING HENS; WELFARE; PIGS; NEUROPHYSIOLOGY; INSENSIBILITY; DEPOPULATION; CESSATION	The objective of this study was to determine the effectiveness of a nonpenetrating captive bolt (NPCB), the Zephyr-Euthanasia (Zephyr-E), for euthanasia of neonatal piglets < 72 h of age using signs of insensibility and death, as well as postmortem assessment of traumatic brain injury (TBI). The Zephyr-E was used by 10 stock people to euthanize 100 low viability neonatal piglets from 3 commercial farrowing units and 1 research farm. Brainstem reflexes, convulsions, and heartbeat were used to assess insensibility, time of brain death, and cardiac arrest after Zephyr-E application. Hemorrhage severity and skull fracture displacement (FD) were quantified from computed tomography scans (n = 10), macroscopic scoring was used to assess brain hemorrhage and skull fracture (SK) severity (n = 100), and microscopic scoring was used to assess subdural (SDH) and parenchymal (PH) hemorrhage within specific brain regions that are responsible for consciousness and vital function (n = 10). All 100 piglets were rendered immediately insensible without return to sensibility. On average, clonic convulsions (CC) ceased in 101 s (+/- 7.4 SE), brain death was achieved in 229 s (+/- 9.18 SE), and cardiac arrest occurred in 420 s (+/- 13.57 SE). Time of cardiac arrest differed significantly among stock people when either body weight (BW: P = 0.0053) or body mass index (BMI: P = 0.0059) was used as a covariate. The BMI was inversely related to the duration of CC (P = 0.0227). Moderate to severe hemorrhage severity was reported in 9 of 10 piglets. There was no relationship between FD and BW (P = 0.8408) or BMI (P = 0.6439). Macroscopic analyses indicated moderate to severe hemorrhage and SK in all piglets. No differences were found among brain sections for SDH (P = 0.2302); PH was greater in the cerebral cortex than in the midbrain and brainstem (P = 0.0328). The Zephyr-E NPCB reliably caused immediate, sustained insensibility followed by death in neonatal piglets. Postmortem assessment confirmed that application of the Zephyr-E caused widespread, irreversible brain damage.	[Casey-Trott, T. M.; Widowski, T. M.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Millman, S. T.] Iowa State Univ, Ames, IA 50011 USA; [Turner, P. V.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Nykamp, S. G.] Ontario Vet Coll, Hlth Sci Ctr, Primary Healthcare Ctr, Guelph, ON N1G 2W1, Canada		Widowski, TM (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	twidowsk@uoguelph.ca		Millman, Suzanne/0000-0001-5752-4647	National Pork Board, Des Moines, IA, USA	Funding was provided by the National Pork Board, Des Moines, IA, USA. The authors wish to thank the dedicated stock people from the farm in Ontario and Elite Pork Partnership LLC, Carroll, IA, who were willing to take on this task. We are also grateful to the students and staff from the University of Guelph and Iowa State University; in particular, Dr. Ray Brooks and research associate Rebecca Parsons, for their contributions to data collection, and to Michelle Edwards for her statistical advice.	AKRITAS MG, 1990, J AM STAT ASSOC, V85, P73, DOI 10.2307/2289527; American Association of Swine Veterinarians (AASV) and National Pork Board (NPB), 2009, AASV PUBL; ANIL MH, 1991, MEAT SCI, V30, P13, DOI 10.1016/0309-1740(91)90030-T; AVMA, 2007, J AM VET MED ASSOC, V218, P669; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; Chevillon P., 2004, P INT SOC AN HYG ST, P45; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Dawson MD, 2007, J APPL POULTRY RES, V16, P583, DOI 10.3382/japr.2007-00023; Dawson MD, 2009, J APPL POULTRY RES, V18, P135, DOI 10.3382/japr.2008-00072; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, J APPL POULTRY RES, V19, P288, DOI 10.3382/japr.2009-00103; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; HANNA JP, 1995, NEUROLOGY, V45, P985, DOI 10.1212/WNL.45.5.985; Hills Teresa E, 2010, Nursing, V40, P34, DOI 10.1097/01.NURSE.0000390667.52579.8e; IRWIN C.K., 2010, AASV ANN M IMPL KNOW, P441; Lee PH, 2005, PARKINSONISM RELAT D, V11, P105, DOI 10.1016/j.parkreldis.2004.09.005; McKeegan DEF, 2011, BRIT POULTRY SCI, V52, P645, DOI 10.1080/00071668.2011.640307; McKinstry JL, 2004, MEAT SCI, V67, P121, DOI 10.1016/j.meatsci.2003.10.002; Millman ST, 2010, AASV ANN M IMPL KNOW, P443; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; OIE, 2011, TERR AN HLTH COD; Raj ABM, 1996, ANIM WELFARE, V5, P71; Sadler LJ, 2013, THESIS IOWA STATE U; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sutherland M., 2010, 08145 NAT PORK BOARD; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Turner PV, 2012, POULTRY SCI, V91, P1558, DOI 10.3382/ps.2012-02139; Viano DC, 2012, ANN BIOMED ENG, V40, P213, DOI 10.1007/s10439-011-0386-2; Vogel KD, 2011, J ANIM SCI, V89, P1412, DOI 10.2527/jas.2010-2920; Whiting TL, 2011, CAN VET J, V52, P753; Widowski T, 2008, ALL D LEM SWIN C P, P107; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Woods J. A., 2011, P HUM SLAUGHT ASS CE; Young RJ, 2002, NEUROIMAG CLIN N AM, V12, P189, DOI 10.1016/S1052-5149(02)00003-5	39	24	25	1	20	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0021-8812	1525-3163		J ANIM SCI	J. Anim. Sci.	NOV	2013	91	11					5477	5484		10.2527/jas.2013-6320			8	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	246CZ	WOS:000326515900043	24045471				2022-02-06	
J	Elkin, BS; Morrison, B				Elkin, Benjamin S.; Morrison, Barclay			Viscoelastic Properties of the P17 and Adult Rat Brain From Indentation in the Coronal Plane	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						rat brain; heterogeneous mechanical properties; age-dependence; viscoelasticity; indentation; TBI; neurosurgery	INJURY; BEHAVIOR; IMPACT; TESTS	This technical brief serves as an update to our previous work characterizing the region-dependence of viscoelastic mechanical properties of the P17 and adult rat brain in the coronal plane (Elkin et al., 2011, "A Detailed Viscoelastic Characterization of the P17 and Adult Rat Brain," J. Neurotrauma, 28, pp. 2235-2244.). Here, modifications to the microindentation device provided for the reliable measurement of load during the ramp portion of load relaxation microindentation tests. In addition, a correction factor for finite sample thickness was incorporated to more accurately assess the intrinsic mechanical properties of the tissue. The shear relaxation modulus was significantly dependent on the anatomic region and developmental age, with a general increase in stiffness with age and increased stiffness in the hippocampal and cortical regions compared with the white matter and cerebellar regions of the brain. The shear modulus ranged from similar to 0.2 kPa to similar to 2.6 kPa depending on region, age, and time scale. Best-fit Prony series parameters from least squares fitting to the indentation data from each region are reported, which describe the shear relaxation behavior for each anatomic region within each age group at both short (<10 ms) and long (similar to 20 s) time scales. These data will be useful for improving the biofidelity of finite element models of rat brain deformation at short time scales, such as models of traumatic brain injury.	[Elkin, Benjamin S.; Morrison, Barclay] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Elkin, Benjamin S.] MEA Forens Engineers & Scientists, Mississauga, ON L4Z 1S6, Canada		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	ben.elkin@meaforensic.com; bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Highway Traffic Safety Administration (NHTSA) [DTNH22-08-C-00088]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by the National Highway Traffic Safety Administration (NHTSA; Project No. DTNH22-08-C-00088) and a Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate scholarship (BSE).	Allen M. P., 1997, UNDERSTANDING REGRES, P113; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bonferroni, 1935, STUDI ONORE PROFESSO, P13; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Elias PZ, 2012, J MECH BEHAV BIOMED, V12, P63, DOI 10.1016/j.jmbbm.2012.03.014; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Finan J. D., 2012, P IRCOBI C; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Lee E. H., 1960, J APPL MECH, V27, P438, DOI DOI 10.1115/1.3644020; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Sakai M, 2002, PHILOS MAG A, V82, P1841, DOI 10.1080/01418610210134738; Shulyakov AV, 2011, J MECH BEHAV BIOMED, V4, P484, DOI 10.1016/j.jmbbm.2010.12.012; Takhounts EG, 2008, STAPP CAR C, V52, P1; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zamir EA, 2004, J BIOMECH ENG-T ASME, V126, P276, DOI 10.1115/1.1695573	29	24	24	0	21	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	NOV	2013	135	11							114507	10.1115/1.4025386			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	240IF	WOS:000326088100016	24026193				2022-02-06	
J	McKeon, JMM; Livingston, SC; Reed, A; Hosey, RG; Black, WS; Bush, HM				McKeon, Jennifer M. Medina; Livingston, Scott C.; Reed, Ashley; Hosey, Robert G.; Black, Williams S.; Bush, Heather M.			Trends in Concussion Return-to-Play Timelines Among High School Athletes From 2007 Through 2009	JOURNAL OF ATHLETIC TRAINING			English	Article						injury incidence; time to event; survival probability	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; SPORTS-RELATED CONCUSSION; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COLLEGIATE FOOTBALL PLAYERS; POSTURAL STABILITY; NCAA CONCUSSION; EPIDEMIOLOGY; RECOVERY; PREVENTION	Context: Whereas guidelines about return-to-play (RTP) after concussion have been published, actual prognoses remain elusive. Objective: To develop probability estimates for time until RTP after sport-related concussion. Design: Descriptive epidemiology study. Setting: High school. Patients or Other Participants: Injured high school varsity, junior varsity, or freshman athletes who participated in 1 of 13 interscholastic sports at 7 area high schools during the 20072009 academic years. Intervention(s): Athletic trainers employed at each school collected concussion data. The athletic trainer or physician on site determined the presence of a concussion. Athlete-exposures for practices and games also were captured. Main Outcome Measure(s): Documented concussions were categorized by time missed from participation using severity outcome intervals (same-day return, 1- to 2-day return, 3- to 6-day return, 7- to 9-day return, 10- to 21-day return, >21-day return, no return [censored data]). We calculated Kaplan-Meier time-to-event probabilities that included censored data to determine the probability of RTP at each of these time intervals. Results: A total of 81 new concussions were documented in 478 775 athlete-exposures during the study period. After a new concussion, the probability of RTP (95% confidence interval) was 2.5% (95% confidence interval = 0.3, 6.9) for a 1- to 2-day return, 71.3% (95% confidence interval = 59.0, 82.9) for a 7-to 9-day return, and 88.8% (95% confidence interval = 72.0, 97.2) for a 10- to 21-day return. Conclusions: For high school athletes, RTP within the first 2 days after concussion was unlikely. After 1 week, the probability of return rose substantially (approximately 71%). Prognostic indicators are used to educate patients about the likely course of disease. Whereas individual symptoms and recovery times vary, prognostic time-to-event probabilities allow clinicians to provide coaches, parents, and athletes with a prediction of the likelihood of RTP within certain timeframes after a concussion.	[McKeon, Jennifer M. Medina] Ithaca Coll, Dept Exercise & Sport Sci, Ithaca, NY 14850 USA; [McKeon, Jennifer M. Medina; Livingston, Scott C.] Univ Kentucky, Coll Hlth Sci, Lexington, KY 40506 USA; [Reed, Ashley] Kent State Univ, Coll Educ Hlth & Human Sci, Kent, OH USA; [Hosey, Robert G.] Univ Kentucky, Coll Med, Lexington, KY 40506 USA; [Black, Williams S.] UK Healthcare, Univ Hlth Serv, Lexington, KY USA; [Bush, Heather M.] Univ Kentucky, Coll Publ Hlth, Lexington, KY 40506 USA		McKeon, JMM (corresponding author), Ithaca Coll, Dept Exercise & Sport Sci, Ctr Hlth Sci 309A, Ithaca, NY 14850 USA.	jmckeon@ithaca.edu					ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chong A, 2010, ASIAN PAC J CANCER P, V11, P953; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hootman JM, 2007, J ATHL TRAINING, V42, P311; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kentucky High School Athletic Association and KHSAA Member Schools, IMPL NFHS PLAYING RU; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McKeag DB, 2009, CLIN J SPORT MED, V19, P343, DOI 10.1097/JSM.0b013e3181b2c114; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Patel DR, 2006, PRIMARY CARE, V33, P545, DOI 10.1016/j.pop.2006.02.001; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sallis RE, 2001, INT J SPORTS MED, V22, P420, DOI 10.1055/s-2001-16246; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Talamini R, 2008, INT J CANCER, V122, P1624, DOI 10.1002/ijc.23205; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	68	24	24	0	22	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2013	48	6					836	843		10.4085/1062-6050-48.6.17			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	268AW	WOS:000328141200014	24143901	Green Published, Bronze			2022-02-06	
J	Wortzel, HS; Brenner, LA; Arciniegas, DB				Wortzel, Hal S.; Brenner, Lisa A.; Arciniegas, David B.			Traumatic Brain Injury and Chronic Traumatic Encephalopathy: A Forensic Neuropsychiatric Perspective	BEHAVIORAL SCIENCES & THE LAW			English	Article							COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; FOOTBALL; DISEASE; RISK; NEUROPATHOLOGY; SYMPTOMS; DEMENTIA; RECOVERY; HISTORY	Recent scientific reports and popular press describing chronic traumatic encephalopathy (CTE) collectively link this condition to a broad array of neuropsychiatric symptoms, including extremely rare and multi-determined behaviors such as murder-suicide. These reports are difficult to reconcile with several decades of research on the science of traumatic brain injury (TBI) and its consequences, especially the natural history and prognosis of mild TBI. This article attempts to reconcile these sources by reviewing the state of the science on CTE, with particular attention to case definitions and neuropathological criteria for this diagnosis. The evidence for links between TBI, CTE, and catastrophic clinical events is explored, and the complexity of attributing rare frequency behavioral events to CTE is highlighted. The clinical and medicolegal implications of the best available evidence are discussed, concluding with a cautionary note against prematurely generalizing current findings on CTE to entire populations of persons with, or at risk for, concussion exposures. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Wortzel, Hal S.; Brenner, Lisa A.; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Neuropsychiat Serv, Aurora, CO 80045 USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Div Forens Psychiat, Aurora, CO 80045 USA; [Wortzel, Hal S.; Brenner, Lisa A.; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Aurora, CO 80045 USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; [Wortzel, Hal S.; Arciniegas, David B.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Arciniegas, David B.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Wortzel, HS (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Anschutz Med Campus,Bldg 500,Mail Stop F546,13001, Aurora, CO 80045 USA.	hal.wortzel@ucdenver.edu	Brenner, Lisa A./AAG-2442-2019				[Anonymous], 1969, Lancet, V2, P1114; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Bedi S., 2012, FORBES          0505; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cearnal L, 2012, ANN EMERG MED, V60, p17A, DOI 10.1016/j.annemergmed.2012.08.013; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Goldstein L E, 2012, SCI TRANSLATIONAL ME, V4; Granier J. P., 2011, AJOB NEUROSCIENCE, V2, P60; Greenemeier L., 2012, SCI AM; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hohler B., 2013, BOSTON GLOBE; Institute of Medicine Committee on Gulf War and Health, 2008, GULF WAR HLTH, V7; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kristof Nicholas D., 2012, NY TIMES; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martin J., 2012, US TODAY; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mihoces G., 2013, US TODAY; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; O'Neil ME, 2012, COMPLICATIONS MILD T; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PEARCE JMS, 1984, BRIT MED J, V288, P933, DOI 10.1136/bmj.288.6421.933-a; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwarz A, 2011, NY TIMES; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; STRUB RL, 1988, NEUROBEHAVIORAL DISO; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilner B., 2013, HUFFINGTON POST; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511	70	24	24	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		721	738		10.1002/bsl.2079			18	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400004	24019038				2022-02-06	
J	Cook, AM; Arora, S; Davis, J; Pittman, T				Cook, Aaron M.; Arora, Shaily; Davis, Justin; Pittman, Thomas			Augmented Renal Clearance of Vancomycin and Levetiracetam in a Traumatic Brain Injury Patient	NEUROCRITICAL CARE			English	Article						Closed head injury; Pharmacokinetics; Antibiotic; Antiepileptic; Creatinine clearance	INTENSIVE-CARE-UNIT; CREATININE CLEARANCE; GLOMERULAR-FILTRATION; PHARMACOKINETICS	Increased creatinine clearance and subsequent elevated antimicrobial clearance is evident in many traumatic brain injury (TBI) patients due to augmented renal clearance (ARC). Little is known about the effects of ARC on other renally-eliminated medications, such as the anti-epileptic drug levetiracetam. This is a case report of serum monitoring of vancomycin and levetiracetam in a 22 year old female with ARC after severe TBI. The patient exhibited ARC of vancomycin as evidenced by her low serum concentrations with standard vancomycin dosing. Her estimated creatinine clearance based on vancomycin clearance was 243.9 ml/min. Serum concentrations also suggested ARC of levetiracetam. No toxicities for either medication were noted, even after dose adjustment to account for possible ARC. Vancomycin and levetiracetam both appear to be subject to ARC after TBI. Clinicians should be mindful that standard dosing of these agents may not achieve typical target concentrations in this clinical scenario.	[Cook, Aaron M.; Arora, Shaily] Univ Kentucky, Serv Pharm, Lexington, KY USA; [Davis, Justin; Pittman, Thomas] Univ Kentucky, Dept Neurosurg, Lexington, KY USA		Cook, AM (corresponding author), Univ Kentucky, Serv Pharm, Lexington, KY USA.	amcook0@email.uky.edu		Cook, Aaron/0000-0001-8539-902X			Baptista JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10262; Benedetti MS, 2003, EUR J CLIN PHARMACOL, V59, P621, DOI 10.1007/s00228-003-0655-6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fay MA, 2005, CLIN THER, V27, P594, DOI 10.1016/j.clinthera.2005.05.010; Herrera-Gutierrez ME, 2007, INTENS CARE MED, V33, P1900, DOI 10.1007/s00134-007-0745-5; http://www.hosp.uky.edu/pharmacy/formulary/criteria/Clinical_PKS_Manual-July_2010.pdf, 2010, CLIN PHARMACOKINETIC; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Klein P, 2012, EPILEPSY BEHAV, V24, P457, DOI 10.1016/j.yebeh.2012.05.011; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; MATZKE GR, 1984, ANTIMICROB AGENTS CH, V25, P433, DOI 10.1128/AAC.25.4.433; Patsalos PN, 2004, CLIN PHARMACOKINET, V43, P707, DOI 10.2165/00003088-200443110-00002; Rybak MJ, 2009, CLIN INFECT DIS, V49, P325, DOI 10.1086/600877; RYBAK MJ, 1990, ANTIMICROB AGENTS CH, V34, P792, DOI 10.1128/AAC.34.5.792; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Udy AA, 2010, INT J ANTIMICROB AG, V35, P606, DOI 10.1016/j.ijantimicag.2010.02.013; Udy AA, 2010, CLIN PHARMACOKINET, V49, P1, DOI 10.2165/11318140-000000000-00000; ZASKE DE, 1976, J TRAUMA, V16, P824, DOI 10.1097/00005373-197610000-00014	23	24	25	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2013	19	2					210	214		10.1007/s12028-013-9837-y			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	221GB	WOS:000324644800012	23907742				2022-02-06	
J	Hou, LJ; Han, X; Sheng, P; Tong, WS; Li, ZQ; Xu, DY; Yu, MK; Huang, LQ; Zhao, ZX; Lu, YC; Dong, Y				Hou, Lijun; Han, Xi; Sheng, Ping; Tong, Wusong; Li, Zhiqiang; Xu, Dayuan; Yu, Mingkun; Huang, Liuqing; Zhao, Zhongxin; Lu, Yicheng; Dong, Yan			Risk Factors Associated with Sleep Disturbance following Traumatic Brain Injury: Clinical Findings and Questionnaire Based Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EXCESSIVE DAYTIME SLEEPINESS; INSOMNIA; COMPLAINTS; PREVALENCE	Background: Sleep disturbance is very common following traumatic brain injury (TBI), which may initiate or exacerbate a variety of co-morbidities and negatively impact rehabilitative treatments. To date, there are paradoxical reports regarding the associations between inherent characteristics of TBI and sleep disturbance in TBI population. The current study was designed to explore the relationship between the presence of sleep disturbance and characteristics of TBI and identify the factors which are closely related to the presence of sleep disturbance in TBI population. Methods: 98 TBI patients (72 males, mean age +/- SD, 47 +/- 13 years, range 18-70) were recruited. Severity of TBI was evaluated based on Glasgow Coma Scale (GCS). All participants performed cranial computed tomography and were examined on self-reported sleep quality, anxiety, and depression. Results: TBI was mild in 69 (70%), moderate in 15 (15%) and severe in 14 (15%) patients. 37 of 98 patients (38%) reported sleep disturbance following TBI. Insomnia was diagnosed in 28 patients (29%) and post-traumatic hypersomnia in 9 patients (9%). In TBI with insomnia group, 5 patients (18%) complained of difficulty falling asleep only, 8 patients (29%) had difficulty maintaining sleep without difficulty in initial sleep and 15 patients (53%) presented both difficulty falling asleep and difficulty maintaining sleep. Risk factors associated with insomnia were headache and/or dizziness and more symptoms of anxiety and depression rather than GCS. In contrast, GCS was independently associated with the presence of hypersomnia following TBI. Furthermore, there was no evidence of an association between locations of brain injury and the presence of sleep disturbance after TBI. Conclusion: Our data support and contribute to a growing body of evidence which indicates that TBI patients with insomnia are prone to suffer from concomitant headache and/or dizziness, report more symptoms of anxiety and depression and severe TBI patients are likely to experience hypersomnia.	[Hou, Lijun; Sheng, Ping; Yu, Mingkun; Lu, Yicheng; Dong, Yan] Second Mil Med Univ, Dept Neurosurg, Shanghai Inst Neurosurg, PLA Inst Neurosurg,Changzhang Hosp, Shanghai, Peoples R China; [Han, Xi] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Tong, Wusong] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Li, Zhiqiang; Xu, Dayuan] Fengxian Cent Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Huang, Liuqing; Zhao, Zhongxin] Second Mil Med Univ, Dept Neurol, Changzhang Hosp, Shanghai, Peoples R China		Hou, LJ (corresponding author), Second Mil Med Univ, Dept Neurosurg, Shanghai Inst Neurosurg, PLA Inst Neurosurg,Changzhang Hosp, Shanghai, Peoples R China.	lj_hou@hotmail.com; dongyan2006@yahoo.com			Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]; Research Foundation for Returned Scholars from Ministry of Education of China	Dr. Yan Dong is supported by Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700) and Research Foundation for Returned Scholars from Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P298; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Flesher MR, 2001, BRAIN INJURY, V15, P879, DOI 10.1080/02699050110065682; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hossain Jamil L, 2002, Sleep Breath, V6, P85, DOI 10.1007/s11325-002-0085-1; Johnson VE, 2012, EXP NEUROL; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Liang Siyu, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P370, DOI 10.3969/j.issn.1672-7347.2013.04.006; Liu Y, 2013, CHINA MED HERALD, V10, P60; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mayers AG, 2006, INT J PSYCHIAT CLIN, V10, P2, DOI 10.1080/13651500500328087; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Plante DT, 2009, SLEEP MED CLIN, V4, P407, DOI 10.1016/j.jsmc.2009.04.008; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Tobe EH, 1999, J NEUROPSYCH CLIN N, V11, P504, DOI 10.1176/jnp.11.4.504; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wu SQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-849	40	24	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76087	10.1371/journal.pone.0076087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OR	WOS:000325427100040	24098425	Green Submitted, Green Published, gold			2022-02-06	
J	Tang, HL; Sha, HY; Sun, HP; Wu, X; Xie, LQ; Wang, P; Xu, CS; Larsen, C; Zhang, HL; Gong, Y; Mao, Y; Chen, XC; Zhou, LF; Feng, XY; Zhu, JH				Tang, Hailiang; Sha, Hongying; Sun, Huaping; Wu, Xing; Xie, Liqian; Wang, Pu; Xu, Chengshi; Larsen, Christian; Zhang, Helen L.; Gong, Ye; Mao, Ying; Chen, Xiancheng; Zhou, Liangfu; Feng, Xiaoyuan; Zhu, Jianhong			Tracking Induced Pluripotent Stem Cells-Derived Neural Stem Cells in the Central Nervous System of Rats and Monkeys	CELLULAR REPROGRAMMING			English	Article							BRAIN; FIBROBLASTS; PARTICLES; INDUCTION; INJURY	Despite of the immense breakthroughs of induced pluripotent stem cells (iPSCs), clinical application of iPSCs and their derivates remains hampered by a lack of definitive in vivo studies. Here, we attempted to track iPSCs-derived neural stem cells (NSCs) in the rodent and primate central nervous system (CNS) and explore their therapeutic viability for stem cell replacement in traumatic brain injury (TBI) rats and monkeys with spinal cord injury (SCI). Superparamagnetic iron oxide (SPIO) particles were used to label iPSCs-derived NSCs in vitro. Labeled NSCs were implanted into TBI rats and SCI monkeys 1 week after injury, and then imaged using gradient reflection echo (GRE) sequence by 3.0T magnetic resonance imaging (MRI) scanner. MRI analysis was performed at 1, 7, 14, 21, and 30 days, respectively, following cell transplantation. Pronounced hypointense signals were initially detected at the cell injection sites in rats and monkeys and were later found to extend progressively to the lesion regions, demonstrating that iPSCs-derived NSCs could migrate to the lesion area from the primary sites. The therapeutic efficacy of iPSCs-derived NSCs was examined concomitantly through functional recovery tests of the animals. In this study, we tracked iPSCs-derived NSCs migration in the CNS of TBI rats and SCI monkeys in vivo for the first time. Functional recovery tests showed obvious motor function improvement in transplanted animals. These data provide the necessary foundation for future clinical application of iPSCs for CNS injury.	[Tang, Hailiang; Wu, Xing; Xie, Liqian; Wang, Pu; Xu, Chengshi; Larsen, Christian; Zhang, Helen L.; Gong, Ye; Mao, Ying; Chen, Xiancheng; Zhou, Liangfu; Zhu, Jianhong] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200040, Peoples R China; [Sha, Hongying] Fudan Univ, Natl Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Sun, Huaping; Feng, Xiaoyuan] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200040, Peoples R China; [Zhu, Jianhong] Fudan Univ, Natl Key Lab Med Neurobiol, Inst Brain Sci, Shanghai Med Coll, Shanghai 200032, Peoples R China		Feng, XY (corresponding author), HuaShan Hosp, Dept Radiol, Shanghai, Peoples R China.	xyfeng@fudan.edu.cn; jzhu@fudan.edu.cn		Mao, Ying/0000-0001-8055-115X	National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [81200936, 2010CB945500, 2012CB966300, 11JC1401000, 2009CB941100]; Ministry of Science and Technology of China and Shanghai City Science Foundation; Shanghai Medical College Young Scientist Fund of Fudan University [11L-24]	We are grateful to the technicians (Luping Chen, Yiwen Shen, and Qisheng Tang) in the stem cell lab for their assistance in animal preparation and advice on experiments. This work was supported by grants (81200936, 2010CB945500, 2012CB966300, 11JC1401000, 2009CB941100) from National Nature Science Foundation, Ministry of Science and Technology of China and Shanghai City Science Foundation, and 2011 Shanghai Medical College Young Scientist Fund of Fudan University (11L-24).	Allen A. R., 1991, PHARM BIOCH BEHAV, V57, P878; Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dixon E.C., 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Henrich C., 1996, SCIENCE, V273, P510; Hoehn M, 2007, J PHYSIOL-LONDON, V584, P25, DOI 10.1113/jphysiol.2007.139451; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Postmantur R., 1997, NEUROSCIENCE, V77, P765; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VILLEGAS J, 2005, CURR PROTOC MOL BIOL, pCH28, DOI DOI 10.1002/0471142727.MB2803S71; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	20	24	25	3	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-4971	2152-4998		CELL REPROGRAM	Cell. Reprogramm.	OCT 1	2013	15	5					435	442		10.1089/cell.2012.0081			8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	293RO	WOS:000329991600016	24020696	Green Published			2022-02-06	
J	Mao, HJ; Elkin, BS; Genthikatti, VV; Morrison, B; Yang, KH				Mao, Haojie; Elkin, Benjamin S.; Genthikatti, Vinay V.; Morrison, Barclay, III; Yang, King H.			Why Is CA3 More Vulnerable Than CA1 in Experimental Models of Controlled Cortical Impact-Induced Brain Injury?	JOURNAL OF NEUROTRAUMA			English	Article						brain injury biomechanics; brain material; controlled cortical impact; finite element method; heterogeneous hippocampus injury; rat brain modeling	FINITE-ELEMENT MODEL; IN-VITRO MODEL; LIVING BRAIN; RAT; HIPPOCAMPUS; CULTURES; STRETCH; STRAIN	One interesting finding of controlled cortical impact (CCI) experiments is that the CA3 region of the hippocampus, which is positioned further from the impact than the CA1 region, is reported as being more injured. The current literature has suggested a positive correlation between brain tissue stretch and neuronal cell loss. However, it is counterintuitive to assume that CA3 is stretched more during CCI injury. Recent mechanical studies of the brain have reported on a level of spatial heterogeneity not previously appreciated-the finding that CA1 was significantly stiffer than all other regions tested and that CA3 was one of the most compliant. We hypothesized that mechanical heterogeneity of anatomical structures could underlie the proposed heterogeneous mechanical response and hence the pattern of cell death. As such, we developed a three-dimensional finite element (FE) rat brain model representing detailed hippocampal structures and simulated various CCI experiments. Four groups of material properties based on recent experiments were tested. In group 1, hyperelastic material properties were assigned to various hippocampal structures, with CA3 more compliant than CA1. In group 2, linear viscoelastic material properties were assigned to hippocampal structures, with CA3 more compliant than CA1. In group 3, the hippocampus was represented by homogenous linear viscoelastic material properties. In group 4, a homogeneous nonlinear hippocampus was adopted. Simulation results demonstrated that for CCI with a 5-mm diameter, flat shape impactor, CA3 experienced increased tensile strains over a larger area and to a greater magnitude than did CA1 for group 1, which best explained why CA3 is more sensitive to CCI injury. However, for groups 2-4, the total volume with high strain (>30%) in CA3 was smaller than that in CA1. The FE rat brain model, with detailed hippocampal structures presented here, will help to engineer desired experimental neurotrauma models by virtually characterizing brain biomechanics before testing.	[Mao, Haojie; Genthikatti, Vinay V.; Yang, King H.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Elkin, Benjamin S.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY USA		Yang, KH (corresponding author), Wayne State Univ, Ctr Bioengn, 818 West Hancock, Detroit, MI 48201 USA.	king.yang@wayne.edu	Morrison, Barclay/B-7132-2008; Mao, Haojie/Q-7514-2018	Morrison, Barclay/0000-0001-7676-0864; Mao, Haojie/0000-0002-7563-9234	National Highway Traffic Safety Administration [DTNH22-08-C-00088]	The authors appreciate Dr. Michelle LaPlaca's help in describing CCI experiments. The authors thank Mr. Amandeep Gill, Mr. Gurdeep Jandir, Mr. Amrinder Singh, and Mr. Chintan Shelat for their help, in part, with meshing and simulation. The authors acknowledge Mr. Abrar Wazir for proofreading. This work was supported, in part, by the National Highway Traffic Safety Administration (DTNH22-08-C-00088).	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Baumgartner D, 2011, COMPUT METHOD BIOMEC, V14, P273, DOI 10.1080/10255842.2011.595240; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shreiber D.I., 1997, 41 STAPP CAR CRASH C; Stemper B.D., 2011, J NEUROTRAUM, V28, pA; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yeoh S., 2011, ASME 2011 SUMM BIOEN	28	24	26	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1521	1530		10.1089/neu.2012.2520			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800008	23557208	Green Published, Green Submitted			2022-02-06	
J	Zimmer, A; Piecora, K; Schuster, D; Webbe, F				Zimmer, Adam; Piecora, Kyle; Schuster, Danielle; Webbe, Frank			Sport and Team Differences on Baseline Measures of Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; baseline assessment; Concussion Resolution Index; Standardized Assessment of Concussion; Balance Error Scoring System	NEUROPSYCHOLOGICAL TEST PROTOCOL; ERROR SCORING SYSTEM; POSTURAL STABILITY; BALANCE; MANAGEMENT; SYMPTOMS; RELIABILITY; DIAGNOSIS; ATHLETE; INJURY	Context: With the advent of the National Collegiate Athletic Association's (NCAA's) mandating the presence and practice of concussion-management plans in collegiate athletic programs, institutions will consider potential approaches for concussion management, including both baseline and normative comparison approaches. Objective: To examine sport and team differences in baseline performance on a computer-based neurocognitive measure and 2 standard sideline measures of cognition and balance and to determine the potential effect of premorbid factors sex and height on baseline performance. Design: Cross-sectional study. Setting: University laboratory. Patients or Other Participants: A total of 437 NCAA Division II student-athletes (males = 273, females = 164; age = 19.61 +/- 1.64 years, height = 69.89 +/- 4.04 inches [177.52 +/- 10.26 cm]) were recruited during mandatory preseason testing conducted in a concussion-management program. Main Outcome Measure(s): The computerized Concussion Resolution Index (CRI), the Standardized Assessment of Concussion (Form A; SAC), and the Balance Error Scoring System (BESS). Results: Players on the men's basketball team tended to perform worse on the baseline measures, whereas soccer players tended to perform better. We found a difference in total BESS scores between these sports (P = .002). We saw a difference between sports on the hard-surface portion of the BESS (F-6,F-347 = 3.33, P = .003, eta(2)(p) = 0.05). No sport, team, or sex differences were found with SAC scores (P > .05). We noted differences between sports and teams in the CRI indices, with basketball, particularly the men's team, performing worse than soccer (P < .001) and softball/baseball (P = .03). When sex and height were considered as possible sources of variation in BESS and CRI team or sport differences, height was a covariate for the team (F-1,F-385 = 5.109, P = .02, eta(2)(p) = 0.013) and sport (F1,326 = 11.212, P = .001, eta(2)(p) = 0.033) analyses, but the interaction of sex and sport on CRI indices was not significant in any test (P > .05). Conclusions: Given that differences in neurocognitive functioning and performance among sports and teams exist, the comparison of posttraumatic and baseline assessment may lead to more accurate diagnoses of concussion and safer return-to- participation decision making than the use of normative comparisons.	[Zimmer, Adam; Piecora, Kyle; Schuster, Danielle; Webbe, Frank] Florida Inst Technol, Sch Psychol, Melbourne, FL 32901 USA		Webbe, F (corresponding author), Florida Inst Technol, 150 W Univ Blvd, Melbourne, FL 32901 USA.	webbe@fit.edu		Webbe, Frank/0000-0002-4370-5698			Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brown CN, 2007, J ATHL TRAINING, V42, P515; Cohen J., 1988, STAT POWER ANAL BEHA, P284; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lovell MR, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P111, DOI 10.1007/0-387-32565-4_6; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; PARDINI JE, 2010, HDB SPORT NEUROPSYCH, P209; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ryan JP, 2004, CLIN J SPORT MED, V14, P18, DOI 10.1097/00042752-200401000-00004	27	24	24	0	16	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2013	48	5					659	667		10.4085/1062-6050-48.5.06			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	268AR	WOS:000328140600010	23952044	Green Published			2022-02-06	
J	Eskridge, SL; Macera, CA; Galarneau, MR; Holbrook, TL; Woodruff, SI; MacGregor, AJ; Morton, DJ; Shaffer, RA				Eskridge, Susan L.; Macera, Caroline A.; Galarneau, Michael R.; Holbrook, Troy L.; Woodruff, Susan I.; MacGregor, Andrew J.; Morton, Deborah J.; Shaffer, Richard A.			Influence of Combat Blast-Related Mild Traumatic Brain Injury Acute Symptoms on Mental Health and Service Discharge Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						combat blast injury; functional outcomes; mental health; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PROFESSIONAL FOOTBALL PLAYERS; RECURRENT CONCUSSION; US SOLDIERS; IRAQ; PREDICTORS; REGISTRY; RISK	Assessment of acute mild traumatic brain injury (mTBI) symptoms after a combat blast could aid diagnosis and guide follow-up care. Our objective was to document acute mTBI symptoms following a combat blast and to examine associations between acute symptoms and mental health and service discharge outcomes. A retrospective cohort study was conducted with 1656 service personnel who experienced a combat blast-related mTBI in Iraq. Acute mTBI symptoms were ascertained from point-of-injury medical records. The associations between acute symptoms and posttraumatic stress disorder (PTSD), postconcussion syndrome (PCS), and type of service discharge were examined. Disability discharge occurred in 11% of patients, while 36% had a non-disability discharge and 52% had no recorded discharge. A PTSD and PCS diagnosis was made in 19% and 15% of the sample, respectively. The most common acute mTBI symptoms were headache (62.8%), loss of consciousness (LOC) (34.5%), and tinnitus (33.2%). LOC was predictive of PTSD (odds ratio [OR] 1.54; 95% confidence interval [CI] 1.18, 2.00) and PCS (OR 2.08; 95% CI 1.56, 2.77), while altered mental status (OR 1.53; 95% CI 1.07, 2.17) and previous blast history (OR 1.83; 95% CI 1.15, 2.90) also were predictive of PCS. While no acute mTBI symptoms were associated with discharge outcomes, injury severity was associated with disability discharge. LOC after blast-related mTBI was associated with PTSD and PCS, and injury severity was predictive of disability discharge. The assessment of cognitive status immediately after a blast could assist in diagnosing mTBI and indicate a need for follow-up care.	[Eskridge, Susan L.; Galarneau, Michael R.; MacGregor, Andrew J.] Naval Hlth Res Ctr, Dept Med Modeling Simulat & Mission Support, San Diego, CA 92106 USA; [Macera, Caroline A.; Shaffer, Richard A.] Naval Hlth Res Ctr, Dept Def, HIV AIDS Prevent Program, San Diego, CA 92106 USA; [Macera, Caroline A.; Shaffer, Richard A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Holbrook, Troy L.] San Diego State Univ, Sch Social Work, San Diego, CA 92182 USA; [Woodruff, Susan I.] EPI SOAR Consulting Inc, San Diego, CA USA; [Morton, Deborah J.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA		Eskridge, SL (corresponding author), Naval Hlth Res Ctr, Dept Med Modeling Simulat & Mission Support, 140 Sylvester Rd, San Diego, CA 92106 USA.	susan.eskridge@med.navy.mil		Eskridge, Susan/0000-0002-1817-8355; MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60808]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured/Psychological Health/Traumatic Brain Injury Program under work unit 60808. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government. Approved for public release; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (protocol NHRC. 2009.0023).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Defense and Veteran Brain Injury (DVBIC), 2008, DEF VET BRAIN INJ CT; Department of Defense, 2010, OP IR FREED OIF US C; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Helmick K., 2007, FEDERAL PRACTITIONER, P58; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; McCracken DL, 2005, TRAUMATIC BRAIN INJU; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M., 2008, MILD TRAUMATIC BRAIN; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Zoroya G., 2009, US TODAY	29	24	24	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1391	1397		10.1089/neu.2012.2537			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500002	23489170				2022-02-06	
J	Katzenell, U; Lipsky, AM; Abramovich, A; Huberman, D; Sergeev, I; Deckel, A; Kreiss, Y; Glassberg, E				Katzenell, Udi; Lipsky, Ari M.; Abramovich, Amir; Huberman, David; Sergeev, Ilia; Deckel, Avishai; Kreiss, Yitshak; Glassberg, Elon			Prehospital intubation success rates among Israel Defense Forces providers: Epidemiologic analysis and effect on doctrine	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Advanced airway management; prehospital; endotracheal intubation; cricothyroidotomy	OPERATION-ENDURING-FREEDOM; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; IRAQI-FREEDOM; AIRWAY; REGISTRY	BACKGROUND: Advanced airway management is composed of a set of vital yet potentially difficult skills for the prehospital provider, with widely different clinical guidelines. In the military setting, there are few data available to inform guideline development. We reevaluated our advanced airway protocol in light of our registry data to determine if there were a preferred maximum number of endotracheal intubation (ETI) attempts; our success with cricothyroidotomy (CRIC) as a backup procedure; and whether there were cases where advanced airway interventions should possibly be avoided. METHODS: This is a descriptive, registry-based study conducted using records of the Israel Defense Forces Trauma Registry at the research section of the Trauma and Combat Medicine Branch, Surgeon General's Headquarters. We included all casualties for whom ETI was the initial advanced airway maneuver, and the number of ETI attempts was known. Descriptive statistics were used. RESULTS: Of 5,553 casualties in the Israel Defense Forces Trauma Registry, 406 (7.3%) met the inclusion criteria. Successful ETI was performed in 317 casualties (78%) after any number of ETI attempts; an additional 46 (11%) underwent CRIC, and 43 (11%) had advanced airway efforts discontinued. ETI was successful in 45%, 36%, and 31% of the first, second, and third attempts, respectively, with an average of 28% success over all subsequent attempts. CRIC was successful in 43 (93%) of 46 casualties in whom it was attempted. Of the 43 casualties in whom advanced airway efforts were discontinued, 29 (67%) survived to hospital discharge. CONCLUSION: After the first ETI attempt, success with subsequent attempts tended to fall, with minimal improvement in overall ETI success seen after the third attempt. Because CRIC exhibited excellent success as a backup airway modality, we advocate controlling the airway with CRIC if ETI efforts have failed after two or three attempts. We recommend that providers reevaluate whether definitive airway control is truly necessary before each attempt to control the airway. Copyright (C) 2013 by Lippincott Williams & Wilkins	[Katzenell, Udi; Lipsky, Ari M.; Abramovich, Amir; Sergeev, Ilia; Deckel, Avishai; Kreiss, Yitshak; Glassberg, Elon] Israel Def Forces, Med Corps, Trauma & Combat Med Branch, IL-02149 Rehovot, Israel; [Huberman, David] Israel Def Forces, Med Corps, Med Informat Branch, IL-02149 Rehovot, Israel; [Katzenell, Udi] Kaplan Med Ctr, Dept Otolaryngol Head & Neck Surg, Rehovot, Israel		Glassberg, E (corresponding author), Israel Def Forces, Surg Gen Headquarters, Med Corps, Mil POB 02149, IL-02149 Rehovot, Israel.	idf_trauma@idf.gov.il					Adams BD, 2008, J TRAUMA, V64, P1548, DOI 10.1097/TA.0b013e3181728c41; [Anonymous], 1981, BAS TEXT, P23; Bennett BL, 2011, MIL MED, V176, P1311, DOI 10.7205/MILMED-D-11-00054; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Butler FK, 2010, PHTLS PREHOSPITAL TR; Committee on Trauma American College of Surgeons, 2008, ATLAS ADV TRAUM LIF; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Irvin CB, 2010, PREHOSP DISASTER MED, V25, P541, DOI 10.1017/S1049023X00008736; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; King DR, 2012, AM J EMERG MED, V30, P1429, DOI 10.1016/j.ajem.2011.10.026; Mabry Robert L, 2012, J Spec Oper Med, V12, P17; Mabry RL, 2010, PREHOSP EMERG CARE, V14, P272, DOI 10.3109/10903120903537205; Macdonald JC, 2008, CAN MED ASSOC J, V178, P1133, DOI 10.1503/cmaj.080036; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Rocca B, 2000, Prehosp Emerg Care, V4, P164, DOI 10.1080/10903120090941443; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Walls RM, 2010, ROSENS EMERGENCY MED; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2011, RESUSCITATION, V82, P378, DOI 10.1016/j.resuscitation.2010.12.014; Warner KJ, 2009, J EMERG MED, V36, P257, DOI 10.1016/j.jemermed.2007.10.058	24	24	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2013	75			2			S178	S183		10.1097/TA.0b013e318299d650			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	300JV	WOS:000330461100016	23883905				2022-02-06	
J	Nyholm, L; Howells, T; Enblad, P; Lewen, A				Nyholm, Lena; Howells, Tim; Enblad, Per; Lewen, Anders			Introduction of the Uppsala Traumatic Brain Injury register for regular surveillance of patient characteristics and neurointensive care management including secondary insult quantification and clinical outcome	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						Database; neurointensive care; outcome; quality register; secondary insults; traumatic brain injury	SEVERE HEAD-INJURY; PROSTACYCLIN TREATMENT; INTRACRANIAL-PRESSURE; GUIDELINE COMPLIANCE; THERAPY; TALK; IMPACT; SCALE; COMA; UNIT	Background. To improve neurointensive care (NIC) and outcome for traumatic brain injury (TBI) patients it is crucial to define and monitor indexes of the quality of patient care. With this purpose we established the web-based Uppsala TBI register in 2008. In this study we will describe and analyze the data collected during the first three years of this project. Methods. Data from the medical charts were organized in three columns containing: 1) Admission data; 2) Data from the NIC period including neurosurgery, type of monitoring, treatment, complications, neurological condition at discharge, and the amount of secondary insults; 3) Outcome six months after injury. Indexes of the quality of care implemented include: 1) Index of improvement; 2) Index of change; 3) The percentages of 'Talk and die' and `Talk and deteriorate' patients. Results. Altogether 314 patients were included 2008-2010: 66 women and 248 men aged 0-86 years. Automatic reports showed that the proportion of patients improving during NIC varied between 80% and 60%. The percentage of deteriorated patients was less than 10%. The percentage of Talk and die/Talk and deteriorate cases was <1%. The mean Glasgow Coma Score (Motor) improved from 5.04 to 5.68 during the NIC unit stay. The occurrences of secondary insults were less than 5% of good monitoring time for intracranial pressure (ICP) >25 mmHg, cerebral perfusion pressure (CPP) <50 mmHg, and systolic blood pressure <100 mmHg. Favorable outcome was achieved by 64% of adults. Conclusion. The Uppsala TBI register enables the routine monitoring of NIC quality indexes.	[Nyholm, Lena; Howells, Tim; Enblad, Per; Lewen, Anders] Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden		Lewen, A (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden.	anders.lewen@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348	Swedish research councilSwedish Research CouncilEuropean Commission	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The study was supported by grants from the Swedish research council.	Afessa B, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-10; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bullock MR, 2007, J NEUROTRAUMA SUPPL, V24, P1; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Howells T, 1995, J NEUROTRAUMA; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Majdan M, 2012, EUR J PUBLIC HEALTH, V10, P1; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Piper I, 2010, ACTA NEUROCHIR, V152, P1859, DOI 10.1007/s00701-010-0719-1; REILLY PL, 1975, LANCET, V2, P375; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	24	24	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.	AUG	2013	118	3					169	180		10.3109/03009734.2013.806616			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180IJ	WOS:000321587100004	23837596	gold, Green Published			2022-02-06	
J	Sela-Kaufman, M; Rassovsky, Y; Agranov, E; Levi, Y; Vakil, E				Sela-Kaufman, Michal; Rassovsky, Yuri; Agranov, Eugenia; Levi, Yifat; Vakil, Eli			Premorbid personality characteristics and attachment style moderate the effect of injury severity on occupational outcome in traumatic brain injury: Another aspect of reserve	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Brain reserve; Cognitive reserve; Functional outcome; Personality	BRIEF SYMPTOM INVENTORY; COGNITIVE RESERVE; RESILIENCE PROCESSES; FIT INDEXES; IMPACT; TBI; TEMPERAMENT; PREDICTORS; VALIDITY; BEHAVIOR	The concept of reserve has been proposed to account for the mismatch between brain pathology and its clinical expression. Prior efforts to characterize this concept focused mostly on brain or cognitive reserve measures. The present study was a preliminary attempt to evaluate premorbid personality and emotional aspects as potential moderators in moderate-to-severe traumatic brain injury. Using structural equation modeling and multiple regression analyses, we found that premorbid personality characteristics provided the most robust moderator of injury severity on occupational outcome. Findings offer preliminary support for premorbid personality features as another relevant reserve construct in predicting outcome in this population.	[Sela-Kaufman, Michal] Acad Coll Tel Aviv Yaffo, Dept Behav Sci, Tel Aviv, Israel; [Rassovsky, Yuri; Levi, Yifat; Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Rassovsky, Yuri; Vakil, Eli] Bar Ilan Univ, Susan Gonda Multidisciplinary Brain Res Ctr, IL-52900 Ramat Gan, Israel; [Rassovsky, Yuri] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Agranov, Eugenia] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Agranov, Eugenia] Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel		Rassovsky, Y (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	yurir@biu.ac.il		Rassovsky, Yuri/0000-0002-6362-9944			Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT, DOI 10.1037/t28248-000; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BENTLER PM, 1996, EQS STRUCTURAL EQUAT; Bigler ED, 2007, COGNITIVE RESERVE TH, P85; Bowlby J., 1973, ATTACHMENT LOSS SEPA; Bowlby J, 1969, ATTACHMENT LOSS ATTA; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Buss A., 1984, TEMPERAMENT EARLY DE; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; Costa Jr P.T., 1992, NEO PI R PROFESSIONA; Costa PT., 1992, PSYCHOL ASSESS, V4, P5, DOI [10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5]; Davey M, 2003, J ADOLESCENT RES, V18, P347, DOI 10.1177/0743558403018004002; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DEROGATIS LR, 1983, SYMPTOM CHECKLIST 90; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Faul M, 2010, TRAUMATIC BRAIN INJU; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Gilbar O, 2002, INT J STRESS MANAGE, V9, P1, DOI 10.1023/A:1013097816238; Handel SF, 2007, PSYCHOSOMATICS, V48, P67, DOI 10.1176/appi.psy.48.1.67; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jamshidian M, 1999, J EDUC BEHAV STAT, V24, P21, DOI 10.2307/1165260; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levi Y., 2013, J INT NEUROPSYCH SOC, V19, P1; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Little TD, 2006, STRUCT EQU MODELING, V13, P59, DOI 10.1207/s15328007sem1301_3; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Magai C, 1997, INT J GERIATR PSYCH, V12, P1092; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Mathiesen KS, 2006, EUR J DEV PSYCHOL, V3, P357, DOI 10.1080/17405620600557797; Mathiesen KS, 2000, J ABNORM CHILD PSYCH, V28, P15, DOI 10.1023/A:1005165916906; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; MIKULINCER M, 1995, PERS SOC PSYCHOL B, V21, P406, DOI 10.1177/0146167295214011; MIKULINCER M, 1990, J PERS SOC PSYCHOL, V58, P273, DOI 10.1037/0022-3514.58.2.273; Mikulincer M, 1998, J PERS SOC PSYCHOL, V75, P420, DOI 10.1037/0022-3514.75.2.420; Mikulincer M, 1999, PERS INDIV DIFFER, V27, P831, DOI 10.1016/S0191-8869(99)00032-X; Mikulincer M., 2000, J PERS SOC PSYCHOL, V79, P240; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ping RA, 1996, PSYCHOL BULL, V119, P166, DOI 10.1037/0033-2909.119.1.166; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Riolli L, 2002, J APPL SOC PSYCHOL, V32, P1604, DOI 10.1111/j.1559-1816.2002.tb02765.x; Roe A., 1956, PSYCHOL OCCUPATIONS; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Rothbart M. K., 1981, ADV DEV PSYCHOL, P37; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Solomon Z, 1998, EUR J PERSONALITY, V12, P271, DOI 10.1002/(SICI)1099-0984(199807/08)12:4<271::AID-PER309>3.0.CO;2-U; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; Svanberg OG., 1998, J MENTAL HLTH, V7, P543, DOI DOI 10.1080/09638239817716; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Ullman JB., 2001, USING MULTIVARIATE S, V4, P653; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; West S. G., 1991, MULTIPLE REGRESSION; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Zillmer E., 2008, PRINCIPLES NEUROPSYC	73	24	24	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 1	2013	35	6					584	595		10.1080/13803395.2013.799123			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	238BH	WOS:000325914900003	23701271				2022-02-06	
J	Cabrera, V; Ramos, E; Gonzalez-Arenas, A; Cerbon, M; Camacho-Arroyo, I; Morales, T				Cabrera, V.; Ramos, E.; Gonzalez-Arenas, A.; Cerbon, M.; Camacho-Arroyo, I.; Morales, T.			Lactation Reduces Glial Activation Induced by Excitotoxicity in the Rat Hippocampus	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						astrocytes; kainate; GFAP; Iba-1; microglial; reproduction	FIBROBLAST-GROWTH-FACTOR; PROLACTIN-INDUCED EXPRESSION; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; CINGULATE CORTEX; FEMALE RATS; NEUROPROTECTIVE ACTIONS; AROMATASE EXPRESSION; CULTURED ASTROCYTES; CELL-PROLIFERATION	Motherhood induces a series of adaptations in the physiology of the female, including an increase of maternal brain plasticity and a reduction of cell damage in the hippocampus caused by kainic acid (KA) excitotoxicity. We analysed the role of lactation in glial activation in the hippocampal fields of virgin and lactating rats after i.c.v. application of 100ng of KA. Immunohistochemical analysis for glial fibrillary acidic protein (GFAP) and ionised calcium binding adaptor molecule 1 (Iba-1), which are markers for astrocytes and microglial cell-surface proteins, respectively, revealed differential cellular responses to KA in lactating and virgin rats. A significant astrocyte and microglial response in hippocampal areas of virgin rats was observed 24h and 72h after KA. By contrast, no increase in either GFAP- or Iba-1-positive cells was observed in response to KA in the hippocampus of lactating rats. Western blot analysis of GFAP showed an initial decrease at 24h after KA treatment, with an increase at 72h in the whole hippocampus of virgin but not of lactating rats. The number of GFAP-positive cells was increased by lactation in the dentate gyrus of the hippocampus but not in CA1 and CA3 areas. The present results indicate that lactating rats exhibit diminished responses of astrocyte and microglial cells in the hippocampus to damage induced by KA, supporting the notion that the maternal hippocampus is resistant to excitotoxic insults.	[Cabrera, V.; Ramos, E.; Morales, T.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Celular & Mol, Queretaro, Mexico; [Gonzalez-Arenas, A.; Cerbon, M.; Camacho-Arroyo, I.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Queretaro, Mexico		Morales, T (corresponding author), UNAM, Inst Neurobiol, Blvd Juriquilla 3001, Queretaro 76230, Qro, Mexico.	marter@unam.mx	Morales, Teresa/I-2941-2019; Morales, Teresa/E-5927-2012; Camacho-Arroyo, Ignacio/AAM-4654-2021; Camacho-Arroyo, Ignacio/AAM-6757-2021	Morales, Teresa/0000-0003-1539-2070; Morales, Teresa/0000-0003-1539-2070; Camacho-Arroyo, Ignacio/0000-0003-2978-1253; Camacho-Arroyo, Ignacio/0000-0003-2978-1253	PAPIIT-DGAPA, UNAMPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN204709, IN202812]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [51044, 128090, 233854]	The present study was supported by PAPIIT-DGAPA, UNAM IN204709, IN202812; CONACYT 51044, 128090. Part of this work was the master's dissertation of VC, who received CONACyT fellowship No. 233854. The authors thank Dr Dorothy Pless for grammatical review, as well as Nydia Hernandez (Digital Imaging), Martin Garcia (Animal Care) and Ana Gabriela Pina-Medina Bsc (Western blot) for technical assistance.	AKWA Y, 1993, J CELL BIOL, V121, P135, DOI 10.1083/jcb.121.1.135; ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Arias C, 2009, HORM BEHAV, V55, P257, DOI 10.1016/j.yhbeh.2008.10.016; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; Azcoitia I, 2001, Prog Brain Res, V132, P469; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; DEVITO WJ, 1993, J NEUROCHEM, V60, P835, DOI 10.1111/j.1471-4159.1993.tb03227.x; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; DEVITO WJ, 1995, J CELL BIOCHEM, V57, P290, DOI 10.1002/jcb.240570213; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Estrada FS, 2012, NEUROSCI LETT, V514, P51, DOI 10.1016/j.neulet.2012.02.055; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Featherstone RE, 2000, BEHAV NEUROSCI, V114, P158, DOI 10.1037/0735-7044.114.1.158; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Furuta M, 2005, DEV BRAIN RES, V156, P61, DOI 10.1016/j.devbrainres.2005.01.008; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gomora-Arrati P, 2010, NEUROSCI LETT, V484, P197, DOI 10.1016/j.neulet.2010.08.052; Haraguchi S, 2010, ENDOCRINOLOGY, V151, P2211, DOI 10.1210/en.2009-1229; Jordan CL, 1999, J NEUROBIOL, V40, P434, DOI 10.1002/(SICI)1097-4695(19990915)40:4<434::AID-NEU2>3.0.CO;2-T; Kinsley CH, 2006, HORM BEHAV, V49, P131, DOI 10.1016/j.yhbeh.2005.05.017; Kinsley CH, 2008, HORM BEHAV, V54, P1, DOI 10.1016/j.yhbeh.2008.01.001; Leuner B, 2007, HIPPOCAMPUS, V17, P434, DOI 10.1002/hipo.20278; Moderscheim TAE, 2007, NEUROSCIENCE, V145, P963, DOI 10.1016/j.neuroscience.2006.12.053; Morales T, 2011, J NEUROENDOCRINOL, V23, P994, DOI 10.1111/j.1365-2826.2011.02141.x; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Oliet Stephane H R, 2006, Novartis Found Symp, V276, P238; Panatier A, 2006, NEURON GLIA BIOL, V2, P51, DOI 10.1017/S1740925X06000019; Pawluski JL, 2006, HORM BEHAV, V49, P143, DOI 10.1016/j.yhbeh.2005.05.016; Pawluski JL, 2009, FRONT NEUROENDOCRIN, V30, P343, DOI 10.1016/j.yfrne.2009.03.007; REPRESA A, 1993, J NEUROCYTOL, V22, P299, DOI 10.1007/BF01187128; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Russell J A, 2001, Prog Brain Res, V133, P1; Salmaso N, 2008, NEUROSCIENCE, V154, P932, DOI 10.1016/j.neuroscience.2008.03.063; Salmaso N, 2006, HORM BEHAV, V50, P448, DOI 10.1016/j.yhbeh.2006.05.006; Salmaso N, 2005, NEUROSCIENCE, V134, P1431, DOI 10.1016/j.neuroscience.2005.05.038; Salmaso N, 2009, EUR J NEUROSCI, V29, P786, DOI 10.1111/j.1460-9568.2009.06627.x; SAWCHENKO PE, 1990, J COMP NEUROL, V291, P269, DOI 10.1002/cne.902910209; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Simard AR, 2007, J COMP NEUROL, V504, P716, DOI 10.1002/cne.21469; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Takahashi DK, 2010, NEUROBIOL DIS, V40, P573, DOI 10.1016/j.nbd.2010.07.018; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Theodosis D T, 2001, Prog Brain Res, V133, P49; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; TORRE ER, 1993, BRAIN RES, V631, P256, DOI 10.1016/0006-8993(93)91543-2; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Yague JG, 2010, BRAIN RES, V1315, P41, DOI 10.1016/j.brainres.2009.09.111; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100	57	24	24	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	JUN	2013	25	6					519	527		10.1111/jne.12028			9	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	152FE	WOS:000319515400001	23356710				2022-02-06	
J	Huang, YH; Lee, TC; Lee, TH; Liao, CC; Sheehan, J; Kwan, AL				Huang, Yu-Hua; Lee, Tao-Chen; Lee, Tsung-Han; Liao, Chen-Chieh; Sheehan, Jason; Kwan, Aij-Lie			Thirty-day mortality in traumatically brain-injured patients undergoing decompressive craniectomy Clinical article	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; decompressive craniectomy mortality; age; Glasgow Coma Scale	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; AGE	Object. Decompressive craniectomy is a life-saving measure for patients who have sustained traumatic brain injury (TBI), but patients undergoing this procedure may still die during an early phase of head injury. The aim of this study was to investigate the incidence, causes, and risk factors of 30-day mortality in traumatically brain-injured patients undergoing decompressive craniectomy. Methods. The authors included 201 head-injured patients undergoing decompressive craniectomy in this 3-year retrospective study. The main outcome evaluated was 30-day mortality in patients who had undergone craniectomy after TBI. Demographic and clinical data, including information on death, were obtained for subsequent analysis. The authors identified differences between survivors and nonsurvivors in terms of clinical parameters; multivariate logistic regression was used to adjust for independent risk factors of short-term death. Results. The 30-day mortality rate was 26.4% in traumatically brain-injured patients undergoing decompressive craniectomy. The majority of deaths following decompression resulted from uncontrollable brain swelling and extensive brain infarction, which accounted for 79.2% of mortality. In the multivariate logistic regression mode, the 2 independent risk factors for 30-day mortality were age (OR 1.035 [95% CI 1.006-1.064]; p = 0.018) and Glasgow Coma Scale (GCS) score before decompressive craniectomy (OR 0.769 [95% CI 0.597-0.990]; p = 0.041). Conclusions. There is a high 30-day mortality rate in traumatically brain-injured patients undergoing decompressive craniectomy. Most of the deaths are attributed to ongoing brain damage, even after decompression. Risk factors of short-term death, including age and preoperative GCS score, are important in patient selection for decompressive craniectomy, and these factors should be considered together to ensure the highest chance of surviving TBI.	[Huang, Yu-Hua; Lee, Tao-Chen; Lee, Tsung-Han; Liao, Chen-Chieh] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Yu-Hua; Lee, Tao-Chen; Lee, Tsung-Han; Liao, Chen-Chieh] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Yu-Hua; Lee, Tsung-Han] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Dept Surg, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan; [Sheehan, Jason; Kwan, Aij-Lie] Univ Virginia Hlth Syst, Dept Neurosurg, Charlottesville, VA USA		Kwan, AL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, 100,Tzyou 1st Rd, Kaohsiung 807, Taiwan.	a_lkwan@yahoo.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Ciesla DJ, 2006, SURGERY, V140, P640, DOI 10.1016/j.surg.2006.06.015; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P373; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	23	24	28	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2013	118	6					1329	1335		10.3171/2013.1.JNS121775			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	150BY	WOS:000319366400033	23472847				2022-02-06	
J	Ortuzar, N; Rico-Barrio, I; Bengoetxea, H; Argandona, EG; Lafuente, JV				Ortuzar, N.; Rico-Barrio, I.; Bengoetxea, H.; Argandona, E. G.; Lafuente, J. V.			VEGF reverts the cognitive impairment induced by a focal traumatic brain injury during the development of rats raised under environmental enrichment	BEHAVIOURAL BRAIN RESEARCH			English	Article						VEGF; Enriched environment; Neurogliovascular unit; Vascularization; Learning and memory	EXPERIENCE-DEPENDENT PLASTICITY; GROWTH-FACTOR EXPRESSION; PRIMARY VISUAL-CORTEX; HIPPOCAMPAL NEUROGENESIS; POSTNATAL-DEVELOPMENT; SYNAPTIC PLASTICITY; NEURONAL PLASTICITY; CEREBRAL-ISCHEMIA; OCCIPITAL CORTEX; ARTERY OCCLUSION	The role of VEGF in the nervous system is extensive; apart from its angiogenic effect, VEGF has been described as a neuroprotective, neurotrophic and neurogenic molecule. Similar effects have been described for enriched environment (EE). Moreover, both VEGF and EE have been related to improved spatial memory. Our aim was to investigate the neurovascular and cognitive effects of intracerebrally-administered VEGF and enriched environment during the critical period of the rat visual cortex development. Results showed that VEGF infusion as well as enriched environment induced neurovascular and cognitive effects in developing rats. VEGF administration produced an enhancement during the learning process of enriched animals and acted as an angiogenic factor both in primary visual cortex (V1) and dentate gyrus (DG) in order to counteract minipump implantation-induced damage. This fact revealed that DG vascularization is critical for normal learning. In contrast to this enriched environment acted on the neuronal density of the DG and V1 cortex, and results showed learning enhancement only in non-operated rats. In conclusion, VEGF administration only has effects if damage is observed due to injury:Once control values were reached, no further effects appeared, showing a ceiling effect. Our results strongly support that in addition to neurogenesis, vascularization plays a pivotal role for learning and memory. (C) 2013 Elsevier B.V. All rights reserved.	[Ortuzar, N.; Rico-Barrio, I.; Bengoetxea, H.; Lafuente, J. V.] Univ Basque Country UPV EHU, Lab Clin & Expt Neurosci LaNCE, Dept Neurosci, Fac Med & Odontol, E-48940 Leioa, Spain; [Argandona, E. G.] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland		Ortuzar, N (corresponding author), Univ Basque Country UPV EHU, Lab Clin & Expt Neurosci LaNCE, Dept Neurosci, Fac Med & Odontol, Barrio Sarriena S-N, E-48940 Leioa, Spain.	naiara.ortuzar@ehu.es	Bengoetxea, Harkaitz/AAD-5751-2021; Lafuente, Jose-Vicente/O-6395-2014; Rico Barrio, Irantzu/H-6757-2015	Lafuente, Jose-Vicente/0000-0001-7246-0987; Rico Barrio, Irantzu/0000-0003-4908-1182	SAIOTEK (Industry Dept., Government of the Basque Country); Basque GovernmentBasque Government [IT/491/10]; UPV/EHU [UFI 11/32]; (FPU) from the Spanish Ministry of Education; University of the Basque Country (UPV/EHU)	This study has been supported by SAIOTEK (Industry Dept., Government of the Basque Country), IT/491/10 (Basque Government) and UFI 11/32 (UPV/EHU). N. Ortuzar is supported by a predoctoral grant (FPU) from the Spanish Ministry of Education and a post-doctoral grant of the University of the Basque Country (UPV/EHU). Confocal microscopy analysis was performed at the "Servicio de Microscopia Analitica y de Alta Resolucion en Biomedicina" (High Resolution Analytical Microscopy Services for Biomedicine) at the University of the Basque Country (UPV/EHU).	Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Argandona EG, 2012, BRAIN RES, V1473, P141, DOI 10.1016/j.brainres.2012.07.008; Argandona EG, 2012, CURR NEUROVASC RES, V9, P72; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; Bengoetxea H, 2008, CEREB CORTEX, V18, P1630, DOI 10.1093/cercor/bhm190; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Dahlqvist P, 1999, NEUROSCIENCE, V93, P527, DOI 10.1016/S0306-4522(99)00183-9; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Jones TA, 2011, DEV PSYCHOBIOL, V53, P466, DOI 10.1002/dev.20557; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kerr AL, 2010, NEUROSCIENCE, V171, P214, DOI 10.1016/j.neuroscience.2010.08.008; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Paban V, 2011, NEUROBIOL AGING, V32, P470, DOI 10.1016/j.neurobiolaging.2009.03.010; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pati S, 2009, BRAIN RES, V1256, P85, DOI 10.1016/j.brainres.2008.11.086; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pizzorusso T, 2007, NEURON, V54, P508, DOI 10.1016/j.neuron.2007.05.003; Plaschke K, 2008, EXP NEUROL, V214, P285, DOI 10.1016/j.expneurol.2008.08.014; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; ROSENZWEIG MR, 1969, BRAIN RES, V14, P427, DOI 10.1016/0006-8993(69)90120-6; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Thau-Zuchman O, 2012, J MOL NEUROSCI, V47, P166, DOI 10.1007/s12031-012-9706-8; Tsanov M, 2008, NEUROSCIENTIST, V14, P584, DOI 10.1177/1073858408315655; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wang YM, 2006, BRAIN RES, V1115, P186, DOI 10.1016/j.brainres.2006.07.060; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336	64	24	24	0	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 1	2013	246	1					36	46		10.1016/j.bbr.2013.02.036			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	140PT	WOS:000318668100006	23470903	Green Submitted			2022-02-06	
J	Picetti, E; Antonini, MV; Lucchetti, MC; Pucciarelli, S; Valente, A; Rossi, I; Schiavi, P; Servadei, F; Caspani, ML; Mergoni, M				Picetti, Edoardo; Antonini, Marta Velia; Lucchetti, Maria Chiara; Pucciarelli, Serena; Valente, Adriana; Rossi, Ilaria; Schiavi, Paolo; Servadei, Franco; Caspani, Maria Luisa; Mergoni, Mario			Intra-hospital Transport of Brain-Injured Patients: A Prospective, Observational Study	NEUROCRITICAL CARE			English	Article						Intra-hospital transport; Traumatic brain injury; Intensive care; Neurocritical care; Complications; Monitoring	CRITICALLY-ILL PATIENTS; SECONDARY INSULTS; STROKE COUNCIL; CARE; COMPLICATIONS; GUIDELINES; MANAGEMENT; HEMORRHAGE; EVENTS; SAFETY	Discrepant data exist regarding the incidence and severity of clinical problems related to intra-hospital transport of brain-injured patients and no consensus exists whether modern-day intra-hospital transport represents a safe or potentially problematic environment for neurointensive care unit (NICU) patients. We examined the incidence of clinical complications and physiological derangements that occurred in 160 neurologically injured patients (90 males, 70 females, mean age 57 +/- A 17 years) who underwent intra-hospital transport (288 cases, 237 scheduled, 51 unscheduled) for computed tomography scans. Our findings indicate that (1) at least one significant complication (predominantly hemodynamic) occurred in over one-third (36 %) of all transports (p = n.s scheduled vs. unscheduled) necessitating the deployment of interventions designed to treat changes in arterial pressure (2) despite the presence of trained medical personnel and availability of specialized equipment, intra-cranial pressure was not adequately monitored during transports (especially in patients with intra-cranial hypertension prior to transport) (3) intra-hospital transfer was associated with minor but statistically significant clinical changes, including a reduction in arterial partial pressure of oxygen ()/inspired oxygen fraction () (only in the scheduled transport population), decreased arterial lactate levels (scheduled transport population), lowered body temperature (scheduled transport population), and increased arterial partial pressure of carbon dioxide () (scheduled transport population). Intra-hospital transport of brain-injured NICU patients may present some hazards even if performed by skilled personnel with specialized equipment. In Trauma Centers such as ours, an improvement in the frequency of neuromonitoring [intra-cranial pressure (ICP) and end-tidal CO2 ()] during transport is recommended.	[Picetti, Edoardo; Antonini, Marta Velia; Rossi, Ilaria; Caspani, Maria Luisa; Mergoni, Mario] Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, I-43100 Parma, Italy; [Lucchetti, Maria Chiara; Pucciarelli, Serena; Valente, Adriana] Univ Parma, Scuola Specializzaz Anestesia & Rianimaz, I-43100 Parma, Italy; [Schiavi, Paolo; Servadei, Franco] Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, I-43100 Parma, Italy		Picetti, E (corresponding author), Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Schiavi, Paolo/AAB-9761-2022	schiavi, paolo/0000-0002-8108-7747; Servadei, Franco/0000-0002-3595-3464			Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Beckmann U, 2004, INTENS CARE MED, V30, P1579, DOI 10.1007/s00134-004-2177-9; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bekar A, 1998, NEUROSURG REV, V21, P98, DOI 10.1007/BF02389312; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crommett John W, 2002, Respir Care Clin N Am, V8, P105, DOI 10.1016/S1078-5337(02)00019-9; Damm C, 2005, ANN FR ANESTH, V24, P24, DOI 10.1016/j.annfar.2004.10.026; Ferdinande P, 1999, INTENS CARE MED, V25, P1441, DOI 10.1007/s001340051096; Gillman L, 2006, EMERG MED J, V23, P858, DOI 10.1136/emj.2006.037697; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; Haupt MT, 2000, CRIT CARE CLIN, V16, P1, DOI 10.1016/S0749-0704(05)70094-4; HURST JM, 1992, J TRAUMA, V33, P582, DOI 10.1097/00005373-199210000-00015; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; Shirley PJ, 2004, INTENS CARE MED, V30, P1508, DOI 10.1007/s00134-004-2293-6; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Stocchetti N, 1993, J NEUROTRAUMA S, V10, P187; Swanson EW, 2010, NEUROSURGERY, V66, P925, DOI 10.1227/01.NEU.0000368543.59446.A4; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; WALLEN E, 1995, CRIT CARE MED, V23, P1588, DOI 10.1097/00003246-199509000-00020; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; Waydhas C, 1999, CRIT CARE, V3, pR83, DOI 10.1186/cc362; WAYDHAS C, 1995, INTENS CARE MED, V21, P784, DOI 10.1007/BF01700959; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386	33	24	26	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2013	18	3					298	304		10.1007/s12028-012-9802-1			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	147II	WOS:000319159600003	23208448				2022-02-06	
J	Booth-Kewley, S; Schmied, EA; Highfill-McRoy, RM; Larson, GE; Garland, CF; Ziajko, LA				Booth-Kewley, Stephanie; Schmied, Emily A.; Highfill-McRoy, Robyn M.; Larson, Gerald E.; Garland, Cedric F.; Ziajko, Lauretta A.			Predictors of psychiatric disorders in combat veterans	BMC PSYCHIATRY			English	Article						Psychiatric disorders; Military populations; Marines; Iraq/Afghanistan wars; Veterans; Combat	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH DIAGNOSES; WAR ZONE STRESSORS; UK ARMED-FORCES; RISK-FACTORS; VIETNAM VETERANS; US SOLDIERS; GULF-WAR; ORGANIZATIONAL COMMITMENT	Background: Most previous research that has examined mental health among Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) combatants has relied on self-report measures to assess mental health outcomes; few studies have examined predictors of actual mental health diagnoses. The objective of this longitudinal investigation was to identify predictors of psychiatric disorders among Marines who deployed to combat in Iraq and Afghanistan. Methods: The study sample consisted of 1113 Marines who had deployed to Iraq or Afghanistan. Demographic and psychosocial predictor variables from a survey that all Marines in the sample had completed were studied in relation to subsequent psychiatric diagnoses. Univariate and multivariate logistic regression were used to determine the influence of the predictors on the occurrence of psychiatric disorders. Results: In a sample of Marines with no previous psychiatric disorder diagnoses, 18% were diagnosed with a new-onset psychiatric disorder. Adjusting for other variables, the strongest predictors of overall psychiatric disorders were female gender, mild traumatic brain injury symptoms, and satisfaction with leadership. Service members who expressed greater satisfaction with leadership were about half as likely to develop a mental disorder as those who were not satisfied. Unique predictors of specific types of mental disorders were also identified. Conclusions: Overall, the study's most relevant result was that two potentially modifiable factors, low satisfaction with leadership and low organizational commitment, predicted mental disorder diagnoses in a military sample. Additional research should aim to clarify the nature and impact of these factors on combatant mental health.	[Booth-Kewley, Stephanie; Schmied, Emily A.; Highfill-McRoy, Robyn M.; Larson, Gerald E.; Garland, Cedric F.] USN, Hlth Res Ctr, Behav Sci & Epidemiol Dept, San Diego, CA 92106 USA; [Garland, Cedric F.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Garland, Cedric F.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Ziajko, Lauretta A.] USN, Med Ctr, San Diego, CA 92134 USA		Booth-Kewley, S (corresponding author), USN, Hlth Res Ctr, Behav Sci & Epidemiol Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	stephanie.kewley@med.navy.mi			U.S. Navy Bureau of Medicine and Surgery, Washington, DC [61111]	This research was supported by the U.S. Navy Bureau of Medicine and Surgery, Washington, DC, under Work Unit No. 61111. The views and opinions expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. Approved for public release; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (protocol NHRC.2007.0003).	Adler AB, 1996, MIL PSYCHOL, V8, P1, DOI 10.1207/s15327876mp0801_1; Allen NJ, 2003, MIL PSYCHOL, V15, P237, DOI 10.1207/S15327876MP1503_06; ALLEN NJ, 1990, J OCCUP PSYCHOL, V63, P1, DOI 10.1111/j.2044-8325.1990.tb00506.x; Bartone PT, 2002, MIL PSYCHOL, V14, P321, DOI 10.1207/S15327876MP1404_6; Bartone PT, 1998, MIL MED, V163, P587, DOI 10.1093/milmed/163.9.587; Booth-Kewley S, 2005, MIL MED, V170, P87, DOI 10.7205/MILMED.170.1.87; Booth-Kewley S, 2010, J TRAUMA STRESS, V23, P69, DOI 10.1002/jts.20485; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Britt TW, 2004, MIL MED, V169, P541, DOI 10.7205/MILMED.169.7.541; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Castro CA, 2007, TRAUMATOLOGY, V13, P6, DOI [DOI 10.1177/1534765607309950, 10.1177/1534765607309950]; Cwikel J, 2008, SOC PSYCH PSYCH EPID, V43, P184, DOI 10.1007/s00127-007-0286-9; Dohrenwend BP, 2007, J TRAUMA STRESS, V20, P449, DOI 10.1002/jts.20296; Engelhard IM, 2007, CAN J PSYCHIAT, V52, P505, DOI 10.1177/070674370705200808; Fontana A, 1999, J TRAUMA STRESS, V12, P111, DOI 10.1023/A:1024750417154; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gade PA, 2003, MIL PSYCHOL, V15, P191, DOI 10.1207/S15327876MP1503_03; Goodman GP, 2011, GEN HOSP PSYCHIAT, V33, P51, DOI 10.1016/j.genhosppsych.2010.10.007; GRIFFITH J, 1988, BASIC APPL SOC PSYCH, V9, P149, DOI 10.1207/s15324834basp0902_6; Gunderson EKE, 2005, MIL MED, V170, P172; Helmus HT, 2005, STEELING MIND COMBAT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; Koenen KC, 2003, J CONSULT CLIN PSYCH, V71, P980, DOI 10.1037/0022-006X.71.6.980; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Litz BT, 1997, J CONSULT CLIN PSYCH, V65, P1001, DOI 10.1037/0022-006X.65.6.1001; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Maguen S, 2006, J APPL SOC PSYCHOL, V36, P820, DOI 10.1111/j.0021-9029.2006.00045.x; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Mental Health Advisory Team VI, 2009, MENT HLTH ADV TEAM M; Oliver LW, 1999, MIL PSYCHOL, V11, P57, DOI 10.1207/s15327876mp1101_4; Richardson JD, 2007, CAN J PSYCHIAT, V52, P510, DOI 10.1177/070674370705200809; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Rona RJ, 2007, INT J EPIDEMIOL, V36, P319, DOI 10.1093/ije/dyl273; Rona RJ, 2009, J TRAUMA STRESS, V22, P11, DOI 10.1002/jts.20383; Rundell JR, 2006, GEN HOSP PSYCHIAT, V28, P352, DOI 10.1016/j.genhosppsych.2006.04.006; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; SOUTHWICK SM, 1995, AM J PSYCHIAT, V152, P1150; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Turner JB, 2007, J TRAUMA STRESS, V20, P643, DOI 10.1002/jts.20245; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Vogt DS, 2005, J TRAUMA STRESS, V18, P115, DOI 10.1002/jts.20018; WOLFE J, 1993, J SOC ISSUES, V49, P15, DOI 10.1111/j.1540-4560.1993.tb01179.x; Zinzow HM, 2008, PSYCHIAT RES, V159, P226, DOI 10.1016/j.psychres.2007.04.008	55	24	24	0	20	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	MAY 7	2013	13								130	10.1186/1471-244X-13-130			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	145TW	WOS:000319041800003	23651663	Green Published, gold			2022-02-06	
J	Birnie, M; Morrison, R; Camara, R; Strauss, KI				Birnie, Matthew; Morrison, Ryan; Camara, Ramatoulie; Strauss, Kenneth I.			Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury	BMC GENOMICS			English	Article						Cytochrome P450 genes; Arachidonic acid metabolic genes; Hippocampus; Parietal cortex; qPCR low density array; In situ hybridization	EPOXIDE HYDROLASE INHIBITION; ARACHIDONIC-ACID METABOLISM; TRANSIENT CEREBRAL-ISCHEMIA; EPOXYEICOSATRIENOIC ACIDS; RETINOIC ACID; PROSTAGLANDIN E-2; CEREBROSPINAL-FLUID; CATALYTIC-ACTIVITY; LEUKOTRIENE C-4; BLOOD-PRESSURE	Background: Traumatic brain injury (TBI) induces arachidonic acid (ArA) release from cell membranes. ArA metabolites form a class of over 50 bioactive eicosanoids that can induce both adaptive and/or maladaptive brain responses. The dynamic metabolism of ArA to eicosanoids, and how they affect the injured brain, is poorly understood due to their diverse activities, trace levels, and short half-lives. The eicosanoids produced in the brain postinjury depend upon the enzymes present locally at any given time. Eicosanoids are synthesized by heme-containing enzymes, including cyclooxygenases, lipoxygenases, and arachidonate monoxygenases. The latter comprise a subset of the cytochrome P450 "Cyp" gene family that metabolize fatty acids, steroids, as well as endogenous and exogenous toxicants. However, for many of these genes neither baseline neuroanatomical nor injury-related temporal expression have been studied in the brain. In a rat model of parietal cortex TBI, Cyp and eicosanoid-related mRNA levels were determined at 6 h, 24 h, 3d, and 7d postinjury in parietal cortex and hippocampus, where dynamic changes in eicosanoids have been observed. Quantitative real-time polymerase chain reaction with low density arrays were used to assay 62 rat Cyps, 37 of which metabolize ArA or other unsaturated fatty acids; 16 eicosanoid-related enzymes that metabolize ArA or its metabolites; 8 eicosanoid receptors; 5 other inflammatory- and recovery-related genes, plus 2 mouse Cyps as negative controls and 3 highly expressed "housekeeping" genes. Results: Sixteen arachidonate monoxygenases, 17 eicosanoid-related genes, and 12 other Cyps were regulated in the brain postinjury (p < 0.05, Tukey HSD). Discrete tissue levels and distinct postinjury temporal patterns of gene expression were observed in hippocampus and parietal cortex. Conclusions: The results suggest complex regulation of ArA and other lipid metabolism after TBI. Due to the temporal nature of brain injury-induced Cyp gene induction, manipulation of each gene (or its products) at a given time after TBI will be required to assess their contributions to secondary injury and/or recovery. Moreover, a better understanding of brain region localization and cell type-specific expression may be necessary to deduce the role of these eicosanoid-related genes in the healthy and injured brain.	[Birnie, Matthew; Morrison, Ryan; Camara, Ramatoulie; Strauss, Kenneth I.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA		Strauss, KI (corresponding author), Michigan State Univ, Coll Human Med, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	kenneth.strauss@hc.msu.edu		Birnie, Matthew/0000-0003-3964-5247	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS054890]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054890] Funding Source: NIH RePORTER	This work was supported by NINDS R01-NS054890. The authors express their appreciation for excellent technical assistance from Nathan Kuhn, Jason Dudley, Andrew Barnikow, and Allyson Cole-Strauss.	Abdu E, 2011, J NEUROCHEM, V117, P632, DOI 10.1111/j.1471-4159.2010.07139.x; ADESUYI SA, 1985, J NEUROCHEM, V45, P770, DOI 10.1111/j.1471-4159.1985.tb04059.x; Ashkar S, 2004, J OCUL PHARMACOL TH, V20, P65, DOI 10.1089/108076804772745473; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Bolbrinker J, 2011, J HYPERTENS, V29, P56, DOI 10.1097/HJH.0b013e32833f5de5; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brenneis C, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-78; Bromek E, 2011, J NEUROCHEM, V118, P806, DOI 10.1111/j.1471-4159.2011.07339.x; Bromek E, 2010, EUR J PHARMACOL, V626, P171, DOI 10.1016/j.ejphar.2009.09.062; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bylund J, 2002, BIOCHEM BIOPH RES CO, V296, P677, DOI 10.1016/S0006-291X(02)00918-X; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; Camara NOS, 2009, CURR OPIN NEPHROL HY, V18, P21, DOI 10.1097/MNH.0b013e32831a9df7; Campbell WB, 2000, TRENDS PHARMACOL SCI, V21, P125, DOI 10.1016/S0165-6147(00)01472-3; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Canals S, 2003, J BIOL CHEM, V278, P21542, DOI 10.1074/jbc.M213174200; Candelario-Jalil E, 2002, BRAIN RES, V927, P212, DOI 10.1016/S0006-8993(01)03358-3; Candelario-Jalil E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-3; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chiba Y, 2006, NEUROSCIENCE, V141, P917, DOI 10.1016/j.neuroscience.2006.04.012; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; ELLIS EF, 1991, ADV PROSTAG THROMB L, V21, P201; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; Ermert L, 2000, AM J PHYSIOL-LUNG C, V278, pL744, DOI 10.1152/ajplung.2000.278.4.L744; Fathali N, 2009, CRIT CARE M IN PRESS; Fathali N, 2010, CRIT CARE MED, V38, P572, DOI 10.1097/CCM.0b013e3181cb1158; Ferroni S, 2003, J NEUROSCI RES, V72, P363, DOI 10.1002/jnr.10580; FITZPATRICK FA, 1988, PHARMACOL REV, V40, P229; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; Gonzalez-Quevedo R, 2010, DEV CELL, V18, P136, DOI 10.1016/j.devcel.2009.11.010; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hagglund M, 2006, J NEUROSCI, V26, P3281, DOI 10.1523/JNEUROSCI.4955-05.2006; Hampson AJ, 2002, J NEUROSCI, V22, P257, DOI 10.1523/JNEUROSCI.22-01-00257.2002; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; HARDER DR, 1994, AM J PHYSIOL, V266, pH2098, DOI 10.1152/ajpheart.1994.266.5.H2098; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Higashimori H, 2010, AM J PHYSIOL-CELL PH, V299, pC1068, DOI 10.1152/ajpcell.00225.2010; Hoch U, 2000, ARCH BIOCHEM BIOPHYS, V373, P63, DOI 10.1006/abbi.1999.1504; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Holla VR, 1999, J CLIN INVEST, V104, P751, DOI 10.1172/JCI7013; Homayoun P, 1997, J NEUROCHEM, V69, P199; Iliff JJ, 2007, EXP PHYSIOL, V92, P653, DOI 10.1113/expphysiol.2006/036889; Iliff JJ, 2010, J NEUROCHEM, V115, P1530, DOI 10.1111/j.1471-4159.2010.07059.x; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; IMAOKA S, 1993, J PHARMACOL EXP THER, V267, P1012; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Imig JD, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001773; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Kawashima H, 1997, ARCH BIOCHEM BIOPHYS, V347, P148, DOI 10.1006/abbi.1997.0342; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kibaly C, 2005, J NEUROCHEM, V93, P1220, DOI 10.1111/j.1471-4159.2005.03113.x; Kimoto T, 2010, ENDOCRINOLOGY, V151, P5795, DOI 10.1210/en.2010-0581; KONTOS HA, 1981, FED PROC, V40, P2326; Kozak W, 2000, AM J PHYSIOL-REG I, V279, pR455, DOI 10.1152/ajpregu.2000.279.2.R455; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Lammers CH, 1996, J NEUROCHEM, V66, P147; Leffler CW, 1997, AM J PHYSIOL-HEART C, V273, pH333, DOI 10.1152/ajpheart.1997.273.1.H333; LESLIE JB, 1985, J NEUROSURG, V63, P659, DOI 10.3171/jns.1985.63.5.0659; Levi G, 1998, BIOCHIMIE, V80, P899, DOI 10.1016/S0300-9084(00)88886-0; Li J, 2011, J CEREBR BLOOD F MET, V31, P413, DOI 10.1038/jcbfm.2010.181; Li Z, 2009, J CEREBR BLOOD F MET, V29, P287, DOI 10.1038/jcbfm.2008.118; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makita K, 1996, FASEB J, V10, P1456, DOI 10.1096/fasebj.10.13.8940291; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Mastyugin V, 1999, J PHARMACOL EXP THER, V289, P1611; Mateos L, 2011, J BIOL CHEM, V286, P25574, DOI 10.1074/jbc.M111.236877; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; McCullough LD, 2003, J NEUROSCI, V23, P8701; McDonough W, 1998, J NEUROPATH EXP NEUR, V57, P449, DOI 10.1097/00005072-199805000-00008; MCGIFF JC, 1991, ADV PROSTAG THROMB L, V21, P675; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Mezentsev A, 2005, J PHARMACOL EXP THER, V315, P42, DOI 10.1124/jpet.105.088211; Michaelis UR, 2005, J CELL SCI; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P1213, DOI 10.1097/00004647-199911000-00005; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nguyen TV, 2010, J NEUROENDOCRINOL, V22, P1013, DOI 10.1111/j.1365-2826.2010.02044.x; Nissbrandt H, 2001, SYNAPSE, V40, P294, DOI 10.1002/syn.1052; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; OHTSUKI T, 1995, AM J PHYSIOL-HEART C, V268, pH1249, DOI 10.1152/ajpheart.1995.268.3.H1249; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Poloyac SM, 2006, J CEREBR BLOOD F MET, V26, P1551, DOI 10.1038/sj.jcbfm.9600309; Poloyac SM, 2005, J NEUROSCI METH, V144, P257, DOI 10.1016/j.jneumeth.2004.11.015; Qian LX, 2010, J LIPID RES, V51, P1781, DOI 10.1194/jlr.M002840; Qu W, 2001, J BIOL CHEM, V276, P25467, DOI 10.1074/jbc.M100545200; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramamurthy S, 2006, J NEUROSCI RES, V84, P1402, DOI 10.1002/jnr.21061; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Ruparel S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-73; Ruparel S, 2012, PAIN, V153, P2031, DOI 10.1016/j.pain.2012.04.027; Sarkar P, 2011, NEUROSCIENCE, V194, P241, DOI 10.1016/j.neuroscience.2011.07.058; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHAW PM, 1993, MOL PHARMACOL, V44, P775; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Snider NT, 2010, PHARMACOL REV, V62, P136, DOI 10.1124/pr.109.001081; Stark K, 2008, FEBS J, V275, P3706, DOI 10.1111/j.1742-4658.2008.06518.x; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; STRAUSS KI, 1993, MOL BRAIN RES, V20, P229, DOI 10.1016/0169-328X(93)90045-Q; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Strauss KI, 2000, RESTOR NEUROL NEUROS, V16, P263; Strauss KI, 2012, PROSTAGLAND IN PRESS; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takemiya T, 2007, NEUROCHEM INT, V51, P112, DOI 10.1016/j.neuint.2007.05.009; Tehranipour M, 2010, J MOTOR BEHAV, V42, P151, DOI 10.1080/00222891003697921; Terashvili M, 2008, J PHARMACOL EXP THER, V326, P614, DOI 10.1124/jpet.108.136739; Tindberg N, 1996, J NEUROCHEM, V67, P2066, DOI 10.1046/j.1471-4159.1996.67052066.x; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Wagner K, 2011, PROSTAG OTH LIPID M, V96, P76, DOI 10.1016/j.prostaglandins.2011.08.001; Wang C, 2011, J BIOL CHEM, V286, P6542, DOI 10.1074/jbc.M110.198382; Wang MH, 1999, AM J PHYSIOL-RENAL, V276, pF246, DOI 10.1152/ajprenal.1999.276.2.F246; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; Wu SN, 2000, BIOCHEM PHARMACOL, V60, P251, DOI 10.1016/S0006-2952(00)00317-8; Xu FY, 2004, J PHARMACOL EXP THER, V308, P887, DOI 10.1124/jpet.103.059626; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; YERGEY JA, 1990, J CEREBR BLOOD F MET, V10, P143, DOI 10.1038/jcbfm.1990.20; Ying CJ, 2008, HYPERTENS RES, V31, P1821, DOI 10.1291/hypres.31.1821; Yu M, 2004, EUR J PHARMACOL, V486, P297, DOI 10.1016/j.ejphar.2004.01.009; Yu ZG, 2000, MOL PHARMACOL, V57, P1011; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang F, 2005, CELL RES, V15, P717, DOI 10.1038/sj.cr.7290341; Zhang F, 2002, ACTA PHARMACOL SIN, V23, P497; Zhang J, 1999, EUR J NEUROSCI, V11, P2651, DOI 10.1046/j.1460-9568.1999.00682.x; Zhang QY, 1997, ARCH BIOCHEM BIOPHYS, V340, P270, DOI 10.1006/abbi.1997.9922; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zou AP, 1996, AM J PHYSIOL-REG I, V270, pR228, DOI 10.1152/ajpregu.1996.270.1.R228	156	24	24	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAY 4	2013	14								303	10.1186/1471-2164-14-303			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	148DU	WOS:000319223900001	23642095	Green Published, gold			2022-02-06	
J	Leopold, E; Gefen, A				Leopold, Efrat; Gefen, Amit			Changes in permeability of the plasma membrane of myoblasts to fluorescent dyes with different molecular masses under sustained uniaxial stretching	MEDICAL ENGINEERING & PHYSICS			English	Article						Fluorescence-activated cell sorting; Dextran; Deformation-diffusion; Skeletal muscle cells; Confocal imaging	DEEP TISSUE-INJURY; SUB-DERMAL TISSUES; MACROMOLECULES; DEFORMATIONS; COMPRESSION; REPERFUSION; STRAINS; MODEL; SIZE; MRI	Deep tissue injury (DTI) is a serious pressure ulcer which onsets in skeletal muscle tissues adjacent to weight-bearing bony prominences. Recent literature points at sustained large deformations in muscle tissue, which translate to static stretching of the plasma membrane (PM) at the cell-scale, as the primary cause of accumulated cell death in DTI. It has been specifically suggested that prolonged exposure to large tensional PM strains interferes with normal cellular homeostasis, primarily by affecting transport through the PM which could become more permeable when stretched. In this context, using confocal imaging and fluorescence-activated cell sorter (FACS), we visualized and quantified here the uptake of fluorescent Dextran dye by myoblasts that were statically stretched uniaxially, up to physiological strains of 3%, 6% and 9%, using two different molecular masses for the Dextran (4 kDa and 20 kDa). The confocal and FACS studies provided consistent evidence that the permeability of the PM increased at large static deformations. Furthermore, the FACS data indicated that the kinetics of the PM permeability very likely depends on the size of the biomolecular marker. Both results were consistent with reports published in the neurotrauma literature on the kinetics of uptake of fluorescent biomolecules by dynamically stretched neurons; hence there are some analogues in the biomechanical pathways of cellular-level injury between DTI and impact insults. The present work provides additional empirical support to the theory of cell-scale deformation-diffusion damage in the etiology of DTI, and may lead to better understanding of time courses for onset of cellular damage in DTI, by exploring mass transport processes across the PM of the involved cells. (C) 2012 IPEM. Published by Elsevier Ltd. All rights reserved.	[Leopold, Efrat; Gefen, Amit] Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel		Gefen, A (corresponding author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	gefen@eng.tau.ac.il	Gefen, Amit/M-4720-2015	Gefen, Amit/0000-0002-0223-7218	Ministry of Science & Technology, IsraelMinistry of Science, Technology and Space (MOST), Israel; Ministry of Research, TaiwanMinistry of Education, Taiwan	We are thankful to the following personnel from the Department of Biomedical Engineering at Tel Aviv University: Dr. Uri Zaretsky for helping with the design of the UCSD, Ms. Naama Shoham for assisting with calibration of the UCSD, and Ms. Riki Levkovitch for helping with the pre-confocal staining. This research is being supported by a grant from the Ministry of Science & Technology, Israel & the Ministry of Research, Taiwan (A.G.).	Agam L, 2007, J Wound Care, V16, P336; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583; Ceelen KK, 2009, EXP MECH, V49, P25, DOI 10.1007/s11340-007-9093-1; Freitas RA, 1999, NANOMEDICINE, V1; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gefen Amit, 2007, Int Wound J, V4, P222, DOI 10.1111/j.1742-481X.2007.00330.x; Gefen A, 2008, J BIOMECH, V41, P845, DOI 10.1016/j.jbiomech.2007.10.023; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Leopold E, 2012, J TISSUE VIABILITY, V21, P27, DOI 10.1016/j.jtv.2011.11.002; Leopold E, 2011, MED ENG PHYS, V33, P1072, DOI 10.1016/j.medengphy.2011.04.008; Levy A, 2012, ANN BIOMED ENG, V40, P1052, DOI 10.1007/s10439-011-0496-x; Linder-Ganz E, 2008, J BIOMECH, V41, P567, DOI 10.1016/j.jbiomech.2007.10.011; Linder-Ganz E, 2007, J BIOMECH, V40, P1443, DOI 10.1016/j.jbiomech.2006.06.020; Loerakker S, 2010, ANN BIOMED ENG, V38, P2577, DOI 10.1007/s10439-010-0002-x; Loerakker S, 2011, J APPL PHYSIOL, V111, P1168, DOI 10.1152/japplphysiol.00389.2011; Mak AFT, 2011, J THEOR BIOL, V289, P65, DOI 10.1016/j.jtbi.2011.08.022; Mak AFT, 2010, ANNU REV BIOMED ENG, V12, P29, DOI 10.1146/annurev-bioeng-070909-105223; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; OLIVER JD, 1992, J AM SOC NEPHROL, V3, P214; Shabshin N, 2010, CLIN BIOMECH, V25, P402, DOI 10.1016/j.clinbiomech.2010.01.019; Shabshin N, 2010, J REHABIL RES DEV, V47, P31, DOI 10.1682/JRRD.2009.07.0105; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shoham N, 2012, AM J PHYSIOL-CELL PH, V302, pC429, DOI 10.1152/ajpcell.00167.2011; Siu PM, 2009, J APPL PHYSIOL, V107, P1266, DOI 10.1152/japplphysiol.90897.2008; Slomka N, 2012, ANN BIOMED ENG, V40, P606, DOI 10.1007/s10439-011-0423-1; Slomka N, 2009, CELL MOL BIOENG, V2, P118, DOI 10.1007/s12195-009-0046-x; Sopher R, 2011, J BIOMECH ENG, V133, P2; Stekelenburg A, 2008, ARCH PHYS MED REHAB, V89, P1410, DOI 10.1016/j.apmr.2008.01.012; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004	33	24	24	1	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	MAY	2013	35	5					601	607		10.1016/j.medengphy.2012.07.004			7	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	137SH	WOS:000318457200006	22854841				2022-02-06	
J	Ragsdale, KA; Neer, SM; Beidel, DC; Frueh, BC; Stout, JW				Ragsdale, Katie A.; Neer, Sandra M.; Beidel, Deborah C.; Frueh, B. Christopher; Stout, Jeremy W.			Posttraumatic stress disorder in OEF/OIF veterans with and without traumatic brain injury	JOURNAL OF ANXIETY DISORDERS			English	Article						Posttraumatic stress disorder; Traumatic brain injury; OEF/OIF; Veteran	PERSISTENT POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; PTSD; MILITARY; AFGHANISTAN; DEPLOYMENT; IRAQ; PREVALENCE; DEPRESSION; SEVERITY	Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) are presenting with high rates of co-occurring posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI). The purpose of this study was to compare the clinical presentations of combat-veterans with PTSD and TBI (N=40) to those with PTSD only (N=56). Results suggest that the groups present two distinct clinical profiles, with the PTSD+TBI group endorsing significantly higher PTSD scores, higher overall anxiety, and more functional limitations. The higher PTSD scores found for the PTSD+TBI group appeared to be due to higher symptom intensity, but not higher frequency, across PTSD clusters and symptoms. Groups did not differ on additional psychopathology or self-report of PTSD symptoms or executive functioning. Further analysis indicated PTSD severity, and not TBI, was responsible for group differences, suggesting that treatments implicated for PTSD would likely be effective for this population. (C) 2013 Elsevier Ltd. All rights reserved.	[Ragsdale, Katie A.; Neer, Sandra M.; Beidel, Deborah C.; Stout, Jeremy W.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA; [Frueh, B. Christopher] Univ Hawaii, Dept Psychol, Hilo, HI 96720 USA		Ragsdale, KA (corresponding author), Univ Cent Florida, Anxiety Disorders Clin, Dept Psychol, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	KatieRagsdale@knights.ucf.edu; Sandra.Neer@ucf.edu; Deborah.Beidel@ucf.edu; frueh@hawaii.edu; jwstout@knights.ucf.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Bunnell B. E., 2013, J ABNORMAL PSYCHOL; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Department of Defense, 2012, DOD WORLDW NUMB TRAU; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Epidemiology Program Post Deployment Health Strategic Healthcare Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Ferrier-Auerbach AG, 2010, J PSYCHIATR RES, V44, P470, DOI 10.1016/j.jpsychires.2009.10.010; First M.B., 1996, STRUCTURED CLIN INTE; Forbes D., 2012, PSYCHIAT RES, V44, P470; FOY DW, 1984, J CONSULT CLIN PSYCH, V52, P79, DOI 10.1037/0022-006X.52.1.79; Gioia GA, 2005, PSYCHOL ASSESS RESOU; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hermann BA, 2012, MIL MED, V177, P1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lauterbach D, 2001, J TRAUMA STRESS, V14, P29; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Ware J., 2000, SCORE VERSION 2 SF 3; Ware J, 2003, VERSION 2 SF 36 HLTH; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F.W., 1993, 9 ANN C ISTSS; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Zawadzki B, 2012, J INDIVID DIFFER, V33, P257, DOI 10.1027/1614-0001/a000074	46	24	24	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6185	1873-7897		J ANXIETY DISORD	J. Anxiety Disord.	MAY	2013	27	4					420	426		10.1016/j.janxdis.2013.04.003			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	184IJ	WOS:000321883000008	23746495				2022-02-06	
J	Sander, AM; Maestas, KL; Nick, TG; Pappadis, MR; Hammond, FM; Hanks, RA; Ripley, DL				Sander, Angelle M.; Maestas, Kacey Little; Nick, Todd G.; Pappadis, Monique R.; Hammond, Flora M.; Hanks, Robin A.; Ripley, David L.			Predictors of Sexual Functioning and Satisfaction 1 Year Following Traumatic Brain Injury: A TBI Model Systems Multicenter Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						sexual dysfunction; traumatic brain injury	PARTICIPATION ASSESSMENT; DEPRESSIVE SYMPTOMS; SELF-REPORT; REHABILITATION; MEN; ADENOCARCINOMA; PRETREATMENT; DYSFUNCTION; BEHAVIOR	Objective: To investigate predictors of sexual functioning 1 year following traumatic brain injury (TBI). Design: Prospective cohort study. Setting: Community. Participants: A total of 255 persons with TBI (187 males; 68 females) who had been treated at 1 of 6 TBI Model Systems inpatient rehabilitation units and were living in the community. Main Measures: Derogatis Interview for Sexual Functioning-Self-Report (DISF-SR); Global Satisfaction With Sexual Functioning (Global Sexual Satisfaction Index); Participation Assessment With Recombined Tools-Objective; Patient Health Questionnaire-9. Results: Older age, female gender, and more severe injury were associated with greater sexual dysfunction 1 year following injury. As age increased from 24 to 49 years, the odds of sexual impairment increased more than 3-fold (95% confidence interval: 1.82-5.88). Females had a 2.5 increase in odds of sexual impairment compared with males (95% confidence interval: 1.23-5.26). Greater social participation was predictive of better sexual functioning. Dissatisfaction with sexual functioning was predicted by older age and depression. Conclusions and Implications: Older persons and females appear to be at greater risk for sexual dysfunction after TBI and may benefit from specialized assessment and treatment services. Relationships were identified between social participation and sexual function and between depression and sexual satisfaction that may serve as clinical indicators for further assessment and intervention. Further research is needed to elucidate these relationships and identify effective clinical approaches.	[Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Baylor Coll Med, Dept Phys Med & Rehabil,Harris Hlth Syst, Houston, TX USA; [Maestas, Kacey Little] TIRR Mem Hermann, Brain Injury Res Ctr, Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA; [Nick, Todd G.] Univ Arkansas Med Sci, Coll Med & Publ Hlth, Dept Pediat, Little Rock, AR 72205 USA; [Nick, Todd G.] Univ Arkansas Med Sci, Coll Med & Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA; [Pappadis, Monique R.] Univ Houston, Grad Coll Social Work, TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Carolinas HealthCare Syst, Carolinas Rehabil, Indianapolis, IN USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI USA; [Ripley, David L.] Craig Hosp, Rehabil Inst Chicago, Chicago, IL USA		Sander, AM (corresponding author), Brain Injury Res Ctr, 2323 South Shepherd Dr,Ste 907, Houston, TX 77019 USA.	asander@bcm.edu	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380; Ripley, David/0000-0002-5349-1830	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A070043, H133B031117, H133A080044, H133A070042, H133A070013, H133A080045, H133A070022]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grant nos. H133A070043, H133B031117, H133A080044, H133A070042, H133A070013, H133A080045, H133A070022).	Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Chandler BJ, 1998, J NEUROL NEUROSUR PS, V65, P877, DOI 10.1136/jnnp.65.6.877; Cyranowski JM, 2004, J PSYCHIATR RES, V38, P267, DOI 10.1016/j.jpsychires.2003.08.003; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis L. R., 1975, DEROGATIS SEXUAL FUN; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Frohlich P, 2002, J SEX RES, V39, P321, DOI 10.1080/00224490209552156; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Nelson CJ, 2007, J SEX MED, V4, P1422, DOI 10.1111/j.1743-6109.2007.00547.x; Nicolosi A, 2004, J AFFECT DISORDERS, V82, P235, DOI 10.1016/j.jad.2003.12.008; NOFZINGER EA, 1993, ARCH GEN PSYCHIAT, V50, P24; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; *STAT U NEW YORK, 1996, GUID UN DAT SET MED; Tan G, 1998, SEX DISABIL, V16, P77, DOI 10.1023/A:1023023924804; TEASDALE G, 1974, LANCET, V2, P81; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P729, DOI 10.1016/0360-3016(90)90503-C; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P1001, DOI 10.1016/0360-3016(90)90025-F	38	24	24	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					186	194		10.1097/HTR.0b013e31828b4f91			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000005	23661070				2022-02-06	
J	Simmons, AN; Flagan, TM; Wittmann, M; Strigo, IA; Matthews, SC; Donovan, H; Lohr, JB; Paulus, MP				Simmons, Alan N.; Flagan, Taru M.; Wittmann, Marc; Strigo, Irina A.; Matthews, Scott C.; Donovan, Heather; Lohr, James B.; Paulus, Martin P.			The effects of temporal unpredictability in anticipation of negative events in combat veterans with PTSD	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Predictability; Anticipation; Insula; Posttraumatic stress disorder; Time; FMRI	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; AVERSIVE VISUAL-STIMULI; INSULA ACTIVATION; ANTERIOR INSULA; NEURAL MECHANISMS; TIME PERCEPTION; ANXIETY; UNCERTAINTY; AMYGDALA	Background: Exposure to psychological stress during combat can lead to posttraumatic stress disorder (PTSD). Anticipation of aversive events is often associated with an intense emotional state in individuals with PTSD. Both the valence (i.e., positive or negative) of the anticipated event and the degree of temporal predictability (i.e., one's ability to predict when an event will occur) have profound effects on an individual's emotional experience. This investigation tested the hypothesis that individuals with combat-related PTSD would show increased activation in the insula and related emotion-processing circuitry when anticipating emotionally significant events such as portrayed in combat-related images, and this heighted response within the insula would be particularly enhanced during temporal unpredictability. Methods: About 15 male veterans with PTSD and 15 male veterans with combat-exposure but no current or lifetime history of PTSD (combat exposed controls/CEC) performed a temporal unpredictability anticipation task of unpleasant (combat-related) and pleasant images during fMRI. Results: As expected, greater activation in the bilateral anterior insulae was observed in the PTSD versus the CEC subjects during anticipation of combat-related images when the anticipatory period was of uncertain duration (p<0.05). Furthermore, activation in the right anterior insula was related to greater perceived threat in the CEC group (rho=0.619). Limitations: The current study looks only at combat-related PTSD in a modest preliminary sized sample. Conclusions: These findings suggest that an excessive anticipatory reaction in individuals with PTSD to temporally unpredictable aversive stimulus may relate to greater perceived threat. These findings are concordant with psychological models of PTSD that focus on the association of PTSD with the experience of decreased predictability and control. Published by Elsevier B.V.	[Simmons, Alan N.; Strigo, Irina A.; Matthews, Scott C.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92130 USA; [Simmons, Alan N.; Wittmann, Marc; Matthews, Scott C.; Donovan, Heather; Lohr, James B.; Paulus, Martin P.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA 92130 USA; [Simmons, Alan N.; Strigo, Irina A.; Donovan, Heather; Lohr, James B.; Paulus, Martin P.] VA Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA USA; [Matthews, Scott C.] VA Mental Illness Res Educ & Clin Ctr MIRECC, San Diego, CA USA; [Simmons, Alan N.; Flagan, Taru M.; Wittmann, Marc; Strigo, Irina A.; Matthews, Scott C.; Donovan, Heather; Lohr, James B.; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Wittmann, Marc] Inst Frontier Areas Psychol & Mental Hlth, Dept Empir & Analyt Psychophys, Freiburg, Germany		Simmons, AN (corresponding author), 3350 La Jolla Village Dr, San Diego, CA 92130 USA.	ansimmons@ucsd.edu	Simmons, Alan N/A-9815-2008; Wittmann, Marc/ABC-6363-2020; strigo, irina A/L-9882-2016	Simmons, Alan N/0000-0003-3963-2112; Wittmann, Marc/0000-0002-4483-7334; strigo, irina A/0000-0002-8799-716X	veteran's association	This paper was funded through research grant administrated by the veteran's association which exerted to bias on the interpretation of the results.	Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Bremner JD, 2003, PSYCHONEUROENDOCRINO, V28, P733, DOI 10.1016/S0306-4530(02)00067-7; Brunia CHM, 2000, EXP BRAIN RES, V130, P328, DOI 10.1007/s002219900293; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Delis DC., 2001, DELIS KAPLAN EXECUTI; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FALK JL, 1954, J EXP PSYCHOL, V47, P279, DOI 10.1037/h0061946; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; First M., 1997, STRUCTURED CLIN INTE; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Gan T, 2009, NEUROREPORT, V20, P839, DOI 10.1097/WNR.0b013e32832be7dc; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; Grillon C, 2008, AM J PSYCHIAT, V165, P898, DOI 10.1176/appi.ajp.2007.07101581; Grillon C, 2009, BIOL PSYCHIAT, V66, P47, DOI 10.1016/j.biopsych.2008.12.028; Grupe DW, 2011, EMOTION, V11, P413, DOI 10.1037/a0022583; Hancock PA, 2005, THEOR ISS ERGON SCI, V6, P193, DOI 10.1080/14639220512331325747; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lake JI, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00055; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Meck WH, 2007, BEHAV NEUROSCI, V121, P707, DOI 10.1037/0735-7044.121.4.707; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Mella N, 2011, BRAIN COGNITION, V75, P182, DOI 10.1016/j.bandc.2010.11.012; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Simmons A, 2004, NEUROREPORT, V15, P2261, DOI 10.1097/00001756-200410050-00024; Simmons A, 2008, NEUROREPORT, V19, P1033, DOI 10.1097/WNR.0b013e328305b722; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Simmons A, 2009, PSYCHOSOM MED, V71, P373, DOI 10.1097/PSY.0b013e3181a56ed8; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Simmons AN, 2012, NEUROREPORT, V23, P234, DOI 10.1097/WNR.0b013e3283503275; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Simmons AN, 2011, HUM BRAIN MAPP, V32, P1836, DOI 10.1002/hbm.21154; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wittmann Marc, 2010, J Neurosci Psychol Econ, V3, P15; Wittmann M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.002.2010; Wittmann M, 2009, PHILOS T R SOC B, V364, P1955, DOI 10.1098/rstb.2009.0003; Wittmann M, 2009, PHILOS T R SOC B, V364, P1809, DOI 10.1098/rstb.2009.0025; Zvolensky MJ, 2000, BEHAV RES THER, V38, P653, DOI 10.1016/S0005-7967(99)00090-X	50	24	25	1	43	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327			J AFFECT DISORDERS	J. Affect. Disord.	APR 25	2013	146	3					426	432		10.1016/j.jad.2012.08.006			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	098WV	WOS:000315580700018	22910447				2022-02-06	
J	Apfelbaum, HL; Ross, NC; Bowers, AR; Peli, E				Apfelbaum, Henry L.; Ross, Nicole C.; Bowers, Alex R.; Peli, Eli			Considering Apical Scotomas, Confusion, and Diplopia When Prescribing Prisms for Homonymous Hemianopia	TRANSLATIONAL VISION SCIENCE & TECHNOLOGY			English	Article						low vision; rehabilitation; prism treatment; perimetry; visual field loss; hemianopia; traumatic brain injury; TBI; stroke		Purpose: While prisms are commonly prescribed for homonymous hemianopia to extend or expand the visual field, they cause potentially troubling visual side effects, including nonveridical location of perceived images, diplopia, and visual confusion. In addition, the field behind a prism at its apex is lost to an apical scotoma equal in magnitude to the amount of prism shift. The perceptual consequences of apical scotomas and the other effects of various designs were examined to consider parameters and designs that can mitigate the impact of these effects. Methods: Various configurations of sector and peripheral prisms were analyzed, in various directions of gaze, and their visual effects were illustrated using simulated perimetry. A novel "percept'' diagram was developed that yielded insights into the patient's view through the prisms. The predictions were verified perimetrically with patients. Results: The diagrams distinguish between potentially beneficial field expansion via visual confusion and the pericentrally disturbing and useless effect of diplopia, and their relationship to prism power and gaze direction. They also illustrate the nonexpanding substitution of field segments of some popular prism designs. Conclusions: Yoked sector prisms have no effect at primary gaze or when gaze is directed toward the seeing hemifield, and they introduce pericentral field loss when gaze is shifted into them. When fitted unilaterally, sector prisms also have an effect only when the gaze is directed into the prism and may cause a pericentral scotoma and/or central diplopia. Peripheral prisms are effective at essentially all gaze angles. Since gaze is not directed into them, they avoid problematic pericentral effects. We derive useful recommendations for prism power and position parameters, including novel ways of fitting prisms asymmetrically. Translational Relevance: Clinicians will find these novel diagrams, diagramming techniques, and analyses valuable when prescribing prismatic aids for hemianopia and when designing new prism devices for patients with various types of field loss.	[Apfelbaum, Henry L.; Ross, Nicole C.; Bowers, Alex R.; Peli, Eli] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA USA; [Ross, Nicole C.; Bowers, Alex R.; Peli, Eli] New England Coll Optometry, Boston, MA USA		Peli, E (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	eli_peli@meei.harvard.edu		Bowers, Alex/0000-0002-6038-0178	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY12890, P30EY003790]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012890, R24EY012890, P30EY003790] Funding Source: NIH RePORTER	Supported by the National Institutes of Health Grants EY12890 and P30EY003790.	BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; Bailey, 1978, OPTOM MONTHLY, V69, P99; Bailey IL., 2007, ROSENBLOOM MORGANS V, P133; Bishop PO., 1998, ADLERS PHYSL EYE CLI, P575; Blake R., 2001, BRAIN MIND, V2, P5, DOI DOI 10.1023/A:1017925416289; Bowers A. R., 2012, STROKE RES TREAT, V2012, P10; Bowers AR, 2008, ARCH OPHTHALMOL-CHIC, V126, P657, DOI 10.1001/archopht.126.5.657; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Bowers AR, JAMA OPHTAL IN PRESS; Brown WL, 1995, CLIN USES PRISM SPEC, P279; Cardenal MS, 2012, OPTOM VIS SCI, V89; Cohen J M, 1993, J Am Optom Assoc, V64, P60; Dickinson C., 1998, LOW VISION PRINCIPLE, P189; Fannin T. E., 1996, CLIN OPTICS, P109; Gall C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-33; Giorgi RG, 2009, OPTOMETRY VISION SCI, V86, P492, DOI 10.1097/OPX.0b013e31819f9e4d; Good Gregory W, 2005, Optometry, V76, P285, DOI 10.1016/S1529-1839(05)70311-0; GOODLAW E, 1982, AM J OPTOM PHYS OPT, V59, P617; Gottlieb D D, 1992, J Am Optom Assoc, V63, P581; Hoppe E, 1993, J Am Optom Assoc, V64, P46; Iorizzo DB, 2011, VISION RES, V51, P1173, DOI 10.1016/j.visres.2011.03.006; Katz Milton, 2004, Optometry, V75, P503, DOI 10.1016/S1529-1839(04)70175-X; Lee A G, 1999, J Am Optom Assoc, V70, P624; LOVIEKITCHIN J, 1990, CLIN VISION SCI, V5, P249; Luo G, 2008, J VISION, V8, DOI 10.1167/8.14.25; Morgan MW., 1963, AM J OPTOM, V40, P111; O'Neill EC, 2011, OPTOMETRY VISION SCI, V88, P263, DOI 10.1097/OPX.0b013e318205a3b8; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; Peli E., 2008, United States patent, Patent No. [7,374,284 B2, 7374284, US 7,374,284 B2]; Perez AM, 2003, J VISUAL IMPAIR BLIN, V97, P173, DOI 10.1177/0145482X0309700306; Perlin R R, 1991, J Am Optom Assoc, V62, P58; Rosenthal BP, 1996, REMEDIATION MANAGEME, P1; ROSSI PW, 1990, NEUROLOGY, V40, P1597, DOI 10.1212/WNL.40.10.1597; Satgunam P, 2012, OPTOMETRY VISION SCI, V89, pE1353, DOI 10.1097/OPX.0b013e3182678d42; Smith AJ, 1976, OPT J REV OPTOM, V12, P33; SMITH JL, 1982, J CLIN NEURO-OPHTHAL, V2, P19; Somani S, 2006, CAN J OPHTHALMOL, V41, P27, DOI 10.1016/S0008-4182(06)80062-1; Szlyk JP, 2005, OPHTHAL PHYSL OPT, V25, P128, DOI 10.1111/j.1475-1313.2004.00265.x; van Waveren M, 2013, GRAEF ARCH CLIN EXP, V251, P575, DOI 10.1007/s00417-012-2045-1; Vargas-Martin F, 2005, OPTOMETRY VISION SCI, V82, P675, DOI 10.1097/01.opx.0000175624.34252.73; WEISS NJ, 1972, AMER J OPT ARCH AM A, V49, P261; Wiener A., 1925, ARCH OPTHALMOL, V55; WOO GC, 1983, AM J OPTOM PHYS OPT, V60, P739; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015; Young CA, 1929, ARCH OPHTHALMOL-CHIC, V2, P560; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	47	24	24	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	2164-2591			TRANSL VIS SCI TECHN	Transl. Vis. Sci. Technol.	APR	2013	2	4							2	10.1167/tvst.2.4.2			18	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	V45JN	WOS:000209813000002	24049719	Green Published			2022-02-06	
J	Carpenter, SL; Abshire, TC; Anderst, JD				Carpenter, Shannon L.; Abshire, Thomas C.; Anderst, James D.		Sect Hematology Oncology; Comm Child Abuse Neglect	Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding	PEDIATRICS			English	Article						intracranial hemorrhage; inherited coagulation disorders; bruising; nonaccidental trauma	EHLERS-DANLOS-SYNDROME; VON-WILLEBRAND-DISEASE; FACTOR-XIII DEFICIENCY; FACTOR-V DEFICIENCY; INTRACRANIAL HEMORRHAGE SECONDARY; CHRONIC SUBDURAL-HEMATOMA; TRAUMATIC BRAIN-INJURY; FACTOR-VII DEFICIENCY; SYNDROME TYPE-IV; OSTEOGENESIS IMPERFECTA	Child abuse might be suspected when children present with cutaneous bruising, intracranial hemorrhage, or other manifestations of bleeding. In these cases, it is necessary to consider medical conditions that predispose to easy bleeding/bruising. When evaluating for the possibility of bleeding disorders and other conditions that predispose to hemorrhage, the pediatrician must consider the child's presenting history, medical history, and physical examination findings before initiating a laboratory investigation. Many medical conditions can predispose to easy bleeding. Before ordering laboratory tests for a disease, it is useful to understand the biochemical basis and clinical presentation of the disorder, condition prevalence, and test characteristics. This technical report reviews the major medical conditions that predispose to bruising/bleeding and should be considered when evaluating for abusive injury.					MacMillan, Harriet/B-4530-2016	MacMillan, Harriet/0000-0002-1223-706X; Sege, Robert/0000-0003-1260-4787			Acharya SS, 2008, HAEMOPHILIA, V14, P1151, DOI 10.1111/j.1365-2516.2008.01831.x; Acharya SS, 2004, J THROMB HAEMOST, V2, P248, DOI 10.1111/j.1538-7836.2003.t01-1-00553.x; Akhavan S, 2003, BRIT J HAEMATOL, V120, P142, DOI 10.1046/j.1365-2141.2003.03986.x; Alamelu J, 2010, BRIT J HAEMATOL, V149, P813, DOI 10.1111/j.1365-2141.2010.08191.x; Albanese A, 2005, J NEUROSURG, V102, P1130, DOI 10.3171/jns.2005.102.6.1130; ALFAWAZ IM, 1992, ACTA HAEMATOL-BASEL, V88, P194; ALMAANI WS, 1986, SURG NEUROL, V26, P457, DOI 10.1016/0090-3019(86)90258-2; Barabas G M, 1967, Br Dent J, V123, P473; Barkovich AJ, 2005, PEDIAT NEUROIMAGING, P190; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bick RL, 1992, DISORDERS THROMBOSIS; Bolton-Maggs PHB, 2006, BRIT J HAEMATOL, V135, P603, DOI 10.1111/j.1365-2141.2006.06343.x; Bolton-Maggs PHB, 2004, HAEMOPHILIA, V10, P593, DOI 10.1111/j.1365-2516.2004.00944.x; Boshkov LK, 2001, DISORDERS HEMOSTASIS, P495; Brenner B, 2000, THROMB HAEMOSTASIS, V84, P935; Brown DL, 2008, HAEMOPHILIA, V14, P1176, DOI 10.1111/j.1365-2516.2008.01856.x; Carpenter RF, 1999, ARCH DIS CHILD, V80, P363, DOI 10.1136/adc.80.4.363; Carpenter SL, 2008, HAEMOPHILIA, V14, P1250, DOI 10.1111/j.1365-2516.2008.01766.x; Clemetson C. A. B., 2004, J AM PHYS SURG, V9, P78; Clemetson CAB, 2004, MED HYPOTHESES, V62, P533, DOI 10.1016/j.mehy.2003.12.023; De Paepe A, 2004, BRIT J HAEMATOL, V127, P491, DOI 10.1111/j.1365-2141.2004.05220.x; Dean JA, 2000, THROMB HAEMOSTASIS, V84, P401; Devaussuzenet VMP, 1998, PEDIATR RADIOL, V28, P978, DOI 10.1007/s002470050513; Di Michele DM, 2001, DISORDERS HEMOSTASIS, P127; Di Minno G, 2009, THROMB HAEMOSTASIS, V102, P1157, DOI 10.1160/TH09-04-0225; Duga S, 2009, SEMIN THROMB HEMOST, V35, P416, DOI 10.1055/s-0029-1225764; Dunstan FD, 2002, ARCH DIS CHILD, V86, P330, DOI 10.1136/adc.86.5.330; Ellestad SC, 2007, HAEMOPHILIA, V13, P432, DOI 10.1111/j.1365-2516.2007.01469.x; EVENSEN SA, 1984, SCAND J HAEMATOL, V33, P177; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Farah RA, 2007, J THROMB HAEMOST, V5, P433, DOI 10.1111/j.1538-7836.2007.02318.x; Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254; Favier R, 2001, BRIT J HAEMATOL, V114, P4, DOI 10.1046/j.1365-2141.2001.02845.x; Fay WP, 1997, BLOOD, V90, P204; FELDMAN KW, 1992, PEDIATRICS, V90, P633; Franchini M, 2010, J THROMB HAEMOST, V8, P421, DOI 10.1111/j.1538-7836.2009.03717.x; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; Ganesh A, 2004, OPHTHALMOLOGY, V111, P1428, DOI 10.1016/j.ophtha.2003.10.028; Gardner HB, 2005, MED HYPOTHESES, V64, P663, DOI 10.1016/j.mehy.2004.09.009; Girolami A, 2006, HAEMOPHILIA, V12, P345, DOI 10.1111/j.1365-2516.2006.01299.x; Goddeau RP, 2010, ARCH NEUROL-CHICAGO, V67, P236, DOI 10.1001/archneurol.2009.319; Gomez K, 2008, HAEMOPHILIA, V14, P1183, DOI 10.1111/j.1365-2516.2008.01667.x; Goodnight SH, 2001, DISORDERS HEMOSTASIS, P184; Goodnight SH, 2001, DISORDERS HEMOSTASIS, P52; Gordon M, 2008, CLIN PEDIATR, V47, P385, DOI 10.1177/0009922807309065; Groninger A, 2005, PEDIATR NEUROL, V32, P140, DOI 10.1016/j.pediatrneurol.2004.07.011; Harrison P, 2009, SEMIN THROMB HEMOST, V35, P150, DOI 10.1055/s-0029-1220323; Hassan Amy A, 2005, Hematology Am Soc Hematol Educ Program, P403; HATHAWAY WE, 1972, BLOOD-J HEMATOL, V39, P500, DOI 10.1182/blood.V39.4.500.500; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hayward CPM, 2006, HAEMOPHILIA, V12, P128, DOI 10.1111/j.1365-2516.2006.01270.x; Herrmann FH, 2006, HAEMOPHILIA, V12, P479, DOI 10.1111/j.1365-2516.2006.01303.x; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hill M, 2008, HAEMOPHILIA, V14, P889, DOI 10.1111/j.1365-2516.2008.01795.x; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; Huang JN, 2008, HAEMOPHILIA, V14, P1164, DOI 10.1111/j.1365-2516.2008.01785.x; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Hymel KP, 2010, PEDIATRICS, V125, P712, DOI 10.1542/peds.2009-2133; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Ivaskevicius V, 2007, THROMB HAEMOSTASIS, V97, P914, DOI 10.1160/TH07-01-0034; Jenny C, 2006, PEDIATRICS, V118, P1299, DOI 10.1542/peds.2006-1795; Karimi M, 2009, SEMIN THROMB HEMOST, V35, P426, DOI 10.1055/s-0029-1225765; Kasper CK, 2007, HAEMOPHILIA, V13, P90, DOI 10.1111/j.1365-2516.2006.01397.x; Kasper CK, 2009, HAEMOPHILIA, V15, P1181, DOI 10.1111/j.1365-2516.2009.02003.x; Kulkarni R, 2009, HAEMOPHILIA, V15, P1281, DOI 10.1111/j.1365-2516.2009.02074.x; Kumar S, 2002, MAYO CLIN PROC, V77, P181; Kuurila K, 2002, ANN OTO RHINOL LARYN, V111, P939, DOI 10.1177/000348940211101014; Lak M, 1999, BRIT J HAEMATOL, V107, P204; Lancellotti S, 2009, SEMIN THROMB HEMOST, V35, P367, DOI 10.1055/s-0029-1225759; Lapecorella M, 2008, HAEMOPHILIA, V14, P1170, DOI 10.1111/j.1365-2516.2008.01844.x; Lee JH, 2009, BLOOD COAGUL FIBRIN, V20, P161, DOI 10.1097/MBC.0b013e3283258028; Lieder HS, 2005, AACN ADV CRIT CARE, V16, P178, DOI 10.1097/00044067-200504000-00009; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Malfait F, 2009, BLOOD REV, V23, P191, DOI 10.1016/j.blre.2009.06.001; Mansouritorgabeh H, 2004, HAEMOPHILIA, V10, P271, DOI 10.1111/j.1365-2516.2004.00890.x; Mariani G, 2005, THROMB HAEMOSTASIS, V93, P481, DOI 10.1160/TH04-10-0650; McIntosh N, 2007, PEDIATRICS, V120, P1074, DOI 10.1542/peds.2007-2097; McKay H, 2004, BLOOD, V104, P159, DOI 10.1182/blood-2003-11-4077; McLean LA, 2012, AM J NEURORADIOL, V33, P1281, DOI 10.3174/ajnr.A2967; Meeks SL, 2008, HAEMOPHILIA, V14, P1159, DOI 10.1111/j.1365-2516.2008.01832.x; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; Menegatti M, 2009, SEMIN THROMB HEMOST, V35, P407, DOI 10.1055/s-0029-1225763; Millar DS, 2000, HUM GENET, V106, P249, DOI 10.1007/s004390051035; Mishra P, 2008, HAEMOPHILIA, V14, P952, DOI 10.1111/j.1365-2516.2008.01814.x; Miyasaka M, 2007, EMERG RADIOL, V14, P323, DOI 10.1007/s10140-007-0632-y; MIZOI K, 1984, SURG NEUROL, V22, P495, DOI 10.1016/0090-3019(84)90310-0; National Heart Lung and Blood Institute National Asthma Education and Prevention Program, 2007, NIH PUBLICATION; Nelson MD, 1999, HAEMOPHILIA, V5, P306; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Newman RS, 2002, AM J HEMATOL, V71, P328, DOI 10.1002/ajh.10225; Nichols WL, 2008, HAEMOPHILIA, V14, P171, DOI 10.1111/j.1365-2516.2007.01643.x; Nuss R, 2001, AM J HEMATOL, V68, P37, DOI 10.1002/ajh.1146; Offiah A, 2009, PEDIATR RADIOL, V39, P461, DOI 10.1007/s00247-009-1157-1; OHARE AE, 1984, ARCH DIS CHILD, V59, P860, DOI 10.1136/adc.59.9.860; OWEN SM, 1984, ARCH DERMATOL, V120, P97, DOI 10.1001/archderm.120.1.97; Paranjothy S, 2009, ARCH DIS CHILD, V94, P421, DOI 10.1136/adc.2008.144881; Parmar CD, 2007, J NEUROSURG, V106, P57, DOI 10.3171/ped.2007.106.1.57; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pepin MG, EHLERS DANLOS SYNDRO; Peyvandi F, 2002, HAEMOPHILIA, V8, P308, DOI 10.1046/j.1365-2516.2002.00633.x; Peyvandi F, 1998, BRIT J HAEMATOL, V100, P773; Peyvandi F, 1999, THROMB HAEMOSTASIS, V82, P1207; POZZATI E, 1983, NEUROSURGERY, V13, P66, DOI 10.1227/00006123-198307000-00014; Remacha PPO, 2000, REV CLIN ESP, V200, P181; ReverdiauMoalic P, 1996, BLOOD, V88, P900, DOI 10.1182/blood.V88.3.900.bloodjournal883900; ROBERTS DLL, 1984, BRIT J DERMATOL, V111, P341, DOI 10.1111/j.1365-2133.1984.tb04733.x; Roberts HR, 1995, WILLIAMS HEMATOLOGY, P1413; Rughani AI, 2009, NEUROSURGERY, V64, P1192, DOI 10.1227/01.NEU.0000345650.60160.07; Sadler JE, 2000, THROMB HAEMOSTASIS, V84, P160; Salooja N, 2000, HAEMOPHILIA, V6, P44; Sasaki-Adams D, 2008, J NEUROSURG-PEDIATR, V1, P229, DOI 10.3171/PED/2008/1/3/229; SCHIEVINK WI, 1990, STROKE, V21, P626, DOI 10.1161/01.STR.21.4.626; Shearer MJ, 2009, BLOOD REV, V23, P49, DOI 10.1016/j.blre.2008.06.001; Sirotnak AP, 2006, ABUSIVE HEAD TRAUMA, P191; Spreafico M, 2008, HAEMOPHILIA, V14, P1201, DOI 10.1111/j.1365-2516.2008.01845.x; Steiner RD, OSTEOGENESIS IMPERFE; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Stray-Pedersen A, 2011, FORENSIC SCI MED PAT, V7, P37, DOI 10.1007/s12024-010-9176-7; Stricker T, 2002, J PAEDIATR CHILD H, V38, P528, DOI 10.1046/j.1440-1754.2002.00049.x; Strijks E, 1999, NEUROPEDIATRICS, V30, P320, DOI 10.1055/s-2007-973512; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; Sullivan PM, 2000, CHILD ABUSE NEGLECT, V24, P1257, DOI 10.1016/S0145-2134(00)00190-3; TAKAHASHI Y, 1991, HAEMOSTASIS, V21, P321; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; TOKORO K, 1988, NEUROSURGERY, V22, P595, DOI 10.1227/00006123-198803000-00029; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Ulinski T, 2004, PEDIATR NEPHROL, V19, P798, DOI 10.1007/s00467-004-1461-9; Vasileiadis I, 2009, BLOOD COAGUL FIBRIN, V20, P309, DOI 10.1097/MBC.0b013e328329e485; Verhovsek M, 2008, AM J HEMATOL, V83, P928, DOI 10.1002/ajh.21293; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Walton LJ, 2010, ARCH DIS CHILD, V95, P53, DOI 10.1136/adc.2009.160978; Wetzstein Viola, 2006, Haematologica, V91, pECR60; Witmer CM, 2007, HAEMOPHILIA, V13, P560, DOI 10.1111/j.1365-2516.2007.01546.x; Wong AYK, 2006, J THROMB HAEMOST, V4, P2623, DOI 10.1111/j.1538-7836.2006.02235.x; Wong WY, 2000, HAEMOPHILIA, V6, P50; WYNNEDAVIES R, 1981, CLIN ORTHOP RELAT R, P26; Zipursky A, 1999, BRIT J HAEMATOL, V104, P430, DOI 10.1046/j.1365-2141.1999.01104.x; Ziv O, 2004, HAEMOPHILIA, V10, P162, DOI 10.1111/j.1365-2516.2003.00871.x	142	24	25	1	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2013	131	4					E1357	E1373		10.1542/peds.2013-0196			17	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	135EF	WOS:000318269500039	23530171	Bronze			2022-02-06	
J	Lathan, C; Spira, JL; Bleiberg, J; Vice, J; Tsao, JW				Lathan, Corinna; Spira, James L.; Bleiberg, Joseph; Vice, Jack; Tsao, Jack W.			Defense Automated Neurobehavioral Assessment (DANA)-Psychometric Properties of a New Field-Deployable Neurocognitive Assessment Tool	MILITARY MEDICINE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT METRICS; TRAUMATIC BRAIN-INJURY; TEST-RETEST RELIABILITY; SCREEN; INDEX	The Defense Automated Neurobehavioral Assessment (DANA) is a new neurocognitive assessment tool that includes a library of standardized cognitive and psychological assessments, with three versions that range from a brief 5-minute screen to a 45-minute complete assessment. DANA is written using the Android open-source operating system and is suitable for multiple mobile platforms. This article presents testing of DANA by 224 active duty U.S. service members in five operationally relevant environments (desert, jungle, mountain, arctic, and shipboard). DANA was found to be a reliable instrument and compared favorably to other computer-based neurocognitive assessments. Implications for using DANA in far-forward military settings are discussed.	[Lathan, Corinna; Vice, Jack] AnthroTronix, Silver Spring, MD 20910 USA; [Spira, James L.] Pacific Isl Hlth Care Syst, Natl Ctr PTSD, Dept Vet Affairs, Honolulu, HI 96819 USA; [Bleiberg, Joseph] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [Tsao, Jack W.] US Navy Bur Med & Surg, Wounded Ill & Injured Directorate, Falls Church, VA 22032 USA		Lathan, C (corresponding author), AnthroTronix, 8737 Colesville Rd,Suite L-203, Silver Spring, MD 20910 USA.			Bleiberg, Joseph/0000-0003-0867-5494	U.S. Navy Bureau of Medicine and Surgery [N00189-10-P-Z967]	We thank the following people for their help in data collection and/or analysis: James Drane, Jon Farris, and Lindsay Long. This work was supported by the U.S. Navy Bureau of Medicine and Surgery, Wounded, Ill and Injured Directorate, Contract No. N00189-10-P-Z967 as well as with resources and the use of facilities at the Department of Veterans Affairs, National Center for PTSD, Pacific Islands Health Care System.	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Raja Beharelle A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00164; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wilson JA, 2010, IEEE T BIO-MED ENG, V57, P1785, DOI 10.1109/TBME.2010.2047259	18	24	24	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2013	178	4					365	371		10.7205/MILMED-D-12-00438			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7TY	WOS:000340805100004	23707818	hybrid			2022-02-06	
J	McDonald, S; Togher, L; Tate, R; Randall, R; English, T; Gowland, A				McDonald, S.; Togher, L.; Tate, R.; Randall, R.; English, T.; Gowland, A.			A randomised controlled trial evaluating a brief intervention for deficits in recognising emotional prosody following severe ABI	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Emotion; Brain injury; Remediation	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSION; RIGHT-HEMISPHERE; RECOGNITION; PEOPLE; REHABILITATION; COMMUNICATION; COMPREHENSION; PERCEPTION; APROSODIA	Many adults with acquired brain injuries, including traumatic brain injuries (TBI) have impaired emotion perception. Impaired perception of emotion in voice can occur independently to facial expression and represents a specific target for remediation. No research to date has addressed this. The current study used a randomised controlled trial to examine the efficacy of a short treatment (three x two-hour sessions) for improving the ability to recognise emotional prosody for people with acquired brain injury, mostly TBI. Ten participants were allocated to treatment and 10 to waitlist. All participants remained involved for the duration of the study in the groups to which they were allocated. There were no significant treatment effects for group, but analyses of individual performances indicated that six of the treated participants made demonstrable improvements on objective measures of prosody recognition. The reasons why some participants showed improvements while others did not, was not obvious. Improvements on objective lab-based measures did not generalise to relative reports of improvements in everyday communicative ability. Nor was there clear evidence of long-term effects. In conclusion, treatment of emotional prosody was effective in the short-term for half of the participants. Further research is required to determine what conditions are required to optimise generalisability and longer-term gains.	[McDonald, S.; Randall, R.; English, T.; Gowland, A.] Univ New S Wales, Sydney, NSW 2052, Australia; [Togher, L.; Tate, R.] Univ Sydney, Sydney, NSW 2006, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014; Togher, Leanne/AAC-7083-2019	McDonald, Skye/0000-0003-0723-6094; Togher, Leanne/0000-0002-4518-6748; Gowland, Alison/0000-0002-6578-4112	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This study was funded by the Australian National Health and Medical Research Council. The authors wish to express their gratitude to staff at the Royal Rehabilitation Centre, Ryde, the Westmead Brain Injury Unit and the Liverpool Brain Injury Unit for their assistance with recruitment. We are especially grateful to the many people with brain injuries and their families who willingly gave of their time to assist this project.	Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baum SR, 1999, APHASIOLOGY, V13, P581, DOI 10.1080/026870399401957; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BOWERS D, 1987, NEUROPSYCHOLOGIA, V25, P317, DOI 10.1016/0028-3932(87)90021-2; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cohen J., 2013, STAT POWER ANAL BEHA; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; HEILMAN KM, 1984, NEUROLOGY, V34, P917, DOI 10.1212/WNL.34.7.917; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Jones J., 2009, INT J SPEECH LANGUAG, V11, P298, DOI [10.1080/17549500902969477, DOI 10.1080/17549500902969477]; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Leon SA, 2005, J REHABIL RES DEV, V42, P93, DOI 10.1682/JRRD.2003.12.0182; Ley P., 1972, QUANTITATIVE ASPECTS; Lovibond S., 1995, DEPRESSION ANXIETY S; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 1997, BRAIN LANG, V57, P195, DOI 10.1006/brln.1997.1736; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; REITAN RM, 1992, TRIAL MAKING TEST; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rosenbek JC, 2004, J INT NEUROPSYCH SOC, V10, P786, DOI 10.1017/S135561770410502X; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Stringer AY, 1996, BRAIN INJURY, V10, P583, DOI 10.1080/026990596124151; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	45	24	25	2	22	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 1	2013	23	2					267	286		10.1080/09602011.2012.751340			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	105KU	WOS:000316068800007	23215966				2022-02-06	
J	Niskanen, JP; Airaksinen, AM; Sierra, A; Huttunen, JK; Nissinen, J; Karjalainen, PA; Pitkanen, A; Grohn, OH				Niskanen, Juha-Pekka; Airaksinen, Antti M.; Sierra, Alejandra; Huttunen, Joanna K.; Nissinen, Jari; Karjalainen, Pasi A.; Pitkanen, Asla; Grohn, Olli H.			Monitoring Functional Impairment and Recovery after Traumatic Brain Injury in Rats by fMRI	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; MRI; recovery; sensory function; TBI	CEREBRAL BLOOD-VOLUME; POSTTRAUMATIC EPILEPSY; NEURONAL DAMAGE; IN-VIVO; INHIBITION; MODELS	The present study was designed to test a hypothesis that functional magnetic resonance imaging (fMRI) can be used to monitor functional impairment and recovery after moderate experimental traumatic brain injury (TBI). Moderate TBI was induced by lateral fluid percussion injury in adult rats. The severity of brain damage and functional recovery in the primary somatosensory cortex (S1) was monitored for up to 56 days using fMRI, cerebral blood flow (CBF) by arterial spin labeling, local field potential measurements (LFP), behavioral assessment, and histology. All the rats had reduced blood-oxygen-level-dependent (BOLD) responses during the 1st week after trauma in the ipsilateral S1. Forty percent of these animals showed recovery of the BOLD response during the 56 day follow-up. Unexpectedly, no association was found between the recovery in BOLD response and the volume of the cortical lesion or thalamic neurodegeneration. Instead, the functional recovery occurred in rats with preserved myelinated fibers in layer VI of S1. This is, to our knowledge, the first study demonstrating that fMRI can be used to monitor post-TBI functional impairment and consequent spontaneous recovery. Moreover, the BOLD response was associated with the density of myelinated fibers in the S1, rather than with neurodegeneration. The present findings encourage exploration of the usefulness of fMRI as a noninvasive prognostic biomarker for human post-TBI outcomes and therapy responses.	[Niskanen, Juha-Pekka; Airaksinen, Antti M.; Sierra, Alejandra; Huttunen, Joanna K.; Grohn, Olli H.] Univ Eastern Finland, Dept Neurobiol, FI-70211 Kuopio, Finland; [Nissinen, Jari; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Epilepsy Res Lab, FI-70211 Kuopio, Finland; [Niskanen, Juha-Pekka; Karjalainen, Pasi A.] Univ Eastern Finland, Dept Appl Phys, FI-70211 Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland		Grohn, OH (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	olli.grohn@uef.fi	Karjalainen, Pasi A/G-4043-2016; Karjalainen, Pasi/AAC-5465-2019; Huttunen, Joanna/F-1645-2011	Karjalainen, Pasi A/0000-0002-1267-493X; Karjalainen, Pasi/0000-0002-1267-493X; Huttunen, Joanna/0000-0002-1188-5604; Sierra Lopez, Alejandra/0000-0001-5399-2056	Academy of FinlandAcademy of FinlandEuropean Commission [123579, 252511, 132970]; Juselius Foundation; Orion-Farmos Research Foundation; University of Eastern Finland (UEF-Brain)	This work was supported by Academy of Finland (grant numbers 123579, 252511, 132970), the Juselius Foundation, Orion-Farmos Research Foundation, and the strategic funding of the University of Eastern Finland (UEF-Brain). We thank Jarmo Hartikainen and Maarit Pulkkinen for technical assistance, and Dr. Nick Hayward of Scientific English, UK, for revising the language of this manuscript.	Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Liao CC, 2008, ANAT REC, V291, P960, DOI 10.1002/ar.20696; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 1996, EPILEPSY RES, V24, P29, DOI 10.1016/0920-1211(95)00093-3; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Silva AC, 2007, MAGN RESON MED, V57, P1110, DOI 10.1002/mrm.21246; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	37	24	24	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					546	556		10.1089/neu.2012.2416			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300006	23259713	Green Published			2022-02-06	
J	Shaw, KE; Bondi, CO; Light, SH; Massimino, LA; McAloon, RL; Monaco, CM; Kline, AE				Shaw, Kaitlyn E.; Bondi, Corina O.; Light, Samuel H.; Massimino, Lire A.; McAloon, Rose L.; Monaco, Christina M.; Kline, Anthony E.			Donepezil Is Ineffective in Promoting Motor and Cognitive Benefits after Controlled Cortical Impact Injury in Male Rats	JOURNAL OF NEUROTRAUMA			English	Article						AChE inhibitor; behavior; CCI; functional recovery; learning and memory; Morris water maze; TBI	TRAUMATIC BRAIN-INJURY; RECEPTOR AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; VESICULAR ACETYLCHOLINE TRANSPORTER; REDUCED EVOKED RELEASE; ENVIRONMENTAL ENRICHMENT; CHOLINESTERASE INHIBITOR; NEUROBEHAVIORAL BENEFIT; CHOLINERGIC MARKERS; CLINICAL-TRIALS; UNITED-STATES	The acetylcholinesterase (AChE) inhibitor donepezil is used as a therapy for Alzheimer's disease and has been recommended as a treatment for enhancing attention and memory after traumatic brain injury (TBI). Although select clinical case studies support the use of donepezil for enhancing cognition, there is a paucity of experimental TBI studies assessing the potential efficacy of this pharmacotherapy. Hence, the aim of this pre-clinical study was to evaluate several doses of donepezil to determine its effect on functional outcome after TBI. Ninety anesthetized adult male rats received a controlled cortical impact (CCI; 2.8mm cortical depth at 4 m/sec) or sham injury, and then were randomly assigned to six TBI and six sham groups (donepezil 0.25, 0.5, 1.0, 2.0, or 3.0 mg/kg, and saline vehicle 1.0 mL/kg). Treatments began 24 h after surgery and were administered i.p. once daily for 19 days. Function was assessed by motor (beam balance/walk) and cognitive (Morris water maze) tests on days 1-5 and 14-19, respectively. No significant differences were observed among the sham control groups in any evaluation, regardless of dose, and therefore the data were pooled. Furthermore, no significant differences were revealed among the TBI groups in acute neurological assessments (e. g., righting reflex), suggesting that all groups received the same level of injury severity. None of the five doses of donepezil improved motor or cognitive function relative to vehicle-treated controls. Moreover, the two highest doses significantly impaired beam-balance (3.0 mg/kg), beam-walk (2.0 mg/kg and 3.0 mg/kg), and cognitive performance (3.0 mg/kg) versus vehicle. These data indicate that chronic administration of donepezil is not only ineffective in promoting functional improvement after moderate CCI injury, but depending on the dose is actually detrimental to the recovery process. Further work is necessary to determine if other AChE inhibitors exert similar effects after TBI.	[Shaw, Kaitlyn E.; Bondi, Corina O.; Light, Samuel H.; Massimino, Lire A.; McAloon, Rose L.; Monaco, Christina M.; Kline, Anthony E.] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Shaw, Kaitlyn E.; Bondi, Corina O.; Light, Samuel H.; Massimino, Lire A.; McAloon, Rose L.; Monaco, Christina M.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912; Light, Sam/0000-0002-8074-1348	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005] Funding Source: NIH RePORTER	This work was supported, in part, by National Institutes of Health (NIH) grants NS060005 and HD069620 (to Dr. Kline)	ALBIN RL, 1988, NEUROSCI LETT, V88, P303, DOI 10.1016/0304-3940(88)90228-5; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bentham P, 2004, LANCET, V363, P2105; Besheer J, 2004, NEUROSCI INTELL UNIT, P113; Bontempi B, 2003, NEUROPSYCHOPHARMACOL, V28, P1235, DOI 10.1038/sj.npp.1300150; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; CDC, 2003, REP C MILD TRAUM BRA; CDC, 1999, TRAUM BRAIN INJ US R; Chen Z, 2002, ACTA PHARMACOL SIN, V23, P355; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creeley CE, 2008, NEUROBIOL AGING, V29, P153, DOI 10.1016/j.neurobiolaging.2006.10.020; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; Haug KH, 2005, NEUROCHEM RES, V30, P1511, DOI 10.1007/s11064-005-8828-6; Hernandez CM, 2006, J PHARMACOL EXP THER, V316, P679, DOI 10.1124/jpet.105.093047; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Li DQ, 2012, INT J MED SCI, V9, P248, DOI 10.7150/ijms.4363; Liang YQ, 2004, NEUROSCI LETT, V361, P56, DOI 10.1016/j.neulet.2003.12.071; Lindner MD, 2006, PSYCHOPHARMACOLOGY, V188, P629, DOI 10.1007/s00213-006-0556-3; Maurice T, 2006, J PHARMACOL EXP THER, V317, P606, DOI 10.1124/jpet.105.097394; McCarthy AD, 2011, PHARMACOL BIOCHEM BE, V98, P76, DOI 10.1016/j.pbb.2010.11.019; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Rezvani AH, 2012, PSYCHOPHARMACOLOGY, V223, P251, DOI 10.1007/s00213-012-2712-2; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seltzer Ben, 2005, Expert Opin Drug Metab Toxicol, V1, P527, DOI 10.1517/17425255.1.3.527; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; SHAW KP, 1985, MOL PHARMACOL, V28, P527; Su DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027632; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo OS, 2006, CURR DRUG THER, V1, P187, DOI 10.2174/157488506776930932; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wise LE, 2007, NEUROPSYCHOPHARMACOL, V32, P1805, DOI 10.1038/sj.npp.1301297; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	73	24	24	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					557	564		10.1089/neu.2012.2782			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300007	23227953	Green Published			2022-02-06	
J	Sullivan, S; Friess, SH; Ralston, J; Smith, C; Propert, KJ; Rapp, PE; Margulies, SS				Sullivan, Sarah; Friess, Stuart H.; Ralston, Jill; Smith, Colin; Propert, Kathleen J.; Rapp, Paul E.; Margulies, Susan S.			Behavioral Deficits and Axonal Injury Persistence after Rotational Head Injury Are Direction Dependent	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; cognitive function; pediatric brain injury; TBI	TRAUMATIC BRAIN-INJURY; QUANTITATIVE ASSESSMENT; ANIMAL-MODELS; RAT BEHAVIOR; NEONATAL PIG; SUS-SCROFA; RESPONSES; MICROSTRUCTURE; DISORDERS; PIGLETS	Pigs continue to grow in importance as a tool in neuroscience. However, behavioral tests that have been validated in the rodent model do not translate well to pigs because of their very different responses to behavioral stimuli. We refined metrics for assessing porcine open field behavior to detect a wide spectrum of clinically relevant behaviors in the piglet post-traumatic brain injury (TBI). Female neonatal piglets underwent a rapid non-impact head rotation in the sagittal plane (n = 8 evaluable) or were instrumented shams (n = 7 evaluable). Open field testing was conducted 1 day prior to injury (day -1) in order to establish an individual baseline for analysis, and at days +1 and +4 after injury. Animals were then killed on day +6 after injury for neuropathological assessment of axonal injury. Injured piglets were less interested in interacting with environmental stimuli and had a lower activity level than did shams. These data were compared with previously published data for axial rotational injuries in neonatal piglets. Acute behavioral outcomes post-TBI showed a dependence on the rotational plane of the brain injury, with animals with sagittal injuries demonstrating a greater level of inactivity and less random usage of the open field space than those with axial injuries. The persistence of axonal injury is also dependent on the rotational plane, with sagittal rotations causing more prolonged injuries than axial rotations. These results are consistent with animal studies, finite element models, and studies of concussions in football, which have all demonstrated differences in injury severity depending upon the direction of head impact rotation.	[Sullivan, Sarah; Ralston, Jill; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Propert, Kathleen J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Rapp, Paul E.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, U01NS069545, K08NS064051]; Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences; Defense Medical Research and Development Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679, K08NS064051, U01NS069545] Funding Source: NIH RePORTER	The authors acknowledge Benjamin Bruins for his contribution in conducting the assessments. This study was made possible by the support of National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grants R01NS039679, U01NS069545, and K08NS064051. Dr. Rapp acknowledges support of the Traumatic Injury Research Program of the Uniformed Services University of the Health Sciences and the Defense Medical Research and Development Program. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as official or reflecting the views of their respective commands, the United States Navy, or the Department of Defense.	Cellucci CJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066208; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Donald RD, 2011, PHYSIOL BEHAV, V104, P906, DOI 10.1016/j.physbeh.2011.05.031; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Emack J, 2011, HORM BEHAV, V60, P589, DOI 10.1016/j.yhbeh.2011.08.008; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fang MR, 2005, NEUROSIGNALS, V14, P102, DOI 10.1159/000086292; Faul M, 2010, TRAUMATIC BRAIN INJU; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA., 1987, 872197 SAE; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; Kanitz E, 2004, BRAIN BEHAV IMMUN, V18, P35, DOI 10.1016/S0889-1591(03)00085-0; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; PAULUS MP, 1992, NEUROPSYCHOPHARMACOL, V7, P15; PAULUS MP, 1993, PSYCHOPHARMACOLOGY, V113, P177, DOI 10.1007/BF02245695; PAULUS MP, 1993, PSYCHOPHARMACOLOGY, V113, P187, DOI 10.1007/BF02245696; PAULUS MP, 1990, P NATL ACAD SCI USA, V87, P723, DOI 10.1073/pnas.87.2.723; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rapp PE, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-119; Rapp PE, 2007, COGN NEURODYNAMICS, V1, P287, DOI 10.1007/s11571-007-9027-8; Serebro-Sorek K, 2007, BRAIN INJURY, V21, P583, DOI 10.1080/02699050701426840; van der Staay FJ, 2009, PSYCHOPHARMACOLOGY, V206, P715, DOI 10.1007/s00213-009-1599-z; Watanabe TAA, 2003, PSYCHOPHYSIOLOGY, V40, P77, DOI 10.1111/1469-8986.00009; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	38	24	24	0	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					538	545		10.1089/neu.2012.2594			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300005	23216054	Green Published			2022-02-06	
J	Alharfi, IM; Stewart, TC; Kelly, SH; Morrison, GC; Fraser, DD				Alharfi, Ibrahim M.; Stewart, Tanya Charyk; Kelly, Shawn H.; Morrison, Gavin C.; Fraser, Douglas D.			Hypernatremia Is Associated with Increased Risk of Mortality in Pediatric Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hypernatremia; mortality, children; severe TBI; TBI interventions	SEVERE HEAD-INJURY; CRITICALLY-ILL; INTRACRANIAL HYPERTENSION; DIABETES-INSIPIDUS; HYPERTONIC SALINE; CHILDREN; THERAPY; SODIUM; COMPLICATIONS; POPULATION	Acquired hypernatremia in hospitalized patients is often associated with poorer outcomes. Our aim was to evaluate the relationship between acquired hypernatremia and outcome in children with severe traumatic brain injury (sTBI). We performed a retrospective cohort study of all severely injured trauma patients (Injury Severity Score >= 12) with sTBI (Glasgow Coma Scale [GCS] <= 8 and Maximum Abbreviated Injury Scale [MAIS] >= 4) admitted to a Pediatric Critical Care Unit ([PCCU]; 2000-2009). In a cohort of 165 patients, 76% had normonatremia (135-150 mmol/L), 18% had hypernatremia (151-160 mmol/L), and 6% had severe hypernatremia (> 160 mmol/L). The groups were similar except for lower GCS (p = 0.002) and increased incidence of fixed pupil(s) on admission in both hypernatremia groups (p < 0.001). Mortality rate was four-fold and six-fold greater with hypernatremia and severe hypernatremia, respectively (p < 0.001), and mortality rates were unchanged when patients with fixed pupils or those with central diabetes insipidus were excluded (p < 0.001). Hypernatremic patients had fewer ventilator-free days (p < 0.001). Survivors with hypernatremia had greater PCCU (p = 0.001) and hospital (p = 0.031) lengths of stays and were less frequently discharged home (p = 0.008). Logistic regression analyses of patient characteristics and sTBI interventions demonstrated that hypernatremia was independently associated with the presence of fixed pupil(s) on admission (odds ratio [OR] 5.38; p = 0.003); administration of thiopental (OR 8.64; p = 0.014), and development of central diabetes insipidus (OR 5.66; p = 0.005). Additional logistic regression analyses demonstrated a significant association between hypernatremia and mortality (OR 6.660; p = 0.034). In summary, acquired hypernatremia appears to signal higher risk of mortality in pediatric sTBI and is associated with a higher discharge level of care in sTBI survivors.	[Alharfi, Ibrahim M.; Kelly, Shawn H.; Morrison, Gavin C.; Fraser, Douglas D.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Dept Pediat Crit Care, Riyadh, Saudi Arabia; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] LHSC, Trauma Program, London, ON N6A 5W9, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada		Fraser, DD (corresponding author), LHSC, Childrens Hosp, Room C2-C82,800 Commissioners Rd East, London, ON N6A 5W9, Canada.	Douglas.Fraser@lhsc.on.ca					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Alharfi I.M., 2013, PEDIAT CRIT CARE MED; An HS, 2010, J KOREAN NEUROSURG S, V47, P252, DOI 10.3340/jkns.2010.47.4.252; [Anonymous], 1995, ABBR INJ SCAL MAN; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; BARZILAY Z, 1988, J MED, V19, P47; Boughey JC, 2004, AM SURGEON, V70, P500; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; Dunn K, 1997, J PAEDIATR CHILD H, V33, P26, DOI 10.1111/j.1440-1754.1997.tb00986.x; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Hoorn EJ, 2008, NEPHROL DIAL TRANSPL, V23, P1562, DOI 10.1093/ndt/gfm831; Hosmer D, 1989, APPL LOGISTIC REGRES; Huynh F, 2009, THER DRUG MONIT, V31, P153, DOI 10.1097/FTD.0b013e318196fb9f; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lekmanov A. U., 2010, Anesteziologiya i Reanimatologiya, P41; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2010, INTENS CARE MED, V36, P1718, DOI 10.1007/s00134-010-1968-4; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Moritz ML, 1999, PEDIATRICS, V104, P435, DOI 10.1542/peds.104.3.435; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Ralston M, 2006, PALS PROVIDER MANUAL; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Yanay O, 2004, J CRIT CARE, V19, P174, DOI 10.1016/j.jcrc.2004.07.008; Zygun DA, 2009, CRIT CARE, V13, DOI 10.1186/cc8014	34	24	28	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	5					361	366		10.1089/neu.2012.2410			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	103CI	WOS:000315891600006	23057958				2022-02-06	
J	Karaca, Z; Tanriverdi, F; Dagli, AT; Selcuklu, A; Casanueva, FF; Unluhizarci, K; Kelestimur, F				Karaca, Z.; Tanriverdi, F.; Dagli, A. T.; Selcuklu, A.; Casanueva, F. F.; Unluhizarci, K.; Kelestimur, F.			Three years prospective investigation of pituitary functions following subarachnoid haemorrhage	PITUITARY			English	Article						Subarachnoid haemorrhage; Pituitary; Cortisol; Growth hormone	TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM	Subarachnoid haemorrhage (SAH) is known to be related to pituitary dysfuntion in retrospective and short-term prospective studies. We aimed to investigate pituitary functions in patients with SAH in longer follow-up periods to demonstrate if pituitary hormone deficiencies recover, persist or new hormone deficiencies occur. Twenty patients with SAH, who were followed up for 3 years, were included in the present study. Patients were evaluated with basal hormone levels and glucagon stimulation test (GST). Serum basal cortisol and adrenocorticotropic hormone (ACTH) levels were found to be significantly elevated at 3rd year of SAH compared to 1st year. Other basal hormone levels at 3rd year did not show a significant change from the levels found at 1st year. One of the patients had ACTH deficiency at 1st year of SAH and recovered at 3rd year. Growth hormone (GH) deficiency, according to GST, was diagnosed in 4 patients. One patient with GH deficiency at first year was still deficient, 3 of them recovered and 3 patients were found to have new-onset GH deficiency 3 years after SAH. SAH is associated with anterior pituitary dysfunction and GH is the most frequently found deficient hormone in the patients. Although one year after SAH seems to be an appropriate time for the evaluation of pituitary functions, further follow-up may be required at least in some cases due to recovered and new-onset hormone deficiencies at 3rd year of SAH.	[Karaca, Z.; Tanriverdi, F.; Unluhizarci, K.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Dagli, A. T.; Selcuklu, A.] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Casanueva, F. F.] Univ Santiago de Compostela, Santiago De Compostela 15705, Spain		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021; Karaca, Zuleyha/ABB-7891-2021				Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; Lamberts SWJ, 1998, LANCET, V352, P127; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shin IY, 2011, STRESS, V14, P156, DOI 10.3109/10253890.2010.522630; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Weant KA, 2008, NEUROSURGERY, V63, P645, DOI 10.1227/01.NEU.0000325728.50939.15	25	24	24	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	MAR	2013	16	1					76	82		10.1007/s11102-012-0377-9			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	087HM	WOS:000314752100009	22315089				2022-02-06	
J	Kurowski, BG; Wade, SL; Kirkwood, MW; Brown, TM; Stancin, T; Cassedy, A; Taylor, HG				Kurowski, Brad G.; Wade, Shari L.; Kirkwood, Michael W.; Brown, Tanya M.; Stancin, Terry; Cassedy, Amy; Taylor, H. Gerry			Association of Parent Ratings of Executive Function With Global- and Setting-Specific Behavioral Impairment After Adolescent Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting of the Association-of-Academic-Physiatrists	APR 14, 2011	Phoenix, AZ	Assoc Acad Physiatrists		Adolescent; Brain injuries; Executive function; Memory; Rehabilitation	PROBLEM-SOLVING SKILLS; SELF-REGULATION; CRITERION VALIDITY; SOCIAL COMPETENCE; YOUNG-CHILDREN; FOLLOW-UP; CHILDHOOD; TERM; OUTCOMES; TBI	Objective: To determine the association of primary caregiver-rated behavioral and metacognitive aspects of executive function (EF) with impaired functioning after adolescent traumatic brain injury (TBI). Design: Multicenter cross-sectional study. Setting: Outpatient. Participants: Primary caregivers and children (N=132) aged 12 to 17 years who sustained a moderate or severe TBI within the past 1 to 6 months. Interventions: Not applicable. Main Outcome Measures: Primary caregiver ratings of EF, tests of memory and processing speed (PS), and a structured parent interview to assess clinical impairments in behavioral functioning were used. Logistic regression was used to examine the relation of ratings of EF with clinical ratings of impairment in global adolescent functioning and in functioning in the home, school, and community settings after controlling for sex, race, socioeconomic status, injury severity, and performance on the tests of memory and PS. Results: Caregiver ratings of poor EF were associated with impairment in both global behavioral functioning (odds ratio [OR] = 4.73; 95% confidence interval [CI], 1.54-14.52; P<.01) and community functioning (OR = 13.28; 95% CI, 1.94-90.87; P<.01). Conclusions: Caregiver ratings of deficits in EF were associated with impaired behavioral functioning after adolescent TBI and were independent of performance on tests of memory and processing speed. Understanding the relation of EF with clinical impairments as manifested in different settings will help hone assessment batteries and focus treatments where they are needed most. Archives of Physical Medicine and Rehabilitation 2013;94:543-50 (C) 2013 by the American Congress of Rehabilitation Medicine	[Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Wade, Shari L.; Cassedy, Amy] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Stancin, Terry/L-7993-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001097, 2K12 HD001097-16] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH073764, R01-MH073764] Funding Source: Medline		Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Centers for Disease Control and Prevention, INJ PREV CONTR TRAM; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; HODGES K, 1999, J CHILD FAM STUD, V8, P109; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hodges K., 2005, CAFAS MANUAL TRAININ; Hodges K, 2004, J CHILD FAM STUD, V13, P325, DOI DOI 10.1023/B:JCFS.0000022038.62940.A3; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Quist RM, 2000, ADOLESCENCE, V35, P181; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shanahan L, 2011, BRAIN INJURY, V25, P1080, DOI 10.3109/02699052.2011.607781; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TEASDALE G, 1974, LANCET, V2, P81; Tonks James, 2011, Clin Child Psychol Psychiatry, V16, P185, DOI 10.1177/1359104511403583; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Wechsler D, 2003, WISC 4 ADM MANUAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	58	24	24	1	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2013	94	3					543	550		10.1016/j.apmr.2012.10.029			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	106PZ	WOS:000316158500020	23131527	Green Accepted			2022-02-06	
J	Lamy, M; Baumgartner, D; Yoganandan, N; Stemper, BD; Willinger, R				Lamy, Michael; Baumgartner, Daniel; Yoganandan, Narayan; Stemper, Brian D.; Willinger, Remy			Experimentally validated three-dimensional finite element model of the rat for mild traumatic brain injury	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Biomechanics; Finite element model; Stress-strain analysis; Traumatic brain injuries	CONTROLLED CORTICAL IMPACT; PRESSURE CHANGES; AXONAL INJURY; HEAD; TISSUE; ACCELERATION; CONTUSION	The aim of our work was to expand on the knowledge concerning mild Traumatic Brain Injuries (TBI), by combining numerical modeling and animal experiments within a joint approach. A three-dimensional finite element model of the rat brain and braincase was developed, and experimental acceleration pulses were applied. Pulse data were obtained from tests conducted using anesthetized rats, subjected to coronal plane rotational acceleration loadings of varying amplitudes and durations, aimed to generate mild TBI. Times of loss of consciousness were obtained. Biomechanical response parameters generally associated with TBI (stresses and strains) in the three anatomical regions, i.e., hypothalamus, thalamus and parietal cortex were analyzed. While the parameters correlated well with changes in injury severity linked to peak rotational acceleration, they were relatively insensitive to the pulse duration or times of loss of consciousness. As a consequence, new stress-time and strain-time metrics were computed, and these metrics were more efficient in predicting changes in injury severity associated both with acceleration characteristics and loss of consciousness outcomes in all three anatomical regions controlling the aforementioned behavior. Results of our analysis tend to show that time-related metrics may be more suited for the explanation of mild TBI than commonly used peak metrics in the three anatomical regions of the brain.	[Lamy, Michael; Baumgartner, Daniel; Willinger, Remy] Univ Strasbourg, Dept Fluid & Solid Mech, IMFS, F-67000 Strasbourg, France; [Yoganandan, Narayan; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		Baumgartner, D (corresponding author), Univ Strasbourg, Dept Fluid & Solid Mech, IMFS, 2 Rue Boussingault, F-67000 Strasbourg, France.	daniel.baumgartner@unistra.fr	Stemper, Brian/AAX-7611-2020				AIS, 1990, ABBR INJ SCAL, P74; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Baumgartner D, 2004, REV EUROPEENNE ELEME, V14, P421; Davidsson J, 2009, NEW MODEL INJURY THR, P73; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Fijalkowski RJ, 2009, STAPP CAR CRASH JO, V53, P193; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1996, MECH PRIMARY HEAD IN, P2611; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Guan FJ, 2011, ANN BIOMED ENG, V39, P85, DOI 10.1007/s10439-010-0125-0; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Kandel E.R., 2000, PRINCIPLES NEURAL SC; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Mao HJ, 2011, J MECH MED BIOL, V11, P1199, DOI 10.1142/S021951941100423X; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MARGULIES SS, 1985, STUDY SCALING HEAD I; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Pena A, 2005, ACT NEUR S, V95, P333; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Winn R, 2004, NEUROLOGICAL SURG; YOGANANDAN N, 1998, FRONTIERS HEAD NECK; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang Jiangyue, 2006, Annu Proc Assoc Adv Automot Med, V50, P1; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	47	24	24	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	MAR	2013	51	3					353	365		10.1007/s11517-012-1004-7			13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	098WN	WOS:000315579900011	23192366				2022-02-06	
J	Mellion, SA; Bennett, KS; Ellsworth, GL; Moore, K; Riva-Cambrin, J; Metzger, RR; Bratton, SL				Mellion, Sarah A.; Bennett, Kimberly Statler; Ellsworth, German L.; Moore, Kevin; Riva-Cambrin, Jay; Metzger, Ryan R.; Bratton, Susan L.			High-Dose Barbiturates for Refractory Intracranial Hypertension in Children With Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						barbiturates; cerebral perfusion pressure; intracranial hypertension; pediatric traumatic brain injury	HYPOTHERMIA THERAPY; HYPOTENSION; PRESSURE; OUTCOMES; COMA	Objectives: To evaluate high-dose barbiturates as a second-tier therapy for pediatric refractory intracranial hypertension complicating severe traumatic brain injury. Design: This is a retrospective cohort study of children with refractory intracranial hypertension treated with high-dose barbiturates. Setting: A single center level I pediatric trauma from 2001 to 2010. Patients: Thirty-six children with refractory intracranial hypertension defined as intracranial pressure greater than 20 mm Hg despite standard management treated with high-dose barbiturates after severe traumatic brain injury. Interventions: High-dose barbiturates were administered for refractory intracranial hypertension for a minimum duration of 6 hours and monitored by continuous electroencephalography. Measurements and Main Results: Exposure was control of -refractory intracranial hypertension defined as > 20 mm Hg -within 6 hours after starting barbiturates. Pediatric cerebral performance category scores at hospital discharge and at 3 months (or longer) follow-up were the primary outcomes. Ten of 36 patients (28%) had control of refractory intracranial hypertension. Neither demographic nor injury characteristics were associated with refractory intracranial hypertension con-trol. Children who responded received barbiturates significantly later after injury (76 vs. 29 median hours). Overall, 14 children died, 13 without control of intracranial pressure. Survival was more common in those who responded compared with those who did not respond to high-dose barbiturates, although this did not reach statistical significance (relative risk of death 0.2; 95% confidence interval; [0.03-1.3]). Of the 22 survivors, 19 had an acceptable survival (pediatric cerebral performance category less than 3) at 3 months or longer after injury; however, only three returned to normal function. Among survivors, control of refractory intracranial hypertension was associated with significantly better pediatric cerebral performance category scores and over two-fold likelihood of acceptable long-term outcome (relative risk 2.3; 95% confidence interval [1.4-4.0]) compared with uncontrolled refractory intracranial hypertension despite high-dose barbiturates. Conclusions: Addition of high-dose barbiturates achieved control of refractory intracranial hypertension in almost 30% of treated children. Control of refractory intracranial hypertension was associated with increased likelihood of an acceptable long-term outcome. (Pediatr Crit Care Med 2013; 14:239-247)	[Mellion, Sarah A.; Bennett, Kimberly Statler; Bratton, Susan L.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Ellsworth, German L.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Moore, Kevin] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Riva-Cambrin, Jay] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Metzger, Ryan R.] Univ Utah, Div Pediat Surg, Salt Lake City, UT USA		Bratton, SL (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.	Susan.Bratton@hsc.utah.edu	Bratton, Susan L./O-2353-2013	Bratton, Susan L./0000-0002-4605-8078	Office of Vice President for Health Sciences Center; Department of Pediatrics	Supported, in part, by the Office of Vice President for Health Sciences Center and the Department of Pediatrics.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Guerra SD, 2010, J PEDIAT-BRAZIL, V86, P73, DOI 10.2223/JPED.1960; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Pittman T, 1998, PEDIAT NEUROSCI, V15, P13; Roberts I, 2008, COCHRANE DB SYST REV; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	20	24	24	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2013	14	3					239	247		10.1097/PCC.0b013e318271c3b2			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	103WG	WOS:000315949600007	23392360				2022-02-06	
J	Timofeev, I; Nortje, J; Al-Rawi, PG; Hutchinson, PJA; Gupta, AK				Timofeev, Ivan; Nortje, Jurgens; Al-Rawi, Pippa G.; Hutchinson, Peter J. A.; Gupta, Arun K.			Extracellular brain pH with or without hypoxia is a marker of profound metabolic derangement and increased mortality after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain ischemia; brain trauma; energy metabolism; microdialysis; neurocritial care; pH	SEVERE HEAD-INJURY; IN-VITRO; ACIDOSIS; BASE; RAT; PATHOPHYSIOLOGY; HYPERGLYCEMIA; TROMETHAMINE; ISCHEMIA; SENSOR	Cerebral hypoxia and acidosis can follow traumatic brain injury (TBI) and are associated with increased mortality. This study aimed to evaluate a relationship between reduced pH(bt) and disturbances of cerebral metabolism. Prospective data from 56 patients with TBI, receiving microdialysis and Neurotrend monitoring, were analyzed. Four tissue states were defined based on pH(bt) and PbtO2: 1-low PbtO2/pH(bt), 2-low pH(bt)/normal PbtO2, 3-normal pH(bt)/low PbtO2, and 4-normal pH(bt)/PbtO2). Microdialysis values were compared between the groups. The relationship between PbtO2 and lactate/pyruvate (LP) ratio was evaluated at different pH(bt) levels. Proportional contribution of each state was evaluated against mortality. As compared with the state 4, the state 3 was not different, the state 2 exhibited higher levels of lactate, LP, and glucose and the state 1-higher LP and reduced glucose (P<0.001). A significant negative correlation between LP and PbtO2 (rho=-0.159, P<0.001) was stronger at low pHbt (rho=-0.201, P<0.001) and nonsignificant at normal pH(bt) (P=0.993). The state 2 was a significant discriminator of mortality categories (P=0.031). Decreased pH(bt) is associated with impaired metabolism. Measuring pH(bt) with PbtO2 is a more robust way of detecting metabolic derangements. Journal of Cerebral Blood Flow & Metabolism (2013) 33, 422-427; doi: 10.1038/jcbfm.2012.186; published online 12 December 2012	[Timofeev, Ivan; Al-Rawi, Pippa G.; Hutchinson, Peter J. A.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Acad Neurosurg Unit, Cambridge CB2 0QQ, England; [Nortje, Jurgens; Gupta, Arun K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England		Timofeev, I (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Acad Neurosurg Unit, Box 167,Hills Rd, Cambridge CB2 0QQ, England.	it227@cam.ac.uk	Timofeev, Ivan/AAE-7019-2019	Timofeev, Ivan/0000-0002-1168-0393	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277] Funding Source: Medline		BROOKE NSR, 1994, P NATL ACAD SCI USA, V91, P1903, DOI 10.1073/pnas.91.5.1903; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Grant SA, 2001, SENSOR ACTUAT B-CHEM, V72, P174, DOI 10.1016/S0925-4005(00)00650-X; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; HOFFMAN TL, 1994, J NEUROSURG, V81, P567, DOI 10.3171/jns.1994.81.4.0567; Hoffman W E, 1997, Neurosurg Focus, V2, pE2; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Huang YZ, 2004, CELL, V118, P665, DOI 10.1016/j.cell.2004.09.004; Jaeger M, 2005, ACTA NEUROCHIR SUPPL, V95, P79; Korostynska O, 2008, IEEE SENS J, V8, P20, DOI 10.1109/JSEN.2007.912522; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; McDonald JW, 1998, J NEUROSCI, V18, P6290; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MELLERGARD P, 1994, ACTA NEUROCHIR, P34; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; NAGY Z, 1985, ACTA NEUROPATHOL, V68, P160, DOI 10.1007/BF00688639; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; Shiogai T, 1999, ACT NEUR S, V75, P49; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Swanson RA, 1996, DEV NEUROSCI-BASEL, V18, P515, DOI 10.1159/000111448; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; Velisek L, 1998, HIPPOCAMPUS, V8, P24, DOI 10.1002/(SICI)1098-1063(1998)8:1<24::AID-HIPO3>3.3.CO;2-2; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Wu SZ, 2010, SENSOR ACTUAT B-CHEM, V144, P255, DOI 10.1016/j.snb.2009.10.058; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x; Yokota H, 2000, CRIT CARE MED, V28, P3275, DOI 10.1097/00003246-200009000-00025; YOSHIDA K, 1990, ACT NEUR S, V51, P317; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	41	24	24	1	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2013	33	3					422	427		10.1038/jcbfm.2012.186			6	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	099AG	WOS:000315590200015	23232949	Green Published, Bronze			2022-02-06	
J	Yeo, RA; Thoma, RJ; Gasparovic, C; Monnig, M; Harlaar, N; Calhoun, VD; Kalyanam, R; Mayer, AR; Durazzo, TC; Hutchison, KE				Yeo, Ronald A.; Thoma, Robert J.; Gasparovic, Charles; Monnig, Mollie; Harlaar, Nicole; Calhoun, Vince D.; Kalyanam, Ravi; Mayer, Andrew R.; Durazzo, Timothy C.; Hutchison, Kent E.			Neurometabolite concentration and clinical features of chronic alcohol use: A proton magnetic resonance spectroscopy study	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Alcohol use disorders; Magnetic resonance spectroscopy; Choline; NAA	TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; RAT-BRAIN; CONSUMPTION; WITHDRAWAL; EXPOSURE; CHOLINE; CORTEX; DAMAGE; SCALE	Chronic, heavy alcohol consumption may affect the concentration of neurometabolites assessed with proton magnetic resonance spectroscopy (H-1-MRS). We investigated the largest sample reported to date (N=213) with the primary goal of determining how specific clinical features impact neurometabolite concentrations in an anterior cingulate gray matter voxel. This community-dwelling sample included both treatment-seeking and non-treatment-seeking individuals. A healthy control group (N=66) was matched for age and education. In multivariate analyses predicting neurometabolite concentrations, the heavy drinking group had greater concentrations overall. An age by group interaction was noted, as group difference across neurometabolites increased with age. More years drinking, but not more drinks per drinking day (DPDD), predicted greater concentrations of choline-containing compounds (Cho), creatine-phosphocreatine (Cre), glutamate-glutamine (Glx), and N-acetyl-aspartate (NAA). The effects of other clinical variables (depression, cigarette smoking, marijuana use) were negligible. After controlling for DPDD and years drinking, treatment-seeking status had no impact on neurometabolites. In the very oldest portion of the sample (mean age=50), however, a negative relationship was seen between NAA and years drinking. These results suggest that the nature of neurometabolite abnormalities in chronic heavy drinkers may vary as a function of duration of abuse. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yeo, Ronald A.; Gasparovic, Charles; Monnig, Mollie; Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Yeo, Ronald A.; Thoma, Robert J.; Gasparovic, Charles; Harlaar, Nicole; Calhoun, Vince D.; Kalyanam, Ravi; Mayer, Andrew R.; Hutchison, Kent E.] Mind Res Network, Albuquerque, NM USA; [Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Thoma, Robert J.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Durazzo, Timothy C.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Hutchison, Kent E.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA		Yeo, RA (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	ryeo@unm.edu			National Institute on Alcoholism and Alcohol AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA012238, AA013930]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB005846]; Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R29AA012238, R01AA012238, R01AA014886, F31AA021631] Funding Source: NIH RePORTER	This research was supported by grants from the National Institute on Alcoholism and Alcohol Abuse (AA012238 and AA013930; KH), the National Institute of Biomedical Imaging and Bioengineering (R01EB005846; VDC) and a grant from the Mind Research Network.	Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cohen E, 2007, DRUG ALCOHOL DEPEN, V86, P214, DOI 10.1016/j.drugalcdep.2006.06.008; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Durazzo TC, 2004, ALCOHOL CLIN EXP RES, V28, P1849, DOI 10.1097/01.ALC.0000148112.92525.AC; Ende G, 2005, BIOL PSYCHIAT, V58, P974, DOI 10.1016/j.biopsych.2005.05.038; Ende G, 2006, NEUROIMAGE, V32, P740, DOI 10.1016/j.neuroimage.2006.03.049; Fein G, 2005, ALCOHOL, V35, P19, DOI 10.1016/j.alcohol.2004.10.007; Flatscher-Bader T, 2006, GENES BRAIN BEHAV, V5, P78, DOI 10.1111/j.1601-183X.2006.00197.x; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Gallinat J, 2007, PHARMACOPSYCHIATRY, V40, P64, DOI 10.1055/s-2007-970144; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gazdzinski S, 2008, ALCOHOL, V42, P67, DOI 10.1016/j.alcohol.2008.01.002; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; KLOSE U, 1990, MAGNET RESON MED, V14, P26, DOI 10.1002/mrm.1910140104; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Lee H, 2003, J MAGN RESON IMAGING, V18, P147, DOI 10.1002/jmri.10335; Maddock R.J., 2012, CURRENT TOPICS BEHAV; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Meyerhoff D. J., 2011, CURRENT TOPICS BEHAV; Meyerhoff DJ, 2004, ALCOHOL CLIN EXP RES, V28, P650, DOI 10.1097/01.ALC.0000121805.12350.CA; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mullins PG, 2008, MAGN RESON MED, V60, P964, DOI 10.1002/mrm.21696; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Pan Y, 2011, BEHAV BRAIN RES, V216, P66, DOI 10.1016/j.bbr.2010.07.017; Pederzolli CD, 2009, METAB BRAIN DIS, V24, P283, DOI 10.1007/s11011-009-9137-6; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; ROSS HE, 1990, J STUD ALCOHOL, V51, P506, DOI 10.15288/jsa.1990.51.506; Schweinsburg BC, 2003, AM J PSYCHIAT, V160, P1180, DOI 10.1176/appi.ajp.160.6.1180; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Smith S, 2010, ALCOHOL CLIN EXP RES, V34, P2097, DOI 10.1111/j.1530-0277.2010.01306.x; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Surendran S, 2011, INT J NEUROSCI, V121, P305, DOI 10.3109/00207454.2011.558225; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zahr NM, 2009, NEUROPSYCHOPHARMACOL, V34, P1427, DOI 10.1038/npp.2008.119	41	24	26	0	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	FEB 28	2013	211	2					141	147		10.1016/j.pscychresns.2012.05.005			7	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	115RA	WOS:000316828400007	23154093	Green Accepted			2022-02-06	
J	Ma, GM; Dennis, M; Rose, K; Spratt, D; Spielman, D				Ma, Gemma; Dennis, Michelle; Rose, Karrie; Spratt, David; Spielman, Derek			Tawny frogmouths and brushtail possums as sentinels for Angiostrongylus cantonensis, the rat lungworm	VETERINARY PARASITOLOGY			English	Article						Angiostrongylosis; Angiostrongylus cantonensis; Podargus strigoides; Trichosurus vulpecula	NEURAL ANGIOSTRONGYLOSIS; PODARGUS-STRIGOIDES; INFECTION; FUSCIPES; SYDNEY; BLACK; DOGS	The objective of this study was to determine the prevalence of angiostrongylosis in tawny frogmouths (Podargus strigoides) and brushtail possums (Trichosurus vulpecula) with signs of neurological disease, and to describe the clinicopathological features of angiostrongylosis in both species. Tawny frogmouths and brushtail possums with signs of neurological disease were sampled from the Sydney metropolitan area between October 1998 and June 2010. Samples from 100 tawny frogmouths and 31 brushtail possums from the Australian Registry of Wildlife Health (ARWH), the Wildlife Assistance and Information Foundation (WAIF) and Wildlife Health and Conservation Centre (WHCC), University of Sydney were examined. Histological examinations of the brain, spinal cord and other available tissues were used to characterize the disease responsible for each animal's clinical signs. Of the 100 tawny frogmouths with neurological disease examined, angiostrongylosis was considered responsible in 80(80%), traumatic injury in 17(17%), protozoal infection in 3(3%) and other diseases in 2 (2%) and the cause of clinical signs was unknown in 10 (10%). Eleven tawny frogmouths presenting with neurological signs associated with head trauma had concurrent angiostrongylosis. Of the 31 brushtail possums, Wobbly Possum Syndrome (WPS) was diagnosed in 21 (68%), angiostrongylosis in 4(13%) and other diseases in the remaining 6 (19%). Angiostrongylosis was overrepresented in hand reared juvenile possums. Cases of angiostrongylosis in tawny frogmouths followed a strong seasonal pattern peaking through late summer and autumn. The results confirm that Angiostrongylus cantonensis is endemic in Sydney, Australia and that tawny frogmouths could be important sentinels for this zoonotic parasite. Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.	[Ma, Gemma] RSPCA NSW, Yagoona, NSW 2199, Australia; [Dennis, Michelle] QML Pathol Vetnost Serv, Mansfield, Qld 4122, Australia; [Rose, Karrie] Taronga Conservat Soc Australia, Australian Registry Wildlife Hlth, Mosman, NSW 2088, Australia; [Spratt, David] CSIRO Ecosyst Sci, Acton, ACT 2601, Australia; [Spielman, Derek] Univ Sydney, Fac Vet Sci, Camperdown, NSW 2006, Australia		Spielman, D (corresponding author), Univ Sydney, Fac Vet Sci, Camperdown, NSW 2006, Australia.	derek.spielman@sydney.edu.au	Spratt, David M/D-4954-2011	Dennis, Michelle M./0000-0002-9075-2032	Australian Biosecurity Intelligence Network (ABIN)	We wish to thank the Taronga Wildlife Hospital, Drs. Cheryl Sangster and Richard Montali, Ms. Jane Hall, the WAIF Wildlife Clinic and the Wildlife Health and Conservation Centre for contributing case material and pathology services and Profs Paul Canfield and Richard Malik for helpful comments on the manuscript. The Australian Registry of Wildlife Health acknowledges the Australian Biosecurity Intelligence Network (ABIN) for information management and communication systems that contributed to this research. ABIN is a project of the National Collaborative Research Infrastructure Strategy (NCRIS).	Barrett JL, 2002, AUST VET J, V80, P554, DOI 10.1111/j.1751-0813.2002.tb11039.x; BHAIBULAYA M, 1975, INT J PARASITOL, V5, P7, DOI 10.1016/0020-7519(75)90091-0; BHAIBULAYA M, 1968, PARASITOLOGY, V58, P789, DOI 10.1017/S0031182000069572; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Britton P., 2011, PAEDIAT ANGIOSTRONGY; Carlisle MS, 1998, AUST VET J, V76, P167, DOI 10.1111/j.1751-0813.1998.tb10121.x; Charles J., 1995, ANN C AUSTR COMM ASS; Chotmongkol Verajit, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P231; COLLINS GH, 1992, AUST VET J, V69, P170, DOI 10.1111/j.1751-0813.1992.tb07505.x; FREEDMAN LS, 1979, J EPIDEMIOL COMMUN H, V33, P223, DOI 10.1136/jech.33.3.223; Gelis S, 2011, AUST VET J, V89, P47, DOI 10.1111/j.1751-0813.2010.00660.x; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Hartley W J, 1991, J Vet Diagn Invest, V3, P167; Hartley W.J., 1993, NZ VET J, V33, P44; Higgins DP, 1997, AUST VET J, V75, P564, DOI 10.1111/j.1751-0813.1997.tb14194.x; JINDRAK K, 1970, AM J VET RES, V31, P449; JINDRAK K, 1968, J COMP PATHOL, V78, P371, DOI 10.1016/0021-9975(68)90015-7; Kwek G., 2010, HARD SWALLOW TRUE SA; Ladds P, 2009, PATHOLOGY AUSTR NATI; MACKERRAS M. JOSEPHINE, 1955, AUSTRALIAN JOUR ZOOL, V3, P1, DOI 10.1071/ZO9550001; MASON KV, 1987, AUST VET J, V64, P201, DOI 10.1111/j.1751-0813.1987.tb15181.x; Mason KV, 1983, THESIS U QUEENSLAND; MCKENZIE RA, 1978, AUST VET J, V54, P86, DOI 10.1111/j.1751-0813.1978.tb00354.x; Monks DJ, 2005, J AVIAN MED SURG, V19, P289, DOI 10.1647/2004-024.1; OWEN HJ, 1995, BIOL CONSERV, V71, P339, DOI 10.1016/0006-3207(94)00058-X; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Reddacliff LA, 1999, AUST VET J, V77, P466, DOI 10.1111/j.1751-0813.1999.tb12095.x; Senanayake SN, 2003, MED J AUSTRALIA, V179, P430, DOI 10.5694/j.1326-5377.2003.tb05623.x; Spratt DM, 2005, MICROBIOL AUST, V26, P63; Spratt DM, 2005, INT J PARASITOL, V35, P717, DOI 10.1016/j.ijpara.2005.01.014; Stokes VL, 2007, AUST J ZOOL, V55, P177, DOI 10.1071/ZO06061	31	24	24	1	45	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4017			VET PARASITOL	Vet. Parasitol.	FEB 18	2013	192	1-3					158	165		10.1016/j.vetpar.2012.11.009			8	Parasitology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Parasitology; Veterinary Sciences	078DP	WOS:000314078900019	23218219				2022-02-06	
J	Hoerold, D; Pender, NP; Robertson, IH				Hoerold, Doreen; Pender, Niall P.; Robertson, Ian H.			Metacognitive and online error awareness deficits after prefrontal cortex lesions	NEUROPSYCHOLOGIA			English	Article						Deficit awareness; Insight; Error monitoring; Error awareness; Brain lesions	TRAUMATIC BRAIN-INJURY; SELF-AWARENESS; SUSTAINED ATTENTION; ANOSOGNOSIA; HEMIPLEGIA; REHABILITATION; INSIGHT; STROKE; TASK	Awareness of deficits after brain injury represents a significant clinical and theoretical challenge, but relatively little is known about the neuroanatomical correlates of specific types of deficit awareness. We examined the awareness correlates of left versus right prefrontal cortex lesions in comparison to left and right posterior lesions including two types of awareness measures-metacognitive and online error monitoring. Frontal lobe frontal lesion patients exhibited impaired metacognitive awareness and also showed deficits in monitoring errors as they occurred. In addition, frontal lobe lesion patients also showed reduced autonomic response to aware errors. Online and metacognitive awareness were not, however, significantly correlated, suggesting that distinct neuroanatomical systems may underpin these two types of awareness deficit. We hypothesize that while metacognitive awareness depends on both left and right frontal regions, accurate moment-to-moment processing of errors depends more on the right than on the left prefrontal cortex. (c) 2012 Elsevier Ltd. All rights reserved.	[Hoerold, Doreen; Robertson, Ian H.] Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Hoerold, Doreen; Robertson, Ian H.] Trinity Coll Dublin, Sch Psychol, Dublin 2, Ireland; [Pender, Niall P.] Beaumont Hosp, Dept Psychol, Dublin 9, Ireland		Hoerold, D (corresponding author), Kings Coll London, Inst Psychiat, Denmark Hill, London SE5 8AF, England.	doreen.hoerold@kcl.ac.uk		Pender, Niall/0000-0002-4172-0704; Robertson, Ian H/0000-0001-8637-561X	Health Research Board (HRB) Ireland grant	This research was supported by a Health Research Board (HRB) Ireland grant to D.H.	Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DUNCAN J, 1993, ATTENTION SELECTION, P53; Fleming JM, 1996, BRAIN INJURY, V10, P1; Jenkinson PM, 2009, CONSCIOUS COGN, V18, P458, DOI 10.1016/j.concog.2008.12.005; Malloy PF., 2002, FRONTAL SYSTEMS BEHA; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Nelson H.E., 1982, NATL ADULT READING T; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Partington JE, 1949, PSYCHOL SERV CTR B, V1, P9; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schacter D. L., 1991, AWARENESS DEFICIT BR, P258; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STARKSTEIN SE, 1995, ARCH NEUROL-CHICAGO, V52, P415, DOI 10.1001/archneur.1995.00540280105024; Stern R.M., 2001, PSYCHOPHYSIOLOGICAL; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss D.T., 2001, FRONTAL LOBES NEUROP, P101; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Venneri A, 2004, NEUROPSYCHOLOGIA, V42, P230, DOI 10.1016/S0028-3932(03)00171-4; Vocat R, 2010, BRAIN, V133, P3578, DOI 10.1093/brain/awq297; Wechsler D, 1998, WECHSLER MEMORY SCAL; Worrall BB, 2005, NEUROLOGY, V65, P500, DOI 10.1212/WNL.65.3.500; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	24	24	0	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	FEB	2013	51	3					385	391		10.1016/j.neuropsychologia.2012.11.019			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	106PU	WOS:000316158000001	23196146	Green Submitted			2022-02-06	
J	Atkins, CM; Cepero, ML; Kang, Y; Liebl, DJ; Dietrich, WD				Atkins, Coleen M.; Cepero, Maria L.; Kang, Yuan; Liebl, Daniel J.; Dietrich, W. Dalton			Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice	NEUROSCIENCE LETTERS			English	Article						Cyclic AMP; Contusion; Controlled cortical impact; Mice; Phosphodiesterase; Rolipram	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; PHOSPHODIESTERASE INHIBITORS; POSTTRAUMATIC HYPOTHERMIA; FUNCTIONAL RECOVERY; PROTEIN-LEVELS; IV INHIBITOR; LONG-TERM; RATS; MEMORY	Traumatic brain injury (TBI) pathology includes contusions, cavitation, cell death, all of which can be exacerbated by inflammation. We hypothesized that an anti-inflammatory drug, rolipram, may reduce pathology after TBI, since in several CNS injury models rolipram reduces inflammation and improves cell survival and functional recovery. Adult male C57BL/6 mice received a craniotomy over the right parietotemporal cortex. Vertically directed controlled cortical impact (CCI) injury was delivered. Naive controls were used for comparison. At 30 min post-surgery, animals were treated with vehicle or rolipram (1 mg/kg), and then once per day for 3 days. On day 3, the brains were systematically sectioned and stained to visualize the resulting pathology using hematoxylin and eosin (H&E) staining and NeuN immunocytochemistry. Total parietotemporal cortical contusion and cavity volume were significantly increased in rolipram-treated as compared to vehicle-treated CCI animals. Contusion areas at specific bregma levels indicated a significant effect of drug across bregma levels. Neuronal cell loss in the dentate hilus and area CA3 of the hippocampus were similar between vehicle and rolipram-treated animals. Although rolipram is well known to reduce pathology and inflammation in several other CNS injury models, the pathology resulting from CCI was worsened with rolipram at this particular dose and administration schedule. These studies suggest that consideration of the unique characteristics of TBI pathology is important in the extrapolation of promising therapeutic interventions from other CNS injury models. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Atkins, Coleen M.; Cepero, Maria L.; Kang, Yuan; Liebl, Daniel J.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace,3-17, Miami, FL 33136 USA.	catkins@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069721, NS056072, NS030291]; Miami Project; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS056072, R01NS069721] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS NS069721 (C.M.A.), NS056072 (W.D.D.), and NS030291 (W.D.D., D.J.L.), and The Miami Project to Cure Paralysis. We thank David Sequiera for technical support.	Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Chang YC, 2008, PEDIATR RES, V64, P234, DOI 10.1203/PDR.0b013e31817cfc87; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M, 2010, TRAUMATIC BRAIN INJU; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Gurney ME, 2011, HANDB EXP PHARMACOL, V204, P167, DOI 10.1007/978-3-642-17969-3_7; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Raghupathi R, 1998, P W PHARMACOL SOC, V41, P241; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Shah MK, 2002, J CARDIOVASC PHARM, V39, P142, DOI 10.1097/00005344-200201000-00015; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092; Zhang J, 2008, TOXICOL PATHOL, V36, P827, DOI 10.1177/0192623308322308	45	24	24	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 4	2013	532						1	6		10.1016/j.neulet.2012.10.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	076DM	WOS:000313936700001	23103712	Green Accepted			2022-02-06	
J	Baraniuk, JN; Adewuyi, O; Merck, SJ; Ali, M; Ravindran, MK; Timbol, CR; Ray-Han, R; Zheng, Y; Le, U; Esteitie, R; Petrie, KN				Baraniuk, James N.; Adewuyi, Oluwatoyin; Merck, Samantha Jean; Ali, Mushtaq; Ravindran, Murugan K.; Timbol, Christian R.; Ray-Han, Rakib; Zheng, Yin; Le, Uyenphuong; Esteitie, Rania; Petrie, Kristina N.			A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Fatigue; pain; fibromyalgia; myalgic encephalomyelitis; proteomics	TRAUMATIC BRAIN-INJURY; ASTHMA SYMPTOM SCORE; MYALGIC ENCEPHALOMYELITIS; DEFINITION; ILLNESS; NEUROPATHOLOGY; FIBROMYALGIA; POPULATION; PREVALENCE; VETERANS	Background: Chronic Fatigue Syndrome case designation criteria are scored as physicians' subjective, nominal interpretations of patient fatigue, pain (headaches, myalgia, arthralgia, sore throat and lymph nodes), cognitive dysfunction, sleep and exertional exhaustion. Methods: Subjects self-reported symptoms using an anchored ordinal scale of 0 (no symptom), 1 (trivial complaints), 2 (mild), 3 (moderate), and 4 (severe). Fatigue of 3 or 4 distinguished "Fatigued" from "Not Fatigued" subjects. The sum of the 8(Sum8) ancillary criteria was tested as a proxy for fatigue. All subjects had history and physical examinations to exclude medical fatigue, and ensure categorization as healthy or CFS subjects. Results: Fatigued subjects were divided into CFS with >= 4 symptoms or Chronic Idiopathic Fatigue (CIF) with <= 3 symptoms. ROC of Sum8 for CFS and Not Fatigued subjects generated a threshold of 14 (specificity=0.934; sensitivity=0.928). CFS (n=256) and CIF (n=55) criteria were refined to include Sum8 >= 14 and <= 13, respectively. Not Fatigued subjects had highly skewed Sum8 responses. Healthy Controls (HC; n=269) were defined by fatigue <= 2 and Sum8 <= 13. Those with Sum8 >= 14 were defined as CFS-Like With Insufficient Fatigue Syndrome (CFSLWIFS; n=20). Sum8 and Fatigue were highly correlated (R-2=0.977; Cronbach's alpha=0.924) indicating an intimate relationship between symptom constructs. Cluster analysis suggested 4 clades each in CFS and HC. Translational utility was inferred from the clustering of proteomics from cerebrospinal fluid. Conclusions: Plotting Fatigue severity versus Sum8 produced an internally consistent classifying system. This is a necessary step for translating symptom profiles into fatigue phenotypes and their pathophysiological mechanisms.	[Baraniuk, James N.; Adewuyi, Oluwatoyin; Ray-Han, Rakib; Le, Uyenphuong; Esteitie, Rania; Petrie, Kristina N.] Georgetown Univ, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA; [Merck, Samantha Jean] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Ali, Mushtaq] Internal Med Residency Program, Des Moines, IA 50309 USA; [Ravindran, Murugan K.] Norwalk Hosp, Dept Internal Med, Norwalk, CT 06856 USA; [Timbol, Christian R.] Georgetown Univ, Sch Med, Washington, DC 20007 USA; [Zheng, Yin] Univ S Florida, Sch Med, Tampa, FL 33620 USA		Baraniuk, JN (corresponding author), Georgetown Univ, Med Ctr, Div Rheumatol Immunol & Allergy, Room 3004F,3rd Floor PHC Bldg,3800 Reservoir Rd N, Washington, DC 20007 USA.	baraniuj@georgetown.edu			National Institute of Environmental and Health Sciences (NIEHS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [RO1 ES015382]; Congressionally Directed Medical Research Program (CDMRP)United States Department of Defense [W81XWH-07-1-0618, W81XWH-09-1-0526]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000101, UL1RR031975]	Funding: This work was funded by the National Institute of Environmental and Health Sciences (NIEHS) (RO1 ES015382) and the Congressionally Directed Medical Research Program (CDMRP awards W81XWH-07-1-0618 and W81XWH-09-1-0526). This project has been funded in whole or in part with Federal funds (Grant # UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." Competing interests: The authors declare they have no competing interests.	Arpino C, 1999, Ann Ist Super Sanita, V35, P435; Baraniuk JN, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-22; Baraniuk JN, 1998, ANN ALLERG ASTHMA IM, V81, P359, DOI 10.1016/S1081-1206(10)63129-8; Baraniuk JN, 2005, AM J RESP CRIT CARE, V171, P5, DOI 10.1164/rccm.200403-357OC; Baraniuk JN, 2000, J CFS, V7, P33; Baraniuk JN, 2011, 10 INT ME CFS C OTT; Baraniuk JN, 2000, J CFS, V7, P3; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Bhui KS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-26; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers B.M., 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [10.1300/J092v11n01_02, DOI 10.1300/J092V11N01_02]; Ciccone DS, 2010, J NERV MENT DIS, V198, P486, DOI 10.1097/NMD.0b013e3181e4ce0b; Darbishire L, 2003, BRIT J GEN PRACT, V53, P441; De Luca C, 2010, TOXICOL APPL PHARM, V248, P285, DOI 10.1016/j.taap.2010.04.017; Eglinton R, 2011, PSYCHIAT RES, V188, P245, DOI 10.1016/j.psychres.2011.04.012; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; Fang H, 2006, PHARMACOGENOMICS, V7, P429, DOI 10.2217/14622416.7.3.429; Fletcher MA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-76; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Furberg H, 2005, J PSYCHOSOM RES, V59, P283, DOI 10.1016/j.jpsychores.2005.05.008; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Janal MN, 2006, BIOL PSYCHOL, V73, P124, DOI 10.1016/j.biopsycho.2006.01.003; Jason LA, 2005, NEUROPSYCHOL REV, V15, P29, DOI 10.1007/s11065-005-3588-2; Jason LA, 2012, J CLIN PSYCHOL, V68, P41, DOI 10.1002/jclp.20827; Jones JF, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-57; KLOCKARS AJ, 1995, PSYCHOL BULL, V118, P300, DOI 10.1037/0033-2909.118.2.300; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McGeary D, 2011, J CLIN PSYCHOL MED S, V18, P155, DOI 10.1007/s10880-011-9236-5; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Naranch K, 2002, OTOLARYNG HEAD NECK, V127, P387, DOI 10.1067/mhn.2002.129038; Neu D, 2008, J SLEEP RES, V17, P427, DOI 10.1111/j.1365-2869.2008.00679.x; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19; Reeves William C, 2007, Popul Health Metr, V5, P5; Rowe PC, 2007, AM J MED, V120, pE13, DOI 10.1016/j.amjmed.2006.02.033; Schmaling KB, 2003, PSYCHOSOM MED, V65, P1047, DOI 10.1097/01.PSY.0000088587.29901.69; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele Lea, 1998, American Journal of Medicine, V105, p83S, DOI 10.1016/S0002-9343(98)00158-2; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; VanNess JM, 2003, MED SCI SPORT EXER, V35, P908, DOI 10.1249/01.MSS.0000069510.58763.E8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 1999, J ASTHMA, V36, P459, DOI 10.3109/02770909909087288; Wasserfallen JB, 1997, J ALLERGY CLIN IMMUN, V100, P16, DOI 10.1016/S0091-6749(97)70189-1; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zheng Y, 2010, 10 INT ME CFS C OTT; [No title captured]	57	24	25	2	23	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2013	5	1					53	68					16	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	135IB	WOS:000318280700006	23390566				2022-02-06	
J	Hamel, A; Llari, M; Piercecchi-Marti, MD; Adalian, P; Leonetti, G; Thollon, L				Hamel, Anissa; Llari, Maxime; Piercecchi-Marti, Marie-Dominique; Adalian, Pascal; Leonetti, Georges; Thollon, Lionel			Effects of fall conditions and biological variability on the mechanism of skull fractures caused by falls	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Skull fractures; Falls; Multibody dynamics; Finite element modeling; Forensic investigations	MULTIBODY DYNAMICS ANALYSIS; TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODELS; HUMAN HEAD; TOLERANCE LIMITS; IMPACT; BIOMECHANICS; RECONSTRUCTION	In a forensic investigation, there is considerable difficulty in distinguishing between different mechanisms that could explain the head injury sustained. The key question is often whether the injury was the consequence of a fall, a blow, or a fall caused by a blow. Better understanding of the parameters influencing the mechanism of skull fracture could be of use when attempting to distinguish between different causes of injury. Numerous parameters concerning fall conditions and biological variability are reported in the literature to influence the mechanism of skull fracture. At the current time, there are no studies that investigate both the effect of a fall and biological parameters. The aim of this paper is to study the influence of these parameters on the mechanism of skull fracture using a numerical approach. We focused on accidental falls from a standing height. A multibody model was used to estimate head impact velocities and a finite element model was used to investigate the effect of the fall conditions and of biological variability on skull fracture. The results show that the mechanism of skull fractures is influenced by a combination of at least four parameters: impact velocity, impact surface, cortical thickness and cortical density.	[Hamel, Anissa; Llari, Maxime; Thollon, Lionel] Fac Med Sect No, Lab Biomecan Appl, F-13916 Marseille 20, France; [Piercecchi-Marti, Marie-Dominique; Adalian, Pascal; Leonetti, Georges] CHU Timone Fac Med, Serv Med Legale & Droit Sante, F-13385 Marseille 5, France; [Hamel, Anissa; Piercecchi-Marti, Marie-Dominique; Adalian, Pascal; Leonetti, Georges] Fac Med Sect No, Lab Anthropol, UMR 6578, F-13385 Marseille 5, France		Thollon, L (corresponding author), Fac Med Sect No, Lab Biomecan Appl, Blvd Pierre Dramard, F-13916 Marseille 20, France.	lionel.thollon@ifsttar.fr	ADALIAN, Pascal/F-4126-2010	ADALIAN, Pascal/0000-0002-5101-9508			BANDAK FA, 1995, J NEUROTRAUM, V12, P679, DOI 10.1089/neu.1995.12.679; Baumgartner D, 2005, SOLID MECH APPL, V124, P195; Behr M., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P263, DOI 10.1080/10255840310001606080; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Cory CZ, 2001, FORENSIC SCI INT, V123, P89, DOI 10.1016/S0379-0738(01)00523-0; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly MC, 2009, INT J CRASHWORTHINES, V14, P503, DOI 10.1080/13588260902826554; Glasson E, 2000, IMECHE CONF TRANS, V2000, P79; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kang HS, 1997, P 41 STAPP CAR CRASH, P329; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; Motherway J, 2009, Leg Med (Tokyo), V11 Suppl 1, pS220, DOI 10.1016/j.legalmed.2009.01.072; North JB, 1991, P INT RES COUNC BIOK, P77; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Ramet M, 1983, P PED IMP INJ ASS DE, P225; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Ruan J, 2001, Stapp Car Crash J, V45, P395; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Turquier F, 1996, P 40 STAPP CAR CRASH, P1912; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang J.K., 2000, J CRASH PREVENTION I, V2, P131, DOI [10.1080/10286580008902559, DOI 10.1080/10286580008902559]; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014	30	24	26	1	32	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2013	127	1					111	118		10.1007/s00414-011-0627-9			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	065QR	WOS:000313164100016	21984166				2022-02-06	
J	Hooson, JM; Coetzer, R; Stew, G; Moore, A				Hooson, J. Marian; Coetzer, R.; Stew, G.; Moore, A.			Patients' experience of return to work rehabilitation following traumatic brain injury: A phenomenological study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Community vocational rehabilitation	EMPLOYMENT; INDIVIDUALS; RECOVERY	Many persons with traumatic brain injury (TBI) are young adults who, prior to their TBI, were in paid employment. Psychosocial outcome after TBI, for many, remains poor. This includes low rates of return to pre-injury work or education, among others. This qualitative study explored the experience of return to work (RTW) rehabilitation with 10 individuals who sustained TBI. Data were collected from semi-structured interviews. Transcripts were analysed using interpretative phenomenological analysis (IPA). Some of the main findings from this study included the following: Individuals find the RTW experience difficult and painful. They experience a distinct grief reaction in the process of exploring re-engagement in occupation following TBI. In view of these and other findings, changes to RTW rehabilitation should be considered to facilitate the optimal support for patients with TBI engaging in the RTW rehabilitation process.	[Hooson, J. Marian; Coetzer, R.] Colwyn Bay Hosp, North Wales Brain Injury Serv, Colwyn Bay, Wales; [Stew, G.; Moore, A.] Univ Brighton, Sch Hlth Profess, Eastbourne, England		Hooson, JM (corresponding author), Betsi Cadwaladr Univ Hlth Board NHS Wales, Colwyn Bay Hosp, North Wales Brain Injury Serv, Hesketh Rd, Colwyn Bay LL29 8AY, Wales.	Marian.hooson@wales.nhs.uk					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Baillie C, 2000, BRIT J HEALTH PSYCH, V5, P377, DOI 10.1348/135910700168991; Barnes MP, 2001, J REHABIL MED, V33, P244; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; British Society of Rehabilitation Medicine, 2003, REH ACQ BRAIN INJ; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Bryden J., 1997, MODELS BRAIN INJURY; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coetzer B. R., 2003, J COGNITIVE REHABILI, V21, P4; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Deegan P, 1996, PSYCHIATR REHABIL J, V19, P91, DOI 10.1037/h0101301; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; Finlay L, 2006, QUALITATIVE RES ALLI; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kissinger DB, 2008, WORK, V31, P309; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; KUBLERROSS E, 1986, DEATH DYING; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marks D, 2004, RES METHODS CLIN HLT; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; O'Hara CC, 1991, REHABILITATION BRAIN; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; PARENTE R, 1991, J HEAD TRAUMA REHAB, V6, P35; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Porter S, 1996, J ADV NURS, V24, P413, DOI 10.1046/j.1365-2648.1996.19126.x; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; Rapp C.A., 1998, STRENGTHS MODEL CASE; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; SALTER S, 1997, ALTERED BODY IMAGE, P1; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith JA., 2006, RES METHODS PSYCHOL, V3; Stroebe M., 2001, HDB BEREAVEMENT RES; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Willig C., 2008, INTRO QUALITATIVE RE; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	44	24	27	1	29	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 1	2013	23	1					19	44		10.1080/09602011.2012.713314			26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	096BD	WOS:000315377800002	22905786				2022-02-06	
J	Moraes, DP; Sassi, FC; Mangilli, LD; Zilberstein, B; de Andrade, CRF				Moraes, Danielle Pedroni; Sassi, Fernanda Chiarion; Mangilli, Laura Davison; Zilberstein, Bruno; Furquim de Andrade, Claudia Regina			Clinical prognostic indicators of dysphagia following prolonged orotracheal intubation in ICU patients	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; FIBEROPTIC ENDOSCOPIC EVALUATION; ENDOTRACHEAL INTUBATION; ACUTE STROKE; OROPHARYNGEAL DYSPHAGIA; REHABILITATIVE MANAGEMENT; SWALLOWING DYSFUNCTION; ASPIRATION PNEUMONIA; FUNCTIONAL OUTCOMES; PREDICTORS	Introduction: The development of postextubation swallowing dysfunction is well documented in the literature with high prevalence in most studies. However, there are relatively few studies with specific outcomes that focus on the follow-up of these patients until hospital discharge. The purpose of our study was to determine prognostic indicators of dysphagia in ICU patients submitted to prolonged orotracheal intubation (OTI). Methods: We conducted a retrospective, observational cohort study from 2010 to 2012 of all patients over 18 years of age admitted to a university hospital ICU who were submitted to prolonged OTI and subsequently received a bedside swallow evaluation (BSE) by a speech pathologist. The prognostic factors analyzed included dysphagia severity rate at the initial swallowing assessment and at hospital discharge, age, time to initiate oral feeding, amount of individual treatment, number of orotracheal intubations, intubation time and length of hospital stay. Results: After we excluded patients with neurologic diseases, tracheostomy, esophageal dysphagia and those who were submitted to surgical procedures involving the head and neck, our study sample size was 148 patients. The logistic regression model was used to examine the relationships between independent variables. In the univariate analyses, we found that statistically significant prognostic indicators of dysphagia included dysphagia severity rate at the initial swallowing assessment, time to initiate oral feeding and amount of individual treatment. In the multivariate analysis, we found that dysphagia severity rate at the initial swallowing assessment remained associated with good treatment outcomes. Conclusions: Studies of prognostic indicators in different populations with dysphagia can contribute to the design of more effective procedures when evaluating, treating, and monitoring individuals with this type of disorder. Additionally, this study stresses the importance of the initial assessment ratings.	[Moraes, Danielle Pedroni] Univ Sao Paulo, Sch Med, Hosp Clin, BR-05403001 Sao Paulo, Brazil; [Sassi, Fernanda Chiarion; Furquim de Andrade, Claudia Regina] Univ Sao Paulo, Sch Med, Dept Physiotherapy Speech Language & Hearing Sci, BR-05403001 Sao Paulo, Brazil; [Mangilli, Laura Davison] Univ Sao Paulo, Sch Med, Med Invest Lab LIM Rehabil Sci 34, BR-05403001 Sao Paulo, Brazil; [Zilberstein, Bruno] Univ Sao Paulo, Sch Med, Digest Surg Div, BR-05403001 Sao Paulo, Brazil		de Andrade, CRF (corresponding author), Univ Sao Paulo, Sch Med, Dept Physiotherapy Speech Language & Hearing Sci, Rua Ovideo Pires Campos,186,Cerqueira Cesar, BR-05403001 Sao Paulo, Brazil.	clauan@usp.br	Mangilli, Laura D/G-6122-2012; Andrade, Claudia F/D-2187-2012; Zilberstein, Bruno/K-2087-2016; Sassi, Fernanda C/I-5384-2013	Mangilli, Laura D/0000-0003-2739-126X; 			Ajemian MS, 2001, ARCH SURG-CHICAGO, V136, P434, DOI 10.1001/archsurg.136.4.434; Almirall J, 2007, MED CLIN-BARCELONA, V129, P424, DOI 10.1157/13110467; American Speech-Language-Hearing Association National Outcome Measurement System (NOMS), 2003, AD SPEECH LANG PATH; Barker J, 2009, CAN J SURG, V52, P119; Barquist E, 2001, CRIT CARE MED, V29, P1710, DOI 10.1097/00003246-200109000-00009; Becker R, 2011, DYSPHAGIA, V26, P108, DOI 10.1007/s00455-009-9270-8; Bordon A, 2011, AM J SURG, V202, P679, DOI 10.1016/j.amjsurg.2011.06.030; Broadley S, 2005, DYSPHAGIA, V20, P303, DOI 10.1007/s00455-005-0032-y; Broadley S, 2003, J CLIN NEUROSCI, V10, P300, DOI 10.1016/S0967-5868(03)00022-5; Brown CVR, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.05.036; Cabre M, 2010, AGE AGEING, V39, P39, DOI 10.1093/ageing/afp100; Clave P, 2005, MED CLIN-BARCELONA, V124, P742, DOI 10.1157/13075447; Clave P, 2008, CLIN NUTR, V27, P806, DOI 10.1016/j.clnu.2008.06.011; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; DELARMINAT V, 1995, CRIT CARE MED, V23, P486, DOI 10.1097/00003246-199503000-00012; Frank U, 2007, DYSPHAGIA, V22, P20, DOI 10.1007/s00455-006-9036-5; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; Heffner JE, 2010, CHEST, V137, P509, DOI 10.1378/chest.09-2477; Kozlow JH, 2003, CRIT CARE MED, V31, P1930, DOI 10.1097/01.CCM.0000069738.73602.5F; Leder SB, 1998, DYSPHAGIA, V13, P208, DOI 10.1007/PL00009573; Leder SB, 2009, GERONTOLOGY, V55, P714, DOI 10.1159/000235824; Luker JA, 2010, INT J STROKE, V5, P466, DOI 10.1111/j.1747-4949.2010.00488.x; Macht M, 2011, CRIT CARE, V15, DOI 10.1186/cc10472; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Mangilli LD, 2012, ACTA TROP, V122, P241, DOI 10.1016/j.actatropica.2012.02.069; Martin-Harris B, 2003, J APPL PHYSIOL, V94, P1735, DOI 10.1152/japplphysiol.00806.2002; McMicken BL, 2009, DISABIL REHABIL, V31, P2196, DOI 10.3109/09638280902956894; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; Moraes Danielle Pedroni, 2011, J. Soc. Bras. Fonoaudiol., V23, P89, DOI 10.1590/S2179-64912011000100018; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; Padovani AR, 2012, DISFAGIA PRATICA BAS, P62; Partik B, 2000, AM J ROENTGENOL, V174, P1409, DOI 10.2214/ajr.174.5.1741409; Postma GN, 2007, LARYNGOSCOPE, V117, P1720, DOI 10.1097/MLG.0b013e31811ff906; Romero CM, 2010, CHEST, V137, P1278, DOI 10.1378/chest.09-2792; Rumbach AF, 2012, J BURN CARE RES, V33, P336, DOI 10.1097/BCR.0b013e3182356143; Schindler A, 2008, DYSPHAGIA, V23, P230, DOI 10.1007/s00455-007-9121-4; Schindler JS, 2002, LARYNGOSCOPE, V112, P589, DOI 10.1097/00005537-200204000-00001; Schroeder MF, 2006, J REHABIL RES DEV, V43, P301, DOI 10.1682/JRRD.2004.12.0154; Skeat J, 2005, DYSPHAGIA, V20, P113, DOI 10.1007/s00455-004-0028-z; Skoretz SA, 2010, CHEST, V137, P665, DOI 10.1378/chest.09-1823; Smith HA, 2000, AGE AGEING, V29, P495, DOI 10.1093/ageing/29.6.495; Solh EA, 2003, INTENS CARE MED, V29, P1451; Starks B, 2011, CRIT CARE NURSE, V31, P38, DOI 10.4037/ccn2011462; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; Terre R, 2006, NEUROGASTROENT MOTIL, V18, P200, DOI 10.1111/j.1365-2982.2005.00729.x; Thwaites CL, 2003, BMJ-BRIT MED J, V326, P117, DOI 10.1136/bmj.326.7381.117; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; Wesling M, 2003, DYSPHAGIA, V18, P203, DOI 10.1007/s00455-002-0098-8; Zaidi NH, 1995, AGE AGEING, V54, pS59	49	24	26	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2013	17	5							R243	10.1186/cc13069			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1HA	WOS:000331540900059	24138781	gold, Green Published			2022-02-06	
J	Rienstra, A; Groot, PFC; Spaan, PEJ; Majoie, CBLM; Nederveen, AJ; Walstra, GJM; de Jonghe, JFM; van Gool, WA; Olabarriaga, SD; Korkhov, VV; Schmand, B				Rienstra, Anne; Groot, Paul F. C.; Spaan, Pauline E. J.; Majoie, Charles B. L. M.; Nederveen, Aart J.; Walstra, Gerard J. M.; de Jonghe, Jos F. M.; van Gool, Willem A.; Olabarriaga, Silvia D.; Korkhov, Vladimir V.; Schmand, Ben			Symptom validity testing in memory clinics: Hippocampal-memory associations and relevance for diagnosing mild cognitive impairment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild cognitive impairment; Alzheimer's disease; Early symptoms; Hippocampal volumetry; Symptom validity testing	TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; TOMM PERFORMANCE; DEMENTIA; DEPRESSION; SEGMENTATION; VALIDATION; VOLUMES; ANXIETY; SCALES	Patients with mild cognitive impairment (MCI) do not always convert to dementia. In such cases, abnormal neuropsychological test results may not validly reflect cognitive symptoms due to brain disease, and the usual brain-behavior relationships may be absent. This study examined symptom validity in a memory clinic sample and its effect on the associations between hippocampal volume and memory performance. Eleven of 170 consecutive patients (6.5%; 13% of patients younger than 65 years) referred to memory clinics showed noncredible performance on symptom validity tests (SVTs, viz. Word Memory Test and Test of Memory Malingering). They were compared to a demographically matched group (n=57) selected from the remaining patients. Hippocampal volume, measured by an automated volumetric method (Freesurfer), was correlated with scores on six verbal memory tests. The median correlation was r = .49 in the matched group. However, the relation was absent (median r =-.11) in patients who failed SVTs. Memory clinic samples may include patients who show noncredible performance, which invalidates their MCI diagnosis. This underscores the importance of applying SVTs in evaluating patients with cognitive complaints that may signify a predementia stage, especially when these patients are relatively young.	[Rienstra, Anne; Spaan, Pauline E. J.; Schmand, Ben] Univ Amsterdam, Dept Brain & Cognit, NL-1018 XA Amsterdam, Netherlands; [Groot, Paul F. C.; Majoie, Charles B. L. M.; Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Rienstra, Anne; Walstra, Gerard J. M.; van Gool, Willem A.; Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [de Jonghe, Jos F. M.] Med Ctr Alkmaar, Dept Geriatr, Alkmaar, Netherlands; [Olabarriaga, Silvia D.; Korkhov, Vladimir V.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, NL-1018 XA Amsterdam, Netherlands		Rienstra, A (corresponding author), Univ Amsterdam, Dept Brain & Cognit, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	a.rienstra@uva.nl	Van Gool, Willem A/G-5985-2012; Korkhov, Vladimir/H-6685-2013	Korkhov, Vladimir/0000-0003-2458-3194; Van Gool, Willem/0000-0003-3174-8233; Spaan, Pauline/0000-0001-5858-2419	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO)Netherlands Organization for Scientific Research (NWO)	We performed computations using the e-bioinfra platform at the Academic Medical Center (AMC), using resources of the Dutch e-Science Grid, BiGGrid project, which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO). There are no conflicts of interest.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cohen J., 2013, STAT POWER ANAL BEHA; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dandachi-FitzGerald B, 2011, CLIN NEUROPSYCHOL, V25, P812, DOI 10.1080/13854046.2011.583280; de Toledo-Morrell L, 2000, HIPPOCAMPUS, V10, P136, DOI 10.1002/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Echavarri C, 2011, BRAIN STRUCT FUNCT, V215, P265, DOI 10.1007/s00429-010-0283-8; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2005, ARCH NEUROL-CHICAGO, V62, P1164, DOI 10.1001/archneur.62.7.1164; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 1996, WORD MEMORY TEST USE; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hejl A, 2002, J NEUROL NEUROSUR PS, V73, P390, DOI 10.1136/jnnp.73.4.390; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Lindeboom J, 2003, VISUAL ASS TEST; Maioli F, 2007, ARCH GERONTOL GERIAT, V44, P233, DOI 10.1016/j.archger.2007.01.032; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Miller L, 2001, NEUROREHABILITATION, V16, P109; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Olabarriaga SD, 2010, IEEE T INF TECHNOL B, V14, P979, DOI 10.1109/TITB.2010.2046742; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2007, SEMIN NEUROL, V27, P22, DOI 10.1055/s-2006-956752; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rosen Gerald, 2004, POSTTRAUMATIC STRESS; Rubenzer S, 2009, PSYCHOL INJ LAW, V2, P114, DOI 10.1007/s12207-009-9045-4; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Spaan P. E., 2010, INT NEUR SOC POL NEU; Spaan PEJ, 2005, NEUROPSYCHOLOGY, V19, P629, DOI 10.1037/0894-4105.19.5.629; Stewart R, 2011, BRIT J PSYCHIAT, V198, P199, DOI 10.1192/bjp.bp.110.078683; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van Egmond J, 2002, EUR PSYCHIAT, V17, P46, DOI 10.1016/S0924-9338(02)00622-3; Visser PJ, 2006, NEUROLOGY, V67, P1201, DOI 10.1212/01.wnl.0000238517.59286.c5; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; World Health Organization, 1992, INT CLASS DIS 10 REV; Yanez YT, 2006, ARCH CLIN NEUROPSYCH, V21, P161, DOI 10.1016/j.acn.2005.07.009; Zakzanis K. K., 2011, NEUROPSYCHOL REV, V13, P1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	24	25	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 1	2013	35	1					59	70		10.1080/13803395.2012.751361			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	189YL	WOS:000322304100007	23228141				2022-02-06	
J	Schirmer-Mikalsen, K; Moen, KG; Skandsen, T; Vik, A; Klepstad, P				Schirmer-Mikalsen, K.; Moen, K. G.; Skandsen, T.; Vik, A.; Klepstad, P.			Intensive care and traumatic brain injury after the introduction of a treatment protocol: a prospective study	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							SEVERE HEAD-INJURY; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; INTRACRANIAL HYPERTENSION; EXTRACRANIAL COMPLICATIONS; DECOMPRESSIVE CRANIECTOMY; SEVERITY SCORE; HYPERGLYCEMIA; HYPOTHERMIA; MANAGEMENT	Background Traumatic brain injury (TBI) treatment protocols have been introduced in the intensive care unit (ICU) to avoid secondary brain injury. In this study, we aimed to evaluate the deviations from such a treatment protocol and the frequency of extracranial complications, and relate these findings to outcome. Methods During a 5-year period (20042009), 133 patients with severe TBI [Glasgow Coma Scale (GCS) score?=?8] were prospectively included. The following deviations from treatment goals were studied: intracranial pressure (ICP), blood pressure, haemoglobin, blood glucose, serum sodium, serum albumin, body temperature and extracranial complications during the ICU stay. Outcome was assessed using Glasgow Outcome Scale Extended score at 12 months. Results The frequencies of deviations from the treatment goals were: episodes of intracranial hypertension 69.5% (of monitored patients), hypotension 20.3%, anaemia 77.4%, hyperglycaemia 42.9%, hyponatremia 34.6%, hypoalbuminemia 30.8% and hyperthermia 54.9%. Pulmonary complications were common (pneumonia 72.2%, acute respiratory distress syndrome/acute lung injury 31.6%). Thrombocytopenia (4.5%), severe sepsis (3.0%), renal failure (0.8%) and liver failure (0.8%) were infrequent. Twenty-six (19.5%) patients died within the first 12 months due to the head injury. Age, GCS score, pupil dilation, Injury Severity Score (ISS), ICP?>?25?mmHg, hyperglycaemia and pneumonia predicted a worse outcome. Conclusions Deviations from the TBI treatment protocol were frequent. Pneumonia was the most frequent extracranial complication. Age, GCS score, pupil dilation, ISS, high ICP, hyperglycaemia and pneumonia predicted a worse outcome.	[Schirmer-Mikalsen, K.; Klepstad, P.] St Olavs Univ Hosp, Dept Anaesthesia & Acute Med, N-7006 Trondheim, Norway; [Moen, K. G.; Vik, A.] St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway; [Moen, K. G.; Skandsen, T.; Vik, A.] Norwegian Univ Sci & Technol, Dept Neurosci, Fac Med, N-7034 Trondheim, Norway; [Skandsen, T.] St Olavs Univ Hosp, Dept Phys Med & Rehabil, N-7006 Trondheim, Norway; [Klepstad, P.] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway		Schirmer-Mikalsen, K (corresponding author), St Olavs Univ Hosp, Dept Anaesthesia & Acute Med, Postboks 3250 Sluppen, N-7006 Trondheim, Norway.	kari.schirmer@stolav.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338	St. Olav University Hospital; Liaison Committee	Funded by the St. Olav University Hospital.; Kent Goran Moen has, during the study period, received a research grant from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bilotta F, 2010, CURR OPIN ANESTHESIO, V23, P539, DOI 10.1097/ACO.0b013e32833e150a; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Grande PO, 2009, ACTA ANAESTH SCAND, V53, P1233, DOI 10.1111/j.1399-6576.2009.02074.x; Grande PO, 2011, J NEUROSURG ANESTH, V23, P251, DOI 10.1097/ANA.0b013e31821a8f10; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Janssens U, 2000, INTENS CARE MED, V26, P1037, DOI 10.1007/s001340051316; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Ramesh VJ, 2011, J NEUROSURG ANESTH, V23, P183, DOI 10.1097/ANA.0b013e31821cb9ec; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2009, AM SURGEON, V75, P25; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	43	24	27	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JAN	2013	57	1					46	55		10.1111/j.1399-6576.2012.02785.x			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	053LA	WOS:000312271800007	23095138				2022-02-06	
J	Stroupe, KT; Smith, BM; Hogan, TP; Andre, JRS; Pape, T; Steiner, ML; Proescher, E; Huo, ZP; Evans, CT				Stroupe, Kevin T.; Smith, Bridget M.; Hogan, Timothy P.; Andre, Justin R. St.; Pape, Theresa; Steiner, Monica L.; Proescher, Eric; Huo, Zhiping; Evans, Charlesnika T.			Healthcare utilization and costs of Veterans screened and assessed for traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cost analysis; Department of Veterans Affairs; evaluation; head injury; healthcare costs; healthcare utilization; Operation Enduring Freedom; Operation Iraqi Freedom; traumatic brain injury; Veterans	POSTTRAUMATIC-STRESS-DISORDER; SERVICE MEMBERS; US VETERANS; AFGHANISTAN; IRAQ; PAIN; POLYTRAUMA; DIAGNOSES; NETWORKS; TAXONOMY	Approximately 15% of casualties in the Afghanistan (Operation Enduring Freedom [OEF]) and Iraq (Operation Iraqi Freedom [OIF]) conflicts received mild traumatic brain injury (TBI). To identify Veterans who may benefit from treatment, the Department of Veterans Affairs (VA) implemented a national clinical reminder in 2007 to screen for TBI. Veterans who screen positive are referred for a comprehensive TBI evaluation. We conducted a national retrospective study of OIF/OEF Veterans receiving care at VA facilities between 2007 and 2008. We examined the association of the TBI screen with healthcare costs over a 12 mo period following the initial evaluation. Of the Veterans, 164,438 met inclusion criteria: 31,627 screened positive, 118,545 screened negative, and 14,266 received no TBI screening. Total healthcare costs of Veterans who screened positive, screened negative, or had no TBI screening were $9,610, $5,184, and $3,399, respectively (p < 0.001). Understanding these healthcare utilization and cost patterns will assist policy-makers to address the ongoing and future healthcare needs of these returning Veterans.	[Stroupe, Kevin T.; Smith, Bridget M.; Pape, Theresa; Huo, Zhiping; Evans, Charlesnika T.] Edward Hines Jr Dept Vet Affairs VA Hosp, Ctr Management Complex Chron Care, Hines, IL USA; [Stroupe, Kevin T.] Loyola Univ Chicago, Stritch Sch Med, Program Hlth Serv Res, Maywood, IL USA; [Smith, Bridget M.; Evans, Charlesnika T.] Edward Hines Jr VA Hosp, Spinal Cord Injury Qual Enhancement Res Initiat Q, Hines, IL USA; [Hogan, Timothy P.] Edith Nourse Rogers Mem Vet Hosp, Natl eHealth QUERI Coordinating Ctr, Ctr Hlth Qual Outcomes & Econ Res & eHealth QUERI, Bedford, MA USA; [Hogan, Timothy P.] Univ Massachusetts, Sch Med, Div Hlth Informat & Implementat Sci, Worcester, MA USA; [Andre, Justin R. St.] Hlth Res & Educ Trust, Chicago, IL USA; [Pape, Theresa; Steiner, Monica L.] Edward Hines Jr VA Hosp, Hines, IL USA; [Pape, Theresa] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Proescher, Eric] Jesse Brown VA Med Ctr, Chicago, IL USA; [Evans, Charlesnika T.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA		Stroupe, KT (corresponding author), Edward Hines Jr VA Hosp, Ctr Management Complex Chron Care, 5000 South 5th Ave,151H,Bldg 1B260, Hines, IL 60141 USA.	kevin.stroupe@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	VA Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs	This material was based on work supported by the VA Office of Research and Development, Health Services Research and Development Service.	Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; [Anonymous], 2013, CAR FAC; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Bass E, 2012, VETERANS HLTH ADM TR; Bazzoli GJ, 1999, HEALTH SERV RES, V33, P1683; Carlson K, 2009, ASSESSMENT TREATMENT; Dubbs NL, 2004, HEALTH SERV RES, V39, P207, DOI 10.1111/j.1475-6773.2004.00222.x; Dunn AS, 2011, J REHABIL RES DEV, V48, P493, DOI 10.1682/JRRD.2010.05.0104; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goldberg M. S., 2007, PROJECTING COSTS CAR; Hagedorn HJ, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-46; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Phibbs C, 2008, RES GUIDE DECISION S; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Smith MW, 2010, FEE BASIS DATA GUIDE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VA Information Resource Center (VIReC), 2008, VIREC RES US GUID VH; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; *VIREC, 2003, VIREC RES US GUID FY; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003	32	24	24	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	8					1047	1068		10.1682/JRRD.2012.06.0107			22	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	270GX	WOS:000328308000005	24458891	Bronze			2022-02-06	
J	Kobayashi, L; Costantini, TW; Coimbra, R				Kobayashi, Leslie; Costantini, Todd W.; Coimbra, Raul			Hypovolemic Shock Resuscitation	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Hemorrhagic shock; Septic shock; Massive transfusion; Blood loss; Crystalloid	PROTHROMBIN COMPLEX CONCENTRATE; FRESH-FROZEN PLASMA; HYPERTONIC SALINE RESUSCITATION; MASSIVE BLOOD-TRANSFUSION; ACTIVATED FACTOR-VII; DAMAGE CONTROL RESUSCITATION; RECOMBINANT-FACTOR-VIIA; LIFE-THREATENING COAGULOPATHY; NATURAL COLLOID RESUSCITATION; TRAUMATIC BRAIN-INJURY	Several changes in the way patients with hemorrhagic shock are resuscitated have occurred over the past decades, including permissive hypotension, minimal crystalloid resuscitation, earlier blood transfusion, and higher plasma and platelet-to-red cell ratios. Hemostatic adjuncts, such as tranexamic acid and prothrombin complex, and the use of new methods of assessing coagulopathy are also being incorporated into resuscitation of the bleeding patient. These ideas have been incorporated by many trauma centers into institutional massive transfusion protocols, and adoption of these protocols has resulted in improvements in mortality and morbidity. This article discusses each of these new resuscitation strategies and the evidence supporting their use.	[Kobayashi, Leslie; Costantini, Todd W.; Coimbra, Raul] Univ Calif San Diego, Sch Med, Div Trauma Surg Crit Care & Burns, Dept Surg, San Diego, CA 92103 USA		Coimbra, R (corresponding author), Univ Calif San Diego, Sch Med, Div Trauma Surg Crit Care & Burns, Dept Surg, 200 W Arbor Dr 8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Costantini, Todd/0000-0002-0215-5327			Alderson P, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001208.pub3, 10.1002/14651858.CD001208.pub4]; ALDERSON P, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001208; Allcock EC, 2011, J ROY ARMY MED CORPS, V157, P365, DOI 10.1136/jramc-157-04-03; American College of Surgeons Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Brakenridge SC, 2011, J TRAUMA, V71, P299, DOI 10.1097/TA.0b013e318224d328; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Cabrales P, 2007, SHOCK, V28, P461, DOI 10.1097/shk.0b013e31804880a1; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Cartmill M, 2000, BRIT J NEUROSURG, V14, P458; CERVERA AL, 1975, J TRAUMA, V15, P498, DOI 10.1097/00005373-197506000-00008; Chapman SA, 2011, ANN PHARMACOTHER, V45, P869, DOI 10.1345/aph.1P605; Cinat ME, 1999, ARCH SURG-CHICAGO, V134, P964, DOI 10.1001/archsurg.134.9.964; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Collier B, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.05.003; Como JJ, 2004, TRANSFUSION, V44, P809, DOI 10.1111/j.1537-2995.2004.03409.x; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Cotton BA, 2010, J TRAUMA, V69, pS33, DOI 10.1097/TA.0b013e3181e42411; Cotton BA, 2009, J TRAUMA, V67, P1004, DOI 10.1097/TA.0b013e3181bcb2a8; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P429, DOI 10.1160/TH11-01-0052; Dente CJ, 2009, J TRAUMA, V66, P1616, DOI 10.1097/TA.0b013e3181a59ad5; Dirks J, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-65; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Duchesne JC, 2011, AM SURGEON, V77, P201; Duchesne JC, 2009, J TRAUMA, V67, P228; Duchesne JC, 2009, J TRAUMA, V67, P33, DOI 10.1097/TA.0b013e31819adb8e; ERRINGTON ML, 1971, J PHYSIOL-LONDON, V217, pP43; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Fraga GP, 2010, J EMERG MED, V39, P253, DOI 10.1016/j.jemermed.2009.02.034; Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grmec S, 2008, INT J EMERG MED, V1, P311, DOI 10.1007/s12245-008-0073-8; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Hartog CS, 2011, INTENS CARE MED, V37, P1725, DOI 10.1007/s00134-011-2385-z; HARVEY MP, 1995, MED J AUSTRALIA, V163, P356, DOI 10.5694/j.1326-5377.1995.tb124628.x; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Healey MA, 1998, J TRAUMA, V45, P894, DOI 10.1097/00005373-199811000-00010; HEWSON JR, 1985, CRIT CARE MED, V13, P387, DOI 10.1097/00003246-198505000-00003; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Inaba K, 2010, J AM COLL SURGEONS, V211, P573, DOI 10.1016/j.jamcollsurg.2010.06.392; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Inaba K, 2008, J TRAUMA, V65, P1222, DOI 10.1097/TA.0b013e31818e8ff3; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Johansson PI, 2009, VOX SANG, V96, P111, DOI 10.1111/j.1423-0410.2008.01130.x; Kashuk JL, 2008, J TRAUMA, V65, P261, DOI 10.1097/TA.0b013e31817de3e1; Kheirabadi BS, 2008, J TRAUMA, V64, P1218, DOI 10.1097/TA.0b013e31816c5c6c; Kheirabadi BS, 2008, J TRAUMA, V64, P1228; KIVIOJA A, 1991, AM SURGEON, V57, P398; Krumrei NJ, 2012, J TRAUMA ACUTE CARE, V72, P211, DOI 10.1097/TA.0b013e318240507b; Leemann H, 2010, J TRAUMA, V69, P1403, DOI 10.1097/TA.0b013e3181faaa25; LESLIE SD, 1991, AM J CLIN PATHOL, V96, P770, DOI 10.1093/ajcp/96.6.770; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; Liberati A, 2006, INTERN EMERG MED, V1, P243, DOI 10.1007/BF02934748; Lissauer ME, 2011, AM J SURG, V202, P53, DOI 10.1016/j.amjsurg.2010.05.002; Lustenberger T, 2011, J TRAUMA, V71, P1144, DOI 10.1097/TA.0b013e318230e89b; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Martini WZ, 2008, J TRAUMA, V65, P535, DOI 10.1097/TA.0b013e31818379a6; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; MCLAUGHLIN DF, 2008, J TRAUMA, V64, pS63, DOI DOI 10.1097/TA.0B013E318160A566.[; McSwain N, 2011, J TRAUMA, V70, pS53, DOI 10.1097/TA.0b013e31821a5e5d; Mitra B, 2012, INJURY, V43, P33, DOI 10.1016/j.injury.2011.10.011; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; Moore FA, 2008, AM J SURG, V196, P948, DOI 10.1016/j.amjsurg.2008.07.043; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Morse BC, 2011, AM SURGEON, V77, P1043; MURRAY DJ, 1988, ANESTHESIOLOGY, V69, P839, DOI 10.1097/00000542-198812000-00007; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nascimento B, 2011, J TRAUMA, V71, pS418, DOI 10.1097/TA.0b013e318232e591; Nienaber U, 2011, INJURY, V42, P697, DOI 10.1016/j.injury.2010.12.015; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Nystrup KB, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-52; O'Keeffe T, 2008, ARCH SURG-CHICAGO, V143, P686, DOI 10.1001/archsurg.143.7.686; OWENS TM, 1995, J TRAUMA, V39, P200, DOI 10.1097/00005373-199508000-00004; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; PHILLIPS TF, 1987, J TRAUMA, V27, P903, DOI 10.1097/00005373-198708000-00010; Plotkin AJ, 2008, J TRAUMA, V64, pS64, DOI 10.1097/TA.0b013e318160772d; Plurad DS, 2011, J TRAUMA, V71, P565, DOI 10.1097/TA.0b013e3182213d52; Rahbar MH, 2012, RESUSCITATION, V83, P459, DOI 10.1016/j.resuscitation.2011.09.019; Riskin DJ, 2009, J AM COLL SURGEONS, V209, P198, DOI 10.1016/j.jamcollsurg.2009.04.016; Rizoli SB, 2006, CRIT CARE, V10, DOI 10.1186/cc5133; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Sambasivan CN, 2011, J TRAUMA, V71, pS329, DOI 10.1097/TA.0b013e318227edd3; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schnuriger B, 2011, J TRAUMA, V70, P603, DOI 10.1097/TA.0b013e3182092abb; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10539; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10078; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Schreiber M, 2008, AM J SURG, V196, P958; Schreiber MA, 2007, J AM COLL SURGEONS, V205, P541, DOI 10.1016/j.jamcollsurg.2007.05.007; Schreiber MA, 2011, J TRAUMA, V70, pS13, DOI 10.1097/TA.0b013e31821a4ba5; SCHWARTZ J, 1981, ENDOCRINOLOGY, V109, P1778, DOI 10.1210/endo-109-5-1778; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Sondeen JL, 2011, TRANSFUSION, V51, P779, DOI 10.1111/j.1537-2995.2010.02928.x; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Spinella PC, 2007, CRIT CARE MED, V35, P2576, DOI 10.1097/01.CCM.0000285996.65226.A9; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Tauber H, 2011, BRIT J ANAESTH, V107, P378, DOI 10.1093/bja/aer158; Teixeira PGR, 2009, J TRAUMA, V66, P693, DOI 10.1097/TA.0b013e31817e5c77; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Van PY, 2010, J TRAUMA, V69, pS64, DOI 10.1097/TA.0b013e3181e453ec; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wafaisade A, 2011, J TRAUMA, V70, P81, DOI 10.1097/TA.0b013e3182032e0b; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957; Wiedermann CJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9308; WILSON RF, 1987, AM SURGEON, V53, P410; Woodruff SI, 2010, EMERG MED J, V27, P121, DOI 10.1136/emj.2008.060657; Yasaka M, 2002, THROMB RES, V108, P25, DOI 10.1016/S0049-3848(02)00402-4; YOUNES RN, 1992, SURGERY, V111, P380; Yucel N, 2006, J TRAUMA, V60, P1228, DOI 10.1097/01.ta.0000220386.84012.bf; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	146	24	27	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	DEC	2012	92	6					1403	+		10.1016/j.suc.2012.08.006			22	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	058JI	WOS:000312629500005	23153876				2022-02-06	
J	Kontos, PC; Miller, KL; Gilbert, JE; Mitchell, GJ; Colantonio, A; Keightley, ML; Cott, C				Kontos, Pia C.; Miller, Karen-Lee; Gilbert, Julie E.; Mitchell, Gail J.; Colantonio, Angela; Keightley, Michelle L.; Cott, Cheryl			Improving Client-Centered Brain Injury Rehabilitation Through Research-Based Theater	QUALITATIVE HEALTH RESEARCH			English	Article						brain injury; emotions / emotion work; health care, interprofessional; performance; research, qualitative	GENERAL INTERNAL-MEDICINE; HEALTH-PROFESSIONALS; BREAST-CANCER; EMOTION WORK; FAMILIES; NURSES; DRAMA; COLLABORATION; COMMUNICATION; PERFORMANCE	Traumatic brain injury often results in physical, behavioral, and cognitive impairments perceived by health care practitioners to limit or exclude clients' full participation in treatment decision making. We used qualitative methods to evaluate the short- and long-term impact of "After the Crash: A Play About Brain Injury," a research-based drama designed to teach client-centered care principles to brain injury rehabilitation staff. We conducted interviews and observations with staff of two inpatient neurorehabilitation units in Ontario, Canada. Findings demonstrate the effectiveness of the play in influencing practice through the avoidance of medical jargon to improve clients' understanding and participation in treatment; newfound appreciation for clients' needs for emotional expression and sexual intimacy; increased involvement of family caregivers; and avoidance of staff discussions as if clients were unaware. These findings suggest that research-based drama can effect reflexivity, empathy, and practice change to facilitate a client-centered culture of practice in brain injury rehabilitation.	[Kontos, Pia C.; Miller, Karen-Lee] Toronto Rehabil Inst UHN, Toronto, ON M5G 2A2, Canada; [Gilbert, Julie E.] Canc Care Ontario, Res & Evaluat, Toronto, ON, Canada; [Mitchell, Gail J.] York Univ, Sch Nursing, Toronto, ON M3J 2R7, Canada; [Colantonio, Angela; Keightley, Michelle L.; Cott, Cheryl] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Cott, Cheryl] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada		Kontos, PC (corresponding author), Toronto Rehabil Inst UHN, 550 Univ Ave,Suite 11-171, Toronto, ON M5G 2A2, Canada.	pia.kontos@uhn.ca		Kontos, Pia/0000-0002-8893-2544; Colantonio, Angela/0000-0003-2094-4765; Miller, Karen-Lee/0000-0001-7583-6724	CIHRCanadian Institutes of Health Research (CIHR) [87726, MOP-86624, 86624, MSH -87726] Funding Source: Medline		Abreu BC, 2002, BRAIN INJURY, V16, P691, DOI 10.1080/02699050210128942; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; Armstrong J., 2008, NZ J OCCUP THER, V55, P20; Bagley C, 2008, QUAL RES, V8, P53, DOI 10.1177/1468794107085296; BARONE T, 2000, AESTHETICS POLITICS; Becker H., 1993, J HEAD TRAUMA REHAB, V8, P88; Blackmer J., 2003, BMC MED ETHICS, P4; Boal A., 1979, THEATRE OPPRESSED; Bolton SC, 2000, J ADV NURS, V32, P580, DOI 10.1046/j.1365-2648.2000.01516.x; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Bournes DA, 2002, RES NURS HEALTH, V25, P58, DOI 10.1002/nur.10019; Boydell, 2011, FORUM QUALITATIVE SO, V12, P1; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Cancienne M., 2001, QUALITATIVE INQUIRY, V7, P221, DOI DOI 10.1177/107780040100700205; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; CHARON R, 1995, ANN INTERN MED, V122, P599, DOI 10.7326/0003-4819-122-8-199504150-00008; Colantonio A, 2008, J CONTIN EDUC HEALTH, V28, P180, DOI 10.1002/chp.177; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Conn LG, 2009, QUAL HEALTH RES, V19, P943, DOI 10.1177/1049732309338282; Corring D J, 1999, Can J Occup Ther, V66, P71; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Denzin N.K., 2003, PERFORMANCE ETHNOGRA; Denzin N. K., 1997, INTERPRETIVE ETHNOGR; Denzin NK, 2003, SYMB INTERACT, V26, P187, DOI 10.1525/si.2003.26.1.187; Denzin NK., 1998, COLLECTING INTERPRET; Dupuis SL, 2011, FAM RELAT, V60, P104, DOI 10.1111/j.1741-3729.2010.00636.x; Eakin Joan M, 2006, Healthc Policy, V2, P54; Eisner, 1993, ED RES, V22, P5, DOI DOI 10.3102/0013189X022007005; Eisner E.W., 1997, EDUC RESEARCHER, V26, P4, DOI [DOI 10.3102/0013189X026006004, 10.3102/0013189x026006004]; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Freemantle N, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003030; Gallagher K, 2005, J AESTHET EDUC, V39, P82, DOI 10.1353/jae.2005.0038; Gesler W.M., 2003, HEALING PLACES; Gold R., 1997, QUALITATIVE INQUIRY, V3, P387, DOI DOI 10.1177/107780049700300401; Gray J, 2011, CAN THEATRE REV, V146, P66, DOI 10.3138/CTR.146.66; Gray RE, 2003, J CANCER EDUC, V18, P223, DOI 10.1207/s15430154jce1804_10; Gray RE, 2001, HEALTH, V5, P233, DOI 10.1177/136345930100500205; Gray Ross, 2000, Health Expect, V3, P137, DOI 10.1046/j.1369-6513.2000.00071.x; Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298; Grimshaw JM, 1998, J ROY SOC MED, V91, P20, DOI 10.1177/014107689809135S06; Hanley J, 2003, DIRECTIONS PSYCHIAT, V23, P151; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hobson S. J. G., 1999, CLIENT CTR PRACTICE, P51; Hochschild AR., 1983, MANAGED HEART COMMER; Holm Gunilla., 2008, FORUM QUALITATIVE SO, V9; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jamieson Margaret, 2006, Can J Occup Ther, V73, P76; Jonas-Simpson C, 2012, J ADV NURS, V68, P1944, DOI 10.1111/j.1365-2648.2011.05877.x; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Knowles J. Gary, 2008, HDB ARTS QUALITATIVE; Kontos PC, 2007, QUAL HEALTH RES, V17, P799, DOI 10.1177/1049732307302838; Kontos PC, 2010, INT J OLDER PEOPLE N, V5, P159, DOI 10.1111/j.1748-3743.2010.00221.x; Kontos PC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-1; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Law M, 1995, Can J Occup Ther, V62, P250; Lawlor MC, 1998, AM J OCCUP THER, V52, P259, DOI 10.5014/ajot.52.4.259; LECOMPTE MD, 1993, ETHNOGRAPHIC QUALITA; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Long D., 2007, DISCOURSE HOSP COMMU, P182; Lorenz KA, 2004, ACAD MED, V79, P481, DOI 10.1097/00001888-200405000-00020; Maitra KK, 2006, AM J OCCUP THER, V60, P298, DOI 10.5014/ajot.60.3.298; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McClure Robert, 2007, J Health Organ Manag, V21, P101, DOI 10.1108/14777260710736813; McCormack B, 2002, J ADV NURS, V38, P94, DOI 10.1046/j.1365-2648.2002.02150.x; McCreight BS, 2005, INT J NURS STUD, V42, P439, DOI 10.1016/j.ijnurstu.2004.07.004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mienczakowski J, 1999, STUD EDUC ETHNOG, V2, P145; Miller KL, 2008, J ADV NURS, V64, P332, DOI 10.1111/j.1365-2648.2008.04768.x; Mitchell GJ, 2011, QUAL INQ, V17, P379, DOI 10.1177/1077800411401200; Miyata H., 2009, INT J QUAL METH, V8, P64, DOI DOI 10.1177/160940690900800106; Naglie G., 2006, QUALITATIVE RES, V6, P301, DOI [10.1177/1468794106065005, DOI 10.1177/1468794106065005]; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Norris J., 2009, PLAYBUILDING QUALITA; Norris J, 2000, YOUTH THEATRE JOURNA, V14, P40, DOI DOI 10.1080/08929092.2000.10012516; Nussbaum M.C., 2004, LIBERAL EDUCATION, V90, P42; Nussbaum M.C., 1997, CULTIVATING HUMANITY; Nussbaum Martha, 2001, UPHEAVALS THOUGHT IN; Oandasan IF., 2009, PRIM HEALTH CARE RES, V10, P151, DOI [10.1017/S1463423609001091, DOI 10.1017/S1463423609001091]; Paget M., 1993, COMPLEX SORROW REFLE; Papadimitriou C, 2008, DISABIL REHABIL, V30, P365, DOI 10.1080/09638280701336306; Patton M.Q., 1990, QUALITATIVE EVALUATI; Payne S, 2000, J ADV NURS, V32, P277, DOI 10.1046/j.1365-2648.2000.01474.x; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; RAFAELI A, 1987, ACAD MANAGE REV, V12, P23, DOI 10.2307/257991; Rapport F., 2008, FORUM QUALITATIVE SO, V9, P1; Reeves S., 2010, INTERPROFESSIONAL TE; Reeves S, 2009, J INTERPROF CARE, V23, P633, DOI 10.3109/13561820902886295; Roberts Brian., 2008, FORUM QUALITATIVE SO, V9, P58; Rosenbaum ME, 2005, MED EDUC, V39, P622, DOI 10.1111/j.1365-2929.2005.02181.x; Rossiter K, 2008, SOC SCI MED, V66, P130, DOI 10.1016/j.socscimed.2007.07.021; Rossiter K, 2008, J HEALTH PSYCHOL, V13, P277, DOI 10.1177/1359105307086707; Rossiter K, 2011, J CONTEMP ETHNOGR, V40, P648, DOI 10.1177/0891241611418970; Salda?a J., 2005, ETHNODRAMA ANTHOLOGY; Sandelowski M, 2006, QUAL HEALTH RES, V16, P1350, DOI 10.1177/1049732306294274; Shapiro J, 2003, MED EDUC, V37, P922, DOI 10.1046/j.1365-2923.2003.01634.x; Sinding C, 2002, QUAL HEALTH RES, V12, P61, DOI 10.1177/104973230201200105; Smith C., 2008, FORUM QUALITATIVE SO, V9; Spano R, 2005, SOC SCI RES, V34, P591, DOI 10.1016/j.ssresearch.2004.05.003; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI [10.1007/s11606-006-0267-9, 10.1111/j.1525-1497.2006.00355.x]; Sudore Rebecca L, 2009, J Clin Outcomes Manag, V16, P20; Sumsion T, 2000, Can J Occup Ther, V67, P15; Sumsion T, 1999, CLIENT CTR PRACTICE, P1; Thorogood N, 2004, QUALITATIVE METHODS; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Townsend E., 1999, GOOD INTENTIONS OVER; Turk M. A., 2007, BRAIN INJURY MED PRI, P27; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Warren N, 2008, J CONTEMP ETHNOGR, V37, P180, DOI 10.1177/0891241607312493; Webster G, 1999, BRAIN INJURY, V13, P593; Webster J., 2007, Practice Development in Health Care, V6, P97, DOI 10.1002/pdh.222; Wilkins S, 2001, Can J Occup Ther, V68, P70; Winston J, 1999, J MORAL EDUC, V28, P459, DOI 10.1080/030572499103016; Wolf Z R, 1989, Holist Nurs Pract, V4, P78	122	24	24	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	DEC	2012	22	12			SI		1612	1632		10.1177/1049732312458370			21	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	027TX	WOS:000310377700002	22941919	Green Accepted, Green Submitted			2022-02-06	
J	Jung, S; Yang, H; Kim, BS; Chu, K; Lee, SK; Jeon, D				Jung, Seungmoon; Yang, Hyunwoo; Kim, Byung Sun; Chu, Kon; Lee, Sang Kun; Jeon, Daejong			The immunosuppressant cyclosporin A inhibits recurrent seizures in an experimental model of temporal lobe epilepsy	NEUROSCIENCE LETTERS			English	Article						Cyclosporin A; Temporal lobe epilepsy; Recurrent seizure; Electroencephalography; Status epilepticus; Chronic period	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; REFRACTORY EPILEPSY; CALCINEURIN; RAT; NEUROPROTECTION; EPILEPTOGENESIS; DYSFUNCTION; INJECTION	The immunosuppressant, cyclosporin A (CsA), is neuroprotective following brain injury. Previous studies suggest that CsA treatment ameliorates seizure severity during status epilepticus (SE) or cell death following SE. The antiepileptic effects of CsA on recurrent seizures, however, have not been investigated. In the present study, the effects of CsA on spontaneous recurrent seizures (SRSs) in a kainate (KA)-induced mouse model of mesial temporal lobe epilepsy (TLE) were examined. Moreover, the effects of CsA on epileptiform activity in a 4-aminopyridine (4-AP)-induced in vitro seizure model were investigated. A mesial TLE mouse model was generated with a unilateral intrahippocampal injection of KA. SRSs were determined in the ipsilateral hippocampal CA1 region with a long-term video-EEG. CsA was systemically administrated to the epileptic mice exhibiting a stable occurrence of SRSs. A 1-mg/kg dose of CsA did not have any effect on SRSs in the epileptic mice. However, a 5-mg/kg dose of CsA significantly reduced the number of SRSs and decreased the severity of the seizures in the epileptic mice. Additionally, CsA treatment inhibited spontaneous burst discharges in 4-AP-treated hippocampal slices. The results of the present study demonstrate that CsA inhibits recurrent seizures in a mouse model of mesial TLE and suggest that CsA may afford both neuroprotection against SE and antiepileptic effects during the chronic period of epilepsy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Jung, Seungmoon; Yang, Hyunwoo; Kim, Byung Sun; Jeon, Daejong] Korea Adv Inst Sci & Technol, Lab Brain Behav & Therapeut, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Chu, Kon; Lee, Sang Kun] Seoul Natl Univ, Coll Med, Dept Neurol, Comprehens Epilepsy Ctr,Biomed Res Inst,Seoul Nat, Seoul, South Korea		Jeon, D (corresponding author), Korea Adv Inst Sci & Technol, Lab Brain Behav & Therapeut, Dept Bio & Brain Engn, 291 Daehak Ro, Taejon 305701, South Korea.	clark@kaist.ac.kr	Lee, Sang Kun/J-5578-2012; Jeon, Daejong/C-1814-2011		National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2011-0014893]	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0014893).	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Bernardi P, 1998, BIOFACTORS, V8, P273, DOI 10.1002/biof.5520080315; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; Folbergrova J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Gijtenbeek JMM, 1999, J NEUROL, V246, P339, DOI 10.1007/s004150050360; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Jeon D, 2008, J BIOL CHEM, V283, P12093, DOI 10.1074/jbc.M800816200; Jeon D, 2011, EPILEPSIA, V52, P1617, DOI 10.1111/j.1528-1167.2011.03182.x; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014; Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009; Kurz JE, 2001, J NEUROCHEM, V78, P304, DOI 10.1046/j.1471-4159.2001.00426.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Martina M, 1996, NEUROSCI LETT, V215, P95, DOI 10.1016/S0304-3940(96)12957-8; MOIA LJMP, 1994, BRAIN RES, V648, P337, DOI 10.1016/0006-8993(94)91138-X; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Santos JB, 2003, EPILEPSIA, V44, P995, DOI 10.1046/j.1528-1157.2003.66302.x; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Setkowicz Z, 2007, EPILEPSY RES, V73, P151, DOI 10.1016/j.eplepsyres.2006.09.001; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; TRAUB RD, 1995, J PHYSIOL-LONDON, V489, P127, DOI 10.1113/jphysiol.1995.sp021036; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Uchino H, 2008, J ANESTH, V22, P253, DOI 10.1007/s00540-008-0617-3; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020; WHITE DJG, 1982, IMMUNOL REV, V65, P115, DOI 10.1111/j.1600-065X.1982.tb00430.x; Yu Y, 2007, ACTA PHARMACOL SIN, V28, P1891, DOI 10.1111/j.1745-7254.2007.00730.x; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	44	24	25	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 7	2012	529	2					133	138		10.1016/j.neulet.2012.08.087			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	039RK	WOS:000311264000007	22981977				2022-02-06	
J	Bushnik, T; Englander, J; Wright, J; Kolakowsky-Hayner, SA				Bushnik, Tamara; Englander, Jeffrey; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.			Traumatic Brain Injury With and Without Late Posttraumatic Seizures: What Are the Impacts in the Post-Acute Phase: A NIDRR Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						late posttraumatic seizures; outcomes; traumatic brain injury	QUALITY-OF-LIFE; DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; HEAD-INJURY; RISK-FACTORS; EPILEPSY; COMMUNITY; ADULTS; SATISFACTION; INDIVIDUALS	Objective: To compare and contrast the levels of impairment, disability, and community participation of individuals with traumatic brain injury (TBI) with or without late posttraumatic seizures (LPTS). Design: Prospective survey study. Setting: Community. Participants: Two groups of 91 individuals with TBI, with and without LPTS, were enrolled in the TBI Model Systems National Database between 1989 and 2002 and interviewed at years 1, 2, and 5 postinjury. Interventions: Not applicable. Main Outcome Measures: Demographic, injury severity, productivity, and psychosocial outcomes. Results: The majority of the demographic and productivity outcomes up to 5 years postinjury were similar between individuals in the LPTS and non-LPTS groups. Both the LPTS and non-LPTS groups showed an increasing percentage of individuals who began to live alone after the first year postinjury and a decreasing percentage of individuals who were living with family members at 5 years postinjury compared with the first year post-TBI. A higher percentage of individuals in the LPTS group reported using more dependent forms of transportation such as riding with others or using public transportation. Individuals in the LPTS group had higher Disability Rating Scale scores at all time points, denoting greater functional disability, than individuals in the non-LPTS group, despite the 2 groups having similar Disability Rating Scale scores at discharge from rehabilitation. Satisfaction With Life Scale scores showed no changes over time but were significantly different between both groups at all time points, with individuals in the LPTS group reporting lower Satisfaction With Life Scale score than individuals in the non-LPTS group. Conclusions: It does appear that the development of LPTS following a TBI is associated with poorer functional and psychosocial outcomes in the first 5 years after injury. It remains to be determined whether there are other factors that also may account for these differences and that may be amenable to intervention.	[Bushnik, Tamara] NYU Langone Sch Med, Rusk Inst Rehabil Med, New York, NY 10016 USA; [Englander, Jeffrey; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA		Bushnik, T (corresponding author), NYU Langone Sch Med, Rusk Inst Rehabil Med, 240 E 38th St,17th Floor, New York, NY 10016 USA.	tamara.bushnik@nyumc.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability and Rehabilitation Research [H133A070038]	This study was funded by grants (H133A070038) from the National Institute on Disability and Rehabilitation Research.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Baker GA, 1997, EPILEPSIA, V38, pS1, DOI 10.1111/j.1528-1157.1997.tb04511.x; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; DICKEY W, 1993, J ROY SOC MED, V86, P566; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jacoby A, 2008, EPILEPSY BEHAV, V12, P557, DOI 10.1016/j.yebeh.2007.11.013; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lehrner J, 1999, SEIZURE-EUR J EPILEP, V8, P88, DOI 10.1053/seiz.1999.0272; Leidy NK, 1999, NEUROLOGY, V53, P162, DOI 10.1212/WNL.53.1.162; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; O'Donoghue MF, 1998, BRAIN, V121, P317, DOI 10.1093/brain/121.2.317; O'Donoghue MF, 1999, BRIT J GEN PRACT, V49, P211; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SALINSKY MC, 1992, ELECTROEN CLIN NEURO, V83, P358, DOI 10.1016/0013-4694(92)90071-O; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Stavem K, 2000, QUAL LIFE RES, V9, P865, DOI 10.1023/A:1008993821253; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vickrey BG, 2000, EPILEPSIA, V41, P760, DOI 10.1111/j.1528-1157.2000.tb00239.x; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594	41	24	24	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E36	E44		10.1097/HTR.0b013e318273375c			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200004	23131969				2022-02-06	
J	Franschman, G; Verburg, N; Brens-Heldens, V; Andriessen, TMJC; Van der Naalt, J; Peerdeman, SM; Valk, JP; Hoogerwerf, N; Greuters, S; Schober, P; Vos, PE; Christiaans, HMT; Boer, C				Franschman, G.; Verburg, N.; Brens-Heldens, V.; Andriessen, T. M. J. C.; Van der Naalt, J.; Peerdeman, S. M.; Valk, J. P.; Hoogerwerf, N.; Greuters, S.; Schober, P.; Vos, P. E.; Christiaans, H. M. T.; Boer, C.			Effects of physician-based emergency medical service dispatch in severe traumatic brain injury on prehospital run time	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Emergency medical service; Traumatic brain injury; Prehospital; Advanced life support; Mortality; Transportation; Mobile medical team	ON-SCENE TIMES; ADVANCED LIFE-SUPPORT; TEAM INVOLVEMENT; HEAD-INJURY; CARE; MORTALITY; IMPACT; HEMS	Introduction: Prehospital care by physician-based helicopter emergency medical services (P-HEMS) may prolong total prehospital run time. This has raised an issue of debate about the benefits of these services in traumatic brain injury (TBI). We therefore investigated the effects of P-HEMS dispatch on prehospital run time and outcome in severe TBI. Methods: Prehospital run times of 497 patients with severe TBI who were solely treated by a paramedic EMS (n = 125) or an EMS/P-HEMS combination (n = 372) were retrospectively analyzed. Other study parameters included the injury severity score (ISS), Glasgow Coma Scale (GCS), prehospital endotracheal intubation and predicted and observed outcome rates. Results: Patients who received P-HEMS care were younger and had higher ISS values than solely EMS-treated patients (10%; P = 0.04). The overall prehospital run time was 74 +/- 54 min, with similar out-of-hospital times for EMS and P-HEMS treated patients. Prehospital endotracheal intubation was more frequently performed in the P-HEMS group (88%) than in the EMS group (35%; P < 0.001). The prehospital run time for intubated patients was similar for P-HEMS (66 (51-80) min) and EMS-treated patients (59 (41-88 min). Unexpectedly, mortality probability scores and observed outcome scores were less favourable for EMS-treated patients when compared to patients treated by P-HEMS. Conclusion: P-HEMS dispatch does not increase prehospital run times in severe TBI, while it assures prehospital intubation of TBI patients by a well-trained physician. Our data however suggest that a subgroup of the most severely injured patients received prehospital care by an EMS, while international guidelines recommend advanced life support by a physician-based EMS in these cases. (C) 2012 Elsevier Ltd. All rights reserved.	[Franschman, G.; Verburg, N.; Greuters, S.; Schober, P.; Christiaans, H. M. T.; Boer, C.] Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, NL-1081 HV Amsterdam, Netherlands; [Verburg, N.; Peerdeman, S. M.] Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, NL-1081 HV Amsterdam, Netherlands; [Brens-Heldens, V.; Hoogerwerf, N.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, Nijmegen, Netherlands; [Andriessen, T. M. J. C.; Vos, P. E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands; [Van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Valk, J. P.] Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands		Franschman, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl	Schober, Patrick/G-7400-2012; Verburg, Niels/ABA-6100-2020; Hoogerwerf, Nico/L-4388-2015	Schober, Patrick/0000-0003-0814-081X; Verburg, Niels/0000-0003-1048-1664; Hoogerwerf, Nico/0000-0003-1815-6989; Boer, Christa/0000-0002-7781-6951; van der Naalt, Joukje/0000-0001-9873-2418	Department of Anaesthesiology of the VU University Medical Centre, Amsterdam, The Netherlands	This study was financially supported by the Department of Anaesthesiology of the VU University Medical Centre, Amsterdam, The Netherlands.	Aydin S, 2010, J TRAUMA, V69, P589, DOI 10.1097/TA.0b013e3181e74858; Brain Trauma Foundation, 2007, GUID PREH MAN TRAUM, VS12, pS1; Butler DP, 2010, EMERG MED J, V27, P692, DOI 10.1136/emj.2009.087486; De Jongh MA, 2012, INJURY; Di Bartolomeo S, 2001, ARCH SURG-CHICAGO, V136, P1293, DOI 10.1001/archsurg.136.11.1293; *FDN NAT AMB EM RO, 2007, LAND PROT AMB LPA7; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lossius HM, 2002, ACTA ANAESTH SCAND, V46, P771, DOI 10.1034/j.1399-6576.2002.460703.x; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Osterwalder Joseph J, 2002, Prehosp Disaster Med, V17, P75; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Ryynanen OP, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-62; Schober P, 2011, J TRAUMA, V70, P1301, DOI 10.1097/TA.0b013e31820d20e8; Slagt C, 2001, Air Med J, V20, P17, DOI 10.1016/S1067-991X(01)70023-5; ten Duis HJ, 2003, INJURY, V34, P722, DOI 10.1016/S0020-1383(03)00162-1; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	21	24	25	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	NOV	2012	43	11					1838	1842		10.1016/j.injury.2012.05.020			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	014VR	WOS:000309404300011	22695322				2022-02-06	
J	Levy, ML; Kasasbeh, AS; Baird, LC; Amene, C; Skeen, J; Marshall, L				Levy, Michael L.; Kasasbeh, Aimen S.; Baird, Lissa Catherine; Amene, Chiazo; Skeen, Jeff; Marshall, Larry			Concussions in Soccer: A Current Understanding	WORLD NEUROSURGERY			English	Article						Concussion; Head injury; Protective headgear; Soccer; Trauma	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; ATHLETIC HEAD-INJURIES; HIGH-SCHOOL; FOOTBALL PLAYERS; UNITED-STATES; PROTECTIVE HEADGEAR; CEREBRAL CONCUSSION; CONTACT-SPORTS; NEUROCOGNITIVE PERFORMANCE	OBJECTIVE: Traumatic brain injury (TBI) is a significant public health problem in the United States, with approximately 1.5-2 million TBIs occurring each year. However, it is believed that these figures underestimate the true toll of TBI. Soccer is the most popular sport in the world and has a following of millions in the United States. Soccer is a sport not traditionally identified as high-risk for concussions, yet several studies have shown that concussion rates in soccer are comparable to, and often exceed those of, other contact sports. As many as 22% of all soccer injuries are concussions. METHODS: Soccer is a sport not traditionally identified as high risk for concussions, yet several studies have shown that concussion rates in soccer are comparable to, and often exceed those of, other contact sports. As many as 22% of all soccer injuries are concussions. Head injury during soccer is usually the result of either "direct contact" or contact with the ball while "heading" the ball. Relationships between the number of headers sustained in a single season and the degree of cognitive impairment (attention and visual/verbal memory) have been demonstrated. It is also likely that multiple concussions may cause cumulative neuropsychologic impairment in soccer players. RESULTS: Although our understanding of risk factors for sports-related concussions is far from complete, there is great potential for prevention in sports-related concussions. Several measures must be taken to avert the development of concussions in soccer and, when they take place, reduce their effects. These include the development and testing of effective equipment during play, the maintenance of regulatory standards for all such equipment, educating young athletes on the safe and appropriate techniques used during play, and strict adherence to the rules of competition. CONCLUSIONS: In spite of such preventive measures, concussions in soccer will continue to occur. Considering the frequency of concussions in soccer, the serious sequelae of these concussions, and because almost half of concussed soccer players were noncompliant with recommended American Academy of Neurology return-to-play guidelines, further measures must be taken to protect players, in addition to understanding those criteria that result in removing an injured player from competition and the steps by which to safely return an athlete to competition after injury.	[Levy, Michael L.; Baird, Lissa Catherine; Amene, Chiazo; Skeen, Jeff] Rady Childrens Hosp San Diego, Div Pediat Neurosurg, San Diego, CA USA; [Levy, Michael L.; Baird, Lissa Catherine; Amene, Chiazo; Skeen, Jeff; Marshall, Larry] Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA; [Kasasbeh, Aimen S.] Univ Arizona, Grad Program Neurosci, Tucson, AZ USA		Levy, ML (corresponding author), Rady Childrens Hosp San Diego, Div Pediat Neurosurg, San Diego, CA USA.	mlevy@rchsd.org	Levy, Michael/AAL-4647-2020				Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Agel J, 2007, J ATHL TRAINING, V42, P270; American Academy of Pediatrics, 1988, PHYSICIAN SPORTSMED, V16, P165; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P153; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Barth JT, 1989, MILD HEAD INJURY, P257; Baum KA, 1996, NEURORADIOLOGY, V38, P755, DOI 10.1007/s002340050342; Biros MH, 2009, ROSENS EMERGENCY MED; Blond L, 1999, BRIT J SPORT MED, V33, P110, DOI 10.1136/bjsm.33.2.110; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2003, J ATHL TRAINING, V38, P220; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Delaney JS, 1999, CLIN J SPORT MED, V9, P121; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick R, 2007, J ATHL TRAINING, V42, P278; Dvorak J, 2000, AM J SPORT MED, V28, pS3; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Elhammali N, 2010, INT J ORAL MAX SURG, V39, P857, DOI 10.1016/j.ijom.2010.04.006; Fields K, 1989, SPORTS MED, V17, P72; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Hoshizaki TB, 2000, NEUROLOGICAL ATHLETI, P41; HOY K, 1992, AM J SPORT MED, V20, P318, DOI 10.1177/036354659202000314; IO Arizona Youth Soccer Association, HEAD INJ GUID PROC P; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; JANDA DH, 1995, AM J SPORT MED, V23, P340, DOI 10.1177/036354659502300316; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KELLER CS, 1987, AM J SPORT MED, V15, P230, DOI 10.1177/036354658701500307; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Krauss Michael D, 2004, Curr Sports Med Rep, V3, P272; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lees K., 1988, SCI FOOTBALL, P385; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luhtanen P., 1994, FOOTBALL SOCCER; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; NEWMAN JA, 2000, P INT RES C BIOM IMP, P223; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prabhu VC, 2002, NEUROSURGERY, V50, P195; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Rabadi MH, 2011, CLIN J SPORT MED, V11, P194; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Reilly TT, 1976, J HUM MOV STUD, V2, P87; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Sallis R. E., 2003, Medicine & Science in Sports & Exercise, V35, pS247, DOI 10.1097/00005768-200305001-01383; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schleimer Jonathan A, 2002, Curr Sports Med Rep, V1, P323; SCHMIDTOLSEN S, 1991, AM J SPORT MED, V19, P273, DOI 10.1177/036354659101900311; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P358, DOI 10.1123/ijsb.4.4.358; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shetter A G, 1979, Adv Neurol, V22, P5; Smodlaka VN, 1984, PHYSICIAN SPORTSMED, V12, P127, DOI DOI 10.1080/00913847.1984.11701777; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STEPHENSON GC, 1992, INJURY, V23, P197, DOI 10.1016/S0020-1383(05)80045-2; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; SULLIVAN JA, 1980, AM J SPORT MED, V8, P325, DOI 10.1177/036354658000800505; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; Tucker AM, 1997, SPORTS MED, V23, P21, DOI 10.2165/00007256-199723010-00003; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; YARNELL PR, 1970, LANCET, V1, P863; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	134	24	25	1	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2012	78	5					535	544		10.1016/j.wneu.2011.10.032			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	049PP	WOS:000311996100037	22120567				2022-02-06	
J	Wolf, EG; Prye, J; Michaelson, R; Brower, G; Profenna, L; Boneta, O				Wolf, E. George; Prye, Jennifer; Michaelson, Robert; Brower, Gerry; Profenna, Leonardo; Boneta, Otto			Hyperbaric side effects in a traumatic brain injury randomized clinical trial	UNDERSEA AND HYPERBARIC MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; OXYGEN THERAPY	Objective: To catalog the side effects of 2.4 atmospheres absolute (atm abs) hyperbaric oxygen (HBO2) vs. sham on post-concussion symptoms in military service members with combat-related, mild traumatic brain injury (TBI). Methods: Fifty subjects diagnosed with TBI were randomized to either a sham (1.3 atm abs breathing air) or treatment (2.4 atm abs breathing 100% oxygen) hyperbaric profile. Forty-eight subjects completed 30 exposures. Medical events during hyperbaric exposures were separately annotated by medical staff and chamber operators. After the blind was broken, events were segregated into the exposure groups. Results: These side effects were observed as rate (sham/treatment): ear block (ear barotrauma) 5.51% (1.09%/5.91%), sinus squeeze 0.14% (0.0%/0.27%), and confinement anxiety 0.27% (0.27%/0.27%). Other conditions that occurred included: headache 0.61% (0.68%/0.54%); nausea 0.2% (0.14%/0.27%); numbness 0.07% (0%/0.13%); heartburn 0.07% (0.14%/0%); musculoskeletal chest pain 0.07% (0%/0.13%); latex allergy 0.07% (0.14%/0%); and hypertension 0.07% (0.14%/0%). Conclusion: This study demonstrated no major adverse events, such as pulmonary barotraumas, pulmonary edema or seizure. Given the infrequent, mild side effect profile, the authors feel the study demonstrated that hyperbaric oxygen therapy (HBO2T) was safe at a relatively high treatment pressure in TBI subjects, and these data can be used to evaluate the risk/benefit calculation when deciding to utilize HBO2T for treatment of various diseases in the TBI population.	[Wolf, E. George; Prye, Jennifer; Michaelson, Robert; Brower, Gerry; Profenna, Leonardo] USAF Sch Aerosp Med, Hyperbar Med Dept, Lackland AFB, TX USA; [Boneta, Otto] Evan Army Community Hosp, Ft Carson, CO USA		Wolf, EG (corresponding author), USAF Sch Aerosp Med, Hyperbar Med Dept, Lackland AFB, TX USA.	earl.wolf.ctr@us.af.mil			Air Force Medical Service; U.S. Navy Bureau of Medicine and Surgery; U.S. Army Medical Materiel Development Activity	The authors would like to recognize and thank the Air Force Medical Service for funding this research project; the U.S. Navy Bureau of Medicine and Surgery for funding temporary duty requirements; the U.S. Army Medical Materiel Development Activity for end of study funding; Ms. Sheila Galvin, Traumatic Brain Injury Program Coordinator for the Wounded Warrior Regiment USMC for her superb service in coordinating subject requirements; Ms. Karen Guenther and the Injured Marine Semper Fi Fund for transportation support for subjects; and Dr. Jason Cromar, USAFSAM, for coordinating the protocol.	Churchill S, 1997, UNDERSEA HYPERB MED; Clark J, 2009, HYPERBARIC OXYGEN TH, P217; Clarke D, 2009, UNDERSEA HYPERBAR M, V36, P13; Dedi D, 1998, UNDERSEA HYPERBAR M, V25, p[93, 34]; Kindwall EP, 2008, HYPERBARIC MED PRACT, P284; Kinney J, 1974, 793 NAV SUBM MED RES; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; McDonagh MS, 2003, AHRQ PUBLICATION, V03-E050; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Rockswold GL, 2010, J NEUROSURG, V112, P1079; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Smerz R, 2009, UNDERSEA HYPERB MED, V36; Stone JA, 1991, UND HYP MED SOC ANN, P80; van Ophoven A, 2006, J UROLOGY, V176, P1442, DOI 10.1016/j.juro.2006.06.065	15	24	28	1	8	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	NOV-DEC	2012	39	6					1075	1082					8	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	250BV	WOS:000326826100004	23342764				2022-02-06	
J	Kemp, K; Gray, E; Wilkins, A; Scolding, N				Kemp, Kevin; Gray, Elizabeth; Wilkins, Alastair; Scolding, Neil			Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum	BRAIN			English	Article						Purkinje cells; multiple sclerosis; fusion; heterokaryon; cerebellum	BONE-MARROW-CELLS; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; HEMATOPOIETIC-CELLS; NEURONS; CORTEX; TRANSPLANTATION; DAMAGE; MICE	A major conceptual consideration in both endogenous and therapeutic central nervous system repair is how damaged (or senescent) neurons, given their often enormously complex and extensive network of connections, can possibly be replaced. The recent observation of fusion of circulating bone marrow cells with, in particular, cerebellar Purkinje cells, as well as the subsequent formation of stable heterokaryons, offers a tantalizing potential solution to this difficulty. Here, we have explored Purkinje cell fusion and heterokaryon formation in the human brain and the influence of central nervous system inflammation. We analysed post-mortem cerebellum tissue from patients who had multiple sclerosis and from appropriate controls. Purkinje cells were analysed for heterokaryon formation using immunohistochemistry techniques and chromosome composition using fluorescence in situ hybridization. For the first time in humans we show a disease-related increase in Purkinje cell fusion and heterokaryon formation. We have shown that heterokaryon formation takes place in control subjects, and that the frequency of this event is considerably increased in patients with multiple sclerosis, the prototypical inflammatory brain disease, with similar to 0.4% of Purkinje cells being binucleate heterokaryons. No mononucleate polyploid Purkinje cell heterokaryons were found. The observation that heterokaryon formation in the cerebellum occurs as part of the central nervous system inflammatory reaction suggests a potential mechanism of neural repair. It also suggests an exciting new avenue for therapeutic intervention, as enhancement or manipulation of fusion events may have a therapeutic role in cellular protection in multiple sclerosis.	[Kemp, Kevin; Gray, Elizabeth; Wilkins, Alastair; Scolding, Neil] Univ Bristol, Sch Clin Sci, Multiple Sclerosis & Stem Cell Grp, Bristol BS16 1JB, Avon, England		Kemp, K (corresponding author), Frenchay Hosp, Multiple Sclerosis & Stem Cell Labs, Burden Ctr, 1st Floor, Bristol BS16 1JB, Avon, England.	Kevin.Kemp@bristol.ac.uk	Kemp, Kevin/B-9755-2017	Kemp, Kevin/0000-0003-1465-1309; Scolding, Neil/0000-0001-9177-1043	Ataxia UK; Burden Institute; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/J012580/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/J012580/1] Funding Source: researchfish; Parkinson&quot;s UKParkinson&apos;s UK [G-0909] Funding Source: researchfish	This work was carried out using a project grant from both Ataxia UK and The Burden Institute.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; Chen KA, 2011, MOL CELL NEUROSCI, V47, P61, DOI 10.1016/j.mcn.2011.03.003; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; Espejel S, 2009, ANN NEUROL, V66, P100, DOI 10.1002/ana.21670; Gray E, 2008, BRAIN PATHOL, V18, P86, DOI 10.1111/j.1750-3639.2007.00110.x; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kozorovitskiy Y, 2003, NAT CELL BIOL, V5, P952, DOI 10.1038/ncb1103-952; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A., 2003, NEUROSURGERY, V53, P702; MANN DMA, 1978, J COMP NEUROL, V180, P345, DOI 10.1002/cne.901800210; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Miyata M, 1999, ACTA NEUROPATHOL, V98, P226, DOI 10.1007/s004010051073; Nern C, 2009, J NEUROSCI, V29, P3799, DOI 10.1523/JNEUROSCI.5848-08.2009; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Priller J, 2001, J CELL BIOL, V155, P733, DOI 10.1083/jcb.200105103; Singec I, 2008, NAT CELL BIOL, V10, P503, DOI 10.1038/ncb0508-503; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wiersema A, 2008, STEM CELL RES, V1, P150, DOI 10.1016/j.scr.2008.02.001; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; ZECEVIC N, 1976, J COMP NEUROL, V167, P27, DOI 10.1002/cne.901670103	32	24	28	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2012	135		10				2962	2972		10.1093/brain/aws226			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	025AX	WOS:000310156700007	22975392	Bronze			2022-02-06	
J	Bartsch, A; Benzel, E; Miele, V; Morr, D; Prakash, V				Bartsch, Adam; Benzel, Edward; Miele, Vincent; Morr, Douglas; Prakash, Vikas			Hybrid III anthropomorphic test device (ATD) response to head impacts and potential implications for athletic headgear testing	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Hybrid III; NOCSAE; Helmet; Head Impact; Concussion	TRAUMATIC BRAIN-INJURY; HUMAN CERVICAL-SPINE; PROFESSIONAL FOOTBALL; STRUCTURAL-PROPERTIES; GAME IMPACTS; CONCUSSION; RECONSTRUCTION; ACCELERATION; BIOMECHANICS; PERFORMANCE	The Hybrid III 50th percentile male anthropomorphic test device (ATD) is the most widely used human impact testing surrogate and has historically been used in automotive or military testing. More recently, this ATD is finding use in applications evaluating athletic helmet protectivity, quantifying head impact dosage and estimating injury risk. But ATD head-neck response has not been quantified in omnidirectional athletic-type head impacts absent axial preload. It is probable that headgear injury reduction that can be quantified in a laboratory, including in American football, boxing, hockey, lacrosse and soccer, is related to a number of interrelated kinetic and kinematic factors, such as head center of gravity linear acceleration, head angular acceleration, head angular velocity, occipito-cervical mechanics and neck stiffness. Therefore, we characterized ATD head-neck dynamic response to direct head impacts in a series of front, oblique front and lateral head impacts. Key findings were: (1) impacts producing highest ATD resultant center of gravity linear acceleration resulted in the lowest resultant occipito-cervical spine bending moment/force. (2) Resultant ATD head angular velocity and angular acceleration did not appear coupled to impact direction at lower impact energy levels; these parameters were coupled at higher energy levels. (3) The ATD had progressively increasing occipito-cervical stiffness in extension, torsion and lateral bending, respectively. Because the ATD neck influenced head and neck impact dosage parameters, testing agencies, manufacturers and researchers should consider using the Hybrid III head form attached to a neck as a means to quantify head and neck injury risks as opposed to systems that do not utilize a neck. This heightened understanding of Hybrid III ATD head-neck response, and consideration of order of stiffest axes in the lateral, oblique and extension directions, respectively, should aid in the development of head and neck injury impact testing standards. (C) 2012 Elsevier Ltd. All rights reserved.	[Bartsch, Adam; Benzel, Edward] Cleveland Clin, Spine Res Lab, Cleveland, OH 44113 USA; [Bartsch, Adam; Benzel, Edward; Prakash, Vikas] Cleveland Traumat Neuromech Consortium, Cleveland, OH USA; [Benzel, Edward; Miele, Vincent] Cleveland Clin, Dept Neurol Surg, Neurol Inst, Cleveland, OH 44113 USA; [Miele, Vincent] United Hosp Ctr, Clarksburg, WV USA; [Miele, Vincent] Neurosurg Spine Ctr, Clarksburg, WV USA; [Prakash, Vikas] Case Western Reserve Univ, Dept Mech Engn, Cleveland, OH 44106 USA; [Morr, Douglas] SEA Ltd, Columbus, OH USA		Bartsch, A (corresponding author), Cleveland Clin, Spine Res Lab, Luth 2-C,1730 W 25th St, Cleveland, OH 44113 USA.	bartsca@ccf.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32AR050959] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32 AR050959] Funding Source: Medline		Agaram V., 2001, P 17 INT TECHN C EXP, P1; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Camacho DL, 1997, SAE T, V106, P3989, DOI [10.4271/ 973345, DOI 10.4271/973345]; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Clemens H. J., 1972, STAPP CAR CRASH J, P76; Danforth JP, 1968, P 12 STAPP CAR CRASH, P302; Dibb Alan T, 2006, Stapp Car Crash J, V50, P567; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2003, ACCIDENT ANAL PREV, V35, P811, DOI 10.1016/S0001-4575(02)00085-4; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Funk J. R., 2009, P 2009 SAE WORLD C S; Gennarelli TA, 2005, ABBREVIATED INJURY S; GOEL VK, 1990, SPINE, V15, P990, DOI 10.1097/00007632-199015100-00002; Got C., 1978, STAPP CAR CRASH J, P441; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HAN C, 1992, J ORTHOPAED RES, V10, P446, DOI 10.1002/jor.1100100318; Hu A. S., 1977, STAPP CAR CRASH J, p[1977, 589]; Kang J., 2001, P SOC AUT ENG 2001 W; LYSELL E, 1969, ACTA ORTHOP SCAND, VS, P4; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2007, ACCIDENT ANAL PREV, V39, P326, DOI 10.1016/j.aap.2006.09.001; Mertz H., 1967, STAPP CAR CRASH J, P267; MERTZ HJ, 1971, P 15 STAPP CAR CRASH, P207; MYERS BS, 1991, SPINE, V16, P870, DOI 10.1097/00007632-199108000-00002; National Committee on Standards for Athletic Equipment, 2006, 08104M04 NOCSAE DOC, P1; National Operating Committee on Standards for Athletic Equipment, 2009, ND00298M09 NOCSAE, P1; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2008, 00108M08B NOCSAE, P1; Newman J, 2000, 44 STAPP CAR CRASH C; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nightingale RW, 2007, J BIOMECH, V40, P535, DOI 10.1016/j.jbiomech.2006.02.015; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PANJABI M, 1988, SPINE, V13, P726, DOI 10.1097/00007632-198807000-00003; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; Patrick L. M., 1976, VRI73 SOC AUT ENG, P1; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pincemaille Y, 1989, P 33 STAPP CAR CRASH, P177; Pintar Frank A, 2005, Stapp Car Crash J, V49, P33; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P89, DOI 10.1243/17543371JSET34; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Seemann M. R., 1986, P 30 STAPP CAR CRASH, V30, P291; SHEA M, 1991, J BIOMECH, V24, P95, DOI 10.1016/0021-9290(91)90354-P; Smith T, 1988, 3 DIMENSIONAL ANAL L, P271; *SOC AUT ENG, 1994, J1733 SAE; Society of Automotive Engineers, 2003, J2111 SAE; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Wismans J., 1983, SAE TECHNICAL PAPERS, DOI [10.4271/831613, DOI 10.4271/831613]; Wismans J, 1986, STAPP CAR CRASH J, V30, P313; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Yoganandan N, 2000, Stapp Car Crash J, V44, P189; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	62	24	24	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2012	48				SI		285	291		10.1016/j.aap.2012.01.032			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	983TB	WOS:000307140500032	22664692				2022-02-06	
J	Grady, MF; Master, CL; Gioia, GA				Grady, Matthew F.; Master, Christina L.; Gioia, Gerard A.			Concussion Pathophysiology: Rationale for Physical and Cognitive Rest	PEDIATRIC ANNALS			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SPORT-RELATED CONCUSSION; FLUID PERCUSSION INJURY; EXERCISE; MANAGEMENT; CHILDREN; RECOVERY	Matthew F. Grady, MD, is the Director of the Primary Care Sports Medicine fellowship program at The Children's Hospital of Philadelphia; and Assistant Professor of Clinical Pediatrics, Departments of Surgery and Pediatrics, Division of Pediatric Orthopedics and Sports Medicine, Perelman School of Medicine at the University of Pennsylvania. Christina L. Master, MD, is the Associate Director of the Primary Care Sports Medicine fellowship program at The Children's Hospital of Philadelphia; and Associate Professor of Clinical Pediatrics, Departments of Surgery and Pediatrics, Division of Pediatric Orthopedics and Sports Medicine, Perelman School of Medicine at the University of Pennsylvania. Gerard A. Gioia, PhD, is the Chief, Division of Pediatric Neuropsychology, and Director, Safe Concussion Outcome, Recovery & Education (SCORE) Program, Children's National Medical Center; and Associate Professor, Departments of Pediatrics and Psychiatry & Behavioral Sciences; The George Washington University School of Medicine, Division of Pediatric Neuropsychology. Address correspondence to: Matthew F. Grady, MD, Center for Performance and Sports Medicine, The Children's Hospital of Philadelphia, 210 Mall Blvd., King of Prussia, PA 19406; email: gradym@email.chop.edu. Disclosure: The authors have no relevant financial relationships to disclose. doi: 10.3928/00904481-20120827-12	[Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Primary Care Sports Med Fellowship Program, King Of Prussia, PA 19406 USA; [Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Div Pediat Orthoped & Sports Med, Dept Surg, Philadelphia, PA 19104 USA; [Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Div Pediat Orthoped & Sports Med, Dept Pediat, Philadelphia, PA 19104 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, SCORE Program,Childrens Natl Med Ctr, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Dept Pediat, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Dept Psychiat & Behav Sci, Washington, DC 20052 USA		Grady, MF (corresponding author), Childrens Hosp Philadelphia, Ctr Performance & Sports Med, 210 Mall Blvd, King Of Prussia, PA 19406 USA.	gradym@email.chop.edu		Master, Christina/0000-0002-6717-4270			Bergschneider M, 2003, J NEUROSURG, V86, P241; Centers for Disease Control and Prevention (CDC), 2007, HEADS BRAIN INJ YOUR; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Donat CK, 2010, INT J DEV NEUROSCI, V28, P31, DOI 10.1016/j.ijdevneu.2009.10.001; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2006, HEADS BRAIN INJURY Y; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Moser RS, 2012, J PEDIAT; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Tang-Schomer MD, 2009, FASEB J; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	32	24	24	0	23	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	SEP	2012	41	9					377	382		10.3928/00904481-20120827-12			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	082NM	WOS:000314398700012	22953984				2022-02-06	
J	McLeod, TCV; Lam, KC; Bay, RC; Sauers, EL; Valier, ARS				McLeod, Tamara C. Valovich; Lam, Kenneth C.; Bay, R. Curtis; Sauers, Eric L.; Valier, Alison R. Snyder		Athletic Training Practice-Based R	Practice-Based Research Networks, Part II: A Descriptive Analysis of the Athletic Training Practice-Based Research Network in the Secondary School Setting	JOURNAL OF ATHLETIC TRAINING			English	Article						PBRN; adolescents; practice characteristics; professional practice; ICD-9; CPT	STATES HIGH-SCHOOL; CLINICAL-OUTCOMES ASSESSMENT; SPORTS-RELATED INJURIES; QUALITY-OF-LIFE; UNITED-STATES; PRACTICE PATTERNS; NORTH-CAROLINA; PHYSICAL-THERAPY; RISK-FACTORS; EPIDEMIOLOGY	Context: Analysis of health care service models requires the collection and evaluation of basic practice characterization data. Practice-based research networks (PBRNs) provide a framework for gathering data useful in characterizing clinical practice. Objective: To describe preliminary secondary school setting practice data from the Athletic Training Practice-Based Research Network (AT-PBRN). Design: Descriptive study. Setting: Secondary school athletic training facilities within the AT-PBRN. Patients or Other Participants: Clinicians (n = 22) and their patients (n = 2523) from the AT-PBRN. Main Outcome Measure(s): A Web-based survey was used to obtain data on clinical practice site and clinician characteristics. Patient and practice characteristics were obtained via deidentified electronic medical record data collected between September 1, 2009, and April 1, 2011. Descriptive data regarding the clinician and CPS practice characteristics are reported as percentages and frequencies. Descriptive analysis of patient encounters and practice characteristic data was performed, with the percentages and frequencies of the type of injuries recorded at initial evaluation, type of treatment received at initial evaluation, daily treatment, and daily sign-in procedures. Results: The AT-PBRN had secondary school sites in 7 states, and most athletic trainers at those sites (78.2%) had less than 5 years of experience. The secondary school sites within the AT-PBRN documented 2523 patients treated across 3140 encounters. Patients most frequently sought care for a current injury (61.3%), followed by preventive services (24.0%), and new injuries (14.7%). The most common diagnoses were ankle sprain/strain (17.9%), hip sprain/strain (12.5%), concussion (12.0%), and knee pain (2.5%). The most frequent procedures were athletic trainer evaluation (53.9%), hot- or cold-pack application (26.0%), strapping (10.3%), and therapeutic exercise (5.7%). The median number of treatments per injury was 3 (interquartile range = 2, 4; range = 2-19). Conclusions: These preliminary data describe services provided by clinicians within the AT-PBRN and demonstrate the usefulness of the PBRN model for obtaining such data.	[McLeod, Tamara C. Valovich; Sauers, Eric L.; Valier, Alison R. Snyder] AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA; [McLeod, Tamara C. Valovich; Lam, Kenneth C.; Bay, R. Curtis; Sauers, Eric L.; Valier, Alison R. Snyder] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Program, 5850 E Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020; Lam, Kenny/ABB-9733-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Bay, Ralph/0000-0003-3525-9269; Lam, Kenneth/0000-0002-2185-0990			Albohm MJ, 1999, J REHABIL OUTCOMES M, V3, P51; American Medical Association, CPT CURR PROC TERM; Andrilla CHA, 2007, 109 WWAMI CTR HLTH W; Board of Certification, 2004, ROL DEL STUD; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Brennan GP, 2006, PHYS THER, V86, P1251, DOI 10.2522/ptj.20050382; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; del Aguila MA, 2005, J AM DENT ASSOC, V136, P790, DOI 10.14219/jada.archive.2005.0265; DeRouen TA, 2010, J AM DENT ASSOC, V141, P889, DOI 10.14219/jada.archive.2010.0289; Deshefy-Longhi T, 2008, J AM ACAD NURSE PRAC, V20, P281, DOI 10.1111/j.1745-7599.2008.00318.x; Downar C., 2001, PROFILING PROFESSION; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Fox CH, 2006, J AM BOARD FAM MED, V19, P54, DOI 10.3122/jabfm.19.1.54; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P170; KIRKLAND M, 2006, NATA NEWS        OCT, P40; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; McLeod TCV, 2009, J ATHL TRAINING, V44, P603, DOI 10.4085/1062-6050-44.6.603; Nagykaldi Z, 2007, J AM BOARD FAM MED, V20, P188, DOI 10.3122/jabfm.2007.02.060084; National Athletic Trainers' Association, 2011, ATHL TRAIN ED COMP; National Athletic Trainers' Association, 2008, NAT OUTC RES AN PROJ; National Federation of State High School Associations, 2010, NFHS 2009 2010 HIGH; National Institutes of Health, RES REP DAT HIPAA PR; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; O'Neill L, 2005, MED CARE RES REV, V62, P339, DOI 10.1177/1077558705275424; Peabody JW, 2004, MED CARE, V42, P1066, DOI 10.1097/00005650-200411000-00005; Powell JW, 1999, J ATHL TRAINING, V34, P277; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Resnik L, 2003, PHYS THER, V83, P990, DOI 10.1093/ptj/83.11.990; Resnik L, 2003, PHYS THER, V83, P1090, DOI 10.1093/ptj/83.12.1090; Rindal DB, 2010, J DENT, V38, P1027, DOI 10.1016/j.jdent.2010.09.003; Sauers EL, 2012, J ATHL TRAIN, V47, pxx; Sauers EL, 2009, ATHL TRAIN SPORTS HL, V1, P244, DOI [10.3928/19425864-20091019-01, DOI 10.3928/19425864-20091019-01]; Sauers EL, 2011, J SPORT REHABIL, V20, P100, DOI 10.1123/jsr.20.1.100; Sauers EL, 2011, J SPORT REHABIL, V20, P3, DOI 10.1123/jsr.20.1.3; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Snyder AR, 2007, ATHL TRAIN ED J, V2, P1; Steves R, 2004, J ATHL TRAINING, V39, P83; Trostler N, 2008, J AM DIET ASSOC, V108, P1060, DOI 10.1016/j.jada.2008.03.001; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; Valovich McLeod TC, 2011, NATL SPORTS SAFETY S; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wasserman RC, 1998, PEDIATRICS, V102, P1350, DOI 10.1542/peds.102.6.1350; Weyer SM, 2010, J AM ACAD NURSE PRAC, V22, P156, DOI 10.1111/j.1745-7599.2009.00482.x; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	54	24	24	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2012	47	5					557	566		10.4085/1062-6050-47.5.05			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	019KA	WOS:000309737300013	23068594	Green Published			2022-02-06	
J	Vuille-Dit-Bille, RN; Ha-Huy, R; Stover, JF				Vuille-Dit-Bille, Raphael N.; Ha-Huy, Riem; Stover, John F.			Changes in plasma phenylalanine, isoleucine, leucine, and valine are associated with significant changes in intracranial pressure and jugular venous oxygen saturation in patients with severe traumatic brain injury	AMINO ACIDS			English	Article						Critical care; Monitoring; Neuromonitoring; Nutrition	CHAIN AMINO-ACIDS; SYSTEM L; MUSCLE; EXCHANGERS; GLUTAMATE; SJVO(2); SEPSIS; BLOOD; VEIN	Changes in plasma aromatic amino acids (AAA = phenylalanine, tryptophan, tyrosine) and branched chain amino acids (BCAA = isoleucine, leucine, valine) levels possibly influencing intracranial pressure (ICP) and cerebral oxygen consumption (SjvO(2)) were investigated in 19 sedated patients up to 14 days following severe traumatic brain injury (TBI). Compared to 44 healthy volunteers, jugular venous plasma BCAA were significantly decreased by 35% (p < 0.001) while AAA were markedly increased in TBI patients by 19% (p < 0.001). The BCAA to AAA ratio was significantly decreased by 55% (p < 0.001) which persisted during the entire study period. Elevated plasma phenylalanine was associated with decreased ICP and increased SjvO(2), while higher plasma isoleucine and leucine levels were associated with increased ICP and higher plasma leucine and valine were linked to decreased SjvO(2). The amount of enterally administered amino acids was associated with significantly increased plasma levels with the exception of phenylalanine. Contrary to the initial assumption that elevated AAA and decreased BCAA levels are detrimental, increased plasma phenylalanine levels were associated with beneficial signs in terms of decreased ICP and reduced cerebral oxygen consumption reflected by increased SjvO(2); concomitantly, elevated plasma isoleucine and leucine levels were associated with increased ICP while leucine and valine were associated with decreased SjvO(2) following severe TBI, respectively. The impact of enteral nutrition on this observed pattern must be examined prospectively to determine if higher amounts of phenylalanine should be administered to promote beneficial effects on brain metabolism and if normalization of plasma BCAA levels is without cerebral side effects.	[Vuille-Dit-Bille, Raphael N.; Ha-Huy, Riem; Stover, John F.] Univ Spital Zurich, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Univ Spital Zurich, CH-8091 Zurich, Switzerland.	john.stover@access.uzh.ch		Vuille-dit-Bille, Raphael/0000-0002-0884-9493	Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF); SUVA Fonds	The help of the nursing staff in collecting plasma samples is gratefully acknowledged. The study was supported by grants from the Swiss National Science Foundation (SNF) and the SUVA Fonds to JFS.	Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; ASKANAZI J, 1980, ANN SURG, V191, P465, DOI 10.1097/00000658-198004000-00013; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Basler T, 2002, INTENS CARE MED, V28, P293, DOI 10.1007/s00134-002-1217-6; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Blomstrand E, 2005, ACTA PHYSIOL SCAND, V185, P203, DOI 10.1111/j.1365-201X.2005.01482.x; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; CANGIANO C, 1982, EUR J CLIN INVEST, V12, P15, DOI 10.1111/j.1365-2362.1982.tb00934.x; CHAPLIN ER, 1976, J NEUROCHEM, V26, P701, DOI 10.1111/j.1471-4159.1976.tb04440.x; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; FEIGIN RD, 1971, AM J CLIN NUTR, V24, P329; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Fernstrom JD, 2000, AM J CLIN NUTR, V71, p1669S, DOI 10.1093/ajcn/71.6.1669S; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; FISCHER JE, 1976, SURGERY, V80, P77; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; FREUND H, 1982, ANN SURG, V196, P209, DOI 10.1097/00000658-198208000-00015; FREUND HR, 1978, ANN SURG, V188, P423, DOI 10.1097/00000658-197809000-00017; Lieberman HR, 2003, APPETITE, V40, P245, DOI 10.1016/S0195-6663(03)00010-2; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Miyazaki T, 2003, HEPATOL RES, V27, P230, DOI 10.1016/S1386-6346(03)00242-0; Oertel MF, 2009, J CLIN NEUROSCI, V16, P1161, DOI 10.1016/j.jocn.2008.11.013; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; Riggio O, 1989, Recenti Prog Med, V80, P591; Roberts LM, 2008, NEUROSCIENCE, V155, P423, DOI 10.1016/j.neuroscience.2008.06.015; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Rossetti P, 2008, DIABETES, V57, P1905, DOI 10.2337/db08-0276; Scarna A, 2005, PSYCHOPHARMACOLOGY, V179, P761, DOI 10.1007/s00213-004-2105-2; Shikata N, 2010, AMINO ACIDS, V38, P179, DOI 10.1007/s00726-008-0226-3; STINNETT JD, 1982, ANN SURG, V195, P75, DOI 10.1097/00000658-198201001-00012; Stover J.F., 2005, EUR, V31, P308, DOI [10.1007/s00068-005-2055-3, DOI 10.1007/S00068-005-2055-3]; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; VENTE JP, 1989, ANN SURG, V209, P57, DOI 10.1097/00000658-198901000-00009; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Vuille-Dit-Bille RN, 2011, MINERVA ANESTESIOL, V77, P870	39	24	24	0	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	SEP	2012	43	3					1287	1296		10.1007/s00726-011-1202-x			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	989BV	WOS:000307536100025	22189890	Green Submitted, Green Accepted			2022-02-06	
J	Klein, P; Herr, D; Pearl, PL; Natale, J; Levine, Z; Nogay, C; Sandoval, F; Trzcinsky, S; Atabaki, SM; Tsuchida, T; van den Anker, J; Soldin, SJ; He, JP; McCarter, R				Klein, Pavel; Herr, Daniel; Pearl, Phillip L.; Natale, JoAnne; Levine, Zachary; Nogay, Claude; Sandoval, Fabian; Trzcinsky, Stacey; Atabaki, Shireen M.; Tsuchida, Tammy; van den Anker, John; Soldin, Steven J.; He, Jianping; McCarter, Robert			Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsy	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizures; Post-traumatic epilepsy; Traumatic brain injury; Head injury; Levetiracetam; Pharmacokinetics; Epilepsy prevention; Saliva	INTRAVENOUS-INFUSION; SEIZURES; PLACEBO; EPILEPTOGENESIS; CHILDREN	Levetiracetam (LEV) has antiepileptogenic effects in animals and is a candidate for prevention of epilepsy after traumatic brain injury. Pharmacokinetics of LEV in TBI patients was unknown. We report pharmacokinetics of TBI subjects >= 6 years with high PTE risk treated with LEV 55 mg/kg/day orally, nasogastrically or intravenously for 30 days starting <= 8 h after injury in a phase II safety and pharmacokinetic study. Forty-one subjects (26 adults and 15 children) were randomized to PK studies on treatment days 3 and 30. Thirty-six out of forty-one randomized subjects underwent PK study on treatment day 3, and 24/41 subjects underwent PK study on day 30. On day 3, mean T-max was 2.2 h, C-max was 60.2 mu g/ml and AUC was 403.7 mu g/h/ml. T-max was longer in the elderly than in children and non-elderly adults (5.96 h vs. 1.5 h and 1.8 h; p=0.0001). AUC was non-significantly lower in children compared with adults and the elderly (317.4 mu g/h/ml vs. 461.4 mu g/h/ml and 450.2 mu g/h/ml; p=0.08). C-max trended higher in i.v.-versus tablet-or n.g.-treated subjects (78.4 mu g/ml vs. 59 mu g/ml and 48.2 mu g/ml; p=0.07). AUC of n.g. and i.v. administrations was 79% and 88% of AUC of oral administration. There were no significant PK differences between days 3 and 30. Treatment of TBI patients with high PTE risk with 55 mg/kg/day LEV, a dose with antiepileptogenic effect in animals, results in plasma LEV levels comparable to those in animal studies. (C) 2012 Elsevier Inc. All rights reserved.	[Klein, Pavel] Mid Atlantic Epilepsy & Sleep Ctr, Bethesda, MD 20817 USA; [Klein, Pavel; Herr, Daniel; Levine, Zachary; Nogay, Claude; Sandoval, Fabian] MedStar Res Inst, Dept Neurol, Washington, DC 20010 USA; [Pearl, Phillip L.; Natale, JoAnne; Trzcinsky, Stacey; Tsuchida, Tammy; van den Anker, John; Soldin, Steven J.; He, Jianping; McCarter, Robert] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Atabaki, Shireen M.] Childrens Natl Med Ctr, Dept Emergency Med, Washington, DC 20010 USA		Klein, P (corresponding author), Mid Atlantic Epilepsy & Sleep Ctr, 6410 Rockledge Dr,Suite 410, Bethesda, MD 20817 USA.	kleinp@epilepsydc.com	Herr, Daniel/X-4215-2019	Herr, Daniel/0000-0001-8533-9000	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R01 NS45656]; NIH National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031988, M01RR020359]; Intellectual and Developmental Disabilities Research Center of the NIH National Center for Child Health and Human Development [P30HD040677]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031988, M01RR020359, KL2RR031987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045656] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010355] Funding Source: NIH RePORTER	The study was supported by the NIH, grant 1 R01 NS45656, and by Award Numbers UL1RR031988 and M01RR020359 from the NIH National Center for Research Resources, as well as Award Number P30HD040677 from the Intellectual and Developmental Disabilities Research Center of the NIH National Center for Child Health and Human Development. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The investigators would like to thank Michelle Mendoza, MD, Be Tadzong, MD, Jennifer Scarito, RN, Nazli Bolouri, MD and Said Goudarzi for assistance with the study.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Fountain NB, 2007, EPILEPSY RES, V74, P60, DOI 10.1016/j.eplepsyres.2006.12.005; Glauser TA, 2006, NEUROLOGY, V66, P1654, DOI 10.1212/01.wnl.0000217916.00225.3a; Guo TD, 2007, CLIN CHIM ACTA, V375, P115, DOI 10.1016/j.cca.2006.06.022; Klein P, ARCH NEUROL IN PRESS; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Patsalos PN, 2000, PHARMACOL THERAPEUT, V85, P77, DOI 10.1016/S0163-7258(99)00052-2; Pellock JM, 2001, EPILEPSIA, V42, P1574, DOI 10.1046/j.1528-1157.2001.41300.x; Ramael S, 2006, CLIN THER, V28, P734, DOI 10.1016/j.clinthera.2006.05.004; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; *UCB PHARM INC, 1999, DAT FIL	15	24	24	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050			EPILEPSY BEHAV	Epilepsy Behav.	AUG	2012	24	4					457	461		10.1016/j.yebeh.2012.05.011			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	980NO	WOS:000306900300013	22771222	Green Accepted			2022-02-06	
J	Marshall, KR; Holland, SL; Meyer, KS; Martin, EM; Wilmore, M; Grimes, JB				Marshall, Kathryn R.; Holland, Sherray L.; Meyer, Kimberly S.; Martin, Elisabeth Moy; Wilmore, Michael; Grimes, Jamie B.			Mild Traumatic Brain Injury Screening, Diagnosis, and Treatment	MILITARY MEDICINE			English	Article								The majority of combat-related traumatic brain injury (TBI) within the U.S. Armed Forces is mild TBI (mTBI). This article focuses specifically on the screening, diagnosis, and treatment aspects of mTBI within the military community. Aggressive screening measures were instituted in 2006 to ensure that the mTBI population is identified and treated. Screenings occur in-theater, outside the contiguous United States, and in-garrison. We discuss specific screening procedures at each screening setting. Current diagnosis of mTBI is based upon self-report or through witnesses to the event. TBI severity is determined by specific Department of Defense criteria. Abundant clinician resources are available for mTBI in the military health care setting. Education resources for both the patient and the clinician are discussed in detail. An evidence-based clinical practice guideline for the care of mTBI was created through collaborative efforts of the DoD and the U.S. Department of Veterans Affairs. Although symptoms following mTBI generally resolve with time, active treatment is centered on symptom management, supervised rest, recovery, and patient education. Medical specialty care, ancillary services, and other therapeutic services may be required.	[Marshall, Kathryn R.; Holland, Sherray L.; Meyer, Kimberly S.; Martin, Elisabeth Moy; Wilmore, Michael; Grimes, Jamie B.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20919 USA; [Meyer, Kimberly S.] Univ Louisville Hosp, Trauma Inst, Louisville, KY 40202 USA		Marshall, KR (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway,Suite 6-100, Silver Spring, MD 20919 USA.		Meyer, Kimberly/L-5430-2019				Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; [Anonymous], 2012, TBI NUMBERS SEVERITY; [Anonymous], 2012, CONCUSSION MANAGEMEN; [Anonymous], 2009, VA DOD CLIN PRACTICE; [Anonymous], 2009, TRAUM BRAIN INJ CAR; [Anonymous], 2011, IND COND INTH POST N; [Anonymous], TBI CLIN TOOLS RES; Barth J, 2010, MIL NEUROPSYCHOL, V1, P135; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Brenner Lisa A, 2012, Front Neurol, V3, P31, DOI 10.3389/fneur.2012.00031; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Chu JJ, 2012, ANN BIOMED ENG, V40, P203, DOI 10.1007/s10439-011-0410-6; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DCoE Resources, DCOE RES; Defense and Veterans Brain Injury Center, 2011, DOD NUMB TRAUM BRAIN; Dempsey KE, 2009, J TRAUMA NURS, V16, P10; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DoD, 2007, ASS SECR DEF MEM TRA; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V6, P1; Dutton RP, 2002, J TRAUMA, V53, P857, DOI 10.1097/00005373-200211000-00009; DVBIC, 2012, MIL AC CONC EV MACE; Heltemes KJ, 2011, INJURY IN PRESS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Krainin Benjamin M, 2011, J Spec Oper Med, V11, P38; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Military Health System Conference, 2011, MIL HLTH SYST C; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shenton ME, 2012, BRAIN IMAGI IN PRESS; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; VA Healthcare, MILD TRAUM BRAIN INJ; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	52	24	24	0	7	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2012	177	8		S	SI		67	75		10.7205/MILMED-D-12-00110			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OB	WOS:000209027000010	22953443	Bronze			2022-02-06	
J	Plantman, S				Plantman, Stefan			Osteopontin is upregulated after mechanical brain injury and stimulates neurite growth from hippocampal neurons through beta 1 integrin and CD44	NEUROREPORT			English	Article						brain injury; cell cultures; central nervous system; extracellular matrix; neurite growth	DORSAL-ROOT GANGLION; SPINAL-CORD-INJURY; EXPRESSION; ADULT; OUTGROWTH; MICROGLIA; STROKE; TISSUE; CELLS; GENE	Brain trauma induces a multitude of reactions at molecular, cellular, and tissue levels, some of which are beneficial to recovery, whereas others are detrimental. Osteopontin (OPN), a glycosylated phosphoprotein, can be found in both the soluble form and as an extracellular matrix constituent in several tissues in the vertebrate body, but its function after brain injury is largely unknown. In this study, the expression of OPN after an experimental traumatic brain injury in rats was examined and its effects on hippocampal neurons and cortical astrocytes were studied using cell-culture techniques. OPN had no influence astrocyte behavior in a scratch assay. However, hippocampal neurons grew well on an OPN substrate with growth comparable to that seen on laminin, but showed a higher degree of primary neurites. Finally, growth on OPN was mediated through beta 1 intregrins and CD44. These findings indicate that injury-induced OPN may support neurite sprouting, suggesting a role for this molecule in recovery from central nervous system trauma. NeuroReport 23:647-652 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden		Plantman, S (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	stefan.plantman@ki.se		plantman, stefan/0000-0003-2236-4238	Swedish Brain Foundation (Hjarnfonden); Karolinska Institutet (KI fonder)	S.P. is supported by a grant from the Swedish Brain Foundation (Hjarnfonden). This study was financed by grants from Karolinska Institutet (KI fonder) to S.P.	Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Hashimoto M, 2003, J NEUROTRAUM, V20, P287, DOI 10.1089/089771503321532879; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hikita ST, 2003, MOL CELL NEUROSCI, V23, P427, DOI 10.1016/S1044-7431(03)00065-4; Hynds DL, 2004, GLIA, V46, P218, DOI 10.1002/glia.10353; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jander S, 2002, J NEUROSCI RES, V67, P156, DOI 10.1002/jnr.10099; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; Marsh BCL, 2007, NEUROREPORT, V18, P153, DOI 10.1097/WNR.0b013e328010d4fa; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Ries A, 2007, J NEUROCHEM, V103, P1491, DOI 10.1111/j.1471-4159.2007.04858.x; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Stylli SS, 2000, J CLIN NEUROSCI, V7, P137, DOI 10.1054/jocn.1999.0187; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Wang XK, 1998, J NEUROSCI, V18, P2075; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	25	24	24	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 1	2012	23	11					647	652		10.1097/WNR.0b013e328355380e			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972AQ	WOS:000306249300003	22692550				2022-02-06	
J	Bilotta, F; Rosa, G				Bilotta, Federico; Rosa, Giovanni			Glycemia management in critical care patients	WORLD JOURNAL OF DIABETES			English	Article						Glycemia management; Intensive insulin therapy; Hyperglycemia; Hypoglycemia; Metabolism; Intensive care		Over the last decade, the approach to clinical management of blood glucose concentration (BGC) in critical care patients has dramatically changed. In this editorial, the risks related to hypo, hyperglycemia and high BGC variability, optimal BGC target range and BGC monitoring devices for patients in the intensive care unit (ICU) will be discussed. Hypoglycemia has an increased risk of death, even after the occurrence of a single episode of mild hypoglycemia (BGC < 80 mg/dL), and it is also associated with an increase in the ICU length of stay, the major determinant of ICU costs. Hyperglycemia (with a threshold value of 180 mg/dL) is associated with an increased risk of death, longer length of stay and higher infective morbidity in ICU patients. In ICU patients, insulin infusion aimed at maintaining BGC within a 140-180 mg/dL target range (NICE-SUGAR protocol) is considered to be the state-of-the-art. Recent evidence suggests that a lower BGC target range (129-145 mg/dL) is safe and associated with lower mortality. In trauma patients without traumatic brain injury, tight BGC (target < 110 mg/dL) might be associated with lower mortality. Safe BGC targeting and estimation of optimal insulin dose titration should include an adequate nutrition protocol, the length of insulin infusion and the change in insulin sensitivity over time. Continuous glucose monitoring devices that provide accurate measurement can contribute to minimizing the risk of hypoglycemia and improve insulin titration. In conclusion, in ICU patients, safe and effective glycemia management is based on accurate glycemia monitoring and achievement of the optimal BGC target range by using insulin titration, along with an adequate nutritional protocol. (C) 2012 Baishideng. All rights reserved.	[Bilotta, Federico; Rosa, Giovanni] Sapienza Univ Rome, Sect Neuroanesthesia & Neurocrit Care, Dept Anesthesiol Crit Care & Pain Med, I-00199 Rome, Italy; [Bilotta, Federico] Albert Einstein Coll Med, Anesthesiol Clin, New York, NY 10461 USA		Bilotta, F (corresponding author), Sapienza Univ Rome, Dept Anesthesiol Crit Care & Pain Med, Via Acherusio 16, I-00199 Rome, Italy.	bilotta@tiscali.it					Al-Tarifi A, 2011, ANN THORAC MED, V6, P207, DOI 10.4103/1817-1737.84774; Arabi YM, 2009, CRIT CARE MED, V37, P2536, DOI 10.1097/CCM.0b013e3181a381ad; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bilotta F, 2009, ANESTHESIOLOGY, V111, P1160, DOI 10.1097/ALN.0b013e3181ba40c0; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Eriksson Evert A, 2011, J Emerg Trauma Shock, V4, P359, DOI 10.4103/0974-2700.83864; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Inzucchi SE, 2011, ANESTHESIOLOGY, V114, P18, DOI 10.1097/ALN.0b013e3181ff419e; King JT, 2011, ANN SURG, V253, P158, DOI 10.1097/SLA.0b013e3181f9bb3a; Klonoff David C, 2011, J Diabetes Sci Technol, V5, P755; Kovatchev BP, 1997, DIABETES CARE, V20, P1655, DOI 10.2337/diacare.20.11.1655; Krinsley J, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-49; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2006, CHEST, V129, P644, DOI 10.1378/chest.129.3.644; Kutcher ME, 2011, J TRAUMA, V71, P1108, DOI 10.1097/TA.0b013e318232e35b; Lundelin K, 2010, CRIT CARE MED, V38, P849, DOI 10.1097/CCM.0b013e3181ce49cf; Maerz LL, 2011, CURR OPIN CRIT CARE, V17, P370, DOI 10.1097/MCC.0b013e328348beb7; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Mowery NT, 2012, WORLD J SURG, V36, P270, DOI 10.1007/s00268-011-1356-4; Rice MJ, 2012, ANESTHESIOLOGY, V116, P199, DOI 10.1097/ALN.0b013e318236abf6; Rice MJ, 2010, ANESTH ANALG, V110, P1056, DOI 10.1213/ANE.0b013e3181cc07de; Schlussel AT, 2012, J SURG RES, V176, P202, DOI 10.1016/j.jss.2011.07.004; SIEBER FE, 1992, CRIT CARE MED, V20, P104, DOI 10.1097/00003246-199201000-00022; SIEGELAAR SE, 2010, CRIT CARE, V14; Skjaervold NK, 2011, ANESTHESIOLOGY, V114, P120, DOI 10.1097/ALN.0b013e3181ff4187; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0	31	24	27	1	3	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1948-9358			WORLD J DIABETES	World J. Diabetes	JUL 15	2012	3	7					130	134		10.4239/wjd.v3.i7.130			5	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	V4N6G	WOS:000219095700001	22816025	hybrid, Green Published			2022-02-06	
J	Kang, GH; Yan, BC; Cho, GS; Kim, WK; Lee, CH; Cho, JH; Kim, M; Kang, IJ; Won, MH; Lee, JC				Kang, Gu Hyun; Yan, Bing Chun; Cho, Geum-Sil; Kim, Won-Ki; Lee, Choong Hyun; Cho, Jun Hwi; Kim, Missok; Kang, Il-Jun; Won, Moo-Ho; Lee, Jae-Chul			Neuroprotective effect of fucoidin on lipopolysaccharide accelerated cerebral ischemic injury through inhibition of cytokine expression and neutrophil infiltration	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Sulfated polysaccharide; Corpus callosum; Neuroprotection; Cytokines/chemokines; Neutrophil recruitment	INFLAMMATORY CELL INFILTRATION; TRAUMATIC BRAIN-INJURY; POLYSACCHARIDE FUCOIDIN; LEUKOCYTE INFILTRATION; REPERFUSION INJURY; BLOOD-FLOW; IN-VIVO; PNEUMOCOCCAL MENINGITIS; CEREBROSPINAL-FLUID; ARTERY OCCLUSION	In our previous study, we reported that lipopolysaccharide (LPS) activated microglia and accelerated cerebral ischemic injury in the rat brain through the overexpression of cytokines in microglia. In the present study, we investigated the effect of the intraperitoneal administration of fucoidin, a potent inhibitor of leukocyte rolling and anti-inflammatory agent, against accelerated cerebral ischemic injury by LPS pretreatment using rats. We found that fucoidin treatment inhibited the expressions of some brain cytokine or chemokine mRNA such as IL-8, TNF-alpha and iNOS in the brain of the rats treated only with LPS. We also observed that fucoidin treatment dramatically decreased the infarct size in accelerated cerebral ischemic injury induced by LPS treatment at an early time after ischemic injury. In addition, the immunoreactivity of myleoperoxidase (MPO), a marker for quantifying neutrophil accumulation, was distinctively decreased in the ischemic brain of the fucoidin-treated rat. In brief, our results indicate that fucoidin showed a neuroprotective effect on LPS accelerated cerebral ischemic injury through inhibiting the expression of some cytokine/chemokine and neutrophil recruitments. (C) 2012 Elsevier B.V. All rights reserved.	[Yan, Bing Chun; Won, Moo-Ho] Kangwon Natl Univ, Dept Neurobiol, Sch Med, Chunchon 200701, South Korea; [Kang, Gu Hyun] Hallym Univ, Dept Emergency Med, Kangnam Sacred Heart Hosp, Coll Med, Seoul 150950, South Korea; [Yan, Bing Chun; Won, Moo-Ho] Kangwon Natl Univ, Inst Med Sci, Sch Med, Chunchon 200701, South Korea; [Cho, Geum-Sil; Kim, Won-Ki] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea; [Lee, Choong Hyun] Dankook Univ, Dept Anat & Physiol, Coll Pharm, Cheonan 330714, South Korea; [Cho, Jun Hwi] Kangwon Natl Univ, Dept Emergency Med, Kangwon Natl Univ Hosp, Sch Med, Chunchon 200701, South Korea; [Cho, Jun Hwi] Kangwon Natl Univ, Inst Med Sci, Kangwon Natl Univ Hosp, Sch Med, Chunchon 200701, South Korea; [Kim, Missok] Dankook Univ, Dept Food Sci & Nutr, Yongin 448701, South Korea; [Kang, Il-Jun] Hallym Univ, Dept Food Sci & Nutr, Chunchon 200702, South Korea; [Lee, Jae-Chul] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 110744, South Korea		Won, MH (corresponding author), Kangwon Natl Univ, Dept Neurobiol, Sch Med, Chunchon 200701, South Korea.	mhwon@kangwon.ac.kr; anajclee@hanmail.net			Brain Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [2010K000823]; Ministry of Education, Science and Technology, the Republic of KoreaMinistry of Education, Science and Technology, Republic of Korea; National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2011-0007307]	This work was supported by a grant (2010K000823) from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, the Republic of Korea, and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0007307).	Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Antonicelli F, 2004, AM J PHYSIOL-LUNG C, V286, pL1319, DOI 10.1152/ajplung.00329.2003; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; BELAYEV L, 1996, STROKE, V27, P1623; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chi OZ, 2011, J NEUROL SCI, V301, P66, DOI 10.1016/j.jns.2010.10.024; Danielisova V, 2007, J NEUROL SCI, V253, P61, DOI 10.1016/j.jns.2006.12.001; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Davies CA, 1998, EXP NEUROL, V154, P199, DOI 10.1006/exnr.1998.6891; De Lema GP, 2001, J AM SOC NEPHROL, V12, P1369, DOI 10.1681/ASN.V1271369; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Durmaz R, 2008, NEUROSCIENCES, V13, P217; Emerich DF, 2002, EXP NEUROL, V173, P168, DOI 10.1006/exnr.2001.7835; Granert C, 1998, CLIN DIAGN LAB IMMUN, V5, P322, DOI 10.1128/CDLI.5.3.322-324.1998; Granert C, 1999, INFECT IMMUN, V67, P2071, DOI 10.1128/IAI.67.5.2071-2074.1999; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Haqqani AS, 2000, NEOPLASIA, V2, P561, DOI 10.1038/sj.neo.7900110; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; KOCHANEK PM, 1987, STROKE, V18, P634, DOI 10.1161/01.STR.18.3.634; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Mirabelli-Badenier M, 2011, THROMB HAEMOSTASIS, V105, P409, DOI 10.1160/TH10-10-0662; Omata M, 1997, J CARDIOVASC PHARM, V30, P717, DOI 10.1097/00005344-199712000-00003; Pochechueva TV, 2003, BIOORG MED CHEM LETT, V13, P1709, DOI 10.1016/S0960-894X(03)00234-8; Raza SS, 2011, J NEUROL SCI, V309, P45, DOI 10.1016/j.jns.2011.07.035; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Samson Y, 2005, REV NEUROL-FRANCE, V161, P1177; Shimaoka M, 1996, AM J RESP CRIT CARE, V153, P307, DOI 10.1164/ajrccm.153.1.8542135; Spencer SJ, 2007, STROKE, V38, P1570, DOI 10.1161/STROKEAHA.106.476507; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; Teixeira MM, 1997, BRIT J PHARMACOL, V120, P1059, DOI 10.1038/sj.bjp.0701024; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236; Wang YP, 2008, J NEUROL SCI, V267, P107, DOI 10.1016/j.jns.2007.10.004; Weston RM, 2007, J CEREBR BLOOD F MET, V27, P100, DOI 10.1038/sj.jcbfm.9600324; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	40	24	27	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	JUL 15	2012	318	1-2					25	30		10.1016/j.jns.2012.04.013			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	964BK	WOS:000305668500003	22560605				2022-02-06	
J	Carthew, HL; Ziebell, JM; Vink, R				Carthew, H. L.; Ziebell, J. M.; Vink, R.			SUBSTANCE P-INDUCED CHANGES IN CELL GENESIS FOLLOWING DIFFUSE TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						traumatic brain injury; substance P; neurogenesis; microglia; hippocampus; subventricular zone	FOCAL CEREBRAL-ISCHEMIA; ADULT MAMMALIAN BRAIN; HIPPOCAMPAL NEUROGENESIS; NEURAL PROGENITOR; MURINE MICROGLIA; STEM-CELLS; RATS; PATHOPHYSIOLOGY; PROLIFERATION; INFLAMMATION	Inhibition of substance P (SP) activity through the use of NK1 receptor antagonists has been shown to be a promising neuroprotective therapy following traumatic brain injury (TBI). Conversely, recent research has implicated SP in the stimulation of neurogenesis, suggesting that the neuropeptide has the potential to promote recovery following TBI. This study characterised the effects of SP and the NK1 antagonist, n-acetyl tryptophan (NAT), on cell proliferation following diffuse TBI. Adult male Sprague-Dawley rats were injured using the impact acceleration model of TBI and randomly assigned to one of five treatment groups: sham, vehicle control, NAT alone, SP alone or SP with NAT. Cellular proliferation was assessed with immunostaining for bromodeoxyuridine (BrdU) and cell-specific markers. Infusion of SP (+/- NAT) promoted cellular proliferation in the subventricular zone and dentate gyrus following TBI. This increase was largely associated with microglial proliferation and did not correspond with functional improvements. These results suggest that NAT treatment results in neuro-protection following TBI, mediated in part via inhibition of microglia. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Carthew, H. L.; Ziebell, J. M.; Vink, R.] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5000, Australia		Vink, R (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5000, Australia.	Robert.Vink@adelaide.edu.au	Ziebell, Jenna/Y-4496-2019; Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ziebell, Jenna/0000-0003-2497-4347	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Neurosurgical Research Foundation (Australia)	Supported, in part, by the National Health and Medical Research Council of Australia and the Neurosurgical Research Foundation (Australia).	Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; Bye N, 2009, INJURY, V40, pS6; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; DEFELIPE C, 1995, SCIENCE, V267, P899, DOI 10.1126/science.7531367; Delgado AV, 2005, EXP BIOL MED, V230, P271; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Lai Xi-nan, 2003, Zhonghua Yi Xue Za Zhi, V83, P1433; LAURENZI MA, 1990, SCAND J IMMUNOL, V31, P529, DOI 10.1111/j.1365-3083.1990.tb02801.x; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Maeda K, 1997, GERONTOLOGY, V43, P11; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Ng SY, 2012, J NEUROTRAUMA; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Rasley A, 2002, GLIA, V37, P258, DOI 10.1002/glia.10034; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2009, J NEUROSURG; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sun HB, 2010, CHIN J TRAUMATOL, V13, P46, DOI 10.3760/cma.j.issn.1008-1275.2010.01.009; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	37	24	25	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUL 12	2012	214						78	83		10.1016/j.neuroscience.2012.04.028			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	962LV	WOS:000305547500008	22531375				2022-02-06	
J	Radford, K; Lah, S; Thayer, Z; Say, MJ; Miller, LA				Radford, Kylie; Lah, Suncica; Thayer, Zoe; Say, Miranda J.; Miller, Laurie A.			Improving Memory in Outpatients with Neurological Disorders Using a Group-Based Training Program	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Prospective memory; Rehabilitation; Brain lesions; Stroke; Epilepsy; Neuropsychological outcome	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; EVERYDAY MEMORY; SELF-AWARENESS; STRESS SCALES; ADULTS; EPILEPSY; AIDS; REMEDIATION; RELIABILITY	Memory problems are common in patients with a range of neurological conditions, but there have been few attempts to provide and evaluate the usefulness of memory training for groups of neurological outpatients. We used a waitlist-controlled trial design to assess the effectiveness of a newly created, 6-session intervention, which involved training in the use of compensatory strategies as well as education regarding memory function, neurological damage, sleep and lifestyle factors that have an impact on memory. Fifty-six patients with neurological conditions (e.g., stroke, epilepsy) and memory complaints completed the training and assessments. Outcomes were evaluated in terms of reported strategy use as well as objective and subjective measures of anterograde and prospective memory. Training resulted in significant improvements on number of strategies used, scores on the Rey Auditory Verbal Learning Test (total learning and delayed recall) and self-report on the Comprehensive Assessment of Prospective Memory. Improvements were stable at 3-month follow-up. Better individual outcomes were related to lower baseline memory scores, fewer symptoms of depression and greater self-awareness of memory function. Overall the study provides encouraging results to indicate that patients with neurological conditions such as stroke and epilepsy can show improvements in memory after a relatively short group-based intervention. (JINS, 2012, 18, 738-748)	[Thayer, Zoe; Miller, Laurie A.] Royal Prince Alfred Hosp, Neuropsychol Unit, Camperdown, NSW 2050, Australia; [Radford, Kylie; Lah, Suncica; Miller, Laurie A.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Say, Miranda J.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Miller, LA (corresponding author), Royal Prince Alfred Hosp, Neuropsychol Unit, Camperdown, NSW 2050, Australia.	laurie.miller@sydney.edu.au	; Radford, Kylie/D-5338-2011	Lah, Suncica/0000-0003-2282-4812; Miller, Laurie/0000-0001-6329-2969; Radford, Kylie/0000-0001-8095-5314; Thayer, Zoe/0000-0003-3801-9236			Andrewes DG, 1996, EXP AGING RES, V22, P305, DOI 10.1080/03610739608254013; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craik FIM, 2007, J INT NEUROPSYCH SOC, V13, P132, DOI 10.1017/S1355617707070166; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Evans S., 2004, MINIM ALLOCATION MIN; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Furst C., 1986, COGNITIVE REHABILITA, V4, P24; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; Hampstead BM, 2008, J INT NEUROPSYCH SOC, V14, P883, DOI 10.1017/S1355617708081009; Helmstaedter C, 2008, EPILEPSY BEHAV, V12, P402, DOI 10.1016/j.yebeh.2007.11.010; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Howell D.C., 2007, STAT METHODS PSYCHOL; INTONSPETERSON MJ, 1986, J EXP PSYCHOL GEN, V115, P267, DOI 10.1037/0096-3445.115.3.267; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jennett S M, 1991, Int Disabil Stud, V13, P83; KAPUR N, 1983, BRIT J PSYCHOL, V74, P409, DOI 10.1111/j.2044-8295.1983.tb01872.x; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; MATEER CA, 1988, NEUROPSYCHOLOGICAL S; Nair RD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub2; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Radford K., 2010, MAKING MOST YOUR MEM; Radford K, 2011, EPILEPSY BEHAV, V22, P272, DOI 10.1016/j.yebeh.2011.06.021; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rey A, 1958, LEXAMEN CLINIQUE PSY; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Tabachnick B.G., 2001, USING MULTIVARIATE S; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; THOMPSON PJ, 1992, EPILEPSIA, V33, pS18; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1992, CLIN MANAGEMENT MEMO; [No title captured]	52	24	24	1	26	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2012	18	4					738	748		10.1017/S1355617712000379			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	978BN	WOS:000306714600012	22594962				2022-02-06	
J	Schober, ME; Ke, XR; Xing, BH; Block, BP; Requena, DF; McKnight, R; Lane, RH				Schober, Michelle E.; Ke, Xingrao; Xing, Bohan; Block, Benjamin P.; Requena, Daniela F.; McKnight, Robert; Lane, Robert H.			Traumatic Brain Injury Increased IGF-1B mRNA and Altered IGF-1 Exon 5 and Promoter Region Epigenetic Characteristics in the Rat Pup Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; developmental; epigenetics; neuroprotective; rat	GROWTH-FACTOR-I; HISTONE H3 ACETYLATION; (IGF)-I E-PEPTIDES; METHYLATION; EXPRESSION; IMPROVES; MODEL; TERM; MGF; INFLAMMATION	Traumatic brain injury (TBI) is a major cause of acquired cognitive disability in childhood. Such disability may be blunted by enhancing the brain's endogenous neuroprotective response. An important endogenous neuroprotective response is the insulin-like growth factor-1 (IGF-1) mRNA variant, IGF-1B. IGF-1B mRNA, characterized by exon 5 inclusion, encodes the IGF-1 and Eb peptides. IGF-1A mRNA excludes exon 5 and encodes the IGF-1 and Ea peptides. A region in the human IGF-1B homologue acts as an exon-splicing enhancer (ESE) to increase IGF-1B mRNA. It is not known if TBI is associated with increased brain IGF-1B mRNA. Epigenetic modifications may underlie altered gene expression in the brain after TBI. We hypothesized that TBI would increase hippocampal IGF-1B mRNA in 17-day-old rats, associated with DNA methylation and/or histone modifications at the promoter site 1 (P1) or exon 5/ESE region. Hippocampi from rat pups after controlled cortical impact (CCI) were used to measure IGF-1B mRNA, DNA methylation, and histone modifications at the P1, P2, and exon5/ESE regions. In CCI hippocampi, IGF-1B mRNA peaked at post-injury day (PID) 2 (1700 +/- 320% sham), but normalized by PID 14. IGF-1A peaked at PID 3 (280 +/- 52% sham), and remained elevated at PID 14. Increased IGF-1B mRNA was associated with increased methylation at P1, and increased histone modifications associated with gene activation at P2 and exon5/ESE, together with differential methylation in the exon 5/ESE regions. We report for the first time that hippocampal IGF-1B mRNA increased after developmental TBI. We speculate that epigenetic modifications at the P2 and exon 5/ESE regions are important in the regulation of IGF-1B mRNA expression. The exon 5/ESE region may present a means for future therapies to target IGF-1B transcription after TBI.	[Schober, Michelle E.] Univ Utah, Sch Med, Div Crit Care, Dept Pediat, Salt Lake City, UT 84158 USA; [Ke, Xingrao; Xing, Bohan; Block, Benjamin P.; Requena, Daniela F.; McKnight, Robert; Lane, Robert H.] Univ Utah, Sch Med, Div Neonatol, Salt Lake City, UT 84158 USA		Schober, ME (corresponding author), Univ Utah, Sch Med, Div Crit Care, Dept Pediat, POB 581289, Salt Lake City, UT 84158 USA.	michelle.schober@hsc.utah.edu					Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Adelson PD, 1998, ACT NEUR S, V71, P104; Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094; Aperghis M, 2004, BRAIN RES, V1009, P213, DOI 10.1016/j.brainres.2004.02.049; Armakolas A, 2010, PROSTATE, V70, P1233, DOI 10.1002/pros.21158; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Beresewicz M, 2010, INT J DEV NEUROSCI, V28, P91, DOI 10.1016/j.ijdevneu.2009.09.002; Cai Z, 2011, NEUROSCIENCE, V194, P195, DOI 10.1016/j.neuroscience.2011.08.003; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gorecki DC, 2007, NEUROCHEM INT, V51, P451, DOI 10.1016/j.neuint.2007.04.030; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Li R.C., 2011, NEUROSCIENCE; Li XS, 1998, MOL BRAIN RES, V57, P92, DOI 10.1016/S0169-328X(98)00075-8; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Lin SY, 2005, BRAIN RES, V1063, P15, DOI 10.1016/j.brainres.2005.09.042; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Molfese DL, 2011, DEV NEUROPSYCHOL, V36, P810, DOI 10.1080/87565641.2011.606395; Musaro A, 2007, EXP GERONTOL, V42, P76, DOI 10.1016/j.exger.2006.05.004; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Pfeffer LA, 2009, MOL BIOL CELL, V20, P3810, DOI 10.1091/mbc.E08-12-1202; Pilch B, 2001, CANCER RES, V61, P6876; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1316, DOI 10.1001/archneurol.2010.275; Riddoch-Contreras J, 2009, EXP NEUROL, V215, P281, DOI 10.1016/j.expneurol.2008.10.014; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; ROTWEIN P, 1993, MOL REPROD DEV, V35, P358, DOI 10.1002/mrd.1080350407; ROTWEIN P, 1986, P NATL ACAD SCI USA, V83, P77, DOI 10.1073/pnas.83.1.77; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith PJ, 2002, ENDOCRINOLOGY, V143, P146, DOI 10.1210/en.143.1.146; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Yan YP, 2006, EUR J NEUROSCI, V24, P45, DOI 10.1111/j.1460-9568.2006.04872.x; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	59	24	24	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2075	2085		10.1089/neu.2011.2276			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800008	22413999				2022-02-06	
J	Garcia-Molina, A; Tormos, JM; Bernabeu, M; Junque, C; Roig-Rovira, T				Garcia-Molina, A.; Tormos, J. M.; Bernabeu, M.; Junque, C.; Roig-Rovira, T.			Do traditional executive measures tell us anything about daily-life functioning after traumatic brain injury in Spanish-speaking individuals?	BRAIN INJURY			English	Article						Traumatic brain injury; executive functioning; activities of daily living	ECOLOGICAL VALIDITY; SELF-AWARENESS; PSYCHOSOCIAL ADJUSTMENT; INSTRUMENTAL ACTIVITIES; NEUROPSYCHOLOGICAL TESTS; DYSEXECUTIVE SYNDROME; ALZHEIMERS-DISEASE; PERFORMANCE; COMPETENCE; PREDICTORS	Primary objective: To examine the relationship between traditional executive function measures and everyday competence in Spanish-speaking individuals with moderate-to-severe traumatic brain injury (TBI). Methods and procedures: Thirty-two TBI patients (24 men, eight women) with an age range of 17-59 years (mean age = 30.73 years; SD = 13.34) were administered a battery of performance-based executive function measures. Such measures included the Trail Making Test part B, Wisconsin Card Sorting Test, Stroop Colour Word Interference Test, Controlled Oral Word Association Test and Letter-Number Sequencing. Behavioural manifestations of executive deficits were assessed by the Behaviour Rating Inventory of Executive Function-Adult version (BRIEF-A). Patient's everyday functioning was examined with the Patient Competency Rating Scale (PCRS). Main outcomes and results: Traditional performance-based executive measures correlated significantly, although moderately, with the PCRS; this relationship was more significant in the Controlled Oral Word Association Test and Trail Making Test part B. A significant correlation was obtained between the BRIEF-A clinical scales and patient's everyday competence as measured by the PCRS. Conclusions: The current findings suggest that traditional performance-based executive measures reveal some degree of ecological validity or real-world relevance, providing relevant information for predicting everyday competence after moderate-to-severe TBI.	[Garcia-Molina, A.; Tormos, J. M.; Bernabeu, M.; Roig-Rovira, T.] Inst Univ Neurorehabil Guttmann UAB, Badalona 08916, Spain; [Junque, C.] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain		Garcia-Molina, A (corresponding author), Inst Univ Neurorehabil Guttmann UAB, C Cami de Can Ruti S-N, Badalona 08916, Spain.	agarciam@guttmann.com	Junque, Carme/B-4400-2011	Junque, Carme/0000-0002-6381-3063; Tormos Munoz, Jose Maria/0000-0002-8764-2289			Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Artiola i Fortuny L, 1999, MANUAL NORMAS PROCED; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benge JF, 2007, BRAIN INJURY, V21, P395, DOI 10.1080/02699050701311091; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Garcia-Molina A, 2007, ANALES PSIQUIATRIA, V23, P217; Golden C.J., 1994, STROOP TEST COLORES; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2002, AM J OCCUP THER, V56, P509, DOI 10.5014/ajot.56.5.509; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton RK, 1997, W TEST CLASIFICACION; INE, 2001, ENC DISC DEF EST SAL; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McClure MM, 2007, SCHIZOPHR RES, V89, P330, DOI 10.1016/j.schres.2006.07.024; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Millis S R, 1994, Int J Neurosci, V79, P165; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Perez C, 2010, LESIONES MEDULARES T; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, ACT NEUR S, V93, P39; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Roth RM, 2005, BRIEF A BEHAV RATING; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Tirapu J, 1997, ANALES SISTEMA SANIT, V20, P101; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wechsler D., 1999, ESCALA INTELIGENCIA; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wolfson, 1993, HALSTEAD REITAN NEUR; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014	65	24	24	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2012	26	6					864	874		10.3109/02699052.2012.655362			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500008	22583177				2022-02-06	
J	Prisco, L; Iscra, F; Ganau, M; Berlot, G				Prisco, L.; Iscra, F.; Ganau, M.; Berlot, G.			Early predictive factors on mortality in head injured patients: a retrospective analysis of 112 traumatic brain injured patients	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Hyperglycemia; Hospital mortality	GLASGOW COMA SCALE; HYPERGLYCEMIA; HYPOXIA; PRESSURE; SCORE; AGE	Aim. Early hyperglycemia is a feature of traumatic brain injured (TBI patients. The aim of our study was to analyze the impact of early hyperglycemia on in-ICU mortality in isolated TBI and its correlations with other factors responsible for secondary injury. Methods. We studied admission values (AV) and worse values in the first 48 hours (WV 48 h) of 112 ICU TBI patients (mortality 29.6%) of blood glucose (BG), base excess (BE), mean arterial pressure (MAP), PaO2/FiO(2) ratio and serum hemoglobin (Hb). Predictive strength as the area under the receiver operating curves (AUROC) and correlation between all variables were calculated. Results. Data are expressed as median, 1st-3rd quartile. Both BG AV (147.5, 126-182 mg/dL; AUROC 0.716, P=0.0002) and WV 48 h (156.5, 132-192 mg/dL; AUROC 0.721, P=0.0001) are predictive of mortality. AV and WV 48 h are respectively: PaO2/FiO(2) (366.8, 237.2-477.6 vs. 320,214.4.426; P=0.05), MAP (90,80-100.5 vs. 75,66-83 mmHg; P<0.0001) and Hb (11.4,9.7-13.1 vs. 10.6,9-12.2 g/dL; P<0.02). BG AV and WV 48 h correlates with: age (r=0.419, P<0.0001 and r=0.489, P<0.0001), PaO2/FiO(2) AV (r -0.223, P<0.03 and r -0.236, P<0.02), PaO2/FiO(2) WV 48 h (r -0.215, P<0.03 and r -0.279, P<0.005) and MAP WV 48 h (r -0.216, P<0.03 and r -0.261, P<0.007). Conclusion. Early hyperglycemia is a major predictor of mortality and correlates with other factors responsible for secondary injury. Early hyperglycemia seems to be a marker of inflammatory reaction responsible for early cardiovascular and respiratory impairment.	[Prisco, L.; Iscra, F.; Berlot, G.] Univ Mista, Dept Perioperat Med Intens Care & Emergency, Osped Rimini Trieste, Aziendct Osped,Cattinara Hosp, Trieste, Italy; [Ganau, M.] Univ Trieste, Grad Sch Nanotechnol, Trieste, Italy		Prisco, L (corresponding author), Via San Francesco 12, I-34133 Trieste, Italy.	sisifo31@hotmail.com	Prisco, Lara/I-9267-2019; Ganau, Mario/AAY-7233-2020; Prisco, Lara/X-9310-2018	Prisco, Lara/0000-0001-6727-7870; Ganau, Mario/0000-0002-8676-1147; BERLOT, GIORGIO/0000-0002-9231-8555			Akopian G, 2007, AM SURGEON, V73, P447; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Donnelly M, 2007, J TRAUMA, V63, P351, DOI 10.1097/01.ta.0000251599.80602.d1; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee EJ, 2001, J NEUROL SCI, V190, P3, DOI 10.1016/S0022-510X(01)00567-6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; TOUHO H, 1989, NEUROSURGERY, V25, P762, DOI 10.1227/00006123-198911000-00011; Turina M, 2006, CRIT CARE MED, V34, pS291, DOI 10.1097/01.ccm.0000231887.84751.04; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Winn HR, 2004, YOUMANS NEUROLOGICAL, V5; WRAY NP, 1978, AM REV RESPIR DIS, V118, P783, DOI 10.1164/arrd.1978.118.4.783; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	28	24	26	0	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	JUN	2012	56	2					131	136					6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	970SO	WOS:000306152800006	22617175				2022-02-06	
J	Riganello, F; Dolce, G; Sannita, WG				Riganello, Francesco; Dolce, Giuliano; Sannita, Walter G.			HEART RATE VARIABILITY AND THE CENTRAL AUTONOMIC NETWORK IN SEVERE DISORDER OF CONSCIOUSNESS	JOURNAL OF REHABILITATION MEDICINE			English	Article; Proceedings Paper	Workshop on Consciousness and the Vegetative State - Today/2nd Conference on Consciousness and Coma	JUL 06, 2010	Salerno, ITALY			disorder of consciousness; brain injury; heart rate variability; HRV; vegetative state; minimally conscious state; central autonomic network	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; NEUROVISCERAL INTEGRATION; ORGAN DYSFUNCTION; ARTIFICIAL-INTELLIGENCE; CINGULATE CORTEX; NEURAL-CONTROL; VAGAL TONE; OWN NAME; DYSAUTONOMIA	Objective: To review the applicability of heart rate variability measures in research on severe disorder of consciousness. Methods: The available evidence on the correlation between heart rate variability measures and the outcome or residual functional state/responsiveness of severely brain-injured patients (including those in vegetative or minimally conscious states) are reviewed and discussed with reference to the central autonomic network model. Results and conclusion: Heart rate variability analyses appear to be applicable to assess residual or emerging (higher level) function in brain-injured patients with disordered consciousness and to predict outcome. In this regard, the central autonomic network model is heuristic in the understanding of heart rate variability descriptors of the central nervous system/autonomic systems relationship.	[Riganello, Francesco; Dolce, Giuliano] S Anna Inst, Crotone, Italy; [Sannita, Walter G.] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Sannita, Walter G.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Riganello, Francesco; Dolce, Giuliano] RAN, Crotone, Italy		Dolce, G (corresponding author), S Anna Inst, Crotone, Italy.	giulianodolce@libero.it	Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020	Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252			Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Benarroch E.E., 2007, CONTIN LIFELONG LEAR, V13, P13, DOI [10.1212/01.CON.0000299964.20642.9a, DOI 10.1212/01.CON.0000299964.20642.9A]; Benarroch EE., 1997, CENTRAL AUTONOMIC NE, P29; BERNE C, 1992, DIABETOLOGIA, V35, P873, DOI 10.1007/BF00399935; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Camm AJ, 1996, CIRCULATION, V93, P1043; Candelieri A, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P138; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Cooke WH, 2006, AVIAT SPACE ENVIR MD, V77, P1107; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; De Jong Marla J, 2005, J Cardiovasc Nurs, V20, P186; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Dolce G, 2008, J PSYCHOPHYSIOL, V22, P150, DOI 10.1027/0269-8803.22.3.150; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ESLER M, 1993, PHARMACOL TOXICOL, V73, P243, DOI 10.1111/j.1600-0773.1993.tb00579.x; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Garan H, 2009, CARDIOLOGY, V114, P273, DOI 10.1159/000235567; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Hui-Min W, 2010, CIRC SYST ISCAS P 20; JENNETT B, 1972, LANCET, V1, P734; Kawahara E, 2003, CIRC J, V67, P753; Kemp CD, 2008, AM SURGEON, V74, P866; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; King ML, 1997, BRAIN INJURY, V11, P445; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leisman G., 2010, INT J DISABIL HUM DE, V9, P357, DOI [DOI 10.1515/IJDHD.2010.041, 10.1515/IJDHD.2010.041]; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Levy MN, 1997, BAILLIERE CLIN NEUR, V6, P227; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; LOWENSOHN RI, 1977, LANCET, V1, P626; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Machado C, 2011, CLIN NEUROPHYSIOL, V122, P1059, DOI 10.1016/j.clinph.2010.08.022; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; Mashin V., 2000, HUMAN PHYSL, V26, P420, DOI DOI 10.1007/BF02760270; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Mowery NT, 2008, J TRAUMA, V65, P621, DOI 10.1097/TA.0b013e3181837980; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Papaioannou VE, 2006, J CRIT CARE, V21, P95, DOI 10.1016/j.jcrc.2005.12.007; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Riganelllo F, 2010, HEALTH 2010 P 3 INT; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Riganello F, 2008, J PSYCHOPHYSIOL, V22, P166, DOI 10.1027/0269-8803.22.4.166; Riganello F, 2011, CLIN NEUROPHYSIOL, V122, P1061, DOI 10.1016/j.clinph.2010.09.006; Riganello F, 2009, J PSYCHOPHYSIOL, V23, P18, DOI 10.1027/0269-8803.23.1.18; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Riordan WP, 2009, J SURG RES, V156, P283, DOI 10.1016/j.jss.2009.03.086; Ryan ML, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/416590; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF., 2004, CRITICAL PERSPECTIVE; Thayer JF., 2007, PSYCHOL TOPICS, V16, P241, DOI DOI 10.1016/J.IJCARD.2012.02.004; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Toni R, 2004, J Endocrinol Invest, V27, P35; Valkonen-Korhonen M, 2003, PSYCHOPHYSIOLOGY, V40, P716, DOI 10.1111/1469-8986.00072; Van Leeuwen P., 2000, HERZSCHRITTMACHERTHE, V11, P127, DOI [10.1007/s003990070031, DOI 10.1007/S003990070031]; Vanhaudenhuyse A, 2008, NEUROLOGY, V71, P1374, DOI 10.1212/01.wnl.0000320110.70134.60; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	94	24	25	0	9	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2012	44	6			SI		495	501		10.2340/16501977-0975			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	956TW	WOS:000305113000004	22660999	Green Submitted, gold			2022-02-06	
J	Rohlwink, UK; Zwane, E; Fieggen, AG; Argent, AC; le Roux, PD; Figaji, AA				Rohlwink, Ursula K.; Zwane, Eugene; Fieggen, A. Graham; Argent, Andrew C.; le Roux, Peter D.; Figaji, Anthony A.			The Relationship Between Intracranial Pressure and Brain Oxygenation in Children With Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Brain oxygenation; Children; Head injury; Intracranial monitoring; Intracranial pressure; Traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; TISSUE OXYGEN; DECOMPRESSIVE CRANIECTOMY; PERFUSION-PRESSURE; NEUROCRITICAL CARE; DIFFUSION; TENSION; MICRODIALYSIS; SATURATION	BACKGROUND: Intracranial pressure (ICP) monitoring is a cornerstone of care for severe traumatic brain injury (TBI). Management of ICP can help ensure adequate cerebral blood flow and oxygenation. However, studies indicate that brain hypoxia may occur despite normal ICP and the relationship between ICP and brain oxygenation is poorly defined. This is particularly important for children in whom less is known about intracranial dynamics. OBJECTIVE: To examine the relationship between ICP and partial pressure of brain tissue oxygen (PbtO2) in children with severe TBI (Glasgow Coma Scale score <= 8) admitted to Red Cross War Memorial Children's Hospital, Cape Town. METHODS: The relationship between time-linked hourly and high-frequency ICP and PbtO2 data was examined using correlation, regression, and generalized estimating equations. Thresholds for ICP were examined against reduced PbtO2 using age bands and receiver-operating characteristic curves. RESULTS: Analysis using more than 8300 hourly (n = 75) and 1 million high-frequency data points (n = 30) demonstrated a weak relationship between ICP and PbtO2 (r = 0.05 and r = 0.04, respectively). No critical ICP threshold for low PbtO2 was identified. Individual patients revealed a strong relationship between ICP and PbtO2 at specific times, but different relationships were evident over longer periods. CONCLUSION: The relationship between ICP and PbtO2 appears complex, and several factors likely influence both variables separately and in combination. Although very high ICP is associated with reduced PbtO2, in general, absolute ICP has a poor relationship with PbtO2. Because reduced PbtO2 is independently associated with poor outcome, a better understanding of ICP and PbtO2 management in pediatric TBI seems to be needed.	[Rohlwink, Ursula K.; Fieggen, A. Graham; Figaji, Anthony A.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, Div Neurosurg, ZA-7925 Cape Town, South Africa; [Zwane, Eugene] Univ Swaziland, Dept Biostat, Kwaluseni, Swaziland; [Argent, Andrew C.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Div Pediat Crit Care, ZA-7925 Cape Town, South Africa; [le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Figaji, AA (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, Div Neurosurg, ICH Bldg,Room 617,Klipfontein Rd, ZA-7925 Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Fieggen, Anthony Graham/AAT-6510-2021; Argent, Andrew/J-1605-2019; Rohlwink, Ursula/AAE-2513-2020; Rohlwink, Ursula Karin/U-8917-2019	Fieggen, Anthony Graham/0000-0001-6541-8377; Argent, Andrew/0000-0001-9333-2036; Rohlwink, Ursula Karin/0000-0002-4469-4935; Figaji, Anthony/0000-0002-3357-6490	Integra Foundation; Integra; National Research Foundation; Wellcome TrustWellcome TrustEuropean Commission	Drs Figaji and le Roux have received funding from the Integra Foundation for the study of cerebral perfusion pressure in children in 2006. Dr le Roux also received research support from Integra and is a consultant for Codman and a member of Edge Therapeutics Scientific Advisory Board. Dr Figaji received honoraria for speaking engagements from Codman and Integra Neurosciences and funding from the National Research Foundation. Ms. Rohlwink receives funding from the Wellcome Trust. The other authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Carney NA, 2003, PEDIATR CRIT CARE ME, V4, P1; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chang TP, 2010, J TRAUMA, V68, P1401, DOI 10.1097/TA.0b013e3181bb9a87; Charalambides C, 2010, CHILD NERV SYST, V26, P215, DOI 10.1007/s00381-009-1031-3; Chesnut R M, 1995, New Horiz, V3, P366; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Huchzermeyer C, 2008, J NEUROSCI, V28, P1153, DOI 10.1523/JNEUROSCI.4105-07.2008; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	24	24	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2012	70	5					1220	1230		10.1227/NEU.0b013e318243fc59			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933VA	WOS:000303390400046	22134142				2022-02-06	
J	Drabek, T; Janata, A; Jackson, EK; End, B; Stezoski, J; Vagni, VA; Janesko-Feldman, K; Wilson, CD; van Rooijen, N; Tisherman, SA; Kochanek, PM				Drabek, Tomas; Janata, Andreas; Jackson, Edwin K.; End, Brad; Stezoski, Jason; Vagni, Vincent A.; Janesko-Feldman, Keri; Wilson, Caleb D.; van Rooijen, Nico; Tisherman, Samuel A.; Kochanek, Patrick M.			Microglial depletion using intrahippocampal injection of liposome-encapsulated clodronate in prolonged hypothermic cardiac arrest in rats	RESUSCITATION			English	Article						Inflammation; Iba-1; Cardiac arrest; Brain ischemia; Resuscitation; Emergency preservation; Hypothermia	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MINOCYCLINE TREATMENT; NEUROLOGICAL DYSFUNCTION; NEURONAL DEATH; TISSUE-DAMAGE; MACROPHAGES; CELLS; MECHANISM; BINDING	Trauma patients who suffer cardiac arrest (CA) from exsanguination rarely survive. Emergency preservation and resuscitation using hypothermia was developed to buy time for resuscitative surgery and delayed resuscitation with cardiopulmonary bypass (CPB), but intact survival is limited by neuronal death associated with microglial proliferation and activation. Pharmacological modulation of microglia may improve outcome following CA. Systemic injection of liposome-encapsulated clodronate (LEC) depletes macrophages. To test the hypothesis that intrahippocampal injection of LEC would attenuate local microglial proliferation after CA in rats, we administered LEC or PBS into the right or left hippocampus, respectively. After rapid exsanguination and 6 min no-flow, hypothermia was induced by ice-cold (IC) or room-temperature (RT) flush. Total duration of CA was 20 min. Pre-treatment (IC, RTpre) and post-treatment (RTpost) groups were studied, along with shams (cannulation only) and CPB controls. On day 7, shams and CPB groups showed neither neuronal death nor microglial activation. In contrast, the number of microglia in hippocampus in each individual group (IC, RTpre, RTpost) was decreased with LEC vs. PBS by similar to 34-46% (P < 0.05). Microglial proliferation was attenuated in the IC vs. RT groups (P < 0.05). Neuronal death did not differ between hemispheres or IC vs. RT groups. Thus, intrahippocampal injection of LEC attenuated microglial proliferation by similar to 40%, but did not alter neuronal death. This suggests that microglia may not play a pivotal role in mediating neuronal death in prolonged hypothermic CA. This novel strategy provides us with a tool to study the specific effects of microglia in hypothermic CA. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Drabek, Tomas; Janata, Andreas; Jackson, Edwin K.; End, Brad; Stezoski, Jason; Vagni, Vincent A.; Janesko-Feldman, Keri; Wilson, Caleb D.; Tisherman, Samuel A.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Drabek, Tomas] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Janata, Andreas; Tisherman, Samuel A.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol & Clin Biol, Pittsburgh, PA 15219 USA; [van Rooijen, Nico] Vrije Univ, VUMC, Dept Mol Cell Biol, Fac Med, NL-1081 BT Amsterdam, Netherlands; [Tisherman, Samuel A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA		Drabek, T (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	drabekt@anes.upmc.edu	Van Rooijen, Nico/Z-1578-2019; Drabek, Tomas/AAJ-1595-2021; Tisherman, Samuel A./AAK-9377-2020; Kochanek, Patrick M/D-2371-2015	Drabek, Tomas/0000-0002-5702-4498; Tisherman, Samuel A./0000-0003-3810-3729; Kochanek, Patrick M/0000-0002-2627-913X; Jackson, Edwin/0000-0002-8101-6009	Department of Anesthesiology, University of PittsburghUniversity of Pittsburgh [09BGIA2310196]; Laerdal Foundation for Acute Medicine;  [NS070003];  [NS30318];  [NS38087]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, R21NS070003, P01NS030318, P50NS030318, R01NS038087] Funding Source: NIH RePORTER	This work was supported by the AHA Beginning Grant-in-Aid # 09BGIA2310196 (TD), Society of Cardiovascular Anesthesiologists Starter Grant (TD), a Seed Grant from The Department of Anesthesiology, University of Pittsburgh (TD), by the Laerdal Foundation for Acute Medicine (TD), and by NS070003, NS30318 and NS38087 (PMK).	Barbe E, 1996, J CELL SCI, V109, P2937; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; BERGH A, 1993, J ENDOCRINOL, V136, P407, DOI 10.1677/joe.0.1360407; Dehghani F, 2004, EXP NEUROL, V189, P241, DOI 10.1016/j.expneurol.2004.06.010; Drabek T, 2007, LIFE SCI, V81, P543, DOI 10.1016/j.lfs.2007.06.015; Drabek T, 2009, ANESTH ANALG, V109, P914, DOI 10.1213/ane.0b013e3181b0511e; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Fleisch H, 1989, Recent Results Cancer Res, V116, P1; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Frediani B, 2009, CLIN DRUG INVEST, V29, P359, DOI 10.2165/00044011-200929060-00001; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Gowing G, 2006, GLIA, V53, P331, DOI 10.1002/glia.20288; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hewlett KA, 2006, NEUROSCIENCE, V141, P27, DOI 10.1016/j.neuroscience.2006.03.071; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Koshinaga M, 2007, HISTOL HISTOPATHOL, V22, P129, DOI 10.14670/HH-22.129; Lahoud-Rahme MS, 2009, RESUSCITATION, V80, P484, DOI 10.1016/j.resuscitation.2009.01.007; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lehenkari PP, 2002, MOL PHARMACOL, V61, P1255, DOI 10.1124/mol.61.5.1255; Liu JL, 2001, J CEREBR BLOOD F MET, V21, P361, DOI 10.1097/00004647-200104000-00005; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; MICKLUS MJ, 1992, BIOCHIM BIOPHYS ACTA, V1124, P7, DOI 10.1016/0005-2760(92)90118-F; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Pavlakis N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003474.pub2; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; Safar P, 2000, CRIT CARE MED, V28, pN214, DOI 10.1097/00003246-200011001-00012; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tang MK, 2010, J CEREBR BLOOD F MET, V30, P119, DOI 10.1038/jcbfm.2009.194; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; Yamashima Tetsumori, 2007, Biotechnology Journal, V2, P596, DOI 10.1002/biot.200600219	50	24	24	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	APR	2012	83	4					517	526		10.1016/j.resuscitation.2011.09.016			10	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	930OO	WOS:000303149100034	21970817	Green Accepted			2022-02-06	
J	Hatic, H; Kane, MJ; Saykally, JN; Citron, BA				Hatic, Haris; Kane, Michael J.; Saykally, Jessica N.; Citron, Bruce A.			Modulation of Transcription Factor Nrf2 in an In Vitro Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; in vitro studies; model of injury; neuronal cell death; traumatic brain injury	INDUCED CELL-DEATH; REDOX REGULATION; GENE-EXPRESSION; THIOREDOXIN; ACTIVATION; APOPTOSIS; DISEASE; ELEMENT; PATHOPHYSIOLOGY; ASTROCYTES	Traumatic brain injury (TBI) afflicts approximately 1.4 million people in the United States and TBIs have been labeled a major cause of death and disability on a global scale. Regulatory responses in a variety of neuronal loss conditions have supported the protective involvement of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) transcription factor. Nrf2 regulates antioxidant enzyme genes, and an increase in Nrf2 expression may counteract oxidative damage that results from TBI. Elevated Nrf2 may ultimately act through the upregulation of downstream target genes such as thioredoxin (Trx) and heat-shock protein-70 (HSP70) and this may reduce neuronal loss. We performed multiple mild biaxial stretch injuries to neuroblastoma cells in culture, and examined the effects of the Nrf2 activator, tert-butylhydroquinone (tBHQ). We also compared the stretch injury to oxidative insult. We confirmed that Trx and HSP70 were upregulated by treatment with tBHQ. We observed that tBHQ protected neurons from either insult, and that this was evident by different measures of cell viability and a decrease in annexin V binding. Neuronal health after insult was improved approximately 50% by tBHQ, indicating that neurons exposed to TBI in vitro can be protected.	[Hatic, Haris; Kane, Michael J.; Saykally, Jessica N.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Mol Biol Lab, Res & Dev 151, Bay Pines, FL 33744 USA; [Saykally, Jessica N.; Citron, Bruce A.] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL USA		Citron, BA (corresponding author), Bay Pines VA Healthcare Syst, Mol Biol Lab, Res & Dev 151, Bldg 22,Room 123,POB 4125, Bay Pines, FL 33744 USA.	bruce.citron@va.gov			Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)US Department of Veterans Affairs; Bay Pines Foundation	We would like to thank Vedad Delic, Carrie Butler, and John S. Dennis for technical assistance and useful discussions. This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) and the Bay Pines Foundation. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Brooks AR, 2002, PHYSIOL GENOMICS, V9, P27, DOI 10.1152/physiolgenomics.00075.2001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Calabrese V, 2008, METHOD ENZYMOL, V441, P83, DOI 10.1016/S0076-6879(08)01206-8; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dennis JS, 2009, NEUROSCIENCE, V158, P745, DOI 10.1016/j.neuroscience.2008.10.030; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Endo H, 2008, ENVIRON HEALTH PERSP, V116, P873, DOI 10.1289/ehp.10696; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Foster JA, 1997, MOL BRAIN RES, V45, P207, DOI 10.1016/S0169-328X(96)00138-6; Gius D, 1999, TOXICOL LETT, V106, P93, DOI 10.1016/S0378-4274(99)00024-7; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hattori I, 2002, REDOX REP, V7, P256, DOI 10.1179/135100002125000749; Heneka MT, 2001, J NEUROCHEM, V77, P568, DOI 10.1046/j.1471-4159.2001.00260.x; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kane MJ, 2011, BRAIN RES, V1425, P123, DOI 10.1016/j.brainres.2011.09.047; Kane Michael J, 2009, Recent Pat CNS Drug Discov, V4, P190; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kelly Stephen, 2002, Curr Med Res Opin, V18 Suppl 2, ps55, DOI 10.1185/030079902125000732; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li CQ, 2009, P NATL ACAD SCI USA, V106, P14547, DOI 10.1073/pnas.0907539106; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Niso-Santano M, 2010, FREE RADICAL BIO MED, V48, P1370, DOI 10.1016/j.freeradbiomed.2010.02.024; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Shih AY, 2007, J NEUROCHEM, V101, P109, DOI 10.1111/j.1471-4159.2006.04345.x; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Soundararajan R, 2008, J BIOL CHEM, V283, P2231, DOI 10.1074/jbc.M703583200; TAVARIA M, 1995, GENOMICS, V29, P266, DOI 10.1006/geno.1995.1242; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang Y, 2007, CELL RES, V17, P363, DOI 10.1038/cr.2007.11	56	24	25	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1188	1196		10.1089/neu.2011.1806			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100019	22201269				2022-02-06	
J	Bogart, E; Togher, L; Power, E; Docking, K				Bogart, Elise; Togher, Leanne; Power, Emma; Docking, Kimberley			Casual conversations between individuals with traumatic brain injury and their friends	BRAIN INJURY			English	Article						Traumatic brain injury; communication; discourse; conversation; friendship; exchange structure analysis	TRAINING COMMUNICATION PARTNERS; HEAD-INJURY; DISCOURSE; PEOPLE; SKILLS; INFORMATION; IMPACT	Primary objective: To investigate casual conversations with friends following severe traumatic brain injury (TBI). Methods: Nine participants with severe TBI were matched by age, gender and education to nine control participants. Each participant also invited a friend to partake in the study. Participants were recorded engaging in a brief casual conversation with a friend. The resulting discourse was analysed using Exchange Structure Analysis (ESA). Rates of information giving, information requesting and communication repair and negotiation were collated. Non-parametric statistical analyses were performed. Results: Participants with and without TBI obtained similar rates of information giving and information requesting. The friends of the participants with TBI produced significantly lower rates of information giving measures when compared to the controls, but achieved comparable rates of information requesting and communication repair and negotiation measures. Participants with TBI were observed to produce tangential language and to have difficulties identifying communication breakdown, asking questions and engaging in conversational joking. Conclusions: People with TBI are able to engage in casual conversations with friends in a similar way to matched controls. Friends of people with TBI are often restricted in contributing information in conversations. Further research is needed to specify the facilitative and restrictive communication behaviours so that they may be translated to clinical practise.	[Bogart, Elise; Togher, Leanne; Power, Emma; Docking, Kimberley] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Lidcombe, NSW 2141, Australia		Bogart, E (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, C42 Cumberland Campus, Lidcombe, NSW 2141, Australia.	elise.bogart@sydney.edu.au	Power, Emma/A-9263-2015; Togher, Leanne/AAC-7083-2019	Power, Emma/0000-0002-2638-0406; Docking, Kimberley/0000-0001-9996-7235; Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Argyrous, 2005, STAT RES GUIDE SPSS; Boles L, 1998, APHASIOLOGY, V12, P547, DOI 10.1080/02687039808249557; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Correll A, 2010, APHASIOLOGY, V24, P612, DOI 10.1080/02687030902732752; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Halliday M., 2004, INTRO FUNCTIONAL GRA; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HUNT KW, 1970, MONOGR SOC RES CHILD, V35, P1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larkins B, 1999, ASIA PACIFIC J SPEEC, V4, P183; Levinson, 1987, POLITENESS SOME UNIV; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1999, COMMUNICATION DISORD; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Poynton C., 1985, LANGUAGE GENDER MAKI; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rowlands A., 2000, BRAIN IMPAIR, V1, P151, DOI [10.1375/brim.1.2.151, DOI 10.1375/BRIM.1.2.151]; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SPSS Inc, 2008, SPSS STAT REL 17 0 1; Tannen Deborah, 2005, CONVERSATIONAL STYLE; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1	49	24	24	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					221	233		10.3109/02699052.2011.648711			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100003	22372410				2022-02-06	
J	Steinbaugh, LA; Lindsell, CJ; Shutter, LA; Szaflarski, JP				Steinbaugh, Linda A.; Lindsell, Christopher J.; Shutter, Lori A.; Szaflarski, Jerzy P.			Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention	EPILEPSY & BEHAVIOR			English	Article						Levetiracetam; Fosphenytoin; Electroencephalogram; Traumatic brain injury; Subarachnoid hemorrhage; Outcomes	TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; STATUS EPILEPTICUS; PHENYTOIN; SUBCOMMITTEE; PROPHYLAXIS	Continuous electroencephalography (cEEG) is increasingly used to detect both clinical and subclinical seizures in patients with traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH). We assess whether EEG findings predict outcomes in TBI/SAH patients enrolled in a levetiracetam (LEV) vs. fosphenytoin (fos-PHT) seizure prevention trial (NCT00618436). This prospective, single-blinded, comparative trial randomized 52 patients with TBI or SAH to receive prophylactic LEV or fos-PHT. Continuous video EEG monitoring was conducted for the initial 72 h of medication administration. The association between EEG findings (degree of generalized and focal slowing, presence and frequency of epileptiform discharges and seizures) and outcomes (Glasgow Outcomes Scale-Extended (GOS-E) and Disability Rating Scale (DRS)) at discharge, 3 and 6 months was assessed using a generalized linear model. Severity of generalized slowing tended to be associated with outcomes in both treatment groups (discharge DRS, p=0.042; discharge GOS-E, p=0.026; 3 month DRS, p=0.051). The presence of focal slowing, the presence and frequency of epileptiform discharges and the presence of seizures were not predictive of outcome in either treatment group (all p > 0.15). While it has been shown that LEV is associated with better outcome than fos-PHT when used as seizure prophylaxis in brain injury, aside from severity of generalized slowing, electrographic findings of focal slowing, epileptiform discharges, and seizures were not themselves associated with outcomes in patients with TBI or SAH enrolled in a randomized clinical trial. (C) 2011 Elsevier Inc. All rights reserved.	[Steinbaugh, Linda A.; Shutter, Lori A.; Szaflarski, Jerzy P.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, Cincinnati, OH 45267 USA; [Lindsell, Christopher J.] Univ Cincinnati, Acad Hlth Ctr, Dept Emergency Med, Cincinnati, OH 45267 USA; [Shutter, Lori A.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurosurg, Cincinnati, OH 45267 USA; [Shutter, Lori A.; Szaflarski, Jerzy P.] Univ Cincinnati, Acad Hlth Ctr, Inst Neurosci, Cincinnati, OH 45267 USA; [Szaflarski, Jerzy P.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurosci, Cincinnati, OH 45267 USA; [Szaflarski, Jerzy P.] Univ Cincinnati, Acad Hlth Ctr, Cincinnati Epilepsy Ctr, Cincinnati, OH 45267 USA		Szaflarski, JP (corresponding author), Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, 260 Stetson St, Cincinnati, OH 45267 USA.	Jerzy.Szaflarski@uc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628; Lindsell, Christopher/0000-0002-3297-2811	UCB Pharma, Inc. (PI)UCB Pharma SA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	This study was supported by UCB Pharma, Inc. (PI: Lori A. Shutter, MD, PT). Dr. Szaflarski has received compensation for educational activities with UCB Pharma, Inc. This study was presented, in part, at the 63rd Annual Meeting of the American Academy of Neurology.	Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Bonett DG, 2002, PSYCHOL METHODS, V7, P370, DOI 10.1037//1082-989X.7.3.370; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Hesdorffer D, 2007, EPILEPSY COMPREHENSI, V57-63; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kilbride RD, 2009, ARCH NEUROL-CHICAGO, V66, P723, DOI 10.1001/archneurol.2009.100; Kurtz P, 2009, CURR OPIN CRIT CARE, V15, P99, DOI 10.1097/MCC.0b013e3283294947; Orta DS, 2009, ARCH NEUROL-CHICAGO, V66, P985, DOI 10.1001/archneurol.2009.137; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Szaflarski JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-264; Szaflarski JP, 2010, EPILEPSY BEHAV, V17, P525, DOI 10.1016/j.yebeh.2010.02.005; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001	28	24	24	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2012	23	3					280	284		10.1016/j.yebeh.2011.12.005			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	910RC	WOS:000301657900017	22342434				2022-02-06	
J	Di Liberto, V; Makela, J; Korhonen, L; Olivieri, M; Tselykh, T; Malkia, A; Thi, HD; Belluardo, N; Lindholm, D; Mudo, G				Di Liberto, Valentina; Makela, Johanna; Korhonen, Laura; Olivieri, Melania; Tselykh, Timofey; Malkia, Annika; Hai Do Thi; Belluardo, Natale; Lindholm, Dan; Mudo, Giuseppa			Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice	NEUROPHARMACOLOGY			English	Article						RSV; Striatum; Dopaminergic neurons; DAT; Antiestrogen; Gene expression	RAT-BRAIN; MONOAMINE TRANSPORTERS; BETA IMMUNOREACTIVITY; DEPENDENT REGULATION; CELL-PROLIFERATION; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; UPTAKE SITES; PC12 CELLS; ER-ALPHA	Treatment with resveratrol (RSV) has been shown to protect vulnerable neurons after various brain injuries and in neurodegenerative diseases. The mechanisms for the effects of RSV in brain are not fully understood, but RSV may affect the expression of various gene products. RSV is structurally related to the synthetic estrogen, diethylstilbestrol so the effects of RSV may be gender-specific. Here we studied the role of RSV in the regulation of dopamine transporter (DAT) in the striatum using male and female mice. The basic levels of DAT in the striatum showed no sex difference, but the levels increased significantly by RSV (20 mg/kg i.p.) in female but not in male mice. Pretreatment of mice with the selective estrogen receptor (ER), ER alpha- and ER beta antagonist ICI 182,780, led to a complete block of RSV effect on DAT protein levels, suggesting that ERs are involved in the up-regulation of DAT by RSV. Similar data was also obtained in culture using human MESC2.10 and mouse SN4741 dopaminergic cells after treatment with RSV. Data further showed that RSV specifically induced gene transcription of DAT in the dopaminergic cells. These results show that estrogen receptors are involved in the up-regulation of DAT by RSV in the dopaminergic neurons, demonstrating a sex-dependent effect of RSV in the brain that may be of clinical importance. This article is part of a Special Issue entitled 'Post-Traumatic Stress Disorder'. (C) 2011 Elsevier Ltd. All rights reserved.	[Di Liberto, Valentina; Olivieri, Melania; Belluardo, Natale; Mudo, Giuseppa] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Div Human Physiol, Mol Neurobiol Lab, IT-90134 Palermo, Italy; [Makela, Johanna; Korhonen, Laura; Tselykh, Timofey; Hai Do Thi; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00014 Helsinki, Finland; [Tselykh, Timofey; Malkia, Annika; Hai Do Thi; Lindholm, Dan] Biomedicum 2 Helsinki, Minerva Med Res Inst, Helsinki, Finland		Mudo, G (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci, Div Human Physiol, Mol Neurobiol Lab, Corso Tukory 129, IT-90134 Palermo, Italy.	giuseppa.mudo@unipa.it	Mudo', Giuseppa/G-7408-2011; Korhonen, Laura/AAW-3256-2020; Lindholm, Dan/B-3777-2014	Mudo', Giuseppa/0000-0002-3275-9981; Di Liberto, Valentina/0000-0002-8574-0061	Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation; Finska Lakaresallskapet; Liv och Halsa; Finnish Parkinson Foundation; Minerva Foundation; Progetti di Ateneo (Universita di Palermo); Ateneo of Palermo	We thank J Lotharius and P Brundin for human MESC2.10, J Son and E Arenas for mouse SN4741 cells, and E. Lehto for skillful technical assistance. Supported by the Academy of Finland, Sigrid Juselius Foundation, Finska Lakaresallskapet, Liv och Halsa, The Finnish Parkinson Foundation, Minerva Foundation, and Progetti di Ateneo (Universita di Palermo). DLV and OM are supported by Ateneo of Palermo.	Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beyer C, 2002, J STEROID BIOCHEM, V81, P319, DOI 10.1016/S0960-0760(02)00119-X; Blanchet J, 2008, PROG NEURO-PSYCHOPH, V32, P1243, DOI 10.1016/j.pnpbp.2008.03.024; Bosse R, 1997, MOL BRAIN RES, V46, P343, DOI 10.1016/S0169-328X(97)00082-X; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Chen C, 2000, ARCH PHARM RES, V23, P605, DOI 10.1007/BF02975249; Creutz LM, 2002, J COMP NEUROL, V446, P288, DOI 10.1002/cne.10207; Currie LJ, 2004, ARCH NEUROL-CHICAGO, V61, P886, DOI 10.1001/archneur.61.6.886; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Dluzen D E, 2000, J Gend Specif Med, V3, P36; Dore S, 2005, NEUROSIGNALS, V14, P61, DOI 10.1159/000085386; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; El-Mowafy AM, 2002, MED PRIN PRACT, V11, P86, DOI 10.1159/000058013; Erixon-Lindroth N, 2005, PSYCHIAT RES-NEUROIM, V138, P1, DOI 10.1016/j.pscychresns.2004.09.005; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gardiner SA, 2004, AM J GERIAT PSYCHIAT, V12, P621, DOI 10.1176/appi.ajgp.12.6.621; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Gelinas S, 2002, J NEUROSCI RES, V70, P90, DOI 10.1002/jnr.10315; Hong SH, 2010, REPROD TOXICOL, V30, P469, DOI 10.1016/j.reprotox.2010.04.009; Howell A, 2000, CANCER, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hulley SB, 2004, JAMA-J AM MED ASSOC, V291, P1769, DOI 10.1001/jama.291.14.1769; Jeng Yow-Jiun, 2009, J Mol Signal, V4, P2, DOI 10.1186/1750-2187-4-2; Jordan VC, 2003, J MED CHEM, V46, P1081, DOI 10.1021/jm020450x; Jourdain S, 2005, J NEUROENDOCRINOL, V17, P509, DOI 10.1111/j.1365-2826.2005.01337.x; Kairisalo M, 2011, NEUROSCI LETT, V488, P263, DOI 10.1016/j.neulet.2010.11.042; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Koh SH, 2003, MOL BRAIN RES, V118, P72, DOI 10.1016/j.molbrainres.2003.07.003; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; Krishnan V, 2000, Vitam Horm, V60, P123, DOI 10.1016/S0083-6729(00)60018-3; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Laflamme N, 1998, J NEUROBIOL, V36, P357, DOI 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V; LANGCAKE P, 1977, EXPERIENTIA, V33, P151, DOI 10.1007/BF02124034; Le Saux M, 2006, J NEUROENDOCRINOL, V18, P25, DOI 10.1111/j.1365-2826.2005.01380.x; Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; MORISSETTE M, 1993, J NEUROCHEM, V60, P1876, DOI 10.1111/j.1471-4159.1993.tb13415.x; MORISSETTE M, 1990, BRAIN RES BULL, V25, P419, DOI 10.1016/0361-9230(90)90231-N; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Robb EL, 2011, FREE RADICAL BIO MED, V50, P821, DOI 10.1016/j.freeradbiomed.2010.12.038; Shimizu T, 2006, BIOCHEM PHARMACOL, V71, P742, DOI 10.1016/j.bcp.2005.12.018; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Van den Bemd GJCM, 1999, BIOCHEM BIOPH RES CO, V261, P1, DOI 10.1006/bbrc.1999.0864; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Watson Cheryl S, 2006, J Mol Signal, V1, P5, DOI 10.1186/1750-2187-1-5; Wu F, 2008, J STEROID BIOCHEM, V110, P104, DOI 10.1016/j.jsbmb.2008.02.008; Yen GC, 2003, FREE RADICAL RES, V37, P509, DOI 10.1080/1071576031000083099; Zhang JQ, 2002, BRAIN RES, V935, P73, DOI 10.1016/S0006-8993(02)02460-5	63	24	25	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	FEB	2012	62	2					1011	1018		10.1016/j.neuropharm.2011.10.010			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	909FZ	WOS:000301549300051	22041555				2022-02-06	
J	Murphy, JC; Gissane, C; Blake, C				Murphy, John C.; Gissane, Conor; Blake, Catherine			Injury in elite county-level hurling: a prospective study	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PROFESSIONAL RUGBY UNION; ICE HOCKEY INJURIES; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; GAELIC FOOTBALL; SPORTS INJURIES; HAND INJURIES; NEW-ZEALAND; LEAGUE; PREVENTION	Objective To determine the incidence, prevalence and nature of sports injuries in elite male hurling players. Design Prospective study of county-grade hurling teams. Incidence, prevalence and descriptions of injuries were collated. Setting Four county teams during the 2007 season; January to September inclusive. Participants A total of 127 male players were followed over 34 weeks. Data were collected on a median (IQR) of 31 (30-32) players per team per week. The mean age was 23.3 +/- 2.5 years. Results There were 204 injuries to 104 players (82%, 95% CI (74 to 88)). Injury incidence rate during match-play (102.5 (84.4 to 123.2)) was 19 times higher than for training (5.3 (4.2 to 6.5)) (RR=19.5 (14.8 to 25.6)). The mean weekly prevalence of injury was 13.9% (12.5 to 14.8). Most injuries were new (n=170, 83.3%, (77.6 to 87.8)) and acute (n=165, 80.9% (74.9 to 85.7)). Muscle strain (n=86) accounted for 42.2% (35.6 to 49) of the total. 71% of injuries were to the lower limb (n=143, (63.5 to 76.0)) with hamstring strain (n=33, 16.5% (11.8 to 21.8)) predominating. Fractures constituted 7.4% injuries (n=15, 95% CI (4.5 to 11.8)), 12 of which were to the upper limb. There were three (1.5% (0.5 to 4.2)) eye injuries and one concussion injury (0.5% (0.1 to 2.7)). Conclusions These results provide data on hurling injuries using definitions that reflect international consensus statements. Injury incidence from match-play in particular is high compared with other sports. These findings have relevance for clinicians and coaches.	[Blake, Catherine] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Hlth Sci Ctr, Dublin 4, Ireland; [Murphy, John C.] Gael Athlet Assoc, Med Sci Comm, Dublin, Ireland; [Gissane, Conor] St Marys Univ Coll, Twickenham, England		Blake, C (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Hlth Sci Ctr, Room A1-03, Dublin 4, Ireland.	c.blake@ucd.ie	Blake, Catherine/M-6728-2016; Gissane, Conor/I-3661-2019	Blake, Catherine/0000-0002-0600-629X; Gissane, Conor/0000-0003-4677-3853	Gaelic Athletic Association	Gaelic Athletic Association.	Agel J, 2007, J ATHL TRAINING, V42, P241; [Anonymous], 2007, SPSS 16 WIND REL 15; [Anonymous], VRP INJ SOFTW; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Bryant T, 2000, CONFIDENCE INTERVAL; Crowley P J, 1989, Br J Sports Med, V23, P183; CUDDIHY B, 1990, IRISH MED J, V83, P98; Dick R, 2007, J ATHL TRAINING, V42, P255; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Flynn TH, 2005, BRIT J SPORT MED, V39, P493, DOI 10.1136/bjsm.2004.013102; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; GAA, 2009, OFF GUID 2; Kiely PD, 2003, INJURY, V34, P561, DOI 10.1016/S0020-1383(02)00050-5; King DA, 2009, CLIN J SPORT MED, V19, P277, DOI 10.1097/JSM.0b013e3181a7c6b0; Kuzuhara K, 2009, J ATHL TRAINING, V44, P208, DOI 10.4085/1062-6050-44.2.208; McIntyre MC, 2005, BRIT J SPORT MED, V39, P437, DOI 10.1136/bjsm.2004.013631; McLean JG, 1989, BRIT J SPORT MED, V23, P179; Newell M, 2006, Ir Med J, V99, P269; O'Connor K, 2006, Ir Med J, V99, P17; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J., 1993, SPORTS HEALTH, V11, P39; OSULLIVAN ME, 1989, IRISH J MED SCI, V158, P79, DOI 10.1007/BF02942110; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Timpka T, 2007, SCAND J MED SCI SPOR, V17, P636, DOI 10.1111/j.1600-0838.2006.00623.x; Timpka T, 2002, MED SCI SPORT EXER, V34, P993, DOI 10.1097/00005768-200206000-00014; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; WALLER AE, 1994, BRIT J SPORT MED, V28, P223, DOI 10.1136/bjsm.28.4.223; Watson AWS, 1996, AM J SPORT MED, V24, P323, DOI 10.1177/036354659602400313; Watson AWS, 1999, J SPORT MED PHYS FIT, V39, P66; Wilson F, 2007, BRIT J SPORT MED, V41, P317, DOI 10.1136/bjsm.2006.033167	32	24	24	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	FEB	2012	46	2					138	142		10.1136/bjsm.2010.072132			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	879CY	WOS:000299308500014	20961917				2022-02-06	
J	Thau-Zuchman, O; Shohami, E; Alexandrovich, AG; Leker, RR				Thau-Zuchman, O.; Shohami, E.; Alexandrovich, A. G.; Leker, R. R.			SUBACUTE TREATMENT WITH VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER TRAUMATIC BRAIN INJURY INCREASES ANGIOGENESIS AND GLIOGENESIS	NEUROSCIENCE			English	Article						angiogenesis; growth factor; neurogenesis; neuroprotection; traumatic brain injury; vascular endothelial	CLOSED-HEAD INJURY; IMPROVES FUNCTIONAL RECOVERY; CELL-PROLIFERATION; CEREBRAL-ISCHEMIA; INFARCT VOLUME; UP-REGULATION; STEM-CELLS; RAT-BRAIN; VEGF; MODEL	Vascular endothelial growth factor (VEGF) is neuroprotective and induces neurogenesis and angiogenesis when given early after traumatic brain injury (TBI). However, the effects of VEGF administration in the subacute phase after TBI remain unknown. Mice were subjected to TBI and treated with vehicle or VEGF beginning 7 days later for an additional 7 days. The animals were injected with BrdU to label proliferating cells and examined with a motor-sensory scale at pre-determined time points. Mice were killed 90 days post injury and immunohistochemistry was used to study cell fates. Our results demonstrate that lesion volumes did not differ between the groups confirming the lack of neuroprotective effects in this paradigm. VEGF treatment led to significant increments in cell proliferation (1.9 fold increase vs. vehicle, P<0.0001) and angiogenesis in the lesioned cortex (1.7 fold increase vs. vehicle, P=0.0001) but most of the proliferating cells differentiated into glia and no mature newly-generated neurons were detected. In conclusion, VEGF induces gliogenesis and angiogenesis when given 7 days post TBI. However, treated mice had only insignificant motor improvements in this paradigm, suggesting that the bulk of the beneficial effects observed when VEGF is given early after TBI results from the neuroprotective effects. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Thau-Zuchman, O.; Leker, R. R.] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel; [Thau-Zuchman, O.; Leker, R. R.] Hadassah Hebrew Univ Med Ctr, Peritz & Chantal Scheinberg Cerebrovasc Res Lab, Jerusalem, Israel; [Thau-Zuchman, O.; Shohami, E.; Alexandrovich, A. G.] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel		Leker, RR (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel.	leker@cc.huji.ac.il	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334; Thau-Zuchman, Orli/0000-0003-0403-7962	Pertiz and Chantal Scheinberg Cerebrovascular Research Fund; Sol Irwin Juni Trust Fund	This study was supported in part by the Pertiz and Chantal Scheinberg Cerebrovascular Research Fund and by the Sol Irwin Juni Trust Fund. E.S. is the incumbent of the Dr. Leon and Mina Deutch Chair in Psychopharmacology at the Hebrew University.	Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Biegon A, 2004, CURR PHARM DESIGN, V10, P2177, DOI 10.2174/1381612043384196; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forsberg-Nilsson K, 1998, J NEUROSCI RES, V53, P521, DOI 10.1002/(SICI)1097-4547(19980901)53:5<521::AID-JNR2>3.0.CO;2-B; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Kim JH, 2004, J KOREAN MED SCI, V19, P879, DOI 10.3346/jkms.2004.19.6.879; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee C, 2009, EXP NEUROL, V220, P400, DOI 10.1016/j.expneurol.2009.08.019; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Manwani B, 2011, BRAIN BEHAV IMMUN, V25, P1689, DOI 10.1016/j.bbi.2011.06.015; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang WY, 2005, NEUROSCIENCE, V134, P1167, DOI 10.1016/j.neuroscience.2005.04.064; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhao XH, 2007, MOL CELL NEUROSCI, V36, P260, DOI 10.1016/j.mcn.2007.07.008	43	24	26	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JAN 27	2012	202						334	341		10.1016/j.neuroscience.2011.11.071			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	887DV	WOS:000299908000032	22173016				2022-02-06	
J	Echemendia, RJ; Iverson, GL; McCrea, M; Broshek, DK; Gioia, GA; Sautter, SW; Macciocchi, SN; Barr, WB				Echemendia, Ruben J.; Iverson, Grant L.; McCrea, Michael; Broshek, Donna K.; Gioia, Gerard A.; Sautter, Scott W.; Macciocchi, Stephen N.; Barr, William B.			Role of Neuropsychologists in the Evaluation and Management of Sport-Related Concussion: An Inter-Organization Position Statement	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Traumatic brain injury; Children; Legislation	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; SEX-DIFFERENCES; RECOVERY; SYMPTOMS; IMPACT; DEFICITS	Over the past 20 years, clinical neuropsychologists have been at the forefront of both scientific and clinical initiatives aimed at developing evidence-based approaches to the evaluation and management of sport-related concussion (SRC). These efforts have directly impacted current policy on strategies for injury assessment and return-to-play by athletes after concussion. Many states are considering legislation requiring (a) education of athletes, parents, coaches, and school/organization officials on the recognition, evaluation, and management of SRCs; (b) removal from play of any youth athlete that is suspected of having sustained a concussion; and (c) not allowing the student to return to participation until the student is evaluated and cleared for return to participation in writing by an appropriate healthcare professional. It is the official position of the American Academy of Clinical Neuropsychology (AACN), American Board of Professional Neuropsychology (ABN), Division 40 (Neuropsychology) of the American Psychological Association (APA), and the National Academy of Neuropsychology (NAN) that neuropsychologists should be included among the licensed healthcare professionals authorized to evaluate, clinically manage, and provide return to play clearance for athletes who sustain a SRC.	[Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA 16801 USA; [Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Rockville, MD USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Rockville, MD USA; [Sautter, Scott W.] Hampton Rd Neuropsychol Inc, Virginia Beach, VA USA; [Macciocchi, Stephen N.] Shepherd Ctr, Atlanta, GA USA; [Barr, William B.] NYU, Sch Med, New York, NY USA		Echemendia, RJ (corresponding author), Psychol & Neurobehav Associates Inc, 204 E Calder Way,Suite 205, State Coll, PA 16801 USA.	rechemendia@comcast.net		Iverson, Grant/0000-0001-7348-9570; Barr, William/0000-0001-7711-7758			Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LOVELL MR, 1996, NEW DEV SPORTS REL C; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	43	24	24	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2012	27	1					119	122		10.1093/arclin/acr077			4	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	885TE	WOS:000299802900011	22180540	Bronze			2022-02-06	
J	Iverson, GL; Echemendia, RJ; LaMarre, AK; Brooks, BL; Gaetz, MB				Iverson, Grant L.; Echemendia, Ruben J.; LaMarre, Amanda K.; Brooks, Brian L.; Gaetz, Michael B.			Possible Lingering Effects of Multiple Past Concussions	REHABILITATION RESEARCH AND PRACTICE			English	Article							COLLEGIATE FOOTBALL PLAYERS; SELF-REPORTED CONCUSSIONS; SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; NEUROPSYCHOLOGICAL CONSEQUENCE; NEUROCOGNITIVE PERFORMANCE; COGNITIVE IMPAIRMENT; INTERPRETING CHANGE	Background. The literature on lingering or "cumulative" effects of multiple concussions is mixed. The purpose of this study was to examine whether athletes with a history of three or more concussions perform more poorly on neuropsychological testing or report more subjective symptoms during a baseline, preseason evaluation. Hypothesis. Athletes reporting three or more past concussions would perform more poorly on preseason neurocognitive testing. Study Design. Case-control study. Methods. An archival database including 786 male athletes who underwent preseason testing with a computerized battery (ImPACT) was used to select the participants. Twenty-six athletes, between the ages of 17 and 22 with a history of three or more concussions, were identified. Athletes with no history of concussion were matched, in a case-control fashion, on age, education, self-reported ADHD, school, sport, and, when possible, playing position and self-reported academic problems. Results. The two groups were compared on the four neuropsychological composite scores from ImPACT using multivariate analysis of variance followed by univariate ANOVAs. MANOVA revealed no overall significant effect. Exploratory ANOVAs were conducted using Verbal Memory, Visual Memory, Reaction Time, Processing Speed, and Postconcussion Scale composite scores as dependent variables. There was a significant effect for only the Verbal Memory composite. Conclusions. Although inconclusive, the results suggest that some athletes with multiple concussions could have lingering memory deficits.	[Iverson, Grant L.] Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada; [Iverson, Grant L.] Copeman Healthcare Ctr, Res Dept, Vancouver, BC V6Z 2L4, Canada; [Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA 16801 USA; [LaMarre, Amanda K.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada; [Gaetz, Michael B.] Univ Fraser Valley, Dept Kinesiol & Phys Educ, Abbotsford, BC V2S 7M8, Canada		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	grant.iverson@ubc.ca	Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462	ImPACT Applications, Inc.	Drs. G. Iverson and R. Echemendia have been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion at meetings, scientific conferences, and symposiums. Dr. G. Iverson has received past research funding from ImPACT Applications, Inc. The developers or publishers of ImPACT did not provide funding for, nor influence the conduct of, this study.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Janusz A, 2004, BRIT J SPORT MED, V38, P659; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	63	24	24	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2867	2090-2875		REHABIL RES PRACT	Rehabil. Res. Pract.		2012	2012								316575	10.1155/2012/316575			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V18NK	WOS:000214757900010	22550590	Green Published, gold			2022-02-06	
J	Janzen, C; Kruger, K; Honeybul, S				Janzen, Courtney; Kruger, Kate; Honeybul, Stephen			Syndrome of the trephined following bifrontal decompressive craniectomy: Implications for rehabilitation	BRAIN INJURY			English	Article						Decompressive craniectomy; syndrome of trephined; traumatic brain injury; rehabilitation	TRAUMATIC BRAIN-INJURY; SINKING SKIN FLAP; NEUROLOGICAL IMPROVEMENT; SURGICAL DECOMPRESSION; BLOOD-FLOW; CRANIOPLASTY; RECOVERY	Objective: The syndrome of the trephined is a rare complication observed following a unilateral decompressive craniectomy for traumatic brain injury. What has not been previously reported is the occurrence of this complication following a bifrontal procedure. The objective of this study was to present two clinical cases that serve to highlight this condition. Design: A case study of two patients who had had a bifrontal decompressive craniectomy for severe traumatic brain injury Method: A review was undertaken detailing the clinical course of the two patients. Results: Both cases were young males. They had initially made significant improvement in their functional and cognitive performance whilst undergoing rehabilitation. However, after some months they demonstrated marked deterioration. Immediately following cranioplasty they showed considerable clinical improvement. Conclusion: If the use of bifrontal decompressive craniectomies continues to increase it is important that those involved in the rehabilitation process are familiar with this rare condition. Early recognition is important so that patients can receive timely intervention and it also avoids valuable health resources being allocated to patients who cannot receive maximal benefit.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, Stephen] Royal Perth Hosp, Perth, WA, Australia; [Janzen, Courtney; Kruger, Kate] Sir Charles Gairdner Hosp, Dept Occupat Therapy, Perth, WA, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Giuffrida CG, 2009, AM J OCCUP THER, V63, P398, DOI 10.5014/ajot.63.4.398; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Helps Y, 2008, INJURY RES STAT SERI, V45; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	28	24	24	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					101	105		10.3109/02699052.2011.635357			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900011	22149449				2022-02-06	
J	Jeter, CB; Hergenroeder, GW; Ward, NH; Moore, AN; Dash, PK				Jeter, Cameron B.; Hergenroeder, Georgene W.; Ward, Norman H., III; Moore, Anthony N.; Dash, Pramod K.			Human Traumatic Brain Injury Alters Circulating L-Arginine and Its Metabolite Levels: Possible Link to Cerebral Blood Flow, Extracellular Matrix Remodeling, and Energy Status	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; biomarker; extracellular matrix; intracranial pressure; metabolism	CONTROLLED CORTICAL IMPACT; NITRIC-OXIDE SYNTHASE; HEAD-INJURY; RATS; EXPRESSION; CREATINE	Altered cerebral blood flow, cell-matrix interactions, and energy metabolism are secondary pathologies contributing to outcome after traumatic brain injury (TBI). Because L-arginine serves as the precursor for metabolites that are critical to these processes, we measured their plasma levels using LC-MS/GC-MS. Samples were collected from healthy volunteers (n = 20), and patients with mild TBI (n = 18), severe TBI (n = 20), or orthopedic injury without a TBI (n = 15), within the first 24 hours of injury. Severe TBI levels of L-arginine, citrulline, ornithine, and hydroxyproline were significantly reduced compared to the other groups. In contrast, the levels of plasma creatine were significantly increased in severe TBI patients compared to healthy volunteers and orthopedic injury subjects. Of interest, the levels of creatine were found to be higher in severe TBI patients (GCS score <= 8) whose intracranial pressure (ICP) remained below 25mm Hg throughout the 5-day monitoring period, compared to TBI patients (GCS score <= 8) who subsequently developed elevated ICP (>= 25mm Hg). The changes in L-arginine and its metabolite levels were not detected in subjects with mild TBI. The altered levels of arginine and its metabolites may contribute to secondary pathologies following severe TBI, and plasma levels of creatine may have prognostic value in identifying patients at risk for ICP elevation.	[Jeter, Cameron B.; Hergenroeder, Georgene W.; Ward, Norman H., III; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Houston, Dept Neurobiol & Anat, Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Houston, Dept Neurobiol & Anat, Med Sch Houston, Vivian L Smith Dept Neurosurg, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Jeter, Cameron B./AAO-1797-2021	Jeter, Cameron B./0000-0001-5303-5897; Hergenroeder, Georgene/0000-0002-6170-2191; Dash, Pramod/0000-0001-6746-1002	Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [R38OT10585]; Mission Connect/TIRR Foundation; Vivian L. Smith Foundation; Gilson-Longenbaugh Foundation	We would like to thank the nurses at Memorial Hermann Hospital-Texas Medical Center, and Elizabeth B. Jones, M.D., Toby T. Thomas, M.D., and Brad Jacobson, M.D. for assistance with recruiting patients. This study was supported by the Health Resources and Services Administration (R38OT10585), Mission Connect/TIRR Foundation, The Vivian L. Smith Foundation, and the Gilson-Longenbaugh Foundation.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; American Association for Automotive Medicine, 2001, ABBR INJ SCAL AIS; Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Bell Scott E, 2006, Curr Treat Options Neurol, V8, P167, DOI 10.1007/s11940-006-0007-9; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Castillo L, 1996, P NATL ACAD SCI USA, V93, P11460, DOI 10.1073/pnas.93.21.11460; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GRODY WW, 1987, ISOZYMES-CURR T BIOL, V13, P181; Hallemeesch MM, 2002, CLIN NUTR, V21, P273, DOI 10.1054/clnu.2002.0571; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hlatky R, 2002, ACT NEUR S, V81, P331; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Klein Autumn M., 2007, V46, P205; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Muellner A, 2003, J NEUROTRAUM, V20, P745, DOI 10.1089/089771503767869971; Rangel-Castilla L, 2010, NEUROL RES, V32, P1033, DOI 10.1179/016164110X12767786356598; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; TEASDALE G, 1974, LANCET, V2, P81; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807	40	24	24	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					119	127		10.1089/neu.2011.2029			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300014	21942884				2022-02-06	
J	Lau, D; El-Sayed, AM; Ziewacz, JE; Jayachandran, P; Huq, FS; Zamora-Berridi, GJ; Davis, MC; Sullivan, SE				Lau, Darryl; El-Sayed, Abdulrahman M.; Ziewacz, John E.; Jayachandran, Priya; Huq, Farhan S.; Zamora-Berridi, Grettel J.; Davis, Matthew C.; Sullivan, Stephen E.			Postoperative outcomes following closed head injury and craniotomy for evacuation of hematoma in patients older than 80 years Clinical article	JOURNAL OF NEUROSURGERY			English	Article						age; craniotomy; hematoma; intracranial hemorrhage; morbidity; trauma; traumatic brain injury	CHRONIC SUBDURAL-HEMATOMA; INTRACEREBRAL HEMORRHAGE; ELDERLY-PATIENTS; SURGERY; MORTALITY; RISK; AGE; COMPLICATIONS; EXPERIENCE; SURVIVAL	Object. Advances in the management of trauma-induced intracranial hematomas and hemorrhage (epidural, subdural, and intraparenchymal hemorrhage) have improved survival in these conditions over the last several decades. However, there is a paucity of research investigating the relation between patient age and outcomes of surgical treatment for these conditions. In this study, the authors examined the relation between patient age over 80 years and postoperative outcomes following closed head injury and craniotomy for intracranial hemorrhage. Methods. A consecutive population of patients undergoing emergent craniotomy for evacuation of intracranial hematoma following closed head trauma between 2006 and 2009 was identified. Using multivariable logistic regression models, the authors assessed the relation between age (> 80 vs <= 80 years) and postoperative complications, intensive care unit stay, hospital stay, morbidity, and mortality. Results. Of 103 patients, 27 were older than 80 years and 76 patients were 80 years of age or younger. Older age was associated with longer length of hospital stay (p = 0.014), a higher rate of complications (OR 5.74, 95% CI 1.29-25.34), and a higher likelihood of requiring rehabilitation (OR 3.28, 95% CI 1.13-9.74). However, there were no statistically significant differences between the age groups in 30-day mortality or ability to recover to functional baseline status. Conclusions. The findings suggest that in comparison with younger patients, patients over 80 years of age may be similarly able to return to preinjury functional baselines but may require increased postoperative medical attention in the forms of rehabilitation and longer hospital stays. Prospective studies concerned with the relation between older age, perioperative parameters, and postoperative outcomes following craniotomy for intracranial hemorrhage are needed. Nonetheless, the findings of this study may allow for more informed decisions with respect to the care of elderly patients with intracranial hemorrhage. (DOI: 10.3171/2011.7.JNS11396)	[El-Sayed, Abdulrahman M.] Columbia Univ, Dept Epidemiol, New York, NY 10031 USA; [Lau, Darryl; Jayachandran, Priya; Huq, Farhan S.; Zamora-Berridi, Grettel J.; Davis, Matthew C.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Ziewacz, John E.; Sullivan, Stephen E.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [El-Sayed, Abdulrahman M.] Univ Oxford, Dept Publ Hlth, Oxford, England; [El-Sayed, Abdulrahman M.] Columbia Univ, Coll Phys & Surg, New York, NY 10031 USA; [Ziewacz, John E.] Harvard Univ, Sch Publ Hlth, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Ziewacz, John E.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA		El-Sayed, AM (corresponding author), Columbia Univ, Dept Epidemiol, 722 W 168th St,15th Floor, New York, NY 10031 USA.	ame2145@columbia.edu	El-Sayed, Abdulrahman/F-7427-2013	El-Sayed, Abdulrahman/0000-0002-4809-5630	Rhodes Trust; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HSO 18537-01]	This study was funded in part by grants from the Rhodes Trust (to A. M. E.-S.) and the NIH (HSO 18537-01 to J.E.Z.). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Awe OO, 2011, NEUROSURGERY, V68, P753, DOI 10.1227/NEU.0b013e318207a9fb; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; BRODERICK J, 1994, HDB NEUROEPIDEMIOLOG, P141; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Hanif S, 2009, Ir Med J, V102, P255; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Iantosca MR, 2000, NEUROSURG CLIN N AM, V11, P447, DOI 10.1016/S1042-3680(18)30107-4; JANNY P, 1982, ACTA NEUROCHIR, V61, P181, DOI 10.1007/BF01740083; KASE CS, 1994, INTRACEREBRAL HEMORR, P467; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; Long DM, 2003, NEUROSURGERY, V52, P1056, DOI 10.1227/01.NEU.0000057745.48813.93; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Polanczyk CA, 2001, ANN INTERN MED, V134, P637, DOI 10.7326/0003-4819-134-8-200104170-00008; Qureshi Adnan I, 2005, J Intensive Care Med, V20, P34, DOI 10.1177/0885066604271619; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Sahni R, 2007, VASC HEALTH RISK MAN, V3, P701; Sawada T, 2008, HEPATO-GASTROENTEROL, V55, P1971; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Stachniak JB, 1996, STROKE, V27, P276, DOI 10.1161/01.STR.27.2.276; Stieg PE, 1998, NEUROL CLIN, V16, P373, DOI 10.1016/S0733-8619(05)70069-4; Sundermann S, 2011, EUR J CARDIO-THORAC, V39, P33, DOI 10.1016/j.ejcts.2010.04.013; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; TUHRIM S, 1995, CRIT CARE MED, V23, P950, DOI 10.1097/00003246-199505000-00026; Vyas NA, 2007, SURG NEUROL, V67, P314, DOI 10.1016/j.surneu.2006.03.039; White M, 2010, BRIT J NEUROSURG, V24, P257, DOI 10.3109/02688691003675218; Wright James D, 2005, Care Manag J, V6, P178, DOI 10.1891/cmaj.6.4.178; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093	39	24	24	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2012	116	1					234	245		10.3171/2011.7.JNS11396			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	869XJ	WOS:000298632500038	21888477				2022-02-06	
J	Murray, LL				Murray, Laura L.			Direct and indirect treatment approaches for addressing short-term or working memory deficits in aphasia	APHASIOLOGY			English	Article						Aphasia; Working memory; Short-term memory; Treatment; Memory training	DIRECT-CURRENT STIMULATION; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; SENTENCE COMPREHENSION; LANGUAGE PRODUCTION; PROCESSING SUPPORT; READING IMPAIRMENT; COGNITIVE FUNCTION; OLDER-ADULTS; MILD APHASIA	Background: A growing literature has documented that aphasia is frequently accompanied by deficits of short-term memory (STM) and working memory (WM), and that such memory impairments may negatively influence language abilities and aphasia treatment outcomes. Consequently, treating STM and WM impairments in individuals with aphasia should not only remediate these memory impairments but also positively affect their response to language therapy programmes. Aims: This paper critically reviews the aphasia literature pertaining to remediating, directly or indirectly, STM and WM deficits. Memory treatment protocols developed for other disordered as well as healthy populations are also discussed as possible therapy approaches to consider in future aphasia research. Main Contribution: Findings from a limited set of studies suggest that STM and WM impairments in individuals with aphasia do respond to treatment, and further that these treatments may also positively affect the language abilities of individuals with aphasia. Conclusions: Further research is warranted to establish the reliability and validity of these preliminary findings and to explore application of these treatments as well as those developed for nonaphasic populations to individuals representing a broader spectrum of aphasia types and severities.	Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA		Murray, LL (corresponding author), Indiana Univ, Dept Speech & Hearing Sci, 200 S Jordan, Bloomington, IN 47405 USA.	lmurray@indiana.edu					Aben L, 2008, J REHABIL MED, V40, P681, DOI 10.2340/16501977-0227; Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Alexander MP, 2006, J INT NEUROPSYCH SOC, V12, P236, DOI 10.1017/S1355617706060309; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Bartha L, 2003, BRAIN LANG, V85, P93, DOI 10.1016/S0093-934X(02)00502-3; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Caspari I, 1998, BRAIN COGNITION, V37, P205, DOI 10.1006/brcg.1997.0970; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Ciancarelli I, 2010, FUNCT NEUROL, V25, P81; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Coelho CA, 2005, APHASIOLOGY, V19, P275, DOI 10.1080/02687030444000741; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Crosson B, 1999, NEUROPSYCHOLOGY, V13, P171, DOI 10.1037/0894-4105.13.2.171; Crosson B, 2007, J INT NEUROPSYCH SOC, V13, P582, DOI 10.1017/S1355617707070737; Dahlin E, 2009, RESTOR NEUROL NEUROS, V27, P405, DOI 10.3233/RNN-2009-0492; Deplanque D, 2009, J NEUROL NEUROSUR PS, V80, P942, DOI 10.1136/jnnp.2009.174490; Duval J, 2008, NEUROPSYCHOL REHABIL, V18, P430, DOI 10.1080/09602010701573950; Fabre C, 2002, INT J SPORTS MED, V23, P415, DOI 10.1055/s-2002-33735; Fillingham JK, 2005, INT J LANG COMM DIS, V40, P505, DOI 10.1080/13682820500138572; Francis DR, 2003, APHASIOLOGY, V17, P723, DOI 10.1080/02687030344000201; Frankel T, 2007, APHASIOLOGY, V21, P814, DOI 10.1080/02687030701192448; Fridriksson J, 2010, J NEUROSCI, V30, P11558, DOI 10.1523/JNEUROSCI.2227-10.2010; Friedmann N, 2003, BRAIN LANG, V86, P23, DOI 10.1016/S0093-934X(02)00530-8; GORDON WP, 1983, NEUROPSYCHOLOGIA, V21, P325, DOI 10.1016/0028-3932(83)90019-2; Holmes J, 2010, APPL COGNITIVE PSYCH, V24, P827, DOI 10.1002/acp.1589; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Howard D., 2011, APHASIOLOGY; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jean L, 2010, AM J GERIAT PSYCHIAT, V18, P281, DOI 10.1097/JGP.0b013e3181c37ce9; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Jolles DD, 2010, NEUROIMAGE, V52, P658, DOI 10.1016/j.neuroimage.2010.04.028; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Kalinyak-Fliszar M., APHASIOLOGY IN PRESS; Kesner RP, 2009, BEHAV NEUROSCI, V123, P1, DOI 10.1037/a0014004; Kirschen MP, 2006, BEHAV NEUROL, V17, P187, DOI 10.1155/2006/469132; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Klusmann V, 2010, J GERONTOL A-BIOL, V65, P680, DOI 10.1093/gerona/glq053; Koenig-Bruhin M, 2007, APHASIOLOGY, V21, P448, DOI 10.1080/02687030600670593; Kolk H, 2006, SYNTAX NONSENTENTIAL; Levaux MN, 2009, NEUROPSYCHOL REHABIL, V19, P244, DOI 10.1080/09602010802091829; Linebarger M, 2007, BRAIN LANG, V100, P53, DOI 10.1016/j.bandl.2006.09.001; Linebarger MC, 2004, COGN NEUROPSYCHOL, V21, P267, DOI 10.1080/02643290342000537; Linebarger MC, 2000, BRAIN LANG, V75, P416, DOI 10.1006/brln.2000.2378; Linebarger MC, 2001, NEUROPSYCHOL REHABIL, V11, P57, DOI 10.1080/09602010042000178; LORENZEN B, 2008, PERSPECT NEUROPHYS N, V18, P99, DOI DOI 10.1044/NNSLD18.3.99; Loukavenko EA, 2007, EUR J NEUROSCI, V26, P3267, DOI 10.1111/j.1460-9568.2007.05879.x; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Majerus S, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P244; Malouin F, 2004, ARCH PHYS MED REHAB, V85, P177, DOI 10.1016/S0003-9993(03)00771-8; Martin N., 2011, APHASIOLOGY; Martin Randi C., 2008, Seminars in Speech and Language, V29, P201, DOI 10.1055/s-0028-1082884; Mayer JF, 2002, APHASIOLOGY, V16, P727, DOI 10.1080/02687030143000870; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDonald-Miszczak L, 1992, J GEN PSYCHOL, V47, P293; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muller U, 1998, J NEUROSCI, V18, P2720; Murray L, 2004, APHASIOLOGY, V18, P785, DOI 10.1080/02687030444000273; Murray LL, 2006, J COMMUN DISORD, V39, P37, DOI 10.1016/j.jcomdis.2005.06.001; Murray LL, 2000, BRAIN LANG, V72, P40, DOI 10.1006/brln.1999.2281; Murray LL, 2004, J MED SPEECH-LANG PA, V12, pXXV; Murray LL, 1997, APHASIOLOGY, V11, P993, DOI 10.1080/02687039708249423; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Nicholas M, 2005, APHASIOLOGY, V19, P1052, DOI 10.1080/02687030544000245; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimage.2003.09.069; Oswald Wolf D, 2006, Eur J Ageing, V3, P179, DOI 10.1007/s10433-006-0035-z; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Redick TS, 2006, APPL COGNITIVE PSYCH, V20, P713, DOI 10.1002/acp.1224; Ronnberg J, 1996, SCAND J PSYCHOL, V37, P46, DOI 10.1111/j.1467-9450.1996.tb00638.x; Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x; Sander AM, 2007, AM J SPEECH-LANG PAT, V16, P316, DOI 10.1044/1058-0360(2007/036); Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Seniow J, 2009, J NEUROL SCI, V283, P91, DOI 10.1016/j.jns.2009.02.315; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Sinotte MP, 2007, NEUROREHABILITATION, V22, P303; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; SOHLBERG MM, 2001, ATTENTION PROCESS TR, V2; Sung JE, 2009, APHASIOLOGY, V23, P1040, DOI 10.1080/02687030802592884; Swanson HL, 2010, J LEARN DISABIL-US, V43, P24, DOI 10.1177/0022219409338743; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; Vallat C, 2005, BRAIN INJURY, V19, P1157, DOI 10.1080/02699050500110595; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Vogt A, 2009, RESTOR NEUROL NEUROS, V27, P225, DOI 10.3233/RNN-2009-0473; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; Walker-Batson D, 2001, STROKE, V32, P2093, DOI 10.1161/hs0901.095720; Ween JE, 1996, NEUROLOGY, V47, P795, DOI 10.1212/WNL.47.3.795; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Whiting E, 2007, J INT NEUROPSYCH SOC, V13, P972, DOI 10.1017/S1355617707071317; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014	106	24	25	0	29	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2012	26	3-4			SI		317	337		10.1080/02687038.2011.589894			21	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	910OT	WOS:000301649800004					2022-02-06	
J	Sandhaug, M; Andelic, N; Berntsen, SA; Seiler, S; Mygland, A				Sandhaug, Maria; Andelic, Nada; Berntsen, Svein A.; Seiler, Stephen; Mygland, Aase			Self and near relative ratings of functional level one year after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Patient competency rating scale; relatives; self; traumatic brain injury	CLOSED-HEAD INJURY; IMPAIRED AWARENESS; POSTTRAUMATIC AMNESIA; COMPETENCE; SEVERITY; SCALE; AGE; LIMITATIONS; MORTALITY	Purpose: To quantify traumatic brain injury (TBI) patients' perceptions of own function by the Patient Competency Rating Scale (PCRS) one year after injury, and to examine self-awareness of functional deficits by comparing PCRS ratings from patients (PCRS-P) and PCRS ratings from near relatives (PCRS-R), and to identify predictors of awareness deficits. Method: A cohort of 50 severe (n = 33) and moderate (n = 17) TBI patients. Awareness of deficits was investigated by subtracting PCRS relative ratings from PCRS patient ratings. Predictors of PCRS ratings and differences were assessed by stepwise multiple regression analyses. Results: The average patient PCRS sum score was 122/150 (95% CI = 115; 129) as compared to a sum score of 117/150 (95% CI = 110; 125), given by their relatives (p = 0.93). The patients scored themselves slightly higher than their relatives in the domains of activities of daily living (ADL) and cognitive function (p < 0.001, p < 0.001). Regression analyses showed that Glasgow Coma Scale (GCS) score at admission to rehabilitation was the strongest predictor of patient PCRS (B = 3.314, p = 0.008). The strongest predictor of differences between patient and relative PCRS was GCS score acute (B = -3.530, p = 0.001). Conclusions: TBI patients demonstrated a slight "awareness gap" in ADL and cognitive function. Low GCS score in the acute phase and high age were the strongest predictors of self-awareness deficits.	[Sandhaug, Maria; Seiler, Stephen] Agder Univ, Fac Hlth & Sports, N-4604 Kristiansand, Norway; [Sandhaug, Maria] Sorlandet Hosp, Dept Res, Kristiansand, Norway; [Andelic, Nada; Mygland, Aase] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Berntsen, Svein A.] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway; [Mygland, Aase] Univ Bergen, Inst Clin Med, Bergen, Norway		Sandhaug, M (corresponding author), Agder Univ, Fac Hlth & Sports, Serv Box 422, N-4604 Kristiansand, Norway.	maria.sandhaug@uia.no		Andelic, Nada/0000-0002-3719-4406	Norwegian Foundation for Health and Rehabilitation	This study has been financed with the aid of extra funds from the Norwegian Foundation for Health and Rehabilitation. No previous presentation of the research, manuscript or abstract exists.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Prigatano GP, 2005, ACT NEUR S, V93, P39; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 2009, ARCH PHYS MED REHAB, V19, P161; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295	28	24	24	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2012	34	11					904	909		10.3109/09638288.2011.626484			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	919YZ	WOS:000302369400003	22148905	Green Submitted			2022-02-06	
J	Slovarp, L; Azuma, T; Lapointe, L				Slovarp, Laurie; Azuma, Tamiko; Lapointe, Leonard			The effect of traumatic brain injury on sustained attention and working memory	BRAIN INJURY			English	Article						Vigilance; 2-back task	CLOSED-HEAD-INJURY; DEFICITS; SYSTEM; TASK; IMPAIRMENT; LOAD	Primary objective: The aim of the study was to evaluate working memory (WM) and sustained attention (SA) following severe traumatic brain injury (TBI). Research design: The study was a quasi-experimental design with two dependent measures. Methods and procedures: Nine individuals with severe TBI and nine non-injured controls completed two visual tasks containing alphabetic stimuli: a WM task (2-back task) and a 10-minute SA task. Main outcomes and results: Participants with TBI had lower hit rates and higher false alarm rates than controls on the WM task. Quantitative analysis of the group data did not reveal a differential deficit in SA; however, post-hoc qualitative visual analysis of individual data revealed considerable variability in four participants with TBI, indicating evidence of impaired SA in select individuals. The hit rates for both tasks were positively correlated, supporting the contention that WM and SA are inter-related. Conclusions: This study provides further evidence of WM deficits following TBI as well as possible SA deficits in some individuals. The results also suggest that WM and SA are inter-related processes. Future studies are needed to replicate the results with larger sample sizes. Based on these findings, patients with TBI may present with WM and SA deficits.	[Slovarp, Laurie] Univ Montana, Dept Communicat Sci & Disorders, Missoula, MT 59812 USA; [Azuma, Tamiko] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85287 USA; [Lapointe, Leonard] Florida State Univ, Dept Commun Sci & Disorders, Tallahassee, FL 32306 USA		Slovarp, L (corresponding author), Univ Montana, Dept Communicat Sci & Disorders, 32 Campus Dr, Missoula, MT 59812 USA.	laurie.slovarp@umontana.edu					AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Baddeley A.D., 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BENNETT T, 1998, J COGN REHABIL, V16, P8; BENYISHAY Y, 1980, REHABILITATION MONOG, V16, P71; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; Caggiano DM, 2004, PSYCHON B REV, V11, P932, DOI 10.3758/BF03196724; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; GILES GM, 1993, BRAIN INJURY REHABIL; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; MATEER C, 1992, SEMINARS SPEECH LANG, V13, P281; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6; [No title captured]	42	24	25	0	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					48	57		10.3109/02699052.2011.635355			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900005	22149444				2022-02-06	
J	Lin, CY; Wright, J; Bushnik, T; Shem, K				Lin, Cindy Y.; Wright, Jerry; Bushnik, Tamara; Shem, Kazuko			Traumatic Spinal Cord Injuries in Horseback Riding A 35-Year Review	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						horseback riding; traumatic spinal cord injury; spine fractures; accidental falls; athletic injuries	EQUESTRIAN INJURIES; UNITED-STATES; RISK-FACTORS; PREVENTION; ACCIDENTS; PATTERNS; SPORTS; RIDERS	Background: Spinal cord injury (SCI) is a potentially disabling neurologic injury that can occur in horseback riding. To date, no published study has examined the epidemiology of SCI from horseback riding in the United States, and few international studies exist on this topic. Several studies have described traumatic brain injuries, spine fractures, and extremity injuries; however, SCI patterns and outcomes in horseback riders are poorly understood. Purpose: This study was undertaken to characterize the demographics, SCI patterns, and neurologic outcomes of persons with SCIs related to horseback riding. Study Design: Descriptive epidemiologic study. Methods: This is a retrospective review of 121 SCI cases from horseback riding in the National SCI Statistical Center database from 1973 to 2008. The treatment setting was 26 U.S. SCI Model Systems of Care. The number of injuries, gender, age, and SCI type for horseback riding were compared with other sports and activities. The level of preserved neurologic function, SCI completeness, American Spinal Injury Association classification, and mechanical ventilation use at discharge were examined in the horseback riding group. Results: The mean age of injury was 37.8 years (standard deviation, 15.2). The majority of patients were white (88%) and female (50.4%). Compared with diving, motorcycle riding, football, and gymnastics, horseback riding involved a significantly higher number of women (P < .005), a higher mean age of injury, and an equal likelihood of resulting in paraplegia and tetraplegia. The most common levels of preserved neurologic function were C4-C6, T12, and L1. Spinal cord injury from horseback riding most commonly resulted in incomplete tetraplegia (41%) followed by complete paraplegia (24%). Only 4 patients required mechanical ventilation on discharge from acute inpatient rehabilitation. Conclusion: Spinal cord injury from horseback riding affects an equal proportion of women and men, has a wide age range, and most commonly results in incomplete tetraplegia followed by complete paraplegia. Study findings improve awareness of the demographics and neurologic outcomes of individuals with SCI from horseback riding and can help guide future studies evaluating SCI mechanisms in horseback riders to improve injury prevention and management.	[Lin, Cindy Y.; Wright, Jerry; Bushnik, Tamara; Shem, Kazuko] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA		Lin, CY (corresponding author), Rehabil Inst Chicago, Spine & Sports Rehabil Ctr, 1030 N Clark St,Suite 500, Chicago, IL 60610 USA.	cindy.lin@post.harvard.edu		Lin, Cindy/0000-0002-1662-8295	National Spinal Cord Injury Statistical Center (NSCISC); Spinal Cord Injury Model Systems (SCIMS); National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of EducationUS Department of Education	One or more of the authors has declared the following potential conflict of interest or source of funding: Funding was provided by the National Spinal Cord Injury Statistical Center (NSCISC), Spinal Cord Injury Model Systems (SCIMS), and the National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of Education.	Balendra G, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038950; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Ball J.E., 2009, J TRAUMA MANAG OUTCO, V3, P2; Banerjee R, 2004, AM J SPORT MED, V32, P1760, DOI 10.1177/0363546504268931; Bixby-Hammett D. M., 1989, SPORTS NEUROLOGY, P229; Boden BP, 2008, NEUROL CLIN, V26, P63, DOI 10.1016/j.ncl.2007.12.005; BROOKS WH, 1988, PHYSICIAN SPORTSMED, V16, P84, DOI 10.1080/00913847.1988.11709646; BROOKS WH, 1998, SPORTS NEUROLOGY, P381; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; CAMPAGNOLO D, 2002, SPINAL CORD MED, P96; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; CORDELL K, RECREATION STAT UPDA; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Ghosh A, 2000, J PEDIATR SURG, V35, P1766, DOI 10.1053/jpsu.2000.19247; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; KELLY P, 2004, J BONE JOINT SURG S, V86, P122; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; McCrory P, 2005, MED SPORT SCI, V48, P8, DOI 10.1159/000084280; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; Murray JK, 2005, VET J, V170, P318, DOI 10.1016/j.tvjl.2005.05.003; National Spinal Cord Injury Statistical Center, 2006, SPIN CORD INJ MOD SY; National Spinal Cord Injury Statistical Center, SPIN CORD INJ FACTS; *PAR VET AM, 1999, CONS SPIN CORD MED C; Roe JP, 2003, ANZ J SURG, V73, P331, DOI 10.1046/j.1445-2197.2003.t01-1-02618.x; Schmitt H, 2001, CLIN J SPORT MED, V11, P17, DOI 10.1097/00042752-200101000-00004; SCHNECK C, 2002, SPINAL CORD MED, P27; Siebenga J, 2006, EUR SPINE J, V15, P465, DOI 10.1007/s00586-005-1012-5; Silver J R, 1991, Br J Sports Med, V25, P105; Silver JR, 2002, SPINAL CORD, V40, P264, DOI 10.1038/sj.sc.3101280; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; THOMAS K, 2008, NY TIMES        0409; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; *US EQ FED, 2009, 2010 US EQ FED RUL B, P85; ZAFONTE RD, 2002, SPINAL CORD MED, P261; US CONSUMER PRODUCT; 1990, MMWR WEEKLY, V39, P329	40	24	25	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	NOV	2011	39	11					2441	2446		10.1177/0363546511419280			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	838KG	WOS:000296287900022	21856930				2022-02-06	
J	Severino, PC; Muller, GDS; Vandresen, S; Tasca, CI				Severino, Patricia Cardoso; Silva Muller, Gabriele do Amaral; Vandresen-Filho, Samuel; Tasca, Carla Ines			Cell signaling in NMDA preconditioning and neuroprotection in convulsions induced by quinolinic acid	LIFE SCIENCES			English	Article; Proceedings Paper	International Symposium on Cell Signaling	OCT 28-31, 2010	Florianopolis, BRAZIL			Preconditioning; N-methyl-D-aspartate; Neuroprotection; Glutamatergic excitotoxicity; Quinolinic acid; NMDA receptor	INHIBITS GLUTAMATE UPTAKE; CEREBELLAR GRANULE CELLS; TRAUMATIC BRAIN-INJURY; D-ASPARTATE; ISCHEMIC TOLERANCE; APOPTOTIC NEURODEGENERATION; INDUCED SEIZURES; RECEPTORS; PHOSPHORYLATION; PROTECTS	The search for novel, less invasive therapeutic strategies to treat neurodegenerative diseases has stimulated scientists to investigate the mechanisms involved in preconditioning. Preconditioning has been report to occur in many organs and tissues. In the brain, the modulation of glutamatergic transmission is an important and promising target to the use of effective neuroprotective agents. The glutamatergic excitotoxicity is a factor common to neurodegenerative diseases and acute events such as cerebral ischemia, traumatic brain injury and epilepsy. In this review we focus on the neuroprotection and preconditioning by chemical agents. Specially, chemical preconditioning models using N-methyl-D-aspartate (NMDA) pre-treatment, which has demonstrated to lead to neuroprotection against seizures and damage to neuronal tissue induced by quinolinic acid (QA). Here we attempted to gather important results obtained in the study of cellular and molecular mechanisms involved in NMDA preconditioning and neuroprotection. (C) 2011 Elsevier Inc. All rights reserved.	[Severino, Patricia Cardoso; Silva Muller, Gabriele do Amaral] Univ Fed Santa Catarina, Dept Bioquim CCB, Ctr Biol Mol & Estrutural, BR-88040900 Florianopolis, SC, Brazil; [Vandresen-Filho, Samuel; Tasca, Carla Ines] Univ Fed Santa Catarina, Dept Bioquim CCB, Lab Neuroquim 4, BR-88040900 Florianopolis, SC, Brazil		Severino, PC (corresponding author), Univ Fed Santa Catarina, Dept Bioquim CCB, Ctr Biol Mol & Estrutural, BR-88040900 Florianopolis, SC, Brazil.	patsics@gmail.com	Tasca, Carla Ines/AAB-8287-2019; Vandresen-Filho, Samuel/A-1239-2013	Tasca, Carla Ines/0000-0002-3414-6150; Vandresen-Filho, Samuel/0000-0002-4718-2900	CAPES/PRODOCCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); REUNI Program scholarship; INCT; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	We want to thank CAPES/PRODOC and Biochemistry Post Graduation program for Patricia Cardoso Severino fellowship. Samuel Vandresen-Filho and Gabriele Muller for REUNI Program scholarship. Carla Tasca is thankful for INCT research funding. And we also thank CNPq for financial support.	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Ahn J, 2008, NEUROSCI LETT, V433, P11, DOI 10.1016/j.neulet.2007.12.045; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Boeck CR, 2007, AMINO ACIDS, V33, P439, DOI 10.1007/s00726-006-0455-2; Boeck CR, 2005, J NEUROCHEM, V94, P48; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x; Bond A, 1999, EUR J PHARMACOL, V380, P91, DOI 10.1016/S0014-2999(99)00523-3; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Oliveira DL, 2004, BRAIN RES, V1018, P48, DOI 10.1016/j.brainres.2004.05.033; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; Featherstone DE, 2010, ACS CHEM NEUROSCI, V1, P4, DOI 10.1021/cn900006n; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Grazioso G, 2005, J MED CHEM, V48, P5489, DOI 10.1021/jm050174x; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Herculano BD, 2011, BEHAV BRAIN RES, V219, P92, DOI 10.1016/j.bbr.2010.12.025; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kelly PJ, 2004, STROKE, V35, P12, DOI 10.1161/01.STR.0000106481.59944.2F; Khaspekov L, 1998, NEUROREPORT, V9, P1273, DOI 10.1097/00001756-199805110-00003; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Kolb B, 2002, NEUROCIENCIA COMPORT, P664; LAPIN IP, 1978, J NEURAL TRANSM, V42, P37, DOI 10.1007/BF01262727; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Loveridge R, 2010, BJA EDUC, V10, P38, DOI 10.1093/bjaceaccp/mkq005; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; MARINI AM, 1992, P NATL ACAD SCI USA, V89, P6555, DOI 10.1073/pnas.89.14.6555; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Miao H, 2005, J VASC RES, V42, P77, DOI 10.1159/000083094; Molz S, 2003, THESIS U FEDERAL SAN; Monti B, 2000, EUR J NEUROSCI, V12, P3117, DOI 10.1046/j.1460-9568.2000.00189.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Noh J, 2009, J NEUROCHEM, V109, P1261, DOI 10.1111/j.1471-4159.2009.06044.x; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; PERKINS MN, 1983, BRAIN RES, V259, P172, DOI 10.1016/0006-8993(83)91084-3; Puisieux F, 2004, BRAIN RES, V1027, P30, DOI 10.1016/j.brainres.2004.08.067; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ravati A, 2001, J NEUROCHEM, V78, P909, DOI 10.1046/j.1471-4159.2001.00463.x; Rebola N, 2005, NEUROCHEM INT, V47, P317, DOI 10.1016/j.neuint.2005.05.009; Rebola N, 2005, NEUROSCIENCE, V133, P79, DOI 10.1016/j.neuroscience.2005.01.054; Rejdak R, 2001, POL J PHARMACOL, V53, P73; Riva MA, 1997, MOL BRAIN RES, V50, P136, DOI 10.1016/S0169-328X(97)00175-7; Rivera-Cervantes MC, 2009, INT J DEV NEUROSCI, V27, P197, DOI 10.1016/j.ijdevneu.2008.09.006; Saleh A, 2007, STROKE, V38, P2733, DOI 10.1161/STROKEAHA.107.481788; Saleh MC, 2009, BRAIN RES, V1247, P212, DOI 10.1016/j.brainres.2008.10.014; Samoilov M O, 2003, Neurosci Behav Physiol, V33, P1, DOI 10.1023/A:1021119112927; Schaller B, 2002, J NEUROL, V249, P1503, DOI 10.1007/s00415-002-0933-8; Schmidt AP, 2010, OPEN NEUROSCI J, V4, P102, DOI DOI 10.2174/1874082001004010113; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; SCHURR A, 1986, BRAIN RES, V374, P244, DOI 10.1016/0006-8993(86)90418-X; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Siegel GJ, 2006, BASIC NEUROCHEMISTRY; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Tasca CI, 1999, NEUROCHEM RES, V24, P1067, DOI 10.1023/A:1021017112717; Tasca CI, 2000, NEUROCHEM RES, V25, P181, DOI 10.1023/A:1007557600687; Tavares RG, 2000, NEUROREPORT, V11, P249, DOI 10.1097/00001756-200002070-00005; Tavares RG, 2005, NEUROCHEM RES, V30, P439, DOI 10.1007/s11064-005-2678-0; Tavares RG, 2002, NEUROCHEM INT, V40, P621, DOI 10.1016/S0197-0186(01)00133-4; Vandresen S, 2007, BRAIN RES, V1184, P38, DOI 10.1016/j.brainres.2007.09.091; Vega-Naredo I, 2005, J PINEAL RES, V39, P266, DOI 10.1111/j.1600-079X.2005.00243.x; Vianna EPM, 2005, EPILEPSIA, V46, P166, DOI 10.1111/j.1528-1167.2005.01027.x; Waring P, 2005, ARCH BIOCHEM BIOPHYS, V434, P33, DOI 10.1016/j.abb.2004.08.001; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P33, DOI 10.1111/j.1469-7793.1998.00033.x; Youssef FF, 2001, BRAIN RES, V907, P144, DOI 10.1016/S0006-8993(01)02594-X; Zhang MJ, 2010, AM J PHYSIOL-HEART C, V299, pH713, DOI 10.1152/ajpheart.00273.2010	93	24	25	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	OCT 10	2011	89	15-16			SI		570	576		10.1016/j.lfs.2011.05.014			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Research & Experimental Medicine; Pharmacology & Pharmacy	827KW	WOS:000295428400010	21683718				2022-02-06	
J	Bahloul, M; Chaari, A; Dammak, H; Medhioub, F; Abid, L; Ksibi, H; Haddar, S; Kallel, H; Chelly, H; Ben Hamida, C; Bouaziz, M				Bahloul, Mabrouk; Chaari, Anis; Dammak, Hassen; Medhioub, Fatma; Abid, Leila; Ksibi, Hichem; Haddar, Sondes; Kallel, Hatem; Chelly, Hedi; Ben Hamida, Chokri; Bouaziz, Mounir			Post-traumatic pulmonary embolism in the intensive care unit	ANNALS OF THORACIC MEDICINE			English	Article						Anticoagulation; ICU; predictive factors; pulmonary embolism; trauma patients	TRAUMATIC BRAIN-INJURY; VENOUS THROMBOEMBOLISM; MAJOR TRAUMA; ACUTE PHYSIOLOGY; RISK-FACTORS; PROPHYLAXIS; SCORE; MANAGEMENT; DIAGNOSIS; HEPARIN	OBJECTIVE: To determine the predictive factors, clinical manifestations, and the outcome of patients with post-traumatic pulmonary embolism (PE) admitted in the intensive care unit (ICU). METHODS: During a four-year prospective study, a medical committee of six ICU physicians prospectively examined all available data for each trauma patient in order to classify patients according to the level of clinical suspicion of pulmonary thromboembolism. During the study period, all trauma patients admitted to our ICU were classified into two groups. The first group included all patients with confirmed PE; the second group included patients without clinical manifestations of PE. The diagnosis of PE was confirmed either by a high-probability ventilation/perfusion (V/Q) scan or by a spiral computed tomography (CT) scan showing one or more filling defects in the pulmonary artery or its branches. RESULTS: During the study period, 1067 trauma patients were admitted in our ICU. The diagnosis of PE was confirmed in 34 patients (3.2%). The mean delay of development of PE was 11.3 +/- 9.3 days. Eight patients (24%) developed this complication within five days of ICU admission. On the day of PE diagnosis, the clinical examination showed that 13 patients (38.2%) were hypotensive, 23 (67.7%) had systemic inflammatory response syndrome (SIRS), three (8.8%) had clinical manifestations of deep venous thrombosis (DVT), and 32 (94%) had respiratory distress requiring mechanical ventilation. In our study, intravenous unfractionated heparin was used in 32 cases (94%) and low molecular weight heparin was used in two cases (4%). The mean ICU stay was 31.6 +/- 35.7 days and the mean hospital stay was 32.7 +/- 35.3 days. The mortality rate in the ICU was 38.2% and the in-hospital mortality rate was 41%. The multivariate analysis showed that factors associated with poor prognosis in the ICU were the presence of circulatory failure (Shock) (Odds ratio (OR) = 9.96) and thrombocytopenia (OR = 32.5). Moreover, comparison between patients with and without PE showed that the predictive factors of PE were: Age > 40 years, a SAPS II score > 25, hypoxemia with PaO2/FiO(2) < 200 mmHg, the presence of spine fracture, and the presence of meningeal hemorrhage. CONCLUSION: Despite the high frequency of DVT in post-traumatic critically ill patients, symptomatic PE remains, although not frequently observed, because systematic screening is not performed. Factors associated with poor prognosis in the ICU are the presence of circulatory failure (shock) and thrombocytopenia. Predictive factors of PE are: Age > 40 years, a SAPS II score > 25, hypoxemia with PaO2/FiO(2) < 200, the presence of a spine fracture, and the presence of meningeal hemorrhage. Prevention is highly warranted.	[Bahloul, Mabrouk; Chaari, Anis; Dammak, Hassen; Medhioub, Fatma; Ksibi, Hichem; Kallel, Hatem; Chelly, Hedi; Ben Hamida, Chokri; Bouaziz, Mounir] Univ Hosp Sfax, Dept Intens Care, Sfax, Tunisia; [Abid, Leila] Univ Hosp Sfax, Dept Cardiol, Sfax, Tunisia; [Haddar, Sondes] Univ Hosp Sfax, Dept Radiol, Sfax, Tunisia		Bahloul, M (corresponding author), Hop Habib Bourguiba, Dept Med Intens Care, Route el Ain Km 1 3029, Sfax, Tunisia.	bahloulmab@yahoo.fr		Bahloul, Mabrouk/0000-0002-6488-8294			Bahloul M, 2010, ANN THORAC MED, V5, P97, DOI 10.4103/1817-1737.62473; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARRITT DW, 1960, LANCET, V1, P1309; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; Chin Paul, 2006, N Z Med J, V119, pU2052; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Goldhaber SZ, 2002, ANN INTERN MED, V136, P691, DOI 10.7326/0003-4819-136-9-200205070-00012; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Gruel Y, 2004, REV MED INTERNE, V25, P35, DOI 10.1016/S0248-8663(03)00109-7; HERMANN RE, 1961, AM J SURG, V102, P19, DOI 10.1016/0002-9610(61)90680-8; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Menaker J, 2007, J TRAUMA, V63, P620, DOI 10.1097/TA.0b013e31812f60aa; Menaker J, 2009, J TRAUMA, V67, P1244, DOI 10.1097/TA.0b013e31818c173a; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; OMALLEY KF, 1990, J TRAUMA, V30, P748, DOI 10.1097/00005373-199006000-00018; Owings JT, 1997, ARCH SURG-CHICAGO, V132, P862; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Qureshi SS, 2001, CLIN EXP IMMUNOL, V125, P258, DOI 10.1046/j.1365-2249.2001.01596.x; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Schultz DJ, 2004, J TRAUMA, V56, P727, DOI 10.1097/01.TA.0000119687.23542.EC; SIMPSON D, 1982, LANCET, V2, P450; Sing RF, 2006, J TRAUMA, V60, P732, DOI 10.1097/01.ta.0000210285.22571.66; STEIN PD, 1992, AM J CARDIOL, V69, P1239, DOI 10.1016/0002-9149(92)90944-T; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	34	24	24	1	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1817-1737	1998-3557		ANN THORAC MED	Ann. Thorac. Med.	OCT-DEC	2011	6	4					199	206		10.4103/1817-1737.84773			8	Cardiac & Cardiovascular Systems; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System	820HX	WOS:000294897400004	21977064	gold, Green Published			2022-02-06	
J	Findling, O; Schuster, C; Sellner, J; Ettlin, T; Allum, JHJ				Findling, O.; Schuster, C.; Sellner, J.; Ettlin, T.; Allum, J. H. J.			Trunk sway in patients with and without, mild traumatic brain injury after whiplash injury	GAIT & POSTURE			English	Article						Balance; Posture; Whiplash; Mild traumatic brain injury	DIZZINESS HANDICAP INVENTORY; POSTURAL STABILITY; HEAD-INJURY; BALANCE; PAIN; GAIT; RELIABILITY; MANAGEMENT; SYMPTOMS; STANCE	Objective: This study assessed the addition effect of mild traumatic brain injury (MTBI) on the balance control of patients who simultaneously suffered a whiplash associated disorder (WAD). Background: Dizziness is common in patients suffering from whiplash injury with or without a MTBI, but data is lacking about the additional balance problems and dizziness caused by MTBI. Methods: 44 patients with WAD and MTBI and 36 WAD patients without MTBI participated in the study. A dizziness handicap index (DHI) was used to quantify self-perceived handicap. Balance control was assessed using measures of trunk sway for a battery of stance and gait tests. Results: Patients with WAD and MTBI perceived significantly higher dizziness and unsteadiness (higher score in DHI Emotional category) and had greater trunk sway than WAD patients without MTBI for stance tasks and complex gait tasks (e.g. walking up and down stairs). Both groups had greater sway than controls for these tasks. Both groups of patients showed equal reductions in trunk sway with respect to controls for simple gait tasks (e.g. walking while rotating the head). Conclusions: A similar pattern of balance impairment was present in patients with whiplash injury with and without MTBI. However, the impairment was greater for stance and complex gait tasks in WAD patients with MTBI. (C) 2011 Elsevier B.V. All rights reserved.	[Allum, J. H. J.] Univ Basel, Univ Basel Hosp, Dept Otorhinolaryngol, CH-4031 Basel, Switzerland; [Findling, O.; Schuster, C.; Ettlin, T.] Reha Rheinfelden, Rheinfelden, Switzerland; [Findling, O.] Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Findling, O.] Univ Bern, CH-3012 Bern, Switzerland; [Sellner, J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany		Allum, JHJ (corresponding author), Univ Basel, Univ Basel Hosp, Dept Otorhinolaryngol, Petersgraben 4, CH-4031 Basel, Switzerland.	jallum@uhbs.ch	Selllner, Johann/AAB-1263-2019; Schuster, Corina/B-6939-2008; Findling, Oliver/AAE-3815-2019	Schuster-Amft, Corina/0000-0003-1120-4423	Swiss National Research FoundationSwiss National Science Foundation (SNSF) [31.104212/1]; Swiss Accident Insurance Organisation (SUVA)	This work was supported by grants from the Swiss National Research Foundation (Grant No. 31.104212/1) and Swiss Accident Insurance Organisation (SUVA) to JHJ Allum.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Allum JHJ, 2005, CURR OPIN NEUROL, V18, P15, DOI 10.1097/00019052-200502000-00005; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; CDC (Centers for Disease Control) and Prevention NCf1PaC, 2003, MILD TRAUM BRAIN INJ; DEANS GT, 1986, BRIT MED J, V292, P94, DOI 10.1136/bmj.292.6513.94-a; Dolinis J, 1997, INJURY, V28, P173, DOI 10.1016/S0020-1383(96)00186-6; Endo K, 2006, EUR SPINE J, V15, P886, DOI 10.1007/s00586-005-0970-y; Evans R, 2000, PROGNOSIS NEUROLOGIC, P152; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Giacomini P, 1997, Acta Otorhinolaryngol Ital, V17, P409; Hegeman J, 2007, J VESTIBUL RES-EQUIL, V17, P75; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; Horlings CGC, 2009, NEUROSCIENCE, V161, P904, DOI 10.1016/j.neuroscience.2009.04.005; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Karlsborg M, 1997, ACTA NEUROL SCAND, V95, P65, DOI 10.1111/j.1600-0404.1997.tb00071.x; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kurre A, 2009, OTOL NEUROTOL, V30, P359, DOI 10.1097/MAO.0b013e3181977e09; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; Mallinson AI, 1998, AM J OTOL, V19, P814; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; SPITZER WO, 1995, SPINE, V20, pS1; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Van de Warrenburg BPC, 2005, MOVEMENT DISORD, P1006; Vonk J, 2010, AUDIOL NEURO-OTOL, V15, P261, DOI 10.1159/000258682; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035	32	24	24	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2011	34	4					473	478		10.1016/j.gaitpost.2011.06.021			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	841AQ	WOS:000296484800006	21803583				2022-02-06	
J	Gonzalez, PG; Walker, MT				Gonzalez, Peter G.; Walker, Matthew T.			Imaging Modalities in Mild Traumatic Brain Injury and Sports Concussion	PM&R			English	Article							DIFFUSE AXONAL INJURY; MINOR HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; WHITE-MATTER INJURY; TECHNETIUM-99M-HMPAO SPECT; FUNCTIONAL MRI; COMPUTED-TOMOGRAPHY; ABNORMALITIES; CHILDREN; MODERATE	Mild traumatic brain injury is a significant public health issue that has been gaining considerable attention over the past few years. After injury, a large percentage of patients experience postconcussive symptoms that affect work and school performance and that carry significant medicolegal implications. Conventional imaging modalities (computed tomography and magnetic resonance imaging) are insensitive to microstructural changes and underestimate the degree of diffuse axonal injury and metabolic changes. Newer imaging techniques have attempted to better diagnose and characterize diffuse axonal injury and the metabolic and functional aspects of traumatic brain injury. The following review article summarizes the currently available imaging studies and describes the novel and more investigational techniques available for mild traumatic brain injury. A suggested algorithm is offered. PM R 2011;3:S413-S424	[Gonzalez, Peter G.] Eastern Virginia Med Sch, Dept Phys Med & Rehabil, Norfolk, VA 23507 USA; [Walker, Matthew T.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA		Gonzalez, PG (corresponding author), Eastern Virginia Med Sch, Dept Phys Med & Rehabil, 721 Fairfax Ave,3rd Floor, Norfolk, VA 23507 USA.	gonzalpg@evms.edu					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Davis PC BJ, 2008, EXPERT PANEL NEUROLO; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Faul M, 2010, TRAUMATIC BRAIN INJU; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; ICHISE M, 1994, J NUCL MED, V35, P217; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LEXA FJ, 1994, AM J NEURORADIOL, V15, P201; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schwartz ES, 2010, PEDIATR RADIOL, V40, P50, DOI 10.1007/s00247-009-1451-y; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	59	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S413	S424		10.1016/j.pmrj.2011.08.536			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100009	22035684				2022-02-06	
J	Volman, V; Bazhenov, M; Sejnowski, TJ				Volman, Vladislav; Bazhenov, Maxim; Sejnowski, Terrence J.			Pattern of trauma determines the threshold for epileptic activity in a model of cortical deafferentation	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						computational model; epilepsy; homeostasis; traumatic brain injury; paroxysmal discharge	ACTIVITY-DEPENDENT MODULATION; HOMEOSTATIC PLASTICITY; QUANTAL AMPLITUDE; SYNAPTIC AMPA; EPILEPTOGENESIS; POTASSIUM; DYNAMICS; SEIZURES	Epileptic activity often occurs in the cortex after a latent period after head trauma; this delay has been attributed to the destabilizing influence of homeostatic synaptic scaling and changes in intrinsic properties. However, the impact of the spatial organization of cortical trauma on epileptogenesis is poorly understood. We addressed this question by analyzing the dynamics of a large-scale biophysically realistic cortical network model subjected to different patterns of trauma. Our results suggest that the spatial pattern of trauma can greatly affect the propensity for developing posttraumatic epileptic activity. For the same fraction of lesioned neurons, spatially compact trauma resulted in stronger posttraumatic elevation of paroxysmal activity than spatially diffuse trauma. In the case of very severe trauma, diffuse distribution of a small number of surviving intact neurons alleviated posttraumatic epileptogenesis. We suggest that clinical evaluation of the severity of brain trauma should take into account the spatial pattern of the injured cortex.	[Volman, Vladislav; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Comp Neurobiol Lab, La Jolla, CA 92037 USA; [Volman, Vladislav; Sejnowski, Terrence J.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA		Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Comp Neurobiol Lab, La Jolla, CA 92037 USA.	terry@salk.edu	Sejnowski, Terrence/AAV-5558-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS059740, R01 NS060870]; Howard Hughes InstituteHoward Hughes Medical Institute; National Science FoundationNational Science Foundation (NSF) [NSF PHY0822283]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059740, R01NS060870] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health Grants R01 NS059740 and R01 NS060870, the Howard Hughes Institute, and National Science Foundation sponsored Center for Theoretical Biological Physics NSF PHY0822283.	Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Bogaard A, 2009, J NEUROSCI, V29, P1677, DOI 10.1523/JNEUROSCI.5218-08.2009; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Frohlich F, 2006, J NEUROSCI, V26, P6153, DOI 10.1523/JNEUROSCI.5509-05.2006; GRAFSTEIN B, 1957, ELECTROEN CLIN NEURO, V9, P723, DOI 10.1016/0013-4694(57)90096-2; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kollevold T, 1976, J Oslo City Hosp, V26, P99; LESCHINGER A, 1993, EXP BRAIN RES, V96, P230; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pan EH, 1997, J NEUROPHYSIOL, V77, P2293, DOI 10.1152/jn.1997.77.5.2293; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	30	24	24	0	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 13	2011	108	37					15402	15407		10.1073/pnas.1112066108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819DF	WOS:000294804900080	21896754	Green Published, Bronze			2022-02-06	
J	Carlomagno, S; Giannotti, S; Vorano, L; Marini, A				Carlomagno, Sergio; Giannotti, Sara; Vorano, Lorenzo; Marini, Andrea			Discourse information content in non-aphasic adults with brain injury: A pilot study	BRAIN INJURY			English	Article						Traumatic brain injury; discourse analysis; pragmatic errors; information content	CONNECTED SPEECH SAMPLES; LANGUAGE; IMPROVEMENT; COHESION; SYSTEM	Background: The functional evaluation of discourse informativeness is widely used in both clinical practice and research, and impoverished and confused discourse has been described in individuals with traumatic brain injury (TBI). These symptoms have been related to language processing deficits at the macrolinguistic level. However, the functional counterpart of these deficits, i.e. poor informativeness in standardized analysis of elicited speech samples, has been less explored. Methods and procedures: In this pilot study, samples of narrative discourse from 10 non-aphasic TBI adults and 28 healthy adults were examined to study the relationship between standardized measures of informativeness (i.e. Correct Information Unit analysis) and language processing errors at the macrolinguistic level and to compare performance of the two groups. Main outcomes and results: The participants with TBI did not produce relevant within-sentence errors and information content of their narratives was not different from that of the healthy participants. However, their production of errors of cohesion, local coherence and global coherence was significantly greater. These macrolinguistic errors corresponded to reduced levels of information efficiency (% CIUs score). Conclusions: Functional measures of speech informativeness such as the CIU scores may be useful for the clinical assessment of discourse processing deficits in TBI individuals without aphasic symptoms.	[Carlomagno, Sergio; Giannotti, Sara] Univ Trieste, Dipartimento Psicol, I-34134 Trieste, Italy; [Vorano, Lorenzo] IMFR Gervasutta, Udine, Italy; [Marini, Andrea] Univ Udine, I-33100 Udine, Italy; [Marini, Andrea] IRCCS E Medea, S Vito Al Tagliamento, Pn, Italy		Carlomagno, S (corresponding author), Univ Trieste, Dipartimento Psicol, Via St Anastasio 12, I-34134 Trieste, Italy.	scarlomagno@units.it	Marini, Andrea/A-1206-2012	Marini, Andrea/0000-0002-6058-3864			Brookshire R. H., 1993, DISCOURSE COMPREHENS; BROOKSHIRE RH, 1994, J SPEECH HEAR RES, V37, P399, DOI 10.1044/jshr.3702.399; BROOKSHIRE RH, 1995, AM J SPEECH-LANG PAT, V4, P118, DOI DOI 10.1044/1058-0360.0404.118; CRAIG HK, 1993, APHASIOLOGY, V7, P155, DOI 10.1080/02687039308249503; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Doyle P. J., 1995, AM J SPEECH-LANG PAT, V4, P130, DOI [10.1044/1058-0360.0404.130, DOI 10.1044/1058-0360.0404.130]; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Giles E, 1996, APHASIOLOGY, V10, P395, DOI 10.1080/02687039608248419; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Goodglass H., 1972, BOSTON DIAGNOSTIC AP; HARAVON A, 1994, STUDIES ADULT CLIN P, P47; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HUBER W, 1982, BRAIN LANG, V16, P1, DOI 10.1016/0093-934X(82)90069-4; Jacobs BJ, 2001, BRAIN LANG, V78, P115, DOI 10.1006/brln.2001.2452; Kertesz A., 1982, W APHASIA BATTERY; Luzzatti C., 1991, AACHENER APHASIE TES; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marini A, 2007, APHASIOLOGY, V21, P164, DOI 10.1080/02687030600633799; MENN L, 1994, APHASIOLOGY, V8, P343, DOI 10.1080/02687039408248664; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Oelschlaeger ML, 1999, J SPEECH LANG HEAR R, V42, P636, DOI 10.1044/jslhr.4203.636; Ross KB, 1999, APHASIOLOGY, V13, P113, DOI 10.1080/026870399402235; Schuell H, 1972, MINNESOTA TEST DIFFE; SHEWAN CM, 1988, J COMMUN DISORD, V21, P103, DOI 10.1016/0021-9924(88)90001-9; Snow PC, 2000, BRAIN INJURY, V14, P397; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27	30	24	24	0	31	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					1010	1018		10.3109/02699052.2011.605097			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800012	21812587				2022-02-06	
J	Grubenhoff, JA; Kirkwood, MW; Deakyne, S; Wathen, J				Grubenhoff, Joseph A.; Kirkwood, Michael W.; Deakyne, Sara; Wathen, Joe			Detailed concussion symptom analysis in a paediatric ED population	BRAIN INJURY			English	Article						Brain concussion; closed head injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT ASSESSMENT; SPORT-RELATED CONCUSSION; GLASGOW COMA SCALE; POSTCONCUSSION SYNDROME; STANDARDIZED ASSESSMENT; EARLY IDENTIFICATION; UNITED-STATES; HEAD-INJURY; PREDICTION	Primary objective: To examine the frequency of acute mild traumatic brain injury (mTBI) symptoms in children using a concussion symptom inventory and to identify which symptoms are most useful in identifying mTBI. It was hypothesized that symptoms associated with mTBI are more common in children with head injury than orthopaedic injury and certain symptoms are more useful than others in identifying mTBI. Research design: Prospective case-control study conducted in a paediatric trauma centre emergency department. Methods and procedures: Children of 6-18 years old with head injury or a minor extremity injury were enrolled. Symptoms were assessed using a graded symptom checklist. Symptom frequency was compared using a chi-square test. The association between individual symptoms with AMS was evaluated with logistic regression analysis. Main outcomes and results: Children with head injury displayed more frequent symptoms than controls. Head-injured cases with altered mental status (AMS) demonstrated the most frequent and severe symptoms (median symptom scores: control 1, cases without AMS 5, cases with AMS 10; p < 0.001). Headache, nausea, dizziness, blurred/double vision and not feeling 'sharp' were associated with AMS. Conclusions: Symptoms associated with mTBI are more frequent in children with head injury. AMS magnifies this effect. A symptom inventory is integral to the evaluation of mTBI in children; a smaller set of dichotomized symptoms may be as useful as and more easily administered than lengthier symptom scales.	[Grubenhoff, Joseph A.; Deakyne, Sara; Wathen, Joe] Univ Colorado, Sch Med, Dept Pediat, Sect Emergency Med, Aurora, CO USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA		Grubenhoff, JA (corresponding author), 13123 E 16th Ave,B-251, Aurora, CO 80045 USA.	grubenhoff.joe@tchden.org	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064			Ahmed S, 2000, BRAIN INJURY, V14, P765; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; GARDEN N, 2001, APL NEUROPSYCHOLOGY, V17, P1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kelly JP, 1997, NEUROLOGY, V48, P581; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange R. T., 2010, J CLIN EXPT NEUROPSY, V30, P1; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	38	24	24	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2011	25	10					943	949		10.3109/02699052.2011.597043			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800003	21749192				2022-02-06	
J	Ross, LM; Register-Mihalik, JK; Mihalik, JP; McCulloch, KL; Prentice, WE; Shields, EW; Guskiewicz, KM				Ross, Luke M.; Register-Mihalik, Johna K.; Mihalik, Jason P.; McCulloch, Karen L.; Prentice, William E.; Shields, Edgar W.; Guskiewicz, Kevin M.			Effects of a Single-Task Versus a Dual-Task Paradigm on Cognition and Balance in Healthy Subjects	JOURNAL OF SPORT REHABILITATION			English	Article						postural stability; concussion; attention	POSTURAL STABILITY; ATTENTIONAL DEMANDS; CONCUSSION; YOUNG; PERFORMANCE; RECOVERY; DEFICITS; SYSTEM; FOCUS; ADVANTAGES	Context: Recent evidence has revealed deficiencies in the ability to divide attention after concussion. Objective: To examine the effects of a single vs a dual task on cognition and balance in healthy subjects and to examine reliability of 2 dual-task paradigms while examining the overall feasibility of the tasks. Design: Pretest-posttest experimental design. Setting: Sports medicine research laboratory. Patients: 30 healthy, recreationally active college students. Intervention: Subjects performed balance and cognitive tasks under the single- and dual-task conditions during 2 test sessions 14 d apart. Main Outcome Measures: The procedural reaction-time (PRT) test of the Automated Neuropsychological Assessment Metrics (eyes-closed tasks) and an adapted Procedural Auditory Task (PAT; eyes-open tasks) were used to assess cognition. The NeuroCom Sensory Organization Test (SOT) and the Balance Error Scoring System (BESS) were used to assess balance performance. Five 2-way, within-subject ANOVAs and a paired-samples t test were used to analyze the data. ICCs were used to assess reliability across 2 test sessions. Results: On the SOT, performance significantly improved between test sessions (F-1.29 = 35.695, P < .001) and from the single to the dual task (F-1.29 = 9.604, P = .004). On the PRT, performance significantly improved between test sessions (F-1.29 = 57.252, P < .001) and from the single to the dual task (F-1.29 = 7.673, P = .010). No differences were seen on the BESS and the PAT. Reliability across test sessions ranged from moderate to poor for outcome measure. Conclusions: The BESS appears to be a more reliable and functional tool in dual-task conditions as a result of its increased reliability and clinical applicability. In addition, the BESS is more readily available to clinicians than the SOT.	[Ross, Luke M.; Prentice, William E.; Shields, Edgar W.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [McCulloch, Karen L.] Univ N Carolina, Div Phys Therapy, Chapel Hill, NC USA		Ross, LM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.			Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130			Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Butter CM, 2003, PROG BRAIN RES, V144, P183, DOI 10.1016/S0079-6123(03)14401-3; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Chien CW, 2007, ARCH PHYS MED REHAB, V88, P374, DOI 10.1016/j.apmr.2006.11.019; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Muller MLTM, 2007, EXP BRAIN RES, V183, P447, DOI 10.1007/s00221-007-1065-2; Otani S, 2003, J PHYSIOL-PARIS, V97, P423, DOI 10.1016/j.jphysparis.2004.01.002; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Siu KC, 2008, AGING CLIN EXP RES, V20, P349, DOI 10.1007/BF03324867; Siu KC, 2008, EXP BRAIN RES, V184, P115, DOI 10.1007/s00221-007-1087-9; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Sosnoff JJ, 2007, EXP AGING RES, V33, P399, DOI 10.1080/03610730701525311; Swan L, 2004, BRIT J PSYCHOL, V95, P31, DOI 10.1348/000712604322779442; Valovich TC, 2003, J ATHL TRAINING, V38, P51; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Wulf G, 1999, RES Q EXERCISE SPORT, V70, P120, DOI 10.1080/02701367.1999.10608029; Wulf G, 2000, RES Q EXERCISE SPORT, V71, P229, DOI 10.1080/02701367.2000.10608903; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336	45	24	25	1	28	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2011	20	3					296	310		10.1123/jsr.20.3.296			15	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	807AY	WOS:000293864100004	21828382				2022-02-06	
J	Schliemann, B; Muder, D; Gessmann, J; Schildhauer, TA; Seybold, D				Schliemann, Benedikt; Muder, Daniel; Gessmann, Jan; Schildhauer, Thomas A.; Seybold, Dominik			Locked posterior shoulder dislocation: treatment options and clinical outcomes	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Locked posterior shoulder dislocation; Shoulder instability; McLaughlin procedure; Reverse Hill-Sachs lesion; Malgaigne fracture	FRACTURE-DISLOCATIONS; ANTERIOR DISLOCATION; EXTERNAL ROTATION; HUMERAL HEAD; IMMOBILIZATION; RECONSTRUCTION; ARTHROPLASTY; MANAGEMENT; ALLOGRAFT	Posterior dislocation of the shoulder is a rare injury and often misdiagnosed during the initial presentation to a physician. Misdiagnosis is due to a lack of clear clinical signs compared to anterior dislocation and inappropriate radiographs. In contrast to anterior dislocations, the humeral head defect accounts for recurrent instability. Depending on the size of the defect and the duration of dislocation, different treatment options include elevation of the defect, bone grafting, McLaughlin procedure, rotation osteotomy or arthroplasty. We reviewed 35 patients who presented to our institution with a locked posterior dislocation of the shoulder between January 1999 and August 2009. In 6 patients, the shoulder remained stable after closed reduction, so the treatment was conservative; 29 patients underwent surgery. The mean follow-up was 55 months (range 11-132 months). The interval between trauma and the diagnosis of posterior shoulder dislocation was 66 days (min. 0, max. 365). Patients treated conservatively achieved a Constant Score of 85 points; patients who underwent operative treatment had a slightly worse outcome with an average Constant Score of 79 points. There was a high correlation between the time to the correct diagnosis and the outcome. Although locked posterior shoulder dislocation is uncommon and often initially misdiagnosed, satisfying results can be achieved by different surgical treatment options. Early diagnosis by detailed clinical examination and sufficient radiographic evaluation with true anterior-posterior and axillary views is essential to improve clinical results. Levl of evidence: IV.	[Muder, Daniel; Gessmann, Jan; Schildhauer, Thomas A.; Seybold, Dominik] BG Univ Hosp Bergmannsheil Bochum, Dept Trauma Surg, D-44789 Bochum, Germany; [Schliemann, Benedikt] Univ Hosp Munster, Dept Trauma Hand & Reconstruct Surg, D-48149 Munster, Germany		Seybold, D (corresponding author), BG Univ Hosp Bergmannsheil Bochum, Dept Trauma Surg, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	dseybold@mac.com	Laumann, Marion/AAX-3607-2021	Schildhauer, Thomas/0000-0002-3232-9869			BLASIER RB, 1988, CLIN ORTHOP RELAT R, P197; BROWN RJ, 1984, INJURY, V15, P267, DOI 10.1016/0020-1383(84)90012-3; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; Cooper A., 1839, GUYS HOSP REP, V4, P265; Diklic ID, 2010, J BONE JOINT SURG BR, V92B, P71, DOI 10.1302/0301-620X.92B1.22142; DORGAN JA, 1955, AM J SURG, V89, P890, DOI 10.1016/0002-9610(55)90159-8; ENGELHARDT MB, 1978, SOUTHERN MED J, V71, P425, DOI 10.1097/00007611-197804000-00024; Gavriilidis I, 2010, INT ORTHOP, V34, P79, DOI 10.1007/s00264-009-0762-9; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; HAMADA K, 1990, CLIN ORTHOP RELAT R, P92; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; HILL N A, 1963, J Trauma, V3, P225, DOI 10.1097/00005373-196305000-00004; Hughes M, 1975, Phys Ther, V55, P850; Irlenbusch L, 2008, UNFALLCHIRURG, V111, P464, DOI 10.1007/s00113-007-1363-y; Itoi E, 1999, J BONE JOINT SURG AM, V81A, P385, DOI 10.2106/00004623-199903000-00011; Itoi E, 2003, J SHOULDER ELB SURG, V12, P413, DOI 10.1016/S1058-2746(03)00171-X; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KELLY JP, 1954, J BONE JOINT SURG BR, V36, P70, DOI 10.1302/0301-620X.36B1.70; Kirchhoff C, 2007, UNFALLCHIRURG, V110, P1059, DOI 10.1007/s00113-007-1285-8; Malgaigne J., 1855, TRAITE FRACTURES LUX; MCLAUGHLIN H, 1952, J BONE JOINT SURG AM, V24, P584; MCLAUGHLIN HL, 1963, SURG CLIN N AM, V43, P1615; MESTDAGH H, 1994, ANN CHIR, V48, P355; OCONNOR SJ, 1956, ARCH SURG-CHICAGO, V72, P479; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; Schliemann B, 2009, SPORTVERLETZ SPORTSC, V23, P100, DOI 10.1055/s-0028-1109418; Seybold D, 2006, CHIRURG, V77, P821, DOI 10.1007/s00104-006-1181-8; SEYBOLD D, 2007, C GERM ASS SHOULD EL; Spencer EE, 2005, J SHOULDER ELB SURG, V14, P650, DOI 10.1016/j.jse.2004.11.008; Sperling JW, 2004, J SHOULDER ELB SURG, V13, P522, DOI 10.1016/j.jse.2004.02.012; WEBER BG, 1984, J BONE JOINT SURG AM, V66A, P1443, DOI 10.2106/00004623-198466090-00019; Wiedemann E, 2010, SCHULTERCHIRURGIE, P437; WILSON JC, 1949, J BONE JOINT SURG AM, V31-A, P160, DOI 10.2106/00004623-194931010-00018	33	24	26	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	AUG	2011	131	8					1127	1134		10.1007/s00402-011-1310-9			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	794EK	WOS:000292878100015	21567148				2022-02-06	
J	Yu, LJ; Stokell, R; Treleaven, J				Yu, Li-Ju; Stokell, Raina; Treleaven, Julia			The effect of neck torsion on postural stability in subjects with persistent whiplash	MANUAL THERAPY			English	Article						Balance; Whiplash; Neck torsion	JOINT POSITION ERROR; BACK-PAIN PATIENTS; STANDING BALANCE; SENSORY CONDITIONS; DIZZINESS; INJURY; POSTUROGRAPHY; DISABILITY; DISORDERS; SELECTION	Dysfunction of cervical receptors in neck disorders has been shown to lead to disturbances in postural stability. The neck torsion manoeuvre used in the smooth pursuit neck torsion (SPNT) test is thought to be a specific measure of neck afferent dysfunction on eye movement in those with neck pain. This study aimed to determine whether neck torsion could change balance responses in those with persistent whiplash-associated disorders (WADs). Twenty subjects with persistent WAD and 20 healthy controls aged between 18 and 50 years stood on a computerised force plate with eyes closed in comfortable stance under 5 conditions: neutral head, head turned to left and right and neck torsion to left and right. Root mean square (rms) amplitude of sway was measured in the anterioreposterior (AP) and medial -lelateral (ML) directions. The whiplash group had significantly greater rms amplitude in the AP direction following neck torsion compared to the control group (p < 0.03). The results show that the neck torsion manoeuvre may lead to greater postural deficits in individuals with persistent WAD and provides further evidence of neck torsion to identify abnormal cervical afferent input, as an underlying cause of balance disturbances in WAD. Further research is warranted. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.	[Yu, Li-Ju; Stokell, Raina; Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia		Treleaven, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia.	j.treleaven@uq.edu.au	Treleaven, Julia M/F-8734-2010; Treleaven, Julia/N-1379-2019	Treleaven, Julia M/0000-0002-6258-3972; Treleaven, Julia/0000-0002-6258-3972			ALUND M, 1991, ACTA OTO-LARYNGOL, P601; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; El-Kahky AM, 2000, ACTA OTO-LARYNGOL, V120, P508, DOI 10.1080/000164800750046018; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Horak F. B., 1996, POSTURAL ORIENTATION; KARLBERG M, 1995, ACTA OTO-LARYNGOL, P440; Karlberg M, 1996, J VESTIBUL RES-EQUIL, V6, P37; Madeleine P, 2004, ARCH PHYS MED REHAB, V85, P432, DOI 10.1016/j.apmr.2003.03.003; MALLINSON AI, 1996, J MUSCULOSKELET PAIN, V4, P105, DOI DOI 10.1300/J094V04N04_10; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; McPartland JM, 1997, J MANIP PHYSIOL THER, V20, P24; Michaelson P, 2003, J REHABIL MED, V35, P229, DOI 10.1080/16501970306093; Mientjes MIV, 1999, CLIN BIOMECH, V14, P710, DOI 10.1016/S0268-0033(99)00025-X; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rocchi L, 2004, MED BIOL ENG COMPUT, V42, P71, DOI 10.1007/BF02351013; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; RUBIN AM, 1995, AM J OTOL, V16, P216; Schieppati M, 2003, NEUROSCIENCE, V121, P277, DOI 10.1016/S0306-4522(03)00439-1; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Speers RA, 1998, GAIT POSTURE, V7, P207, DOI 10.1016/S0966-6362(98)00006-X; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Tesio L, 1999, AM J PHYS MED REHAB, V78, P233, DOI 10.1097/00002060-199905000-00009; Tjell C, 1998, AM J OTOL, V19, P76; Tjell C, 2003, J WHIPLASH ASS DISOR, V1, P9; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2005, GAIT POSTURE, V21, P395, DOI 10.1016/j.gaitpost.2004.04.008; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vuillerme N, 2005, NEUROSCI LETT, V378, P135, DOI 10.1016/j.neulet.2004.12.024; Vuillerme N, 2009, EXP BRAIN RES, V192, P723, DOI 10.1007/s00221-008-1639-7	34	24	25	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X			MANUAL THER	Man. Ther.	AUG	2011	16	4					339	343		10.1016/j.math.2010.12.006			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	798XH	WOS:000293245000006	21256074				2022-02-06	
J	Al-Jishi, A; Saluja, RS; Al-Jehani, H; Lamoureux, J; Maleki, M; Marcoux, J				Al-Jishi, Ahmed; Saluja, Rajeet Singh; Al-Jehani, Hosam; Lamoureux, Julie; Maleki, Mohammad; Marcoux, Judith			Primary or Secondary Decompressive Craniectomy: Different Indication and Outcome	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL PERFUSION-PRESSURE; MANAGEMENT; CHILDREN; IMPACT; ICP; CLASSIFICATION; COMPLICATIONS	Background: Intracranial hypertension can cause secondary damage after a traumatic brain injury. Aggressive medical management might not be sufficient to alleviate the increasing intracranial pressure (ICP), and decompressive craniectomy (DC) can be considered. Decompressive craniectomy can be divided into categories, according to the timing and rationale for performing the procedure: primary (done at the time of mass lesion evacuation) and secondary craniectomy (done to treat refractory ICP). Most studies analyze primary and secondary DC together. Our hypothesis is that these two groups are distinct and the aim of this retrospective study is to evaluate the differences in order to better predict outcome after DC. Methods: Seventy patients had DC over a period of four years at our center. They were divided into two groups based on the timing of the DC. Primary DC (44 patients) was done within 24 hours of the injury for mass lesion evacuation. Secondary DC (26 patients) was done after 24 hours and purely for the treatment of refractory ICP. Pre-op characteristics and post-op outcomes were compared between the two groups. Results: There was a significant difference in the mechanism of injury, the pupil abnormalities and Marshall grade between primary and secondary DC. There was also a significant difference in outcome with primary DC showing 45.5% good outcome and 40.9% mortality and secondary DC showing 73.1% good outcome and 15.4% mortality. Conclusions: Primary and secondary DC have different indications and patients characteristics. Outcome prediction following DC should be adjusted according to the surgical indication.	[Marcoux, Judith] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Al-Jishi, Ahmed; Saluja, Rajeet Singh; Al-Jehani, Hosam] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Neurol Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Montreal, PQ, Canada; [Al-Jehani, Hosam] Dammam Univ, King Fahad Univ Hosp, Dept Neurosurg, Al Khobar, Saudi Arabia		Marcoux, J (corresponding author), McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Gen Hosp, 1650 Cedar Ave,Room L7-524, Montreal, PQ H3G 1A4, Canada.						Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Csokay A, 2002, NEUROL RES, V24, P157, DOI 10.1179/016164102101199701; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Faleiro RM, 2005, ARQ NEURO-PSIQUIAT, V63, P508, DOI 10.1590/S0004-282X2005000300026; Faleiro RM, 2008, ARQ NEURO-PSIQUIAT, V66, P369, DOI 10.1590/S0004-282X2008000300017; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kunze E, 1998, ACT NEUR S, V71, P16; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meier U, 2005, ACT NEUR S, V95, P55; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Sahuquillo J, 2009, COCHRANE DATABASE SY; Schneider GH, 2002, ACT NEUR S, V81, P77; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Young Jeffrey S, 2003, Neurosurg Focus, V15, pE2	52	24	24	1	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2011	38	4					612	620		10.1017/S0317167100012154			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	802AT	WOS:000293482400013	21672701	Bronze			2022-02-06	
J	Dolce, G; Lucca, LF; Candelieri, A; Rogano, S; Pignolo, L; Sannita, WG				Dolce, Giuliano; Lucca, Lucia F.; Candelieri, Antonio; Rogano, Stefania; Pignolo, Loris; Sannita, Walter G.			Visual Pursuit in the Severe Disorder of Consciousness	JOURNAL OF NEUROTRAUMA			English	Article						consciousness; minimally conscious state; outcome; prognosis; vegetative state; visual tracking	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; SCALE; COMA; PROGNOSIS; RECOVERY	Visual pursuit is a key descriptor of the minimally conscious state (above 80% of cases). It is also observable in about 20% of subjects in vegetative state. Its reappearance after severe brain damage anticipates a favorable outcome, with recovery of consciousness in 73% of subjects (45% in the absence of it). We considered retrospectively 395 subjects in vegetative state because of traumatic (63%), massive acute vascular (30%), or diffuse anoxic-hypoxic (7%) brain damage consecutively admitted to one dedicated unit during the years 1998 - 2008. Visual tracking was observed in 290 subjects (73.4%) and was already detectable within 50 days from brain injury in about 60% of post-traumatic or vascular subjects and 21% of anoxic-hypoxic patients. After 230 days of follow-up or more, it was observed in 89% and 88% of post-traumatic and vascular subjects and in 67% of anoxic-hypoxic patients. Rating with the Glasgow Outcome Scale (GOS) was better in those subjects with recovered visual tracking and inversely correlated with the time of reappearance in post-traumatic and vascular subjects; also the subjects with late recovery of eye tracking (230 days or more) had better GOS outcome than those without it. The observation of visual tracking reappearing in subjects in vegetative state would reflect recuperation of the brainstem-cortical interaction and overall brain functional organization that are thought to sustain consciousness and are interfered with by the "functional disconnection," resulting in the vegetative state.	[Dolce, Giuliano; Lucca, Lucia F.] S Anna Inst, Semiintens Care Unit Vegetat State, Crotone, Italy; [Candelieri, Antonio] Univ Calabria, Lab Decis Engn Hlth Care Delivery, I-87036 Cosenza, Italy; [Sannita, Walter G.] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Sannita, Walter G.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA		Dolce, G (corresponding author), S Anna Inst, Semiintens Care Unit Vegetat State, Via Siris 11, Crotone, Italy.	giulianodolce@libero.it	Lucca, Lucia Francesca/AAB-8558-2022; /AAI-7627-2021	/0000-0003-1431-576X; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711	S. Anna-RAN Institute	This study was supported by the S. Anna-RAN Institute through funds dedicated to research. Thanks are due to Professor L. Sazbon (the University of Tel Aviv, Israel) for continuing support and valuable advice.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; DOLCE G, 2010, BRAIN INJURY, V24, P13; Dolce G., 2002, POSTTRAUMATIC VEGETA; Dolce G, 2010, BRAIN INJURY, V24, P1628, DOI 10.3109/02699052.2010.523055; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagen C., 1972, LEVELS COGNITIVE FUN; Hassler R., 1972, PATHOPHISIOLOGIE BEW, P1; JENNETT B, 1972, LANCET, V1, P734; Jennett B., 2002, VEGETATIVE STATE; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JUNG R, 1967, PSYCHIAT GEGENWART, P612; Kim JS, 2001, J VESTIBUL RES-EQUIL, V11, P3; KIRK C, 1975, LANCET, V1, P1180; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Pignolo L, 2009, BRAIN INJURY, V23, P1, DOI 10.1080/02699050802595873; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosano C, 2002, CEREB CORTEX, V12, P107, DOI 10.1093/cercor/12.2.107; Royal College of Physicians, 1996, GUID DIAGN MAN REP W; *ROYAL HOSP NEUR D, 1996, INT WORK PART MAN VE; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Silva S, 2010, NEUROLOGY, V74, P313, DOI 10.1212/WNL.0b013e3181cbcd96; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	47	24	24	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1149	1154		10.1089/neu.2010.1405			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600003	21175278				2022-02-06	
J	Kahalley, LS; Conklin, HM; Tyc, VL; Wilson, SJ; Hinds, PS; Wu, SJ; Xiong, XP; Hudson, MM				Kahalley, Lisa S.; Conklin, Heather M.; Tyc, Vida L.; Wilson, Stephanie J.; Hinds, Pamela S.; Wu, Shengjie; Xiong, Xiaoping; Hudson, Melissa M.			ADHD and Secondary ADHD Criteria Fail to Identify Many At-Risk Survivors of Pediatric ALL and Brain Tumor	PEDIATRIC BLOOD & CANCER			English	Article						ADHD; attention; cancer; children; cognitive assessment; hyperactivity; oncology	CONTINUOUS PERFORMANCE-TEST; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SLUGGISH COGNITIVE TEMPO; LONG-TERM SURVIVORS; CLOSED-HEAD INJURY; DOUBLE-BLIND; NEUROPSYCHOLOGICAL PERFORMANCE; CHILDHOOD-CANCER; CHILDREN	Background. Post-treatment attention problems experienced by pediatric cancer survivors have been described as similar to symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) experienced in physically healthy children. Accordingly, the objectives of this study were to: (a) estimate the rate of occurrence of ADHD and secondary ADHD (SADHD) in a sample of pediatric cancer survivors, (b) compare the rate of ADHD/SADHD among survivors to the prevalence of ADHD in the general population, and (c) examine clinical correlates of ADHD/SADHD in this sample. Procedure. Survivors of pediatric ALL or brain tumor (n = 100) participated in an assessment of attention including a Computerized Performance Measure [Conners' Continuous Performance test-II (CPT-II)], parent and self-report measures (Conners 3), and a structured diagnostic interview for ADHD and other psychological disorders [Diagnostic Interview for Children and Adolescents-IV (DICA-IV)]. Results. Binomial tests revealed that the rate of ADHD/SADHD in our sample (9%) was significantly greater than the lower limits of ADHD prevalence among children in the US (3%; P < 0.001), while no difference was identified compared to the upper limits of ADHD prevalence (7%; P > 0.05). Many additional survivors (> 25% of the sample) obtained clinical elevations on Conners 3 scales but did not meet ADHD/SADHD criteria. Conclusions. Attentional deficits experienced by pediatric cancer survivors do not appear to resemble the clinical presentation of ADHD or SADHD. Many survivors with cognitive and behavioral difficulties related to attention were not identified using this diagnostic approach. Findings offer needed clarification to guide researchers and clinicians in conceptualizing, assessing, and intervening on attentional late effects. Pediatr Blood Cancer 2011;57:110-118. (C) 2011 Wiley-Liss, Inc.	[Kahalley, Lisa S.] Baylor Coll Med, Dept Pediat, Psychol Sect, Houston, TX 77030 USA; [Conklin, Heather M.; Tyc, Vida L.; Wilson, Stephanie J.] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN 38105 USA; [Hinds, Pamela S.] Childrens Natl Med Ctr, Dept Nursing Res & Qual Outcomes, Washington, DC 20010 USA; [Hinds, Pamela S.] George Washington Univ, Dept Pediat, Washington, DC 20052 USA; [Wu, Shengjie; Xiong, Xiaoping] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Hudson, Melissa M.] St Jude Childrens Res Hosp, Dept Oncol, Div Canc Survivorship, Memphis, TN 38105 USA		Kahalley, LS (corresponding author), Texas Childrens Hosp, 1102 Bates,Suite 730, Houston, TX 77030 USA.	lskahall@texaschildrens.org	Hudson, Melissa M/N-4441-2018; Hinds, Pamela/W-8115-2019; Conklin, Heather M/N-2696-2018	Hudson, Melissa M/0000-0001-6984-2407; 	National Institute of Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F32DA024503]; NIH Cancer CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA21765]; American Lebanese Syrian Associated Charities (ALSAC)American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R25CA023944, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [F32DA024503] Funding Source: NIH RePORTER	Grant sponsor: National Institute of Drug Abuse; Grant number: F32DA024503; Grant sponsor: NIH Cancer Center Support CORE Grant; Grant number: CA21765; Grant sponsor: American Lebanese Syrian Associated Charities (ALSAC).	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Agay N, 2010, PSYCHOPHARMACOLOGY, V210, P511, DOI 10.1007/s00213-010-1853-4; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson V, 1997, Pediatr Rehabil, V1, P63; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; Barkley R. A., 2006, ATTENTION DEFICIT HY; Butler RW, 2005, J PEDIATR PSYCHOL, V30, P65, DOI 10.1093/jpepsy/jsi017; Carlson CL, 2002, J CLIN CHILD ADOLESC, V31, P123, DOI 10.1207/S15374424JCCP3101_14; Conklin HM, 2007, J PEDIATR PSYCHOL, V32, P1127, DOI 10.1093/jpepsy/jsm045; Conklin HM, 2010, J PEDIATR PSYCHOL, V35, P144, DOI 10.1093/jpepsy/jsp044; Conners CK, 2008, CONNERS MANUAL; Conners CK, 2000, MHS STAFF CONNERS CO; Edwards MC, 2007, J ABNORM CHILD PSYCH, V35, P393, DOI 10.1007/s10802-007-9098-3; Epstein JN, 1998, CLIN NEUROPSYCHOL, V12, P155, DOI 10.1076/clin.12.2.155.2000; Fossen A, 1998, PEDIATR HEMAT ONCOL, V15, P479, DOI 10.3109/08880019809018309; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Hartman CA, 2004, J ABNORM CHILD PSYCH, V32, P491, DOI 10.1023/B:JACP.0000037779.85211.29; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Holmquist LA, 2002, J CLIN PSYCHOL MED S, V9, P315, DOI 10.1023/A:1020791018897; Homer CJ, 2000, PEDIATRICS, V105, P1158; Kaplan S, 2004, J Atten Disord, V8, P45, DOI 10.1177/108705470400800202; KAVALE K, 1982, J LEARN DISABIL-US, V15, P280, DOI 10.1177/002221948201500508; KLORMAN R, 1984, PSYCHOPHARMACOL BULL, V20, P3; Krull KR, 2008, J PEDIATR-US, V152, P101, DOI 10.1016/j.jpeds.2007.05.047; LAHEY BB, 1988, J AM ACAD CHILD PSY, V27, P330, DOI 10.1097/00004583-198805000-00011; Langer T, 2002, MED PEDIATR ONCOL, V38, P320, DOI 10.1002/mpo.10055; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lockwood KA, 1999, J PEDIATR PSYCHOL, V24, P55, DOI 10.1093/jpepsy/24.1.55; Mackie S, 2007, AM J PSYCHIAT, V164, P647, DOI 10.1176/appi.ajp.164.4.647; Maddrey AM, 2005, J NEURO-ONCOL, V72, P245, DOI 10.1007/s11060-004-3009-z; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McClellan JM, 2000, J AM ACAD CHILD PSY, V39, P19, DOI 10.1097/00004583-200001000-00013; McGee RA, 2000, J ABNORM CHILD PSYCH, V28, P415, DOI 10.1023/A:1005127504982; Merchant TE, 2002, INT J RADIAT ONCOL, V53, P1271, DOI 10.1016/S0360-3016(02)02828-6; Moleski M, 2000, ARCH CLIN NEUROPSYCH, V15, P603, DOI 10.1016/S0887-6177(99)00050-5; Mostofsky SH, 2002, BIOL PSYCHIAT, V52, P785, DOI 10.1016/S0006-3223(02)01412-9; Mulhern RK, 2004, J CLIN ONCOL, V22, P4795, DOI 10.1200/JCO.2004.04.128; Mulhern RK, 2004, J INT NEUROPSYCH SOC, V10, P180, DOI 10.1017/S135561770410204X; Patel SK, 2007, PEDIATR BLOOD CANCER, V49, P970, DOI 10.1002/pbc.21151; PELOQUIN LJ, 1986, J ABNORM PSYCHOL, V95, P88, DOI 10.1037/0021-843X.95.1.88; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Pineda DA, 2007, EUR CHILD ADOLES PSY, V16, P337, DOI 10.1007/s00787-007-0605-4; Reddick WE, 2006, CANCER-AM CANCER SOC, V106, P941, DOI 10.1002/cncr.21679; Reddick WE, 2003, CANCER-AM CANCER SOC, V97, P2512, DOI 10.1002/cncr.11355; Reeves CB, 2007, J PEDIATR PSYCHOL, V32, P1050, DOI 10.1093/jpepsy/jsm063; Reeves CB, 2006, J PEDIATR PSYCHOL, V31, P272, DOI 10.1093/jpepsy/jsj019; RIS MD, 1994, J CLIN EXP NEUROPSYC, V16, P21, DOI 10.1080/01688639408402615; Rodgers J, 1999, ARCH DIS CHILD, V80, P318, DOI 10.1136/adc.80.4.318; Rogers R., 2001, HDB DIAGNOSTIC STRUC; Thompson SJ, 2001, J CLIN ONCOL, V19, P1802, DOI 10.1200/JCO.2001.19.6.1802; Troy L, 2000, PSYCHO-ONCOL, V9, P29, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.0.CO;2-Z; WELNER Z, 1987, J AM ACAD CHILD PSY, V26, P649, DOI 10.1097/00004583-198709000-00007	53	24	24	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	JUL	2011	57	1					110	118		10.1002/pbc.22998			9	Oncology; Hematology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Hematology; Pediatrics	762DL	WOS:000290452400019	21337681	Green Accepted			2022-02-06	
J	Kieffer-Kristensen, R; Teasdale, TW; Bilenberg, N				Kieffer-Kristensen, Rikke; Teasdale, Thomas W.; Bilenberg, Niels			Post-traumatic stress symptoms and psychological functioning in children of parents with acquired brain injury	BRAIN INJURY			English	Article						Children; caregiver; post-traumatic stress disorder; family; prevention	SOMATICALLY ILL PARENTS; EVENT SCALE CRIES; CANCER-PATIENTS; PSYCHOSOCIAL CONSEQUENCES; BEHAVIORAL-PROBLEMS; NATIONAL-SURVEY; REVISED IMPACT; BREAST-CANCER; FOLLOW-UP; FAMILY	Introduction/objectives: The effect of parental brain injury on children has been relatively little investigated. This study examines post-traumatic stress symptoms (PSS) and psychological functioning in children with a parent with an acquired brain injury. Participants, materials and methods: The participants were 35 patients with acquired brain injury, their spouses and children aged 7-14 years recruited from out-patient brain injury rehabilitation units across Denmark. Children self-reported psychological functioning using the Becks Youth Inventory (BYI) and Child Impact of Events revised (CRIES) measuring PSS symptoms. Emotional and behavioural problems among the children were also identified by the parents using the Achenbach's Child Behaviour Checklist (CBCL). A matched control group, consisting of 20 children of parents suffering from diabetes, was recruited from the National Danish Diabetes Register. Results: Post-traumatic stress symptoms above cut-off score (<30) were found (CRIES) in 46% of the children in the brain injury group compared to 10% in the diabetes group. The parents in the brain injury group reported more emotional and behavioural problems in their children when compared to published norms (CBCL). Conclusions: When parents have acquired brain injury, their children appear to be at a substantial risk for developing post-traumatic stress symptoms. These results indicate the need for a child-centred family support service to reduce the risk of children being traumatized by parental brain injury, with a special focus on the relational changes within the family.	[Kieffer-Kristensen, Rikke; Teasdale, Thomas W.] Univ Copenhagen, Dept Psychol, DK-1353 Copenhagen, Denmark; [Bilenberg, Niels] Univ So Denmark, Dept Child, Odense, Denmark; [Bilenberg, Niels] Univ So Denmark, Dept Adolescence Psychiat, Odense, Denmark		Kieffer-Kristensen, R (corresponding author), Univ Copenhagen, Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.	rikke.kieffer@psy.ku.dk	Bilenberg, Niels/I-6027-2014	Bilenberg, Niels/0000-0002-5838-556X			ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Alderfer MA, 2003, J PEDIATR PSYCHOL, V28, P281, DOI 10.1093/jpepsy/jsg016; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARMISTEAD L, 1995, CLIN PSYCHOL REV, V15, P409, DOI 10.1016/0272-7358(95)00023-I; BECK JS, 2001, BECK YOUTH INVENTORY; Bilenberg N, 1999, ACTA PSYCHIAT SCAND, V100, P2, DOI 10.1111/j.1600-0447.1999.tb10703.x; Birenbaum L K, 1999, Oncol Nurs Forum, V26, P1639; BOWLBY J, 1969, ATTACHTMENT LOSS; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Compas BE, 1996, HEALTH PSYCHOL, V15, P167, DOI 10.1037/0278-6133.15.3.167; Dyregrov A, 1996, SCAND J PSYCHOL, V37, P339, DOI 10.1111/j.1467-9450.1996.tb00667.x; Edwards L, 2008, PSYCHO-ONCOL, V17, P1039, DOI 10.1002/pon.1323; ETH S, 1985, 137 ANN M AM PSYCH A; Giannopoulou L, 2006, PERS INDIV DIFFER, V40, P1027, DOI 10.1016/j.paid.2005.11.002; Gosling J, 1999, BRAIN INJURY, V13, P785; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Huizinga GA, 2003, PSYCHO-ONCOL, V12, pS209; KOBAK R, 1999, HDB ATTACHMENT THEOR, P21; KOBAK R, 2006, HDB DEV PSYCHOPATHOL, P333; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; LECLERE FB, 1994, J MARRIAGE FAM, V56, P457, DOI 10.2307/353112; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Perrin S, 2000, J CHILD PSYCHOL PSYC, V41, P277, DOI 10.1017/S0021963099005454; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Pynoos RS, 2009, J TRAUMA STRESS, V22, P391, DOI 10.1002/jts.20450; Pynoos RS., 1992, BEREAVE CARE, V11, P2, DOI [DOI 10.1080/02682629208657280, 10.1080/02682629208657280]; Romer G, 2007, PRAX KINDERPSYCHOL K, V56, P870, DOI 10.13109/prkk.2007.56.10.870; RUTTER M, 1966, I PSYCHIAT MAUDSLEY, V16; Sanchez L, 1994, Ann Clin Psychiatry, V6, P39, DOI 10.3109/10401239409148838; Schmitt F, 2008, J CLIN ONCOL, V26, P5877, DOI 10.1200/JCO.2007.12.8132; SHAW JA, 1995, J AM ACAD CHILD PSY, V34, P1185, DOI 10.1097/00004583-199509000-00016; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Smith P, 2002, J TRAUMA STRESS, V15, P147, DOI 10.1023/A:1014812209051; Steck B, 2007, EUR CHILD ADOLES PSY, V16, P199, DOI 10.1007/s00787-006-0589-5; Stoppelbein L, 2000, J AM ACAD CHILD PSY, V39, P1112, DOI 10.1097/00004583-200009000-00010; Stoppelbein LA, 2006, J PEDIATR PSYCHOL, V31, P367, DOI 10.1093/jpepsy/jsj055; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Thastum M, 2009, SCAND J PSYCHOL, V50, P47, DOI 10.1111/j.1467-9450.2008.00690.x; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Visser A, 2007, ACTA ONCOL, V46, P67, DOI 10.1080/02841860600949560; Visser-Meily A, 2005, J REHABIL MED, V37, P236, DOI 10.1080/16501970510025990; Watson M, 2006, BRIT J CANCER, V94, P43, DOI 10.1038/sj.bjc.6602887; Webster G, 2007, CLIN REHABIL, V21, P1097, DOI 10.1177/0269215507079833; Yule W, 2001, J CLIN PSYCHIAT, V62, P23	52	24	24	1	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					752	760		10.3109/02699052.2011.579933			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600011	21604930				2022-02-06	
J	Bjelobaba, I; Parabucki, A; Lavrnja, I; Stojkov, D; Dacic, S; Pekovic, S; Rakic, L; Stojiljkovic, M; Nedeljkovic, N				Bjelobaba, Ivana; Parabucki, Ana; Lavrnja, Irena; Stojkov, Danijela; Dacic, Sanja; Pekovic, Sanja; Rakic, Ljubisa; Stojiljkovic, Mirjana; Nedeljkovic, Nadezda			Dynamic Changes in the Expression Pattern of Ecto-5 '-Nucleotidase in the Rat Model of Cortical Stab Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain; ecto-5 '-nucleotidase; purinergic systems; ATP; astrocytes	SYNAPTIC PLASMA-MEMBRANES; P2 PURINERGIC RECEPTORS; EXTRACELLULAR ATP; BRAIN-INJURY; IN-VIVO; REACTIVE ASTROCYTES; GENE-EXPRESSION; CEREBRAL-CORTEX; UP-REGULATION; ADENOSINE	Traumatic injury induces massive release of ATP in the extracellular space, where it influences numerous aspects of neuronal, astrocytic, and microglial responses to injury by activating P2X and P2Y receptors. The extracellular ATP actions are controlled by the ectonucleotidase enzyme pathway, which hydrolyses ATP to adenosine at all neuronal and nonneuronal cell types. Adenosine activates its P1 receptors, which have important neuroprotective roles. The rate-limiting enzyme in the ectonucleotidase pathway is ecto-5 '-nucleotidase (e-5NT), which catalyzes the final step of dephosphorylation of AMP to adenosine. The aim of the present study was to characterize the expression pattern and cellular distribution of e-5NT in the perilesioned cortex at 4 hr and 1, 2, 7, and 15 days after unilateral cortical stab injury (CSI). Immunoblot and immunohistochemical studies showed that overall e-5NT expression was lower 4 hr and 1 day postinjury and then gradually increased above the control levels. Double-immunofluorescence studies further showed in control tissue the presence of the enzyme in the membranes surrounding neuronal somata and apical dendrites and less frequently in astrocytes. CSI caused a rapid (after 4 hr) and irreversible loss of the enzyme from neurons, accounting for a decrease in the overall enzyme expression. This was accompanied with a gradual increase in e-5NT-positive astrocytes, accounting for up-regulation of the enzyme levels in the injured area. Thus, CSI induced dynamic changes in the expression pattern of e-5NT that modify the ATP/adenosine ratio and the extent of P1 and P2 receptors activation and, therefore, outcome of the pathological processes after CSI. (C) 2011 Wiley-Liss, Inc.	[Nedeljkovic, Nadezda] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Dept Gen Physiol & Biophys, Belgrade 11001, Serbia; [Bjelobaba, Ivana; Parabucki, Ana; Lavrnja, Irena; Stojkov, Danijela; Pekovic, Sanja; Stojiljkovic, Mirjana] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Belgrade 11001, Serbia; [Rakic, Ljubisa] Serbian Acad Arts & Sci, Belgrade, Serbia		Nedeljkovic, N (corresponding author), Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Dept Gen Physiol & Biophys, Studentski Trg 3, Belgrade 11001, Serbia.	nnedel@bio.bg.ac.rs	Bjelobaba, Ivana/ABA-1538-2020; Lavrnja, Irena/ABA-1558-2020	Bjelobaba, Ivana/0000-0002-7649-0304; Lavrnja, Irena/0000-0002-0607-5594; Savic, Danijela/0000-0001-7411-4527; Nedeljkovic, Nadezda/0000-0003-3046-0983	Serbian Ministry of Science and TechnologyMinistry of Education, Science & Technological Development, Serbia [41014]	Contract grant sponsor: Serbian Ministry of Science and Technology; Contract grant number: 41014.	Abbracchio MP, 1998, JPN J PHARMACOL, V78, P113, DOI 10.1254/jjp.78.113; Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Bjelobaba I, 2010, NEUROSCIENCE, V170, P107, DOI 10.1016/j.neuroscience.2010.06.063; Bonan CD, 2000, NEUROCHEM RES, V25, P775, DOI 10.1023/A:1007557205523; Bonan CD, 2000, EPILEPSY RES, V39, P229, DOI 10.1016/S0920-1211(00)00095-4; Braun N, 1998, J NEUROSCI, V18, P4891; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Edwards FA, 1996, CIBA F SYMP, V198, P278; Franke H, 2006, INT J DEV NEUROSCI, V24, P123, DOI 10.1016/j.ijdevneu.2005.11.016; Franke H, 2006, PFLUG ARCH EUR J PHY, V452, P622, DOI 10.1007/s00424-006-0071-8; GRAY EG, 1962, J ANAT, V96, P79; Gyoneva S, 2009, PARKINSONISM RELAT D, V15, pS195, DOI 10.1016/S1353-8020(09)70813-2; Hansen KR, 1995, GENE, V167, P307, DOI 10.1016/0378-1119(95)00574-9; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; INOUE K, 1995, NEUROREPORT, V6, P437; JAMES S, 1993, J NEUROCHEM, V60, P219, DOI 10.1111/j.1471-4159.1993.tb05841.x; Kalsi K, 2002, MOL CELL BIOCHEM, V232, P113, DOI 10.1023/A:1014806916844; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P1398, DOI 10.1021/bi011579w; Letho MT, 1998, BIOCHEM J, V332, P101, DOI 10.1042/bj3320101; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Nagy AK, 1997, MOL CHEM NEUROPATHOL, V31, P135, DOI 10.1007/BF02815238; Narravula S, 2000, J IMMUNOL, V165, P5262, DOI 10.4049/jimmunol.165.9.5262; Neary Joseph T, 2006, Novartis Found Symp, V276, P131; Neary JT, 2006, J NEUROSCI RES, V84, P515, DOI 10.1002/jnr.20969; Neary JT, 2005, MOL NEUROBIOL, V31, P95, DOI 10.1385/MN:31:1-3:095; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nedeljkovic N, 2005, INT J DEV NEUROSCI, V23, P45, DOI 10.1016/j.ijdevneu.2004.09.001; Nedeljkovic N, 1998, GEN PHYSIOL BIOPHYS, V17, P3; Nedeljkovic N, 2006, CELL BIOL INT, V30, P541, DOI 10.1016/j.cellbi.2006.03.001; Nedeljkovic N, 2008, NEUROCHEM RES, V33, P873, DOI 10.1007/s11064-007-9529-0; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Ochiishi T, 1999, J COMP NEUROL, V411, P301; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; OREGAN MH, 1992, BRAIN RES, V582, P22, DOI 10.1016/0006-8993(92)90312-W; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stone TW, 2007, METAB BRAIN DIS, V22, P337, DOI 10.1007/s11011-007-9064-3; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; Tarumoto T, 2000, BLOOD, V96, P1716, DOI 10.1182/blood.V96.5.1716.h8001716_1716_1722; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; Villa RF, 2002, NEUROCHEM RES, V27, P861, DOI 10.1023/A:1020381829107; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Xiang ZH, 2006, J NEUROSCI RES, V83, P91, DOI 10.1002/jnr.20709; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	57	24	25	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2011	89	6					862	873		10.1002/jnr.22599			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	749OI	WOS:000289477500009	21337375				2022-02-06	
J	Kobeissy, FH; Guingab-Cagmat, JD; Razafsha, M; O'Steen, L; Zhang, ZQ; Hayes, RL; Chiu, WT; Wang, KKW				Kobeissy, Firas H.; Guingab-Cagmat, Joy D.; Razafsha, Mandi; O'Steen, Laura; Zhang, Zhiqun; Hayes, Ronald L.; Chiu, Wen-Ta; Wang, Kevin K. W.			Leveraging Biomarker Platforms and Systems Biology for Rehabilomics and Biologics Effectiveness Research	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; S-100 PROTEIN MEASUREMENTS; POST-CONCUSSION SYMPTOMS; LONG-TERM DISABILITY; OXIDATIVE LIPIDOMICS; CEREBROSPINAL-FLUID; UNITED-STATES; OUTCOME PREDICTION	Although traumatic brain injury (TBI) remains a major health problem, with approximately 2 million incidents occurring annually in the United States, no therapeutic agents to treat TBI have been approved by the Food and Drug Administration despite several clinical trials. It is estimated that 3.5 million Americans now have a lifelong condition that might be termed "chronic traumatic brain, injury disease." Some health care providers categorize TBI as an "event" for which patients require brief periods of rehabilitation with no further treatment. On the contrary, TBI should be seen as a chronic disease process that fits the World Health Organization definition as being a non-reversible pathologic condition requiring special rehabilitation training. Among the major obstacles that contribute to this type of misconception is the absence of brain injury specific diagnostic biomarker(s) that can indicate and monitor the long-term health status of patients with TBI after use of conventional therapeutics and a rehabilitation process. It is of interest that recent advances in genomics, proteomics, and systems biology have enabled us to use these high throughput based approaches in developing biomarkers and therapeutic targets in the area of TBI. One aim of this article is to provide an overview that evaluates the current status of TBI biomarker discovery using neuroproteomics/systems biology techniques, along with their clinical utilization. In addition, we discuss the need for strengthening the role of biomarker-based neuroproteomics/systems biology and its potential utility in the field of rehabilitation, which would lead to the establishment of rehabilomics studies, where biomarkers would indicate and predict the long-term efficacy and health status of patients with chronic TBI conditions. PM R 201,1;3:S139-S147	[Kobeissy, Firas H.; Guingab-Cagmat, Joy D.; Razafsha, Mandi; O'Steen, Laura; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, McKnight Brain Inst, Gainesville, FL 32611 USA; [Kobeissy, Firas H.; Guingab-Cagmat, Joy D.; Zhang, Zhiqun; Hayes, Ronald L.; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL 32615 USA; [Hayes, Ronald L.; Chiu, Wen-Ta; Wang, Kevin K. W.] Taipei Med Univ, Taipei, Taiwan		Wang, KKW (corresponding author), Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, McKnight Brain Inst, Gainesville, FL 32611 USA.	kwang@banyanbio.com	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473			Adams JE, 1999, CLIN CHIM ACTA, V284, P127, DOI 10.1016/S0009-8981(99)00074-1; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; [Anonymous], 2010, TRAUM BRAIN INJ MOD; Armstrong JD, 2006, PROTEOMICS, V6, P4724, DOI 10.1002/pmic.200500895; Assmus HE, 2006, EXPERT REV MOL DIAGN, V6, P891, DOI 10.1586/14737159.6.6.891; Bard J, 2007, MAMM GENOME, V18, P402, DOI 10.1007/s00335-007-9027-3; Barrett CL, 2006, CURR OPIN BIOTECH, V17, P488, DOI 10.1016/j.copbio.2006.08.001; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Boettler T, 2007, DEUT MED WOCHENSCHR, V132, P2702, DOI 10.1055/s-2007-993122; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen S. S., 2007, DATA MINING BIOMEDIC, P1; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Davidov EJ, 2003, DRUG DISCOV TODAY, V8, P175, DOI 10.1016/S1359-6446(03)02600-X; Davidsson P, 2005, DIS MARKERS, V21, P81, DOI 10.1155/2005/848676; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Dumont D, 2004, PROTEOMICS, V4, P2117, DOI 10.1002/pmic.200300715; Faul M, 2010, TRAUMATIC BRAIN INJU; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Guan ZQ, 2009, J CHROMATOGR B, V877, P2814, DOI 10.1016/j.jchromb.2009.03.002; Guingab JD, ESSENTIALS IN PRESS; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Hammack BN, 2004, MULT SCLER, V10, P245, DOI 10.1191/1352458504ms1023oa; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JENNETT B, 1975, LANCET, V1, P480; Kagan VE, 2006, CHEM-BIOL INTERACT, V163, P15, DOI 10.1016/j.cbi.2006.04.019; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, ANTIOXID REDOX SIGN, V6, P199, DOI 10.1089/152308604322899260; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Niemoller TD, 2010, PROSTAG OTH LIPID M, V91, P85, DOI 10.1016/j.prostaglandins.2009.09.005; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shin BK, 2002, J MAMMARY GLAND BIOL, V7, P407, DOI 10.1023/A:1024038132381; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Svetlov SI, 2006, BIOMARKERS, V11, P355, DOI 10.1080/13547500600775110; Tanaka Hiroki, 2009, Tanpakushitsu Kakusan Koso, V54, P224; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P3; Tepe V, SCREENING DIAGNOSIS; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Turner-Stokes L., 2005, MULTIDISCIPLINARY RE; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Tyurin VA, 2010, METHODS MOL BIOL, V610, P353, DOI 10.1007/978-1-60327-029-8_21; Vance DE, 2008, N COMP BIOC, P1; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Waybright T, 2010, J PROTEOMICS, V73, P1156, DOI 10.1016/j.jprot.2010.02.004; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	93	24	24	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2011	3	6		S			S139	S147		10.1016/j.pmrj.2011.02.012			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961BB	WOS:000305437800023	21703572				2022-02-06	
J	Nishihara, T; Ochi, M; Sugimoto, K; Takahashi, H; Yano, H; Kumon, Y; Ohnishi, T; Tanaka, J				Nishihara, Tasuku; Ochi, Michihisa; Sugimoto, Kana; Takahashi, Hisaaki; Yano, Hajime; Kumon, Yoshiaki; Ohnishi, Takanori; Tanaka, Junya			Subcutaneous injection containing IL-3 and GM-CSF ameliorates stab wound-induced brain injury in rats	EXPERIMENTAL NEUROLOGY			English	Article						Macrophage; Traumatic brain injury; IL-3; GM-CSF; Subcutaneous injection; Iba1; NG2	COLONY-STIMULATING FACTOR; NG2 PROTEOGLYCAN; IN-VITRO; CELLS; MICROGLIA; ISCHEMIA; PROGESTERONE; HIPPOCAMPAL; NEURONS; PROFILE	Macrophage-like cells densely accumulate in stab wound-induced brain lesions in rats. Many of these cells express the macrophage marker Iba1 and the oligodendrocyte progenitor cell marker NG2 chondroitin sulfate proteoglycan (NG2), and have been termed BINCs (brain Iba1(+)/NG2(+) cells). Results from our previous study showed that BINCs elicit neuroprotective action, and agents inducing BINC activation or proliferation are expected to ameliorate traumatic brain injuries (TBIs). In the present study, TBI was established by inserting a needle into the cerebrum and moving the needle in a longitudinal, fan-like movement. Isolated BINCs from these stab lesions expressed mRNAs encoding receptors for interleukin-3 (IL-3) and granulocyte/macrophage colony-stimulating factor (GM-CSF). When this mixture of cytokines was added to the cultured BINCs, expression of mRNAs encoding insulin-like growth factor-1, hepatocyte growth factor, and proliferating cell nuclear antigen increased. The cytokine mixture induced enhanced wound healing in BINCs-brain cell co-cultures in vitro. Stab wounds in the rats resulted in significant brain tissue loss at 2 months post-lesion. However, tissue loss was reduced by 40% when the combination of IL-3 and GM-CSF was subcutaneously injected 7 times (once per day) beginning at 2 or 3 days post-lesion (dpl). BINCs are highly proliferative and an intraperitoneal injection of 5-fluorouracil (5FU) at 2 dpl eliminated the BINCs, resulting in death of the rats. The cytokine mixture injection significantly reduced mortality of the 5FU-treated rats. These results suggest that the combination of IL-3 and GM-CSF serves as a promising agent to ameliorate TBI via action on BINCs. (C) 2011 Elsevier Inc. All rights reserved.	[Nishihara, Tasuku; Ochi, Michihisa; Sugimoto, Kana; Takahashi, Hisaaki; Yano, Hajime; Kumon, Yoshiaki; Ohnishi, Takanori; Tanaka, Junya] Ehime Univ, Ehime Proteomed Res Ctr, Dept Basic & Clin Neurosci, Toon, Ehime 7910295, Japan; [Nishihara, Tasuku; Ochi, Michihisa; Sugimoto, Kana; Takahashi, Hisaaki; Yano, Hajime; Tanaka, Junya] Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime 7910295, Japan; [Kumon, Yoshiaki; Ohnishi, Takanori] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime 7910295, Japan		Tanaka, J (corresponding author), Ehime Univ, Ehime Proteomed Res Ctr, Dept Basic & Clin Neurosci, Toon, Ehime 7910295, Japan.	jtanaka@m.ehime-u.ac.jp	Tanaka, Junya/Y-1033-2019	Tanaka, Junya/0000-0003-1056-5948	Setsuro Fujii Memorial; The Osaka Foundation for Promotion of Fundamental Medical Research; Ehime University; Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23659688] Funding Source: KAKEN	This study was supported by grants from the Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research, and Ehime University and was also supported by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Program for Enhancing Systematic Education in Graduate School).	ANTMAN KH, 1990, YALE J BIOL MED, V63, P387; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Berezovskaya O, 1996, ACTA NEUROPATHOL, V92, P479, DOI 10.1007/s004010050550; Bethel A, 1997, STROKE, V28, P609, DOI 10.1161/01.STR.28.3.609; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Tanaka J, 1998, GLIA, V24, P198, DOI 10.1002/(SICI)1098-1136(199810)24:2<198::AID-GLIA5>3.0.CO;2-0; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457	30	24	25	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2011	229	2					507	516		10.1016/j.expneurol.2011.04.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	774XF	WOS:000291419400036	21515263				2022-02-06	
J	Sun, D; Gugliotta, M; Rolfe, A; Reid, W; McQuiston, AR; Hu, WH; Young, H				Sun, Dong; Gugliotta, Marinella; Rolfe, Andrew; Reid, Wendy; McQuiston, A. Rory; Hu, Wenhui; Young, Harold			Sustained Survival and Maturation of Adult Neural Stem/Progenitor Cells after Transplantation into the Injured Brain	JOURNAL OF NEUROTRAUMA			English	Article						neural stem/progenitor cells; subventricular zone; transplantation; traumatic brain injury	MARROW STROMAL CELLS; PROGENITOR CELLS; STEM-CELLS; INFLAMMATORY RESPONSE; COGNITIVE RECOVERY; RAT-BRAIN; DIFFERENTIATION; NEURONS; MIGRATION; IMPROVES	Multipotent neural stem/progenitor cells (NS/NPCs) that are capable of generating neurons and glia offer enormous potential for treating neurological diseases. Adult NS/NPCs that reside in the mature mammalian brain can be isolated and expanded in vitro, and could be a potential source for autologous transplantation to replace cells lost to brain injury or disease. When these cells are transplanted into the normal brain, they can survive and become region-specific cells. However, it has not been reported whether these cells can survive for an extended period and become functional cells in an injured heterotypic environment. In this study, we tested survival, maturation fate, and electrophysiological properties of adult NS/NPCs after transplantation into the injured rat brain. NS/NPCs were isolated from the subventricular zone of adult Fisher 344 rats and cultured as a monolayer. Recipient adult Fisher 344 rats were first subjected to a moderate fluid percussive injury. Two days later, cultured NS/NPCs were injected into the injured brain in an area between the white matter tracts and peri-cortical region directly underneath the injury impact. The animals were sacrificed 2 or 4 weeks after transplantation for immunohistochemical staining or patch-clamp recording. We found that transplanted cells survived well at 2 and 4 weeks. Many cells migrated out of the injection site into surrounding areas expressing astrocyte or oligodendrocyte markers. Whole cell patch-clamp recording at 4 weeks showed that transplanted cells possessed typical mature glial cell properties. These data demonstrate that adult NS/NPCs can survive in an injured heterotypic environment for an extended period and become functional cells.	[Sun, Dong; Gugliotta, Marinella; Rolfe, Andrew; Reid, Wendy; Young, Harold] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [McQuiston, A. Rory] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Hu, Wenhui] Temple Univ, Dept Neurosci, Philadelphia, PA 19122 USA		Sun, D (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, POB 980631,Med Coll Virginia Campus, Richmond, VA 23298 USA.	dsun@vcu.edu	McQuiston, Adam Rory/A-3072-2008		A.D. William Fund; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062369, NS055086, 5P30NS047463]; Virginia Commonwealth Neurotrauma Initiative Trust [RFP07-302]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS062369, P30NS047463, R01NS055086] Funding Source: NIH RePORTER	Sponsored by the A.D. William Fund (Sun), National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grant NS062369 (Sun), NIH/NINDS grant NS055086 (Sun), and the Virginia Commonwealth Neurotrauma Initiative Trust Fund (RFP07-302, Sun). Microscopy work was performed at the VCU-Department of Anatomy and Neurobiology Microscopy Facility, supported in part by funding from NIH/NINDS center core grant 5P30NS047463.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Dziewczapolski G, 2003, EXP NEUROL, V183, P653, DOI 10.1016/S0014-4886(03)00212-7; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gates M A, 2000, Prog Brain Res, V127, P115; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Klassen H, 2003, VISION RES, V43, P947, DOI 10.1016/S0042-6989(03)00094-4; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McQuiston AR, 2007, J NEUROPHYSIOL, V97, P2301, DOI 10.1152/jn.01179.2006; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Richardson RM, 2005, MOL CELL NEUROSCI, V28, P674, DOI 10.1016/j.mcn.2004.11.013; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Soares HD, 1995, J NEUROSCI, V15, P8223; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	47	24	26	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					961	972		10.1089/neu.2010.1697			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600010	21332258	Green Submitted, Green Published			2022-02-06	
J	Tu, LV; Togher, L; Power, E				Tu, Lan Vy; Togher, Leanne; Power, Emma			The impact of communication partner and discourse task on a person with traumatic brain injury: The use of multiple perspectives	BRAIN INJURY			English	Article						Traumatic brain injury; communication partner; conversation; communication skills; rehabilitation	QUALITY-OF-LIFE; REHABILITATION; PEOPLE; IMPAIRMENT; MANAGEMENT; CHILDREN; DEFICITS; ABILITY; INTERVENTION; COMPETENCE	Primary objective: This study investigated whether varying the communication partner (i.e. mother vs paid caregiver) and discourse task (i.e. casual conversation vs purposeful conversation vs problem-solving task) affected the nature of information exchange for a person with traumatic brain injury (TBI). Methods: Three discourse tasks were recorded involving a TBI participant with his mother and, on a separate occasion, with his paid caregiver. Texts were analysed using multiple perspectives, comprising exchange structure analysis, ratings by independent observers and self and others' perceptions of communication. Results: The TBI participant was more likely to give information when interacting with his mother than with the paid caregiver, as shown by exchange structure analysis. The participants also varied the way they exchanged information according to the discourse tasks. Results from exchange structure analysis were corroborated by the ratings by independent observers. Additionally, the mother was found to perceive that the TBI participant 'usually' had communication difficulty, while the caregiver perceived that he 'rarely' had communication difficulty. Conclusion: The nature of information exchange for a person with TBI varied with the communication partner and discourse task. The multiple perspectives used in this study appeared promising for the examination of discourse ability following TBI.	[Tu, Lan Vy] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Lidcombe, NSW 1825, Australia		Tu, LV (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, 75 E St,POB 170, Lidcombe, NSW 1825, Australia.	latu5513@uni.sydney.edu.au	Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was funded by a National Health and Medical Research Council Project Grant. The granting body did not have any input into the research study design, implementation and outcomes. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; BERRY M, 1981, STUDIES DISCOURSE AN, P120; BODY R, 1999, BRAIN DAM B, P147; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Eggins S., 1997, ANAL CASUAL CONVERSA; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Halliday M., 2004, INTRO FUNCTIONAL GRA; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HUNT KW, 1970, MONOGR SOC RES CHILD, V35, P1; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larkins B, 1999, ASIA PACIFIC J SPEEC, V4, P183; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; Marshall RC, 2003, BRAIN INJURY, V17, P589, DOI 10.1080/0269905031000088496; Martin J. R., 1992, ENGLISH TEXT SYSTEM; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rosenthal M, 1999, REHABILITATION ADULT; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SPENCER EL, 2005, THESIS U SYDNEY SYDN; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1998, THESIS NSW U SYDNEY; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; TOGHER L, 2002, INT APH RES C BRISB; Togher L., 1998, ANAL INTERPERSONAL M; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; VENTOLA E, 1987, STRUCTURE SOCIAL INT; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57	59	24	24	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					560	580		10.3109/02699052.2011.571655			21	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300003	21534734				2022-02-06	
J	Christidi, F; Bigler, ED; McCauley, SR; Schnelle, KP; Merkley, TL; Mors, MB; Li, XQ; Macleod, M; Chu, ZL; Hunter, JV; Levin, HS; Clifton, GL; Wilde, EA				Christidi, Foteini; Bigler, Erin D.; McCauley, Stephen R.; Schnelle, Kathleen P.; Merkley, Tricia L.; Mors, Matthew B.; Li, Xiaoqi; Macleod, Marianne; Chu, Zili; Hunter, Jill V.; Levin, Harvey S.; Clifton, Guy L.; Wilde, Elisabeth A.			Diffusion Tensor Imaging of the Perforant Pathway Zone and Its Relation to Memory Function in Patients with Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; memory; perforant pathway; traumatic brain injury	MILD COGNITIVE IMPAIRMENT; CLOSED-HEAD-INJURY; AXONAL INJURY; HIPPOCAMPAL ATROPHY; CORPUS-CALLOSUM; NEURONAL INJURY; IN-VIVO; MODERATE; DAMAGE; MRI	Based on the importance of the perforant pathway (PP) for normal hippocampal function, the vulnerability of temporal structures, and significant memory impairment in patients with traumatic brain injury (TBI), we investigated in vivo changes in the PP zone, hippocampus, and temporal lobe white and gray matter using diffusion tensor imaging (DTI) and volumetric analysis, and any specific relations with memory performance (Verbal Selective Reminding Test, Rey-Osterrieth Complex Figure Test), in 14 patients with severe TBI. Compared to a demographically-similar control group, our patients had significantly decreased fractional anisotropy (FA) and higher apparent diffusion coefficient (ADC) for the PP zone bilaterally, and higher ADC bilaterally in the hippocampus. Volumetric analysis revealed significantly decreased volumes in both hippocampi and temporal gray matter bilaterally. Consistent long-term retrieval (CLTR) and delayed recall were significantly related to (1) right and left PP zone ADC, (2) left hippocampus ADC, and (3) left hippocampal volume. Nonverbal memory (immediate and delayed recall) was significantly associated with (1) right and left PP zone ADC, (2) left hippocampal volume, and (3) gray (immediate recall) and white (immediate recall, bilaterally; delayed recall, left) matter temporal volumes. Advanced neuroimaging analysis can detect in vivo changes in the PP zone and temporal structures in patients with severe TBI, with these changes being highly associated with memory impairment.	[Christidi, Foteini] Natl & Kapodistrian Univ, Eginit Hosp, Sch Med, Postgrad Program Clin Neuropsychol, Athens, Greece; [Christidi, Foteini] Natl & Kapodistrian Univ, Eginit Hosp, Sch Med, Neuropsychol Lab,Dept Neurol 1, Athens, Greece; [Bigler, Erin D.; Merkley, Tricia L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Mors, Matthew B.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA; [Clifton, Guy L.] Univ Texas Houston, Sch Med, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX USA; [Chu, Zili; Hunter, Jill V.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Chu, Zili; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA		Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ewilde@bcm.edu	Merkley, Tricia L./AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391	Dana Foundation; Medical School, National and Kapodistrian University of Athens, Greece; University of Texas Health Science Center at Houston, Texas	Funding for this project was provided by a grant from the Dana Foundation (PI: Wilde). We also gratefully acknowledge the organization committee of the clinical neuropsychology program of the Medical School, National and Kapodistrian University of Athens, Greece, and The University of Texas Health Science Center at Houston, Texas (A. C. Papanicolaou, D. Vassilopoulos; I. Evdokimidis, I. Zalonis, S. G. Papageorgiou, C. Potagas, and N. Smyrnis) for their financial assistance to author F. C. We wish to acknowledge the contribution of Dr. Ramon Arrastia-Diaz for his assistance in developing the DTI protocol for the perforant pathway. We thank Jonathan Chia, Vipulkumar Patel, and Dr. Ponnada Narayana for their assistance in the development and implementation of the MR sequences. We also wish to acknowledge the assistance of Ragini Yallampalli in manuscript preparation. Finally, we wish to thank the participants of this study.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Augustinack JC, 2010, FRONT HUM NEUROSCI, V4, DOI [10.3389/fnhum.2010.000421985, 10.3389/fnhum.2010.00042]; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BIASCA N, 2007, PROG BRAIN RES, V161, P719; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 2009, AM PSYCHIAT PUBLISHI, P229; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cohen, 1988, STAT POWER ANAL BEHA, P412; Conti AC, 1998, J NEUROSCI, V18, P5663; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gozal E, 2001, NEUROSCI LETT, V305, P197, DOI 10.1016/S0304-3940(01)01853-5; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoschl C, 2001, EUR ARCH PSY CLIN N, V251, P81; Holmberg P, 2009, CURR NEUROVASC RES, V6, P1; Hoogenraad F., 2002, MULTICENTER EVALUATI; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kadar T, 1998, J NEURAL TRANSM, V105, P987, DOI 10.1007/s007020050107; Kalus P, 2006, NEUROIMAGE, V30, P713, DOI 10.1016/j.neuroimage.2005.10.035; Kantarci K, 2005, NEUROLOGY, V64, P902, DOI 10.1212/01.WNL.0000153076.46126.E9; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1998, J NEUROL NEUROSUR PS, V5, P1294; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; MAPOU RL, 1992, HDB HEAD TRAUMA EARL, V75, P75; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Meyers JE., 1995, REY COMPLEX FIGURE T; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; NETSCH T, 2001, INT C COMP VIS; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rogalski EJ, 2009, BEHAV NEUROL, V21, P51, DOI [10.3233/BEN-2009-0235, 10.1155/2009/408037]; Ropper AH, 2009, ADAMS VICTORS PRINCI; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Stark C., 2007, HIPPOCAMPUS BOOK, P549; Strauss E., 2006, COMPENDIUM NEUROPSYC, P811; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wolkowitz OM, 2007, NEUROCASE, V13, P189, DOI 10.1080/13554790701475468; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	88	24	24	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2011	28	5					711	725		10.1089/neu.2010.1644			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	762JI	WOS:000290472100272	21381986				2022-02-06	
J	Kennedy, MRT; Krause, MO				Kennedy, Mary R. T.; Krause, Miriam O.			Self-Regulated Learning in a Dynamic Coaching Model for Supporting College Students With Traumatic Brain Injury: Two Case Reports	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive rehabilitation; college students; self-regulation; supported education	COGNITIVE REHABILITATION; POSTSECONDARY STUDENTS; ADULTS; EXPERIENCES; TRANSITION; RETURN	Objective: To describe a program that integrates self-regulated learning theory with supported education for college students with traumatic brain injury using a dynamic coaching model; to demonstrate the feasibility of developing and implementing such a program; and to identify individualized outcomes. Design: Case study comparisons. Setting: University setting. Participants: Two severely injured students with cognitive impairments. Interventions: A dynamic coaching model of supported education which incorporated self-regulated learning was provided for students with traumatic brain injury while attending college. Outcomes: Outcomes were both short and long term including decontextualized standardized test scores, self-reported academic challenges, number and specificity of reported strategies, grades on assignments, number of credits completed versus attempted, and changes in academic status and campus life. Results: Students improved on graded assignments after strategy instruction and reported using more strategies by the end of the year. Students completed most of the credits they attempted, were in good academic standing, and made positive academic decisions. Performance on decontextualized tests pre- and postintervention was variable. Conclusions: It is feasible to deliver a hybrid supported education program that is dynamically responsive to individual students' needs and learning styles. Reasons for including both functional and standardized test outcomes are discussed.	[Kennedy, Mary R. T.; Krause, Miriam O.] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA		Kennedy, MRT (corresponding author), Univ Minnesota, Dept Speech Language Hearing Sci, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@umn.edu		Krause, Miriam/0000-0002-6798-3991	Office of the Vice President for Research; Graduate School, University of Minnesota, Minneapolis, MinnesotaUniversity of Minnesota System	The authors thank Disability Services at the University of Minnesota-Twin Cities, Minneapolis, MN, Marie Meyer and Valerie Blouch for their contribution to the study and manuscript preparation. This study was made possible in part due to a Grant-in-Aid awarded to the first author by the Office of the Vice President for Research and the Graduate School, University of Minnesota, Minneapolis, Minnesota.	Bandura A., 1997, SELF EFFICACY EXERCI; BUETHE C, 1989, J COLL STUDENT DEV, V30, P172; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cook J, 1991, J HEAD TRAUMA REHAB, V6, P64, DOI [10.1097/00001199-199103000-00011, DOI 10.1097/00001199-199103000-00011]; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dunlosky J., 2009, METACOGNITION; Dunlosky J., 2005, COGNITIVE TECHNOLOGY, V10, P4; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Getzel E, 2006, GOING COLL, P139; Getzel EE, 2008, CAREER DEV TRANSIT E, V31, P77, DOI 10.1177/0885728808317658; Harrington D E, 1987, Brain Inj, V1, P65, DOI 10.3109/02699058709034447; Harris JR, 1997, J HEAD TRAUMA REHAB, V12, P67, DOI 10.1097/00001199-199704000-00007; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kennedy MRT, 2004, NEUROPSYCHOL REHABIL, V14, P449, DOI 10.1080/09602010443000038; Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; KENNEDY MRT, 2010, BRAIN INJURY, V24, P325; Kirby JR, 2008, J LEARN DISABIL-US, V41, P85, DOI 10.1177/0022219407311040; Krause M, 2009, BRAIN INJURY, V23, P965, DOI 10.3109/02699050903373485; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; MOWBRAY CT, 1993, PSYCHOSOC REHABIL, V17, P129, DOI DOI 10.1037/H0095619; NELSON HE, 1991, NATL ADULT READING; RANDOLPH C, PEARSON ED, V1; Randolph C., 1998, REPEATABLE BATTERY A; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schunk D.H., 2000, HDB SELF REGULATION, P631, DOI [10.1016/b978-012109890-2/50048-2, DOI 10.1016/B978-012109890-2/50048-2]; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Wagner M., 2005, HIGH SCH 1 LOOK POST; Winne PH, 1998, EDUC PSYCHOL SER, P277; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	45	24	25	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2011	26	3					212	223		10.1097/HTR.0b013e318218dd0e			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	760CY	WOS:000290301800005	21552070				2022-02-06	
J	Sher, L				Sher, L.			Brain-derived neurotrophic factor and suicidal behavior	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NEURODEGENERATIVE DISORDERS; GENE-EXPRESSION; BDNF; DEPRESSION; PATHOGENESIS; INJURY; 5-HT; AREA	Studies of the neurobiology of suicidal behavior have become an important and integral part of psychiatric research. Over the past several years, studies of the role of brain-derived neurotrophic factor (BDNF) in the pathophysiology of suicidality have attracted significant interest of researchers. Multiple lines of evidence including studies of levels of BDNF in blood cells and plasma of suicidal patients, postmortem brain studies in suicidal subjects with or without depression, and genetic association studies linking BDNF to suicide suggest that suicidal behavior may be associated with a decrease in BDNF functioning. Studies of the BDNF function are important for suicide research and prevention because of the multiple reasons including the following: (i) BDNF plays a role in the pathophysiology of depression, post-traumatic stress disorder, substance use disorders and other conditions associated with suicidal behavior. Treatment-induced enhancements of BDNF can facilitate neural integrity and recovery of function in psychiatric disorders, and consequently prevent suicidal behavior; (ii) abnormal BDNF function may be associated with elevated suicidality independently of psychiatric diagnoses. It is possible that treatment-induced improvement in the BDNF function prevents suicidal behavior independently of improvement in psychiatric disorders; (iii) BDNF may be a biological marker of suicidal behavior in certain patient populations. It is to be hoped that the studies of the neurobiology of suicidal behavior will lead to the development of new methods of suicide prevention.	James J Peters Vet Adm Med Ctr, Mt Sinai Sch Med, Dept Psychiat, New York, NY 10468 USA		Sher, L (corresponding author), James J Peters Vet Adm Med Ctr, Mt Sinai Sch Med, Dept Psychiat, 130 W Kingsbridge Rd, New York, NY 10468 USA.	drleosher@gmail.com					*AM FDN SUIC PREV, FACT FIG INT STAT; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Carballo Juan J, 2006, Int J Adolesc Med Health, V18, P15; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Dwivedi Y, 2010, ANN MED, V42, P87, DOI 10.3109/07853890903485730; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Lee BH, 2010, J AFFECT DISORDERS, V125, P369, DOI 10.1016/j.jad.2010.01.074; Logrip ML, 2009, J NEUROCHEM, V109, P1459, DOI 10.1111/j.1471-4159.2009.06073.x; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; *NAT I MENT HLTH, SUIC US STAT PREV; *OFF NAT STAT, SUIC UK SUIC INCR 20; Pardon MC, 2010, VITAM HORM, V82, P185, DOI 10.1016/S0083-6729(10)82010-2; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; PREGELJ P, J AFFECT DI IN PRESS; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sher L, 2004, QJM-INT J MED, V97, P677, DOI 10.1093/qjmed/hch106; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; TADIC A, PROG NEUROP IN PRESS; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Zetterstrom TSC, 1999, NEUROPHARMACOLOGY, V38, P1063, DOI 10.1016/S0028-3908(99)00022-2	33	24	26	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	MAY	2011	104	5					455	458		10.1093/qjmed/hcq207			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754EY	WOS:000289838200017	21051476	Bronze			2022-02-06	
J	Tong, WS; Zheng, P; Xu, JF; Guo, YJ; Zeng, JS; Yang, WJ; Li, GY; He, B; Yu, H				Tong, Wu-song; Zheng, Ping; Xu, Jun-fa; Guo, Yi-jun; Zeng, Jing-song; Yang, Wen-jin; Li, Gao-yi; He, Bin; Yu, Hui			Early CT signs of progressive hemorrhagic injury following acute traumatic brain injury	NEURORADIOLOGY			English	Article						Traumatic brain injury (TBI); Progressive hemorrhagic injury (PHI); Early CTscan; CTsigns	HEAD-INJURY; PREDICTORS; LESIONS	Since progressive hemorrhagic injury (PHI) was introduced in neurosurgical literatures, several studies have been performed, the results of which have influenced doctors but do not define guidelines for the best treatment of PHI. PHI may be confirmed by a serial computerized tomography (CT) scan, and it has been shown to be associated with a fivefold increase in the risk of clinical worsening and is a significant cause of morbidity and mortality as well. So, early detection of PHI is practically important in a clinical situation. To analyze the early CT signs of progressive hemorrhagic injury following acute traumatic brain injury (TBI) and explore their clinical significances, PHI was confirmed by comparing the first and repeated CT scans. Data were analyzed and compared including times from injury to the first CT and signs of the early CT scan. Logistic regression analysis was used to show the risk factors related to PHI. A cohort of 630 TBI patients was evaluated, and there were 189 (30%) patients who suffered from PHI. For patients with their first CT scan obtained as early as 2 h post-injury, there were 116 (77.25%) cases who suffered from PHI. The differences between PHIs and non-PHIs were significant in the initial CT scans showing fracture, subarachnoid hemorrhage (SAH), brain contusion, epidural hematoma (EDH), subdural hematoma (SDH), and multiple hematoma as well as the times from injury to the first CT scan (P < 0.01). Logistic regression analysis showed that early CT scans (EDH, SDH, SAH, fracture, and brain contusion) were predictors of PHI (P < 0.01). For patients with the first CT scan obtained as early as 2 h post-injury, a follow-up CT scan should be performed promptly. If the initial CT scan shows SAH, brain contusion, and primary hematoma with brain swelling, an earlier and dynamic CT scan should be performed for detection of PHI as early as possible and the medical intervention would be enforced in time.	[Tong, Wu-song; Zheng, Ping; Xu, Jun-fa; Guo, Yi-jun; Zeng, Jing-song; Yang, Wen-jin; Li, Gao-yi; He, Bin; Yu, Hui] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai 201200, Peoples R China		Tong, WS (corresponding author), Pudong New Area Peoples Hosp, Dept Neurosurg, 490 S Chuanhuan Rd, Shanghai 201200, Peoples R China.	tongws0599@yahoo.com.cn; jojo_ras@hotmail.com					Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Jiang J., 2008, CLIN GUIDELINES MANA, P1; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; LIANG YM, 2006, CHIN J TRAUMA, V22, pL56; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004	11	24	31	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAY	2011	53	5					305	309		10.1007/s00234-010-0659-8			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	750SU	WOS:000289569100001	20131047				2022-02-06	
J	Wu, HT; Jiang, H; Lu, DY; Qu, CS; Xiong, Y; Zhou, D; Chopp, M; Mahmood, A				Wu, Hongtao; Jiang, Hao; Lu, Dunyue; Qu, Changsheng; Xiong, Ye; Zhou, Dong; Chopp, Michael; Mahmood, Asim			Induction of Angiogenesis and Modulation of Vascular Endothelial Growth Factor Receptor-2 by Simvastatin After Traumatic Brain Injury	NEUROSURGERY			English	Article						Angiogenesis; Simvastatin; Traumatic brain injury; VEGFR-2	NITRIC-OXIDE SYNTHASE; CEREBRAL-ISCHEMIA; KINASE AKT; NEUROGENESIS; STROKE; RATS; INCREASE; STATINS; CELLS; PATHOPHYSIOLOGY	BACKGROUND: Our previous studies demonstrated that simvastatin reduced neuronal death, increased neurogenesis, and promoted functional recovery after traumatic brain injury (TBI). OBJECTIVE: To investigate the effect of simvastatin on angiogenesis after TBI and the related signaling pathways. METHODS: Saline or simvastatin (1 mg/kg) was administered orally to rats starting at day 1 after TBI or sham surgery and then daily for 14 days. Rats were sacrificed at 3 and 14 days after treatment. Brain sections and tissues were prepared for immunohistochemical staining, enzyme-linked immunosorbent assay, and Western blot analysis. Cultured rat brain microvascular endothelial cells were subjected to oxygen-glucose deprivation followed by immunocytochemical staining with phallotoxins and vascular endothelial growth factor receptor-2 (VEGFR-2). Western blot analysis was carried out to examine the simvastatin-induced activation of the v-akt murine thymoma viral oncogene homolog (Akt) signaling pathway. The expression of VEGFR-2 was detected by enzyme-linked immunosorbent assay. RESULTS: Simvastatin significantly increased the length of vascular perimeter, promoted the proliferation of endothelial cells, and improved the sensorimotor function after TBI. Simvastatin stimulated endothelial cell tube formation after oxygen-glucose deprivation in vitro. VEGFR-2 expression in both brain tissues and cultured rat brain microvascular endothelial cells was enhanced after simvastatin treatment, which may be modulated by activation of Akt. Akt-dependent endothelial nitric oxide synthase phosphorylation was also induced by simvastatin in vivo and in vitro. CONCLUSION: Simvastatin augments TBI-induced angiogenesis in the lesion boundary zone and hippocampus and improves functional recovery. Simvastatin also promotes angiogenesis in vitro. These beneficial effects on angiogenesis may be related to simvastatin-induced activation of the VEGFR-2/Akt/endothelial nitric oxide synthase signaling pathway.	[Wu, Hongtao; Qu, Changsheng; Xiong, Ye; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Jiang, Hao; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Wu, Hongtao] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Lu, Dunyue] Suny Downstate Med Ctr, Dept Psychiat, Brooklyn, NY USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu		Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS052280-01A1, PO1NS23345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS023345, R01NS052280] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants R01NS052280-01A1 (Dr Mahmood) and PO1NS23345 (Dr Chopp). The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Chen JL, 2009, STROKE, V40, P2532, DOI 10.1161/STROKEAHA.108.545095; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; Freitas-Andrade M, 2008, J NEUROCHEM, V107, P756, DOI 10.1111/j.1471-4159.2008.05660.x; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Kashiwagi S, 2005, J CLIN INVEST, V115, P1816, DOI 10.1172/JCI24015; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Shimamura M, 2007, STROKE, V38, P3251, DOI 10.1161/STROKEAHA.107.485045; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sugawara T, 2008, J NEUROSCI RES, V86, P3635, DOI 10.1002/jnr.21807; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127	37	24	25	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2011	68	5					1363	1371		10.1227/NEU.0b013e31820c06b9			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	746GE	WOS:000289230300065	21307798	Green Accepted			2022-02-06	
J	Yuge, L; Sasaki, A; Kawahara, Y; Wu, S; Matsumoto, M; Manabe, T; Kajiume, T; Takeda, M; Magaki, T; Takahashi, T; Kurisu, K; Matsumoto, M				Yuge, Louis; Sasaki, Akira; Kawahara, Yumi; Wu, Shu-liang; Matsumoto, Masaya; Manabe, Tomotaka; Kajiume, Teruyuki; Takeda, Masaaki; Magaki, Takuro; Takahashi, Tetsuya; Kurisu, Kaoru; Matsumoto, Masayasu			Simulated Microgravity Maintains the Undifferentiated State and Enhances the Neural Repair Potential of Bone Marrow Stromal Cells	STEM CELLS AND DEVELOPMENT			English	Article							MESENCHYMAL STEM-CELLS; CEREBRAL-ISCHEMIA MODEL; TRAUMATIC BRAIN-INJURY; THERAPEUTIC BENEFIT; FUNCTIONAL RECOVERY; PROGENITOR CELLS; ADULT-RAT; DIFFERENTIATION; EXPRESSION; GROWTH	Recently, regenerative medicine with bone marrow stromal cells (BMSCs) has gained significant attention for the treatment of central nervous system diseases. Here, we investigated the activity of BMSCs under simulated microgravity conditions. Mouse BMSCs (mBMSCs) were isolated from C57BL/6 mice and harvested in 1G condition. Subjects were divided into 4 groups: cultured under simulated microgravity and 1G condition in growth medium and neural differentiation medium. After 7 days of culture, the mBMSCs were used for morphological analysis, reverse transcription (RT)-polymerase chain reaction, immunostaining analysis, and grafting. Neural-induced mBMSCs cultured under 1G conditions exhibited neural differentiation, whereas those cultured under simulated microgravity did not. Moreover, under simulated microgravity conditions, mBMSCs could be cultured in an undifferentiated state. Next, we intravenously injected cells into a mouse model of cerebral contusion. Graft mBMSCs cultured under simulated microgravity exhibited greater survival in the damaged region, and the motor function of the grafted mice improved significantly. mBMSCs cultured under simulated microgravity expressed CXCR4 on their cell membrane. Our study indicates that culturing cells under simulated microgravity enhances their survival rate by maintaining an undifferentiated state of cells, making this a potentially attractive method for culturing donor cells to be used in grafting.	[Yuge, Louis; Sasaki, Akira; Wu, Shu-liang; Matsumoto, Masaya; Manabe, Tomotaka] Hiroshima Univ, Grad Sch Hlth Sci, Div Bioenvironm Adaptat Sci, Minami Ku, Hiroshima 7348551, Japan; [Yuge, Louis; Kawahara, Yumi] Space Biolabs YK, Hiroshima, Japan; [Kawahara, Yumi; Takahashi, Tetsuya; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima 7348551, Japan; [Kajiume, Teruyuki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat, Hiroshima 7348551, Japan; [Takeda, Masaaki; Magaki, Takuro; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Neurosurg, Hiroshima 7348551, Japan		Yuge, L (corresponding author), Hiroshima Univ, Grad Sch Hlth Sci, Div Bioenvironm Adaptat Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	ryuge@hiroshima-u.ac.jp	Takahashi, Tetsuya/ABG-8566-2021	Takahashi, Tetsuya/0000-0001-6891-0842; Kajiume, Teruyuki/0000-0002-4068-3921	American Society for Gravitational and Space Biology at NASA Ames Research Center, San Francisco	The authors thank Dr. Masaru Okabe at Osaka University for kindly providing GFP mice; Mr. Ryuji Hirose, Mr. Toshimasa Ochiai, and Mr. Eiji Matsubara, Mitsubishi Heavy Industries, Ltd., for providing information and suggestions; and Dr. Araceli Espinosa-Jeffrey and Prof. Jean de Vellis at Department of Neurobiology, Semel Institute for Neuroscience, UCLA, for their comments during data analysis and preparation of the manuscript. This study received the award from the 23rd Annual Meeting of the American Society for Gravitational and Space Biology at NASA Ames Research Center, San Francisco, October 27, 2007.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Gonzalez R, 2007, BIOCHEM BIOPH RES CO, V362, P491, DOI 10.1016/j.bbrc.2007.08.033; Higashibata Akira, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-19; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Katano H, 1998, BRAIN RES, V800, P69, DOI 10.1016/S0006-8993(98)00493-4; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Masada T, 2001, J CEREBR BLOOD F MET, V21, P22, DOI 10.1097/00004647-200101000-00004; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Roche S, 2007, J CELL BIOCHEM, V101, P271, DOI 10.1002/jcb.21185; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Takeda M, 2009, NEUROSCI LETT, V463, P54, DOI 10.1016/j.neulet.2009.07.045; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V351, P853, DOI 10.1016/j.bbrc.2006.10.125	31	24	24	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	MAY	2011	20	5					893	900		10.1089/scd.2010.0294			8	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	759NT	WOS:000290255300013	20828292				2022-02-06	
J	Blennow, K; Jonsson, M; Andreasen, N; Rosengren, L; Wallin, A; Hellstrom, PA; Zetterberg, H				Blennow, K.; Jonsson, M.; Andreasen, N.; Rosengren, L.; Wallin, A.; Hellstrom, P. A.; Zetterberg, H.			No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons	ACTA NEUROLOGICA SCANDINAVICA			English	Article						biomarkers; blast injury; cerebrospinal fluid; neurofilament protein; tau protein; traumatic brain injury; war injury	FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; NEUROFILAMENT PROTEIN; TAU-PROTEIN; RAT-BRAIN; CSF; MARKER; IRAQ; DEMENTIA; EXPOSURE	Background - Psychiatric and neurological symptoms are common among soldiers exposed to blast without suffering a direct head injury. It is not known whether such symptoms are direct consequences of blast overpressure. Objective - To examine if repeated detonating explosions or firing if of heavy weapons is associated with neurochemical evidence of brain damage. Materials and methods - Three controlled experimental studies. In the first, army officers were exposed to repeated firing of a FH77B howitzer or a bazooka. Cerebrospinal fluid (CSF) was taken post-exposure to measure biomarkers for brain damage. In the second, officers were exposed for up to 150 blasts by firing a bazooka, and in the third to 100 charges of detonating explosives of 180 dB. Serial serum samples were taken after exposure. Results were compared with a control group consisting of 19 unexposed age-matched healthy volunteers. Results - The CSF biomarkers for neuronal/axonal damage (tau and neurofilament protein), glial cell injury (GFAP and S-100b), blood-brain barrier damage (CSF/serum albumin ratio) and hemorrhages (hemoglobin and bilirubin) and the serum GFAP and S-100b showed normal and stable levels in all exposed officers. Discussion - Repeated exposure to high-impact blast does not result in any neurochemical evidence of brain damage. These findings are of importance for soldiers regularly exposed to high-impact blast when firing artillery shells or other types of heavy weapons.	[Blennow, K.; Zetterberg, H.] Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Gothenburg, Sweden; [Jonsson, M.; Wallin, A.] Univ Gothenburg, Dept Neuropsychiat, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Gothenburg, Sweden; [Andreasen, N.] Karolinska Univ Hosp, Dept Geriatr Med, Huddinge, Sweden; [Rosengren, L.] Univ Gothenburg, Dept Neurol, Gothenburg, Sweden; [Hellstrom, P. A.] Swedish Armed Forces, Mil Headquarters, Stockholm, Sweden		Blennow, K (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp Molndal, Clin Neurochem Lab, SE-43180 Molndal, Sweden.	kaj.blennow@neuro.gu.se		Rosengren, Lars/0000-0003-0505-8896	Swedish Armed Forces; Sahlgrenska University Hospital; University of Gothenburg	Dr Hellstrom is an employee of the Swedish Armed Forces, Military Headquarters, Stockholm. Funded by the Swedish Armed Forces, The Sahlgrenska University Hospital, and University of Gothenburg. We thank Monica Christiansson, Asa Kallen, Christina Sjodin, Steinar Syversen, Ewa Styrud, Christina Holmberg, and Ingela Isblad, for technical assistance.	Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; HAYAKAWA T, 1979, STROKE, V10, P685, DOI 10.1161/01.STR.10.6.685; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Lidstrom AM, 2001, J ALZHEIMERS DIS, V3, P435, DOI 10.3233/JAD-2001-3501; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Otto M, 1997, NEUROSCI LETT, V225, P210, DOI 10.1016/S0304-3940(97)00215-2; Petzold A, 2007, NEURODEGENER DIS, V4, P185, DOI 10.1159/000101843; Petzold A, 2006, NEUROCRIT CARE, V4, P153, DOI 10.1385/NCC:4:2:153; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Sjogren M, 2000, NEUROLOGY, V54, P1960, DOI 10.1212/WNL.54.10.1960; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Zachrisson OCG, 2000, PSYCHIAT RES, V96, P157, DOI 10.1016/S0165-1781(00)00202-X; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	31	24	24	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2011	123	4					245	251		10.1111/j.1600-0404.2010.01408.x			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	728GR	WOS:000287863100003	20637009				2022-02-06	
J	Cecil, S; Chen, PM; Callaway, SE; Rowland, SM; Adler, DE; Chen, JW				Cecil, Sandy; Chen, Patrick M.; Callaway, Sarah E.; Rowland, Susan M.; Adler, David E.; Chen, Jefferson W.			Traumatic Brain Injury Advanced Multimodal Neuromonitoring From Theory to Clinical Practice	CRITICAL CARE NURSE			English	Article							CEREBRAL-BLOOD-FLOW; MODERATE HYPOTHERMIA; TISSUE OXYGEN; MICRODIALYSIS; AUTOREGULATION; METABOLISM; MANAGEMENT; PRESSURE; THERAPY; GLUCOSE	Traumatic brain injury accounts for nearly 1.4 million injuries and 52 000 deaths annually in the United States. Intensive bedside neuromonitoring is critical in preventing secondary ischemic and hypoxic injury common to patients with traumatic brain injury in the days following trauma. Advancements in multimodal neuromonitoring have allowed the evaluation of changes in markers of brain metabolism (eg, glucose, lactate, pyruvate, and glycerol) and other physiological parameters such as intracranial pressure, cerebral perfusion pressure, cerebral blood flow, partial pressure of oxygen in brain tissue, blood pressure, and brain temperature. This article highlights the use of multimodal monitoring in the intensive care unit at a level I trauma center in the Pacific Northwest. The trends in and significance of metabolic, physiological, and hemodynamic factors in traumatic brain injury are reviewed, the technical aspects of the specific equipment used to monitor these parameters are described, and how multimodal monitoring may guide therapy is demonstrated. As a clinical practice, multimodal neuromonitoring shows great promise in improving bedside therapy in patients with traumatic brain injury, ultimately leading to improved neurological outcomes. (Critical Care Nurse. 2011;31:25-37)	[Cecil, Sandy; Callaway, Sarah E.] Legacy Emanuel Med Ctr, Surg Intens Care Unit, Portland, OR USA; [Chen, Patrick M.] Dartmouth Coll, Hanover, NH 03755 USA		Cecil, S (corresponding author), 2801 N Gantenbein Ave, Portland, OR 97227 USA.	scecil@lhs.org	chen, jeff/AAR-7375-2020; Chen, Patrick M./AAX-9264-2020	chen, jeff/0000-0003-0624-6864; Chen, Patrick M./0000-0003-4505-964X			Bader Mary Kay, 2006, J Neurosci Nurs, V38, P248; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; Buggy DJ, 2000, BRIT J ANAESTH, V84, P615, DOI 10.1093/bja/84.5.615; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chesnut RM, 1998, SURG NEUROL, V50, P187, DOI 10.1016/S0090-3019(98)00075-5; *CODM SHURTL INC, 2008, HEMEDEX POCK REF GUI; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; DOBERSTEIN C, 1996, NEUROTRAUMA, P539; Gallagher CN, 2009, NEUROSURGERY, V64, P555, DOI 10.1227/01.NEU.0000338430.49461.D2; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Gwinnutt CL, 2005, ANAEST INTENS CARE M, V6, P153, DOI 10.1383/anes.6.5.153.65040; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Horn P, 2007, EUR NEUROL DIS, V7, P6; *INT NEUROSCIENCES, 2004, LIC IMC COMPL NEUR D; *INT NEUROSCIENCES, 2004, CAM US MAN; Jenkinson MD, 2009, J NEUROSURG, V110, P861, DOI 10.3171/2008.10.JNS17667; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Peerdeman SM, 2000, INTENS CARE MED, V26, P662, DOI 10.1007/s001340051230; Peerdeman SM, 2003, J NEUROL, V250, P797, DOI 10.1007/s00415-003-1079-z; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Phan N, 2009, J NEUROTRAUM, V26, pA66; Presciutti M, 2009, J NEUROSCI NURS, V41, P131, DOI 10.1097/JNN.0b013e3181a23e7d; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sahuquillo J, 2004, CURR PHARM DESIGN, V10, P2193, DOI 10.2174/1381612043384051; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Shardlow E, 2008, ANAEST INTENS CARE M, V9, P222, DOI 10.1016/j.mpaic.2008.03.009; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; TISDALL MM, 2008, BRIT J ANAESTH, V97, P18; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; WALTERS FJ, 1998, UPDATE ANAESTH, V8; WEINBERG AD, 1993, ANN EMERG MED, V22, P370, DOI 10.1016/S0196-0644(05)80467-6; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; Wolfe TJ, 2009, CURR NEUROL NEUROSCI, V9, P477, DOI 10.1007/s11910-009-0070-1; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	46	24	28	0	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	APR	2011	31	2					25	36		10.4037/ccn2010226			12	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	744AX	WOS:000289065500086	20592189				2022-02-06	
J	Oliveira, L; Fregni, F				Oliveira, Lais; Fregni, Felipe			Pharmacological and electrical stimulation in chronic disorders of consciousness: New insights and future directions	BRAIN INJURY			English	Article						Vegetative state; minimally conscious state; anoxia; traumatic brain injury; therapy; outcome	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; RECOVERY; PREDICTORS; AMANTADINE; ZOLPIDEM; THERAPY; COMA	Background: Chronic disorders of consciousness are costly and challenging conditions to treat. Although recent studies that have tested pharmacological and electrical stimulation for these conditions are promising, the optimal intervention, mechanisms of action and side effects of these experimental therapies are unclear. Objective: To systematically review the clinical results of treatments for vegetative state (VS) and minimally conscious state (MCS) from the last 10 years. Methods: MEDLINE, LILACS and SCOPUS were searched as data sources. Because the potential bias when search is limited to databases of peer-reviewed journals, reference lists were examined and experts in the field were contacted for other relevant or unpublished articles (i.e. negative studies). No negative unpublished studies were found. Studies were included related to therapeutic interventions in adult MCS or VS patients at least 3 and 12 months after non-traumatic and traumatic injuries, respectively. Eight studies met the inclusion criteria. The following interventions were reviewed: levodopa, amantadine, zolpidem, baclofen, dorsal column stimulation and deep brain stimulation. Conclusions: The adverse effects that were associated with these treatments were typically mild. Most of the studies demonstrated considerable improvements with the interventions, but their low strength of evidence limit the generalizability of the findings.	[Oliveira, Lais; Fregni, Felipe] Harvard Univ, Sch Med, Lab Neuromodulat, Phys Med & Rehabil Dept,Spaulding Rehabil Hosp, Boston, MA USA; [Oliveira, Lais; Fregni, Felipe] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Sch Med,Neurol Dept, Boston, MA 02215 USA		Fregni, F (corresponding author), 125 Nashua St,Room 725, Boston, MA 02114 USA.	ffregni@bidmc.harvard.edu		Fregni, Felipe/0000-0001-9359-8643; Oliveira, Lais/0000-0002-1980-6755			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bates D, 2003, CLIN MED, V3, P249; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Fridman EA, 2009, BRAIN INJURY, V23, P172, DOI 10.1080/02699050802649662; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; JENNETT B, 1972, LANCET, V1, P734; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kanno T, 2009, NEUROMODULATION, V12, P33, DOI 10.1111/j.1525-1403.2009.00185.x; Kobylarz EJ, 2005, NEUROPSYCHOL REHABIL, V15, P323, DOI 10.1080/09602010443000605; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; Monti MM, 2009, ANN NY ACAD SCI, V1157, P81, DOI 10.1111/j.1749-6632.2008.04121.x; Moseley AM, 2002, AUST J PHYSIOTHER, V48, P43, DOI 10.1016/S0004-9514(14)60281-6; Noda R, 2003, ACTA NEUROCHIR SUPPL, V87, P23; Oxford Centre for Evidence-based Medicine, 2009, LEV EV; PORTNEY LG, 2008, FDN CLIN RES APPL PR, P357; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2006, J NEUROTRAUM, V23, P1436, DOI 10.1089/neu.2006.23.1436; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wu TS, 2005, J EMERG MED, V28, P289, DOI 10.1016/j.jemermed.2004.11.016; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	32	24	24	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2011	25	4					315	327		10.3109/02699052.2011.556103			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600001	21314279				2022-02-06	
J	Stein, DM; Kufera, JA; Lindell, A; Murdock, KR; Menaker, J; Bochicchio, GV; Aarabi, B; Scalea, TM				Stein, Deborah M.; Kufera, Joseph A.; Lindell, Allison; Murdock, Karen R.; Menaker, Jay; Bochicchio, Grant V.; Aarabi, Bizhan; Scalea, Thomas M.			Association of CSF Biomarkers and Secondary Insults Following Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Biomarkers; Cerebral perfusion pressure; Intracranial pressure; Secondary insults	NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; INTRACTABLE INTRACRANIAL HYPERTENSION; DECOMPRESSIVE LAPAROTOMY; CEREBROSPINAL-FLUID; PROTEIN FAMILY; SERUM-LEVELS; PRESSURE; S100B; CHILDREN	Management of severe traumatic brain injury (TBI) focuses on mitigating secondary insults. There are a number of biomarkers that are thought to play a part in secondary injury following severe TBI. Two of these, S100 beta and neuron-specific enolase (NSE), have been extensively studied in the setting of neurological injury. This pilot study was undertaken to investigate the relationship of S100 beta and NSE to clinical markers of severity and poor outcome: intracranial hypertension (ICH), and cerebral hypoperfusion (CH). Patients at the R Adams Cowley Shock Trauma Center were prospectively enrolled over an 18-month period. Inclusion criteria were: age > 18, admission within the first 6 h after injury, Glasgow Coma Scale (GCS) < 9 on admission, isolated TBI, and placement of an intraventricular catheter (IVC). Patients were managed according to an institutional protocol based on the Brain Trauma Foundation Guidelines. CSF was collected from the IVC on admission and twice daily for 7 days. S100 beta and NSE levels were analyzed by ELISA. CSF levels drawn before (PRE) and after (POST) 12-h time periods were compared to percentage time intracranial pressure (ICP) > 20 mmHg (% ICP(20)) and cerebral perfusion pressure (CPP) < 60 mmHg (% CPP(60)), and cumulative "Pressure times Time Dose" (PTD) for episodes of ICP > 20 mmHg (PTD ICP(20)) and CPP < 60 mmHg (PTD CPP(60)). Statistical analysis was performed using the Student's t test to compare means and non-parametric Wilcoxon statistic to compare ranked data. Linear regression methods were applied to compare levels of S100 beta and NSE with ICP and CPP(.) Twenty-three patients were enrolled. The cohort of patients was severely injured and neurologically compromised on admission (admission GCS = 5.6 +/- A 3.1, Injury Severity Score (ISS) = 31.9 +/- A 10.6, head Abbreviated Injury Scale (AIS) = 4.4 +/- A 0.7, Marshall score = 2.6 +/- A 0.9). Elevated levels of S100 beta and NSE were found in all 223 CSF samples analyzed. ICH was found to be associated with PRE and POST S100 beta levels when measured as % ICP(20) (r = 0.20 and r = 0.23, P < 0.01) and PTD ICP(20) (r = 0.35 and r = 0.26, P < 0.001). POST increasing NSE levels were weakly correlated with increasing PTD ICP(20) (r = 0.17, P = 0.01). PRE S100 beta levels were associated with episodes of CH as measured by % CPP(60) (r = 0.20, P = 0.002) and both PRE and POST S100 beta levels were associated with PTD CPP(60) (r = 0.24 and r = 0.23, P < 0.001). PRE and POST NSE levels were also associated with episodes of CH as measured by % CPP(60) (r = 0.22 and r = 0.18, P < 0.01) and PTD CPP(60) (r = 0.20 and r = 0.21, P < 0.01). In this preliminary analysis, S100 beta levels were associated with ICH and CH over a full week of ICP monitoring. We also found associations between CH and NSE levels in CSF of patients with severe TBI. Our results suggest that there is an association between levels of ICH and CH and these biomarkers when measured before episodes of clinically significant secondary insults. These markers of neuronal cell death demonstrate promise as both indicators of impending clinical deterioration and targets of future therapeutic interventions.	[Stein, Deborah M.; Menaker, Jay; Bochicchio, Grant V.; Aarabi, Bizhan; Scalea, Thomas M.] Univ Maryland, Sch Med, Div Crit Care, Program Trauma,R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Stein, Deborah M.; Kufera, Joseph A.; Lindell, Allison; Murdock, Karen R.; Menaker, Jay; Bochicchio, Grant V.; Scalea, Thomas M.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Organized Res Ctr, Baltimore, MD 21201 USA		Stein, DM (corresponding author), Univ Maryland, Sch Med, Div Crit Care, Program Trauma,R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu; jkufera@som.umaryland.edu; alindell@stapa.umm.edu; kmurdock@som.umaryland.edu; jmenaker@umm.edu; gbochicchio@umm.edu; baarabi@smail.umaryland.edu; tscalea@umm.edu		Stein, Deborah/0000-0003-3683-3963	 [W81XWH-07-2-0118]	This study was funded in part by W81XWH-07-2-0118.	Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL 2005; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bridges E, 2010, AACN ADV CRIT CARE, V21, P260, DOI 10.1097/NCI.0b013e3181e67385; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; KENNEDY CS, 2004, CLIN PEDIAT EMERG ME, V5, P224; Kirchhoff C, 2008, EUR J MED RES, V13, P511; KRAMER M, 2008, STAT MED, V27, P6137; Kraus J, 2006, NEUROLOGY AND TRAUMA, P3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P432; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rotondo MF, 2004, J TRAUMA, V57, P693; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	43	24	26	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	APR	2011	14	2					200	207		10.1007/s12028-010-9496-1			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	738SY	WOS:000288663800009	21210304				2022-02-06	
J	Wauters, S; Verleden, GM; Belmans, A; Coosemans, W; De Leyn, P; Nafteux, P; Lerut, T; Van Raemdonck, D				Wauters, Shana; Verleden, Geert M.; Belmans, Ann; Coosemans, Willy; De Leyn, Paul; Nafteux, Philippe; Lerut, Toni; Van Raemdonck, Dirk			Donor cause of brain death and related time intervals: does it affect outcome after lung transplantation?	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Brain death; Lung donors; Lung transplantation	BRONCHIOLITIS OBLITERANS; HEART-TRANSPLANTATION; SURVIVAL; INJURY; DURATION; DYSFUNCTION; REGISTRY; IMPACT; MODEL	Objective: It remains uncertain whether donor cause of brain death (DCBD) affects survival and freedom from bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). In addition, it is unknown whether the length of time interval from brain insult to brain death [BI-BD] and from brain death to cold preservation [BD-CP] has an impact on outcome. Methods: Medical charts of isolated lung transplant recipients from 400 consecutive donors were reviewed and classified according to DCBD: 190 vascular [V], 185 traumatic [T], 25 others [0]. Demographics were compared between donor groups. Hospital outcome, survival, and freedom from BUS in recipients were analyzed in relation to DCBD and related time intervals. Results: Donor age, gender, and weight differed between donor groups ( p < 0.001, p < 0.001, p < 0.05; respectively). No differences in recipient hospital outcome, survival, and freedom from BUS were found between groups. [BD-CP] longer than 10 h resulted in a survival advantage (69% vs 58% and 51% vs 42% at 5 and 10 years, respectively; p < 0.05) and a reduced hazard risk (0.952) of dying after LTx; (p < 0.05). Multivariable analysis failed to show a significant correlation between DCBD and [BI-BD] versus survival and BUS. Conclusion: DCBD and [BI-BD] do not affect survival and freedom from BUS after LTx. Lung recipients from donors certified brain dead with a time interval longer than 10 h prior to organ preservation showed improved survival unrelated to BUS. This may result from longer and better donor management with reduced lung injury. (C) 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.	[Wauters, Shana; Van Raemdonck, Dirk] Catholic Univ Louvain, Lab Expt Thorac Surg, B-3000 Louvain, Belgium; [Verleden, Geert M.] Univ Hosp Leuven, Dept Pneumol, Louvain, Belgium; [Belmans, Ann] Catholic Univ Louvain, Biostat & Stat Bioinformat Ctr, B-3000 Louvain, Belgium; [Coosemans, Willy; De Leyn, Paul; Nafteux, Philippe; Lerut, Toni; Van Raemdonck, Dirk] Univ Hosp Leuven, Dept Thorac Surg, Louvain, Belgium		Van Raemdonck, D (corresponding author), Univ Hosp Gasthuisberg, Dept Thorac Surg, Herestr 49, B-3000 Louvain, Belgium.	dirk.vanraemdonck@uzleuven.be	Van Raemdonck, Dirk/AAL-4147-2020	Van Raemdonck, Dirk/0000-0003-1261-0992	Fund for Research-Flanders [G.0282.07, G.3C04.99]	The work was supported by grant G.0282.07 from the Fund for Research-Flanders. Dirk Van Raemdonck is a senior clinical investigator supported by the Fund for Research-Flanders (G.3C04.99).	Avlonitis VS, 2007, AM J TRANSPLANT, V7, P83, DOI 10.1111/j.1600-6143.2006.01593.x; Avlonitis VS, 2003, TRANSPLANTATION, V75, P1928, DOI 10.1097/01.TP.0000066351.87480.9E; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; European Ombudsman, 2008, ANN REP 2008 EUR INT, P29; Ganesh JS, 2005, J HEART LUNG TRANSPL, V24, P1544, DOI 10.1016/j.healun.2004.11.316; Ganesh JS, 2005, J THORAC CARDIOV SUR, V129, P1153, DOI 10.1016/j.jtcvs.2004.09.029; Hadjiliadis D, 2006, AM J TRANSPLANT, V6, P183, DOI 10.1111/j.1600-6143.2005.01159.x; Kaneda H, 2006, AM J TRANSPLANT, V6, P544, DOI 10.1111/j.1600-6143.2005.01204.x; Kunzendorf U, 2002, AM J TRANSPLANT, V2, P292, DOI 10.1034/j.1600-6143.2002.20316.x; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Meers C, 2009, TRANSPL P, V41, P572, DOI 10.1016/j.transproceed.2008.12.029; Neyrinck AR, 2006, EUR J CARDIO-THORAC, V30, P628, DOI 10.1016/j.ejcts.2006.06.027; Novitzky D, 1997, TRANSPLANT P, V29, P3770, DOI 10.1016/S0041-1345(97)01149-4; Odim J, 2005, J THORAC CARDIOV SUR, V130, P187, DOI 10.1016/j.jtcvs.2005.02.038; Pessione F, 2003, TRANSPLANTATION, V75, P361, DOI 10.1097/01.TP.0000044171.97375.61; Singhal AK, 2009, TRANSPL P, V41, P3539, DOI 10.1016/j.transproceed.2009.06.192; van der Hoeven JAB, 2003, KIDNEY INT, V64, P1874, DOI 10.1046/j.1523-1755.2003.00272.x; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO; VANRAEMDONCK DEM, 2009, EUR RESP MON, V45, P1; Verleden GM, 2009, TRANSPL INT, V22, P771, DOI 10.1111/j.1432-2277.2009.00872.x; WALLER DA, 1995, J HEART LUNG TRANSPL, V14, P318; Zweers N, 2004, TRANSPLANTATION, V78, P1251, DOI 10.1097/01.TP.0000142679.45418.96	25	24	25	2	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	APR	2011	39	4					E68	E76		10.1016/j.ejcts.2010.11.049			9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	747SX	WOS:000289341100051	21232966	Bronze			2022-02-06	
J	Cunningham, J; Brison, RJ; Pickett, W				Cunningham, John; Brison, Robert J.; Pickett, William			CONCUSSIVE SYMPTOMS IN EMERGENCY DEPARTMENT PATIENTS DIAGNOSED WITH MINOR HEAD INJURY	JOURNAL OF EMERGENCY MEDICINE			English	Article						epidemiology; concussion; emergency medicine; minor head injury; trauma	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; CHILDREN; OUTCOMES; QUESTIONNAIRE; COMPLAINTS; RETURN	Background: Evidence-based protocols exist for Emergency Department (ED) patients diagnosed with minor head injury. These protocols focus on the need for acute intervention or in-hospital management. The frequency and nature of concussive symptoms experienced by patients discharged from the ED are not well understood. Objectives: To examine the prevalence and nature of concussive symptoms, up to 1 month post-presentation, among ED patients diagnosed with minor head injury. Methods: Eligible and consenting patients presenting to Kingston EDs with minor head injury (n = 94) were recruited for study. The Rivermead Post-Concussion Symptoms Questionnaire was administered at baseline and at 1 month post-injury to assess concussive symptoms. This analysis focused upon acute and ongoing symptoms. Results: Proportions of patients reporting concussive symptoms were 68/94 (72%) at baseline and 59/94 (63%) at follow-up. Seventeen percent of patients (18/102) were investigated with computed tomography scanning during their ED encounter. The prevalence of somatic symptoms declined between baseline and follow-up, whereas some cognitive and emotional symptoms persisted. Conclusion: The majority of patients who present to the ED with minor head injuries suffer from concussive symptoms that do not resolve quickly. This information should be incorporated into discharge planning for these patients. (C) 2011 Elsevier Inc.	[Cunningham, John; Brison, Robert J.; Pickett, William] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Cunningham, John; Brison, Robert J.; Pickett, William] Queens Univ, Dept Emergency Med, Kingston, ON, Canada		Brison, RJ (corresponding author), Queens Univ Emergency Med Res, Kingston Gen Hosp, Angada 3,76 Stuart St, Kingston, ON K7L 2V7, Canada.				Child Injury Section of the Public Health Agency of Canada; Ontario Neurotrauma Foundation [2003-PREV-MS-03]	This study was supported by the Canadian Hospital Injury Reporting and Prevention Program (RJ Brison, Kingston medical director) funded by the Child Injury Section of the Public Health Agency of Canada; and the Ontario Neurotrauma Foundation (Grant # 2003-PREV-MS-03).	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Finkelstein E., 2006, INCIDENCE EC BURDEN; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Heck J., 2001, SPORTS MED UPDATE, V15, P46; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Mackenzie S G, 1999, Inj Prev, V5, P208; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Riggs JE, 2001, MIL MED, V166, P1029, DOI 10.1093/milmed/166.11.1029; *STAT CAN, 2006, COMM PROF 2001; Stiell IG, 2000, CAN MED ASSOC J, V163, P1465; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; World Health Organization, 1993, ICD 10 CLASS MENT BE	30	24	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2011	40	3					262	266		10.1016/j.jemermed.2008.08.017			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	740DQ	WOS:000288772200003	19157755				2022-02-06	
J	Sullivan, K; Garden, N				Sullivan, Karen; Garden, Natalie			A Comparison of the Psychometric Properties of 4 Postconcussion Syndrome Measures in a Nonclinical Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; neuropsychology; postconcussion syndrome; psychometric evaluation; traumatic brain injury	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; BASE-RATE; MILD; STRESS; QUESTIONNAIRE	Objective: To investigate the psychometric properties of 4 established postconcussive symptoms (PCS) measures. Participants: Ninety-six nonclinical participants (49 university students and 47 nonstudents; 73% male). Nonclinical participants were recruited because PCS symptoms are common in both clinical and nonclinical groups. Main Outcome Measures: Rivermead Postconcussion Symptoms Questionnaire, the Postconcussion Syndrome Symptom Scale, the Postconcussion Syndrome Checklist, and the British Columbia Postconcussion Symptom Inventory were completed in a counterbalanced order. Analysis: Internal consistency and split-half reliability coefficients were calculated for each PCS measure. Convergent validity was examined using intercorrelations between PCS measures. Divergent validity was examined using correlations between each of the PCS measures and depression. Results: PCS measures had moderate to good reliability and were significantly and positively correlated with each other. Divergent validity correlations were generally weaker than those between PCS measures. Conclusion: This study is the first to examine the psychometric properties of multiple PCS measures in a single sample. Given that clinicians may not know in advance the clinical or nonclinical group status of their clients, particularly in mild trauma cases, our data may help researchers and clinicians compare and select PCS measures.	[Sullivan, Karen] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Kelvin Grove, Qld 4059, Australia; [Sullivan, Karen; Garden, Natalie] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia		Sullivan, K (corresponding author), Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Kelvin Grove Campus,O Block B Wing Room 523,Victo, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The Human Research Ethics Committee of Queensland University of Technology (approval no. 0700000965) approved all research documented in this report. The authors thank Dr Patricia Obst, Statistics advisor, School of Psychology and Counselling, Queensland University of Technology, for generous assistance.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Sundstrom A, 2006, THESIS UMEA U SWEDEN; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2016, INT STAT CLASS DIS R; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	37	24	24	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2011	26	2					170	176		10.1097/HTR.0b013e3181e47f95			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	732OR	WOS:000288197200007	20535029				2022-02-06	
J	Wang, JP; Zhao, YZ; Liu, CL; Jiang, C; Zhao, CY; Zhu, ZJ				Wang, Jianping; Zhao, Yuanzheng; Liu, Chunling; Jiang, Chao; Zhao, Chunyan; Zhu, Zhongjun			Progesterone inhibits inflammatory response pathways after permanent middle cerebral artery occlusion in rats	MOLECULAR MEDICINE REPORTS			English	Article						adhesion molecule; cerebral ischemia; macrophage; neutrophil; pregnancy hormone	TRAUMATIC BRAIN-INJURY; EXPRESSION; ALLOPREGNANOLONE; MECHANISMS; ISCHEMIA; RECOVERY; DEFICITS; PROTEIN	Recent studies have indicated that progesterone (PROG) reduces the expression of inflammatory factors in brain tissue. The present study was designed to investigate whether PROG inhibits the inflammatory response and the infiltration of inflammatory cells in the brain. One hundred and seventy-six adult male Sprague-Dawley rats were randomly divided into four groups: a sham-operated (control) group, a permanent middle cerebral artery occlusion (pMCAO) group, a vehicle-treated group and a PROG-treated group. After pMCAO, the rats received an initial intraperitoneal injection of PROG (8 mg/kg) or vehicle at 1 h post-occlusion, followed by subcutaneous injections at 6, 24 and 48 h. The expression levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and CD68 in the brain were measured by immunohistochemistry and Western blotting. The level of myeloperoxidase (MPO) activity was detected by spectrophotometry. The rats were sacrificed 72 h after surgery and isolated brain was sectioned into coronal slices and stained with 2,3,5-triphenyltetrazolium chloride (TTC). Western blotting and spectrophotometry revealed that the expression levels of ICAM-1, VCAM-1, CD68 and MPO were reduced in the brain tissue of PROG-treated rats. In addition, PROG-treated rats showed a substantial reduction in the infarct volume compared to vehicle controls. PROG effectively inhibited the inflammatory response and reduced the infiltration of leukocytes in the ischemic brain by inhibiting the expression of ICAM-1 and VCAM-1.	[Wang, Jianping; Zhao, Yuanzheng; Jiang, Chao; Zhao, Chunyan; Zhu, Zhongjun] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Liu, Chunling] Zhengzhou Univ, Cerebrovasc Dis Inst, Zhengzhou 450052, Henan, Peoples R China		Zhao, YZ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, 3 Kangfuqian St, Zhengzhou 450052, Henan, Peoples R China.	zhaoyuanzheng@126.com			School of Basic Medical Sciences, Zhengzhou University	The study was supported by Mrs. Xiuhua Ren at the School of Basic Medical Sciences, Zhengzhou University.	Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Ishikawa M, 2003, STROKE, V34, P1777, DOI 10.1161/01.STR.0000074921.17767.F2; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Mani SK, 2006, MOL ENDOCRINOL, V20, P1322, DOI 10.1210/me.2005-0466; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Smith S., 2004, CLEV CLIN J MED, P4; Takaba H, 2004, CELL MOL NEUROBIOL, V24, P589, DOI 10.1023/B:CEMN.0000036400.55503.5e; VAGEROVA K, 2008, ANESTH ANALG, V107, P201; Vemuganti R, 2004, STROKE, V35, P179, DOI 10.1161/01.STR.0000106479.53235.3E; WARD PA, 1991, AM J MED, V91, pS89, DOI 10.1016/0002-9343(91)90290-E; YANG J, 2001, CHINESE PHARMACOL B, V17, P9; ZHANG RL, 1995, BRAIN RES, V682, P182, DOI 10.1016/0006-8993(95)00346-R; 叶心国, 2005, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V27, P442	28	24	24	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAR-APR	2011	4	2					319	324		10.3892/mmr.2011.418			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	727GK	WOS:000287785800020	21468571	Bronze			2022-02-06	
J	Heltemes, KJ; Dougherty, AL; MacGregor, AJ; Galameau, MR				Heltemes, Kevin J.; Dougherty, Amber L.; MacGregor, Andrew J.; Galameau, Michael R.			Alcohol Abuse Disorders Among US Service Members With Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							OPERATION-IRAQI-FREEDOM; COMBAT DEPLOYMENT; SUBSTANCE-ABUSE; NECK INJURIES; DRUG-USE; VETERANS; WAR; AFGHANISTAN; DRINKING; OUTCOMES	Traumatic brain injury (TBI) has emerged as a preeminent injury in Iraq and Afghanistan. The relationship between TBI and post-injury alcohol use in military personnel has not been clearly defined. The aim of this study was to examine the prevalence of alcohol abuse disorders among combat-injured service members with mild TB! (MTBI). Male U.S. service members with combat injuries were identified from the Expeditionary Medical Encounter Database (n = 3,123). Diagnoses of alcohol abuse disorders were collected from the standard inpatient and ambulatory data records. Overall, a slightly higher proportion of service members with MTBI were diagnosed with an alcohol abuse disorder compared to those with other injury (6.1% vs. 4.9%). In a multivariate analysis, however, it was found that MTBI was not associated with higher levels of alcohol abuse (odds ratio, 1.24; 95% confidence interval, 0.90, 1.70). To better define the consequences of MTBI, future research should include other alcohol dependency measures along with comorbid mental health disorders.	[Heltemes, Kevin J.; Dougherty, Amber L.; MacGregor, Andrew J.; Galameau, Michael R.] USN, Hlth Res Ctr, San Diego, CA 92106 USA		Heltemes, KJ (corresponding author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.			MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery, Washington, DC, under Work Unit [60808]	The authors thank Science Applications International Corporation for its contributions to this work. This study was supported by the U.S. Navy Bureau of Medicine and Surgery, Washington, DC, under Work Unit No. 60808.	Ames Genevieve M, 2002, Prev Sci, V3, P135, DOI 10.1023/A:1015435401380; [Anonymous], 1997, JAMA, V277, P238; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; BRAY RM, 1999, 1998 DEP DEFENCE SUR; CHANDLER D, 2006, ASHA LEADER, V11, P29; Chandler D, 2006, ASHA LEADER, V11, p[8, 29]; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kalaydjian A, 2009, COMPR PSYCHIAT, V50, P299, DOI 10.1016/j.comppsych.2008.09.012; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; REISTER FA, 1973, BATTLE CASUALTIES ME, pCH3; RICHARDS MS, 1989, AM J PUBLIC HEALTH, V79, P1011, DOI 10.2105/AJPH.79.8.1011; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Tonnesen H, 1999, BMJ-BRIT MED J, V318, P1311, DOI 10.1136/bmj.318.7194.1311; TONNESEN H, 1991, J BONE JOINT SURG BR, V73, P511, DOI 10.1302/0301-620X.73B3.1670461; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	34	24	24	0	8	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	FEB	2011	176	2					147	150		10.7205/MILMED-D-10-00191			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825BL	WOS:000295245800008	21366075	Bronze			2022-02-06	
J	Li, S; Rymer, WZ				Li, Sheng; Rymer, William Zev			Voluntary Breathing Influences Corticospinal Excitability of Nonrespiratory Finger Muscles	JOURNAL OF NEUROPHYSIOLOGY			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY-EVOKED POTENTIALS; CEREBRAL BLOOD-FLOW; MOTOR IMAGERY; VOLITIONAL INSPIRATION; RESPIRATORY AFFERENTS; BRAIN ACTIVATION; ISOMETRIC FORCE; HUMANS; DIAPHRAGM	Li S, Rymer WZ. Voluntary breathing influences corticospinal excitability of nonrespiratory finger muscles. J Neurophysiol 105: 512-521, 2011. First published December 15, 2010; doi:10.1152/jn.00946.2010. The present study aimed to investigate neurophysiologic mechanisms mediating the newly discovered phenomenon of respiratory-motor interactions and to explore its potential clinical application for motor recovery. First, young and healthy subjects were instructed to breathe normally (NORM); to exhale (OUT) or inhale (IN) as fast as possible in a self-paced manner; or to voluntarily hold breath (HOLD). In experiment 1 (n = 14), transcranial magnetic stimulation (TMS) was applied during 10% maximal voluntary contraction (MVC) finger flexion force production or at rest. The motor-evoked potentials (MEPs) were recorded from flexor digitorum superficialis (FDS), extensor digitorum communis (EDC), and abductor digiti minimi (ADM) muscles. Similarly, in experiment 2 (n = 11), electrical stimulation (ES) was applied to FDS or EDC during the described four breathing conditions while subjects maintained 10%MVC of finger flexion or extension and at rest. In the exploratory clinical experiments (experiment 3), four patients with chronic neurological disorders (three strokes, one traumatic brain injury) received a 30-min session of breathing-controlled ES to the impaired EDC. In experiment 1, the EDC MEP magnitudes increased significantly during IN and OUT at both 10%MVC and rest; the FDS MEPs were enhanced only at 10%MVC, whereas the ADM MEP increased only during OUT, compared with NORM for both at rest and 10%MVC. No difference was found between NORM and HOLD for all three muscles. In experiment 2, when FDS was stimulated, force response was enhanced during both IN and OUT, but only at 10% MVC. When EDC was stimulated, force response increased at both 10% MVC and rest, only during IN, but not OUT. The averaged response latency was 83 ms for the finger extensors and 79 ms for the finger flexors. After a 30-min intervention of ES to EDC triggered by forced inspiration in experiment 3, we observed a significant reduction in finger flexor spasticity. The spasticity reduction lasted for >= 4 wk in all four patients. TMS and ES data, collectively, support the phenomenon that there is an overall respiration-related enhancement on the motor system, with a strong inspiration-finger extension coupling during voluntary breathing. As such, breathing-controlled electrical stimulation (i.e., stimulation to finger extensors delivered during the voluntary inspiratory phase) could be applied for enhancing finger extension strength and finger flexor spasticity reduction in poststroke patients.	[Li, Sheng] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Li, Sheng] Inst Rehabil & Res, Motor Recovery Lab, Houston, TX USA; [Rymer, William Zev] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Rymer, William Zev] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA		Li, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	sheng.li@uth.tmc.edu	Li, Sheng/ABC-5392-2021		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-060774]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060774] Funding Source: NIH RePORTER	This study was supported in part by the National Institute of Neurological Disorders and Stroke Grant R01-NS-060774.	AMINOFF MJ, 1971, J PHYSIOL-LONDON, V215, P557, DOI 10.1113/jphysiol.1971.sp009485; Bakhtiary AH, 2008, CLIN REHABIL, V22, P418, DOI 10.1177/0269215507084008; Balzamo E, 1997, NEUROSCI LETT, V236, P127, DOI 10.1016/S0304-3940(97)00782-9; Balzamo E, 1999, NEUROSCI LETT, V270, P157, DOI 10.1016/S0304-3940(99)00482-6; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Chae John, 2003, Phys Med Rehabil Clin N Am, V14, pS93, DOI 10.1016/S1047-9651(02)00051-7; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Corfield DR, 1998, RESP PHYSIOL, V114, P109, DOI 10.1016/S0034-5687(98)00083-8; Danion F, 2003, CLIN NEUROPHYSIOL, V114, P1445, DOI 10.1016/S1388-2457(03)00105-6; DAVIS JN, 1972, EXP NEUROL, V34, P78, DOI 10.1016/0014-4886(72)90189-6; DICK JPR, 1987, NEUROSCI LETT, V75, P349, DOI 10.1016/0304-3940(87)90548-9; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; Filippi MM, 2000, BRAIN RES, V881, P159, DOI 10.1016/S0006-8993(00)02837-7; Fink GR, 1995, J PHYSIOL-LONDON, V489, P663, DOI 10.1113/jphysiol.1995.sp021081; Fontanari P, 1996, NEUROSCI LETT, V210, P130, DOI 10.1016/0304-3940(96)12564-7; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; GANDEVIA SC, 1989, RESP PHYSIOL, V77, P203, DOI 10.1016/0034-5687(89)90007-8; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Haouzi P, 2006, RESP PHYSIOL NEUROBI, V152, P169, DOI 10.1016/j.resp.2005.08.004; Hara Y, 2000, ARCH PHYS MED REHAB, V81, P418, DOI 10.1053/mr.2000.3872; Ikeda ER, 2009, J STRENGTH COND RES, V23, P127, DOI 10.1519/JSC.0b013e31818eb256; Kamper DG, 2001, MUSCLE NERVE, V24, P673, DOI 10.1002/mus.1054; LAHUERTA J, 1992, J NEUROL NEUROSUR PS, V55, P1142, DOI 10.1136/jnnp.55.12.1142; Li S, 2004, J NEUROSCI, V24, P9674, DOI 10.1523/JNEUROSCI.2781-04.2004; Li S, 2004, COGNITIVE BRAIN RES, V20, P273, DOI 10.1016/j.cogbrainres.2004.03.003; Li S, 2007, EXP BRAIN RES, V179, P517, DOI 10.1007/s00221-006-0809-8; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Li S, 2006, MUSCLE NERVE, V34, P651, DOI 10.1002/mus.20592; Li S, 2009, CLIN NEUROPHYSIOL, V120, P1154, DOI 10.1016/j.clinph.2008.12.045; Li ZM, 2001, J BIOMECH, V34, P1097, DOI 10.1016/S0021-9290(01)00061-6; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Maluf KS, 2007, CLIN NEUROPHYSIOL, V118, P2063, DOI 10.1016/j.clinph.2007.06.009; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Plum F., 1981, REGULATION BREATHI 2, P989; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Sharshar T, 2004, J PHYSIOL-LONDON, V560, P897, DOI 10.1113/jphysiol.2004.061150; Smejkal V, 1999, PHYSIOL RES, V48, P21; Smejkal V, 2000, PHYSIOL RES, V49, P659; Yue GH, 2000, MUSCLE NERVE, V23, P376, DOI 10.1002/(SICI)1097-4598(200003)23:3<376::AID-MUS9>3.3.CO;2-U; ZIFKO UA, 1995, MUSCLE NERVE, V18, P1487, DOI 10.1002/mus.880181224	41	24	24	0	13	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	FEB	2011	105	2					512	521		10.1152/jn.00946.2010			10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	718OG	WOS:000287133200002	21160006	Green Published			2022-02-06	
J	Potvin, MJ; Rouleau, I; Audy, J; Charbonneau, S; Giguere, JF				Potvin, Marie-Julie; Rouleau, Isabelle; Audy, Julie; Charbonneau, Simon; Giguere, Jean-Francois			Ecological prospective memory assessment in patients with traumatic brain injury	BRAIN INJURY			English	Article						Prospective memory; traumatic brain injury; assessment; neuropsychology	CLOSED-HEAD INJURY; COMPLEX INTENTIONS; PERFORMANCE; EVENT; REALIZATION; IMPAIRMENT; DAMAGE; AGE	Primary objective: Prospective memory (PM) impairments are often observed after traumatic brain injury (TBI). Although PM is crucial for daily functioning, few sensitive, valid and ecological clinical tests are available. To address these concerns, the authors developed a PM task, the TEMP, using naturalistic stimuli, in which each PM phase and component is evaluated independently in time- and event-based conditions. Main outcomes and results: The results show that moderate and severe TBI patients (n = 30), evaluated after spontaneous neurological recovery, experienced problems in learning the delayed intentions content and retrieving these intentions in the right context (prospective component), especially in the time-based condition. They also recalled fewer associated actions (retrospective component), but only in the time-based condition. Correlations revealed that the retrospective component was mainly supported by episodic retrospective memory processes, while the prospective component was supported by episodic retrospective memory processes, along with attentional and executive functions. Moreover, there was a significant correlation between performance on the TEMP and results on a questionnaire assessing PM functioning in daily living completed by participants' relatives. Conclusions: The TEMP therefore appears to be a sensitive tool for assessing PM problems that combines internal and ecological validity.	[Rouleau, Isabelle] Univ Quebec, Dept Psychol, Inst Cognit Sci, Montreal, PQ H3C 3P8, Canada; [Potvin, Marie-Julie; Giguere, Jean-Francois] Hop Sacre Coeur Montreal, Neurotraumatol Programme, Montreal, PQ, Canada		Rouleau, I (corresponding author), Univ Quebec, Dept Psychol, Inst Cognit Sci, CP 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.	rouleau.isabelle@uqam.ca		Potvin, Marie-Julie/0000-0001-5503-8063	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); FRSQFonds de la Recherche en Sante du Quebec	This research was supported by NSERC and FRSQ scholarships (M.-J. Potvin). The authors report no conflicts of interest.	Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1993, BECK ANXIETY INVENTO; Brandt J., 2001, BRIEF VISUOSPATIAL M; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein, 2008, PROSPECTIVE MEMORY C, P283; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kliegel M, 2005, J NEUROL NEUROSUR PS, V76, P1501, DOI 10.1136/jnnp.2004.051268; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kopp UA, 2003, INT J PSYCHOL, V38, P229, DOI 10.1080/00207590344000150; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Mackinnon A., 1999, INT J METHODS PSYCHI, V8, P27, DOI [10.1002/mpr.54, DOI 10.1002/MPR.54]; Madjan A., 1996, J CLIN EXP NEUROPSYC, V18, P416; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel M. A., 1992, ADV LEARNING BEHAVIO, V7, P87; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Mesulam M., 1985, CONT NEUROLOGY SERIE, V26; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Palmer HM, 2000, BRAIN COGNITION, V44, P103; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Sullivan K, 2005, ARCH CLIN NEUROPSYCH, V20, P745, DOI 10.1016/j.acn.2005.04.006; Titov N, 2000, BRAIN INJURY, V14, P877; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; Waugh N., 1999, THESIS GRIFFITH U BR; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	50	24	26	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2011	25	2					192	205		10.3109/02699052.2010.541896			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800006	21219091				2022-02-06	
J	Bercaw, EL; Hanks, RA; Millis, SR; Gola, TJ				Bercaw, Edwin L.; Hanks, Robin A.; Millis, Scott R.; Gola, Thomas J.			Changes in Neuropsychological Performance after Traumatic Brain Injury from Inpatient Rehabilitation to 1-Year Follow-Up in Predicting 2-Year Functional Outcomes	CLINICAL NEUROPSYCHOLOGIST			English	Article						Cognitive recovery; Rehabilitation; Serial assessment; Longitudinal; Recovery of function; Brain injury outcomes	SEVERE HEAD-INJURY; FALSE DISCOVERY RATE; RECOVERY; MODERATE; INTEGRATION; ATTENTION; SEVERITY	The present study explored the predictive value of interval change in neuropsychological performance at three time-points following moderate-to-severe TBI (inpatient rehabilitation, 1-year, and 2-year follow-up) on functional outcome measures collected at 2-year follow-up. Symmetrized percent change scores were calculated and used to predict scores on functional measures using linear regression while controlling for age and injury severity. Results showed that change in performance from inpatient to 1-year on total list learning (CVLT-II or RAVLT) and oral SDMT significantly predicted 2-year ratings of functional status. By comparison, most neuropsychological measures taken at 1-year follow-up also accounted for unique variance in 2-year functional outcomes. These results indicate that changes in learning and processing speed during the first year of recovery are sensitive indicators when predicting long-term disability and degree of functional independence, though absolute performance at 1 year is also highly associated with functional outcome at 2 years post-injury.	[Bercaw, Edwin L.] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin A.; Millis, Scott R.; Gola, Thomas J.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Bercaw, EL (corresponding author), 1250 S Tamiami Trail,Suite 201, Sarasota, FL 34239 USA.	ed.bercaw@gmail.com			U.S. Department of Education - National Institute of Disability and Rehabilitation ResearchUS Department of Education [H133A080044]	This study was supported, in part, by a grant from the U.S. Department of Education - National Institute of Disability and Rehabilitation Research (H133A080044).	Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DA, 2006, AM STAT, V60, P27, DOI 10.1198/000313006X90684; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Delis D.C., 2000, CALIFORNIA VERBAL LE; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Gladsjo JA, 1999, NORMS LETT CATEGORY; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JOHNSON SC, 1994, NEUROPSYCHOLOGY, V8, P301; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KlOve H, 1963, MED CLIN N AM; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Millis S R, 1994, Int J Neurosci, V79, P165; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack T, 2000, ORIENTATION LOG; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1982, SYMBOL DIGIT MODALIT; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	50	24	24	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	1					72	89		10.1080/13854046.2010.532813			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	722FM	WOS:000287417100005	21120763				2022-02-06	
J	Borg, J; Roe, C; Nordenbo, A; Andelic, N; de Boussard, C; af Geijerstam, JL				Borg, Jorgen; Roe, Cecilie; Nordenbo, Annette; Andelic, Nada; de Boussard, Catharina; af Geijerstam, Jean-Luc			Trends and Challenges in the Early Rehabilitation of Patients with Traumatic Brain Injury A Scandinavian Perspective	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Incidence; Risk; Acute Rehabilitation; Early Rehabilitation	RANDOMIZED CONTROLLED-TRIAL; POST-CONCUSSION SYMPTOMS; MILD HEAD-INJURY; FOLLOW-UP; EARLY INTERVENTION; LIFE SATISFACTION; NORTHERN SWEDEN; UNITED-STATES; DISABILITY; NORWAY		[Borg, Jorgen; de Boussard, Catharina] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden; [Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Nordenbo, Annette] Copenhagen Univ Hosp Glostrup, Dept Neurorehabil, Traumat Brain Injury Unit, Hvidovre, Denmark; [af Geijerstam, Jean-Luc] Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden; [af Geijerstam, Jean-Luc] Swedish Council Hlth Technol Assessment, Stockholm, Sweden		Borg, J (corresponding author), Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden.			Andelic, Nada/0000-0002-3719-4406; Borg, Jorgen/0000-0002-2372-7478			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; ANDELIC N, 2008, BRAIN INJ S1, V22, P87; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Heskestad B, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-10; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Indredavik B, 2003, CEREBROVASC DIS, V15, P19, DOI 10.1159/000068213; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Langhorne P, 1995, Rev Neurol, V23, P394; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lindberg PG, 2007, NEUROREHAB NEURAL RE, V21, P315, DOI 10.1177/1545968306296965; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Muller Kay, 2006, Tidsskr Nor Laegeforen, V126, P1205; Nestvold K, 2005, ACTA NEUROL SCAND, V112, P13, DOI 10.1111/j.1600-0404.2005.00344.x; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Paniak C, 2000, BRAIN INJURY, V14, P219; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Sorbo AK, 2009, INT J REHABIL RES, V32, P139, DOI 10.1097/MRR.0b013e328325a5d1; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tengvar Christer, 2006, Lakartidningen, V103, P3685; Terent A, 2009, J NEUROL NEUROSUR PS, V80, P881, DOI 10.1136/jnnp.2008.169102; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	65	24	24	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2011	90	1					65	73		10.1097/PHM.0b013e3181fc80e7			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	695ZW	WOS:000285412700009	21169746				2022-02-06	
J	Hammond, FM; Davis, CS; Whiteside, OY; Philbrick, P; Hirsch, MA				Hammond, Flora M.; Davis, Christine S.; Whiteside, Omar Y.; Philbrick, Peggy; Hirsch, Mark A.			Marital Adjustment and Stability Following Traumatic Brain Injury: A Pilot Qualitative Analysis of Spouse Perspectives	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adjustment; brain injury; caregiving; craniocerebral trauma; marriage	REHABILITATION; INDIVIDUALS; PREDICTORS; CAREGIVERS; APPRAISAL; FAMILIES; STRESS; ISSUE	Background: Traumatic brain injury (TBI), causing various impairments and functional changes, may adversely impact marital relationships. However, dynamics of the interactions that contribute to these marital difficulties are complex and poorly understood. There has been little research on marital quality and stability in families of a person with TBI. Objective: By identifying themes of marital adjustment and stability, this qualitative exploratory study examines how a spouse who has experienced TBI affects the marital relationship. Methods: Two gender-specific focus groups, each with 5 spouses of individuals living with the effects of TBI, were conducted to collect data on marital interactions that were analyzed for themes related to marital adjustment and stability. The data were analyzed using grounded theory, and then relational theories were applied as a framework for organizing the metacodes and concepts. Results: This study suggests that, after TBI, changes in family dynamics and the way spouses perceive those dynamics affect movement toward pulling together or pulling apart. Conclusion: Changes in spousal perceptions, interactions, responsibilities, and reactions to brain injury may impact marital stability and satisfaction. Further study is warranted to better understand and determine whether and how awareness of these changes may be incorporated into treatment.	[Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46202 USA; [Hirsch, Mark A.] Univ N Carolina, Carolinas Healthcare Syst, Carolinas Rehabil, Charlotte, NC 28223 USA; [Davis, Christine S.] Univ N Carolina, Dept Commun Studies, Charlotte, NC 28223 USA; [Whiteside, Omar Y.] Univ S Carolina, Dept Epidemiol & Biostat, Charlotte, NC USA		Hammond, FM (corresponding author), Indiana Univ, 541 N Clin Dr,Sute 626, Indianapolis, IN 46202 USA.	flora.hammond@rhin.com	Davis, Christine/K-4850-2019; Hirsch, Mark A./D-2798-2016	Hirsch, Mark A./0000-0002-8997-7971	US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability Rehabilitation and Research [H133A20016]; Carolinas Medical Center, Carolinas HealthCare System, Charlotte, North Carolina	This study was partially supported by US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability Rehabilitation and Research grant H133A20016, and by a grant from Carolinas Medical Center, Carolinas HealthCare System, Charlotte, North Carolina.	Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Buehlman K, 1996, ORAL HIST INTERVIEW; Buehlman K.T., 1992, J FAMILY PSYCHOL, V5, DOI [DOI 10.1037/0893-3200.5.3-4.295, https://doi.org/10.1037/0893-3200.5.3-4.295]; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Charmaz KC., 2000, HDB QUALITATIVE RES, V2nd edn, P509, DOI DOI 10.1177/0891241609342193; Christensen T.M., 1997, FAM J, V5, P317; Cline RJ, 1986, COMMUNICATION Q, V34, P41; Corbin JM, 1988, UNENDINGWORK ANDCARE; Davis C, 2010, BRAIN INJURY, V24, P210; Davis CS, 2010, STRAIGHT TALK COMMUN; Dues MT, 1999, PSYCHIAT TIMES, V16, P48; Fern E. F., 2001, ADV FOCUS GROUP RES; Glaser B., 1967, DISCOVERY GROUNDED T; Gottman J., 1993, J FAM PSYCHOL, V7, P57, DOI [DOI 10.1037/0893-3200.7.1.57, 10.1037/0893-3200.7.1.57]; Gottman JM., 1994, WHAT PREDICTS DIVORC; HALEY WE, 1987, PSYCHOL AGING, V2, P323, DOI 10.1037/0882-7974.2.4.323; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KROKOFF L, 1984, THESIS U ILLINOIS UR; Lawton MP, 1998, J GERONTOL, V46, pP181; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lindlof T.L., 2002, QUALITATIVE COMMUNIC; Long C J, 1983, Psychiatr Med, V1, P35; Lyons R.F., 1995, RELATIONSHIPS CHRONI; McGrew KB, 1998, J WOMEN AGING, V10, P49, DOI 10.1300/J074v10n02_05; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MILLER B, 1992, GERONTOLOGIST, V32, P498, DOI 10.1093/geront/32.4.498; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pecchioni L. L., 2006, FAMILY COMMUNICATION, P447; Peters MS, 2002, INT FAM COMM DIV NAT; PETRONIO S, 1984, COMMUN MONOGR, V51, P268, DOI 10.1080/03637758409390200; Pohl JM, 1997, J WOMEN AGING, V9, P133, DOI 10.1300/J074v09n01_11; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Raveis VH, 1998, CANCER, V83, P1652, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1652::AID-CNCR22>3.3.CO;2-H; Schopp LH, 2006, BRAIN INJURY, V20, P1155, DOI 10.1080/02699050600983735; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Strauss A., 1990, BASICS QUALITATIVE R; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Van doorne-huiskes A., 2003, COMMUNITY WORK FAM, V6, P223, DOI [10.1080/1366880032000143438, DOI 10.1080/136688003200014343810.1080/1366880032000143438]; Webster G, 1999, BRAIN INJURY, V13, P593; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Wood JT., 1993, J APPL COMMUN RES, V21, P279, DOI [10.1080/00909889309365372, DOI 10.1080/00909889309365372]	49	24	24	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2011	26	1					69	78		10.1097/HTR.0b013e318205174d			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	703GA	WOS:000285965200007	21209564				2022-02-06	
J	Man, DWK; Fleming, J; Hohaus, L; Shum, D				Man, David W. K.; Fleming, Jennifer; Hohaus, Lydia; Shum, David			Development of the Brief Assessment of Prospective Memory (BAPM) for use with traumatic brain injury populations	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Prospective memory; Questionnaire; Self-report; Reliability; Validity; Rehabilitation	COMPREHENSIVE ASSESSMENT; PSYCHOMETRIC PROPERTIES; RETROSPECTIVE MEMORY; SELF-AWARENESS; NORMATIVE DATA; QUESTIONNAIRE; ADULTS; PERFORMANCE; CAPM	Impairment of prospective memory (PM) is a common problem following traumatic brain injury (TBI) which can affect functional outcomes. PM failures in everyday life can be assessed using self-report questionnaires; however, existing measures tend to be lengthy, which may be problematic for individuals with fatigue and other cognitive impairments. This study aimed to develop a short form of the Comprehensive Assessment of Prospective Memory (CAPM) and examine its psychometric properties. Using theoretical and statistical considerations, the number of items on the CAPM was reduced to 16 including equal numbers representing the basic activities of daily living (BADL) and instrumental activities of daily living (IADL) subscales. The psychometric properties of the new measure, named the Brief Assessment of Prospective Memory (BAPM), were examined by secondary analysis of data from two samples of community dwelling adults (aged 17 to 91 years, n = 527, and 15 to 60 years, n = 95) with no history of brain injury, and a sample of rehabilitation patients with moderate to severe TBI (n = 45). Results indicate that the BAPM has a robust factor structure, strong agreement with the original CAPM, acceptable internal consistency and test-retest reliability, and evidence of criterion-related validity with psychosocial integration as the point of reference for people with TBI.	[Man, David W. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Queensland Hlth, Ctr Functioning & Hlth Res, Metro S Hlth Serv Dist, Brisbane, Qld, Australia; [Hohaus, Lydia; Shum, David] Griffith Univ, Behav Basis Hlth Program, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Hohaus, Lydia; Shum, David] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	david.man@polyu.edu.hk	Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262	Griffith UniversityGriffith University	Preparation of this manuscript was partly supported by a Griffith University Jackson Memorial Visiting Fellowship awarded to David Man.	Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Edwards P, 2004, CONTROL CLIN TRIALS, V25, P31, DOI 10.1016/j.cct.2003.08.013; Fleming J, 2009, BRAIN IMPAIR, V10, P34, DOI 10.1375/brim.10.1.34; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Herrmann D. J., 1983, EVERYDAY MEMORY ACTI, P133; Hobart JC, 2001, CLINICAL TRIALS IN NEUROLOGY, P17; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Levin H., 1989, HDB NEUROPSYCHOLOGY; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Waugh N., 1999, THESIS GRIFFITH U BR; Wilson B., 2005, CAMBRIDGE PROSPECTIV; World Health Organization, 2007, INT CLASS FUNCT DIS	23	24	25	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	6					884	898		10.1080/09602011.2011.627270			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	885OT	WOS:000299789200007	22150453				2022-02-06	
J	Morali, G; Montes, P; Hernandez-Morales, L; Monfil, T; Espinosa-Garcia, C; Cervantes, M				Morali, Gabriela; Montes, Pedro; Hernandez-Morales, Lucia; Monfil, Tomas; Espinosa-Garcia, Claudia; Cervantes, Miguel			Neuroprotective effects of progesterone and allopregnanolone on long-term cognitive outcome after global cerebral ischemia	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Neuroprotection; global cerebral ischemia; progesterone; allopregnanolone; long-term cognitive performance; hippocampal pyramidal neurons loss	TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; RADIAL-ARM MAZE; PREFRONTAL CORTEX; ARTERY OCCLUSION; CELL-DEATH; NEURONAL DAMAGE; WORKING-MEMORY; INFLAMMATORY RESPONSE; FUNCTIONAL DEFICITS	Purpose: To assess the long-term neuroprotective effects of progesterone (P-4) and allopregnanolone (ALLO) on functional and morphological parameters of the integrity of the hippocampus, after global cerebral ischemia. Methods: Adult male Sprague-Dawley rats were subjected to a transient severe (20 min) forebrain ischemia (Isch) episode and treated with P-4 or ALLO (8 mg/kg i.v.) or its vehicle, at 20 min, 2, 6, 24, 48 and 72 h after ischemia. Rats subjected to Sham procedures, and intact rats were included as non-ischemic controls. Three months after ischemia, both the functional (spatial learning and memory, and reference and working memory), and the morphological integrity (dimensions of the hippocampal formation, thickness of the CA1 subfield, and pyramidal neuron population) of the hippocampus and the medial prefrontal cortex (mPFC) were determined. Results: Treatment with P-4 or ALLO significantly reduced the impairment in spatial learning and memory, as well as in reference and working memory, and prevented the narrowing of the hippocampus, otherwise induced by ischemia. This better performance of P-4-and ALLO-treated rats than vehicle (Veh) -treated rats, occurred in spite of a loss of pyramidal neurons in the CA1, CA2, CA3 and hilus subfields of the Ammon's horn (remaining neurons: Isch+Veh: 21.0, 35.6, 44.1, and 40.3%; Isch+P-4: 19.9, 32.2, 41.1, and 32.5%; Isch+ALLO: 25.5, 62.0, 73.7, and 56.7%), and non-significant changes in the mPFC, as compared to the Intact group (100%). Conclusions: Performance of P-4-or ALLO-treated rats in learning and memory tests suggests that these steroids promoted neural conditions accounting for adequate functioning long after ischemia, in spite of the loss of hippocampal pyramidal neurons.	[Morali, Gabriela; Montes, Pedro; Hernandez-Morales, Lucia; Monfil, Tomas; Espinosa-Garcia, Claudia] IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Med Farmacol, Mexico City 03100, DF, Mexico; [Cervantes, Miguel] Univ Michoacana, Neurosci Lab, Div Estudios Posgrad, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico		Morali, G (corresponding author), IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Med Farmacol, Eugenia 626 Girasol 302, Mexico City 03100, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Espinosa-Garcia, Claudia/0000-0002-9909-9092; Montes, Pedro/0000-0003-1630-5047	Consejo Nacional de Ciencia y Tecnologia (CONACYT)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [31073-M]; Instituto Mexicano del Seguro Social [FP-2003/035, FP-2003/451]	Partially supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT, 31073-M), and by Instituto Mexicano del Seguro Social (FP-2003/035 and FP-2003/451). Laboratory expenses including a system for image analysis under the microscope, steroid hormones, reagents, and maintenance of laboratory rats, were the main aspects in which the work was funded.	Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Crepel V, 2003, J CELL MOL MED, V7, P401, DOI 10.1111/j.1582-4934.2003.tb00242.x; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DAVIS HP, 1986, PHYSIOL BEHAV, V37, P387, DOI 10.1016/0031-9384(86)90195-2; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DOWNIE MM, 1983, BASIC STAT METHODS; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Floresco SB, 1997, J NEUROSCI, V17, P1880; Frye CA, 2000, PSYCHONEUROENDOCRINO, V25, P407, DOI 10.1016/S0306-4530(99)00068-2; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; Fuster JM, 1999, ACTA PSYCHIAT SCAND, V99, P51, DOI 10.1111/j.1600-0447.1999.tb05983.x; Garcia-Chavez D, 2008, NEUROSCI LETT, V448, P148, DOI 10.1016/j.neulet.2008.10.043; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Gonzalez-Burgos I, 2007, NEUROSCI LETT, V423, P162, DOI 10.1016/j.neulet.2007.06.050; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; GWAG BJ, 2002, METH NE FRO NEUROSCI, P79; HARA H, 1993, PROG NEUROBIOL, V40, P645, DOI 10.1016/0301-0082(93)90009-H; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hoffman GE, 2003, EXP NEUROL, V182, P124, DOI 10.1016/S0014-4886(03)00104-3; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Ito U, 2006, STROKE, V37, P2134, DOI 10.1161/01.STR.0000231875.96714.b1; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Langdon KD, 2008, EUR J NEUROSCI, V28, P2310, DOI 10.1111/j.1460-9568.2008.06513.x; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Letechipia-Vallejo G, 2007, J PINEAL RES, V42, P139, DOI 10.1111/j.1600-079X.2006.00395.x; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MCDONALD RJ, 1995, BEHAV NEUROSCI, V109, P579, DOI 10.1037/0735-7044.109.4.579; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; NAKANO S, 1990, NEUROSCIENCE, V38, P115, DOI 10.1016/0306-4522(90)90378-H; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; NUNN JA, 1994, BEHAV BRAIN RES, V62, P41, DOI 10.1016/0166-4328(94)90036-1; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oliveira MGM, 1997, NEUROBIOL LEARN MEM, V68, P32, DOI 10.1006/nlme.1996.3761; OLSEN GM, 1994, BEHAV NEUROSCI, V108, P681, DOI 10.1037/0735-7044.108.4.681; OLTON DS, 1987, PHYSIOL BEHAV, V40, P793, DOI 10.1016/0031-9384(87)90286-1; Olvera-Cortes E, 2004, BRAIN RES BULL, V62, P379, DOI 10.1016/j.brainresbull.2003.10.003; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Plamondon H, 2008, PHYSIOL BEHAV, V95, P492, DOI 10.1016/j.physbeh.2008.07.020; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; ROD MR, 1990, CAN J PSYCHOL, V44, P196, DOI 10.1037/h0084242; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Sarraf-Yazdi S, 1999, NEUROL DIS, V48, P243; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; VOLPE BT, 1984, STROKE, V15, P558, DOI 10.1161/01.STR.15.3.558; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	104	24	25	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2011	29	1					1	15		10.3233/RNN-2011-0571			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	722ZZ	WOS:000287476200001	21335664				2022-02-06	
J	Peng, QY; Park, HS; Shah, P; Wilson, N; Ren, YP; Wu, YN; Liu, J; Gaebler-Spira, DJ; Zhang, LQ				Peng, Qiyu; Park, Hyung-Soon; Shah, Parag; Wilson, Nicole; Ren, Yupeng; Wu, Yi-Ning; Liu, Jie; Gaebler-Spira, Deborah J.; Zhang, Li-Qun			Quantitative evaluations of ankle spasticity and stiffness in neurological disorders using manual spasticity evaluator	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						catch angle; cerebral palsy; contracture; manual spasticity evaluator; neurological disorders; quantitative measurement; range of motion; spasticity; Tardieu scale; velocity	MODIFIED ASHWORTH SCALE; MODIFIED TARDIEU SCALE; CEREBRAL-PALSY; BRAIN-INJURY; INTERRATER RELIABILITY; MUSCLE SPASTICITY; CHILDREN; MANAGEMENT; VELOCITY; SYSTEM	Spasticity and contracture are major sources of disability in people with neurological impairments that have been evaluated using various instruments: the Modified Ashworth Scale, tendon reflex scale, pendulum test, mechanical perturbations, and passive joint range of motion (ROM). These measures generally are either convenient to use in clinics but not quantitative or they are quantitative but difficult to use conveniently in clinics. We have developed a manual spasticity evaluator (MSE) to evaluate spasticity/contracture quantitatively and conveniently, with ankle ROM and stiffness measured at a controlled low velocity and joint resistance and Tardieu catch angle measured at several higher velocities. We found that the Tardieu catch angle was linearly related to the velocity, indicating that increased resistance at higher velocities was felt at further stiffer positions and, thus, that the velocity dependence of spasticity may also be position-dependent. This finding indicates the need to control velocity in spasticity evaluation, which is achieved with the MSE. Quantitative measurements of spasticity, stiffness, and ROM can lead to more accurate characterizations of pathological conditions and outcome evaluations of interventions, potentially contributing to better healthcare services for patients with neurological disorders such as cerebral palsy, spinal cord injury, traumatic brain injury, and stroke.	[Peng, Qiyu; Park, Hyung-Soon; Shah, Parag; Wilson, Nicole; Ren, Yupeng; Wu, Yi-Ning; Liu, Jie; Gaebler-Spira, Deborah J.; Zhang, Li-Qun] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Park, Hyung-Soon; Gaebler-Spira, Deborah J.; Zhang, Li-Qun] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Park, Hyung-Soon] NIH, Clin Res Ctr, Dept Rehabil Med, Bethesda, MD 20892 USA; [Liu, Jie; Zhang, Li-Qun] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA		Zhang, LQ (corresponding author), Rehabil Inst Chicago, 345 E Super St,Suite 1406, Chicago, IL 60611 USA.	l-zhang@northwestern.edu	Park, Hyung-Soon/B-3334-2010; peng, qiyu/G-1586-2013; Wilson, Nicole A/C-4049-2008	Park, Hyung-Soon/0000-0003-4274-7420; Wilson, Nicole A/0000-0002-0844-1885; Wu, Yi-Ning/0000-0001-8369-6717; Gaebler-Spira, Deborah/0000-0001-6827-4241	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD044295]; National Institute on Disability and Rehabilitation Research [H133S080074]; National Science FoundationNational Science Foundation (NSF) [CBET-0854498, IIP-0750515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD044295] Funding Source: NIH RePORTER	This material was based on work supported with resources from the National Institutes of Health (grant R01-HD044295), National Institute on Disability and Rehabilitation Research (grant H133S080074), and National Science Foundation (grants CBET-0854498 and IIP-0750515).	Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; Bell KR, 1998, PRINCIPLES OF NEUROLOGIC REHABILITATION, P309; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Chung SG, 2005, ARCH PHYS MED REHAB, V86, P318, DOI 10.1016/j.apmr.2004.04.048; Damiano DL, 2002, DEV MED CHILD NEUROL, V44, P112, DOI 10.1017/S0012162201001761; Gracies JM, 2010, ARCH PHYS MED REHAB, V91, P421, DOI 10.1016/j.apmr.2009.11.017; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Lance J W, 1981, Clin Exp Neurol, V18, P27; Liu J, 2010, P AM SOC BIOM ANN M; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Moseley A, 1991, Aust J Physiother, V37, P175, DOI 10.1016/S0004-9514(14)60540-7; Nef T, 2009, NEURODEGENER DIS, V6, P240, DOI 10.1159/000262444; Park HS, 2008, IEEE T NEUR SYS REH, V16, P245, DOI 10.1109/TNSRE.2008.920067; Rymer WZ., 1994, PHYS MED REHABIL STA, V8, P441; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Singer BJ, 2003, CLIN BIOMECH, V18, P157, DOI 10.1016/S0268-0033(02)00173-0; Sunnerhagen KS, 2010, J NEUROL NEUROSUR PS, V81, P2, DOI 10.1136/jnnp.2009.189068; TARDIEU C, 1989, PHYS THER, V69, P656, DOI 10.1093/ptj/69.8.656; Tederko Piotr, 2007, Ortop Traumatol Rehabil, V9, P467; Wu YN, 2010, DEV MED CHILD NEUROL, V52, P563, DOI 10.1111/j.1469-8749.2009.03602.x; Yam WKL, 2006, J CHILD NEUROL, V21, P1031, DOI 10.2310/7010.2006.00222; YOUNG RR, 1994, NEUROLOGY, V44, P12; Zafonte R, 2004, J HEAD TRAUMA REHAB, V19, P89, DOI 10.1097/00001199-200403000-00002; Zhang LQ, 2002, IEEE T NEUR SYS REH, V10, P149, DOI 10.1109/TNSRE.2002.802857	26	24	27	2	16	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	4					473	481		10.1682/JRRD.2010.04.0053			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	774GB	WOS:000291372200013	21674395	Green Accepted, Bronze			2022-02-06	
S	Tachtsidis, I; Tisdall, MM; Pritchard, C; Leung, TS; Ghosh, A; Elwell, CE; Smith, M		LaManna, JC; Puchowicz, MA; Xu, K; Harrison, DK; Bruley, DF		Tachtsidis, Ilias; Tisdall, Martin M.; Pritchard, Caroline; Leung, Terence S.; Ghosh, Arnab; Elwell, Clare E.; Smith, Martin			Analysis of the Changes in the Oxidation of Brain Tissue Cytochrome-c-Oxidase in Traumatic Brain Injury Patients during Hypercapnoea A Broadband NIRS Study	OXYGEN TRANSPORT TO TISSUE XXXII	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	37th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue	JUL 05-09, 2009	Cleveland, OH	Rockland Technimed Ltd, Seahorse Bioscience, Sherwin Williams, Int Soc Cerebral Blood Flow & Metabolism, Case Western Reserve Univ, Perimed, STARR Life Sci Corp, Univ Akron, HypOxygen			CARBON-DIOXIDE; BLOOD-FLOW; METABOLISM; MICRODIALYSIS; SPECTROSCOPY; TOMOGRAPHY; HYPEROXIA	Using broadband near-infrared spectroscopy (NIRS) and cerebral micro-dialysis (MD), we investigated cerebral cellular metabolism and mitochondrial redox states, following hypercapnoea in 6 patients with traumatic brain injury (TBI). In all patients hypercapnoea increased intracranial pressure and cerebral blood flow velocity measured with transcranial Doppler. Despite the likely increase in cerebral oxygen delivery, we did not see an increase in the oxidation status of cytochrome-c-oxidase [oxCCO] in every patient. Analysis of the NIRS data demonstrated two patterns of the changes; Group A (n = 4) showed an increase in [oxCCO] of 0.34(+/-0.34)mu M and Group B (n = 2) a decrease of 0.40(+/- 0.41)mu M. Although no obvious association was seen between the Delta[oxCCO] and the MD, measured changes in lactate and pyruvate concentrations. Further work using model informed data interpretation may be helpful in understanding the multimodal signals acquired in this heterogeneous patient group.	[Tachtsidis, Ilias; Leung, Terence S.; Elwell, Clare E.; Smith, Martin] UCL, Biomed Opt Res Lab, Dept Med Phys & Bioengn, London WC1E 6BT, England; [Tisdall, Martin M.; Pritchard, Caroline; Ghosh, Arnab; Smith, Martin] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neurocrit Care Unit, London, England		Tachtsidis, I (corresponding author), UCL, Biomed Opt Res Lab, Dept Med Phys & Bioengn, Gower St, London WC1E 6BT, England.	iliastac@medphys.ucl.ac.uk	Ghosh, Arnab/C-9513-2013; Tachtsidis, Ilias/N-2747-2018	Ghosh, Arnab/0000-0002-6498-258X; Tachtsidis, Ilias/0000-0002-8125-0313; Elwell, Clare/0000-0002-7281-7234; Tisdall, Martin/0000-0001-8880-8386	EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/D060982/1]; Department of Health's National Institute for Health Research CentresNational Institute for Health Research (NIHR); Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/D060982/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000292, G0701458] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1000292, G0701458] Funding Source: UKRI	The authors would like to thank the EPSRC (EP/D060982/1) for the financial support of this work. This work was undertaken at University College London Hospitals and partially funded by the Department of Health's National Institute for Health Research Centres funding scheme.	Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; MATCHER SJ, 1994, PHYS MED BIOL, V39, P177, DOI 10.1088/0031-9155/39/1/011; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P315, DOI 10.1007/978-0-387-85998-9_47; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tisdall MM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718541; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x	11	24	24	0	7	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0065-2598		978-1-4419-7755-7	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2011	701						9	14					6	Biology; Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine; Physiology	BVG71	WOS:000291499500002	21445763	Green Published			2022-02-06	
J	Villemure, R; Nolin, P; Le Sage, N				Villemure, R.; Nolin, P.; Le Sage, N.			Self-reported symptoms during post-mild traumatic brain injury in acute phase: Influence of interviewing method	BRAIN INJURY			English	Article						Mild traumatic brain injury; self-reported symptoms; symptom assessment; Rivermead post-concussion symptoms questionnaire	HEAD-INJURY; POSTCONCUSSION SYNDROME; EPIDEMIOLOGY; EXPECTATION; CONCUSSION; KNOWLEDGE; RECOVERY; OUTCOMES; RETURN; PAIN	Primary objective: To examine the role played by two interviewing methods used in the evaluation of acute self-reported symptoms after a mild traumatic brain injury (mTBI). Method and procedures: A cohort of 354 mTBI-adult participants was recruited over a period of 36 months in emergency rooms of five Canadian trauma hospitals. Participants were contacted by phone at the first and fourth week and at the third month following their mTBI in order to evaluate their symptoms. First, with the 'spontaneous' method, they freely identified those symptoms. Secondly, with the 'suggested' method, they identified their symptoms according to a standardized checklist made-up of the most common post-mTBI symptoms (Rivermead Post-Concussion Symptoms Questionnaire). Results: Globally, results showed a significant interaction effect between the interviewing method and measurement times of the symptoms. Participants reported significantly more symptoms with the suggested method compared to the spontaneous method for each measurement time. On the other hand, they reported significantly fewer symptoms from the first week to the third month of evaluation for either interviewing method. Moreover, the types of symptoms reported for both interviewing methods were different. Conclusion: The interviewing method used influences number and type of self-reported symptoms during the first 3 months post-mTBI.	[Villemure, R.; Nolin, P.] Univ Quebec Trois Rivieres, Dept Psychol, Ctr Etud Interdisciplinaires Dev Enfant Famille, Trois Rivieres, PQ G9A 5H7, Canada; [Le Sage, N.] Univ Quebec Trois Rivieres, Ctr Hosp Univ Affilie Quebec Traumatol & Med Urge, Trois Rivieres, PQ G9A 5H7, Canada		Villemure, R (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Ctr Etud Interdisciplinaires Dev Enfant Famille, POB 500, Trois Rivieres, PQ G9A 5H7, Canada.	rene.villemure@uqtr.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de la recherche en sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec	The authors would like to point out the co-operation from each of the teams from the hospitals that participated in recruiting participants, and would like to especially thank Patricia Chabot and Valerie Murat at the Centre hospitalier universitaire affilie of Quebec for their remarkable work. This study was also made possible through the support of the Fonds de la recherche en sante du Quebec (FRSQ) and the Canadian Institutes of Health Research (CIHR).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KIRSCH I, 1999, EXPECTANCIES SHAPE E; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; MARCOTTE AC, 2005, ORIENTATIONS MINISTE; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MCCREA MA, 2008, MILD TRAUM BRAIN INJ; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 2001, HEAD TRAUMA, P327; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	68	24	24	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2011	25	1					53	64		10.3109/02699052.2010.531881			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700007	21117920				2022-02-06	
J	Cocchi, MN; Lucas, JM; Salciccioli, J; Carney, E; Herman, S; Zimetbaum, P; Donnino, MW				Cocchi, Michael N.; Lucas, Jason M.; Salciccioli, Justin; Carney, Erin; Herman, Susan; Zimetbaum, Peter; Donnino, Michael W.			The role of cranial computed tomography in the immediate post-cardiac arrest period	INTERNAL AND EMERGENCY MEDICINE			English	Article						Cardiac arrest; Neuroimaging; Intracranial hemorrhage; Cerebral edema	AMERICAN-HEART-ASSOCIATION; SUBARACHNOID HEMORRHAGE; RECOMMENDED GUIDELINES; UTSTEIN STYLE; WHITE-MATTER; RESUSCITATION; DENSITY	Patients who initially survive cardiac arrest are often admitted to an intensive care unit comatose and on mechanical ventilation. It is not clear whether or not a screening cranial computed tomography (CT scan) is necessary in the immediate post-arrest period. We hypothesized that there may be clinically relevant information gleaned from head CT scans obtained early in the post-arrest period that could affect immediate management of these patients, even when non-neurologic causes of cardiac arrest are suspected. A retrospective data analysis was conducted of all survivors (age > 18 years) of non-traumatic out-of-hospital cardiac arrest (OHCA) who underwent non-contrast head CT (NCHCT) within the first 24 h of admission. A total of 84 patients were identified and 51 (60.7%) met the inclusion criteria. As much as 45 (88.2%) patients in the total cohort had an NCHCT negative for ICH or herniation; of this group, 39 (76.5%) had a normal NCHCT, while six (11.8%, 95% CI: 5.1-23.8%) demonstrated varying degrees of cerebral edema or loss of gray-white matter distinction consistent with anoxic brain injury, but without herniation. Six patients (11.8%, 95% CI: 5.1-23.8%) exhibited findings consistent with either an ICH (with or without herniation) or herniation without an ICH. Four (7.8%) of these patients had an ICH without herniation, one had an acute SAH with edema and herniation, and one had frank herniation due to massive cerebral edema. The overall incidence of any kind of intracranial hemorrhage in our cohort was 9.8% (95% CI: 3.8-21.4%). In this cohort of post-cardiac arrest patients who underwent cranial computed tomography, 11.8% of patients had clinically significant abnormalities identified. The exact role of neuroimaging in this population is still in evolution, and further prospective evaluation is warranted.	[Cocchi, Michael N.; Lucas, Jason M.; Salciccioli, Justin; Carney, Erin; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Herman, Susan] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Zimetbaum, Peter] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care Med, Dept Med, Boston, MA 02215 USA		Cocchi, MN (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA.	mcocchi@bidmc.harvard.edu		Herman, Susan/0000-0002-6556-083X	American Heart AssociationAmerican Heart Association [0735533T]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK040561] Funding Source: NIH RePORTER	This study was funded in part by a grant from the American Heart Association (grant number 0735533T).	Berek K, 1997, J NEUROL, V244, P556, DOI 10.1007/s004150050143; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Inamasu J, 2009, RESUSCITATION, V80, P977, DOI 10.1016/j.resuscitation.2009.05.010; Inamasu J, 2009, J HEADACHE PAIN, V10, P357, DOI 10.1007/s10194-009-0138-y; Kitahara Takao, 1993, Neurological Surgery, V21, P781; Kuisma M, 1997, EUR HEART J, V18, P1122; Kurkciyan I, 2001, RESUSCITATION, V51, P27, DOI 10.1016/S0300-9572(01)00381-1; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; Naples R, 2009, AM J EMERG MED, V27, P63, DOI 10.1016/j.ajem.2008.01.014; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Puettgen HA, 2007, J NEUROL SCI, V261, P108, DOI 10.1016/j.jns.2007.04.041; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sasson C, 2008, JAMA-J AM MED ASSOC, V300, P1432, DOI 10.1001/jama.300.12.1432; Torbey MT, 2004, RESUSCITATION, V63, P55, DOI 10.1016/j.resuscitation.2004.03.021; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; Yanagawa Y, 2005, RESUSCITATION, V64, P97, DOI 10.1016/j.resuscitation.2004.06.015	18	24	24	0	3	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1828-0447	1970-9366		INTERN EMERG MED	Intern. Emerg. Med.	DEC	2010	5	6					533	538		10.1007/s11739-010-0403-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684LN	WOS:000284551500011	20454869				2022-02-06	
J	Huang, HK; Su, YP; Chen, CM; Chiu, FY; Liu, CL				Huang, Hui-Kuang; Su, Yu-Ping; Chen, Chuan-Mu; Chiu, Fang-Yao; Liu, Chien-Lin			Displaced Femoral Neck Fractures in Young Adults Treated With Closed Reduction and Internal Fixation	ORTHOPEDICS			English	Article								This article describes the effect of closed reduction and internal fixation with 3 different screw configurations for acute completely displaced femoral neck fractures in young adults. From 2001 to 2006, 136 patients (age range, 20-50 years) who had acute unilaterally completely displaced femoral neck fractures were evaluated retrospectively. All fractures were managed with closed reduction and internal fixation with 3 cannulated screws. The follow-up period was 55 months on average (range, 36-90 months). One hundred twenty-two patients were available for final evaluation of union condition and late complication. Twenty-three patients (18.9%) had nonunion, 15 (12.3%) had fixation failure, and 21 (17.2%) had avascular necrosis of the femoral head. The average duration from injury to surgery was 18.4 hours in the union group and 23.3 hours in the nonunion group, with no statistical significance (P=.196). The average duration from injury to surgery was 17.3 hours in the avascular necrosis of the femoral head group and 22.3 hours in the non-avascular necrosis of the femoral head group, with no statistical significance (P=.155). Vertical-and separated-type screw configurations resulted in a significantly higher nonunion rate (P=.001 and P=.0017, respectively) than parallel configuration. The complication rate in treating completely displaced femoral neck fractures with internal fixation in young adults is high, and screw configuration may further affect results.	[Huang, Hui-Kuang; Su, Yu-Ping; Chen, Chuan-Mu; Chiu, Fang-Yao; Liu, Chien-Lin] Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei 112, Taiwan; [Chen, Chuan-Mu; Chiu, Fang-Yao; Liu, Chien-Lin] Natl Yang Ming Univ, Taipei 112, Taiwan		Chiu, FY (corresponding author), Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan.	fychiu@vghtpe.gov.tw					ALBERTS KA, 1990, CLIN ORTHOP RELAT R, P129; Alho A, 1999, ACTA ORTHOP SCAND, V70, P141, DOI 10.3109/17453679909011252; American Society of Anesthesiologists, 2009, ANESTHESIOLOGY, V24, P111; Aminian A, 2007, J ORTHOP TRAUMA, V21, P544, DOI 10.1097/BOT.0b013e31814b822e; ASNIS SE, 1994, J BONE JOINT SURG AM, V76A, P1793, DOI 10.2106/00004623-199412000-00005; Baitner AC, 1999, CLIN ORTHOP RELAT R, P300; Bartonicek J, 2001, J ORTHOP TRAUMA, V15, P358, DOI 10.1097/00005131-200106000-00009; Bjorgul K, 2007, ACTA ORTHOP, V78, P498, DOI 10.1080/17453670710014149; Bjorgul K, 2006, ACTA ORTHOP, V77, P368, DOI 10.1080/17453670610046271; Bonnaire F, 1998, CLIN ORTHOP RELAT R, P148; Butt MF, 2008, INJURY, V39, P238, DOI 10.1016/j.injury.2007.09.002; Castillo RC, 2005, J ORTHOP TRAUMA, V19, P151, DOI 10.1097/00005131-200503000-00001; Caviglia HA, 2002, CLIN ORTHOP RELAT R, P17; Chen F, 2001, Am J Orthop (Belle Mead NJ), V30, P486; CLARK DI, 1990, J BONE JOINT SURG BR, V72, P797, DOI 10.1302/0301-620X.72B5.2211759; CRAWFURD EJP, 1988, J BONE JOINT SURG BR, V70, P195, DOI 10.1302/0301-620X.70B2.3279041; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; DEDRICK DK, 1986, J TRAUMA, V26, P932, DOI 10.1097/00005373-198610000-00013; ELMERSON S, 1987, ACTA ORTHOP SCAND, V58, P109, DOI 10.3109/17453678709146451; Gurusamy K, 2005, J BONE JOINT SURG BR, V87B, P632, DOI 10.1302/0301-620X.87B5.15237; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; HARPER WM, 1991, J BONE JOINT SURG BR, V73, P73, DOI 10.1302/0301-620X.73B1.1991780; HEDLUND R, 1987, CLIN ORTHOP RELAT R, P132; HODGES DL, 1986, AM FAM PHYSICIAN, V34, P149; Kauffman JI, 1999, J ORTHOP TRAUMA, V13, P155, DOI 10.1097/00005131-199903000-00001; KOFOED H, 1982, INJURY, V14, P146, DOI 10.1016/0020-1383(82)90049-3; KYRO A, 1993, ANN CHIR GYNAECOL FE, V82, P254; Lagerby M, 1998, ACTA ORTHOP SCAND, V69, P387, DOI 10.3109/17453679808999052; Lee CH, 2003, ARCH ORTHOP TRAUM SU, V123, P527, DOI 10.1007/s00402-003-0579-8; LINDEQUIST S, 1993, ACTA ORTHOP SCAND, V64, P289, DOI 10.3109/17453679308993627; Liporace F, 2008, J BONE JOINT SURG AM, V90A, P1654, DOI 10.2106/JBJS.G.01353; Ly TV, 2008, J BONE JOINT SURG AM, V90A, P2254; Ly Thuan V, 2009, Instr Course Lect, V58, P69; Lykke N, 2003, J BONE JOINT SURG BR, V85B, P426, DOI 10.1302/0301-620X.85B3.13788; MADSEN F, 1987, ACTA ORTHOP SCAND, V58, P212, DOI 10.3109/17453678709146468; MARTENS M, 1979, CLIN ORTHOP RELAT R, P199; Maruenda JI, 1997, CLIN ORTHOP RELAT R, P172; MATSUO K, 1988, CLIN ORTHOP RELAT R, P115; Oakey JW, 2006, CLIN ORTHOP RELAT R, P302, DOI 10.1097/01.blo.0000188557.65387.fc; Pape HC, 1999, J TRAUMA, V46, P58, DOI 10.1097/00005373-199901000-00010; PARKER MJ, 1991, J BONE JOINT SURG BR, V73, P826, DOI 10.1302/0301-620X.73B5.1894675; Paus A, 1986, J Oslo City Hosp, V36, P55; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; Raaymakers Ernst L F B, 2006, Acta Chir Orthop Traumatol Cech, V73, P45; REHNBERG L, 1989, ACTA ORTHOP SCAND, V60, P579, DOI 10.3109/17453678909150126; RUBIN R, 1981, J TRAUMA, V21, P1036, DOI 10.1097/00005373-198112000-00006; SCHECK M, 1980, CLIN ORTHOP RELAT R, P138; Schmitz MA, 1999, CLIN ORTHOP RELAT R, P184, DOI 10.1097/00003086-199908000-00024; Selvan VT, 2004, INJURY, V35, P136, DOI 10.1016/S0020-1383(03)00059-7; SHIH CH, 1991, CLIN ORTHOP RELAT R, P195; Stankewich CJ, 1996, J ORTHOP TRAUMA, V10, P248, DOI 10.1097/00005131-199605000-00005; Stiasny Jerzy, 2008, Ortop Traumatol Rehabil, V10, P350; STROMQVIST B, 1988, J BONE JOINT SURG BR, V70, P192, DOI 10.1302/0301-620X.70B2.3346286; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; Tian Wei, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P440; Upadhyay A, 2004, J BONE JOINT SURG BR, V86B, P1035, DOI 10.1302/0301-620X.86B7.15047; Wosje KS, 2007, OSTEOPOROSIS INT, V18, P391, DOI 10.1007/s00198-006-0249-0; ZETTERBERG CH, 1982, ACTA ORTHOP SCAND, V53, P427, DOI 10.3109/17453678208992237; Zlowodzki M, 2005, J TRAUMA, V59, P969, DOI 10.1097/01.ta.0000188130.99626.8c	59	24	24	0	7	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	DEC	2010	33	12								10.3928/01477447-20101021-15			13	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	V24SP	WOS:000208430400009					2022-02-06	
J	von Morze, C; Kelley, DAC; Shepherd, TM; Banerjee, S; Xu, DA; Hess, CP				von Morze, Cornelius; Kelley, Douglas A. C.; Shepherd, Timothy M.; Banerjee, Suchandrima; Xu, Duan; Hess, Christopher P.			Reduced field-of-view diffusion-weighted imaging of the brain at 7 T	MAGNETIC RESONANCE IMAGING			English	Article						Field of view; Diffusion-weighted imaging; Brain	OUTER VOLUME SUPPRESSION; SPINAL-CORD; RF PULSES; DESIGN; EPI; RELAXATION; TENSOR; RESOLUTION; MOTION; DWI	Ventral and rostral regions of the brain are of emerging importance for the MRI characterization of early dementia, traumatic brain injury and epilepsy. Unfortunately, standard single-shot echo planar diffusion-weighted imaging of these regions at high fields is contaminated by severe imaging artifacts in the vicinity of air tissue interfaces. To mitigate these artifacts and improve visualization of the temporal and frontal lobes at 7 T, we applied a reduced field-of-view strategy, enabled by outer volume suppression (OVS) with novel quadratic phase radiofrequency (RF) pulses, combined with partial Fourier and parallel imaging methods. The new acquisition greatly reduced the level of artifacts in six human subjects (including four patients with early symptoms of dementia). (C) 2010 Elsevier Inc. All rights reserved.	[von Morze, Cornelius; Kelley, Douglas A. C.; Shepherd, Timothy M.; Xu, Duan; Hess, Christopher P.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA; [Kelley, Douglas A. C.; Banerjee, Suchandrima] GE Healthcare, San Francisco, CA USA		von Morze, C (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, MC 2512, San Francisco, CA 94158 USA.	morze@radiology.ucsf.edu	Xu, Duan/B-3197-2013; Shepherd, Timothy M/N-1730-2019	Shepherd, Timothy M/0000-0003-0232-1636; Hess, Christopher/0000-0002-5132-5302; Xu, Duan/0000-0003-0550-4235	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EB009756]; NIH/NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32 EB001631]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009756, T32EB001631] Funding Source: NIH RePORTER	We acknowledge grant support from NIH R01EB009756. TMS was supported by the NIH/NIBIB T32 EB001631 training fellowship.	Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; COX EF, 2008, P INT SOC MAGN RESON, V16; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; HAMMOND KE, 2006, P INT SOC MAGN RESON, V14; Holdsworth SJ, 2008, EUR J RADIOL, V65, P36, DOI 10.1016/j.ejrad.2007.09.016; Jaermann T, 2004, MAGN RESON MED, V51, P230, DOI 10.1002/mrm.10707; Kalus P, 2006, NEUROIMAGE, V30, P713, DOI 10.1016/j.neuroimage.2005.10.035; KELLEY DA, 2008, P INT SOC MAGN RESON, V16; Larkman DJ, 2007, PHYS MED BIOL, V52, pR15, DOI 10.1088/0031-9155/52/7/R01; Le Roux P, 1998, JMRI-J MAGN RESON IM, V8, P1022, DOI 10.1002/jmri.1880080505; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; Mukherjee P, 2008, MAGN RESON IMAGING, V26, P171, DOI 10.1016/j.mri.2007.05.011; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; PAULY J, 1991, IEEE T MED IMAGING, V10, P53, DOI 10.1109/42.75611; Pipe JG, 2006, MAGN RESON MED, V55, P380, DOI 10.1002/mrm.20768; ROHRER JD, NEUROIMAGE IN PRESS; Saritas EU, 2008, MAGN RESON MED, V60, P468, DOI 10.1002/mrm.21640; Schulte RF, 2007, J MAGN RESON, V186, P167, DOI 10.1016/j.jmr.2007.02.004; Schulte RF, 2004, J MAGN RESON, V166, P111, DOI 10.1016/j.jmr.2003.10.009; Skare S, 2007, MAGN RESON MED, V57, P881, DOI 10.1002/mrm.21176; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Van AT, 2009, IEEE T MED IMAGING, V28, P1770, DOI 10.1109/TMI.2009.2023212; Wheeler-Kingshott CAM, 2002, MAGN RESON MED, V47, P24, DOI 10.1002/mrm.10016; Wilm BJ, 2007, MAGN RESON MED, V57, P625, DOI 10.1002/mrm.21167; Yang QX, 2004, MAGN RESON MED, V52, P1016, DOI 10.1002/mrm.20245	27	24	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X			MAGN RESON IMAGING	Magn. Reson. Imaging	DEC	2010	28	10					1541	1545		10.1016/j.mri.2010.06.025			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	687ZD	WOS:000284816400017	20850242	Green Accepted			2022-02-06	
J	Yang, DY; Chen, YJ; Wang, MF; Pan, HC; Chen, SY; Cheng, FC				Yang, Dar-Yu; Chen, Ying-Ju; Wang, Ming-Fu; Pan, Hung-Chuan; Chen, Shen-Ying; Cheng, Fu-Chou			Granulocyte colony-stimulating factor enhances cellular proliferation and motor function recovery on rats subjected to traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						G-CSF; TBI; Osmotic pump; Neurogenesis; Neuroprotection	CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; G-CSF; GROWTH-FACTOR; NEUROGENESIS; MICE; CELLS; MIGRATION; PROTECTS; CHILDREN	Objective: Traumatic brain injury (TBI) results in neurological dysfunction and death through primary or secondary mechanisms. Here, we evaluated the effect of osmotic pump delivery of granulocyte colony-stimulating factor (G-CSF) on the histopathology and motor function recovery of rats after experimental TBI. Methods: Sprague-Dawley rats were used as experimental model by fluid percussion device to cause brain injury on the motor cortex area. The rats were simultaneously subjected to TBI and were implanted of min-osmotic pump containing recombinant human G-CSF (300 mu g/700 mu l) via intraperitoneal injection. Motor function was assessed by rotarod test. 5-bromo-2'-deoxyuridine (BrdU) was used to label the proliferating cells and their differentiation was evaluated by histology and immunohistochemistry. Results: The G-CSF group showed significantly better motor function recovery than the control group, and the effect lasted up to 14 days after TBI. Moreover, the G-CSF group exhibited a greater increase in the number of BrdU-positive cells compared with the control group. The G-CSF group also had a significantly higher number of DCX-positive cells in the ipsilateral subventricular zone (SVZ) than the control group. Conclusions: These data suggest that the beneficial effect of delivering G-CSF via an osmotic pump may improve the motor function and enhance neurogenesis in the SVZ of the injured brain.	[Chen, Ying-Ju; Chen, Shen-Ying; Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, Taichung 407, Taiwan; [Yang, Dar-Yu] Chang Bing Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan; [Chen, Ying-Ju; Wang, Ming-Fu; Chen, Shen-Ying] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung 407, Taiwan		Cheng, FC (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, 160,Sec 3,Taichung Port Rd, Taichung 407, Taiwan.	fucheng@vghtc.gov.tw			Taichung Veterans General Hospital and Providence University [TCVGH-PU-978107]	This study was supported by a grant from Taichung Veterans General Hospital and Providence University (TCVGH-PU-978107). We also thank the Biostatistics Task Force of TCVGH for their assistance with the statistical analyses.	Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Cao XQ, 2006, J NEUROCHEM, V99, P861, DOI 10.1111/j.1471-4159.2006.04125.x; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Conley R, 2006, CURR MED RES OPIN, V22, P1879, DOI 10.1185/030079906X132613; Cooper JD, 2007, J NEUROSCI METH, V160, P269, DOI 10.1016/j.jneumeth.2006.09.014; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huang HY, 2007, NEUROBIOL AGING, V28, P1258, DOI 10.1016/j.neurobiolaging.2006.05.037; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lee ST, 2008, BRAIN RES, V1194, P130, DOI 10.1016/j.brainres.2007.11.058; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Lu CZ, 2006, BIOCHEM SOC T, V34, P1327, DOI 10.1042/BST0341327; Nygren J, 2006, STROKE, V37, P2824, DOI 10.1161/01.STR.0000244769.39952.90; Paredes J, 2000, BRAIN RES, V887, P157, DOI 10.1016/S0006-8993(00)02972-3; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ren JM, 2005, CNS NEUROL DISORD-DR, V4, P121, DOI 10.2174/1568007053544101; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sehara Y, 2007, BRAIN RES, V1151, P142, DOI 10.1016/j.brainres.2007.01.149; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Volmar CH, 2008, CYTOKINE, V42, P336, DOI 10.1016/j.cyto.2008.03.007; Whittlesey KJ, 2004, EXP NEUROL, V190, P1, DOI 10.1016/j.expneurol.2004.06.020; Yang SX, 2008, STROKE, V39, P2079, DOI 10.1161/STROKEAHA.107.508911	33	24	24	0	4	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	DEC	2010	32	10					1041	1049		10.1179/016164110X12807570510013			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	670LD	WOS:000283422300005	20810026				2022-02-06	
J	Ciapetti, M; Circelli, A; Zagli, G; Migliaccio, ML; Spina, R; Alessi, A; Acquafresca, M; Bartolini, M; Peris, A				Ciapetti, Marco; Circelli, Alessandro; Zagli, Giovanni; Migliaccio, Maria Luisa; Spina, Rosario; Alessi, Alessandro; Acquafresca, Manlio; Bartolini, Marco; Peris, Adriano			Diagnosis of carotid arterial injury in major trauma using a modification of Memphis criteria	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							BLUNT CEREBROVASCULAR INJURIES; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CT ANGIOGRAPHY; ASSOCIATION; OUTCOMES	Background: Incidence of Blunt Cerebrovascular Injuries (BCVI) after head injury has been reported as 0.5-1% of all admissions for blunt trauma, with a high stroke and mortality rate. The purpose of this study is to evaluate if a modification of Memphis criteria could improve the rate of BCVI diagnosis. Methods: Trauma patients consecutively admitted to Intensive Care Unit (ICU) from Jan 2008 to Oct 2009 were considered for the study. Memphis criteria comprehend: basilar skull fracture with involvement of the carotid canal, cervical spine fracture, neurological exam not explained by brain imaging, Horner's syndrome, LeFort II-III fractures, and neck soft tissue injury. As single criteria modification, we included all patients with petrous bone fracture, even without carotid canal involvement. In all patients at risk of BCVI, 64-slice angio-CT-scans was performed. Results: During the study period, 266 patients were admitted to the ICU for blunt major trauma. Among them, 162 presented traumatic brain injury or cervical spine fracture. In accordance with the proposed modified-Memphis criteria, 53 patients showed risk factors for BCVI compared to 45 using the original Memphis criteria. Among the 53 patients, 6 resulted as having carotid lesions (2.2% of all blunt major traumas; one patient more than when using Memphis criteria). Anticoagulant therapy with low molecular weight heparin was administered in all patients. No stroke or hemorrhagic complications occurred. Clinical examination at 6-months showed no central neurological deficit. Conclusion: A modification of a single criteria of Memphis screening protocol might permit the identification of a higher percentage of BCVI. Limited by sample size, this study needs to be validated.	[Ciapetti, Marco; Zagli, Giovanni; Migliaccio, Maria Luisa; Spina, Rosario; Peris, Adriano] Careggi Teaching Hosp, Emergency Dept, Anesthesia & Intens Care Unit, I-50139 Florence, Italy; [Circelli, Alessandro] Univ Florence, I-50139 Florence, Italy; [Alessi, Alessandro] Careggi Teaching Hosp, Dept Vasc Surg, I-50139 Florence, Italy; [Acquafresca, Manlio; Bartolini, Marco] Careggi Teaching Hosp, Dept Diagnost Imaging, I-50139 Florence, Italy		Zagli, G (corresponding author), Careggi Teaching Hosp, Emergency Dept, Anesthesia & Intens Care Unit, Largo Brambilla 3, I-50139 Florence, Italy.	giovanni.zagli@unifi.it		Bartolini, Marco/0000-0003-2518-6369			Berne JD, 2004, J TRAUMA, V57, P11, DOI 10.1097/01.TA.0000135499.70048.C7; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; BERNE JD, 2009, J VASC SURG, V30, P30; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Cothren CC, 2003, J TRAUMA, V55, P811, DOI 10.1097/01.TA.0000092700.92587.32; CRISSEY MM, 1974, SURGERY, V75, P543; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Mutze S, 2005, RADIOLOGY, V237, P884, DOI 10.1148/radiol.2373042189; Rogers FB, 1999, J TRAUMA, V46, P380, DOI 10.1097/00005373-199903000-00005; Schneidereit NP, 2006, J TRAUMA, V60, P209, DOI 10.1097/01.ta.0000195651.60080.2c; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Stuhlfaut JW, 2005, AM J ROENTGENOL, V185, P1063, DOI 10.2214/AJR.04.1217; Utter GH, 2006, J AM COLL SURGEONS, V203, P838, DOI 10.1016/j.jamcollsurg.2006.08.003; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001	21	24	24	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 22	2010	18								61	10.1186/1757-7241-18-61			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	691PE	WOS:000285092500001	21092211	Green Published, gold			2022-02-06	
J	Chauhan, NB; Gatto, R				Chauhan, Neelima B.; Gatto, Roclolfo			Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury	BRAIN RESEARCH			English	Article						Axonal injury; Cell proliferation; Spatial learning; Memory; Cortex; Dentate gyrus	CONTROLLED CORTICAL IMPACT; RECOMBINANT-HUMAN-ERYTHROPOIETIN; AMYLOID PRECURSOR PROTEIN; RECOVERY TRIAL NEUSTART; NITRIC-OXIDE SYNTHASE; ACUTE ISCHEMIC-STROKE; HIGH-DOSE LOVASTATIN; AGED GARLIC EXTRACT; NERVE GROWTH-FACTOR; MORRIS WATER MAZE	Simvastatin and recombinant human erythropoietin (rhEpo) are implicated as potential therapeutic candidates for traumatic brain injury (TBI). Prominent effects of simvastatin include its anti-inflammatory, neurotrophic and neuroregenerative actions studied in various models of neuronal injury. On the other hand, rhEpo has been shown to promote cell survival mechanisms by producing anti-apoptotic and cell proliferative actions. Beneficial effects of rhEpo and statin monotherapies have been well studied. However, there are no reports showing combined use of rhEpo and statins after TBI. This investigation examined if combined efficacy of cell proliferative ability of rhEpo along with the neuroregenerative ability of simvastatin will render maximum recovery in a controlled cortical impact (CCI) mouse model of TBI. Results showed that compared to baseline TBI, rhEpo was more effective than simvastatin in promoting cell proliferation while simvastatin was more effective than rhEpo in restoring axonal damage following TBI. Combined treatment with simvastatin and rhEpo maximally restored axonal integrity while simultaneously inducing greater proliferation of newly formed cells resulting in better functional recovery after TBI than either alone. This is the first study showing the efficacy of erythropoietin simvastatin combinational therapeutic approach in achieving greater structural and cognitive recovery after TBI. Published by Elsevier B.V.	[Chauhan, Neelima B.; Gatto, Roclolfo] Univ Illinois, Jesse Brown VA Med Ctr, Chicago, IL USA; [Chauhan, Neelima B.; Gatto, Roclolfo] Univ Illinois, Westside Inst Sci & Educ, Chicago, IL USA; [Chauhan, Neelima B.] Univ Illinois, Dept Pediat, Chicago, IL USA; [Chauhan, Neelima B.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Gatto, Roclolfo] Univ Illinois, Dept Bioengn, Chicago, IL USA		Chauhan, NB (corresponding author), Jesse Brown VA Med Ctr Chicago, 820 S Damen Ave, Chicago, IL 60612 USA.	nchauhan@uic.edu	Gatto, Rodolfo Gabriel/R-7155-2018	Gatto, Rodolfo Gabriel/0000-0003-2170-6662	Department of Veterans AffairsUS Department of Veterans Affairs [B6285R]; Westside Institute for Science and Education Chicago; Department of Pediatrics, University of Illinois at Chicago; Department of Anatomy & Cell Biology, University of Illinois at Chicago; Department of BioEngineering, University of Illinois at Chicago; Veterans AffairsUS Department of Veterans Affairs [I01RX000880] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs (VA MERIT Grant #B6285R, Chauhan NB). Authors are thankful for the support provided by the Westside Institute for Science and Education Chicago; and by the Departments of Pediatrics, Anatomy & Cell Biology, and BioEngineering, University of Illinois at Chicago.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; Balduini W, 2001, STROKE, V32, P2185, DOI 10.1161/hs0901.094287; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Carloni S, 2006, NEUROBIOL DIS, V21, P119, DOI 10.1016/j.nbd.2005.06.014; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chauhan NB, 2005, NEUROSCI LETT, V375, P143, DOI 10.1016/j.neulet.2004.10.090; Chauhan NB, 2005, NEUROPHARMACOLOGY, V48, P93, DOI 10.1016/j.neuropharm.2004.09.014; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Chauhan NB, 2003, NEUROCHEM INT, V43, P225, DOI 10.1016/S0197-0186(03)00006-8; Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Chauhan NB, 2006, J ETHNOPHARMACOL, V108, P385, DOI 10.1016/j.jep.2006.05.030; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Chauhan NB, 2007, J NEUROSCI RES, V85, P451, DOI 10.1002/jnr.21110; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Cheng Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-156; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; Chung RS, 2003, J NEUROSCI, V23, P3336; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Elkind MSV, 2008, INT J STROKE, V3, P210, DOI 10.1111/j.1747-4949.2008.00200.x; Elkind MSV, 2009, CEREBROVASC DIS, V28, P266, DOI 10.1159/000228709; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; Fenjves ES, 2003, TRANSPLANTATION, V75, P1356, DOI 10.1097/01.TP.0000062862.88375.BD; Fisher JW, 2003, EXP BIOL MED, V228, P1; Fonseca ACRG, 2010, EXP NEUROL, V223, P282, DOI 10.1016/j.expneurol.2009.09.013; Franklin K, 1998, MOUSE BRAIN STEREOTA; Giles GM, 2009, ARCH PHYS MED REHAB, V90, P530, DOI 10.1016/j.apmr.2009.01.004; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hoffman SW, 2010, NEUROREHABILITATION, V26, P257, DOI 10.3233/NRE-2010-0561; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoglund K, 2007, CNS DRUGS, V21, P449; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Knowlton BJ, 1998, CURR OPIN NEUROBIOL, V8, P293, DOI 10.1016/S0959-4388(98)80154-2; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Laufs U, 2002, BRAIN RES, V942, P23, DOI 10.1016/S0006-8993(02)02649-5; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Lee S, 2008, ACTA NEUROCHIR SUPPL, V102, P405, DOI 10.1007/978-3-211-85578-2_79; Li BY, 2009, ACTA CRYSTALLOGR E, V65, pM1, DOI 10.1107/S1600536808039846; Liao ZB, 2009, NEUROL INDIA, V57, P722, DOI 10.4103/0028-3886.59466; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Liu P, 1998, BEHAV NEUROSCI, V112, P304, DOI 10.1037/0735-7044.112.2.304; Liu XB, 2008, CNS NEUROL DISORD-DR, V7, P227, DOI 10.2174/187152708784936617; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Matchett G, 2006, J NEUROSCI METH, V158, P234, DOI 10.1016/j.jneumeth.2006.06.003; Michikawa Makoto, 2004, Current Alzheimer Research, V1, P271, DOI 10.2174/1567205043331983; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Poucet B, 2000, REV NEUROSCIENCE, V11, P95; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Savage LM, 1997, BEHAV BRAIN RES, V82, P133, DOI 10.1016/S0166-4328(97)80983-7; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schmeer C, 2006, RESTOR NEUROL NEUROS, V24, P79; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Szczepanska-Szerej A, 2007, PHARMACOL REP, V59, P94; Tanaka K, 2009, NEUROSCI LETT, V462, P235, DOI 10.1016/j.neulet.2009.07.024; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang LN, 2010, NEUROSCI LETT, V471, P152, DOI 10.1016/j.neulet.2010.01.030; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whishaw IQ, 1997, CURR OPIN NEUROBIOL, V7, P228, DOI 10.1016/S0959-4388(97)80011-6; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	115	24	26	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 11	2010	1360						177	192		10.1016/j.brainres.2010.09.010			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680RR	WOS:000284252600017	20833152				2022-02-06	
J	Shain, KS; Madigan, ML; Rowson, S; Bisplinghoff, J; Duma, SM				Shain, Kellen S.; Madigan, Michael L.; Rowson, Steven; Bisplinghoff, Jill; Duma, Stefan M.			Analysis of the Ability of Catcher's Masks to Attenuate Head Accelerations on Impact With a Baseball	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						catcher's masks; head accelerations; concussions; baseball impacts	TRAUMATIC BRAIN-INJURY; UNITED-STATES; MILD; FOOTBALL; CONCUSSION; SEVERITY; RISK	Objective: The goals of this study were to measure the ability of catcher's masks to attenuate head accelerations on impact with a baseball and to compare these head accelerations to established injury thresholds for mild traumatic brain injury. Design: Testing involved using a pneumatic cannon to shoot baseballs at an instrumented Hybrid III headform (a 50th percentile male head and neck) with and without a catcher's mask on the head. The ball speed was controlled from approximately 26.8 to 35.8 m/s (60-80 mph), and the regulation National Collegiate Athletic Association baseballs were used. Setting: Research laboratory. Patients: None. Independent Variables: Catcher's masks and impact velocity. Main Outcome Measures: The linear and angular head accelerations of the Hybrid III headform. Results: Peak linear resultant acceleration was 140 to 180 g without a mask and 16 to 30 g with a mask over the range of ball's speed investigated. Peak angular resultant acceleration was 19 500 to 25 700 rad/s(2) without a mask and 2250 to 3230 rad/s(2) with a mask. The Head Injury Criterion was 93 to 181 without a mask and 3 to 13 with a mask, and the Severity Index was 110 to 210 without a mask and 3 to 15 with a mask. Conclusions: Catcher's masks reduced head acceleration metrics by approximately 85%. Head acceleration metrics with a catcher's mask were significantly lower than contemporary injury thresholds, yet reports in the mass media clearly indicate that baseball impacts to the mask still occasionally result in mild traumatic brain injuries. Further research is needed to address this apparent contradiction.	[Shain, Kellen S.; Madigan, Michael L.; Rowson, Steven; Bisplinghoff, Jill; Duma, Stefan M.] Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA		Madigan, ML (corresponding author), Virginia Tech, Dept Engn Sci & Mech, 326 Norris Hall, Blacksburg, VA 24061 USA.	mlm@vt.edu	Rowson, Steven/B-1270-2012; Duma, Stefan/A-8368-2012	Rowson, Steven/0000-0002-3227-0596; Madigan, Michael/0000-0002-4299-3851			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BRAINARD LL, 2009, ANN M AM SOC BIOM SL; *CDCP, HEADS UP FACTS PHYS; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; DRAPER R, CONCUSSIONS END MATH; *ESPN, UMP SUST CONC; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy, 2003, P INT RES C BIOM IMP; HEALD JH, 1994, AM SOC TEST MATER, V1229, P223, DOI 10.1520/STP12816S; HIBBARD D, FOUL TIP TRAUMA; Hodgson VR, 1970, P 14 STAPP CAR CRASH; Jones I. S., 1984, HEAD IMPACT TOLERANC; KING WF, 1973, GEN MOTORS S SERIES; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MELVIN JW, 1984, UMTRI8436; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; WHITE P, USA TODAY; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	30	24	24	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2010	20	6					422	427		10.1097/JSM.0b013e3181f7db25			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	682DC	WOS:000284379100007	21079437				2022-02-06	
J	Wigginton, JG; Pepe, PE; Idris, AH				Wigginton, Jane G.; Pepe, Paul E.; Idris, Ahamed H.			Rationale for routine and immediate administration of intravenous estrogen for all critically ill and injured patients	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Conference on Thinking Outside the Box	MAR, 2010	Brussels, BELGIUM			resuscitation; cardiopulmonary resuscitation; cardiac arrest; hemorrhagic shock; trauma; traumatic brain injury; burns; estrogen; progesterone; antiapoptotic; anti-inflammatory	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; CEREBRAL-ARTERY OCCLUSION; RECEPTOR-BETA AGONIST; HEAT-SHOCK PROTEINS; GENDER-DIFFERENCES; CEREBROSPINAL-FLUID; HEMORRHAGIC-SHOCK	In addition to a number of very compelling clinical observations, an extensive body of extremely supportive experimental data has generated a very persuasive argument that intravenous estrogen should be routinely administered, as soon as possible, to all persons identified as having a critical illness or injury. Although, to date, definitive gold-standard clinical trials are lacking, what has made this provocative argument even more convincing is the longstanding, documented safety of intravenous estrogen for various illnesses and conditions as well as the relative ease and inexpensive cost of treatment. As such, even routine prehospital administration becomes extremely feasible for a myriad of conditions. More importantly, the worldwide magnitude of potential patients who could benefit is profound. Even if estrogen only changes the outcome in a relatively small percentage of applicable cases, the potential impact may still be of dramatic proportions in terms of the absolute number of lives saved and the resources spared worldwide. Resources may be spared not only in terms of diminishing the economic impact of death and long-term disability, but also in terms of preventing extended intensive care unit stays and treatment of preventable complications that result in longer recovery. (Crit Care Med 2010; 38[Suppl.]: S620-S629)	[Pepe, Paul E.; Idris, Ahamed H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wigginton, Jane G.; Pepe, Paul E.; Idris, Ahamed H.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Pepe, Paul E.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Pepe, Paul E.] Univ Texas SW Med Ctr Dallas, Sch Publ Hlth, Dallas, TX 75390 USA; Parkland Hlth & Hosp Syst, Dallas, TX USA; [Wigginton, Jane G.; Pepe, Paul E.; Idris, Ahamed H.] Dallas Ft Worth Ctr Resuscitat Res, Dallas, TX USA		Pepe, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Paul.Pepe@UTSW.edu		Wigginton, Jane/0000-0002-8561-3492; Idris, Ahamed/0000-0001-7113-6499	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5 UL1 RR024982-04] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024982] Funding Source: NIH RePORTER		Allen DB, 2009, PEDIATRICS, V123, P1556, DOI 10.1542/peds.2008-2951; *AM HEART ASS, MISS LIF LIN ST EL M; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Angele Martin K., 2006, Clinics, V61, P479, DOI 10.1590/S1807-59322006000500017; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Cekic M, 2010, FUTUR NEUROL, V5, P37, DOI 10.2217/FNL.09.72; Chae SU, 2007, ARCH PHARM RES, V30, P1225, DOI 10.1007/BF02980263; Choudhry MA, 2007, INJURY, V38, P1382, DOI 10.1016/j.injury.2007.09.027; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Elhendy A, 1999, AM J CARDIOL, V84, P865, DOI 10.1016/S0002-9149(99)00456-7; Ely JW, 2006, J AM BOARD FAM MED, V19, P590, DOI 10.3122/jabfm.19.6.590; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Gan SC, 2000, NEW ENGL J MED, V343, P8, DOI 10.1056/NEJM200007063430102; Gannon CJ, 2002, J AM COLL SURGEONS, V195, P11, DOI 10.1016/S1072-7515(02)01187-0; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; GREGOR RD, 1994, CLIN INVEST MED, V17, P551; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hawk T, 1998, BRAIN RES, V796, P296, DOI 10.1016/S0006-8993(98)00327-8; Hsieh YC, 2007, AM J PHYSIOL-LUNG C, V292, pL1227, DOI 10.1152/ajplung.00479.2006; Hsu JT, 2008, AM J PHYSIOL-REG I, V294, pR1825, DOI 10.1152/ajpregu.00112.2008; Idris AH, 2005, CRIT CARE MED, V33, P2043, DOI 10.1097/01.CCM.0000174104.50799.BD; JARVIS J, 2009, FORT WORTH STAR 0709, pA1; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Lu AG, 2002, J CEREBR BLOOD F MET, V22, P183, DOI 10.1097/00004647-200202000-00006; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Meldrum DR, 2007, AM J PATHOL, V170, P1148, DOI 10.2353/ajpath.2007.070025; Merchant RM, 2009, CIRC-CARDIOVASC QUAL, V2, P421, DOI 10.1161/CIRCOUTCOMES.108.839605; Messingham KAN, 2001, J LEUKOCYTE BIOL, V70, P887; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; MURRAY CJC, 1996, GLOBAL BURDEN DIS IN, P373; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; *NAT HEART LUNG BL, 2008, WHAT HEART ATT; *NIH, 1998, NIH, P1; Nohria Anju, 1998, Cardiology Clinics, V16, P45, DOI 10.1016/S0733-8651(05)70383-0; Norman G, 2008, BRIT J CANCER, V98, P697, DOI 10.1038/sj.bjc.6604230; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oberholzer A, 2000, J TRAUMA, V48, P932, DOI 10.1097/00005373-200005000-00019; Ozveri ES, 2001, INFLAMM RES, V50, P585, DOI 10.1007/PL00000238; Palacios B, 1998, J CARDIOVASC PHARM, V31, P479, DOI 10.1097/00005344-199804000-00001; Pepe PE, 2009, CRIT CARE MED, V37, pS91, DOI 10.1097/CCM.0b013e318192154d; PEPE PE, 2003, EX SUMM NAT I NEUR D, pR5; Petitti DB, 1998, JAMA-J AM MED ASSOC, V280, P650, DOI 10.1001/jama.280.7.650; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROBERTS I, 1999, COCHRANE DB SYST REV; ROBERTS LJ, 1994, ANN NY ACAD SCI, V744, P237, DOI 10.1111/j.1749-6632.1994.tb52741.x; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roppolo LP, 2004, 2004 YB INTENSIVE CA, P139; SALAHUDEEN A, 1995, J AM SOC NEPHROL, V6, P1300; Sener G, 2005, J SURG RES, V128, P70, DOI 10.1016/j.jss.2005.02.019; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; SKELLY LM, 2009, EMORY ANNOUNCES PHAS; Sonke GS, 1996, BRIT MED J, V313, P853; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sribnick E.A., 2003, ANN NY ACAD SCI, V993, P159; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Suzuki T, 2008, CYTOKINE, V42, P32, DOI 10.1016/j.cyto.2008.02.002; Szalay L, 2005, AM J PHYSIOL-HEART C, V289, pH92, DOI 10.1152/ajpheart.01247.2004; Topjian AA, 2010, CRIT CARE MED, V38, P1254, DOI 10.1097/CCM.0b013e3181d8ca43; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wichmann MW, 1996, CYTOKINE, V8, P853, DOI 10.1006/cyto.1996.0114; Wigginton J, 2010, INFLAMM RES, V59, pS138; Wigginton J, 2009, CRIT CARE MED, V37, pA409; Wigginton J, 2009, CIRCULATION, V120, pS1441; Wigginton JG, 2002, CRIT CARE MED, V30, pS131, DOI 10.1097/00003246-200204001-00002; WIGGINTON JG, 2007, 2007 YB INTENSIVE CA, P880; WIGGINTON JG, 2006, ACAD EMERG MED S1, V13, P17; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Yang SH, 2002, J APPL PHYSIOL, V92, P195, DOI 10.1152/jappl.2002.92.1.195; Yu HP, 2006, AM J PHYSIOL-LUNG C, V290, pL1004, DOI 10.1152/ajplung.00504.2005; Yu HP, 2006, J MOL CELL CARDIOL, V40, P185, DOI 10.1016/j.yjmcc.2005.10.001; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; ZDENKO H, 1999, MOL CELL BIOL, V19, P5124; Zellweger Rene, 1995, Surgical Forum, V46, P65; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zuckerbraun BS, 2009, CRIT CARE MED, V37, P2471, DOI 10.1097/CCM.0b013e3181a9f62c	89	24	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2010	38			S			S620	S629		10.1097/CCM.0b013e3181f243a9			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	745EP	WOS:000289148900018	21164406				2022-02-06	
J	Zhang, GL; Yang, WZ; Jiang, YW; Zeng, T				Zhang Guo-liang; Yang Wei-zhong; Jiang Yan-wei; Zeng Tao			Extensive duraplasty with autologous graft in decompressive craniectomy and subsequent early cranioplasty for severe head trauma	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Activities of daily living; Brain injuries; Decompressive craniectomy		Objective: To compare the effect of extensive duraplasty and subsequent early cranioplasty on the recovery of neurological function in management of patients with severe traumatic brain injuries received decompressive craniectomy. Methods: The computer-aided designation of titanium armor plate was used as a substitute for the repair of skull defect in all the patients. The patients were divided into three groups. Twenty-three patients were in early cranioplasty group who received extensive duraplasty in craniectomy and subsequent cranioplasty within 3 months after previous operation (Group I). Twenty-one patients whose cranioplasty was performed more than 3 months after the first operation were in the group without duraplasty (Group II); while the other 26 patients in the group with duraplasty in previous craniotomy (Group III). Both the Barthel index of activity of daily living (ADL) 3 months after craniotomy for brain injuries and 1 month after cranioplasty and Karnofsky Performance Score (KPS) at least 6 months after cranioplasty were assessed respectively. Results: The occurrence of adverse events commonly seen in cranioplasty, such as incision healing disturbance, fluid collection below skin flap, infection and onset of postoperative epilepsy was not significantly higher than other 2 groups. The ADL scores at 3 months after craniotomy in Groups I-III were 58.9 +/- 26.7, 40.8 +/- 20.2 and 49.2 +/- 18.6. The ADL scores at 1 month after cranioplasty were 70.2 +/- 25.2, 50.8 +/- 24.8 and 61.2 +/- 21.5. The forward KPS scores were 75.4 +/- 19.0, 66.5 +/- 24.7 and 57.6 +/- 24.7 respectively. The ADL and KPS socres were significantly higher in group I than other 2 groups. Conclusion: The early cranioplasty in those with extensive duraplasty in previous craniotomy is feasible and helpful to improving ADL and long-term quality of life in patients with severe traumatic brain injuries.	[Zhang Guo-liang; Yang Wei-zhong; Jiang Yan-wei; Zeng Tao] Fujian Med Univ, Affiliated Union Hosp, Neurosurg Dept, Fuzhou 350001, Fujian, Peoples R China		Zeng, T (corresponding author), Fujian Med Univ, Affiliated Union Hosp, Neurosurg Dept, Fuzhou 350001, Fujian, Peoples R China.	ztbox73@163.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Liu MY, 2003, PRACTICAL CRANIOCERE, P403; Muramatsu H, 2007, INT J REHABIL RES, V30, P103, DOI 10.1097/MRR.0b013e32813a2e34; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Schimidek H., 2000, OPERATIVE NEUROSURGI, P29; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	14	24	25	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2010	13	5					259	264		10.3760/cma.j.issn.1008-1275.2010.05.001			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1AS	WOS:000441916900001	20880449				2022-02-06	
J	Iverson, GL				Iverson, Grant L.			Clinical and Methodological Challenges With Assessing Mild Traumatic Brain Injury in the Military	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; epidemiology; screening; surveillance	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION-SYNDROME; DISSOCIATIVE SYMPTOMS; FOOTBALL PLAYERS; CHRONIC PAIN; HEAD-INJURY; CONCUSSION; IRAQ; DEPRESSION; DEPLOYMENT	Background: A vast majority of traumatic brain injuries sustained by military personnel are mild in severity. In 2008, the United States Department of Defense officially mandated a screening program designed to identify deployment-related mild traumatic brain injuries and associated residual symptoms. Objective: This article reviews this screening program, illustrates the clinical and methodological challenges associated with screening, and makes recommendations for improving the process of screening for mild traumatic brain injuries and related symptoms.	[Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			*ARM FORC HLTH SUR, 2008, MED SURVEILL MON REP, V10, P2; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Birmes P, 2003, AM J PSYCHIAT, V160, P1337, DOI 10.1176/appi.ajp.160.7.1337; CARDENA E, 1993, AM J PSYCHIAT, V150, P474; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; *DEF VET BRAIN INJ, TBI NUMB; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; FREINKEL A, 1994, AM J PSYCHIAT, V151, P1335; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harvey AG, 1999, J TRAUMA STRESS, V12, P673, DOI 10.1023/A:1024773202939; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MADAKASIRA S, 1987, J NERV MENT DIS, V175, P286, DOI 10.1097/00005053-198705000-00008; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mental Health Advisory Team (MHAT-V), OP IR FREED 06 08 IR; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Morgan CA, 2001, AM J PSYCHIAT, V158, P1239, DOI 10.1176/appi.ajp.158.8.1239; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	43	24	24	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					313	319		10.1097/HTR.0b013e3181d6f9bd			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400003	20220528				2022-02-06	
J	Melo, JRT; Di Rocco, F; Blanot, S; Laurent-Vannier, A; Reis, RC; Baugnon, T; Sainte-Rose, C; Olveira, J; Zerah, M; Meyer, P				Melo, Jose Roberto Tude; Di Rocco, Federico; Blanot, Stephane; Laurent-Vannier, Anne; Reis, Rodolfo Casimiro; Baugnon, Thomas; Sainte-Rose, Christian; Olveira-Filho, Jamary; Zerah, Michel; Meyer, Philippe			Acute hyperglycemia is a reliable outcome predictor in children with severe traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Pediatric; Head injury; Hyperglycemia; Prognosis; Outcome	SEVERE HEAD-INJURY; INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; PROGNOSTIC FACTORS; EPIDEMIOLOGY; METABOLISM; EXPERIENCE; MANAGEMENT; MORTALITY; IMPACT	Hyperglycemia in the acute phase after trauma could adversely affect outcome in children with severe traumatic brain injury (TBI). The goal of this study was to identify the relationship between acute spontaneous hyperglycemia and outcome in children with severe TBI at hospital discharge and 6 months later. A retrospective analysis of blood glucose levels in children with severe TBI at a Pediatric level I Trauma Center, between January 2000 and December 2005. Hyperglycemia was considered for a cut-off value of 11.1 mmol/l (200 mg/dl). Outcome was measured with Glasgow Outcome Scale (GOS) at hospital discharge and at 6 months. A multiple logistic regression analysis, the Student's t test and the chi (2) test were done. Hyperglycemia was noted within the first 48 h in 34% of the patients. Mortality (70% vs 14%, p < 10(-5)) was more frequent in hyperglycemic children and bad outcome upon hospital discharge in those who remained hyperglycemic during the first 48 h of hospitalization. GOS after 6 months demonstrated that those normoglycemic children had a better outcome (95%) than those who developed hyperglycemia during the first 48 h (83%, p = 0.01) after trauma. Hyperglycemia could be considered as a marker of brain injury and when present upon admission, could reflect extensive brain damage with frequently associated mortality and bad outcome. The inability to maintain normal blood glucose levels during the first 48 h could be a predictive factor of bad outcome. Avoiding hyperglycemia in the initial phase could be a major issue in children with severe TBI.	[Melo, Jose Roberto Tude; Reis, Rodolfo Casimiro; Olveira-Filho, Jamary] Univ Fed Bahia, Sch Med, Postgrad Program Med & Hlth, BR-40296200 Salvador, BA, Brazil; [Melo, Jose Roberto Tude; Di Rocco, Federico; Sainte-Rose, Christian; Zerah, Michel] Univ Descartes Paris 5, Hop Necker Enfants Malad, AP HP, Dept Pediat Neurosurg, Paris, France; [Blanot, Stephane; Baugnon, Thomas; Meyer, Philippe] Univ Descartes Paris 5, Hop Necker Enfants Malad, AP HP, Pediat Surg Crit Care Unit, Paris, France; [Laurent-Vannier, Anne] Hop Natl Rehabil St Maurice, St Maurice, France		Melo, JRT (corresponding author), Univ Fed Bahia, Sch Med, Postgrad Program Med & Hlth, Alameda Jasmins 200 702 B Cidade Jardim, BR-40296200 Salvador, BA, Brazil.	robertotude@gmail.com	DI ROCCO, Federico/C-6343-2015; ZERAH, Michel/E-6473-2012; Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Di Rocco, Federico/0000-0003-2145-5533	CAPES Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	The authors acknowledge Mrs. Adeline Noiriat, secretary of the Department of Pediatric Neurosurgery-Hopital Necker-Enfants Malades.; CAPES Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Exchange Program for PhD studies, is a source of support.; This study is supported in part by a grant from Direction Regionale de la Recherche Clinique Assistance Publique Hopitaux de Paris PHRC 2003 No. AOM 03018.	Alexandrou G, 2010, PEDIATRICS, V125, pE584, DOI 10.1542/peds.2009-0449; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Bardella IJ, 1999, AM FAM PHYSICIAN, V60, P1743; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bochicchio GV, 2007, J TRAUMA, V63, P1353, DOI 10.1097/TA.0b013e31815b83c4; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Danzl D, 2002, SEMIN RESP CRIT CARE, V23, P57, DOI 10.1055/s-2002-20589; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; DURR JA, 1992, DIABETES, V41, P627, DOI 10.2337/diabetes.41.5.627; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; GAILLARD M, 1989, ANN PEDIATR-PARIS, V36, P194; Grinkeviciute DE, 2007, MEDICINA-LITHUANIA, V43, P861, DOI 10.3390/medicina43110111; Hirsch IB, 2002, J CLIN ENDOCR METAB, V87, P975, DOI 10.1210/jc.87.3.975; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; KUSHNER M, 1990, ANN NEUROL, V28, P129, DOI 10.1002/ana.410280204; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pierrot M, 2003, ANN FR ANESTH, V22, P12, DOI 10.1016/S0750-7658(02)00003-5; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Tentillier E, 2004, ANN FR ANESTH, V23, P109, DOI 10.1016/j.annfar.2003.11.019; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vinchon M, 2003, PEDIATR NEUROSURG, V39, P122, DOI 10.1159/000071648; [No title captured]	33	24	27	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	SEP	2010	152	9					1559	1565		10.1007/s00701-010-0680-z			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	642UO	WOS:000281246500017	20461419				2022-02-06	
J	Guerrero, AF; Alfonso, A				Guerrero, Arthur F.; Alfonso, Abel			Traumatic Brain Injury-Related Hypopituitarism: A Review and Recommendations for Screening Combat Veterans	MILITARY MEDICINE			English	Article							ANTERIOR-PITUITARY FUNCTION; DIABETES-INSIPIDUS; STALK RUPTURE; ACUTE-PHASE; DYSFUNCTION; INSUFFICIENCY; CHILD	Recent civilian data obtained in those sustaining head injuries, has found a high prevalence of pituitary dysfunction. Currently, there is no data available in the military population. We reviewed the literature for traumatic brain injury (TBI)-related hypopituitarism and found that the prevalence of anterior hypopituitarism may be as high as 30-80% after 24-36 months. Since many of the symptoms of hypopituitarism are similar to those of TBI, it is important to make clinicians caring for combat veterans aware of its occurrence. Herein, we provide an overview of the literature and recommendations for hormonal testing when TBI-related hypopituitarism is suspected.	[Guerrero, Arthur F.; Alfonso, Abel] Walter Reed Army Med Ctr, Dept Internal Med, Endocrinol Diabet & Metab Serv, Washington, DC 20307 USA		Guerrero, AF (corresponding author), Walter Reed Army Med Ctr, Dept Internal Med, Endocrinol Diabet & Metab Serv, 6900 Georgia Ave NW, Washington, DC 20307 USA.						Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dusick J. R., 2008, PITUITARY; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; GIRARD J, 1977, J PEDIATR-US, V90, P241, DOI 10.1016/S0022-3476(77)80637-9; HALIMI P, 1988, J COMPUT ASSIST TOMO, V12, P135, DOI 10.1097/00004728-198801000-00026; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; MASSOL J, 1987, NEURORADIOLOGY, V29, P299, DOI 10.1007/BF00451773; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; MILLER WL, 1980, NEW ENGL J MED, V302, P724, DOI 10.1056/NEJM198003273021305; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	31	24	24	0	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	AUG	2010	175	8					574	580		10.7205/MILMED-D-09-00189			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VB	WOS:000280456000008	20731261				2022-02-06	
J	Levine, RL; Hergenroeder, GW; Francis, JL; Miller, CC; Hursting, MJ				Levine, Robert L.; Hergenroeder, Georgene W.; Francis, John L.; Miller, Charles C.; Hursting, Marcie J.			Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study	JOURNAL OF THROMBOSIS AND THROMBOLYSIS			English	Article						Heparin; Platelet factor 4; Antibody; Prevalence; Heparin-induced thrombocytopenia	CRITICALLY-ILL PATIENTS; INDUCED THROMBOCYTOPENIA; THROMBOSIS; RISK; ASSOCIATION; POPULATION; PREVALENCE; FREQUENCY; ARTERIAL	Heparin-platelet factor 4 (PF4) antibodies mediate heparin-induced thrombocytopenia (HIT) and, irrespective of thrombocytopenia, are associated with poorer outcomes in some patients. The prevalence of heparin-PF4 antibodies, including platelet-activating ones, in patients in the medical, neurotrauma, or shock-trauma intensive care unit (ICU) remains unclear. In this single-center, observational study, heparin-PF4 antibodies (IgG/A/M) were measured by ELISA in 185 adults (median APACHE II score, 16) admitted to the medical (n = 27), neurotrauma (n = 96), or shock-trauma (n = 62) ICU and after 7 +/- A 2 days. Seropositive patients and heparin-treated patients with unexplained, new-onset thrombocytopenia were also tested for platelet-activating antibodies using a serotonin release assay (SRA). Of 185 patients, seropositivity occurred in 20 patients (10.8%; 95% CI 6.7-16.2%) at admission and 54 (29.2%, 95% CI 22.8-36.3%) after 7 days (P < 0.001). Platelet-activating antibodies occurred in 4 seropositive patients at admission and 9 seropositive patients after 7 days (including in 1 patient at each assessment), each without thrombocytopenia or new thrombosis. Of 12 seropositive patients with platelet-activating antibodies, 6 had an ELISA optical density (OD) > 1.0. ELISA-positive, SRA-negative, suspected HIT occurred in 1 patient. Heparin-PF4 antibodies are present in 10.8% of medical, neurotrauma, or shock-trauma ICU patients at admission and increase significantly to 29.2% within 7 days. Approximately 17-20% of seropositive ICU patients, often those with an ELISA OD > 1.0, have platelet-activating heparin-PF4 antibodies.	[Hursting, Marcie J.] Clin Sci Consulting, Austin, TX 78746 USA; [Hergenroeder, Georgene W.] Univ Texas Med Sch Houston, Dept Neurosurg, Houston, TX USA; [Levine, Robert L.] Methodist Hosp, Houston, TX 77030 USA; [Francis, John L.] Florida Hosp Inst Translat Res, Orlando, FL USA		Hursting, MJ (corresponding author), Clin Sci Consulting, 3001 Loveland Cove, Austin, TX 78746 USA.	mhursting@sprintmail.com		Hergenroeder, Georgene/0000-0002-6170-2191	GlaxoSmithKlineGlaxoSmithKline	This study was supported by a grant from GlaxoSmithKline. Dr. Levine and Dr. Francis have received grant support and consultancy fees from GlaxoSmithKline. Dr. Hursting has received consultancy fees from GlaxoSmithKline. Ms. Hergenroeder and Dr. Miller have no conflicts of interest related to this study.	Arepally GM, 2008, J THROMB THROMBOLYS, V26, P55, DOI 10.1007/s11239-008-0217-y; Bennett-Guerrero E, 2005, J THORAC CARDIOV SUR, V130, P1567, DOI 10.1016/j.jtcvs.2005.07.052; Calaitges JG, 1999, J VASC SURG, V29, P779, DOI 10.1016/S0741-5214(99)70203-X; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; Dattalo P., 2008, DETERMINING SAMPLE S; de la Vega LP, 2005, MAYO CLIN PROC, V80, P995, DOI 10.4065/80.8.995; Everett BM, 2007, ANN THORAC SURG, V83, P592, DOI 10.1016/j.athoracsur.2006.09.040; Francis JL, 2004, SEMIN THROMB HEMOST, V30, P359, DOI 10.1055/s-2004-831049; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gettings EM, 2006, CRIT CARE, V10, DOI 10.1186/cc5100; Greinacher A, 2005, BLOOD, V106, P2921, DOI 10.1182/blood-2005-05-1824; Hirsh J, 2004, ARCH INTERN MED, V164, P361, DOI 10.1001/archinte.164.4.361; Hourigan LA, 2002, J HEART LUNG TRANSPL, V21, P1283, DOI 10.1016/S1053-2498(02)00458-8; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Keeling D, 2006, BRIT J HAEMATOL, V133, P259, DOI 10.1111/j.1365-2141.2006.06018.x; Kress DC, 2007, ANN THORAC SURG, V83, P1737, DOI 10.1016/j.athoracsur.2006.12.011; Levy JH, 2007, HEMATOL ONCOL CLIN N, V21, P65, DOI 10.1016/j.hoc.2006.11.003; Lo GK, 2007, AM J HEMATOL, V82, P1037, DOI 10.1002/ajh.21032; Mascelli MA, 2005, J THROMB THROMBOLYS, V18, P171, DOI 10.1007/s11239-005-0342-9; Mattioli A V, 2000, Ital Heart J, V1, P39; Mullen MP, 2008, ANESTH ANALG, V107, P371, DOI 10.1213/ane.0b013e3181734604; Napolitano LM, 2006, CRIT CARE MED, V34, P2898, DOI 10.1097/01.CCM.0000248723.18068.90; Risch L, 2003, BLOOD COAGUL FIBRIN, V14, P113, DOI 10.1097/00001721-200301000-00020; Schmugge M, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e10; Scott JR, 2007, J BURN CARE RES, V28, P71, DOI 10.1097/BCR.0b013E31802C8929; Selleng K, 2007, CRIT CARE MED, V35, P1165, DOI 10.1097/01.CCM.0000259538.02375.A5; Shalansky SJ, 2002, PHARMACOTHERAPY, V22, P803, DOI 10.1592/phco.22.11.803.33634; Verma AK, 2003, PHARMACOTHERAPY, V23, P745, DOI 10.1592/phco.23.6.745.32188; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Warkentin TE, 2008, AM J MED, V121, P632, DOI 10.1016/j.amjmed.2008.03.012; Williams RT, 2003, CIRCULATION, V107, P2307, DOI 10.1161/01.CIR.0000066696.57519.AF; Zwicker JI, 2004, J THROMB HAEMOST, V2, P2133, DOI 10.1111/j.1538-7836.2004.01039.x	33	24	27	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5305	1573-742X		J THROMB THROMBOLYS	J. Thromb. Thrombolysis	AUG	2010	30	2					142	148		10.1007/s11239-009-0425-0			7	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Hematology	630GZ	WOS:000280262500004	19911252				2022-02-06	
J	Rienstra, A; Spaan, PEJ; Schmand, B				Rienstra, A.; Spaan, P. E. J.; Schmand, B.			Validation of Symptom Validity Tests Using a "Child-model" of Adult Cognitive Impairments	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						symptom validity testing; validity; Amsterdam Short-Term Memory test; Word Memory Test; Test of Memory Malingering; Word Completion Memory Test	WORD MEMORY TEST; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TESTS; RECOGNITION MEMORY; MALINGERING TOMM; TEST-PERFORMANCE; CLAIMANTS; FAMILIAR; SAMPLE; SPAN	Validation studies of symptom validity tests (SVTs) in children are uncommon. However, since children's cognitive abilities are not yet fully developed, their performance may provide additional support for the validity of these measures in adult populations. Four SVTs, the Test of Memory Malingering (TOMM), the Word Memory Test (WMT), the Amsterdam Short-Term Memory (ASTM) test, and the Word Completion Memory Test (WCMT), along with several neuropsychological instruments were administered to 48 Dutch school children aged 7-12. All children scored above the established adult cut-offs on the TOMM and the WMT. They could pass the ASTM test if their reading skills were at a level equivalent to that of 9 year olds. All children passed our criterion of a negative WCMT score. However, the WCMT does seem sensitive to the level of verbal fluency. Implications for the applicability of these SVTs in adult populations are discussed.	[Rienstra, A.; Schmand, B.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Rienstra, A.; Spaan, P. E. J.; Schmand, B.] Univ Amsterdam, Dept Psychon, Amsterdam, Netherlands		Rienstra, A (corresponding author), Acad Med Ctr, Dept Neurol H2 222, POB 22660, NL-1100 DD Amsterdam, Netherlands.	a.rienstra@amc.uva.nl		Spaan, Pauline/0000-0001-5858-2419	Psychology Research Institute University of Amsterdam	This work was supported by Psychology Research Institute University of Amsterdam.	ALLEN LM, 1999, 1999 COMPUTERIZED AS; Anglin J. M., 1993, MONOGR SOC RES CHILD, V58, pi, DOI [10.2307/1166112, DOI 10.2307/1166112]; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Benton A., 1976, MULTILINGUAL APHASIA; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Brandt KR, 2005, APPL COGNITIVE PSYCH, V19, P1113, DOI 10.1002/acp.1163; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CERCY SP, 1997, CLIN ASSESSMENT MALI; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Flaro L, 2000, ARCH CLIN NEUROPSYCH, V15, P840, DOI 10.1016/S0887-6177(00)80344-3; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Hall H. V., 1996, DETECTING MALINGERIN, P3; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Hilsabeck R. C., 1997, WORD COMPLETION MEMO; Hilsabeck RC, 2001, ARCH CLIN NEUROPSYCH, V16, P669, DOI 10.1016/S0887-6177(00)00077-9; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; KOHNSTAMM GA, 1981, NIEUWE STREEFLIJST W; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; PHAF RH, 1991, SPONTANEOUS COMPLETI; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reitan RM, 1992, TRAIL MAKING TEST MA; Rienstra A, 2009, ARCH CLIN NEUROPSYCH, V24, P255, DOI 10.1093/arclin/acp035; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B., 2004, AMSTERDAM SHORT TERM; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Rijn, 1995, CELEX LEXICAL DATABA; Verhoeven L, 1995, DRIE MINUTEN TOETS H; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weinborn M, 2003, J CLIN EXP NEUROPSYC, V25, P979, DOI 10.1076/jcen.25.7.979.16481; [No title captured]	59	24	26	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2010	25	5					371	382		10.1093/arclin/acq035			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	627BN	WOS:000280013100003	20484327	Bronze			2022-02-06	
J	Zeng, LH; McDaniel, S; Rensing, NR; Wong, M				Zeng, Ling-Hui; McDaniel, Sharon; Rensing, Nicholas R.; Wong, Michael			Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR) A double-edged sword?	CELL CYCLE			English	Article						kainate; apoptosis; epilepsy; seizure; rat	TUBEROUS SCLEROSIS COMPLEX; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAY; ANTIEPILEPTIC DRUGS; MOUSE MODEL; KINASE; INHIBITION; GROWTH; HYPERTROPHY	Identification of cell signaling mechanisms mediating seizure-related neuronal death and epileptogenesis is important for developing more effective therapies for epilepsy. The mammalian target of rapamycin (mTOR) pathway has recently been implicated in regulating neuronal death and epileptogenesis in rodent models of epilepsy. In particular, kainate-induced status epilepticus causes abnormal activation of the mTOR pathway, and the mTOR inhibitor, rapamycin, can decrease the development of neuronal death and chronic seizures in the kainate model. Here, we discuss the significance of these findings and extend them further by identifying upstream signaling pathways through which kainate status epilepticus activates the mTOR pathway and by demonstrating limited situations where rapamycin may paradoxically increase mTOR activation and worsen neuronal death in the kainate model. Thus, the regulation of seizure-induced neuronal death and epileptogenesis by mTOR is complex and may have dual, opposing effects depending on the physiological and pathological context. Overall, these findings have important implications for designing potential neuroprotective and antiepileptogenic therapies that modulate the mTOR pathway.	[McDaniel, Sharon; Rensing, Nicholas R.; Wong, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [McDaniel, Sharon; Rensing, Nicholas R.; Wong, Michael] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Zeng, Ling-Hui] Zhejiang Univ City Coll, Dept Pharm, Hangzhou 310027, Zhejiang, Peoples R China		Wong, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K02 NS045583, R01 NS056872]; Tuberous Sclerosis Alliance, and Citizens United for Research in Epilepsy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056872, K02NS045583] Funding Source: NIH RePORTER	Work from the authors has been supported by the National Institutes of Health (K02 NS045583, R01 NS056872), the Tuberous Sclerosis Alliance, and Citizens United for Research in Epilepsy.	Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj.cdd.4400978; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Daniel C, 2004, LAB INVEST, V84, P588, DOI 10.1038/labinvest.3700078; Dichter MA, 2006, EPILEPSY RES, V68, P31, DOI 10.1016/j.eplepsyres.2005.09.014; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kawamata S, 1998, BLOOD, V91, P561, DOI 10.1182/blood.V91.2.561.561_561_569; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Loscher W, 2006, EPILEPSY RES, V69, P183, DOI 10.1016/j.eplepsyres.2006.03.014; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Sandsmark DK, 2007, HISTOL HISTOPATHOL, V22, P895, DOI 10.14670/HH-22.895; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Stefan H, 2006, ACTA NEUROL SCAND, V113, P139, DOI 10.1111/j.1600-0404.2005.00561.x; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhu D, 2002, AMINO ACIDS, V23, P11, DOI 10.1007/s00726-001-0103-9	32	24	26	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	JUN 15	2010	9	12					2281	2285		10.4161/cc.9.12.11866			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	615QC	WOS:000279149000015	20603607	Green Published, Green Accepted, Bronze			2022-02-06	
J	Baldo, S; Tacconi, L				Baldo, Sara; Tacconi, Leonello			Effectiveness and Safety of Subcutaneous Abdominal Preservation of Autologous Bone Flap after Decompressive Craniectomy: A Prospective Pilot Study	WORLD NEUROSURGERY			English	Article						Autologous bone flap; Decompressive craniectomy; Subcutaneous abdominal preservation	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL-ARTERY INFARCTION; HEAD-INJURIES; MULTICENTER; HEMICRANIECTOMY; CRANIOPLASTY; SURGERY; TRIAL; LIFE	BACKGROUND: The aim was to assess the effectiveness and safety of reconstructing a cranial bone defect after decompressive craniectomy using an autologous bone flap banked in a subcutaneous pocket in the patient's abdominal wall. METHODS: A prospective pilot study was performed on 12 of 15 consecutive patients who had undergone decompressive craniotomy and subsequent autologous bone flap replacement. The bone flap had been stored in the abdominal wall for an average period of 40 days. To assess the safety of this method, we evaluated the infections rate and the need for a surgical revision. Efficacy was evaluated under different points of view: 1) clinical standpoint, as the cosmetic reconstructive result at 6 months after the replacement; 2) imaging point of view, as the extent of residual bony gap detectable on a three-dimensional computed tomography scan as well as the extent of the bone flap revascularization, detected with a three-phase technetium bone scan. All the bone flaps were evaluated to assess their viability by histological investigations. RESULTS: There was no bone flap infection. The only significant complication encountered in two cases was the formation of a collection under the bone flap, which required its removal. CONCLUSIONS: This preliminary and limited experience has led us to believe that the subcutaneous preservation of autologous bone flap is feasible. This method may be a very inexpensive option that preserves the viability of the bone flap, which can be ultimately responsible for the good cosmetic results and the very low infection rate.	[Baldo, Sara; Tacconi, Leonello] Osped Riuniti, Azienda Osped Univ, Dept Neurosurg, Trieste, Italy		Baldo, S (corresponding author), Osped Riuniti, Azienda Osped Univ, Dept Neurosurg, Trieste, Italy.	sara.baldo@aots.sanita.fvg.it		tacconi, leonello/0000-0003-3915-5635			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; CHANG V, 2009, J NEUROSURG, V17, P1; Colohan Austin R T, 2005, Clin Neurosurg, V52, P19; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Marion DW, 2006, NEUROSURGERY, V58, P655; Meier U, 2005, ACT NEUR S, V95, P55; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Unterberg A, 2007, CURR OPIN CRIT CARE, V13, P175; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	24	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2010	73	5					552	556		10.1016/j.wneu.2010.02.018			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	792UL	WOS:000292775800034	20920941				2022-02-06	
J	Elliott, JT; Diop, M; Tichauer, KM; Lee, TY; St Lawrence, K				Elliott, Jonathan T.; Diop, Mamadou; Tichauer, Kenneth M.; Lee, Ting-Yim; St. Lawrence, Keith			Quantitative measurement of cerebral blood flow in a juvenile porcine model by depth-resolved near-infrared spectroscopy	JOURNAL OF BIOMEDICAL OPTICS			English	Article						near-infrared spectroscopy; traumatic brain injury; cerebral blood flow; indocyanine green; depth resolved; Monte Carlo	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; INDOCYANINE GREEN; TECHNICAL IMPLEMENTATIONS; OPTICAL SPECTROSCOPY; ABSORPTION CHANGES; NEWBORN PIGLETS; THEORETIC BASIS; CT PERFUSION; HUMAN HEAD	Nearly half a million children and young adults are affected by traumatic brain injury each year in the United States. Although adequate cerebral blood flow (CBF) is essential to recovery, complications that disrupt blood flow to the brain and exacerbate neurological injury often go undetected because no adequate bedside measure of CBF exists. In this study we validate a depth-resolved, near-infrared spectroscopy (NIRS) technique that provides quantitative CBF measurement despite significant signal contamination from skull and scalp tissue. The respiration rates of eight anesthetized pigs (weight: 16.2 +/- 0.5 kg, age: 1 to 2 months old) are modulated to achieve a range of CBF levels. Concomitant CBF measurements are performed with NIRS and CT perfusion. A significant correlation between CBF measurements from the two techniques is demonstrated (r(2)=0.714, slope=0.92, p<0.001), and the bias between the two techniques is -2.83 mL . min(-1) . 100 g(-1) (Cl(0.95): -19.63 mL . min(-1) . 100 g(-1) -13.9 mL . min(-1) . 100 g(-1)). This study demonstrates that accurate measurements of CBF can be achieved with depth-resolved NIRS despite significant signal contamination from scalp and skull. The ability to measure CBF at the bedside provides a means of detecting, and thereby preventing, secondary ischemia during neurointensive care. (C) 2010 Society of Photo-Optical Instrumentation Engineers. [DOI:10.1117/1.3449579]	[Elliott, Jonathan T.; Diop, Mamadou; Tichauer, Kenneth M.; Lee, Ting-Yim; St. Lawrence, Keith] Lawson Hlth Res Inst, Imaging Program, London, ON N6A 4V2, Canada; [Elliott, Jonathan T.; Diop, Mamadou; Lee, Ting-Yim; St. Lawrence, Keith] Univ Western Ontario, Dept Med Biophys, London, ON N6A 3K7, Canada; [Lee, Ting-Yim] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5K8, Canada		Elliott, JT (corresponding author), Lawson Hlth Res Inst, Imaging Program, 268 Grosvenor St, London, ON N6A 4V2, Canada.	jelliott@lawsonimaging.ca	Lee, Ting-Yim/M-1721-2013; Diop, Mamadou/B-6487-2015; St. Lawrence, Keith/B-5726-2015	St Lawrence, Keith/0000-0001-8022-8205; Tichauer, Kenneth/0000-0003-1667-3026	Lawson Health Research Institute; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	This study was supported through grants from the Lawson Health Research Institute and the Heart and Stroke Foundation of Canada. This work was made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET, see http://www.sharcnet.ca) and Compute/Calcul Canada. The authors would also like to thank Jennifer Hadway and Lise Desjardins for their help in conducting the animal experiments, and Chris d'Esterre for his assistance in the CT perfusion measurements.	Brown DW, 2002, PEDIATR RES, V51, P564, DOI 10.1203/00006450-200205000-00004; Cenic A, 1999, AM J NEURORADIOL, V20, P63; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; COPE M, 1991, THESIS U COLL LONDON, P290; Diop M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3123347; Fabbri F, 2004, PHYS MED BIOL, V49, P1183, DOI 10.1088/0031-9155/49/7/007; Gora F, 2002, J NEUROSURG ANESTH, V14, P218, DOI 10.1097/00008506-200207000-00008; HIRAOKA M, 1993, PHYS MED BIOL, V38, P1859, DOI 10.1088/0031-9155/38/12/011; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Kohl-Bareis M, 2002, J BIOMED OPT, V7, P464, DOI 10.1117/1.1482719; Kohno S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2814249; Konstas AA, 2009, AM J NEURORADIOL, V30, P885, DOI 10.3174/ajnr.A1492; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Leung TS, 2007, APPL OPTICS, V46, P1604, DOI 10.1364/AO.46.001604; Liebert A, 2006, NEUROIMAGE, V31, P600, DOI 10.1016/j.neuroimage.2005.12.046; Liebert A, 2005, NEUROIMAGE, V24, P426, DOI 10.1016/j.neuroimage.2004.08.046; Liebert A, 2004, APPL OPTICS, V43, P3037, DOI 10.1364/AO.43.003037; MATCHER SJ, 1994, PHYS MED BIOL, V39, P177, DOI 10.1088/0031-9155/39/1/011; MCCORMICK PW, 1991, CRIT CARE MED, V19, P89, DOI 10.1097/00003246-199101000-00020; Muehlschlegel S, 2006, J CARDIOTHOR VASC AN, V20, P613, DOI 10.1053/j.jvca.2006.05.015; OwenReece H, 1996, BRIT J ANAESTH, V76, P43, DOI 10.1093/bja/76.1.43; Patel J, 1998, PEDIATR RES, V43, P34, DOI 10.1203/00006450-199801000-00006; Rothoerl RD, 2003, NEUROL RES, V25, P528, DOI 10.1179/016164103101201779; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Schytz HW, 2009, EUR J NEUROL, V16, P461, DOI 10.1111/j.1468-1331.2008.02398.x; Singhi SC, 2009, INDIAN J PEDIATR, V76, P519, DOI 10.1007/s12098-009-0137-7; Springett R, 2001, PHYS MED BIOL, V46, P2209, DOI 10.1088/0031-9155/46/8/312; Steinbrink J, 2001, PHYS MED BIOL, V46, P879, DOI 10.1088/0031-9155/46/3/320; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Strangman G, 2003, NEUROIMAGE, V18, P865, DOI 10.1016/S1053-8119(03)00021-1; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P315, DOI 10.1007/978-0-387-85998-9_47; Themelis G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710250; Tichauer KM, 2006, J CEREBR BLOOD F MET, V26, P722, DOI 10.1038/sj.jcbfm.9600230; VANDERZEE P, 1992, ADV EXP MED BIOL, V316, P143; Wang R. S., 1995, J MATH SCI-U TOKYO, V2, P131; Wright TM, 2007, J ADDICT MED, V1, P15, DOI 10.1097/ADM.0b013e318044ce4f; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048	40	24	24	0	1	SPIE-SOC PHOTOPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668			J BIOMED OPT	J. Biomed. Opt.	MAY-JUN	2010	15	3							037014	10.1117/1.3449579			9	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	635GF	WOS:000280642900056	20615043	Bronze			2022-02-06	
J	Nicasio, AM; Eagye, KJ; Kuti, EL; Nicolau, DP; Kuti, JL				Nicasio, Anthony M.; Eagye, Kathryn J.; Kuti, Effie L.; Nicolau, David P.; Kuti, Joseph L.			Length of Stay and Hospital Costs Associated with a Pharmacodynamic-Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator-Associated Pneumonia	PHARMACOTHERAPY			English	Article						ventilator-associated pneumonia; VAP; clinical pathway; cost analysis; antibiotics	ACQUIRED PNEUMONIA; RESOURCE UTILIZATION; GUIDELINES; THERAPY; IMPACT; OUTCOMES; ADULTS; ICU	Study Objective. To determine hospital costs associated with the use of a clinical pathway implemented in our intensive care units (ICUs) to optimize antibiotic regimen selection for patients with ventilator-associated pneumonia (VAP) compared with costs in a historical control group treated according to prescriber preference. Design. Retrospective cost analysis from the hospital perspective. Setting. Single, tertiary-care medical center. Patients. One hundred sixty-six adults with VAP from the medical, surgical, and neurotrauma ICUs (73 historical control patients [2004-2005] and 93 patients given an empiric antibiotic clinical pathway for VAP [2006-2007]). Measurements and Main Results. The VAN clinical pathway consisted of an ICU-specific three-drug regimen that considered local minimum inhibitory concentration distributions and a pharmacodynamically optimized dosing strategy Hospital cost data were collected and inflated to 2007 according to the consumer price index. The VAP-related length of treatment, hospitalization costs, and antibiotic costs were compared between groups. The median VAP length of treatment was 24 days (interquartile range [IQR] 13-35 days] and 111 days (IQR 7-17 days) for historical and clinical pathway groups, respectively (p<0.001). Daily hospital costs were similar for both cohorts over the first 7 clays, after which costs declined significantly for patients treated with the clinical pathway (p<0.001). When controlling for baseline differences between groups and length of stay before development of VAP, patients treated with the clinical pathway had shorter lengths of ICU stay after VAP, shorter total hospital lengths of stay after VAP, and lower hospital costs after the treatment of VAP. Median total antibiotic costs for individual patients were similar between groups ($535 [1QR $261-998] vs $482 [IQR $222-985] clinical pathway vs control, p=0.45), and the proportion of VAP hospital resources consumed by antibiotics for both groups was low Conclusion. Although aggressive closing of more costly antibiotics was empirically prescribed using the clinical pathway, patients in this group exhibited a shorter duration of treatment, reduced hospital length of stay after VAP, and lower hospital costs without any significant increase in antibiotic expenditures.	[Nicasio, Anthony M.; Eagye, Kathryn J.; Nicolau, David P.; Kuti, Joseph L.] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT 06102 USA; [Nicolau, David P.] Hartford Hosp, Dept Med, Div Infect Dis, Hartford, CT 06102 USA; [Kuti, Effie L.] Univ Connecticut, Sch Pharm, Storrs, CT USA		Kuti, JL (corresponding author), Hartford Hosp, Ctr Antiinfect Res & Dev, 80 Seymour St, Hartford, CT 06102 USA.	jkuti@harthosp.org					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Eagye KJ, 2009, SEMIN RESP CRIT CARE, V30, P116, DOI 10.1055/s-0028-1119815; Hoffman JM, 2007, AM J HEALTH-SYST PH, V64, P298, DOI 10.2146/ajhp060545; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Ibrahim EH, 2001, CRIT CARE MED, V29, P1109, DOI 10.1097/00003246-200106000-00003; Kollef KE, 2008, CHEST, V134, P281, DOI 10.1378/chest.08-1116; Kuti JL, 2009, SEMIN RESP CRIT CARE, V30, P102, DOI 10.1055/s-0028-1119814; Lancaster JW, 2008, PHARMACOTHERAPY, V28, P852, DOI 10.1592/phco.28.7.852; McKinnon PS, 1997, CLIN INFECT DIS, V24, P57, DOI 10.1093/clinids/24.1.57; Meyer E, 2007, J ANTIMICROB CHEMOTH, V59, P1148, DOI 10.1093/jac/dkm088; Nicasio AM, 2010, J CRIT CARE, V25, P69, DOI 10.1016/j.jcrc.2009.02.014; Nicolau D. P., 1994, Journal of Burn Care and Rehabilitation, V15, P244, DOI 10.1097/00004630-199405000-00008; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shorr AF, 2008, CRIT CARE MED, V36, P2335, DOI 10.1097/CCM.0b013e31818103ea; Sun HK, 2006, CHEST, V130, P807, DOI 10.1378/chest.130.3.807; Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06	21	24	25	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	MAY	2010	30	5					453	462		10.1592/phco.30.5.453			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	588XD	WOS:000277107000005	20411997				2022-02-06	
J	Gao, GY; Oda, Y; Wei, EP; Povlishock, JT				Gao, Guoyi; Oda, Yasutaka; Wei, Enoch P.; Povlishock, John T.			The adverse pial arteriolar and axonal consequences of traumatic brain injury complicated by hypoxia and their therapeutic modulation with hypothermia in rat	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain arterioles; DAI rat; hypothermia; hypoxia; traumatic brain injury	TO-MODERATE HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; MILD HYPOTHERMIA; CEREBRAL MICROCIRCULATION; SECONDARY INSULTS; PROGNOSTIC VALUE; RELAXING FACTOR; CATS; HYPOTENSION; IMPACT	This study examined the effect of posttraumatic hypoxia on cerebral vascular responsivity and axonal damage, while also exploring hypothermia's potential to attenuate these responses. Rats were subjected to impact acceleration injury (IAI) and equipped with cranial windows to assess vascular reactivity to topical acetylcholine, with postmortem analyses using antibodies to amyloid precursor protein to assess axonal damage. Animals were subjected to hypoxia alone, IAI and hypoxia, IAI and hypoxia before induction of moderate hypothermia (33 degrees C), IAI and hypoxia induced during hypothermic intervention, and IAI and hypoxia initiated after hypothermia. Hypoxia alone had no impact on vascular reactivity or axonal damage. Acceleration injury and posttraumatic hypoxia resulted in dramatic axonal damage and altered vascular reactivity. When IAI and hypoxia were followed by hypothermic intervention, no axonal or vascular protection ensued. However, when IAI was followed by hypoxia induced during hypothermia, axonal and vascular protection followed. When this same hypoxic insult followed the use of hypothermia, no benefit ensued. These studies show that early hypoxia and delayed hypoxia exert damaging axonal and vascular consequences. Although this damage is attenuated by hypothermia, this follows only when hypoxia occurs during hypothermia, with no benefit found if the hypoxic insult proceeds or follows hypothermia. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 628-637; doi: 10.1038/jcbfm.2009.235; published online 11 November 2009	[Gao, Guoyi; Oda, Yasutaka; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Gao, Guoyi] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Oda, Yasutaka] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 057175, HD 055813]	This study was supported by NIH Grants NS 057175 and HD 055813. No portion of the paper has been presented previously.	Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1988, AM J PHYSIOL, V255, pH1259, DOI 10.1152/ajpheart.1988.255.5.H1259; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Povlishock J T, 1980, Adv Exp Med Biol, V131, P227; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Reed AR, 2002, SAMJ S AFR MED J, V92, P221; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Rockswold GL, 2006, J NEUROSURG, V104, P170, DOI 10.3171/jns.2006.104.1.170; ROSNER G, 2003, JEMS, V28, P118; Rosner Gregg, 2003, JEMS, V28, P100; Schneider A, 2008, ANAESTHESIST, V57, P197, DOI 10.1007/s00101-008-1311-4; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Thomas S, 2000, ACT NEUR S, V76, P397; WEI EP, 1992, STROKE, V23, P1623, DOI 10.1161/01.STR.23.11.1623; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	42	24	24	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2010	30	3					628	637		10.1038/jcbfm.2009.235			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	563DV	WOS:000275108900017	19904286	Bronze, Green Published			2022-02-06	
J	Munjal, SK; Panda, NK; Pathak, A				Munjal, Sanjay Kumar; Panda, Naresh K.; Pathak, Ashis			Relationship between severity of traumatic brain injury (TBI) and extent of auditory dysfunction	BRAIN INJURY			English	Article						Audiological assessment; head injury; auditory brainstem responses	HEAD-INJURY; EVOKED-POTENTIALS	Objective: To find out the relationship between severity of traumatic brain injury (TBI) and extent of auditory dysfunction Background: Most of the studies have taken the subjects with TBI as one group without taking into account the extent of head injury viz, mild, moderate and severe. Combining all the three groups has resulted in presenting an incomplete picture of auditory deficits following TBI. Methods and procedures: The sample population consisted of 290 subjects with TBI (study group) and 50 otologically normal subjects as controls. The subjects in the study group were further sub-divided into mild (n = 150), moderate (n = 100) and severe (n = 40) TBI. The audiological assessment consisted of pure tone audiometry, speech audiometry, tympanometry, acoustic reflex testing, auditory brainstem response and middle latency response audiometry. Results and conclusions: An association was observed between the extent of auditory dysfunction and severity of TBI. This association was more pronounced for hearing status at high frequencies and ABR/MLR components. ABR Wave V absolute latency and I-V interpeak latency increased with severity of TBI. Amplitude of MLR wave Na and Pa decreased with increasing severity. It is suggested that subjects should be evaluated for hearing difficulties based on their severity of TBI.	[Munjal, Sanjay Kumar; Panda, Naresh K.] Postgrad Inst Med Educ & Res, Dept Otolaryngol Head & Neck Surg, Chandigarh 160012, India; [Pathak, Ashis] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India		Panda, NK (corresponding author), Postgrad Inst Med Educ & Res, Dept Otolaryngol Head & Neck Surg, Chandigarh 160012, India.	npanda59@yahoo.co.in		Munjal, Sanjay/0000-0002-5738-6114			AGUILAR EA, 1986, OTOLARYNG HEAD NECK, V94, P211, DOI 10.1177/019459988609400214; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; FACCO E, 1985, ELECTROEN CLIN NEURO, V62, P332, DOI 10.1016/0168-5597(85)90041-3; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HALL JW, 1982, LARYNGOSCOPE, V92, P883; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; KITCHENS JL, 1991, J PEDIATR SURG, V26, P992, DOI 10.1016/0022-3468(91)90849-O; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2004, AM J PHYS MED REHAB, V83, P210, DOI 10.1097/01.PHM.0000113402.85460.59; LIDEN G, 1974, ARCH OTOLARYNGOL, V99, P23; Mahapatra AK, 1997, NEUROSCIENCE TODAY, V1, P197; Penn C, 2009, INT J AUDIOL, V48, P135, DOI 10.1080/14992020802635309; SATALOFF R, 2006, OCCUPATIONAL HEARING, P411; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; VALENTE M, 2008, AUDIOLOGY TREATMENT, P241	16	24	28	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2010	24	3					525	532		10.3109/02699050903516872			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	574JR	WOS:000275985800008	20184409				2022-02-06	
J	Rao, V; Munro, CA; Rosenberg, P; Ward, J; Bertrand, M; Degoankar, M; Horska, A; Pham, D; Yousem, DM; Barker, PB				Rao, Vani; Munro, Cynthia A.; Rosenberg, Paul; Ward, Julianna; Bertrand, Melaine; Degoankar, Mahaveer; Horska, Alena; Pham, Dzung; Yousem, David M.; Barker, Peter B.			Neuroanatomical Correlates of Depression in Post Traumatic Brain Injury: Preliminary Results of a Pilot Study	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MAJOR DEPRESSION; DYSFUNCTION	The authors present preliminary results from a pilot study on patterns of brain injury associated with incident major depression after traumatic brain injury (TBI). Brain metabolite ratios, regional brain volumes, and cognitive performance were compared between 10 subjects with incident major depression post-TBI and seven TBI patients without major depression. TBI-depressed participants performed poorly on tests of frontotemporal functioning, had lower choline/creatine and N-acetylaspartate/creatine ratios in the right basal ganglia and had lower regional brain volumes in the right frontal, left occipital, and temporal lobes. The results suggest a possible role of frontotemporal lobe and basal ganglia pathology in depression after TBI. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22: 231-235)	[Rao, Vani; Rosenberg, Paul; Bertrand, Melaine] Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA; [Munro, Cynthia A.; Ward, Julianna] Johns Hopkins Sch Med, Dept Psychiat, Div Med Psychol, Baltimore, MD 21287 USA; [Degoankar, Mahaveer; Horska, Alena; Pham, Dzung; Yousem, David M.; Barker, Peter B.] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Neuroradiol, Baltimore, MD 21287 USA		Rao, V (corresponding author), Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA.	vrao@jhmi.edu	Pham, Dzung/AAR-8263-2020		National Center for Research Resources (NCRR/NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1RR00052]; PfizerPfizer; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000052] Funding Source: NIH RePORTER	This study was supported by National Center for Research Resources (NCRR/NIH) Grant # MO1RR00052. The abstract was presented at the 2008 annual neuropsychiatry conference, Savannah, GA.; Dr. Rao has a grant from Forest to conduct a clinical trial in post-TBI depression and a grant from Pfizer to conduct a clinical trial in poststroke anxiety.; The authors wish to acknowledge Drs. Barbara A. Holshouser and Karen A. Tong, Department of Radiology, Section of Neuroradiology, Loma Linda University School of Medicine, California, for their invaluable assistance during the preparation of this manuscript.	Bazin PL, 2007, J NEUROSCI METH, V165, P111, DOI 10.1016/j.jneumeth.2007.05.024; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Deb S, 1999, AM J PSYCHIAT, V156, P374; DeBattista Charles, 2005, Expert Rev Neurother, V5, P79, DOI 10.1586/14737175.5.1.79; Degl'Innocenti A, 1998, ACTA PSYCHIAT SCAND, V97, P182, DOI 10.1111/j.1600-0447.1998.tb09985.x; DUYN JH, 1993, RADIOLOGY, V188, P277, DOI 10.1148/radiology.188.1.8511313; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Inzaghi M G, 2005, Eura Medicophys, V41, P265; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; National Institute of Neurological Disorders and Stroke Traumatic Brain Injury: Hope through research National Institutes of Health, 2002, NIH PUBL; Rao V, 2006, EUR J PSYCHIAT, V20, P65, DOI 10.4321/s0213-61632006000200002; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x	22	24	26	0	3	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2010	22	2					231	235					5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	595ZY	WOS:000277654200011	20463117				2022-02-06	
J	Aviv, RI; Tomlinson, G; Kendall, B; Thakkar, C; Valentine, A				Aviv, Richard I.; Tomlinson, George; Kendall, Brian; Thakkar, Chandrashekhar; Valentine, Alan			Cavum Septi Pellucidi in Boxers	CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES			English	Article						Cavum pellucidi; Boxers; Head injury	TRAUMATIC BRAIN-INJURY; PROFESSIONAL BOXERS; SOCCER PLAYERS; VERGAE; DAMAGE; CT	Objective: Controversy exists over the significance of the isolated finding of cavum septi pellucidi (CSP) and its prevalence rate in healthy individuals and in professional boxers. Few magnetic resonance imaging (MRI) studies have looked at large cohorts of boxers. The aim of this study was to identify the prevalence and extent of a CSP among professional boxers and to compare these with a control group. Methods: MRI studies of 164 male boxers scanned for annual British boxing board license renewal were reviewed and compared with 43 control patients. CSP prevalence, size, and extent were recorded. Extent was classified as type 1, anterior to the fornix; type 2, extending up to the fornix; and type 3, extending into the cavum vergae. Parenchymal abnormalities were documented, and the Evan's ratio was used as an indication of brain atrophy. Results: A CSP was present in 40% of controls and 49% of boxers. There was a trend to a higher CSP prevalence in boxers (P = .099). No control patient had type 2 or 3 extension (P < .0009), as opposed to 30% and 16% prevalence in boxers. Three boxers increased their extent over serial imaging. No difference in CSP size was established between the 2 groups (P= .43), but there was an association between progressive scans and increased CSP size over time in boxers, independent of age (P = .05). Eight boxers demonstrated a CSP on a subsequent scan not seen on an earlier scan. Conclusion: The prevalence of a CSP is high among both control patients and boxers. There is a trend to a larger CSP with increasing number of scans without evidence of atrophy and independent of age. Boxers also have a greater posterior extent than controls. The findings may be explained by sudden increases in intracranial pressure that forced cerebrospinal fluid (CSF) through small defects in the septal leaflets, which result in an increase in size and or extent of a CSP.	[Aviv, Richard I.] Sunnybrook Med Ctr, Div Neuroradiol, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Kendall, Brian; Valentine, Alan] Royal Free Hosp, London NW3 2QG, England; [Thakkar, Chandrashekhar] Royal London Hosp, London E1 1BB, England; [Tomlinson, George] Toronto Gen Res Inst, Div Clin Decis Making & Hlth Care, Toronto, ON, Canada		Aviv, RI (corresponding author), Sunnybrook Med Ctr, Div Neuroradiol, Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Richard.aviv@sunnybrook.ca	Tomlinson, George A/L-5432-2016	Tomlinson, George A/0000-0002-9328-6399			Bodensteiner JB, 1997, SPORTS MED, V24, P361, DOI 10.2165/00007256-199724060-00002; Cabanis E A, 1986, Acta Radiol Suppl, V369, P365; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; HARVEY PKP, 1974, LANCET, V2, P928; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; MACPHERSON P, 1988, NEURORADIOLOGY, V30, P506, DOI 10.1007/BF00339691; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MAWDSLEY C, 1963, LANCET, V2, P795; MILLER ME, 1986, ARCH NEUROL-CHICAGO, V43, P821, DOI 10.1001/archneur.1986.00520080061022; Moseley IF, 2000, NEURORADIOLOGY, V42, P1, DOI 10.1007/s002340050001; NAKANO S, 1981, J COMPUT ASSIST TOMO, V5, P348, DOI 10.1097/00004728-198106000-00006; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; SCHWIDDE JT, 1952, AMA ARCH NEUROL PSY, V67, P625, DOI 10.1001/archneurpsyc.1952.02320170043006; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; SPILLANE J D, 1962, Br Med J, V2, P1205; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	21	24	25	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0846-5371			CAN ASSOC RADIOL J	Can. Assoc. Radiol. J.-J. Assoc. Can. Radiol.	FEB	2010	61	1					29	32		10.1016/j.carj.2009.09.002			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	554AT	WOS:000274408600006	19854608				2022-02-06	
J	Ley, EJ; Park, R; Dagliyan, G; Palestrant, D; Miller, CM; Conti, PS; Margulies, DR; Salim, A				Ley, Eric J.; Park, Ryan; Dagliyan, Grant; Palestrant, David; Miller, Chad M.; Conti, Peter S.; Margulies, Daniel R.; Salim, Ali			In Vivo Effect of Propranolol Dose and Timing on Cerebral Perfusion After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	39th Annual Meeting of the Western-Trauma-Association	FEB 22-28, 2009	Crested Butte, CO	Western Trauma Assoc		Trauma; Traumatic brain injury; Beta blocker; Propranolol; Perfusion	BETA-BLOCKER EXPOSURE; BLOOD-FLOW; BETA(2)-ADRENERGIC RECEPTOR; IMPROVED SURVIVAL; IMPROVED OUTCOMES; RATS; IMPACT; TBI; PET	Background: In vivo models of traumatic brain injury (TBI) demonstrate increased cerebral perfusion. decreased cerebral hypoxia, reduced cerebral edema, and improved neurologic recovery with propranolol administration. The purpose of this study was to determine the effect of different propranolol doses and timing on cerebral perfusion in a nutrine TBI model. Methods: Fifteen minutes after TBI, three groups of mice (four mice per group) were randomized to receive intravenous injections of placebo, 4 mg/kg propranolol, or 1 mg/kg propranolol. Two delayed treatment groups were randomized to receive placebo or 4 mg/kg propranolol 60 minutes after TBI. Cerebral perfusion was then imaged by micropositron emission tomography. Results: With placebo injection 15 minutes after TBI, the standard uptake value (SUV) mean was 0.395 +/- 0.01: with 4 mg/kg propranolol, the SUV mean was 0.515 +/- 0.04; and with 4 mg/kg propranolol, the SUV mean was 0.46 +/- 0.01. Animals receiving 4 mg/kg propranolol demonstrated significant improvement (p < 0.01) in cerebral perfusion compared with placebo and compared with 1 mg/kg propranolol. With placebo injection at 60 minutes after TBI, the SUV mean was 0.26 +/- 0.03; and with 4 mg/kg propranolol, the SUV mean was 0.43 +/- 0.02. After 60 minutes, animals receiving 4 mg/kg, propranolol demonstrated significant improvement 3 < 0.01) in cerebral perfusion compared with placebo. Conclusion: In a murine model of TBI, higher doses of propranolol were preferable to lower doses and both early and late propranolol administration improved cerebral perfusion. Potential mechanisms and therapeutic potential require further research.	[Ley, Eric J.; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Palestrant, David; Miller, Chad M.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Park, Ryan; Dagliyan, Grant; Conti, Peter S.] Univ So Calif, Dept Radiol, Los Angeles, CA USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org					Alauddin MM, 2007, NUCL MED BIOL, V34, P267, DOI 10.1016/j.nucmedbio.2006.12.009; AQYAGI M, 1976, STROKE, V7, P291, DOI 10.1161/01.STR.7.3.291; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Chi OZ, 1999, ANESTH ANALG, V89, P690, DOI 10.1097/00000539-199909000-00030; Chiu W, 2007, J TRAUMA, V63, P510; Conti PS, 2008, NUCL MED BIOL, V35, P131, DOI 10.1016/j.nucmedbio.2007.09.003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; EDVINSSON L, 1979, ACTA PHYSIOL SCAND, V107, P289, DOI 10.1111/j.1748-1716.1979.tb06478.x; Enderson BL, 2007, J TRAUMA, V62, P33; FRIEDLAND RP, 1991, NEUROLOGY, V41, P10, DOI 10.1212/WNL.41.1.10; GREEN MA, 1990, J NUCL MED, V31, P1989; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HEMMINGSEN R, 1979, ACTA PHYSIOL SCAND, V105, P274, DOI 10.1111/j.1748-1716.1979.tb06342.x; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; LASBENNES F, 1986, EXP BRAIN RES, V63, P169; Lewis JS, 1999, J NUCL MED, V40, P177; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Pryor JP, 2007, J TRAUMA, V62, P61; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Young H, 1994, J Nucl Biol Med, V38, P89	28	24	25	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2010	68	2					353	356		10.1097/TA.0b013e3181c8269a			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	555FC	WOS:000274492600026	20154548				2022-02-06	
J	Valable, S; Francony, G; Bouzat, P; Fevre, MC; Mahious, N; Bouet, V; Farion, R; Barbier, E; Lahrech, H; Remy, C; Petit, E; Segebarth, C; Bernaudin, M; Payen, JF				Valable, Samuel; Francony, Gilles; Bouzat, Pierre; Fevre, Marie-Cecile; Mahious, Nouara; Bouet, Valentine; Farion, Regine; Barbier, Emmanuel; Lahrech, Hana; Remy, Chantal; Petit, Edwige; Segebarth, Christoph; Bernaudin, Myriam; Payen, Jean-Francois			The impact of erythropoietin on short-term changes in phosphorylation of brain protein kinases in a rat model of traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain trauma; cerebral edema; EPO (erythropoietin); inhibitors; MAPK (mitogen-activated protein kinase); MAPK activation after brain trauma	FOCAL CEREBRAL-ISCHEMIA; PREVENTS NEURONAL APOPTOSIS; SIGNAL-REGULATED KINASE; NITRIC-OXIDE FORMATION; IN-VIVO; BARRIER PERMEABILITY; AKT PHOSPHORYLATION; EDEMA; NEUROPROTECTION; MICE	We found that recombinant human erythropoietin (rhEPO) reduced significantly the development of brain edema in a rat model of diffuse traumatic brain injury (TBI) (impact-acceleration model). In this study, we investigated the molecular and intracellular changes potentially involved in these immediate effects. Brain tissue nitric oxide (NO) synthesis, phosphorylation level of two protein kinases (extracellular-regulated kinase (ERK)-1/-2 and Akt), and brain water content were measured 1 (H1) and 2 h (H2) after insult. Posttraumatic administration of rhEPO (5,000 IU/kg body weight, intravenously, 30 mins after injury) reduced TBI-induced upregulation of ERK phosphorylation, although it increased Akt phosphorylation at H1. These early molecular changes were associated with a reduction in brain NO synthesis at H1 and with an attenuation of brain edema at H2. Intraventricular administration of the ERK-1/-2 inhibitor, U0126, or the Akt inhibitor, LY294002, before injury showed that ERK was required for brain edema formation, and that rhEPO-induced reduction of edema could involve the ERK pathway. These results were obtained in the absence of any evidence of blood-brain barrier damage on contrast-enhanced magnetic resonance images. The findings of our study indicate that the anti edematous effect of rhEPO could be mediated through an early inhibition of ERK phosphorylation after diffuse TBI. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 361-369; doi: 10.1038/jcbfm.2009.222; published online 7 October 2009	[Payen, Jean-Francois] Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, U836,Equipe 5, F-38042 Grenoble 9, France; [Valable, Samuel; Petit, Edwige; Bernaudin, Myriam] Univ Paris 05, Univ Caen Basse Normandie, Equipe CERVOxy,CI NAPS,UMR 6232, CNRS,CEA, Caen, France; [Francony, Gilles; Bouzat, Pierre; Fevre, Marie-Cecile; Payen, Jean-Francois] Hop Michallon, Dept Anesthesie Reanimat, Grenoble, France; [Bouet, Valentine] Univ Caen Basse Normandie, GMPc, UFR Sci Pharmaceut, Caen, France		Payen, JF (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, U836,Equipe 5, Site Sante La Tronche,BP 170, F-38042 Grenoble 9, France.	jfpayen@ujf-grenoble.fr	valable, samuel/B-7578-2008; PETIT, Edwige/C-1896-2008; Bouzat, Pierre/L-6881-2014; Payen, Jean-Francois/L-6667-2014; Bernaudin, Myriam/B-7663-2008; Bouzat, Pierre/AAC-4105-2019; Remy, Chantal/L-9459-2014; Barbier, Emmanuel/E-6302-2011; Lahrech, Hana/M-5229-2018; BOUET, Valentine/N-9593-2015	valable, samuel/0000-0003-0355-0270; Bernaudin, Myriam/0000-0003-0778-3397; Bouzat, Pierre/0000-0003-4667-6738; Barbier, Emmanuel/0000-0002-4952-1240; Lahrech, Hana/0000-0003-3843-3410	Institut National de la Sante et de la Recherche Medicale (INSERM)Institut National de la Sante et de la Recherche Medicale (Inserm); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Association Francaise contre les Myopathies (AFM)Association Francaise contre les Myopathies; Centre National de la Recherche Scientifique (CNRS)Centre National de la Recherche Scientifique (CNRS); Ligue contre le CancerLigue nationale contre le cancer; Ministere de l'Education, de la Recherche et de la Technologie, France. Epoetin alfa (Eprex); INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission [U836]; Universite Joseph Fourier, Grenoble, France	This study was supported in part by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME), Association Francaise contre les Myopathies (AFM), Centre National de la Recherche Scientifique (CNRS), Ligue contre le Cancer, and Ministere de l'Education, de la Recherche et de la Technologie, France. Epoetin alfa (Eprex) was kindly provided by Janssen-Cilag Division Ortho Biotech, Issy-les-Moulineaux, France. Study support was received from INSERM U836 and Universite Joseph Fourier, Grenoble, France.	Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Grillon E, 2008, NMR BIOMED, V21, P427, DOI 10.1002/nbm.1206; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Huang H, 2009, J INT MED RES, V37, P511, DOI 10.1177/147323000903700227; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kobayashi H, 2008, CLIN EXP PHARMACOL P, V35, P812, DOI 10.1111/j.1440-1681.2008.04925.x; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Liot G, 2004, EXP NEUROL, V187, P38, DOI 10.1016/j.expneurol.2004.01.002; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; NAGAFUJI T, 1992, NEUROSCI LETT, V147, P159, DOI 10.1016/0304-3940(92)90584-T; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Noguchi K, 2001, BRIT J PHARMACOL, V133, P395, DOI 10.1038/sj.bjp.0704083; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Pacary E, 2006, NEURODEGENER DIS, V3, P87, DOI 10.1159/000092098; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Salter M, 1996, J NEUROCHEM, V66, P1683; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Thippeswamy T, 2006, HISTOL HISTOPATHOL, V21, P445, DOI 10.14670/HH-21.445; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	42	24	27	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2010	30	2					361	369		10.1038/jcbfm.2009.222			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	551TS	WOS:000274233800012	19809465	Bronze, Green Published			2022-02-06	
J	Ahmadi, SA; Meier, U; Lemcke, J				Ahmadi, Sebastian A.; Meier, Ullrich; Lemcke, Johannes			Detailed long-term outcome analysis after decompressive craniectomy for severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; decompressive craniectomy; TBI; outcome	SF-36 HEALTH SURVEY; SEVERE HEAD-INJURY; QUALITY-OF-LIFE; FUNCTIONAL INDEPENDENCE MEASURE; BECK DEPRESSION INVENTORY; BARTHEL INDEX; FOLLOW-UP; DISABILITY; SCALE; ADULTS	Objective: To assess detailed long-term clinical outcome at least 1 year after decompressive craniectomy ( DC) in patients with severe traumatic brain injury (TBI). Methods: One hundred and thirty-one patients with severe TBI underwent DC between September 1997 and September 2005. Outcome was measured using the Glasgow Outcome Scale (GOS). Detailed outcome analysis was performed using Glasgow Outcome Scale Extended, Short-Form 36 (SF-36), Beck Depression Inventory, Trail Making Test B (TMT-B), Digit-Symbol Test (DST) and Barthel Index (BI). Results: Sixty-three patients (48.1%) died during their initial hospital stay, 27 (20.6%) were discharged in a vegetative state, 32 (24.4%) with severe disability and nine (6.9%) with moderate disability ( GOS 3 and 4, respectively). At time of follow-up 75 patients (67.7%) were either dead or in a vegetative state. Thirty patients with GOS > 2 were recruited for a detailed outcome analysis: Major depression, neurologic deficits and impaired TMT-B and DST performances were common and significantly more prevalent than in normative controls. Yet, patients reported only modestly reduced SF-36 and high BI scores. Conclusions: Despite multiple health-related problems after DC, many patients proved highly functional in activities of daily living and reported qualities of life not significantly inferior to that of healthy individuals. Depression was common and requires to be addressed with patients and caregivers. Better targeted therapies could improve neuropsychological and psychiatric outcomes in this complex cohort.	[Ahmadi, Sebastian A.] Univ Klinikum Dusseldorf, Neurochirurg Klin, D-40225 Dusseldorf, Germany; [Ahmadi, Sebastian A.; Meier, Ullrich; Lemcke, Johannes] Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany		Ahmadi, SA (corresponding author), Univ Klinikum Dusseldorf, Neurochirurg Klin, Moorenstr 5, D-40225 Dusseldorf, Germany.	ahmadi@med.uni-duesseldorf.de		Lemcke, Johannes/0000-0002-8073-1625			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; BAK JS, 1980, J CONSULT CLIN PSYCH, V48, P395, DOI 10.1037/0022-006X.48.3.395; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; DAVIES ADM, 1968, J CLIN PSYCHOL, V24, P98; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V4th ed, P1016; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; MAHONEY F I, 1965, Md State Med J, V14, P61; McDermott S, 2005, DISABIL REHABIL, V27, P117, DOI 10.1080/09638280400007380; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R.M, 1992, TRAIL MAKING TEST MA, P10; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; RICKELS E, 2006, SCHADELHIRN VERLETZU; *RKI, 2000, BGS98 RKI; Sangha H, 2005, INT J REHABIL RES, V28, P135, DOI 10.1097/00004356-200506000-00006; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schneider GH, 2002, ACT NEUR S, V81, P77; Spreen O, 1998, COMPENDIUM NEUROPSYC, P736; STEWART AL, 1992, MEASURING FUNCTIONIN, P449; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tewes U, 1991, HDB TESTANWEISUNG; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; TREMEL SJE, 2003, THESIS HUMBOLDT U BE, P122; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wechsler D, 1981, WECHSLER ADULT INTEL; Wechsler D., 1955, MANUAL WECHSLER ADUL; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wittchen HU, 2002, HUM PSYCHOPHARM CLIN, V17, pS1, DOI 10.1002/hup.398; Woldag H, 2006, FORTSCHR NEUROL PSYC, V74, P367, DOI 10.1055/s-2006-932142; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013	76	24	26	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	13-14					1539	1549		10.3109/02699052.2010.523049			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800003	20973624				2022-02-06	
J	Alla, S; Sullivan, SJ; McCrory, P; Schneiders, AG; Handcock, P				Alla, Sridhar; Sullivan, S. John; McCrory, Paul; Schneiders, Anthony G.; Handcock, Phil			Does exercise evoke neurological symptoms in healthy subjects?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Neurological manifestations; Postconcussion symptoms; Exercise; Athletic injuries; Return-to-play	SPORTS-RELATED CONCUSSION; EXERTION	Concussion is a common injury in collision sports and is evidenced by a variety of signs and symptoms. The recording of neurological symptoms is an important component of screening for a concussion and in return-to-play decisions. However similar symptoms are prevalent in the general population and are reported to be associated with participation in physical activities. The purpose of this study was to document the neurological symptoms reported by healthy individuals following controlled bouts of exercise. A crossover randomised design with 2 levels of exercise intensity, moderate intensity and high intensity, each of 15 min duration was used. Participants completed a standardised postconcussion symptom checklist prior to exercise (pre), immediately following exercise (post-1) and again after 15 min of rest (post-2). 60 participants were recruited into the study. A summed symptom score was calculated and analysed with a 2-way repeated measures ANOVA procedure. The intensity x time interaction (F(2,118) = 23.94, p < 0.001) demonstrated a significant increase in symptom scores for the high intensity condition immediately following exercise (p < 0.001). Although the moderate intensity showed a similar trend this was not significant. These findings suggest that sports medicine professionals need to be aware of the effect of exercise on symptom reporting when assessing and in making return-to-play decisions. (C) 2009 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Alla, Sridhar; Sullivan, S. John; Schneiders, Anthony G.] Univ Otago, Ctr Physiotherapy Res, Christchurch, New Zealand; [McCrory, Paul] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic 3010, Australia; [Handcock, Phil] Univ Otago, Sch Phys Educ, Christchurch, New Zealand		Alla, S (corresponding author), Univ Otago, Ctr Physiotherapy Res, Christchurch, New Zealand.	allsr357@student.otago.ac.nz	Handcock, Phil/P-2400-2019; McCrory, Paul/Q-8688-2019; Schneiders, Anthony/F-4212-2015	Handcock, Phil/0000-0002-0753-1117; Schneiders, Anthony/0000-0002-1583-3879; McCrory, Paul/0000-0003-4850-0568			BORG G, 1987, EUR J APPL PHYSIOL O, V56, P679, DOI 10.1007/BF00424810; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Susco TM, 2004, J ATHL TRAINING, V39, P241	8	24	24	0	7	SPORTS MEDICINE AUSTRALIA	MITCHELL	3-5 CHENEY PL, PO BOX 78, MITCHELL, ACT 2911, AUSTRALIA	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	JAN	2010	13	1					24	26		10.1016/j.jsams.2008.12.629			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	547AX	WOS:000273858300006	19231284				2022-02-06	
J	Ashwal, S; Wycliffe, ND; Holshouser, BA				Ashwal, Stephen; Wycliffe, Nathaniel D.; Holshouser, Barbara A.			Advanced Neuroimaging in Children with Nonaccidental Trauma	DEVELOPMENTAL NEUROSCIENCE			English	Article						Children; Infants; Nonaccidental trauma; Magnetic resonance imaging; Magnetic resonance spectroscopy; Traumatic brain injury	DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; INFLICTED HEAD-INJURY; HYPOXIC-ISCHEMIC INJURY; PROTON MR SPECTROSCOPY; WHITE-MATTER INJURY; BRAIN-INJURY; YOUNG-CHILDREN; OUTCOME PREDICTION; CORPUS-CALLOSUM	Physical abuse associated with nonaccidental trauma (NAT) affects approximately 144,000 children per year in the USA and, frequently, these injuries affect the developing brain. Most infants with suspected NAT are initially evaluated by skull X-rays and computed tomography to determine whether fractures are present, the severity of the acute injury and the need for urgent neurosurgical intervention. Increasingly, magnetic resonance imaging (MRI) is conducted as it provides additional diagnostic and prognostic information about the extent and nature of the injury. In this review, we examine 4 MRI techniques as they apply to children who present acutely after NAT. Susceptibility-weighted imaging is a 3-D high-resolution MRI technique that is more sensitive than conventional imaging in detecting hemorrhagic lesions that are often associated with diffuse axonal injury (DAI). Magnetic resonance spectroscopy acquires metabolite information reflecting neuronal integrity and function from multiple brain regions and provides a sensitive, noninvasive assessment of neurochemical alterations that offers early prognostic information regarding outcome. Diffusion-weighted imaging (DWI) is based on differences in the diffusion of water molecules within the brain and has been shown to be very sensitive in the early detection of ischemic injury. It is now being used to study the direct effects of traumatic injury as well as those due to secondary ischemia. Diffusion tensor imaging is a form of DWI and allows better evaluation of white matter fiber tracts by taking advantage of the intrinsic directionality (anisotropy) of water diffusion in the human brain. It has been shown to be useful in identifying white matter abnormalities after DAI when conventional imaging appears normal. Although these imaging methods have been studied primarily in adults and children with accidental traumatic brain injury, it is clear that they have the potential to provide additional value in the imaging and clinical evaluation of children with NAT. Copyright (C) 2010 S. Karger AG, Basel	[Ashwal, Stephen] Loma Linda Univ, Sch Med, Dept Pediat, Div Child Neurol, Loma Linda, CA 92354 USA; [Wycliffe, Nathaniel D.; Holshouser, Barbara A.] Loma Linda Univ, Sch Med, Dept Radiol, Loma Linda, CA 92354 USA		Ashwal, S (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, Div Child Neurol, 11175 Campus St,Room A1120, Loma Linda, CA 92354 USA.	sashwal@llu.edu					Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ajilogba K, 2006, PEDIATR RADIOL, V36, P1326, DOI 10.1007/s00247-006-0286-z; Akpinar E, 2007, J COMPUT ASSIST TOMO, V31, P657, DOI 10.1097/RCT.0b013e318033df1a; Alessandri B, 2000, NEUROL RES, V22, P705; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 1997, ANN NEUROL, V41, P470, DOI 10.1002/ana.410410410; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Bammer R, 2009, MAGN RESON IMAGING C, V17, P175, DOI 10.1016/j.mric.2009.01.011; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; Barlow KM, 1999, DEV MED CHILD NEUROL, V41, P220, DOI 10.1017/S0012162299000481; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beitzke D, 2008, EUR J RADIOL, V68, P199, DOI 10.1016/j.ejrad.2008.07.016; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Blitstein MK, 2007, AM J ROENTGENOL, V189, P720, DOI 10.2214/AJR.07.2249; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Carty H, 2002, EUR RADIOL, V12, P2919, DOI 10.1007/s00330-002-1436-9; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chan YL, 2003, PEDIATR RADIOL, V33, P574, DOI 10.1007/s00247-003-0949-y; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; COLBERT C, 2010, RADIOLOGY IN PRESS; Dan B, 2008, DEV MED CHILD NEUROL, V50, P78; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fernando S, 2008, PEDIATR RADIOL, V38, P827, DOI 10.1007/s00247-007-0729-1; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gill JR, 2009, ARCH PATHOL LAB MED, V133, P619, DOI 10.1043/1543-2165-133.4.619; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jaspan T, 2003, CLIN RADIOL, V58, P44, DOI 10.1053/crad.2002.1094; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Karandikar S., 2004, CHILD ABUSE REV, V13, P178, DOI DOI 10.1002/CAR.850; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Mao H, 2007, J NEUROIMAGING, V17, P292, DOI 10.1111/j.1552-6569.2007.00146.x; McGraw P, 2002, AM J ROENTGENOL, V179, P1515, DOI 10.2214/ajr.179.6.1791515; McKinney AM, 2008, PEDIATR RADIOL, V38, P164, DOI 10.1007/s00247-007-0673-0; McLean MA, 2000, MAGNET RESON MED, V44, P401, DOI 10.1002/1522-2594(200009)44:3<401::AID-MRM10>3.0.CO;2-W; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Mukherjee P, 2001, RADIOLOGY, V219, P756, DOI 10.1148/radiology.219.3.r01jn48756; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Nimkin K, 2001, RADIOL CLIN N AM, V39, P843, DOI 10.1016/S0033-8389(05)70314-6; Parizel PM, 2003, PEDIATR RADIOL, V33, P868, DOI 10.1007/s00247-003-1025-3; Pierce MC, 2002, NEUROSURG CLIN N AM, V13, P155, DOI 10.1016/S1042-3680(01)00006-7; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Robertson IH, 2008, ARCH PHYS MED REHAB, V89, pS1, DOI 10.1016/j.apmr.2008.10.001; Robertson RL, 2007, PEDIATR RADIOL, V37, P749, DOI 10.1007/s00247-007-0515-0; Rovaris M, 2009, NEUROIMAG CLIN N AM, V19, P37, DOI 10.1016/j.nic.2008.08.001; *ROYAL COLL RAD, 2008, STAND RAD INV SUSP N; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Schuff N, 2001, MAGN RESON MED, V45, P899, DOI 10.1002/mrm.1119; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Slovis T L, 2000, Radiology, V215 Suppl, P805; Soher BJ, 2000, MAGN RESON IMAGING, V18, P1159, DOI 10.1016/S0730-725X(00)00212-5; Stoodley N, 2005, CLIN RADIOL, V60, P22, DOI 10.1016/j.crad.2004.06.023; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Triulzi F, 2008, NEUROL SCI, V29, pS342, DOI 10.1007/s10072-008-1013-3; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; vanderToorn A, 1996, MAGN RESON MED, V36, P52, DOI 10.1002/mrm.1910360110; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeo RA, 2006, ADV EXP MED BIOL, V576, P215; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zimmerman RA, 2007, J NEURORADIOLOGY, V34, P109, DOI 10.1016/j.neurad.2007.01.124; [No title captured]	129	24	25	1	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					343	360		10.1159/000316801			18	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900003	20938158				2022-02-06	
J	Degeneffe, CE; Olney, MF				Degeneffe, Charles Edmund; Olney, Marjorie F.			'We are the forgotten victims': Perspectives of adult siblings of persons with traumatic brain injury	BRAIN INJURY			English	Article						Adult siblings; family; family adjustment; caregiving; qualitative research	MENTAL-RETARDATION; FAMILY; FUTURE; PREDICTORS; ILLNESS; ROLES	Primary objective: This study determined how the lives of a cross-national sample of adult siblings had changed since their brothers and sisters incurred a traumatic brain injury. Research design: A total of 272 participants provided responses to the question, 'How is your life different since your sibling had a TBI?' Responses were analysed through the constant comparative method of textual analysis. Methods and procedures: Responses were collected through a mailed-survey. The analysed question appeared at the end of a 243-item quantitatively-based survey containing five open-ended questions. Outcomes and results: Three themes emerged: (1) 'Family impacts' such as growing up with a sibling with TBI and impact on family closeness; (2) 'Caring' including caring for and about the family member; and (3) 'Making sense of the experience' through adjustment and personal development. Conclusions: The study demonstrates that having a sibling with a TBI can result in profound and enduring negative and positive life changes for non-injured siblings. Professionals need to attend to the needs of siblings for support and guidance and should be considered as key informants about their injured family members during intake and service planning.	[Degeneffe, Charles Edmund; Olney, Marjorie F.] San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, San Diego, CA 92108 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, 3590 Camino Rio N, San Diego, CA 92108 USA.	cdegenef@mail.sdsu.edu					Bogdan R.C., 1998, QUALITATIVE RES ED I, V3rd; Creswell J., 2009, RES DESIGN, V3rd; CRIMANDO W, 2008, 2008 ANN M NAT COUNC; DEFENEFFE CE, 2001, HLTH SOCIAL WORK, V26, P257; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2009, AUST J REHABIL COUNS, V15, P12, DOI 10.1375/jrc.15.1.12; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; DENZIN NK, 1994, STRATEGIES INQUIRY 3, P199; DEPUIS PR, 1994, HYPERRESEARCH VERSIO; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Grant G, 1998, J INTELL DISABIL RES, V42, P58, DOI 10.1046/j.1365-2788.1998.00079.x; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; Krauss MW, 1996, MENT RETARD, V34, P83; Lukens EP, 2004, AM J ORTHOPSYCHIAT, V74, P489, DOI 10.1037/0002-9432.74.4.489; NOLAN G, 1992, REGULAR RESPITE EVAL; Nolan M, 1996, UNDERSTANDING FAMILY; OLNEY MF, 2009, 2009 ANN M NAT COUNC; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pruchno RA, 1996, FAM RELAT, V45, P318, DOI 10.2307/585504; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; SELTZER MM, 1989, AM BEHAV SCI, V33, P107, DOI 10.1177/0002764289033001010; Seltzer MM, 1997, FAM RELAT, V46, P395, DOI 10.2307/585099; Smith MJ, 2007, AM J ORTHOPSYCHIAT, V77, P29, DOI 10.1037/0002-9432.77.1.29; Willer B., 1990, CANADIAN J REHABILIT, V3, P167	30	24	24	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1416	1427		10.3109/02699052.2010.514317			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800005	20858030				2022-02-06	
J	Kean, J; Trzepacz, PT; Murray, LL; Abell, M; Trexler, L				Kean, Jacob; Trzepacz, Paula T.; Murray, Laura L.; Abell, Malene; Trexler, Lance			Initial validation of a brief provisional diagnostic scale for delirium	BRAIN INJURY			English	Article						Posttraumatic amnesia; delirium; traumatic brain injury; rehabilitation	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA; ACUTE CONFUSION; COGNITIVE TEST; HEAD-INJURIES; RATING-SCALE; REHABILITATION; REVISED-98; CONCUSSION; SEVERITY	Primary objective: The Delirium Diagnostic Tool-Provisional (DDT-Pro) is a newly developed provisional diagnostic tool for delirium presented here. This study evaluated its accuracy and validity in a population of participants with acquired brain injury (ABI). Research design: Cross-sectional study. Methods: Thirty-six patients with ABI, including traumatic brain injury (TBI; n = 29) and intraparenchymal haemorrhage (ICH; n = 7) were assessed at admission to inpatient rehabilitation using the DDT-Pro, the Delirium Rating Scale-Revised 98 (DRS-R98) and DSM-IV-TR diagnostic criteria for delirium. Results: Using receiver operating characteristic (ROC) analysis, the estimate of accuracy, the area under the curve (AUC), was 0.994, and the DDT-Pro accurately classified 35/36 (97%) observations vs the DSM-IV-TR gold standard. The DDTPro correlated well with the DRS-R98 both in terms of raw score (r -0.913, p < 0.0001) and estimates of the duration of delirium (r = 0.975, p < 0.0001). Conclusions: The DDT-Pro is supported as a measure of delirium following ABI. Further validation in ABI and other medical populations is recommended.	[Kean, Jacob; Murray, Laura L.] Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA; [Kean, Jacob; Trexler, Lance] Rehabil Hosp Indiana, Indianapolis, IN USA; [Trzepacz, Paula T.] Eli Lilly & Co, Neurosci, Indianapolis, IN USA; [Trzepacz, Paula T.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA; [Abell, Malene] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Trexler, Lance] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA		Kean, J (corresponding author), 4141 Shore Dr, Indianapolis, IN 46254 USA.	jakean@indiana.edu	Trzepacz, Paula/AAQ-3330-2021	Kean, Jacob/0000-0002-8577-0586			Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; *AM PSYCH PUBL, 2000, AM PSYCH PUBL STAT M; Burns A, 2004, J NEUROL NEUROSUR PS, V75, P362, DOI 10.1136/jnnp.2003.023366; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Franco JG, 2009, PSYCHOSOMATICS, V50, P255, DOI 10.1176/appi.psy.50.3.255; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; HSU LM, 1994, MULTIVAR BEHAV RES, V29, P127, DOI 10.1207/s15327906mbr2902_1; Katz D, 1992, J HEAD TRAUMA REHAB, V72, P1, DOI [10.1097/00001199-200501000-00008, DOI 10.1097/00001199-200501000-00008]; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; Lipowski ZJ., 1990, DELIRIUM ACUTE CONFU; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ROCKWOOD K, 1994, J AM GERIATR SOC, V42, P252, DOI 10.1111/j.1532-5415.1994.tb01747.x; Rolfson D B, 1999, Int Psychogeriatr, V11, P431, DOI 10.1017/S1041610299006043; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RYAN K, 2007, VALIDATION CONFUSION; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; *SPSS INC, 2008, SPSS 17 WIND; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Symonds CP, 1935, LANCET, V1, P486; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; TRZEPACZ PT, 2004, TXB TRAUMATIC BRAIN; TRZEPACZ T, 2002, ESSENTIALS NEUROPSYC, V4, P525; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	24	24	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	10					1222	1230		10.3109/02699052.2010.498008			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	667MJ	WOS:000283197100009	20645705				2022-02-06	
J	Mansell, JL; Tierney, RT; Higgins, M; McDevitt, J; Toone, N; Glutting, J				Mansell, Jamie L.; Tierney, Ryan T.; Higgins, Michael; McDevitt, Jane; Toone, Nieka; Glutting, Joseph			Concussive signs and symptoms following head impacts in collegiate athletes	BRAIN INJURY			English	Article						Clinical outcomes; MTBI	SEGMENT DYNAMIC STABILIZATION; FOOTBALL PLAYERS; RECURRENT CONCUSSION; INJURY; EPIDEMIOLOGY	Objective: To evaluate the association between having a previously documented concussion and experiencing concussive signs and symptoms (S&S) following head impacts in collegiate athletes. Methods: Two hundred and one college male football (n = 168) and female women's soccer (n = 33) athletes participated in this retrospective case-control study. Athletes completed a questionnaire and reported if they had been diagnosed with concussion and if they experienced concussive S&S following a head impact during a game or practice in the previous year. Results: Almost 60% (89 of 152) of non-concussed athletes reported experiencing S&S following head impacts in the previous year compared to 80% (39 of 49) of concussed athletes. The Phi coefficient (r = 0.196, p = 0.005) results indicated a significant association between previous history of concussion and the occurrence of S&S following a head impact. Conclusions: A large percentage of non-concussed athletes are experiencing concussive S&S following head impacts during games and practices. Previously concussed athletes, however, report experiencing S&S more frequently following head impacts than their non-concussed counterparts. Although this study is subject to the limitations of a retrospective research design, these findings highlight the need for more diligent surveillance from clinicians, as many concussions are being missed.	[Tierney, Ryan T.; McDevitt, Jane; Toone, Nieka] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Higgins, Michael] Towson Univ, Dept Kinesiol, Towson, MD USA; [Glutting, Joseph] Univ Delaware, Newark, DE USA			jmansell23@gmail.com					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; GENNARELLI TA, 1982, PHYSL RESPONSE ANGUL; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA	21	24	25	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1070	1074		10.3109/02699052.2010.494589			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700003	20597635				2022-02-06	
J	O'Neil-Pirozzi, TM; Strangman, GE; Goldstein, R; Katz, DI; Savage, CR; Kelkar, K; Supelana, C; Burke, D; Rauch, SL; Glenn, MB				O'Neil-Pirozzi, Therese M.; Strangman, Gary E.; Goldstein, Richard; Katz, Douglas I.; Savage, Cary R.; Kelkar, Kalika; Supelana, Christina; Burke, David; Rauch, Scott L.; Glenn, Mel B.			A Controlled Treatment Study of Internal Memory Strategies (I-MEMS) Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						group; memory deficit; rehabilitation; traumatic brain injury	CLOSED-HEAD-INJURY; COGNITIVE REHABILITATION; FREE-RECALL; PEOPLE; TRIAL; ERRORLESS; THERAPY; DEVICES	Objective: To evaluate the effects of participation in a memory group intervention focusing on internal strategy use on persons with traumatic brain injury-related memory impairment. Participants: Ninety-four adults with traumatic brain injury (54 in the experimental group and 40 controls) and resulting memory impairment, with severities ranging from mild to severe. All participants were at least 18 years of age at the time of injury and at least 1 year post injury at the time of study. Design: Non randomized pre/posttest group comparison design. Main Outcome Measures: Hopkins Verbal Learning Test-Revised and Rivermead Behavioral Memory Test II. Results: Participation in the memory group intervention was associated with improved memory performance immediately postintervention, and improvements were maintained I month postintervention. Severe injury was associated with less improvement in memory outcomes than mild and moderate injuries. Age and preinjury education were not related to outcome. Conclusions: Individuals with traumatic brain injury may benefit from memory group intervention focusing on internal strategy use. Study hypotheses should be retested using a randomized, controlled design, and further research is needed to better delineate influences on intervention candidacy and outcomes.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.; Strangman, Gary E.; Goldstein, Richard; Kelkar, Kalika; Glenn, Mel B.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Strangman, Gary E.; Supelana, Christina] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Braintree Rehabil Hosp, Dept Neurol, Braintree, MA USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA; [Burke, David] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Rauch, Scott L.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Dept Speech Language Pathol & Audiol, 250 Huntington Ave,Forsyth Bldg,Room 103, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu		Katz, Douglas/0000-0002-7502-8505; Strangman, Gary/0000-0001-8896-2164	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020513]	This project was supported by grant NIDRR: H133A020513 from the National Institute on Disability and Rehabilitation Research, US Department of Education.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 1997, GUIDE UNIFORM DATA S; Benedict, 2001, HOPKINS VERBAL LEARN; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Hardin James W., 2003, GEN ESTIMATING EQUAT, DOI [10.1201/b13880, DOI 10.1201/B13880]; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Kaplan E., 2001, BOSTON NAMING TEST; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kaschel R., 1993, DEV ASSESSMENT REHAB, P145; KENNEDY M, 2006, AHSA LEAD, V11, P8; Kennedy M, 2006, AHSA LEAD, V11, P34; KERNER MJ, 1985, COGNITIVE REHABI NOV, P26; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MALEC J, 1990, J HEAD TRAUMA REHAB, V5, P60; MCKINLAY W, 1999, REHABILITATION ADULT, P74; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Parente R, 1999, NEUROREHABILITATION, V13, P157; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; TULVING E, 1962, PSYCHOL REV, V69, P344, DOI 10.1037/h0043150; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Wechsler D, 1987, MEMORY SCALE REVISED; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WILSON BA, 1995, HDB MEMORY DISORDERS, P451; Wilson BA, 2003, RIVERMEAD BEHAV MEMO; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146; [No title captured]	57	24	25	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2010	25	1					43	51		10.1097/HTR.0b013e3181bf24b1			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	550XC	WOS:000274165800006	20051897				2022-02-06	
J	Rockhill, CM; Fann, JR; Fan, MY; Hollingworth, W; Katon, WJ				Rockhill, Carol M.; Fann, Jesse R.; Fan, Ming-Yu; Hollingworth, William; Katon, Wayne J.			Healthcare costs associated with mild traumatic brain injury and psychological distress in children and adolescents	BRAIN INJURY			English	Article						Traumatic brain injury; psychiatry; child; cost	HEAD-INJURY; PSYCHIATRIC-ILLNESS; CAREGIVER BURDEN; MEDICAL COSTS; DISORDERS; IMPACT; COHORT; REHABILITATION; POPULATION; PREDICTORS	Primary objective: Comparison of healthcare costs for youth with mild traumatic brain injuries (TBIs) to costs in a matched cohort of children without TBI in the 3 years following injury. Research design: This study used a prospective cohort design with 3-year follow-up. Costs were examined using the well-established two-step model and controlling for potential confounding variables. Methods and procedures: Four-hundred and ninety subjects from a large health maintenance organization, 14 years old or younger, who sustained a mild TBI in 1993, were identified using computerized records. For each youth with mild TBI, three control subjects were selected (n = 1470), matched on age, sex and enrolment at the time of injury. Experimental interventions: Not applicable. Main outcomes and results: TBI exposure was associated with an increase in the proportion of subjects who had non-zero medical costs in all categories examined and a 75% increase in mean total costs. Presence of psychological distress was also associated with increased proportion of subjects with costs in all categories examined and was associated with an approximate doubling of mean total costs. Conclusions: Mild TBI and psychological distress were each associated with significant increases in healthcare costs in an HMO setting.	[Rockhill, Carol M.; Fann, Jesse R.; Fan, Ming-Yu; Katon, Wayne J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Hollingworth, William] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Hollingworth, William] Univ Washington, Dept Pharm, Seattle, WA 98195 USA		Rockhill, CM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Box 356560,1959 NE Pacific St, Seattle, WA 98195 USA.	rockhill@u.washington.edu		Hollingworth, William/0000-0002-0840-6254	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GAUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007543/1] Funding Source: researchfish; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007543/1] Funding Source: UKRI	This research was supported by a grant to the second author from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA. The funding organizations role was limited to review of the design of the study. We thank David Rubanowice, BS, for his computer programming assistance.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Appleton R., 2006, MANAGEMENT BRAIN INJ; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; COSTELLO EJ, 1988, PEDIATRICS, V82, P435; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Katon WJ, 2006, MED CARE, V44, P1064, DOI 10.1097/01.mlr.0000237421.17555.8f; Katon WJ, 2003, ARCH GEN PSYCHIAT, V60, P897, DOI 10.1001/archpsyc.60.9.897; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lofgren R, 2006, ACAD MED, V81, P713, DOI 10.1097/00001888-200608000-00007; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; *NAT CTR HLTH STAT, 1991, 911260 NAT CTR HLTH; Ortendahl M, 2002, J CLIN EPIDEMIOL, V55, P843, DOI 10.1016/S0895-4356(02)00447-X; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Saunders KW, 1994, PHARMACOEPIDEM DR S, P171; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith N S, 1994, Manag Care Q, V2, P21; Sokol DK, 1996, BRAIN INJURY, V10, P439, DOI 10.1080/026990596124296; Thurman DJ., 1995, GUIDELINES SURVEILLA; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; US Bureau of Labor Statistics, CONS PRIC IND; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Weiner J P, 1992, HMO Pract, V6, P13; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417	53	24	25	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1051	1060		10.3109/02699052.2010.494586			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700001	20597633				2022-02-06	
J	Stewart, CR; Landseadel, JP; Gurka, MJ; Fairchild, KD				Stewart, Corrine R.; Landseadel, Jessica P.; Gurka, Matthew J.; Fairchild, Karen D.			Hypothermia increases interleukin-6 and interleukin-10 in juvenile endotoxemic mice	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hypothermia; cytokines; interleukin-10; interleukin-6; endotoxin	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; INFLAMMATORY RESPONSE; HEMORRHAGIC-SHOCK; IL-10 PRODUCTION	Objective: To develop a juvenile mouse model to establish effects of in vivo hypothermia on expression of the inflammation-modulating cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-10. Although induced hypothermia is neuroprotective in some patients, the mechanisms of protection are not well understood and concerns remain over potential detrimental effects, particularly in the setting of infection. We previously showed that in vitro hypothermia increases production of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-treated monocytes. Design: Laboratory investigation. Setting: Research laboratory. Subjects: Juvenile (4-wk) male C57BL/6 mice. Interventions: Mice were given chlorpromazine to suspend thermoregulation and lipopolysaccharide to stimulate cytokine production. Core temperature was maintained at 32 degrees C or 37 degrees C for 6 hrs by adjusting environmental temperature. In separate experiments, lipopolysaccharide-treated mice were kept in a cooling chamber without chlorpromazine treatment. Measurements and Main Results. Plasma and organs were collected for cytokine quantitation. Chlorpromazine-treated hypo-thermic mice had 2.3-fold and 1.8-fold higher plasma interleukin-6 and interleukin-10 levels at 6 hrs compared with identically treated normothermic mice (p < .05), whereas plasma tumor necrosis factor-alpha and interleukin-1 beta were not significantly different at 2 hrs or 6 hrs. Liver tumor necrosis factor-alpha and interleukin-6 were significantly higher in hypothermic vs. normothermic mice, but lung and brain cytokines were not different. Lipopolysaccharide-treated mice kept in a cooling chamber without chlorpromazine treatment developed varying degrees of hypothermia with associated increases in plasma interleukin-6 and interleukin-10. A nonspecific marker of stress (plasma corticosterone) was not affected by hypothermia in lipopolysaccharide-treated mice. Conclusion. Further studies are necessary to determine the mechanism and physiologic consequences of augmented systemic interleukin-6 and interleukin-10 expression during induced hypothermia. (Pediatr Crit Care Med 2010; 11:109-116)	[Stewart, Corrine R.; Landseadel, Jessica P.; Gurka, Matthew J.; Fairchild, Karen D.] Univ Virginia, Dept Pediat, Childrens Hosp, Charlottesville, VA 22903 USA; [Gurka, Matthew J.] Univ Virginia, Dept Publ Hlth Sci, Childrens Hosp, Charlottesville, VA USA		Fairchild, KD (corresponding author), Univ Virginia, Dept Pediat, Childrens Hosp, Charlottesville, VA 22903 USA.	kdf2n@virginia.edu			University of Virginia Children's Hospital Fellow Grant (CRS); American Heart AssociationAmerican Heart Association [0365547U]; Jeffress Memorial Research Trust; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K08HD051609-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD051609] Funding Source: NIH RePORTER	This work was supported, in part, by a University of Virginia Children's Hospital Fellow Grant (CRS) and Grant 0365547U from the American Heart Association, Jeffress Memorial Research Trust, and Grant 5K08HD051609-02 (KDF) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Albaiceta Guillermo M., 2007, Inflammation & Allergy Drug Targets, V6, P191, DOI 10.2174/187152807783334337; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOSCHI G, 1987, BRIT J PHARMACOL, V90, P745, DOI 10.1111/j.1476-5381.1987.tb11228.x; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Carlson NG, 1999, J IMMUNOL, V163, P3963; CHERNOW B, 1983, CRIT CARE MED, V11, P677, DOI 10.1097/00003246-198309000-00001; Chu SJ, 2005, CHEST, V128, P327, DOI 10.1378/chest.128.1.327; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; Druker J, 2006, ANN NY ACAD SCI, V1088, P297, DOI 10.1196/annals.1366.007; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Elenkov IJ, 1996, P ASSOC AM PHYSICIAN, V108, P374; Fairchild KD, 2005, AM J PHYSIOL-CELL PH, V289, pC1114, DOI 10.1152/ajpcell.00152.2005; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; GINSBERG MD, 2005, THERAPEUTIC HYPOTHER, P85; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Grunenfelder J, 2000, EUR J CARDIO-THORAC, V17, P723, DOI 10.1016/S1010-7940(00)00401-2; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hong SB, 2005, CRIT CARE MED, V33, P2049, DOI 10.1097/01.CCM.0000178186.37167.53; Horan MR, 2004, J PEDIATR-US, V144, P301, DOI 10.1016/j.jpeds.2003.11.034; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kentner R, 2002, SHOCK, V17, P521, DOI 10.1097/00024382-200206000-00014; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lee SL, 2001, J SURG RES, V100, P150, DOI 10.1006/jsre.2001.6230; Leon LR, 2006, J APPL PHYSIOL, V100, P1400, DOI 10.1152/japplphysiol.01040.2005; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Luhm J, 1998, EUR J BIOCHEM, V256, P325, DOI 10.1046/j.1432-1327.1998.2560325.x; LundgrenEriksson L, 1996, ANTICANCER RES, V16, P333; Matsui T, 2004, ACTA ANAESTH SCAND, V48, P205, DOI 10.1111/j.0001-5172.2004.00293.x; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Monroy M, 2001, AM J PHYSIOL-HEART C, V280, pH1448, DOI 10.1152/ajpheart.2001.280.4.H1448; Pang Y, 2005, DEV BRAIN RES, V157, P141, DOI 10.1016/j.devbrainres.2005.03.015; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Scumpia PO, 2004, CHEST, V125, P1483, DOI 10.1378/chest.125.4.1483; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Stravitz RT, 2008, NEUROCRIT CARE, V9, P90, DOI 10.1007/s12028-008-9090-y; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Torossian A, 2004, CRIT CARE MED, V32, P1899, DOI 10.1097/01.CCM.0000139608.34486.FD; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wu XR, 2003, CRIT CARE MED, V31, P195, DOI 10.1097/00003246-200301000-00030; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3	51	24	28	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2010	11	1					109	116		10.1097/PCC.0b013e3181b01042			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	541FX	WOS:000273401800017	19602992	Green Accepted			2022-02-06	
J	Chen, SH; Chang, CY; Chang, HK; Chen, WC; Lin, MT; Wang, JJ; Chen, JCY; Chang, FM				Chen, Sheng-Hsien; Chang, Chia-Yu; Chang, Hsiu-Kang; Chen, Wei-Chun; Lin, Mao-Tsun; Wang, Jhi-Joung; Chen, Jeffrey Cheng-Yu; Chang, Fong-Ming			Premarin stimulates estrogen receptor-alpha to protect against traumatic brain injury in male rats	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; conjugated; estrogen; inflammation; angiogenesis; neurogenesis	CEREBRAL-ARTERY OCCLUSION; BETA-ESTRADIOL PROTECTS; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; FLUID PERCUSSION; NERVOUS-SYSTEM; ISCHEMIA; NEUROGENESIS; DAMAGE; EXCITOTOXICITY	Objectives: To establish mechanisms of neuroprotective actions induced by Premarin (an estrogen sulfate) during traumatic brain injury. Design: Chi Mei Medical Center research laboratory. Subjects: Male Sprague-Dawley rats 244 to 268 g. Interventions: Anesthetized rats, immediately after the onset of fluid percussion injury, were divided into three major groups and given the vehicle solution (1 mL/kg of body weight), Premarin (1 mg/kg of body weight), or Premarin (1 mg/kg of body weight) plus the nonselective estrogen receptor-alpha antagonist ICI 182, 780 (0.25 mg/kg of body weight) intravenously and immediately after fluid percussion injury. Measurements and Main Results: Premarin, in addition to inducing pharmacologic levels of estradiol, causes attenuation of fluid percussion injury-induced cerebral infarction and motor and cognitive function deficits. Fluid percussion injury-induced apoptosis (e.g., increased numbers of both terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive and caspase-3-positive cells) as well as activated inflammation (e.g., increased levels of tumor necrosis factor-alpha) was also significantly Premarin-reduced. In peri-ischemic areas of hippocampus, both angiogenesis (e.g., increased numbers of both 5-bromodeoxyuridine-positive endothelial and vascular endothelial growth factor-positive cells) and neurogenesis (e.g., increased numbers of both 5-bromodeoxyuridine/neuronal-specific nuclear protein double-positive and glial cell line-derived neurotrophic factor-positive cells) were Premarin therapy-promoted. In estrogen receptor-a. blockade rats, Premarin therapy had less or no effect on fluid percussion injury-induced behavioral deficits, cerebral infarction and apoptosis, and activated inflammation. Furthermore, Premarin-induced angiogenesis and neurogenesis were estrogen receptor-a blockade-reduced. Conclusions: Our results indicate that pharmacologic levels of Premarin therapy-induced estradiol protect against cortical and hippocampal programmed cell death after fluid percussion injury through mechanisms stimulating estrogen receptor-a in the male rats. (Crit Care Med 2009; 37:3097-3106)	[Chang, Fong-Ming] Natl Cheng Kung Univ, Dept Obstet & Gynecol, Sch Med, Tainan 70101, Taiwan; [Chen, Sheng-Hsien] Chi Mei Med Ctr, Dept Obstet & Gynecol, Tainan, Taiwan; [Chang, Chia-Yu] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Lin, Mao-Tsun; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chen, Sheng-Hsien; Chang, Chia-Yu] So Taiwan Univ Technol, Dept Biotechnol, Tainan, Taiwan; [Chen, Sheng-Hsien] Taipei Med Univ, Dept Obstet & Gynecol, Taipei, Taiwan; [Chang, Hsiu-Kang; Chen, Wei-Chun] Hlth Banks Biotech Co Ltd, Stem Cell Res Ctr, Taipei, Taiwan; [Chen, Jeffrey Cheng-Yu] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia		Chang, FM (corresponding author), Natl Cheng Kung Univ, Dept Obstet & Gynecol, Sch Med, Tainan 70101, Taiwan.	fchang@mail.ncku.edu.tw		chang, chia-yu/0000-0002-3403-7165	 [NSC 96-2314-B-384006-MY3];  [NSC 97-2321-B-384-001-MY2]	Supported, in part, by grants NSC 96-2314-B-384006-MY3 and NSC 97-2321-B-384-001-MY2.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Cardona-Gomez GP, 2000, J NEUROBIOL, V43, P269, DOI 10.1002/(SICI)1097-4695(20000605)43:3<269::AID-NEU5>3.0.CO;2-D; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen SH, 2006, CRIT CARE MED, V34, P1113, DOI 10.1097/01.CCM.0000205756.04845.15; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; Clark KE, 2000, AM J OBSTET GYNECOL, V183, P12, DOI 10.1067/mob.2000.105200; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189, DOI 10.1097/01.wcb.0000037991.07114.4e; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Matejuk A, 2001, J NEUROSCI RES, V65, P529, DOI 10.1002/jnr.1183; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Oberholzer A, 2000, CRIT CARE MED, V28, pN3, DOI 10.1097/00003246-200004001-00002; Paxinos G, 1982, RAT BRAIN STEREOTOXI; PEREZPOLO JR, 1977, LIFE SCI, V21, P1535, DOI 10.1016/0024-3205(77)90211-9; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Shen KH, 2008, SHOCK, V30, P668, DOI 10.1097/SHK.0b013e31817538cb; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Togashi H, 1998, NEUROSCI LETT, V240, P53, DOI 10.1016/S0304-3940(97)00918-X; TORANALLERAND CD, 1980, BRAIN RES, V184, P517; Wang Y, 1997, J NEUROSCI, V17, P4341; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; Wilson ME, 2000, BRAIN RES, V873, P235, DOI 10.1016/S0006-8993(00)02479-3; Wolf D, 2001, HEPATOLOGY, V34, P535, DOI 10.1053/jhep.2001.27218; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zhang WR, 2002, BRAIN RES, V947, P140, DOI 10.1016/S0006-8993(02)02923-2; Zhang WR, 2001, BRAIN RES, V903, P253, DOI 10.1016/S0006-8993(01)02364-2	45	24	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2009	37	12					3097	3106		10.1097/CCM.0b013e3181bc7986			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529IR	WOS:000272509800014	19789448				2022-02-06	
J	Laalo, JP; Kurki, TJ; Sonninen, PH; Tenovuo, OS				Laalo, Jussi P.; Kurki, Timo J.; Sonninen, Pirkko H.; Tenovuo, Olli S.			Reliability of Diagnosis of Traumatic Brain Injury by Computed Tomography in the Acute Phase	JOURNAL OF NEUROTRAUMA			English	Article						CT scanning; head trauma; traumatic brain injury	RADIOLOGY RESIDENT INTERPRETATIONS; ACUTE INTRACRANIAL HEMORRHAGE; DIFFUSE AXONAL INJURY; MINOR HEAD-INJURY; EMERGENCY-DEPARTMENT; CT; S100B; MILD; MR; SERUM	The purpose of our study was to determine the accuracy and reliability of the computed tomographic (CT) diagnosis of acute traumatic brain injury (TBI) and to evaluate the inter-observer variation of CT reports of acute TBI between two experienced neuroradiologists and a neuroradiologist in training. One hundred cranial CT examinations of suspected TBI were chosen randomly from those taken during 1 year at a university central hospital, with institutional ethics committee approval. Two neuroradiologists and one neuroradiologist in training read the scans independently and were blinded to the clinical data. The original reports of radiologists on call, who were either radiology residents or general radiologists, were reviewed. Main outcome measures were false-positive and false-negative findings, and the congruency of different readers' reports. The reference standard was a group consensus formed by three neuroradiologists. Radiologists on call missed a significant number of brain contusions (67%), but with regard to intraventricular and subarachnoid hemorrhages and edema, their accuracy was moderate. They reported practically no false-positive brain contusion findings, and all readers found subdural hemorrhages reliably. The two experienced neuroradiologists had the smallest number of false-negative findings, but their reports differed significantly. Of the other neuroradiologists' mistakes, 75% were false-positive, nearly all of these concerning contusions, whereas the other made random mistakes. In conclusion, there was a marked variation between readers in the detection of brain contusion findings on acute brain CT. Experience increased accuracy, yet even between the reports of the most experienced readers, there were marked differences.	[Laalo, Jussi P.; Sonninen, Pirkko H.] Turku Univ, Cent Hosp, Med Imaging Ctr, Turku 20521, Finland; [Tenovuo, Olli S.] Turku Univ, Cent Hosp, Dept Neurol, Turku, Finland; [Kurki, Timo J.; Sonninen, Pirkko H.] Pulssi Med Imaging Ctr, Turku, Finland		Laalo, JP (corresponding author), Turku Univ, Cent Hosp, Med Imaging Ctr, PL 52, Turku 20521, Finland.	jlaalo@utu.fi		Kurki, Timo/0000-0001-5532-3534			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; ALFARO D, 1995, ANN EMERG MED, V25, P169, DOI 10.1016/S0196-0644(95)70319-5; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Branstetter BF, 2007, ACAD RADIOL, V14, P201, DOI 10.1016/j.acra.2006.11.001; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chan T, 2008, ACAD RADIOL, V15, P290, DOI 10.1016/j.acra.2007.09.022; Chan T, 2007, COMPUT MED IMAG GRAP, V31, P285, DOI 10.1016/j.compmedimag.2007.02.010; Cooper VF, 2008, ACAD RADIOL, V15, P1198, DOI 10.1016/j.acra.2008.02.011; Davis P C, 2000, Radiology, V215 Suppl, P507; Erly WK, 2003, AM J ROENTGENOL, V180, P1727, DOI 10.2214/ajr.180.6.1801727; Ezaki Y, 2006, ACTA NEUROCHIR, V148, P547, DOI 10.1007/s00701-005-0692-2; Filippi CG, 2008, RADIOLOGY, V249, P972, DOI 10.1148/radiol.2493071543; Fiser SM, 1998, AM SURGEON, V64, P1088; GRANT JM, 1991, LANCET, V337, P215, DOI 10.1016/0140-6736(91)92169-3; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; HILLMAN BJ, 1976, AM J ROENTGENOL, V127, P807, DOI 10.2214/ajr.127.5.807; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kuhlmann J. N., 2008, Morphologie, V92, P68, DOI 10.1016/j.morpho.2008.06.002; Le AH, 2007, EMERG RADIOL, V14, P311, DOI 10.1007/s10140-007-0645-6; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Rieger M, 2009, J TRAUMA, V66, P648, DOI 10.1097/TA.0b013e31816275f3; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Ruchhjoltz S, 2002, CHIRURG, V73, P1005, DOI 10.1007/s00104-002-0429-1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Sistrom C, 2008, ACAD RADIOL, V15, P934, DOI 10.1016/j.acra.2008.02.013; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Strub WM, 2007, AM J NEURORADIOL, V28, P1679, DOI 10.3174/ajnr.A0653; Strub WM, 2006, EMERG RADIOL, V13, P19, DOI 10.1007/s10140-006-0498-4; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4; Wysoki MG, 1998, RADIOLOGY, V208, P125, DOI 10.1148/radiology.208.1.9646802; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590	45	24	24	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2169	2178		10.1089/neu.2009.1011			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200004	19691423				2022-02-06	
J	Li, YZ; Bondada, V; Joshi, A; Geddes, JW				Li, Yanzhang; Bondada, Vimala; Joshi, Aashish; Geddes, James W.			Calpain 1 and Calpastatin expression is developmentally regulated in rat brain	EXPERIMENTAL NEUROLOGY			English	Article						Calcium; Apoptosis; Necrosis; Cell death; Injury	APOPTOSIS-INDUCING FACTOR; CELL-DEATH; MU-CALPAIN; HYPOXIA-ISCHEMIA; TRAUMATIC BRAIN; DIFFERENTIAL EXPRESSION; POSTNATAL DEVELOPMENT; CEREBRAL-CORTEX; NEURONAL DEATH; INJURY	Calpains and caspases are cysteine endopeptidases which share many similar substrates. Caspases are essential for caspase-dependent apoptotic death where calpains may play an augmentive role, while calpains are strongly implicated in necrotic cell death morphologies. Previous studies have demonstrated a down-regulation in the expression of many components of the caspase-dependent cell death pathway during CNS development. We therefore sought to determine if there is a corresponding upregulation of calpains. The major CNS calpains are the g-and m-isoforms, composed of the unique 80 kDa calpain 1 and 2 subunits, respectively, and the shared 28 kDa small subunit. In rat brain, relative protein and mRNA levels of calpain 1, calpain 2, caspase 3, and the endogenous calpain inhibitor-calpastatin, were evaluated using western blot and real-time RT-PCR. The developmental time points examined ranged from embryonic day IS until postnatal day 90. Calpain 1 and calpastatin protein and mRNA levels were low at early developmental time points and increased dramatically by P30. Conversely, caspase-3 expression was greatest at E18, and was rapidly downregulated by P30. Calpain 2 protein and mRNA levels were relatively constant throughout the E18-P90 age range examined. The inverse relationship of calpain I and caspase 3 levels during CNS development is consistent with the shift from caspase-dependent to caspase-independent cell death mechanisms following CNS injury in neonatal vs. adult rat brain. (C) 2009 Elsevier Inc. All rights reserved.	[Geddes, James W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, SCoBIRC, Lexington, KY 40536 USA; [Joshi, Aashish; Geddes, James W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, SCoBIRC, B477 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	jgeddes@uky.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1AG10836, PO1NS058484, P30NS051220]; Kentucky Spinal Cord and Brain Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058484, P30NS051220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG010836] Funding Source: NIH RePORTER	The funding for this research was provided by NIH grants PO1AG10836, PO1NS058484, and P30NS051220; and support from the Kentucky Spinal Cord and Brain Injury Research Trust.	AGHAJANIAN G. K., 1967, BRAIN RES, V6, P716, DOI 10.1016/0006-8993(67)90128-X; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; BLOMGREN K, 1989, NEUROCHEM RES, V14, P1149, DOI 10.1007/BF00965622; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; CHAKRABARTI AK, 1993, DEV BRAIN RES, V71, P107, DOI 10.1016/0165-3806(93)90111-M; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; EAYRS JT, 1959, J ANAT, V93, P385; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Gill R, 2002, J CEREBR BLOOD F MET, V22, P420, DOI 10.1097/00004647-200204000-00006; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Honda M, 2008, AM J PHYSIOL-CELL PH, V294, pC957, DOI 10.1152/ajpcell.00505.2007; Honda S, 2004, J BIOL CHEM, V279, P10615, DOI 10.1074/jbc.M308841200; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Kar P, 2008, ARCH BIOCHEM BIOPHYS, V470, P176, DOI 10.1016/j.abb.2007.11.018; Kar P, 2007, ARCH BIOCHEM BIOPHYS, V466, P290, DOI 10.1016/j.abb.2007.07.022; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Liu CL, 2004, NEUROSCIENCE, V127, P113, DOI 10.1016/j.neuroscience.2004.03.062; Liu WF, 2002, J BIOL CHEM, V277, P8273, DOI 10.1074/jbc.M110768200; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Madden SD, 2007, INT J DEV BIOL, V51, P415, DOI 10.1387/ijdb.062263sm; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Pang Z, 2003, J NEUROPATH EXP NEUR, V62, P633, DOI 10.1093/jnen/62.6.633; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; PYSH JJ, 1970, BRAIN RES, V18, P325, DOI 10.1016/0006-8993(70)90332-X; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raynaud F, 2008, INT J DEV BIOL, V52, P383, DOI 10.1387/ijdb.072448fr; Raynaud P, 2005, ARCH BIOCHEM BIOPHYS, V437, P69, DOI 10.1016/j.abb.2005.02.026; Shimohama S, 2001, BIOCHEM BIOPH RES CO, V289, P1063, DOI 10.1006/bbrc.2001.6108; SIMONSON L, 1985, BRAIN RES, V327, P153, DOI 10.1016/0006-8993(85)91509-4; STURROCK RR, 1974, J ANAT, V117, P37; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yeo W, 2004, DEV BIOL, V274, P233, DOI 10.1016/j.ydbio.2004.07.026; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	51	24	25	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2009	220	2					316	319		10.1016/j.expneurol.2009.09.004			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	528FV	WOS:000272428700014	19751724	Green Accepted			2022-02-06	
J	Bouilleret, V; Cardamone, L; Liu, YR; Fang, K; Myers, DE; O'Brien, TJ				Bouilleret, Viviane; Cardamone, Lisa; Liu, Ying Rui; Fang, Ke; Myers, Damian E.; O'Brien, Terence J.			Progressive Brain Changes on Serial Manganese-Enhanced MRI following Traumatic Brain Injury in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						atrophy; manganese-enhanced MRI; plasticity; prognostic; traumatic brain injury	CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; IN-VIVO; HEAD-INJURY; TIME-COURSE; SELECTIVE VULNERABILITY; SYNAPTIC REORGANIZATION; POSTTRAUMATIC EPILEPSY; DENTATE GYRUS; MOUSE-BRAIN	Traumatic brain injury (TBI) has a high incidence of long-term morbidity. Manganese-enhanced MRI (MEMRI) provides high contrast structural and functional detail of the brain in-vivo. The study utilized serial MEMRI scanning in the fluid percussion injury (FPI) rat's model to assess long-term changes in the brain following TBI. Rats underwent a left-sided craniotomy and a 3.5 atmosphere FPI pulse (n = 23) or sham procedure (n = 22). MEMRI acquisition was performed at baseline, 1 day, 1 month, and 6 months after FPI. Volume changes and MnCl2 enhancement were measured blindly using region-of-interest analysis and the results analyzed with repeated measures MANOVA. Compared to the shams, FPI animals showed a progressive decrease in brain volume from 1 (right, p = 0.02; left, p = 0.008) to 6 months (right, p = 0.04; left, p = 0.006), with progression over time (F = 7.16, p = 0.00018). Similar changes were found in the cortex and the hippocampus. Conversely, the ventricular volume was increased at 1 (p = 0.02) and 6 months (p = 0.003), with progression over time (F = 7.27, p = 0.0001). There were no differences in thalamic or amygdalae volumes. The severity of the early neuromotor deficits and the T2 signal intensity of the subacute focal lesion were highly predictive of the severity of the long-term hippocampal decrease, and the former was also associated with the degree of neuronal sprouting. Differential MnCl2 enhancement occurred only in the dentate gyrus at 1 month on the side of trauma (p = 0.04). Progressive functional and structural changes occur in specific brain regions post-FPI. The severity of the neuromotor deficit and focal signal changes on MRI subacutely post-injury are predictive of severity of these long-term neurodegenerative changes.	[Bouilleret, Viviane; Cardamone, Lisa; Liu, Ying Rui; Myers, Damian E.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia; [Bouilleret, Viviane] CHU Bicetre, ApHp, Dept Neurophysiol & Epilepsy, Paris, France; [Fang, Ke] Howard Florey Inst, Parkville, Vic, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia		O'Brien, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Clin Sci Bldg,4th Floor Royal Parade, Parkville, Vic 3050, Australia.	obrientj@unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Bouilleret, viviane/AAQ-5878-2021; Myers, Damian E/L-5302-2013	O'Brien, Terence/0000-0002-7198-8621; Myers, Damian/0000-0002-7569-9907	Victorian Government Transport Accident Commission (TAC) [DP0023]	Funding for this project was provided by the Victorian Government Transport Accident Commission (TAC) in the form of a Victorian Neurotrauma Initiative Project grant (DP0023).	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alvestad S, 2007, NEUROIMAGE, V38, P57, DOI 10.1016/j.neuroimage.2007.07.027; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bouilleret V, 2009, NEUROIMAGE, V45, P267, DOI 10.1016/j.neuroimage.2008.12.019; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Conti AC, 1998, J NEUROSCI, V18, P5663; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Elmer E, 1997, NEUROREPORT, V8, P1193, DOI 10.1097/00001756-199703240-00027; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Franco-Pons N, 2000, NEUROSCIENCE, V98, P429, DOI 10.1016/S0306-4522(00)00153-6; FREDERICKSON CJ, 1983, BRAIN RES, V273, P335, DOI 10.1016/0006-8993(83)90858-2; Frumberg DB, 2007, BRAIN RES, V1144, P209, DOI 10.1016/j.brainres.2007.01.134; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hsu YH, 2007, BRAIN, V130, P3124, DOI 10.1093/brain/awm207; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kuo YT, 2005, J MAGN RESON IMAGING, V21, P334, DOI 10.1002/jmri.20285; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Longo BM, 1998, EPILEPSY RES, V32, P172, DOI 10.1016/S0920-1211(98)00049-7; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mathern GW, 1998, J NEUROSCI RES, V54, P734, DOI 10.1002/(SICI)1097-4547(19981215)54:6<734::AID-JNR2>3.0.CO;2-P; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nairismagi J, 2006, NEUROIMAGE, V30, P130, DOI 10.1016/j.neuroimage.2005.09.007; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Obenaus A, 2007, EPILEPSIA, V48, P11, DOI 10.1111/j.1528-1167.2007.01237.x; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; REPRESA A, 1993, HIPPOCAMPUS, V3, P257, DOI 10.1002/hipo.450030303; RINK A, 1995, AM J PATHOL, V147, P1575; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULL, V34, P595, DOI 10.1093/schbul/sbn056; Sloviter RS, 2006, J COMP NEUROL, V494, P944, DOI 10.1002/cne.20850; Sloviter RS, 1999, EPILEPSIA, V40, pS34, DOI 10.1111/j.1528-1157.1999.tb00876.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; TAKEDA A, 1994, BRAIN RES, V640, P341, DOI 10.1016/0006-8993(94)91891-0; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Toth Z, 1997, J NEUROSCI, V17, P8106; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; van Raay L, 2009, J NEUROSCI METH, V179, P184, DOI 10.1016/j.jneumeth.2009.01.024; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Watanabe T, 2004, NMR BIOMED, V17, P554, DOI 10.1002/nbm.937; Watanabe T, 2002, MAGN RESON MED, V48, P852, DOI 10.1002/mrm.10276; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477	74	24	24	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1999	2013		10.1089/neu.2009.0943			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600015	19604101				2022-02-06	
J	Charrueau, C; Belabed, L; Besson, V; Chaumeil, JC; Cynober, L; Moinard, C				Charrueau, Christine; Belabed, Linda; Besson, Valerie; Chaumeil, Jean-Claude; Cynober, Luc; Moinard, Christophe			Metabolic Response and Nutritional Support in Traumatic Brain Injury: Evidence for Resistance to Renutrition	JOURNAL OF NEUROTRAUMA			English	Article						enteral nutrition; intestine; muscle; protein metabolism	IMMUNE-ENHANCING DIET; SEVERE HEAD-INJURY; INTESTINAL MUCOSAL APOPTOSIS; BACTERIAL TRANSLOCATION; ENTERAL NUTRITION; URINARY-EXCRETION; PROTEIN-TURNOVER; FLUID PERCUSSION; ENTEROCYTE MASS; SKELETAL-MUSCLE	Traumatic brain injury (TBI) is one of the most severe injuries encountered in intensive care units. TBI patients exhibit protein wasting and gastrointestinal dysfunction, which may be risk factors for a septic state. Specific nutritional support may be required for these patients, and we hypothesize that standard nutritional support does not allow restoration of the nutritional state of TBI patients. A well-validated rat model of TBI by fluid percussion was used. Rats were randomized into three groups: healthy rats receiving standard chow diet ad libitum (AL), rats sustaining TBI and receiving standard chow diet (TBI), and rats sustaining TBI and receiving a standard enteral diet (TBI-EN) for 4 days. TBI in rats was characterized by anorexia, body weight loss (AL: +15 +/- 5 g versus TBI: -11 +/- 4 g and TBI-EN: -8 +/- 4g; p < 0.05), decrease in nitrogen balance (AL: 2.9 +/- 0.2 g versus TBI: 1.0 +/- 0.2 g and TBI-EN: 0.2 +/- 0.2 g, p < 0.05) associated with decrease in muscular protein content (extensor digitorum longus [EDL]: AL: 36 +/- 2 mg versus TBI: 26 +/- 3 mg and TBI-EN: 28 +/- 2 mg; p < 0.05), and intestinal atrophy (ileum: AL: 673 +/- 42 mg versus TBI: 442 +/- 23 mg and TBI-EN: 377 +/- 27 mg; p < 0.05). Interestingly, standard enteral nutrition was not effective in restoring any of these parameters. This work confirms that TBI is associated with profound nutritional alterations and has a major impact on nitrogen metabolism and on intestinal trophicity. It also demonstrates that using standard enteral nutrition cannot reverse this phenomenon. Thus, developing new nutritional strategies to cover TBI patients' specific nutritional requirements appears mandatory.	[Belabed, Linda; Cynober, Luc; Moinard, Christophe] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Biol Nutr, EA2498, F-75270 Paris 06, France; [Charrueau, Christine; Chaumeil, Jean-Claude] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharm Galen Lab, EA2498, F-75270 Paris 06, France; [Besson, Valerie] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale, EA2510, F-75270 Paris 06, France; [Cynober, Luc] Interhosp Cochin Hotel Dieu, APHP, Serv Biochim, Paris, France		Moinard, C (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Biol Nutr, EA2498, 4 Ave Observ, F-75270 Paris 06, France.	christophe.moinard@parisdescartes.fr	besson, valerie C/L-7388-2017; BESSON, VALERIE/AAZ-9989-2020; Cynober, Luc/ABB-2368-2020	besson, valerie C/0000-0002-1491-2380; BESSON, VALERIE/0000-0002-1491-2380; 	Ministry of Research and TechnologyMinistry of Research and Technology of the Republic of Indonesia (RISTEK) [EA2498]; Nestle Clinical Nutrition (Noisiel, France)Nestle SA	We thank S. Gupta and A. Paillard for their technical assistance. The authors thank Harvard Apparatus and Minerve, which provided the devices used in this study. This work was supported in part by funds from the Ministry of Research and Technology (EA2498) and in part by a grant from Nestle Clinical Nutrition (Noisiel, France).	Aydin S, 2005, SURG TODAY, V35, P751, DOI 10.1007/s00595-005-3034-3; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Belabed L, 2006, CLIN NUTR, V25, P832, DOI 10.1016/j.clnu.2006.02.003; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Blanc MC, 2000, CLIN CHEM LAB MED, V38, P465, DOI 10.1515/CCLM.2000.067; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; COUDRAYLUCAS C, 1985, CLIN NUTR, V4, P179, DOI 10.1016/0261-5614(85)90026-3; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; Cui XL, 2001, SURG TODAY, V31, P615, DOI 10.1007/s005950170096; Curis E, 2007, CURR OPIN CLIN NUTR, V10, P620, DOI 10.1097/MCO.0b013e32829fb38d; Cynober L., 2004, METABOLIC THERAPEUTI, V2nd ed; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; FLEURY P, 1951, Ann Biol Clin (Paris), V9, P453; GRIMBLE G, 1991, JPEN-PARENTER ENTER, V15, P696, DOI 10.1177/0148607191015006696; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; HASSELGREN PO, 1986, ARCH SURG-CHICAGO, V121, P918; Heimburger DC, 1997, JPEN-PARENTER ENTER, V21, P162, DOI 10.1177/0148607197021003162; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jeevanandam M., 1995, Amino acid metabolism and therapy in health and nutritional disease., P245; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Loi C, 2005, NUTRITION, V21, P255, DOI 10.1016/j.nut.2004.05.021; LONG CL, 1981, METABOLISM, V30, P765, DOI 10.1016/0026-0495(81)90022-6; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Louin G, 2004, J NEUROSCI METH, V138, P73, DOI 10.1016/j.jneumeth.2004.03.010; MacFie J, 2006, BRIT J SURG, V93, P87, DOI 10.1002/bjs.5184; MALTIN CA, 1989, AM J PHYSIOL, V257, pE823, DOI 10.1152/ajpendo.1989.257.6.E823; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898, DOI 10.1152/ajpendo.1997.273.5.E898; Martindale RG, 2001, JPEN-PARENTER ENTER, V25, pS27, DOI 10.1177/014860710102500207; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Moinard C, 2006, NUTRITION, V22, P1039, DOI 10.1016/j.nut.2006.06.005; Neveux N, 2004, METABOLIC THERAPEUTI, P17; PEREL P, 2007, COCHRANE DB SYST REV, P1; Pernet P, 1996, CLIN CHIM ACTA, V249, P141, DOI 10.1016/0009-8981(96)06283-3; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; Scarlett CJ, 2004, CLIN NUTR, V23, P1135, DOI 10.1016/j.clnu.2004.02.008; SJOLIN J, 1989, METABOLISM, V38, P23, DOI 10.1016/0026-0495(89)90175-3; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Todd S Rob, 2006, Nutr Clin Pract, V21, P421, DOI 10.1177/0115426506021005421; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Ulusoy H, 2003, J CLIN NEUROSCI, V10, P596, DOI 10.1016/S0967-5868(03)00142-5; YOUNG VR, 1978, FED PROC, V37, P2291; Zarrabian S, 1999, NUTRITION, V15, P474, DOI 10.1016/S0899-9007(99)00054-4; Zarrabian S, 1998, CLIN NUTR, V17, P169, DOI 10.1016/S0261-5614(98)80053-8	52	24	25	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1911	1920		10.1089/neu.2008.0737			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600006	19929216				2022-02-06	
J	Farias, S; Frey, LC; Murphy, RC; Heidenreich, KA				Farias, Santiago; Frey, Lauren C.; Murphy, Robert C.; Heidenreich, Kim A.			Injury-Related Production of Cysteinyl Leukotrienes Contributes to Brain Damage following Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cysteinyl leukotrienes; inflammation; mass spectrometry; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; ARACHIDONIC-ACID; MOLECULAR-CLONING; RAT-BRAIN; BIOSYNTHESIS; RECEPTOR; MICE; 5-LIPOXYGENASE; NEUTROPHILS; METABOLISM	The leukotrienes belong to a family of biologically active lipids derived from arachidonate that are often involved in inflammatory responses. In the central nervous system, a group of leukotrienes, known as the cysteinyl leukotrienes, is generated in brain tissue in response to a variety of acute brain injuries. Although the exact clinical significance of this excess production remains unclear, the cysteinyl leukotrienes may contribute to injury-related disruption of the brain-blood barrier and exacerbate secondary injury processes. In the present study, the formation and role of cysteinyl leukotrienes was explored in the fluid percussion injury model of traumatic brain injury in rats. The results showed that levels of the cysteinyl leukotrienes were elevated after fluid percussion injury with a maximal formation 1 hour after the injury. Neutrophils contributed to cysteinyl leukotriene formation in the injured brain hemisphere, potentially through a transcellular biosynthetic mechanism. Furthermore, pharmacological reduction of cysteinyl leukotriene formation after the injury, using MK-886, resulted in reduction of brain lesion volumes, suggesting that the cysteinyl leukotrienes play an important role in traumatic brain injury.	[Farias, Santiago; Murphy, Robert C.; Heidenreich, Kim A.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Farias, Santiago; Frey, Lauren C.; Murphy, Robert C.; Heidenreich, Kim A.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; [Frey, Lauren C.] Colorado Injury Control & Res Ctr, Ft Collins, CO USA; [Heidenreich, Kim A.] Eastern Colorado Hlth Care Syst, VA Res Serv, Denver, CO USA		Heidenreich, KA (corresponding author), Univ Colorado Denver, Dept Pharmacol, Anschutz Med Campus,MS 8303,12800 E 19th Ave,POB, Aurora, CO 80045 USA.	kim.heidenreich@uchsc.edu			Colorado TBI Trust Fund; Colorado Injury Control and Research Center; Eastern Colorado Health Care System; National Institute of Heart, Lung and BloodUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL25785]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL025785]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL025785, R37HL025785] Funding Source: NIH RePORTER	This project was supported by grants from the Colorado TBI Trust Fund Research Program, the Colorado Injury Control and Research Center, the Eastern Colorado Health Care System, the National Institute of Heart, Lung and Blood (HL25785), and the National Institutes of Health (HL025785). The authors wish to thank Erin Genova and Storey Wilson (Pathology Department, UCDenver) for their help with the histological studies, and Aaron Lepkin and Cheri Unkart for their help with the behavioral testing.	BABA T, 1991, J CEREBR BLOOD F MET, V11, P638, DOI 10.1038/jcbfm.1991.115; Ballerini P, 2005, INT J IMMUNOPATH PH, V18, P255, DOI 10.1177/039463200501800208; Beray-Berthat V, 2003, BRAIN RES, V987, P32, DOI 10.1016/S0006-8993(03)03224-4; BORGEAT P, 1979, J BIOL CHEM, V254, P7865; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Busse W, 2005, CHEST, V127, P1312, DOI 10.1378/chest.127.4.1312; Capra V, 2004, PHARMACOL RES, V50, P1, DOI 10.1016/j.phrs.2003.12.012; CHIAMULERA C, 1993, BRAIN RES, V606, P251, DOI 10.1016/0006-8993(93)90992-V; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Deutsch J, 1997, NEUROCHEM RES, V22, P759, DOI 10.1023/A:1022030306359; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Farias SE, 2007, J NEUROCHEM, V103, P1310, DOI 10.1111/j.1471-4159.2007.04830.x; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; FISHER H, 2008, CRS REP C WASH DC; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; GUHLMANN A, 1989, J EXP MED, V170, P1905, DOI 10.1084/jem.170.6.1905; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hu H, 2005, ACTA PHARMACOL SIN, V26, P685, DOI 10.1111/j.1745-7254.2005.00092.x; JATANA M, 2006, J NEUROINFLAMM, V11, P3; Kitagawa K, 2004, BRAIN RES, V1004, P198, DOI 10.1016/j.brainres.2004.01.018; Lam BK, 2003, PROSTAG LEUKOTR ESS, V69, P111, DOI 10.1016/S0952-3278(03)00071-1; LANGOIS JA, 2006, TRAUMATIC BRAIN INJU; Leslie CC, 2004, PROSTAG LEUKOTR ESS, V70, P373, DOI 10.1016/j.plefa.2003.12.012; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601; PALMBLAD J, 1984, J IMMUNOL, V132, P3041; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Provost P, 1998, BRIT J PHARMACOL, V123, P251, DOI 10.1038/sj.bjp.0701611; Rao AM, 1999, NEUROCHEM RES, V24, P1225, DOI 10.1023/A:1020916905312; Rouzer C A, 1986, Adv Prostaglandin Thromboxane Leukot Res, V16, P3; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Soares HD, 1995, J NEUROSCI, V15, P8223; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Wang ML, 2006, BIOCHEM BIOPH RES CO, V350, P399, DOI 10.1016/j.bbrc.2006.09.057; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Yu GL, 2005, PHARMACOLOGY, V73, P31, DOI 10.1159/000081072; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	54	24	25	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1977	1986		10.1089/neu.2009.0877			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600013	19886806	Green Published			2022-02-06	
J	Scharbrodt, W; Stein, M; Schreiber, V; Boker, DK; Oertel, MF				Scharbrodt, Wolfram; Stein, Marco; Schreiber, Vanessa; Boeker, Dieter-Karsten; Oertel, Matthias F.			The prediction of long-term outcome after subarachnoid hemorrhage as measured by the Short Form-36 Health Survey	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Glasgow Outcome Scale score; SF-36; Subarachnoid hemorrhage; Outcome	QUALITY-OF-LIFE; GOOD NEUROLOGICAL RECOVERY; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL VASOSPASM; INTRACRANIAL ANEURYSMS; PSYCHOSOCIAL OUTCOMES; COOPERATIVE ANEURYSM; SCALE; PROGNOSIS	The Glasgow Outcome Scale (GOS) score is widely used to assess Outcome after a subarachnoid hemorrhage (SAH). Patients who have recovered fully or with a mild disability (GOS scores 4 and 5) frequently complain about difficulties in conducting their daily activities. The Short Form-36 (SF-36) Health Survey is a questionnaire that assesses outcomes in multiple categories. This study was conducted to compare the quality of outcome assessment between the SF-36 Health Survey and COS scores. A total of 128 patients with SAH (all data expressed as mean +/- standard deviation) aged 53.1 +/- 12.1 years, and a mean Hunt and Hess grade on admission of 2 +/- 1, were retrospectively included in the Study. Medical charts were reviewed to assess previous medical history, location of the aneurysm and the presence of vasospasm. The SF-36 and GOS scores were collected in structured interviews approximately 5 years (+/- 2 years) after the SAH. The SF-36 data were compared to a historical healthy control cohort of 2,474 individuals. The results showed that 52% of patients experienced a favourable outcome after SAH (GOS scores 4 and 5). Vasospasm was recorded in 25% of patients. However, the average SF-36 results were lower in all tested categories for patients after SAH than the healthy normal controls. None of the SF-36 categories except physical function correlated significantly with the GOS score. Aneurysm location did not have an impact on SF-36 data. Patients after a SAH assessed as COS score 5 are significantly impaired in social functioning and general health. We conclude that patients continue to suffer neuropsychological deficits years after a SAH. The GOS score is a rough outcome measure that primarily focuses on physical functioning. SF-36 is a useful tool to include in the neuropsychological Outcome assessment of patients with SAH. (C) 2009 Elsevier Ltd. All rights reserved.	[Scharbrodt, Wolfram; Stein, Marco; Schreiber, Vanessa; Boeker, Dieter-Karsten; Oertel, Matthias F.] Univ Hosp Giessen, Dept Neurosurg, D-35385 Giessen, Germany		Oertel, MF (corresponding author), Univ Hosp Giessen, Dept Neurosurg, Klin Str 29, D-35385 Giessen, Germany.	matthias.oertel@neuro.med.uni-giessen.de					ADAMS HP, 1987, NEUROLOGY, V37, P1586, DOI 10.1212/WNL.37.10.1586; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Cedzich C, 2005, ZBL NEUROCHIR, V66, P112, DOI 10.1055/s-2005-836477; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1993, NEUROSURGERY, V33, P999; Hutter BO, 2001, J NEUROSURG, V94, P241, DOI 10.3171/jns.2001.94.2.0241; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1975, CIBA F SYMP, V4, P3; KASSELL NF, 1983, NEUROSURGERY, V13, P479, DOI 10.1227/00006123-198311000-00001; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; Katati MJ, 2007, CEREBROVASC DIS, V24, P66, DOI 10.1159/000103118; Kim DH, 2005, STROKE, V36, P792, DOI 10.1161/01.STR.0000157594.58180.97; King W A, 1994, Neurosurg Clin N Am, V5, P767; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Ohkuma H, 2001, STROKE, V32, P1176, DOI 10.1161/01.STR.32.5.1176; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; Ransom ER, 2007, NEUROCRIT CARE, V6, P174, DOI 10.1007/s12028-007-0019-7; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schuiling WJ, 2005, STROKE, V36, P578, DOI 10.1161/01.STR.0000154862.33213.73; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Ware J.E., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1987, J CHRON DIS, V40, P473; Wik Kirsten E, 2005, Tidsskr Nor Laegeforen, V125, P152	33	24	24	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2009	16	11					1409	1413		10.1016/j.jocn.2009.01.011			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	509YB	WOS:000271054100004	19581094				2022-02-06	
J	Larson, MJ; Perlstein, WM				Larson, Michael J.; Perlstein, William M.			Awareness of deficits and error processing after traumatic brain injury	NEUROREPORT			English	Article						attention; awareness; cognitive control; electroencephalogram; error-related negativity; executive; traumatic brain injury	COGNITIVE CONTROL; ANTISACCADE TASK; SEVERE TBI; COMPONENTS; ERP; POTENTIALS; NEGATIVITY; ATTENTION	Severe traumatic brain injury is frequently associated with alterations in performance monitoring, including reduced awareness of physical and cognitive deficits. We examined the relationship between awareness of deficits and electrophysiological indices of performance monitoring, including the error-related negativity and posterior positivity (Pe) components of the scalp-recorded event-related potential, in 16 traumatic brain injury survivors who completed a Stroop color-naming task while event-related potential measurements were recorded. Awareness of deficits was measured as the discrepancy between patient and significant-other ratings on the Frontal Systems Behavior Scale. The amplitude of the Pe, but not error-related negativity, was reliably associated with decreased awareness of deficits. Results indicate that Pe amplitude may serve as an electrophysiological indicator of awareness of abilities and deficits. NeuroReport 20:1486-1490 (C) 2009 Wolters Kluwer Health I Lippincott Williams & Wilkins.	[Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Perlstein, William M.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	michael_larson@byu.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	National Institute of Health (NIH) FellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31NS053335]; Evelyn F McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Research Trust Fund; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01 MH01857, R21 MH073076]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH001857, R21MH073076] Funding Source: NIH RePORTER	The study was supported by a National Institute of Health (NIH) Fellowship to M.J.L. (F31NS053335) and grants from the Evelyn F McKnight Brain Research Grant Program, the Florida Brain and Spinal Cord Injury Research Trust Fund, and the National Institute of Health to WMT (K01 MH01857; R21 MH073076).	ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; ARBEL Y, PSYCHOPHYSI IN PRESS; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; TEASDALE G, 1974, LANCET, V2, P81; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	25	24	24	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	OCT 28	2009	20	16					1486	1490		10.1097/WNR.0b013e32833283fe			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	512ZY	WOS:000271292400018	19809369				2022-02-06	
J	Abouzari, M; Rashidi, A; Zandi-Toghani, M; Behzadi, M; Asadollahi, M				Abouzari, Mehdi; Rashidi, Armin; Zandi-Toghani, Mehdi; Behzadi, Mehrdad; Asadollahi, Marjan			Chronic subdural hematoma outcome prediction using logistic regression and an artificial neural network	NEUROSURGICAL REVIEW			English	Article						Chronic subdural hematoma; Neural network; Regression; Outcome prediction	TRANSPORT-RELATED INJURIES; TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; SURGICAL-TREATMENT; RECURRENCE; MODEL; EPIDEMIOLOGY; TEHRAN; AGE	Artificial neural networks (ANN) have not been used in chronic subdural hematoma (CSDH) outcome prediction following surgery. We used two methods, namely logistic regression and ANN, to predict using eight variables CSDH outcome as assessed by the Glasgow outcome score (GOS) at discharge. We had 300 patients (213 men and 87 women) and potential predictors were age, sex, midline shift, intracranial air, hematoma density, hematoma thickness, brain atrophy, and Glasgow coma score (GCS). The dataset was randomly divided to three subsets: (1) training set (150 cases), (2) validation set (75 cases), and (3) test set (75 cases). The training and validation sets were combined for regression analysis. Patients aged 56.5 +/- 18.1 years and 228 (76.0%) of them had a favorable outcome. The prevalence of brain atrophy, intracranial air, midline shift, low GCS, thick hematoma, and hyperdense hematoma was 142 (47.3%), 156 (52.0%), 177 (59.0%), 82 (27.3%), 135 (45.0%), and 52 (17.3%), respectively. The regression model did not show an acceptable performance on the test set (area under the curve (AUC) = 0.594; 95% CI, 0.435-0.754; p = 0.250). It had a sensitivity of 69% and a specificity of 46%, and correctly classified 50.7% of cases. A four-layer 8-3-4-1 feedforward backpropagation ANN was then developed and trained. The ANN showed a remarkably superior performance compared to the regression model (AUC = 0.767; 95% CI, 0.652-0.882; p = 0.001). It had a sensitivity of 88% and a specificity of 68%, and correctly classified 218 (72.7%) cases. Considering that GOS strongly correlates with the risk of recurrence, the ANN model can also be used to predict the recurrence of CSDH.	[Abouzari, Mehdi; Rashidi, Armin; Behzadi, Mehrdad] Univ Tehran Med Sci, Amir Alam Hosp, Tehran, Iran; [Rashidi, Armin] Univ Tehran, Dept Math, Tehran, Iran; [Zandi-Toghani, Mehdi] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Asadollahi, Marjan] Shahid Beheshti Univ Med Sci, Loghman Hosp, Tehran, Iran		Abouzari, M (corresponding author), Univ Tehran Med Sci, Amir Alam Hosp, 48 Alaei Alley,Ard E Iran St, Tehran, Iran.	abouzari.m@gmail.com		Abouzari, Mehdi/0000-0002-3585-698X; Rashidi, Armin/0000-0002-9384-272X			Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232; Amirjamshidi A, 2007, J CLIN NEUROSCI, V14, P1240, DOI 10.1016/j.jocn.2006.03.030; Amirjamshidi A, 2007, CLIN NEUROL NEUROSUR, V109, P152, DOI 10.1016/j.clineuro.2006.07.007; Asano Y, 1992, No To Shinkei, V44, P827; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; CAMERON MM, 1978, J NEUROL NEUROSUR PS, V41, P834, DOI 10.1136/jnnp.41.9.834; Cucchiara Brett L., 2002, Curr Treat Options Neurol, V4, P445, DOI 10.1007/s11940-002-0012-6; DiRusso SM, 2000, J TRAUMA, V49, P212, DOI 10.1097/00005373-200008000-00006; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; El-Kadi H, 2000, NEUROSURG CLIN N AM, V11, P553, DOI 10.1016/S1042-3680(18)30122-0; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; FOGELHOLM R, 1975, ACTA NEUROCHIR, V32, P247, DOI 10.1007/BF01405457; Fukuhara T, 1996, SURG NEUROL, V45, P570, DOI 10.1016/0090-3019(95)00471-8; Fuller J Joseph, 2005, W V Med J, V101, P120; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Kapetanovic IM, 2004, ANN NY ACAD SCI, V1020, P10, DOI 10.1196/annals.1310.003; KAWAKAMI Y, 1989, NEUROSURGERY, V25, P25, DOI 10.1227/00006123-198907000-00005; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Mock CN, 1999, ACCIDENT ANAL PREV, V31, P359, DOI 10.1016/S0001-4575(98)00064-5; Moini M, 2000, J TRAUMA, V48, P503, DOI 10.1097/00005373-200003000-00023; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; NAGATA K, 1987, NEURORADIOLOGY, V29, P327, DOI 10.1007/BF00348909; Nagata K, 1986, No To Shinkei, V38, P1019; Nagata K, 1985, No To Shinkei, V37, P255; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pearl A, 2006, STUD HEALTH TECHNOL, V124, P1019; Ramesh AN, 2004, ANN ROY COLL SURG, V86, P334, DOI 10.1308/147870804290; Roudsari BS, 2004, ACCIDENT ANAL PREV, V36, P391, DOI 10.1016/S0001-4575(03)00032-0; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; SELKER HP, 1995, J INVEST MED, V43, P468; Stephan, 1986, UNDERSTANDING REGRES; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; WAKAI S, 1990, NEUROSURGERY, V26, P771, DOI 10.1227/00006123-199005000-00006; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217; Yeong EK, 2005, BURNS, V31, P415, DOI 10.1016/j.burns.2004.12.003; Zargar M, 2001, INJURY, V32, P613, DOI 10.1016/S0020-1383(01)00029-8; Zingale A, 1999, J Neurosurg Sci, V43, P277	44	24	24	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	OCT	2009	32	4					479	484		10.1007/s10143-009-0215-3			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	495AA	WOS:000269860300023	19653019				2022-02-06	
J	Goverover, Y; Arango-Lasprilla, JC; Hillary, FG; Chiaravalloti, N; DeLuca, J				Goverover, Yael; Arango-Lasprilla, Juan Carlos; Hillary, Frank G.; Chiaravalloti, Nancy; DeLuca, John			Application of the Spacing Effect to Improve Learning and Memory for Functional Tasks in Traumatic Brain Injury: A Pilot Study	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; cognition disorders; learning; memory	CHILDRENS FREE-RECALL; COGNITIVE REHABILITATION; HEAD-INJURY; REPETITIONS; RECOGNITION; VOCABULARY; RETENTION; MODERATE; MILD; SPEED	Research has indicated that many people with traumatic brain injury (TBI) experience learning and memory difficulties because of impairments in the initial acquisition of information. We examined a strategy, the spacing effect, known to enhance new learning in a laboratory setting in healthy control participants (HCs) and in people with TBI. The spacing effect indicates that information is learned better when presentation trials are distributed over time (spaced presentation) rather than consecutively (massed presentation). In this study, we examined the application of the spacing effect in improving functional tasks. We used a within-subject design and included 10 participants with TBI and 15 HCs. In both the TBI and the HC groups, material learned under the spaced learning condition was recalled better than that learned under massed learning conditions. These results provide initial evidence supporting the use of the spacing effect to improve new learning of functional tasks for people with TBI.	[Goverover, Yael] NYU, Dept Occupat Therapy, Sch Culture Educ & Human Dev, New York, NY 10012 USA; [Goverover, Yael] Kessler Med Rehabil Res & Educ, W Orange, NJ USA; [Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Chiaravalloti, Nancy] Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ USA; [DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA		Goverover, Y (corresponding author), NYU, Dept Occupat Therapy, Sch Culture Educ & Human Dev, 35 W 4th St,11th Floor, New York, NY 10012 USA.	yg243@nyu.edu	Hillary, Frank/AAN-8622-2021				Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; BAHRICK HP, 1987, J EXP PSYCHOL LEARN, V13, P344, DOI 10.1037/0278-7393.13.2.344; BAHRICK HP, 1993, PSYCHOL SCI, V4, P316, DOI 10.1111/j.1467-9280.1993.tb00571.x; CAHILL A, 1993, B PSYCHONOMIC SOC, V31, P481; CAMP CJ, 1997, PROSPECTIVE MEMORY T, P311; Cermak LS, 1996, NEUROPSYCHOLOGY, V10, P219; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P389, DOI 10.1037/0278-7393.19.2.389; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; DELIS DC, 2000, DELISKAPLAN EXECUTIV; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DEMPSTER FN, 1988, AM PSYCHOL, V43, P627, DOI 10.1037/0003-066X.43.8.627; DEMPSTER FN, 1987, J EDUC PSYCHOL, V79, P162, DOI 10.1037/0022-0663.79.2.162; Dempster FN, 1989, EDUC PSYCHOL REV, V1, P309, DOI 10.1007/BF01320097; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; GLENBERG AM, 1976, J VERB LEARN VERB BE, V15, P1, DOI 10.1016/S0022-5371(76)90002-5; GLENBERG AM, 1980, MEM COGNITION, V8, P528, DOI 10.3758/BF03213772; GLENBERG AM, 1977, J EXP PSYCHOL-HUM L, V3, P282, DOI 10.1037/0278-7393.3.3.282; GLENBERG AM, 1979, MEM COGNITION, V7, P95, DOI 10.3758/BF03197590; GLOVER JA, 1987, J EDUC PSYCHOL, V79, P198, DOI 10.1037/0022-0663.79.2.198; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goverover Y, 2009, J CLIN EXP NEUROPSYC, V31, P513, DOI 10.1080/13803390802287042; Hall KG, 1995, J MOTOR BEHAV, V27, P299, DOI 10.1080/00222895.1995.9941719; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Hintzman D.L., 1974, THEORIES COGNITIVE P; Janiszewski C, 2003, J CONSUM RES, V30, P138, DOI 10.1086/374692; JENSEN TD, 1981, B PSYCHONOMIC SOC, V18, P183; Kahana MJ, 2005, PSYCHON B REV, V12, P159, DOI 10.3758/BF03196362; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MELTON AW, 1970, J VERB LEARN VERB BE, V9, P596, DOI 10.1016/S0022-5371(70)80107-4; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; REA CP, 1985, HUM LEARN, V4, P11; Rohrer D, 2007, CURR DIR PSYCHOL SCI, V16, P183, DOI 10.1111/j.1467-8721.2007.00500.x; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; SHAUGHNESSY JJ, 1972, J VERB LEARN VERB BE, V11, P1, DOI 10.1016/S0022-5371(72)80053-7; Smith A., 1982, SYMBOL DIGIT MODALIT; Sosin DM, 1996, BRAIN INJURY, V10, P47; TOPPINO TC, 1993, B PSYCHONOMIC SOC, V31, P27; TOPPINO TC, 1991, MEM COGNITION, V19, P159, DOI 10.3758/BF03197112; UNDERWOOD BJ, 1970, J VERB LEARN VERB BE, V9, P573, DOI 10.1016/S0022-5371(70)80104-9; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler, 1997, WECHSLER ADULT INTEL; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; ZECHMEISTER EB, 1980, B PSYCHONOMIC SOC, V15, P41	49	24	24	0	10	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2009	63	5			SI		543	548		10.5014/ajot.63.5.543			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	493SG	WOS:000269757700004	19785253				2022-02-06	
J	Togher, L; McDonald, S; Tate, R; Power, E; Rietdijk, R				Togher, Leanne; McDonald, Skye; Tate, Robyn; Power, Emma; Rietdijk, Rachel			Training Communication Partners of People With Traumatic Brain Injury: Reporting the Protocol for a Clinical Trial	BRAIN IMPAIRMENT			English	Article						traumatic brain injury (TBI); communication partner training; cognitive-communication deficits; social skills; rehabilitation	MEASURING PSYCHOSOCIAL RECOVERY; SELF-ESTEEM; HEAD-INJURY; DISCOURSE; SKILLS; CONVERSATION; INFORMATION; ADULTS; REHABILITATION; RELIABILITY	This article reports on the design of a three-arm, nonrandomised controlled trial of interventions targeting social communication skills following traumatic brain injury (TBI) in adult participants. People with severe TBI were allocated to one of the three groups: the TBI group, where only the person with TBI was trained, the JOINT group where both the everyday communication partner (ECP) and the person with TBI were trained together, and a delayed treatment control condition. The trial is comparing whether including everyday communication partners in the training process provide additional benefit when compared to training the person with TBI alone; and additionally, whether training the person with TBI alone is more effective than no training. A range of primary and secondary outcome measures will be used to evaluate outcomes. Publishing the protocol prior to the results of the trial being available has several important benefits (Godlee, 2001). The original hypotheses and intentions of the research are made explicit to ensure that the process of conducting this clinical trial is transparent to readers, and so that comments may be made before results are finalised. It provides the opportunity to outline a detailed description of this intervention and methodology, or to acknowledge changes to methodology, which may assist with eventual clinical application of the intervention. This article also informs the research community of the work that is underway to promote opportunities for collaboration and reduce unnecessary duplication of research. The protocol for this trial has previously been registered on Current Controlled Trials (http://www.controlled-trials.com/ISRCTN57815281).	[Togher, Leanne; Power, Emma; Rietdijk, Rachel] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Tate, Robyn] Univ Sydney, Fac Med, No Clin Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Tate, Robyn] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia		Togher, L (corresponding author), Natl Hlth & Med Res Council, Canberra, ACT, Australia.	l.togher@usyd.edu.au	Rietdijk, Rachael/J-6573-2012; Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015; McDonald, Skye/G-4118-2014	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406; McDonald, Skye/0000-0003-0723-6094; Togher, Leanne/0000-0002-4518-6748	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia	This study was supported by a National Health and Medical Research Council (NH&MRC) project grant.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Benton AL, 1994, MULTILINGUAL APHASIA; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bute JJ, 2007, HEALTH COMMUN, V21, P235, DOI 10.1080/10410230701307675; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; COOPERSMITH S, 1987, SELF ESTEEM INVENTOR; CRAMON DY, 1992, NEUROPSYCHOL REHABIL, V2, P207; Creswell J.W., 2017, RES DESIGN QUALITATI; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DEMO DH, 1985, J PERS SOC PSYCHOL, V48, P1490, DOI 10.1037/0022-3514.48.6.1490; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Eggins S., 1997, ANAL CASUAL CONVERSA; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; GAJAR A, 1984, J APPL BEHAV ANAL, V17, P353, DOI 10.1901/jaba.1984.17-353; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Glaser B., 1967, DISCOVERY GROUNDED T; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Godlee F, 2001, BMC NEWS VIEWS, V2; Halliday M., 2004, INTRO FUNCTIONAL GRA; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; JUSTICE LM, 2007, EVIDENCE BASED COMMU, V1, P37; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; KILOV A, APHASIOLOGY IN PRESS; Kovarsky D, 2007, TOP LANG DISORD, V27, P50, DOI 10.1097/00011363-200701000-00006; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; *MAA, 1998, TRAIN NEEDS ATT CAR; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Maher CG, 2003, PHYS THER REHABIL J, V83, P713, DOI 10.1093/ptj/83.8.713; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Meyers J., 1995, REY COMPLEX FIGURE R; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; PRIGATANO G, 1985, HDB CONT REHABILITAT; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosenberg M., 1965, SOC ADOLESCENT SELF; SHAHANI C, 1990, J PERS ASSESS, V54, P276, DOI 10.1207/s15327752jpa5401&2_26; Shelton C, 2007, BRAIN INJURY, V21, P1259, DOI 10.1080/02699050701716935; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; SPSS Inc, 2008, SPSS STAT REL 17 0 1; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; TATE RL, 1987, SCAND J REHABIL MED, V19, P19; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1998, COMMUNITY POLI UNPUB; TOGHER L, 2004, BRAIN IMPAIRMENT, V5, P13; TOGHER L, 2001, COMMUNICATION TRAINI; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; World Health Organization, 2007, INT CLASS FUNCT DIS; Wrightsman, 1993, MEASURES PERSONALITY, P115, DOI DOI 10.1016/B978-0-12-590241-0.50008-3; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	78	24	25	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2009	10	2					188	204		10.1375/brim.10.2.188			17	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	488UR	WOS:000269376200005					2022-02-06	
J	Philip, S; Udomphorn, Y; Kirkham, FJ; Vavilala, MS				Philip, Shaji; Udomphorn, Yuthana; Kirkham, Fenella J.; Vavilala, Monica S.			Cerebrovascular Pathophysiology in Pediatric Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	National Summit on Pediatric Disaster and Emergency Services	SEP 11-12, 2008	Los Angeles, CA	Eastern Assoc Surg Trauma, Trauma Assoc Canada, Western Trauma Assoc		Brain injury; Pediatrics; Autoregulation	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; CARBON-DIOXIDE REACTIVITY; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; INTRACRANIAL-PRESSURE; OXIDATIVE-METABOLISM; CO2 REACTIVITY; OXYGEN-CONSUMPTION; PERFUSION-PRESSURE; CHILDREN	Background: Traumatic brain injury (TBI) is the leading cause of traumatic morbidity and mortality in children. Although there is increasing information concerning TBI in adults and experimental animal models, relatively little is known regarding cerebrovascular pathophysiology specific to children. Materials: A review of the pertinent medical literature. Results: Systemic and cerebral hemodynamic factors such as hypotension, hypoxia, hyperglycemia, and fever are associated with poor outcome in pediatric TBI. Similarly, cerebral autoregulation is often impaired after TBI and may adversely affect outcome, especially if systemic hemodynamics are altered. Furthermore, CO2 vasoreactivity may be altered after pediatric TBI and lead to either cerebral ischemia or hyperemia. Conclusions: Understanding the effect of pediatric TBI on the cerebral circulation is needed to potentially develop protocols to improve outcome in this vulnerable population. Specifically, changes in pediatric cerebrovascular physiology and pathophysiology, including CO2 vasoreactivity and pressure autoregulation, must be understood and their mechanism elucidated.	[Philip, Shaji; Udomphorn, Yuthana; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; [Kirkham, Fenella J.] UCL Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London, England; [Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Pediat, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pediat, Box 359724,325 9th Ave, Seattle, WA 98104 USA.	vavilala@u.washington.edu	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958			AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; APARICIO JM, 2001, CEREBROVASC DIS, V11, P38; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; BODE H, 1988, PEDIAT APPL TRANSCRA, P1; Bouma GJ, 1998, ACT NEUR S, V71, P272; Brenet O, 1998, ANN FR ANESTH, V17, P227, DOI 10.1016/S0750-7658(98)80004-X; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; CHAN KH, 1992, SURG NEUROL, V38, P433, DOI 10.1016/0090-3019(92)90111-Y; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; HARPER AM, 1965, J NEUROL NEUROSUR PS, V28, P449, DOI 10.1136/jnnp.28.5.449; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Karsli C, 2003, PAEDIATR ANAESTH, V13, P26, DOI 10.1046/j.1460-9592.2003.01017.x; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; KIRKHAM FJ, 1986, ULTRASOUND MED BIOL, V12, P15, DOI 10.1016/0301-5629(86)90139-0; KIRKHAM FJ, 1991, CLIN DEV MED, V113, P283; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; LAM AM, 1995, J CEREBR BLOOD F MET, V15, P714, DOI 10.1038/jcbfm.1995.88; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lenzi P, 2000, Sleep Res Online, V3, P77; LEON JE, 1991, CAN J ANAESTH, V38, P817, DOI 10.1007/BF03036954; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MADSEN PL, 1991, J APPL PHYSIOL, V70, P2597, DOI 10.1152/jappl.1991.70.6.2597; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; NAKAYAMA DK, 1991, J TRAUMA, V31, P1521, DOI 10.1097/00005373-199111000-00010; Newton CRJC, 1996, PEDIATR NEUROL, V15, P41, DOI 10.1016/0887-8994(96)00115-4; Ng SCP, 2002, ACT NEUR S, V81, P125; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Ogawa A, 1987, No To Shinkei, V39, P113; OGAWA A, 1989, Neurological Research, V11, P173; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; QUINT SR, 1980, STROKE, V11, P286, DOI 10.1161/01.STR.11.3.286; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Rowney DA, 2002, BRIT J ANAESTH, V88, P357, DOI 10.1093/bja/88.3.357; Sanchez-Olmedo JI, 2005, TRANSPL P, V37, P1990, DOI 10.1016/j.transproceed.2005.03.048; SETTERGREN G, 1980, ACTA PAEDIATR SCAND, V69, P457, DOI 10.1111/j.1651-2227.1980.tb07114.x; SEVERINGHAUS JW, 1967, CIRC RES, V20, P272, DOI 10.1161/01.RES.20.2.272; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; SILVERMAN BW, 1985, J R STAT SOC B, V47, P1; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; STOYKA WW, 1975, CAN ANAESTH SOC J, V22, P275, DOI 10.1007/BF03004836; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Thal SC, 2005, CURR OPIN ANESTHESIO, V18, P490, DOI 10.1097/01.aco.0000182561.32680.30; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Vavilala MS, 2002, ACTA ANAESTH SCAND, V46, P393, DOI 10.1034/j.1399-6576.2002.460411.x; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Visocchi M, 2007, ACTA NEUROCHIR, V149, P347, DOI 10.1007/s00701-006-1102-0; WARD JD, 1995, MANAGEMENT PEDIAT TR, P177; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642	84	24	25	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2009	67	2		S			S128	S134		10.1097/TA.0b013e3181ad32c7			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	482OM	WOS:000268898600016	19667845				2022-02-06	
J	Bishop, FS; Finn, MA; Samuelson, M; Schmidt, RH				Bishop, Frank S.; Finn, Michael A.; Samuelson, Mical; Schmidt, Richard H.			Endovascular balloon angioplasty for treatment of posttraumatic venous sinus thrombosis Case report	JOURNAL OF NEUROSURGERY			English	Article						dural venous sinus thrombosis; balloon angioplasty; trauma; endovascular treatment	SUPERIOR SAGITTAL SINUS; CLOSED-HEAD-INJURY; DEPRESSED SKULL FRACTURE; INTRACRANIAL HYPERTENSION; MECHANICAL THROMBOLYSIS; THROMBECTOMY; UROKINASE; INFUSION; OCCLUSION; CHILDREN	In severe cases, posttraumatic cerebral sinus thrombosis can result in venous congestion and persistent intracranial hypertension refractory to both conventional medical therapy and surgical decompression. The authors report a unique case of a patient Successfully treated with endovascular mechanical thrombolysis using balloon angioplasty for clinically significant posttraumatic venous sinus thrombosis and review the reported treatments for cerebral venous sinus occlusive disease. This 18-year-old man Suffered severe closed head injury from a fall while skateboarding. A head CT scan demonstrated basilar skull fractures involving the left jugular foramen. A CT angiogram revealed thrombosis of the left transverse sinus and occlusion of the sigmoid sinus and internal jugular vein. Despite treatment with anticoagulation therapy and decompressive hemi- and suboccipital craniectomies, intracranial hypertension remained refractory. Serial angiography demonstrated progressive sinus Occlusion. Endovascular balloon thrombolysis of the left transverse and sigmoid sinuses resulted in immediate reduction of intracranial pressures and improved sinus patency. Intracranial pressure measurements remained low after the procedure. The patient eventually improved neurologically, was able to follow commands and walk, and was discharged to a rehabilitation facility for further recovery. Anticoagulation therapy, Surgical decompression, and endovascular thrombolysis have been reported as treatment modalities for clinically significant posttraumatic venous sinus thrombosis. In this case, endovascular mechanical thrombolysis with balloon angioplasty resulted in resolution of thrombus and successful immediate reduction of intracranial pressure. This treatment may be considered in patients with critically elevated intracranial pressure from posttraumatic venous sinus occlusion refractory to other treatment measures. (DOI: 10.3171/2009.2.JNS08491)	[Bishop, Frank S.; Finn, Michael A.; Samuelson, Mical; Schmidt, Richard H.] Univ Utah, Dept Neurosurg, Sch Med, Salt Lake City, UT 84132 USA		Schmidt, RH (corresponding author), Univ Utah, Dept Neurosurg, Sch Med, 175 N Med Dr E, Salt Lake City, UT 84132 USA.	neuropub@hsc.utah.edu					Canhao P, 2003, CEREBROVASC DIS, V15, P159, DOI 10.1159/000068833; Chaloupka JC, 1999, NEUROSURGERY, V45, P650, DOI 10.1097/00006123-199909000-00045; Chow K, 2000, STROKE, V31, P1420, DOI 10.1161/01.STR.31.6.1420; Curtin KR, 2004, AM J NEURORADIOL, V25, P1807; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Gurley MB, 1996, J ENDOVASC SURG, V3, P306, DOI 10.1583/1074-6218(1996)003<0306:SSTAWI>2.0.CO;2; Kasner S E, 1998, J Stroke Cerebrovasc Dis, V7, P421, DOI 10.1016/S1052-3057(98)80126-2; Kirsch J, 2007, NEUROSURGERY, V60, P577, DOI 10.1227/01.NEU.0000255339.26027.68; Kobayashi S, 2004, J CLIN NEUROSCI, V11, P322, DOI 10.1016/S0967-5868(03)00149-8; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Novak Z, 2000, AM J NEURORADIOL, V21, P143; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; PERSSON L, 1990, NEUROSURGERY, V26, P117, DOI 10.1227/00006123-199001000-00016; Philips MF, 1999, J NEUROSURG, V90, P65, DOI 10.3171/jns.1999.90.1.0065; Prasad RS, 2006, J PEDIAT HEMATOL ONC, V28, P196, DOI 10.1097/01.mph.0000210408.66803.f2; Soleau SW, 2003, NEUROSURGERY, V52, P534, DOI 10.1227/01.NEU.0000047815.21786.C1; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; STRINGER WL, 1983, NEUROSURGERY, V12, P95; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Tamimi A, 2005, PEDIATR NEUROSURG, V41, P237, DOI 10.1159/000087480; Tsai FY, 2007, CARDIOVASC INTER RAD, V30, P675, DOI 10.1007/s00270-007-9046-1; vandenBrink WA, 1996, NEUROSURGERY, V38, P1044, DOI 10.1097/00006123-199605000-00039; VINES F, 1971, RADIOLOGY, V98, P9, DOI 10.1148/98.1.9; Wasay M, 2001, STROKE, V32, P2310, DOI 10.1161/hs1001.096192; Yamashita S, 2005, NEUROL MED-CHIR, V45, P635, DOI 10.2176/nmc.45.635; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849	27	24	25	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2009	111	1					17	21		10.3171/2009.2.JNS08491			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	462VA	WOS:000267383900005	19326975				2022-02-06	
J	Jia, YL; Alkayed, N; Wang, RK				Jia, Yali; Alkayed, Nabil; Wang, Ruikang K.			Potential of optical microangiography to monitor cerebral blood perfusion and vascular plasticity following traumatic brain injury in mice in vivo	JOURNAL OF BIOMEDICAL OPTICS			English	Article						Optical microangiography; cerebral blood perfusion; vascular remodeling; traumatic brain injury	FLOW; ANGIOGRAPHY	Optical microanglography (OMAG) is a recently developed imaging modality capable of volumetric imaging of dynamic blood perfusion, down to capillary level resolution, with an imaging depth up to 2.00 mm beneath the tissue surface. We report the use of OMAG to monitor the cerebral blood flow (CBF) over the cortex of mouse brain upon traumatic brain injury (TBI), with the cranium left intact, for a period of two weeks on the same animal. We show the ability of OMAG to repeatedly image 3-D cerebral vasculatures during pre- and post-traumatic phases, and to visualize the changes of regulated CBF and the vascular plasticity after TBI. The results indicate the potential of OMAG to explore the mechanism involved in the rehabilitation of TBI. (C) 2009 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3207121]	[Jia, Yali; Wang, Ruikang K.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA; [Alkayed, Nabil; Wang, Ruikang K.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA		Wang, RK (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA.	r.k.wang@bme.ogi.edu	Wang, Ruikang K./L-3889-2019	Wang, Ruikang K./0000-0001-5169-8822; Jia, Yali/0000-0002-2784-1905	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EB009682, R01HL093140, R01DC010201]; American Heart AssociationAmerican Heart Association [0855733G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044313, P30NS061800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC010201] Funding Source: NIH RePORTER	This research was supported in part by grants from the National Institutes of Health (Nos. R01EB009682, R01HL093140, and R01DC010201) and the American Heart Association (0855733G).	BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Guyton C. A., 2006, TXB MED PHYSL, P195; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Wang RKK, 2007, OPT EXPRESS, V15, P11402, DOI 10.1364/OE.15.011402; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	10	24	24	0	1	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	JUL-AUG	2009	14	4							040505	10.1117/1.3207121			3	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	503MV	WOS:000270540100005	19725710	Bronze, Green Accepted			2022-02-06	
J	Malham, GM; Ackland, HM; Jones, R; Williamson, OD; Varma, DK				Malham, Gregory M.; Ackland, Helen M.; Jones, Rachel; Williamson, Owen D.; Varma, Dinesh K.			Occipital condyle fractures: incidence and clinical follow-up at a level 1 trauma centre	EMERGENCY RADIOLOGY			English	Article						Occipital condyle fractures; Atlanto-occipital joint; Skull fractures; Cervical pain; Neck pain		The purpose of the study was to investigate the incidence, management, and outcomes of occipital condyle fractures at a level 1 trauma center. Blunt trauma patients with occipital condyle fracture admitted to a level 1 trauma center over a 3-year period were identified. Prospective clinical and functional follow- up was undertaken, including further radiographic imaging.The incidence of occipital condyle fracture in patients presenting to our level 1 trauma center was 1.7/1,000 per year. Twenty-four patients were followed up at a mean of 27 months post-injury. There was one case of isolated occipital condyle fracture; all other patients had sustained additional orthopedic, cervical spine, and/or head injury. Seven (29%) patients sustained unilat-eral Type III avulsion fractures, none of which were isolated injuries. Traumatic brain injury was detected in 46% of study patients, and 42% had cervical spine injury. External halothoracic immobilization was used in 33% of cases. Fracture union with anatomical alignment occurred in 21 patients (88%). No patient had cranial nerve deficit at admission or follow-up. Three patients (12.5%)had moderate to severe neck pain/disability at follow- up, all of whom had sustained multiple injuries. Occipital condyle fractures most frequently occur in conjunction with additional injuries, particularly head and cervical spine injuries. Most cases can be managed successfully nonoperatively. Functional outcome is generally determined by pain and disability related to other injuries, rather than occipital fracture configuration.	[Malham, Gregory M.; Jones, Rachel] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Malham, Gregory M.; Varma, Dinesh K.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Ackland, Helen M.] Natl Trauma Res Inst, Alfred Hosp, Melbourne, Vic, Australia; [Ackland, Helen M.; Williamson, Owen D.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Varma, Dinesh K.] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia		Malham, GM (corresponding author), Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia.	g.malham@alfred.org.au			Transport Accident Commission	The authors gratefully acknowledge the assistance of the Transport Accident Commission for assistance with funding the position of the second author, and Steven White, Information Systems Manager, Department of Trauma Surgery, for assistance with data retrieval from the prospective institutional trauma registry database.	ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; Atkin C, 2005, INJURY, V36, P1277, DOI 10.1016/j.injury.2005.05.011; Aulino JM, 2005, EMERG RADIOL, V11, P342, DOI 10.1007/s10140-005-0425-0; Bhalaik V, 2001, INJURY, V32, P157, DOI 10.1016/S0020-1383(00)00160-1; BLACKSIN MF, 1995, AM J ROENTGENOL, V165, P1201, DOI 10.2214/ajr.165.5.7572503; Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Capuano C, 2004, ACTA NEUROCHIR, V146, P779, DOI 10.1007/s00701-004-0289-1; Caroli E, 2005, EUR SPINE J, V14, P487, DOI 10.1007/s00586-004-0832-z; Cirak B, 2000, NEUROSURG REV, V23, P161, DOI 10.1007/PL00011949; Daffner RH, 2000, SKELETAL RADIOL, V29, P125, DOI 10.1007/s002560050582; Freeman BJC, 2006, INJURY, V37, P83, DOI 10.1016/j.injury.2005.03.017; Hadley MN, 2002, NEUROSURGERY, V50, pS114; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hanson JA, 2002, AM J ROENTGENOL, V178, P1261, DOI 10.2214/ajr.178.5.1781261; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; Muthukumar N, 2002, J CLIN NEUROSCI, V9, P580, DOI 10.1054/jocn.2001.1067; Noble ER, 1996, AM J NEURORADIOL, V17, P507; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Scrimshaw SV, 2001, J MANIP PHYSIOL THER, V24, P501, DOI 10.1067/mmt.2001.118208; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; TEMPLETON PA, 1987, SKELETAL RADIOL, V16, P98, DOI 10.1007/BF00367755; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; Vaccaro AR, 2005, INJURY, V36, P44, DOI 10.1016/j.injury.2005.06.014; WASSERBERG J, 1995, NEURORADIOLOGY, V37, P370; Wheeler AH, 1999, DEV NECK PAIN DISABI	29	24	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	JUL	2009	16	4					291	297		10.1007/s10140-008-0789-z			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	V1X6R	WOS:000217328800006	19189141				2022-02-06	
J	Shang, Y; Li, XW; Prasad, PV; Xu, SP; Yao, SL; Liu, D; Yuan, SY; Feng, D				Shang, You; Li, Xingwang; Prasad, Pramod V.; Xu, Sanpeng; Yao, Shanglong; Liu, Dong; Yuan, Shiying; Feng, Dan			Erythropoietin attenuates lung injury in lipopolysaccharide treated rats	JOURNAL OF SURGICAL RESEARCH			English	Article						endotoxin; acute lung injury; inducible nitric oxide synthase; nitric oxide; nitrotyrosine	NITRIC-OXIDE SYNTHASE; RESPIRATORY-DISTRESS-SYNDROME; ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; NEONATAL-RATS; INOS ACTIVITY; KAPPA-B; ENDOTOXIN; MODEL; SHOCK	Background. Erythropoietin (EPO) elicits protective effects in lung ischemia-reperfusion, hyperoxia, acute necrotizing pancreatitis, and some other tissues. In the present study, we investigated the possible protective roles of EPO in the lipopolysaccharide (LPS) induced lung injury. Materials and Methods. Male Sprague-Dawley rats were treated with EPO (3000 U/kg, i.p.) or vehicle (saline), 30 min prior to LPS administration (6 mg/kg, i.v.). Four h following LPS injection, samples of pulmonary tissue were collected. Optical microscopy was performed to examine pathological changes in lungs. Validated methods were used to measure wet/dry ratios (W/D), myeloperoxidase (MPO) activity, malondialdehyde (MDA) concentrations, and nitrite/nitrate (NO2-/NO3-) levels in lungs. Western blotting was performed to study the pulmonary expression of inducible nitric oxide synthase (iNOS) and nitrotyrosine protein. Results. Pretreatment with EPO led to (1) significant attenuation of endotoxemia induced evident lung histologic injury and edema; (2) inhibition of LPS mediated induction in MPO activity and MDA concentration; (3) inhibition of LPS mediated overporduction of pulmonary NO2-/NO3- levels; and (4) marked suppression in endotoxin induced expression of iNOS and nitrotyrosine. Conclusions. This study provides considerable evidence that EPO has an ability to significantly attenuate endotoxin-induced acute lung injury in rats.	[Shang, You; Li, Xingwang; Yao, Shanglong; Liu, Dong; Yuan, Shiying; Feng, Dan] Huazhong Univ Sci & Technol, Dept Anesthesiol & Intens Care Med, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Li, Xingwang] Wenzhou Med Coll, Dept Anesthesiol, Hosp 2, Wenzhou, Peoples R China; [Li, Xingwang; Prasad, Pramod V.] Rockefeller Univ, Ctr Biomed Res, Populat Council, New York, NY USA; [Xu, Sanpeng] Huazhong Univ Sci & Technol, Dept Pathol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Liu, Dong] Lanzhou Gen Hosp PLA, Dept Anesthesiol & Intens Care Med, Lanzhou, Peoples R China		Shang, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Anesthesiol & Intens Care Med, Union Hosp, Tongji Med Coll, 1277 Jiefangdadao, Wuhan 430022, Peoples R China.	shang_you@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30571787]	This work was supported by the National Natural Science Foundation of China (no. 30571787) to SY.	Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Cetin H, 2007, CLIN EXP PHARMACOL P, V34, P1181, DOI 10.1111/j.1440-1681.2007.04695.x; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cuzzocrea S, 2006, CRIT CARE MED, V34, P1168, DOI 10.1097/01.CCM.0000207346.56477.E8; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Ermert M, 2002, LAB INVEST, V82, P425, DOI 10.1038/labinvest.3780436; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Fulkerson WJ, 1996, ARCH INTERN MED, V156, P29, DOI 10.1001/archinte.156.1.29; GHOSH S, 1993, CRIT CARE MED, V21, pS19, DOI 10.1097/00003246-199302001-00005; Grasso G, 2007, DRUG NEWS PERSPECT, V20, P315, DOI 10.1358/dnp.2007.20.5.1120219; Gray KD, 2003, AM J SURG, V186, P526, DOI 10.1016/j.amjsurg.2003.07.010; Guneli E, 2007, MOL MED, V13, P509, DOI 10.2119/2007-00032.Guneli; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; King VR, 2007, EUR J NEUROSCI, V26, P90, DOI 10.1111/j.1460-9568.2007.05635.x; Koksel O, 2004, PULM PHARMACOL THER, V17, P263, DOI 10.1016/j.pupt.2004.05.002; KOOY NW, 1995, AM J RESP CRIT CARE, V151, P1250; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; Lee JH, 2007, J KOREAN MED SCI, V22, P1042, DOI 10.3346/jkms.2008.22.6.1042; Lipsic E, 2006, J AM COLL CARDIOL, V48, P2161, DOI 10.1016/j.jacc.2006.08.031; Liu D, 2005, CRIT CARE MED, V33, P2309, DOI 10.1097/01.CCM.0000183161.81503.7D; Liu SF, 1997, J IMMUNOL, V159, P3976; Liu XM, 2006, LIFE SCI, V78, P2255, DOI 10.1016/j.lfs.2005.09.053; Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13; Mitra A, 2007, NEPHROL DIAL TRANSPL, V22, P2349, DOI 10.1093/ndt/gfm216; Naidu BV, 2003, J HEART LUNG TRANSPL, V22, P784, DOI 10.1016/S1053-2498(02)00556-9; Ng T, 2003, POSTGRAD MED J, V79, P367, DOI 10.1136/pmj.79.933.367; Numata M, 1998, J IMMUNOL, V160, P3031; Ozer EA, 2005, PEDIATR RES, V58, P38, DOI 10.1203/01.PDR.0000163391.75389.52; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Parsey MV, 1998, J IMMUNOL, V160, P1007; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Sato K, 2002, FASEB J, V16, P1713, DOI 10.1096/fj.02-0331com; Shenkar R, 1999, J IMMUNOL, V163, P954; Squadrito F, 1999, BRIT J PHARMACOL, V127, P482, DOI 10.1038/sj.bjp.0702521; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Tascilar O, 2007, WORLD J GASTROENTERO, V13, P6172, DOI 10.3748/wjg.13.6172; Wang LF, 2001, BIOCHEM BIOPH RES CO, V283, P694, DOI 10.1006/bbrc.2001.4842; Wu HW, 2006, EUR J CARDIO-THORAC, V29, P902, DOI 10.1016/j.ejcts.2006.02.036; Yang CW, 2003, FASEB J, V17, P1754, DOI 10.1096/fj.02-1191fje; Yidirim E, 2005, J TRAUMA, V58, P1252, DOI 10.1097/01.TA.0000169803.09482.F8; Yildirim E, 2004, J HEART LUNG TRANSPL, V23, P1423, DOI 10.1016/j.healun.2003.10.006; Zhou JL, 2003, WORLD J GASTROENTERO, V9, P1318, DOI 10.3748/wjg.v9.i6.1318	46	24	26	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2009	155	1					104	110		10.1016/j.jss.2008.10.003			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	463RC	WOS:000267448500027	19285686				2022-02-06	
J	Morita, K; Lee, MS; Her, S				Morita, Kyoji; Lee, Mi-Sook; Her, Song			Possible Relation of Hemin-Induced HO-1 Expression to the Upregulation of VEGF and BDNF mRNA Levels in Rat C6 Glioma Cells	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Hemin; Glial cells; Neurogenic factor; Angiogenic factor; Brain damage; Cerebral hemorrhage	ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELLS; OXYGENASE-1 HO-1; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; COMPLETE SEQUENCE; OXIDATIVE STRESS; GENE-EXPRESSION; COBALT CHLORIDE	Glial cells are generally considered to contribute to retaining the integrity of neural function through the protection of neuronal cells against neurodegenerative insults and also expected to play a potential role in the protection of cerebrovascular systems from various toxic insults of hemorrhaged blood, thus proposing a possible implication of glial cells in the recovery of brain function from the damage caused by cerebral hemorrhage. Based on this hypothetical idea, the direct effect of hemin on the expression of genes encoding heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) in glial cells was examined using rat C6 glioma cells as an in vitro model system. Hemin elevated both HO-1 and VEGF mRNA levels in the glioma cells at the concentration causing no critical damage to the cells, and the elevation of BDNF mRNA levels was also observed by exposing the cells to hemin under the same conditions. Furthermore, the elevation of VEGF and BDNF mRNA levels induced by hemin was blocked by pretreatment of the cells with the agents inhibiting not only HO-1 gene expression but also its enzymatic activity. These pharmacological studies indicate that hemin can induce the enhancement of VEGF and BDNF gene expression probably through the mechanism mediated by HO-1 activity in the glioma cells, proposing the possibility that glial cells are capable of contributing to the recovery of brain function from the damage caused by cerebral hemorrhage through the production of neurogenic and angiogenic factors.	[Morita, Kyoji] Shikoku Univ Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima 7711192, Japan; [Lee, Mi-Sook; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Bioimaging, Chunchon 200701, South Korea		Morita, K (corresponding author), Shikoku Univ Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima 7711192, Japan.	kmorita@shikoku-u.ac.jp					Andoh Y, 2006, J BIOCHEM, V140, P483, DOI 10.1093/jb/mvj187; Anjos-Ramos L, 2006, VIRCHOWS ARCH, V448, P472, DOI 10.1007/s00428-005-0140-y; ARCARI P, 1984, NUCLEIC ACIDS RES, V12, P9179, DOI 10.1093/nar/12.23.9179; Bova R, 1998, MOL BRAIN RES, V57, P321, DOI 10.1016/S0169-328X(98)00092-8; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Chen-Roetling J, 2006, BIOCHEM BIOPH RES CO, V350, P233, DOI 10.1016/j.bbrc.2006.09.036; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; CUEVAS P, 1994, NEUROL RES, V16, P181; Cuevas P, 1997, NEUROL RES, V19, P254, DOI 10.1080/01616412.1997.11758613; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; EyssenHernandez R, 1996, FEBS LETT, V382, P229, DOI 10.1016/0014-5793(96)00127-5; FAUTZ R, 1991, MUTAT RES, V253, P173, DOI 10.1016/0165-1161(91)90130-Z; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2005, EXP SUPPL, V94, P209; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Gowing G, 2006, GLIA, V53, P331, DOI 10.1002/glia.20288; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jing CR, 2005, J NEUROSCI RES, V82, P802, DOI 10.1002/jnr.20681; Kawai T, 2006, NEUROSCIENCE, V141, P1209, DOI 10.1016/j.neuroscience.2006.04.064; Ke ZJ, 2004, NEUROCHEM INT, V45, P361, DOI 10.1016/j.neuint.2003.09.008; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Levy YS, 2002, NEUROTOX RES, V4, DOI 10.1080/1029842021000045624; Loboda A, 2005, CELL MOL BIOL, V51, P347, DOI 10.1170/T637; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Marton LS, 2000, AM J PHYSIOL-HEART C, V279, pH2405, DOI 10.1152/ajpheart.2000.279.5.H2405; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Morita K, 1999, BRAIN RES, V830, P179, DOI 10.1016/S0006-8993(99)01292-5; Morita K, 1999, BRAIN RES, V816, P309, DOI 10.1016/S0006-8993(98)01093-2; Morita K, 2000, CELL BIOL INT, V24, P223, DOI 10.1006/cbir.1999.0494; Morita K, 2006, BRAIN RES, V1085, P49, DOI 10.1016/j.brainres.2006.02.033; Nimura T, 1996, MOL BRAIN RES, V37, P201, DOI 10.1016/0169-328X(95)00315-J; Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431; Parfenova H, 2005, AM J PHYSIOL-HEART C, V288, pH2843, DOI 10.1152/ajpheart.01274.2004; Schipper HM, 2006, NEUROBIOL AGING, V27, P252, DOI 10.1016/j.neurobiolaging.2005.01.016; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0; Sehara Y, 2007, BRAIN RES, V1151, P142, DOI 10.1016/j.brainres.2007.01.149; Shrivastava K, 2008, NEUROCHEM INT, V52, P368, DOI 10.1016/j.neuint.2007.07.005; Simard AR, 2007, J COMP NEUROL, V504, P716, DOI 10.1002/cne.21469; Smith SL, 2001, BIOCHEM PHARMACOL, V61, P409, DOI 10.1016/S0006-2952(00)00556-6; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Suzuki H, 1999, J CLIN INVEST, V104, P59, DOI 10.1172/JCI5357; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Valenzuela MJ, 2007, BRAIN RES REV, V56, P198, DOI 10.1016/j.brainresrev.2007.07.007; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Warner-Schmidt JL, 2008, CURR OPIN PHARMACOL, V8, P14, DOI 10.1016/j.coph.2007.10.013; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104	58	24	27	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2009	38	1					31	40		10.1007/s12031-008-9156-5			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	434AL	WOS:000265247500005	18937073				2022-02-06	
J	Keller, E; Mudra, R; Gugl, C; Seule, M; Mink, S; Frohlich, J				Keller, Emanuela; Mudra, Regina; Gugl, Christoph; Seule, Martin; Mink, Susanne; Frohlich, Juerg			Theoretical evaluations of therapeutic systemic and local cerebral hypothermia	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Hypothermia; Cerebral temperature; Modelling; Simulation	PROMISING TREATMENT MODALITY; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; SUBARACHNOID HEMORRHAGE; MILD HYPOTHERMIA; BLOOD-FLOW; CARDIAC-ARREST; TEMPERATURE; ISCHEMIA; FEVER	Purpose: To simulate cerebral temperature behaviour with hypothermia treatment applying different cooling devices and to find the optimal brain temperature monitoring. Methods: Models based on hourly temperature values recorded in patients with severe aneurysmal subarachnoid hemorrhage, taking MRI data, thermal conductive properties, metabolism and blood flow into account were applied to different scenarios of hypothermia. Results: Systemic hypothermia by endovascular cooling leads to an uniform temperature decrease within the brain tissue. Cooling with head caps lead to 33 degrees C only in the superficial brain while the deep brain remains higher than 36 degrees C. Cooling with neckbands lead to 35.8 degrees C for dry and 32.8 degrees C for wet skin in the deep brain. Conclusions: With head caps temperatures below 36 degrees C cannot be reached in the deep brain tissue, whereas neckbands, covering the carotid triangles, may lead to hypothermic temperatures in the deep brain tissue. Temperature sensors have to be applied at least 2 cm below the cortical surface to give values representative for deep brain tissue. (C) 2009 Elsevier B.V. All rights reserved.	[Keller, Emanuela; Seule, Martin; Mink, Susanne] Univ Zurich Hosp, Dept Neurosurg, Neurointens Care Unit, CH-8091 Zurich, Switzerland; [Mudra, Regina] Swiss Fed Inst Technol, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Gugl, Christoph; Frohlich, Juerg] Swiss Fed Inst Technol, Lab Electromagnet Fields & Microwave Elect, CH-8092 Zurich, Switzerland		Keller, E (corresponding author), Univ Zurich Hosp, Dept Neurosurg, Neurointens Care Unit, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	Emanuela.keller@usz.ch	Keller, Emanuela/M-2917-2015; Keller, Emanuela/G-4040-2013	Keller, Emanuela/0000-0001-7892-8261; Frohlich, Jurg/0000-0002-5923-3410; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574			AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BAKER MA, 1982, ANNU REV PHYSIOL, V44, P85, DOI 10.1146/annurev.ph.44.030182.000505; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BIGELOW WG, 1950, AM J PHYSIOL, V160, P125, DOI 10.1152/ajplegacy.1949.160.1.125; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; deDear RJ, 1997, INT J BIOMETEOROL, V40, P141, DOI 10.1007/s004840050035; DEXTER F, 1994, ANN THORAC SURG, V57, P1171, DOI 10.1016/0003-4975(94)91350-1; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Hegner T, 2001, ACT NEUR S, V77, P131; Karam AM, 2006, ARCH FACIAL PLAST S, V8, P105, DOI 10.1001/archfaci.8.2.105; Keller E, 2000, CRIT CARE MED, V28, P511, DOI 10.1097/00003246-200002000-00037; Konstas AA, 2007, J APPL PHYSIOL, V102, P1329, DOI 10.1152/japplphysiol.00805.2006; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; MAHER J, 1993, CEREBROVAS BRAIN MET, V5, P277; Mariak Z, 2002, J THERM BIOL, V27, P219, DOI 10.1016/S0306-4565(01)00087-0; MELLERGARD P, 1990, British Journal of Neurosurgery, V4, P31, DOI 10.3109/02688699009000679; Nelson DA, 1998, EUR J APPL PHYSIOL O, V78, P353, DOI 10.1007/s004210050431; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; OLSEN RW, 1985, J BIOMECH ENG-T ASME, V107, P354, DOI 10.1115/1.3138569; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; SAFAR P, 1997, TXB NEUROANESTHESIA, P557; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Sukstanskii AL, 2007, EUR J APPL PHYSIOL, V101, P41, DOI 10.1007/s00421-007-0452-5; Thome C, 2005, NEUROL RES, V27, P229, DOI 10.1179/016164105X25252; Wang H, 2006, ACTA NEUROCHIR, V148, P681, DOI 10.1007/s00701-006-0748-y; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Xu XJ, 1999, J APPL PHYSIOL, V86, P265, DOI 10.1152/jappl.1999.86.1.265; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; Zhu MM, 2006, J APPL PHYSIOL, V101, P1481, DOI 10.1152/japplphysiol.00319.2006	36	24	27	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	APR 15	2009	178	2					345	349		10.1016/j.jneumeth.2008.12.030			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	425BG	WOS:000264611400015	19167429				2022-02-06	
J	Maruichi, K; Kuroda, S; Chiba, Y; Hokari, M; Shichinohe, H; Hida, K; Iwasaki, Y				Maruichi, Katsuhiko; Kuroda, Satoshi; Chiba, Yasuhiro; Hokari, Masaaki; Shichinohe, Hideo; Hida, Kazutoshi; Iwasaki, Yoshinobu			Graded model of diffuse axonal injury for studying head injury-induced cognitive dysfunction in rats	NEUROPATHOLOGY			English	Article						animal model; cognitive dysfunction; diffuse axonal injury	TRAUMATIC BRAIN-INJURY; PATHOPHYSIOLOGY; PATHOBIOLOGY	Diffuse axonal injury (DAI) plays a major role in the development of cognitive dysfunction, emotional difficulties and behavioral disturbances in patients following closed head injury, even when they have no definite abnormalities on conventional MRI. This study aimed to develop a highly controlled and reproducible model for DAI that simulates post-traumatic cognitive dysfunction in humans. Sprague-Dawley (SD) rats were subjected to impact acceleration head injury, using a pneumatic impact targeted to a steel disc centered onto their skull. The severity of injury was graded as three levels by adjusting the driving pressure at 60, 70 or 80 pounds per square inch. In vivo MRI was obtained 2 days post-injury. Cognitive function was evaluated using the Morris water maze at 1 and 2 weeks post-injury. HE staining and immunohistochemistry were performed to assess neuronal and axonal damages after 2 weeks. MRI demonstrated that this model induced no gross structural modification in the brain. The degree and duration of cognitive dysfunction were dependent on the force of impact. Histological analysis revealed the force-dependent damage of the neurons and microtubule-associated protein 2-positive axons in the neocortex. Hippocampal damage was much less pronounced and was not linked to cognitive dysfunction. This is the first report that precisely evaluates the threshold of impact energy to lead to neocortical damage and cognitive dysfunction in rodents. This model would be suitable for clarifying the complex mechanisms of post-traumatic brain damage and testing novel therapeutic approaches against post-traumatic cognitive dysfunction due to diffuse axonal damage.	[Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan		Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Hokari, Masaaki/G-5395-2012; Shichinohe, Hideo/G-5367-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17390389, 18390387, 19390371]	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No. 17390389, No. 18390387 and No. 19390371). The authors deeply thank Yumiko Shinohe for her technical assistance and Miki Shinada for her secretarial work.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2006, ACTA NEUROCHIR WIEN, V148, P93; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Ellingson Benjamin M., 2005, V41, P86; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Pineda JA, 2001, J NEUROTRAUM, V18, P625, DOI 10.1089/089771501750291864; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	24	24	24	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	APR	2009	29	2					132	139		10.1111/j.1440-1789.2008.00956.x			8	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	420SU	WOS:000264310300004	18702633				2022-02-06	
J	Bickerdike, MJ; Thomas, GB; Batchelor, DC; Sirimanne, ES; Leong, W; Lin, H; Sieg, F; Wen, J; Brimble, MA; Harris, PW; Gluckman, PD				Bickerdike, Michael J.; Thomas, Gregory B.; Batchelor, David C.; Sirimanne, Ernest S.; Leong, Wing; Lin, Hai; Sieg, Frank; Wen, Jingyuan; Brimble, Margaret A.; Harris, Paul W.; Gluckman, Peter D.			NNZ-2566: A Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Neuroprotection; Stroke; Ischaemia; Hypoxia; Apoptosis	N-TERMINAL TRIPEPTIDE; GLYCINE-PROLINE-GLUTAMATE; GROWTH-FACTOR-I; CEREBRAL-ARTERY OCCLUSION; OKADAIC ACID; PHARMACOLOGICAL EVALUATION; GPE; BRAIN; ISCHEMIA; LESION	The N-terminal cleavage product of human insulin-like growth factor-1 (IGF-1) in the brain is the tripeptide molecule Glypromate (R) (Gly-Pro-Glu). Glypromate (R) has demonstrated neuroprotective effects in numerous in vitro and in vivo models of brain injury and is in clinical trials for the prevention of cognitive impairment following cardiac surgery. NNZ-2566 is a structural analogue of Glypromate (R), resulting from alpha-methylation of the proline moiety, which has improved the elimination half-life and oral bioavailability over the parent peptide. fit vivo, NNZ-2566 reduces injury size in rats subjected to focal stroke. An intravenous infusion of NNZ-2566 of 4 h duration (3-10 mg/kg/h), initiated 3 h after endothelin-induced middle-cerebral artery constriction, significantly reduced infarct area as assessed on day 5. Neuroprotective efficacy in the MCAO model was also observed following oral administration of the drug (30-60 mg/kg), when formulated as a microemulsion. In vitro, NNZ-2566 significantly attenuates apoptotic cell death in primary striatal cultures, suggesting attenuation of apoptosis is one mechanism of action underlying its neuroprotective effects. NNZ-2566 is currently in clinical trials for the treatment of cognitive deficits following traumatic brain injury, and these data further support the development of the drug as a neuroprotective agent for acute brain injury. (c) 2008 Elsevier B.V. All rights reserved.	[Bickerdike, Michael J.; Thomas, Gregory B.; Batchelor, David C.; Sirimanne, Ernest S.; Leong, Wing; Lin, Hai; Sieg, Frank; Gluckman, Peter D.] Neuren Pharmaceut Ltd, Auckland 1011, New Zealand; [Wen, Jingyuan] Univ Auckland, Dept Pharm, Auckland 1, New Zealand; [Brimble, Margaret A.; Harris, Paul W.] Univ Auckland, Dept Med Chem, Auckland 1, New Zealand; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand		Bickerdike, MJ (corresponding author), Neuren Pharmaceut Ltd, 57 Wellington St,Freemans Bay, Auckland 1011, New Zealand.	mbickerdike@neurenpharma.com		Sieg, Frank/0000-0001-9637-3239; Brimble, Margaret/0000-0002-7086-4096			AGNATI LF, 1991, ITAL J NEUROL SCI, V12, P49; Aguado-Liera D, 2004, NEUROREPORT, V15, P1979, DOI 10.1097/00001756-200408260-00029; Alexi T, 1999, EXP NEUROL, V159, P84, DOI 10.1006/exnr.1999.7168; De Diego SA, 2006, BIOORG MED CHEM LETT, V16, P3396, DOI 10.1016/j.bmcl.2006.04.033; Baker AM, 2005, NEUROPEPTIDES, V39, P81, DOI 10.1016/j.npep.2004.11.001; Batchelor DC, 2003, ANAL BIOCHEM, V323, P156, DOI 10.1016/j.ab.2003.08.032; Biernaskie J, 2001, MAGNET RESON MED, V46, P827, DOI 10.1002/mrm.1263; Brimble MA, 2005, BIOORGAN MED CHEM, V13, P519, DOI 10.1016/j.bmc.2004.10.006; Cagnoli CM, 1996, J MOL NEUROSCI, V7, P65, DOI 10.1007/BF02736849; Callaway JK, 1999, STROKE, V30, P2704, DOI 10.1161/01.STR.30.12.2704; CARLSSONSKWIRUT C, 1986, FEBS LETT, V201, P46, DOI 10.1016/0014-5793(86)80568-3; De Diego SAA, 2006, BIOORG MED CHEM LETT, V16, P1392, DOI 10.1016/j.bmcl.2005.11.040; De Diego SAA, 2005, BIOORG MED CHEM LETT, V15, P2279, DOI 10.1016/j.bmcl.2005.03.015; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Guan J, 2004, NEUROPHARMACOLOGY, V47, P892, DOI 10.1016/j.neuropharm.2004.07.002; Guan J, 2000, BRAIN RES, V859, P286, DOI 10.1016/S0006-8993(00)01988-0; HARRIS KA, 1993, ANN NEUROL, V33, P77, DOI 10.1002/ana.410330113; Harris PWR, 2006, J LABELLED COMPD RAD, V49, P571, DOI 10.1002/jlcr.1075; Harris PWR, 2005, TETRAHEDRON, V61, P10018, DOI 10.1016/j.tet.2005.08.026; Kanwar JR, 2004, BRAIN, V127, P1313, DOI 10.1093/brain/awh156; Krishnamurthi R, 2004, NEUROREPORT, V15, P1601, DOI 10.1097/01.wnr.0000127461.15985.07; Lai MYH, 2005, BIOORGAN MED CHEM, V13, P533, DOI 10.1016/j.bmc.2004.10.004; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; NILSSONHAKANSSON L, 1993, NEUROREPORT, V4, P1111; Raja PV, 2004, CNS SPECTRUMS, V9, P763, DOI 10.1017/S1092852900022409; ROUSSEL S, 1992, HYPERTENSION, V19, P40, DOI 10.1161/01.HYP.19.1.40; SARA VR, 1989, BIOCHEM BIOPH RES CO, V165, P766, DOI 10.1016/S0006-291X(89)80032-4; Saura J, 1999, NEUROREPORT, V10, P161, DOI 10.1097/00001756-199901180-00031; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; SHARKEY J, 1994, J AUTONOM NERV SYST, V49, pS177; Sizonenko SV, 2001, BRAIN RES, V922, P42, DOI 10.1016/S0006-8993(01)03148-1; Souid-Mensi G, 2008, TOXICON, V51, P1338, DOI 10.1016/j.toxicon.2008.03.002; Svedin P, 2007, DEV NEUROSCI-BASEL, V29, P393, DOI 10.1159/000105480; Trotter NS, 2005, BIOORGAN MED CHEM, V13, P501, DOI 10.1016/j.bmc.2004.10.005; Zhao XR, 2005, STROKE, V36, P129, DOI 10.1161/01.STR.0000149624.87661.18	35	24	26	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2009	278	1-2					85	90		10.1016/j.jns.2008.12.003			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	411ZF	WOS:000263692300017	19157421				2022-02-06	
J	Frey, LC; Hellier, J; Unkart, C; Lepkin, A; Howard, A; Hasebroock, K; Serkova, N; Liang, LP; Patel, M; Soltesz, I; Staley, K				Frey, Lauren C.; Hellier, Jennifer; Unkart, Cheri; Lepkin, Aaron; Howard, Allyson; Hasebroock, Kendra; Serkova, Natalie; Liang, LiPing; Patel, Manisha; Soltesz, Ivan; Staley, Kevin			A novel apparatus for lateral fluid percussion injury in the rat	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Lateral fluid percussion injury; Rat; Experimental TBI; Picospritzer	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC EPILEPSY; EXPERIMENTAL-MODELS; CELL LOSS; HYPEREXCITABILITY; HIPPOCAMPUS	Lateral fluid percussion injury (LFPI) is the most commonly used experimental model of human traumatic brain injury (TBI). To date, investigators using this model have produced injury using a pendulum-and-piston-based device (PPBD) to drive fluid against an intact dural surface. Two disadvantages of this method, however, are (1) the necessary reliance on operator skill to position and release the pendulum, and (2) reductions in reproducibility due to variable friction between the piston's o-rings and the cylinder. To counteract these disadvantages, we designed a low-priced, novel, fluid percussion apparatus that delivers a pressure pulse of air to a standing column of fluid, forcing it against the intact dural surface. The pressure waveforms generated by this apparatus are similar to those reported in the LFPI/PPBD literature and had little variation in appearance between trials. In addition, our apparatus produced an acute and chronic TBI syndrome similar to that in the LFPI/PPBD literature, as quantified by histological changes, MRI structural changes and chronic behavioral sequelae. (C) 2008 Elsevier B.V. All rights reserved.	[Frey, Lauren C.; Unkart, Cheri; Lepkin, Aaron] Univ Colorado, Dept Neurol, Denver, CO USA; [Hellier, Jennifer] Univ Colorado Denver, Neurosci Program, Denver, CO USA; [Hasebroock, Kendra; Serkova, Natalie] Univ Colorado Denver, Dept Anesthesiol, Denver, CO USA; [Liang, LiPing; Patel, Manisha] Univ Colorado Denver, Dept Pharmaceut Sci, Denver, CO USA; [Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Staley, Kevin] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Howard, Allyson] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA		Frey, LC (corresponding author), POB 6510,Mail Stop F727, Aurora, CO 80045 USA.	lauren.frey@uchsc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-35915]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035915, R29NS035915, R37NS035915] Funding Source: NIH RePORTER	This work was supported by the Colorado Injury Control Research Center and the National Institutes of Health (NS-35915, I.S.).	Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gallyas F, 2002, ACTA NEUROPATHOL, V103, P36, DOI 10.1007/s004010100424; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LAURER HL, 1999, CURRENT OPINIONS NEU, P715; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MCCAMAN RE, 1977, BRAIN RES, V136, P141, DOI 10.1016/0006-8993(77)90138-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Rangel P, 2005, ARQ NEURO-PSIQUIAT, V63, P972, DOI 10.1590/S0004-282X2005000600013; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	27	24	27	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2009	177	2					267	272		10.1016/j.jneumeth.2008.10.022			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	407VV	WOS:000263393300002	19022291	Green Accepted			2022-02-06	
J	Frederick, RI; Bowden, SC				Frederick, Richard I.; Bowden, Stephen C.			Evaluating Constructs Represented by Symptom Validity Tests in Forensic Neuropsychological Assessment of Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						forensic neuropsychology; feigned cognitive impairment; malingering assessment; test validation	MIXED GROUP VALIDATION; TOMM; EXAGGERATION	This study uses a new method to summarize diagnostic validity information to explore which constructs are captured by malingering tests. ne Test Validation Summary applies mixed-groups validation to investigate the meaning of test constructs and to estimate test classification characteristics when test validation groups are not "pure" criterion groups (ie, "compliant" vs "malingering"), but members have variable probability of malingering. The method permits the use of tests with relatively low validity to validate tests of greater validity. In our initial analysis, we argue that the Rey 15-Item Memory Test is best construed as an "intention test" (capturing the intention of test takers when taking a test) as opposed to an "effort test." Using the Test Validation Summary and mixed-groups validation, we demonstrate that as an indicator of "intention to feign cognitive impairment," the Rey 15-Item Memory Test has estimated false-positive rate (FPR) = 0.02 and true-positive rate (TPR) = 0.57. We then explore the meaning of failure on the Word Memory Test (WMT), which uses a dichotomous classification of performance as valid or invalid. Although the WMT is commonly referred to as an "effort test," we argue that it likely captures both "intention" and "effort" but collapses this information into a single dichotomous classification of symptom validity. We demonstrate that, as a result of this dichotomous classification process, the WMT likely has a problematic FPR. In our analysis of previously published WMT data, the WMT FPR is estimated at 0.12 when there is no predisposition to perform poorly but rises dramatically and unrealistically as the predisposition to perform poorly increases. We compare these findings to those of the Validity Indicator Profile (VIP), which captures both intent and effort to classify 4 different sorts of response styles in cognitive testing. In our analyses, the VIP demonstrates that FPR = 0 and TPR = 0.86 when the construct being measured is "intent to perform poorly," and reveals that FPR = 0.06 and TPR = 0.63 when the construct being measured is "inconsistent responding" or "poor effort." We were able to demonstrate for the VIP the same "oversensitivity" shown by the WMT when the VIP was interpreted only as a dichotomous classification test. These results indicate that researchers who attempt to generate classification characteristics for malingering tests must carefully consider what constructs are being captured by the test.	[Frederick, Richard I.] US Med Ctr Fed Prisoners, Dept Psychol, Springfield, MO 65807 USA; [Bowden, Stephen C.] Univ Melbourne, Dept Psychol, Parkville, Vic 3052, Australia		Frederick, RI (corresponding author), US Med Ctr Fed Prisoners, Dept Psychol, 1900 W Sunshine St, Springfield, MO 65807 USA.	rickfrederick@gmail.com	Bowden, Stephen C/C-3726-2012				Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J, 1989, MANUAL ADM SCORING M; Cochrane RE, 2001, BEHAV SCI LAW, V19, P565, DOI 10.1002/bsl.454.abs; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; DAWES RM, 1966, PSYCHOL BULL, V66, P63, DOI 10.1037/h0023584; FAUST D, 2003, MALINGERING ILLNESS, P107; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Frederick R. I., 1997, VALIDITY INDICATOR P; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; Frederick R. I, 2002, J FORENSIC NEUROPSYC, V2, P125; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Frederick RI, 2001, NEUROREHABILITATION, V16, P309; Frederick RI, 2000, LAW HUMAN BEHAV, V24, P59, DOI 10.1023/A:1005426803586; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Frederick RI, 2000, BEHAV SCI LAW, V18, P693, DOI 10.1002/bsl.432; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Frederick RI, 2009, ASSESSMENT, V16, P215, DOI 10.1177/1073191108325005; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Graham J. R, 2006, MMPI 2 ASSESSING PER; Green P, 2001, NEUROREHABILITATION, V16, P231; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; GREEN P, 2000, J FORENSIC NEUROPSYC, V2, P97; Green P., 1996, WORD MEMORY TEST USE; GREEN P, 2007, DETECTION NONCREDIBL; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Rey A, 1958, LEXAMEN CLINIQUE PSY; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Straus SE., 2005, EVIDENCE BASED MED P, V3rd; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; [No title captured]	39	24	24	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2009	24	2					105	122		10.1097/HTR.0b013e31819b1210			18	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427WF	WOS:000264809100005	19333066				2022-02-06	
J	Heskestad, B; Baardsen, R; Helseth, E; Romner, B; Waterloo, K; Ingebrigtsen, T				Heskestad, Ben; Baardsen, Roald; Helseth, Eirik; Romner, Bertil; Waterloo, Knut; Ingebrigtsen, Tor			Incidence of hospital referred head injuries in Norway: A population based survey from the Stavanger region	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; GUIDELINES; MILD; MANAGEMENT	Background: In three previous Norwegian studies conducted between 1974 and 1993, the annual incidence rates of hospital admitted head injuries were 236, 200 and 169 per 100,000 population. The aim of this study was to describe the incidence of head injury in the Stavanger region and to compare it with previous Norwegian studies. Methods: All head injured patients referred to Stavanger University Hospital during a one-year period (2003) were registered in a partly prospective and partly retrospective study. The catchment area for the hospital is strictly defined to a local population of 283,317 inhabitants (2003). Results: The annual incidence rate was 207/100,000 population for hospital referred head injury and 157/100,000 population for hospital admitted head injury. High age-and sex specific incidence rates were observed among the oldest, and the highest rate (882/100,000) among men above 90 years. More than 50% of the injuries were caused by falls. Conclusion: Comparison with previous Norwegian studies indicates decreasing annual incidence rates for hospital admitted head injury during the last 30 years.	[Romner, Bertil; Ingebrigtsen, Tor] Univ Tromso, Inst Clin Med, Dept Neurosurg, Tromso, Norway; [Heskestad, Ben; Helseth, Eirik] Ullevaal Univ Hosp, Dept Neurosurg, Oslo, Norway; [Heskestad, Ben; Baardsen, Roald] Stavanger Univ Hosp, Dept Neurosurg, Stavanger, Norway; [Waterloo, Knut] Univ Hosp N Norway, Dept Neurol, Tromso, Norway		Ingebrigtsen, T (corresponding author), Univ Tromso, Inst Clin Med, Dept Neurosurg, Tromso, Norway.	ben.heskestad@ulleval.no; baar@sus.no; eirik.helseth@ulleval.no; bertil.romner@rh.dk; knut.waterloo@unn.no; tor.ingebrigtsen@unn.no	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Ytterstad Borge, 2003, Int J Circumpolar Health, V62, P61	14	24	24	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 20	2009	17								6	10.1186/1757-7241-17-6			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	665HG	WOS:000283025400001	19232086	gold, Green Published			2022-02-06	
J	Goverover, Y; Chiaravalloti, N; Gaudino-Goering, E; Moore, N; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy; Gaudino-Goering, Elizabeth; Moore, Nancy; DeLuca, John			The Relationship Among Performance of Instrumental Activities of Daily Living, Self-Report of Quality of Life, and Self-Awareness of Functional Status in Individuals With Multiple Sclerosis	REHABILITATION PSYCHOLOGY			English	Article						self-awareness; cognitive rehabilitation; multiple sclerosis; outcome measures	TRAUMATIC BRAIN-INJURY; NEUROBEHAVIORAL SYMPTOMS; COGNITIVE DYSFUNCTION; SENILE DEMENTIA; ALZHEIMER-TYPE; DEFICITS; DISABILITY; ASSOCIATION; PERCEPTIONS; METAMEMORY	Objective: To investigate the relationship between self-awareness of functional status and performance of Instrumental Activities of Daily Living (IADL), and self-reports of quality of life (QOL) in persons with multiple sclerosis (MS). Design: A between-groups design, using a correlational approach to examine the relationship between self-awareness of functional status, IADL and QOL. Participants: We studied 47 individuals with clinically definite MS and 26 healthy controls (HCs). Measures: The Functional Behavior Profile was completed by both participants and their informants. Participants' scores were subtracted from those of their informants', and the absolute value was used as the self-awareness/concordance score. The Executive Function Performance Test measured IADL performance; QOL was measured with the Functional Assessment of Multiple Sclerosis. Results: MS participants showed lower levels of self-awareness relative to HCs. Significant correlations were observed between performance of IADL, reports of QOL and self-awareness levels of functional status. However, reports of QOL were not significantly correlated with performance of IADL. Conclusions: The positive association between self-awareness of functional status with IADL performance and QOL reports provides support for the role of awareness in rehabilitation.	[Goverover, Yael] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, New York, NY 10012 USA; [Goverover, Yael; Chiaravalloti, Nancy; Gaudino-Goering, Elizabeth; Moore, Nancy; DeLuca, John] Kessler Med Rehabil Res & Educ Ctr, Keesler AFB, MS USA; [Chiaravalloti, Nancy; DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Dept Neurol & Neurosci, Newark, NJ 07103 USA		Goverover, Y (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 35 W 4th St,11th Floor, New York, NY 10012 USA.	yg243@nyu.edu					Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Barker-Collo SL, 2006, ARCH CLIN NEUROPSYCH, V21, P167, DOI 10.1016/j.acn.2005.08.008; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; BEATTY WW, 1995, J NEUROLOGIC REHABIL, V9, P67; Beck AT, 1987, BECK DEPRESSION INVE; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DOBLE SE, 1994, ARCH PHYS MED REHAB, V75, P843, DOI 10.1016/0003-9993(94)90107-4; Edwards, 2003, TEST MANUAL EXECUTIV; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Finlayson M., 1998, CANADIAN J OCCUPATIO, V65, P299, DOI DOI 10.1177/000841749806500508; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; FITZGERALD JF, 1993, J GERONTOLOGY SOCIAL, V48, P28; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Halper June, 2003, J Neurosci Nurs, V35, P70; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; JACOBS JW, 1984, SOURCE BOOK GERIATRI, V2, P50; JACOBS JW, 1984, SOURCE BOOK GERIATRI, V1, P121; Kanner AM, 2005, EPILEPSY BEHAV, V6, P303, DOI 10.1016/j.yebeh.2005.02.008; Katz N., 2007, OCCUPATIONAL THERAPY, V27, P1; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mansson E, 2004, DISABIL REHABIL, V26, P576, DOI 10.1080/09638280410001684587; Maor Y, 2001, MULT SCLER, V7, P131, DOI 10.1191/135245801678227658; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Provinciali L, 1999, ACTA NEUROL SCAND, V100, P156; Randolph JJ, 2004, ARCH CLIN NEUROPSYCH, V19, P259, DOI 10.1016/S0887-6177(03)00026-X; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Schwartz CE, 1999, SOC SCI MED, V48, P1563, DOI 10.1016/S0277-9536(99)00049-0; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherman TE, 2008, J CLIN EXP NEUROPSYC, V30, P301, DOI 10.1080/13803390701380617; Shevil E, 2006, DISABIL REHABIL, V28, P779, DOI 10.1080/09638280500387013; Tham K, 2001, AM J OCCUP THER, V55, P46, DOI 10.5014/ajot.55.1.46; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia JP, 2005, COGNITION OCCUPATION, P29	52	24	24	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2009	54	1					60	68		10.1037/a0014556			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	410WJ	WOS:000263608700007	19618704				2022-02-06	
J	Oda, Y; Tsuruta, R; Kasaoka, S; Inoue, T; Maekawa, T				Oda, Yasutaka; Tsuruta, Ryosuke; Kasaoka, Shunji; Inoue, Takeshi; Maekawa, Tsuyoshi			The cutoff values of intrathecal interleukin 8 and 6 for predicting the neurological outcome in cardiac arrest victims	RESUSCITATION			English	Article						Interleukin 8; Interleukin 6; Cerebrospinal fluid; Cardiopulmonary arrest; Ischemia reperfusion injury	TRAUMATIC BRAIN INJURY; SUCCESSFUL CARDIOPULMONARY-RESUSCITATION; GROWTH-FACTOR PRODUCTION; NEURON-SPECIFIC ENOLASE; TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; CEREBROSPINAL-FLUID; REGAINING CONSCIOUSNESS; SERUM INTERLEUKIN-8; S-100 PROTEIN	Objectives: To evaluate the changes in inflammatory cytokines, such as interleukin (IL)-8 and IL-6, in the cerebrospinal fluid (CSF) and serum, and to identify any correlations with the neurological outcomes in patients resuscitated from cardiopulmonary arrest (CPA). Materials and methods: This study was designed as a prospective clinical trial. Thirteen patients, who were resuscitated from out-of-hospital CPA and survived for more than 48 h, were enrolled in this study. Arterial blood was taken from the patients at 48 h after the return of spontaneous circulation (ROSC) and CSF was taken by lumbar puncture at the same time. Results: In the CSF, the median levels of IL-8 and IL-6 in the patients resuscitated from CPA were significantly higher than those in the control subjects (1311 pg/ml vs 82 pg/ml, P < 0.001; 2040 pg/ml vs 1 pg/ml, P < 0.001, respectively). The Glasgow outcome Scale (GOS) score evaluated at 6 months after the ROSC correlated significantly with the levels of IL-8 and IL-6. The cutoff values and sensitivity values with 100% specificity for the prediction of an unfavorable neurological outcome were 1423 pg/ml and 86% for IL-8, and 2708 pg/ml and 86% for IL-6, respectively. Conclusion: We demonstrated the cutoff values of IL-8 and IL-6 in the CSF to predict the neurological outcome in the patients resuscitated from CPA. The excessive inflammatory cytokine reactions in the brain might therefore be related to the poor neurological outcome in patients with post-resuscitation encephalopathy. (c) 2008 Elsevier Ireland Ltd. All rights reserved.	[Oda, Yasutaka; Tsuruta, Ryosuke] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi 7558505, Japan; [Kasaoka, Shunji; Inoue, Takeshi; Maekawa, Tsuyoshi] Yamaguchi Univ, Grad Sch Med, Dept Stress & Bioresponse Med, Yamaguchi 7558505, Japan		Oda, Y (corresponding author), Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.	yasutaka-ygc@umin.ac.jp					Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bottiger BW, 2001, CIRCULATION, V103, P2694; Ekmektzoglou KA, 2007, RESUSCITATION, V75, P219, DOI 10.1016/j.resuscitation.2007.03.016; Hachimi-Idrissi S, 2005, RESUSCITATION, V64, P187, DOI 10.1016/j.resuscitation.2004.08.008; Hachimi-Idrissi S, 2002, RESUSCITATION, V53, P251, DOI 10.1016/S0300-9572(02)00027-8; Ito T, 2001, RESUSCITATION, V51, P47, DOI 10.1016/S0300-9572(01)00382-3; JENNETT B, 1975, LANCET, V1, P480; Kettritz R, 1998, KIDNEY INT, V53, P84, DOI 10.1046/j.1523-1755.1998.00741.x; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Madl Christian, 2004, Curr Opin Crit Care, V10, P213, DOI 10.1097/01.ccx.0000127542.32890.fa; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; MARTICH GD, 1991, J EXP MED, V173, P1021, DOI 10.1084/jem.173.4.1021; Matsumoto T, 1997, LAB INVEST, V77, P119; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Shyu KG, 1997, AM HEART J, V134, P551, DOI 10.1016/S0002-8703(97)70094-2; SIESJO BK, 1995, ANN THORAC SURG, V59, P1316, DOI 10.1016/0003-4975(95)00077-X; Snyder-Ramos SA, 2003, RESTOR NEUROL NEUROS, V21, P123; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; WHITE M, 2000, FAMILY THERAPY FIELD, V1, P33	33	24	24	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2009	80	2					189	193		10.1016/j.resuscitation.2008.10.001			5	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	408OB	WOS:000263443200010	19010583				2022-02-06	
J	Zhang, Z; Majava, V; Greffier, A; Hayes, RL; Kursula, P; Wang, KKW				Zhang, Z.; Majava, V.; Greffier, A.; Hayes, R. L.; Kursula, P.; Wang, K. K. W.			Collapsin response mediator protein-2 is a calmodulin-binding protein	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						CRMP-2; proteolysis; calmodulin; calmodulin-binding protein; oligomerization	TRAUMATIC BRAIN-INJURY; MYELIN BASIC-PROTEIN; MOUSE-BRAIN; NEURONAL POLARITY; CALPAIN; CLEAVAGE; CRMP-2; PROTEOLYSIS; DYNAMICS; GROWTH	Collapsin response mediator protein-2 (CRMP-2) plays a crucial role in axonal guidance and neurite outgrowth during neural development and regeneration. We have studied the interaction between calmodulin (CaM) and CRMP-2 and how Ca(2+)/CaM binding modulates the biological functions of CRMP-2. We have shown that CRMP-2 binds to CaM directly in a Ca(2+)-dependent manner. The CaM binding site of CRMP-2 is proposed to reside in the last helix of the folded domain, and in line with this, a synthesized peptide representing this helix bound to CaM. In addition, CaM binding inhibits a homotetrameric assembly of CRMP-2 and attenuates calpainmediated CRMP-2 proteolysis. Furthermore, a CaM antagonist reduces the number and length of process induced by CRMP-2 overexpression in HEK293 cells. Take together, our data suggest that CRMP-2 is a novel CaM-binding protein and that CaM binding may play an important role in regulating CRMP-2 functions.	[Zhang, Z.; Hayes, R. L.; Wang, K. K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL 32615 USA; [Majava, V.; Greffier, A.; Kursula, P.] Univ Oulu, Dept Biochem, Oulu, Finland; [Hayes, R. L.] Univ Florida, McKnight Brain Inst, Dept Anesthesiol, Gainesville, FL USA; [Wang, K. K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Gainesville, FL USA		Zhang, Z (corresponding author), Banyan Biomarkers Inc, Ctr Innovat Res, 12805 Res Dr, Alachua, FL 32615 USA.	zqzhang@banyanbio.com; petri.kursula@oulu.fi; kwang@banyanbio.com	Kursula, Petri/AAF-4563-2020; Kursula, Petri/K-1058-2012	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Wang, Kevin/0000-0002-9343-6473	Department of DefenseUnited States Department of Defense [DAMD-03-1-0066]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS049175- 01-A1, R01 NS051431]; Academy of FinlandAcademy of FinlandEuropean Commission; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049175] Funding Source: NIH RePORTER	The authors thank Jingxiang Mo for the CRMP- 2 construct and Dr. Nobuhiro Hayashi for the pETCM vector. We wish to thank Drs Andrew K. Ottens, Michael Bubb, Juan A. Martinez and Stephen F. Larner for insightful discussions and editorial assistance. This work was supported by the Department of Defense grant DAMD-03-1-0066, NIH grants R01 NS049175- 01-A1 and R01 NS051431, and by the Academy of Finland. K. K. W. Wang and R. L. Hayes own stock of Banyan Biomarkers Inc., and may benefit financially as a result of the outcome of this research or the work reported in this publication.	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Berggard T, 2006, J PROTEOME RES, V5, P669, DOI 10.1021/pr050421l; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Chung MA, 2005, NEUROREPORT, V16, P1647, DOI 10.1097/01.wnr.0000176520.49841.e6; Croall DE, 1996, BBA-PROTEIN STRUCT M, V1298, P276, DOI 10.1016/S0167-4838(96)00138-0; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gerendasy D, 1999, J NEUROSCI RES, V58, P107, DOI 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; KOSAKI G, 1983, BIOCHEM INT, V6, P767; Krucker T, 2002, J NEUROSCI, V22, P5525; Libich DS, 2003, BIOCHEM BIOPH RES CO, V308, P313, DOI 10.1016/S0006-291X(03)01380-9; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; O'Day DH, 2004, BIOCHEM BIOPH RES CO, V320, P1051, DOI 10.1016/j.bbrc.2004.06.070; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Sola C, 1999, PROG NEUROBIOL, V58, P207, DOI 10.1016/S0301-0082(98)00082-3; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; TSUNEKAWA S, 1989, FEBS LETT, V250, P493, DOI 10.1016/0014-5793(89)80783-5; van Dalen JJW, 2003, EUR J NEUROSCI, V18, P13, DOI 10.1046/j.1460-9568.2003.02720.x; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; [No title captured]	43	24	24	0	3	BIRKHAUSER VERLAG AG	BASEL	VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND	1420-682X			CELL MOL LIFE SCI	Cell. Mol. Life Sci.	FEB	2009	66	3					526	536		10.1007/s00018-008-8362-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	402GT	WOS:000263002900014	19151921	Green Accepted			2022-02-06	
J	Ji, SY; Smith, R; Huynh, T; Najarian, K				Ji, Soo-Yeon; Smith, Rebecca; Huynh, Toan; Najarian, Kayvan			A comparative analysis of multi-level computer-assisted decision making systems for traumatic injuries	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article							LOGISTIC-REGRESSION; CLASSIFICATION; HELICOPTER; TREE; SUPPORT; TRANSPORT; SERVICES; CART	Background: This paper focuses on the creation of a predictive computer-assisted decision making system for traumatic injury using machine learning algorithms. Trauma experts must make several difficult decisions based on a large number of patient attributes, usually in a short period of time. The aim is to compare the existing machine learning methods available for medical informatics, and develop reliable, rule-based computer-assisted decision-making systems that provide recommendations for the course of treatment for new patients, based on previously seen cases in trauma databases. Datasets of traumatic brain injury (TBI) patients are used to train and test the decision making algorithm. The work is also applicable to patients with traumatic pelvic injuries. Methods: Decision-making rules are created by processing patterns discovered in the datasets, using machine learning techniques. More specifically, CART and C4.5 are used, as they provide grammatical expressions of knowledge extracted by applying logical operations to the available features. The resulting rule sets are tested against other machine learning methods, including AdaBoost and SVM. The rule creation algorithm is applied to multiple datasets, both with and without prior filtering to discover significant variables. This filtering is performed via logistic regression prior to the rule discovery process. Results: For survival prediction using all variables, CART outperformed the other machine learning methods. When using only significant variables, neural networks performed best. A reliable rule-base was generated using combined C4.5/CART. The average predictive rule performance was 82% when using all variables, and approximately 84% when using significant variables only. The average performance of the combined C4.5 and CART system using significant variables was 89.7% in predicting the exact outcome (home or rehabilitation), and 93.1% in predicting the ICU length of stay for airlifted TBI patients. Conclusion: This study creates an efficient computer-aided rule-based system that can be employed in decision making in TBI cases. The rule-bases apply methods that combine CART and C4.5 with logistic regression to improve rule performance and quality. For final outcome prediction for TBI cases, the resulting rule-bases outperform systems that utilize all available variables.	[Ji, Soo-Yeon; Smith, Rebecca; Najarian, Kayvan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Huynh, Toan] Carolinas Healthcare Syst, Dept Surg, Charlotte, NC USA		Ji, SY (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, 401 E Main St, Richmond, VA 23284 USA.	jisy@vcu.edu; smithr@vcu.edu; toan.huyhn@carolinashealthcare.org; knajarian@vcu.edu	Najarian, Kayvan/B-2303-2010		Health Services Foundation; Carolinas HealthCare System; Virginia Commonwealth University; National Science FoundationNational Science Foundation (NSF) [IIS0758410]; Div Of Information & Intelligent SystemsNational Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE) [0758410] Funding Source: National Science Foundation	This research was partially funded by research grants from Health Services Foundation, Carolinas HealthCare System, and Virginia Commonwealth University. This material is based upon work supported by the National Science Foundation under Grant No. IIS0758410. The authors would like to thank these institutions for their support.	ANDERSON RN, 2001, NATL VITAL STAT REP, V52, P1; Andrews PJD, 2003, J NEUROSURG, V98, P442; Arfken CL, 1998, J TRAUMA, V45, P785, DOI 10.1097/00005373-199810000-00031; Breiman L., 1993, CLASSIFICATION REGRE; *CDCP, 2004, FACTS CONC BRAIN INJ; Clarke JR, 2002, WORLD J SURG, V26, P536, DOI 10.1007/s00268-001-0263-5; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Eckstein M, 2002, J TRAUMA, V53, P340, DOI 10.1097/00005373-200208000-00025; *EXP WORK GROUP, 2000, TRAUM BRAIN INJ US A; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Fan W., 1999, P 5 ACM SIGKDD INT C, DOI [10.1145/312129.312283, DOI 10.1145/312129.312283]; Fitzmaurice JM, 2002, J AM MED INFORM ASSN, V9, P144; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Fu CY, 2004, COMPUT STAT DATA AN, V45, P865, DOI 10.1016/S0167-9473(03)00092-6; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gearhart PA, 1997, ANN EMERG MED, V30, P500, DOI 10.1016/S0196-0644(97)70010-6; Guo HM, 2006, ST HEAL T, V122, P891; HASFORD J, 1993, THERAPIE, V48, P479; HAUG PJ, 1994, COMPUT BIOMED RES, V27, P396, DOI 10.1006/cbmr.1994.1030; HOSMER D, 1989, WILEY SERIES PROBABI, pCH1; Jagielska I, 1998, 1998 SECOND INTERNATIONAL CONFERENCE ON KNOWLEDGE-BASED INTELLIGENT ELECTRONIC SYSTEMS, KES '98, PROCEEDINGS, VOL 2, P89, DOI 10.1109/KES.1998.725897; JI SY, 2007, ACM SE 45 P 45 ANN S, P198; Joachims T., 1998, P 10 EUR C MACH LEAR, P137, DOI [10.1007/BFb0026683, DOI 10.1007/BFB0026683]; KELEMEN A, 2002, ADV SIMULATION COMPU; Kuhnert PM, 2000, COMPUT STAT DATA AN, V34, P371, DOI 10.1016/S0167-9473(99)00099-7; Lee CC, 1999, IEEE T SYST MAN CY B, V29, P674, DOI 10.1109/3477.809023; LOH WY, 1988, J AM STAT ASSOC, V83, P715, DOI 10.2307/2289295; LONG WJ, 1993, COMPUT BIOMED RES, V26, P74, DOI 10.1006/cbmr.1993.1005; Lu YW, 1998, IEEE T NEURAL NETWOR, V9, P308, DOI 10.1109/72.661125; Mac Namee B, 2002, ARTIF INTELL MED, V24, P51, DOI 10.1016/S0933-3657(01)00092-6; NAJARIAN K, 2006, WILEY ENCY BIOMEDICA; Quinlan J.R., 2014, C4 5 PROGRAMS MACHIN; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; QUINLAN JR, 1987, P 10 INT JOINT C ART, P997; QUINLAN JR, 1983, MACHINE LEARNING ART, V1, P463, DOI DOI 10.1007/978-3-662-12405-5_; Ruggieri S, 2002, IEEE T KNOWL DATA EN, V14, P438, DOI 10.1109/69.991727; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; SNEDECOR GW, STAT METHODS; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; [No title captured]	41	24	25	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	JAN 14	2009	9								2	10.1186/1472-6947-9-2			17	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	430XS	WOS:000265026500001	19144188	Green Published, gold			2022-02-06	
J	Arango-Lasprilla, JC; Ketchum, JM; Gary, K; Hart, T; Corrigan, J; Forster, L; Mascialino, G				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Gary, Kelli; Hart, Tessa; Corrigan, John; Forster, Lauren; Mascialino, Guido			Race/ethnicity differences in satisfaction with life among persons with traumatic brain injury	NEUROREHABILITATION			English	Article						Satisfaction with life; TBI; Race/ethnicity	COMMUNITY INTEGRATION; OUTCOMES; MODEL; RACE; DISABILITY; RETURN; WORK; CARE	Objective: To determine differences in life satisfaction at 1-year post-TBI among Caucasian, African American, Hispanic, and Asian individuals with TBI, after adjusting for covariates that significantly differ between ethnic groups and/or affect the Satisfaction with Life Scale (SWLS) at one year post-injury. Design: Retrospective study. Setting: Longitudinal dataset of the TBI Model Systems National Database. Participants: 3,368 individuals with moderate to severe TBI (2478 Caucasian, 629 African American, 180 Hispanic, and 81 Asian/Pacific Islander) hospitalized between 1989 and 2005. Main Outcome Measures: Satisfaction with Life Total score at 1 year post injury. Results: African Americans had 3.21 units lower SWLS scores one year post-injury than Asian/Pacific Islanders (95% CI = 0.61-5.81) and 1.99 units lower SWLS scores than Caucasians (95% CI = 0.97-3.00) after controlling for marital status, employment at admission, cause of injury, FIM at discharge, and LOS in acute care. Conclusions: African Americans have poorer self-reported life satisfaction than Caucasians and Asians one year after TBI. This effect is not due to pre-injury marital or employment status, cause of injury, nor injury severity or functional status. Further research on the factors which might explain these differences is warranted, so that targeted rehabilitation programs can be designed and implemented that enhance quality of life for all individuals who have suffered a TBI.	[Arango-Lasprilla, Juan Carlos; Gary, Kelli; Forster, Lauren] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23219 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23219 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Corrigan, John] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Mascialino, Guido] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 730 E Broad St,4th Floor,Room 4230A, Richmond, VA 23219 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020; Corrigan, John D./E-2921-2011	MASCIALINO, GUIDO/0000-0001-7408-6546; Ketchum, Jessica/0000-0002-5566-3691	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133P040006, H133A070036] Funding Source: Medline		Allison D., 1991, BEHAV THERAPIST, V5, P15; Alston RJ, 1996, J REHABIL, V62, P16; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; BROWN SD, 2004, J ANTIMICROB CHEM S1, V54, P7; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Casagrande SS, 2007, J GEN INTERN MED, V22, P389, DOI 10.1007/s11606-006-0057-4; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; GERHART K, 1917, J TRAUMA, V55, P1045; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Hoofien D, 2001, BRAIN INJURY, V15, P189; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LASPRILLA JCA, 2008, BRAIN INJURY, P1; LoBello SC, 2003, J REHABIL RES DEV, V40, P293, DOI 10.1682/JRRD.2003.07.0293; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mazaux JM, 2002, ACT NEUR S, V79, P49; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; PAVOT W, 1993, SOC INDIC RES, V28, P1, DOI 10.1007/BF01086714; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rosenthal M., 1996, J HEAD TRAUMA REHAB, V11, P69; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Shermer CR, 2007, J TRAUMA, V63, P1268; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warren L, 1996, J REHABIL RES DEV, V33, P404	40	24	24	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	1					5	14		10.3233/NRE-2009-0449			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	412DS	WOS:000263704400002	19208953				2022-02-06	
J	Barker-Collo, SL; Wilde, NJ; Feigin, VL				Barker-Collo, Suzanne L.; Wilde, Nancy J.; Feigin, Valery L.			Trends in Head Injury Incidence in New Zealand: A Hospital-Based Study from 1997/1998 to 2003/2004	NEUROEPIDEMIOLOGY			English	Article						Head injury incidence, New Zealand; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SOCIOECONOMIC-STATUS; ASSOCIATION; CAREGIVERS; SYMPTOMS; DISTRESS; MOTHERS; MAORI; CARE	Traumatic brain injury (TBI) is a leading cause of disability and death in young adults. Globally, the incidence of TBI hospitalizations is estimated at 200-300 people per 100,000 annually. Using a national health database, we examined the incidence of TBI-related hospital discharges ( including 1-day stays) to New Zealand Hospitals from 1997/1998 to 2003/2004. Crude annual hospital-based incidence rates for the total population ranged from 226.9 per 100,000 in 1998/1999 to a high rate of 349.2 in 2002/2003. There was a noticeable increase in rates with the change from ICD-9 to ICD-10 diagnostic codes and there was also disparity in incidence rates according to ethnicity, age and gender. Crude annual hospital-based incidence rates for males and females in Maori (689/100,000 and 302.8/100,000 person-years) and Pacific Island populations (582.6/100,000 and 217.6/100,000 person-years) were much higher than those for the remaining population (435.4/100,000 and 200.9/100,000 person-years), particularly for males. The overall age-standardized hospitalbased incidence rate for 2003/2004 was 342 per 100,000 per year (95% CI = 337-349/100,000), and 458 per 100,000 per year for Maori (95% CI = 438-479/100,000) with Maori males experiencing a peak in incidence between 30 and 34 years of age that was not evidenced for the wider population. Standardized hospital-based incidence rates for the total population and for Maori by age, gender and ICD-10 diagnostic codes are also examined. Copyright (C) 2008 S. Karger AG, Basel	[Barker-Collo, Suzanne L.; Wilde, Nancy J.] Univ Auckland, Dept Psychol, Clin Training Programme, Auckland 1142, New Zealand; [Feigin, Valery L.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Rehabil & Occupat Studies, Sch Publ Hlth & Psychol,Natl Res Ctr Stroke Appl, Auckland, New Zealand		Barker-Collo, SL (corresponding author), Univ Auckland, Dept Psychol, Clin Training Programme, Tamaki Campus,Private Bag 92019, Auckland 1142, New Zealand.	s.barker-collo@auckland.ac.nz	Feigin, Valery/AAF-2313-2019	Feigin, Valery L./0000-0002-6372-1740			ALBEDA R, HARMS WAY DOMESTIC V; Bassuk EL, 1996, JAMA-J AM MED ASSOC, V276, P640; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Braver ER, 2003, ACCIDENT ANAL PREV, V35, P295, DOI 10.1016/S0001-4575(01)00106-3; Breslow N, 1987, DESIGN ANAL COHORT S, V2; Brooks MG, 1996, AM J ORTHOPSYCHIAT, V66, P526, DOI 10.1037/h0080202; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CARADOCDAVIES TH, 1995, NEUROEPIDEMIOLOGY, V14, P199, DOI 10.1159/000109797; CHIU W, 1997, CLIN NEUROL NEUROSUR, V99, P78; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; Malcolm L, 1996, NEW ZEAL MED J, V109, P356; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; *NZ GUID GROUP, 2005, DIAGN AC MAN REH PEO; Ogden JA, 1997, NEW ZEAL J PSYCHOL, V26, P2; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reiss A. J., 1993, UNDERSTANDING PREVEN; RIZZO M, 1996, HEAD INJURY POSTCONC; ROPER P, 1993, HALF WOMEN PUBLIC AS; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Shin S, 2007, ANN EMERG MED, V50, pS100, DOI 10.1016/j.annemergmed.2007.06.381; SUTHERLAND HJ, 2002, U OTAGO EC DISCUSSIO, V204; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torner JC, 1996, HEAD INJURY POSTCONC; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Wrightson P, 1998, NEW ZEAL MED J, V111, P99	32	24	24	2	13	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2009	32	1					32	39		10.1159/000170090			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	375RL	WOS:000261130900007	18997476				2022-02-06	
J	Bekinschtein, TA; Golombek, DA; Simonetta, SH; Coleman, MR; Manes, FF				Bekinschtein, T. A.; Golombek, D. A.; Simonetta, S. H.; Coleman, M. R.; Manes, F. F.			Circadian rhythms in the vegetative state	BRAIN INJURY			English	Article						vegetative state; circadian rhythms; body temperature; guidelines	HYPOXIA; CLOCK; TEMPERATURE; SCALE; GENES; BRAIN	Objective: To evaluate whether vegetative state patients maintain circadian rhythms. Research design: An observational study of five single cases. Methods and procedures: Five chronic vegetative state patients underwent clinical and neurological evaluations and 2-week continuous temperature measurements. Main outcomes and results: The two patients with traumatic brain injury showed well-formed circadian temperature rhythms and had more reflexive behaviours and relatively low cortical and sub-cortical atrophy, whereas the three patients from anoxic-hypoxic origin demonstrated no cycles or rhythmic behaviour. Conclusions: The presence of periods of wakefulness does not imply preserved sleep-wake cycling capacity, nor preserved circadian rhythms and it should not be taken as a distinguishing feature for the definition of the vegetative state.	[Bekinschtein, T. A.] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Bekinschtein, T. A.; Manes, F. F.] Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina; [Bekinschtein, T. A.; Manes, F. F.] Raul Carrea Inst Neurol Res, Buenos Aires, DF, Argentina; [Bekinschtein, T. A.; Coleman, M. R.] Addenbrookes Hosp, Impaired Consciousness Res Grp, Cambridge, England; [Golombek, D. A.; Simonetta, S. H.] Quilmes Univ, Chronobiol Lab, Buenos Aires, DF, Argentina; [Manes, F. F.] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina		Bekinschtein, TA (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England.	tristan.bekinschtein@mrc-cbu.cam.ac.uk		Bekinschtein, Tristan/0000-0001-5501-8628; Golombek, Diego/0000-0002-6291-5586	Antorchas Foundation (TAB) and PICT (DAG)	This research was supported by the following grants: Antorchas Foundation (TAB) and PICT (DAG). We thank the patients and their families for their participation.	Alster Jason, 1993, Brain Injury, V7, P191, DOI 10.3109/02699059309029672; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Auer R. N., 2002, GREENFIELDS NEUROPAT; BEKINSCHTEIN TA, 2006, THESIS U BUENOS AIRE; Bekinschtein T, 2009, PROG BRAIN RES, V177, P171, DOI 10.1016/S0079-6123(09)17712-9; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Chilov D, 2001, FASEB J, V15, P2613, DOI 10.1096/fj.01-0092com; Davidson AJ, 2003, J BIOL RHYTHM, V18, P430, DOI 10.1177/0748730403256066; Dominguez-Rodriguez A, 2006, AM J CARDIOL, V97, P1162, DOI 10.1016/j.amjcard.2005.11.033; Fukudome Y, 1996, AM J PHYSIOL-REG I, V270, pR1109, DOI 10.1152/ajpregu.1996.270.5.R1109; Galton CJ, 2001, J NEUROL NEUROSUR PS, V70, P165, DOI 10.1136/jnnp.70.2.165; Ghorbel MT, 2003, MOL CELL NEUROSCI, V22, P396, DOI 10.1016/S1044-7431(02)00019-2; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; Pattoneri Paolo, 1800, J Clin Hypertens (Greenwich), V7, P734, DOI 10.1111/j.1524-6175.2005.04780.x; PONCET L, 1999, AM J PHYSIOL, V277, P66; Rosato E, 2007, CIRCADIAN RHYTHMS ME; *ROYAL COLL PHYS, 2003, VEG STAT GUID DIAGN; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; VOGEL HP, 1990, CLIN ENDOCRINOL, V33, P631	21	24	24	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	11					915	919	PII 915243110	10.1080/02699050903283197			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	498JY	WOS:000270137300008	20100128				2022-02-06	
J	Fridman, EA; Calvar, J; Bonetto, M; Gamzu, E; Krimchansky, BZ; Meli, F; Leiguarda, RC; Zafonte, R				Fridman, Esteban A.; Calvar, Jorge; Bonetto, Mariana; Gamzu, Elkan; Krimchansky, Ben Zion; Meli, Francisco; Leiguarda, Ramon C.; Zafonte, Ross			Fast awakening from minimally conscious state with apomorphine	BRAIN INJURY			English	Article						Brain injury; minimally conscious; dopaminergic; apomorphine; diffusion tensor	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; VEGETATIVE STATE; SUBCUTANEOUS APOMORPHINE; FOLLOW-UP; BROMOCRIPTINE; LEVODOPA; THERAPY; SCALE; COMA	Background: Traumatic brain injury (TBI) can induce long-term severe disorders of consciousness. Evidence suggests an underlying dopaminergic deficit. Dopamine agonists may therefore play an important role in recovery of consciousness. Objective: To explore the response to continuous subcutaneous administration of apomorphine in a patient who had remained in minimally conscious state for 104 days and to evaluate the anatomical substrate of the effect. Design: A prospective, open-label, daily treatment, dose-escalation single case clinical study, with retrospective diffusion tensor image (DTI) evaluation. Results: On the fist day of treatment, the patient was able to move his limbs on command and answer yes/no questions which had not been the case prior to apomorphine administration. Subsequently there was a full recovery of consciousness and substantial functional recovery that was sustained even after apomorphine discontinuation. At the highest dose, mild dyskinesias were observed. These resolved with a lowering of the dose. DTI demonstrated a decrease of thalamocortical and corticothalamic projections in this MCS patient compared to normal volunteers. Conclusion: Although this is an open-label single-patient case report, the data are consistent with the theory that a dopaminergic deficit underlies MCS and that it may be overcome with apomorphine administration.	[Fridman, Esteban A.; Bonetto, Mariana] FLENI, Neurol Res Inst, Dept Neurol, Neurorehabil Sect & Spast Clin, RA-2325 Buenos Aires, DF, Argentina; [Fridman, Esteban A.; Meli, Francisco; Leiguarda, Ramon C.] FLENI, Neurol Res Inst, Dept Neurosci, Neurorehabil Sect & Spast Clin, RA-2325 Buenos Aires, DF, Argentina; [Fridman, Esteban A.; Calvar, Jorge] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Krimchansky, Ben Zion] Lowenstein Rehabil Hosp, Dept Neurol, Ranaana, Israel; [Zafonte, Ross] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Boston, MA USA		Fridman, EA (corresponding author), FLENI, Neurol Res Inst, Dept Neurol, Neurorehabil Sect & Spast Clin, RA-2325 Buenos Aires, DF, Argentina.	efridman@fleni.org.ar		Fridman, Esteban A./0000-0001-7879-8874	NeuroHealing Pharmaceuticals Inc; Research Department of the Institute for Neurological Research-FLENI	Funding for this study came from NeuroHealing Pharmaceuticals Inc and the Research Department of the Institute for Neurological Research-FLENI. We specially thank Professor Brent Masel for his helpful comments on the manuscript, Claudia Navarro for all her efforts at the ANMAT (Argentinean Drugs Administrative Office) and manuscript edition.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Freeman A, 2001, ANN NEUROL, V50, P321, DOI 10.1002/ana.1119; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; HUGHES AJ, 1991, NEUROLOGY, V41, P1723, DOI 10.1212/WNL.41.11.1723; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Katzenschlager R, 2005, MOVEMENT DISORD, V20, P151, DOI 10.1002/mds.20276; Kolls BJ, 2006, CLIN NEUROPHARMACOL, V29, P292, DOI 10.1097/01.WNF.0000220824.57769.E5; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MONTASTRUC JL, 1989, J NEUROL NEUROSUR PS, V52, P773, DOI 10.1136/jnnp.52.6.773; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pahwa R, 2007, J NEUROL SCI, V258, P137, DOI 10.1016/j.jns.2007.03.013; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; POEWE WH, 1986, NEUROLOGY, V36, P1528, DOI 10.1212/WNL.36.11.1528; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	26	24	25	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	2					172	177	PII 908449772	10.1080/02699050802649662			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	403LD	WOS:000263083200012	19191097				2022-02-06	
J	Park, BS; Allen, DN; Barney, SJ; Ringdahl, EN; Mayfield, J				Park, Brandon S.; Allen, Daniel N.; Barney, Sally J.; Ringdahl, Erik N.; Mayfield, Joan			Structure of Attention in Children with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						adolescents; attention; CPT; children; factor analysis; trail making; traumatic brain injury	CLOSED-HEAD INJURY; SUSTAINED ATTENTION; URBAN CHILDREN; CHILDHOOD; DEFICITS; INFORMATION; RECOVERY; SKILLS; ADOLESCENTS; PERFORMANCE	Traumatic brain injury (TBI) is a common cause of disability among children in the United States, and attention deficits are frequently observed in both the acute and chronic phases of injury. The current study investigated models of attention in children with TBI and examined differential sensitivity of various components of these attention models to the severity of the brain injury. Participants included 151 children and adolescents (mean age 12.9 years, SD=2.6) who had suffered TBI, and 50 normal controls (mean age 12.5 years old, SD=2.2). All children were administered neuropsychological tests of attention as part of a comprehensive neuropsychological battery for brain injury (TBI group) or for the purposes of the current investigation (normal controls). Confirmatory factor analysis (CFA) of the attention tests indicated that a four-factor model of attention composed of Shift, Focus, Encode, and Sustain factors provided the best fit of the TBI group data. Factor scores were subsequently created and used to predict the severity of brain injury. All four factors were sensitive to TBI in that those with TBI performed significantly worse than the controls, but regression analysis indicated that only the Shift and Focus factors were significant predictors of TBI severity. These findings support the utility of a multicomponent model of attention to understand attention deficits resulting from TBI, and may be useful in determining those aspects of attention that are differentially impacted by TBI, in order to assist in assessment and rehabilitation planning.	[Allen, Daniel N.] Univ Nevada, Dept Psychol, Neuropsychol Res Program, Las Vegas, NV 89154 USA; [Mayfield, Joan] Baylor Univ, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Neuropsychol Res Program, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 1997, SCHIZOPHR RES, V25, P53, DOI 10.1016/S0920-9964(97)00006-6; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2006, J INT NEUROPSYCH SOC, V12, P519, DOI 10.1017/S135561770606067X; *ARM IND TEST BAT, 1994, MAN DIR SCOR; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BYRNE BM, 1989, PRIMER LISREL; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; *CDCP, 2004, TBI GEN FACT SHEET G; Chan RCK, 2006, BRAIN INJURY, V20, P653, DOI 10.1080/02699050600676974; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cohen J., 1997, SCI APPROACHES CONSC; Conners C. K., 2000, CONNERS CONTINUOUS P; DEJONG R, 1991, PERCEPT PSYCHOPHYS, V50, P333, DOI 10.3758/BF03212226; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Duncan C.C., 2004, COMPREHENSIVE HDB PS, V1, P263; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Goldstein G, 2001, J AUTISM DEV DISORD, V31, P433, DOI 10.1023/A:1010620820786; Gray J. A., 2004, CONSCIOUSNESS CREEPI; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Kelloway E. K., 1998, USING LISREL STRUCTU; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Kline R. B., 2016, PRINCIPLES PRACTICE, VFourth; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; KREMEN WS, 1992, J NERV MENT DIS, V180, P89, DOI 10.1097/00005053-199202000-00004; Lehnung M, 2003, BRAIN INJURY, V17, P855, DOI 10.1080/0269905031000089369; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Luria A.R., 1973, WORKING BRAIN; Maruyama G. M., 1998, BASICS STRUCTURAL EQ; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Mesulam M., 1985, PRINCIPLES BEHAV NEU; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A. F., 2002, EVOLUTIONARY NEUROET, P215; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; Mirsky AF, 1999, MENT RETARD DEV D R, V5, P169, DOI 10.1002/(SICI)1098-2779(1999)5:3<169::AID-MRDD2>3.3.CO;2-B; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Pascualvaca DM, 1997, CHILD NEUROPSYCHOL, V3, P13, DOI 10.1080/09297049708401365; POGGE DL, 1994, J CLIN EXP NEUROPSYC, V16, P344, DOI 10.1080/01688639408402645; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rebok GW, 1997, CHILD NEUROPSYCHOL, V3, P28, DOI 10.1080/09297049708401366; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; SHUM DHK, 1994, J CLIN EXP NEUROPSYC, V16, P547, DOI 10.1080/01688639408402666; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1986, BRAIN LANG, V28, P66, DOI 10.1016/0093-934X(86)90091-X; TEASDALE G, 1974, LANCET, V2, P81; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; ZUBIN J, 1975, EXPT APPROACHES PSYC, P00139; [No title captured]; [No title captured]	70	24	24	0	16	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2009	16	1					1	10	PII 908616865	10.1080/09084280802636371			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	406AI	WOS:000263267000001	19205942				2022-02-06	
J	Park, HK; Joo, WI; Chough, CK; Cho, CB; Lee, KJ; Rha, HK				Park, Hae-Kwan; Joo, Won-Il; Chough, Chung-Kee; Cho, Chul-Beom; Lee, Kyung-Jin; Rha, Hyoung-Kyun			The clinical efficacy of repeat brain computed tomography in patients with traumatic intracranial haemorrhage within 24 hours after blunt head injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head trauma; intracranial haemorrhage; computed tomography; epidural haematoma	FOLLOW-UP; CT; MANAGEMENT; HEMATOMAS; UTILITY; SCAN	This study was performed to determine the usefulness of repeated brain computed tomography (CT) within 24 hours of blunt head trauma in patients with traumatic intracranial haemorrhages (ICH) and who were initially treated nonsurgically. Factors associated with the worsening of lesions on repeat CT were evaluated. Medical records of all blunt head trauma patients with traumatic ICH admitted to our hospital from January 2003 to December 2006 were retrospectively reviewed. Patients older than 16 years of age with an initial Glasgow Coma Scale (GCS) of 8 or greater were included. From the results of the repeat CT, patients were categorized as Group 1 (improved or unchanged condition) or Group 2 (worsened condition). A total of 168 patients (mean age of 44.8 +/- 19.2; mean admission GCS of 13.42 +/- 2.07; male to female ratio 2.1:1) were included. In 161 patients, repeat CT was obtained on a routine basis. In the remaining 7, it was prompted by a worsening neurological condition. The mean time from initial to repeat CT was 10.10 +/- 7.25 hours. Based on the results of the repeat CT, 108 patients were included in Group 1 and 60 in Group 2. The mean initial GCS was lower in patients from Group 2 versus those from Group 1 (11.9 +/- 2.6 compared with 14.3 +/- 0.96; p < 0.001). After repeat CT, 28 (47%) of the patients in Group 2 underwent neurosurgical interventions. Of the 28 surgically treated patients from Group 2, 6 (10%) exhibited neurological worsening and 22 (37%) appeared neurologically stable. According to our data, we suggest that routine repeat CT within 24 hours after blunt head trauma might minimize potential neurological deterioration in patients with either a GCS lower than 12 or with an epidural haematoma or multiple lesions as indicated on initial CT.	[Park, Hae-Kwan; Joo, Won-Il; Chough, Chung-Kee; Cho, Chul-Beom; Lee, Kyung-Jin; Rha, Hyoung-Kyun] Catholic Univ Korea, Dept Neurosurg, St Marys Hosp, Seoul 150713, South Korea		Joo, WI (corresponding author), Catholic Univ Korea, Dept Neurosurg, St Marys Hosp, 62 Youido Dong, Seoul 150713, South Korea.	jwi@catholic.ac.kr					Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; FRENCH BN, 1997, SURG NEUROL, V4, P171; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; ROBERSON FC, 1979, SURG NEUROL, V12, P161; Schuster R, 2005, AM SURGEON, V71, P701; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; Stearley H E, 1998, Am J Crit Care, V7, P282; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; WADDELL G, 1975, BRIT MED J, V2, P417, DOI 10.1136/bmj.2.5968.417; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	15	24	26	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2009	23	6					617	621		10.3109/02688690902999302			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	585TK	WOS:000276851900011	19922276				2022-02-06	
J	Narotam, PK; Puri, V; Roberts, JM; Taylon, C; Vora, Y; Nathoo, N				Narotam, Pradeep K.; Puri, Varun; Roberts, John M., Jr.; Taylon, Charles; Vora, Yashail; Nathoo, Narendra			Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation Clinical article	JOURNAL OF NEUROSURGERY			English	Article						acute brain disease; brain tissue oxygen; nicardipine	PROLONGED-RELEASE IMPLANTS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; BLOOD-PRESSURE; TISSUE OXYGEN; DOUBLE-BLIND; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; PERFUSION-PRESSURE; PREVENTION; STROKE	Object. Inappropriate sudden blood pressure (BP) reductions may adversely affect cerebral perfusion. This study explores the effect of nicardipine on regional brain tissue O-2 (PbtO(2)) during treatment of acute hypertensive emergencies. Methods. A prospective case-control Study was performed in 30 patients with neurological conditions and clinically elevated BP. All patients had a parenchymal PbtO(2) and intracranial pressure bolt inserted following resuscitation. Using a critical care guide, PbtO(2) was optimized. Intravenous nicardipine (5-15 mg/hour) was titrated to systolic BP < 160 mm Hg, diastolic BP < 90 mm Hg, mean arterial BP (MABP) 90-110 mg/Hg, and PbtO(2) > 20 mm Hg. Physiological parameters-intracranial pressure. PbtO(2), central venous pressure, systolic BP. diastolic BP, MABP, fraction of inspired O-2, and cerebral perfusion pressure (CPP)-were compared before infusion, at 4 hours, and at 8 hours using a t-test. Results. Sixty episodes of hypertension were reported in 30 patients (traumatic brain injury in 13 patients: aneurysmal subarachnoid hemorrhage in 11: intracerebral and intraventricular hemorrhage in 3 and 1, respective]),: arteriovenous malformation in 1; and hypoxic brain injury ill 1). Nicardipine was effective in 87%, of the patients (with intravenous (3 blockers in 4 patients). with a 19.7% reduction in mean 4-hour MABP (115.3 +/- 13.1 mm Hg preinfusion vs 92.9 +/- 11.40 mm Hg after 4 hours of therapy. p < 0.001). No deleterious effect on mean PbtO(2) was recorded (26.74 +/- 15.42 mm Hg preinfusion vs 27.68 +/- 12.51 mm Hg after 4 hours of therapy, p = 0.883) despite significant reduction in CPP. Less dependence oil normobaric hyperoxia was achieved at 8 hours (0.72 +/- 0.299 mm Hg preinfusion vs 0.626 +/- 0.286 mm Hg after 8 hours of therapy, p < 0.01). Subgroup analysis revealed that 12 patients had low pretreatment PbtO(2) (10.30 +/- 6.49 mm Hg), with higher CPP (p < 0.001) requiring, hyperoxia (p = 0.02). In this group, intravenous nicardipine resulted in air 83% improvement in 4- and 8-hour PbtO(2) levels (18.1 +/- 11.33 and respectively: p < 0.01) despite significant red 19.59 +/- 23.68 mm Hg, respectively; p < 0.01) despite significant reductions in both mean MABP (120.6 +/- 16.65 vs 95.8 +/- 8.3 mm Hg, p < 0.001) and CPP (105.00 +/- 20.7 vs 81.2 +/- 15.4 mm Hg, p < 0.001). Conclusions. Intravenous nicardipine is effective for the treatment of hypertensive neurological emergencies and has no adverse effect on PbtO(2). (DOI: 10.317.JNS.2008.109.12.1065)	[Narotam, Pradeep K.; Puri, Varun; Roberts, John M., Jr.; Taylon, Charles; Vora, Yashail; Nathoo, Narendra] Creighton Univ, Med Ctr, Div Neurosurg, Omaha, NE USA		Narotam, PK (corresponding author), Union Hosp Neurosci, 1530 N 7th St,501, Terre Haute, IN 47807 USA.	narotam@mac.com			PDL BioPharma	Dr. Narotam serves as a consultant for Integra Life Sciences. He has no direct financial gain from the sale of Licox or nicardipine (Cardene).; Financial support for this investigator-initiated study, to Dr. Narotam, was provided as an unrestricted research grant by PDL BioPharma.	Ahmed N, 2003, CEREBROVASC DIS, V15, P235, DOI 10.1159/000069498; Ahmed N, 2001, J INTERN MED, V249, P467, DOI 10.1046/j.1365-2796.2001.00831.x; Ahmed N, 2000, STROKE, V31, P1250, DOI 10.1161/01.STR.31.6.1250; ALABADI JA, 1993, NEUROSURGERY, V33, P707, DOI 10.1227/00006123-199310000-00022; Amenta F, 2004, CLIN EXP HYPERTENS, V26, P351, DOI 10.1081/CEH-120034139; Badjatia N, 2004, AM J NEURORADIOL, V25, P819; Bardt TF, 1998, ACT NEUR S, V71, P153; Barth M, 2007, STROKE, V38, P330, DOI 10.1161/01.STR.0000254601.74596.0f; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Cherney D, 2002, J GEN INTERN MED, V17, P937, DOI 10.1046/j.1525-1497.2002.20389.x; Cheung AT, 1999, ANESTH ANALG, V89, P1116, DOI 10.1213/00000539-199911000-00008; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; Denolle T, 2002, FUND CLIN PHARMACOL, V16, P527, DOI 10.1046/j.1472-8206.2002.00110.x; Elliott William J, 1800, J Clin Hypertens (Greenwich), V6, P587, DOI 10.1111/j.1524-6175.2004.03608.x; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; Filippi R, 2000, NEUROSURG REV, V23, P94; FLAMM ES, 1988, J NEUROSURG, V68, P393, DOI 10.3171/jns.1988.68.3.0393; Fogelholm R, 1997, STROKE, V28, P1396, DOI 10.1161/01.STR.28.7.1396; GAAB MR, 1985, BRIT J CLIN PHARMACO, V20, pS67, DOI 10.1111/j.1365-2125.1985.tb05145.x; GROTTA J, 1986, STROKE, V17, P213, DOI 10.1161/01.STR.17.2.213; Haas CE, 2004, AM J HEALTH-SYST PH, V61, P1661, DOI 10.1093/ajhp/61.16.1661; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; HALEY EC, 1993, J NEUROSURG, V78, P548, DOI 10.3171/jns.1993.78.4.0548; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Jarus-Dziedzic K, 2003, ACT NEUR S, V86, P473; Kasuya H, 2005, NEUROSURGERY, V56, P895; Kasuya H, 2002, STROKE, V33, P1011, DOI 10.1161/01.STR.0000014563.75483.22; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kross RA, 2000, ANESTH ANALG, V91, P904, DOI 10.1097/00000539-200010000-00024; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; MASSO JFM, 1990, CLIN THER, V12, P344; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; MUNDO MR, 1990, J CARDIOVASC PHARM, V16, pS16, DOI 10.1097/00005344-199006162-00006; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; NEUTEL JM, 1994, AM J HYPERTENS, V7, P623, DOI 10.1093/ajh/7.7.623; Patel HP, 2005, CURR OPIN PEDIATR, V17, P210, DOI 10.1097/01.mop.0000150769.38484.b3; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; Qureshi AI, 2006, CRIT CARE MED, V34, P1975, DOI 10.1097/01.CCM.0000220763.85974.E8; Qureshi Adnan I, 2005, J Intensive Care Med, V20, P34, DOI 10.1177/0885066604271619; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; RINKEL GJ, 2002, COCHRANE DB SYST REV, V4; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; ROSENBAUM D, 1991, STROKE, V22, P437, DOI 10.1161/01.STR.22.4.437; ROSENBAUM DM, 1990, ANGIOLOGY, V41, P1017; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sahuquillo J, 2000, REV NEUROLOGIA, V30, P401, DOI 10.33588/rn.3005.99063; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; SINGH BN, 1990, AM HEART J, V119, P427, DOI 10.1016/S0002-8703(05)80063-8; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; Stiefel MF, 2004, J NEUROSURG, V101, P594, DOI 10.3171/jns.2004.101.4.0594; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Tuncel Meryem, 2003, Am J Cardiovasc Drugs, V3, P21, DOI 10.2165/00129784-200303010-00003; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van den Brink WA, 1998, ACT NEUR S, V71, P190; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vaughan CJ, 2000, LANCET, V356, P411, DOI 10.1016/S0140-6736(00)02539-3; WALLIN JD, 1989, ARCH INTERN MED, V149, P2662, DOI 10.1001/archinte.149.12.2662; Yang HJ, 2004, J INT MED RES, V32, P118, DOI 10.1177/147323000403200203	67	24	28	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2008	109	6					1065	1074		10.3171/JNS.2008.109.12.1065			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	376SY	WOS:000261204500017	19035721				2022-02-06	
J	Steigelman, M; Lopez, P; Dent, D; Myers, J; Corneille, M; Stewart, R; Cohn, S				Steigelman, Megan; Lopez, Peter; Dent, Daniel; Myers, John; Corneille, Michael; Stewart, Ronald; Cohn, Stephen			Screening cervical spine MRI after normal cervical spine CT scans in patients in whom cervical spine injury cannot be excluded by physical examination	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	60th Annual Meeting of the Southwestern-Surgical-Congress	MAR 30, 2008	Acapulco, MEXICO	SW Surg Cong		Cervical spine MRI; Cervical spine CT; Obtunded trauma patients; Cervical spine injury	BLUNT TRAUMA; COMPUTED-TOMOGRAPHY; OBTUNDED PATIENTS; CLEARANCE	BACKGROUND: Cervical spine injuries can occur in as many as 10% of patients with blunt trauma with mental status changes from closed head injuries. Despite normal results on cervical spine computed tomography (CT), magnetic resonance imaging (MRI) is often recommended to exclude ligamentous or soft tissue injury. METHODS: A retrospective review was conducted of trauma patients admitted to a level I trauma center from 2002 to 2006, in whom cervical spine injuries could not be excluded by physical examination. All patients with normal results on cervical spine CT followed by cervical spine MRI were included in the analysis. RESULTS: One hundred twenty patients underwent MRI to examine their cervical spines. Seven patients had abnormal MRI findings suggestive of acute traumatic injury. No MRI studies led to operative intervention. Screening MRI increased from 1% of comatose patients in 2002 to 18% in 2006. CONCLUSIONS: The use of MRI in patients with normal results on cervical spine CT does not appear to alter treatment. (C) 2008 Elsevier Inc. All rights reserved.	[Steigelman, Megan; Lopez, Peter; Dent, Daniel; Myers, John; Corneille, Michael; Stewart, Ronald; Cohn, Stephen] Univ Texas Hlth Sci Ctr San Antonio, Div Trauma, San Antonio, TX 78229 USA		Lopez, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Trauma, San Antonio, TX 78229 USA.	lopez@uthscsa.edu					Ackland HM, 2007, SPINE, V32, P423, DOI 10.1097/01.brs.0000255096.52871.4e; Adams JM, 2006, AM SURGEON, V72, P101; Ajani AE, 1998, ANAESTH INTENS CARE, V26, P487, DOI 10.1177/0310057X9802600502; Barba CA, 2001, J TRAUMA, V51, P652, DOI 10.1097/00005373-200110000-00005; Como JJ, 2007, J TRAUMA, V63, P544, DOI 10.1097/TA.0b013e31812e51ae; Ghanta MK, 2002, AM SURGEON, V68, P563; Grossman MD, 1999, J TRAUMA, V47, P684, DOI 10.1097/00005373-199910000-00012; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697; Horn EM, 2004, J NEUROSURG-SPINE, V1, P39, DOI 10.3171/spi.2004.1.1.0039; Menaker J, 2008, J TRAUMA, V64, P898, DOI 10.1097/TA.0b013e3181674675; Muchow RD, 2008, J TRAUMA, V64, P179, DOI 10.1097/01.ta.0000238664.74117.ac; Richards PJ, 2005, INJURY, V36, P248, DOI 10.1016/j.injury.2004.07.027; Stassen NA, 2006, J TRAUMA, V60, P171, DOI 10.1097/01.ta.0000197647.44202.de; Tomycz ND, 2008, J TRAUMA, V64, P1258, DOI 10.1097/TA.0b013e318166d2bd	15	24	25	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2008	196	6					857	862		10.1016/j.amjsurg.2008.07.040			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	388NG	WOS:000262025900015	19095100				2022-02-06	
J	Urbach, A; Redecker, C; Witte, OW				Urbach, Anja; Redecker, Christoph; Witte, Otto W.			Induction of Neurogenesis in the Adult Dentate Gyrus by Cortical Spreading Depression	STROKE			English	Article						spreading depression; neurogenesis; dentate gyrus; cognition	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; NMDA RECEPTOR; PROGENITOR CELLS; BLOOD-FLOW; RAT; NEURONS; CORTEX	Background and Purpose-Spreading depression (SD) is an epiphenomenon of neurological disorders, like stroke or traumatic brain injury. These diseases have been associated with an increased neurogenesis in the adult rodent dentate gyrus. Such proliferative activity can also be induced by conditions that-like SD-coincide with a disturbed neuronal excitability, eg, epilepsy. Thus we hypothesized that SD might likewise influence hippocampal neurogenesis and potentially act as mediator of injury-induced neurogenesis. Methods-Repetitive cortical SD were induced by epidural application of 3 mol/L KCl. At different time points thereafter dentate gyrus neurogenesis was investigated by means of intraperitoneal bromodeoxyuridine injections and immunocytochemistry. Spatial learning and memory was tested in a Morris water maze. Results-Cortical SD significantly increased proliferative activity in the ipsilateral subgranular zone on days 2 and 4. We detected about 280% more newborn cells in the dentate gyrus of rats that received bromodeoxyuridine during the first week after SD and were allowed to recover for 6 weeks. Most of these cells expressed the mature neuronal marker NeuN. The mitogenic action of SD was suppressed by systemic administration of the NMDA receptor antagonist MK-801. Behavioral performance of SD animals in the Morris water maze did not improve significantly. Conclusions-From our data we postulate that the increased dentate gyrus neurogenesis observed after brain injury may at least partly be mediated by SD-like epiphenomena. Furthermore they indicate that even a strongly enhanced dentate gyrus neurogenesis may occur without significant improvements in hippocampus-dependent spatial learning and memory. (Stroke. 2008; 39: 3064-3072.)	[Urbach, Anja; Redecker, Christoph; Witte, Otto W.] Univ Jena, Dept Neurol, D-07747 Jena, Germany		Urbach, A (corresponding author), Univ Jena, Dept Neurol, Erlanger Allee 101-FZL, D-07747 Jena, Germany.	anja.urbach@med.uni-jena.de	Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	Federal Ministry for Education and ResearchFederal Ministry of Education & Research (BMBF) [01GI9905, 01GZ0306]	This work was supported by the Federal Ministry for Education and Research (grants 01GI9905 and 01GZ0306).	Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.0.CO;2-8; Bernabeu R, 2000, J CEREBR BLOOD F MET, V20, P1669, DOI 10.1097/00004647-200012000-00006; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Lauritzen M, 2001, CEPHALALGIA, V21, P757, DOI 10.1046/j.1468-2982.2001.00244.x; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Markakis EA, 1999, J COMP NEUROL, V406, P449; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MESHI D, 2006, NAT NEUROSCI; MIES G, 1993, J NEUROCHEM, V60, P360, DOI 10.1111/j.1471-4159.1993.tb05860.x; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Parent JM, 1997, J NEUROSCI, V17, P3727; Paxinos G., 2004, RAT NERVOUS SYSTEM; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wernsmann B, 2006, EUR J NEUROSCI, V23, P1103, DOI 10.1111/j.1460-9568.2006.04643.x; Yanamoto H, 2005, STROKE, V36, P1544, DOI 10.1161/01.STR.0000169903.09253.c7; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	47	24	25	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	NOV	2008	39	11					3064	3072		10.1161/STROKEAHA.108.518076			9	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	365SC	WOS:000260427100025	18802207	Bronze			2022-02-06	
J	Karger, B; Rand, S; Fracasso, T; Pfeiffer, H				Karger, B.; Rand, S.; Fracasso, T.; Pfeiffer, H.			Bloodstain pattern analysis - Casework experience	FORENSIC SCIENCE INTERNATIONAL			English	Article						Bloodstain distribution pattern; Casework; Interpretation	CLOSE-RANGE SHOTS; BACKSPATTER; DISTANCE; SPATTER; HEAD	The morphology of bloodstain distribution patterns at the crime scene carries vital information for a reconstruction of the events. Contrary to experimental work, case reports where the reconstruction has been verified have rarely been published. This is the reason why a series Of four illustrative cases is presented where bloodstain pattern analysis at the crime scene made a reconstruction of the events possible and where this reconstruction was later verified by a confession of the offender. The cases include various types of bloodstains such as contact and smear stains, drop stains, arterial blood spatter and splash stains from both impact and cast-off pattern. Problems frequently encountered in practical casework are addressed, such as unfavourable environmental conditions or combinations of different bloodstain patterns. It is also demonstrated that the analysis of bloodstain morphology can support individualisation of stains by directing the selection of a limited number of stains from a complex pattern for DNA analysis. The complexity of real situations suggests a step-by-step approach starting with a Comprehensive view of the overall picture. This is followed by a differentiation and analysis of single bloodstain patterns and a search for informative details. It is ideal when the expert inspecting the crime scene has also performed the autopsy, but he definitely must have detailed knowledge of the injuries of the deceased/injured and of the possible mechanisms of production. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Karger, B.; Rand, S.; Fracasso, T.; Pfeiffer, H.] Univ Munster, Inst Med Legale, D-48149 Munster, Germany		Karger, B (corresponding author), Univ Munster, Inst Med Legale, Rontgenstr 62, D-48149 Munster, Germany.	karger@uni-muenster.de					Anderson S, 2005, FORENSIC SCI INT, V148, P37, DOI 10.1016/j.forsciint.2004.04.071; Balthazard V., 1939, ANN MED, V19, P265; BRINKMANN B, 1985, Z RECHTSMED, V94, P237; Brinkmann B, 1986, Beitr Gerichtl Med, V44, P67; Burnett BR, 1997, J FORENSIC SCI, V42, P519; DeForest PR., 1990, J FORENSIC SCI, V35, P1491; Du Chesne Alfred, 1993, Archiv fuer Kriminologie, V192, P159; Hulse-Smith L, 2007, J FORENSIC SCI, V52, P65, DOI 10.1111/j.1556-4029.2006.00298.x; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 1998, INT J LEGAL MED, V111, P17; Karger B, 1997, INT J LEGAL MED, V110, P27; Kleiber M, 2001, FORENSIC SCI INT, V119, P260, DOI 10.1016/S0379-0738(00)00363-7; Knock C, 2007, J FORENSIC SCI, V52, P1044, DOI 10.1111/j.1556-4029.2007.00505.x; LOCHTE T, 1933, DTSCH Z GERICHTL MED, V22, P387; MacDonell HL., 1982, BLOODSTAIN PATTERN I, P16; PIZZOLA PA, 1986, J FORENSIC SCI, V31, P50; PIZZOLA PA, 1986, J FORENSIC SCI, V31, P36; Rand S, 1986, Beitr Gerichtl Med, V44, P75; RAYMOND MA, 1986, FORENSIC SCI INT, V31, P189, DOI 10.1016/0379-0738(86)90187-8; Raymond MA, 1996, SCI JUSTICE, V36, P153, DOI 10.1016/S1355-0306(96)72590-X; Raymond MA, 1996, SCI JUSTICE, V36, P161, DOI 10.1016/S1355-0306(96)72591-1; RISENBATT RR, 1995, J FORENSIC SCI, V40, P139; Rowe WF, 2006, FORENSIC SCI INT, V161, P47, DOI 10.1016/j.forsciint.2005.10.023; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; WHITE B, 1986, CAN SOC FORENSIC SCI, V19, P3; Willis C, 2001, FORENSIC SCI INT, V123, P1, DOI 10.1016/S0379-0738(01)00506-0; Wilson CI, 2004, AM J FOREN MED PATH, V25, P80, DOI 10.1097/01.paf.0000113857.07024.fa; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f; ZWEIDINGER R A, 1973, Journal of Forensic Sciences, V18, P296	29	24	25	3	142	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	OCT 25	2008	181	1-3					15	20		10.1016/j.forsciint.2008.07.010			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	377WC	WOS:000261281500003	18790581				2022-02-06	
J	Tran, TY; Dunne, IE; German, JW				Tran, Timothy Y.; Dunne, Irie E.; German, John W.			Beta blockers exposure and traumatic brain injury: a literature review	NEUROSURGICAL FOCUS			English	Article						adrenergic receptor; beta blocker; brain injury; catecholamine; trauma	CEREBRAL-BLOOD-FLOW; HEART-RATE-VARIABILITY; CARDIOVASCULAR MORBIDITY; INTRACRANIAL-PRESSURE; ADRENERGIC-BLOCKADE; TROPONIN ELEVATION; ENERGY-METABOLISM; IMPROVED OUTCOMES; TARGETED THERAPY; LUND CONCEPT	Traumatic brain injury (TBI) continues to carry a significant public health burden and is anticipated to worsen worldwide over the next century. Recently the authors of several articles have suggested that exposure to beta blockers may improve mortality rates following TBI. The exact mechanism through which beta blockers mediate this effect is unknown. In this paper, the authors review the literature regarding the safety of beta blockers in patients with TBI. The findings of several recent retrospective cohort studies are examined and implications for future investigation are discussed. Future questions to be addressed include: the specific indications for the use of beta blockers in patients with TBI, the optimal type and dose of beta blocker given, the end point of beta blocker therapy, and the safety of beta blockers in cases of severe TBIs.	[Tran, Timothy Y.; Dunne, Irie E.; German, John W.] Albany Med Coll, Dept Surg, Div Neurosurg, Albany, NY 12108 USA		German, JW (corresponding author), Albany Med Coll, Dept Surg, Div Neurosurg, 47 New Scotland Ave, Albany, NY 12108 USA.	jwgerman@hotmail.com					ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269, DOI 10.1152/ajpheart.1990.259.2.H269; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Friese RS, 2008, J TRAUMA, V64, P1061, DOI 10.1097/TA.0b013e3181684cf0; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Gisvold SE, 2001, ACTA ANAESTH SCAND, V45, P399, DOI 10.1034/j.1399-6576.2001.045004399.x; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hays A, 2006, NEUROLOGY, V66, P1330, DOI 10.1212/01.wnl.0000210523.22944.9b; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; JOYCE JN, 1992, SYNAPSE, V10, P228, DOI 10.1002/syn.890100306; KRAUS J, 1985, J NEUROSURG, V63, P537, DOI 10.3171/jns.1985.63.4.0537; Lampert R, 2003, AM J CARDIOL, V91, P137, DOI 10.1016/S0002-9149(02)03098-9; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; MOREL DR, 1984, INTENS CARE MED, V10, P133, DOI 10.1007/BF00265802; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MOSS E, 1995, BRIT J ANAESTH, V74, P635, DOI 10.1093/bja/74.6.635; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Nilsson F, 1997, ACTA ANAESTH SCAND, V41, P1257, DOI 10.1111/j.1399-6576.1997.tb04641.x; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; Peden M., 2004, WORLD REPORT ROAD TR; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schmalbruch IK, 2002, STROKE, V33, P251, DOI 10.1161/hs0102.101233; Seekamp A, 1998, J TRAUMA, V44, P874, DOI 10.1097/00005373-199805000-00022; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; WALTER P, 1982, BRIT MED J, V284, P1661, DOI 10.1136/bmj.284.6330.1661; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1988, AM J PHYSIOL, V254, pE287, DOI 10.1152/ajpendo.1988.254.3.E287; WOOLF PD, 1983, J CLIN ENDOCR METAB, V56, P246, DOI 10.1210/jcem-56-2-246; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	52	24	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2008	25	4							E8	10.3171/FOC.2008.25.10.E8			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	355HX	WOS:000259701100008	18828706	Bronze			2022-02-06	
J	Turegano-Fuentes, F; Perez-Diaz, D; Sanz-Sanchez, M; Alonso, JO				Turegano-Fuentes, Fernando; Perez-Diaz, Dolores; Sanz-Sanchez, Mercedes; Ortiz Alonso, Javier			Overall Asessment of the Response to Terrorist Bombings in Trains, Madrid, 11 March 2004	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Blast injury; Mass casualty incident; Injury Severity Score; Terrorist attack; Injury pattern; Preparedness; Surge capacity	BLAST INJURIES; MANAGEMENT; DISASTERS; INCIDENTS; LONDON	Objectives: To provide an overall assessment of the response to the terrorist bombings in Madrid, 11 March 2004, which were considered the deadliest terrorist attack on European soil in modern times. Materials and Methods: Overall data on the number of victims treated at the scenes and at primary care facilities and hospitals, as well as the logistics involved, were reported by the EMS and the Health Authority of the Comunidad de Madrid local government. Data were mainly obtained by retrospective chart review, and did not include casualties who had only emotional shock, superficial bruises or transient hearing loss from barotraumas without eardrum perforation. We defined as critical any casualty with an Injury Severity Score (ISS) > 15. Results: Over 70,000 personnel were mobilized in the care of the victims. EMS response and total evacuation times at the four blast scenes averaged 7 and 99 min, respectively. There were around 2,000 casualties, and a typical bimodal distribution of deaths, with 177 immediate fatalities and 14 subsequent in-hospital deaths. Almost 6o% of casualties were taken to the two closest hospitals. Problems related to security, identification of casualties and record-keeping were encountered at the closest hospital. Closed doors increased the immediate fatality rate in the trains. Most survivors had noncritical injuries, but 14% of the 512 casualties assessed had an ISS > 15. The critical mortality rate was 19.5%. The most frequently injured body regions were the head/neck and face. In all, 124 major surgical interventions were performed on 82 victims in the first 24 h, and orthopedic trauma procedures accounted for 50% of the case load. Most patients with lung injuries from the blasts required intubation and mechanical ventilation, and their survival rate was 88.3%. Also, 35% of laparotomies were either negative or nontherapeutic. Conclusion: There was a rapid EMS response and evacuation, but also overtriage, uneven distribution of casualties and difficulties in communication. The sizes and resources of the closest hospitals, as well as the early hour, were probably decisive in the adequacy of the overall response.	[Turegano-Fuentes, Fernando; Perez-Diaz, Dolores; Sanz-Sanchez, Mercedes; Ortiz Alonso, Javier] Univ Hosp Gregorio Maranon, Dept Gen Surg & Emergency Surg 2, Madrid, Spain		Turegano-Fuentes, F (corresponding author), Univ Hosp Gregorio Maranon, Dept Gen Surg & Emergency Surg 2, Madrid, Spain.	fturegano.hgugm@salud.madrid.org					Almogy G, 2005, ARCH SURG-CHICAGO, V140, P390, DOI 10.1001/archsurg.140.4.390; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Aylwin CJ, 2006, LANCET, V368, P2219, DOI 10.1016/S0140-6736(06)69896-6; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; CEBALLOS JPD, 2005, CRIT CARE MED, V33, pS107; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Frykberg ER, 2004, ANN SURG, V239, P319, DOI 10.1097/01.sla.0000116001.97770.ce; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Frykberg ER, 2005, CRIT CARE, V9, P20, DOI 10.1186/cc2997; Hamilton-Farrell M, 2004, INJURY, V35, P359, DOI 10.1016/j.injury.2003.08.020; Hirshberg A, 2005, J TRAUMA, V58, P686, DOI 10.1097/01.TA.0000159243.70507.86; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Lennquist S, 2007, J TRAUMA, V62, P1321, DOI 10.1097/TA.0b013e31805ba373; Lucci EB, 2006, SURG CLIN N AM, V86, P579, DOI 10.1016/j.suc.2006.03.001; Stein M, 2005, SCAND J SURG, V94, P286, DOI 10.1177/145749690509400407; Stein M, 1999, SURG CLIN N AM, V79, P1537, DOI 10.1016/S0039-6109(05)70091-8; TANIELIAN T, 2005, EXEMPLARY PRACTICES; Turegano-Fuentes F, 2006, LANCET, V368, P2188, DOI 10.1016/S0140-6736(06)69871-1	18	24	24	1	16	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2008	34	5					433	441		10.1007/s00068-008-8805-2			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	360FH	WOS:000260042300003	26815987				2022-02-06	
J	Buckman, JE; Bates, ME; Morgenstern, J				Buckman, Jennifer E.; Bates, Marsha E.; Morgenstern, Jon			Social support and cognitive impairment in clients receiving treatment for alcohol- and drug-use disorders: A replication study	JOURNAL OF STUDIES ON ALCOHOL AND DRUGS			English	Article; Proceedings Paper	115th Annual Convention of the American-Psychological-Association	AUG 17-20, 2007	San Francisco, CA	Amer Psychol Assoc			TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NETWORKS; MECHANISMS; ABSTINENCE; PREVENTION; RETENTION; RECOVERY; OUTCOMES; FRIENDS	Objective: The influence that social network members exert on the drinking behaviors of alcohol-dependent individuals may represent a behavioral change process that is sensitive to co-occurring cognitive impairment and operates outside treatment to promote or impede outcomes. This study was aimed at extending earlier research support for this hypothesis by assessing impairment in memory as well as executive functions in a more heterogeneous population with alcohol- and/or drug-use disorders. Method: Latent class analysis was used as a person-centered approach to characterize the nature and extent of social support for abstinence from alcohol and drug use in 122 men and women entering treatment for substance-use disorders. Substance use, executive dysfunction, and memory impairments were compared across latent classes at four points during the first year after treatment entry The interrelationship of impairment and social support on treatment outcomes was also examined. Results: Three independent social support classes-(1) Frequent Positive Support, (2) Limited Positive Support, and (3) Negative Support-were identified. The Frequent Positive Support class demonstrated the most frequent substance use and greatest executive impairment at treatment entry but-by the end of treatment-showed pronounced improvements in both. In addition, less recovery of executive function by the end of treatment predicted better 12-month substance-use outcomes in the Frequent Positive Support class, whereas it predicted poorer outcomes in the Negative Support class. Conclusions: The results offer further evidence for the heightened importance of informal social network processes in the treatment outcomes of persons with severe and ongoing deficits in executive functioning.	[Bates, Marsha E.] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA; [Morgenstern, Jon] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA		Bates, ME (corresponding author), Rutgers State Univ, Ctr Alcohol Studies, 607 Allison Rd, Piscataway, NJ 08854 USA.	mebates@rci.rutgers.edu	Bates, Marsha/AAD-6426-2020	Buckman, Jennifer/0000-0002-1898-5499	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA011594, K02AA000325, P50AA008747] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K02 AA000325, R01 AA011594, K02 AA00325, P50 AA08747, R01 AA11594] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; Bates ME, 2006, PSYCHOL ADDICT BEHAV, V20, P241, DOI 10.1037/0893-164X.20.3.241; Bates ME, 2005, ALCOHOL CLIN EXP RES, V29, P367, DOI 10.1097/01.ALC.0000156131.88125.2A; Bates ME, 1999, ASSESSMENT OF NEUROPSYCHOLOGICAL FUNCTIONS IN PSYCHIATRIC DISORDERS, P373; Bates ME, 2002, PSYCHOL ADDICT BEHAV, V16, P35, DOI 10.1037//0893-164X.16.1.35; Beattie MC, 1999, ADDICT BEHAV, V24, P593, DOI 10.1016/S0306-4603(98)00120-8; Benton A., 1976, MULTILINGUAL APHASIA; Buckman JF, 2007, J STUD ALCOHOL DRUGS, V68, P738, DOI 10.15288/jsad.2007.68.738; CARLIN AS, 1996, NEUROPSYCHOLOGICAL A, P486; Clifford PR, 1991, MANUAL ADM IMPORTANT; Cohen J., 2013, STAT POWER ANAL BEHA; DELIS D, 1987, CALIFORNIA VERBAL LE; DONOVAN DM, 2000, NIAAA PROJECT MATCH, V8, P62; FALSSTEWART W, 1992, J CLIN PSYCHOL, V48, P539, DOI 10.1002/1097-4679(199207)48:4<539::AID-JCLP2270480416>3.0.CO;2-I; Giancola PR, 1998, RECENT DEV ALCOHOL, V14, P227, DOI 10.1007/0-306-47148-5_10; Golden CJ, 1978, STROOP COLOR WORD TE; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; Knight DK, 1996, J SUBST ABUSE, V8, P417, DOI 10.1016/S0899-3289(96)90003-6; Knight RG, 1994, CLIN NEUROPSYCHOLOGY; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Little RJA., 1987, STAT ANAL MISSING DA; LONGABAUGH R, 1993, J STUD ALCOHOL, V54, P465, DOI 10.15288/jsa.1993.54.465; LONGABAUGH R, 2001, PROJECT MATCH MONOGR, V8, P260; Manuel JK, 2007, J STUD ALCOHOL DRUGS, V68, P871, DOI 10.15288/jsad.2007.68.871; Marlatt G.A., 1985, RELAPSE PREVENTION M, P128; McCrady BS, 2004, PSYCHOL ADDICT BEHAV, V18, P113, DOI 10.1037/0893-164X.18.2.113; McCutcheon AL, 1987, LATENT CLASS ANAL; Mohr CD, 2001, J STUD ALCOHOL, V62, P637, DOI 10.15288/jsa.2001.62.637; Morgenstern J, 1999, J STUD ALCOHOL, V60, P846, DOI 10.15288/jsa.1999.60.846; Morgenstern J, 1996, J STUD ALCOHOL, V57, P53, DOI 10.15288/jsa.1996.57.53; Morgenstern J, 1997, J CONSULT CLIN PSYCH, V65, P768, DOI 10.1037/0022-006X.65.5.768; Muthen L., 1998, MPLUS COMPREHENSIVE; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NIXON SJ, 1995, ALCOHOL HEALTH RES W, V19, P97; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Prigatano GP, 1996, COGNITIVE REHABILITA, P223; Reitan R, 1985, HALSTEAD REITAN NEUR; Richter S S, 1991, J Subst Abuse, V3, P371; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; RUSSELL EW, 1987, J CONSULT CLIN PSYCH, V55, P898, DOI 10.1037/0022-006X.55.6.898; SIDDALL JW, 1988, INT J ADDICT, V23, P1241, DOI 10.3109/10826088809058855; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sussman S, 1996, J PSYCHOACTIVE DRUGS, V28, P169, DOI 10.1080/02791072.1996.10524389; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Witkiewitz K, 2004, AM PSYCHOL, V59, P224, DOI 10.1037/0003-066X.59.4.224; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Zachary R. A., 1986, SHIPLEY I LIVING SCA; Zywiak WH, 2002, J STUD ALCOHOL, V63, P114	57	24	24	0	9	ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV	PISCATAWAY	C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA	1937-1888			J STUD ALCOHOL DRUGS	J. Stud. Alcohol Drugs	SEP	2008	69	5					738	746		10.15288/jsad.2008.69.738			9	Substance Abuse; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Substance Abuse; Psychology	348IW	WOS:000259205200013	18781249	Green Published			2022-02-06	
J	Harris, OA; Bruce, CA; Reid, M; Cheeks, R; Easley, K; Surles, MC; Pan, Y; Rhoden-Salmon, D; Webster, D; Crandon, I				Harris, Odette A.; Bruce, Carl A.; Reid, Marvin; Cheeks, Randolph; Easley, Kirk; Surles, Monique C.; Pan, Yi; Rhoden-Salmon, Donnahae; Webster, Dwight; Crandon, Ivor			Examination of the management of traumatic brain injury in the developing and developed world: focus on resource utilization, protocols, and practices that alter outcome	JOURNAL OF NEUROSURGERY			English	Article						cohort study; functional independence measure; Glasgow Outcome Scale; traumatic brain injury	SEVERE HEAD-INJURIES; CONTROLLED-TRIALS	Object. We evaluated management and outcome of traumatic brain injury (TBI) in a developed country (US) and a developing country (Jamaica). Methods. Data were collected prospectively at Grady Memorial Hospital (GMH) in the US and at University Hospital of the West Indies (UHWI) and Kingston Public Hospital (KPH) in Jamaica between September 1, 2003, and September 30, 2004. Results. Complete data were available for 1607 patients. Grady Memorial Hospital had a higher proportion of females (p = 0.003), and patients were older at GMH (p = 0.0009) compared with patients at KPH and UHWI. The most common mode of injury was a motor vehicle accident at KPH and GMH (42 and 66%, respectively) and assaults at UHWI (37%). Grady Memorial Hospital admitted more patients with severe head injuries (25.5%) than KPH (18.5%) and UHWI (14.4%). More CT scans were performed (p < 0.0001) and a higher proportion of patients were admitted to the intensive care unit (p < 0.0001) at GMH. There were no statistically significant differences in median days in the intensive care unit among the 3 hospitals. Patients experienced statistically significant differences in days undergoing ventilation between GMH, KPH, and UHWI (p = 0.004). Intracranial pressure monitoring was performed in 1 patient at KPH, in 6 at UHWI, and in 91 at GMH. There were 174 total deaths, but no statistically significant differences in mortality rates between the 3 sites (p = 0.3). Hospital location and TBI severity were associated with a decreased risk of mortality; patients with severe TBI at GMH had a 53% decrease in the risk of mortality (odds ratio = 0.47, p = 0.04). Patients at GMH had lower mean Glasgow Outcome Scale scores (p < 0.0001) and lower Functional Independence Measure self-feed (p = 0.0003), locomotion (p = 0.04), and verbal scores (p < 0.0001). Conclusions. Despite the availability of advanced technology and more aggressive neurological support at GMH, the overall mortality rate for TBI was similar at all locations. Patients identified with severe TBI had a significantly decreased risk of mortality if they were treated at GMH compared with those patients treated at hospitals in the developing world.	[Easley, Kirk; Pan, Yi] Emory Univ, Sch Publ Hlth, Dept Biostat, Atlanta, GA 30303 USA; [Bruce, Carl A.; Rhoden-Salmon, Donnahae; Crandon, Ivor] Univ Hosp W Indies, Div Neurosurg, Mona, Jamaica; [Reid, Marvin] Univ Hosp W Indies, Sickle Cell Unit, Mona, Jamaica; [Cheeks, Randolph; Webster, Dwight] Kingston Publ Hosp, Dept Neurosurg, Kingston, Jamaica		Harris, OA (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, Grady Mem Hosp, 49 Jesse Hill Jr Dr SE,Fac Off Bldg,Room 33, Atlanta, GA 30303 USA.	oharris@emory.edu	Reid, Marvin/J-2884-2014; Easley, Kirk/K-6910-2015	Reid, Marvin/0000-0003-4005-9384; Easley, Kirk/0000-0003-4419-2617; Surles-Zeigler, Monique/0000-0002-2308-8813	William P. Van Wagenen Fellowship of the American Association of Neurological Surgeons	Support for this research was provided by a fellowship from the William P. Van Wagenen Fellowship of the American Association of Neurological Surgeons, awarded to Odette Harris, M.D., M.P.H.	Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Granger, 1987, FUNCTIONAL INDEPENDE; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Maejima S, 2001, WORLD J SURG, V25, P1205, DOI 10.1007/s00268-001-0083-7; MARION DW, 1999, TRAUMATIC BRAIN INJU; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; Raja IA, 2001, WORLD J SURG, V25, P1230	13	24	24	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2008	109	3					433	438		10.3171/JNS/2008/109/9/0433			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	344CX	WOS:000258904400012	18759573				2022-02-06	
J	Mas, E; Michel, F; Guy, A; Bultel, V; Falquet, Y; Chardon, P; Rossi, JC; Cristol, JP; Durand, T				Mas, Emilie; Michel, Francoise; Guy, Alexandre; Bultel, Valerie; Falquet, Yoan; Chardon, Patrick; Rossi, Jean-Claude; Cristol, Jean Paul; Durand, Thierry			Quantification of urinary F-2-isoprostanes with 4(RS)-F-4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry - Application to polytraumatized patients	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						isoprostanes; GC-MS; 15-F-2t-IsoP; 4(RS)-F-4t-NeuroP; polytraurnatized patients	TRAUMATIC BRAIN-INJURY; PERFORMANCE LIQUID-CHROMATOGRAPHY; PEROXIDATION IN-VIVO; LIPID-PEROXIDATION; 8-EPI-PROSTAGLANDIN F2-ALPHA; DOCOSAHEXAENOIC ACID; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; 8-ISO-PROSTAGLANDIN F2-ALPHA; PROSTANOIDS F2-ISOPROSTANES	Isoprostanes are a family of prostaglandin isomers produced from oxidation of polyunsaturated fatty acids through a non-enzymatic free radical-catalyzed mechanism. Quantification of F-2-isoprostanes (F-2-IsoPs) provides a good index of oxidative stress and allows non-invasive assessment of lipid peroxidation in vivo. Since "interferences peaks" at m/z 573 co-elute with d(4)-15-F-2t-IsoP preferentially used, we propose a new GC-NICI-MS approach to quantify urinary F-2-IsoPs by using 4(RS)-F-4t-neuroprostane as the internal standard. This method was applied to quantify urinary F-2-IsoPs excretion in healthy volunteers and polytraumatized patients. Our results showed a significant increase (p < 0.0001) in urinary F-2-IsoPs in polytraumatized patients compared with healthy volunteers (4.73 +/- 2.75 ng/mg vs. 0.811 +/- 0.359 ng/mg creatinine). (c) 2008 Elsevier B.V. All rights reserved.	[Mas, Emilie; Michel, Francoise; Rossi, Jean-Claude] Lapeyronie Hosp, Dept Biochem, F-34295 Montpellier 5, France; [Guy, Alexandre; Bultel, Valerie; Rossi, Jean-Claude; Durand, Thierry] CNRS, IBMM, UM 1, Fac Pharm,UMR 5247,UM 2, Montpellier, France; [Falquet, Yoan; Chardon, Patrick] Lapeyronie Hosp, Dept Anesthesiol & Crit Care Med, Montpellier, France		Michel, F (corresponding author), Lapeyronie Hosp, Dept Biochem, 371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.	francoise-michel@chu-montpellier.fr					Arneson KO, 2007, METHOD ENZYMOL, V433, P127, DOI 10.1016/S0076-6879(07)33007-3; Bachi A, 1996, FREE RADICAL BIO MED, V20, P619, DOI 10.1016/0891-5849(95)02087-X; Basu S, 2005, ANTIOXID REDOX SIGN, V7, P221, DOI 10.1089/ars.2005.7.221; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bessard J, 2001, J CHROMATOGR B, V754, P333, DOI 10.1016/S0378-4347(00)00621-6; Bohnstedt KC, 2005, J CHROMATOGR B, V827, P39, DOI 10.1016/j.jchromb.2005.02.023; Cracowski JL, 2002, TRENDS PHARMACOL SCI, V23, P360, DOI 10.1016/S0165-6147(02)02053-9; Cuzzorcrea S, 2004, CURR MED CHEM, V11, P1147, DOI 10.2174/0929867043365396; Davies SS, 2006, ANAL BIOCHEM, V348, P185, DOI 10.1016/j.ab.2005.10.012; Durand T, 2001, BIOORG MED CHEM LETT, V11, P2495, DOI 10.1016/S0960-894X(01)00473-5; Durand T, 2000, TETRAHEDRON LETT, V41, P3859, DOI 10.1016/S0040-4039(00)00508-6; Durant R, 2004, SHOCK, V22, P34, DOI 10.1097/01.shk.0000129197.46212.7e; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; HELMERSSON J, 1999, ESSENT FATTY ACIDS, V61, P203; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Klein T, 1997, J PHARMACOL EXP THER, V282, P1658; Lawson JA, 1998, J BIOL CHEM, V273, P29295, DOI 10.1074/jbc.273.45.29295; Lawson JA, 2006, J LIPID RES, V47, P2515, DOI 10.1194/jlr.M600327-JLR200; Lee CYJ, 2004, BIOCHEM BIOPH RES CO, V320, P696, DOI 10.1016/j.bbrc.2004.06.015; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Montine TJ, 2002, ANN NEUROL, V52, P175, DOI 10.1002/ana.10272; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1992, J CLIN INVEST, V90, P2502, DOI 10.1172/JCI116143; MORROW JD, 1994, METHOD ENZYMOL, V233, P163; Murai Y, 2000, PROSTAG OTH LIPID M, V62, P173, DOI 10.1016/S0090-6980(00)00061-7; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; NOUROOZZADEH J, 1995, J CHROMATOGR B, V667, P199, DOI 10.1016/0378-4347(95)00035-H; Ohashi N, 2000, J CHROMATOGR B, V746, P17, DOI 10.1016/S0378-4347(00)00201-2; Pratico D, 2004, CHEM PHYS LIPIDS, V128, P165, DOI 10.1016/j.chemphyslip.2003.09.012; Pratico D, 2001, TRENDS ENDOCRIN MET, V12, P243, DOI 10.1016/S1043-2760(01)00411-8; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Proudfoot J, 1999, ANAL BIOCHEM, V272, P209, DOI 10.1006/abio.1999.4187; Schwedhelm E, 2000, J CHROMATOGR B, V744, P99, DOI 10.1016/S0378-4347(00)00236-X; Song WL, 2008, J BIOL CHEM, V283, P6, DOI 10.1074/jbc.M706124200; Tsikas D, 1998, J CHROMATOGR B, V716, P7, DOI 10.1016/S0378-4347(98)00275-8; Tsikas D, 2003, J CHROMATOGR B, V794, P237, DOI 10.1016/S1570-0232(03)00457-4; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Walter MF, 2000, ANAL BIOCHEM, V280, P73, DOI 10.1006/abio.1999.4476; WANG ZY, 1995, J PHARMACOL EXP THER, V275, P94	46	24	24	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232			J CHROMATOGR B	J. Chromatogr. B	SEP 1	2008	872	1-2					133	140		10.1016/j.jchromb.2008.07.037			8	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	356FT	WOS:000259764800017	18706873				2022-02-06	
J	Collins, RC; Kennedy, MC				Collins, Rose C.; Kennedy, Maureen C.			Serving families who have served: Providing family therapy and support in interdisciplinary polytrauma rehabilitation	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						traumatic brain injury; polytrauma; rehabilitation; family support; psychotherapy; family therapy	TRAUMATIC BRAIN-INJURY	Severe polytraumatic injuries sustained in combat operations require intensive rehabilitation and often result in complex, long-term disabilities. Understandably, these significant injuries have a substantial emotional impact on families. In this article, the authors discuss the importance of a family-centered care philosophy, the interdisciplinary team approach, the therapeutic milieu, and two family-systems treatments (medical family therapy and ambiguous loss theory). A case example illustrates the key processes of psychological support and therapy when treating polytrauma patients and their families. (c) 2008 Wiley Periodicals, Inc.	[Collins, Rose C.; Kennedy, Maureen C.] Vet Affairs Med Ctr, Polytrauma Rehabil Ctr, Minneapolis, MN 55417 USA		Collins, RC (corresponding author), Vet Affairs Med Ctr, Polytrauma Rehabil Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	Rose.Collins@va.gov					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BLOCH DA, 1992, MEDICAL FAMILY THERA; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss P.G., 2006, LOSS TRAUMA RESILIEN; CAVALLO MM, 2005, TXB TRAUMATIC BRAIN, P533; Doherty W.J., 1992, MED FAMILY THERAPY B; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Hagen C., 1972, LEVELS COGNITIVE FUN; Kay, 1991, HEAD INJURY FAMILY M, P81; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MUIR C, 1990, REHABILITATION ADULT, P433; Pollack IW, 2005, TXB TRAUMATIC BRAIN, P641; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	18	24	24	0	1	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	AUG	2008	64	8					993	1003		10.1002/jclp.20515			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	330ES	WOS:000257922900008	18553369				2022-02-06	
J	Jin, XY; Shen, G; Gao, F; Zheng, XS; Xu, XY; Shen, F; Li, G; Gong, JB; Wen, L; Yang, XF; Bie, XD				Jin, Xiaoying; Shen, Gang; Gao, Feng; Zheng, Xuesheng; Xu, Xiaoyan; Shen, Fang; Li, Gu; Gong, Jiangbiao; Wen, Liang; Yang, Xiaofeng; Bie, Xiaodong			Traditional Chinese drug ShuXueTong facilitates angiogenesis during wound healing following traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						ShuXueTong; angiogenesis; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; INHIBITOR; SU5416; VEGF; MECHANISMS; RECEPTORS	Ethnopharmacological relevance: ShuXueTong injection is a traditional Chinese drug designed to treat the patients of "blood stasis and stagnation (yu xue yu zhi)", including subacute brain trauma. However, the mechanism of the therapeutic effect of ShuXueTong on traumatic brain injury is unknown yet. Aim of the study: We hypothesized that ShuXueTong may promote the brain wound healing by facilitating angiogenesis. Thus this study was designed to explore this hypothesis. Materials and methods: By means of microvessel count, Western blotting, immunocytochemistry, methyl thiazolyl tetrazolium assay and etc., the effect of ShuXueTong on the angiogenesis of brain wound was studied and then its influence on the VEGF/VEGFR-2 pathway were explored. Results: ShuXueTong facilitates angiogenesis in the brain wound and improves the neurological function of the traumatized rats. VEGF expression in the lesion was elevated due to ShuXueTong induction. The in vitro experiment revealed VEGFR-2 and SRF expression in the endothelial cells were enhanced when exposed to ShuXueTong for merely 1 d. Moreover, ShuXueTong promoted the endothelial cell proliferation via the VEGF/VEGFR-2 pathway. Conclusions: The mechanism of the therapeutic effect of ShuXueTong on traumatic brain injury lies at least partly in the enhanced angiogenesis in the lesion. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Jin, Xiaoying; Bie, Xiaodong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Tradit Chinese Med, Hangzhou 310009, Zhejiang, Peoples R China; [Shen, Gang; Gao, Feng; Zheng, Xuesheng; Xu, Xiaoyan; Shen, Fang; Li, Gu; Gong, Jiangbiao; Wen, Liang; Yang, Xiaofeng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China		Bie, XD (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Tradit Chinese Med, Hangzhou 310009, Zhejiang, Peoples R China.	xdbie@163.com	shen, fang/G-8439-2011				Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chai JY, 2004, FASEB J, V18, P1264, DOI 10.1096/fj.03-1232fje; CONSTANTINO RSS, 2007, EXP CELL RES, V313, P1561; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Fong TAT, 1999, CANCER RES, V59, P99; Li Ai-hua, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P879; Li K. J., 2007, CLIN MED CHINA, V23, P7; LI ZG, 2003, Patent No. 031482813; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang X R, 1994, Zhongguo Zhong Xi Yi Jie He Za Zhi, V14, P349; Zhang Xuan, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1950; Zheng XS, 2007, BRAIN INJURY, V21, P275, DOI 10.1080/02699050701225754; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912	20	24	27	0	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	MAY 22	2008	117	3					473	477		10.1016/j.jep.2008.02.033			5	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	310UN	WOS:000256556100014	18417308				2022-02-06	
J	VandeVord, PJ; Leung, LY; Hardy, W; Mason, M; Yang, KH; King, AI				VandeVord, Pamela J.; Leung, Lai Yee; Hardy, Warren; Mason, Matthew; Yang, King H.; King, Albert I.			Up-regulation of reactivity and survival genes in astrocytes after exposure to short duration overpressure	NEUROSCIENCE LETTERS			English	Article						astrocytes; overpressure; reactivity; survival; apoptosis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; NEURONAL CELL-DEATH; INFLAMMATORY RESPONSE; NEUROTROPHIC FACTOR; CEREBRAL-CORTEX; KINASE PATHWAY; MESSENGER-RNA; EXPRESSION; RATS	Gurdjian et al. proposed decades ago that pressure gradients played a major factor in neuronal injury due to impact. In the late 1950s, their experiments on concussion demonstrated that the principal factor in the production of concussion in animals was the sudden increase of intracranial pressure accompanying head injury. They reported the increase in pressure severity correlated with an increase in 'altered cells' resulting in animal death. More recently, Hardy et al. (2006) demonstrated the presence of transient pressure pulses with impact conditions. These studies indicate that short duration overpressure should be further examined as a mechanism of traumatic brain injury (TBI). In the present study, we designed and fabricated a barochamber that simulated overpressure noted in various head injury studies. We tested the effect of overpressure on astrocytes. Expressions of apoptotic, reactivity and survival genes were examined at 24, 48 and 72 It post-overpressure exposure. At 24 h, we found elevated levels of reactivity and survival gene expression. By 48 h, a decreased expression of apoptotic genes was demonstrated. This study reinforces the hypothesis that transient pressure acts to instigate the cellular response displayed following TBI. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[VandeVord, Pamela J.; Leung, Lai Yee; Hardy, Warren; Mason, Matthew; Yang, King H.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [VandeVord, Pamela J.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA		VandeVord, PJ (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock, Detroit, MI 48202 USA.	pvord@wayne.edu	VandeVord, Pamela/B-4606-2012; Leung, Lai Yee/H-8204-2013				Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; CHASON JL, 1957, EXP NEUROL, V16, P102; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; CONDORELLI DF, 1990, J NEUROSCI RES, V26, P251, DOI 10.1002/jnr.490260216; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Grosjean MB, 2007, HISTOL HISTOPATHOL, V22, P235, DOI 10.14670/HH-22.235; Gurdjian E S, 1964, Clin Neurosurg, V12, P112; Hardy W.N., 2006, J BIOMECH, V39, pS155; Katano H, 2001, NEUROSCI LETT, V306, P101, DOI 10.1016/S0304-3940(01)01832-8; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nicole O, 2001, J NEUROSCI, V21, P3024, DOI 10.1523/JNEUROSCI.21-09-03024.2001; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Penkowa M, 1999, GLIA, V25, P343; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Smith DH, 1999, J NEUROSCI, V19, P4263; Wen TC, 1998, J EXP MED, V188, P635, DOI 10.1084/jem.188.4.635; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	32	24	26	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR	2008	434	3					247	252		10.1016/j.neulet.2008.01.056			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YQ	WOS:000255302400002	18342445				2022-02-06	
J	Elovic, EP; Jasey, NN; Eisenberg, ME				Elovic, Elie Paul; Jasey, Neil N., Jr.; Eisenberg, Michal E.			The use of atypical Antipsychotics after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						agitation; atypical antipsychotic; aripiprazole; behavior; clozapine; olanzapine; quetiapine; risperidone; traumatic brain injuiy; ziprasidone	DRUGS; RISPERIDONE; QUETIAPINE; SCHIZOPHRENIA; ZIPRASIDONE; CLOZAPINE		[Elovic, Elie Paul; Jasey, Neil N., Jr.; Eisenberg, Michal E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Kessler Med Rehabil Res & Educ Ctr, Dept Phys Med & Rehabil,Traumat Brain Injury Res, W Orange, NJ 07052 USA		Elovic, EP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Kessler Med Rehabil Res & Educ Ctr, Dept Phys Med & Rehabil,Traumat Brain Injury Res, W Orange, NJ 07052 USA.	eelovic@kmrrec.org					Akdede BBK, 2005, PROG NEURO-PSYCHOPH, V29, P233, DOI 10.1016/j.pnpbp.2004.11.005; Alderfer BS, 2006, J NEUROPSYCH CLIN N, V18, P551, DOI 10.1176/appi.neuropsych.18.4.551; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Cosi C, 2005, BRAIN RES, V1043, P32, DOI 10.1016/j.brainres.2005.02.072; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; Gardner DM, 2005, CAN MED ASSOC J, V172, P1703, DOI 10.1503/cmaj.1041064; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; JESTE DV, 2007, NEUROPSYCHOPHARMACOL; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kurosawa S, 2007, J NEURAL TRANSM, V114, P1121, DOI 10.1007/s00702-007-0747-z; McGurk Susan R, 2004, MedGenMed, V6, P27; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Mizoguchi Y, 2002, J NEUROPSYCH CLIN N, V14, P87, DOI 10.1176/appi.neuropsych.14.1.87-a; Newcomer JW, 2005, CNS DRUGS, V19, P1; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Oster TJ, 2007, CNS SPECTRUMS, V12, P764, DOI 10.1017/S1092852900015455; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Silver BV, 2003, BRAIN INJURY, V17, P237, DOI 10.1080/0269905021000013192; Stahl S.M, 2000, ESSENTIAL PSYCHOPHAR; TAHIR R, 2007, US PHARM, V32, pHS3; US Food and Drug Administration, 2005, DEATHS ANT ELD PAT B; Weiser M, 2000, SCHIZOPHR RES, V46, P81, DOI 10.1016/S0920-9964(00)00025-6	23	24	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2008	23	2					132	135		10.1097/01.HTR.0000314532.07530.e5			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	280KW	WOS:000254426700008	18362767				2022-02-06	
J	Stipanicic, A; Nolin, P; Fortin, G; Gobeil, MF				Stipanicic, Annie; Nolin, Pierre; Fortin, Gilles; Gobeil, Marie-France			Comparative study of the cognitive sequelae of school-aged victims of Shaken Baby Syndrome	CHILD ABUSE & NEGLECT			English	Article						Shaken Baby Syndrome; non-accidental head injury; neuropsychology; executive functions	TRAUMATIC BRAIN-INJURY; INFANT SYNDROME; CHILD-ABUSE; SHAKING; IMPACT; DAMAGE	Objective: Shaken Baby Syndrome (SBS) is now recognized as being the main cause of severe traumatic brain injury in infancy. However, our understanding of the impact of this type of abuse on child development remains sketchy. The main objective of the current study was therefore to shed light on the cognitive dysfunctions that are particular to SBS victims once they are school-aged. Method: A clinical group was formed of I I children diagnosed with SBS who had been admitted between 1988 and 1999 to a tertiary pediatric hospital in Quebec, Canada. The children were matched for age, gender, socioeconomic status, and family composition to I I healthy Quebec children, who made up the control group. A battery of composite tests was developed to assess the children's main cognitive functions and was administered individually to the 22 children. A univariate t-test was used to compare the performances of the two groups. Results: The mean age of the children in the clinical and control groups at the time of the assessment was 87.64 months and 90.18 months, respectively. Pairing and birth data were equivalent for both groups. Significant weaknesses were noted in the clinical group for intelligence quotient (IQ), working memory, mental organization, alternation, and inhibition. These deficits seemed to have a greater impact on the verbal sphere of the children's mental functioning. Conclusion: Primary results point to the anterior cerebral regions of the brain as the principal site of dysfunctions that persist years post-trauma. It is important to consider these results longitudinally, even in children apparently less extensively affected, since the frontal regions only reach maturity at the end of adolescence. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.	[Stipanicic, Annie; Nolin, Pierre; Fortin, Gilles; Gobeil, Marie-France] Univ Quebec Trois Rivieres, Dept Psychol, Child & Family Dev Res Unit, Trois Rivieres, PQ G9A 5H7, Canada		Stipanicic, A (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Child & Family Dev Res Unit, POB 500, Trois Rivieres, PQ G9A 5H7, Canada.						ANDERSON V, 2004, NEUROPSYCHOLOGIE COG, P83; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Baddeley A.D., 1986, WORKING MEMORY; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BARLOW KM, 1999, EUR J PAEDIATR NEURO, V3, pA139; BEERY KE, 1997, BEERY BUKTENICA DEV; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BOURQUE C, 1999, CADRE REFERENCE CLIN; BRENNER SL, 1989, J NATL MED ASSOC, V81, P183; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Cahill LT, 1999, CHILD ADOL PSYCH CL, V8, P827; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Cummings E. M, 1994, CHILDREN MARITAL CON; DESGRANGES B, 2003, EVALUATION PRISE CHA, P123; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; ELMER E, 1967, PEDIATRICS, V40, P596; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FISCHER H, 1994, CLIN PEDIATR, V33, P696, DOI 10.1177/000992289403301113; Gervais M, 1999, ETUDE EXPLORATOIRE B; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; *HLTH CAN, JOINT STAT SHAK BAB; HOFFMANPLOTKIN D, 1984, CHILD DEV, V55, P794, DOI 10.2307/1130130; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KING W, 2003, CANADIAN MED ASS J, V168, P1; KING WJ, 2000, CANADIAN COLLABORATI; Korkman M., 2003, NEPSY BILAN NEUROPSY; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; MAZEAU M, 2003, CONDUITE BILAN NEURO; MINER ME, 1986, NEURAL TRAUMA TREATM, P233; MORSE CW, 1970, AM J DIS CHILD, V120, P439, DOI 10.1001/archpedi.1970.02100100103011; Palacio-Quintin E., 1995, UNIVERSEL DIFFERENTI, P305; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; REITAN RM, 1994, NEUROPSYCHOLOGICAL E; Shallice T, 1990, NEUROPSYCHOLOGY MENT; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); THORNDIKE RL, 1986, ECHELLE INTELLIGENCE; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; TROCME N, 2001, CANADIAN INCIDENCE S; Tulving E., 1983, ELEMENTS EPISODIC ME; Wechsler D, 2000, WECHSLER INTELLIGENC	51	24	24	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	MAR	2008	32	3					415	428		10.1016/j.chiabu.2007.07.008			14	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	294WI	WOS:000255436600009	18377985				2022-02-06	
J	Baker, AJ; Park, E; Hare, GMT; Liu, E; Sikich, N; Mazer, DC				Baker, Andrew J.; Park, Eugene; Hare, Greg M. T.; Liu, Elaine; Sikich, Nancy; Mazer, David C.			Effects of resuscitation fluid on neurologic physiology after cerebral trauma and hemorrhage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						albumin; electrophysiology; fluid resuscitation; hemorrhage; TBI	EXPERIMENTAL BRAIN INJURY; HEAD-INJURY; TRANSMISSION DAMAGE; TISSUE OXYGEN; HUMAN ALBUMIN; BLOOD-FLOW; HEMODILUTION; RAT; ISCHEMIA; PRESSURE	Background: The current standard of care for fluid resuscitation of hemorrhagic hypotensive patients involves the use of crystalloid solutions. Traumatic brain injury (TBI) is often associated with hemorrhage and hypotension, which can contribute significantly to morbidity and mortality. Guidelines for the choice of fluid resuscitation and the use of red blood cell transfusions are not yet clear in the context of brain injury. Methods: Various fluid resuscitation strategies were evaluated in Sprague-Dawley rats using fresh blood, normal saline, hypertonic saline, and albumin fluid resuscitation protocols. Mean arterial blood pressure (MAP) and cerebral oximetry were assessed in hemorrhaged groups and the mean population spike amplitudes (PSA) from the hippocampus were examined in fluid percussion injured (FPI) animals subject to hemorrhage and fluid resuscitation. Results: MAP in control animals, hemorrhage and hemorrhage + albumin treated groups was 82.4 +/- 1.5 mm Hg, 55.7 +/- 1.5 mm Hg, and 97.0 +/- 3.4 mm Hg, respectively. Arterial PaO2 was higher in albumin-treated animals relative to other fluid alternatives. Regional tissue oxygen tension (PbrO2) levels in hemorrhaged animals reached significantly higher levels in albumin treated group compared with in normal saline and hypertonic saline (p < 0.001, p=0.034, respectively). After FPI+hemorrhage, PSA values in albuminresuscitated animals were significantly higher than in normal saline-resuscitated animals (p=0.012). Conclusions: The results of normal saline resuscitation, relative to other fluid alternatives, suggest that a re-evaluation of current treatment strategies in hemorrhagic hypotensive TBI patients is warranted. Albumin demonstrated the greatest beneficial effects on neurophysiology endpoints over crystalloid alternatives. These data suggests that albumin resuscitation may play an important role in the treatment of hemorrhagic hypotension and TBI.	[Baker, Andrew J.] Cara Phelan Ctr Trauma Res, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.; Park, Eugene; Hare, Greg M. T.; Liu, Elaine; Sikich, Nancy; Mazer, David C.] St Michaels Hosp, Cara Phelan Ctr Trauma Res, Dept Anesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Hare, Greg M. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada		Baker, AJ (corresponding author), Cara Phelan Ctr Trauma Res, 7086 Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	bakera@smh.toronto.on.ca		Mazer, Cyril David/0000-0003-2566-4308			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ALDERSON P, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001208.PUB2; American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; BAVETTA S, 1995, BRAIN INJURY, V9, P635, DOI 10.3109/02699059509008221; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; COLE DJ, 1993, ANESTHESIOLOGY, V78, P335, DOI 10.1097/00000542-199302000-00018; COLE DJ, 1990, AM J PHYSIOL, V259, pH211, DOI 10.1152/ajpheart.1990.259.1.H211; COLE DJ, 1990, STROKE, V21, P1333, DOI 10.1161/01.STR.21.9.1333; Cook D, 2004, NEW ENGL J MED, V350, P2294, DOI 10.1056/NEJMe048095; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Dings J, 1998, NEUROL RES, V20, pS71; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; EMLING RH, 1986, CURR STUD HEMATOL BL, P36; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fried E, 1995, J PHYSIOL-LONDON, V489, P557, DOI 10.1113/jphysiol.1995.sp021072; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hare GMT, 2003, J APPL PHYSIOL, V94, P2058, DOI 10.1152/japplphysiol.00931.2002; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOLT ME, 1984, BRIT J EXP PATHOL, V65, P231; KAUFMANN MA, 1995, J PHARMACOL EXP THER, V273, P855; KEANEY JF, 1993, J CLIN INVEST, V91, P1582, DOI 10.1172/JCI116364; Kramer MS, 1996, NEUROSURGERY, V38, P355, DOI 10.1097/00006123-199602000-00024; MATSUI T, 1993, NEUROSURGERY, V32, P79, DOI 10.1227/00006123-199301000-00012; MATSUI T, 1993, NEUROSURGERY, V33, P293, DOI 10.1227/00006123-199308000-00017; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Shen H, 2002, ANESTHESIOLOGY, V96, P142, DOI 10.1097/00000542-200201000-00027; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tian GF, 2000, J NEUROPHYSIOL, V83, P1830, DOI 10.1152/jn.2000.83.4.1830; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; Traylor RJ, 1996, ANESTH ANALG, V83, P209, DOI 10.1097/00000539-199608000-00001; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vincent JL, 2004, CRIT CARE MED, V32, P2029, DOI 10.1097/01.CCM.0000142574.00425.E9; WEIL MH, 1979, CRIT CARE MED, V7, P113, DOI 10.1097/00003246-197903000-00006; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	59	24	26	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					348	357		10.1097/01.ta.0000245973.71929.db			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	264KV	WOS:000253287100020	18301197				2022-02-06	
J	Van de Voorde, P; Sabbe, M; Rizopoulos, D; Tsonaka, R; De Jaeger, A; Lesaffre, E; Peters, M				Van de Voorde, Patrick; Sabbe, Marc; Rizopoulos, Dimitris; Tsonaka, Roula; De Jaeger, Annick; Lesaffre, Emmanuel; Peters, Mark		PENTA Study Grp	Assessing the level of consciousness in children: A plea for the Glasgow Coma Motor subscore	RESUSCITATION			English	Article						Glasgow coma scale; child; brain injury	TRAUMATIC BRAIN-INJURY; SCALE SCORE; EMERGENCY-DEPARTMENT; RELIABILITY; TRIAGE	Aim: The Glasgow Coma Scale (GCS) is not always easy to score and its reliability has been questioned. In adults the GCS Motor score has proven a valuable alternative, as it is easier to assess yet shows similar predictive capacity for outcome. We wanted to test the non-inferiority of the Glasgow Coma Motor score GCS-M versus the Total score GCS-T for predicting outcome in children. Materials and methods: As part of the Flemish paediatric trauma registry (PENTA) we collected data on 96 consecutive children (0-18 years) with moderate to severe traumatic brain injury. Outcome was evaluated using a three level ordinal scale: [normal to mild disability, moderate to severe disability and death]. A number of proportional odds models were fitted for various choices of predictive variables (GCS-T, GCS-M, age, sex, and injury severity score ISS). For each model we calculated Somers' D(xy) rank correlation and NagelKerke's R(2)N index, both measures of the predictive performance of the model. Results: All. children had an injury to the brain that resulted in a hospital stay of more than 48 h. Half of them had a "best" initial GCS of 15; 60%, a Motor score of 6. The median Injury Severity Score ISS was 16. Outcome was 'normal to mild' in 79 children, 'moderate to severe' in 7, and 'death' in 10. D(xy) values were 0.983 for the model with the Motor score and 0.972 for that with the total GCS, indicating excellent predictive performance for both. R(2)N indices were 0.862 and 0.813, respectively. Overall the difference between all models was small. Conclusion: The GCS Motor subscore was shown to have at least the same predictive ability for outcome as the total GCS. It is our opinion that the total GCS is unnecessarily complicated (especiatly in children). Using the Motor score alone wilt improve scoring compliance and statistical performance. We do not believe that the reduction in number of potential scores from 13 to 6 would decrease the descriptive capacity significantly, since clinical algorithms typically group values of the total GCS into five or fewer ranges. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	[Van de Voorde, Patrick; De Jaeger, Annick] UZ Gent, B-9000 Ghent, Belgium; [Sabbe, Marc; PENTA Study Grp] UZ Leuven Gasthuisberg, Dept Emergency Med, B-3000 Louvain, Belgium; [Rizopoulos, Dimitris; Tsonaka, Roula; Lesaffre, Emmanuel] Katholieke Univ Leuven, Sch Publ Hlth, Ctr Biostat, B-3000 Louvain, Belgium; [Peters, Mark] Great Ormond St Hosp Sick Children, Clin Unit Chair Resp & Emergency Med, London WC1N 3JH, England; [Peters, Mark] Inst Child Hlth, Crit Care Grp, Protex Unit, London WC1N 1EH, England		Van de Voorde, P (corresponding author), UZ Gent, PICU 1K12 IC,De Pintelaan 185, B-9000 Ghent, Belgium.	Patrick.vandevoorde@ugent.be	Rizopoulos, Dimitris/D-6919-2012; Peters, Mark/AAD-7518-2019	Rizopoulos, Dimitris/0000-0001-9397-0900; Peters, Mark/0000-0003-3653-4808; Van de Voorde, Patrick/0000-0001-9053-0475			Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; *AM ASS AUT MED, 1990, ABBR INJ SCAL 1990 R; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Browne G J, 2001, Emerg Med (Fremantle), V13, P418, DOI 10.1046/j.1035-6851.2001.00255.x; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Guisan A, 2000, J VEG SCI, V11, P617, DOI 10.2307/3236568; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; *R DEV COR TEAM, 2006, LANG ENV STAT COMP V; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; *ROYAL COLL PAED C, 2001, GUID GOOD PRACT EARL; SIMPSON D, 1982, LANCET, V2, P450; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; [No title captured]	25	24	24	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2008	76	2					175	179		10.1016/j.resuscitation.2007.07.007			5	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	270RQ	WOS:000253738300005	17728046				2022-02-06	
J	Ahn, ES; Robertson, CL; Vereczk, V; Hoffman, GE; Fiskum, G				Ahn, Edward S.; Robertson, Courtney L.; Vereczk, Viktoria; Hoffman, Gloria E.; Fiskum, Gary			Normoxic ventilatory resuscitation following controlled cortical impact reduces peroxynitrite-mediated protein nitration in the hippocampus - Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						controlled cortical impact; free radical; hyperoxia; nitrotyrosine; reactive oxygen species; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FREE-RADICAL PRODUCTION; SEVERE HEAD-INJURY; RATS POSSIBLE ROLE; NORMOBARIC HYPEROXIA; TYROSINE NITRATION; INSPIRED OXYGEN; CEREBRAL METABOLISM; 100-PERCENT OXYGEN; LIPID-PEROXIDATION	Object. Ventilatory resuscitation with 100% O-2 after severe traumatic brain injury (TBI) raises concerns about the increased production of reactive oxygen species (ROS). The product of peroxynitrite-meditated tyrosine residue nitration, 3-nitrotyrosine (3-NT), is a marker for oxidative damage to proteins. The authors hypothesized that posttraumatic resuscitation with hyperoxia (100% fraction of inspired oxygen [FiO(2)] concentration) results in increased ROS-induced damage to proteins compared with resuscitation using normoxia (21% FiO(2) concentration). Methods. Male Sprague-Dawley rats underwent controlled cortical impact (CCI) injury and resuscitation with either normoxic or hyperoxic ventilation for I hour (5 rats per group). Twenty-four hours after injury, rat hippocampi were evaluated using 3-NT immunostaining. In a second experiment, animals similarly underwent CCI injury and normoxic or hyperoxic ventilation for 1 hour (4 rats per group). One week after injury, neuronal counts were performed after neuronal nuclei immunostaining. Results. The 3-NT staining was significantly increased in the hippocampi of the hyperoxic group. The normoxic group showed a 51.0% reduction of staining in the CA1 region compared with the hyperoxic group and a 50.8% reduction in the CA3 region (p < 0.05, both regions). There was no significant difference in staining between the injured normoxic group and sham-operated control groups. In the delayed analysis of neuronal survival (neuronal counts), there was no significant difference between the hyperoxic and normoxic groups. Conclusions. In this clinically relevant model of TBI, normoxic resuscitation significantly reduced oxidative damage to proteins compared with hyperoxic resuscitation. Neuronal counts showed no benefit from hyperoxic resuscitation. These findings indicate that hyperoxic ventilation in the early stages after severe TBI may exacerbate oxidative damage to proteins.	[Robertson, Courtney L.; Vereczk, Viktoria; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Anesthesiol Res Labs, Baltimore, MD 21201 USA; [Ahn, Edward S.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Robertson, Courtney L.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Hoffman, Gloria E.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Anesthesiol Res Labs, 685 W Baltimore St,MSTF 5-34, Baltimore, MD 21201 USA.	gfisk001@umaryland.edu	Hoffman, Gloria E/AAU-3760-2021		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS K08 42805] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS042805] Funding Source: NIH RePORTER		ADAMS HP, 1994, STROKE, V25, P1901, DOI 10.1161/01.STR.25.9.1901; ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HOFFMAN GE, 1992, NEUROPROTOCOLS, V1, P52; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; JACKSON RM, 1990, CLIN CHEST MED, V11, P73; JACOBSON I, 1964, SURG GYNECOL OBSTET, V119, P737; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Lorch Scott, 2002, Methods Mol Biol, V196, P247; Love S, 1999, BRAIN PATHOL, V9, P119; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; MICKEL HS, 1987, STROKE, V18, P426, DOI 10.1161/01.STR.18.2.426; Nakamura H, 2003, ACT NEUR S, V86, P309; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rossi S, 2001, J NEUROTRAUM, V18, P163, DOI 10.1089/08977150150502596; SINGER MM, 1970, NEW ENGL J MED, V283, P1473, DOI 10.1056/NEJM197012312832701; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sukoff MH, 2001, J NEUROSURG, V95, P544; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZWEMER CF, 1994, RESUSCITATION, V27, P159, DOI 10.1016/0300-9572(94)90009-4	50	24	25	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2008	108	1					124	131		10.3171/JNS/2008/108/01/0124			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	248AI	WOS:000252123300018	18173321				2022-02-06	
J	Baguley, IJ; Nott, MT; Slewa-Younan, S				Baguley, Ian J.; Nott, Melissa T.; Slewa-Younan, Shameran			Long-term mortality trends in functionally-dependent adults following severe traumatic-brain injury	BRAIN INJURY			English	Article						Mortality; life expectancy; brain injury; severe disability	SEVERE HEAD-INJURY; LOCKED-IN SYNDROME; LIFE EXPECTANCY; SURVIVAL; DEATH; POPULATION; CARE	Primary objective: To investigate mortality trends in functionally dependent adults following traumatic brain injury (TBI). Methods: Data for 966 consecutive admissions to a specialist TBI rehabilitation service were reviewed. Details for 69 subjects who were functionally dependent at rehabilitation discharge were cross-referenced against the State Government Death Register. The observed mortality rate was compared to an equivalent population sample derived from Australian Life Tables. Results: Twenty-five subjects (36%) were deceased at an average 10.5 years post-injury (SD 5 years; range 1.7-18.8 years). The observed numbers of deaths far exceeded the expected population figure (1.9) for the same period (1989-2007) yielding a standardized mortality rate of 13.2. Mortality trends suggested a bimodal distribution, with more deaths in the first 5 years post-injury followed by no further deaths until 9 years post-injury. Conclusions: Mortality in this functionally-dependent group was significantly associated with age, male sex and degree of disability at discharge. The bimodal distribution of mortality data suggests different contributory mechanisms to early vs. late mortality in this group.	[Baguley, Ian J.; Nott, Melissa T.; Slewa-Younan, Shameran] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia		Baguley, IJ (corresponding author), Brain Injury Rehabil Serv, Res Team Leader, POB 533, Wentworthville, NSW 2145, Australia.	ianb@biru.wsahs.nsw.gov.au	Nott, Melissa T/M-6778-2018; Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Nott, Melissa T/0000-0001-7088-5826; Baguley, Ian J/0000-0001-5650-3705; 			*AUSTR BUR STAT, 2005, 33020 AUSTR BUR STAT; Baguley I, 2000, BRAIN INJURY, V14, P505; BARNES MP, 2008, INT BRAIN INJURY ASS, P1; Brown AW, 2004, NEUROREHABILITATION, V19, P37; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; HAIG AJ, 1994, NEW ENGL J MED, V331, P1380; Haig AJ, 2008, ARCH PHYS MED REHAB, V89, P1005, DOI 10.1016/j.apmr.2008.03.005; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P403; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; Shavelle RM, 2008, ARCH PHYS MED REHAB, V89, P1005, DOI 10.1016/j.apmr.2008.03.004; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TATE R, 2003, BRAIN IMPAIR, V4, P82; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; WHYTE J, 1994, NEW ENGL J MED, V331, P1381	28	24	25	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	12					919	925	PII 905450535	10.1080/02699050802448578			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	371RV	WOS:000260849900002	19005883				2022-02-06	
J	Boutin, D; Lassonde, M; Robert, M; Vanassing, P; Ellemberg, D				Boutin, David; Lassonde, Maryse; Robert, Manon; Vanassing, Phetsamone; Ellemberg, Dave			Neurophysiological assessment prior to and following sports-related concussion during childhood: A case study	NEUROCASE			English	Article						concussion; childhood; soccer; neurophysiology; neuropsychology	TRAUMATIC BRAIN-INJURY; SPECTRAL-ANALYSIS; NEUROPSYCHOLOGICAL IMPAIRMENT; HIGH-SCHOOL; CHILDREN; RECOVERY; IMPACT; RETURN; PLAY	The goal of this study was to measure the neurophysiological and cognitive functions of a sport-concussed child and to longitudinally assess the recovery pattern. An 8-year-old girl suffered a concussion while playing soccer. Visual evoked potentials (VEPs) were recorded at 7 weeks pre-injury and 24 h, 7, 22, 32 and 55 weeks post-injury. A neuropsychological assessment performed at 24 h post-injury reveals cognitive impairments, mainly attentional, that resolved within 22 weeks. VEPs and spectral analyses confirm the presence of cortical impairments up to 1 year post-injury, especially affecting vigilance and attention, which were reflected in school performance.	[Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ H3C 3J7, Canada; [Boutin, David; Lassonde, Maryse; Robert, Manon] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Boutin, David; Lassonde, Maryse; Robert, Manon; Ellemberg, Dave] Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Lassonde, Maryse; Vanassing, Phetsamone; Ellemberg, Dave] Univ Hosp Ctr Mother Child Ste Justine, Res Ctr, Montreal, PQ, Canada		Ellemberg, D (corresponding author), Univ Montreal, Dept Kinesiol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	dave.ellemberg@umontreal.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR) Dave Ellemberg and Maryse Lassonde. Disclosure: The authors report no conflicts of interest.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bertrand O, 2000, INT J PSYCHOPHYSIOL, V38, P211, DOI 10.1016/S0167-8760(00)00166-5; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Debener S, 2003, NEUROREPORT, V14, P683, DOI 10.1097/00001756-200304150-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Fehr T, 2001, BIOL PSYCHIAT, V50, P108, DOI 10.1016/S0006-3223(01)01122-2; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FISCH BJ, 2000, FISCH SPEHLMANNS 3 R; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kelly JP, 1997, NEUROLOGY, V48, P581; KlOve H, 1963, MED CLIN N AM; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; PAPATHANASOPOULOS P, 1994, EUR NEUROL, V34, P268, DOI 10.1159/000117054; PARKS RW, 1988, J CLIN EXP NEUROPSYC, V10, P565, DOI 10.1080/01688638808402795; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; RIZZO PA, 1983, NEUROPSYCHOBIOLOGY, V9, P78, DOI 10.1159/000117941; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Smith A., 1982, SYMBOL DIGIT MODALIT; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WITOL A, 1994, ARCH CLIN NEUROPSYCH, V9, P204	53	24	24	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2008	14	3					239	248		10.1080/13554790802247543			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	337RT	WOS:000258453900003	18654931				2022-02-06	
J	Faria, JCM; Rodrigues, ML; Scopel, GP; Kowalski, LP; Ferreira, MC				Faria, Jose Carlos Marques; Rodrigues, Monica Lucia; Scopel, Gean Paulo; Kowalski, Luiz Paulo; Ferreira, Marcus Castro			The versatility of the free lateral arm flap in head and neck soft tissue reconstruction: clinical experience of 210 cases	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						lateral arm; free flap; head and neck; reconstruction	DONOR	A study of the authors' experience with 210 free lateral arm flaps used to repair head and neck oncological. defects over an 8-year period. Patients' ages ranged from 4 to 83 years (average: 49.7 years). One hundred and forty-one were mate and 66 female. Three patients received two consecutive flaps each. They were used to reconstruct: the tongue, 53 cases; retromolar trigone, 42 cases; soft/hard palate, 34 cases; skin/facial contour, 19 cases; hypopharynx, 17 cases; buccal. mucosa, 12 cases; lips, five cases. Flap cutaneous dimensions ranged from 4 x 2 cm to 17 x 8 cm. Flap was composed of: skin and fascia, 18 cases; sensate (neurovascular) skin, six cases; subcutaneous fat tissue, five cases; skin and vascularised nerve graft, three cases, skin and partial triceps muscle, three cases. Nerve coaptations were performed for all lip reconstructions. All flaps survived except for nine (success rate: 95.2%). Severe postoperative clinical complications preceded flap failure and death in two cases. All. but six donor sites were closed primarily. Complications related to the donor site were: paresthesia of the forearm, 210 cases; dog ear, 16 cases; hypertropic scar, 14 cases; weakness, nine cases; haematoma, five cases; seroma, three cases; dehiscence, one case. Radial nerve injury was not observed in this series. The lateral arm flap can be considered safe and versatile for most soft tissue head and neck microsurgical reconstructions. The possibility of sensory recovery through neural anastomoses and low donor site morbidity enhances its efficiency. (c) 2007 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Faria, Jose Carlos Marques; Rodrigues, Monica Lucia] Hosp Canc AC Camargo, Microsurg Surg Div, Sao Paulo, Brazil; [Kowalski, Luiz Paulo] Hosp Canc AC Camargo, Head & Neck Surg & Otorhinolaryngol Dept, Sao Paulo, Brazil; [Faria, Jose Carlos Marques; Scopel, Gean Paulo; Ferreira, Marcus Castro] Hosp & Clin, Div Plast Surg, Sao Paulo, Brazil		Faria, JCM (corresponding author), 377 Cjs 58-86,Rua Maestro Cardim, BR-01323 Sao Paulo, Brazil.	microcirurgia@terra.com.br	de Faria, Jose Carlos Marques/D-3577-2013; Kowalski, Luiz P/D-1701-2012	de Faria, Jose Carlos Marques/0000-0002-7072-5651; Kowalski, Luiz P/0000-0002-0481-156X			Aviv JE, 1997, ARCH OTOLARYNGOL, V123, P154; Blackwell KE, 1997, ARCH OTOLARYNGOL, V123, P1332; BOYD B, 1994, PLAST RECONSTR SURG, V93, P1350, DOI 10.1097/00006534-199406000-00003; Chen I-Chen, 2003, J Chin Med Assoc, V66, P544; Civantos FJ, 1997, ARCH OTOLARYNGOL, V123, P830; Eckardt A, 2003, J CRANIO MAXILL SURG, V31, P197, DOI 10.1016/S1010-5182(03)00039-8; Fogdestam I, 1996, SCAND J PLAST RECONS, V30, P49, DOI 10.3109/02844319609072404; Gellrich NC, 2000, INT J ORAL MAX SURG, V29, P104, DOI 10.1016/S0901-5027(00)80006-5; GRAHAM B, 1992, J HAND SURG-BRIT EUR, V17B, P189, DOI 10.1016/0266-7681(92)90086-H; HAGE JJ, 2005, ANN PLAST SURG, V54, P53; Haughey BH, 2001, OTOLARYNG HEAD NECK, V125, P10, DOI 10.1067/mhn.2001.116788; Hidalgo DA, 1998, PLAST RECONSTR SURG, V102, P722, DOI 10.1097/00006534-199809030-00016; Karamursel S, 2005, J RECONSTR MICROSURG, V21, P107, DOI 10.1055/s-2005-864843; KATSAROS J, 1984, ANN PLAS SURG, V12, P489, DOI 10.1097/00000637-198406000-00001; KUEK LBK, 1991, J RECONSTR MICROSURG, V7, P167, DOI 10.1055/s-2007-1006775; Nahabedian MY, 2001, ANN PLAS SURG, V46, P501, DOI 10.1097/00000637-200105000-00008; Reinert S, 2000, J CRANIO MAXILL SURG, V28, P69, DOI 10.1054/jcms.2000.0118; Rosenthal E, 2004, HEAD NECK-J SCI SPEC, V26, P930, DOI 10.1002/hed.20076; Ross DA, 1996, LARYNGOSCOPE, V106, P14, DOI 10.1097/00005537-199601000-00004; Sieg P, 2003, INT J ORAL MAX SURG, V32, P544, DOI 10.1054/ijom.2002.0397; SONG RY, 1982, CLIN PLAST SURG, V9, P27; Urken ML, 2003, LARYNGOSCOPE, V113, P1473, DOI 10.1097/00005537-200309000-00008; WENIG BL, 1993, OTOLARYNG HEAD NECK, V109, P116, DOI 10.1177/019459989310900121	23	24	25	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.		2008	61	2					172	179		10.1016/j.bjps.2007.10.035			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	265GJ	WOS:000253346800009	18042444				2022-02-06	
J	Grinkeviciute, DE; Kevalas, R; Matukevicius, A; Ragaisis, V; Tamasauskas, A				Grinkeviciute, Dovile Evalda; Kevalas, Rimantas; Matukevicius, Algimantas; Ragaisis, Vytautas; Tamasauskas, Arimantas			Significance of intracranial pressure and cerebral perfusion pressure in severe pediatric traumatic brain injury	MEDICINA-LITHUANIA			English	Article						cerebral perfusion pressure; intracranial pressure; decompressive craniotomy; severe head injury	EARLY DECOMPRESSIVE CRANIECTOMY; CRITICAL-CARE MANAGEMENT; CHILDREN; SURVIVAL; OUTCOMES; SYSTEM; AGE	The aim of the study was to evaluate outcome of children after severe traumatic brain injury treated according to intracranial pressure (ICP)-targeted protocol, to define threshold values of peak ICP and minimal cerebral perfusion pressure (CPP)for decompressive osteoplastic craniotomy, and to determine the relationship between ICR, CPP and long-term outcome in these children. All children admitted to Pediatric Intensive Care Unit of Kaunas University of Medicine Hospital after severe head injury from January 2004 to June 2006 and treated according to ICP-targeted protocol for the management of severe head trauma were prospectively included in the study. Raised ICP was defined as a level higher than 20 mmHg. Minimal CPP was considered to be at a level of 40 mmHg. Outcome was defined using Glasgow Outcome Scale (GOS) at discharge from the hospital and after 6 months. Forty-eight patients (32 boys and 16 girls) were included into the study. Favorable outcome (GOS score of 4 and 5) after 6 months was achieved in 43 (89.6%) cases. Mean peak ICP was 24.2 +/- 7.2 mmHg and mean minimal CPP - 53.1 +/- 14.7 mmHg. Decompressive craniotomy was performed in 13 cases. Threshold values of peak ICP and minimal CPP for decompressive craniotomy were 22.5 mmHg (area under the curve, 0.880) and 46.5 mmHg (area under the curve, 0.898), respectively. The differences in peak ICP and minimal CPP in groups of favorable and unfavorable outcomes were not statistically significant. Treating children after severe traumatic brain injury according to the ICP-targeted protocol for the management of severe pediatric traumatic brain injury resulted in a favorable long-term outcome.	[Grinkeviciute, Dovile Evalda; Kevalas, Rimantas] Kaunas Univ Med, Dept Children Dis, LT-50009 Kaunas, Lithuania; [Matukevicius, Algimantas; Tamasauskas, Arimantas] Kaunas Univ Med, Inst Biomed Res, Kaunas, Lithuania; [Ragaisis, Vytautas] Kaunas Univ Med, Dept Neurosurg, Kaunas, Lithuania		Grinkeviciute, DE (corresponding author), Kaunas Univ Med, Dept Children Dis, Eiveniu 2, LT-50009 Kaunas, Lithuania.	dovilgrin@hotmail.com					Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; CHAMBERS IR, 2003, NEUROSURG FOCUS, V15, P1; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Figaji AA, 2007, CHILD NERV SYST, V23, P1331, DOI 10.1007/s00381-007-0388-4; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grinkeviciute Dovile, 2006, Medicina (Kaunas), V42, P278; Grinkeviciute DE, 2007, MEDICINA-LITHUANIA, V43, P861, DOI 10.3390/medicina43110111; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Jennett B., 2005, NEPAL J NEUROSCI, V2, P24; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Mukherjee KK, 2006, SURG NEUROL, V66, P305, DOI 10.1016/j.surneu.2005.12.035; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Polin RS, 2003, CRIT CARE, V7, P409, DOI 10.1186/cc2370; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; ROWLANDS HE, 2007, PAEDIAT CHILD HLTH, V17, P82; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Simma B, 2002, INTENS CARE MED, V28, P1000, DOI 10.1007/s00134-002-1333-3; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; STARKUVIENE S, 2003, CAUSES CONSEQUENCES; TAPE TG, 2007, INTERPRETING DIAGNOS; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011	33	24	27	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.		2008	44	2					119	125		10.3390/medicina44020015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280IO	WOS:000254419900004	18344664	hybrid, Green Submitted			2022-02-06	
J	Salvatore, C; Marco, M; Antonio, R; Salvatore, I; Eugenio, B				Salvatore, Chibbaro; Marco, Marsella; Antonio, Romano; Salvatore, Ippolito; Eugenio, Benericem			Combined internal uncusectomy and decompressive craniectomy for the treatment of severe closed head injury: experience with 80 cases	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; raised intracranial pressure; tentorial incision; severe head trauma; transtentorial herniation; uncoparahippocampectomy	ACUTE SUBDURAL HEMATOMA; TRANSTENTORIAL HERNIATION; INTRACRANIAL-PRESSURE; TEMPORAL LOBECTOMY; CEREBRAL EDEMA; MANAGEMENT; CRANIOTOMY; RECOVERY; COMA	Object. Transtentorial brain herniation is a major cause of morbidity and death following severe closed head injury. The purpose of this study was to evaluate the efficacy of selective uncoparahippocampectomy and tentorial splitting as an adjuvant method of treating otherwise uncontrollable elevated intracranial pressure (ICP) while attempting to prevent or minimize the devastating consequences caused by transtentorial herniation. Methods. The authors retrospectively reviewed data from a series of 80 consecutive cases of severe closed head injury (Glasgow Coma Scale [GCS] score < 8) treated in their neurosurgical unit. All patients had elevated ICP and downward tentorial herniation, as documented with ICP monitoring, and clinical examination and computed tomography, respectively. Given the evidence of acute and ongoing neurological deterioration, all patients were treated with selective uncoparahippocampectomy and tentorial edge incision followed by wide decompressive craniectomy and duraplasty. Results. All injuries were caused by blunt trauma with signs of acute and/or progressive increased ICP causing downward transtentorial herniation. Fifty-eight patients were male and 22 were female with a mean age of 35 years and a mean preoperative GCS score of 5. Based on the current American Association of Neurological Surgeons guidelines for head trauma, an intraparenchymal ICP device (Camino, Integra) was placed in all patients who had a GCS score < 8, and ICP was consistently > 20 cm H2O. Whenever possible, risks and benefits were explained to family members, and then surgery was per-formed within 3-16 hours (median 6 hours). At a mean follow-up of 30 months, the outcome was favorable (Glasgow Outcome Scale [GOS] score of 4 or 5) in 60 patients (75%) and unfavorable (GOS score of 3) in 8 (10%), whereas the remaining 12 patients (15%) died at some point during the postoperative course. There was no survivor patient in a vegetative state. A younger age had a significant effect on positive outcome (p < 0.0005), as did an earlier operation (p < 0.04). The preoperative neurological status as assessed using the GCS as well as pupillary reactivity had no significant effect on outcome (p = 0.054 and p > 0.05, respectively). Conclusions. A selective uncoparahippocampectomy with a tentorial edge incision and a wide decompressive craniectomy with duraplasty can be an effective adjuvant form of aggressive treatment to improve outcome in patients with severe closed head injury, especially in those who are younger if they are treated promptly.	[Salvatore, Chibbaro; Antonio, Romano; Salvatore, Ippolito; Eugenio, Benericem] Univ Hosp, Dept Neurosurg, Parma, Italy; [Marco, Marsella] Univ Hosp, Dept Neurosurg, Tucson, AZ USA		Salvatore, C (corresponding author), Via Enrico Toti 19, I-34100 Trieste, Italy.	schibbaro@hotmail.com	Chibbaro, Salvatore/AAI-6368-2020				ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BLINKOV SM, 1992, J NEUROSURG, V76, P973, DOI 10.3171/jns.1992.76.6.0973; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CUSHING HW, 1908, J HOPKINS HOSP B, V19, P48; FREEDMAN H, 1952, J NEUROSURG, V9, P52, DOI 10.3171/jns.1952.9.1.0052; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1992, GREENFIELDS NEUROPAT, P69; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MUNRO D, 1952, NEW ENGL J MED, V247, P699, DOI 10.1056/NEJM195211062471901; NUSSBAUM ES, 1991, NEUROSURGERY, V29, P62, DOI 10.1227/00006123-199107000-00010; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; REICH JB, 1993, ANN NEUROL, V33, P159, DOI 10.1002/ana.410330205; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SCOVILLE WB, 1979, ACTA NEUROCHIR, V47, P149, DOI 10.1007/BF01406400; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WALKER AE, 1960, J NEUROSURG, V26, P184	33	24	33	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2008	108	1					74	79		10.3171/JNS/2008/108/01/0074			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	248AI	WOS:000252123300010	18173313				2022-02-06	
J	Henninger, N; Sicard, KM; Li, ZX; Kulkarni, P; Dutzmann, S; Urbanek, C; Schwab, S; Fisher, M				Henninger, Nils; Sicard, Kenneth M.; Li, Zhixin; Kulkarni, Praveen; Duetzmann, Stephan; Urbanek, Christian; Schwab, Stefan; Fisher, Marc			Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat	CRITICAL CARE MEDICINE			English	Article						apparent diffusion coefficient; cerebral concussion; diffusion weighted imaging; functional magnetic resonance imaging; perfusion weighted imaging; pixel-by-pixel analysis	CEREBRAL-BLOOD-FLOW; APPARENT DIFFUSION-COEFFICIENT; CONTROLLED CORTICAL IMPACT; WATER DIFFUSION; WALLERIAN DEGENERATION; IN-VIVO; PERFUSION; MRI; METABOLISM; TISSUE	Objective: The relationship between cerebral integrity, recovery of brain function, and neurologic status after mild traumatic brain injury is incompletely characterized. Design. Prospective and randomized study in rodents. Setting: University laboratory. Subjects: Male Wistar rats (290-310 g). Interventions: In rats, quantitative diffusion weighted imaging (DWI), perfusion weighted imaging (PWI), T2-weighted imaging (T2WI), and functional magnetic resonance imaging (fMRI) were performed up to 21 days after weight-induced, closed-head, mild traumatic brain injury (MTBI, n = 6) or sham operation (n = 6). Pixel-by-pixel analysis and region of interest analysis were used to evaluate structural (apparent diffusion coefficient [ADC] and basal cerebral blood flow [bCBF]) and functional magnetic resonance signal changes within the brain, respectively. Quantitative fMRI signal changes were correlated with behavioral measures. Measurements and Main Results. Despite normal appearing DWI and T2WI findings following MTBI, persistent hypoperfusion developed that was not associated with cytotoxic edema. In contrast, the ADC was significantly increased by -5% at 1 and 7 days post-MTBI. Post-MTBI fMRI responses to hypercapnia and forepaw stimulation were significantly impaired and showed a differential recovery rate between and within investigated region of interests. Significant dysfunction in forepaw placement test persisted up to day I and correlated significantly with fMRI signal changes in the primary somatosensory and motor cortices. Conclusions. MTBI produced distinct changes on multimodal MRI and behavioral variables acutely and chronically. Following MTBI, fMRI and ADC-bCBF pixel-by-pixel analysis identified subtle structural and functional alterations in the brain that appeared completely normal on conventional DWI and T2WI after concussion injury. The former techniques may therefore provide great potential for understanding mild traumatic brain injury, identifying mechanisms underlying recovery, and investigating specific interventions to enhance functional outcome.	Univ Massachusetts, Sch Med, Dept Internal Med, Worcester, MA 01605 USA; Med Coll Wisconsin, Dept Biol, Milwaukee, WI 53226 USA; Ctr Comparat Neurolmaging, Dept Psychiat, Worcester, MA USA; Goethe Univ Frankfurt, Dept Neurosurg, D-6000 Frankfurt, Germany; Klinikum Stadt Ludwigshafen, Dept Neurol, Ludwigshafen, Germany; Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany		Henninger, N (corresponding author), Univ Massachusetts, Sch Med, Dept Internal Med, Worcester, MA 01605 USA.	henningn@ummhc.org		Kulkarni, Praveen/0000-0002-8876-4544; Henninger, Nils/0000-0002-3883-5623			Adams A, 2001, BCS CONF SERIES, P49; Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bennett SAL, 1998, NEUROREPORT, V9, P161; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Chen SF, 2004, J CEREBR BLOOD F MET, V24, P1025, DOI 10.1097/01.WCB.0000129415.34520.47; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; DERYCK M, 1992, BRAIN RES, V573, P44; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Duhaime AC, 2006, J NEUROSURG, V104, P259, DOI 10.3171/ped.2006.104.4.259; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Hakumaki JM, 1998, CANCER RES, V58, P3791; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; HENNINGER N, 2007, J CEREB BLOOD FLOW M; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Londono A, 2003, AM J NEURORADIOL, V24, P1582; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Sicard KM, 2006, J CEREBR BLOOD F MET, V26, P1451, DOI 10.1038/sj.jcbfm.9600299; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Valonen PK, 2004, J MAGN RESON IMAGING, V19, P389, DOI 10.1002/jmri.20026; Virley D, 2000, J CEREBR BLOOD F MET, V20, P563, DOI 10.1097/00004647-200003000-00015; ZHANG JQ, 2003, 11 SCI M INT SOC MAG	39	24	26	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2007	35	11					2607	2614		10.1097/01.CCM.0000286395.79654.8D			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224CN	WOS:000250423500019	17828037				2022-02-06	
J	Sosnoff, JJ; Broglio, SP; Hillman, CH; Ferrara, MS				Sosnoff, Jacob J.; Broglio, Steven P.; Hillman, Charles H.; Ferrara, Michael S.			Concussion does not impact intraindividual response time variability	NEUROPSYCHOLOGY			English	Article						response time; response variability; mild traumatic brain injury; concussion resolution index	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; RECOVERY; PERFORMANCE; COGNITION; SYMPTOMS; TRACKING; DEFICITS	This investigation examined the effect of concussion on intraindividual variability in 5 processing speed tasks. Forty-four adults, including 22 concussed and 22 healthy age- and gender-matched participants, completed the Headminder Concussion Resolution Index (D. M. Erlanger. D. J. Feldman, K. C. Kutner, & M. McCrea, 2001) twice. The test consists of a series of tasks including 25 trials of simple response time task, 70 trials of cued response time task (CURT), 60 trials each for 2 visual recognition tasks, and 30 trials of symbol scanning task. Concussed participants completed a preinjury baseline assessment and were retested within 48 hours of injury diagnosis. The nonconcussed participants were retested 45 days after initial assessment. Average response time (RT). standard deviation, and response accuracy were calculated for each individual. Overall, concussed individuals had increased RTs across all tasks and were less accurate in the CURT. RT variability for all tasks was elevated in concussed individuals, but controlling for mean RT at follow-up eliminated group differences. These findings indicate that response-time-variability increases in concussed individuals are proportional to processing-time increases. As Such. RT variability is not a unique identifier of cognitive dysfunction following concussion. These results highlight that transient brain injury has significantly different neurobiological consequences than chronic conditions have.	Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, 906 s Goodwin Ave,207 Freer Hall, Urbana, IL 61801 USA.	jsosnoff@uiuc.edu	Hillman, Charles/AAD-4828-2019; Sosnoff, Jacob/P-3397-2019; Hillman, Charles/A-4479-2009	Sosnoff, Jacob/0000-0002-0286-9207; Hillman, Charles/0000-0002-3722-5612			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Crawford JR, 2006, COGN NEUROPSYCHOL, V23, P877, DOI 10.1080/02643290500538372; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; ERLANGER DM, 2001, CONCUSSION RESOLUTIO; Finkelstein E., 2006, INCIDENCE EC BURDEN; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Hultsch D. F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; NORMAN DA, 1986, CONSCIOUSNESS SELFRE; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	38	24	24	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2007	21	6					796	802		10.1037/0894-4105.21.6.796			7	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226EK	WOS:000250570100017	17983293				2022-02-06	
J	Mitchell, P; Gregson, BA; Vindlacheruvu, RR; Mendelow, AD				Mitchell, Patrick; Gregson, Barbara A.; Vindlacheruvu, Raghu R.; Mendelow, A. David			Surgical options in ICH including decompressive craniectomy	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						intracerebral haemorrhage; decompressive craniectomy; ictoliaemorrhagic lesions; surgery	CEREBRAL ARTERIOVENOUS-MALFORMATIONS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; PROSPECTIVE RANDOMIZED TRIAL; GAMMA-KNIFE RADIOSURGERY; HIPPEL-LINDAU-DISEASE; NATURAL-HISTORY; CAVERNOUS MALFORMATIONS	Intracerebral haemorrhage (ICH) accounts for 15 to 20% of strokes. The condition carries a higher morbidity and mortality than occlusive stroke. Despite considerable research effort, no therapeutic modality either medical or surgical has emerged with clear evidence of benefit other than in rare aneurysmal cases. Intracerebral haemorrhages can be divided into those that arise from pre-existing macroscopic vascular lesions-so called "ictohaemorrhagic lesions", and those that do not; the latter being the commoner. Most of the research that has been done on the benefits of surgery has been in this latter group. Trial data available to date precludes a major benefit from surgical evacuation in a large proportion of cases however there are hypotheses of benefit still under investigation, specifically superficial lobar ICH treated by open surgical evacuation, deeper ICH treated with minimally invasive surgical techniques, and decompressive craniectomy. When an ICH arises from an ictohaemorrhagic lesion, therapy has two goals: to treat the effects of the acute haemorrhage and to prevent a recurrence. Three modalities are available for treating lesions to prevent recurrence: stereotactic radiosurgery, endovascular embolisation, and open surgical resection. As with ICH without an underlying lesion there is no evidence to support surgical removal of the haemorrhage in most cases. An important exception is ICHs arising from intracranial aneurysms where there is good evidence to support evacuation of the haematoma as well as repair of the aneurysm. (C) 2007 Elsevier B.V All rights reserved.	Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England		Mitchell, P (corresponding author), Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	patrick.mitchell@ncl.ac.uk	Mendelow, Alexander/AAW-2878-2021	Gregson, Barbara/0000-0003-4868-9137	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0501444] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0501444] Funding Source: Medline		Andaluz N, 2002, NEUROSURG CLIN N AM, V13, P385, DOI 10.1016/S1042-3680(02)00006-2; AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; BATJER HH, 1990, ARCH NEUROL-CHICAGO, V47, P1103, DOI 10.1001/archneur.1990.00530100071015; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brown RD, 1996, J NEUROSURG, V85, P29, DOI 10.3171/jns.1996.85.1.0029; BROWN RD, 1988, J NEUROSURG, V68, P352, DOI 10.3171/jns.1988.68.3.0352; Bullock R, 1984, Neurol Res, V6, P184; Chen X., 1992, ACTA ACAD MED SHANGH, V19, P237; Chen X-C, 2001, CHIN J CLIN NEUROSCI, V4, P365; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; CRAWFORD PM, 1986, J NEUROL NEUROSUR PS, V49, P1, DOI 10.1136/jnnp.49.1.1; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Detwiler PW, 1998, J NEUROSURG, V89, P167; Ellis TL, 1998, J NEUROSURG, V89, P104, DOI 10.3171/jns.1998.89.1.0104; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; FOURNIER D, 1991, J NEUROSURG, V75, P228, DOI 10.3171/jns.1991.75.2.0228; FRIEDMAN WA, 1995, J NEUROSURG, V82, P180, DOI 10.3171/jns.1995.82.2.0180; Glasker S, 2005, NEUROSURGERY, V57, P71, DOI 10.1227/01.NEU.0000163250.71951.18; GRAF CJ, 1983, J NEUROSURG, V58, P331, DOI 10.3171/jns.1983.58.3.0331; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; HAMILTON MG, 1994, NEUROSURGERY, V34, P2; Hattori N, 2004, J NEUROSURG, V101, P417, DOI 10.3171/jns.2004.101.3.0417; HEISKANEN O, 1988, ACTA NEUROCHIR, V90, P81, DOI 10.1007/BF01560559; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Henkes H, 1998, NEUROL RES, V20, P479; HEROS RC, 1990, NEUROSURGERY, V26, P570, DOI 10.1227/00006123-199004000-00003; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hofmeijer J, 2003, Ned Tijdschr Geneeskd, V147, P2594; Hosseini H, 2003, CEREBROVASC DIS, V16S$, P57; HOUNSFIELD GN, 1980, MED PHYS, V7, P283, DOI 10.1118/1.594709; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; KADER A, 1994, NEUROSURGERY, V34, P801, DOI 10.1227/00006123-199405000-00003; Karlsson B, 2001, INT J RADIAT ONCOL, V49, P1045, DOI 10.1016/S0360-3016(00)01432-2; Kato M, 2005, J NEURO-ONCOL, V72, P267, DOI 10.1007/s11060-004-2244-7; Kato Y, 1997, NEUROL RES, V19, P117; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; KONDZIOLKA D, 1995, J NEUROSURG, V83, P825, DOI 10.3171/jns.1995.83.5.0825; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kunze E, 1998, ACT NEUR S, V71, P16; Kwon Y, 2000, J NEUROSURG, V93, P104, DOI 10.3171/jns.2000.93.supplement_3.0104; Liu HB, 2003, J INCL PHENOM MACRO, V45, P9, DOI 10.1023/A:1023092402944; LUNSFORD LD, 1991, J NEUROSURG, V75, P512, DOI 10.3171/jns.1991.75.4.0512; Makino H, 1979, Acta Neurochir Suppl (Wien), V28, P193; MARAIRE JN, 1995, NEUROSURGERY, V37, P591, DOI 10.1227/00006123-199510000-00001; Mast H, 1997, LANCET, V350, P1065, DOI 10.1016/S0140-6736(97)05390-7; MATHEW P, 1995, J NEUROL NEUROSUR PS, V59, P287, DOI 10.1136/jnnp.59.3.287; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; MCKISSOCK W, 1961, LANCET, V2, P221; Mendelow A D, 1984, Neurol Res, V6, P189; Mendelow AD, 2005, LANCET, V365, P387; Mitchell P, 2000, BRIT J NEUROSURG, V14, P96; Miyamoto S, 2000, NEUROSURGERY, V46, P589, DOI 10.1097/00006123-200003000-00013; Miyawaki L, 1999, INT J RADIAT ONCOL, V44, P1089, DOI 10.1016/S0360-3016(99)00102-9; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Morgenstern LB, 1998, NEUROLOGY, V51, P1359, DOI 10.1212/WNL.51.5.1359; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Naff NJ, 2004, NEUROSURGERY, V54, P577, DOI 10.1227/01.NEU.0000108422.10842.60; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; NEHLS DG, 1990, NEUROSURGERY, V27, P674, DOI 10.1227/00006123-199011000-00002; Niemann DB, 2003, J NEUROSURG, V99, P843, DOI 10.3171/jns.2003.99.5.0843; *NOV NORD, 2007, STOCK MARK ANN; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; PORTER LP, 1999, SPUD TOPICS, V44, P2; Porter PJ, 1997, J NEUROSURG, V87, P190, DOI 10.3171/jns.1997.87.2.0190; Porter RW, 1999, J NEUROSURG, V90, P50, DOI 10.3171/jns.1999.90.1.0050; Schaller C, 1998, J NEUROL NEUROSUR PS, V65, P547, DOI 10.1136/jnnp.65.4.547; SISTI MB, 1993, J NEUROSURG, V79, P653, DOI 10.3171/jns.1993.79.5.0653; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Steiger HJ, 2005, ACT NEUR S, V94, P115; STEINER L, 1992, J NEUROSURG, V77, P1, DOI 10.3171/jns.1992.77.1.0001; TAPANINAHO A, 1988, ACTA NEUROCHIR, V91, P21, DOI 10.1007/BF01400522; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Taylor CL, 2004, J NEUROSURG, V100, P810, DOI 10.3171/jns.2004.100.5.0810; Teernstra OPM, 2003, STROKE, V34, P968, DOI 10.1161/01.STR.0000063367.52044.40; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Wanebo JE, 2003, J NEUROSURG, V98, P82, DOI 10.3171/jns.2003.98.1.0082; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; YANG GY, 1994, ACTA NEUROCHIR, P555; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Yu SCH, 2004, AM J NEURORADIOL, V25, P1139; Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833	88	24	29	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2007	261	1-2					89	98		10.1016/j.jns.2007.04.040			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216JO	WOS:000249874500012	17543995				2022-02-06	
J	Weninger, P; Hertz, H				Weninger, Patrick; Hertz, Harald			Factors influencing the injury pattern and injury severity after high speed motor vehicle accident - A retrospective study	RESUSCITATION			English	Article						motor vehicle accident; injury pattern; multiple injury; prehospitat triage	MULTIPLE TRAUMA; CAR OCCUPANTS; CRASHES; POLYTRAUMA; FRACTURES; MORTALITY; IMPACT; LEVEL	Introduction: Motor vehicular accidents (MVA) are the leading cause of death among people under 40 years of age. Despite improvement in car safety and driver awareness of the use of safety devices, fatalities and severe injuries continue to occur. Material and methods: From 1997 to 2004, 13,678 patients after MVA were admitted to our institution. Out of this cohort, 584 (4.3%) patients suffered blunt major trauma defined as Injury Severity Score (ISS) >= 16 and at least one life-threatening injury in one body region. Preclinical data were recorded in 458 patients matching the inclusion criteria. The circumstances of the trauma scene such as weather conditions were analysed as well as technical crash data such as direction of impact, security devices used and type and severity of automobile damage. In a retrospective trial, the influence of preclinical variables on the injury pattern and on injury severity was investigated. Results: 314 (68.6%) patients were mate and 144 (31.4%) female. Injury severity (p = 0.015) and rate of multiple injuries (p = 0.012) were higher in patients after side-impact crashes. If automobiles with SIPS were used, injury severity was significantly reduced in case of side-impact crashes (p = 0.003). Patients after frontal impact crashes had a higher rate of severe traumatic brain injury (TBI) compared to the overall cohort (p = 0.014). Patients suffering blunt aortic (n = 29) dissection were involved in frontal crashes with seat belt use (p < 0.001). If patients were entrapped, injury severity (p = 0.021) and rate of multiple injuries (p = 0.018) were significantly higher. Rear-end collisions with trucks without rear protection led to higher mortality rates (p = 0.011). Conclusion: According to our data significant association between technical crash data and injury pattern and injury severity can be assumed. In case of high speed MVA in rural areas the trauma mechanism and the circumstances (i.e., impact direction, automobile deformation) should be considered to identify patients at high risk of severe blunt trauma and multiple injuries. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	Trauma Hosp Lorenz Boehler, A-1200 Vienna, Austria		Weninger, P (corresponding author), Trauma Hosp Lorenz Boehler, Donaueschingenstrasse 13, A-1200 Vienna, Austria.	patrick.weninger@gmx.net; harald.hertz@auva.at					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; BURGESS AR, 1995, J TRAUMA, V38, P509, DOI 10.1097/00005373-199504000-00008; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; Fitzharris M, 2004, J TRAUMA, V57, P582, DOI 10.1097/01.TA.0000088015.83951.D0; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; *KUR VERK I UNF, 2005, VERK OST, P10; Loo GT, 1996, J TRAUMA, V41, P935, DOI 10.1097/00005373-199612000-00001; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; Nirula R, 2005, J TRAUMA, V59, P132, DOI 10.1097/01.TA.0000171465.80722.0C; Palanca Sylvia, 2003, Emerg Med (Fremantle), V15, P423, DOI 10.1046/j.1442-2026.2003.00496.x; Redeker N S, 1995, Am J Crit Care, V4, P370; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71; Richter M, 2001, J TRAUMA, V51, P10, DOI 10.1097/00005373-200107000-00002; Richter M, 2001, J ORTHOP TRAUMA, V15, P287, DOI 10.1097/00005131-200105000-00009; Rowe SA, 2004, SURGERY, V136, P842, DOI 10.1016/j.surg.2004.07.003; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; Singleton Michael, 2004, Traffic Inj Prev, V5, P144, DOI 10.1080/713903941; TRUNKEY D, 1989, CARE SURG PATIENT, V1; Weninger P, 2005, UNFALLCHIRURG, V108, P559, DOI 10.1007/s00113-005-0949-5; World Health Organisation, 2004, WORLD REPORT ROAD TR, P3; ZADOR PL, 1993, AM J PUBLIC HEALTH, V83, P661, DOI 10.2105/AJPH.83.5.661	23	24	24	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	OCT	2007	75	1					35	41		10.1016/j.resuscitation.2007.03.011			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	221ZG	WOS:000250265300006	17481799				2022-02-06	
J	Vivancos-Matellano, F; Pascual-Pascual, SI; Nardi-Vilardaga, J; Miquel-Rodriguez, F; de Miguel-Leon, I; Martinez-Garre, MC; Martinez-Caballero, I; Lanzas-Melendo, G; Garreta-Figuera, R; Garcia-Ruiz, PJ; Garcia-Bach, M; Garcia-Aymerich, V; Bori-Fortuny, I; Aguilar-Barbera, M				Vivancos-Matellano, F.; Pascual-Pascual, S. I.; Nardi-Vilardaga, J.; Miquel-Rodriguez, F.; de Miguel-Leon, I.; Martinez-Garre, M. C.; Martinez-Caballero, I.; Lanzas-Melendo, G.; Garreta-Figuera, R.; Garcia-Ruiz, P. J.; Garcia-Bach, M.; Garcia-Aymerich, V.; Bori-Fortuny, I.; Aguilar-Barbera, M.		Grp Espanol Espasticidad	Guide to the comprehensive treatment of spasticity	REVISTA DE NEUROLOGIA			French	Article						comprehensive treatment; multidisciplinary team; pathophysiology; spasticity; treatment guide; upper motoneuron syndrome	INTRATHECAL BACLOFEN INFUSION; CEREBRAL-PALSY; FUNCTIONAL CLASSIFICATION; INTERNATIONAL STANDARDS; PROGRAMMABLE PUMP; BOTULINUM TOXIN; SPINAL ORIGIN; THERAPY; CHILDREN; PATHOPHYSIOLOGY	Aims and development. Spasticity is an important medical problem with a high rate of incidence both in childhood, mainly as a result of cerebral palsy, and in adults, which is frequently brought about by traumatic brain injuries, strokes and spinal cord injuries. Spasticity is part of upper motoneuron syndrome, which gives rise to important problems, such as limited joint movement, abnormal postures that can produce pain, impaired functional capacity, aesthetic or hygiene disorders, among others. It progresses naturally towards chronicity, accompanied by static phenomena due to alterations affecting the properties of soft tissues (elasticity, plasticity and viscosity). Numerous therapeutic options are available for the treatment of spasticity, including medication, physiotherapy, orthopaedic aid, surgery, and so forth. Moreover treatment should be individualised and realistic, with goals that have been agreed between the patient or caregiver and the medical team. The aim of the following guide is to further our knowledge of this condition, its causes, epidemiology and progression, as well as to outline an approach that is both rational and global from the point of view of pharmacological, rehabilitation and surgical treatment. Conclusions. Spasticity is a complex problem that requires specialists (neurologist, rehabilitation doctor occupational therapist, orthopaedic surgeon, general practitioner etc.) to work as a team in order to achieve the goals set out when treatment is begun. Early treatment is important to avoid or reduce, as far as possible, the severe complications stemming from this condition.	Hosp La Paz, Serv Neurol, E-28046 Madrid, Spain; Hosp La Paz, Serv Neurol Pediat, E-28046 Madrid, Spain; Hosp Gen Valle Hebron, Serv Cirugia Ortoped & Traumatol, Barcelona, Spain; Hosp Gen Valle Hebron, Neurol Serv, Barcelona, Spain; Hosp Gen Valle Hebron, Rehabil Serv, Barcelona, Spain; Hosp La Fe, Serv Rehabil, Valencia, Spain; Hosp Nino Jesus, Serv Traumatol, Madrid, Spain; Hosp Cent Def, Rehabil Serv, Madrid, Spain; Hosp Mutua Terrassa, Serv Rehabil, Barcelona, Spain; Hosp Mutua Terrassa, Serv Neurocirugia, Barcelona, Spain; Hosp Mutua Terrassa, Serv Neurol, Barcelona, Spain; Fdn Jimenez Diaz, Serv Neurol, E-28040 Madrid, Spain		Vivancos-Matellano, F (corresponding author), Hosp La Paz, Serv Neurol, Paseo de la Castellana 261, E-28046 Madrid, Spain.	franvivancos@wanadoo.es	Garcia Ruiz, Pedro J/G-8660-2013	Garcia Ruiz, Pedro J/0000-0001-6194-672X; Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121			Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Aguilar-Barbera M, 2004, REV NEUROLOGIA, V38, P971, DOI 10.33588/rn.3810.2003648; AICARDI J, 1998, DIS NERVOUS SYSTEM C, P210; Alberman E., 2000, CLIN DEV MED, P151; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; ASCH PV, 2002, 2 C SOC ESP NEUR; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Bache CE, 2003, CURR ORTHOPAED, V17, P88, DOI 10.1054/cuor.2003.0328; BAROLATROMANA G, 1985, J NEUROSURG, V62, P558, DOI 10.3171/jns.1985.62.4.0558; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BAX M C, 1964, Dev Med Child Neurol, V6, P295; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; BECKER WJ, 1995, CAN J NEUROL SCI, V22, P208, DOI 10.1017/S031716710003986X; Ben Smail D, 2006, MULT SCLER, V12, P101, DOI 10.1191/1352458506ms1232sr; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Brin MF, 2002, SPASTICITY ETIOLOGY, P110; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Dario A, 2004, J Neurosurg Sci, V48, P177; Dawson D M, 2001, Curr Neurol Neurosci Rep, V1, P501, DOI 10.1007/s11910-001-0051-5; De Souza L H, 1980, Int Rehabil Med, V2, P3; DELEAIDE PJ, 1990, SPASTICITE RENCONTRE, P37; DENYS P, 2002, 2 C SOC ESP NEUR; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; Emery DFG, 2003, CURR ORTHOPAED, V17, P81, DOI 10.1054/cuor.2003.0335; FAHN S, 1986, CLIN NEUROPHARMACOL, V9, pS37, DOI 10.1097/00002826-198600092-00005; Foerster O., 1913, SURG GYNECOL OBSTET, V16, P463; GARCIARENESES J, 1995, MEDULA ESPINAL, V1, P111; Gazzani F, 1999, SPINAL CORD, V37, P336, DOI 10.1038/sj.sc.3100821; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; GINER M, 2001, GUFA AUTOCUIDADOS LE; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Graham HK, 2005, J PEDIATR ORTHOPED, V25, P127, DOI 10.1097/00004694-200501000-00026; Guerra Romero L, 1996, Med Clin (Barc), V107, P377; Guillaume D, 2005, ARCH PHYS MED REHAB, V86, P2165, DOI 10.1016/j.apmr.2005.05.018; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Herring J, 2002, TACHDJIANS PEDIAT OR, P1122; JOHNSON A, DEV MED NEUROL, V44, P633; Johnson DC, 1997, J PEDIATR ORTHOPED, V17, P392, DOI 10.1097/00004694-199705000-00022; Knapp DR, 2002, J PEDIATR ORTHOPED, V22, P668, DOI 10.1097/00004694-200209000-00018; KRAGELOHMANN I, 1994, DEV MED CHILD NEUROL, V36, P473; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Lance JW, 1984, ELECTROMYOGRAPHY CNS, P1; LOUBSER PG, 1991, PARAPLEGIA, V29, P48, DOI 10.1038/sc.1991.7; Mayer H, 2002, SPASTICITY ETIOLOGY, P16; Mayer N.H., 2002, SPASTICITY ETIOLOGY, P1; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; MAZAIRAALVAREZ J, 1997, MEDULA ESPINAL, V3, P28; Miller F, 2005, CEREBRAL PALSY, P3; Molenaers G, 2001, EUR J NEUROL, V8, P88, DOI 10.1046/j.1468-1331.2001.00041.x; Munuera L, 1997, INTRO TRAUMATOLOGIA, P118; Ochs G, 1999, NEUROMODULATION, V2, P108, DOI 10.1046/j.1525-1403.1999.00108.x; Ordia JI, 2002, NEUROMODULATION, V5, P16, DOI 10.1046/j.1525-1403.2002._2004.x; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pascual-Pascual SI, 2007, REV NEUROLOGIA, V44, P303, DOI 10.33588/rn.4405.2006340; REMYNERIS O, 2003, KINESITERAPIA ESPAST; Renshaw TS, 1996, AAOS INSTR COURS LEC, V45, P475; RICHARDSON RR, 1978, SURG NEUROL, V9, P153; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; SHEEAN G, 2001, NEUROPHYSIOLOGY SPAS, P12; Shewmon DA, 1999, SPINAL CORD, V37, P313, DOI 10.1038/sj.sc.3100836; Siegfried J, 1980, Int Rehabil Med, V2, P31; SINDOU M, 1974, REV NEUROL, V130, P201; Singer AJ, 1997, NEW ENGL J MED, V337, P1142, DOI 10.1056/NEJM199710163371607; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Thompson PD, 1998, PARKINSONS DIS MOVEM, P755; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Vidal J, 2000, NEUROMODULATION, V3, P175, DOI 10.1046/j.1525-1403.2000.00175.x; Watanabe T, 2004, AM J PHYS MED REHAB, V83, pS45, DOI 10.1097/01.PHM.0000141130.58285.DA; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Welmer AK, 2006, CEREBROVASC DIS, V21, P247, DOI 10.1159/000091222; YOUNG RR, 1981, NEW ENGL J MED, V304, P28	75	24	28	0	8	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	SEP 16	2007	45	6					365	375		10.33588/rn.4506.2007239			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	217DW	WOS:000249929600010	17899519				2022-02-06	
J	Griebenow, M; Casalis, P; Woiciechowsky, C; Majetschak, M; Thomale, UW				Griebenow, Martin; Casalis, Pablo; Woiciechowsky, Christian; Majetschak, Matthias; Thomale, Ulrich-Wilhelm			Ubiquitin reduces contusion volume after controlled cortical impact injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; controlled cortical impact; contusion; neuroprotection; ubiquitin	EXTRACELLULAR UBIQUITIN; CEREBROSPINAL-FLUID; POSSIBLE INVOLVEMENT; EXOGENOUS UBIQUITIN; RESUSCITATION; PERFUSION; INCREASE; CELLS	Recent data suggest that ubiquitin has anti-inflammatory properties and therapeutic potential after severe trauma and brain injuries. However, direct evidence for its neuroprotective effects has not yet been provided. We hypothesized that ubiquitin treatment is neuroprotective, and thus reduces brain edema formation and cortical contusion volume after closed traumatic brain injuries. To test this hypothesis, a focal cortical contusion was induced using a controlled cortical impact (CCI) model in Sprague-Dawley rats. Animals (n = 27) were randomized to either 1.5 mg/kg ubiquitin or vehicle (placebo) intravenously within 5 min after CCI. Blood pressure, arterial blood gases (ABG) and intracranial pressure (ICP) were monitored. Ubiquitin serum and cerebrospinal fluid levels were measured by ELISA. Brain water content was quantified gravimetrically after 24 h and cerebral contusion volume was determined in triphenyltetrazolium-chloride stained brains after 7 days. All animals recovered to normal activity. ICP and cerebral perfusion pressures were normal at the end of the observation period. Ubiquitin serum and CSF levels at 24 h and 7 days after CCI were similar in both groups. With ubiquitin brain water content of the injured hemisphere was slightly lower (n = 6/group; 79.97 +/- 0.29% vs. 81.11 +/- 0.52%; p = 0.08). Cortical contusion volume was significantly lower with ubiquitin (n = 7-8/group; 32.88 +/- 2.1 mm(3) vs. 43.96 +/- 4.56 mm(3); p = 0.025). This study shows that ubiquitin treatment after brain injury has direct neuroprotective effects, as demonstrated by improved brain morphology 7 days after brain injury. In connection with its beneficial effects in our previous studies, these data suggest ubiquitin as a promising candidate protein therapeutic for the treatment of brain injuries.	Humboldt Univ, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany; Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma & Surg Crit Care, Miami, FL 33152 USA		Thomale, UW (corresponding author), Humboldt Univ, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany.	uthomale@charite.de		Misch, Martin/0000-0001-5283-5753			Akarsu E, 2001, DIABETES CARE, V24, P100, DOI 10.2337/diacare.24.1.100; ASSEMAN C, 1994, J IMMUNOL METHODS, V173, P93, DOI 10.1016/0022-1759(94)90286-0; Daino H, 2000, BLOOD, V95, P2577; EARLE SA, 2005, TRANSPLANTATION, V138, P31; GARCIACOVARRUBI.L, 2007, AM TRANSPL C SAN FRA; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; KUDO T, 1994, BRAIN RES, V639, P1, DOI 10.1016/0006-8993(94)91757-4; Kurimura M, 1997, Rinsho Shinkeigaku, V37, P963; Majetschak M, 2006, IMMUNOL CELL BIOL, V84, P59, DOI 10.1111/j.1440-1711.2005.01399.x; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; MANAKA H, 1992, NEUROSCI LETT, V139, P47, DOI 10.1016/0304-3940(92)90854-Z; OKADA M, 1993, CLIN CHIM ACTA, V220, P135, DOI 10.1016/0009-8981(93)90042-3; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; Patel MB, 2006, J SURG RES, V135, P226, DOI 10.1016/j.jss.2006.04.037; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Takagi M, 1999, ALCOHOL CLIN EXP RES, V23, p76S, DOI 10.1111/j.1530-0277.1999.tb04539.x; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Thomale UW, 2004, J NEUROTRAUM, V21, P1737	25	24	24	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2007	24	9					1529	1535		10.1089/neu.2007.0306			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	214ZT	WOS:000249777600010	17892413				2022-02-06	
J	Jokel, R; De Nil, L; Sharpe, K				Jokel, Regina; De Nil, Luc; Sharpe, Katie			Speech disfluencies in adults with neurogenic stuttering associated with stroke and traumatic brain injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							RIGHT-HEMISPHERE LESION; INFARCTION; BEHAVIOR; FLUENCY; DISEASE; SYMPTOM; DAMAGE	This study is part of a larger project aimed at exploring the speech, language, cognitive, psychosocial, and medical characteristics of adult neurogenic stuttering. In the present article, speech disfluency patterns in adults with neurogenic stuttering in two diagnostic groups, traumatic brain injury and stroke, were compared. The results revealed that people with neurogenic stuttering do not present as a homogeneous group but that they may present with different speech disfluency characteristics, as well as etiology-dependent self-perceptions. It is anticipated that the observations in the present article ultimately will lead to a greater understanding of the neural mechanisms underlying speech fluency and will result in more effective diagnostic and interventional approaches.	Univ Toronto, Dept Speech Language Pathol, Bayrest Ctr Geriatr Care, Toronto, ON M5G 1V7, Canada; Univ Toronto, Dept Speech Language Pathol, Toronto Western Res Inst, Sick Kids Res Inst, Toronto, ON, Canada; Catholic Univ Louvain, B-3000 Louvain, Belgium		Jokel, R (corresponding author), Univ Toronto, Dept Speech Language Pathol, Bayrest Ctr Geriatr Care, Rehabil Sci Bldg,Univ Ave,Room 160, Toronto, ON M5G 1V7, Canada.	r.jokel@utoronto.ca					ABE K, 1993, J NEUROL NEUROSUR PS, V56, P1024, DOI 10.1136/jnnp.56.9.1024; Ackerman H, 1996, APHASIOLOGY, V10, P409, DOI 10.1080/02687039608248420; ANDREWS G, 1974, J SPEECH HEAR DISORD, V39, P312, DOI 10.1044/jshd.3903.312; ARDILA A, 1986, BRAIN LANG, V27, P239, DOI 10.1016/0093-934X(86)90018-0; Ardila A, 1999, NEUROCASE, V5, P435; BIJLEVELD H, 1994, FOLIA PHONIATR LOGO, V46, P250, DOI 10.1159/000266323; BLOODSTEIN O, 1995, HDB SHUTTERING; BLOOM CM, 1973, J SPEECH HEAR RES, V16, P518, DOI 10.1044/jshr.1603.518; BRUTTEN GJ, 1980, P 18 C INT ASS LOG P; CANTER GJ, 1971, BRIT J DISORD COMMUN, V6, P139; Carluer L, 2000, MOVEMENT DISORD, V15, P343, DOI 10.1002/1531-8257(200003)15:2<343::AID-MDS1026>3.0.CO;2-I; Ciabarra AM, 2000, J NEUROL NEUROSUR PS, V69, P546, DOI 10.1136/jnnp.69.4.546; COMMODORE RW, 1978, J FLUENCY DISORD, V3, P1, DOI 10.1016/0094-730X(78)90002-5; CRAIG AR, 1984, BRIT J MED PSYCHOL, V57, P173, DOI 10.1111/j.2044-8341.1984.tb01597.x; DALE P, 1977, J FLUENCY DISORD, V2, P311, DOI 10.1016/0094-730X(77)90036-5; Fabbro F., 1999, NEUROLINGUISTICS BIL; Fairbanks G, 1954, J SPEECH HEAR DISORD, V19, P133, DOI 10.1044/jshd.1902.133; FLEET WS, 1985, NEUROLOGY, V35, P1343, DOI 10.1212/WNL.35.9.1343; FOLSTEIN M, 1975, J PSYCHIAT RES, V12, P187; GRANDIN CB, 1998, NEUROIMAGE, V7, pS159; Grant AC, 1999, ARCH NEUROL-CHICAGO, V56, P624, DOI 10.1001/archneur.56.5.624; Hagiwara H, 2000, Rinsho Shinkeigaku, V40, P605; Hall N. E., 2004, THEORY RES THERAPY F, P363; Helm-Estabrooks N., 1993, STUTTERING RELATED D, P205; Helm-Estabrooks Nancy, 1998, Seminars in Speech and Language, V19, P23, DOI 10.1055/s-2008-1064032; HELMESTABROOKS N, 1986, NEUROLOGY, V36, P1109, DOI 10.1212/WNL.36.8.1109; HORNER J, 1983, BRAIN LANG, V18, P71, DOI 10.1016/0093-934X(83)90007-X; Howell P, 1999, J SPEECH LANG HEAR R, V42, P345, DOI 10.1044/jslhr.4202.345; Jankelowitz DL, 1996, J COMMUN DISORD, V29, P223, DOI 10.1016/0021-9924(95)00050-X; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; KNOPMAN DS, 1983, NEUROLOGY, V33, P1170, DOI 10.1212/WNL.33.9.1170; Kully, 1985, COMPREHENSIVE STUTTE; LEBRUN Y, 1983, J FLUENCY DISORD, V8, P161, DOI 10.1016/0094-730X(83)90029-3; LEBRUN Y, 1985, J FLUENCY DISORD, V10, P137, DOI 10.1016/0094-730X(85)90021-X; LEBRUN Y, 1987, ACTA NEUROCHIR, V85, P103, DOI 10.1007/BF01456105; LEBRUN Y, 1983, J FLUENCY DISORD, V8, P323, DOI 10.1016/0094-730X(83)90012-8; LEBRUN Y, 1990, J FLUENCY DISORD, V15, P251, DOI 10.1016/0094-730X(90)90040-Y; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; Manning WH., 2001, CLIN DECISION MAKING, V2nd; MARAIST JA, 1957, J SPEECH HEAR DISORD, V22, P385, DOI 10.1044/jshd.2203.385; MARKET KE, 1990, J FLUENCY DISORD, V15, P21, DOI 10.1016/0094-730X(90)90029-R; MAZZUCCHI GM, 1981, BRIT J DISORDERS COM, V16, P19; NASS R, 1994, DEV MED CHILD NEUROL, V36, P73; NWOKAH EE, 1988, J FLUENCY DISORD, V13, P357, DOI 10.1016/0094-730X(88)90004-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pillai JJ, 2003, NEUROIMAGE, V19, P565, DOI 10.1016/S1053-8119(03)00151-4; Riley, 1994, STUTTERING SEVERITY; Ringo C. C., 1995, J MED SPEECH-LANG PA, V3, P111; ROSENBEK J, 1978, BRAIN LANG, V6, P82, DOI 10.1016/0093-934X(78)90046-9; Stewart T, 1996, EUR J DISORDER COMM, V31, P1; Thacker RC, 1996, J FLUENCY DISORD, V21, P227, DOI 10.1016/S0094-730X(96)00025-3; Tsumoto T, 1999, NEUROL SURG TOKYO, V27, P79; Van Borsel J, 1998, J FLUENCY DISORD, V23, P49, DOI 10.1016/S0094-730X(98)00002-3; Van Borsel J, 2001, J COMMUN DISORD, V34, P385, DOI 10.1016/S0021-9924(01)00057-0; Van Riper C, 1955, STUTTERING CHILDREN, P199; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; WINGATE ME, 1964, J SPEECH HEAR DISORD, V29, P484, DOI 10.1044/jshd.2904.484; Yaruss JS, 1998, AM J SPEECH-LANG PAT, V7, P25, DOI 10.1044/1058-0360.0702.25	58	24	24	0	12	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2007	15	3					243	261					19	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	211FH	WOS:000249509200007					2022-02-06	
J	Royo, NC; LeBold, D; Magge, SN; Chen, I; Hauspurg, A; Cohen, AS; Watson, DJ				Royo, N. C.; LeBold, D.; Magge, S. N.; Chen, I.; Hauspurg, A.; Cohen, A. S.; Watson, D. J.			Neurotrophin-mediated neuroprotection of hippocampal neurons following traumatic brain injury is not associated with acute recovery of hippocampal function	NEUROSCIENCE			English	Article						neurotrophins; rats; hippocampal neurons; neuroprotection; neuropharmacology	LATERAL FLUID-PERCUSSION; CORTICAL IMPACT INJURY; CA3 NMDA RECEPTORS; TRKB MESSENGER-RNA; RATS POSSIBLE ROLE; MORRIS WATER MAZE; CELL LOSS; COGNITIVE DEFICITS; SELECTIVE VULNERABILITY; MEMORY DYSFUNCTION	Traumatic brain injury (TBI) causes selective hippocampal cell death which is believed to be associated with the cognitive impairment observed in both clinical and experimental settings. The endogenous neurotrophin-4/5 (NT-4/5), a TrkB ligand, has been shown to be neuroprotective for vulnerable CA3 pyramidal neurons after experimental brain injury. In this study, infusion of recombinant NT-4/5 increased survival of CA2/3 pyramidal neurons to 71% after lateral fluid percussion brain injury in rats, compared with 55% in vehicle-treated controls. The functional outcome of this NT-4/5-mediated neuroprotection was examined using three hippocampal-dependent behavioral tests. Injujry-induced impairment was evident in all three tests, but interestingly, there was no treatment-related improvement in any of these measures. Similarly, injury-induced decreased excitability in the Schaffer collaterals was not affected by NT-4/5 treatment. We propose that a deeper understanding of the factors that link neuronal survival to recovery of function will be important for future studies of potentially therapeutic agents. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Abramson Res Ctr 816h, Div Neurol, Philadelphia, PA 19104 USA		Watson, DJ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 371A Stemmler Hall 6071, Philadelphia, PA 19104 USA.	royo@hotmail.com; David.LeBold@jefferson.edu; Suresh.Magge@uphs.upenn.edu; hisaac@mail.med.upenn.edu; alissekh@sas.upenn.edu; Cohena@email.chop.edu; djw3@mail.med.upenn.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045975, R01NS040978] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD059288, R01 HD059288-06] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS45975, R01 NS045975, R01 NS040978, R01-NS040978, R01 NS040978-06A1] Funding Source: Medline		ALTAR CA, 1994, EXP NEUROL, V130, P31, DOI 10.1006/exnr.1994.1182; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; ARDELT AA, 1994, BRAIN RES, V647, P340, DOI 10.1016/0006-8993(94)91333-1; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Dumas TC, 2001, TRENDS NEUROSCI, V24, P695, DOI 10.1016/S0166-2236(00)01956-1; Fan G, 2000, NAT NEUROSCI, V3, P350, DOI 10.1038/73921; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gewirtz JC, 2000, BEHAV BRAIN RES, V110, P83, DOI 10.1016/S0166-4328(99)00187-4; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Ibanez CF, 1996, NEUROCHEM RES, V21, P787, DOI 10.1007/BF02532301; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MAAS A, 2005, PATHOPHYSIOLOGY MANA, P406; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Research Council, 1996, GUID CAR US LAB AN; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; PHILLIP I, 2005, GOOD PERMUTATION PAR; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; Salin T, 1997, MOL CELL NEUROSCI, V9, P264, DOI 10.1006/mcne.1997.0625; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Schwyzer L, 2002, EUR J NEUROSCI, V16, P1939, DOI 10.1046/j.1460-9568.2002.02259.x; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yan Q, 1997, J COMP NEUROL, V378, P135	95	24	24	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 24	2007	148	2					359	370		10.1016/j.neuroscience.2007.06.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	213AK	WOS:000249638100004	17681695	Green Accepted			2022-02-06	
J	Marten-Lobenhoffer, J; Sulyok, E; Czeiterc, E; Buki, A; Kohl, J; Firsching, R; Troger, U; Bode-Boger, SM				Marten-Lobenhoffer, Jens; Sulyok, Endre; Czeiterc, Endre; Buki, Andras; Kohl, Jana; Firsching, Raimund; Troeger, Uwe; Bode-Boeger, Stefanie M.			Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage	JOURNAL OF NEUROSCIENCE METHODS			English	Article						CSF; traumatic brain injury; subarachnoid haemorrhage; L-arginine; ADMA; SDMA	NITRIC-OXIDE SYNTHASE; DELAYED CEREBRAL VASOSPASM; DIMETHYL-L-ARGININE; ASYMMETRIC DIMETHYLARGININE; BIOLOGICAL-FLUIDS; CHROMATOGRAPHY/MASS SPECTROMETRY; IN-VIVO; DIMETHYLAMINOHYDROLASE; DERIVATIZATION; METABOLITES	Elevated cerebrospinal fluid (CSF) concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), are assumed to be related to delayed vasospasm after subarachnoid haemorrhage (SAH). However, data on CSF concentrations Of L-arginine, ADMA and its structural isomer symmetric dimethylarginine (SDMA) are very sparse in humans. We here present a new hydrophilic interaction chromatography-tandem mass spectrometry (HILIC-MS-MS) method for the precise determination of these substances in CSF. The method requires only minimal sample preparation and features isotope labeled internal standards. First data of patients with SAH showed that on the day of admission CSF concentration values Of L-arginine and ADMA were not significantly different from controls, but increased markedly during the course of the hospital stay. The decrease of the L-arginine to ADMA ratio points to a progressive impairment of the NO production rate in the brain after SAH which is confirmed by a simultaneous decrease in nitrate and nitrite concentrations in CSF. (C) 2007 Elsevier B.V. All rights reserved.	Otto Von Guericke Univ, Inst Clin Pharmacol, D-39120 Magdeburg, Germany; Univ Pecs, Fac Hlth Sci, Dept Hlth Promot & Family Care, Pecs, Hungary; Univ Pecs, Fac Med, Dept Neurosurg, Pecs, Hungary; Otto Von Guericke Univ, Dept Neurosurg, Magdeburg, Germany		Marten-Lobenhoffer, J (corresponding author), Otto Von Guericke Univ, Inst Clin Pharmacol, Leipziger Str 44, D-39120 Magdeburg, Germany.	jens.martens-lobenhoffer@medizin.uni-magdeburg.de	Buki, Andras/B-1960-2010	Bode-Boger, Stefanie/0000-0002-5132-6591			BodeBoger SM, 1996, BIOCHEM BIOPH RES CO, V219, P598, DOI 10.1006/bbrc.1996.0279; Conte C, 2005, ANAL BIOCHEM, V338, P347, DOI 10.1016/j.ab.2004.11.018; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Fedele E, 1999, PROG NEUROBIOL, V58, P89, DOI 10.1016/S0301-0082(98)00077-X; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Martens-Lobenhoffer J, 2006, CLIN CHEM, V52, P488, DOI 10.1373/clinchem.2005.060152; Martens-Lobenhoffer J, 2004, J MASS SPECTROM, V39, P1287, DOI 10.1002/jms.684; Mulder C, 2002, J NEURAL TRANSM, V109, P1203, DOI 10.1007/s00702-002-0760-1; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Pluta RM, 2005, J NEUROSURG, V103, P731, DOI 10.3171/jns.2005.103.4.0731; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Pluta RM, 2006, NEUROL RES, V28, P730, DOI 10.1179/016164106X152052; RAWAL N, 1995, J NEUROL SCI, V129, P186, DOI 10.1016/0022-510X(94)00277-U; Rejdak K, 2004, J NEUROL SCI, V219, P71, DOI 10.1016/j.jns.2003.12.011; Shou WZ, 2005, J CHROMATOGR B, V825, P186, DOI 10.1016/j.jchromb.2005.01.011; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Tsikas D, 2000, ANAL CHEM, V72, P4064, DOI 10.1021/ac9913255; Woszczyk A, 2003, ACTA NEUROCHIR, V145, P257, DOI 10.1007/s00701-003-0004-7	21	24	25	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	AUG 15	2007	164	1					155	160		10.1016/j.jneumeth.2007.04.005			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	191ZK	WOS:000248170300017	17512604				2022-02-06	
J	Martin, RT; Whyte, J				Martin, Robert T.; Whyte, John			The effects of methylphenidate on command following and yes/no communication in persons with severe disorders of consciousness - A meta-analysis of n-of-1 studies	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injuries; vegetative state; minimally conscious state; methylphenidate; n-of-1 studies	TRAUMATIC BRAIN-INJURY; ATTENTION; DEFICITS; MEMORY	Objective: To determine the effects of methylpheniclate (MPH) on. command following and yes/no communication in brain injured patients with severe disorders of consciousness (DOC). Design: A meta-analysis of a series of single-subject repeated crossover trials, using doses ranging from 7.5 to 25 mg (median dose: 10 mg), generally given twice a day. A Wilcoxon signed ranks test was performed,, comparing mean responsiveness and accuracy by drug condition. Drug effect sizes were calculated for the full group and for participant subgroups of interest. Results: No significant effect of MPH was seen on either responsiveness or on accuracy in the whole group. None of the patient subgroups examined showed a substantial drug effect size. Conclusions: This study did not identify a clinically meaningful effect of MPH in the doses used on responsiveness or accuracy in standardized command-following protocols in the overall study group of patients with severe DOC, or in any subgroup that was assessed. Because MPH has been shown to have some positive effects in higher-level patients with TBI, more research is needed to, define the types of individuals with TBI who do and do not benefit from this drug, and/or the dose that provides optimal benefit.	Albert Einstein Healthcare Network, Moss Rehab Res Inst, Philadelphia, PA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA		Whyte, J (corresponding author), Moss Rehab Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.			Whyte, John/0000-0002-4381-1474			Braha RED, 1999, NEUROREHABILITATION, V12, P201; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Glenn MB, 2002, J HEAD TRAUMA REHAB, V17, P273, DOI 10.1097/00001199-200208000-00002; GRAHAM DI, 1999, REHABILITATION ADULT, P19; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Laborde A, 1997, J HEAD TRAUMA REHAB, V12, P90, DOI 10.1097/00001199-199708000-00009; MACMILLAN NA, 1991, DETECTION THEORY USE, P88; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Portney LG, 1993, FDN CLIN RES APPL PR, P651; TRAVERNI J, 1998, BRAIN INJURY, V12, P77; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; Whyte J, 1999, REHABILITATION ADULT, P435; ZAFONTE R, 1999, REHABILITATION ADULT, P536; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; 1994, N ENGL J MED, V3300, P1499	25	24	25	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2007	86	8					613	620		10.1097/PHM.0b013e3181154a84			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	194ZX	WOS:000248383400003	17667191				2022-02-06	
J	Wright, G; Bell, A; McGlashan, G; Vincent, C; Welbury, RR				Wright, Graeme; Bell, Aileen; McGlashan, Gregor; Vincent, Carolyn; Welbury, Richard R.			Dentoalveolar trauma in Glasgow: an audit of mechanism and injury	DENTAL TRAUMATOLOGY			English	Article						tooth injuries; tooth fractures; tooth avulsion; child; dental audit	DENTAL INJURIES; PERMANENT INCISORS; CHILDREN; PREVALENCE; TURKEY; UNIVERSITY; DENTISTRY; ANKARA	Traumatic dental injuries in children often require multiple follow-up visits to the dentist and may have long-term consequences for the developing dentition. The aim of this audit was to examine age, gender, location, time of year, mechanism of injury and type of injury sustained in relation to dentoalveolar trauma in children attending the paediatric dental trauma clinic at Glasgow Dental Hospital from 2002 to 2004, and to compare our findings with data in the published literature. Males suffered 60% of all dental trauma, 79% of sporting injuries and 85% of assaults. The injuries in males were more severe, representing 65% of enamel dentine and pulp fractures, 100% of crown root fractures and 66% of crown root and pulp fractures. A peak for trauma was seen in the 8-11-year-old group (43%). The majority of injuries in the under four age group resulted from falls (87%). Taken as a whole, falls accounted for 49%, sports related injuries 18%, bicycle and scooter 13%, assault 7%, and road traffic accidents 1.5% of all injuries. They also accounted for a far higher percentage of intrusive luxations (67%). The largest proportion of injuries occurred during the summer months (33%). Sixty-four percent of children suffered trauma to more than one tooth. Fifty-eight percent of injuries involved the dental hard tissues and pulp and the majority of these (82%) were crown fractures. Most subjects (82%) suffered trauma to their periodontal tissues, (26% concussion or subluxation, 26% lateral luxation and 23% avulsion). Injuries to the supporting bone were uncommon. Sixty-six percent of all injuries occurred outdoors. Our findings were similar to a number of published studies, but in contrast to several others. More consistency is required in the collection and reporting of trauma data to be able to draw meaningful conclusions by comparison.	Glasgow Dent Hosp & Sch, Dept Paediat Dent, Glasgow, Lanark, Scotland; Glasgow Dent Hosp & Sch, Dept Oral Surg, Glasgow, Lanark, Scotland		Welbury, RR (corresponding author), Glasgow Dent Hosp & Sch, Dept Paediat Dent, Glasgow, Lanark, Scotland.	r.r.welbury@dental.gla.ac.uk		Welbury, Richard/0000-0002-9322-2440			Altay N, 2001, DENT TRAUMATOL, V17, P201; Borssen E, 1997, ENDOD DENT TRAUMATOL, V13, P276; Canakci V, 2003, DENT TRAUMATOL, V19, P248, DOI 10.1034/j.1600-9657.2003.00199.x; da Silva AC, 2004, DENT TRAUMATOL, V20, P6, DOI 10.1111/j.1600-4469.2004.00212.x; Gabris K, 2001, DENT TRAUMATOL, V17, P103, DOI 10.1034/j.1600-9657.2001.017003103.x; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Glendor U, 2000, Swed Dent J Suppl, V140, P1; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-9657.2003.00203.x; Locker D, 2005, CAN J PUBLIC HEALTH, V96, P73, DOI 10.1007/BF03404023; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; Saroglu I, 2002, DENT TRAUMATOL, V18, P299, DOI 10.1034/j.1600-9657.2002.00093.x; Skaare AB, 2003, DENT TRAUMATOL, V19, P304, DOI 10.1046/j.1600-9657.2003.00211.x; Tapias MA, 2003, DENT TRAUMATOL, V19, P119, DOI 10.1034/j.1600-9657.2003.00141.x; Wood EB, 2002, AUST DENT J, V47, P142, DOI 10.1111/j.1834-7819.2002.tb00318.x; Zaragoza AA, 1998, J DENT CHILD, V65, P492; Zerfowski M, 1998, Clin Oral Investig, V2, P120, DOI 10.1007/s007840050056	16	24	26	0	11	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	AUG	2007	23	4					226	231		10.1111/j.1600-9657.2006.00430.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	197CX	WOS:000248532400007	17635356				2022-02-06	
J	Feary, DJ; Magdesian, KG; Aleman, MA; Rhodes, DM				Feary, Darien J.; Magdesian, K. Gary; Aleman, Monica A.; Rhodes, Diane M.			Traumatic brain injury in horses: 34 cases (1994-2004)	JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION			English	Article; Proceedings Paper	12th Annual Symposium of the International-Veterinary-Emergency-and-Critical-Card-Society	SEP 08, 2006	San Antonio, TX	Int Vet Emergency & Crit Care Soc			SEVERE HEAD-INJURY; ELEVATED INTRACRANIAL-PRESSURE; PLACEBO-CONTROLLED TRIAL; BASILAR SKULL FRACTURES; SPINAL-CORD INJURY; HYPERTONIC SALINE; MRC CRASH; HYPERGLYCEMIA; METHYLPREDNISOLONE; CORTICOSTEROIDS	Objective- To investigate the clinical, clinicopathologic, and diagnostic characteristics; treatment; and outcome associated with acute traumatic brain injury (TBI) in horses and assess risk factors for nonsurvival in TBI-affected horses. Design- Retrospective case series. Animals- 34 horses with TBI. Procedures- Medical records of horses that had sustained trauma to the head and developed neurologic signs were reviewed. Data that included signalment, clinicopathologic findings, diagnosis, treatment, and outcome were analyzed. Clinicopathologic variables among horses in survivor and nonsurvivor groups were compared, and risk factors for nonsurvival were determined. Results- Median age of affected horses was 12 months. Findings of conventional survey radiography of the head alone failed to identify all horses with fractures of the calvarium. Horses with basilar bone fractures were 75 times as likely not to survive as horses without this type of fracture. Depending on clinical signs, horses received supportive care, osmotic or diuretic treatments, antimicrobials, anti-inflammatory drugs, analgesics, or anticonvulsants. Twenty-one (62%) horses survived to discharge from the hospital. In the nonsurvivor group, mean PCV was significantly higher, compared with the value in the survivor group (40% vs 33%). Risk factors associated with nonsurvival included recumbency of more than 4 hours' duration after initial evaluation (odds ratio, 18) and fracture of the basilar bone (odds ratio, 75). Conclusions and Clinical Relevance- Results suggest that prognosis for survival in horses with acute TBI may be more favorable than previously reported. Among horses with TBI, persistent recumbency and fractures involving the basilar bones were associated with a poor prognosis.	Univ Calif Davis, Vet Med Teaching Hosp, Sch Vet Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA		Magdesian, KG (corresponding author), Equine Med Ctr Ocala, 7107 W Hwy 326, Ocala, FL 34482 USA.						ACKERMAN N, 1974, J AM VET RADIOL SOC, V15, P79; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bernard F, 2006, CRIT CARE MED, V34, P583, DOI 10.1097/01.CCM.0000199042.80034.A8; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Brosnan RJ, 2002, AM J VET RES, V63, P1252, DOI 10.2460/ajvr.2002.63.1252; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; BUTLER JA, 1993, CLIN RADIOLOGY HORSE, P285; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Edwards P, 2005, LANCET, V365, P1957; Feige K, 2000, EQUINE VET EDUC, V12, P220, DOI 10.1111/j.2042-3292.2000.tb00044.x; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; KORTZ GD, 1995, AM J VET RES, V56, P1351; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; LITTLE CB, 1985, AUST VET J, V62, P89, DOI 10.1111/j.1751-0813.1985.tb14146.x; MacKay RJ, 2004, VET CLIN N AM-EQUINE, V20, P199, DOI 10.1016/j.cveq.2003.11.006; MAGDESIAN KG, 2000, 4 ANN UC DAV SVECCS, P137; Marmarou A, 2005, ACT NEUR S, V95, P277; Mayhew IG, 1989, LARGE ANIMAL NEUROLO, P113; MCGRAW CP, 1983, J NEUROSURG, V3, P269; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nau R, 2000, CLIN PHARMACOKINET, V38, P23, DOI 10.2165/00003088-200038010-00002; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Pusterla N, 2006, SCHWEIZ ARCH TIERH, V148, P161, DOI 10.1024/0036-7281.148.3.161; RAGLE CA, 1988, VET RADIOLOGY, V29, P206, DOI 10.1111/j.1740-8261.1988.tb01500.x; RAGLE CA, 1993, VET CLIN N AM-EQUINE, V9, P171, DOI 10.1016/S0749-0739(17)30422-4; Ramirez O, 1998, VET RADIOL ULTRASOUN, V39, P391, DOI 10.1111/j.1740-8261.1998.tb01624.x; REED SM, 1993, VET CLIN N AM-EQUINE, V15, P270; Rhoney Denise H, 2006, Nutr Clin Pract, V21, P462, DOI 10.1177/0115426506021005462; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; STICK JA, 1980, J AM VET MED ASSOC, V176, P228; STICKLE R, 1998, TXB VET DIAGNOSTIC R, P105; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P531; Tonnesen A S, 1995, New Horiz, V3, P499; TYLER CM, 1993, AUST VET J, V70, P445, DOI 10.1111/j.1751-0813.1993.tb00846.x; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115; ZORNOW MH, 1990, ACT NEUR S, V51, P324; 2000, J NEUROTRAUMA, V19, P149	50	24	25	0	16	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0003-1488	1943-569X		JAVMA-J AM VET MED A	JAVMA-J. Am. Vet. Med. Assoc.	JUL 15	2007	231	2					259	266		10.2460/javma.231.2.259			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Veterinary Sciences	190AD	WOS:000248029200029	17630894				2022-02-06	
J	Larson, MJ; Kelly, KG; Stigge-Kaufman, DA; Schmalfuss, IM; Perlstein, WM				Larson, Michael J.; Kelly, Kiesa G.; Stigge-Kaufman, David A.; Schmalfuss, Ilona M.; Perlstein, William M.			Reward context sensitivity impairment following severe TBI: An event-related potential investigation	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						traumatic brain injury (TBI); event-related potential (ERP); feedback; rehabilitation; feedback related negativity (FRN); error related negativity (ERN); contingency	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; COGNITIVE CONTROL; DECISION-MAKING; NEGATIVITY REFLECTS; SOCIAL-ADJUSTMENT; DEFICITS; BAD; FEEDBACK; MODERATE	Many rehabilitation protocols following traumatic brain injury (TBI) utilize reinforcement and reward to influence behavior and facilitate recovery; however, previous studies suggest survivors of severe TBI demonstrate impairments in contingency utilization and sensitivity. The precise neurobiological mechanisms underlying these deficits have not been thoroughly explored. but can be examined using the "feedback-related negativity" (FRN)-an event-related potential (ERP) component evoked following performance or response feedback (e.g., whether a monetary reward is obtained) with a larger FRN following unfavorable than favorable outcomes-particularly when unfavorable feedback occurs in the context of high reward probability. We examined ERPs elicited by favorable (monetary gain: "reward") and unfavorable (no monetary gain: "non-reward") feedback during a guessing task where probability of reward outcome was manipulated in survivors of severe TBI and demographically matched healthy participants. Consistent with previous findings, controls showed larger amplitude FRN to non-reward feedback and the largest amplitude FRN following a non-reward when reward probability context was greatest. In contrast. FRN in TBI participants did not significantly differentiate non-reward from reward trials and their FRN was largest to reward trials in the low reward probability context. Findings implicate an electrophysiological marker of impaired reward context sensitivity following severe TBI.	Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; Tennessee State Univ, Dept Psychol, Nashville, TN 37203 USA; N Florida S Georgia Vet Adm, Gainesville, FL USA; Univ Florida, Gainesville, FL USA; Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA		Perlstein, WM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, HSC Box 100165, Gainesville, FL 32610 USA.	wmp@phhp.ufl.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH073076, K01MH001857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS053335] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH01857, R21 MH073076] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31 NS053335] Funding Source: Medline		Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; BIGLER, 1990, TRAUMATIC BRAIN INJU; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CLARK JH, 1924, J PHYSL OPTICS, V5, P269; Cohen J., 2013, STAT POWER ANAL BEHA; Fuster, 2015, PREFRONTAL CORTEX; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Holroyd C, 2004, ERRORS CONFLICTS BRA, V78, P447, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Ille N., 1997, BIOMED TECHNOL, V42, P80; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2006, NEUROREPORT, V17, P329, DOI 10.1097/01.wnr.0000199461.01542.db; LARSON MJ, UNPUB PERFORMANCE MO; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MILLER LA, 1992, NEUROPSYCHOLOGIA, V30, P69, DOI 10.1016/0028-3932(92)90015-E; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Park NW, 2003, NEUROCASE, V9, P51, DOI 10.1076/neur.9.1.51.14371; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Ruchsow M, 2002, NEUROSCI LETT, V325, P203, DOI 10.1016/S0304-3940(02)00288-4; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Speilberger C, 1983, MANUAL STATE TRAIT A; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027	61	24	25	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2007	13	4					615	625		10.1017/S1355617707070762			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	186GJ	WOS:000247766800007	17521495				2022-02-06	
J	Proctor, KG; Atapattu, SA; Duncan, RC				Proctor, Kenneth G.; Atapattu, Suresh A.; Duncan, Robert C.			Heart rate variability index in trauma patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						EKG; computed axial tomography; traumatic brain injury; screening test	BRAIN-INJURY; ASSOCIATION; PREDICTOR; MORTALITY; DEATH	Background. Heart rate variability (HRV) changes often reflect autonomic dysfunction with high sensitivity, but the specificity is also low. There are several different methods for measuring HRV, but interpretation is often complex, and the units are not interchangeable. For these reasons, HRV monitoring is not routinely used in many clinical situations. We hypothesized that the specificity of HRV as a screening tool for trauma patients could be improved by controlling some of the confounding influences using multiple logistic regression. Methods: A prospective observational trial with waiver of consent was performed in 243 healthy student volunteers and 257 trauma patients, in the resuscitation bay and intensive care units of a Level I trauma center, who received computed axial tomography (CT) scans of the head as part of the initial work up. Electrocardiogram results were recorded for 5 minutes. HRV was defined by SD of normal R-R intervals (SDNN5) and by root mean square of successive differences of R-R intervals (RMSSD5). A head CT scan was considered positive (+) if there were abnormalities in the parenchyma (diffuse axonal injury or contusion), vasculature (intraparenchymal, subdural, or epidural hemorrhage), and/or structural or bony components (fractures of the face or cranium). Results:. In volunteers, SDNN5 was 73 15 (M +/- SD) milliseconds, compared with 42 22, 31 19, 28 17, and 12 8 milliseconds in, CT(-) patients with no sedation (n = 82), CT(-) with sedation (n = 60), CT(+) with no sedation (n = 55)9 and CT(+) with sedation (n = 60), respectively. The differences between trauma, sedation, and CT categories were significant (all p < 0.001). RMSSD5, differences were similar and also highly significant (all p < 0.001). For both SDNN5 and RMSSD5, in each category, there was wide overlap in the range of values, and strong inverse correlations with heart rate (all p < 0.001). Using multiple logistic regression in a subset with no missing data (n = 194), an index was derived from factors. With a negative predictive value held constant at 0.90, compared with ln(SDNN5) alone, the stepwise addition of heart rate, sedation, age, gender, and blood pressure progressively improved the specificity of the HRV index from 0.56 to 0.77, positive predictive value from 0.55 to 0.68, and efficiency from 0.68 to 0.80. This index was then normalized (0-100 scale) for ease of interpretation. Conclusions. (1) Several factors alter HRV in patients; (2) when HRV was indexed for some of these factors, its specificity and efficiency were improved for predicting a discrete pathologic state in trauma patients, i.e. (+) or (-) cranial CT scans; (3) the algorithm can incorporate other factors to further refine the diagnostic and/or prognostic ability of HRV as a noninvasive clinical tool; (4) this concept should be applicable to any other HRV measurement technique or outcome.	Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Daughtry Family Dept Surg,Div Trauma, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Daughtry Family Dept Surg,Div Surg Crit Care, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Daughtry Family Dept Surg,Div Trauma, 1800 NW 10th Ave, Miami, FL 33136 USA.	kproctor@miami.edu	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628			Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; DUNCAN RC, 1983, INTRO BIOSTATISTICS; Fathizadeh P, 2004, CRIT CARE MED, V32, P1300, DOI 10.1097/01.CCM.0000127776.78490.E4; Fauchier L, 1998, J AUTONOM NERV SYST, V73, P1, DOI 10.1016/S0165-1838(98)00110-6; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Grogan EL, 2005, J TRAUMA, V58, P7, DOI 10.1097/01.TA.0000151179.74839.98; Grogan EL, 2004, ANN SURG, V240, P547, DOI 10.1097/01.sla.0000137143.65540.9c; Huikuri HV, 1999, J AM COLL CARDIOL, V34, P1878, DOI 10.1016/S0735-1097(99)00468-4; King ML, 1997, BRAIN INJURY, V11, P445; Lachin JM., 2000, WILEY SER PROB STAT; LOWENSOHN RI, 1977, LANCET, V1, P626; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Morris John A Jr, 2005, Adv Surg, V39, P77, DOI 10.1016/j.yasu.2005.04.004; Muhlnickel B, 1991, Anaesthesiol Reanim, V16, P37; Muhlnickel B, 1990, Anaesthesiol Reanim, V15, P342; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Novak V, 1997, CIRCULATION, V96, P1056; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; Stein PK, 2001, CRIT CARE MED, V29, P1738, DOI 10.1097/00003246-200109000-00014; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010	28	24	25	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2007	63	1					33	43		10.1097/01.ta.0000251593.32396.df			11	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	190MI	WOS:000248062600008	17622866				2022-02-06	
J	Nehrt, A; Rodgers, R; Shapiro, S; Borgens, R; Shi, R				Nehrt, A.; Rodgers, R.; Shapiro, S.; Borgens, R.; Shi, R.			The critical role of voltage-dependent calcium channel in axonal repair following mechanical trauma	NEUROSCIENCE			English	Article						axon; neurotrauma; membrane integrity; membrane; depolarization; resealing; guinea pig	MAMMALIAN SPINAL-CORD; WHITE-MATTER; NEURITE TRANSECTION; NERVE MEMBRANES; CA2+ CHANNELS; CUT END; INJURY; DEGENERATION; DISRUPTION; NEURONS	Membrane disruption following mechanical injury likely plays a critical role in the pathology of spinal cord trauma. It is known that intracellular calcium is a key factor that is essential to membrane resealing. However, the differential role of calcium influx through the injury site and through voltage dependent calcium channels (VDCC) has not been examined in detail. Using a well-established ex vivo guinea-pig spinal cord white matter preparation, we have found that axonal membrane resealing was significantly inhibited following transection or compression in the presence of cadmium, a non-specific calcium channel blocker, or nimodipine, a specific L-type calcium channel blocker. Membrane resealing was assessed by the changes of membrane potential and compound action potential (CAP), and exclusion of horseradish peroxidase 60 min following trauma. Furthermore, I mu M BayK 8644, a VDCC agonist, significantly enhanced membrane resealing. Interestingly, this effect was completely abolished when the concentration of BayK 8644 was increased to 30 mu M. These data suggest that VDCC play a critical role in membrane resealing. Further, there is likely an appropriate range of calcium influx through VDCC which ensures effective axonal membrane resealing. Since elevated intracellular calcium has also been linked to axonal deterioration, blockage of VDCC is proposed to be a clinical treatment for various injuries. The knowledge gained in this study will likely help us better understand the role of calcium in various CNS trauma, which is critical for designing new approaches or perhaps optimizing the effectiveness of existing methods in the treatment of CNS trauma. (C) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	Purdue Univ, Weldon Sch Biomed Engn, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Shi, R (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	riyi@purdue.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD041371] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD041371-01A1, R03 HD041371-02, R03 HD041371] Funding Source: Medline		Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Cocucci E, 2004, MOL BIOL CELL, V15, P5356, DOI 10.1091/mbc.E04-07-0577; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Detrait E, 2000, J NEUROBIOL, V44, P382, DOI 10.1002/1097-4695(20000915)44:4<382::AID-NEU2>3.0.CO;2-Q; Eddleman CS, 2000, BIOPHYS J, V79, P1883, DOI 10.1016/S0006-3495(00)76438-1; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Fern R, 1996, J NEUROPHYSIOL, V76, P3264, DOI 10.1152/jn.1996.76.5.3264; FERN R, 1995, J NEUROPHYSIOL, V74, P369, DOI 10.1152/jn.1995.74.1.369; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GROSS GW, 1983, J NEUROSCI, V3, P1979; GROSS GW, 1987, EXP BRAIN RES, V67, P52, DOI 10.1007/BF00269452; Imaizumi T, 1999, BRAIN RES, V817, P84, DOI 10.1016/S0006-8993(98)01214-1; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; Kulbatski I, 2004, J NEUROTRAUM, V21, P357, DOI 10.1089/089771504322972130; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; Luo J, 2002, SPINAL CORD, V40, P656, DOI 10.1038/sj.sc.3101363; Mason RP, 1999, J NEUROCHEM, V72, P1448, DOI 10.1046/j.1471-4159.1999.721448.x; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Ouardouz M, 2005, NEUROPHARMACOLOGY, V48, P566, DOI 10.1016/j.neuropharm.2004.12.007; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POINTILLART V, 1993, J NEUROTRAUM, V10, P201, DOI 10.1089/neu.1993.10.201; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; QUARDOUZ M, 2003, NEURON, V40, P53; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Rhee RY, 1996, INT ANGIOL, V15, P153; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Sattler R, 1996, BRAIN RES, V719, P239, DOI 10.1016/0006-8993(96)00125-4; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; SCHLAEPFER WW, 1973, J CELL BIOL, V59, P456, DOI 10.1083/jcb.59.2.456; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 2001, J NEUROCYTOL, V30, P829, DOI 10.1023/A:1019645505848; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; SHI R, 2002, J NEUROTRAUM, V19, P1394; Shi RY, 1989, J NEUROTRAUM, V6, P261, DOI 10.1089/neu.1989.6.261; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Shi RY, 2004, J NEUROCYTOL, V33, P203, DOI 10.1023/B:NEUR.0000030695.76840.19; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Ueda K, 1997, J NEUROCHEM, V68, P265; XIE XY, 1991, J NEUROSCI, V11, P3257; YAWO H, 1983, SCIENCE, V222, P1351, DOI 10.1126/science.6658457; YAWO H, 1985, J NEUROSCI, V5, P1626; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x	62	24	29	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 8	2007	146	4					1504	1512		10.1016/j.neuroscience.2007.02.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	176RB	WOS:000247101500008	17448606	Green Accepted			2022-02-06	
J	Rafols, JA; Kreipke, CW; Petrov, T				Rafols, Jose A.; Kreipke, Christian W.; Petrov, Theodor			Alterations in cerebral cortex microvessels and the microcirculation in a rat model of traumatic brain injury: a correlative EM and laser Doppler flowmetry study	NEUROLOGICAL RESEARCH			English	Article						brain trauma; cerebral blood flow; ultrastructure; vascular tone	BLOOD-FLOW; AXONAL INJURY; HYPOPERFUSION; ENDOTHELIN-1; HIPPOCAMPUS; EXPRESSION; CONTUSION; PERFUSION; ISCHEMIA	Objectives: We sought to establish the temporal association of fluctuations in cortical cerebral blood flow (CBF) with ultrastructural alterations of microvessels in rat sensorimotor cortex (smCx) following administration of a rodent acceleration impact model of traumatic brain injury (TBI). Methods: Laser Doppler flowmetry (LDF) and electron microscopy (EM) were used in parallel experiments that lasted for up to 48 hours after induction of TBI. Results: Compared to sham-operated control, there was a 37% reduction of cortical CBF between 12 and 24 hours, this reduction remaining unchanged for up to 48 hours post-TBI. Ultrastructural alterations in the lumen and wall of smCx microvessels, including endothelial cell distortion and luminal collapse, were seen at hour 1 and continued up to 48 hours after trauma. Compared to control, there was a 40% decrease in the average microvascular luminal area 4 hours and a trend to recover (21%) by 48 hours after trauma. Smooth muscle (SM) in the wall of reacting microvessels showed evidence of increase contractility that coincided temporally with the decreased perfusion of cortical CBF. Discussion: Based on these observations, it is proposed that TBI causes alterations in the vascular tone of reacting microvessels which leads to prolonged vasoreactivity and restriction of the lumen in many but not all microvessels.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Scott Hall,Room 9312,540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline		Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; ENDELBORGHS K, 2000, J NEUROTRAUM, V17, P667; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GABELLA G, 1976, CELL TISSUE RES, V170, P187; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GOSHGARIAN HG, 1989, J COMP NEUROL, V284, P519, DOI 10.1002/cne.902840404; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; *I LAB AN RES COMM, 1996, NIH PUBL; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MACDONALD RL, 1991, NEUROSURGERY, V29, P544; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; McBeth BD, 2005, ACAD EMERG MED, V12, P483, DOI 10.1197/j.aem.2004.11.028; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETERS A, 1991, FINE STRUCTURE NERVO, P344; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; PHELPS PC, 1969, AM J ANAT, V125, P399, DOI 10.1002/aja.1001250404; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; Uehara Y, 1990, ULTRASTRUCTURE SMOOT, P237; USHIWATA I, 1990, J NEUROSURG, V73, P82, DOI 10.3171/jns.1990.73.1.0082; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	40	24	26	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2007	29	4					339	347		10.1179/016164107X204648			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	192PM	WOS:000248214200002	17626728				2022-02-06	
J	Williams, R; Delaney, T; Nelson, E; Gratton, J; Laurent, J; Heath, B				Williams, Robert; Delaney, Thomas; Nelson, Eliot; Gratton, Jennifer; Laurent, Jennifer; Heath, Barry			Speeds associated with skiing and snowboarding	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						helmet; traumatic brain injury; head trauma; head injury; skiing; snowboarding; speed; terrain park	HELMET USE; HEAD-INJURIES; SKIERS	Background/Objective.-Traumatic brain injury (TBI) is an important cause of morbidity and mortality in skiing and snowboarding. Although previous studies have advocated the use of a helmet to reduce the incidence of TBI, only a minority of skiers and snowboarders wear helmets. The low use of helmets may be partially due to controversy regarding their effectiveness in a high-speed crash. The protective effect of a ski helmet is diminished at the high speeds a skier or snowboarder can potentially obtain on an open slope. However, ski areas have undergone significant changes in the past decade. Many skiers and snowboarders frequent nontraditional terrain such as gladed areas and terrain parks. Since these areas contain numerous physical obstacles, we hypothesized that skiers and snowboarders would traverse these areas at speeds slow enough to expect a significant protective effect from a helmet. Methods.-Speed data were obtained via radar analysis of 2 groups of expert level skiers and snowboarders traversing a gladed woods trail and terrain park. Results.-A total of 113 observations were recorded. Forty-eight observations were made of 9 skiers and snowboarders in gladed terrain, and 65 observations were conducted of 21 skiers and snowboarders in the terrain park. In 79% of the cases in gladed terrain and 94% of the instances in the terrain park, observed speeds were less than 15 mph. Conclusions.-Skiers and snowboarders navigate nontraditional terrain at speeds slower than on open slopes. At the observed velocities, a helmet would be expected to provide significant help in diminishing the occurrence of TBI. Medical authorities should advocate the use of helmets as an important component of an overall strategy to reduce the incidence of TBI associated with skiing and snowboarding	Vermont Childrens Hosp, Div Pediat Crit Care, Burlington, VT USA; Univ Vermont, Vermont Childrens Hosp, Coll Med, Dept Anesthesia & Pediat, Burlington, VT USA		Williams, R (corresponding author), Vermont Childrens Hosp, Div Pediat Crit Care, Burlington, VT USA.	robert.williams@vtmednet.org					*ASTM, F2040 ASTM; Buller DB, 2003, J TRAUMA, V55, P939, DOI 10.1097/01.TA.0000078694.53320.CA; Corra Stefano, 2004, Inj Control Saf Promot, V11, P281, DOI 10.1080/156609704/233/289788; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; HEATH B, 2004, 2004 M PED AC SOC SA; Johnson SM, 2001, WILD ENVIRON MED, V12, P244, DOI 10.1580/1080-6032(2001)012[0244:ATACHI]2.0.CO;2; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Made C, 2004, SCAND J MED SCI SPOR, V14, P128, DOI 10.1111/j.1600-0838.2003.00342.x; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Shealy J. E., 2005, J ASTM INT, V2; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; Xiang H, 2004, INJURY PREV, V10, P99, DOI 10.1136/ip.2003.004655; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD	16	24	24	1	6	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	SUM	2007	18	2					102	105		10.1580/06-WEME-OR-037R1.1			4	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	184KU	WOS:000247641100004	17590072	Bronze			2022-02-06	
J	Wang, MC; Temkin, NR; Deyo, RA; Jurkovich, GJ; Barber, J; Dikmen, S				Wang, Marjorie C.; Temkin, Nancy R.; Deyo, Richard A.; Jurkovich, Gregory J.; Barber, Jason; Dikmen, Sureyya			Timing of surgery after multisystem injury with traumatic brain injury: Effect on neuropsychological and functional outcome	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	54th Annual Meeting of the Congress-of-Neurological-Surgeons	OCT 16-21, 2004	San Francisco, CA	Congress Neurol Surg		timing of surgery; multisystem injury; traumatic brain injury; neuropsychological outcome; functional outcome	SEVERE HEAD-INJURIES; FRACTURE FIXATION; RANDOMIZED-TRIAL; MAJOR FRACTURES; PRACTICAL SCALE; MANAGEMENT; STABILIZATION; OSTEOSYNTHESIS; VALPROATE; DAMAGE	Objective: The optimal timing for noncranial surgery after multisystem injury is not known. Early surgery may lead to decreased pulmonary complications and length of stay, but also predispose to secondary brain injury if decreased cerebral perfusion occurs intraoperatively. Previous work has not consistently evaluated neuropsychological or functional outcome. We sought to determine whether 6-month neuropsychologieal and functional outcome was associated with timing of noncranial surgery after traumatic brain injury. Materials: We performed a cohort study to evaluate the effect of the timing of non-neurosurgical operative interventions on neuropsychological and functional outcome, morbidity, and mortality. Early surgery was defined as <= 24 hours after injury, and late surgery, >24 hours after injury but during the same admission. Patients with a nonoperative brain injury and an operative facial or orthopedic fracture were selected from two randomized trials previously performed at our Level I trauma center. Data were abstracted from medical records and outcome had been prospectively gathered as part of the two clinical trials. Results: Patients undergoing early or late surgery had similar demographics, overall injury severity, traumatic brain injury severity, and admission characteristics. The early group had more open orthopedic fractures, but also underwent multiple operations more often than did the late group. At 6 months postinjury, patients in the early group had a better composite neuropsychological score than did those in the late group on unadjusted analysis and after including a propensity score. After adjusting for potential confounders, this difference was significant. No significant differences in return to work or Glasgow Outcome Score were noted. The late group had a higher incidence of pneumonia and a longer hospital stay (p < 0.10). Conclusions: In traumatic brain injury patients with multisystem trauma, early timing of orthopedic and facial fracture fixation under general anesthesia was not associated with worse neuropsychological or functional outcome when compared with the outcomes associated with late surgery. Clinical conclusions may be limited by inherent selection bias and unmeasured confounding. However, these results contribute to equipoise regarding timing of surgery after multiple injuries, and emphasize the need for a randomized trial.	Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; Univ Washington, Ctr Cost & Outcomes Res Surg Rehabil, Dept Neurosurg, Seattle, WA 98195 USA; Univ Washington, Ctr Cost & Outcomes Res Surg Rehabil, Dept Internal Med, Seattle, WA 98195 USA		Wang, MC (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	mwang@mcw.edu					Anglen JO, 2003, J TRAUMA, V54, P1166, DOI 10.1097/01.TA.0000057232.66613.AC; BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BROOS PLO, 1987, INJURY, V18, P235, DOI 10.1016/0020-1383(87)90004-0; Brundage SI, 2002, J TRAUMA, V52, P299, DOI 10.1097/00005373-200202000-00016; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Dunham CM, 2001, J TRAUMA, V50, P958, DOI 10.1097/00005373-200105000-00037; DYER FN, 1973, MEM COGNITION, V1, P106, DOI 10.3758/BF03198078; FAKHRY SM, 1994, J TRAUMA, V37, P255, DOI 10.1097/00005373-199408000-00018; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; HOFMAN PAM, 1991, J TRAUMA, V31, P261, DOI 10.1097/00005373-199131020-00020; Hunt JP, 1999, SURGERY, V126, P191, DOI 10.1067/msy.1999.98749; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; JENNETT B, 1975, LANCET, V1, P480; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; KOTWICA Z, 1990, ACTA NEUROCHIR, V102, P19, DOI 10.1007/BF01402180; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1995, MEMORY NEUROPSYCHOLO; LOZMAN J, 1986, ARCH SURG-CHICAGO, V121, P992; McKee MD, 1997, J TRAUMA, V42, P1041, DOI 10.1097/00005373-199706000-00009; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; RIXECKER H, 1980, J CLIN PSYCHOL, V36, P465, DOI 10.1002/jclp.6120360213; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; TEMKIN NR, 2005, 23 ANN NAT NEUR SOC; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wolfson, 1993, HALSTEAD REITAN NEUR	36	24	26	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2007	62	5					1250	1258		10.1097/01.ta.0000215581.50234.56			9	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	168OF	WOS:000246533200036	17495732				2022-02-06	
J	Ward, EC; Green, K; Morton, AL				Ward, Elizabeth C.; Green, Karly; Morton, Ann-Louise			Patterns and predictors of swallowing resolution following adult traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dysphagia; natural history; swallowing; traumatic brain injury	HEAD-INJURY; DYSPHAGIA	Objective: To examine the patterns of swallowing resolution and outcomes of traumatic brain injury (TBI) patients in an acute care setting and document the risk factors or predictors of resolution of swallowing function. Participants: 117 consecutive TBI patients who had received speech pathology intervention for dysphagia during acute postinjury care. Main outcome measure: Temporal measures relating to pattern of resolution of dysphagia postinjury. Results: 75% of patients were assessed by 2 weeks postinjury, commenced oral intake by 17 days, and ceased supplementation by 3 weeks. By an average of 22 days after admission, 47% had progressed to normal-consistency diet and fluids. Duration to the first swallowing assessment was a predictor for achieving total oral intake and returning to normal intake. There was some preliminary support for severity of CT data and presence/absence of a tracheostomy as predictors for return to normal intake. Conclusion: The current data document the natural history of swallowing resolution and proposes prognostic factors for patients with impaired swallowing following TBI. Establishing clinical parameters that can help predict patterns of swallowing resolution over the course of acute care admission may greatly assist inpatient management and discharge/rehabilitation planning.	Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; Royal Brisbane & Womens Hosp, Speech Pathol Dept, Brisbane, Qld, Australia		Ward, EC (corresponding author), Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, Therapies Bldg, St Lucia, Qld 4072, Australia.	liz.ward@uq.edu.au	Ward, Elizabeth/F-9652-2010	Ward, Elizabeth/0000-0002-2680-8978			COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; LANGMORE S E, 1991, Seminars in Speech and Language, V12, P199, DOI 10.1055/s-2008-1064221; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Reilly S., 2005, ADV SPEECH LANGUAGE, V7, P14; Ward E, 1999, ASIA PACIFIC J SPEEC, V4, P109, DOI DOI 10.1179/136132899805577051; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	9	24	28	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					184	191		10.1097/01.HTR.0000271119.96780.f5			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100005	17510594				2022-02-06	
J	Heitger, MH; Jones, RD; Dalrymple-Alford, JC; Frampton, CM; Ardagh, MW; Anderson, TJ				Heitger, Marcus H.; Jones, Richard D.; Dalrymple-Alford, John C.; Frampton, Chris M.; Ardagh, Michael W.; Anderson, Tim J.			Mild head injury - a close relationship between motor function at 1 week post-injury and overall recovery at 3 and 6 months	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						head injury; recovery; motor function; oculomotor; upper-limb visuomotor; prediction of outcome	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYMPTOMS; S-100 PROTEIN MEASUREMENTS; SACCADIC EYE-MOVEMENTS; FOLLOW-UP; NEUROIMAGING FINDINGS; PREDICTIVE-VALUE; MODERATE; DEFICITS; WHIPLASH	Based on previous findings of impaired eye and arm motor control after mild closed head injury (CHI), this study examined whether early eye and arm motor function, and the level of post-injury cerebral dysfunction manifested in motor control, relates systematically to recovery at 3 and 6 months after mild CHI. At 1 week post-injury, we assessed oculomotor function, upper-limb visuomotor performance, and cognitive status in 37 mild CHI patients. Re-examination at 3 and 6 months determined outcome in terms of postconcussional symptoms and performance of everyday tasks, as assessed by the Rivermead Postconcussion Symptoms Questionnaire, the Rivermead Head Injury Follow-up Questionnaire and the SF-36 Health Survey. We then examined the association of early motor function, cognitive status and self-reported health condition with outcome using linear regression. Motor-based regression models explained a high proportion of the variance in outcome (70-89%), with motor function at 1 week being more closely related to outcome at 3 and 6 months than early psychometric assessment (13-32%) or self-reported health status (54-79%). These motor-based models incorporated subcortical/subconscious motor functions alongside motor functions that are subject to volitional control and are primarily mediated by frontal, parietal and temporal cortical brain regions. Early assessment of eye and arm motor function may help in improving accuracy of outcome prediction after mild CHI. Such assessment may assist in the better targeting of early health care intervention and help decrease head-trauma-related morbidity and rehabilitation costs. (c) 2006 Elsevier B.V. All rights reserved.	Van der Veer Inst Parkinsons & Brain Res, Christchurch, New Zealand; Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand; Christchurch Hosp, Dept Med Phys & Bioengn, Christchurch, New Zealand; Christchurch Hosp, Emergency Dept, Christchurch, New Zealand; Christchurch Hosp, Dept Neurol, Christchurch, New Zealand; Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand		Heitger, MH (corresponding author), Van der Veer Inst Parkinsons & Brain Res, POB 2682, Christchurch, New Zealand.	marcus.heitger@chmeds.ac.nz		Jones, Richard/0000-0003-2287-3358			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BITTENCOURT PRM, 1981, BRIT J CLIN PHARMACO, V12, P523, DOI 10.1111/j.1365-2125.1981.tb01261.x; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; *CDCP NAT CTR INJ, 1999, TRAUM BRAIN INJ US R; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Enderle JD, 2002, PROG BRAIN RES, V140, P21; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; GRONWALL DMA, 1977, PACED AUDITORY SERIA; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JONES RD, 2000, BIOMEDICAL ENG HDB, V149, P1; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Mallinson AI, 1998, AM J OTOL, V19, P809; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Muir S. R., 2003, Australasian Physical & Engineering Sciences in Medicine, V26, P18; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; Reitan R M, 1997, Appl Neuropsychol, V4, P16, DOI 10.1207/s15324826an0401_3; Reitan RM, 2003, ARCH CLIN NEUROPSYCH, V18, P11, DOI 10.1016/S0887-6177(01)00177-9; REULEN JPH, 1988, MED BIOL ENG COMPUT, V26, P20, DOI 10.1007/BF02441823; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith, 1973, SYMBOL DIGIT MODALIT; Spreen O, 1991, COMPENDIUM NEUROPSYC; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; Thier P, 2002, ANN NY ACAD SCI, V978, P50, DOI 10.1111/j.1749-6632.2002.tb07555.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Umile EM, 1998, BRAIN INJURY, V12, P577; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; WARE JE, 2000, HOW SCORE VERSION 2; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Wrightson P, 1998, NEW ZEAL MED J, V111, P99; Zee D.S., 1999, NEUROLOGY EYE MOVEME, V3rd	76	24	24	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	FEB 15	2007	253	1-2					34	47		10.1016/j.jns.2006.11.007			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	141ZY	WOS:000244619200005	17207818	Green Published			2022-02-06	
J	Chang, TT; Schecter, WP				Chang, Tammy T.; Schecter, William P.			Injury in the elderly and end-of-life decisions	SURGICAL CLINICS OF NORTH AMERICA			English	Article							TRAUMATIC BRAIN-INJURY; BLUNT SPLENIC INJURY; ACTIVATED FACTOR-VII; GERIATRIC TRAUMA; NONOPERATIVE MANAGEMENT; INTRACRANIAL HEMORRHAGE; TRANSTHORACIC ECHOCARDIOGRAPHY; PREEXISTING CONDITIONS; PREINJURY WARFARIN; SURGICAL-PATIENTS	The elderly constitute the fastest growing sector of the population of the United States and geriatric trauma patients are presenting for care with increasing frequency. These patients are challenging particularly because of their vulnerability to severe injury limited physiologic response to stress, and frequent presence of comorbid medical conditions complicating care. Many elderly trauma victims require prolonged intensive care and some fail to improve or succumb despite the best efforts because of the extent of their injuries and their underlying disease. These patients may present profound ethical challenges for trauma surgeons as the goals of care shift from salvage to end-of-life care.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Surg, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA		Schecter, WP (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Surg, 1001 Potrero Ave,Ward 3A17, San Francisco, CA 94110 USA.	bschect@sfghsurg.ucsf.edu					ABRAMS FR, 1993, NEW ENGL J MED, V328, P975, DOI 10.1056/NEJM199304013281320; [Anonymous], 1968, JAMA, V205, P337; Barone JE, 1999, J TRAUMA, V46, P87, DOI 10.1097/00005373-199901000-00014; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; Bochicchio GV, 2001, J TRAUMA, V50, P612, DOI 10.1097/00005373-200104000-00004; Cassell J, 2003, CRIT CARE MED, V31, P1551, DOI 10.1097/00003246-200305000-00039; Cocanour CS, 2000, J TRAUMA, V48, P606, DOI 10.1097/00005373-200004000-00005; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Epstein CD, 2002, HEART LUNG, V31, P315, DOI 10.1067/mhl.2002.126104; Fakhry SM, 1996, J TRAUMA, V41, P999, DOI 10.1097/00005373-199612000-00010; Fakhry SM, 2001, J TRAUMA, V50, P617; Falimirski ME, 2000, AM SURGEON, V66, P631; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Fishkind D, 1997, J AM GERIATR SOC, V45, P809, DOI 10.1111/j.1532-5415.1997.tb01506.x; Grossman M, 2003, J TRAUMA, V55, P26, DOI 10.1097/01.TA.0000072109.52351.0D; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Harbrecht BG, 2001, J TRAUMA, V51, P887, DOI 10.1097/00005373-200111000-00010; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; He W., 2005, 65 US 2005; Henry SM, 2002, J TRAUMA, V53, P15, DOI 10.1097/00005373-200207000-00004; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Jensen MB, 2004, EUR J ANAESTH, V21, P700, DOI 10.1017/S0265021504009068; KHOURY AF, 1994, AM HEART J, V127, P1363, DOI 10.1016/0002-8703(94)90057-4; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Knudson MM, 1999, SURG CLIN N AM, V79, P1357, DOI 10.1016/S0039-6109(05)70082-7; KNUDSON MM, 1994, ARCH SURG-CHICAGO, V129, P448; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Koval KJ, 2003, J BONE JOINT SURG AM, V85A, P1380, DOI 10.2106/00004623-200307000-00027; Krause KR, 2000, AM SURGEON, V66, P636; Lavery GG, 2004, CRIT CARE, V8, P433, DOI 10.1186/cc2998; Levy MM, 2004, CRIT CARE CLIN, V20, P541, DOI 10.1016/j.ccc.2004.03.013; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Lin J, 2003, J NEUROSURG, V98, P737, DOI 10.3171/jns.2003.98.4.0737; Ma MHM, 1999, J TRAUMA, V46, P168; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; Manasia AR, 2005, J CARDIOTHOR VASC AN, V19, P155, DOI 10.1053/j.jvca.2005.01.023; Mandavia D, 1998, EMERG MED CLIN N AM, V16, P257, DOI 10.1016/S0733-8627(05)70358-8; MARTIN R E, 1990, Emergency Medicine Clinics of North America, V8, P411; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Morenski John D, 2003, J Intensive Care Med, V18, P211, DOI 10.1177/0885066603254359; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Myers JG, 2000, J TRAUMA, V48, P801, DOI 10.1097/00005373-200005000-00002; O'Brien DP, 2002, SURGERY, V132, P710, DOI 10.1067/msy.2002.127690; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pande I, 2006, ANN RHEUM DIS, V65, P87, DOI 10.1136/ard.2004.034611; PELLICANE JV, 1992, J TRAUMA, V33, P440, DOI 10.1097/00005373-199209000-00018; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Roudsari BS, 2005, INJURY, V36, P1316, DOI 10.1016/j.injury.2005.05.024; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; SCHECTER WP, 1994, SURG CLIN N AM, V74, P245, DOI 10.1016/S0039-6109(16)46282-1; Schulman AM, 2002, AM SURGEON, V68, P942; SCHULTZ RJ, 1985, J TRAUMA, V25, P309, DOI 10.1097/00005373-198504000-00005; Schurr MJ, 2004, J TRAUMA, V57, P718; Schwartsman R, 1998, Am J Orthop (Belle Mead NJ), V27, P512; Sexson S B, 1987, J Orthop Trauma, V1, P298, DOI 10.1097/00005131-198701040-00005; SHABOT MM, 1995, J TRAUMA, V39, P254, DOI 10.1097/00005373-199508000-00011; SHMERLING RH, 1988, J GEN INTERN MED, V3, P317, DOI 10.1007/BF02595786; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; SMITH DP, 1990, SOUTHERN MED J, V83, P171, DOI 10.1097/00007611-199002000-00010; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stricker KH, 2005, ACTA ANAESTH SCAND, V49, P975, DOI 10.1111/j.1399-6576.2005.00702.x; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; TOMLINSON T, 1990, JAMA-J AM MED ASSOC, V264, P1276, DOI 10.1001/jama.264.10.1276; VANAALST JA, 1991, J TRAUMA, V31, P1096; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; YOUNGER SJ, 1988, JAMA-J AM MED ASSOC, V260, P2094, DOI 10.1001/jama.260.14.2094; ZIMMERGEMBECK MJ, 1995, J TRAUMA, V39, P922, DOI 10.1097/00005373-199511000-00017; ZUCKERMAN JD, 1992, CLIN ORTHOP RELAT R, P213	86	24	27	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	FEB	2007	87	1					229	+		10.1016/j.suc.2006.09.010			18	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	123NI	WOS:000243302200013	17127130				2022-02-06	
J	Bittner, RM; Crowe, SF				Bittner, Robyn M.; Crowe, Simon F.			The relationship between working memory, processing speed, verbal comprehension and FAS performance following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; verbal fluency; working memory; processing speed; verbal comprehension	CLOSED HEAD-INJURY; NORMATIVE DATA; WORD FLUENCY; DISSOCIATION; IMPAIRMENT; EDUCATION; APHASIA; TIME; AGE	Primary objective: To investigate the relationship of working memory, processing speed and verbal comprehension with FAS performance in individuals who had sustained a traumatic brain injury ( TBI). Methods and procedure: Sixty- three patients with a TBI were grouped according to the presence of impaired verbal fluency performance and then compared on a number of cognitive and demographic variables. Results: Following a TBI, working memory and processing speed had the greatest influence on verbal fluency performance. For those individuals who have not sustained a TBI, education, verbal intelligence, working memory and speed of information processing were related to FAS performance. Conclusions: The findings of the study indicate that FAS performance was related to verbal intelligence, working memory ability, attention and speed of information processing. The results further suggest that different variables are related to FAS performance following a TBI as compared with control group performances.	La Trobe Univ, Sch Psychol Sci, Fac Sci Technol & Engn, Bundoora, Vic 3083, Australia		Crowe, SF (corresponding author), La Trobe Univ, Sch Psychol Sci, Fac Sci Technol & Engn, Bundoora, Vic 3083, Australia.	s.crowe@latrobe.edu.au		Crowe, Simon/0000-0002-4407-8542			Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BUNN T, 1995, ED CHILD PSYCHOL, V12, P46; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; ELLIOTT M, 1981, J LEARN DISABIL, V14, P84, DOI 10.1177/002221948101400210; Erickson M. T., 1975, J LEARNING DISABILIT, V8, P52; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLLAND AL, 1982, APHASIA APHASIA PROB; Jurado MA, 2000, BRAIN INJURY, V14, P789; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SULLIVAN R, 2000, 6 ANN C APS COLL CLI; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	32	24	24	1	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	7					709	719		10.1080/02699050701468917			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400007	17653945				2022-02-06	
J	Blais, MC; Boisvert, JM				Blais, Marie Claude; Boisvert, Jean-Marie			Psychological adjustment and marital satisfaction following head injury. Which critical personal characteristics should both partners develop?	BRAIN INJURY			English	Article						traumatic brain injury; personal characteristics; psychological and marital adjustment	TRAUMATIC BRAIN-INJURY; COPING STRATEGIES; SELF-AWARENESS; FAMILY CAREGIVERS; DYADIC ADJUSTMENT; HOSPITAL ANXIETY; DEPRESSION; DISTRESS; SCALE; STRESS	Primary objective and research design: Using a correlational design, this study verifies the relationships between personal characteristics of individuals with TBI and their spouses and their level of psychological and marital adjustment. Methods and procedure: Seventy individuals with TBI and their spouses in the post-acute rehabilitation phase completed self-report questionnaires assessing the predictive variables ( coping and social problem- solving strategies; perceived communication skills) and the criteria variables of psychological and marital adjustment. Main outcomes and results: In the target group, the characteristics most strongly related to adjustment variables were an effective attitude towards problems, infrequent use of avoidance coping strategies, and a positive perception of one's spouse's communication skills. Individuals with TBI and their spouses report significantly lower scores on some of these personal characteristics, compared to those of a matched control group of 70 couples from the general population. Conclusions: Specific personal characteristics are critical for psychological and marital adjustment following TBI. This knowledge may be of relevance for detecting couples at risk for developing difficulties in the post-acute rehabilitation phase. Rehabilitation interventions targeting the personal characteristics identified as critical for the adjustment process could help to prevent these difficulties.	Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ G9A 5H7, Canada; Univ Laval, Sch Psychol, Quebec City, PQ, Canada		Blais, MC (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, CP 500,Pavillon, Trois Rivieres, PQ G9A 5H7, Canada.	Marie-Claude.Blais1@uqtr.ca					Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beaudry M., 2004, J DIVORCE REMARRIAGE, V42, P85, DOI DOI 10.1300/J087V42N01_04; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bodenmann G, 2001, SWISS J PSYCHOL, V60, P3, DOI 10.1024//1421-0185.60.1.3; BOUCHARD G, 1995, CAN J BEHAV SCI, V27, P371, DOI 10.1037/0008-400X.27.3.371; BOYD LA, 1977, J COUNS PSYCHOL, V24, P540; Bravo G, 1996, CAN J AGING, V15, P112, DOI 10.1017/S0714980800013325; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Cohen S., 1995, MEASURING STRESS GUI, P3; Crane DR, 2000, AM J FAM THER, V28, P53, DOI 10.1080/019261800261815; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; D'Zurilla T.J., 1990, PSYCHOL ASSESSMENT, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; DUGAS M, 1996, THERAPIE COMPORTEMEN, V6, P59; DUGAS MJ, 1995, COGNITIVE THER RES, V19, P109, DOI 10.1007/BF02229679; DUPUY HJ, 1978, SELF REPRESENTATION; DZURILLA TJ, 1995, COGNITIVE THER RES, V19, P547, DOI 10.1007/BF02230513; DZURILLA TJ, 1995, BEHAV THER, V26, P409, DOI 10.1016/S0005-7894(05)80091-7; EDWARDS DW, 1978, EVALUATION QUART, V2, P275, DOI 10.1177/0193841X7800200206; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; ELLIOTT TR, 1991, COGNITIVE THER RES, V15, P387, DOI 10.1007/BF01173033; ELLIOTT TR, 1995, J COUNS PSYCHOL, V42, P105, DOI 10.1037/0022-0167.42.1.105; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Ey S, 1998, J PSYCHOSOC ONCOL, V16, P59; Fazio A.F., 1977, CONCURRENT VALIDATIO; Finset A, 2000, BRAIN INJURY, V14, P887; Folkman, 1984, HDB BEHAV MED, P282, DOI DOI 10.1016/S0002-7138(09)61635-6; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Folkman S., 1988, WAYS COPING QUESTION; Freeston MH, 1997, PSYCHOL REP, V81, P419, DOI 10.2466/pr0.1997.81.2.419; GADOURY M, 1999, CADRE REFERENCE CLIN; Gortner ET, 1998, J CONSULT CLIN PSYCH, V66, P377, DOI 10.1037/0022-006X.66.2.377; GOSSELIN P, 2002, J THERAPIE COMPORTEM, V12, P49; GOTTMAN J, 1977, J MARRIAGE FAM, V39, P461, DOI 10.2307/350902; GROVER KJ, 1984, PSYCHOL REP, V54, P629, DOI 10.2466/pr0.1984.54.2.629; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Jacobson NS, 2000, J CONSULT CLIN PSYCH, V68, P351, DOI 10.1037/0022-006X.68.2.351; Julien D, 2000, CAN J BEHAV SCI, V32, P84, DOI 10.1037/h0087103; Karlovits T, 1999, BRAIN INJURY, V13, P845; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; Kosciulek JF, 1997, BRAIN INJURY, V11, P821, DOI 10.1080/026990597123034; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LOCKE HJ, 1959, MARRIAGE FAM LIVING, V21, P251, DOI 10.2307/348022; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; MARKMAN HJ, 1993, CLIN PSYCHOL REV, V13, P29, DOI 10.1016/0272-7358(93)90006-8; MARKMAN HJ, 1993, J CONSULT CLIN PSYCH, V61, P70, DOI 10.1037/0022-006X.61.1.70; MARKMAN HJ, 1984, MARITAL INTERACTION, P233; MARKMAN HJ, 1987, UNDERSTANDING MAJOR, P266; MARKMAN HJ, 1984, MARITAL INTERACTION; Martell C.R., 2001, DEPRESSION CONTEXT S; MIGNEAULT S, 2002, THESIS QUEBEC CANADA; Minnes P, 2000, BRAIN INJURY, V14, P737; MISHARA B, 1987, TRADUCTION FRANCAISE; MITCHELL SE, 1983, PSYCHOL REP, V53, P545, DOI 10.2466/pr0.1983.53.2.545; MONK M, 1981, CLIN INVEST MED, V4, P183; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PTACEK JT, 1994, J PSYCHOSOC ONCOL, V12, P47, DOI 10.1300/J077V12N03_04; Rath JF, 2003, REHABIL PSYCHOL, V48, P137, DOI 10.1037/0090-5550.48.3.137; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RENICK MJ, 1992, FAM RELAT, V41, P141, DOI 10.2307/584825; ROY R, 1985, INT J FAM THER, V7, P271, DOI 10.1007/BF00924028; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Sabourin S., 1985, INTERVENTION AUPRES; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Savard J, 1998, J PERS ASSESS, V71, P349, DOI 10.1207/s15327752jpa7103_5; SCHUMM WR, 1986, J MARRIAGE FAM, V48, P381, DOI 10.2307/352405; SCHUMM WR, 1983, PSYCHOL REP, V53, P583, DOI 10.2466/pr0.1983.53.2.583; SCHUMM WR, 1983, PSYCHOL REP, V53, P567, DOI 10.2466/pr0.1983.53.2.567; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; STEBBINS P, 1997, AUSTR J REHABILITATI, V3, P30; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; TURK DC, 1992, REHABIL PSYCHOL, V37, P259, DOI 10.1037/h0079108; WARE J, 1979, CONCEPTUALIZATION ME, V3; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; WHITE MB, 1994, FAMILY PERSPECTIVE, V0028, P00053; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	93	24	24	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	4					357	372		10.1080/02699050701311075			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	168IY	WOS:000246518600002	17487634				2022-02-06	
J	Rice, J; Philbin, N; Handrigan, M; Hall, C; McGwin, G; Ahlers, S; Pearce, LB; Arnaud, F; McCarron, R; Freilich, D				Rice, Jennifer; Philbin, Nora; Handrigan, Michael; Hall, Carrie; McGwin, Gerald; Ahlers, Stephen; Pearce, L. B.; Arnaud, Francoise; McCarron, Richard; Freilich, Daniel			Vasoactivity of bovine polymerized hemoglobin (HBOC-201) in swine with traumatic hemorrhagic shock with and without brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						hemoglobin based oxygen carrier; HBOC-201; hemorrhagic shock; resuscitation; blood pressure; vasoactivity; hypoperfusion	CROSS-LINKED HEMOGLOBIN; DELAYED EVACUATION; BLOOD SUBSTITUTE; OXYGEN CARRIER; LIVER-INJURY; VOLUME RESUSCITATION; HETASTARCH HEX; MODEL; TRANSFUSION; MULTICENTER	Background: We previously reported that bovine polymerized hemoglobin (HBOC- 201) improved outcome in swine with hemorrhagic shock (HS) with and without traumatic brain injury (TBI). Herein, we add analyses of blood pressure (BP) responses, associated physiologic data, and HS fluid infusion guidelines. Methods: HBOC-201 versus standard fluid resuscitation was compared in four anesthetized invasively monitored swine models: moderate controlled HS, severe controlled HS, severe uncontrolled HS (liver injury), and severe uncontrolled HS/TBI (liver/parietal brain injuries). Pigs received fluid for hypotension and tachycardia, and were followed up to 6 (HS alone) or 72 hours (HS/TBI). The change in mean arterial pressure (Delta MAP) response severity was stratified and analyzed based on infusion number and HS severity, using Student's t and Fisher's exact tests. Results: HBOC-201 vasoactivity resulted in higher MAP in all studies. Among HBOC-201 pigs, Delta MAP responses were significant for the first two infusions and inversely related to HS severity. Among controls, ANUP responses remained significant through the fourth infusion in controlled HS models, and through the first in severe uncontrolled HS/TBI; none were significant in severe uncontrolled HS. Delta MAP was higher with HBOC-201 through the first infusion in moderate controlled HS, the fifth in severe uncontrolled HS, and the second in severe uncontrolled HS/TBI; there were no group differences in severe controlled HS. No severe MAP responses occurred. Higher Delta MAP severity did not impact outcome. Hypotension satisfied fluid reinfusion criteria less consistently than tachycardia. Overall, HBOC-201 improved physiologic parameters and survival without causing hypoperfusion; in severe HS, perfusion improved. Conclusions: In swine with HS :t TBI, HBOC-201 had mild to moderate vasoactivity, resulting in significant ANUP responses mainly after initial infusions, no severe/adverse responses, and improved outcome. Our data suggest that use of physiologic parameters (e.g., tachycardia), in addition to hypotension to guide fluid reinfusion during HS resuscitation with HBOC-201, will minimize hypoperfusion risk and maximize potential benefit.	USN, Med Res Ctr, Combat Casualty Directorate, Silver Spring, MD 20910 USA; Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; Biopure Corp, Cambridge, MA USA		Freilich, D (corresponding author), USN, Med Res Ctr, Combat Casualty Directorate, Silver Spring, MD 20910 USA.	freilichd@nmrc.navy.mil					ABASSI Z, 1997, J LAB CLIN MED, V129, P580; Baldwin AL, 2002, AM J PHYSIOL-HEART C, V283, pH1292, DOI 10.1152/ajpheart.00221.2002; Butler FK, 2001, MIL MED, V166, P625, DOI 10.1093/milmed/166.7.625; Doyle MP, 1999, J BIOL CHEM, V274, P2583, DOI 10.1074/jbc.274.4.2583; ENZAN K, 1991, J APPL PHYSIOL, V71, P2231, DOI 10.1152/jappl.1991.71.6.2231; Fitzpatrick CM, 2004, J AM COLL SURGEONS, V199, P693, DOI 10.1016/j.jamcollsurg.2004.07.025; Freilich E, 2002, ARTIF CELL BLOOD SUB, V30, P83, DOI 10.1081/BIO-120003190; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Gould SA, 1996, WORLD J SURG, V20, P1200; Greenburg AG, 2004, J AM COLL SURGEONS, V198, P373, DOI 10.1016/j.jamcollsurg.2003.11.020; Gulati A, 1996, CRIT CARE MED, V24, P137, DOI 10.1097/00003246-199601000-00023; Gurney J, 2004, J TRAUMA, V57, P726, DOI 10.1097/01.TA.0000147520.84792.B4; Handrigan MT, 2005, SHOCK, V23, P337, DOI 10.1097/01.shk.0000156667.04628.1f; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; Johnson T, 2006, CRIT CARE MED, V34, P1464, DOI 10.1097/01.CCM.0000215824.85190.89; Katz LM, 2002, RESUSCITATION, V54, P77, DOI 10.1016/S0300-9572(02)00053-9; Kerner T, 2003, INTENS CARE MED, V29, P378, DOI 10.1007/s00134-002-1622-x; Knudson MM, 2003, J TRAUMA, V54, P242, DOI 10.1097/01.TA.0000037776.28201.75; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; LaMuraglia GM, 2000, J VASC SURG, V31, P299, DOI 10.1016/S0741-5214(00)90161-7; Lee SK, 2002, ACAD EMERG MED, V9, P969; Levy JH, 2002, J THORAC CARDIOV SUR, V124, P35, DOI 10.1067/mtc.2002.121505; LUNA GK, 1989, AM J SURG, V157, P512, DOI 10.1016/0002-9610(89)90649-1; Manning JE, 2001, CRIT CARE MED, V29, P2067, DOI 10.1097/00003246-200111000-00005; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; Maxwell RA, 2000, J TRAUMA, V49, P200, DOI 10.1097/00005373-200008000-00005; McNeil JD, 2001, J TRAUMA, V50, P1063, DOI 10.1097/00005373-200106000-00015; Moisan S, 1998, CAN J PHYSIOL PHARM, V76, P434, DOI 10.1139/cjpp-76-4-434; Philbin N, 2005, RESUSCITATION, V66, P367, DOI 10.1016/j.resuscitation.2005.03.019; RICE J, 2006, 35 CRIT CAR C SOC CR; Rice J, 2006, SHOCK, V26, P302, DOI 10.1097/01.shk.0000226338.48033.c2; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; Sampei K, 2005, AM J PHYSIOL-HEART C, V289, pH1191, DOI 10.1152/ajpheart.00251.2005; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHARMA AC, 1995, CRIT CARE MED, V23, P874, DOI 10.1097/00003246-199505000-00016; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sprung J, 2002, ANESTH ANALG, V94, P799, DOI 10.1097/00000539-200204000-00006; THOMPSON D, 1990, ANN EMERG MED, V19, P268, DOI 10.1016/S0196-0644(05)82042-6; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1411, DOI 10.1152/ajpheart.00307.2003; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; VLAHAKES GJ, 1990, J THORAC CARDIOV SUR, V100, P379; WANG Y, 1993, AM REV RESPIR DIS, V147, P927, DOI 10.1164/ajrccm/147.4.927; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F	44	24	24	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2006	61	5					1085	1099		10.1097/01.ta.0000236640.62893.fa			15	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	105TB	WOS:000242054100010	17099513				2022-02-06	
J	Dombrowski, SM; Schenk, S; Leichliter, A; Leibson, Z; Fukamachi, K; Luciano, MG				Dombrowski, Stephen M.; Schenk, Soren; Leichliter, Anna; Leibson, Zack; Fukamachi, Kiyotaka; Luciano, Mark G.			Chronic hydrocephalus-induced changes in cerebral blood flow: mediation through cardiac effects	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						aquaductal stenosis; autoregulation; canine; cerebrovascular; compliance	NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; ELECTROCARDIOGRAPHIC CHANGES; VENTRICULOPERITONEAL SHUNT; OBSTRUCTIVE HYDROCEPHALUS; CEREBROSPINAL-FLUID; MATHEMATICAL-MODEL	Decreased cerebral blood flow (CBF) in hydrocephalus is believed to be related to increased intracranial pressure (ICP), vascular compression as the result of enlarged ventricles, or impaired metabolic activity. Little attention has been given to the relationship between cardiac function and systemic blood flow in chronic h ydrocephalus (CH). Using an experimental model of chronic obstructive hydrocephalus developed in our laboratory, we investigated the relationship between the duration and severity of hydrocephalus and cardiac output (CO), CBF, myocardial tissue perfusion (MTP), and peripheral blood flow (PBF). Blood flow measures were obtained using the microsphere injection method under controlled hemodynamic conditions in experimental CH (n = 23) and surgical control (n = 8) canines at baseline and at 2, 4, 8, 12, and 16 weeks. Cardiac output measures were made using the Swan-Ganz thermodilution method. Intracranial compliance (ICC) via cerebrospinal fluid (CSF) bolus removal and infusion, and oxygen delivery in CSF and prefrontal cortex (PFC) were also investigated. We observed an initial surgical effect relating to 30% CO reduction and similar to 50% decrease in CBF, MTP, and PBF in both groups 2 weeks postoperatively, which recovered in control animals but continued to decline further in CH animals at 16 weeks. Cerebral blood flow, which was positively correlated with CO (P = 0.028), showed no significant relationship with either CSF volume or pressure. Decreased CBF correlated with oxygen deprivation in PFC (P = 0.006). Cardiac output was inversely related with ventriculomegaly (P = 0.019), but did not correlate with ICP. Decreased CO corresponded to increased ICC, as measured by CSF infusion (P = 0.04). Our results suggest that CH may have more of an influence on CO and CBF in the chronic stage than in the early condition, which was dominated by surgical effect. The cause of this late deterioration of cardiac function in hydrocephalus is uncertain, but may reflect cardiac regulation secondary to physiologic response or brain injury. The relationship between cardiac function and CBF should be considered in the pathophysiology and clinical treatment of CH.	Cleveland Clin Fdn, Dept Neurol Surg Pediat & Congenital Neurol Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA		Dombrowski, SM (corresponding author), Cleveland Clin Fdn, Dept Neurosurg, 9500 Euclid Ave,S-80, Cleveland, OH 44195 USA.	dombros@ccf.org			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 R01 NS4153353-01A1] Funding Source: Medline		Bateman GA, 2005, NEURORADIOLOGY, V47, P741, DOI 10.1007/s00234-005-1418-0; Bateman GA, 2004, MED HYPOTHESES, V62, P182, DOI 10.1016/S0306-9877(03)00330-X; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; CASMIRO M, 1989, J NEUROL NEUROSUR PS, V52, P847, DOI 10.1136/jnnp.52.7.847; Chang CC, 1999, NUCL MED COMMUN, V20, P167, DOI 10.1097/00006231-199902000-00009; CROPP GJ, 1960, CIRCULATION, V22, P25, DOI 10.1161/01.CIR.22.1.25; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka ZH, 2002, NEUROSURGERY, V50, P526, DOI 10.1097/00006123-200203000-00018; DASILVA MC, 1995, J CEREBR BLOOD F MET, V15, P1057, DOI 10.1038/jcbfm.1995.132; DAVIS DH, 1980, J NEUROSURG, V52, P745, DOI 10.3171/jns.1980.52.6.0745; de Hoon JN, 2003, CEPHALALGIA, V23, P96, DOI 10.1046/j.1468-2982.2003.00465.x; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; DELBIGIO MR, 1988, J NEUROSURG, V69, P115, DOI 10.3171/jns.1988.69.1.0115; DELBIGIO MR, 1988, ACTA NEUROPATHOL, V77, P186, DOI 10.1007/BF00687430; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DICKER D, 1983, ISRAEL J MED SCI, V19, P364; Edwards RJ, 2004, BRAIN PATHOL, V14, P325; Elrifai AM, 1996, STROKE, V27, P737, DOI 10.1161/01.STR.27.4.737; Fukuhara T, 2001, J NEUROSURG, V94, P573, DOI 10.3171/jns.2001.94.4.0573; GOH D, 1995, CHILD NERV SYST, V11, P392, DOI 10.1007/BF00717403; GRAFFRADFORD NR, 1987, NEUROLOGY, V37, P868, DOI 10.1212/WNL.37.5.868; GRAFFRADFORD NR, 1987, J NEUROL NEUROSUR PS, V50, P1589, DOI 10.1136/jnnp.50.12.1589; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; GREITZ D, 1992, NEURORADIOLOGY, V34, P370, DOI 10.1007/BF00596493; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; HERSCH C, 1964, BRIT HEART J, V26, P785; HIGASHI K, 1986, Neurological Research, V8, P169; IBAYASHI S, 1986, STROKE, V17, P261, DOI 10.1161/01.STR.17.2.261; Johnson MJ, 1999, J NEUROSCI METH, V91, P55, DOI 10.1016/S0165-0270(99)00072-2; JONES HC, 1993, J CEREBR BLOOD F MET, V13, P531, DOI 10.1038/jcbfm.1993.69; Kadas ZM, 1997, NEUROL RES, V19, P441, DOI 10.1080/01616412.1997.11740840; Kawamata T, 2003, ACTA NEUROCHIR SUPPL, V86, P545; Klinge P, 2002, ACT NEUR S, V81, P47; Klinge P, 2002, ACTA NEUROCHIR SUPPL, V81, P39; Klinge PM, 2003, STROKE, V34, P193, DOI 10.1161/01.STR.0000048820.17198.15; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Lakin WD, 2003, J MATH BIOL, V46, P347, DOI 10.1007/s00285-002-0177-3; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; LARSSON A, 1994, EUR J NUCL MED, V21, P118; Lieb K, 1996, J NEUROCHEM, V67, P2039; Luciano MG, 2001, J CEREBR BLOOD F MET, V21, P285, DOI 10.1097/00004647-200103000-00012; MABE H, 1990, CHILD NERV SYST, V6, P388, DOI 10.1007/BF00302224; MAMO HL, 1987, STROKE, V18, P1074, DOI 10.1161/01.STR.18.6.1074; MARION DW, 1986, NEUROSURGERY, V18, P101, DOI 10.1227/00006123-198601000-00019; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Mataro M, 2003, J NUCL MED, V44, P1884; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; Minhas PS, 2004, NEUROSURGERY, V55, P63, DOI 10.1227/01.NEU.0000126876.10254.05; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Mori K, 2002, ACTA NEUROCHIR, V144, P255, DOI 10.1007/s007010200033; NAKADA J, 1992, ACTA NEUROCHIR, V114, P43, DOI 10.1007/BF01401113; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Owler BK, 2004, J CEREBR BLOOD F MET, V24, P17, DOI 10.1097/01.WCB.0000093326.88757.49; Owler BK, 2001, ACTA NEUROL SCAND, V104, P325, DOI 10.1034/j.1600-0404.2001.00092.x; Reinhardt CP, 2001, AM J PHYSIOL-HEART C, V280, pH108, DOI 10.1152/ajpheart.2001.280.1.H108; RUDEHILL A, 1987, ACTA ANAESTH SCAND, V31, P265, DOI 10.1111/j.1399-6576.1987.tb02563.x; RUDEHILL A, 1987, J NEUROL NEUROSUR PS, V50, P1375, DOI 10.1136/jnnp.50.10.1375; Rupprecht T, 2001, ULTRASCHALL MED, V22, P122, DOI 10.1055/s-2001-15241; Silvestrini M, 2004, HEADACHE, V44, P29, DOI 10.1111/j.1526-4610.2004.04006.x; TALMAN WT, 1985, ANN NEUROL, V18, P1, DOI 10.1002/ana.410180102; Tanaka A, 1997, NEUROSURGERY, V40, P1161, DOI 10.1097/00006123-199706000-00009; TRANMER BI, 1992, J NEUROSURG, V77, P253, DOI 10.3171/jns.1992.77.2.0253; Ursino M, 2003, MED ENG PHYS, V25, P655, DOI 10.1016/S1350-4533(02)00251-5; van Aken J, 2003, MINIM INVAS NEUROSUR, V46, P198; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; Williams DJ, 2001, CLIN EXP PHARMACOL P, V28, P868, DOI 10.1046/j.1440-1681.2001.03540.x; WOZNIAK M, 1975, J NEUROSURG, V43, P535, DOI 10.3171/jns.1975.43.5.0535; Zierski J, 1987, Acta Neurochir Suppl (Wien), V40, P95	69	24	25	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2006	26	10					1298	1310		10.1038/sj.jcbfm.9600282			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	087MO	WOS:000240746700008	16495938	Bronze			2022-02-06	
J	Klasner, B; Lumenta, DB; Pruneau, D; Zausinger, S; Plesnila, N				Klaesner, Benjamin; Lumenta, David B.; Pruneau, Didier; Zausinger, Stefan; Plesnila, Nikolaus			Therapeutic window of bradykinin B-2 receptor inhibition after focal cerebral ischemia in rats	NEUROCHEMISTRY INTERNATIONAL			English	Article						focal cerebral ischemia; stroke; kallilcrein-kinin system; bradykinin; kinin receptors; bradykinin B-2 receptor; inhibition; rats	VASOGENIC BRAIN EDEMA; KALLIKREIN-KININ SYSTEM; CLOSED-HEAD TRAUMA; LF 16-0687 MS; REGIONAL-DISTRIBUTION; BINDING-SITES; ANTAGONIST; INJURY; MODEL; MEDIATOR	Following cerebral ischemia bradykinin/kinin B-2 receptors mediate inflammatory responses resulting in edema formation and secondary brain damage. However, the therapeutic window for B-2 receptor inhibition determining its potential clinical use has not been investigated so far. The aim of the current study was therefore to investigate the effect of delayed B-2 receptor inhibition on morphological and functional outcome following experimental stroke. Rats were subjected to 90 min of middle cerebral artery occlusion(MCAo) by an intraluminal filament. Animals received 0.9% NaCl or 1.0 mg/kg/day Anatibant (LF 16-0687 Ms), a selective bradykinin 13, receptor antagonist, for 3 days beginning at different time points after MCAo: 1, 2.5, 4.5, or 6.5 h (n = 10 per group). Neurological recovery was examined daily, infarct volume on day 7 after MCAo. Animal physiology was not influenced by B-2 receptor inhibition. Significant improvement of functional outcome was observed when treatment was delayed up to 4.5 It after ischemia (p < 0.05 versus vehicle). Inhibition of B-2 receptors during ischemia, i.e. when the inhibitor was given I h after MCAo, reduced infarct volume in the basal ganglia and in the cortex by 49% (p < 0.05) and 26% (p < 0.05), resp < ectively. Inhibition of B-2 receptors at later time points (2.5, 4.5, or 6.5 after MCAo) reduced penumbral damage, i.e. cortical infarction, by 19-26% (p < 0.05). In conclusion, the current study shows that the therapeutic window of B-2 receptor inhibition extends for up to 6.5 h after MCAo. Our data therefore suggest that inhibition of kinin B-2 receptors represents a treatment strategy for ischemic stroke which may warrant clinical validation. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Munich, Klinikum Grosshadern, Med Ctr, Dept Neurosurg,Lab Expt Neurosurg, D-81377 Munich, Germany; Univ Munich, Klinikum Grosshadern, Med Ctr, Inst Surg Res, D-81377 Munich, Germany; Fournier Pharma, Ctr Rech, Grp Pharmacochim Recepteurs, Daix, France		Plesnila, N (corresponding author), Univ Munich, Klinikum Grosshadern, Med Ctr, Dept Neurosurg,Lab Expt Neurosurg, Marchioninistr 15, D-81377 Munich, Germany.	plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019; Lumenta, David Benjamin/AAD-5935-2019	Lumenta, David Benjamin/0000-0003-0903-252X			Asa I, 2003, J TRAUMA, V54, P881, DOI 10.1097/01.TA.0000046700.45106.4B; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Chalela JA, 2004, CURR OPIN NEUROL, V17, P447, DOI 10.1097/01.wco.0000137536.06986.f9; CHAO J, 1983, J BIOL CHEM, V258, P5173; Chen Er-Yun, 2000, Journal of Comparative Neurology, V427, P1; CHOLEWINSKI AJ, 1991, J NEUROCHEM, V57, P1456, DOI 10.1111/j.1471-4159.1991.tb08314.x; CORREA FMA, 1979, P NATL ACAD SCI USA, V76, P1489, DOI 10.1073/pnas.76.3.1489; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; FRANCEL PC, 1992, J NEUROTRAUM, V9, pS27; GARCIA JH, 1992, J NEUROPATH EXP NEUR, V51, P387, DOI 10.1097/00005072-199207000-00001; GARCIA JH, 1993, AM J PATHOL, V142, P623; GIMPL G, 1992, NEUROSCI LETT, V144, P139, DOI 10.1016/0304-3940(92)90735-P; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; HOSLI E, 1993, NEUROREPORT, V4, P159; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; Kamiya T, 1990, Adv Neurol, V52, P543; Kamiya T, 1990, Nihon Ika Daigaku Zasshi, V57, P180; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; KARIYA K, 1981, J NEUROCHEM, V36, P2086, DOI 10.1111/j.1471-4159.1981.tb10838.x; KARIYA K, 1982, BIOCHEM BIOPH RES CO, V107, P1461, DOI 10.1016/S0006-291X(82)80163-0; KARIYA K, 1985, J NEUROCHEM, V44, P1892, DOI 10.1111/j.1471-4159.1985.tb07185.x; KLENIEWSKI J, 1980, EXPERIENTIA, V36, P354, DOI 10.1007/BF01952323; Lehmberg J, 2003, J CEREBR BLOOD F MET, V23, P441, DOI 10.1097/01.WCB.0000052280.23292.35; Li DZ, 2003, BRIT J PHARMACOL, V139, P1539, DOI 10.1038/sj.bjp.0705385; Lorenzl S, 1996, EUR J PHARMACOL, V308, P335, DOI 10.1016/0014-2999(96)00375-5; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Noda M, 2003, LIFE SCI, V72, P1573, DOI 10.1016/S0024-3205(02)02449-9; Pan WH, 2001, NEUROSCI LETT, V307, P25, DOI 10.1016/S0304-3940(01)01904-8; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; Pruneau D, 1999, IMMUNOPHARMACOLOGY, V43, P187, DOI 10.1016/S0162-3109(99)00128-9; Pruneau D, 1998, BRIT J PHARMACOL, V125, P365, DOI 10.1038/sj.bjp.0702083; Raidoo DM, 1996, IMMUNOPHARMACOLOGY, V33, P104, DOI 10.1016/0162-3109(96)00021-5; Relton JK, 1997, STROKE, V28, P1430, DOI 10.1161/01.STR.28.7.1430; RELTON JK, 1996, BRIT J PHARMACOL, V120, pC81; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; Schwaninger M, 1999, J NEUROCHEM, V73, P1461, DOI 10.1046/j.1471-4159.1999.0731461.x; SCICLI AG, 1984, CLIN EXP HYPERTENS A, V6, P1731, DOI 10.3109/10641968409046068; STEPHENS GJ, 1993, NEUROSCI LETT, V153, P223, DOI 10.1016/0304-3940(93)90327-H; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; UNTERBERG A, 1984, J NEUROSURG, V61, P87, DOI 10.3171/jns.1984.61.1.0087; WAHL M, 1983, J CEREBR BLOOD F MET, V3, P231, DOI 10.1038/jcbfm.1983.31; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; WHITTLE IR, 1992, ACTA NEUROCHIR, V115, P53, DOI 10.1007/BF01400591; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yong T, 1996, BRAIN INJURY, V10, P385, DOI 10.1080/026990596124395; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	55	24	26	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	OCT	2006	49	5					442	447		10.1016/j.neuint.2006.02.010			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	080CX	WOS:000240225600003	16624448				2022-02-06	
J	O'Callaghan, C; Powell, T; Oyebode, J				O'Callaghan, Catherine; Powell, Theresa; Oyebode, Jan			An exploration of the experience of gaining awareness of deficit in people who have suffered a traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							IMPAIRED SELF-AWARENESS; ALZHEIMERS-DISEASE; HEAD-INJURY; ANOSOGNOSIA; MODEL; UNAWARENESS; DYSFUNCTION; NARRATIVES; KNOWLEDGE; ILLNESS	Gaining awareness of deficits was explored in 10 people with moderate to severe traumatic brain injury (TBI) using a semi-structured interview and interpretative phenomenological analysis. Eight master themes emerged from the transcripts. Knowledge of deficits was acquired through personal discovery and the reactions of others, often outside the rehabilitation environment. Rehabilitation provided explanations and a normalising and supportive environment that facilitated people in acknowledging their deficits. Most participants spontaneously referred to denial and saw this as an active cognitive and behavioural process that both helped and hindered recovery. The emotional reaction to learning about deficits was described largely in terms of fear and loss and resonates with psychological models of grief.	Univ Birmingham, Dept Clin Psychol, Birmingham B15 2TT, W Midlands, England		Powell, T (corresponding author), Univ Birmingham, Dept Clin Psychol, Birmingham B15 2TT, W Midlands, England.	t.powell@bham.ac.uk		Oyebode, Jan/0000-0002-0263-8740; Powell, Theresa/0000-0002-3351-9453			Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Barco PP, 1991, COGNITIVE REHABILITA, P129; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Chittum WR, 1996, BRAIN INJURY, V10, P763; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P155, DOI 10.1348/014466504323088033; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dalla Barba G, 1999, NEUROCASE, V5, P59, DOI 10.1093/neucas/5.1.59; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Fleming JM, 1996, BRAIN INJURY, V10, P1; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Goldbeck R, 1997, J PSYCHOSOM RES, V43, P575, DOI 10.1016/S0022-3999(97)00168-2; Goldstein K, 1942, EFFECTS BRAIN INJURI; Goldstein K., 1939, ORGANISM; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; LEVINE J, 1994, J PSYCHOSOM RES, V38, P99, DOI 10.1016/0022-3999(94)90083-3; LEVINE J, 1975, J CONSULT CLIN PSYCH, V43, P751; Malan D. H., 1995, INDIVIDUAL PSYCHOTHE; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Meredith K., 1999, J COGNITIVE REHABILI, V17, P10; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Rubin SS, 1999, DEATH STUD, V23, P681, DOI 10.1080/074811899200731; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SMITH JA, 2001, QUALITATIVE PSYCHOL, P51; TINDALL C, 1994, QUALITATIVE METHODSE; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Wallace CA, 2000, BRAIN INJURY, V14, P549; Zhou J, 1996, J HEAD TRAUMA REHAB, V11, P51, DOI 10.1097/00001199-199602000-00007	44	24	24	0	12	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT	2006	16	5					579	593		10.1080/09602010500368834			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	096FI	WOS:000241362600004	16952894				2022-02-06	
J	Schonberger, M; Humle, F; Zeeman, P; Teasdale, TW				Schoenberger, Michael; Humle, Frank; Zeeman, Peter; Teasdale, Thomas W.			Patient compliance in brain injury rehabilitation in relation to awareness and cognitive and physical improvement	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							SUBJECTIVE EXPERIENCE; CLOSE RELATIVES; INTERVENTION; EXERCISE; STROKE	The purpose of the present study was to investigate the relationship between patients' compliance and awareness and outcome of brain injury rehabilitation. Subjects were 98 patients who underwent a holistic neuropsychological outpatient rehabilitation programme. Patients had suffered a traumatic brain injury (n = 26), a cerebrovascular accident (n = 58), or another neurological insult (n = 14). Measures: Two staff members, a neuropsychologist and a physiotherapist, retrospectively and separately rated patients' awareness and their compliance. Outcome was measured with the d2 test of concentration, measures of oxygen uptake, strength endurance, running speed, and patients' and relatives' ratings of patients' cognitive, physical, and overall problems on the European Brain Injury Questionnaire (EBIQ). The discrepancy between patients' and relatives' ratings on the EBIQ was incorporated as a second measure of patients' awareness. Results: The neuropsychologist's compliance ratings were significantly related to measures of insight, improvement of d2 performance accuracy and stability, improvement of oxygen uptake, and reduction of cognitive and overall problems as reported by the patients, while the physiotherapist's compliance ratings were related to measures of insight, improvement of d2 performance speed, improvement of oxygen uptake and strength endurance, and all three EBIQ patient scales. Discussion: The results suggest a differential relationship between situation-specific compliance and outcome.	Univ Copenhagen, Ctr Rehabil Brain Injury, DK-2300 Copenhagen S, Denmark		Schonberger, M (corresponding author), Univ Copenhagen, Ctr Rehabil Brain Injury, Njalsgade 88, DK-2300 Copenhagen S, Denmark.	michael@cfh.ku.dk					Astrand PO, 1986, TXB WORK PHYSL; Brickenkamp R., 1981, AUFMERKSAMKEITS BELA; CAETANO C, 2000, INT HDB NEUROPSYCHOL, P259; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FLEMING J, 1995, BRIT J OCCUPATIONAL, V98, P55; Hesse S, 2001, ARCH PHYS MED REHAB, V82, P1547, DOI 10.1053/apmr.2001.26607; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Kime SK, 1996, BRAIN INJURY, V10, P17; Kramer AF, 2003, J MOL NEUROSCI, V20, P213, DOI 10.1385/JMN:20:3:213; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Meichenbaum D., 1987, FACILITATING TREATME; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Pepping M, 2003, NEURO S B C, P313; Petermann F., 1998, COMPLIANCE SELBSTMAN, P73; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RASMUSSEN G, 1995, PHYSIOTHERAPY STROKE, P295; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; SCHONBERGER M, 2004, UNAWARENESS; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; SOHLBERG MM, 2001, COGNITIVE REHABILIAT; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P434, DOI 10.1016/j.neuropsychologia.2003.09.001; STURM W, 1993, DEV ASSESSMENT REHAB, P49; STURM W, 1999, APPL NEUROPSYCHOLOGY; Sturm W., 1994, Z NEUROPSYCHOL, V5, P15; Stuss D. T., 1999, COGNITIVE NEUROREHAB, P188; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; VOLMER T, 1998, COMPLIANCE SELBSTMAN, P45; Wannamethee SG, 1999, J CARDIOVASC RISK, V6, P213	34	24	24	2	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT	2006	16	5					561	578		10.1080/09602010500263084			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	096FI	WOS:000241362600003	16952893				2022-02-06	
J	Corbett, SM; Moore, J; Rebuck, JA; Rogers, FB; Greene, CM				Corbett, Stephanie Mallow; Moore, Jesse; Rebuck, Jill A.; Rogers, Frederick B.; Greene, Christopher M.			Survival of propofol infusion syndrome in a head-injured patient	CRITICAL CARE MEDICINE			English	Article						propofol; acidosis; brain injuries; intracranial pressure; catecholamines	METABOLIC-ACIDOSIS; LACTIC-ACIDOSIS; CATECHOLAMINE CARDIOTOXICITY; INTENSIVE-CARE; ADULT; ANESTHESIA; RHABDOMYOLYSIS; DYSFUNCTION; CHILDREN; FAILURE	Objective. To describe the clinical progression of an adult patient with traumatic brain injury who. survived propofol infusion syndrome. Design. Case report. Setting: Tertiary care surgical intensive care unit. Patient. A 21-yr-old male with traumatic brain injury was administered high doses of propofol for sedation and intracranial pressure control combined with vasopressor therapy to maintain cerebral perfusion pressure >60 mmHg. He developed a significant metabolic acidosis with a lactic acid level of 10.9 mmol/L. Interventions: Exploratory laparotomy, discontinuation of propofol infusion. Measurements and Main Results, An exploratory abdominal laparotomy was negative for traumatic injury. During the procedure, the propofol infusion was considered a possible cause and was discontinued. On review, it became apparent that a combination of high-dose propofol and catecholamines were responsible for the lactic acidosis. An echocardiogram revealed severe left ventricular dysfunction and cardiomyopathy, which resolved within 19 days. Conclusions: High-dose propofol should be avoided and alternative agents should be instituted for sedation and intracranial pressure management. The use of catecholamine infusions to maintain cerebral perfusion pressure in the setting of a high-dose propofol infusion may be pharmacologically unsound and may be a triggering factor for propofol infusion syndrome. Identification of the syndrome and discontinuation of propofol resulted in complete reversal of symptoms in the case described.	Univ Vermont, Coll Med, Dept Surg, Div Trauma Crit Care, Burlington, VT 05405 USA; Fletcher Allen Hlth Care, Dept Pharmacotherapy, Burlington, VT USA; Fletcher Allen Hlth Care, Dept Anesthesiol, Burlington, VT USA		Corbett, SM (corresponding author), Univ Vermont, Coll Med, Dept Surg, Div Trauma Crit Care, Burlington, VT 05405 USA.						Akashi YJ, 2002, J ELECTROCARDIOL, V35, P351, DOI 10.1054/jelc.2002.36277; Burow BK, 2004, ANESTHESIOLOGY, V101, P239, DOI 10.1097/00000542-200407000-00035; Cannon ML, 2001, J NEUROSURG, V95, P1053, DOI 10.3171/jns.2001.95.6.1053; Cray SH, 1998, CRIT CARE MED, V26, P2087, DOI 10.1097/00003246-199812000-00046; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Culp KE, 2004, ANESTH ANALG, V99, P221, DOI [10.1213/01.ANE.0000117285.12600.C1, 10.1213/01.ane.0000117285.12600.c1]; Girard F, 2004, ANESTH ANALG, V99, P573, DOI 10.1213/01.ANE.0000133138.86133.38; Johnson KB, 2004, ANESTHESIOLOGY, V101, P647, DOI 10.1097/00000542-200409000-00013; Kang TM, 2002, ANN PHARMACOTHER, V36, P1453; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kelly DF, 2001, J NEUROSURG, V95, P925, DOI 10.3171/jns.2001.95.6.0925; Koch M, 2004, INTENS CARE MED, V30, P522, DOI 10.1007/s00134-003-2130-3; Kurita T, 2004, ANESTHESIOLOGY, V100, P871, DOI 10.1097/00000542-200404000-00017; Liolios A, 2005, ANESTH ANALG, V100, P1804, DOI 10.1213/01.ANE.0000153017.93666.BF; Machata AM, 2005, J TRAUMA, V58, P643, DOI 10.1097/01.TA.0000159697.03562.D6; Marinella MA, 1996, CHEST, V109, P292, DOI 10.1378/chest.109.1.292; Myburgh JA, 2001, INTENS CARE MED, V27, P276, DOI 10.1007/s001340000793; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; Perrier ND, 2000, CRIT CARE MED, V28, P3071, DOI 10.1097/00003246-200008000-00066; Rigby-Jones AE, 2002, ANESTHESIOLOGY, V97, P1393, DOI 10.1097/00000542-200212000-00010; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Salengros JC, 2004, ANESTHESIOLOGY, V101, P241, DOI 10.1097/00000542-200407000-00036; Shafer SL, 2004, ANESTHESIOLOGY, V101, P567, DOI 10.1097/00000542-200409000-00002; Stelow EB, 2000, CLIN CHEM, V46, P577; Takizawa D, 2005, CAN J ANAESTH, V52, P463, DOI 10.1007/BF03016523; Vane LA, 2004, ANESTHESIOLOGY, V101, P1136, DOI 10.1097/00000542-200411000-00013; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Wolf A, 2001, LANCET, V357, P606, DOI 10.1016/S0140-6736(00)04064-2; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007	29	24	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2006	34	9					2479	2483		10.1097/01.CCM.0000230238.72846.B3			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077EK	WOS:000240010400028	16791112				2022-02-06	
J	Haber, AH; Fichtenberg, NL				Haber, Adele H.; Fichtenberg, Norman L.			Replication of the Test of Memory Malingering (TOMM) in a traumatic brain injury and head trauma sample	CLINICAL NEUROPSYCHOLOGIST			English	Article							COGNITIVELY INTACT; NORMATIVE DATA; VALIDATION; DEPRESSION	The purpose of the current study was to replicate the clinical validation study of the Test of Memory Malingering (Tombaugh, 19961997). Fifty cases were selected from two different participant pools: medically documented traumatic brain-injury patients and compensation-seeking, mild head trauma cases. Results replicated and expanded those found by Tombaugh and indicated that employing a Trial 2 cutting score of greater than 5 errors provided adequate sensitivity to suboptimal effort while demonstrating remarkable insensitivity to cognitively impaired traumatic brain-injury cases. Use of a lower cutting score (e.g., 2 to 5 errors) is also discussed.	Tampa Gen Hosp, Rehabil Ctr, Tampa, FL 33601 USA; Inst Rehabil Michigan, Detroit, MI USA		Haber, AH (corresponding author), Tampa Gen Hosp, Rehabil Ctr, POB 1289, Tampa, FL 33601 USA.	ahaber@tgh.org					Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Colby F, 2001, NEUROREHABILITATION, V16, P253; Delain SL, 2003, ASSESSMENT, V10, P370, DOI 10.1177/1073191103259156; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gutheil TG, 2003, J AM ACAD PSYCHIATRY, V31, P6; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; Weinborn M, 2003, J CLIN EXP NEUROPSYC, V25, P979, DOI 10.1076/jcen.25.7.979.16481	17	24	24	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					524	532		10.1080/13854040590967595			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000012	16895863				2022-02-06	
J	Kilmer, RP; Demakis, GJ; Hammond, FM; Grattan, KE; Cook, JR; Kornev, AA				Kilmer, Ryan P.; Demakis, George J.; Hammond, Flora M.; Grattan, Karen E.; Cook, James R.; Kornev, Aleksandr A.			Use of the neuropsychiatric inventory in traumatic brain injury: A pilot investigation	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; assessment; Neuropsychiatric Inventory	COGNITIVE STATUS EXAMINATION; CLOSED-HEAD-INJURY; ALZHEIMERS-DISEASE; PRACTICAL SCALE; FAMILY MEMBERS; SELF-AWARENESS; CAREGIVER; DEMENTIA; DISTURBANCES; CONCORDANCE	Objective: The goal of this investigation was to pilot the Neuropsychiatric Inventory (NPI) among individuals with traumatic brain injury (TBI) and their caregivers, assessing its screen-metric approach. Design and Participants: Using the NPI, caregivers rated neurobehavioral disturbances in 5 1 individuals with moderate-to-severe TBI. The NPI was completed 1 or 2 years after the individuals were injured. Results: Caregivers reported the highest symptom levels for participants on h-ritability/Lability, Apathy, and Agitation/Aggression, and rated greater levels of distress tied to those domains and to Dysphoria. Caregivers endorsing domain screening items endorsed significantly more metric items (vs. screen non-endorsers) within that domain, as would be expected if the screen accurately measured the psychopathology under consideration. In addition, the screen-metric yielded extremely low false-positive rates, although 5 of the 12 domains had elevated false-negative rates. Conclusions: Findings provide preliminary support for the accuracy of the NPI's screen-metric in this population and are consistent with prior work detailing common problematic neurobehavioral consequences of TBI. These results lay groundwork for research and clinical use of this measure in populations with TBI.	Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA		Kilmer, RP (corresponding author), Univ N Carolina, Dept Psychol, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	rpkilmer@email.uncc.edu					Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL; COHEN J, 1908, STAT POWER ANAL BEHA; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Greene J G, 1982, Age Ageing, V11, P121, DOI 10.1093/ageing/11.2.121; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; HAYS WL, 1988, STATISTICS; Kaufer D, 1998, J NEUROPSYCH CLIN N, V10, P55, DOI 10.1176/jnp.10.1.55; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levy ML, 1996, ARCH NEUROL-CHICAGO, V53, P687, DOI 10.1001/archneur.1996.00550070129021; LEZAK MD, 2003, MAYO PORTLAND ADAPTA; Litvan I, 1996, NEUROLOGY, V47, P1184, DOI 10.1212/WNL.47.5.1184; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Marcotte TD, 1997, J CLIN EXP NEUROPSYC, V19, P386, DOI 10.1080/01688639708403867; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Morey L. C., 1996, INTERPRETIVE GUIDE P; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Oehlert ME, 1997, J CLIN PSYCHOL, V53, P733, DOI 10.1002/(SICI)1097-4679(199711)53:7<733::AID-JCLP11>3.0.CO;2-M; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; REISBERG B, 1987, J CLIN PSYCHIAT, V48, P9; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; Yates William R., 1996, P305	43	24	24	0	3	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2006	51	3					232	238		10.1037/0090-5550.51.3.232			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	072OK	WOS:000239682500006					2022-02-06	
J	Rush, BK; Malec, JF; Brown, AW; Moessner, AM				Rush, Beth K.; Malec, James F.; Brown, Allen W.; Moessner, Anne M.			Personality and functional outcome following traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; personality; outcome	SELF-AWARENESS; HEAD-INJURY; PREDICTION; SEVERITY; TRAITS; IMPACT	Obiective: To investigate pre- to postinjury personality change in relation to outcomes following traumatic brain injury (TBI). Design: Prospective analysis of personality ratings, depression, and outcome using multiple regression analyses. Participants: Cohort of 3 clinical trauma groups (mild TBI, moderate-severe TBI, orthopedic injury) and their significant others (SO). Outcome Measures: Independent Living Scale, Vocational Independence Scale, and Mayo-Portland Adaptability Inventory, 1-2 years postinjury. Predictor Variables: Posttraumatic amnesia (PTA); patient and SO NEO Personality Inventory-Revised ratings of preinjury personality taken at 1-2 months postinjury. Results: Personality function was normal for all groups (regardless of rating source) and stable over time. Neuroticism, and specifically depression, accounted for small proportions of variance in functional outcome, beyond PTA. Conclusions: There is little empirical evidence for significant personality disturbance or change up to 2 years post-TBI. Personality and depression contribute modestly to functional outcomes. Results support a distinction between "personality change" and behavior change following TBI.	Mayo Clin, Dept Psychiat & Psychol, Coll Med, Jacksonville, FL 32224 USA; Mayo Clin, Dept Psychiat Med & Rehabil, Coll Med, Jacksonville, FL 32224 USA; Mayo Clin, Dept Nursing, Coll Med, Jacksonville, FL 32224 USA; Mayo Clin, Coll Med, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA		Rush, BK (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Coll Med, 4500 San Pablo Rd,Minnesota Campus, Jacksonville, FL 32224 USA.	rush.beth@mayo.edu		Brown, Allen W./0000-0001-7228-3351			Bond T, 2001, APPL RASCH MODEL FUN; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; COSTA JPT, 1992, PROFESSIONAL MANUAL; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; GOLDSTEIN FC, 1989, INTEGRATING THEORY P, P217; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; JOHNSON O, 1991, POLYCYCL AROMAT COMP, V2, P155; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; MALEC JF, 2003, ANN M INT BRAIN INJ; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P854; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372	26	24	24	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2006	51	3					257	264		10.1037/0090-5550.51.3.257			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	072OK	WOS:000239682500009					2022-02-06	
J	Tehranian, R; Rose, ME; Vagni, V; Griffith, RP; Wu, SS; Maits, S; Zhang, XP; Clark, RSB; Dixon, CE; Kochanek, PM; Bernard, O; Graham, SH				Tehranian, Roya; Rose, Marie E.; Vagni, Vincent; Griffith, R. P.; Wu, Shasha; Maits, Sara; Zhang, Xiaopeng; Clark, Robert S. B.; Dixon, C. Edward; Kochanek, Patrick M.; Bernard, Ora; Graham, Steven H.			Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury	BRAIN RESEARCH			English	Article						traumatic brain injury; transgenic mice; Bcl-2; apoptosis	CEREBRAL-ARTERY OCCLUSION; PROGRAMMED CELL-DEATH; NEURONAL DEATH; SPATIAL PROFILE; EXPRESSION; RAT; MECHANISMS; ISCHEMIA; PROTEOLYSIS; CALPAIN	Increasing evidence suggests that apoptosis is a contributing factor to neuronal cell death in traumatic brain injury (TBI). There is increased expression, cleavage and activation of caspases as well as other proteins known to regulate apoptosis in neurons after TBI. These proteins include the proto-oncogene Bcl-2 which belongs to a family of proteins with both pro- and anti-apoptotic properties. To investigate the role of apoptosis in TBI and the importance of Bcl-2 protein on the severity and outcome of injury, Bcl-2 overexpressing transgenic and wild-type control mice were subjected to the controlled cortical impact model of TBI. There was no significant difference in the cleavage of caspase-3 or caspase-9 detected by Western blotting of hippocampal samples from transgenic or wild-type mice after TBI. Bcl-2 transgenic mice had smaller contusion volumes and increased numbers of surviving neurons in CA2 but not other regions of hippocampus compared to wild-type controls. By contrast, there was no difference in motor function determined by the round beam balance and wire grip tests between transgenic and wild-type mice after TBI. Cognitive function assessed by the Morris water maze was also not different between groups. These results suggest that overexpression of Bcl-2 is only partially neuroprotective and other members of this protein family may prove to be more important in protecting neurons from cell death.	VA Pittsburgh Healthcare Syst 151UH, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA 15206 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA		Graham, SH (corresponding author), VA Pittsburgh Healthcare Syst 151UH, Ctr Geriatr Res Educ & Clin, 7108 Highland Dr, Pittsburgh, PA 15206 USA.	steven.graham@med.va.gov	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318] Funding Source: Medline		BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; CARONLESLIE LAM, 1994, FASEB J, V8, P639, DOI 10.1096/fasebj.8.9.8005391; Chen J, 2000, J CEREBR BLOOD F MET, V20, P1033, DOI 10.1097/00004647-200007000-00002; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; DeVries AC, 2001, P NATL ACAD SCI USA, V98, P11824, DOI 10.1073/pnas.201215298; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; Gillardon F, 1996, MOL BRAIN RES, V40, P254, DOI 10.1016/0169-328X(96)00059-9; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Graham SH, 2000, J NEUROTRAUM, V17, P831, DOI 10.1089/neu.2000.17.831; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Lawrence MS, 1997, J CEREBR BLOOD F MET, V17, P740; LINNIK MD, 1995, STROKE, V26, P1670, DOI 10.1161/01.STR.26.9.1670; LINNIK MD, 1995, STROKE, V26, P1675; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RINK A, 1995, AM J PATHOL, V147, P1575; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Shacka JJ, 2005, CNS NEUROL DISORD-DR, V4, P25, DOI 10.2174/1568007053005127; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	44	24	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 26	2006	1101						126	135		10.1016/j.brainres.2006.05.049			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070RK	WOS:000239541000016	16782076				2022-02-06	
J	Shore, PM; Hand, LL; Roy, L; Trivedi, P; Kochanek, PM; Adelson, PD				Shore, Paul M.; Hand, Linda L.; Roy, Lonnie; Trivedi, Prernal; Kochanek, Patrick M.; Adelson, P. David			Reliability and validity of the Pediatric Intensity Level of Therapy (PILOT) scale: A measure of the use of intracranial pressure-directed therapies	CRITICAL CARE MEDICINE			English	Article						head injury; clinical research; therapeutic intensity; child abuse; nonaccidental trauma; hypothermia; barbiturates; decompressive craniectomy; scale development	TRAUMATIC BRAIN-INJURY; CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; GLASGOW COMA SCALE; LENGTH-OF-STAY; DECOMPRESSIVE CRANIECTOMY; 20-PERCENT MANNITOL; RANDOMIZED TRIAL; PRACTICAL SCALE; VOLUME INDEX	Objective. To test the reliability and validity of the Pediatric Intensity Level of Therapy (PILOT) scale, a novel measure of overall therapeutic effort directed at controlling intracranial pressure (ICP) in the setting of severe (Glasgow Coma Scale of :5 8) pediatric traumatic brain injury (TBI). Design. Case-control study via retrospective review of medical records. Setting. Tertiary-care, university-based children's hospital intensive care unit. Patients., Randomly selected patients <= 18 yrs old admitted to the intensive care unit in 2002-2003 with severe TBI (cases: group 1, n = 27), mild-moderate TBI (control: group 2, n = 30), extracranial trauma (control: group 3, n = 29), or nontraumatic illnesses (control: group 4, n = 27). Interventions., None. Measurements and Main Results. A 38-point scale was developed to quantify daily ICP-directed therapeutic effort. All currently recommended therapies are represented. Demographic and physiologic data were collected on all patients. A total of 24 of 27 patients with severe TBI received ICP-directed therapy; three did not because of judgments of futility. No control patients received ICP-directed therapy. The PILOT scale score was assessed for the first 7 days posttrauma or postadmission. Interrater reliability was 0.91 (intraclass correlation coefficient) and intrarater reliability was 0.94. The highest PILOT scale scores were in patients with severe TBI (11.7 +/- 5.6 vs. 1.3 +/- 1.7 vs. 2.0 +/- 2.1 vs. 1.9 +/- 1.8 for groups 1, 2, 3 and 4, respectively [mean +/- SD]; p <.001 by analysis of variance/ Bonferroni). Patients with severe TBI who received ICP-directed therapy had higher PILOT scale scores (12.6 +/- 5.3 vs. 5.0 +/- 3.0, p =.001) than those who did not. Pearson's correlation coefficients of mean PILOT scale scores with measures of injury severity, outcome, and ICP were as follows: Glasgow Coma Scales score, -0.73 (P <.001); overall Injury Severity Score, 0.37 (p <.001); Injury Severity Score (head component only), 0.53 (p <.001); 6-month Glasgow Outcome Scale, -0.26 (p =.006); ICP burden (hours per day with ICP above treatment threshold), 0.59 (p =.002); and mean ICP, 0.41 (p=.044). Conclusions: The PILOT scale score can be obtained retrospectively and has good reliability. It can discriminate patients receiving ICP-directed therapy, even among patients with severe TBI, and correlates with measures of injury severity, outcome, and ICP in an expected way. Thus, it seems to be a valid measure of the use of ICP-directed therapy, although prospective, multiple-center validation is recommended.	Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Childrens Med Ctr, Dallas, TX 75235 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Shore, PM (corresponding author), Univ Texas, SW Med Ctr, Dallas, TX 75390 USA.		Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; 	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T-32 HD 40686] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER		Alexander RH, 1993, ADV TRAUMA LIFE SUPP, V5th; Allen Elizabeth M., 1996, P809; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bedell EA, 1998, ANESTH ANALG, V87, P751; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brown SA, 2001, AM J PHYS MED REHAB, V80, P196, DOI 10.1097/00002060-200103000-00009; BULLOCK MR, 2000, J NEUROTRAUM, V17, P451; BULLOCK MR, 2000, J NEUROTRAUM, V17, P527; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS49; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS45; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS53; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS38; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS34; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS56; CARNEY NA, 2003, PEDIAT CRIT CARE MED, V4, pS40; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; JENNETT B, 1975, LANCET, V1, P480; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; LEVIN AB, 1979, NEUROSURGERY, V5, P570, DOI 10.1227/00006123-197911000-00005; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; PLETS C, 1989, AM J CARDIOL, V63, pC40, DOI 10.1016/0002-9149(89)90405-0; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Roberts IG, 2003, COCHRANE DB SYST REV, V2; Robertson Charlene M. T., 2001, Pediatr Crit Care Med, V2, P145, DOI 10.1097/00130478-200104000-00009; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SEGATORE M, 1992, HEART LUNG, V21, P548; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF	57	24	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2006	34	7					1981	1987		10.1097/01.CCM.0000220765.22184.ED			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058BN	WOS:000238639300017	16691131				2022-02-06	
J	Weiss, AH; Phillips, JO				Weiss, Avery H.; Phillips, James O.			Congenital and compensated vestibular dysfunction in childhood: An overlooked entity	JOURNAL OF CHILD NEUROLOGY			English	Article; Proceedings Paper	30th Annual Meeting of the American-Association-for-Pediatric-Ophthalmology-and-Strabismus	MAR 27-31, 2004	Washington, DC	Amer Assoc Pediat Ophthalmol & Strabismus			VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VISUAL-ACUITY; CHILDREN; INTEGRATION; PHYSIOLOGY; DISORDERS	We report five children with previously unrecognized vestibular dysfunction detected by clinical examination and confirmed by quantitative vestibular testing. Patient I presented with fluctuating visual acuity and intermittent nystagmus. Patient 2 had congenital hearing loss associated with imbalance, delayed motor development, and cyclic vomiting. Patient 3 had neurotrophic keratitis with an intermittent head tilt, imbalance, and motor delays. Patient 4 showed ataxia and eye movement abnormalities following traumatic brain injury and had reading difficulties. Patient 5 had episodic vertigo and eye movement abonormalities from infancy. Clinical vestibular testing emphasized spontaneous nystagmus, rapid head thrust, and assessment of post-rotatory nystagmus. Quantitative vestibular testing included the sinusoidal chair rotation and velocity step tests, measurement of dynamic visual acuity, post-head-shake nystagmus, and computerized platform posturography. Pediatric neurologists encounter children with congenital and compensated vestibular dysfunction, which can be recognized on the basis of relevant history and clinical abnormalities of the ocular-ocular reflex.	Childrens Hosp & Reg Med Ctr, Div Ophthalmol, Seattle, WA 98115 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA		Weiss, AH (corresponding author), Childrens Hosp & Reg Med Ctr, Div Ophthalmol, 4800 Sand Point Way NE,G0035, Seattle, WA 98115 USA.	avery.weiss@seattlechildrens.org					Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; AVIATOR L, 1994, OTOLORYNGOL CLIN N A, V27, P557; Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; Baloh RW, 2003, NEW ENGL J MED, V348, P1027, DOI 10.1056/NEJMcp021154; Bodensteiner JB, 2003, J CHILD NEUROL, V18, P171, DOI 10.1177/08830738030180030701; BROOME J, 1991, ECON PHILOS, V7, P1, DOI 10.1017/S0266267100000882; Carpenter M.B, 1996, CARPENTERS HUMAN NEU; CYR DG, 1980, ANN OTO RHINOL LARYN, V89, P63, DOI 10.1177/00034894800890S519; Eviatar L, 1986, Pediatr Neurol, V2, P61, DOI 10.1016/0887-8994(86)90058-5; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P996, DOI 10.1152/jn.1976.39.5.996; Fife TD, 2000, NEUROLOGY, V55, P1431, DOI 10.1212/WNL.55.10.1431; FINOCCHIO DV, 1991, VISION RES, V31, P1717, DOI 10.1016/0042-6989(91)90022-W; FUKUSHIMA K, 1995, NEUROSCI RES, V22, P249, DOI 10.1016/0168-0102(95)00904-8; FUKUSHIMA K, 1992, PROG NEUROBIOL, V39, P609, DOI 10.1016/0301-0082(92)90016-8; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Galvez MJN, 2002, AM J OTOLARYNG, V23, P99, DOI 10.1053/ajot.2002.30635; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Hotson JR, 1998, NEW ENGL J MED, V339, P680, DOI 10.1056/NEJM199809033391007; HUYGEN PLM, 1993, INT J PEDIATR OTORHI, V25, P39, DOI 10.1016/0165-5876(93)90008-Q; Kaga K, 1999, INT J PEDIATR OTORHI, V49, P215, DOI 10.1016/S0165-5876(99)00206-2; Kumar A, 2002, OTOL NEUROTOL, V23, P727, DOI 10.1097/00129492-200209000-00021; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; LEIGH RJ, 1991, NEUROLOGY EYE MOVEME; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; MCDONALD M, 1985, INVEST OPHTH VIS SCI, V26, P1158; Mencher G T, 2001, Am J Audiol, V10, P3; Mets M B, 2000, Trans Am Ophthalmol Soc, V98, P237; METS MB, 2000, T AM OPHTHAL SOC, V98, P243; Parving A, 1996, INT J PEDIATR OTORHI, V34, P9, DOI 10.1016/0165-5876(95)01227-3; Phillips JO, 2002, OTOLARYNG CLIN N AM, V35, P765, DOI 10.1016/S0030-6665(02)00062-2; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; ROBINSON DA, 1968, SCIENCE, V161, P1219, DOI 10.1126/science.161.3847.1219; Selz PA, 1996, OTOLARYNG HEAD NECK, V115, P70, DOI 10.1016/S0194-5998(96)70139-0; SHERMAN KR, 1986, INVEST OPHTH VIS SCI, V27, P1154; Steiner AM, 1989, TXB PHYSL; Tian JR, 2002, EXP BRAIN RES, V142, P486, DOI 10.1007/s00221-001-0959-7; TUSA RJ, 1994, J CHILD NEUROL, V9, P261, DOI 10.1177/088307389400900308; VARTIAINEN E, 1985, INT J PEDIATR OTORHI, V9, P135, DOI 10.1016/S0165-5876(85)80013-6; Vatovec J, 2001, SCAND AUDIOL, V30, P191, DOI 10.1080/010503901300007498; WAESPE W, 1985, SCIENCE, V228, P199, DOI 10.1126/science.3871968; WARD PH, 1969, ANN OTO RHINOL LARYN, V78, P227, DOI 10.1177/000348946907800203; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847	42	24	24	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUL	2006	21	7					572	579		10.1177/08830738060210071501			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics	075SR	WOS:000239906000005	16970846				2022-02-06	
J	Wu, S; Fang, CX; Kim, J; Ren, J				Wu, Shan; Fang, Cindy X.; Kim, Jihye; Ren, Jun			Enhanced pulmonary inflammation following experimental intracerebral hemorrhage	EXPERIMENTAL NEUROLOGY			English	Article						intracerebral hemorrhage; brain; lung; inflammation; cytokine	TRAUMATIC BRAIN-INJURY; CONTUSION; BLOOD; RATS	The association between brain damage and respiratory dysfunction has been recognized although mechanistic link between the two is still poorly defined. Intracerebral hemorrhage is accompanied by brain injury, stroke, and parenchymal hematoma formation with surrounding inflammation. Increase intracranial pressure as a result of intracerebral hemorrhage may promote localized activation of cytokines and coagulation system including tissue factor release. However, whether intracerebral hemorrhage triggers inflammation in noncerebral organs has not been elucidated. The aim of the present study was to examine the impact of intracerebral hemorrhage on lung inflammatory response. Intracerebral hemorrhage was induced by stereotaxic intrastriatal administration of bacterial collagenase. Expression of intracellular adhesion molecule-1 (ICAM-1), I kappa B-alpha, tissue factor, tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta) was evaluated by Western blot analysis. Our results revealed that intracerebral hemorrhage upregulated expression of ICAM-I and tissue factor in both brain and lung, whereas it enhanced TNF-alpha and IL-I beta mainly in brain within 6 and 24 h of the brain injury. Levels of I kappa B-alpha remained unchanged in brain and lung tissues. Appearance of inflammatory markers in the lung was accompanied by morphological pulmonary damage. These data suggest that intracerebral hemorrhage may trigger acute inflammatory response in both brain and lung. (c) 2006 Elsevier Inc. All rights reserved.	Univ Wyoming, Div Pharmaceut Sci, Laramie, WY 82071 USA; Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA		Ren, J (corresponding author), Univ Wyoming, Div Pharmaceut Sci, 1000 E Univ Ave,Dept 3375, Laramie, WY 82071 USA.	jren@uwyo.edu					Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Chen HI, 1995, BIOL SIGNAL, V4, P186; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Donnelly SC, 1996, ANN INTERN MED, V125, P191, DOI 10.7326/0003-4819-125-3-199608010-00005; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Fisher AJ, 1999, LANCET, V353, P1412, DOI 10.1016/S0140-6736(99)00494-8; Garnier Y, 2003, J SOC GYNECOL INVEST, V10, P450, DOI 10.1016/S1071-5576(03)00150-3; Goel Radha, 2005, Congest Heart Fail, V11, P99; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Lampl Y, 2005, CEREBROVASC DIS, V20, P433, DOI 10.1159/000088981; NISHINO A, 1994, ACTA NEUROCHIR, P86; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Owens R, 2005, NEONATAL NETW, V24, P55, DOI 10.1891/0730-0832.24.3.55; PASINETTI GM, 1992, EXP NEUROL, V118, P117, DOI 10.1016/0014-4886(92)90028-O; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pyeron A M, 2001, J Neurosci Nurs, V33, P203; Ren J, 2006, FRONT BIOSCI-LANDMRK, V11, P15, DOI 10.2741/1776; SCHRANZ D, 1983, MONATSSCHR KINDERH, V131, P109; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; Whalen MJ, 1999, CRIT CARE MED, V27, P1014, DOI 10.1097/00003246-199905000-00049; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X	23	24	29	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2006	200	1					245	249		10.1016/j.expneurol.2006.01.027			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070EL	WOS:000239503000026	16516197				2022-02-06	
J	Kedar, S; Zhang, XJ; Lynn, MJ; Newman, NJ; Biousse, V				Kedar, Sachin; Zhang, Xiaojun; Lynn, Michael J.; Newman, Nancy J.; Biousse, Valerie			Pediatric homonymous hemianopia	JOURNAL OF AAPOS			English	Article; Proceedings Paper	31st Annual Meeting of the American-Association-for-Pediatric-Ophthalmology-and-Strabismus	MAR 09-13, 2005	Orlando, FL	Amer Assoc Pediat Ophthalmol & Strabismus			VISUAL-FIELD DEFECTS; OPTIC TRACT SYNDROME; INFARCTION; RECOVERY; STROKE	Introduction: Homonymous hemianopia is a disabling condition caused by numerous lesions affecting the retrochiasmal visual pathways. Little is known about homonymous hemianopia in childhood. Methods: All patients seen in the Neuro-Ophthalmology Unit at Emory University with homonymous hemianopia (confirmed by Goldmann, Humphrey, or confrontation visual fields) between 1989 and 2004 were included. Demographic characteristics, clinical features, and evolution of the visual field defects were compared between the pediatric group (18 years of age or younger) and the adult group (older than 18 years). Results: Among 852 patients with homonymous hemianopia, there were 81 children (86 homonymous hemianopias) and 771 adults (818 homonymous hemianopias). Formal visual field testing was obtained in 93% of pediatric cases and 96% of adults; a majority of patients in both groups were evaluated with Goldmann visual field testing. Demographic and visual field characteristics were similar in both groups. Significant differences were noted for the causative lesions and their location. Traumatic brain injury (34%) and tumor (27%) were the most common causes of homonymous hemianopia in the pediatric group, whereas infarction (63%), traumatic brain injury (12%), and hemorrhage (11%) were the most common causes in the adult group. Most lesions involved the optic radiations (37%), followed by the occipital lobes (26%), in the pediatric group, whereas occipital lobes (47%), followed by optic radiations (32%), were most commonly involved in adults. Approximately one third of the pediatric patients were seen in follow-up, and one third of these homonymous hemianopias spontaneously improved over the course of time. Of the 16 pediatric homonymous hemianopias evaluated within 1 month of onset of the cerebral disorder, 8 (50%) improved. Conclusion: Trauma and tumors are the most common cause of homonymous hemianopia in childhood. Although spontaneous improvement can be expected in approximately one third to one half of patients within the first few months, the recognition of homonymous hemianopia frequently is delayed in this population.	Emory Univ, Ctr Eye, Dept Ophthalmol, Neuroophthalmol Unit, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Dept Neurol Surg, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA		Biousse, V (corresponding author), Emory Univ, Ctr Eye, Dept Ophthalmol, Neuroophthalmol Unit, 1365 B Clifton Rd NE, Atlanta, GA 30322 USA.	vbiouss@emory.edu	KEDAR, SACHIN/B-2579-2008; Newman, Nancy/AAB-2532-2021	Kedar, Sachin/0000-0002-7293-5556	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30-EY06360] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360] Funding Source: NIH RePORTER		Donahue SP, 2001, J AAPOS, V5, P114, DOI 10.1067/mpa.2001.113840; FUJINO T, 1986, NEURO-OPHTHALMOLOGY, V6, P17, DOI 10.3109/01658108608997320; Gilhotra JS, 2002, STROKE, V33, P2417, DOI 10.1161/01.STR.0000037647.10414.d2; GRAY CS, 1989, AGE AGEING, V18, P419, DOI 10.1093/ageing/18.6.419; Isa K, 2001, EUR NEUROL, V46, P126, DOI 10.1159/000050785; Jacobson DM, 1997, ARCH NEUROL-CHICAGO, V54, P401, DOI 10.1001/archneur.1997.00550160045014; KATTAH JC, 1981, COMPUT TOMOGR, V5, P301, DOI 10.1016/0363-8235(81)90037-5; KAUL SN, 1974, J NEUROL NEUROSUR PS, V37, P1022, DOI 10.1136/jnnp.37.9.1022; Lepore FE, 2001, NEUROLOGY, V57, P1918, DOI 10.1212/WNL.57.10.1918; Levin LA., 2005, WALSH HOYT CLIN NEUR, V6th, P503; Liu GT, 1997, NEUROLOGY, V49, P1748, DOI 10.1212/WNL.49.6.1748; MCAULEY DL, 1979, J NEUROL NEUROSUR PS, V42, P298, DOI 10.1136/jnnp.42.4.298; NEWMAN SA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1241, DOI 10.1001/archopht.1983.01040020243018; PARISI JL, 1991, CAN J OPHTHALMOL, V26, P252; PESSIN MS, 1987, ANN NEUROL, V21, P290, DOI 10.1002/ana.410210311; SAVINO PJ, 1978, ARCH OPHTHALMOL-CHIC, V96, P656, DOI 10.1001/archopht.1978.03910050352011; SMITH JL, 1962, AM J OPHTHALMOL, V54, P616, DOI 10.1016/0002-9394(62)92192-X; TIEL K, 1991, NEURO-OPHTHALMOLOGY, V11, P33, DOI 10.3109/01658109109009640; TROBE JD, 1973, ARCH OPHTHALMOL-CHIC, V89, P377, DOI 10.1001/archopht.1973.01000040379005; TROBE JD, 2001, NEUROLOGY VISION, P109; Wall M, 2005, WALSH HOYT CLIN NEUR, P83	21	24	24	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1091-8531	1528-3933		J AAPOS	J. AAPOS	JUN	2006	10	3					249	252		10.1016/j.jaapos.2006.01.181			4	Ophthalmology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Ophthalmology; Pediatrics	062QK	WOS:000238959400012	16814179				2022-02-06	
J	Cameron, CM; Purdie, DM; Kliewer, EV; McClure, RJ				Cameron, Cate M.; Purdie, David M.; Kliewer, Erich V.; McClure, Rod J.			Mental health: A cause or consequence of injury? A population-based matched cohort study	BMC PUBLIC HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; SATISFACTION 12 MONTHS; SPINAL-CORD-INJURY; GENERAL HEALTH; WORK STATUS; FOLLOW-UP; ASSOCIATION; COMORBIDITY; DISORDERS; MORTALITY	Background: While a number of studies report high prevalence of mental health problems among injured people, the temporal relationship between injury and mental health service use has not been established. This study aimed to quantify this relationship using 10 years of follow-up on a population-based cohort of hospitalised injured adults. Methods: The Manitoba Injury Outcome Study is a retrospective population-based matched cohort study that utilised linked administrative data from Manitoba, Canada, to identify an inception cohort ( 1988 - 1991) of hospitalised injured cases (ICD-9-CM 800 - 995) aged 18 - 64 years (n = 21,032), which was matched to a non-injured population-based comparison group ( n = 21,032). Pre-injury comorbidity and post-injury mental health data were obtained from hospital and physician claims records. Negative Binomial regression was used to estimate adjusted rate ratios (RRs) to measure associations between injury and mental health service use. Results: Statistically significant differences in the rates of mental health service use were observed between the injured and non-injured, for the pre-injury year and every year of the follow-up period. The injured cohort had 6.56 times the rate of post-injury mental health hospitalisations (95% CI 5.87, 7.34) and 2.65 times the rate of post-injury mental health physician claims ( 95% CI 2.53, 2.77). Adjusting for comorbidities and pre-existing mental health service use reduced the hospitalisations RR to 3.24 ( 95% CI 2.92, 3.60) and the physician claims RR to 1.53 ( 95% CI 1.47, 1.59). Conclusion: These findings indicate the presence of pre-existing mental health conditions is a potential confounder when investigating injury as a risk factor for subsequent mental health problems. Collaboration with mental health professionals is important for injury prevention and care, with ongoing mental health support being a clearly indicated service need by injured people and their families. Public health policy relating to injury prevention and control needs to consider mental health strategies at the primary, secondary and tertiary level.	Griffith Univ, Sch Med, Meadowbrook, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; CancerCare Manitoba, Dept Epidemiol, Winnipeg, MB, Canada; CancerCare Manitoba, Canc Registry, Winnipeg, MB, Canada; Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia		Cameron, CM (corresponding author), Griffith Univ, Sch Med, Meadowbrook, Australia.	cate.cameron@griffith.edu.au; davidpurdie@fastmail.fm; erich.kliewer@cancercare.mb.ca; r.mcclure@griffith.edu.au		McClure, Roderick/0000-0002-9067-8282; Cameron, Cate/0000-0003-1476-5744			Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Cameron CM, 2005, J TRAUMA, V59, P639, DOI 10.1097/01.ta.0000183222.79685.23; CAMERON DJ, 1983, INT J IMMUNOPHARMACO, V5, P345, DOI 10.1016/0192-0561(83)90038-3; Carrico CJ, 2000, J TRAUMA, V48, P848; COHEN MM, 1995, MED CARE S, V33, P42; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; DUFORT GG, 1993, J NERV MENT DIS, V181, P467, DOI 10.1097/00005053-199308000-00001; Dunn LT, 2000, BRIT J NEUROSURG, V14, P219; Field CA, 2001, J TRAUMA, V50, P13, DOI 10.1097/00005373-200101000-00002; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Greenspan AI, 2002, J TRAUMA, V53, P709, DOI 10.1097/00005373-200210000-00015; Klabunde CN, 2002, MED CARE, V40, P26; Koven R, 2005, PREV MED, V41, P240, DOI 10.1016/j.ypmed.2004.11.009; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; MCEVOY S, 2004, SCI BASIS INJURY PRE, P62; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Patterson DR, 2003, J BURN CARE REHABIL, V24, P347, DOI 10.1097/01.BCR.0000086070.91033.7F; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Roos LL, 1997, HEALTH SERV RES, V32, P229; ROOS LL, 1997, HEALTH SERV RES, V32, P239; ROOS NP, 1995, MED CARE S, V33, P20; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Statistics Canada, 2002, CAN COMM HLTH SURV M; Wadsworth EJK, 2005, HUM PSYCHOPHARM CLIN, V20, P391, DOI 10.1002/hup.709; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; Young TK, 2000, AM J PUBLIC HEALTH, V90, P1466, DOI 10.2105/AJPH.90.9.1466; Zatzick D, 2004, J TRAUMA, V57, P360, DOI 10.1097/01.TA.0000141332.43183.7F; [No title captured]	36	24	24	0	4	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	MAY 2	2006	6								114	10.1186/1471-2458-6-114			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	069GD	WOS:000239433500001	16650287	gold, Green Published			2022-02-06	
J	Andermahr, J; Elsner, A; Brings, AE; Hensler, T; Gerbershagen, H; Jubel, A				Andermahr, J; Elsner, A; Brings, AE; Hensler, T; Gerbershagen, H; Jubel, A			Reduced collagen degradation in polytraumas with traumatic brain injury causes enhanced osteogenesis	JOURNAL OF NEUROTRAUMA			English	Article						fracture healing; heterotopic ossification; hypertrophic callus; polytrauma; traumatic brain injury; serologic parameters of bone remodeling	GROWTH-FACTOR-I; IGF-BINDING PROTEIN-3; BONE-FORMATION; HEAD-INJURY; FACTOR BFGF; HETEROTOPIC OSSIFICATION; TIBIAL FRACTURES; CLINICAL ASPECTS; INSULIN; HORMONE	Patients with traumatic brain injury (TBI) and skeletal injuries have increased rates of excessive bone healing (EH = hypertrophic callus formation and/or heterotopic ossification). Polytrauma patients are often attributed higher rates of delayed fracture union. This study compares 182 total fractures in 29 isolated polytrauma patients (POLY) and 48 patients after TBI and polytrauma (TBI+POLY), examining the clinical parameters of EH versus delay. A subset of 28 patients (13 TBI+POLY, 15 POLY) underwent serological testing for the following bone turnover parameters: carboxy-terminal extension peptide of type 1 procollagen (P1CP), pyridinolene cross-linked carboxy-terminal telopeptide (ICTP), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and basic fibroblast growth factor (bFGF). There were higher rates of delayed union in the POLY patients (45% vs. 23%) and EH in the TBI+POLY patients (33% vs. 17%) (not significant = NS). More delayed unions were observed in diaphyseal fractures suffered by POLY (28%) than in TBI+POLY (15%) patients (NS). EH after pelvic fracture was apparent in 52% TBI+POLY and in 21% POLY fractures (NS). P1CP levels did not differ between the groups, but the collagen breakdown parameter 1CTP was significantly higher in the POLY group (p = 0.01-0.04). IGF-1 levels were below normal in both groups, and did not differ. IGFBP-3, an IGF-1-inhibiting and collagenase-3-activating protein, was significantly higher in POLY patients (p = 0.017-0.037). bFGF levels did not vary between groups. Increased serum levels of 1CTP and IGFBP-3 in POLY patients suggest that EH in TBI patients is secondary to decreased collagen breakdown rather than increased synthesis.	Univ Cologne, Clin Trauma Hand & Reconstruct Surg, D-50924 Cologne, Germany; Univ Cologne, Dept Surg 2, Cologne, Germany; Univ Cologne, Dept Anaesthesia, Cologne, Germany		Andermahr, J (corresponding author), Univ Cologne, Clin Trauma Hand & Reconstruct Surg, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.	Jandermahr@t-online.de		Jubel, Axel/0000-0003-4402-4816			BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boguszewski M, 1996, J CLIN ENDOCR METAB, V81, P3902, DOI 10.1210/jc.81.11.3902; Bosch U, 1999, CHIRURG, V70, P1202, DOI 10.1007/s001040050771; BOSSE A, 1994, INT J SPORTS MED, V15, P325, DOI 10.1055/s-2007-1021068; Braun W, 1996, UNFALLCHIRURG, V99, P59; CENTRELLA M, 1993, ANN PLAS SURG, V31, P434, DOI 10.1097/00000637-199311000-00008; Delany AM, 1998, AM J PHYSIOL-CELL PH, V274, pC734, DOI 10.1152/ajpcell.1998.274.3.C734; Delany AM, 1998, J BIOL CHEM, V273, P16595, DOI 10.1074/jbc.273.26.16595; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Fernandez AM, 1997, NEUROSCIENCE, V76, P117; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Giannobile WV, 1997, J DENT RES, V76, P1569, DOI 10.1177/00220345970760090901; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3864, DOI 10.1210/jc.81.11.3864; GutierrezOspina G, 1996, ENDOCRINOLOGY, V137, P5484, DOI 10.1210/en.137.12.5484; HEUWINKEL R, 1978, HELV CHIR ACTA, V45, P581; HEUWINKEL R, 1978, UNFALLHEILKUNDE, V81, P577; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; HILL RJ, 1995, ENDOCRINOLOGY, V136, P124; JOERRING S, 1992, ARCH ORTHOP TRAUM SU, V111, P265, DOI 10.1007/BF00571521; JOERRING S, 1994, ARCH ORTHOP TRAUM SU, V113, P334, DOI 10.1007/BF00426183; Kuner EH, 1996, ORTHOPADE, V25, P394, DOI 10.1007/s001320050040; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; Lalou C, 1996, ENDOCRINOLOGY, V137, P3206, DOI 10.1210/en.137.8.3206; Meyer NA, 1996, J TRAUMA, V41, P1008, DOI 10.1097/00005373-199612000-00011; Mohan S, 1996, HORM RES, V45, P59, DOI 10.1159/000184833; MUNSTER AM, 1972, J TRAUMA, V12, P1071, DOI 10.1097/00005373-197212000-00008; Noh E, 1972, Hefte Unfallheilkd, V111, P277; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RussellJones DL, 1996, EUR J ENDOCRINOL, V135, P631, DOI 10.1530/eje.0.1350631; Schonau E, 1997, HORM RES, V48, P50, DOI 10.1159/000191329; Schonau E, 1997, EUR J ENDOCRINOL, V137, P603, DOI 10.1530/eje.0.1370603; Schratz W, 1998, UNFALLCHIRURG, V101, P12, DOI 10.1007/s001130050226; SEILER H, 1979, CHIRURG, V50, P384; Skjaerbaek C, 1997, EUR J ENDOCRINOL, V137, P132, DOI 10.1530/eje.0.1370132; Skjaerbaek C, 1996, EUR J ENDOCRINOL, V135, P672, DOI 10.1530/eje.0.1350672; Slootweg MC, 1996, GROWTH REGULAT, V6, P238; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; THALLER SR, 1993, ANN PLAS SURG, V31, P421, DOI 10.1097/00000637-199311000-00006; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wiltfang J, 1996, J CRANIO MAXILL SURG, V24, P300, DOI 10.1016/S1010-5182(96)80063-1	44	24	25	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2006	23	5					708	720		10.1089/neu.2006.23.708			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	042LJ	WOS:000237529200009	16689672				2022-02-06	
J	Fontela, PS; Tampieri, D; Atkinson, JD; Daniel, SJ; Teitelbaum, J; Shemie, SD				Fontela, Patricia S.; Tampieri, Donatella; Atkinson, Jeffrey D.; Daniel, Sam J.; Teitelbaum, Jeanne; Shemie, Sam D.			Posttraumatic pseudoaneurysm of the intracavernous internal carotid artery presenting with massive epistaxis	PEDIATRIC CRITICAL CARE MEDICINE			English	Article							TRAUMATIC PSEUDOANEURYSM; ANEURYSM; DIAGNOSIS; BLINDNESS; THERAPY	Objectives: To report a case of posttraumatic pseudoaneurysm of the intracavernous internal carotid artery presenting with massive epistaxis and to discuss its pathophysiology and management. Design. Case report and literature review. Setting. Pediatric intensive care unit in a tertiary-care center. Patients and Results: Twelve days after a motor vehicle accident causing a head injury and facial fractures, this patient presented with massive epistaxis due to a pseudoaneurysm of the intracavernous internal carotid artery. Nasal packing was performed and subsequent angiography demonstrated the vascular lesion that had dissected into the sphenoid sinus. Endovascular stent and coil occlusion of the vascular lesion was performed, and the patient's condition improved without any ischemic or thromboembolic sequelae. Conclusion. Posttraumatic aneurysms of the intracavernous internal carotid artery can be associated with delayed and sometimes lethal massive epistaxis. This vascular lesion should be considered in patients with traumatic brain injury presenting with basal skull fractures in the region of the carotid canal or cavernous sinus and/or orbital fractures and compromise of the optical nerves. Knowledge of these risk factors and early diagnosis can minimize the high mortality risk.	Montreal Childrens Hosp, Div Pediat Crit Care, Montreal, PQ H3H 1P3, Canada; Montreal Childrens Hosp, Div Pediat Neurosurg, Montreal, PQ H3H 1P3, Canada; Montreal Childrens Hosp, Div Pediat Otolaryngol, Montreal, PQ H3H 1P3, Canada; McGill Univ, Ctr Hlth, Montreal Neurol Hosp & Inst, Div Radiol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal Neurol Hosp & Inst, Div Neurol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal Neurol Hosp & Inst, Div Neurosurg, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal Neurol Hosp & Inst, Div Neurol & Crit Care, Montreal, PQ, Canada		Fontela, PS (corresponding author), Montreal Childrens Hosp, Div Pediat Crit Care, Montreal, PQ H3H 1P3, Canada.		Daniel, Sam J/AAY-6826-2020; Fontela, Patricia/S-6455-2019	Teitelbaum, Jeanne/0000-0002-9834-3882			ARAKI C, 1965, J NEUROSURG, V23, P64, DOI 10.3171/jns.1965.23.1.0064; BURTON R, 1973, MED J AUSTRALIA, V1, P692, DOI 10.5694/j.1326-5377.1973.tb110625.x; Chen DS, 1998, LARYNGOSCOPE, V108, P326, DOI 10.1097/00005537-199803000-00004; GOLEAS J, 1991, ANN OTO RHINOL LARYN, V100, P577, DOI 10.1177/000348949110000711; HAN MH, 1994, LARYNGOSCOPE, V104, P370; HIGASHIDA RT, 1990, J NEUROSURG, V72, P857, DOI 10.3171/jns.1990.72.6.0857; HORNIBROOK J, 1981, AUST NZ J SURG, V51, P206, DOI 10.1111/j.1445-2197.1981.tb05942.x; Jackson F E, 1970, J Trauma, V10, P1158, DOI 10.1097/00005373-197012000-00008; KARAMOSKOS P, 1989, AUST NZ J SURG, V59, P745, DOI 10.1111/j.1445-2197.1989.tb01668.x; KEANE JR, 1972, ARCH OPHTHALMOL-CHIC, V87, P701, DOI 10.1001/archopht.1972.01000020703017; MAURER JJ, 1961, J NEUROSURG, V18, P837, DOI 10.3171/jns.1961.18.6.0837; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; SALMON JH, 1968, J THORAC CARDIOV SUR, V56, P28, DOI 10.1016/S0022-5223(19)42868-7; SHIRAI S, 1977, EUR NEUROL, V15, P212, DOI 10.1159/000114835; SIMPSON RK, 1988, J NEUROSURG, V68, P142, DOI 10.3171/jns.1988.68.1.0142; Wanebo JE, 2004, NEUROSURGERY, V55, P395, DOI 10.1227/01.NEU.0000129549.99061.94; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5; WORTHINGTON BS, 1983, AM J NEURORADIOL, V4, P835; Zarins CK, 2004, SABISTON TXB SURG, P1965	19	24	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2006	7	3					260	262		10.1097/01.PCC.0000216418.01278.5E			3	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	087ZL	WOS:000240781200013	16575350				2022-02-06	
J	Rudehill, S; Muhallab, S; Wennersten, A; von Gertten, C; Al Nimer, F; Sandberg-Nordqvist, AC; Holmin, S; Mathiesen, T				Rudehill, S; Muhallab, S; Wennersten, A; von Gertten, C; Al Nimer, F; Sandberg-Nordqvist, AC; Holmin, S; Mathiesen, T			Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in rats	ACTA NEUROCHIRURGICA			English	Article						autoantibodies; autoimmunity; B cells; brain injury; rat; T cells	MYELIN BASIC-PROTEIN; INTRACEREBRAL INFLAMMATORY RESPONSE; SPINAL-CORD-INJURY; T-CELLS; POSTOPERATIVE CHANGES; NERVOUS-TISSUE; IMMUNOREACTIVITY; AUTOANTIBODIES; CONSEQUENCES; DEGENERATION	Background. Brain trauma is a risk factor for delayed CNS degeneration which may be attenuated by anti-inflammatory treatment. CNS injuries may cause anti-brain reactivity. This study was undertaken to analyze the pattern of delayed post-traumatic anti-brain immunity in experimental brain contusion. Method. Adult Sprague-Dawley and Lewis rats were subjected to experimental brain contusions. For B-cell investigations, serum was obtained from contused, control and naive rats, and used for immunohistochemistry on slices of rat brains to first detect autoreactive IgG and IgM antibodies in rat serum. Secondly, anti-rat IgG and IgM antibodies were used to search for auto-antibodies already bound to the brain tissue. Double staining with rat-serum and NeuN or anti-GFAP antibody was used to detect anti-neuronal and anti-astrocytic antibodies, respectively. For T-cell reactivity, cells from brains and cervical lymph nodes of rats were used in FACS analysis and elispot with MBP and MOG stimulation. Findings. Anti-vascular basal lamina IgG antibodies were detected at three months in 6/8 rats, following experimental contusion. Anti-neuronal IgG antibodies were detected 2 weeks after experimental contusion and sham surgery, while naive controls were negative. Individual rats showed a prolonged response, or an anti-astrocytic staining. Tissue bound anti-self IgG or IgM was not detected in the brain tissue. Anti-MBP or anti-MOG T-cell responses were not detectable. Conclusions. Experimental brain trauma and to some degree even sham surgery lead to an individually variable pattern of specific anti-brain reactive B-cells, while a T-cell response did not seem to be a consequence of moderate experimental contusion. The mere presence of anti brain-antibodies may be epiphenomenal, but could also be pathogenic for delayed degeneration. It is reasonable to regard the presence of an actual anti-brain reactivity as a potential threat to brain tissue integrity.	Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Med, Ctr Mol Med, Neuroimmunol Unit, S-17176 Stockholm, Sweden		Mathiesen, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, R3 02 KS, S-17176 Stockholm, Sweden.	tiit.mathiesen@ks.se	Nimer, Faiez Al/ABB-9465-2020; mathiesen, tiit/ABC-3627-2021	Holmin, Staffan/0000-0002-1628-1615; Al Nimer, Faiez/0000-0003-0937-5995; Mathiesen, Tiit/0000-0001-9463-1919			ALLING C, 1980, J NEUROL, V223, P225, DOI 10.1007/BF00313336; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; CASTIGLI E, 1995, INT ARCH ALLERGY IMM, V107, P37, DOI 10.1159/000236923; CLAUSEN F, 2005, ACTA NEUROCHIR; Crimando J, 1997, ANN NY ACAD SCI, V823, P303, DOI 10.1111/j.1749-6632.1997.tb48404.x; Cross AH, 2001, J NEUROIMMUNOL, V112, P1, DOI 10.1016/S0165-5728(00)00409-4; Dropcho EJ, 2002, NEUROL CLIN, V20, P85, DOI 10.1016/S0733-8619(03)00055-0; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Hauss-Wegrzyniak B, 2000, EXP NEUROL, V165, P347, DOI 10.1006/exnr.2000.7469; HOFFMANN SA, 1988, ARTHRITIS RHEUM, V28, P789; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; HOYLE NR, 1984, J NEUROSURG, V61, P49, DOI 10.3171/jns.1984.61.1.0049; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Morozov SG, 1996, VOP MED KHIM, V42, P147; Muhallab S, 2001, J NEUROIMMUNOL, V113, P202, DOI 10.1016/S0165-5728(00)00438-0; OLSSON T, 1992, AUTOIMMUNITY, V13, P117, DOI 10.3109/08916939209001912; Popovic M, 1998, INT J NEUROSCI, V95, P203, DOI 10.3109/00207459809003341; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; RUTTER JV, 1987, GERONTOLOGY, V33, P187, DOI 10.1159/000212874; SEELDRAYERS PA, 1984, ACTA NEUROCHIR, V70, P269, DOI 10.1007/BF01406655; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; SINHA S, 1991, LANCET, V338, P75, DOI 10.1016/0140-6736(91)90073-X; Sjogren M, 2001, MECH AGEING DEV, V122, P1923, DOI 10.1016/S0047-6374(01)00303-7; Stankova I, 1999, PHYSIOL RES, V48, P383; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; THOMAS DGT, 1984, J NEUROL NEUROSUR PS, V47, P173, DOI 10.1136/jnnp.47.2.173; WATERHOUSE DM, 1991, CANCER, V68, P1835, DOI 10.1002/1097-0142(19911015)68:8<1835::AID-CNCR2820680833>3.0.CO;2-N; Weissert R, 1998, J IMMUNOL, V160, P681	38	24	26	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2006	148	2					199	205		10.1007/s00701-005-0673-5			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	005WS	WOS:000234856900031	16362182				2022-02-06	
J	Aikman, J; O'Steen, B; Silver, X; Torres, R; Boslaugh, S; Blackband, S; Padgett, K; Wang, KKW; Hayes, R; Pineda, J				Aikman, J.; O'Steen, B.; Silver, X.; Torres, R.; Boslaugh, S.; Blackband, S.; Padgett, K.; Wang, K. K. W.; Hayes, R.; Pineda, J.			Alpha-II-spectrin after controlled cortical impact in the immature rat brain	DEVELOPMENTAL NEUROSCIENCE			English	Article						spectrin; cerebrospinal fluid; developing brain; pediatric traumatic brain injury; magnetic resonance imaging	SEVERE HEAD-INJURY; CEREBRAL HYPOXIA-ISCHEMIA; APOPTOTIC CELL-DEATH; CASPASE-3 ACTIVATION; CEREBROSPINAL-FLUID; EXPERIMENTAL-MODELS; MU-CALPAIN; NEURONAL APOPTOSIS; COGNITIVE DEFICITS; BREAKDOWN PRODUCTS	Proteolytic processing plays an important role in regulating a wide range of important cellular functions, including processing of cytoskeletal proteins. Loss of cytoskeletal proteins such as spectrin is an important characteristic in a variety of acute central nervous system injuries including ischemia, spinal cord injury and traumatic brain injury (TBI). The literature contains extensive information on the proteolytic degradation of alpha-II-spectrin after TBI in the adult brain. By contrast, there is limited knowledge on the characteristics and relevance of these important processes in the immature brain. The present experiments examine TBI-induced proteolytic processing of alpha-II-spectrin after TBI in the immature rat brain. Distinct proteolytic products resulting from the degradation of the cytoskeletal protein alpha-II-spectrin by calpain and caspase 3 were readily detectable in cortical brain parenchyma and cerebrospinal fluid after TBI in immature rats. Copyright (c) 2006 S. Karger AG, Basel.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Univ Florida, Ctr Traumat Brain Injury Studies, Evelyn F & William L McKnight Brain Inst, Gainesville, FL USA; Univ Florida, Ctr Neuroproteom & Biomarkers Res, Dept Psychiat, McKnight Brain Inst, Gainesville, FL USA		Pineda, J (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8116,1 Childrens Pl,Suite 5S20, St Louis, MO 63110 USA.	Pineda_J@kids.wustl.edu	Pineda, Jose/W-2806-2019; Silver, Xeve/AAP-3398-2021	Wang, Kevin/0000-0002-9343-6473; Padgett, Kyle/0000-0002-6277-5317	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS052831, R01-NS36992] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036992, R01NS052831] Funding Source: NIH RePORTER		Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Armstead WM, 1999, EXP TOXICOL PATHOL, V51, P137, DOI 10.1016/S0940-2993(99)80087-6; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Blomgren K, 1997, ANN NY ACAD SCI, V825, P104, DOI 10.1111/j.1749-6632.1997.tb48420.x; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CHAKRABARTI AK, 1993, DEV BRAIN RES, V71, P107, DOI 10.1016/0165-3806(93)90111-M; Cho S, 2003, BRAIN RES, V982, P146, DOI 10.1016/S0006-8993(03)02846-4; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Eldadah BA, 1997, J NEUROSCI, V17, P6105; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; FISCHER I, 1991, NEUROCHEM RES, V16, P891, DOI 10.1007/BF00965538; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Jordan J, 1997, J NEUROCHEM, V68, P1612; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kawamura M, 2005, BRAIN RES, V1037, P59, DOI 10.1016/j.brainres.2004.12.050; KIMURA F, 1987, J NEUROCYTOL, V16, P649, DOI 10.1007/BF01637657; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kochanek PM, 2006, ANESTH ANALG, V102, P72, DOI 10.1213/01.ANE.0000181101.71587.8A; Kochanek PM, 2001, PEDIATR CLIN N AM, V48, P661, DOI 10.1016/S0031-3955(05)70333-3; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; Levi L, 1998, CHILD NERV SYST, V14, P195, DOI 10.1007/s003810050210; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OSTWALD K, 1993, BRAIN RES, V630, P289, DOI 10.1016/0006-8993(93)90668-D; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Scheidler MG, 2000, J TRAUMA, V49, P864, DOI 10.1097/00005373-200011000-00012; SHEPPARD A, 1991, SYNAPSE, V9, P231, DOI 10.1002/syn.890090310; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Verger K, 2000, BRAIN INJURY, V14, P495; Villa PG, 1998, J CELL SCI, V111, P713; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 2002, NEUROBIOL DIS, V10, P289, DOI 10.1006/nbdi.2002.0526; Zhang J, 2003, DEV BRAIN RES, V142, P105, DOI 10.1016/S0165-3806(03)00057-9; Zhao X, 1999, NEUROCHEM RES, V24, P371, DOI 10.1023/A:1020933616351; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	84	24	25	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2006	28	4-5					457	465		10.1159/000094171			9	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	080ZS	WOS:000240287600022	16943668				2022-02-06	
J	Guerin, F; Kennepohl, S; Leveille, G; Dominique, A; McKerral, M				Guerin, Fanny; Kennepohl, Stephan; Leveille, Genevieve; Dominique, Aysha; McKerral, Michelle			Vocational outcome indicators in atypically recovering mild TBI: A post-intervention	NEUROREHABILITATION			English	Article; Proceedings Paper	1st International Conference on Vocational Outcomes in Traumatic Brain Injury	APR 14-16, 2005	Vancouver, CANADA			mild traumatic brain injury; post-concussion symptomatology; vocational outcome; prognostic indicators	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CONCUSSION SYMPTOMS; PREDICTING RETURN; WORK; REHABILITATION; MODERATE	Beyond issues of MTBI etiology, a key question remains the characterization and early identification of those individuals at risk of poor functional outcome. Using a retrospective analysis, the current study aimed at identifying the specific indicators related to return to work in adults with both symptomatic MTBI and functional impacts, having completed a specialized intervention program. In terms of outcome, 59.1% of the cohort (n=110) returned to some form of work-related activity by the end of intervention whereas the rest had not. Three of the sixteen variables studied were retained (logistic regression) as providing unique and significant (p < 0.05) contributions to the prediction outcome model, namely age, number of subjective symptoms and the presence of a public insurance provider. There was also an interaction between the presence of a public insurance provider and referral delay. Overall percentage of cases correctly classified by the model was 70%, positive predictive accuracy was 72.9%, whereas negative predictive accuracy was 65%. Our findings suggest that any studies attempting to assess functional outcome need to take account of the multifactorial nature of MTBI, including not only more objective psychological/physiological variables related to the injury, but also subjective complaints and environmental factors.	Ctr Readaptat Lucie Bruneau, TBI Program, Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ H2H 2N8, Canada; Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; Univ Montreal, Dept Psychol, Montreal, PQ, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada		McKerral, M (corresponding author), Ctr Readaptat Lucie Bruneau, TBI Program, Ctr Rech Interdisciplinaire Readaptat, 2275 Laurier Ave E, Montreal, PQ H2H 2N8, Canada.	michelle.mckerral@umontreal.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, 2003, US STEPS PREV SER PU, P56; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; GUERIN F, 2005, INTERDISCIPLINARY RE, P55; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McKerral M, 2005, J REHABIL MED, V37, P61, DOI 10.1080/16501970510026647; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	38	24	24	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	4					295	303					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	145VU	WOS:000244894700004	17361046				2022-02-06	
J	Huh, JW; Franklin, MA; Widing, AG; Raghupathi, R				Huh, Jimmy W.; Franklin, Michael A.; Widing, Ashley G.; Raghupathi, Ramesh			Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats	DEVELOPMENTAL NEUROSCIENCE			English	Article						pediatric traumatic brain injury; traumatic axonal injury; calpains; amyloid precursor protein; closed head injury	AMYLOID PRECURSOR PROTEIN; HEAD-INJURY; SPECTRIN PROTEOLYSIS; BREAKDOWN; AGE; DEGRADATION; INHIBITION; MECHANISMS; TRANSPORT; CHILDREN	Impact-induced head injury in infants results in acute focal contusions and traumatic axonal injury (TAI) that are associated with chronic holohemispheric cortical and white matter atrophy and may contribute to poor outcome in brain-injured children less than 4 years of age. Contusive brain trauma in postnatal day (PND) 11 or PND 17 rat pups, ages neurologically equivalent to a human infant and toddler, respectively, leads to cortical tissue loss and white matter atrophy which are associated with cognitive deficits. In adult models of brain trauma and in brain-injured humans, acute and sustained activation of the calpain family of calcium-activated neutral proteases has been implicated in neuronal death and TAI. PND 11 or PND 17 rat pups were subjected to closed head injury over the left hemisphere using the controlled cortical impact device and sacrificed at 6 h, 24 h or 3 days. Hemorrhagic contusions and tissue tears in the cortex and white matter were visible at 6 h, and neuronal loss was evident by 3 days. Calpain activation was observed in cell soma and dendrites of injured neurons at 6 h, and in degenerating dendrites and atrophic neurons at 24 h after injury at both ages. Axonal accumulation of amyloid precursor protein, indicative of TAI, was observed in the corpus callosum and lateral aspects of the white matter below the site of impact, and in the thalamus in PND 11 rats only. Intra-axonal calpain activation was observed to a limited extent in the corpus callosum and subcortical white matter tracts in both brain-injured PND 11 and PND 17 rats. Collectively, these results provide evidence that calpain activation may participate in neuronal loss in the injured cortex, but may not contribute to the pathogenesis of TAI following contusive brain trauma in the immature rat. Copyright (c) 2006 S. Karger AG, Basel.	Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexelmed.edu	Raghupathi, Ramesh/AAX-5538-2021		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R01NS041561, P50NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, NS41561] Funding Source: Medline		Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; BLOMGREN K, 1995, BRAIN RES, V684, P143, DOI 10.1016/0006-8993(95)00399-B; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen M, 2005, BIOCHEM BIOPH RES CO, V330, P714, DOI 10.1016/j.bbrc.2005.03.029; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kirazov E, 2001, INT J DEV NEUROSCI, V19, P287, DOI 10.1016/S0736-5748(01)00012-0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SIMAN R, 1990, J NEUROSCI, V10, P2400; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	36	24	24	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866			DEV NEUROSCI-BASEL	Dev. Neurosci.		2006	28	4-5					466	476		10.1159/000094172			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	080ZS	WOS:000240287600023	16943669				2022-02-06	
J	Nolin, P				Nolin, P			Executive memory dysfunctions following mild traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						CVLT; executive functions; memory; mild traumatic brain injury; MTBI; registration; retrieval; storage; verbal learning	VERBAL-LEARNING TEST; HEAD-INJURY; PERFORMANCE; SYMPTOMS; PATTERNS; DEFICITS; MODERATE	Objectives: To explore the contribution of executive dysfunctions to mnemonic problems in adults with mild traumatic brain injury (MTBI). Design: Prospective quasiexperimental between-groups design. Participants: Ninety-nine persons with MTBI were compared to 90 control group participants matched for gender, age, and education. Setting: Two Canadian brain injury rehabilitation programs. Main Outcome Measure: California Verbal Learning Test. Results: Participants with MTBI showed a significant deficit in free recall on the California Verbal Learning Test but performed similarly to the comparison group on the recognition task. Furthermore, the participants with MTBI were less likely to use semantic clustering as a memorizing strategy and made more intrusion errors and false-positive errors on the recognition task. Conclusions: While the scores for the participants with MTBI are only slightly lower than the norm, they demonstrate that MTBI has a negative effect on mnemonic performance. The results are explained in terms of a deficit in registration/retrieval processes rather than a malfunction of the storage processes. This supports the initial hypothesis that executive dysfunctions are detrimental to the quality of mnemonic functions in patients with MTBI.	Univ Quebec Trois Rivieres, Grp Rech Dev Enfant & Famille, Dept Psychol, Trois Rivieres, PQ G9A 5H7, Canada		Nolin, P (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Dev Enfant & Famille, Dept Psychol, CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	Pierre.Nolin@uqtr.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1989, ASSESSMENT CONSEQUEN, V7, P37; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BOLL TJ, 1983, PSYCHIAT DEV, V1, P263; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis DC, 1987, CALIFORNIA VERBAL LE; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199606000-00004; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; KAY T, 1992, PHYSICAL MED REHABIL, V6, P109; LENINGER B, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, NEUROBEHAVIORAL RECO, P221; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MIDDLETON J, 1989, J CHILD PSYCHOL PSYC, V30, P663, DOI 10.1111/j.1469-7610.1989.tb00780.x; MILLIS S, 1995, PSYCHOL ASSESSMENT, V7, P384; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nolin P., 2000, Annales de Readaptation et de Medecine Physique, V43, P236, DOI 10.1016/S0168-6054(00)89087-X; Nolin P, 2001, REV NEUROPSYCHOL, V11, P23; NOLIN P, 1999, REV QUEBECOISE PSYCH, V20, P39; Numan B, 2000, J CLIN PSYCHOL, V56, P553, DOI 10.1002/(SICI)1097-4679(200004)56:4<553::AID-JCLP8>3.0.CO;2-Q; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; VANDERLINDEN M, 1999, NEUROPSYCHOLOGIE TOB; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B	41	24	24	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2006	21	1					68	75		10.1097/00001199-200601000-00007			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004WW	WOS:000234784300007	16456393				2022-02-06	
J	Wu, D; Shibuya, S; Miyamoto, O; Itano, T; Yamamoto, T				Wu, Di; Shibuya, Sei; Miyamoto, Osamu; Itano, Toshifumi; Yamamoto, Tetsuji			Increase of NG2-positive cells associated with radial glia following traumatic spinal cord injury in adult rats	JOURNAL OF NEUROCYTOLOGY			English	Article							CHONDROITIN-SULFATE PROTEOGLYCAN; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; NG2 PROTEOGLYCAN; PRECURSOR CELLS; STEM-CELLS; OLIGODENDROGLIAL PROGENITORS; SCAR TISSUE; EXPRESSION; BRAIN	In the CSN including the spinal cord, NG2 proteoglycan is a marker of oligodendrocyte progenitors. To elucidate the dynamics of the endogenous neural stem (progenitor) cells in adult rats with spinal cord injury (SCI), we examined an immunohistochemical analysis of NG2, GFAP, and 3CB2, a specific marker of radial glia (RG). SD rats were divided into a SCI group (n = 25) and a sham-operated group (n = 5). In the injury group, laminectomy was performed at Th11-12 and contusive compression injury was created by applying a weight of 30 g for 10 min. Rats were sacrificed at 24 h, and 1, 4, 8 and 12 weeks post-injury. Frozen 20-mu m sections of tissue 5 and 10 mm rostral and caudal to the epicenter of injury were prepared. Immunohistochemistry was performed using antibodies against NG2, GFAP and 3CB2. At 4 weeks after injury, NG2-positive glial cells arose from below the pial surface as bipolar cells with processes extending throughout the entire white matter. NG2 expression peaked at 4 weeks after injury, showing a 7-fold increase compared to the 24 h after injury. The NG2-positive cells with processes which increased in the white matter of the spinal cord were GFAP-positive and also co-localized with 3CB2 antigen. The pattern of NG2 expression of these cells was temporally and spatially different from the pattern of NG2 expression that accumulated around the hemorrhagic and necrotic epicenter. These results suggest that NG2 positive cells which derived from subpial layer, may have some lineage to RG after SCI in adult rodents.	Kagawa Univ, Dept Neurobiol, Sch Med, Miki, Kagawa 7610793, Japan; Kagawa Univ, Dept Orthopaed Surg, Sch Med, Miki, Kagawa 7610793, Japan		Itano, T (corresponding author), Kagawa Univ, Dept Neurobiol, Sch Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	toshi@kms.ac.jp					Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Berry M, 2002, J NEUROCYTOL, V31, P457, DOI 10.1023/A:1025735513560; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Horner PJ, 2000, J NEUROSCI, V20, P2218; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pasterkamp RJ, 2001, EUR J NEUROSCI, V13, P457, DOI 10.1046/j.0953-816X.2000.01398.x; Pouly S, 2001, ACTA NEUROPATHOL, V102, P313; Prada FA, 1995, GLIA, V15, P389, DOI 10.1002/glia.440150404; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Shibuya S, 2003, GLIA, V42, P172, DOI 10.1002/glia.10203; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; WALLACE MC, 1986, NEUROSURGERY, V18, P433; Weiss S, 1996, J NEUROSCI, V16, P7599; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798	44	24	24	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-4864			J NEUROCYTOL	J. Neurocytol.	DEC	2005	34	6					459	469		10.1007/s11068-006-8998-4			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	073FX	WOS:000239729500009	16902766				2022-02-06	
J	Zagorac, D; Yamaura, K; Zhang, C; Roman, RJ; Harder, DR				Zagorac, D; Yamaura, K; Zhang, C; Roman, RJ; Harder, DR			The effect of superoxide anion on autoregulation of cerebral blood flow	STROKE			English	Article						free radicals; cerebral blood flow	CA2+-ACTIVATED K+ CHANNELS; NITRIC-OXIDE; BRAIN-INJURY; IMPAIRED AUTOREGULATION; POTASSIUM CHANNELS; EXPERIMENTAL-MODEL; HYDROGEN-PEROXIDE; HYPERTENSION; ENDOTHELIUM; MECHANISMS	Background and Purpose - Recent studies have suggested that autoregulation of cerebral blood flow (CBF) is impaired after traumatic and ischemic brain injury. Given that the levels of superoxide anion (O-2(.-)) are increased in these conditions, we postulate that O-2(.-) contributes to the impairment of CBF autoregulation. Methods - CBF was monitored with laser Doppler flowmetry during increases in blood pressure. Results - During the control period, CBF was well autoregulated after the increase in mean arterial pressure (MAP) from 98 +/- 3 to 140 +/- 6 mm Hg. The autoregulation index (AI;Delta CBF/Delta MAP) averaged 0.25 +/- 0.02 (n = 6). O-2(.-) in the brain was then increased by subdural perfusion of xanthine/xanthine oxidase (different concentrations) and catalase. Low concentrations of O-2(.-) decreased basal CBF by 10 +/- 1.6% but had no effect on autoregulation (AI, 0.19 +/- 0.02; n = 6). Higher concentrations of O-2(.-) (0.2 mmol/L xanthine and either 3 or 20 mU xanthine oxidase) increased basal CBF by 30 +/- 2% and 42 +/- 4%, respectively, and impaired autoregulation of CBF (AI, 0.55 +/- 0.03 and 0.76 +/- 0.02; n = 6). Inclusion of superoxide dismutase in the O-2(.-)-generating system restored autoregulation (AI, 0.28 +/- 0.05; n = 6). Neither inhibition of NO synthase nor the addition of deferioxamine had any effect on the ability of higher concentrations of O-2(.-) to impair autoregulation of CBF (AI, 0.65 +/- 0.07 and 0.72 +/- 0.05 respectively; n = 6). O-2(.-) also increased the activity of K-Ca channels in cerebral vascular smooth muscle cells (VSMCs; n = 8). Conclusion - These results suggest that O-2(.-) increases basal CBF and impairs autoregulation of CBF, likely through the activation of KCa channels in cerebral VSMCs.	Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; Clement Zablocki VA Med Ctr, Milwaukee, WI USA		Harder, DR (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	dharder@mcw.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R37HL033833, P01HL068769, P01HL059996, R01HL033833] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5PO1 HL068769-04, HL33833-21, 2PO1 HL059996-06A1] Funding Source: Medline		Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; HARDER DR, 1985, ANN BIOMED ENG, V13, P335, DOI 10.1007/BF02584252; HARDER DR, 1994, AM J PHYSIOL, V266, pH2098, DOI 10.1152/ajpheart.1994.266.5.H2098; Hoagland KM, 2003, HYPERTENSION, V41, P697, DOI 10.1161/01.HYP.0000047881.15426.DC; Hodges GR, 2000, FREE RADICAL BIO MED, V29, P434, DOI 10.1016/S0891-5849(00)00298-7; Hong KW, 2001, AM J PHYSIOL-HEART C, V281, pH308, DOI 10.1152/ajpheart.2001.281.1.H308; Iida Y, 2000, STROKE, V31, P2224, DOI 10.1161/01.STR.31.9.2224; Irikura K, 1996, STROKE, V27, P1399, DOI 10.1161/01.STR.27.8.1399; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Milhorat T H, 1989, Neurol Res, V11, P29; Paterno R, 2000, AM J PHYSIOL-HEART C, V278, pH2003, DOI 10.1152/ajpheart.2000.278.6.H2003; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Prat R, 1998, ACT NEUR S, V71, P123; Rey FE, 2002, CIRCULATION, V106, P2497, DOI 10.1161/01.CIR.0000038108.71560.70; Szentivanyi M, 2000, HYPERTENSION, V35, P418, DOI 10.1161/01.HYP.35.1.418; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; WEI EP, 1985, AM J PHYSIOL, V248, P157; Wolin MS, 2000, ARTERIOSCL THROM VAS, V20, P1430, DOI 10.1161/01.ATV.20.6.1430	26	24	25	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2005	36	12					2589	2594		10.1161/01.STR.0000189997.84161.95			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	986LZ	WOS:000233452400024	16293785	Bronze, Green Published			2022-02-06	
J	Crisp, R				Crisp, R			Key factors related to vocational outcome: Trends for six disability groups	JOURNAL OF REHABILITATION			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; PSYCHOSOCIAL RISK-FACTORS; SEVERE MENTAL-ILLNESS; LOW-BACK-PAIN; COMMUNITY INTEGRATION; MYOCARDIAL-INFARCTION; EMPLOYMENT STATUS; FOLLOW-UP; ACUTE PREDICTORS	This paper reviewed empirical studies published since 1987 and identified variables related to employment outcomes for six disability groups. These groups included persons with spinal cord injuries, traumatic brain injuries, amputations, chronic pain, myocardial infarction / coronary artery bypass grafting, and severe mental illness. The five key factors that were most consistently related to vocational outcome were: severity of disability, socio-demographic factors, psychosocial factors, psychological factors, and enduring employment status. While severity of disability continues to be an important factor, there was less of a medical than psychosocial flavor evident. The key predictors of vocational outcome were socio-demographic (i.e., age, education, race/ethnicity, litigation/financial compensation), psychosocial (e.g, coping strategies, social support) and psychological factors (in particular, depressive symptoms). Socio-demographic factors that identified clients at high risk of long-term employment, and related access and equity were issues frequently reported. Enduring employment status had recently emerged as an area of interest to researchers. Implications for vocational rehabilitation service providers were discussed.	CRS Australia, Croydon, Vic 3136, Australia		Crisp, R (corresponding author), CRS Australia, POB 1172, Croydon, Vic 3136, Australia.	ross.crisp@crsrehab.gov.au					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blyth FM, 2003, PAIN, V103, P41, DOI 10.1016/S0304-3959(02)00380-9; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Boudrez H, 2000, ACTA CARDIOL, V55, P341, DOI 10.2143/AC.55.6.2005765; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cook J. A., 2003, J VOCATIONAL REHABIL, V18, P25; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; CRISP R, 1992, J REHABIL, V58, P27; CRISP R, 1990, J REHABIL, V56, P28; Crook J, 2002, J OCCUP REHABIL, V12, P277, DOI 10.1023/A:1020278708861; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DEVIVO MJ, 1987, ARCH PHYS MED REHAB, V68, P494; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dunn DS, 1996, REHABIL PSYCHOL, V41, P285, DOI 10.1037/0090-5550.41.4.285; Elinson L, 2004, PSYCHIAT SERV, V55, P29, DOI 10.1176/appi.ps.55.1.29; Elliott TR, 1996, ARCH PHYS MED REHAB, V77, P816, DOI 10.1016/S0003-9993(96)90263-4; Ericsson M, 2002, DISABIL REHABIL, V24, P334, DOI 10.1080/09638280110096241; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fisher K, 2003, INT J REHABIL RES, V26, P51, DOI 10.1097/00004356-200303000-00007; Fleming J, 1999, BRAIN INJURY, V13, P417; FRANK RG, 1987, J CONSULT CLIN PSYCH, V55, P727; Gatchel RJ, 1995, SPINE, V20, P2702, DOI 10.1097/00007632-199512150-00011; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Haldorsen EMH, 1998, SPINE, V23, P1202, DOI 10.1097/00007632-199806010-00004; Hammen C, 2000, J CONSULT CLIN PSYCH, V68, P220, DOI 10.1037/0022-006X.68.2.220; Hansson L, 1993, Qual Assur Health Care, V5, P41; Hess DW, 2000, ARCH PHYS MED REHAB, V81, P359, DOI 10.1053/apmr.2000.0810359; Ide M, 2002, ARCH PHYS MED REHAB, V83, P1394, DOI 10.1053/apmr.2002.35095; JENSEN MP, 1991, J CONSULT CLIN PSYCH, V69, P655; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Kemp B, 1999, REHABIL PSYCHOL, V44, P235, DOI 10.1037/0090-5550.44.3.235; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Krause JS, 1998, REHABIL PSYCHOL, V43, P41, DOI 10.1037/0090-5550.43.1.41; Krause JS, 1996, REHABIL COUNS BULL, V39, P244; Krause JS, 1998, ARCH PHYS MED REHAB, V79, P615, DOI 10.1016/S0003-9993(98)90033-8; Krause JS, 1996, ARCH PHYS MED REHAB, V77, P737; Krause JS, 1997, ARCH PHYS MED REHAB, V78, P651, DOI 10.1016/S0003-9993(97)90432-9; Krause JS, 2003, ARCH PHYS MED REHAB, V84, P1282, DOI 10.1016/S0003-9993(03)00265-X; Krause JS, 1999, REHABIL PSYCHOL, V44, P354, DOI 10.1037/0090-5550.44.4.354; Krause JS, 1997, REHABIL PSYCHOL, V42, P31, DOI 10.1037/0090-5550.42.1.31; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LIVINGSTON DH, 1994, J TRAUMA, V37, P495, DOI 10.1097/00005373-199409000-00027; MACDONALD MR, 1987, ARCH PHYS MED REHAB, V68, P339; MAELAND JG, 1987, J PSYCHOSOM RES, V31, P471, DOI 10.1016/0022-3999(87)90005-5; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MCSHANE SL, 1993, REHABIL PSYCHOL, V38, P27, DOI 10.1037/0090-5550.38.1.27; MILHOUS RL, 1989, ARCH PHYS MED REHAB, V70, P589; Mittag O, 2001, SOC SCI MED, V52, P1441, DOI 10.1016/S0277-9536(00)00250-1; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MOWBRAY CT, 1995, PSYCHIATR REHABIL J, V19, P17, DOI 10.1037/h0095444; Mueser KT, 1997, J NERV MENT DIS, V185, P419, DOI 10.1097/00005053-199707000-00001; Mullins J, 1997, J REHABIL, V63, P21; Myrtek M, 1997, INT J CARDIOL, V59, P291, DOI 10.1016/S0167-5273(97)02925-2; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Ormel J, 2000, ARCH GEN PSYCHIAT, V57, P381, DOI 10.1001/archpsyc.57.4.381; Petrie KJ, 1996, BRIT MED J, V312, P1191; Pezzin LE, 2000, ARCH PHYS MED REHAB, V81, P292, DOI 10.1053/apmr.2000.0810292; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P1603, DOI 10.1053/apmr.2002.35115; Rainville J, 1997, SPINE, V22, P2016, DOI 10.1097/00007632-199709010-00016; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RINTALA DH, 1994, REHABIL PSYCHOL, V39, P15, DOI 10.1037/h0080311; Roessler RT, 2002, REHABIL COUNS BULL, V45, P207, DOI 10.1177/00343552020450040301; Rohe DE, 1998, J VOCAT BEHAV, V52, P45, DOI 10.1006/jvbe.1996.1560; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; ROST K, 1992, ARCH INTERN MED, V152, P381, DOI 10.1001/archinte.152.2.381; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Russinova Z, 2002, INT REV PSYCHIATR, V14, P303, DOI 10.1080/0954026021000016941; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Schoppen T, 2001, ARCH PHYS MED REHAB, V82, P239, DOI 10.1053/apmr.2001.18231; Schultz IZ, 2002, SPINE, V27, P2720, DOI 10.1097/00007632-200212010-00012; SHANKAR J, 2003, AUSTR E J ADV MENTAL, V2; SHERBOURNE CD, 1995, J CONSULT CLIN PSYCH, V63, P345, DOI 10.1037/0022-006X.63.3.345; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Soderman E, 2003, SOC SCI MED, V56, P193, DOI 10.1016/S0277-9536(02)00024-2; Suter PB, 2002, PAIN, V100, P249, DOI 10.1016/S0304-3959(02)00238-5; Trieschmann R, 1988, SPINAL CORD INJURIES; Tsang H, 2000, J REHABIL, V66, P19; Vahle VJ, 2000, ARCH PHYS MED REHAB, V81, pS53, DOI 10.1053/apmr.2000.20625; Ville I, 1996, INT J REHABIL RES, V19, P241, DOI 10.1097/00004356-199609000-00005; Waghorn G, 2002, J REHABIL, V68, P40; Waghorn G., 1999, J VOCATIONAL REHABIL, V13, P153; WEED R, 1997, J REHABILITATION OUT, V1, P35; Whyte AS, 2002, DISABIL REHABIL, V24, P462, DOI 10.1080/09638280110105213; YOUNG ME, 1994, REHABIL COUNS BULL, V37, P229	93	24	24	0	14	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	2005	71	4					30	37					8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	990ZM	WOS:000233781900005					2022-02-06	
J	Mcilvoy, LH				Mcilvoy, Laura H.			The Effect of Hypothermia and Hyperthermia on Acute Brain Injury	AACN ADVANCED CRITICAL CARE			English	Article						acute brain injury; hyperthermia; hypothermia; secondary brain injury; stroke; temperature; traumatic brain injury	CEREBRAL-ARTERY OCCLUSION; ADMISSION BODY-TEMPERATURE; INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; ACUTE STROKE; POSTISCHEMIC HYPERTHERMIA	The brain is extraordinarily susceptible to changes in temperature. Hyperthermia has been shown to exacerbate the biochemical cascade of secondary brain injury. Inversely, hypothermia limits the damaging effects of secondary brain injury. There has been a great deal of investigation regarding the detrimental effects of hyperthermia and the neuroprotection of hypothermia in animal studies. Within the last decade, clinical trials have begun to establish how the brain reacts to both temperature extremes. In the future, studies of hypothermia will continue in the quest of the optimal timing and degree of hypothermia. Hyperthermia will be examined in depth for its detrimental effects on an injured brain. Interventions for the prevention and treatment of hyperthermia will be explored. Nurses will implement cooling strategies to induce hypothermia, applying interventions to prevent complications, and they will also diagnose hyperthermia, deciding when and if to intervene pharmacologically and therapeutically. These advanced nursing actions will be guided by knowledge and understanding of available evidence. This article presents the pathophysiology of secondary brain injury and how it is affected by both hypothermia and hyperthermia. A review of the research leading up to clinical trials is explored, as well as a discussion of the future of temperature modulation for the brain injury patient. This information will help healthcare providers understand the effect that both hypothermia and hyperthermia have on the acutely injured brain.	[Mcilvoy, Laura H.] Indiana Univ Southeast, Dept Nursing, New Albany, IN 47150 USA		Mcilvoy, LH (corresponding author), Indiana Univ Southeast, 1661 Silver Creek Dr, New Albany, IN 47150 USA.	lmcilvoy@att.net					Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Bullock R, 1995, GUIDELINES MANAGEMEN; Bullock R, 2001, J NEUROTRAUM, V17, P451; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Busto R, 1989, STROKE, V22, P37; CARUSO CC, 1992, NURS RES, V41, P68; CASTILLO J, 1994, CEREBROVASC DIS, V4, P66, DOI 10.1159/000108454; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; CHEN H, 1991, NEUROLOGY, V41, P1133, DOI 10.1212/WNL.41.7.1133; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Clifton GL, 2001, J NEUROSURG, V94, P855; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; Dietrich W, 1991, J CEREB BLOOD FLO S2, V11, pS846; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Fritz HG, 2004, J NEUROSURG ANESTH, V16, P43, DOI 10.1097/00008506-200401000-00009; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Georgilis K, 1999, J INTERN MED, V246, P203, DOI 10.1046/j.1365-2796.1999.00539.x; Ginsberg M, 1989, J CEREB BLOOD FLOW M, V9, pS380; GINSBERG MD, 1993, PROG BRAIN RES, V96, P13; Globus M-T, 1993, J NEUROTRAUMA S2, V2, P10; GLOBUS MYT, 1988, NEUROSCI LETT, V91, P36, DOI 10.1016/0304-3940(88)90245-5; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Henker R, 1999, Am J Crit Care, V8, P481; HINDFELT B, 1976, ACTA NEUROL SCAND, V53, P72, DOI 10.1111/j.1600-0404.1976.tb04326.x; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Jorgensen HS, 1996, LANCET, V348, P193, DOI 10.1016/S0140-6736(05)66135-1; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kammersgaard LP, 2002, STROKE, V33, P1759, DOI 10.1161/01.STR.0000019910.90280.F1; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; KUROIWA T, 1990, J CEREBR BLOOD F MET, V10, P550, DOI 10.1038/jcbfm.1990.97; Luan XD, 2004, ACTA NEUROPATHOL, V107, P227, DOI 10.1007/s00401-003-0802-2; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Marion DW, 2001, CURR PHARM DESIGN, V7, P1533, DOI 10.2174/1381612013397302; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Morgan S P, 1990, J Neurosci Nurs, V22, P19; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; O'Grady NP, 1998, CRIT CARE MED, V26, P392, DOI 10.1097/00003246-199802000-00046; ODonnell J, 1997, CLIN INFECT DIS, V24, P1208, DOI 10.1086/513660; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Polderman KH, 2004, CRIT CARE MED, V32, P313, DOI 10.1097/01.CCM.0000104936.28288.7A; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2001, J NEUROSURG, V94, P853; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 1998, ACT NEUR S, V71, P131; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Sternau L, 1991, J CEREB BLOOD FLOW M, V11, pS123; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770, DOI 10.1152/ajpheart.1994.267.5.H1770; TERENT A, 1981, UPSALA J MED SCI, V86, P63, DOI 10.3109/03009738109179211; Theard MA, 1997, J NEUROSURG ANESTH, V9, P250; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tymianski M, 1996, NEUROSURGERY, V38, P1176; US Department of Health and Human Services National Institute of Health National Library of Medicine, CLIN TRIALS; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang J, 2000, J NEUROPHYSIOL, V83, P3462, DOI 10.1152/jn.2000.83.6.3462; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; Whalen MJ, 1997, ACT NEUR S, V70, P260; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zuccarelli L A, 2000, Crit Care Nurs Clin North Am, V12, P403	98	24	25	0	3	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	OCT-DEC	2005	16	4					488	500		10.1097/00044067-200510000-00006			13	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF0BG	WOS:000441621700006	16269894				2022-02-06	
J	Nagel, BJ; Barlett, VC; Schweinsburg, AD; Tapert, SF				Nagel, BJ; Barlett, VC; Schweinsburg, AD; Tapert, SF			Neuropsychological predictors of BOLD response during a spatial working memory task in adolescents: What can performance tell us about fMRI response patterns?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	31st Annual Meeting of the International-Neuropsychological-Society	FEB 05-08, 2003	HONOLULU, HI	Int Neuropsychol Soc			DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; FUNCTIONAL MRI; ALCOHOL DEPENDENCE; EXECUTIVE FUNCTION; SUBSTANCE-ABUSE; FAMILY-HISTORY; NEURAL BASIS; TERM-MEMORY; DATA SETS	The relationship between standardized neuropsychological test performance and functional magnetic resonance imaging (fMRI) response during cognitive tasks is largely unknown. This exploratory investigation examined the relationship between neuropsychological test performance and fMRI response to a spatial working memory (SWM) task among 49 typically developing adolescents. Participants were administered a variety of neuropsychological tests in the domains of working memory, visuospatial skills, executive functioning, attention, learning and memory, visuomotor skills and processing speed, and language functioning. Neuropsychological domain scores were used to predict fMRI response during a SWM task. Results suggest that in many brain regions, neuropsychological performance negatively predicts fMRI response, suggesting that those teens with better neuropsychological abilities required fewer neural resources to adequately perform the task. This study provides further understanding of how neuropsychological abilities relate to neural activity during fMRI tasks, and provides an important link between neuropsychological and fMRI research.	VA San Diego Healthcare Syst, La Jolla, CA 92161 USA; Vet Med Res Fdn, San Diego, CA USA; Univ Calif San Diego, Sch Arts & Sci, Dept Psychol, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Psychiat, Sch Med, San Diego, CA 92103 USA		Tapert, SF (corresponding author), VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, La Jolla, CA 92161 USA.	stapert@ucsd.edu	Tapert, Susan/AAE-8208-2020; Dager, Alecia D/V-5798-2017		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA013419, R21AA012519] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA013419, R01 AA13419, R21 AA12519, R01 AA013419-01] Funding Source: Medline		Adams JW, 1997, J EXP CHILD PSYCHOL, V67, P21, DOI 10.1006/jecp.1997.2397; Akshoomoff NA, 1997, INT REV NEUROBIOL, V41, P575, DOI 10.1016/S0074-7742(08)60371-2; Baddeley A.D., 1986, WORKING MEMORY; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BROWN SA, 1989, ADDICT BEHAV, V14, P291, DOI 10.1016/0306-4603(89)90060-9; Brown SA, 1998, J STUD ALCOHOL, V59, P427, DOI 10.15288/jsa.1998.59.427; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Delis D, 1994, MANUAL CALIFORNIA VE; DELIS DC, 2001, MANUAL DELIS KAPLAN; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gathercole S.E., 2003, EDUC CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Golden CJ, 1978, STROOP COLOR WORD TE; Horwitz B, 2000, NEUROIMAGE, V12, P434, DOI 10.1006/nimg.2000.0632; Johnson SC, 2001, J INT NEUROPSYCH SOC, V7, P55, DOI 10.1017/S135561770171106X; Kalechstein AD, 1998, CLIN NEUROPSYCHOL, V12, P339, DOI 10.1076/clin.12.3.339.1991; Kindermann SS, 2004, SCHIZOPHR RES, V68, P203, DOI 10.1016/j.schres.2003.08.010; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; LEATHER CV, 1994, J EXP CHILD PSYCHOL, V58, P88, DOI 10.1006/jecp.1994.1027; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; LOGIE RH, 1994, MEM COGNITION, V22, P395, DOI 10.3758/BF03200866; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; McInnes A, 2003, J ABNORM CHILD PSYCH, V31, P427, DOI 10.1023/A:1023895602957; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; MEYER CH, 1987, P 6 ANN M SOC MAGN R; Nelson CA, 2000, DEV PSYCHOL, V36, P109, DOI 10.1037/0012-1649.36.1.109; Niendam TA, 2003, AM J PSYCHIAT, V160, P2060, DOI 10.1176/appi.ajp.160.11.2060; NOLL DC, 1992, MAGNET RESON MED, V25, P319, DOI 10.1002/mrm.1910250210; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimage.2003.09.069; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RICE JP, 1995, ALCOHOL CLIN EXP RES, V19, P1018, DOI 10.1111/j.1530-0277.1995.tb00983.x; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Swanson HL, 2003, J EXP CHILD PSYCHOL, V85, P1, DOI 10.1016/S0022-0965(03)00043-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tapert S. F., 2001, Alcoholism Clinical and Experimental Research, V25, p80A; Tapert SF, 2000, ADDICTION, V95, P1043, DOI 10.1046/j.1360-0443.2000.95710436.x; Tapert SF, 1999, J INT NEUROPSYCH SOC, V5, P481, DOI 10.1017/S1355617799566010; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Thompson AP, 1998, PSYCHOL REP, V82, P1339, DOI 10.2466/PR0.82.3.1339-1346; WARD BD, 1997, SIMULTANEOUS INFEREN; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1981, WECHSLER ADULT INTEL; WECHSLER D, 1993, MANUAL WECHSLER INTE; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; WONG EC, 2000, P INT SOC MAGN RESON, V8, P683	69	24	25	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	2005	27	7					823	839		10.1080/13803390490919038			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	970GN	WOS:000232293400004	16183616	Green Accepted			2022-02-06	
J	Cooper, EB; Scherder, EJA; Cooper, JB				Cooper, EB; Scherder, EJA; Cooper, JB			Electrical treatment of reduced consciousness: Experience with coma and Alzheimer's disease	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Conference of the International-Neuropsychological-Society	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc			NERVE-STIMULATION TENS; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; MEDIAN NERVE; AFFECTIVE BEHAVIOR; CINGULATE CORTEX; BASAL FOREBRAIN; LOCUS-COERULEUS; MEMORY; CT	The right median nerve can be stimulated electrically to help arouse the central nervous system for persons with reduced levels of consciousness. The mechanisms of central action include increased cerebral blood flow and raised levels of dopamine. There is 11 years of experience in the USA of using nerve stimulation for acute coma after traumatic brain injury There is a much longer period of experience by neurosurgeons in Japan with implanted electrodes on the cervical spinal cord for persons in the persistent vegetative state (PVS). But the use of right median nerve electrical stimulation (RMNS) for patients in the subacute and chronic phases of coma is relatively new. Surface electrical stimulation to treat anoxic brain injury as well as traumatic brain injury is evolving. Novel applications of electrical stimulation in Amsterdam have produced cognitive behavioural effects in persons with early and mid-stage Alzheimer's disease employing transcutaneous electrical nerve stimulation (TENS). Improvements in short-term memory and speech fluency have also been noted. Regardless of the aetiology of the coma or reduced level of awareness, electrical stimulation may serve as a catalyst to enhance central nervous system functions. It remains for the standard treatments and modalities to retrain the injured brain emerging from reduced levels of consciousness.	Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; E Carolina Univ, Dept Phys Med & Rehabil, Brody Sch Med, Greenville, NC USA; Vrije Univ Amsterdam, Dept Neuropsychol, Amsterdam, Netherlands; Univ Groningen, Dept Human Movement Sci, Groningen, Netherlands; Virginia Commonwealth Univ Med Coll Virginia, Dept Neurol, Richmond, VA USA		Cooper, EB (corresponding author), 1001 N Queen St, Kinston, NC 28501 USA.	edwincooper@earthlink.net					Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Buitrago MM, 2004, EXP BRAIN RES, V158, P336, DOI 10.1007/s00221-004-1906-1; Cedazo-Minguez A, 2001, J CELL MOL MED, V5, P254, DOI 10.1111/j.1582-4934.2001.tb00159.x; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; COOPER E, IN PRESS ELECT TREAT; COOPER E, 1996, P AM INP OUTP SYST A; Cooper E B Jr, 1973, Surg Forum, V24, P477; Cooper EB, 2003, ACT NEUR S, V87, P7; COOPER J, 1996, THESIS E CAROLINA U; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; DAVEY M, 2004, COMMUNICATION; DORAISWAMY M, 2003, PSYCHOPHARMACOLOGY B, V37, P41; Dringenberg HC, 2003, NEUROSCIENCE, V119, P839, DOI 10.1016/S0306-4522(03)00197-0; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ezrokhi VL, 1999, NEUROSCIENCE, V88, P741, DOI 10.1016/S0306-4522(98)00232-2; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; GERSH MR, 1992, ELECTROTHERAPY REHAB, P260; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; GREENAMYRE JT, 1988, PROG NEURO-PSYCHOPH, V12, P421, DOI 10.1016/0278-5846(88)90102-9; Hayashi N., 1997, SOC TREAT COMA, V6, P133; Ho GJ, 2002, NEUROREPORT, V13, P1825, DOI 10.1097/00001756-200210070-00028; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KANNO T, 1989, PACE, V12, P733, DOI 10.1111/j.1540-8159.1989.tb02724.x; KANNO T, 1995, UNPUB DORSAL COLUMN; KANNO T, 2000, SOC TREATMENT COMA, V9, P23; KANNO T, 1992, SOC TREATMENT COMA, V1, P67; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; Le Bars PL, 2002, NEUROPSYCHOBIOLOGY, V45, P19, DOI 10.1159/000048668; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; Luijpen MW, 2003, REV NEUROSCIENCE, V14, P343; MARSHALL F, 1996, NEUROSURGERY, P2717; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MONTGOMERY G, 1989, DISCOVER, V10, P58; Moriya T, 2000, SOC TREAT COMA, V9, P159; MORIYA T, 1999, SOC TREAT COMA, V8, P111; OKUMA I, 2001, SOC TREATMENT COMA, V10, P67; PARENT A, 1996, CARPENTERS HUMAN NEU, P381; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; Salehi A, 1999, J NEURAL TRANSM, V106, P955, DOI 10.1007/s007020050216; Sauvage M, 2001, NEUROSCIENCE, V104, P643, DOI 10.1016/S0306-4522(01)00137-3; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; SCHERDER EJA, 1995, BEHAV BRAIN RES, V67, P211, DOI 10.1016/0166-4328(94)00115-V; Scherder EJA, 2003, CHINESE J PHYSIOL, V46, P143; Scherder EJA, 1999, BEHAV BRAIN RES, V101, P105, DOI 10.1016/S0166-4328(98)00150-8; Scherder EJA, 2001, BRAIN INJURY, V15, P545, DOI 10.1080/02699050010007399; SCHERDER EJA, 1992, J CLIN EXP NEUROPSYC, V14, P951, DOI 10.1080/01688639208402546; Scherder EJA, 1998, BIOL PSYCHIAT, V43, P417, DOI 10.1016/S0006-3223(97)00208-4; Scherder EJA, 1999, BIOL PSYCHIAT, V45, P743, DOI 10.1016/S0006-3223(98)00072-9; SCHERDER EJA, 2004, UNPUB EFFECTS RIGHT; SCHERDER EJA, 1996, CHILDRENS HOSP Q, V8, P187; Shinotoh H, 2003, ANN NY ACAD SCI, V985, P411; Spiegel J, 1999, CLIN NEUROPHYSIOL, V110, P47, DOI 10.1016/S0168-5597(98)00043-4; SWAAB DF, 2004, HDB CLIN NEUROLOGY, V80; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; van Dijk KRA, 2002, REV NEUROSCIENCE, V13, P257; Van Someren EJW, 1998, ALZ DIS ASSOC DIS, V12, P114, DOI 10.1097/00002093-199806000-00010; YAMAMOTO K, 1997, SOC TREATMENT COMA, V6, P117; Yokoyama T, 1996, SOC TREAT COMA, V5, P117	67	24	42	0	6	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					389	405		10.1080/09602010443000317			17	Neurosciences; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900024	16350980	Green Published			2022-02-06	
J	Wiese, H; Stude, P; Sarge, R; Nebel, K; Diener, HC; Keidel, M				Wiese, H; Stude, P; Sarge, R; Nebel, K; Diener, HC; Keidel, M			Reorganization of motor execution rather than preparation in poststroke hemiparesis	STROKE			English	Article						electroencephalography; evoked potentials; paresis; recovery of function; stroke	MOVEMENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; HUMAN CEREBRAL-CORTEX; FUNCTIONAL REORGANIZATION; CORTICAL POTENTIALS; STROKE; RECOVERY; ACTIVATION; INFARCTION; LESIONS	Background and Purpose - The aim of the present study was to examine movement-related potentials (MRPs) in patients in the "chronic" stage after cortical stroke with recovered hemiparesis compared with healthy control subjects. Methods - Right index finger MRPs were derived from 12 patients >= 1 year after infarction in the territory of the left middle cerebral artery as well as from 12 control subjects. MRP components were compared between groups. Results - In the patient group, the component directly preceding movement onset ( negative slope [NS]) was significantly reduced over the lesioned hemisphere contralateral to the movement. Furthermore, increased motor potentials (MPs) were observed over the contralesional hemisphere during movement execution. No changes in the early MRP (Bereitschaftspotential) reflecting movement preparation were found. Conclusions - Because the NS is supposed to be generated by the primary motor cortex, the decreased component over the lesioned hemisphere is interpreted to represent impaired contralateral M1 functioning in stroke patients. Contralesional activity has been reported as a probable sign of brain plasticity by functional imaging studies. Our results broaden these findings, giving new insights into the temporal course of movement- related brain activity in recovered cortical stroke patients. The data point to a functional reorganization of motor execution rather than preparation in poststroke hemiparesis.	Univ Duisburg Essen, Dept Neurol, D-45122 Essen, Germany; District Hosp, Dept Neurol, Bayreuth, Germany		Wiese, H (corresponding author), Univ Duisburg Essen, Dept Neurol, Hufelandstr 55, D-45122 Essen, Germany.	holger.wiese@uni-essen.de	Wiese, Holger/M-5281-2014; Diener, Hans-Christoph/AAF-7275-2019	Wiese, Holger/0000-0003-4928-0771; 			Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; GERLOFF C, 2003, BEREITSCHAFTSPOTENTI; Green JB, 1999, STROKE, V30, P2659, DOI 10.1161/01.STR.30.12.2659; Hallett M, 2001, REV NEUROL-FRANCE, V157, P822; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Ikeda A., 2003, BEREITSCHAFTSPOTENTI, P45, DOI DOI 10.1007/978-1-4615-0189-3_4; KEIDEL M, 1983, NATURWISSENSCHAFTEN, V70, P180, DOI 10.1007/BF01047555; Kitamura JI, 1996, ELECTROEN CLIN NEURO, V98, P149, DOI 10.1016/0013-4694(95)00218-9; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lang W., 2003, BEREITSCHAFTSPOTENTI, P19; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Nelles G, 1999, ANN NEUROL, V46, P901, DOI 10.1002/1531-8249(199912)46:6<901::AID-ANA13>3.0.CO;2-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Schreiber H, 1983, Hum Neurobiol, V2, P197; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; SHIBASAKI H, 1975, J NEUROL, V209, P189, DOI 10.1007/BF00312541; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; WEILLER C, 1993, ANN NEUROL, V33, P181; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1	26	24	27	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JUL	2005	36	7					1474	1479		10.1161/01.STR.0000170639.26891.30			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	941BW	WOS:000230190600029	15947274	Bronze			2022-02-06	
J	Eftekharpour, E; Karimi-Abdolrezaee, S; Sinha, K; Velumian, AA; Kwiecien, JM; Fehlings, MG				Eftekharpour, E; Karimi-Abdolrezaee, S; Sinha, K; Velumian, AA; Kwiecien, JM; Fehlings, MG			Structural and functional alterations of spinal cord axons in adult Long Evans Shaker (LES) dysmyelinated rats	EXPERIMENTAL NEUROLOGY			English	Article						Caspr; western blotting; real-time PCR; compound action potential; K+ channels	K+ CHANNELS; MOLECULAR ARCHITECTURE; PARANODAL JUNCTIONS; POTASSIUM CHANNELS; MYELINATED AXONS; PROTEIN CASPR; LOCALIZATION; EXPRESSION; CONTACTIN; INJURY	Abnormal formation or loss of myelin is a distinguishing feature of many neurological disorders and contributes to the pathobiology of neurotrauma. In this study we characterize the functional and molecular changes in CNS white matter in Long Evans Shaker (LES) rats. These rats have a spontaneous Mutation Of the gene encoding myelin basic protein which results in severe dysmyelination of the central nervous system (CNS), providing a unique model for demyelinating/dysmyelinating disorders. To date, the functional and molecular changes in CNS white matter in this model are not well understood. We have used in vivo somatosensory evoked potential (SSEP), in vitro compound action potential (CAP) recording in isolated dorsal columns, confocal immunohistochemistry, Western blotting and real-time PCR to examine the electrophysiological, molecular and cellular changes in spinal cord white matter in LES rats. We observed that dysmyelination is associated with dispersed labeling of Kv1.1 and Kv1.2 K+ channel subunits, as well as Caspr, a protein normally confined to paranodes, along the LES rat spinal cord axons. Abnormal electrophysiological properties including attenuation of CAP amplitude and conduction velocity, high frequency conduction failure and enhanced sensitivity to K+ channel blockers 4-aminopyridine and dendrotoxin-I were observed in spinal cord axons from LES rats. Our results in LES rats clarify some of the key molecular, cellular and functional consequences of dysmyelination and myelin-axon interactions. Further understanding of these issues in this model could provide critical insights for neurological disorders characterized by demyelination. (c) 2005 Elsevier Inc. All rights reserved.	Univ Toronto, Toronto Western Hosp, Hlth Network, Div Neurosurg, Toronto, ON M5T 2S8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5T 2S8, Canada; McMaster Univ, Toronto Western Res Inst, Krembil Neurosci Ctr, Div Cell & Mol Biol, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada		Fehlings, MG (corresponding author), Univ Toronto, Toronto Western Hosp, Hlth Network, Div Neurosurg, Room 4W-449,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364; Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663; Eftekharpour, Eftekhar/0000-0002-2849-3754			Arroyo EJ, 2002, J NEUROSCI, V22, P1726, DOI 10.1523/JNEUROSCI.22-05-01726.2002; Arroyo EJ, 2001, CELL TISSUE RES, V305, P53, DOI 10.1007/s004410100403; Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; Baracskay KL, 2002, J NEUROSCI RES, V70, P645, DOI 10.1002/jnr.10418; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; Craner MJ, 2003, BRAIN, V126, P1552, DOI 10.1093/brain/awg153; DELANEY KH, 1995, LAB ANIM SCI, V45, P547; Dodson PD, 2002, J NEUROSCI, V22, P6953; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; EFTEKHARPOUR E, 2003, 21 NAT NEUR SOC BIL, P425; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Fehlings MG, 1997, J NEUROSCI METH, V71, P215, DOI 10.1016/S0165-0270(96)00147-1; Fehlings MG, 1996, BRAIN RES, V736, P135, DOI 10.1016/S0006-8993(96)00667-1; FEHLINGS MG, 1988, ELECTROEN CLIN NEURO, V69, P65, DOI 10.1016/0013-4694(88)90036-3; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Kwiecien JM, 1998, J NEUROCYTOL, V27, P581, DOI 10.1023/A:1006922227791; Mathis C, 2001, DEVELOPMENT, V128, P4881; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; Nashmi R, 1997, J NEUROTRAUM, V14, P151, DOI 10.1089/neu.1997.14.151; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570; O'Connor LT, 1999, J NEUROSCI, V19, P3404; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Sobko A, 1998, J NEUROSCI, V18, P10398; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Waxman SG, 2002, J REHABIL RES DEV, V39, P233; ZELLER NK, 1984, P NATL ACAD SCI-BIOL, V81, P18, DOI 10.1073/pnas.81.1.18	43	24	25	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2005	193	2					334	349		10.1016/j.expneurol.2005.01.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	926PK	WOS:000229134900007	15869936				2022-02-06	
J	Ferman, TJ; Lucas, JA; Ivnik, RJ; Smith, GE; Willis, FB; Petersen, RC; Graff-Radford, NR				Ferman, TJ; Lucas, JA; Ivnik, RJ; Smith, GE; Willis, FB; Petersen, RC; Graff-Radford, NR			Mayo's Older African American Normative Studies: Auditory Verbal Learning Test norms for African American elders	CLINICAL NEUROPSYCHOLOGIST			English	Article							WHITE COMMUNITY RESIDENTS; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MILD COGNITIVE IMPAIRMENT; CLOSED-HEAD-INJURY; ALZHEIMERS-DISEASE; HIPPOCAMPAL ATROPHY; MEMORY; DEMENTIA; SPECIFICITY; SENSITIVITY	The Auditory Verbal Learning Test (AVLT) is frequently used in clinical practice to assess for memory dysfunction in the elderly. Aspart of the Mayo Older African Americans Normative Studies (MOAANS), we provide age and education adjusted normative data for the AVLT. The sample consists of 306 self-identified African Americans who are cognitively normal, community-dwelling and ranging in age from 56 through 94. Additional summary indices are included in the normative data, including learning efficiency, delayed recall, percent retention, and an index representing recognition memory corrected for false-positive identifications. Given the importance of using a normative reference sample that closely represents the population of interest, the current norms should provide clinically useful data for evaluating African American elders, especially those who were educated in the southern United States.	Mayo Fdn, Dept Psychiat & Psychol, Jacksonville, FL USA; Mayo Fdn, Dept Family Med, Jacksonville, FL USA; Mayo Fdn, Dept Neurol, Jacksonville, FL USA; Mayo Fdn, Dept Psychiat & Psychol, Rochester, MN USA; Mayo Fdn, Dept Neurol, Rochester, MN USA		Lucas, JA (corresponding author), Mayo Clin, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	jlucas@mayo.edu		Smith, Glenn/0000-0003-1506-9484	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016574] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG16574] Funding Source: Medline		Albert SM, 1999, AM J PUBLIC HEALTH, V89, P95, DOI 10.2105/AJPH.89.1.95; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; BUTTERS N, 1995, ANNU REV PSYCHOL, V46, P493; FILLENBAUM G, 1990, J CLIN EPIDEMIOL, V43, P651, DOI 10.1016/0895-4356(90)90035-N; Fillenbaum GG, 1998, J CLIN EPIDEMIOL, V51, P587, DOI 10.1016/S0895-4356(98)00024-9; Fillenbaum GG, 2001, J INT NEUROPSYCH SOC, V7, P502, DOI 10.1017/S1355617701744062; Gainotti G, 1998, ALZ DIS ASSOC DIS, V12, P152, DOI 10.1097/00002093-199809000-00006; GEFFEN GM, 1994, BRAIN INJURY, V8, P405, DOI 10.3109/02699059409150992; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; Harris ME, 2002, J CLIN EXP NEUROPSYC, V24, P214, DOI 10.1076/jcen.24.2.214.995; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Heun R, 1997, DEMENT GERIATR COGN, V8, P329, DOI 10.1159/000106651; HEYMAN A, 1991, ARCH NEUROL-CHICAGO, V48, P594, DOI 10.1001/archneur.1991.00530180046016; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P162, DOI 10.1080/13854040590945265; Lucas MD, 1996, J CLIN EXP NEUROPSYC, V18, P88, DOI 10.1080/01688639608408265; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; MANLY JJ, 1998, NEUROLOGY, V50, P1; MICELI G, 1981, Journal of Clinical Neuropsychology, V3, P53, DOI 10.1080/01688638108403113; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROSENBERG SJ, 1984, J CLIN PSYCHOL, V40, P785, DOI 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4; Sencakova D, 2001, ARCH NEUROL-CHICAGO, V58, P1593, DOI 10.1001/archneur.58.10.1593; Simard M, 1999, DRUG AGING, V14, P197, DOI 10.2165/00002512-199914030-00004; Smith GE, 1996, AGING NEUROPSYCHOL C, V3, P141, DOI 10.1080/13825589608256619; Tangalos, 1992, CLIN NEUROPSYCHOL, V6, P83, DOI [10.1080/13854049208401880, DOI 10.1080/13854049208401880]; Taylor E., 1959, PSYCHOL APPRAISAL CH; TERESI JA, 1995, J CLIN EPIDEMIOL, V48, P473, DOI 10.1016/0895-4356(94)00159-N; Tierney M, 1994, PSYCHOL ASSESSMENT, V6, P129, DOI DOI 10.1037/1040-3590.6.2.129; Tierney MC, 2001, ARCH NEUROL-CHICAGO, V58, P1654, DOI 10.1001/archneur.58.10.1654; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; Welsh KA, 1995, NEUROLOGY, V45, P2207, DOI 10.1212/WNL.45.12.2207	35	24	25	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUN	2005	19	2					214	228		10.1080/13854040590945300			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	932LN	WOS:000229555300056	16019705				2022-02-06	
J	Pickett, W; Streight, S; Simpson, K; Brison, RJ; Cusimano, M				Pickett, W; Streight, S; Simpson, K; Brison, RJ; Cusimano, M			Head injuries in youth soccer players presenting to the emergency department	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; FOOTBALL PLAYERS; DAMAGE	Background: There has been recent concern about neuropsychological injuries experienced by soccer players, particularly related to the purposeful heading of the ball. There are few population based analyses examining whether this is a legitimate concern. Objectives: To explore, using an existing injury surveillance system, one of many parts of this issue: acute injuries requiring emergency medical care experienced by youth soccer players. Methods: Descriptive epidemiological analysis of emergency department injury surveillance data (1996-2001) for youths aged 10-24 years from the Kingston sites of the Canadian Hospital Injury Reporting and Prevention Program. Results: A total of 1714 cases of soccer injury were identified (mean 286 a year); 235 (13.7%) involved diagnoses of injuries to the head. Leading mechanical factors resulting in head injury were contact with other players or persons (153/235; 65.1%) and balls (62/235; 26.4%). Heading was reported in 4/62 (6%) of the ball contact injuries, and attempted heading was reported in 15/153 (9.8%) of the cases involving person to person contact. Unspecified head to head contact between players was reported in 39 cases. Conclusions: Minor head injuries that result in emergency medical treatment do not happen often in youth soccer, and very few can be attributed to the purposeful heading of the ball. Player contact injuries appear to be a more important injury control concern. This study informs one of many aspects of the soccer heading injury debate.	Queens Univ, Dept Emergency Med, Kingston, ON K7L 2V7, Canada; Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 2V7, Canada; St Michaels Univ Hosp, Div Neurosurg, Toronto, ON M5B 1A6, Canada		Pickett, W (corresponding author), Queens Univ, Kingston Gen Hosp, Dept Emergency Med, Angada 3, Kingston, ON K7L 2V7, Canada.	simpsonk@kgh.kari.net; injuryprevention@smh.toronto.on.ca	Cusimano, Michael/X-4059-2019				Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Broglio SP, 2003, J ATHL TRAINING, V38, P220; *CAN SOCC ASS, COACH GRASS ROOTS IT; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Filipe JAC, 2003, ARCH OPHTHALMOL-CHIC, V121, P687; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; *HLTH CAN, 1996, CAN HOSP INJ REP PRE; Horn EP, 2000, RETINA-J RET VIT DIS, V20, P604, DOI 10.1097/00006982-200011000-00003; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; LOBNES JH, 1996, SOCCER SPORTS MED SC, P71; Mackenzie S G, 1999, Inj Prev, V5, P208; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Nilsson S, 1978, Am J Sports Med, V6, P358, DOI 10.1177/036354657800600608; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prabhu VC, 2002, NEUROSURGERY, V50, P195; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Tysvaer A, 1981, Br J Sports Med, V15, P163; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421	31	24	24	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR 1	2005	39	4					226	231		10.1136/bjsm.2004.013169			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	911CV	WOS:000227980000019	15793093	Green Published, Bronze			2022-02-06	
J	Fujisawa, H; Yonaha, H; Okumoto, K; Uehara, H; Ie, T; Nagata, Y; Suehiro, E; Suzuki, M				Fujisawa, H; Yonaha, H; Okumoto, K; Uehara, H; Ie, T; Nagata, Y; Suehiro, E; Suzuki, M			Mutism after evacuation of acute subdural hematoma of the posterior fossa	CHILDS NERVOUS SYSTEM			English	Article						acute subdural hematoma; posterior fossa; mutism; head injury	TRANSIENT CEREBELLAR MUTISM; CHILDREN; SPEECH	Case report: A 7-year-old boy was involved in a road traffic accident. A computed tomography scan revealed an acute subdural hematoma (ASDH) of the posterior fossa, traumatic subarachnoid hemorrhage, and distortion of the brain stem. Removal of the ASDH was completed 3.5 h after injury. After extubation, the patient rapidly recovered consciousness. He was able to follow commands, although he did not speak. He began to utter 14 days after the injury. His speech became normal 39 days after injury. A magnetic resonance imaging scan revealed a post-contusional change in the right cerebellum and an ischemic lesion in the pons. Discussion: Immediate removal of the hematoma is the only therapy for patients with ASDH of the posterior fossa. Although any lesions of the dentate nucleus, red nucleus, thalamus, cerebral cortex, and pons, all of which are involved in this case, are able to cause mutism, his mutism was primarily caused by the severe ASDH of the posterior fossa. The transient nature of this syndrome suggests that the cause of the mutism is trauma-related edema and/or transient ischemia of these structures.	Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi 7558505, Japan; Okinawa Prefectural Yaeyama Hosp, Dept Surg, Ishigaki, Japan; Okinawa Prefectural Yaeyama Hosp, Dept Radiol, Ishigaki, Japan		Fujisawa, H (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.	hirofuji@yamaguchi-u.ac.jp	Suehiro, Eiichi/I-5852-2019				Coplin WM, 1997, BRAIN LANG, V59, P473, DOI 10.1006/brln.1997.1790; Hecimovic I, 1999, SURG NEUROL, V51, P247, DOI 10.1016/S0090-3019(97)00473-4; KINGMA A, 1994, ACTA NEUROCHIR, V131, P74, DOI 10.1007/BF01401456; Koh S, 1997, PEDIATR NEUROL, V16, P218, DOI 10.1016/S0887-8994(97)00018-0; MAHONEY F I, 1965, Md State Med J, V14, P61; Miyakita Y, 1999, ACTA NEUROCHIR, V141, P209, DOI 10.1007/s007010050288; Niskikawa M, 1998, NEUROL MED-CHIR, V38, P569, DOI 10.2176/nmc.38.569; RAFTOPOULOS C, 1990, CLIN NEUROL NEUROSUR, V92, P57, DOI 10.1016/0303-8467(90)90008-S; Sinha AK, 1998, CHILD NERV SYST, V14, P460, DOI 10.1007/s003810050261; Turgut M, 1998, CHILD NERV SYST, V14, P161, DOI 10.1007/s003810050204; Wang MC, 2002, J NEUROSURG, V96, P607, DOI 10.3171/jns.2002.96.3.0607; YOKOTA H, 1990, Neurological Surgery, V18, P67	12	24	25	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2005	21	3					234	236		10.1007/s00381-004-0999-y			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	902OY	WOS:000227367600012	15290193				2022-02-06	
J	Salomone, JP; Ustin, JS; McSwain, NE; Feliciano, DV				Salomone, JP; Ustin, JS; McSwain, NE; Feliciano, DV			Opinions of trauma practitioners regarding prehospital interventions for critically injured patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 11-13, 2003	MINNEAPOLIS, MN	Amer Assoc Surg Trauma		emergency medical services; prehospital care; trauma; airway management; intravenous fluid resuscitation; pneumatic antishock garment	EMERGENCY MEDICAL-SERVICES; FLUID RESUSCITATION; PROMPT TRANSPORT; CARE; FIELD; IMMOBILIZATION; STABILIZATION; INTUBATION; PARAMEDICS; SURVIVAL	Background. Significant controversy surrounds the prehospital management of trauma patients. Methods. A questionnaire describing clinical scenarios was mailed to a random sample of 345 trauma practitioners. Results. The 182 trauma practitioners (52.8%) who returned the surveys were predominantly general or trauma surgeons (83.5%) in academic or university practice (68.1%). For a patient with a severe traumatic brain injury, 84.5% of trauma practitioners recommended that emergency medical services personnel attempt intubation at least once when transport time was 20 to 40 minutes. For a with a gunshot wound to the epigastrium in decompensated shock, the majority of trauma practitioners believed that a relatively hypotensive state should be maintained, regardless of transport time. Trauma practitioners (52.2%) have recommended the use of the pneumatic antishock garment for transports of 20 to 40 minutes for patients with an unstable pelvic fracture and decompensated shock. Conclusion. most trauma practitioners believe that emergency medical services providers should attempt intubation for a patient with a severe traumatic brain injury, should treat decompensated shock in a patient with penetrating torso trauma but maintain the patient in a relatively hypotensive state, and should apply and inflate the pneumatic antishock garment for a suspected pelvic fracture accompanied by decompensated shock if the patient is 20 to 40 minutes from a trauma center. The recommendations of trauma practitioners regarding appropriate prehospital care are significantly influenced by the time required for transport to the trauma center.	Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30303 USA; Tulane Univ, Sch Med, Dept Surg, New Orleans, LA 70118 USA		Salomone, JP (corresponding author), Emory Univ, Sch Med, Dept Surg, Glenn Mem Bldg,312,69 Jesse Hill Jr Dr,SE, Atlanta, GA 30303 USA.	jsalomo@emory.edu					Ali J, 1997, J TRAUMA, V42, P1018, DOI 10.1097/00005373-199706000-00005; *AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP P; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BLAISDELL FW, 1985, J TRAUMA, V25, P856, DOI 10.1097/00005373-198509000-00008; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; CHAN D, 1994, ANN EMERG MED, V23, P48, DOI 10.1016/S0196-0644(94)70007-9; Cornwell EE, 2001, ARCH SURG-CHICAGO, V136, P324, DOI 10.1001/archsurg.136.3.324; Cornwell EE, 2000, ARCH SURG-CHICAGO, V135, P315, DOI 10.1001/archsurg.135.3.315; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Demetriades D, 1996, ARCH SURG-CHICAGO, V131, P133; Domeier R M, 1997, Prehosp Emerg Care, V1, P32, DOI 10.1080/10903129708958782; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; FLINT LM, 1979, ANN SURG, V189, P709, DOI 10.1097/00000658-197906000-00006; Fortune JB, 1997, J TRAUMA, V42, P832, DOI 10.1097/00005373-199705000-00013; GERVIN AS, 1982, J TRAUMA, V22, P443, DOI 10.1097/00005373-198206000-00001; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; IVATURY RR, 1987, J TRAUMA, V27, P1066, DOI 10.1097/00005373-198709000-00019; Jacobson LE, 1996, J TRAUMA, V41, P15, DOI 10.1097/00005373-199607000-00004; JONES SE, 1989, ANN EMERG MED, V18, P244, DOI 10.1016/S0196-0644(89)80405-6; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; LEWIS FR, 1986, J TRAUMA, V26, P804, DOI 10.1097/00005373-198609000-00005; Liberman M, 2003, ANN SURG, V237, P153, DOI 10.1097/00000658-200302000-00001; MATTOX KL, 1989, J TRAUMA, V29, P1104, DOI 10.1097/00005373-198908000-00007; MCSWAIN NE, 1988, ANN EMERG MED, V17, P506, DOI 10.1016/S0196-0644(88)80248-8; MCSWAIN NE, 2003, PHTLS BASIC ADV PREH; OGORMAN M, 1989, J TRAUMA, V29, P84, DOI 10.1097/00005373-198901000-00017; PANTRIDGE JF, 1969, AM J CARDIOL, V24, P666, DOI 10.1016/0002-9149(69)90454-8; PONS PT, 1988, J TRAUMA, V28, P1460, DOI 10.1097/00005373-198810000-00009; ROCKWOOD CA, 1976, J TRAUMA, V16, P299, DOI 10.1097/00005373-197604000-00008; SMITH JP, 1985, J TRAUMA, V25, P65, DOI 10.1097/00005373-198501000-00011; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Totten V Y, 1999, Prehosp Emerg Care, V3, P347, DOI 10.1080/10903129908958967; TRUNKEY DD, 1984, J TRAUMA, V24, P86, DOI 10.1097/00005373-198401000-00017; WAYNE MA, 1999, PREHOSP EMERG CARE, V3, P377; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	35	24	24	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2005	58	3					509	515		10.1097/01.TA.0000152807.63559.2E			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	906JK	WOS:000227636800019	15761344				2022-02-06	
J	Wennberg, R				Wennberg, R			Effect of ice surface size on collision rates and head impacts at the World Junior Hockey Championships, 2002 to 2004	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						collision; concussion; head impact; hockey; injury; ice surface size	CONCUSSIONS; LEAGUE	Objective: To determine if collision rates and head impacts in elite junior hockey differed between games played on the small North American ice surface (85 ft wide), an intermediate-size Finnish ice surface (94 ft wide), and the large standard international ice surface (100 ft wide). Design: Videotape analysis of all games involving Team Canada from the 2002 (large ice, Czech Republic), 2003 (small ice, Canada), and 2004 (intermediate ice, Finland) World Junior Championships. All collisions were counted and separated into various categories (volitional player/player bodychecks, into boards or open ice, plus accidental/incidental player/boards, player/ice, head/stick, head/puck). Further subdivisions included collisions involving the head directly or indirectly and notably severe head impacts. Results: Small, intermediate, and large ice surface mean collisions/game, respectively, were 295, 258, 222, total collisions; 251, 220, 181, volitional bodychecks; 126, 115, 88, into boards; 125, 106, 93, open ice; 71, 52, 44, total head; 44, 36, 30, indirect head; 26, 16, 13, direct head; and 1.3, 0.5, 0.3, severe head (P < 0.05 for small-intermediate ice and intermediate-large ice differences in total collisions; P < 0.005 for small-large ice difference; P < 0.05 for small-intermediate ice differences in head impacts; P < 0.01 for small-large ice differences in total and severe head impacts). Conclusions: There is a significant inverse correlation between ice size and collision rates in elite hockey, including direct, indirect, and severe head impacts. These findings suggest that uniform usage of the larger international rinks could reduce the risk of injury, and specifically, concussions in elite hockey by decreasing the occurrence of collisions and head impacts.	Univ Toronto, Toronto Western Hosp, Div Neurol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada		Wennberg, R (corresponding author), Univ Toronto, Toronto Western Hosp, Div Neurol, 399 Bathurst St,5W444, Toronto, ON M5T 2S8, Canada.	r.wennberg@utoronto.ca					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596	5	24	24	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2005	15	2					67	72		10.1097/01.jsm.0000152712.27968.fe			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	943CF	WOS:000230328800005	15782049				2022-02-06	
J	Henry, GK				Henry, GK			Probable malingering and performance on the test of variables of attention	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; HEAD-INJURY; ATTORNEYS	Fifty subjects with mild head injury involved in personal injury litigation and 2 subjects referred for evaluation of their disability status underwent comprehensive neuropsychological examination including the Test of Variables of Attention (TOVA). Group status was determined by performance on symptom validity testing. Twenty-six subjects who failed symptom validity testing formed the probable malingering (PM) group, while 26 subjects who passed symptom validity testing comprised the not malingering (NM) group. Subjects in the PM group performed significantly worse on all TOVA variables relative to subjects in the NM group. Discriminant function analyses revealed that TOVA omission errors >= 3 errors was the best predictor of group status. Malingering research employing a group of probable clinical malingerers has direct generalizability to real-world settings.	Los Angeles Neuropsychol Grp, Los Angeles, CA 90025 USA		Henry, GK (corresponding author), Los Angeles Neuropsychol Grp, 1950 Sawtelle Blvd,Suite 342, Los Angeles, CA 90025 USA.	GHenry0249@aol.com					Cohen J., 1988, STAT POWER BEHAV SCI; CONDER R, 1992, COMPUTERIZED ASSESSM; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Green P, 1996, WORD MEMORY TEST; Greenberg LM., 1996, TEST VARIABLES ATTEN; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leark RA, 2002, ARCH CLIN NEUROPSYCH, V17, P335, DOI 10.1016/S0887-6177(01)00118-4; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Neter J., 1996, APPL LINEAR REGRESSI, V3rd ed; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh T.N., 1996, TEST MEMORY MALINGER; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474	24	24	24	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2005	19	1					121	129		10.1080/13854040490516604			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	912YF	WOS:000228115300009	15814483				2022-02-06	
J	Cherington, M				Cherington, M			Spectrum of neurologic complications of lightning injuries	NEUROREHABILITATION			English	Article						lightning injuries; post-hypoxic encephalopathy; myelopathy; delayed syndromes; keraunoparalysis; neurorehabilitation; safety recommendations	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; LICHTENBERG FIGURES; ELECTRICAL INJURIES; STRIKE; ENCEPHALOPATHY	Lightning is responsible for a wide spectrum of neurologic complications. Many of the persistent symptoms require long-term neurorehabilitation. The lightning-related neurologic conditions are divided into four categories. Category I consists of signs and symptoms that are temporary and usually benign. Category II conditions are prolonged or permanent produced by significant central nervous system lesions. Two of the most devastating complications are lightning-related encephalopathy and myelopathy. The disabilities that accompany these lesions call for concentrated neurorehabilitation. A large number of patients are afflicted with neurobehavioral symptoms that may last for months or years. Category III contains delayed neurologic syndromes. Category IV encompasses neurologic lesions that are not directly activated by the lightning strike but are the result of trauma secondary to falls or blasts effects. The sensible course for individuals at risk is to learn and follow lightning safety recommendations.	St Anthony Hosp, Lightning Data Ctr, Denver, CO 80204 USA		Cherington, M (corresponding author), St Anthony Hosp, Lightning Data Ctr, 4231 W 16th Ave, Denver, CO 80204 USA.	Lightningdatacenter@Centura.org					Abrahamson J, 2000, NATURE, V403, P519, DOI 10.1038/35000525; ANDREWS C, 1995, SEMIN NEUROL, V15, P296, DOI 10.1055/s-2008-1041035; BLUMBERG MS, 2002, BODY HEAT; Brewer KL, 2004, ACAD EMERG MED, V11, P125, DOI 10.1197/j.aem.2003.09.010; Bychkov VL, 2002, PHILOS T ROY SOC A, V360, P37, DOI 10.1098/rsta.2001.0918; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Charcot JM, 1889, B MED PARIS, V3, P1323; CHARCOT JM, 1890, WIEN MED WOCH, V40; CHERINGTON M, 1993, NEUROLOGY, V43, P1437, DOI 10.1212/WNL.43.7.1437; Cherington M, 2003, J BURN CARE REHABIL, V24, P175, DOI 10.1097/01.BCR.0000066783.15017.A4; Cherington M, 2003, INJURY, V34, P367, DOI 10.1016/S0020-1383(02)00313-3; Cherington M, 2003, NEUROLOGY, V60, P182, DOI 10.1212/01.WNL.0000033801.15204.B5; CHERINGTON M, 1995, SEMIN NEUROL, V15, P233, DOI 10.1055/s-2008-1041028; Cherington M, 2002, J TRAUMA, V52, P579, DOI 10.1097/00005373-200203000-00031; CHERINGTON M, 1990, PHYSICIAN SPORTSMED, V18, P58, DOI 10.1080/00913847.1990.11710113; CHERINGTON M, 1992, ANN EMERG MED, V21, P575, DOI 10.1016/S0196-0644(05)82529-6; Cherington M., 1999, 11 C APPL CLIM DALL, P379; COHEN JA, 1995, SEMIN NEUROL, V15, P413; COOPER MA, 1980, ANN EMERG MED, V9, P134, DOI 10.1016/S0196-0644(80)80268-X; Coubrough Valerie, 2002, Axone, V23, P14; Critchley M, 1934, LANCET, V1, P68; Critchley Macdonald, 1932, Bristol Med Chir J (1883), V49, P285; CURRAN EB, 1997, SR193 NOAA NWS, P1; Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558; DAVIDSON GS, 1988, ACTA NEUROPATHOL, V77, P104, DOI 10.1007/BF00688250; Dmitriev M.T., 1986, ORTHOPEDY TRAUMATOL, V11, P66; Duff K, 2001, NEUROPSYCHOL REV, V11, P101, DOI 10.1023/A:1016623318049; Gilliam FG, 2004, NEUROLOGY, V62, P23, DOI 10.1212/WNL.62.1.23; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; Jafari H, 2001, J NEUROL NEUROSUR PS, V71, P265, DOI 10.1136/jnnp.71.2.265; LICHTENBERG R, 1993, J AM COLL CARDIOL, V21, P531, DOI 10.1016/0735-1097(93)90699-2; LOPEZ RE, 1993, B AM METEOROL SOC, V74, P2171, DOI 10.1175/1520-0477(1993)074<2171:TUOLIA>2.0.CO;2; LOPEZ RE, 1995, SEMIN NEUROL, V15, P286, DOI 10.1055/s-2008-1041034; MANN H, 1983, AM J NEURORADIOL, V4, P976; New PW, 2004, ARCH PHYS MED REHAB, V85, P87, DOI 10.1016/S0003-9993(03)00378-2; OZGUN B, 1995, AM J NEURORADIOL, V16, P1370; PRIMEAU M, 1995, SEMIN NEUROL, V15, P279, DOI 10.1055/s-2008-1041033; Resnik BI, 1996, AM J FOREN MED PATH, V17, P99, DOI 10.1097/00000433-199606000-00002; SHARMA M, 1978, BRIT MED J, V2, P1464, DOI 10.1136/bmj.2.6150.1464-a; Shmatov ML, 2003, J PLASMA PHYS, V69, P507, DOI 10.1017/S002237780300237X; Singer S, 2002, PHILOS T R SOC A, V360, P5, DOI 10.1098/rsta.2001.0916; STANLEY LD, 1985, NEUROSURGERY, V16, P686, DOI 10.1227/00006123-198505000-00020; STEINBAUM S, 1994, J TRAUMA, V36, P113, DOI 10.1097/00005373-199401000-00019; TENDUIS HJ, 1985, BURNS, V12, P54, DOI 10.1016/0305-4179(85)90183-4; TENDUIS HJ, 1987, BURNS, V13, P141, DOI 10.1016/0305-4179(87)90104-5; Tsuei BJ, 2004, INJURY, V35, P7, DOI 10.1016/S0020-1383(03)00309-7; WEERAMANTHRI TS, 1991, J ROY SOC MED, V84, P687; Wilson FC, 2003, NEUROREHABILITATION, V18, P291; Yarnell PR, 1995, SEMIN NEUROL, V15, P391, DOI 10.1055/s-2008-1041050; Zimmermann C, 2002, ANN EMERG MED, V39, P660, DOI 10.1067/mem.2002.124439	50	24	25	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2005	20	1					3	8					6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	912UL	WOS:000228105300002	15798349				2022-02-06	
J	Talbert, DG				Talbert, DG			Paroxysmal cough injury, vascular rupture and 'shaken baby syndrome'	MEDICAL HYPOTHESES			English	Article							RESPIRATORY-DISTRESS SYNDROME; BLOOD-FLOW VELOCITY; INTRAVENTRICULAR HEMORRHAGE; PULMONARY; INFANTS	It is widely assumed that subdural and retinal haemorrhage in infants can only result from traumatic rupture of vulnerable blood vessels. An alternative aetiology, that of vascular rupture resulting from excessive intraluminal pressure, is presented in three disease conditions. (1) Perlman et al., studying premature neonates requiring mechanical ventilation for respiratory distress syndrome, observed "cough-like" fluctuations in oesophageal pressure greater than 18 cms H2O, whose timing matched fluctuations in anterior cerebral artery flow. When 14 out of 24 neonates were paralysed (to prevent abdominal muscle activity) intraventricular haemorrhage developed in all 10 controls but in only one of the paralysed group during paralysis. (2) New analysis of pressure data extracted from a previous study of prolonged expiratory apnoea showed alveolar collapse induced 100 mmHg intrathoracic cough pressure surges. Superior vena cava pressures up to 50 mmHg were implied, and radial artery systolic pressures over 180 mmHg recorded. (3) Bordetella pertussis bacteria attach to cilia in the airways, but do not invade the underlying tissue. The irritation causes the powerful coughing paroxysms of whooping cough. Brain haemorrhages and retinal detachment have been observed to result from the high intravascular pressures produced. The data suggest that any source of intense airway irritation not easily removed (laryngeal infection, inhalation of regurgitated feed, fluff, smoke, etc.) could induce similar bleeding, a paroxysmal cough injury (PCI). Additional objective evidence of inflicted trauma is necessary to distinguish between 'shaken baby syndrome' and PCI. (C) 2004 Elsevier Ltd. All rights reserved.	Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Sch Med, Inst Reprod & Dev Biol, London W12 0NN, England		Talbert, DG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Queen Charlottes Hosp, Sch Med, Inst Reprod & Dev Biol, Du Cane Rd, London W12 0NN, England.	d.talbert@imperial.ac.uk					BANNISTER R, 1996, OXFORD TXB MED, P3881; GANONG WF, 1987, REV MED PHYSL, P493; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; HEISTAD DD, 1983, HDB PHYSL 2, V0003, P00137; LINNEMANN CC, 1996, OXFORD TXB MED, V7, P587; Lumb AB, 2000, NUNNS APPL RESP PHYS, P82; MCKENDRICK GDW, 1978, PRICES TXB PRACTICE, P49; MORSE SI, 1979, TXB MED, V203, P341; PERLMAN J, 1988, PEDIATRICS, V81, P399; PERLMAN JM, 1983, NEW ENGL J MED, V309, P204, DOI 10.1056/NEJM198307283090402; PERLMAN JM, 1985, NEW ENGL J MED, V312, P1353, DOI 10.1056/NEJM198505233122104; SADUN AS, 1988, DUANES CLIN OPTHALMO, V4, P1; SOUTHALL DP, LANCET, P571; SOUTHALL DP, 1987, CURRENT TOPICS PULMO, P210; SOUTHALL DP, 1990, ARCH DIS CHILD, V65, P935; WEST JB, 1991, J APPL PHYSIOL, V70, P1731, DOI 10.1152/jappl.1991.70.4.1731; WIDDICOMBE JG, 1982, J EXP BIOL, V100, P41; WIDDICOMBE JG, 1986, RESP SYSTEM 1, V2, P363	18	24	24	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses		2005	64	1					8	13		10.1016/j.mehy.2004.07.017			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	876FH	WOS:000225481400002	15533602				2022-02-06	
J	Sommer, JL; Witkiewicz, PM				Sommer, JL; Witkiewicz, PM			The therapeutic challenges of dual diagnosis: TBI/SCI	BRAIN INJURY			English	Article							SPINAL-CORD-INJURY; HEAD-INJURY	Rehabilitation centres provide therapeutic intervention to both patients with traumatic brain injury (TBI) and spinal cord injury (SCI). Patients with a dual diagnosis of TBI and SCI present a challenge to the rehabilitation professional. Previous studies indicate an incidence of concomitant TBI and SCI to be between 24-59%. Many research articles discuss how a diagnosis of TBI is often missed during the medical examination of a person with a suspected SCI. This article will focus on the implications of dual diagnosis encountered during the rehabilitation process. A case study is used to highlight the challenges presented by the cognitive impairments of a TBI in combination with the motoric deficits of SCI. Management strategies utilised by the rehabilitation team are discussed.	Virginia Commonwealth Univ, Med Ctr, North Hosp, Rehabil & Res Ctr, Richmond, VA 23298 USA		Sommer, JL (corresponding author), Virginia Commonwealth Univ, Med Ctr, North Hosp, Rehabil & Res Ctr, 1st Floor,13th & Marshall St,POB 960661, Richmond, VA 23298 USA.	jsommer@mail2.vcu.edu					DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; Fee FA, 1995, SCI PSYCHOSOCIAL PRO, V8, P106; GRIEVE J, 1999, NEUROPSYCHOLOGY OCCU; GUTMAN SA, 2001, CE18 AOTA CONT ED; Hammond MC, 2000, YES YOU CAN GUIDE SE; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Lemke D M, 1995, SCI Nurs, V12, P40; NEIMIER JP, 1 STEPS REC BRAIN IN; NOLDELOPEZ G, 1995, ADV REHABILITATION, V4, P65; PEDRETTI LW, 1996, OCCUPATIONAL THERAPY, P765; POVOLNY MA, 1993, J REHABIL, V59, P22; *RANCH LOS AM MED, 1980, LEV COGN FUNCT; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; RICKER HJ, 1999, TOPICS SPINAL CORD I, V5, P76; Ricker JH, 1999, TOP SPINAL CORD INJ, V5, P76; Stutts M, 1991, NEUROREHABILITATION, V1; TROSPER RM, 2000, SCI PSYCHOSOCIAL PRO, V13, P1; WAGNER KA, 1984, ASIA ABSTR DIG, P1096; Watanabe T, 1999, TOP SPINAL CORD INJ, V5, P83; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; [No title captured]	24	24	24	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2004	18	12					1297	1308		10.1080/02699050410001672288			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	871BW	WOS:000225105300010	15666572				2022-02-06	
J	Svendsen, HA; Teasdale, TW; Pinner, M				Svendsen, HA; Teasdale, TW; Pinner, M			Subjective experience in patients with brain injury and their close relatives before and after a rehabilitation programme	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							SELF-AWARENESS; HEAD-INJURY; FAMILY; PERFORMANCE; DYSFUNCTION; RECOVERY; OUTCOMES	This study reports results from 143 adult patients with cerebrovascular accident, traumatic brain injury or other acquired brain injury who underwent a neuropsychologically-based post-acute rehabilitation programme. Immediately pre- and post-programme, patients, as well as close relatives, completed the European Brain Injury Questionnaire (EBIQ) regarding patient symptoms, together with the impact of injury on the relative. Results for the three groups of patients were compared to those of 64 control subjects without brain injury. There were three major findings. First, significantly higher levels of symptoms were found in the patient groups at pre-programme evaluation, compared to the control group.Within the patient groups there were comparatively few differences between the self-reports of the patients and the reports of their relatives. Second, the patients showed significantly reduced levels of symptoms post-programme, both in their self-reports and in their relatives' reports. These levels remained however above those of the control group. Third, the reported impact of the injury to the patient upon their relatives was significantly reduced post-programme. Thus, this study further documents that patient symptoms, and the impact of these on close relatives, may be broadly reduced, but perhaps not eliminated, as a result of neuropsychological rehabilitation.	Univ Copenhagen, Ctr Rehabil Brain Injury, DK-2300 Copenhagen S, Denmark; Univ Copenhagen, Dept Psychol, DK-1168 Copenhagen, Denmark		Svendsen, HA (corresponding author), Univ Copenhagen, Ctr Rehabil Brain Injury, Njalsgade 88, DK-2300 Copenhagen S, Denmark.	aaby@cfh.ku.dk					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Bond M R, 1975, Ciba Found Symp, P141; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1984, CLOSED HEAD INJURY P; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burgess P, 1996, BEHAV ASSESSMENT DYS; CHRISTENSEN AL, 1988, NEUROPSYCHOL REHABIL, P115; ELSASS P, 1993, SUNDHEDSPSYKOLOGI; ENGBERG A, 1995, ACTA NEUROLOGICA S S, V164; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Fleminger S, 1999, NEUROPSYCHOL REHABIL, V9, P225, DOI 10.1080/096020199389338; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; HOWELL DC, 2001, FUNDAMENTAL STAT BEH; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Stilwell P, 1999, NEUROPSYCHOL REHABIL, V9, P277, DOI 10.1080/096020199389374; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale T W, 1995, Appl Neuropsychol, V2, P116; Teasdale TW, 1997, BRIT MED J, V315, P569; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TREXLER LE, 1996, AMBULANTE TEILSTATIO, P25; Voogt RD, 1998, NEUROREHABILITATION, V11, P107, DOI 10.1016/S1053-8135(98)00015-8; Wade D, 1992, MEASUREMENT NEUROLOG; Willer B, 2001, BRAIN DAM B, P47; Williams WH, 1999, NEUROPSYCHOL REHABIL, V9, P421, DOI 10.1080/096020199389482; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	47	24	24	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2004	14	5					495	515		10.1080/09602010343000318			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	863AY	WOS:000224533800002					2022-02-06	
J	Sribnick, EA; Ray, SK; Banik, NL				Sribnick, EA; Ray, SK; Banik, NL			Estrogen as a multi-active neuroprotective agent in traumatic injuries	NEUROCHEMICAL RESEARCH			English	Article						estrogen; development; apoptosis; oxidative stress; neurotrauma	SPINAL-CORD-INJURY; PRIMARY CORTICAL-NEURONS; NF-KAPPA-B; RECEPTOR-ALPHA; LIPID-PEROXIDATION; OXIDATIVE STRESS; BRAIN-INJURY; INFLAMMATORY RESPONSE; HIPPOCAMPAL-NEURONS; LEUKOCYTE ADHESION	In the past decade, research has demonstrated that estrogen's role in physiology and development is far more complicated than previously assumed. Among these discoveries, there has been an increased recognition of the impact estrogen has in neurodevelopment, central nervous system physiology, and neuropathophysiology. These observations have led many researchers to consider using estrogen pharmacotherapeutically, at physiologic or supraphysiologic doses, for a variety of injury and toxicity models. In this short review, the effects of estrogen as an anti-apoptotic agent, as an anti-oxidant, and as an anti-inflammatory agent are discussed. Finally, the possibility of using estrogen as a neuroprotectant in neurotrauma is addressed.	Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA		Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurol, 96 Johnathan Lucas St,Suite 309, Charleston, SC 29425 USA.	baniknl@musc.edu	Sribnick, Eric/AAH-6693-2020		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA091460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038146, R01NS031622, R01NS045967, R01NS041088] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA-91460] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM08716] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-41088, R01 NS-45967, R01 NS-38146, R01 NS-31622] Funding Source: Medline		Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Anderson Aileen J, 2002, J Spinal Cord Med, V25, P70; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Bimonte HA, 1999, PSYCHONEUROENDOCRINO, V24, P161, DOI 10.1016/S0306-4530(98)00068-7; BIRK K, 1986, ARCH NEUROL-CHICAGO, V43, P719, DOI 10.1001/archneur.1986.00520070075022; Bomstein Y, 2003, J NEUROIMMUNOL, V142, P10, DOI 10.1016/S0165-5728(03)00260-1; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Burke KA, 2000, J NEUROSCI RES, V61, P329, DOI 10.1002/1097-4547(20000801)61:3<329::AID-JNR11>3.0.CO;2-A; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chaban VV, 2003, NEUROSCIENCE, V118, P941, DOI 10.1016/S0306-4522(02)00915-6; Clarke CH, 2000, NEUROENDOCRINOLOGY, V71, P34, DOI 10.1159/000054518; Cordey M, 2003, J NEUROCHEM, V84, P1340, DOI 10.1046/j.1471-4159.2003.01631.x; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fiore C, 2004, J NEUROSCI RES, V75, P391, DOI 10.1002/jnr.10821; Gollapudi L, 1999, J NEUROSCI RES, V56, P471, DOI 10.1002/(SICI)1097-4547(19990601)56:5<471::AID-JNR3>3.3.CO;2-T; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green P S, 2000, Novartis Found Symp, V230, P202, DOI 10.1002/0470870818.ch15; Green P.S., 2000, NOVART FDN SYMP, V230, P213; Green PS, 1998, NEUROSCIENCE, V84, P7, DOI 10.1016/S0306-4522(97)00595-2; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hendriks JJA, 2003, BIOCHEM PHARMACOL, V65, P877, DOI 10.1016/S0006-2952(02)01609-X; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Hosoda T, 2001, NEUROREPORT, V12, P1965, DOI 10.1097/00001756-200107030-00038; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Islamov RR, 2002, BRAIN RES, V943, P283, DOI 10.1016/S0006-8993(02)02827-5; JACOBS D, 1995, J INT NEUROPSYCH SOC, V1, P131; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Koc RK, 1999, SPINAL CORD, V37, P29, DOI 10.1038/sj.sc.3100732; Koski CL, 2004, ENDOCRINOLOGY, V145, P95, DOI 10.1210/en.2003-0803; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Mermelstein PG, 1996, J NEUROSCI, V16, P595; MONROE DG, MOL ENDOCRINOL, V16, P1322; Nakamizo T, 2000, NEUROREPORT, V11, P3493, DOI 10.1097/00001756-200011090-00019; Nomura M, 2003, MOL BRAIN RES, V110, P7, DOI 10.1016/S0169-328X(02)00544-2; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Polanczyk M, 2003, AM J PATHOL, V163, P1599, DOI 10.1016/S0002-9440(10)63516-X; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Prokai L, 2003, P NATL ACAD SCI USA, V100, P11741, DOI 10.1073/pnas.2032621100; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Robertson DMW, 2001, NEUROLOGY, V57, P2114, DOI 10.1212/WNL.57.11.2114; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Santizo RA, 2000, STROKE, V31, P2231, DOI 10.1161/01.STR.31.9.2231; Santizo RA, 2002, STROKE, V33, P613, DOI 10.1161/hs0202.102363; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Singer CA, 1999, J NEUROSCI, V19, P2455; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; SRIBNICK EA, 2003 M SOC NEUR; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Sudoh N, 2001, CIRCULATION, V103, P724; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Tiidus PM, 2001, CAN J PHYSIOL PHARM, V79, P400, DOI 10.1139/cjpp-79-5-400; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wang L, 2003, P NATL ACAD SCI USA, V100, P703, DOI 10.1073/pnas.242735799; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Xie LP, 2002, EUR J IMMUNOL, V32, P2837, DOI 10.1002/1521-4141(2002010)32:10<2837::AID-IMMU2837>3.0.CO;2-V; Young W, 1985, Cent Nerv Syst Trauma, V2, P109	77	24	24	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2004	29	11					2007	2014		10.1007/s11064-004-6874-0			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	876ZS	WOS:000225538200008	15662835				2022-02-06	
J	Denes, Z				Denes, Z			The influence of severe malnutrition on rehabilitation in patients with severe head injury	DISABILITY AND REHABILITATION			English	Article								Objective: The purpose of the study was to evaluate the consequences of severe malnutrition in patients with severe head injury during rehabilitation. Patients and methods: The data were collected from medical records of patients admitted to the neurorehabilitation unit over the last 5 years. Twenty of 1850 patients had severe malnutrion, the body mass index (BMI) of these patients were under 15 (10 - 14) kg/m(2). The majority of patients suffered traumatic brain damage (17/20). Thirteen patients arrived with percutaneous endoscopic gastrotomy / PEG, three nasogastric tube in 3 cases we placed PEG. The nutritional strategy included a high-calorie diet, by means of bolus feeding five times during the day, continuous feeding during the night; the daily intake target being more than 2500 kcal. Results: During rehabilitation treatment the majority of patients (13/20) revealed weight gain with a rate of 0.5-2 kg/week. The following complications were treated during the rehabilitation phase: 20 pressure sores, 20 contractures, 11 urinal infections, 6 cases of pneumonia, 2 of purulent bronchitis, 6 of sepsis, 1 penoscrotal abscess, epidydymitis, and 1 case of purulent arthritis. The patients required total assistance at the time of admission. At discharge 10 patients remained completely dependent, 6 patients needed minimal assistance, and 4 patients could perform daily activities independently. The average length of stay in our unit was 78/6 - 150/days. Conclusion: Patients with head injury suffering from severe malnutrition exhibit serious complications at the time of admission as well as during rehabilitation treatment. The patients were very difficult to mobilize. The length of stay at the rehabilitation unit was 28 days longer when complicated by malnutrition, than head injuries showing normal nutritional status. These findings underline the importance of adequate nutrition in patients with head injury in both the acute ward and in the rehabilitation unit.	Natl Inst Med Rehabil, H-1528 Budapest, Hungary		Denes, Z (corresponding author), Natl Inst Med Rehabil, 12 Szanatorium 19, H-1528 Budapest, Hungary.	z.denes@rehabint.hu	Denes, Zoltan/ABD-3470-2021				Annoni JM, 1998, DISABIL REHABIL, V20, P308, DOI 10.3109/09638289809166086; Brooke MM, 1989, J NEUROL REHABIL, V3, P27; DENES Z, 1997, REHABILITACIO, V7, P2; MAHONEY F I, 1965, Md State Med J, V14, P61; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; WEEKES E, 1996, JPEN, V24, P31; [No title captured]	8	24	26	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 7	2004	26	19					1163	1165		10.1080/09638280412331270380			3	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	852QR	WOS:000223772000007	15371030				2022-02-06	
J	Dedoukou, X; Spyridopoulos, T; Kedikoglou, S; Alexe, DM; Dessypris, N; Petridou, E				Dedoukou, X; Spyridopoulos, T; Kedikoglou, S; Alexe, DM; Dessypris, N; Petridou, E			Incidence and risk factors of fall injuries among infants	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							YOUNG-CHILDREN; ABUSE	Objective: To assess the incidence of fall injuries among infants in Greece, overall and by type of nursery equipment. Design: Review of data from a large injury database. Setting: The Emergency Department Injury Surveillance System in Greece. Patients: A total of 2672 injured infants. Interventions: Specially trained health visitors performed in-person interviews with the children's guardians, using a preceded questionnaire. The results of an independent survey of 777 mothers of noninjured children younger than 2 years attending the same emergency departments were used to allow quantification of the role of specific nursery equipment in the causation of infant fall injuries. Main Outcome Measures: Annual rate of injury by falling in infants, overall and by cause. Results: About 4400 infant fall injuries occur annually in Greece, corresponding to an annual incidence rate of 44 injuries per 1000 infants. The incidence of falls increases with increasing infant age. A high percentage of severe injuries was detected, most of them concussions (14.3%) and fractures (9.4%). Approximately 10% of infants with fall-related injuries required hospitalization. More than 36% of fall injuries involved nursery equipment. Infant walker use was associated with a higher incidence of falls (about 9 per 1000 infant-years), and these falls occasionally involved stairs and caused serious injuries. Infant bouncers, strollers, and changing tables were all associated with a similar incidence of falls (about 4 per 1000 infant-years). Conclusions: Falls are a common cause of serious infant injuries, and nursery equipment is frequently involved in the injury-causing event.	Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens 11527, Greece; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA		Petridou, E (corresponding author), Univ Athens, Sch Med, Dept Hyg & Epidemiol, 75 Mikras Asias Str, Athens 11527, Greece.	epetrid@med.uoa.gr		PETRIDOU, ELENI/0000-0003-3695-3439			[Anonymous], Leading Causes of Death in Africa 2019 j Statista; Bull MJ, 2001, PEDIATRICS, V108, P790, DOI 10.1542/peds.108.3.790; CHIAVIELLO CT, 1994, PEDIATRICS, V93, P974; Conners GP, 2002, PATIENT EDUC COUNS, V46, P169, DOI 10.1016/S0738-3991(01)00210-5; DALTON HJ, 1990, AM J DIS CHILD, V144, P875, DOI 10.1001/archpedi.1990.02150320039022; Dessypris N, 2002, J Cancer Epidemiol Prev, V7, P123; Emanuelson I, 2003, Inj Control Saf Promot, V10, P139, DOI 10.1076/icsp.10.3.139.14553; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kypri K, 2001, J PAEDIATR CHILD H, V37, P603, DOI 10.1046/j.1440-1754.2001.0776b.x; Macgregor D M, 2000, Inj Prev, V6, P291, DOI 10.1136/ip.6.4.291; Mathers LJ, 1998, ACAD EMERG MED, V5, P1064, DOI 10.1111/j.1553-2712.1998.tb02663.x; Mayr JM, 1999, ACTA PAEDIATR, V88, P319, DOI 10.1080/08035259950170105; *NAT CTR INJ PREV, 2001, UN FALL DEATHS RAT 1; *NAT STAT SERV GRE, 1998, NAT MOV POP GREEC, P129; Petridou E, 1996, Inj Prev, V2, P118, DOI 10.1136/ip.2.2.118; Powell EC, 2002, AMBUL PEDIATR, V2, P276, DOI 10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2; Ridenour MV, 1999, PERCEPT MOTOR SKILL, V88, P669; SHENDUT IH, 1995, MED J MALAYSIA, V50, P192; Smith GA, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.2.e1; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; THOMAS SA, 1991, PEDIATRICS, V88, P471; Trogan I, 2001, ARCH DIS CHILD, V85, P289, DOI 10.1136/adc.85.4.289; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x; Wickham T, 2002, ARCH DIS CHILD, V86, P168, DOI 10.1136/adc.86.3.168; World Health Organization, 2003, WORLD HLTH REP 2002, V1; World Health Organization, WHO STAT INF SYST WH; 10 LEADING CAUSES HO; FALL PREVENTION CHIL; FALL PREVENTION INFA	29	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	1072-4710	1538-3628		ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	OCT	2004	158	10					1002	1006		10.1001/archpedi.158.10.1002			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	859PA	WOS:000224279200010	15466690	Bronze, Green Accepted			2022-02-06	
J	Vink, R; Donkin, JJ; Cruz, MI; Nimmo, AJ; Cernak, L				Vink, R; Donkin, JJ; Cruz, MI; Nimmo, AJ; Cernak, L			A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats	JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION			English	Article						brain trauma; brain Mg; inflammation; functional outcome; rats; substance P-antagonist	NEUROKININ; EDEMA	Objective: Magnesium (Mg) deficiency has been shown to increase substance P release and induce a pro-inflammatory response that can be attenuated with the administration of a substance P-antagonist. Neurogenic inflammation has also been implicated in traumatic brain injury (TBI), a condition where brain intracellular free magnesium (Mg-f) decline is known to occur and has been correlated with functional outcome. We therefore examined whether a substance P antagonist restores brain intracellular free magnesium concentration following TBI. Methods: Male, adult Sprague-Dawley rats were injured using. the Cernak impact acceleration model of diffuse TBI. At 30 min after injury, animals were administered either 0.25 mg/kg i.v. n-acetyl tryptophan or equal volume saline. Prior to and 4 h after induction of injury, phosphorus magnetic resonance spectra were acquired using a 7-tesla magnet interfaced with a Broker console. Mgf was calculated from the chemical shift of the beta ATP. Before injury, Mgf was 0.51 +/- 0.05 mM (SEM). Results: By 4 hr after injury, Mgf had significantly declined to 0.27 +/- 0.02 mM in saline treated rats. In contrast, rats treated with n-acetyl tryptophan had a Mgf of 0.47 +/- 0.06 mM at 4 h after injury, which was not significantly different from preinjury values. There were no significant differences in pH between the treatment groups. Conclusion: It seems that any beneficial effect of a substance P antagonist on functional outcome following TBI may be related to improvement in brain Mg homeostasis induced by the compound.	Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; James Cook Univ N Queensland, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; Georgetown Univ, Dept Neurosci, Washington, DC USA		Vink, R (corresponding author), Univ Adelaide, Dept Pathol, GPO Box 498, Adelaide, SA, Australia.	Robert.vink@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X; Nimmo, Alan/0000-0002-0718-7934			Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bereiter DA, 1998, NEUROSCIENCE, V83, P525, DOI 10.1016/S0306-4522(97)00433-8; CERNAK I, 2004, IN PRESS NEUROBIOL D; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; Hasenohrl RU, 2000, NEUROPEPTIDES, V34, P272, DOI 10.1054/npep.2000.0824; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x; HUSTON JP, 1995, BEHAV BRAIN RES, V66, P117, DOI 10.1016/0166-4328(94)00132-Y; Kramer JH, 1997, J MOL CELL CARDIOL, V29, P97, DOI 10.1006/jmcc.1996.0255; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Murck H, 2002, NUTR NEUROSCI, V5, P375, DOI 10.1080/1028415021000039194; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Parker D, 1998, J NEUROSCI, V18, P4800; Rupniak NMJ, 1999, TRENDS PHARMACOL SCI, V20, P485, DOI 10.1016/S0165-6147(99)01396-6; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 2000, REST NEUROL NEUROSCI, V16, P164; VINK R, 2002, EXPERT OPIN INV DRUG, V11, P1; WALSH DT, 1995, BRIT J PHARMACOL, V114, P1343, DOI 10.1111/j.1476-5381.1995.tb13354.x	23	24	24	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0731-5724	1541-1087		J AM COLL NUTR	J. Am. Coll. Nutr.	OCT	2004	23	5					538S	540S		10.1080/07315724.2004.10719398			3	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	863AF	WOS:000224531900019	15466960				2022-02-06	
J	Crookes, BA; Cohn, SM; Bonet, H; Burton, EA; Nelson, J; Majetschak, M; Varon, AJ; Linden, JM; Proctor, KG				Crookes, BA; Cohn, SM; Bonet, H; Burton, EA; Nelson, J; Majetschak, M; Varon, AJ; Linden, JM; Proctor, KG			Building a better fluid for emergency resuscitation of traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 11-13, 2003	MINNEAPOLIS, MN	Amer Assoc Surg Trauma		Hemorrhagic Shock; adenosine; ATL-146e; A2A receptor; Hextend Swine	ADENOSINE RECEPTOR AGONISTS; SPINAL-CORD ISCHEMIA; REPERFUSION INJURY; HEMORRHAGIC-SHOCK; REDUCES PARALYSIS; A(2A) AGONIST; SALINE; PROTECTION; RABBIT; INFLAMMATION	Hextend (HEX) is a colloid solution that is FDA-approved for volume expansion during surgery. ATL-146e is a novel adenosine A2A receptor agonist that has anti-inflammatory, neuroprotective, and coronary vasodilator properties. Three series of experiments were designed to evaluate the therapeutic potential of HEX ATL-146e for emergency resuscitation from traumatic brain injury (TBI) + hemorrhagic hypotension. Methods: In the first two studies in vivo, anesthetized, ventilated pigs (30-45 kg) received a fluid percussion TBI, 45% arterial hemorrhage, and 30 minutes shock period. In Series 1, resuscitation consisted of unlimited crystalloid (n = 8) or HEX (n = 8) to correct systolic arterial pressure > 100 mm Hg and heart rate < 100 bpm for the first 60 minutes ("emergency phase"), and then maintain cerebral perfusion pressure (CPP) > 70 mm Hg for 60-240 minutes. In Series 2 (n = 31), resuscitation consisted of a 1 L bolus of HEX + ATL-146e (10 ng/kg/min, n = 10) or HEX +placebo (n = 10) followed by crystalloid to the same endpoints. In Series 3 in vivo, the hemodynamic response evoked by 0, 10, 50, or 100 ng/kg/min ATL-146e was measured before or 60 minutes after HEX resuscitation from 45% hemorrhage. Results: Following TBI+hemorrhage, there were 4/22 deaths in series 1 and 11/31 deaths in series 2. In those alive at 30 minutes, mean arterial pressure, cardiac index, mixed venous 02 saturation, and cerebral venous 0, saturation were all reduced by 40-60%, while heart rate and lactate were increased 2-5 fold. With no resuscitation (n = 2), there was minimal hemodynamic compensation and progressive acidosis. Upon resuscitation, these values corrected but intracranial pressure progressively rose from <5 nun Hg to 15-20 nun Hg. Series 1: With HEX m = 8) versus crystalloid (n = 8), CPP was less labile, acid/base was maintained, and the fluid requirement was reduced by 60% (all p < 0.05) Series 2: With ATL-146e (n = 10) versus placebo (n = 10), stroke volume and cardiac output were improved by 40-60%, and the fluid requirement was reduced by 30% (all p < 0.05). Series 3: ATL-146e caused a dose-related increase (p < 0.05) in stroke volume after, but not before, hemorrhage. The effects on preload, afterload, and heart rate were similar before and after hemorrhage. Conclusions: HEX alone is a safe and efficacious low volume alternative to initial crystalloid resuscitation after TBI. An adenosine A2A agonist combined with I L of HEX safely and effectively counteracted a decrease in cardiac performance noted after TBI + hemorrhage without causing hypotension or bradycardia.	Univ Miami, Sch Med, Dept Surg, Div Trauma, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Surg, Div Surg Crit Care, Miami, FL USA; Univ Miami, Sch Med, Dept Anesthesiol, Miami, FL USA; Univ Miami, Sch Med, Dept Med, Miami, FL USA; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA		Proctor, KG (corresponding author), Univ Miami, Sch Med, Dept Surg, Div Trauma, Miami, FL 33101 USA.	kproctor@miami.edu	Proctor, Kenneth/AAA-2199-2022; Linden, Joel/AAH-5690-2020	Proctor, Kenneth/0000-0003-1326-6628; 			Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Bowen TE, 1988, EMERGENCY WAR SURG; *BRAIN TRAUM FDN, GUID PREH MAN TRAUM; Cassada DC, 2002, J VASC SURG, V35, P994, DOI 10.1067/mva.2002.123091; Cassada DC, 2002, J TRAUMA, V53, P225, DOI 10.1097/00005373-200208000-00005; Cassada DC, 2001, ANN THORAC SURG, V72, P1245, DOI 10.1016/S0003-4975(01)03057-0; Cassada DC, 2001, J VASC SURG, V34, P482, DOI 10.1067/mva.2001.117996; Cassada DC, 2001, SURGERY, V130, P230, DOI 10.1067/msy.2001.115838; Cassada DC, 2002, ANN THORAC SURG, V74, P846, DOI 10.1016/S0003-4975(02)03793-1; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fabian MJ, 2002, J TRAUMA, V53, P864, DOI 10.1097/00005373-200211000-00010; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; Glover DK, 2001, CIRCULATION, V104, P1181, DOI 10.1161/hc3601.093983; Hartl R, 1997, ACT NEUR S, V70, P126; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; KING DR, IN PRESS SURGERY; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MAZZONI MC, 1990, CIRC SHOCK, V31, P407; McPherson JA, 2001, ARTERIOSCL THROM VAS, V21, P791, DOI 10.1161/01.ATV.21.5.791; MENASCHE P, 1995, J THORAC CARDIOV SUR, V110, P1096, DOI 10.1016/S0022-5223(05)80179-5; Murphree LJ, 2002, MOL PHARMACOL, V61, P455, DOI 10.1124/mol.61.2.455; Obata T, 2002, LIFE SCI, V71, P2083, DOI 10.1016/S0024-3205(02)01993-8; Ongini E, 2001, FARMACO, V56, P87, DOI 10.1016/S0014-827X(01)01024-2; Peirce SM, 2001, AM J PHYSIOL-HEART C, V281, pH67, DOI 10.1152/ajpheart.2001.281.1.H67; POPE A, 1999, FLUID RES STAT SCI T; Rieger JM, 2001, J MED CHEM, V44, P531, DOI 10.1021/jm0003642; Riou LM, 2002, J AM COLL CARDIOL, V40, P1687, DOI 10.1016/S0735-1097(02)02372-0; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wilkes NJ, 2002, ANESTH ANALG, V94, P538, DOI 10.1097/00000539-200203000-00011; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003	37	24	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2004	57	3					547	554		10.1097/01.TA.0000135162.85859.4C			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	859YH	WOS:000224303800017	15454801				2022-02-06	
J	Melo, JRT; da Silva, RA; Moreira, ED				Melo, JRT; da Silva, RA; Moreira, ED			Characteristics of patients with head injury at Salvador City (Bahia - Brazil)	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						head injury; epidemiology; morbidity; mortality	TRAUMATIC BRAIN INJURY; EPIDEMIOLOGY	Objective: To describe the characteristics from people with head injury at Salvador city, as well, to point out the most frequent age groups, their disabilities and lethality rates. Method: Assessment and notification of 555 medical files from victims with head injury assisted at the General Hospital of Bahia during 2001. Results: 82.9% from all victims were male and 17.1% female; the most frequent age group was 21 to 30 years; the most relevant cause of head injury was traffic accident (40.7%), followed by physical violence with or without weapons (25.4%) and falls (24%). Conclusion: The most evident profile group involved in accidents with head trauma implications was young male that usually had traffic injuries, with expressive rates of disabilities and lethality.	Hosp Sao Rafael, BR-41256900 Salvador, BA, Brazil; Hosp Geral Estado Bahia, Salvador, BA, Brazil; Univ Fed Bahia, Curso Pos Grad Med & Saude, Salvador, BA, Brazil; Univ Sao Paulo, BR-05508 Sao Paulo, Brazil		Melo, JRT (corresponding author), Hosp Sao Rafael, Ave Sao Rafael 2152,3 Andar,Setor A, BR-41256900 Salvador, BA, Brazil.	robertotude@hotmail.com	Moreira, Edson D/J-1758-2012; Moreira, Edson/W-7437-2019	Moreira, Edson D/0000-0002-7081-8348; Moreira, Edson/0000-0002-7081-8348			ANDRADE AF, 2003, ORIENTACAO AOS FAMIL; ANDRIS JS, 1996, ANTIBODIES, V2, P1; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Basso A, 2001, WORLD J SURG, V25, P1174; Bordignon KC, 2002, ARQ NEURO-PSIQUIAT, V60, P204, DOI 10.1590/S0004-282X2002000200004; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Eker C, 2000, BRAIN INJURY, V14, P605; FARAGE L, 2002, REV ASSOC MED BRAS, V48, P133; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FONSECA A, 2002, J TARDE CADERNO 01; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; *I BRAS GEOGR EST, 2002, RES U CENS 2000 DISP; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KOIZUME MS, 2000, ARQ NEURO-PSIQUIAT, V58, P1; KRUASS JF, 1996, NEUROLOGY TRAUMA, P3; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MASINI M, 1994, THESIS U FEDERAL SAO; Mattos P, 2002, ARQ NEURO-PSIQUIAT, V60, P319, DOI 10.1590/S0004-282X2002000200027; Melo JRT, 2003, CIENCIA SAUDE, V3, P31; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; TEASDALE G, 1974, LANCET, V2, P81; van der Sluis CK, 1998, INJURY, V29, P281, DOI 10.1016/S0020-1383(97)00199-X	22	24	31	0	5	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2004	62	3A					711	714		10.1590/S0004-282X2004000400027			4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	853AV	WOS:000223799400027	15334236	Green Submitted, Green Published, gold			2022-02-06	
J	Orme, DR; Johnstone, B; Hanks, R; Novack, T				Orme, DR; Johnstone, B; Hanks, R; Novack, T			The WRAT-3 reading subtest as a measure of premorbid intelligence among persons with brain injury	REHABILITATION PSYCHOLOGY			English	Article							PRACTICAL SCALE; IQ	Objective: To examine whether the Wide Range Achievement Test-3 (WRAT-3) Reading subtest (S. Jastak & G. S. Wilkenson, 1984; G. S. Wilkinson, 1993) measures premorbid intelligence in persons with traumatic brain injury (TBI). Participants: Sixty individuals (63% male, 78% Caucasian, mean age = 38 years) tested during acute rehabilitation hospitalization following TBI and I year later. Results: Slight (4.4 points) increase in WRAT-3 Reading scores was observed but with greater, although nonsignificant (p = .12), increase for those with greater injury severity. Conclusions: The WRAT-3 Reading subtest is a better hold test for individuals who sustain mild TBI.	Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; Inst Rehabil, Detroit, MI USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA		Orme, DR (corresponding author), Univ Missouri, Dept Hlth Psychol, 1 Hosp Dr,DC 046-46, Columbia, MO 65212 USA.	ormed@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; KAREKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147, DOI 10.1016/0887-6177(94)E0012-E; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Orme D, 2001, ARCH CLIN NEUROPSYCH, V16, P679, DOI 10.1016/S0887-6177(00)00091-3; REITAN R, 1985, HALSTEAD REITAN NEUO; Reynolds C. R., 1997, ARCH CLIN NEUROPSYCH, V12; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1987, MANUAL WECHSLER MEMO; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889; Wilkinson, 1984, WIDE RANGE ACHIEVEME; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	14	24	24	0	2	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2004	49	3					250	253		10.1037/0090-5550.49.3.250			4	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	847BX	WOS:000223364900008					2022-02-06	
J	Kneafsey, R; Gawthorpe, D				Kneafsey, R; Gawthorpe, D			Head injury: long-term consequences for patients and families and implications for nurses	JOURNAL OF CLINICAL NURSING			English	Article						brain injury; narrative review; nursing	TRAUMATIC BRAIN-INJURY; PERCEPTIONS; DISABILITY	Background. Head injury as a result of trauma is an important cause of long-term disability. Recently published guidance from the National Institute for Clinical Excellence on Acute Head Injuries and a forthcoming National Service Framework for Long-Term Neurological Conditions provides renewed focus on this practice speciality. Aims and objectives. This article presents a narrative review of a range of quantitative and qualitative studies that have explored the impact of head injury and postinjury disabilities on patients' and families lives. Results. Patients may experience a range of physical, emotional, cognitive, social and behavioural problems after head injury that will have a significant impact on both their own and their families' everyday lives. It is important that the behavioural, physical and psychological aspects of head injury are addressed. Carers may be vulnerable to stress and anxiety as a result of their caring role. Conclusions. It is often in the longer term that the true complexity and impact of head injury may become apparent. Ongoing support, from a range of services, will be required to assist both patient and family to cope with their circumstances. Ensuring that practice is evidence based, it is necessary to conduct further research, both to explore the effectiveness of current service provision and investigate those aspects deemed important by patients and carers. Relevance to clinical practice. As nurses play an important role in both the acute and long-term care and support of those who have suffered a head injury, it is vital that they are aware of the wide ranging needs with which patients and families may present.	Univ Salford, Sch Nursing, Manchester M30 ONN, Lancs, England		Kneafsey, R (corresponding author), Univ Salford, Sch Nursing, Peel House,Albert St, Manchester M30 ONN, Lancs, England.	r.kneafsey@salford.ac.uk					Acorn S., 1993, CANADIAN J REHABILIT, V7, P149; ANNELLS M, 1999, NURSE RES, V6, P5; BLACK N, 1994, J EPIDEMIOL COMMUN H, V48, P425, DOI 10.1136/jech.48.5.425-a; BLOSSER J, 1995, J HEAD TRAUMA REHAB, V10, P46, DOI 10.1097/00001199-199504000-00006; BREWIN J, 2001, BRIT J THERAPY REHAB, V8, P218; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Chesnut R.M., 1999, REHABILITATION TRAUM, P1; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; *CRIT REV ADV GROU, 1996, INTRO SYST REV SCH H; DARRACH W, 2000, J NEUROSURGICAL PSYC, V68, P8; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Davies C, 2000, BRIT J THERAPY REHAB, V7, P521; *DEP HLTH, 2001, NURS CONTR PROV COMP; *DEP HLTH, 2001, GOV RESP HLTH SEL CO; *DEP HLTH, 1996, HIDD DIS REP SSI TRA; Department of Health, 2000, COMPR CRIT CAR REV A; FLEMINGER S, 2003, COCHRANE LIB; GRAVELL R, 2002, HEAD INJURY REHABILI; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hassan N, 2002, CLIN REHABIL, V16, P534, DOI 10.1191/0269215502cr523oa; HEMMINGWAY S, 1997, NURSING STANDARD, V12, P40; Hodgkinson D W, 1994, Eur J Emerg Med, V1, P9, DOI 10.1097/00063110-199403000-00003; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, LANCET, V1, P1031; Johnson D, 1999, J HYDROL ENG, V4, P117, DOI 10.1061/(ASCE)1084-0699(1999)4:2(117); Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Long AF, 2002, J ADV NURS, V37, P70, DOI 10.1046/j.1365-2648.2002.02059.x; Long AF, 2002, NURS EDUC TODAY, V22, P136, DOI 10.1054/nedt.2001.0671; LONG AF, 2001, RES REPORTS SERIES N, V19; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MCDOWELL I, 1995, CLIN REHABIL, V9, P150; Mead D., 2001, NURSE RES, V8, P4, DOI DOI 10.7748/NR2001.07.8.4.4.C6162; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; *NAT I CLIN EXC, 2003, HEAD INJ TRIAG ASS I; *NHS EX, 1997, REH GUID HOLD REP; Nichols KA, 1993, PSYCHOL CARE PHYS IL; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; PICKETHAUBER R, 2000, J NEUROSCIENCE NURSI, V32, P22; Polgar S., 1995, INTRO RES HLTH SCI; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; *ROYAL COLL SURG, 1999, WORK PART MAN PAT HE; SANTBRINK H, 1996, NEUROSURGERY, V38, P21; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SULLIVAN J, 2000, J NEUROSCIENCE NURSI, V32, P4; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; WESTCOTT E, 1998, NURSING TIMES RES, V3, P421; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]	55	24	24	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	JUL	2004	13	5					601	608		10.1111/j.1365-2702.2004.00903.x			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	827VV	WOS:000221932700009	15189413				2022-02-06	
